PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zakaria, A; Berthault, C; Cosson, B; Jung, V; Guerrera, IC; Rachdi, L; Scharfmann, R				Zakaria, Albatoul; Berthault, Claire; Cosson, Bertrand; Jung, Vincent; Guerrera, Ida Chiara; Rachdi, Latif; Scharfmann, Raphael			Glucose treatment of human pancreatic beta-cells enhances translation of mRNAs involved in energetics and insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROINSULIN BIOSYNTHESIS; PROTEIN; PC2; MASS; PROLIFERATION; PATHOGENESIS; INHIBITION; CONVERTASE; PUROMYCIN	Glucose-mediated signaling regulates the expression of a limited number of genes in human pancreatic beta-cells at the transcriptional level. However, it is unclear whether glucose plays a role in posttranscriptional RNA processing or translational control of gene expression. Here, we asked whether glucose affects posttranscriptional steps and regulates protein synthesis in human beta-cell lines. We first showed the involvement of the mTOR pathway in glucose-related signaling. We also used the surface sensing of translation technique, based on puromycin incorporation into newly translated proteins, to demonstrate that glucose treatment increased protein translation. Among the list of glucose-induced proteins, we identified the proconvertase PCSK1, an enzyme involved in the proteolytic conversion of proinsulin to insulin, whose translation was induced within minutes following glucose treatment. We finally performed global proteomic analysis by mass spectrometry to characterize newly translated proteins upon glucose treatment. We found enrichment in proteins involved in translation, glycolysis, TCA metabolism, and insulin secretion. Taken together, our study demonstrates that, although glucose minorly affects gene transcription in human beta-cells, it plays a major role at the translational level.	[Zakaria, Albatoul; Berthault, Claire; Rachdi, Latif; Scharfmann, Raphael] Univ Paris, Inst Cochin, INSERM U1016, CNRS UMR 8104, Paris, France; [Cosson, Bertrand] Univ Paris, Epigenet & Cell Fate Ctr, CNRS UMR 7216, Paris, France; [Jung, Vincent; Guerrera, Ida Chiara] Univ Paris, Struct Federat Rech Necker, Plateforme Proteom Necker, INSERM US24 CNRS UMS3633, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rachdi, L; Scharfmann, R (corresponding author), Univ Paris, Inst Cochin, INSERM U1016, CNRS UMR 8104, Paris, France.	latif.rachdi@inserm.fr; raphael.scharfmann@inserm.fr	GUERRERA, Ida Chiara/GOJ-9151-2022	GUERRERA, Ida Chiara/0000-0002-4832-6793; Scharfmann, Raphael/0000-0001-7619-337X	IDEX University Paris; Agence Nationale de la Recherche (ANR BromoBeta); Innovative Medicines Initiative 2 Joint Undertaking Rhapsody - European Union's Horizon 2020 research and innovation program EFPIA [115881]; Swiss State Secretariat for Education Research, and Innovation (SERI) from the European Union's Seventh Framework Program (FP7/2007-2013) [16.0097]; Innovative Medicines Initiative 2 Joint Undertaking [115797, 945268]; Union's Horizon 2020 research and innovation program EFPIA; JDRF; Leona M. and Harry B. Helmsley Charitable Trust; Laboratoire d'Excellence consortium Revive; Fondation pour la Recherche Medicale [EQU201903007793]; Dutch Diabetes Research Foundation; DON Foundation; Fondation Francophone pour la Recherche sur le Diabetes (FFRD)	IDEX University Paris; Agence Nationale de la Recherche (ANR BromoBeta)(French National Research Agency (ANR)); Innovative Medicines Initiative 2 Joint Undertaking Rhapsody - European Union's Horizon 2020 research and innovation program EFPIA; Swiss State Secretariat for Education Research, and Innovation (SERI) from the European Union's Seventh Framework Program (FP7/2007-2013); Innovative Medicines Initiative 2 Joint Undertaking; Union's Horizon 2020 research and innovation program EFPIA; JDRF(Juvenile Diabetes Research Foundation); Leona M. and Harry B. Helmsley Charitable Trust; Laboratoire d'Excellence consortium Revive; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Dutch Diabetes Research Foundation; DON Foundation; Fondation Francophone pour la Recherche sur le Diabetes (FFRD)	The R. S. laboratory received funding from IDEX University Paris, Agence Nationale de la Recherche (ANR BromoBeta), the Innovative Medicines Initiative 2 Joint Undertaking Rhapsody under grant agreement no. 115881 supported by the European Union's Horizon 2020 research and innovation program EFPIA and the Swiss State Secretariat for Education Research, and Innovation (SERI) under contract number 16.0097, resources of which are composed of a financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013); and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 115797 (INNODIA) and no. 945268 (INNODIA HARVEST). This joint undertaking receives support from the Union's Horizon 2020 research and innovation program EFPIA, JDRF, and the Leona M. and Harry B. Helmsley Charitable Trust. The R. S. laboratory was also supported by the Laboratoire d'Excellence consortium Revive, Fondation pour la Recherche Medicale (EQU201903007793), the Dutch Diabetes Research Foundation, the DON Foundation, and Fondation Francophone pour la Recherche sur le Diabetes (FFRD).	ALARCON C, 1993, J BIOL CHEM, V268, P4276; Alarcon C, 2012, ENDOCRINOLOGY, V153, P2082, DOI 10.1210/en.2011-2019; Alvarez-Dominguez JR, 2020, CELL STEM CELL, V26, P108, DOI 10.1016/j.stem.2019.11.011; Beckelman BC, 2019, J CLIN INVEST, V129, P820, DOI 10.1172/JCI122954; Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Blanchet E, 2015, CELL REP, V10, P1149, DOI 10.1016/j.celrep.2015.01.046; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dadon D, 2012, DIABETES OBES METAB, V14, P101, DOI 10.1111/j.1463-1326.2012.01646.x; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Ikushima Y. M., 2021, DIABETES; Irminger JC, 1996, BIOCHEM J, V320, P11, DOI 10.1042/bj3200011; Jaafar R, 2019, J CLIN INVEST, V129, P4124, DOI 10.1172/JCI127021; Jing G, 2016, MOL METAB, V5, P1208, DOI 10.1016/j.molmet.2016.09.010; KAHN SE, 1995, DIABETES, V44, P173, DOI 10.2337/diabetes.44.2.173; Kobiita A, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107846; Kwon G, 2006, J BIOL CHEM, V281, P3261, DOI 10.1074/jbc.M508821200; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Marciano R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0056-x; Mastrolia V, 2017, DIABETES, V66, P897, DOI 10.2337/db16-0336; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyamoto-Sato E, 2000, NUCLEIC ACIDS RES, V28, P1176, DOI 10.1093/nar/28.5.1176; NATHANS D, 1964, P NATL ACAD SCI USA, V51, P585, DOI 10.1073/pnas.51.4.585; PESTKA S, 1971, ANNU REV MICROBIOL, V25, P487, DOI 10.1146/annurev.mi.25.100171.002415; Ramos-Molina B, 2016, PROG MOL BIOL TRANSL, V140, P47, DOI 10.1016/bs.pmbts.2015.12.001; Ramzy A, 2020, DIABETES, V69, P1451, DOI 10.2337/db19-0276; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Ravi Venkatraman, 2020, Curr Protoc Mol Biol, V133, pe127, DOI 10.1002/cpmb.127; Ravi V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22903-8; Richards P, 2018, DIABETES, V67, P461, DOI 10.2337/db17-0595; Roux PP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00070-18; Scharfmann R, 2016, DIABETES OBES METAB, V18, P128, DOI 10.1111/dom.12728; Scharfmann R, 2014, J CLIN INVEST, V124, P2087, DOI 10.1172/JCI72674; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schmidt SF, 2016, CELL REP, V16, P2359, DOI 10.1016/j.celrep.2016.07.063; SCOPSI L, 1995, J CLIN ENDOCR METAB, V80, P294, DOI 10.1210/jc.80.1.294; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Skelly RH, 1996, DIABETES, V45, P37, DOI 10.2337/diabetes.45.1.37; Stijnen P, 2016, ENDOCR REV, V37, P347, DOI 10.1210/er.2015-1117; Tran KA, 2019, J BIOL CHEM, V294, P5408, DOI 10.1074/jbc.TM118.000831; Truyen I, 2005, DIABETOLOGIA, V48, P2322, DOI 10.1007/s00125-005-1959-0; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Weir GC, 2020, LANCET DIABETES ENDO, V8, P249, DOI 10.1016/S2213-8587(20)30022-X; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	49	1	1	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100839	10.1016/j.jbc.2021.100839	http://dx.doi.org/10.1016/j.jbc.2021.100839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051232	gold, Green Published			2022-12-26	WOS:000678068400039
J	Sen, P; Majumdar, U; Zein, J; Hatipoglu, U; Attaway, AH				Sen, Payal; Majumdar, Uddalak; Zein, Joe; Hatipoglu, Umur; Attaway, Amy H.			Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic's COVID-19 registry	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NEW-YORK-CITY; PREVALENCE; ASTHMA; RISK; INFECTION; EPIDEMIOLOGY; POPULATION; MORTALITY; STRENGTH	Inhaled Corticosteroids (ICS) are commonly prescribed to patients with severe COPD and recurrent exacerbations. It is not known what impact ICS cause in terms of COVID-19 positivity or disease severity in COPD. This study examined 27,810 patients with COPD from the Cleveland Clinic COVID-19 registry between March 8th and September 16th, 2020. Electronic health records were used to determine diagnosis of COPD, ICS use, and clinical outcomes. Multivariate logistic regression was used to adjust for demographics, month of COVID-19 testing, and comorbidities known to be associated with increased risk for severe COVID-19 disease. Amongst the COPD patients who were tested for COVID-19, 44.1% of those taking an ICS-containing inhaler tested positive for COVID-19 versus 47.2% who tested negative for COVID-19 (p = 0.033). Of those who tested positive for COVID-19 (n = 1288), 371 (28.8%) required hospitalization. In-hospital outcomes were not significantly different when comparing ICS versus no ICS in terms of ICU admission (36.8% [74/201] vs 31.2% [53/170], p = 0.30), endotracheal intubation (21.9% [44/201] vs 16.5% [28/170], p = 0.24), or mortality (18.4% [37/201] vs 20.0% [34/170], p = 0.80). Multivariate logistic regression demonstrated no significant differences in hospitalization (adj OR 1.12, CI: 0.90-1.38), ICU admission (adj OR: 1.31, CI: 0.82-2.10), need for mechanical ventilation (adj OR 1.65, CI: 0.69-4.02), or mortality (OR: 0.80, CI: 0.43-1.49). In conclusion, ICS therapy did not increase COVID-19 related healthcare utilization or mortality outcome in patients with COPD followed at the Cleveland Clinic health system. These findings should encourage clinicians to continue ICS therapy for COPD patients during the COVID-19 pandemic.	[Sen, Payal; Majumdar, Uddalak; Zein, Joe; Hatipoglu, Umur; Attaway, Amy H.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Zein, Joe] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Attaway, AH (corresponding author), Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA.	attawaa@ccf.org		Attaway, Amy/0000-0003-1959-9773	National Institutes of Health -National Heart, Lung and Blood Institute [K08 HL133381]	National Institutes of Health -National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the National Institutes of Health -National Heart, Lung and Blood Institute Grant: K08 HL133381 (JZ).	[Anonymous], 2017, PNEUMOLOGIE, V71, P9; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Attaway AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100515; Aveyard P, 2021, LANCET RESP MED, V9, P909, DOI 10.1016/S2213-2600(21)00095-3; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Bhatt SP, 2013, TRANSL RES, V162, P237, DOI 10.1016/j.trsl.2013.05.001; Bloom CI, 2021, LANCET RESP MED, V9, P699, DOI 10.1016/S2213-2600(21)00013-8; Boose E, HOME MONITORING COVI; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Cantoli M, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00451-2017; Chatterjee Kshitij, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc059; Cheng VCC, 2020, INFECT CONT HOSP EP, V41, P493, DOI 10.1017/ice.2020.58; Cobb NL, 2021, ANN AM THORAC SOC, V18, P632, DOI 10.1513/AnnalsATS.202007-805OC; Cukic Vesna, 2012, Mater Sociomed, V24, P100, DOI 10.5455/msm.2012.24.100-105; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; FDA, 2020, EM US AUTH SUMM CLEV; Finney Lydia J, 2021, J Allergy Clin Immunol, V147, P510, DOI 10.1016/j.jaci.2020.09.034; Gerayeli FV, 2021, ECLINICALMEDICINE, V33, DOI 10.1016/j.eclinm.2021.100789; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Halpin DMG, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.01009-2020; Halpin DMG, 2020, LANCET RESP MED, V8, P436, DOI 10.1016/S2213-2600(20)30167-3; Han MK, 2007, AM J RESP CRIT CARE, V176, P1179, DOI 10.1164/rccm.200704-553CC; Heron Melonie, 2016, Natl Vital Stat Rep, V65, P1; Homma T, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56030098; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horwitz LI, 2021, J HOSP MED, V16, P90, DOI 10.12788/jhm.3552; Hosseini M, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1198-4; Nannini LJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006826.pub2; Jeon S, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00819-20; Johnston Sebastian L, 2005, Proc Am Thorac Soc, V2, P150, DOI 10.1513/pats.200502-018AW; Jones SE, 2015, THORAX, V70, P213, DOI 10.1136/thoraxjnl-2014-206440; Kiljander T, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.47; Kowalewski M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02925-3; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee JY, 2020, INT J INFECT DIS, V98, P462, DOI 10.1016/j.ijid.2020.07.017; Leung JM, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02108-2020; Li PF, 2021, INT J INFECT DIS, V102, P375, DOI 10.1016/j.ijid.2020.11.127; Liao SY, 2021, RESP MED, V176, DOI 10.1016/j.rmed.2020.106275; Marin BG, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2146; Matsuyama S, 2021, J VIROL, V95, DOI 10.1128/JVI.01648-20; Mehta N., 2020, JAMA CARDIOL, V5, P1020, DOI [DOI 10.1001/jamacardio.2020.1855, 10.1001/jamacardio.2020.1855]; Milinovich A, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.01.13; Oliver BGG, 2014, EUR RESPIR J, V44, P1666, DOI 10.1183/09031936.00047714; Organization WH, 2018, GLOB HLTH EST 2016 C; Park YJ, 2020, EMERG INFECT DIS, V26, P2465, DOI 10.3201/eid2610.201315; Peters MC, 2020, AM J RESP CRIT CARE, V202, P83, DOI 10.1164/rccm.202003-0821OC; Prescott E, 1997, EUR RESPIR J, V10, P822; Remels AHV, 2013, J APPL PHYSIOL, V114, P1253, DOI 10.1152/japplphysiol.00790.2012; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Roig M, 2011, J CARDIOPULM REHABIL, V31, P120, DOI 10.1097/HCR.0b013e3181f68ae4; Rycroft CE, 2012, INT J CHRONIC OBSTR, V7, P457, DOI 10.2147/COPD.S32330; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Schultze A, 2020, LANCET RESP MED, V8, P1106, DOI 10.1016/S2213-2600(20)30415-X; Shaipanich, 2020, INHALED CORTICOSTERO; Shekar K, 2020, ASAIO J, V66, P707, DOI 10.1097/MAT.0000000000001193; Singanayagam A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04574-1; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Titmarsh S, 2019, INT J CHRONIC OBSTR, V14, P2799, DOI 10.2147/COPD.S222139; von Haehling S, 2014, J CACHEXIA SARCOPENI, V5, P261, DOI 10.1007/s13539-014-0164-8; Wu F, 2020, J THORAC DIS, V12, P1811, DOI 10.21037/jtd-20-1914; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yamaya M, 2020, RESPIR INVESTIG, V58, P155, DOI 10.1016/j.resinv.2019.12.005; Yang, 2020, INHALED CORTICOSTERO; Yang MJ, 2019, INFECTION, V47, P377, DOI 10.1007/s15010-018-1229-y; Yang MJ, 2017, INHAL TOXICOL, V29, P219, DOI 10.1080/08958378.2017.1346006	67	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252576	10.1371/journal.pone.0252576	http://dx.doi.org/10.1371/journal.pone.0252576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081722	gold, Green Published			2022-12-26	WOS:000664639200028
J	Gulut, KY				Gueluet, Kemal Yalcin			Nitrogen and boron nutrition in grafted watermelon I: Impact on pomological attributes, yield and fruit quality	PLOS ONE			English	Article							PUMPKIN ROOTSTOCK IMPROVES; USE-EFFICIENCY; ACRYLAMIDE FORMATION; FERTILIZATION; EXPRESSION; PLANTS; ASSIMILATION; POTATOES; GROWTH; SUGAR	Watermelon is extensively consumed fruit across the globe. However, limited is known about interactive effect of nitrogen (N) and boron (B) nutrition on pomological, yield and fruit quality attributes of grafted watermelon. This two-year study tested the influence of different N and B doses on pomological, yield and fruit quality attributes of grafted watermelon under field conditions in Cukurova plains of Turkey. Four different N (0, 90, 180 and 270 kg ha(-1)) and two B doses (0 and 2 kg ha(-1) B) were tested. The individual and interactive effects of N and B significantly altered pomological, yield and fruit quality attributes during both years. Overall, application of 270 kg ha(-1) N and 2 kg ha(-1) B improved yield, pomological and fruit quality attributes during both years. The highest values for yield, main stem length, stem diameter, fruit weight, fruit width, number nodes and branches per stem were recorded for 270 kg ha(-1) N during both years. However, rind thickness was not altered by N application. Similarly, the highest values for quality attributes such as sucrose, glucose, fructose, citric acid, tartaric acid and ascorbic acid were noted for 270 kg ha(-1) N during both years. Interestingly, no N application and 90 kg ha(-1) N recorded the highest values of maleic acid during both years. The highest values of rind thickness, fruit length, fruit width and fruit weight were noted for 2 kg ha(-1) B during both years, while B application had no effect on main stem length, main stem diameter, number of nodes and number of branches. Regarding N by B interactions, 180 and 270 kg ha(-1) N with both B doses observed the highest values for yield, pomological and quality attributes during each year. These results indicate that N has significant contribution towards yield, pomological attributes and fruit quality of grafted watermelon. Therefore, N should be applied at the rate of 270 kg ha(-1) for better yield, pomological attributes and fruit quality. Nonetheless, where necessary grafted watermelon should be fertilized with 2 kg ha(-1) B for better fruit quality and pomological attributes.	[Gueluet, Kemal Yalcin] Cukurova Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Adana, Turkey	Cukurova University	Gulut, KY (corresponding author), Cukurova Univ, Fac Agr, Dept Soil Sci & Plant Nutr, Adana, Turkey.	kygulut@cu.edu.tr		GULUT, KEMAL YALCIN/0000-0003-0534-2969	Cukurova University Scientific Research Projects Coordination Unit [FBA-2018-10970]	Cukurova University Scientific Research Projects Coordination Unit(Cukurova University)	This study was partially supported by Cukurova University Scientific Research Projects Coordination Unit (Project No: FBA-2018-10970). There were no additional external funding involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires A, 2006, J SCI FOOD AGR, V86, P1512, DOI 10.1002/jsfa.2535; Baig MJ, 2005, PHOTOSYNTHETICA, V43, P47, DOI 10.1007/s11099-005-7053-5; Barbet-Massin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133067; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Boualem A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155444; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; Camargo JA, 2006, ENVIRON INT, V32, P831, DOI 10.1016/j.envint.2006.05.002; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Colla G, 2011, J PLANT NUTR SOIL SC, V174, P933, DOI 10.1002/jpln.201000325; Colla G, 2010, HORTSCIENCE, V45, P559, DOI 10.21273/HORTSCI.45.4.559; Curci PL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01377-0; Curtis TY, 2009, J AGR FOOD CHEM, V57, P1013, DOI 10.1021/jf8031292; De Wilde T, 2006, J AGR FOOD CHEM, V54, P404, DOI 10.1021/jf0521810; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Eppendorfer WH, 1996, J SCI FOOD AGR, V71, P449, DOI 10.1002/(SICI)1097-0010(199608)71:4&lt;449::AID-JSFA601&gt;3.0.CO;2-N; Goldbach HE, 2001, J PLANT NUTR SOIL SC, V164, P173, DOI 10.1002/1522-2624(200104)164:2<173::AID-JPLN173>3.0.CO;2-F; Goodall AJ, 2013, PLANT CELL PHYSIOL, V54, P492, DOI 10.1093/pcp/pct006; Gupta U., 2013, INT J BIOASSAYS, V2, P1048; Halford NG, 2011, ANN APPL BIOL, V158, P1, DOI 10.1111/j.1744-7348.2010.00443.x; Ibrahim MH, 2011, INT J MOL SCI, V12, P5238, DOI 10.3390/ijms12085238; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Kumar D, 2004, ANN APPL BIOL, V145, P247, DOI 10.1111/j.1744-7348.2004.tb00380.x; Landi M., 2012, American Journal of Agricultural and Biological Sciences, V7, P255; Landi M, 2019, PLANTA, V250, P1011, DOI 10.1007/s00425-019-03220-4; Lawlor DW, 2002, J EXP BOT, V53, P773, DOI 10.1093/jexbot/53.370.773; Lea PJ, 2007, ANN APPL BIOL, V150, P1, DOI 10.1111/j.1744-7348.2006.00104.x; Liu P., 2015, FUTURE FOOD AGR TREN; Luo J, 2013, J EXP BOT, V64, P4207, DOI 10.1093/jxb/ert234; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Moustafa-Farag M, 2016, J PLANT NUTR, V39, P1989, DOI 10.1080/01904167.2015.1105263; Muttucumaru N, 2006, J AGR FOOD CHEM, V54, P8951, DOI 10.1021/jf0623081; Nawaz MA, 2017, PLANT GROWTH REGUL, V82, P233, DOI 10.1007/s10725-017-0254-7; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; Ozturk M, 2010, PLANT ADAPTATION AND PHYTOREMEDIATION, P275, DOI 10.1007/978-90-481-9370-7_13; Pal PK, 2015, IND CROP PROD, V65, P556, DOI 10.1016/j.indcrop.2014.09.060; Prinsi B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-113; Rodrigues MA, 2017, ARCH AGRON SOIL SCI, V63, P626, DOI 10.1080/03650340.2016.1230272; Shahrokhnia MH, 2016, AGR WATER MANAGE, V172, P18, DOI 10.1016/j.agwat.2016.04.010; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shewry PR, 2001, PLANT GROWTH REGUL, V34, P105, DOI 10.1023/A:1013382803849; Shireen F, 2020, PLANT PHYSIOL BIOCH, V154, P204, DOI 10.1016/j.plaphy.2020.06.003; Shireen F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071856; Sigee D. C., 2005, FRESHWATER MICROBIOL; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Sun YM, 2019, PLANT PHYSIOL BIOCH, V141, P240, DOI 10.1016/j.plaphy.2019.06.008; Tafteh A, 2012, AGR WATER MANAGE, V113, P19, DOI 10.1016/j.agwat.2012.06.011; Takei K, 2001, PLANT CELL PHYSIOL, V42, P85, DOI 10.1093/pcp/pce009; Tischner R, 2000, PLANT CELL ENVIRON, V23, P1005, DOI 10.1046/j.1365-3040.2000.00595.x; Tombuloglu H, 2017, J PLANT PHYSIOL, V216, P212, DOI 10.1016/j.jplph.2017.06.013; Torun AA., 2018, INT J AGR NAT SCI, V1, P228; Ullah I., 2018, INT J SCI ENG RES, V9, P595, DOI DOI 10.14299/IJSER.2018.09.01; Wysocki DJ., 2007, IRRIGATED DRYLAND CA; Yadav AK, 2011, CAN J PLANT SCI, V91, P1, DOI 10.4141/CJPS10086; Zhu SS, 2016, APPL SOIL ECOL, V107, P324, DOI 10.1016/j.apsoil.2016.07.009	55	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252396	10.1371/journal.pone.0252396	http://dx.doi.org/10.1371/journal.pone.0252396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048470	gold, Green Published			2022-12-26	WOS:000664636100044
J	Clements, MN; Russell, N; Bielicki, JA; Ellis, S; Gastine, S; Hsia, YF; Standing, JF; Walker, AS; Sharland, M				Clements, Michelle N.; Russell, Neal; Bielicki, Julia A.; Ellis, Sally; Gastine, Silke; Hsia, Yingfen; Standing, Joseph F.; Walker, A. Sarah; Sharland, Mike			Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines	PLOS ONE			English	Article								Background Paediatric global antibiotic guidelines are inconsistent, most likely due to the limited pharmacokinetic and efficacy data in this population. We investigated factors underlying variation in antibiotic dosing using data from five global point prevalence surveys. Methods & findings Data from 3,367 doses of the 16 most frequent intravenous antibiotics administered to children 1 month-12 years across 23 countries were analysed. For each antibiotic, we identified standard doses given as either weight-based doses (in mg/kg/day) or fixed daily doses (in mg/day), and investigated the pattern of dosing using each strategy. Factors underlying observed variation in weight-based doses were investigated using linear mixed effects models. Weight-based dosing (in mg/kg/day) clustered around a small number of peaks, and all antibiotics had 1-3 standard weight-based doses used in 5%-48% of doses. Dosing strategy was more often weight-based than fixed daily dosing for all antibiotics apart from teicoplanin, which had approximately equal proportions of dosing attributable to each strategy. No strong consistent patterns emerged to explain the historical variation in actual weight-based doses used apart from higher dosing seen in central nervous system infections, and lower in skin and soft tissue infections compared to lower respiratory tract infections. Higher dosing was noted in the Americas compared to the European region. Conclusions Antibiotic dosing in children clusters around a small number of doses, although variation remains. There is a clear opportunity for the clinical, scientific and public health communities to consolidate behind a consistent set of global antibiotic dosing guidelines to harmonise current practice and prioritise future research.	[Clements, Michelle N.; Walker, A. Sarah] UCL, MRC Clin Trials Unit, London, England; [Russell, Neal; Bielicki, Julia A.; Hsia, Yingfen; Sharland, Mike] St Georges Univ, Inst Infect & Immun, Paediat Infect Dis Res Grp, London, England; [Ellis, Sally] Global Antibiot Res & Dev Partnership, Geneva, Switzerland; [Gastine, Silke; Standing, Joseph F.] UCL, Inst Child Hlth, Infect Immun & Inflammat, London, England; [Hsia, Yingfen] Queens Univ, Sch Pharm, Belfast, Antrim, North Ireland	Medical Research Council Clinical Trials Unit; University of London; University College London; St Georges University London; University of London; University College London; Queens University Belfast	Clements, MN (corresponding author), UCL, MRC Clin Trials Unit, London, England.	michelle.clements@ucl.ac.uk	Walker, Sarah/HDM-8717-2022	Gastine, Silke/0000-0002-1069-6123; Clements, Michelle/0000-0002-3442-3947; Hsia, Yingfen/0000-0002-7955-852X	GARDP; PENTA Foundation; Medical Research Council UK [MC_UU_12023/22]; German Federal Ministry of Health; Medecins Sans Frontieres; Netherlands Ministry of Health, Welfare and Sport; UK Department for International Development	GARDP; PENTA Foundation; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Federal Ministry of Health; Medecins Sans Frontieres; Netherlands Ministry of Health, Welfare and Sport; UK Department for International Development	Funding/Support: This study was funded by GARDP. GARPEC was funded by the PENTA Foundation. MC and ASW are supported by core support from the Medical Research Council UK to the MRC Clinical Trials Unit [MC_UU_12023/22]. ASW is an NIHR Senior Investigator. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. This analysis was facilitated by Global Antibiotic R&D Partnership with funding from German Federal Ministry of Health, Medecins Sans Frontieres, Netherlands Ministry of Health, Welfare and Sport, and UK Department for International Development Role of Funder/Sponsor (if any): SE contributed to the design of data collection tools for the GARPEC project, and is a co-author.	Bates D., 2015, CONVERGENCE, V12, P2, DOI DOI 10.18637/JSS.V067.I01; Downes KJ, 2014, INT J ANTIMICROB AG, V43, P223, DOI 10.1016/j.ijantimicag.2013.11.006; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Hartman S., 2019, P43 PHARMACOKINETICS; Hsia YF, 2019, LANCET GLOB HEALTH, V7, pE861, DOI 10.1016/S2214-109X(19)30071-3; Jackson C, 2019, PEDIATR INFECT DIS J, V38, P1104, DOI 10.1097/INF.0000000000002433; Kadambari S, 2011, J ANTIMICROB CHEMOTH, V66, P2647, DOI 10.1093/jac/dkr351; Kimberlin D. W., 2018, Red Book: 2018-2021 report of the committee on infectious diseases; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Leroux S, 2015, ARCH DIS CHILD, V100, P394, DOI 10.1136/archdischild-2014-306873; Liem TBY, 2010, J ANTIMICROB CHEMOTH, V65, P1270, DOI 10.1093/jac/dkq107; Mamishi S, 2014, IRAN J MICROBIOL, V6, P198; Mathur S, 2020, B WORLD HEALTH ORGAN, V98, P406, DOI 10.2471/BLT.19.234310; Paediatric Formulary Committee, 2016, BNF CHILDR 2016 207; Porta A, 2012, J ANTIMICROB CHEMOTH, V67, P1278, DOI 10.1093/jac/dks021; Rashed AN, 2019, EXPERT REV CLIN PHAR, V12, P1099, DOI 10.1080/17512433.2019.1693257; RCore Team, 2020, R LANG ENV STAT COMP; Sharland M., 2016, MANUAL CHILDHOOD INF, V4th; Spyridis N, 2016, ARCH DIS CHILD, V101, P72, DOI [10.1136/archdischild-2015-308255, 10.1136/]; Sviestina I, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54050074; Tasawer Baig M., 2017, PAK J PHARM SCI, P30; van Houten MA, 1998, INT J ANTIMICROB AG, V10, P161, DOI 10.1016/S0924-8579(98)00022-3; Venables WN., 2002, MODERN APPL STAT S 4; Venkatesh S., 2011, NATL TREATMENT GUIDE, P1; Versporten A, 2016, J ANTIMICROB CHEMOTH, V71, P1106, DOI 10.1093/jac/dkv418; Williams K, 2012, PEDIATRICS, V129, pS153, DOI 10.1542/peds.2012-0055I; World Health Organization, 2013, POCK BOOK HOSP CAR C	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252223	10.1371/journal.pone.0252223	http://dx.doi.org/10.1371/journal.pone.0252223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043696	Green Accepted, gold, Green Published			2022-12-26	WOS:000664635700073
J	Field, JC; Miller, RR; Santora, JA; Tolimieri, N; Haltuch, MA; Brodeur, RD; Auth, TD; Dick, EJ; Monk, MH; Sakuma, KM; Wells, BK				Field, John C.; Miller, Rebecca R.; Santora, Jarrod A.; Tolimieri, Nick; Haltuch, Melissa A.; Brodeur, Richard D.; Auth, Toby D.; Dick, E. J.; Monk, Melissa H.; Sakuma, Keith M.; Wells, Brian K.			Spatiotemporal patterns of variability in the abundance and distribution of winter-spawned pelagic juvenile rockfish in the California Current	PLOS ONE			English	Article							US WEST-COAST; ESTIMATE COMMON TRENDS; SEBASTES SPP.; NORTHERN CALIFORNIA; ENVIRONMENTAL-CONDITIONS; INTERANNUAL VARIATION; ASSEMBLAGE STRUCTURE; CONTINENTAL-SLOPE; MARINE ECOSYSTEM; TIME-SERIES	Rockfish are an important component of West Coast fisheries and California Current food webs, and recruitment (cohort strength) for rockfish populations has long been characterized as highly variable for most studied populations. Research efforts and fisheries surveys have long sought to provide greater insights on both the environmental drivers, and the fisheries and ecosystem consequences, of this variability. Here, variability in the temporal and spatial abundance and distribution patterns of young-of-the-year (YOY) rockfishes are described based on midwater trawl surveys conducted throughout the coastal waters of California Current between 2001 and 2019. Results confirm that the abundance of winter-spawning rockfish taxa in particular is highly variable over space and time. Although there is considerable spatial coherence in these relative abundance patterns, there are many years in which abundance patterns are very heterogeneous over the scale of the California Current. Results also confirm that the high abundance levels of YOY rockfish observed during the 2014-2016 large marine heatwave were largely coastwide events. Species association patterns of pelagic YOY for over 20 rockfish taxa in space and time are also described. The overall results will help inform future fisheries-independent surveys, and will improve future indices of recruitment strength used to inform stock assessment models and marine ecosystem status reports.	[Field, John C.; Miller, Rebecca R.; Santora, Jarrod A.; Dick, E. J.; Monk, Melissa H.; Sakuma, Keith M.; Wells, Brian K.] Natl Ocean & Atmospher Adm, Fisheries Ecol Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Santa Cruz, CA 95060 USA; [Field, John C.; Miller, Rebecca R.; Santora, Jarrod A.] Univ Calif Santa Cruz, Inst Marine Sci, Fisheries Collaborat Program, Santa Cruz, CA 95064 USA; [Tolimieri, Nick] Natl Ocean & Atmospher Adm, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Haltuch, Melissa A.] Natl Ocean & Atmospher Adm, Fisheries Res Anal & Monitoring Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Brodeur, Richard D.] Natl Ocean & Atmospher Adm, Fish Ecol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Newport, OR USA; [Auth, Toby D.] Pacific States Marine Fisheries Commiss, Newport, OR USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Field, JC (corresponding author), Natl Ocean & Atmospher Adm, Fisheries Ecol Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Santa Cruz, CA 95060 USA.; Field, JC (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Fisheries Collaborat Program, Santa Cruz, CA 95064 USA.	John.Field@noaa.gov		Field, John/0000-0002-7178-600X; Haltuch, Melissa/0000-0003-2821-1267	Southwest Fisheries Science Center [NA150AR4320071]; University of California Santa Cruz [NA150AR4320071]	Southwest Fisheries Science Center; University of California Santa Cruz(University of California System)	This study was supported by the Cooperative Institute for Marine Ecosystems and Climate, a partnership between the Southwest Fisheries Science Center and University of California Santa Cruz, in the form of an award to RRM (NA150AR4320071).	Adams GD., 2019, STOCK ASSESSMENT UPD; Adams PB, 1996, FISH B-NOAA, V94, P156; [Anonymous], 2017, COMBINED STATUS BLUE; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Beyer SG, 2015, ENVIRON BIOL FISH, V98, P81, DOI 10.1007/s10641-014-0238-7; Bjorkstedt EP, 2002, MAR ECOL PROG SER, V242, P215, DOI 10.3354/meps242215; Brodeur RD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026614; Brodeur RD, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00212; Burnham K. P., 1998, MODEL SELECTION INFE; Caselle JE, 2010, CAL COOP OCEAN FISH, V51, P91; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; CHELTON DB, 1982, J MAR RES, V40, P1095; Cury PM, 2014, OCEANOGRAPHY, V27, P42, DOI 10.5670/oceanog.2014.85; Dick EJ, 2004, FISH RES, V70, P351, DOI 10.1016/j.fishres.2004.08.013; Field JC, 2005, CAN J FISH AQUAT SCI, V62, P2199, DOI 10.1139/F05-134; Field JC., 2017, CALIFORNIA CURRENT 2; Field JC, 2010, CAL COOP OCEAN FISH, V51, P77; Friedman WR, 2018, MAR ECOL PROG SER, V596, P181, DOI 10.3354/meps12598; Gottscho AD, 2016, BIOL REV, V91, P235, DOI 10.1111/brv.12167; Haltuch MA, 2019, FISH RES, V217, P198, DOI 10.1016/j.fishres.2018.12.016; Haltuch MA, 2020, FISH OCEANOGR, V29, P122, DOI 10.1111/fog.12459; Harvey C., 2020, NOAA TECH MEMO NMFS, V160, DOI [10.25923/e5rb-9f55, DOI 10.25923/p0ed-ke21]; Harvey CJ, 2020, PROG OCEANOGR, V188, DOI 10.1016/j.pocean.2020.102418; He X., 2017, CONCEPTION MONTEREY; He X, 2019, FISH RES, V217, P21, DOI 10.1016/j.fishres.2018.06.001; Holder AM, 2019, FISH B-NOAA, V117, P180, DOI 10.7755/FB.117.3.5; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; Hyde JR, 2007, MOL PHYLOGENET EVOL, V44, P790, DOI 10.1016/j.ympev.2006.12.026; Johansson ML, 2018, FISH B-NOAA, V116, P266, DOI 10.7755/FB.116.3-4.5; Johnson DW, 2006, ECOLOGY, V87, P319, DOI 10.1890/04-1665; Keller AA, 2019, MAR ECOL PROG SER, V623, P175, DOI 10.3354/meps13019; Laidig TE, 2007, FISH B-NOAA, V105, P39; Le Pape O, 2020, ICES J MAR SCI, V77, P1953, DOI 10.1093/icesjms/fsaa051; LEAMAN B M, 1984, International North Pacific Fisheries Commission Bulletin, P85; Lee HH, 2012, FISH RES, V125, P254, DOI 10.1016/j.fishres.2012.03.001; Lefebvre LS, 2018, FISH RES, V204, P258, DOI 10.1016/j.fishres.2018.03.002; Lindley S.T., 2009, NOAA TECHNICAL MEMOR; Love M. S., 2002, ROCKFISHES NE PACIFI; Love MS, 2006, FISH B-NOAA, V104, P383; Markel RW, 2020, CAN J FISH AQUAT SCI, V77, P950, DOI 10.1139/cjfas-2019-0179; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Miller RR, 2019, CAL COOP OCEAN FISH, V60, P94; Oksanen J., 2020, ORDINATION METHODS D; Peterson B, 2006, CAL COOP OCEAN FISH, V47, P30; Phillips AJ, 2007, CAL COOP OCEAN FISH, V48, P215; RALSTON S, 1995, FISH B-NOAA, V93, P710; Ralston S, 2013, FISH OCEANOGR, V22, P288, DOI 10.1111/fog.12022; Ralston S, 2015, J MARINE SYST, V146, P26, DOI 10.1016/j.jmarsys.2014.06.013; Ralston S, 2013, CAL COOP OCEAN FISH, V54, P155; Ross JRM, 2003, CAL COOP OCEAN FISH, V44, P65; Sakuma KM, 2006, CAL COOP OCEAN FISH, V47, P127; Sakuma KM, 2016, CAL COOP OCEAN FISH, V57, P163; Sakuma KM, 2013, CAL COOP OCEAN FISH, V54, P167; Santora JA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14215-w; Santora JA, 2017, MAR ECOL PROG SER, V580, P205, DOI 10.3354/meps12278; Santora JA, 2014, ECOL APPL, V24, P1730, DOI 10.1890/13-1605.1; Schroeder ID, 2019, CAN J FISH AQUAT SCI, V76, P950, DOI 10.1139/cjfas-2017-0480; Schwing FB, 2000, CAL COOP OCEAN FISH, V41, P148; Schwing FB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026911; Stachura MM, 2014, FISH OCEANOGR, V23, P389, DOI 10.1111/fog.12066; Stige LC, 2013, MAR ECOL PROG SER, V480, P245, DOI 10.3354/meps10246; Sydeman WJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047212; Sydeman WJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026736; Szoboszlai AI, 2015, ECOL INFORM, V29, P45, DOI 10.1016/j.ecoinf.2015.07.003; Szuwalski CS, 2015, FISH FISH, V16, P633, DOI 10.1111/faf.12083; Szymkowiak M, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.602281; Peiro-Alcantar MT, 2020, SCI MAR, V84, P253, DOI 10.3989/scimar.04996.11A; Thompson AR, 2019, ECOL INDIC, V105, P215, DOI 10.1016/j.ecolind.2019.05.057; Thompson AR, 2016, MAR ECOL PROG SER, V547, P177, DOI 10.3354/meps11633; Thorson J, 2015, STATUS CANARY ROCKFI; Thorson JT, 2019, FISH RES, V217, P11, DOI 10.1016/j.fishres.2018.03.014; Thorson JT, 2013, MAR ECOL PROG SER, V483, P245, DOI 10.3354/meps10295; Tolimieri N, 2018, FISH OCEANOGR, V27, P458, DOI 10.1111/fog.12266; Tolimieri N, 2007, ENVIRON BIOL FISH, V78, P241, DOI 10.1007/s10641-006-9093-5; Tolimieri N, 2006, T AM FISH SOC, V135, P317, DOI 10.1577/T05-092.1; Tolimieri Nick, 2015, P227; Wallace DR., 2018, STATUS DARKBLOTCHED; Warzybok P, 2018, J MARINE SYST, V185, P25, DOI 10.1016/j.jmarsys.2018.04.009; Wells BK, 2017, J MARINE SYST, V174, P54, DOI 10.1016/j.jmarsys.2017.05.008; WOODBURY D, 1991, FISH B-NOAA, V89, P523; Woodson CB, 2012, LIMNOL OCEANOGR, V57, P582, DOI 10.4319/lo.2012.57.2.0582; Zuur AF, 2003, CAN J FISH AQUAT SCI, V60, P542, DOI 10.1139/F03-030; Zuur AF, 2003, ENVIRONMETRICS, V14, P665, DOI 10.1002/env.611	84	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251638	10.1371/journal.pone.0251638	http://dx.doi.org/10.1371/journal.pone.0251638			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043656	gold, Green Published			2022-12-26	WOS:000664635700029
J	Kim, M; Xi, H; Park, J				Kim, Mangi; Xi, Hong; Park, Jongsun			Genome-wide comparative analyses of GATA transcription factors among 19 Arabidopsis ecotype genomes: Intraspecific characteristics of GATA transcription factors	PLOS ONE			English	Article							COMPLETE CHLOROPLAST GENOME; DISTICHUM NAKAI OLEACEAE; JAPONICA L. THEACEAE; COMMON CAMELLIA TREE; ZINC-FINGER PROTEIN; CIRCADIAN CLOCK; HANABA-TARANU; COFFEE TREE; GENE FAMILY; LLM-DOMAIN	GATA transcription factors (TFs) are widespread eukaryotic regulators whose DNA-binding domain is a class IV zinc finger motif (CX2CX17-20CX2C) followed by a basic region. Due to the low cost of genome sequencing, multiple strains of specific species have been sequenced: e.g., number of plant genomes in the Plant Genome Database (http://www.plantgenome.info/) is 2,174 originated from 713 plant species. Thus, we investigated GATA TFs of 19 Arabidopsis thaliana genome-widely to understand intraspecific features of Arabidopsis GATA TFs with the pipeline of GATA database (http://gata.genefamily.info/). Numbers of GATA genes and GATA TFs of each A. thaliana genome range from 29 to 30 and from 39 to 42, respectively. Four cases of different pattern of alternative splicing forms of GATA genes among 19 A. thaliana genomes are identified. 22 of 2,195 amino acids (1.002%) from the alignment of GATA domain amino acid sequences display variations across 19 ecotype genomes. In addition, maximally four different amino acid sequences per each GATA domain identified in this study indicate that these position-specific amino acid variations may invoke intraspecific functional variations. Among 15 functionally characterized GATA genes, only five GATA genes display variations of amino acids across ecotypes of A. thaliana, implying variations of their biological roles across natural isolates of A. thaliana. PCA results from 28 characteristics of GATA genes display the four groups, same to those defined by the number of GATA genes. Topologies of bootstrapped phylogenetic trees of Arabidopsis chloroplasts and common GATA genes are mostly incongruent. Moreover, no relationship between geographical distribution and their phylogenetic relationships was found. Our results present that intraspecific variations of GATA TFs in A. thaliana are conserved and evolutionarily neutral along with 19 ecotypes, which is congruent to the fact that GATA TFs are one of the main regulators for controlling essential mechanisms, such as seed germination and hypocotyl elongation.	[Kim, Mangi; Xi, Hong; Park, Jongsun] InfoBoss Inc, Seoul, South Korea; [Kim, Mangi; Xi, Hong; Park, Jongsun] InfoBoss Res Ctr, Seoul, South Korea	Infoboss Co., Ltd.	Park, J (corresponding author), InfoBoss Inc, Seoul, South Korea.; Park, J (corresponding author), InfoBoss Res Ctr, Seoul, South Korea.	starflr@infoboss.co.kr		Park, Jongsun/0000-0003-0786-4701	InfoBoss Research Grant [IBI-0001]	InfoBoss Research Grant	This research was fully supported by InfoBoss Research Grant (IBI-0001; http://www.infoboss.co.kr/) to J.P. The funder provided support in the form of salaries for authors [JP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Alonso-Blanco C, 2016, CELL, V166, P481, DOI 10.1016/j.cell.2016.05.063; An Y, 2020, J EXP BOT, V71, P1969, DOI 10.1093/jxb/erz564; [Anonymous], 2013, PREPRINTS; Ao Tao, 2015, Plant Diversity and Resources, V37, P453; Ashelford K, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r28; Bastakis E, 2018, PLANT CELL, V30, P582, DOI 10.1105/tpc.17.00947; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; Bleidorn C, 2016, SYST BIODIVERS, V14, P1, DOI 10.1080/14772000.2015.1099575; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chen HF, 2017, GENE, V627, P460, DOI 10.1016/j.gene.2017.06.049; Chiang YH, 2012, PLANT PHYSIOL, V160, P332, DOI 10.1104/pp.112.198705; Chini A, 2009, PLANT J, V59, P77, DOI 10.1111/j.1365-313X.2009.03852.x; Cho MS, 2019, MITOCHONDRIAL DNA B, V4, P2424, DOI 10.1080/23802359.2019.1598802; Choi YG, 2020, MITOCHONDRIAL DNA B, V5, P271, DOI 10.1080/23802359.2019.1698360; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Doherty C, 2019, PLANT DIRECT, V3, DOI 10.1002/pld3.109; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Evans LM, 2014, NAT GENET, V46, P1089, DOI 10.1038/ng.3075; Fahrenkrog AM, 2017, NEW PHYTOL, V213, P799, DOI 10.1111/nph.14154; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gendron JM, 2012, P NATL ACAD SCI USA, V109, P3167, DOI 10.1073/pnas.1200355109; Georganas E, 2014, INT CONF HIGH PERFOR, P437, DOI 10.1109/SC.2014.41; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Gupta P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01944; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Hartmann B, 2011, RNA, V17, P453, DOI 10.1261/rna.2460411; Heo KI, 2020, MITOCHONDRIAL DNA B, V5, P2264, DOI 10.1080/23802359.2020.1772144; Heo KI, 2019, MITOCHONDRIAL DNA B, V4, P1354, DOI 10.1080/23802359.2019.1597654; Heo KI, 2019, MITOCHONDRIAL DNA B, V4, P1289, DOI 10.1080/23802359.2019.1591213; Huang Q, 2021, GENOME WIDE SURVEY G; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hudson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026765; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackman SD, 2017, GENOME RES, V27, P768, DOI 10.1101/gr.214346.116; Jain M, 2018, NAT BIOTECHNOL, V36, P338, DOI 10.1038/nbt.4060; Jeon JH, 2019, MITOCHONDRIAL DNA B, V4, P176, DOI 10.1080/23802359.2018.1545529; Jiang L, 2020, INT J AGRIC BIOL, V23, P637, DOI 10.17957/IJAB/15.1334; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanei M, 2012, DEVELOPMENT, V139, P2436, DOI 10.1242/dev.081547; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Kerr KM, 2012, HISTOPATHOLOGY, V60, P531, DOI 10.1111/j.1365-2559.2011.03854.x; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kim Y, 2020, MITOCHONDRIAL DNA B, V5, P1616, DOI 10.1080/23802359.2020.1715867; Kim Y, 2019, MITOCHONDRIAL DNA B, V4, P3404, DOI 10.1080/23802359.2019.1674213; Kim Y, 2019, MITOCHONDRIAL DNA B, V4, P2433, DOI 10.1080/23802359.2019.1637296; Kim Y, 2019, MITOCHONDRIAL DNA B, V4, P1310, DOI 10.1080/23802359.2019.1591179; Klermund C, 2016, PLANT CELL, V28, P646, DOI 10.1105/tpc.15.00783; Kong WL, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00565; Krishnan SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098843; Kujur A., 2016, SCI REP-UK, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-828442746]; Kumar Dhavendra, 2007, Genomic Med, V1, P95, DOI 10.1007/s11568-007-9013-6; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kwon W, 2019, MITOCHONDRIAL DNA B, V4, P769, DOI 10.1080/23802359.2019.1565975; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lee B, 2021, MITOCHONDRIAL DNA B, V6, P572, DOI 10.1080/23802359.2021.1875907; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li JY, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-8; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lim JH, 2014, MOL CELLS, V37, P149, DOI 10.14348/molcells.2014.2336; Lin YC, 2018, P NATL ACAD SCI USA, V115, pE10970, DOI 10.1073/pnas.1801437115; Liu H, 2019, J INTEGR PLANT BIOL, V61, P359, DOI 10.1111/jipb.12720; Liu PP, 2005, PLANT J, V44, P960, DOI 10.1111/j.1365-313X.2005.02588.x; Liu YC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-354; Long Q, 2013, NAT GENET, V45, P884, DOI 10.1038/ng.2678; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mara CD, 2008, PLANT PHYSIOL, V147, P707, DOI 10.1104/pp.107.115634; Marchant DB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53968-8; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; Merker JD, 2018, GENET MED, V20, P159, DOI 10.1038/gim.2017.86; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Min J, 2019, MITOCHONDRIAL DNA B, V4, P3716, DOI 10.1080/23802359.2019.1679678; Min J, 2019, MITOCHONDRIAL DNA B, V4, P2240, DOI 10.1080/23802359.2019.1624213; Min J, 2019, MITOCHONDRIAL DNA B, V4, P1510, DOI 10.1080/23802359.2019.1601044; Moch H, 2012, VIRCHOWS ARCH, V460, P3, DOI 10.1007/s00428-011-1179-6; Nagaoka M, 2002, BIOCHEM BIOPH RES CO, V296, P553, DOI 10.1016/S0006-291X(02)00898-7; Nagasaki M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9018; Naito T, 2007, BIOSCI BIOTECH BIOCH, V71, P1557, DOI 10.1271/bbb.60692; Nakamura N, 2018, DNA RES, V25, P113, DOI 10.1093/dnares/dsx042; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Nawy T, 2010, DEV CELL, V19, P103, DOI 10.1016/j.devcel.2010.06.004; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nishii A, 2000, BIOSCI BIOTECH BIOCH, V64, P1402, DOI 10.1271/bbb.64.1402; Niu LJ, 2020, J PLANT GROWTH REGUL, V39, P1647, DOI 10.1007/s00344-020-10201-5; Oh SH, 2020, MITOCHONDRIAL DNA B, V5, P3769, DOI 10.1080/23802359.2020.1835571; Oh SH, 2019, MITOCHONDRIAL DNA B, V4, P2692, DOI 10.1080/23802359.2019.1641439; Oh SH, 2019, MITOCHONDRIAL DNA B, V4, P626, DOI 10.1080/23802359.2018.1564390; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Park J., 2017, 19 INT BOT C; Park J., 2018, PLANT ANIMAL GENOME; Park Jongsun, 2006, Genomics & Informatics, V4, P147; Park J, 2021, INT J GENOMICS, V2021, DOI 10.1155/2021/6643444; Park J, 2021, MITOCHONDRIAL DNA B, V6, P135, DOI 10.1080/23802359.2020.1851157; Park J, 2020, INT J GENOMICS, V2020, DOI 10.1155/2020/3236461; Park J, 2020, MITOCHONDRIAL DNA B, V5, P1868, DOI 10.1080/23802359.2020.1752837; Park J, 2020, MITOCHONDRIAL DNA B, V5, P1654, DOI 10.1080/23802359.2020.1715885; Park J, 2020, MITOCHONDRIAL DNA B, V5, P1619, DOI 10.1080/23802359.2020.1715883; Park J, 2020, MITOCHONDRIAL DNA B, V5, P517, DOI 10.1080/23802359.2019.1710588; Park J, 2019, MITOCHONDRIAL DNA B, V4, P3713, DOI 10.1080/23802359.2019.1679676; Park J, 2019, MITOCHONDRIAL DNA B, V4, P2523, DOI 10.1080/23802359.2019.1598822; Park J, 2019, MITOCHONDRIAL DNA B, V4, P2436, DOI 10.1080/23802359.2019.1636729; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1619, DOI 10.1080/23802359.2019.1602012; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1541, DOI 10.1080/23802359.2019.1600386; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1640, DOI 10.1080/23802359.2019.1605851; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1428, DOI 10.1080/23802359.2019.1598807; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1292, DOI 10.1080/23802359.2019.1591214; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1083, DOI 10.1080/23802359.2019.1586472; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1059, DOI 10.1080/23802359.2019.1584060; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1038, DOI 10.1080/23802359.2019.1580164; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1023, DOI 10.1080/23802359.2019.1584062; Park J, 2019, MITOCHONDRIAL DNA B, V4, P1014, DOI 10.1080/23802359.2019.1565968; Park J, 2019, MITOCHONDRIAL DNA B, V4, P864, DOI 10.1080/23802359.2019.1573114; Peng WY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22042026; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Price DC, 2019, DNA RES, V26, P287, DOI 10.1093/dnares/dsz009; Qi Y, 2017, CHIN AGR SCI B, V2017, P5; Qiu J, 2014, PLANTA, V240, P1353, DOI 10.1007/s00425-014-2159-2; Ramirez V, 2009, PLANT J, V58, P578, DOI 10.1111/j.1365-313X.2009.03804.x; Ranftl QL, 2016, PLANT PHYSIOL, V170, P2295, DOI 10.1104/pp.15.01556; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Richter R, 2013, P NATL ACAD SCI USA, V110, P13192, DOI 10.1073/pnas.1304250110; Richter R, 2013, PLANT PHYSIOL, V162, P1992, DOI 10.1104/pp.113.219238; Richter R, 2010, GENE DEV, V24, P2093, DOI 10.1101/gad.594910; Sabot F, 2011, PLANT J, V66, P241, DOI 10.1111/j.1365-313X.2011.04492.x; Saleh A., 2003, GENETIKA+, V35, P37, DOI DOI 10.2298/GENSR0301037S; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Santos LA, 2012, PLANT BIOTECHNOL REP, V6, P327, DOI 10.1007/s11816-012-0227-2; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schulze WX, 2012, PLANT J, V69, P529, DOI 10.1111/j.1365-313X.2011.04812.x; Seo JS, 2016, NATURE, V538, P243, DOI 10.1038/nature20098; Shaikhali J, 2012, PLANT CELL, V24, P3009, DOI 10.1105/tpc.112.100099; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Stadermann KB, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00975-16; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Subbaiyan GK, 2012, PLANT BIOTECHNOL J, V10, P623, DOI 10.1111/j.1467-7652.2011.00676.x; Suh HJ, 2021, MITOCHONDRIAL DNA B, V6, P1256, DOI 10.1080/23802359.2021.1906173; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Tallec LPL, 2004, EUR J ENDOCRINOL, V150, P585, DOI 10.1530/eje.0.1500585; Teakle GR, 2002, PLANT MOL BIOL, V50, P43, DOI 10.1023/A:1016062325584; Teakle GR, 1998, TRENDS BIOCHEM SCI, V23, P100, DOI 10.1016/S0968-0004(98)01174-8; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Tian CG, 2004, PLANT MOL BIOL, V54, P519, DOI 10.1023/B:PLAN.0000038256.89809.57; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wang HL, 2010, ADV ANAT PATHOL, V17, P23, DOI 10.1097/PAP.0b013e3181c6962f; Wang T, 2019, BIORXIV, P744003; Wang WC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041037; Wu GA, 2018, NATURE, V554, P311, DOI 10.1038/nature25447; Xu JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-656; Xu K, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0532-3; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang WN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6087; Yano K, 2016, NAT GENET, V48, P927, DOI 10.1038/ng.3596; Yu CY, 2021, J APPL GENET, V62, P265, DOI 10.1007/s13353-021-00618-3; Yu R, J PLANT BIOCHEM BIOT, V2021, P1; Yuan Q, 2018, INT J AGRIC BIOL, V20, P1274, DOI 10.17957/IJAB/15.0626; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125174; Zhang J, 2020, NAT PLANTS, V6, P107, DOI 10.1038/s41477-019-0588-4; Zhang XL, 2013, PLANT CELL, V25, P83, DOI 10.1105/tpc.112.107854; Zhang Z, 2018, GENOME, V61, P713, DOI 10.1139/gen-2018-0042; Zhang Z, 2019, GENE, V680, P72, DOI 10.1016/j.gene.2018.09.039; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2; Zhao YX, 2004, PLANT CELL, V16, P2586, DOI 10.1105/tpc.104.024869; Zhu W, 2020, GENOME WIDE IDENTIFI; Zou YP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1378-9; Zubo YO, 2018, PLANT PHYSIOL, V178, P130, DOI 10.1104/pp.18.00414	183	14	14	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252181	10.1371/journal.pone.0252181	http://dx.doi.org/10.1371/journal.pone.0252181			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038437	Green Published, gold			2022-12-26	WOS:000664633500059
J	Proulx, R				Proulx, Raphael			On the general relationship between plant height and aboveground biomass of vegetation stands in contrasted ecosystems	PLOS ONE			English	Article							DENSITY RELATIONSHIP; ALLOCATION	Ecological communities are unique assemblages of species that coexist in consequence of multi-causal processes that have proven hard to generalize. One possible exception are processes that control the biomass packing of vegetation stands; the amount of aboveground standing biomass expressed per unit volume. In this paper, I investigated the empirical and geometric underpinnings of biomass packing in terrestrial plant communities. I support that biomass packing in nature peaks around 1 kg m(-3) across contrasted contexts, ranging from grasslands to forest ecosystems. Using published experimental and long-term survey data, I show that expressing biomass per unit volume cancels the effects of air temperature, species richness and soil fertility on aboveground stocks, thus providing a general comparative measure of storage efficiency in plant communities.	[Proulx, Raphael] Univ Quebec Trois Rivieres, Canada Res Chair Ecol Integr, Ctr Rech Interact Bassins Versants Ecosyst Aquat, Trois Rivieres, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres	Proulx, R (corresponding author), Univ Quebec Trois Rivieres, Canada Res Chair Ecol Integr, Ctr Rech Interact Bassins Versants Ecosyst Aquat, Trois Rivieres, PQ, Canada.	raphael.proulx@uqtr.ca			Natural Sciences and Engineering Research Council (NSERC) Canada Research Chair (CRC) [CRC-950-229255]	Natural Sciences and Engineering Research Council (NSERC) Canada Research Chair (CRC)	RP: Natural Sciences and Engineering Research Council (NSERC) Canada Research Chair (CRC) CRC-950-229255 https://www.chairschaires.gc.ca The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; Canadian Forest Inventory Committee, 2004, CAN NAT FOR INV DES; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; DUARTE CM, 1990, HYDROBIOLOGIA, V196, P17, DOI 10.1007/BF00008889; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Franco M, 1998, P NATL ACAD SCI USA, V95, P7830, DOI 10.1073/pnas.95.13.7830; Heymsfield SB, 2007, AM J CLIN NUTR, V86, P82, DOI 10.1093/ajcn/86.1.82; Jucker T, 2017, GLOBAL CHANGE BIOL, V23, P177, DOI 10.1111/gcb.13388; KIRA TATUO, 1967, JAP J ECOL, V17, P70; Koenker G., 2021, quantreg: Quantile Regression. R package version 5.85; Nash RDM, 2006, FISHERIES, V31, P236; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Peterson EB., 1982, UPPER LIMITS ABOVEGR; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Proulx R, 2015, PEERJ, V3, DOI 10.7717/peerj.849; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA, DOI [10.1152/jappl.1984.57.2.293, DOI 10.1152/JAPPL.1984.57.2.293]; Skovsgaard JP, 2008, FORESTRY, V81, P13, DOI 10.1093/forestry/cpm041; Stepper C, 2015, CAN J FOREST RES, V45, P111, DOI 10.1139/cjfr-2014-0297; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; WELLER DE, 1989, AM NAT, V133, P20, DOI 10.1086/284899; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	24	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252080	10.1371/journal.pone.0252080	http://dx.doi.org/10.1371/journal.pone.0252080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038429	gold, Green Published			2022-12-26	WOS:000664633500047
J	Zou, H; Pei, P; Zhang, J				Zou, Hang; Pei, Peng; Zhang, Jin			Impacts of hydrogeological characters of fractured rock on thermodynamic performance of ground-coupled heat pump	PLOS ONE			English	Article							THERMAL IMBALANCE; SYSTEMS	Ground-coupled heat pump (GCHP) is used to recovery shallow geothermal energy, a widely distributed green energy source. Due to the imbalance between heat rejection and extraction, heat buildup underground is commonly associated with the long-term operation of GCHPs, which undermine system performance. Heat buildup intrinsically results the irreversibilities (entropy production) in subsurface heat sink, in which thermodynamic and transport properties are largely influenced by hydrogeologic properties, especially the existence of fractures and groundwater. This study investigates the influence of water flow in fractures on the thermodynamic performance of a single borehole heat exchanger (BHX) and heat buildup in the underground heat exchange zone (UHXZ). Potential influence factors were screened out, and new terms were proposed to quantify the scale of fractures and available heat and cold in the heat sink. Governing equations were established to calculate the impacts of vertical and horizontal fractures on the heat exchange rate in BHX as well as on the heat flow across the UHXZ. The analysis results show that water flow in fractures can significantly enhance heat transfer, reduce required number of boreholes, mitigate heat buildup and reduce irreversibilities underground. The results also suggest that the role of fracture scales and water velocity in GCHP operation should be carefully evaluated. Therefore, detailed hydrogeological survey is necessary. The study results provide a guide on more accurately evaluating the risk of heat buildup and how to take advantage of hydrogeological characters to improve the performance of GCHPs.	[Zou, Hang; Pei, Peng] Guizhou Univ, Coll Mines, Guiyang, Guizhou, Peoples R China; [Zhang, Jin] Jinan Univ, Inst Groundwater & Earth Sci, Guangzhou, Guangdong, Peoples R China	Guizhou University; Jinan University	Pei, P (corresponding author), Guizhou Univ, Coll Mines, Guiyang, Guizhou, Peoples R China.	ppei@gzu.edu.cn	Zhang, Jin/L-6993-2017	Zhang, Jin/0000-0002-0946-5520; Pei, Peng/0000-0002-9616-5066	National Natural Science Foundation of China [52066005]; Guizhou Science and Technology Department [[2020] 2Y025]; Guizhou Education Department Youth Science and Technology Talents Growth Project [KY[2017]117]; Natural Science Foundation of Guangdong Province [2020A1515011130]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guizhou Science and Technology Department; Guizhou Education Department Youth Science and Technology Talents Growth Project; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This project is supported by the following project funds: National Natural Science Foundation of China, Grant/Award Number: 52066005; Guizhou Science and Technology Department: Grant/Award Number: [2020] 2Y025; Guizhou Education Department Youth Science and Technology Talents Growth Project, Grant/Award Number: KY[2017]117; and Natural Science Foundation of Guangdong Province, Grant/Award Number: 2020A1515011130.	ASHRAE, 2004, 552013 ASHRAE ANSI; Bejan A, 2002, INT J ENERG RES, V26, P545, DOI 10.1002/er.804; Benli H, 2011, ENERG CONVERS MANAGE, V52, P581, DOI 10.1016/j.enconman.2010.07.033; Dehkordi SE, 2014, HYDROGEOL J, V22, P189, DOI 10.1007/s10040-013-1060-6; Emmi G, 2015, ENERG CONVERS MANAGE, V106, P660, DOI 10.1016/j.enconman.2015.10.016; Fleuchaus P, 2017, GEOTHERM ENERGY, V5, DOI 10.1186/s40517-017-0067-y; Friberg I., 2015, THESIS CHALMERS U TE; Hermans T, 2014, ENERGIES, V7, P5083, DOI 10.3390/en7085083; Jia P, 2014, THESIS BEIJING U TEC; Kavanaugh S., 2014, GEOTHERMAL HEATING C; Moran M., 2000, FUNDAMENTALS ENG THE, V4th ed.; Sanner B., 2016, EUR GEOTH C STRASB F, P1, DOI [10.1111/lic3.12402, DOI 10.1111/LIC3.12402]; Sarbu I, 2014, ENERG BUILDINGS, V70, P441, DOI 10.1016/j.enbuild.2013.11.068; Shang PY, 2016, PROCEDIA ENGINEER, V146, P585, DOI 10.1016/j.proeng.2016.06.406; Taira H, 2019, J ENERG RESOUR-ASME, V141, DOI 10.1115/1.4042403; Tang FJ, 2019, ENERG CONVERS MANAGE, V181, P571, DOI 10.1016/j.enconman.2018.12.044; Tissen C, 2019, GEOTHERM ENERGY, V7, DOI 10.1186/s40517-019-0125-8; Vienken T, 2019, GEOTHERM ENERGY, V7, DOI 10.1186/s40517-019-0123-x; Wong KV, 2015, J ENERG RESOUR-ASME, V137, DOI 10.1115/1.4028138; Yang S.-M., 2006, HEAT TRANSFER THEORY; Yang WB, 2013, APPL THERM ENG, V58, P626, DOI 10.1016/j.applthermaleng.2013.04.061; You T, 2018, ENERG CONVERS MANAGE, V178, P123, DOI 10.1016/j.enconman.2018.10.027; Yuzhou Cui, 2014, Advanced Materials Research, V960-961, P603, DOI 10.4028/www.scientific.net/AMR.960-961.603; Zeng ZT, 2018, ENERG BUILDINGS, V158, P971, DOI 10.1016/j.enbuild.2017.10.071; Zhang X., 2014, HEAT TRANSF; Zhou SY, 2016, SUSTAIN CITIES SOC, V24, P1, DOI 10.1016/j.scs.2016.03.014; Zhu N., 2007, ANAL HEAT ACCUMULATE	27	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252056	10.1371/journal.pone.0252056	http://dx.doi.org/10.1371/journal.pone.0252056			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038478	Green Published, gold			2022-12-26	WOS:000664633500042
J	Amark, H; Pilo, C; Varli, IH				Amark, Hanna; Pilo, Christina; Varli, Ingela Hulthen			Stillbirth in term and late term gestations in Stockholm during a 20-year period, incidence and causes	PLOS ONE			English	Article							ROUTINE ULTRASOUND; FETAL; RISK	Introduction The incidence of stillbirth has decreased marginally or remained stable during the past decades in high income countries. A recent report has shown Stockholm to have a lower incidence of stillbirth at term than other parts of Sweden. The risk of antepartum stillbirth increases in late term and postterm pregnancies which is one of the factors contributing to the current discussion regarding the optimal time of induction of labor due to postterm pregnancy. Material and methods This is a cohort study based on the Stockholm Stillbirth Database which contains all cases of stillbirth from 1998-2018 in Stockholm County. All cases were reviewed systematically and the cause of death was evaluated according to the Stockholm Stillbirth Classification. Stillbirths diagnosed between gestational week (GW) 37+0 and 40+6 n = 605 were compared to stillbirths diagnosed from GW 41+0 and onwards n = 157, according to the cause of stillbirth and pregnancy and maternal characteristics. The aim was to evaluate the incidence of stillbirth over time and the incidence of stillbirth diagnosed from GW 41+0. Results In Stockholm County the overall incidence of stillbirth has decreased from 4.6/1000 births during the period 1998-2004 to 3.4/1000 births during the period 2014-2018, p-value <0.001. When comparing the same time periods, the incidence of stillbirth diagnosed from GW 41+0 and onwards has decreased from 0.5/1000 births to 0.15/1000 births, p-value <0.001. Among women still pregnant at GW 41+0 the incidence of stillbirth has decreased from 1.8/ 1000 to 0.5/ 1000. When comparing stillbirths diagnosed at GW 37+0-40+6 with stillbirths diagnosed from GW 41+0 and onwards infection was a more common cause of stillbirth in the latter group. Conclusion In Stockholm County there was a decreasing incidence of stillbirth overall and in stillbirths diagnosed from 41+0 weeks of gestation and onwards during the period 1998-2018. In stillbirths diagnosed from GW 41+0 and onwards infection was a more common cause of death compared to stillbirths diagnosed between GW 37+0 and 40+6.	[Amark, Hanna] Karolinska Inst, Dept Clin Sci & Educ, Unit Obstet & Gynecol, Sodersjukhuset, Stockholm, Sweden; [Pilo, Christina] Sodersjukhuset Hosp, Dept Obstet & Gynecol, Stockholm, Sweden; [Varli, Ingela Hulthen] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital; Sodersjukhuset Hospital; Karolinska Institutet	Amark, H (corresponding author), Karolinska Inst, Dept Clin Sci & Educ, Unit Obstet & Gynecol, Sodersjukhuset, Stockholm, Sweden.	hanna.amark@sll.se		Hulthen Varli, Ingela/0000-0001-6801-9398	Spadbarnsfonden and KI Research Foundation	Spadbarnsfonden and KI Research Foundation	This study was supported by Spadbarnsfonden and KI Research Foundation.	Baardman ME, 2014, ULTRASOUND OBST GYN, V44, P58, DOI 10.1002/uog.13269; Balogun OA, 2018, OBSTET GYNECOL, V132, P1358, DOI 10.1097/AOG.0000000000002970; Bodnar LM, 2015, AM J CLIN NUTR, V102, P858, DOI 10.3945/ajcn.115.112250; Bring HS, 2014, ACTA OBSTET GYN SCAN, V93, P86, DOI 10.1111/aogs.12278; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; CHAMBERLAIN PF, 1984, AM J OBSTET GYNECOL, V150, P245, DOI 10.1016/S0002-9378(84)90359-4; Ekeus C, 2011, EUR J PUBLIC HEALTH, V21, P788, DOI 10.1093/eurpub/ckq200; Fahmi S, 2018, J MATERN-FETAL NEO M, V31, P2265, DOI 10.1080/14767058.2017.1340447; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; Graviditeter W., 2015, FORLOSSNINGAR NYFODD; Grunewald C, 2011, ACTA OBSTET GYN SCAN, V90, P26, DOI 10.1111/j.1600-0412.2010.01019.x; Hagberg H., 2008, Obstetrik, V1; Henrichs J, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5517; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lindqvist PG, 2014, BJOG-INT J OBSTET GY, V121, P1108, DOI 10.1111/1471-0528.12654; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Muglu J, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002838; PERSSON PH, 1986, ACTA OBSTET GYN SCAN, V65, P169, DOI 10.3109/00016348609158374; Phipps E, 2016, CLIN J AM SOC NEPHRO, V11, P1102, DOI 10.2215/CJN.12081115; Reitan T, 2017, NICOTINE TOB RES, V19, P282, DOI 10.1093/ntr/ntw188; Skrastad RB, 2013, ACTA OBSTET GYN SCAN, V92, P1353, DOI 10.1111/aogs.12249; Socialstyrelsen, 2020, REGL BLODG; Stacey T, 2019, BJOG-INT J OBSTET GY, V126, P973, DOI 10.1111/1471-0528.15659; Varli IH, 2008, ACTA OBSTET GYN SCAN, V87, P1202, DOI 10.1080/00016340802460271; Wennerholm UB, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6131; WHO, 1993, INT STAT CLASS DIS R, V2; Zeitlin J, 2016, J EPIDEMIOL COMMUN H, V70, P609, DOI 10.1136/jech-2015-207013	27	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251965	10.1371/journal.pone.0251965	http://dx.doi.org/10.1371/journal.pone.0251965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033674	Green Published, gold			2022-12-26	WOS:000664633100017
J	Freiman, JM; Fatch, R; Cheng, D; Emenyonu, N; Ngabirano, C; Geadas, C; Adong, J; Muyindike, WR; Linas, BP; Jacobson, KR; Hahn, JA				Freiman, J. Morgan; Fatch, Robin; Cheng, Debbie; Emenyonu, Nneka; Ngabirano, Christine; Geadas, Carolina; Adong, Julian; Muyindike, Winnie R.; Linas, Benjamin P.; Jacobson, Karen R.; Hahn, Judith A.			Prevalence of elevated liver transaminases and their relationship with alcohol use in people living with HIV on anti-retroviral therapy in Uganda	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; HEPATOTOXICITY; TUBERCULOSIS; PHOSPHATIDYLETHANOL; AMINOTRANSFERASE	Background Isoniazid preventive therapy (IPT) reduces tuberculosis reactivation and mortality among persons living with HIV (PLWH), yet hepatotoxicity concerns exclude "regular and heavy alcohol drinkers" from IPT. We aimed to determine the prevalence of elevated liver transaminases among PLWH on antiretroviral therapy (ART) who engage in alcohol use. Setting The Immune Suppression Syndrome Clinic of Mbarara, Uganda. Methods We defined elevated liver transaminases as >= 1.25 times (X) the upper limit of normal (ULN) for alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST). We evaluated the associations of current alcohol use and other variables of interest (sex, body mass index, and ART regimen) with elevated transaminases at study screening, using multivariable logistic regression to obtain adjusted odds ratios (aOR) and 95% confidence intervals (CI). Results Among 1301 participants (53% female, median age 39 years, 67.4% current alcohol use), 18.8% (95% CI: 16.8-21.1) had elevated transaminases pre-IPT, with few (1.1%) severe (>= 5X the ULN). The proportion with any elevation among those currently using alcohol and those abstaining was 22.3% and 11.6%, respectively (p<0.01). In multivariable analyses, those currently using alcohol had higher odds of elevated transaminases compared to those abstaining (aOR 1.65, 95% CI 1.15-2.37) as did males compared to females (aOR 2.68, 95% CI 1.90-3.78). Conclusions Pre-IPT elevated transaminases among PLWH receiving ART were common, similar to prior estimates, but severe elevations were rare. Current drinking and male sex were independently associated with elevated transaminases. Further research is needed to determine the implications of such transaminase elevations and alcohol use on providing IPT.	[Freiman, J. Morgan; Geadas, Carolina; Linas, Benjamin P.; Jacobson, Karen R.] Boston Med Ctr, Dept Med, Boston, MA USA; [Freiman, J. Morgan; Geadas, Carolina; Linas, Benjamin P.; Jacobson, Karen R.] Boston Med Ctr, Sect Infect Dis, Boston, MA USA; [Fatch, Robin; Emenyonu, Nneka; Hahn, Judith A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cheng, Debbie] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA USA; [Ngabirano, Christine; Adong, Julian; Muyindike, Winnie R.] Mbarara Univ Sci & Technol, Dept Med, Mbarara, Uganda; [Muyindike, Winnie R.] Mbarara Reg Referral Hosp, Mbarara, Uganda; [Hahn, Judith A.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Freiman, J. Morgan] Lahey Hosp & Med Ctr, Dept Med, Burlington, MA USA; [Freiman, J. Morgan] Lahey Hosp & Med Ctr, Sect Infect Dis, Burlington, MA USA	Boston Medical Center; Boston Medical Center; University of California System; University of California San Francisco; Boston University; Mbarara University of Science & Technology; University of California System; University of California San Francisco; Lahey Hospital & Medical Center; Lahey Hospital & Medical Center	Hahn, JA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Hahn, JA (corresponding author), Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA.	Judy.hahn@ucsf.edu	Hahn, Judith/J-5813-2014; Jacobson, Karen/AAX-9461-2021	Hahn, Judith/0000-0002-2697-8264; 	National Institute on Alcohol Abuse and Alcoholism [U01 AA020776, K24 AA022586, U24 AA020779]; National Institute of Allergy and Infectious Disease [P30 AI042853, R01 AI119037]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We received funding from the National Institute on Alcohol Abuse and Alcoholism U01 AA020776 (Judith A. Hahn), K24 AA022586 (Judith A. Hahn), and U24 AA020779 (Debbie Cheng), and the National Institute of Allergy and Infectious Disease P30 AI042853 (Debbie Cheng), and R01 AI119037 (Karen R Jacobson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoakwa K, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofu120; [Anonymous], 2018, TB CAUSES 1 3 HIV DE; Bonacini M, 2011, ANN HEPATOL, V10, P502, DOI 10.1016/S1665-2681(19)31519-4; Crum-Cianflone N, 2010, CLIN GASTROENTEROL H, V8, P183, DOI 10.1016/j.cgh.2009.09.025; Freiman JM, 2018, JAIDS-J ACQ IMM DEF, V77, P405, DOI 10.1097/QAI.0000000000001610; Hahn JA, 2018, JAIDS-J ACQ IMM DEF, V77, P492, DOI 10.1097/QAI.0000000000001624; Hahn JA, 2016, ALCOHOL CLIN EXP RES, V40, P2292, DOI 10.1111/acer.13213; Hahn JA, 2016, ADDICTION, V111, P272, DOI 10.1111/add.13173; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Iddi S, 2019, AIDS RES TREAT, V2019, DOI 10.1155/2019/6375714; Imtiaz S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00216-2017; Mulu W, 2013, ETHIOP J HEALTH SCI, V23, P217, DOI 10.4314/ejhs.v23i3.4; Muyindike WR, 2017, AIDS CARE, V29, P1442, DOI 10.1080/09540121.2017.1290209; Nagu TJ, 2012, HIV MED, V13, P541, DOI 10.1111/j.1468-1293.2012.01006.x; Ngongondo M, 2018, JAIDS-J ACQ IMM DEF, V78, P54, DOI [10.1097/qai.0000000000001641, 10.1097/QAI.0000000000001641]; Oh RC, 2017, AM FAM PHYSICIAN, V96, P709; Organization WH, 2018, LAT TUB INF UPD CONS; Radcke S, 2015, EUR J GASTROEN HEPAT, V27, P1, DOI 10.1097/MEG.0000000000000233; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Tsui JI, 2013, J STUD ALCOHOL DRUGS, V74, P266, DOI 10.15288/jsad.2013.74.266; U.S. Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases Division of AIDS, 2017, DIVISION AIDS DAIDS; Volkmann T, 2015, INT J TUBERC LUNG D, V19, P111, DOI 10.5588/ijtld.14.0516; Volkmann Tyson, 2016, J Tuberc Res, V4, P18; Weidle PJ, 2008, AIDS PATIENT CARE ST, V22, P787, DOI 10.1089/apc.2008.0020	24	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0250368	10.1371/journal.pone.0250368	http://dx.doi.org/10.1371/journal.pone.0250368			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061870	Green Published, gold			2022-12-26	WOS:000656813600010
J	Li, Y; Huang, YJ; Wen, YZ; Wang, D; Liu, HF; Li, YF; Zhao, J; An, LJ; Yu, F; Liu, XY				Li, Yan; Huang, Yujia; Wen, Yunze; Wang, Dan; Liu, Haofeng; Li, Yuanfeng; Zhao, Jun; An, Lijun; Yu, Fei; Liu, Xiayan			The domain of unknown function 4005 (DUF4005) in an Arabidopsis IQD protein functions in microtubule binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE SYNTHASE; HELICAL GROWTH; CORTICAL MICROTUBULES; PLASMA-MEMBRANE; CELL ELONGATION; ORGANIZATION; ASSOCIATION; ORIENTATION; INTERACT; ENCODES	The dynamic responses of microtubules (MTs) to internal and external signals are modulated by a plethora of microtubule-associated proteins (MAPs). In higher plants, many plant-specific MAPs have emerged during evolution as advantageous to their sessile lifestyle. Some members of the IQ67 domain (IQD) protein family have been shown to be plant-specific MAPs. However, the mechanisms of interaction between IQD proteins and MTs remain elusive. Here we demonstrate that the domain of unknown function 4005 (DUF4005) of the Arabidopsis IQD family protein ABS6/AtIQD16 is a novel MT-binding domain. Cosedimentation assays showed that the DUF4005 domain binds directly to MTs in vitro. GFP-labeled DUF4005 also decorates all types of MT arrays tested in vivo. Furthermore, we showed that a conserved stretch of 15 amino acid residues within the DUF4005 domain, which shares sequence similarity with the C-terminal MT-binding domain of human MAP Kif18A, is required for the binding to MTs. Transgenic lines overexpressing the DUF4005 domain displayed a spectrum of developmental defects, including spiral growth and stunted growth at the organismal level. At the cellular level, DUF4005 overexpression caused defects in epidermal pavement cell and trichome morphogenesis, as well as abnormal anisotropic cell elongation in the hypocotyls of dark-grown seedlings. These data establish that the DUF4005 domain of ABS6/AtIQD16 is a new MT-binding domain, overexpression of which perturbs MT homeostasis in plants. Our findings provide new insights into the MT-binding mechanisms of plant IQD proteins.	[Li, Yan; Huang, Yujia; Wen, Yunze; Wang, Dan; Liu, Haofeng; Li, Yuanfeng; Zhao, Jun; An, Lijun; Yu, Fei; Liu, Xiayan] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Li, Yan; Huang, Yujia; Wen, Yunze; Wang, Dan; Liu, Haofeng; Li, Yuanfeng; Zhao, Jun; An, Lijun; Yu, Fei; Liu, Xiayan] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Yu, Fei] Northwest A&F Univ, Inst Future Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Liu, XY (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Liu, XY (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	xyliu@nwafu.edu.cn			National Natural Science Foundation of China [31770205, 31970186, 31870268]; Natural Science Basic Research Program of Shaanxi [2021JC-17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Program of Shaanxi	This work was supported by the National Natural Science Foundation of China (31770205 and 31970186 to X. L. and 31870268 to F. Y.) and Natural Science Basic Research Program of Shaanxi (Program No. 2021JC-17 to X. L.).	Abel S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-72; Alberico EO, 2017, METHOD CELL BIOL, V141, P115, DOI 10.1016/bs.mcb.2017.06.015; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Ambrose JC, 2008, MOL PLANT, V1, P950, DOI 10.1093/mp/ssn054; Balkunde R, 2019, J BIOL CHEM, V294, P16374, DOI 10.1074/jbc.RA119.008866; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Bodakuntla S, 2019, TRENDS CELL BIOL, V29, P804, DOI 10.1016/j.tcb.2019.07.004; Bringmann M, 2012, PLANT CELL, V24, P163, DOI 10.1105/tpc.111.093575; Burstenbinder K, 2017, PLANT PHYSIOL, V173, P1692, DOI 10.1104/pp.16.01743; Burstenbinder K, 2013, J BIOL CHEM, V288, P1871, DOI 10.1074/jbc.M112.396200; Buschmann H, 2004, CURR BIOL, V14, P1515, DOI 10.1016/j.cub.2004.08.033; Buschmann H, 2009, PLANT CELL, V21, P2090, DOI 10.1105/tpc.108.061242; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Duan PG, 2017, MOL PLANT, V10, P685, DOI 10.1016/j.molp.2017.03.009; Elliott A, 2018, PLANT PHYSIOL, V176, P94, DOI 10.1104/pp.17.01329; Fan YW, 2018, CURR BIOL, V28, P987, DOI 10.1016/j.cub.2018.02.014; Furutani I, 2000, DEVELOPMENT, V127, P4443; Galva C, 2014, PLANT CELL, V26, P4409, DOI 10.1105/tpc.114.131482; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Hamada T, 2014, INT REV CEL MOL BIO, V312, P1, DOI 10.1016/B978-0-12-800178-3.00001-4; Hamant O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10207-y; Ishida T, 2007, P NATL ACAD SCI USA, V104, P8544, DOI 10.1073/pnas.0701224104; Kolling M, 2019, J EXP BOT, V70, P387, DOI 10.1093/jxb/ery397; Lazzaro MD, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01766; Lefevre J, 2011, J BIOL CHEM, V286, P3065, DOI 10.1074/jbc.M110.144089; Li YF, 2021, J INTEGR PLANT BIOL, V63, P646, DOI 10.1111/jipb.13003; Liang H, 2018, PLANT PHYSIOL, V177, P1555, DOI 10.1104/pp.18.00558; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; Livanos P, 2019, ANNU REV PLANT BIOL, V70, P239, DOI 10.1146/annurev-arplant-050718-100444; Luo DL, 1999, DEVELOPMENT, V126, P5547; Mitra D, 2019, J EXP BOT, V70, P529, DOI 10.1093/jxb/ery395; Nakajima K, 2004, PLANT CELL, V16, P1178, DOI 10.1105/tpc.017830; Nakamura M, 2018, J CELL BIOL, V217, P915, DOI 10.1083/jcb.201708130; Nakamura M, 2009, J CELL SCI, V122, P2208, DOI 10.1242/jcs.044131; Nishiyama T, 2018, CELL, V174, P448, DOI 10.1016/j.cell.2018.06.033; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Schaefer E, 2017, SCIENCE, V356, P186, DOI 10.1126/science.aal3016; Sedbrook JC, 2004, PLANT CELL, V16, P1506, DOI 10.1105/tpc.020644; Shoji T, 2004, PLANT PHYSIOL, V136, P3933, DOI 10.1104/pp.104.051748; Smertenko A, 2017, TRENDS CELL BIOL, V27, P885, DOI 10.1016/j.tcb.2017.08.008; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Sugiyama Y, 2017, CURR BIOL, V27, P2522, DOI 10.1016/j.cub.2017.06.059; Thitamadee S, 2002, NATURE, V417, P193, DOI 10.1038/417193a; Weaver LN, 2011, CURR BIOL, V21, P1500, DOI 10.1016/j.cub.2011.08.005; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Wightman R, 2013, CURR BIOL, V23, P1902, DOI 10.1016/j.cub.2013.07.061; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	51	4	4	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100849	10.1016/j.jbc.2021.100849	http://dx.doi.org/10.1016/j.jbc.2021.100849			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058197	Green Published, gold			2022-12-26	WOS:000678068400049
J	Kyei-Arthur, F; Agyekum, MW; Afrifa-Anane, GF				Kyei-Arthur, Frank; Agyekum, Martin Wiredu; Afrifa-Anane, Grace Frempong			The association between paternal characteristics and exclusive breastfeeding in Ghana	PLOS ONE			English	Article							MOTHERS; DETERMINANTS; FATHERS; BARRIERS	Background Studies have shown that partners play an influential role in exclusive breastfeeding practice and that they can act as either deterrents or supporters to breastfeeding. However, there are limited studies on the influence of partners' characteristics on exclusive breastfeeding in Ghana. This study examined the association between partners' characteristics and exclusive breastfeeding in Ghana. Methods This cross-sectional study used data from the 2014 Ghana Demographic and Health Survey. Infants less than 6 months old (exclusively breastfed or not) with maternal and paternal characteristics were included in the study. A total of 180 participants were used for the study. A binary logistic regression was used to examine the influence of partners' characteristics on exclusive breastfeeding. Results Partners' characteristics such as education, desire for children, religion, and children ever born were associated with exclusive breastfeeding. Mothers whose partners had primary education (AOR = 0.12; CI 95%: 0.02-0.93; p = 0.04) were less likely to practice exclusive breastfeeding compared to those whose partners had no formal education. Also, mothers whose partners desired more children (AOR = 0.20; CI 95%: 0.06-0.70; p = 0.01) were less likely to practice exclusive breastfeeding compared to those whose partners desire fewer children. Conclusion Improving EBF requires the involvement of partners in exclusive breastfeeding campaigns/programmes. A more couple-oriented approach is required by health practitioners to educate and counsel both mothers and partners on the importance of exclusive breastfeeding in Ghana.	[Kyei-Arthur, Frank; Agyekum, Martin Wiredu; Afrifa-Anane, Grace Frempong] Univ Ghana, Reg Inst Populat Studies, Legon, Accra, Ghana; [Kyei-Arthur, Frank; Afrifa-Anane, Grace Frempong] Univ Environm & Sustainable Dev, Dept Environm & Publ Hlth, Somanya, Eastern Region, Ghana	University of Ghana	Kyei-Arthur, F (corresponding author), Univ Ghana, Reg Inst Populat Studies, Legon, Accra, Ghana.; Kyei-Arthur, F (corresponding author), Univ Environm & Sustainable Dev, Dept Environm & Publ Hlth, Somanya, Eastern Region, Ghana.	fkyei-arthur@uesd.edu.gh	Agyekum, Martin Wiredu/AGZ-9620-2022; Afrifa-Anane, Grace Frempong/AFU-6337-2022	Agyekum, Martin Wiredu/0000-0003-2268-4856; Kyei-Arthur, Frank/0000-0001-9794-8524; Frempong Afrifa-Anane, Grace/0000-0003-1958-5646				Abekah-Nkrumah G, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-00300-0; Aborigo RA, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-76; Acheampong AK, 2020, S AFR FAM PRACT, V62, DOI 10.4102/safp.v62i1.5108; Adda L, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03272-5; Agrasada GV, 2011, ASIA PAC J CLIN NUTR, V20, P62; Agyekum MW., 2019, THESIS U GHANA CITTY; Amosa IA., 2019, FIGH FAST; Apanga P. A., 2015, British Journal of Medicine and Medical Research, V8, P343, DOI 10.9734/BJMMR/2015/17261; Arifeen S, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e67; Asare BYA, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0156-y; Baranowski T, 2003, OBES RES, V11, p23S, DOI 10.1038/oby.2003.222; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; CALDWELL JC, 1980, POPUL DEV REV, V6, P225, DOI 10.2307/1972729; Chowdhury R, 2015, ACTA PAEDIATR, V104, P96, DOI 10.1111/apa.13102; Chudasama Rajesh K, 2009, J Clin Med Res, V1, P102, DOI 10.4021/jocmr2009.06.1242; Diji AKA, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0104-2; Dun-Dery EJ, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0083-8; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Frempong GA, 2017, J POPUL RES, V34, P313, DOI 10.1007/s12546-017-9188-1; Ghana Health Service, 2007, NAT INF YOUNG CHILD; Ghana Health Service, 2005, IM GHAN FREE MALN CO; Ghana News Agency, 2006, GHANA NEWS AGEN 0116; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF International, 2015, GHAN DEM HLTH SURV 2; Global Breastfeeding Collective, 2019, GLOB BREASTF SCOR 20; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Jacdonmi I, 2016, INT J HLTH SCI RES, V6; Kavle JA, 2017, PUBLIC HEALTH NUTR, V20, P3120, DOI 10.1017/S1368980017002531; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Ludvigsson JF, 2005, ACTA PAEDIATR, V94, P1310, DOI [10.1080/08035250510037588, 10.1111/j.1651-2227.2005.tb02093.x]; Mahesh PKB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6037-x; Manyeh AK, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-0253-6; Mascarenhas Maria Laura W., 2006, J. Pediatr. (Rio J.), V82, P289, DOI [10.2223/JPED.1506, 10.1590/S0021-75572006000500011]; Mgongo M, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1962-3; Ministry of Health, 2000, GHAN BREASTF PROM RE; Mogre V, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0071-z; Mueller MK, 2018, BMC PUBLIC HEALTH, V18, DOI [10.1186/s12889-018-5188-0, 10.1186/s12889-018-5585-4]; Nkrumah J, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0100-6; Nsiah-Asamoah C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239278; Nurturing the Health Wealth of Nations, 2017, INV CAS BREASTF; Susin LRO, 2008, J HUM LACT, V24, P386, DOI 10.1177/0890334408323545; Ogbo FA, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020413; Ogbo FA, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173152; Olufunlayo TF, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12788; Onah S, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-6; Operto E, 2020, INT J HEALTH PLAN M, V35, P888, DOI 10.1002/hpm.2966; orld Health Organization (WHO), 1991, IND ASS BREASTF PRAC; Pickin M., 2009, BRIT J MIDWIFERY, V17, P223, DOI DOI 10.12968/bjom.2009.17.4.41670; Pisacane A, 2005, PEDIATRICS, V116, pE494, DOI 10.1542/peds.2005-0479; Rempel LA, 2011, J HUM LACT, V27, P115, DOI 10.1177/0890334410390045; SPRING, 2017, OPP INT NUTR AGR INF; Talbert A, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-00260-5; Tampah-Naah AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215285; Tampah-Naah AM, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-13; Tan K L Jr, 2009, Malays J Nutr, V15, P11; Tawiah-Agyemang C, 2008, J PERINATOL, V28, pS46, DOI 10.1038/jp.2008.173; Tohotoa J, 2009, INT BREASTFEED J, V4, DOI 10.1186/1746-4358-4-15; Tsai SY, 2014, BREASTFEED MED, V9, P222, DOI 10.1089/bfm.2013.0127; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; World Health Organization, 2013, ESS NUTR ACT IMPR MA; World Health Organization and UNICEF, 2009, GLOB ACT PLAN PREV C	60	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252517	10.1371/journal.pone.0252517	http://dx.doi.org/10.1371/journal.pone.0252517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081726	Green Published, gold			2022-12-26	WOS:000664639200023
J	Amador, S; Rapaport, P; Lang, I; Sommerlad, A; Mukadam, N; Stringer, A; Hart, N; Nurock, S; Livingston, G				Amador, Sarah; Rapaport, Penny; Lang, Iain; Sommerlad, Andrew; Mukadam, Naaheed; Stringer, Aisling; Hart, Nicola; Nurock, Shirley; Livingston, Gill			Implementation of START (STrAtegies for RelaTives) for dementia carers in the third sector: Widening access to evidence-based interventions	PLOS ONE			English	Article							FAMILY CARERS; PSYCHOLOGICAL INTERVENTION; CLINICAL EFFECTIVENESS; COST-EFFECTIVENESS; MENTAL-HEALTH; PEOPLE; ANXIETY; DEPRESSION; CAREGIVERS; FRAMEWORK	Family members remain the main care providers for the increasing numbers of people with dementia, and often become depressed or anxious. In an implementation research project, we aimed to widen access to Strategies for RelaTives (START), a clinically and cost-effective intervention for the mental health of family carers, by laying the foundations for its implementation in the third sector. We used the integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) framework to guide implementation of START, a manual-based, individually-delivered, multicomponent eight-session coping strategy intervention. We interviewed a maximum variation sample of twenty-seven stakeholders from the English Alzheimer's Society (AS), about possible difficulties in management, training, and delivery of START. We trained and supervised three AS dementia support workers in different locations, to each deliver START to three family carers. Two researchers independently coded pre-intervention interviews for themes. We assessed intervention feasibility through monitoring delivery fidelity, rating audio-recordings from 1-5 (5 being high) and interviewing facilitators, family carers and AS managers about their experiences. We assessed effectiveness on family carers' mental health using the Hospital Anxiety and Depression Scale (HADS) before and after receiving START (scores 0-42). We changed START's format by reflecting carer diversity more and increasing carer stories prominence, but core content or delivery processes were unchanged. All carers received START and attended every session. The mean fidelity score was 4.2. Mean HADS-total score reduced from baseline 18.4 (standard deviation 7.4) to follow-up 15.8 (9.7). Six (67%) carers scored as clinically depressed on baseline HADS and 2 (22%) at follow-up. Facilitators and carers rated START positively. Appropriately experienced third sector workers can be trained and supervised to deliver START and it remains effective. This has the potential for widened access at scale.	[Amador, Sarah; Rapaport, Penny; Sommerlad, Andrew; Mukadam, Naaheed; Stringer, Aisling; Livingston, Gill] UCL, London, England; [Lang, Iain] Univ Exeter, Exeter, Devon, England; [Hart, Nicola; Nurock, Shirley] Alzheimers Soc, London, England	University of London; University College London; University of Exeter	Amador, S (corresponding author), UCL, London, England.	s.amador@ucl.ac.uk		Livingston, Gill/0000-0001-6741-5516; Lang, Iain/0000-0002-8473-2350; Rapaport, Penny/0000-0003-0479-6950	Alzheimer's Society, UK [367 (AS-IGF-16-001)]	Alzheimer's Society, UK	This work was funded by grant number 367 (AS-IGF-16-001) awarded to GL by the Alzheimer's Society, UK (https://www.alzheimers.org.uk/). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach-Mortensen AM, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0789-7; Barry TL, 2007, J NURS MEAS, V15, P24, DOI 10.1891/106137407780851778; Beecham J., 2001, MEASURING MENTAL HLT, P200; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Cooper C, 2007, INT PSYCHOGERIATR, V19, P175, DOI 10.1017/S1041610206004297; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Harvey G, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0398-2; Kirk MA, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0437-z; Kitson A, 1998, QUAL HEALTH CARE, V7, P149, DOI 10.1136/qshc.7.3.149; Knapp M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6342; Li R, 2014, J AFFECT DISORDERS, V168, P298, DOI 10.1016/j.jad.2014.07.008; Livingston G, 2020, BRIT J PSYCHIAT, V216, P35, DOI 10.1192/bjp.2019.160; Livingston G, 2014, HEALTH TECHNOL ASSES, V18, pVII, DOI 10.3310/hta18610; Livingston G, 2014, LANCET PSYCHIAT, V1, P539, DOI 10.1016/S2215-0366(14)00073-X; Livingston G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6276; Lord K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017759; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Pettit T, 2001, INT J GERIATR PSYCH, V16, P1061, DOI 10.1002/gps.479; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Sommerlad A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005273; Spijker A, 2008, J AM GERIATR SOC, V56, P1116, DOI 10.1111/j.1532-5415.2008.01705.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	24	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0250410	10.1371/journal.pone.0250410	http://dx.doi.org/10.1371/journal.pone.0250410			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QL	34077465	Green Published, gold			2022-12-26	WOS:000664638500005
J	Crooke, SN; Ovsyannikova, IG; Kennedy, RB; Poland, GA				Crooke, Stephen N.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Poland, Gregory A.			Identification of naturally processed Zika virus peptides by mass spectrometry and validation of memory T cell recall responses in Zika convalescent subjects	PLOS ONE			English	Article							CLASS-I; EPITOPE PREDICTION; MEASLES; FETAL; INFECTION; DISEASE; PROTEIN; IMMUNOGENICITY; TRANSMISSION; PROTECTION	Once an obscure pathogen, Zika virus (ZIKV) has emerged as a significant global public health concern. Several studies have linked ZIKV infection in pregnant women with the development of microcephaly and other neurological abnormalities, emphasizing the need for a safe and effective vaccine to combat the spread of this disease. Preclinical studies and vaccine development efforts have largely focused on the role of humoral immunity in disease protection. Consequently, relatively little is known in regard to cellular immunity against ZIKV, although an effective vaccine will likely need to engage both the humoral and cellular arms of the immune system. To that end, we utilized two-dimensional liquid chromatography coupled with tandem mass spectrometry to identify 90 ZIKV peptides that were naturally processed and presented on HLA class I and II molecules (HLA-A*02:01/HLA-DRB1*04:01) of an immortalized B cell line infected with ZIKV (strain PRVABC59). Sequence identity clustering was used to filter the number of candidate peptides prior to evaluating memory T cell recall responses in ZIKV convalescent subjects. Peptides that individually elicited broad (4 of 7 subjects) and narrow (1 of 7 subjects) T cell responses were further analyzed using a suite of predictive algorithms and in silico modeling to evaluate HLA binding and peptide structural properties. A subset of nine broadly reactive peptides was predicted to provide robust global population coverage (97.47% class I; 70.74% class II) and to possess stable structural properties amenable for vaccine formulation, highlighting the potential clinical benefit for including ZIKV T cell epitopes in experimental vaccine formulations.	[Crooke, Stephen N.; Ovsyannikova, Inna G.; Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA	Mayo Clinic	Poland, GA (corresponding author), Mayo Clin, Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Crooke, Stephen/0000-0002-4711-5767; Kennedy, Rick/0000-0001-6164-4967; Poland, Gregory/0000-0001-5057-4457	Mayo Clinic Department of General Internal Medicine; Maurice R. Hilleman Early-Stage Career Investigator Award	Mayo Clinic Department of General Internal Medicine; Maurice R. Hilleman Early-Stage Career Investigator Award	The research presented here was supported by funding from the Mayo Clinic Department of General Internal Medicine and the Maurice R. Hilleman Early-Stage Career Investigator Award to SNC (National Foundation for Infectious Diseases and Merck & Co. Inc.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157; Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA; Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bailey MJ, 2019, MBIO, V10, DOI [10.1128/mBio.02861-18, 10.1128/mbio.02861-18]; Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0; Beaufays J, 2012, J PEPT SCI, V18, P17, DOI 10.1002/psc.1410; Brady OJ, 2019, LANCET, V394, P1991, DOI 10.1016/S0140-6736(19)32790-4; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Camacho CJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000231; Camproux AC, 2004, J MOL BIOL, V339, P591, DOI 10.1016/j.jmb.2004.04.005; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; Grubor-Bauk B, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2388; Henderson AD, 2020, ELIFE, V9, DOI 10.7554/eLife.48460; Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889; Johansson MA, 2016, NEW ENGL J MED, V375; Johnson KL, 2009, VACCINE, V28, P38, DOI 10.1016/j.vaccine.2009.09.126; Johnson KL, 2005, J PROTEOME RES, V4, P2243, DOI 10.1021/pr0501416; Johnson KL, 2005, J AM SOC MASS SPECTR, V16, P1812, DOI 10.1016/j.jasms.2005.07.015; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lima NS, 2017, TRENDS IMMUNOL, V38, P594, DOI 10.1016/j.it.2017.05.004; Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9; Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Moore TV, 2020, NAT REV CLIN ONCOL, V17, P71, DOI 10.1038/s41571-019-0315-0; Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Ovsyannikova IG, 2007, CLIN PHARMACOL THER, V82, P644, DOI 10.1038/sj.clpt.6100389; Ovsyannikova IG, 2004, J VIROL, V78, P42, DOI 10.1128/JVI.78.1.42-51.2004; Ovsyannikova IG, 2003, VIROLOGY, V312, P495, DOI 10.1016/S0042-6822(03)00281-2; Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16; Philip C, 2019, J PUBLIC HEALTH MAN, V25, P277, DOI [10.1097/phh.0000000000000990, 10.1097/PHH.0000000000000990]; Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011; Poland GA., 2018, LANCET INFECT DIS, DOI [10.1016/S1473-3099%2818%2930063-X, DOI 10.1016/S1473-3099%2818%2930063-X]; Poland GA, 2019, MAYO CLIN PROC, V94, P2572, DOI 10.1016/j.mayocp.2019.05.016; Putz MM, 2003, INT J PARASITOL, V33, P525, DOI 10.1016/S0020-7519(03)00062-6; Rocklov J, 2020, NAT IMMUNOL, V21, P479, DOI 10.1038/s41590-020-0648-y; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744; Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564; Sarkizova S, 2020, NAT BIOTECHNOL, V38, P199, DOI 10.1038/s41587-019-0322-9; Scheiblhofer S, 2017, EXPERT REV VACCINES, V16, P479, DOI 10.1080/14760584.2017.1306441; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027; STORKUS WJ, 1993, J IMMUNOTHER, V14, P94, DOI 10.1097/00002371-199308000-00003; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Wilkins MR, 1999, METH MOL B, V112, P531; World Health Organization WH, 2016, GUILLAIN BARRE SYNDR; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974	62	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252198	10.1371/journal.pone.0252198	http://dx.doi.org/10.1371/journal.pone.0252198			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077451	Green Published, gold			2022-12-26	WOS:000664638500032
J	Liao, YN; Liu, Y; Shao, ZL; Xia, XH; Deng, YF; Cai, JY; Yao, LY; He, JC; Yu, CF; Hu, TM; Sun, WS; Liu, F; Tang, DL; Liu, JB; Huang, HBA				Liao, Yuning; Liu, Yuan; Shao, Zhenlong; Xia, Xiaohong; Deng, Yuanfei; Cai, Jianyu; Yao, Leyi; He, Jinchan; Yu, Cuifu; Hu, Tumei; Sun, Wenshuang; Liu, Fang; Tang, Daolin; Liu, Jinbao; Huang, Hongbiao			A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance	ONCOGENE			English	Article							SIX1; PROLIFERATION; HOMEOPROTEIN; INHIBITOR; APOPTOSIS; AR-V7	Prostate cancer (PC) is the second most common cancer with limited treatment option in males. Although the reactivation of embryonic signals in adult cells is one of the characteristics of cancer, the underlying protein degradation mechanism remains elusive. Here, we show that the molecular chaperone GRP75 is a key player in PC cells by maintaining the protein stability of SIX1, a transcription factor for embryonic development. Mechanistically, GRP75 provides a platform to recruit the deubiquitinating enzyme USP1 to inhibit K48-linked polyubiquitination of SIX1. Structurally, the C-terminus of GRP75 (433-679 aa) contains a peptide binding domain, which is required for the formation of GRP75-USP1-SIX1 protein complex. Functionally, pharmacological or genetic inhibition of the GRP75-USP1-SIX1 protein complex suppresses tumor growth and overcomes the castration resistance of PC cells in vitro and in xenograft mouse models. Clinically, the protein expression of SIX1 in PC tumor tissues is positively correlated with the expression of GRP75 and USP1. These new findings not only enhance our understanding of the protein degradation mechanism, but also may provide a potential way to enhance the anti-cancer activity of androgen suppression therapy.	[Liao, Yuning; Liu, Yuan; Shao, Zhenlong; Xia, Xiaohong; Liu, Jinbao; Huang, Hongbiao] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou, Guangdong, Peoples R China; [Liao, Yuning; Liu, Yuan; Shao, Zhenlong; Xia, Xiaohong; Cai, Jianyu; Yao, Leyi; He, Jinchan; Yu, Cuifu; Hu, Tumei; Sun, Wenshuang; Liu, Jinbao; Huang, Hongbiao] Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou Municipal & Guangdong Prov Key Lab Prot, Guangzhou, Guangdong, Peoples R China; [Deng, Yuanfei; Liu, Fang] First Peoples Hosp Foshan, Dept Pathol, Foshan, Guangdong, Peoples R China; [Tang, Daolin] Univ Texas Southwestern Med Ctr Dallas, Dept Surg, Dallas, TX USA	Guangzhou Medical University; Guangzhou Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, JB; Huang, HBA (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Guangzhou, Guangdong, Peoples R China.; Liu, JB; Huang, HBA (corresponding author), Guangzhou Med Univ, Sch Basic Med Sci, Guangzhou Municipal & Guangdong Prov Key Lab Prot, Guangzhou, Guangdong, Peoples R China.	jliu@gzhmu.edu.cn; hhb800616@126.com	Tang, Daolin/B-2905-2010; Tang, Daolin/ABD-5062-2021	Tang, Daolin/0000-0002-1903-6180; Liao, Yuning/0000-0003-0343-1933; shao, zhenlong/0000-0001-8039-8706	National Natural Science Foundation of China [82072810, 82002481, 81972399]; Science and Technology Program of Guangzhou [202002030107]; projects from Foundation for Higher Education of Guangdong [2019KQNCX113]; Special fund of Foshan Summit plan [2019D001]; Foshan Science technology and Medical foundation [1920001000958]; Guangzhou key medical discipline construction project fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangzhou; projects from Foundation for Higher Education of Guangdong; Special fund of Foshan Summit plan; Foshan Science technology and Medical foundation; Guangzhou key medical discipline construction project fund	This work was supported by National Natural Science Foundation of China (82072810, 82002481, 81972399), the Science and Technology Program of Guangzhou (202002030107), projects from Foundation for Higher Education of Guangdong (2019KQNCX113), Special fund of Foshan Summit plan (2019D001), Grant from Foshan Science technology and Medical foundation (1920001000958) and Guangzhou key medical discipline construction project fund.	Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Behbakht K, 2007, CANCER RES, V67, P3036, DOI 10.1158/0008-5472.CAN-06-3755; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burress H, 2019, J BIOL CHEM, V294, P12122, DOI 10.1074/jbc.RA119.008568; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Chen Z, 2018, P NATL ACAD SCI USA, V115, P6810, DOI 10.1073/pnas.1718811115; Christensen KL, 2007, ONCOGENE, V26, P3406, DOI 10.1038/sj.onc.1210122; Culig Z, 2014, CANCER METAST REV, V33, P413, DOI 10.1007/s10555-013-9474-0; Fizazi K, 2020, LANCET ONCOL; Fushimi C, 2018, ANN ONCOL, V29, P979, DOI 10.1093/annonc/mdx771; He L, 2018, CELL RES, V28, P934, DOI 10.1038/s41422-018-0079-6; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Li L, 2018, CANCER CELL, V33, P368, DOI 10.1016/j.ccell.2018.01.010; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Li ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059203; Liang Q, 2014, NAT CHEM BIOL, V10, P298, DOI [10.1038/NCHEMBIO.1455, 10.1038/nchembio.1455]; Liao YN, 2020, THERANOSTICS, V10, P3366, DOI 10.7150/thno.41849; Liao YN, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0092-z; Liao YN, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1165-4; Liao YN, 2018, ONCOGENE, V37, P1896, DOI 10.1038/s41388-017-0069-z; Liao YN, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.477; Lim KS, 2018, MOL CELL, V72, P925, DOI 10.1016/j.molcel.2018.10.045; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Ng KT, 2006, BRIT J CANCER, V95, P1050, DOI 10.1038/sj.bjc.6603399; Ryu SW, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000606; Saad F, 2020, EUR UROL; Starenki D, 2015, ONCOGENE, V34, P4624, DOI 10.1038/onc.2014.392; Tian SR, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01508-0; Tucci M, 2019, CANCER TREAT REV, V74, P35, DOI 10.1016/j.ctrv.2019.01.002; Wen SM, 2020, ONCOGENE, V39, P6556, DOI 10.1038/s41388-020-01456-z; Wu KM, 2013, CANCER RES, V73, P4488, DOI 10.1158/0008-5472.CAN-12-4078; Wu PK, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay1478; Wu PK, 2020, ONCOGENE, V39, P4257, DOI 10.1038/s41388-020-1285-5; Wu PK, 2013, MOL CELL BIOL, V33, P4051, DOI 10.1128/MCB.00021-13; Xia XH, 2019, CANCER LETT, V465, P118, DOI 10.1016/j.canlet.2019.09.003; Yi X, 2008, MOL CELL PROTEOMICS, V7, P315, DOI 10.1074/mcp.M700116-MCP200; Zeng J, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0215-z; Zhu ZL, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1054-7	38	8	8	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2021	40	25					4291	4306		10.1038/s41388-021-01851-0	http://dx.doi.org/10.1038/s41388-021-01851-0		JUN 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SY4AZ	34079090				2022-12-26	WOS:000657217400007
J	Qiao, YN; Jin, T; Guan, SD; Cheng, SJ; Wen, SY; Zeng, H; Zhao, MJ; Yang, LP; Wan, XY; Qiu, YX; Li, Q; Liu, MR; Hou, YX				Qiao, Yina; Jin, Ting; Guan, Shengdong; Cheng, Shaojie; Wen, Siyang; Zeng, Huan; Zhao, Maojia; Yang, Liping; Wan, Xueying; Qiu, Yuxiang; Li, Qiao; Liu, Manran; Hou, Yixuan			Long non-coding RNA Lnc-408 promotes invasion and metastasis of breast cancer cell by regulating LIMK1	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LNCRNA HOTAIR; MIGRATION; MOTILITY; GROWTH; DIFFERENTIATION; PROGRESSION; STATISTICS; ACTIVATION; APOPTOSIS	Invasion and metastasis are the leading causes of death in patients with breast cancer (BC), and epithelial-mesenchymal transformation (EMT) plays an essential role in this process. Here, we found that Lnc-408, a novel long noncoding RNA (lncRNA), is significantly upregulated in BC cells undergoing EMT and in BC tumor with lymphatic metastases compared with those without lymphatic metastases. Lnc-408 can enhance BC invasion and metastasis by regulating the expression of LIMK1. Mechanistically, Lnc-408 serves as a sponge for miR-654-5p to relieve the suppression of miR-654-5p on its target LIMK1. Knockdown or knockout of Lnc-408 in invasive BC cells clearly decreased LIMK1 levels, and ectopic Lnc-408 in MCF-7 cells increased LIMK1 expression to promote cell invasion. Lnc-408-mediated enhancement of LIMK1 plays a key role in cytoskeletal stability and promotes invadopodium formation in BC cells via p-cofilin/F-actin. In addition, the increased LIMK1 also facilitates the expression of MMP2, ITGB1, and COL1A1 by phosphorylating CREB. In conclusion, our findings reveal that Lnc-408 promotes BC invasion and metastasis via the Lnc-408/miR-654-5p/LIMK1 axis, highlighting a novel promising target for the diagnosis and treatment of BC.	[Qiao, Yina; Jin, Ting; Guan, Shengdong; Cheng, Shaojie; Wen, Siyang; Zeng, Huan; Zhao, Maojia; Yang, Liping; Wan, Xueying; Qiu, Yuxiang; Li, Qiao; Liu, Manran] Chongqing Med Univ, Chinese Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China; [Hou, Yixuan] Chongqing Med Univ, Expt Teaching & Lab Management Ctr, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Hou, YX (corresponding author), Chongqing Med Univ, Expt Teaching & Lab Management Ctr, Chongqing, Peoples R China.	yixuan_hou@cqmu.edu.cn		Qiao, Yina/0000-0001-5351-0870	National Natural Science Foundation of China (NSFC) [81874199, 31671481, 81773078, 81560430]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of China (NSFC 81773078, NSFC 81560430) for YH. And also supported by the National Natural Science Foundation of China (NSFC 81874199, and NSFC 31671481) for ML.	Aggelou H, 2018, VIRCHOWS ARCH, V472, P727, DOI 10.1007/s00428-018-2298-0; Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Chen PX, 2014, ONCOL REP, V32, P2070, DOI 10.3892/or.2014.3461; Chi YJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091015; Collette J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112319; Dong LF, 2019, J CELL BIOCHEM, V120, P4851, DOI 10.1002/jcb.27435; Fan CN, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1640-2; Grayson M, 2012, NATURE, V485, pS49, DOI 10.1038/485S49a; Hu P, 2014, CELL SIGNAL, V26, P83, DOI 10.1016/j.cellsig.2013.10.001; Huang FD, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4914707; Huang QY, 2019, CANCERS, V11, DOI 10.3390/cancers11111802; Huang Y, 2018, J CELL MOL MED, V22, P5768, DOI 10.1111/jcmm.13866; Jang I, 2012, KOREAN J PHYSIOL PHA, V16, P159, DOI 10.4196/kjpp.2012.16.3.159; Kang CG, 2015, BIOORG MED CHEM LETT, V25, P1956, DOI 10.1016/j.bmcl.2015.03.024; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030; Li DF, 2018, MOL CELL BIOCHEM, V444, P169, DOI 10.1007/s11010-017-3241-4; Li M, 2017, MOL ONCOL, V11, P1698, DOI 10.1002/1878-0261.12133; Li Z, 2017, J BIOCHEM MOL TOXIC, V31, DOI 10.1002/jbt.21933; Li ZW, 2017, ONCOTARGET, V8, P67329, DOI 10.18632/oncotarget.18622; Liang YR, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01206-5; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Lu H, 2018, INT J ONCOL, V53, P2695, DOI 10.3892/ijo.2018.4592; Lu RZ, 2018, CANCER BIOMARK, V22, P249, DOI 10.3233/CBM-170874; Majem B, 2019, ONCOGENE, V38, P6035, DOI 10.1038/s41388-019-0860-0; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mitra A, 2015, ONCOTARGET, V6, P10697, DOI 10.18632/oncotarget.4037; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Perkel JM, 2013, BIOTECHNIQUES, V54, P119, DOI 10.2144/000113997; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Tan YY, 2016, AM J CANCER RES, V6, P522; Tapia T, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-6; Todorovski Z, 2015, MOL CELL BIOL, V35, P1316, DOI 10.1128/MCB.01263-14; Wang LY, 2013, MOL ONCOL, V7, P1116, DOI 10.1016/j.molonc.2013.08.007; Wu YA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00407; Xu XZ, 2020, EUR REV MED PHARMACO, V24, P3517, DOI 10.26355/eurrev_202004_20811; Yang EJ, 2004, J BIOL CHEM, V279, P8903, DOI 10.1074/jbc.M311913200; Yang JJ, 2016, INT J BIOCHEM CELL B, V71, P62, DOI 10.1016/j.biocel.2015.12.004; Yin JL, 2020, FASEB J, V34, P4557, DOI 10.1096/fj.201901384RR; Yu TH, 2014, J STEROID BIOCHEM, V143, P392, DOI 10.1016/j.jsbmb.2014.05.003; Yu Y, 2017, BIOMED PHARMACOTHER, V90, P555, DOI 10.1016/j.biopha.2017.03.054; Zhao WY, 2018, CANCER MED-US, V7, P842, DOI 10.1002/cam4.1353; Zhou ML, 2016, STEM CELLS, V34, P55, DOI 10.1002/stem.2219	46	6	7	1	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4198	4213		10.1038/s41388-021-01845-y	http://dx.doi.org/10.1038/s41388-021-01845-y		JUN 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34079084	Green Published, hybrid			2022-12-26	WOS:000657217400002
J	Thomson, CS; Pundavela, J; Perrino, MR; Coover, RA; Choi, K; Chaney, KE; Rizvi, TA; Largaespada, DA; Ratner, N				Thomson, Craig S.; Pundavela, Jay; Perrino, Melissa R.; Coover, Robert A.; Choi, Kwangmin; Chaney, Katherine E.; Rizvi, Tilat A.; Largaespada, David A.; Ratner, Nancy			WNT5A inhibition alters the malignant peripheral nerve sheath tumor microenvironment and enhances tumor growth	ONCOGENE			English	Article							BETA-CATENIN; SCHWANN-CELLS; STEM-CELLS; MECHANISMS; PROMOTES; TRANSFORMATION; PROGRESSION; ACTIVATION; INVASION; MITOGENS	Malignant peripheral nerve sheath tumors (MPNST) are aggressive soft-tissue sarcomas that cause significant mortality in adults with neurofibromatosis type 1. We compared gene expression of growth factors in normal human nerves to MPNST and normal human Schwann cells to MPNST cell lines. We identified WNT5A as the most significantly upregulated ligand-coding gene and verified its protein expression in MPNST cell lines and tumors. In many contexts WNT5A acts as an oncogene. However, inhibiting WNT5A expression using shRNA did not alter MPNST cell proliferation, invasion, migration, or survival in vitro. Rather, shWNT5A-treated MPNST cells upregulated mRNAs associated with the remodeling of extracellular matrix and with immune cell communication. In addition, these cells secreted increased amounts of the proinflammatory cytokines CXCL1, CCL2, IL6, CXCL8, and ICAM1. Versus controls, shWNT5A-expressing MPNST cells formed larger tumors in vivo. Grafted tumors contained elevated macrophage/stromal cells, larger and more numerous blood vessels, and increased levels of Mmp9, Cxcl13, Lipocalin-1, and Ccl12. In some MPNST settings, these effects were mimicked by targeting the WNT5A receptor ROR2. These data suggest that the non-canonical Wnt ligand WNT5A inhibits MPNST tumor formation by modulating the MPNST microenvironment, so that blocking WNT5A accelerates tumor growth in vivo.	[Thomson, Craig S.] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH 45220 USA; [Thomson, Craig S.; Pundavela, Jay; Perrino, Melissa R.; Coover, Robert A.; Choi, Kwangmin; Chaney, Katherine E.; Rizvi, Tilat A.; Ratner, Nancy] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Perrino, Melissa R.; Ratner, Nancy] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45220 USA; [Largaespada, David A.] Univ Minnesota, Coll Biol Sci, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Coover, Robert A.] High Point Univ, Fred Wilson Sch Pharm, Dept Basic Pharmaceut Sci, High Point, NC USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Minnesota System; University of Minnesota Twin Cities	Ratner, N (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Ratner, N (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45220 USA.	Nancy.ratner@cchmc.org		Pundavela, Jay/0000-0003-2861-4736; RATNER, NANCY/0000-0001-5030-9354; Perrino, Melissa/0000-0002-0598-7102	National Institute of Health (NIH) [5R01NS086219]	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the CCHMC research pathology core for tissue processing and embedding and the viral vector core for lentivirus preparation. This research was supported by the National Institute of Health (NIH) 5R01NS086219, to DAL and NR.	Ahsan S, 2016, ONCOTARGET, V7, P57171, DOI 10.18632/oncotarget.11036; Asem MS, 2016, CANCERS, V8, DOI 10.3390/cancers8090079; Banerjee J, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020226; Berger H, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00031; Bi LQ, 2014, INT J CLIN EXP PATHO, V7, P987; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brohl AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15183-1; Brosseau JP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07452-y; Cadigan KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007906; Cho H, 2016, WOUND REPAIR REGEN, V24, P829, DOI 10.1111/wrr.12453; Choi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep43315; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; DeLeon-Pennell KY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94207; Dong S, 2015, CLIN LAB, V61, P537, DOI 10.7754/Clin.Lab.2014.141127; Ekstrom EJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-88; Evans DG, 2010, AM J MED GENET A, V152A, P327, DOI 10.1002/ajmg.a.33139; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Green J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009175; Grigoryan T, 2013, P NATL ACAD SCI USA, V110, P18174, DOI 10.1073/pnas.1310490110; Handolias D, 2008, FUTURE ONCOL, V4, P211, DOI 10.2217/14796694.4.2.211; Huang L, 2016, EXP THER MED, V12, P3851, DOI 10.3892/etm.2016.3885; Huang TC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181034; Jang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep41612; Jiang HJ, 2013, NEUROCHEM RES, V38, P346, DOI 10.1007/s11064-012-0925-8; Katoh M, 2017, INT J ONCOL, V51, P1357, DOI 10.3892/ijo.2017.4129; Katoh M, 2017, INT J MOL MED, V40, P587, DOI 10.3892/ijmm.2017.3071; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Khan AQ, 2019, SEMIN CANCER BIOL, V54, P1, DOI 10.1016/j.semcancer.2018.03.001; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kobayashi C, 2006, CANCER GENET CYTOGEN, V165, P98, DOI 10.1016/j.cancergencyto.2005.07.006; Largaespada D, 2013, CANCER CELL, V23, P269, DOI 10.1016/j.ccr.2013.03.001; Li H, 2016, LAB INVEST, V96, P1105, DOI 10.1038/labinvest.2016.88; Li ZQ, 2018, INT J MED SCI, V15, P1415, DOI 10.7150/ijms.26741; Liu AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090229; Long HT, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1693-z; Lopez-Bergami P, 2020, CANCER METAST REV, V39, P933, DOI 10.1007/s10555-020-09878-7; Luo C, 2020, J CLIN INVEST, V130, P853, DOI 10.1172/JCI130038; Luscan A, 2014, CLIN CANCER RES, V20, P358, DOI 10.1158/1078-0432.CCR-13-0780; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Mahller YY, 2006, PEDIATR BLOOD CANCER, V46, P745, DOI 10.1002/pbc.20565; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Miettinen MM, 2017, HUM PATHOL, V67, P1, DOI 10.1016/j.humpath.2017.05.010; Miller SJ, 2009, EMBO MOL MED, V1, P236, DOI 10.1002/emmm.200900027; Miller SJ, 2006, CANCER RES, V66, P2584, DOI 10.1158/0008-5472.CAN-05-3330; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Prada CE, 2013, ACTA NEUROPATHOL, V125, P159, DOI 10.1007/s00401-012-1056-7; Prasad CP, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0421-0; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Rebalka IA, 2018, AM J PHYSIOL-CELL PH, V315, pC714, DOI 10.1152/ajpcell.00195.2017; Reilly KM, 2013, CANCER DISCOV, V3, P610, DOI 10.1158/2159-8290.CD-13-0192; RIDLEY AJ, 1989, J CELL BIOL, V109, P3419, DOI 10.1083/jcb.109.6.3419; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Sapi Z, 2016, GENE CHROMOSOME CANC, V55, P786, DOI 10.1002/gcc.22379; Shurell E, 2016, ONCOTARGET, V7, P64300, DOI 10.18632/oncotarget.11734; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Sohier P, 2017, GENE CHROMOSOME CANC, V56, P421, DOI 10.1002/gcc.22446; Tian F, 2015, INT J MOL SCI, V16, P3178, DOI 10.3390/ijms16023178; de Vasconcelos RAT, 2019, CANCER MED-US, V8, P972, DOI 10.1002/cam4.1977; Tu B, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130811; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Wang TX, 2019, J CANCER RES THER, V15, P904, DOI 10.4103/jcrt.JCRT_886_18; Wang ZG, 2015, ONCOL REP, V34, P391, DOI 10.3892/or.2015.3966; Watson AL, 2013, CANCER DISCOV, V3, P674, DOI 10.1158/2159-8290.CD-13-0081; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Widemann BC, 2009, CURR ONCOL REP, V11, P322, DOI 10.1007/s11912-009-0045-z; Yamagata K, 2012, J BIOL CHEM, V287, P1588, DOI 10.1074/jbc.M111.315127; Yamamoto T, 1999, J BIOCHEM-TOKYO, V126, P799, DOI 10.1093/oxfordjournals.jbchem.a022519; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Zhang C, 2017, CHIN J CANCER, V36, DOI 10.1186/s40880-017-0246-z; Zhang CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10999-3; Zhao LY, 2017, EBIOMEDICINE, V16, P87, DOI 10.1016/j.ebiom.2017.01.021; Zhurinsky J, 2000, MOL CELL BIOL, V20, P4238, DOI 10.1128/MCB.20.12.4238-4252.2000	76	4	4	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4229	4241		10.1038/s41388-021-01773-x	http://dx.doi.org/10.1038/s41388-021-01773-x		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34079083	Green Accepted			2022-12-26	WOS:000657217400006
J	Nakagawa, Y; Kumagai, K; Han, SI; Mizunoe, Y; Araki, M; Mizuno, S; Ohno, H; Matsuo, K; Yamada, Y; Kim, JD; Miyamoto, T; Sekiya, M; Konishi, M; Itoh, N; Matsuzaka, T; Takahashi, S; Sone, H; Shimano, H				Nakagawa, Yoshimi; Kumagai, Kae; Han, Song-iee; Mizunoe, Yuhei; Araki, Masaya; Mizuno, Seiya; Ohno, Hiroshi; Matsuo, Kazuya; Yamada, Yasunari; Kim, Jun-dal; Miyamoto, Takafumi; Sekiya, Motohiro; Konishi, Morichika; Itoh, Nobuyuki; Matsuzaka, Takashi; Takahashi, Satoru; Sone, Hirohito; Shimano, Hitoshi			Starvation-induced transcription factor CREBH negatively governs body growth by controlling GH signaling	FASEB JOURNAL			English	Article						CREBH; FGF21; GH resistance; GHR; growth delay; IGFBP1	FACTOR-BINDING PROTEIN-1; ACTIVATED RECEPTOR-ALPHA; FATTY-ACID OXIDATION; I IGF-I; GENE-EXPRESSION; PPAR-ALPHA; HORMONE RECEPTORS; TRANSGENIC MICE; NUTRITIONAL REGULATION; INSULIN-RESISTANCE	cAMP responsive element-binding protein H (CREBH) is a hepatic transcription factor to be activated during fasting. We generated CREBH knock-in flox mice, and then generated liver-specific CREBH transgenic (CREBH L-Tg) mice in an active form. CREBH L-Tg mice showed a delay in growth in the postnatal stage. Plasma growth hormone (GH) levels were significantly increased in CREBH L-Tg mice, but plasma insulin-like growth factor 1 (IGF1) levels were significantly decreased, indicating GH resistance. In addition, CREBH overexpression significantly increased hepatic mRNA and plasma levels of FGF21, which is thought to be as one of the causes of growth delay. However, the additional ablation of FGF21 in CREBH L-Tg mice could not correct GH resistance at all. CREBH L-Tg mice sustained GH receptor (GHR) reduction and the increase of IGF binding protein 1 (IGFBP1) in the liver regardless of FGF21. As GHR is a first step in GH signaling, the reduction of GHR leads to impairment of GH signaling. These data suggest that CREBH negatively regulates growth in the postnatal growth stage via various pathways as an abundant energy response by antagonizing GH signaling.	[Nakagawa, Yoshimi; Matsuo, Kazuya; Yamada, Yasunari; Kim, Jun-dal] Univ Toyama, Inst Nat Med, Div Complex Biosyst Res, Dept Res & Dev, Toyama 9300194, Japan; [Nakagawa, Yoshimi; Kumagai, Kae; Han, Song-iee; Mizunoe, Yuhei; Araki, Masaya; Ohno, Hiroshi; Miyamoto, Takafumi; Sekiya, Motohiro; Takahashi, Satoru; Shimano, Hitoshi] Univ Tsukuba, Dept Internal Med Endocrinol & Metab, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Nakagawa, Yoshimi; Han, Song-iee; Shimano, Hitoshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Nakagawa, Yoshimi; Shimano, Hitoshi] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol AMED CREST, Tokyo, Japan; [Mizuno, Seiya; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr LARC, Fac Med, Tsukuba, Ibaraki, Japan; [Konishi, Morichika] Kobe Pharmaceut Univ, Dept Microbial Chem, Kobe, Hyogo, Japan; [Itoh, Nobuyuki] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan; [Matsuzaka, Takashi; Takahashi, Satoru] Univ Tsukuba, Transborder Med Res Ctr TMRC, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki, Japan; [Sone, Hirohito] Niigata Univ, Dept Hematol Endocrinol & Metab, Fac Med, Niigata, Japan; [Shimano, Hitoshi] Univ Tsukuba, Life Sci Ctr Survival Dynam, Tsukuba Adv Res Alliance TARA, Tsukuba, Ibaraki, Japan	University of Toyama; University of Tsukuba; University of Tsukuba; University of Tsukuba; Kobe Pharmaceutical University; Kyoto University; University of Tsukuba; University of Tsukuba; Niigata University; University of Tsukuba	Nakagawa, Y (corresponding author), Univ Toyama, Inst Nat Med, Div Complex Biosyst Res, Dept Res & Dev, Toyama 9300194, Japan.; Shimano, H (corresponding author), Univ Tsukuba, Dept Internal Med Endocrinol & Metab, Fac Med, Tsukuba, Ibaraki 3058575, Japan.	ynaka@inm.u-toyama.ac.jp; hshimano@md.tsukuba.ac.jp	Sone, Hirohito/ABC-9346-2021	Sone, Hirohito/0000-0003-1263-2817; Jun-Dal, Kim/0000-0002-7361-0999; Miyamoto, Takafumi/0000-0001-9363-2864; Mizunoe, Yuhei/0000-0001-6716-1544	JSPS KAKENHI [16H03253, 21H04861, 19H00449, 17H06395]; Japan Health Foundation; Tamura Foundation; Uehara Memorial Foundation; AMED-CREST [20gm1110008s0303, 16gm0910003h0002]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Health Foundation(Japan Health Foundation); Tamura Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); AMED-CREST	This work was supported by JSPS KAKENHI (Grant Number 16H03253 and 21H04861 (to YN), 19H00449 (to KK), and 17H06395 (to H. Shimano)), the Japan Health Foundation (to YN), the Tamura Foundation (to YN), The Uehara Memorial Foundation (to YN), and AMED-CREST (Grant number 20gm1110008s0303 (to YN) and 16gm0910003h0002 (to H. Shimano)). The authors would like to thank Enago () for the English language review.	AMSELEM S, 1989, NEW ENGL J MED, V321, P989, DOI 10.1056/NEJM198910123211501; Araki M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072148; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0; BAXTER RC, 1978, BIOCHEM BIOPH RES CO, V84, P350, DOI 10.1016/0006-291X(78)90177-8; Beauloye V, 2002, ENDOCRINOLOGY, V143, P792, DOI 10.1210/en.143.3.792; BORNFELDT KE, 1989, J ENDOCRINOL, V122, P651, DOI 10.1677/joe.0.1220651; Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23938; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Crossey PA, 2000, DIABETES, V49, P457, DOI 10.2337/diabetes.49.3.457; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Davey HW, 2001, ENDOCRINOLOGY, V142, P3836, DOI 10.1210/en.142.9.3836; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; EMLER CA, 1987, ENDOCRINOLOGY, V120, P832, DOI 10.1210/endo-120-2-832; Fang F, 2019, P NATL ACAD SCI USA, V116, P7449, DOI 10.1073/pnas.1901867116; FLIESEN T, 1989, PEDIATR RES, V26, P415, DOI 10.1203/00006450-198911000-00010; Fujimoto Y, 2013, ENDOCRINOLOGY, V154, P3577, DOI 10.1210/en.2013-1203; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Gan YJ, 2014, MOL ENDOCRINOL, V28, P1841, DOI 10.1210/me.2014-1174; Gay E, 1997, ENDOCRINOLOGY, V138, P2937, DOI 10.1210/en.138.7.2937; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; GODOWSKI PJ, 1989, P NATL ACAD SCI USA, V86, P8083, DOI 10.1073/pnas.86.20.8083; Goto T, 2017, J BIOL CHEM, V292, P9175, DOI 10.1074/jbc.M116.767590; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Hasegawa Y, 2013, EXP ANIM TOKYO, V62, P295; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hoeflich A, 1999, ENDOCRINOLOGY, V140, P5488, DOI 10.1210/en.140.12.5488; Huang Y, 2004, MOL ENDOCRINOL, V18, P1471, DOI 10.1210/me.2003-0418; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Kim SH, 2017, ANN PEDIATR ENDOCRIN, V22, P145, DOI 10.6065/apem.2017.22.3.145; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; LeRoith D, 2005, J CLIN INVEST, V115, P233, DOI 10.1172/JCI200524228; LeRoith D, 2007, NAT CLIN PRACT ENDOC, V3, P302, DOI 10.1038/ncpendmet0427; Leung KC, 2000, J CLIN ENDOCR METAB, V85, P4712, DOI 10.1210/jc.85.12.4712; List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; LOWE WL, 1989, J CLIN INVEST, V84, P619, DOI 10.1172/JCI114207; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; MURPHY LJ, 1991, ENDOCRINOLOGY, V128, P689, DOI 10.1210/endo-128-2-689; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334; Nakagawa Y, 2021, CELL MOL GASTROENTER, V11, P949, DOI 10.1016/j.jcmgh.2020.11.004; Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39182; Nakagawa Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep27857; Nakagawa Y, 2014, ENDOCRINOLOGY, V155, P4706, DOI 10.1210/en.2014-1113; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Ono M, 2007, MOL ENDOCRINOL, V21, P1443, DOI 10.1210/me.2006-0543; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Satoh A, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100930; SENEVIRATNE C, 1990, MOL ENDOCRINOL, V4, P1199, DOI 10.1210/mend-4-8-1199; Silha JV, 2002, ENDOCRINOLOGY, V143, P3711, DOI 10.1210/en.2002-220116; STRAUS DS, 1990, MOL ENDOCRINOL, V4, P91, DOI 10.1210/mend-4-1-91; Takei K, 2017, J DIABETES INVEST, V8, P446, DOI 10.1111/jdi.12621; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; THISSEN JP, 1990, J ENDOCRINOL, V124, P159, DOI 10.1677/joe.0.1240159; THISSEN JP, 1994, ENDOCR REV, V15, P80, DOI 10.1210/er.15.1.80; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; UNDERWOOD LE, 1994, HORM RES, V42, P145, DOI 10.1159/000184187; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Wang XD, 2015, CELL METAB, V22, P811, DOI 10.1016/j.cmet.2015.09.010; Woelfle J, 2004, AM J PHYSIOL-ENDOC M, V286, pE393, DOI 10.1152/ajpendo.00389.2003; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	78	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21663	10.1096/fj.202002784RR	http://dx.doi.org/10.1096/fj.202002784RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042217				2022-12-26	WOS:000655695900015
J	Choto, ET; Mduluza, T; Chimbari, MJ				Choto, Emilia T.; Mduluza, Takafira; Chimbari, Moses J.			Interleukin-13 rs1800925/-1112C/T promoter single nucleotide polymorphism variant linked to anti-schistosomiasis in adult males in Murehwa District, Zimbabwe	PLOS ONE			English	Article							PROSTATE-CANCER; HEPATIC-FIBROSIS; INFECTION LEVELS; CYTOKINE; IL-13; ASSOCIATION; GENE; RECEPTOR; INFLAMMATION; IMMUNOPATHOLOGY	Background Chronic schistosomiasis is predominantly induced through up-regulation of inflammatory cytokines such as interleukin (IL)-13. IL-13 may contribute to the disease outcomes by increasing eosinophil infiltration thereby promoting fibrosis. IL-13 may act as an immunosuppressive inflammatory cytokine that may promote carcinogenesis and also may offer protection against schistosomiasis thereby reducing risk of schistosome infections. Our study evaluated the frequency of the IL-13 rs1800925/-1112 C/ T promoter single nucleotide polymorphisms (SNPs) among schistosomiasis infected individuals and assessed the association of the variants on IL-13 cytokine levels. We also investigated IL-13 rs1800925 polymorphisms on prostate-specific antigen levels as an indicator for risk of prostate cancer development. Methodology The study was cross-sectional and included 50 schistosomiasis infected and 316 uninfected male participants residing in Murehwa District, Zimbabwe. IL-13 rs1800925 SNPs were genotyped by allele amplification refractory mutation system-polymerase chain reaction. Concentrations of serum prostate-specific antigens and plasma IL-13 were measured using enzyme-linked immunosorbent assay. Results Frequencies of the genotypes CC, CT and TT, were 20%, 58% and 22% in schistosomiasis infected, and 18.3%, 62.1% and 19.6% in uninfected participants with no statistical differences. There were significantly (p<0.05) higher IL-13 cytokine levels among both infected and uninfected participants with the genotypes CC and CT; median 92.25 pg/mL and 106.5 pg/mL, respectively, compared to TT variant individuals; 44.78 pg/mL. Within the schistosomiasis uninfected group, CC and CT variants had significantly (p<0.05) higher IL-13 levels; median 135.0 pg/mL and 113.6 pg/mL, respectively compared to TT variant individuals; 47.15 pg/mL. Within the schistosomiasis infected group, CC, CT and TT variant individuals had insignificant differences of IL-13 level. Using logistic regression, no association was observed between prostate-specific antigen levels, IL-13 cytokine levels and IL-13 rs1800925 variants (p>0.05). Conclusion IL-13 rs1800925 C variant individuals had the highest IL-13 cytokine levels among the schistosomiasis uninfected suggesting that they may be protective against Schistosoma infections. There was no association between IL-13 concentrations or IL-13 rs1800925 variants and risk of prostate cancer indicating that IL-13 levels and IL-13 rs10800925 may not be utilised as biomarker for risk of prostate cancer in schistosome infections.	[Choto, Emilia T.; Chimbari, Moses J.] Univ KwaZulu Natal, Sch Publ Hlth Med, Coll Hlth Sci, Durban, South Africa; [Mduluza, Takafira] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Mduluza, Takafira] Univ Zimbabwe, Dept Biochem, Harare, Zimbabwe	University of Kwazulu Natal; University of Kwazulu Natal; University of Zimbabwe	Choto, ET (corresponding author), Univ KwaZulu Natal, Sch Publ Hlth Med, Coll Hlth Sci, Durban, South Africa.	emiliachoto@gmail.com		choto, emilia/0000-0002-0285-761X	OAK Foundation; University of KwaZuluNatal -College of Health Sciences Scholarship [636753]	OAK Foundation; University of KwaZuluNatal -College of Health Sciences Scholarship	The research study was supported by the OAK Foundation and the University of KwaZuluNatal -College of Health Sciences Scholarship for operational funds (identifier number 636753). All authors are supported by OAK Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedokun SA, 2018, INFECT GENET EVOL, V65, P28, DOI 10.1016/j.meegid.2018.07.012; [Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barbosa Constança S., 2017, J. Bras. Patol. Med. Lab., V53, P110, DOI 10.5935/1676-2444.20170018; Berg AO, 2002, ANN INTERN MED, V137, P915, DOI 10.7326/0003-4819-137-11-200212030-00013; Cheever AW, 2000, IMMUNOL TODAY, V21, P465, DOI 10.1016/S0167-5699(00)01626-1; Chen SLS, 2019, J UROLOGY, V201, P486, DOI 10.1016/j.juro.2018.10.015; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Chiaramonte MG, 2001, HEPATOLOGY, V34, P273, DOI 10.1053/jhep.2001.26376; Choto ET, 2020, INFECT AGENTS CANCER, V15, DOI 10.1186/s13027-020-00327-2; COHEN RJ, 1993, J UROLOGY, V150, P365, DOI 10.1016/S0022-5347(17)35484-8; Cooke A., 1996, ADV IMMUNOLOGY; de Jesus AR, 2002, J INFECT DIS, V185, P98, DOI 10.1086/324668; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; de Moira AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000820; Doumenge JP, 1987, ATLAS GLOBAL DISTRIB; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Elsasser-Beile U, 1998, TUMOR BIOL, V19, P470, DOI 10.1159/000030039; Fairfax K, 2012, SEMIN IMMUNOPATHOL, V34, P863, DOI 10.1007/s00281-012-0354-4; Fried B, 2011, CANCER LETT, V305, P239, DOI 10.1016/j.canlet.2010.07.008; Fujisawa T, 2012, INT J CANCER, V131, P344, DOI 10.1002/ijc.26366; Gatlin MR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000375; Gazzinelli G, 1992, Rev Soc Bras Med Trop, V25, P125, DOI 10.1590/S0037-86821992000200006; Grant AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035863; Graves PE, 2000, J ALLERGY CLIN IMMUN, V105, P506, DOI 10.1067/mai.2000.104940; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; He H, 2008, GENES IMMUN, V9, P195, DOI 10.1038/gene.2008.2; Hobisch A, 2000, J PATHOL, V191, P239, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hoffmann KF, 2000, J IMMUNOL, V164, P6406, DOI 10.4049/jimmunol.164.12.6406; Hofmann SR, 2002, CURR OPIN ALLERGY CL, V2, P495, DOI 10.1097/00130832-200212000-00004; Howard TD, 2001, AM J RESP CELL MOL, V25, P377, DOI 10.1165/ajrcmb.25.3.4483; Hummelshoj T, 2003, EUR J IMMUNOGENET, V30, P355, DOI 10.1046/j.1365-2370.2003.00416.x; Ilic D, 2007, CANCER CAUSE CONTROL, V18, P279, DOI 10.1007/s10552-006-0087-6; Isnard A, 2011, GENES IMMUN, V12, P31, DOI 10.1038/gene.2010.43; Ito T, 2009, J BIOL CHEM, V284, P24289, DOI 10.1074/jbc.M109.007286; Karan D, 2009, CANCER RES, V69, P2, DOI 10.1158/0008-5472.CAN-08-1230; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; Ko C, 2008, J PATHOL, V214, P603, DOI 10.1002/path.2316; Kouriba B, 2005, J IMMUNOL, V174, P6274, DOI 10.4049/jimmunol.174.10.6274; Kraan TCTMV, 1999, GENES IMMUN, V1, P61, DOI 10.1038/sj.gene.6363630; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Lee K, 2009, GLOB INST, P1; Lodhia J, 2020, J SURG CASE REP, DOI 10.1093/jscr/rjaa144; Long X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135360; Mbanefo EC, 2020, INFECT AGENTS CANCER, V15, DOI 10.1186/s13027-020-00331-6; Metrogos V, 2017, ACTA UROLOGICA PORTU, V34, P41, DOI DOI 10.24915/AUP.34.3; Midzi N, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003014; Montresor A., 1998, GUIDELINES EVALUATIO; MOTT KE, 1982, TROPENMED PARASITOL, V33, P227; Mukendi AM, 2020, J CLIN UROL, V13, P451, DOI 10.1177/2051415819889203; Mutengo Mable M, 2018, J Parasitol Res, V2018, P9754060, DOI 10.1155/2018/9754060; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Orr N, 2008, ADV GENET, V62, P1, DOI 10.1016/S0065-2660(08)00601-9; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Robert F, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00507; Seyfizadeh N, 2015, ACTA MICROBIOL IMM H, V62, P341, DOI 10.1556/030.62.2015.4.2; Stanilova S, 2008, TISSUE ANTIGENS, V71, P169, DOI 10.1111/j.1399-0039.2007.00985.x; Terabe M, 2004, CANCER IMMUNOL IMMUN, V53, P79, DOI 10.1007/s00262-003-0445-0; Tindall EA, 2010, CARCINOGENESIS, V31, P1748, DOI 10.1093/carcin/bgq081; Verjee MA, 2019, RES REP TROP MED, V10, P153, DOI 10.2147/RRTM.S204345; Wang MJ, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027966; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; Wills-Karp M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1.51.pe55; Wise GJ, 2000, J UROLOGY, V164, P722, DOI 10.1016/S0022-5347(05)67289-8; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; WRIGHT ED, 1982, T ROY SOC TROP MED H, V76, P822, DOI 10.1016/0035-9203(82)90118-3; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Zabaleta J, 2008, CARCINOGENESIS, V29, P573, DOI 10.1093/carcin/bgm277; Zabaleta J, 2009, CARCINOGENESIS, V30, P1358, DOI 10.1093/carcin/bgp124; Zimbabwe National Cancer Registry (ZNCR), 2015, PROF CANC ZIMB 2014	72	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252220	10.1371/journal.pone.0252220	http://dx.doi.org/10.1371/journal.pone.0252220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048465	gold, Green Published			2022-12-26	WOS:000664636100025
J	de Leon-Guerrero, SD; Mendez-Alonzo, R; Bullock, SH; Vivoni, ER				Diaz de Leon-Guerrero, Samantha; Mendez-Alonzo, Rodrigo; Bullock, Stephen H.; Vivoni, Enrique R.			Hydrological and topographic determinants of biomass and species richness in a Mediterranean-climate shrubland	PLOS ONE			English	Article							BAJA-CALIFORNIA; ABOVEGROUND BIOMASS; CHAPARRAL SHRUB; PLANT DIVERSITY; SEMIARID BASIN; SOIL-MOISTURE; WATER; PRODUCTIVITY; FIRE; PATTERNS	Background In arid and semiarid shrublands, water availability directly influences ecosystem properties. However, few empirical tests have determined the association between particular soil and hydrology traits with biodiversity and ecosystem biomass at the local scale. Methods We tested if plant species richness (S) and aboveground biomass (AGB) were associated with soil and topographic properties on 36 plots (ca. 12.5 m(2)) in 17 hectares of chaparral in the Mediterranean-climate of Valle de Guadalupe, Baja California, Mexico. We used close-to-the-ground aerial photography to quantify sky-view cover per species, including all growth forms. We derived an elevation model (5 cm) from other aerial imagery. We estimated six soil properties (soil water potential, organic matter content, water content, pH, total dissolved solids concentration, and texture) and four landscape metrics (slope, aspect, elevation, and topographic index) for the 36 plots. We quantified the biomass of stems, leaves, and reproductive structures, per species. Results 86% of AGB was in stems, while non-woody species represented 0.7% of AGB but comprised 38% of S (29 species). Aboveground biomass and species richness were unrelated across the landscape. S was correlated with aspect and elevation (R = 0.53, aspect P = 0.035, elevation P = 0.05), while AGB (0.006-9.17 Kg m(-2)) increased with soil water potential and clay content (R = 0.51, P = 0.02, and P = 0.04). Only three species (11% of total S) occupied 65% of the total plant cover, and the remaining 26 represented only 35%. Cover was negatively correlated with S (R = -0.38, P = 0.02). 75% of AGB was concentrated in 30% of the 36 plots, and 96% of AGB corresponded to only 20% of 29 species. Discussion At the scale of small plots in our studied Mediterranean-climate shrubland in Baja California, AGB was most affected by soil water storage. AGB and cover were dominated by a few species, and only cover was negatively related to S. S was comprised mostly by uncommon species and tended to increase as plant cover decreased.	[Diaz de Leon-Guerrero, Samantha; Mendez-Alonzo, Rodrigo; Bullock, Stephen H.] Ctr Invest Cient & Educ Super Ensenada CICESE, Dept Biol Conservac, Ensenada, Baja California, Mexico; [Vivoni, Enrique R.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Vivoni, Enrique R.] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ USA	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Mendez-Alonzo, R (corresponding author), Ctr Invest Cient & Educ Super Ensenada CICESE, Dept Biol Conservac, Ensenada, Baja California, Mexico.	mendezal@cicese.mx	Vivoni, Enrique/E-1202-2012	Vivoni, Enrique/0000-0002-2659-9459; Bullock, Stephen H./0000-0001-5312-9324	Fondo Sectorial CONACYT INEGI [278755]; CONACYT [274874]	Fondo Sectorial CONACYT INEGI; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	RMA 278755 Fondo Sectorial CONACYT INEGI Website: https://www.inegi.org.mx/investigacion/conacyt/default.html SDDLG 274874 CONACYT Scholarship for PhD students NO: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Aguiar MR, 1999, TRENDS ECOL EVOL, V14, P273, DOI 10.1016/S0169-5347(99)01612-2; Alhamad MN, 2010, J ARID ENVIRON, V74, P277, DOI 10.1016/j.jaridenv.2009.08.009; Alvarez-Davila E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171072; Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; [Anonymous], 2014, SOIL CONSERV SERV, V12; Ansley RJ, 2012, RANGELAND ECOL MANAG, V65, P189, DOI 10.2111/REM-D-11-00112.1; Bassa M, 2012, BIODIVERS CONSERV, V21, P1101, DOI 10.1007/s10531-012-0245-y; Becerra PI, 2016, REV CHIL HIST NAT, V89, DOI 10.1186/s40693-016-0062-x; Beven KJ., 1979, HYDROL SCI J, V24, P43, DOI [10.1080/ 02626667909491834, 10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Bohlman Gabrielle N., 2018, Madrono, V65, P28, DOI 10.3120/0024-9637-65.1.28; Bouyoucos GJ, 1936, SOIL SCI, V42, P225, DOI 10.1097/00010694-193609000-00007; Buchanan BP, 2014, HYDROL EARTH SYST SC, V18, P3279, DOI 10.5194/hess-18-3279-2014; Burgess SSO, 1998, OECOLOGIA, V115, P306, DOI 10.1007/s004420050521; Burquez A, 2010, J ARID ENVIRON, V74, P1240, DOI 10.1016/j.jaridenv.2010.04.004; CALDWELL MM, 1989, OECOLOGIA, V79, P1, DOI 10.1007/BF00378231; Cardinale BJ, 2002, NATURE, V415, P426, DOI 10.1038/415426a; Cervantes JHF, 2014, ECOHYDROLOGY, V7, P242, DOI 10.1002/eco.1333; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Conti G, 2013, ANN FOREST SCI, V70, P515, DOI 10.1007/s13595-013-0285-9; Cornet A. F., 1992, LANDSCAPE BOUNDARIES, P327, DOI [10.1007/978-1-4612-2804-2_16, DOI 10.1007/978-1-4612-2804-2_16]; Cowling RM, 1996, TRENDS ECOL EVOL, V11, P362, DOI 10.1016/0169-5347(96)10044-6; Craven D, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0277; Cueva AlejandroHiram., 2016, ESTADO ACTUAL CONOC, P37; Deng L, 2016, ECOL ENG, V94, P525, DOI 10.1016/j.ecoleng.2016.06.048; DeSimone SA, 1992, MADRONO, V39, P170; Diaz S., 2009, BIODIVERSITY ECOSYST, P149; DIXON PM, 1987, ECOLOGY, V68, P1548, DOI 10.2307/1939238; Ensslin A, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00492.1; Esch EH, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2802; ESRI ArcGIS, 2014, ARCGIS DESKT REL 10; FrancoVizcaino E, 1997, ACTA OECOL, V18, P503, DOI 10.1016/S1146-609X(97)80037-9; Fraser LH, 2014, J VEG SCI, V25, P1160, DOI 10.1111/jvs.12167; Gherardi LA, 2019, GLOBAL CHANGE BIOL, V25, P269, DOI 10.1111/gcb.14480; Gillman LN, 2006, ECOLOGY, V87, P1234, DOI 10.1890/0012-9658(2006)87[1234:TIOPOT]2.0.CO;2; Gillman LN, 2014, J BIOGEOGR, V41, P39, DOI 10.1111/jbi.12173; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Gutierrez-Jurado HA, 2013, WATER RESOUR RES, V49, P8263, DOI 10.1002/2013WR014364; HANES TL, 1971, ECOL MONOGR, V41, P27, DOI 10.2307/1942434; Harrison S, 2006, ECOL MONOGR, V76, P41, DOI 10.1890/05-0910; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; INEGI. Instituto Nacional de Estadistica Geografia e Informatica, 2008, HIGH RES DIG EV MOD; Isenburg M, 2014, LASTOOLS EFFICIENT T, P150715; Ivosevic Bojana, 2015, Journal of Ecology and Environment, V38, P113, DOI 10.5141/ecoenv.2015.012; Jacobsen AL, 2018, NEW PHYTOL, V219, P498, DOI 10.1111/nph.15186; Jimenez-Alfaro B, 2014, J VEG SCI, V25, P160, DOI 10.1111/jvs.12060; Del Toro-Guerrero FJ, 2018, WATER-SUI, V10, DOI 10.3390/w10121844; del Toro-Guerrero FJ, 2014, TECNOL CIENC AGUA, V5, P69; Del-Toro-Guerrero FJ, 2019, INT J BIOMETEOROL, V63, P1425, DOI 10.1007/s00484-019-01763-5; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kelemen A, 2013, J VEG SCI, V24, P1195, DOI 10.1111/jvs.12027; Leon E, 2014, SOIL BIOL BIOCHEM, V77, P12, DOI 10.1016/j.soilbio.2014.05.029; Li LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066450; Liu GF, 2018, J ECOL, V106, P218, DOI 10.1111/1365-2745.12868; Liu L, 2016, J HYDROMETEOROL, V17, P2733, DOI 10.1175/JHM-D-15-0240.1; Love J, 2019, J STAT SOFTW, V88, P1, DOI 10.18637/jss.v088.i02; Luo WX, 2019, J ECOL, V107, P1106, DOI 10.1111/1365-2745.13129; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Meentemeyer RK, 2001, PLANT ECOL, V156, P19, DOI 10.1023/A:1011944805738; MINNICH RA, 1983, SCIENCE, V219, P1287, DOI 10.1126/science.219.4590.1287; Mooney H. A., 1989, CALIFORNIA CHAPARRAL, P85; OLIVER M, 2013, SIGNIFICANCE, V10, P17, DOI DOI 10.1111/J.1740-9713.2013.00646.X; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perez-Harguindeguy N, 2013, AUST J BOT, V61, P167, DOI 10.1071/BT12225; Potts JB, 2010, PLANT ECOL, V210, P303, DOI 10.1007/s11258-010-9758-1; Pratt RB, 2014, GLOBAL CHANGE BIOL, V20, P893, DOI 10.1111/gcb.12477; Quantum G., 2013, QUANT GIS GEOGR INF; Rebman JP, 2016, P SAN DIEGO SOC NAT, V45; Reinking L, 2007, WORD J INT LINGUIST; RH Y, 1904, NATURE, V70, P573, DOI [10.1038/070573a0, DOI 10.1038/070573A0]; Rietkerk M, 2000, PLANT ECOL, V148, P207, DOI 10.1023/A:1009828432690; Ripley B, 2019, PACKAGE MASS VERSION; Scanlon TM, 2007, NATURE, V449, P209, DOI 10.1038/nature06060; Schade JD, 2005, BIOGEOCHEMISTRY, V73, P541, DOI 10.1007/s10533-004-1718-1; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; SCHLESINGER WH, 1980, ECOLOGY, V61, P781, DOI 10.2307/1936748; Sternberg PD, 1996, GEODERMA, V72, P89, DOI 10.1016/0016-7061(96)00019-5; Team R Core., 2016, R LANGUAGE ENV STAT; Thompson J., 1996, USDA SERV GEN TECH R, V338; Tilman D, 2007, J ECOL, V95, P231, DOI 10.1111/j.1365-2745.2007.01201.x; VALIENTEBANUET A, 1991, J VEG SCI, V2, P15, DOI 10.2307/3235893; Verhoeven GJJ, 2009, ARCHAEOL PROSPECT, V16, P233, DOI 10.1002/arp.354; Vila M, 2007, ECOL LETT, V10, P241, DOI 10.1111/j.1461-0248.2007.01016.x; Vivoni ER, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00217.1; Wang JG., 2011, CHINESE J APPL ECOL, V22; WESTMAN WE, 1981, ECOLOGY, V62, P439, DOI 10.2307/1936717; WESTMAN WE, 1983, VEGETATIO, V52, P3; Williamson GB, 2010, AM J BOT, V97, P519, DOI 10.3732/ajb.0900243; Xu HX, 2016, SCI REP-UK, V6, DOI 10.1038/srep27503; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Zedler PH, 1995, PLANT LIFE HIST DYNA, DOI [10.1007/978-1-4612-2490-7_4, DOI 10.1007/978-1-4612-2490-7_4]; Zeileis A., 2009, REP	96	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252154	10.1371/journal.pone.0252154	http://dx.doi.org/10.1371/journal.pone.0252154			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043686	gold, Green Published			2022-12-26	WOS:000664635700061
J	Kim, HS; Kim, MG; Min, KW; Jung, US; Kim, DH				Kim, Hyung Suk; Kim, Min Gyu; Min, Kyueng-Whan; Jung, Un Suk; Kim, Dong-Hoon			High MMP-11 expression associated with low CD8+T cells decreases the survival rate in patients with breast cancer	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; DRUG-SENSITIVITY; STROMELYSIN-3; INHIBITORS; KINASE; MMP11; DISCOVERY; INSIGHTS; RECEPTOR; ANTIGEN	Matrix metalloproteinase-11 (MMP-11) promote cancer invasion and metastasis through degrading the extracellular matrix. Protein degradation by MMP-11 in tumor cells may progressively suppress cancer surveillance activities with blocking immune response in breast cancer. The aim of study is to analyze clinicopathological parameters, molecular interactions and anticancer immune response in patients with MMP-11 expression and to provide candidate target drugs. We investigated the clinicopathologic parameters, specific gene sets, tumor antigenicity, and immunologic relevance according to MMP-11 expression in 226 and 776 breast cancer patients from the Hanyang University Guri Hospital (HUGH) cohort and The Cancer Genome Atlas (TCGA) data, respectively. We analyzed pathway networks and in vitro drug response. High MMP-11 expression was associated with worse survival rate in breast cancer from HUGH cohort and TCGA data (all p < 0.05). In analysis of immunologic gene sets, high MMP-11 expression was related to low immune response such as CD8+T cell, CD4+T cell and B cell. In silico cytometry, there was a decrease of cancer testis antigen and low tumor infiltrating lymphocyte in patient with high MMP-11 expression: activated dendritic cell, CD8+T cell, CD4+ memory T cell, and memory B cell. In pathway networks, MMP-11 was linked to the pathways including low immune response, response to growth hormone and catabolic process. We found that pictilisib and AZ960 effectively inhibited the breast cancer cell lines with high MMP-11 expression. Strategies making use of MMP-11-related hub genes could contribute to better clinical management/research for patients with breast cancer.	[Kim, Hyung Suk] Hanyang Univ, Div Breast Surg, Dept Surg, Guri Hosp,Coll Med, Guri, Gyeonggi Do, South Korea; [Kim, Min Gyu] Hanyang Univ, Dept Surg, Coll Med, Guri Hosp, Guri, Gyeonggi Do, South Korea; [Min, Kyueng-Whan] Hanyang Univ, Dept Pathol, Coll Med, Guri Hosp, Guri, Gyeonggi Do, South Korea; [Jung, Un Suk] Hanyang Univ, Dept Obstet & Gynecol, Coll Med, Guri Hosp, Guri, Gyeonggi Do, South Korea; [Kim, Dong-Hoon] Sungkyunkwan Univ, Sch Med, Dept Pathol, Kangbuk Samsung Hosp, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center	Jung, US (corresponding author), Hanyang Univ, Dept Obstet & Gynecol, Coll Med, Guri Hosp, Guri, Gyeonggi Do, South Korea.; Kim, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Pathol, Kangbuk Samsung Hosp, Seoul, South Korea.	petrow@naver.com; idavid.kim@samsung.com	Min, Kyueng-Whan/F-3981-2017	Min, Kyueng-Whan/0000-0002-4757-9211; Jung, Un Suk/0000-0003-0421-4148	Hanyang University [HY201800000000609]	Hanyang University	Yes -This work was supported by the research fund of Hanyang University(HY201800000000609).	Barrasa JI, 2012, BBA-MOL CELL RES, V1823, P570, DOI 10.1016/j.bbamcr.2011.12.010; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Becker JC, 2013, CANCER IMMUNOL IMMUN, V62, P1137, DOI 10.1007/s00262-013-1434-6; Bi Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040169; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boulay A, 2001, CANCER RES, V61, P2189; Brown GT, 2015, J PATHOL, V237, P273, DOI 10.1002/path.4586; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chenard MP, 1996, INT J CANCER, V69, P448, DOI 10.1002/(SICI)1097-0215(19961220)69:6<448::AID-IJC5>3.3.CO;2-4; Eiro N, 2019, HISTOPATHOLOGY, V75, P916, DOI 10.1111/his.13956; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Han J, 2017, BREAST CANCER RES TR, V164, P41, DOI 10.1007/s10549-017-4234-4; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jayatilaka Hasini, 2018, Oncotarget, V9, P32556, DOI 10.18632/oncotarget.25863; Juric V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207255; Kasper G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-12; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Lei X, 2020, CANCER LETT, V470, P126, DOI 10.1016/j.canlet.2019.11.009; Li MY, 2016, ONCOL REP, V35, P1329, DOI 10.3892/or.2016.4547; Liu KL, 2018, CANCER SCI, V109, P1369, DOI 10.1111/cas.13575; Mahmoud AM, 2018, IMMUNOTHERAPY-UK, V10, P769, DOI 10.2217/imt-2017-0179; Min KW, 2013, ANN SURG ONCOL, V20, pS433, DOI 10.1245/s10434-012-2734-3; Naghshvar F, 2017, MIDDLE EAST J CANCER, V8, P69; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Peruzzi D, 2009, CLIN CANCER RES, V15, P4104, DOI 10.1158/1078-0432.CCR-08-3226; Poulsen A, 2012, J COMPUT AID MOL DES, V26, P437, DOI 10.1007/s10822-012-9572-z; REMMELE W, 1987, PATHOLOGE, V8, P138; Reznik N, 2019, ACS CHEM BIOL, V14, P2538, DOI 10.1021/acschembio.9b00667; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Sauerbrei W, 2018, JNCI-J NATL CANCER I, V110, P803, DOI 10.1093/jnci/djy088; Spoerke JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11579; Stratikopoulos EE, 2015, CANCER CELL, V27, P837, DOI 10.1016/j.ccell.2015.05.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wan XC, 2016, ONCOTARGET, V7, P51284, DOI 10.18632/oncotarget.9992; Waresijiang N, 2016, MOL MED REP, V13, P4859, DOI 10.3892/mmr.2016.5141; Wei L, 2005, HISTOL HISTOPATHOL, V20, P177, DOI 10.14670/HH-20.177; Winer A, 2018, MOL CANCER THER, V17, P1147, DOI 10.1158/1535-7163.MCT-17-0646; Wu XY, 2017, ONCOTARGET, V8, P20741, DOI 10.18632/oncotarget.15119; Yang HR, 2019, MOL THER-ONCOLYTICS, V14, P82, DOI 10.1016/j.omto.2019.03.012; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yi T, 2007, CANCER GENE THER, V14, P156, DOI 10.1038/sj.cgt.7700994; Yokoyama Y, 2008, CLIN CANCER RES, V14, P5503, DOI 10.1158/1078-0432.CCR-07-4041; Zhang X, 2016, INT J ONCOL, V48, P1783, DOI 10.3892/ijo.2016.3400	49	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252052	10.1371/journal.pone.0252052	http://dx.doi.org/10.1371/journal.pone.0252052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038440	gold, Green Published			2022-12-26	WOS:000664633500040
J	Lim, D; Wu, KC; Lee, A; Saunders, TL; Ritchie, HH				Lim, Dandrich; Wu, Ko-Chien; Lee, Arthur; Saunders, Thomas L.; Ritchie, Helena H.			DSPP dosage affects tooth development and dentin mineralization	PLOS ONE			English	Article							SIALOPHOSPHOPROTEIN DSPP; SIALOPROTEIN DSP; BAC TRANSGENE; IN-VITRO; EXPRESSION; COLLAGEN; ODONTOBLASTS; EFFICIENCY; MUTATIONS; DISTANT	Dentin Sialoprotein (DSP) and phosphophoryn (PP) are two most dominant non-collagenous proteins in dentin, which are the cleavage products of the DSPP (dentin sialophosphoprotein) precursor protein. The absence of the DSPP gene in DSPP knock-out (KO) mice results in characteristics that are consistent with dentinogenesis imperfecta type III in humans. Symptoms include thin dentin, bigger pulp chamber with frequent pulp exposure as well as abnormal epithelial-mesenchymal interactions, and the appearance of chondrocyte-like cells in dental pulp. To better understand how DSPP influences tooth development and dentin formation, we used a bacterial artificial chromosome transgene construct (BAC-DSPP) that contained the complete DSPP gene and promoter to generate BAC-DSPP transgenic mice directly in a mouse DSPP KO background. Two BAC-DSPP transgenic mouse strains were generated and characterized. DSPP mRNA expression in BAC-DSPP Strain A incisors was similar to that from wild-type (wt) mice. DSPP mRNA expression in BAC-DSPP Strain B animals was only 10% that of wt mice. PP protein content in Strain A incisors was 25% of that found in wt mice, which was sufficient to completely rescue the DSPP KO defect in mineral density, since microCT dentin mineral density analysis in 21-day postnatal animal molars showed essentially identical mineral density in both strain A and wt mice. Strain B mouse incisors, with 5% PP expression, only partially rescued the DSPP KO defect in mineral density, as microCT scans of 21-day postnatal animal molars indicated a reduced dentin mineral density compared to wt mice, though the mineral density was still increased over that of DSPP KO. Furthermore, our findings showed that DSPP dosage in Strain A was sufficient to rescue the DSPP KO defect in terms of epithelial-mesenchymal interactions, odontoblast lineage maintenance, along with normal dentin thickness and normal mineral density while DSPP gene dosage in Strain B only partially rescued the aforementioned DSPP KO defect.	[Lim, Dandrich; Wu, Ko-Chien; Lee, Arthur; Ritchie, Helena H.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA; [Saunders, Thomas L.] Univ Michigan, Sch Med, Dept Internal Med, Div Med Med & Genet Transgen Anim Model Core, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ritchie, HH (corresponding author), Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA.	helenar@umich.edu		Saunders, Thom/0000-0003-2015-101X	National Institute of Health [DE18901]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health DE18901 grant to HHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleicher F, 1999, MATRIX BIOL, V18, P133, DOI 10.1016/S0945-053X(99)00007-4; Boskey A, 2000, CALCIFIED TISSUE INT, V67, P472, DOI 10.1007/s002230001169; BRONCKERS ALJJ, 1993, CELL TISSUE RES, V272, P237, DOI 10.1007/BF00302729; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chuang SF., 2018, DENT J-BASEL, V6, P70; Deal KK, 2006, DEV DYNAM, V235, P1413, DOI 10.1002/dvdy.20769; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; DuBose AJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1463; Godovikova V, 2006, DEV BIOL, V289, P507, DOI 10.1016/j.ydbio.2005.10.002; Guo SL, 2014, STEM CELLS DEV, V23, P2883, DOI 10.1089/scd.2014.0066; Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450; Lee SY, 2012, J DENT RES, V91, P407, DOI 10.1177/0022034511436113; Linde A, 1989, Connect Tissue Res, V21, P197, DOI 10.3109/03008208909050009; LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763; LINDE A, 1989, ANAT REC, V224, P154, DOI 10.1002/ar.1092240206; Ritchie HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041110; Ritchie HH, 1997, EUR J ORAL SCI, V105, P405, DOI 10.1111/j.1600-0722.1997.tb02137.x; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Veis A, 1985, CHEM BIOL MINERALIZE, P170; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Wan CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29666; WEINSTOCK M, 1973, J CELL BIOL, V56, P838, DOI 10.1083/jcb.56.3.838; WEINSTOCK M, 1974, J CELL BIOL, V60, P92, DOI 10.1083/jcb.60.1.92; Wu L, 2008, CELLS TISSUES ORGANS, V187, P103, DOI 10.1159/000110079; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Yamakoshi Y, 2006, J BIOL CHEM, V281, P38235, DOI 10.1074/jbc.M607767200; Yang RT, 2013, J BIOL CHEM, V288, P6024, DOI 10.1074/jbc.M112.382952; Zhang H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195854; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhu QL, 2012, J BIOL CHEM, V287, P30426, DOI 10.1074/jbc.M112.388587	32	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0250429	10.1371/journal.pone.0250429	http://dx.doi.org/10.1371/journal.pone.0250429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038418	Green Published, gold			2022-12-26	WOS:000664633500009
J	Sobolev, VV; Mezentsev, AV; Ziganshin, RH; Soboleva, AG; Denieva, M; Korsunskaya, IM; Svitich, OA				Sobolev, V. V.; Mezentsev, A. V.; Ziganshin, R. H.; Soboleva, A. G.; Denieva, M.; Korsunskaya, I. M.; Svitich, O. A.			LC-MS/MS analysis of lesional and normally looking psoriatic skin reveals significant changes in protein metabolism and RNA processing	PLOS ONE			English	Article							BINDING; DIFFERENTIATION; QUANTIFICATION; IDENTIFICATION; EXPRESSION; COPPER; DEFICIENCY; HELICASES; INSIGHTS; STRESS	Background Plaque psoriasis is a chronic autoimmune disorder characterized by the development of red scaly plaques. To date psoriasis lesional skin transcriptome has been extensively studied, whereas only few proteomic studies of psoriatic skin are available. Aim The aim of this study was to compare protein expression patterns of lesional and normally looking skin of psoriasis patients with skin of the healthy volunteers, reveal differentially expressed proteins and identify changes in cell metabolism caused by the disease. Methods Skin samples of normally looking and lesional skin donated by psoriasis patients (n = 5) and samples of healthy skin donated by volunteers (n = 5) were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). After protein identification and data processing, the set of differentially expressed proteins was subjected to protein ontology analysis to characterize changes in biological processes, cell components and molecular functions in the patients' skin compared to skin of the healthy volunteers. The expression of selected differentially expressed proteins was validated by ELISA and immunohistochemistry. Results The performed analysis identified 405 and 59 differentially expressed proteins in lesional and normally looking psoriatic skin compared to healthy control. In normally looking skin of the patients, we discovered decreased expression of KNG1, APOE, HRG, THBS1 and PLG. Presumably, these changes were needed to protect the epidermis from spontaneous activation of kallikrein-kinin system and delay the following development of inflammatory response. In lesional skin, we identified several large groups of proteins with coordinated expression. Mainly, these proteins were involved in different aspects of protein and RNA metabolism, namely ATP synthesis and consumption; intracellular trafficking of membrane-bound vesicles, pre-RNA processing, translation, chaperoning and degradation in proteasomes/immunoproteasomes. Conclusion Our findings explain the molecular basis of metabolic changes caused by disease in skin lesions, such as faster cell turnover and higher metabolic rate. They also indicate on downregulation of kallikrein-kinin system in normally looking skin of the patients that would be needed to delay exacerbation of the disease. Data are available via ProteomeXchange with identifier PXD021673.	[Sobolev, V. V.; Mezentsev, A. V.; Svitich, O. A.] Mechnikov Res Inst Vaccines & Sera RAMS, Moscow, Russia; [Sobolev, V. V.; Mezentsev, A. V.; Soboleva, A. G.; Korsunskaya, I. M.] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Ziganshin, R. H.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Soboleva, A. G.] Sci Res Inst Human Morphol, Moscow, Russia; [Denieva, M.] Chechen State Univ, Grozny, Russia	Russian Academy of Medical Sciences; Research Institute of Vaccines and Sera Mechnikov, RAMS; Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Medical Sciences; Research Institute of Human Morphology; Kadyrov Chechen State University	Sobolev, VV (corresponding author), Mechnikov Res Inst Vaccines & Sera RAMS, Moscow, Russia.; Sobolev, VV (corresponding author), Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia.	vlsobolew@gmail.com	Mezentsev, Alexandre/B-2559-2008; Soboleva, Anna/ABH-1033-2020	Mezentsev, Alexandre/0000-0001-7100-1068; Mezentsev, Alexandre/0000-0002-4972-9922; Sobolev, Vladimir/0000-0003-4779-156X				Albani D, 1997, J LAB CLIN MED, V130, P339, DOI 10.1016/S0022-2143(97)90029-9; Alves TO, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01470; Barrea L, 2017, REV ENDOCR METAB DIS, V18, P195, DOI 10.1007/s11154-017-9411-6; Bartelt-Kirbach B, 2014, CELL STRESS CHAPERON, V19, P145, DOI [10.1007/s12192-013-0452-9, 10.1007/s12192-013-0465-4]; Bissonnette R, 1998, J INVEST DERMATOL, V111, P586, DOI 10.1046/j.1523-1747.1998.00345.x; Bouillon R, 2020, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00910; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Cardoso RM, 2019, BBA-MOL CELL BIOL L, V1864, P976, DOI 10.1016/j.bbalip.2019.03.008; Carlen LM, 2005, J INVEST DERMATOL, V124, P63, DOI 10.1111/j.0022-202X.2004.23501.x; Carlyle BC, 2018, PROTEOMES, V6, DOI 10.3390/proteomes6030032; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Deng M, 2018, NATURE, V562, P605, DOI 10.1038/s41586-018-0615-z; Dsouza PH., 2013, INT J RES MED SCI, V1, P53; FEINGOLD DS, 1967, NEW ENGL J MED, V276, P1135, DOI 10.1056/NEJM196705182762009; Furumoto H, 2002, ELECTROPHORESIS, V23, P161, DOI 10.1002/1522-2683(200202)23:2<161::AID-ELPS161>3.0.CO;2-P; Grantham J, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00172; Hilliker A, 2012, METHOD ENZYMOL, V511, P323, DOI 10.1016/B978-0-12-396546-2.00015-2; Jensen T, 1998, BRIT J DERMATOL, V138, P225; Karpouzis A, 2009, ARCH DERMATOL RES, V301, P405, DOI 10.1007/s00403-009-0968-0; Khan I, 2019, CANCER RES, V79, P4689, DOI 10.1158/0008-5472.CAN-19-0492; Kovalchuk SI, 2019, MOL CELL PROTEOMICS, V18, P383, DOI 10.1074/mcp.TIR118.000953; Krueger JG, 2015, J EXP MED, V212, P2186, DOI 10.1084/jem.21213insight3; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Li ZL, 2020, CELL MOL IMMUNOL, V17, P272, DOI 10.1038/s41423-019-0321-2; Liu HB, 2019, INDIAN J DERMATOL VE, V85, P653, DOI 10.4103/ijdvl.IJDVL_741_18; Lopez-Dee Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/296069; Mogulevtseva J.A., 2019, CLOSER LOOK METALLOP, P97; Nagasawa T, 2014, ONCOL REP, V32, P1291, DOI 10.3892/or.2014.3278; Oestreicher J. L., 2001, Pharmacogenomics Journal, V1, P272; Pan Q, 2002, CANCER RES, V62, P4854; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pietrzak D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201589; Piruzian E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-41; Ponikowska M, 2019, POSTEP HIG MED DOSW, V73, P359, DOI 10.5604/01.3001.0013.3450; Prinz JC, 2017, AUTOIMMUN REV, V16, P970, DOI 10.1016/j.autrev.2017.07.011; Quaranta M, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008946; Rashmi R, 2010, CLIN CHIM ACTA, V411, P1390, DOI 10.1016/j.cca.2010.05.028; Ryu J, 2011, INT J MOL MED, V28, P785, DOI 10.3892/ijmm.2011.757; Safadi FF, 1999, J CLIN INVEST, V103, P239, DOI 10.1172/JCI5244; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Schonthaler HB, 2013, IMMUNITY, V39, P1171, DOI 10.1016/j.immuni.2013.11.011; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shin JB, 2013, NAT NEUROSCI, V16, P365, DOI 10.1038/nn.3312; Solvsten H, 1996, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 1, NO 1, APRIL 1996, V1, P28; Speeckaert MM, 2014, ADV CLIN CHEM, V63, P1, DOI 10.1016/B978-0-12-800094-6.00001-7; Swindell WR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18404-9; Swindell WR, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0208-5; Tay SS, 2014, CURR DERMATOL REP, V3, P13, DOI 10.1007/s13671-013-0063-9; Tekin NS, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/78454; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vedder VL, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00109; Wang SJJ, 2012, ANAL BIOANAL CHEM, V402, P1229, DOI 10.1007/s00216-011-5527-9; Wei H, 2012, ATHEROSCLEROSIS, V223, P306, DOI 10.1016/j.atherosclerosis.2012.06.013; Yang KY, 2009, J AUTOIMMUN, V32, P94, DOI 10.1016/j.jaut.2008.12.004; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	61	3	3	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0240956	10.1371/journal.pone.0240956	http://dx.doi.org/10.1371/journal.pone.0240956			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038424	gold, Green Published, Green Submitted			2022-12-26	WOS:000664633500002
J	Che, XR; Liu, Y; Wang, J; Xu, YY; Zhang, XC; Gu, WW; Jiang, W; Du, J; Zhang, XP				Che, Xinren; Liu, Yan; Wang, Jun; Xu, Yuyang; Zhang, Xuechao; Gu, Wenwen; Jiang, Wei; Du, Jian; Zhang, Xiaoping			Booster immunization of meningococcal meningitis vaccine among children in Hangzhou, China, 2014-2019	PLOS ONE			English	Article								Background Despite China's Expanded Program on Immunization (EPI) provides 2 doses of group A and group C meningococcal polysaccharide vaccine (MPV-AC) for children at 3 years and 6 years old, more self-paying group ACYW135 meningococcal polysaccharide vaccines (MPV-ACYW135) have been used as an alternative to MPV-AC to prevent Neisseria meningitidis serogroup C,Y,W135. We provide recommendations for Chinese booster immunization of meningococcal meningitis vaccine by analyzing the service status of MPV-AC and MPV-ACYW135. Methods Reported data of routine immunization coverage from all districts of Hangzhou registered in the China Information Management System For Immunization Programming (CIMSFIP) between 2014 to 2019 were described and evaluated. Descriptive epidemiological methods were used to characterize the data. Adverse event following immunization (AEFI) were collected from Chinese national adverse event following immunization information system (CNAEFIIS) to compare the safety of MPV-AC and MPV-ACYW135. Results 1376919 doses of booster immunization of meningococcal meningitis vaccine (MenV) in CIMSFIP were conducted in China Hangzhou from 2014 to 2019, with reported immunization coverage rates above 95%. The proportion of children using MPV-ACYW135 increased from 12.63% in 2014 to 29.45% in 2019. The incidence of AEFI of MPV-AC and MPV-ACYW135 were 49.75 per 100,000 and 45.44 per 100,000, respectively, without statistical difference. Conclusion Children in Hangzhou had high booster immunization of MenV coverage. The use amount and use rate of MPV-ACYW135 increased year by year, indicating more and more parents had chosen MPV-ACYW135 as an alternative to MPV-AC at their own expense for children. The use proportions of MPV-ACYW135 were different in urban, suburban and rural areas. Both MPV-AC and MPV-ACYW135 were safe for children.	[Che, Xinren; Liu, Yan; Wang, Jun; Xu, Yuyang; Zhang, Xuechao; Gu, Wenwen; Jiang, Wei; Du, Jian; Zhang, Xiaoping] Hangzhou Ctr Dis Control & Prevent, Dept Expanded Program Immunizat, Hangzhou, Zhejiang, Peoples R China		Liu, Y (corresponding author), Hangzhou Ctr Dis Control & Prevent, Dept Expanded Program Immunizat, Hangzhou, Zhejiang, Peoples R China.	smileforever81@126.com			Hangzhou Science and Technology Development Guide Plan [20171226Y25]	Hangzhou Science and Technology Development Guide Plan	Our study was funded by the Hangzhou Science and Technology Development Guide Plan [grant number: 20171226Y25]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, CHIN J PREV MED, V53, P141, DOI [10.3760/cma.j.issn.0253-9624.2019.02.004, DOI 10.3760/CMA.J.ISSN.0253-9624.2019.02.004]; Bai XL, 2019, J INFECTION, V79, P528, DOI 10.1016/j.jinf.2019.10.018; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; jian Cui., 2016, CHINESE J VACCINES I, V22, P34; Jianxiong Xiao., 2019, CHIN J PUBLIC HLTH, V35, P438; Li Lanjan., 2019, INFECT DIS VERSION 9; Li Shi-hui, 2014, Chinese Journal of Biologicals, V27, P1378; Liang Jian, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P948; ling Yuan., 2010, DIS SURVEILLANCE, V25, P195; linlin Wu., 2020, CHINESE J BIOL, V33, P813; Luo XiaoYan, 2018, Disease Surveillance, V33, P569; Lv Hai-ying, 2018, Chinese Journal of Biologicals, V31, P392; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Plotkin SA., 2018, VACCINES M, V7th, P622; qun Xie., 2018, OCCUP HLTH, V34, P3115; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; Renfeng Fan., 2020, GUANGDONG MED J, V41, P1241; Shao Zhu-jun, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P891; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Vyse A, 2011, EPIDEMIOL INFECT, V139, P967, DOI 10.1017/S0950268811000574; weibo Dong., 2015, INT J EPIDEMIOL INFE, V42, P19; Wen- ting LIU., 2016, CHINESE J VACCINES I, P179; Xuan Deng., 2018, DIS SURVEILLANCE, V33, P547; yanan Li., 2018, PROG MICROBIOL IMMUN, V46, P49; yu Hu., 2016, INT J EPIDEMIOL INFE, V43, P95, DOI [10.3760/cma.j.issn.1673-4149.2016.02.006, DOI 10.3760/CMA.J.ISSN.1673-4149.2016.02.006]; yun Wu., 2019, PRACT PREV MED, V26, P1459; Zhiqiang Xie., PHASE 3 CLIN TRIAL S	27	0	0	17	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251567	10.1371/journal.pone.0251567	http://dx.doi.org/10.1371/journal.pone.0251567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34032806	Green Published, gold			2022-12-26	WOS:000664633100009
J	Olczak, M; Szulc, B				Olczak, Mariusz; Szulc, Bozena			Modified secreted alkaline phosphatase as an improved reporter protein for N-glycosylation analysis	PLOS ONE			English	Article							CHO-CELLS; CULTURE; TEMPERATURE; INCREASES	N-glycosylation is a common posttranslational modification of proteins in eukaryotic cells. The modification is often analyzed in cells which are able to produce extracellular, glycosylated proteins. Here we report an improved method of the use of genetically modified, secreted alkaline phosphatase (SEAP) as a reporter glycoprotein which may be used for glycoanalysis. Additional N-glycosylation sites introduced by site-directed mutagenesis significantly increased secretion of the protein. An improved purification protocol of recombinant SEAP from serum or serum-free media is also proposed. The method enables fast and efficient separation of reporter glycoprotein from a relatively small amount of medium (0.5-10 ml) with a high recovery level. As a result, purified SEAP was ready for enzymatic de-glycosylation without buffer exchange, sample volume reductions or other procedures, which are usually time-consuming and may cause partial loss of the reporter glycoprotein.	[Olczak, Mariusz; Szulc, Bozena] Univ Wroclaw, Fac Biotechnol, Lab Biochem, Wroclaw, Poland	University of Wroclaw	Olczak, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Lab Biochem, Wroclaw, Poland.	mariusz.olczak@uwr.edu.pl		Olczak, Mariusz/0000-0001-8629-6364; Szulc, Bozena/0000-0002-7782-9592	National Science Center (NCN), Krakow, Poland [2016/21/B/NZ5/00144]	National Science Center (NCN), Krakow, Poland	This research was supported by funding from National Science Center (NCN), Krakow, Poland, Website: www.ncn.gov.pl, Grant No. 2016/21/B/NZ5/00144 (MO) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2008, BIOTECHNOL BIOENG, V101, P1234, DOI 10.1002/bit.22006; An HJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010660; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bollati-Fogolin M, 2005, BIOTECHNOL PROGR, V21, P17, DOI 10.1021/bp049825t; Butler M, 2006, CYTOTECHNOLOGY, V50, P57, DOI 10.1007/s10616-005-4537-x; ENDO T, 1988, J BIOCHEM-TOKYO, V103, P182, DOI 10.1093/oxfordjournals.jbchem.a122228; Etzler M.E., 2009, ESSENTIAL GLYCOBIOLO; Hamouda H, 2014, J PROTEOME RES, V13, P6144, DOI 10.1021/pr5003005; Hamouda H, 2013, STEM CELLS DEV, V22, P3100, DOI 10.1089/scd.2013.0108; Lin CH, 2014, PROTEOMICS, V14, P87, DOI 10.1002/pmic.201300343; Maszczak-Seneczko D, 2011, FEBS LETT, V585, P3090, DOI 10.1016/j.febslet.2011.08.038; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; Mun JY, 2013, ANAL CHEM, V85, P7462, DOI 10.1021/ac401431u; Nam JH, 2008, BIOTECHNOL BIOENG, V100, P1178, DOI 10.1002/bit.21853; Reinke SO, 2011, J CARBOHYD CHEM, V30, P218, DOI 10.1080/07328303.2011.600489; Rodriguez J, 2005, BIOTECHNOL PROGR, V21, P22, DOI 10.1021/bp049807b; Sagt CMJ, 2000, APPL ENVIRON MICROB, V66, P4940, DOI 10.1128/AEM.66.11.4940-4944.2000; Schjoldager KT, 2020, NAT REV MOL CELL BIO, V21, P729, DOI 10.1038/s41580-020-00294-x; TAKEUCHI M, 1989, P NATL ACAD SCI USA, V86, P7819, DOI 10.1073/pnas.86.20.7819; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251805	10.1371/journal.pone.0251805	http://dx.doi.org/10.1371/journal.pone.0251805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34032812	gold, Green Published			2022-12-26	WOS:000664633100013
J	Lapane, KL; Shridharmurthy, D; Khan, S; Lindstrom, D; Beccia, A; Yi, E; Kay, J; Dube, C; Liu, SH				Lapane, Kate L.; Shridharmurthy, Divya; Khan, Sara; Lindstrom, Daniel; Beccia, Ariel; Yi, Esther; Kay, Jonathan; Dube, Catherine; Liu, Shao-Hsien			Primary care physician perspectives on screening for axial spondyloarthritis: A qualitative study	PLOS ONE			English	Article							INFLAMMATORY BACK-PAIN; ELECTRONIC MEDICAL-RECORD; ANKYLOSING-SPONDYLITIS; CRITERIA; CLASSIFICATION; PREVALENCE; DIAGNOSIS; SYSTEM	Background Many patients with axial spondylarthritis (axSpA) experience lengthy diagnostic delays upwards of 14 years. (5-14 years). Screening tools for axSpA have been proposed for use in primary care settings, but whether this approach could be implemented into busy primary care settings remains unknown. Objective To solicit feedback from primary care physicians regarding questions from the Inflammatory Back Pain Assessment: the Assessment of Spondyloarthritis International Society (ASAS) Expert Criteria and gain insight about barriers and facilitators for implementing axSpA screening in primary care. Methods Guided by Consolidated Criteria for reporting Qualitative Research (COREQ-criteria), we recorded, transcribed, and analyzed in-depth interviews with eight family medicine physicians and ten internists (purposeful sampling) using immersion/crystallization techniques. Results Few physicians reported awareness of existing classification criteria for axSpA, and many reported a lack of confidence in their ability to distinguish between inflammatory and mechanical back pain. From three domains, 10 subthemes emerged: 1) typical work-up of axSpA patients in primary care, with subthemes including the clues involved in work-up and role of clinical examinations for axSpA; 2) feedback on questions from the Inflammatory Back Pain Assessment: ASAS Expert Criteria, with subthemes to evaluate contents/questions of a potential screening tool for axSpA; and 3) implementation of the screening tool in primary care settings, with subthemes of perceived barriers including awareness, time, other conditions to screen, rare disease, and lack of structured questionnaire for back pain and perceived facilitators including workflow issues and awareness. Conclusions Primary care physicians believed that an improved screening instrument and a strong evidence-base to support the need for screening for axSpA are required. The implementation of axSpA screening into a busy primary care practice requires integration into the practice workflow, with use of technology suggested as a possible way to improve efficiency.	[Lapane, Kate L.; Shridharmurthy, Divya; Khan, Sara; Beccia, Ariel; Kay, Jonathan; Dube, Catherine; Liu, Shao-Hsien] Univ Massachusetts, Sch Med, Div Epidemiol, Dept Populat & Quantitat Hlth Sci, Worcester, MA 01605 USA; [Shridharmurthy, Divya; Beccia, Ariel; Liu, Shao-Hsien] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Clin & Populat Hlth Res Program, Worcester, MA 01605 USA; [Lindstrom, Daniel; Liu, Shao-Hsien] Univ Massachusetts, Sch Med, Internal Med, Grad Med Educ, Worcester, MA 01605 USA; [Yi, Esther] Novartis Pharmaceut, E Hanover, NJ USA; [Kay, Jonathan; Liu, Shao-Hsien] Univ Massachusetts, Sch Med, Div Rheumatol, Dept Med, Worcester, MA 01605 USA; [Kay, Jonathan] UMass Mem Med Ctr, Div Rheumatol, Worcester, MA USA; [Liu, Shao-Hsien] Univ Massachusetts, Sch Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Novartis; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Liu, SH (corresponding author), Univ Massachusetts, Sch Med, Div Epidemiol, Dept Populat & Quantitat Hlth Sci, Worcester, MA 01605 USA.; Liu, SH (corresponding author), Univ Massachusetts, Sch Med, Div Rheumatol, Dept Med, Worcester, MA 01605 USA.; Liu, SH (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA USA.	shaohsien.liu@umassmed.edu	Kay, Jonathan/HGE-1248-2022	Liu, Shao-Hsien/0000-0003-4317-4986; Khan, Sara/0000-0001-5411-3383	Novartis Pharmaceuticals Corporation; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000161]; SAA/Jane Bruckel Early Career Investigator in AxSpA Award	Novartis Pharmaceuticals Corporation(Novartis); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); SAA/Jane Bruckel Early Career Investigator in AxSpA Award	Funding for this project was provided by Novartis Pharmaceuticals Corporation. Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR000161 (KLL). This work was also supported by a charitable contribution to the UMass Memorial Foundation from Timothy S. and Elaine L. Peterson (JK, SHL). This project was also supported by the SAA/Jane Bruckel Early Career Investigator in AxSpA Award (SHL). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders provided support in the form of salaries for authors [KLL, DS, SK, CD, JK, SHL, EY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akenroye AT, 2017, ARTHRIT CARE RES, V69, P625, DOI 10.1002/acr.22966; AMOR B, 1990, REV RHUM, V57, P85; Anzai Y, 2020, J AM COLL RADIOL, V17, P194, DOI 10.1016/j.jacr.2019.08.011; Bishop TE, 2017, HEALTHCARE-J DEL SCI, V5, P17, DOI 10.1016/j.hjdsi.2016.04.001; Bohn R, 2018, CLIN EXP RHEUMATOL, V36, P263; Borkan J., 1999, DOING QUALITATIVE RE, V2nd ed., P179; CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613, DOI 10.1001/jama.237.24.2613; Chaudhry R, 2007, ARCH INTERN MED, V167, P606, DOI 10.1001/archinte.167.6.606; Danve A, 2019, CLIN RHEUMATOL, V38, P625, DOI 10.1007/s10067-018-4397-3; Danve A, 2015, CLIN RHEUMATOL, V34, P987, DOI 10.1007/s10067-015-2958-2; Deal CL, 2007, ARTHRITIS RHEUM, V56, P722, DOI 10.1002/art.22437; DeJesus RS, 2012, J EVAL CLIN PRACT, V18, P89, DOI 10.1111/j.1365-2753.2010.01528.x; Deodhar A, 2014, ANN RHEUM DIS, V73, P198, DOI 10.1136/annrheumdis-2014-eular.1135; Deodhar A, 2016, ARTHRITIS RHEUMATOL, V68, P1669, DOI 10.1002/art.39612; DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003; Force UPST, USPSTF REC DEV PROC; Guiriguet C, 2016, BRIT J GEN PRACT, V66, pE483, DOI 10.3399/bjgp16X685657; Hamilton L, 2013, SPINE, V38, P502, DOI 10.1097/BRS.0b013e318273aa4f; Haroon NN, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006634; Hye RJ, 2014, J VASC SURG, V59, P1535, DOI 10.1016/j.jvs.2013.12.016; Jamal M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227025; Jois RN, 2008, RHEUMATOLOGY, V47, P1364, DOI 10.1093/rheumatology/ken224; Lapane KL, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-01274-y; Levinson W, 2015, BMJ QUAL SAF, V24, P167, DOI 10.1136/bmjqs-2014-003821; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; Navarro-Compan V, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0838-5; Poddubnyy D, 2015, ANN RHEUM DIS, V74, P1483, DOI 10.1136/annrheumdis-2014-207151; Proft F, 2018, THER ADV MUSCULOSKEL, V10, P129, DOI 10.1177/1759720X18773726; Reveille JD, 2012, ARTHRIT CARE RES, V64, P905, DOI 10.1002/acr.21621; Robinson OC, 2014, QUAL RES PSYCHOL, V11, P25, DOI 10.1080/14780887.2013.801543; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P535, DOI 10.1136/ard.2003.011247; Sieper J, 2002, ANN RHEUM DIS, V61, P8; Sieper J, 2009, ANN RHEUM DIS, V68, P784, DOI 10.1136/ard.2008.101501; Sieper J, 2017, LANCET, V390, P73, DOI 10.1016/S0140-6736(16)31591-4; Statistics NCfH, 2016, NAT AMB MED CAR SURV; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van Hoeven L, 2014, ARTHRIT CARE RES, V66, P446, DOI 10.1002/acr.22180; van Onna M, 2014, J RHEUMATOL, V41, P897, DOI 10.3899/jrheum.131293; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wang R, 2018, CURR OPIN RHEUMATOL, V30, P137, DOI 10.1097/BOR.0000000000000475; Weisman MH, 2012, RHEUM DIS CLIN N AM, V38, P501, DOI 10.1016/j.rdc.2012.09.002; Yi EH, 2020, RHEUMATOL THER, V7, P65, DOI 10.1007/s40744-020-00194-8	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252018	10.1371/journal.pone.0252018	http://dx.doi.org/10.1371/journal.pone.0252018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029339	Green Published, gold			2022-12-26	WOS:000664632800022
J	Wang, ZC; Li, LM; Ouyang, LJ				Wang, Zechen; Li, Limei; Ouyang, Lejun			Efficient genetic transformation method for Eucalyptus genome editing	PLOS ONE			English	Article							UROPHYLLA; REGENERATION; RESISTANCE; COTYLEDON; CULTURE	Plantation forestry of Eucalyptus urophylla x Eucalyptus grandis supplies high-quality raw material for pulp, paper, wood, and energy and thereby reduces the pressures on native forests and their associated biodiversity. Nevertheless, owing to the heterozygosity of the E. urophylla x E. grandis genetic background, germplasm improvement by crossbreeding tends to be inefficient. As an alternative approach, genetic engineering of Eucalyptus can be used to effectively improve germplasm resources. From a strategic standpoint, increasing the plantation productivity and wood quality by transgenic technology has become increasingly important for forest industry. In this study, we established a fluorescence labelling method using CRISPR/Cas9 technology to obtain positive transformed progenies. The positive transformed progenies were easily obtained from the genetically modified population via fluorescence screening. This system can be used as a plant genome site-specific editing tool and may be useful for improving Eucalyptus genetic resources.	[Li, Limei; Ouyang, Lejun] Guangdong Univ Petrochem Technol, Coll Biol & Food Engn, Maoming, Guangdong, Peoples R China; [Wang, Zechen] Kashi Univ, Yarkand Oasis Colleges & Univ, Dept Educ Xinjiang Uygur Autonomous Reg, Key Lab Ecol & Biol Resources, Kashi City, Xinjiang Uygur, Peoples R China	Guangdong University of Petrochemical Technology	Ouyang, LJ (corresponding author), Guangdong Univ Petrochem Technol, Coll Biol & Food Engn, Maoming, Guangdong, Peoples R China.	ouyanglejun@163.com		, Lejun/0000-0001-8114-5540	National Natural Science Foundation of China [32071780]; Key Project of Basic Research and Applied Research of Guangdong Province [2018KZDXM047]; Natural Science Foundation of Guangdong Province [2017A030307017, 2019A1515010709]; Science and Technology Tackle Key Problem of Guangdong Province [mmkj2020035]; College Students' innovation and entrepreneurship training program of Guangdong Province [733163, 733164, 733317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Basic Research and Applied Research of Guangdong Province; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Tackle Key Problem of Guangdong Province; College Students' innovation and entrepreneurship training program of Guangdong Province	This research was supported by the National Natural Science Foundation of China (32071780), the Key Project of Basic Research and Applied Research of Guangdong Province (2018KZDXM047), the Natural Science Foundation of Guangdong Province (2017A030307017; 2019A1515010709), the Science and Technology Tackle Key Problem of Guangdong Province (mmkj2020035), and College Students' innovation and entrepreneurship training program of Guangdong Province (733163: 733164; 733317).	BASSLER BL, 1994, MOL MICROBIOL, V13, P273, DOI 10.1111/j.1365-2958.1994.tb00422.x; de la Torre F, 2014, PLANT CELL TISS ORG, V117, P77, DOI 10.1007/s11240-013-0422-z; ESCANDON AS, 1991, PHYSIOL PLANTARUM, V81, P367; Gao XH, 2016, PLANT PHYSIOL, V171, P1794, DOI 10.1104/pp.16.00663; Giri CC, 2004, TREES-STRUCT FUNCT, V18, P115, DOI 10.1007/s00468-003-0287-6; Guertler P, 2013, EUR FOOD RES TECHNOL, V236, P599, DOI 10.1007/s00217-013-1916-y; Huang ZhenChi, 2019, Journal of Northeast Forestry University, V47, P21; [孔华 Kong Hua], 2008, [热带作物学报, Chinese Journal of Tropical Crops], V29, P424; Kuo HC, 2009, J GLOBAL OPTIM, V44, P563, DOI 10.1007/s10898-008-9357-z; Li LM, 2015, J TROP FOR SCI, V27, P289; Li LiMei, 2018, Journal of Southern Agriculture, V49, P411; Liu Huihui, 2017, Scientia Silvae Sinicae, V53, P119; Liu X, 2018, WORLD FORESTRY RES, P37; Mezghani N, 2007, BIOLOGIA, V62, P704, DOI 10.2478/s11756-007-0146-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ouyang LJ, 2016, TRANSGENIC RES, V25, P441, DOI 10.1007/s11248-016-9940-x; Ouyang LJ, 2012, J TROP FOR SCI, V24, P198; Ouyang LJ, 2020, PEERJ, V8, DOI 10.7717/peerj.8776; Ouyang Lejun, 2014, Xibei Zhiwu Xuebao, V34, P1345, DOI 10.7606/j.issn.1000-4025.2014.07.1345; Ouyang LJ, 2012, BRAZ ARCH BIOL TECHN, V55, P329, DOI 10.1590/S1516-89132012000300001; Prakash MG, 2009, IN VITRO CELL DEV-PL, V45, P429, DOI 10.1007/s11627-008-9179-1; SAS Institute Inc, 1997, SAS STATO US GUID VE; Scheidt GN., 2011, J BIOTECNOL BIODIVER, V2, P1, DOI DOI 10.20873/JBB.UFT.CEMAF.V2N1.SILVA; [沙月娥 Sha Yuee], 2012, [植物生理学报, Plant Physiology Journal], V48, P325; Wang C., 2017, BULL BOT RES, P35; Wang G. L., 2002, PLANT GENETIC ENG	26	2	2	13	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252011	10.1371/journal.pone.0252011	http://dx.doi.org/10.1371/journal.pone.0252011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029322	Green Published, gold			2022-12-26	WOS:000664632800021
J	Seol, HJ; Kim, HY; Cho, GJ; Oh, MJ				Seol, Hyun-Joo; Kim, Ho Yeon; Cho, Geum-Joon; Oh, Min-Jeong			Hourly fetal urine production rate in isolated oligohydramnios at term	PLOS ONE			English	Article							AMNIOTIC-FLUID VOLUME; 3-DIMENSIONAL ULTRASOUND; PERINATAL OUTCOMES; NORMAL-PREGNANCY; NORMAL RANGE; INDEX; ASSOCIATION; 3RD; INTRAPARTUM; POCKET	Objective The aim of this study was to evaluate the hourly fetal urine production rate (HFUPR) via three-dimensional ultrasonography in women with isolated oligohydramnios and compare with normal pregnant women at term. Materials and methods This was a prospective observational cohort study of 112 women from 34 to 40 6/7 weeks' gestation. They were classified into three groups according to the amniotic fluid index (AFI) and ultrasonographic estimated fetal weight (EFW) as isolated oligohydramnios (defined as AFI below 5% and appropriate EFW corresponding to gestational age) (n = 34) and IUGR (defined as EFW below 5% corresponding to gestational age irrespective amniotic fluid) (n = 17), and normal pregnancy (n = 61). HFUPR was measured using three-dimensional virtual organ computer-aided analysis. Adverse perinatal outcomes in all participants were examined. Results There was no significant difference in HFUPR between patients with isolated oligohydramnios and women with normal pregnancies (median, 40.0 mL/h [interquartile range [IQR] 31.0-66.5] vs. 48.6 [31.5-81.2], p = 0.224). HFUPR was significantly decreased in the IUGR group (13.8 mL/h [IQR 10.1-24.8]), compared to the normal pregnancy group (p<0.001) and the isolated oligohydramnios group (p<0.001). HFUPR was significantly decreased in neonates with adverse perinatal outcomes compared to the control (24.7 mL/h [IQR 13.4-47.4] vs. 43.6 [29.8-79.0], p = 0.016). Conclusion HFUPR was not decreased in patients with isolated oligohydramnios but was decreased in patients with IUGR when compared to normal controls at term.	[Seol, Hyun-Joo; Oh, Min-Jeong] Kyung Hee Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Kim, Ho Yeon; Cho, Geum-Joon; Oh, Min-Jeong] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Kyung Hee University; Korea University; Korea University Medicine (KU Medicine)	Oh, MJ (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.	mjohmd@korea.ac.kr			Korean Society of Ultrasound in Obstetrics and Gynecology Research Fund	Korean Society of Ultrasound in Obstetrics and Gynecology Research Fund	This research was supported by the Korean Society of Ultrasound in Obstetrics and Gynecology Research Fund in 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwal E, 2014, ARCH GYNECOL OBSTET, V290, P875, DOI 10.1007/s00404-014-3292-7; BARON C, 1995, AM J OBSTET GYNECOL, V173, P167, DOI 10.1016/0002-9378(95)90185-X; BARSS VA, 1984, OBSTET GYNECOL, V64, P608; Brace RA, 2014, ADV EXP MED BIOL, V814, P49, DOI 10.1007/978-1-4939-1031-1_5; Budunoglu MD, 2019, J GYNECOL OBSTET HUM, V48, P495, DOI 10.1016/j.jogoh.2019.06.002; Casey BM, 2000, AM J OBSTET GYNECOL, V182, P909, DOI 10.1016/S0002-9378(00)70345-0; GILBERT WM, 1989, OBSTET GYNECOL, V74, P748; Gramellini Dandolo, 2004, Acta Biomed, V75 Suppl 1, P40; GROOME LJ, 1991, AM J OBSTET GYNECOL, V165, P1077, DOI 10.1016/0002-9378(91)90474-6; Hashimoto K, 2013, J PERINAT MED, V41, P349, DOI 10.1515/jpm-2012-0130; HEBERTSON RM, 1986, OBSTET GYNECOL, V68, P74; HEDRIANA HL, 1994, AM J OBSTET GYNECOL, V170, P1250; HILL LM, 1983, AM J OBSTET GYNECOL, V147, P407, DOI 10.1016/S0002-9378(16)32235-9; Kehl S, 2016, ULTRASOUND OBST GYN, V47, P674, DOI 10.1002/uog.14924; Lee SM, 2007, ULTRASOUND OBST GYN, V30, P281, DOI 10.1002/uog.4038; Lee SM, 2014, J ULTRAS MED, V33, P2165, DOI 10.7863/ultra.33.12.2165; Magann EF, 2004, AM J OBSTET GYNECOL, V190, P164, DOI 10.1016/S0002-9378(03)00859-7; Maged AM, 2014, J MATERN-FETAL NEO M, V27, P1790, DOI 10.3109/14767058.2013.879709; MANNING FA, 1980, AM J OBSTET GYNECOL, V136, P787, DOI 10.1016/0002-9378(80)90457-3; Melamed N, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.013; Miremberg H, 2020, PLACENTA, V90, P37, DOI 10.1016/j.placenta.2019.12.004; MOORE TR, 1990, AM J OBSTET GYNECOL, V162, P1168, DOI 10.1016/0002-9378(90)90009-V; Nabhan AF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006593.pub2; NICOLAIDES KH, 1990, AM J OBSTET GYNECOL, V162, P387, DOI 10.1016/0002-9378(90)90392-K; Peixoto FM, 2013, ARCH GYNECOL OBSTET, V287, P31, DOI 10.1007/s00404-012-2516-y; Peixoto FM, 2011, ARCH GYNECOL OBSTET, V283, P497, DOI 10.1007/s00404-010-1397-1; RABINOWITZ R, 1989, AM J OBSTET GYNECOL, V161, P1264, DOI 10.1016/0002-9378(89)90679-0; Raine-Fenning NJ, 2003, ULTRASOUND OBST GYN, V21, P283, DOI 10.1002/uog.61; Riccabona M, 1996, J ULTRAS MED, V15, P627; Roberts D, 1998, J PERINAT MED, V26, P390, DOI 10.1515/jpme.1998.26.5.390; Rossi AC, 2013, EUR J OBSTET GYN R B, V169, P149, DOI 10.1016/j.ejogrb.2013.03.011; Sande JA, 2015, PRENATAL DIAG, V35, P434, DOI 10.1002/pd.4504; Scifres CM, 2009, AM J PERINAT, V26, P723, DOI 10.1055/s-0029-1223284; SEEDS AE, 1980, AM J OBSTET GYNECOL, V138, P575, DOI 10.1016/0002-9378(80)90289-6; SHENKER L, 1991, AM J OBSTET GYNECOL, V164, P1597, DOI 10.1016/0002-9378(91)91442-Y; Tahmina S, 2020, J MATERN-FETAL NEO M, V33, P2190, DOI 10.1080/14767058.2018.1543654; Touboul C, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.003; TRIMMER KJ, 1990, AM J OBSTET GYNECOL, V163, P1900, DOI 10.1016/0002-9378(90)90771-X; Zhang J, 2004, BJOG-INT J OBSTET GY, V111, P220, DOI 10.1111/j.1471-0528.2004.00060.x; Zhu XQ, 2009, PLACENTA, V30, P670, DOI 10.1016/j.placenta.2009.05.010	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0250659	10.1371/journal.pone.0250659	http://dx.doi.org/10.1371/journal.pone.0250659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019576	Green Published, gold			2022-12-26	WOS:000664632300011
J	Chen, ZH; Yu, M; Wang, YX; Zhou, L				Chen, Zhenhua; Yu, Meng; Wang, Yuxuan; Zhou, Lei			The effect of the synchronized multi-dimensional policies on imported COVID-19 curtailment in China	PLOS ONE			English	Article							SPREAD; RISK; TRANSMISSION; COUNTRIES	As countries are lifting restrictions and resuming international travels, the rising risk of COVID-19 importation remains concerning, given that the SARS-CoV-2 virus could be transmitted unintentionally through the global transportation network. To explore and assess the effective strategies for curtailing the epidemic risk from international importation nationwide, we evaluated "the joint prevention and control" mechanism, which made up of 19 containment policies, on how it impacted the change of medical observation and detection time from border arrival to laboratory confirmation of COVID-19 in its burst in China. Based on 1,314 epidemiological-survey cases from February 29 to May 25, 2020, we found that the synchronized approach of implementing multi-dimensional interventional policies, such as a centralized quarantine and nucleic acid testing (NAT), flight service adjustment and border closure, effectively facilitate early identification of infected case. Specifically, the implementation of the international flight service reduction was found to be associated with a reduction of the mean intervals of diagnosis from arrival to lab-confirmation by 0.44 days maximally, and the border closure was associated with a reduction of the diagnosis interval of imported cases by 0.69 days, from arrival to laboratory confirmation. The study suggests that a timely and synchronized implementation of multi-dimensional policies is compelling in preventing domestic spreading from importation.	[Chen, Zhenhua; Yu, Meng; Wang, Yuxuan] Ohio State Univ, City & Reg Planning, Columbus, OH 43210 USA; [Zhou, Lei] Shanghai Maritime Univ, Sch Econ & Management, Shanghai, Peoples R China	University System of Ohio; Ohio State University; Shanghai Maritime University	Chen, ZH (corresponding author), Ohio State Univ, City & Reg Planning, Columbus, OH 43210 USA.	chen.7172@osu.edu		YU, MENG/0000-0003-0261-0390; Wang, Yuxuan/0000-0002-1512-8846; Chen, Zhenhua/0000-0003-0473-1508				Abi-Habib M., 2020, NEW YORK TIMES; Adolph C., 2020, TIMING STATE LEVEL S; Allison PD, 2002, SOCIOL METHODOL, V32, P247, DOI 10.1111/1467-9531.00117; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, PREVENTING SPREAD CO; [Anonymous], 2020, S CHINA MORNING POST; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016591; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Benzell SG, 2020, P NATL ACAD SCI USA, V117, P14642, DOI 10.1073/pnas.2008025117; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Bynander F., 2019, COLLABORATIVE CRISIS; Chandrashekhar V., 2020, SCIENCE, DOI [10.1126/science.abc0030, DOI 10.1126/SCIENCE.ABC0030]; Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Christidis P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103356; Cohen J, 2020, SCIENCE, V367, P1287, DOI 10.1126/science.367.6484.1287; Demertzis K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134693; Dollard P, 2020, MMWR-MORBID MORTAL W, V69, P1681, DOI 10.15585/mmwr.mm6945a4; Erkhembayar R., EARLY POLICY ACTIONS; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Gostic K, 2020, ELIFE, V9, DOI 10.7554/eLife.55570; Greene W., 2006, FDN TRENDS ECONOMETR, V1, P113, DOI [DOI 10.1561/0800000008, 10.1561/0800000008]; Guimaraes P, 2008, ECON LETT, V99, P63, DOI 10.1016/j.econlet.2007.05.030; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Hunter DJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005755; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Li XY, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa109; Liu Y., 2020, J MED VIROL; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Madrigal Alexis C., 2020, THE ATLANTIC 0321; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Mulfati J., 2020, APEX; National Health Commission of the People's Republic of China and relevant departments joint prevention and control mechanism, 2020, REP CHIN REL DEP JOI; Ning Y, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00161-4; Peng JH, 2020, INFLUENZA OTHER RESP, V14, P599, DOI 10.1111/irv.12768; Poletto C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1787-5; Quilty BJ, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.5.2000080; Roser M., CORONAVIRUS DIS COVI; Ruktanonchai NW, 2020, SCIENCE, V369, P1465, DOI 10.1126/science.abc5096; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; Tang B, 2020, INT J INFECT DIS, V95, P288, DOI 10.1016/j.ijid.2020.03.018; Tenda ED, 2020, ACTA MED INDONES, V52, P68; The Civil Aviation Administration of China, 2020, NOT CONTR INT PASS F; The Civil Aviation Administration of China, 2020, NOT JOINTL REL RER S; The Civil Aviation Administration of China, 2020, CAAC FURTH RED INT P; The State Council Information Office of the People's Republic of China, 2020, FULL TEXT FIGHT COVI; Tsiotas D., 2021, ARXIV PREPRINT ARXIV; Tsiotas D, 2020, PHYSICS-BASEL, V2, P325, DOI 10.3390/physics2020017; VariFlight, 2020, 2019 STAT B DEV CHIN; Wells CR, 2020, P NATL ACAD SCI USA, V117, P7504, DOI 10.1073/pnas.2002616117; WHO, 2020, ADV INT TRAV TRAV TR; WHO, 2020, CRIT REL COVID 19 PA; Woloshin S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2015897; Yan J., RISK MANAG HEALTHC P; Yang Q., 2020, BEIJINGS INBOUND FLI; Yu XX, 2020, INFLUENZA OTHER RESP, V14, P474, DOI 10.1111/irv.12743; Zavascki AP, 2020, NEW ENGL J MED, V382, P1859, DOI 10.1056/NEJMc2005203; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117; Zhang Z., 2020, CHINA BRIEFING NEWS	63	4	4	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252224	10.1371/journal.pone.0252224	http://dx.doi.org/10.1371/journal.pone.0252224			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061912	Green Published, gold			2022-12-26	WOS:000656813600017
J	Immerzeel, B; Vermaat, JE; Riise, G; Juutinen, A; Futter, M				Immerzeel, Bart; Vermaat, Jan E.; Riise, Gunnhild; Juutinen, Artti; Futter, Martyn			Estimating societal benefits from Nordic catchments: An integrative approach using a final ecosystem services framework	PLOS ONE			English	Article							CLIMATE-CHANGE; WATER-QUALITY; VALUATION; CLASSIFICATION; METAANALYSIS	Nordic catchments provide a variety of ecosystem services, from harvestable goods to mitigation of climate change and recreational possibilities. Flows of supplied ecosystem services depend on a broad range of factors, including climate, hydrology, land management and human population density. The aims of this study were: 1) to quantify the total economic value (TEV) of consumed ecosystem services across Nordic catchments, 2) to explain variation in ecosystem service value using socio-geographic and natural factors as explanatory variables in multiple linear regression, and 3) to determine which societal groups benefit from these ecosystem services. Furthermore, we tested the scientific rigour of our framework based on the concept of final ecosystem services (FES). We used a spatially explicit, integrative framework for ecosystem services quantification to compile data on final ecosystem services provision from six catchments across Denmark, Finland, Norway and Sweden. Our estimates showed a broad variation in TEV and in the proportion contributed by separate services, with the highest TEV of euro7,199 +/- 4,561 ha(-1) y(-1) (mean +/- standard deviation) in the Norwegian Orrevassdraget catchment, and the lowest TEV of euro183 +/- 517 ha(-1) y(-1) in the Finnish Simojoki catchment. The value of material services was dependent on both geographic factors and land management practices, while the value of immaterial services was strongly dependent on population density and the availability of water. Using spatial data on land use, forest productivity and population density in a GIS analysis showed where hotspots of ecosystem services supply are located, and where specific stakeholder groups benefit most. We show that our framework is applicable to a broad variety of data sources and across countries, making international comparative analyses possible.	[Immerzeel, Bart; Vermaat, Jan E.; Riise, Gunnhild] Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway; [Juutinen, Artti] Nat Resources Inst Finland, Oulu, Finland; [Futter, Martyn] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden	Norwegian University of Life Sciences; Natural Resources Institute Finland (Luke); Swedish University of Agricultural Sciences	Immerzeel, B (corresponding author), Norwegian Univ Life Sci, Fac Environm Sci & Nat Resource Management, As, Norway.	bart.immerzeel@nmbu.no	Immerzeel, Bart/GWR-0497-2022; Vermaat, Jan E/I-5856-2012	Vermaat, Jan E/0000-0003-4250-6790; Immerzeel, Bart/0000-0002-1619-4239	NordForsk [82263]	NordForsk	B.I. -82263 -NordForsk - https://www.nordforsk.org/projects/integrating-nexus-land-andwater-management-sustainable-nordic-bioeconomy-biowater J.V. -82263 -NordForsk https://www.nordforsk.org/projects/integrating-nexus-land-and-water-management-sustainablenordic-bioeconomy-biowater G.R. -82263 NordForsk -https://www.nordforsk.org/projects/integrating-nexus-land-and-water-managementsustainable-nordic-bioeconomy-biowater A.J. 82263 - NordForsk -https://www.nordforsk.org/projects/integrating-nexus-land-and-watermanagement-sustainable-nordic-bioeconomy-biowater M.F. -82263 - NordForsk -https://www.nordforsk.org/projects/integrating-nexus-land-andwater-management-sustainable-nordic-bioeconomy-biowater The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett J., 2020, CARBON STORAGE NORWE; Barton D.N., 2012, VALUATION ECOSYSTEM, P162; Bateman IJ, 2011, ENVIRON RESOUR ECON, V50, P365, DOI 10.1007/s10640-011-9476-8; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Boerema A, 2017, J APPL ECOL, V54, P358, DOI 10.1111/1365-2664.12696; Boyd J, 2007, ECOL ECON, V63, P616, DOI 10.1016/j.ecolecon.2007.01.002; Brander LM, 2006, ENVIRON RESOUR ECON, V33, P223, DOI 10.1007/s10640-005-3104-4; Brander LM, 2012, ECOSYST SERV, V1, P62, DOI 10.1016/j.ecoser.2012.06.003; Brander LM, 2011, J ENVIRON MANAGE, V92, P2763, DOI 10.1016/j.jenvman.2011.06.019; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Burkhard B, 2012, ECOL INDIC, V21, P17, DOI 10.1016/j.ecolind.2011.06.019; Buttner G, 2000, NATO ASI 2, V72, P89; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; de Groot RS, 2010, ECOL COMPLEX, V7, P260, DOI 10.1016/j.ecocom.2009.10.006; de Groot R, 2012, ECOSYST SERV, V1, P50, DOI 10.1016/j.ecoser.2012.07.005; Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826; Dworak T., 2009, STUDY RWS WATERDIENS; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Grizzetti B, 2016, ENVIRON SCI POLICY, V66, P179, DOI 10.1016/j.envsci.2016.09.006; Haines-Young R., 2017, COMMON INT CLASSIFIC; Hanna DEL, 2018, J APPL ECOL, V55, P1299, DOI 10.1111/1365-2664.13045; Hristov J, 2020, APPL ECON PERSPECT P, V42, P716, DOI 10.1002/aepp.13037; Johnston RJ, 2011, ECOL ECON, V70, P2243, DOI 10.1016/j.ecolecon.2011.07.003; Juutinen A, 2020, ECOL ECON, V175, DOI 10.1016/j.ecolecon.2020.106704; Juutinen A, 2014, J FOREST ECON, V20, P396, DOI 10.1016/j.jfe.2014.10.003; Keeler BL, 2012, P NATL ACAD SCI USA, V109, P18619, DOI 10.1073/pnas.1215991109; Kumar P, 2009, EC ECOSYSTEMS BIODIV; Kumm KI, 2020, LAND-BASEL, V9, DOI 10.3390/land9020042; La Notte A, 2017, ECOL INDIC, V74, P392, DOI 10.1016/j.ecolind.2016.11.030; Landers DH., 2013, EPA600R13CRD004914 U; Lankia T, 2015, J OUTDO RECREAT TOUR, V10, P14, DOI 10.1016/j.jort.2015.04.006; Lant CL, 2008, BIOSCIENCE, V58, P969, DOI 10.1641/B581010; Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728; Lehmann LM, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135429; Lempinen H, 2019, ENERG POLICY, V128, P1, DOI 10.1016/j.enpol.2018.12.041; Malczewski J, 2004, PROG PLANN, V62, P3, DOI 10.1016/j.progress.2003.09.002; MEEUS JHA, 1990, LANDSCAPE URBAN PLAN, V18, P289, DOI 10.1016/0169-2046(90)90016-U; Milner JM, 2013, EUR J FOREST RES, V132, P959, DOI 10.1007/s10342-013-0727-9; Mononen L, 2016, ECOL INDIC, V61, P27, DOI 10.1016/j.ecolind.2015.03.041; Nahlik AM, 2012, ECOL ECON, V77, P27, DOI 10.1016/j.ecolecon.2012.01.001; Nikodinoska N, 2018, ECOL MODEL, V368, P411, DOI 10.1016/j.ecolmodel.2017.10.013; Oygarden L, 2014, AGR ECOSYST ENVIRON, V198, P114, DOI 10.1016/j.agee.2014.06.025; Pearce D., 1991, AM J AGR ECON, V73, P100, DOI [10.2307/1242904, DOI 10.2307/1242904]; Queiroz C, 2015, AMBIO, V44, pS89, DOI 10.1007/s13280-014-0601-0; Remme RP, 2015, ECOL ECON, V112, P116, DOI 10.1016/j.ecolecon.2015.02.015; Saarikoski H, 2015, ECOSYST SERV, V14, P144, DOI 10.1016/j.ecoser.2015.03.006; Schild JE, 2018, J ARID ENVIRON, V159, P11, DOI 10.1016/j.jaridenv.2017.09.001; Schroter M, 2014, CONSERV LETT, V7, P514, DOI 10.1111/conl.12091; Spangenberg JH, 2010, ECOL COMPLEX, V7, P327, DOI 10.1016/j.ecocom.2010.04.007; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7; Vallecillo S., 2019, JRC116334; Vermaat JE, 2020, AMBIO, V49, P1784, DOI 10.1007/s13280-020-01348-2; Vermaat JE, 2016, HYDROBIOLOGIA, V769, P121, DOI 10.1007/s10750-015-2482-z; Wallace KJ, 2007, BIOL CONSERV, V139, P235, DOI 10.1016/j.biocon.2007.07.015; Watson KB, 2016, ECOL ECON, V130, P16, DOI 10.1016/j.ecolecon.2016.05.015; Wustemann H, 2014, LAND USE POLICY, V36, P307, DOI 10.1016/j.landusepol.2013.08.009; Zhou T, 2019, URBAN ECOSYST, V22, P1207, DOI 10.1007/s11252-019-00894-2	62	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252352	10.1371/journal.pone.0252352	http://dx.doi.org/10.1371/journal.pone.0252352			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SL3JC	34061872	Green Published, gold			2022-12-26	WOS:000656813600044
J	Yamashita, H; Koike, K; Shinzato, C; Jimbo, M; Suzuki, G				Yamashita, Hiroshi; Koike, Kazuhiko; Shinzato, Chuya; Jimbo, Mitsuru; Suzuki, Go			Can Acropora tenuis larvae attract native Symbiodiniaceae cells by green fluorescence at the initial establishment of symbiosis?	PLOS ONE			English	Article							FREE-LIVING SYMBIODINIUM; CORAL LARVAE; ULTRAVIOLET-RADIATION; INDO-PACIFIC; MICROADRIATICUM; PATTERNS; FLEXIBILITY; PENETRATION; SURVIVAL; BEHAVIOR	Most corals acquire symbiodiniacean symbionts from the surrounding environment to initiate symbiosis. The cell densities of Symbiodiniaceae in the environment are usually low, and mechanisms may exist by which new coral generations attract suitable endosymbionts. Phototaxis of suitable symbiodiniacean cells toward green fluorescence in corals has been proposed as one such mechanism. In the present study, we observed the phototaxis action wavelength of various strains of Symbiodiniaceae and the fluorescence spectra of aposymbiotic Acropora tenuis larvae at the time of endosymbiont uptake. The phototaxis patterns varied among the Symbiodiniaceae species and "native" endosymbionts-commonly found in Acropora juveniles present in natural environments; that is, Symbiodinium microadriaticum was attracted to blue light rather than to green light. Another native endosymbiont, Durusdinium trenchii, showed no phototaxis specific to any wavelength. Although the larvae exhibited green and broad orange fluorescence under blue-violet excitation light, the maximum green fluorescence peak did not coincide with that of the phototaxis action spectrum of S. microadriaticum. Rather, around the peak wavelength of larval green fluorescence, this native endosymbiont showed slightly negative phototaxis, suggesting that the green fluorescence of A. tenuis larvae may not play a role in the initial attraction of native endosymbionts. Conversely, broad blue larval fluorescence under UV-A excitation covered the maximum phototaxis action wavelength of S. microadriaticum. We also conducted infection tests using native endosymbionts and aposymbiotic larvae under red LED light that does not excite visible larval fluorescence. Almost all larvae failed to acquire S. microadriaticum cells, whereas D. trenchii cells were acquired by larvae even under red illumination. Thus, attraction mechanisms other than visible fluorescence might exist, at least in the case of D. trenchii. Our results suggest that further investigation and discussion, not limited to green fluorescence, would be required to elucidate the initial attraction mechanisms.	[Yamashita, Hiroshi; Suzuki, Go] Japan Fisheries Res & Educ Agcy, Fisheries Technol Inst, Ishigaki, Okinawa, Japan; [Koike, Kazuhiko] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan; [Shinzato, Chuya] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Jimbo, Mitsuru] Kitasato Univ, Sch Marine Biosci, Sagamihara, Kanagawa, Japan	Japan Fisheries Research & Education Agency (FRA); Hiroshima University; University of Tokyo; Kitasato University	Yamashita, H (corresponding author), Japan Fisheries Res & Educ Agcy, Fisheries Technol Inst, Ishigaki, Okinawa, Japan.	hyamashita@fra.affrc.go.jp			Japan Society for the Promotion of Science (JSPS) [26291094, 18H02270, 17KT0027, 20H03235, 24570028]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grant Numbers 26291094 and 18H02270 for HY., 17KT0027 and 20H03235 for CS., 24570028 for KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Abrego D, 2009, MOL ECOL, V18, P3518, DOI 10.1111/j.1365-294X.2009.04275.x; Aihara Y, 2019, P NATL ACAD SCI USA, V116, P2118, DOI 10.1073/pnas.1812257116; Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baria MVB, 2010, J EXP MAR BIOL ECOL, V394, P149, DOI 10.1016/j.jembe.2010.08.003; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Christiansen NA, 2009, CORAL REEFS, V28, P47, DOI 10.1007/s00338-008-0429-9; Cumbo VR, 2013, CORAL REEFS, V32, P111, DOI 10.1007/s00338-012-0951-7; Dunne RP, 1996, MAR ECOL PROG SER, V144, P109, DOI 10.3354/meps144109; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; FITT WK, 1985, J PHYCOL, V21, P62; FITT WK, 1984, MAR BIOL, V81, P9, DOI 10.1007/BF00397620; Franklin EC, 2012, MOL ECOL RESOUR, V12, P369, DOI 10.1111/j.1755-0998.2011.03081.x; Fujise L, 2021, MOL ECOL, V30, P343, DOI 10.1111/mec.15719; Gruber DF, 2008, BIOL BULL-US, V215, P143, DOI 10.2307/25470695; Haryanti Dwi, 2019, Galaxea - Tokyo, V21, P13; Hollingsworth L. L., 2006, P 10 INT COR REEF S, P99; Hollingsworth LL, 2005, CORAL REEFS, V24, P523, DOI 10.1007/s00338-005-0063-8; Horiguchi Takeo, 1999, Phycological Research, V47, P101, DOI 10.1111/j.1440-1835.1999.tb00290.x; Ishikura M, 2004, MAR BIOTECHNOL, V6, P378, DOI 10.1007/s10126-004-1800-7; Kenkel CD, 2011, P ROY SOC B-BIOL SCI, V278, P2691, DOI 10.1098/rspb.2010.2344; Kuwahara VS, 2010, CORAL REEFS, V29, P693, DOI 10.1007/s00338-010-0618-1; LaJeunesse TC, 2005, MOL BIOL EVOL, V22, P570, DOI 10.1093/molbev/msi042; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; LaJeunesse TC, 2009, BIOL INVASIONS, V11, P995, DOI 10.1007/s10530-008-9311-5; Lapshin G, 2015, J INNOV OPT HEAL SCI, V8, DOI 10.1142/S1793545815500285; Lee SY, 2015, EUR J PHYCOL, V50, P155, DOI 10.1080/09670262.2015.1018336; Manning MM, 2008, LIMNOL OCEANOGR, V53, P1853, DOI 10.4319/lo.2008.53.5.1853; Meyer E, 2011, MOL ECOL, V20, P3599, DOI 10.1111/j.1365-294X.2011.05205.x; Nitschke MR, 2020, J PHYCOL, V56, P923, DOI 10.1111/jpy.12999; Pasternak Z, 2006, CORAL REEFS, V25, P201, DOI 10.1007/s00338-005-0085-2; Pasternak Z, 2004, MAR ECOL PROG SER, V279, P113, DOI 10.3354/meps279113; Quigley KM, 2018, PEERJ, V6, DOI 10.7717/peerj.5022; R Core Team, 2018, R LANG ENV STAT COMP; Shick JM, 1996, GLOBAL CHANGE BIOL, V2, P527, DOI 10.1111/j.1365-2486.1996.tb00065.x; Suzuki G, 2020, FISHERIES SCI, V86, P665, DOI 10.1007/s12562-020-01425-1; Suzuki G, 2018, MAR ECOL PROG SER, V603, P105, DOI 10.3354/meps12698; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; Takahashi-Kariyazono S, 2016, GENOME BIOL EVOL, V8, P3271, DOI 10.1093/gbe/evw265; Takeuchi R, 2021, MAR DRUGS, V19, DOI 10.3390/md19030146; Takeuchi R, 2017, FISHERIES SCI, V83, P479, DOI 10.1007/s12562-017-1069-1; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Wellington GM, 2003, MAR BIOL, V143, P1185, DOI 10.1007/s00227-003-1150-4; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yamashita H, 2013, CORAL REEFS, V32, P355, DOI 10.1007/s00338-012-0980-2; Yamashita Hiroshi, 2016, Galaxea - Tokyo, V18, P13; Yamashita H, 2018, MAR ECOL PROG SER, V592, P119, DOI 10.3354/meps12474; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097003; Yamashita H, 2013, PHYCOL RES, V61, P68, DOI 10.1111/pre.12004; Yamashita H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006303; Yorifuji M, 2021, MOL PHYLOGENET EVOL, V161, DOI 10.1016/j.ympev.2021.107158	52	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252514	10.1371/journal.pone.0252514	http://dx.doi.org/10.1371/journal.pone.0252514			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061893	gold, Green Published			2022-12-26	WOS:000656813600048
J	Liew, JJM; El Saudi, IM; Nguyen, SV; Wicht, DK; Dowling, DP				Liew, Jeremy J. M.; El Saudi, Israa M.; Nguyen, Son, V; Wicht, Denyce K.; Dowling, Daniel P.			Structures of the alkanesulfonate monooxygenase MsuD provide insight into C-S bond cleavage, substrate scope, and an unexpected role for the tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED FLAVIN MONONUCLEOTIDE; CRYSTAL-STRUCTURE; PSEUDOMONAS-PUTIDA; METHANESULFONIC-ACID; ESCHERICHIA-COLI; DIMETHYL SULFIDE; FUNCTIONAL-ROLE; PROTEIN; SULFUR; DIBENZOTHIOPHENE	Bacterial two-component flavin-dependent monooxygenases cleave the stable C-S bond of environmental and anthropogenic organosulfur compounds. The monooxygenase MsuD converts methanesulfonate (MS-) to sulfite, completing the sulfur assimilation process during sulfate starvation, but the mechanism of this conversion remains unclear. To explore the mechanism of C-S bond cleavage, we report a series of crystal structures of MsuD from Pseudomonas fluorescens in different liganded states. This report provides the first crystal structures of an alkanesulfonate monooxygenase with a bound flavin and alkanesulfonate, elucidating the roles of the active site lid, the protein C terminus, and an active site loop in flavin and/or alkanesulfonate binding. These structures position MS- closest to the flavin N5 position, consistent with an N5-(hydro) peroxyflavin mechanism rather than a classical C4a-(hydro) peroxyflavin mechanism. A fully enclosed active site is observed in the ternary complex, mediated by interchain interaction of the C terminus at the tetramer interface. These structures identify an unexpected function of the protein C terminus in this protein family in stabilizing tetramer formation and the alkanesulfonate-binding site. Spurred by interest from the crystal structures, we conducted biochemical assays and molecular docking that redefine MsuD as a small- to medium-chain alkanesulfonate monooxygenase. Functional mutations verify the sulfonate-binding site and reveal the critical importance of the protein C terminus for monooxygenase function. These findings reveal a deeper understanding of MsuD's functionality at the molecular level and consequently how it operates within its role as part of the sulfur assimilation pathway.	[Liew, Jeremy J. M.; El Saudi, Israa M.; Dowling, Daniel P.] Univ Massachusetts, Dept Chem, Boston, MA 02125 USA; [Nguyen, Son, V; Wicht, Denyce K.] Suffolk Univ, Dept Chem & Biochem, Boston, MA 02114 USA; [Nguyen, Son, V] Univ New Hampshire, Dept Chem, Durham, NH 03824 USA	University of Massachusetts System; University of Massachusetts Boston; Suffolk University; University System Of New Hampshire; University of New Hampshire	Dowling, DP (corresponding author), Univ Massachusetts, Dept Chem, Boston, MA 02125 USA.	daniel.dowling@umb.edu		Liew, Jeremy J.M./0000-0002-9190-8772; Dowling, Daniel/0000-0002-2536-0905	National Science Foundation, USA [1807480]; National Institutes of Health (NIH) [2R25GM076321]; Undergraduate Research Funds	National Science Foundation, USA(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Undergraduate Research Funds	This work was supported by the National Science Foundation, USA (1807480 to D. K. W. and D. P. D.). Opinions, findings, and conclusions or recommendations expressed are those of the authors and do not necessarily reflect the views of the National Science Foundation. I. M. E. was supported by a National Institutes of Health (NIH) IMSD grant award (2R25GM076321) and Undergraduate Research Funds. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adak S, 2019, BIOCHEMISTRY-US, V58, P1181, DOI 10.1021/acs.biochem.9b00012; Adak S, 2017, BIOCHEMISTRY-US, V56, P3708, DOI 10.1021/acs.biochem.7b00493; Adak S, 2016, J AM CHEM SOC, V138, P6424, DOI 10.1021/jacs.6b00583; AUTRY AR, 1990, BIOL FERT SOILS, V10, P50; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; Barnes I, 2006, CHEM REV, V106, P940, DOI 10.1021/cr020529+; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Bhandari D, 2017, THESIS TEXAS A M U THESIS TEXAS A M U; Borodina E, 2000, ARCH MICROBIOL, V173, P425, DOI 10.1007/s002030000165; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Campbell ZT, 2009, BIOCHEMISTRY-US, V48, P6085, DOI 10.1021/bi900003t; Cao HY, 2018, ACTA CRYSTALLOGR F, V74, P781, DOI 10.1107/S2053230X18015844; Carpenter RA, 2011, BIOCHEMISTRY-US, V50, P6469, DOI 10.1021/bi200429d; Chenprakhon P, 2014, BIOCHEMISTRY-US, V53, P4084, DOI 10.1021/bi500480n; Clifton M. C., 2011, Protein data bank, DOI 10.2210/pdb3SDO/pdb; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Gonzalo G, 2010, CHEMBIOCHEM, V11, P2208, DOI 10.1002/cbic.201000395; Domagalski M. J., 2011, PROTEIN DATA BANK, DOI [10.2210/pdb3RAO, DOI 10.2210/PDB3RAO]; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Eichhorn E, 2002, J MOL BIOL, V324, P457, DOI 10.1016/S0022-2836(02)01069-0; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Ellis HR, 2011, BIOORG CHEM, V39, P178, DOI 10.1016/j.bioorg.2011.08.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endoh T, 2005, MOL MICROBIOL, V55, P897, DOI 10.1111/j.1365-2958.2004.04431.x; Endoh T, 2003, MICROBIOL-SGM, V149, P991, DOI 10.1099/mic.0.26031-0; Fisher AJ, 1996, J BIOL CHEM, V271, P21956, DOI 10.1074/jbc.271.36.21956; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GALLAGHER JR, 1993, FEMS MICROBIOL LETT, V107, P31, DOI 10.1111/j.1574-6968.1993.tb05999.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Habe H, 2007, MICROBIOL-SGM, V153, P3091, DOI 10.1099/mic.0.2007/008151-0; Higgins TP, 1997, J BACTERIOL, V179, P1974, DOI 10.1128/jb.179.6.1974-1979.1997; Higgins TP, 1996, MICROBIOL-SGM, V142, P251, DOI 10.1099/13500872-142-2-251; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Jun SY, 2016, MOL MICROBIOL, V100, P989, DOI 10.1111/mmi.13363; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KELLY DP, 1990, ADV MICROB ECOL, V11, P345; KELLY DP, 1994, MICROBIOL-SGM, V140, P1419, DOI 10.1099/00221287-140-6-1419; KERTESZ MA, 1993, J BACTERIOL, V175, P1187, DOI 10.1128/JB.175.4.1187-1190.1993; Kertesz MA, 1999, J BACTERIOL, V181, P1464, DOI 10.1128/JB.181.5.1464-1473.1999; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li L, 2008, J MOL BIOL, V376, P453, DOI 10.1016/j.jmb.2007.11.069; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Lundgren BR, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00606-18; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Matthews A, 2020, NAT CHEM BIOL, V16, P556, DOI 10.1038/s41589-020-0476-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee T, 2010, J AM CHEM SOC, V132, P5550, DOI 10.1021/ja9107676; Okai M, 2017, PROTEINS, V85, P1171, DOI 10.1002/prot.25267; OMORI T, 1995, BIOSCI BIOTECH BIOCH, V59, P1195, DOI 10.1271/bbb.59.1195; Quadroni M, 1996, EUR J BIOCHEM, V239, P773, DOI 10.1111/j.1432-1033.1996.0773u.x; Nguyen QT, 2017, APPL MICROBIOL BIOT, V101, P2831, DOI 10.1007/s00253-016-8038-y; Robbins JM, 2019, METHOD ENZYMOL, V620, P399, DOI 10.1016/bs.mie.2019.03.018; Robbins JM, 2014, BIOCHEMISTRY-US, V53, P161, DOI 10.1021/bi401234e; Robbins JM, 2012, BIOCHEMISTRY-US, V51, P6378, DOI 10.1021/bi300138d; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saleem-Batcha R, 2018, P NATL ACAD SCI USA, V115, P4909, DOI 10.1073/pnas.1801189115; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrodinger L., 2020, PYMOL; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simo R, 1999, GLOBAL BIOGEOCHEM CY, V13, P1173, DOI 10.1029/1999GB900081; Smart O. S., 2011, GRADE V 1 2 9 GRADE V 1 2 9; Soule J, 2020, BIOCHEM BIOPH RES CO, V522, P107, DOI 10.1016/j.bbrc.2019.11.008; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Su TT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00231; Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643; THYSSE GJE, 1972, ANTON VAN LEE J M S, V38, P53, DOI 10.1007/BF02328077; THYSSE GJE, 1974, A VAN LEEUW J MICROB, V40, P25, DOI 10.1007/BF00394550; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Wicht DK, 2016, ARCH BIOCHEM BIOPHYS, V604, P159, DOI 10.1016/j.abb.2016.07.001; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Xiong JY, 2012, BBA-PROTEINS PROTEOM, V1824, P898, DOI 10.1016/j.bbapap.2012.04.005; Zhang R., 2003, Structural Genomics, Crystal Structure of Alkanesulfonate Monooxygenase, protein databank entry, DOI 10.2210/pdb1NQK/pdb	87	2	2	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100823	10.1016/j.jbc.2021.100823	http://dx.doi.org/10.1016/j.jbc.2021.100823			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029591	gold, Green Published			2022-12-26	WOS:000678068400025
J	Siriwut, W; Jeratthitikul, E; Panha, S; Chanabun, R; Ngor, PB; Sutcharit, C				Siriwut, Warut; Jeratthitikul, Ekgachai; Panha, Somsak; Chanabun, Ratmanee; Ngor, Peng Bun; Sutcharit, Chirasak			Evidence of cryptic diversity in freshwater Macrobrachium prawns from Indochinese riverine systems revealed by DNA barcode, species delimitation and phylogenetic approaches	PLOS ONE			English	Article							DECAPODA CARIDEA PALAEMONIDAE; ABBREVIATED LARVAL DEVELOPMENT; GENUS MACROBRACHIUM; MOLECULAR PHYLOGENY; THAILAND DECAPODA; SHRIMPS CRUSTACEA; HIDDEN DIVERSITY; MALAYANUM ROUX; NOV DECAPODA; DIVERSIFICATION	The diversity of Indochinese prawns in genus Macrobrachium is enormous due to the habitat diversification and broad tributary networks of two river basins: the Chao Phraya and the Mekong. Despite long-standing interest in SE-Asian decapod diversity, the subregional Macrobrachium fauna is still not yet comprehensively clarified in terms of taxonomic identification or genetic diversification. In this study, integrative taxonomic approaches including morphological examination, DNA barcoding, and molecular species delimitation were used to emphasize the broad scale systematics of Macrobrachium prawns in Indochina. Twenty-seven nominal species were successfully re-verified by traditional and molecular taxonomy. Barcode gap analysis supported broad overlapping of species boundaries. Taxonomic ambiguity of several deposited samples in the public database is related to inter- and intraspecific genetic divergence as indicated by BOLD discordance. Diagnostic nucleotide positions were found in six Macrobrachium species. Eighteen additional putative lineages are herein assigned using the consensus of species delimitation methods. Genetic divergence indicates the possible existence of cryptic species in four morphologically complex and wide-ranging species: M. lanchesteri, M. niphanae, M. sintangense, and some members of the M. pilimanus group. The geographical distribution of some species supports the connections and barriers attributed to paleo-historical events of SE-Asian rivers and land masses. Results of this study show explicitly the importance of freshwater ecosystems in Indochinese subregions, especially for the Mekong River Basin due to its high genetic diversity and species composition found throughout its tributaries.	[Siriwut, Warut; Jeratthitikul, Ekgachai] Mahidol Univ, Fac Sci, Dept Biol, Anim Systemat & Mol Ecol Lab, Bangkok, Thailand; [Panha, Somsak; Sutcharit, Chirasak] Chulalongkorn Univ, Fac Sci, Dept Biol, Anim Systemat Res Unit, Bangkok, Thailand; [Panha, Somsak] Royal Soc Thailand, Acad Sci, Bangkok, Thailand; [Chanabun, Ratmanee] Sakon Nakhon Rajabhat Univ, Fac Agr Technol, Program Anim Sci, Bangkok, Thailand; [Ngor, Peng Bun] Fisheries Adm, Inland Fisheries Res & Dev Inst IFReDI, Phnom Penh, Cambodia; [Ngor, Peng Bun] Wonders Mekong Project, Phnom Penh, Cambodia	Mahidol University; Chulalongkorn University	Sutcharit, C (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biol, Anim Systemat Res Unit, Bangkok, Thailand.	chirasak.s@chula.ac.th		Ngor, Peng Bun/0000-0002-3659-6577; Jeratthitikul, Ekgachai/0000-0002-3477-9548	Center of Excellence on Biodiversity [BDC-PG2160023]; Thailand Research Fund [TRF-DPG6280001]	Center of Excellence on Biodiversity; Thailand Research Fund(Thailand Research Fund (TRF))	This study was mainly funded by the Center of Excellence on Biodiversity (BDC-PG2160023) to CS and the Thailand Research Fund (TRF-DPG6280001) to SP.	Adamson EAS, 2012, FRESHWATER BIOL, V57, P2211, DOI 10.1111/j.1365-2427.2012.02864.x; Adamson EAS, 2010, MOL PHYLOGENET EVOL, V56, P707, DOI 10.1016/j.ympev.2010.03.027; Gonzalez-Vaquero RA, 2016, GENOME, V59, P889, DOI 10.1139/gen-2016-0006; Anger K, 2013, J CRUSTACEAN BIOL, V33, P151, DOI 10.1163/1937240X-00002124; [Anonymous], 2021, NTR; [Anonymous], 2020, WORLD REGISTER MARIN; AVME, 2020, AVMA GUIDELINES EUTH; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barraclough, 2013, R PACKAGE SPLITS SPE, DOI [10.1111/ijcp.12111, DOI 10.1111/IJCP.12111]; BAUER RT, 1977, MAR BIOL, V40, P261, DOI 10.1007/BF00390881; Bernardes SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08494-w; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter M, 2004, P ROY SOC B-BIOL SCI, V271, pS189, DOI 10.1098/rsbl.2003.0130; Bloom DD, 2013, EVOLUTION, V67, P2040, DOI 10.1111/evo.12074; Bolotov IN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63612-5; Borges LMS, 2012, INVERTEBR SYST, V26, P572, DOI 10.1071/IS12028; Borrell YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183347; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Cai Y, 2004, J NAT HIST, V38, P581, DOI 10.1080/0022293021000033238; Cai Y, 1999, HYDROBIOLOGIA, V400, P211, DOI 10.1023/A:1003717109973; CAI Y, 2018, ZOOL STUD, V57, P33, DOI DOI 10.6620/ZS.2018.57%26%23X2013%3B27; Cai YX, 2016, RAFFLES B ZOOL, V64, P117; Cai YX, 2002, HYDROBIOLOGIA, V487, P59, DOI 10.1023/A:1022991224381; Calvignac S, 2011, MITOCHONDRION, V11, P246, DOI 10.1016/j.mito.2010.10.004; Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304; Castelin M, 2017, EUR J TAXON, V289, P1, DOI 10.5852/ejt.2017.289; Chareontawee K, 2007, AQUACULTURE, V271, P121, DOI 10.1016/j.aquaculture.2007.07.001; Chen G., 2007, FAUNA SINICA INVERTE; Chen PC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173490; Chen PC, 2015, LIMNOLOGICA, V52, P51, DOI 10.1016/j.limno.2015.03.002; Cheng J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02059-7; CHONG SSC, 1987, J NAT HIST, V21, P903, DOI 10.1080/00222938700770551; CHONG SSC, 1987, J NAT HIST, V21, P763, DOI 10.1080/00222938700770431; CHONG SSC, 1987, CRUSTACEANA, V53, P29, DOI 10.1163/156854087X00592; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Cornils A, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-19; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; Dalton DL, 2011, FORENSIC SCI INT, V207, pE51, DOI 10.1016/j.forsciint.2010.12.017; Dang Ngoc Thanh, 1975, Tap San Sinhvat-Dia Hoc, V13, P65; Dang NT., 1998, J BIOL, V20, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis AM, 2012, J EVOLUTION BIOL, V25, P1163, DOI 10.1111/j.1420-9101.2012.02504.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Bruyn M, 2005, HEREDITY, V94, P370, DOI 10.1038/sj.hdy.6800613; de Bruyn M, 2004, MOL PHYLOGENET EVOL, V30, P251, DOI 10.1016/S1055-7903(03)00176-3; De Bruyn M, 2007, MOL ECOL, V16, P4295, DOI 10.1111/j.1365-294X.2007.03481.x; De Grave S, 2008, HYDROBIOLOGIA, V595, P287, DOI 10.1007/s10750-007-9024-2; De Grave S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120198; De Mattia F, 2012, BOT J LINN SOC, V169, P518, DOI 10.1111/j.1095-8339.2012.01251.x; de Vere N, 2015, METHODS MOL BIOL, V1245, P101, DOI 10.1007/978-1-4939-1966-6_8; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dimmock A, 2004, AQUACULT INT, V12, P435, DOI 10.1023/B:AQUI.0000042140.48340.c8; Do VTN C.T., 2015, TAP CHI SINH HOC, V36, P309; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duarte RC, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0796-8; Dudgeon D, 2000, ANNU REV ECOL SYST, V31, P239, DOI 10.1146/annurev.ecolsys.31.1.239; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Espindola A, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1529; Fiedler GC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-297; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Garcia-Melo JE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216786; Geraci CJ, 2011, J N AM BENTHOL SOC, V30, P163, DOI 10.1899/10-011.1; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Hanamura Y, 2011, ZOOTAXA, P1; Hawlitschek O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201763; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellberg RS, 2017, FOOD CONTROL, V80, P23, DOI 10.1016/j.foodcont.2017.04.025; Hendry AP, 2016, J HERED, V107, P25, DOI 10.1093/jhered/esv060; Hernawati R, 2020, HYDROBIOLOGIA, V847, P647, DOI [10.1007/s10750-019-04127-7, 10.1]; Holthuis L. B., 1950, Siboga Expeditie Leiden, V39a9, P1; Holthuis L.B., 1980, FAO SPECIES CATALOGU, V125, P1; Hongjamrassilp W, 2021, J ZOOL, V313, P87, DOI 10.1111/jzo.12841; Imai Hideyuki, 2014, Biogeography, V16, P1; Jirapatrasilp P, 2019, MOL PHYLOGENET EVOL, V139, DOI 10.1016/j.ympev.2019.106531; Jorger KM, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-59; Johnson DS., 1960, P CENT BIC C BIOL; Jordan-Hernandez M, 2019, ZOOL SCR, V48, P667, DOI 10.1111/zsc.12364; Kapli P, 2017, BIOINFORMATICS, V33, P1630, DOI 10.1093/bioinformatics/btx025; Khanarnpai R, 2019, COGENT BIOL, V5, DOI 10.1080/23312025.2019.1677126; Khedkar GD, 2016, MITOCHONDRIAL DNA A, V27, P3932, DOI 10.3109/19401736.2014.987270; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lal MM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-568; Larson ER, 2016, PEERJ, V4, DOI 10.7717/peerj.1915; Le Thi Binh, 2006, Tap Chi Sinh Hoc, V28, P5; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Li JC, 2006, RAFFLES B ZOOL, V54, P277; LI W., 2001, J GUANGXI NORMAL U, V19, P72; Liu JN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16920-2; Maddison W., 2018, MESQUITE MODULAR SYS; Mar W, 2018, ZOOTAXA, V4388, P123, DOI 10.11646/zootaxa.4388.1.9; Martin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044541; Mathews LM, 2006, MOL ECOL, V15, P4049, DOI 10.1111/j.1365-294X.2006.03077.x; Mejia-Ortiz LM, 2010, CRUSTACEANA, V83, P385, DOI 10.1163/001121610X489368; Miller M.A., 2010, P GAT COMP ENV WORKS; Hoang MTV, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01647; Murphy NP, 2003, J CRUSTACEAN BIOL, V23, P169, DOI 10.1651/0278-0372(2003)023[0169:MTAPOS]2.0.CO;2; Naiyanetr P, 2001, CRUSTACEANA, V74, P609, DOI 10.1163/156854001750377885; Naiyanetr P., 1998, CHECKLIST CRUSTACEAN; Ng Peter K. L., 1995, Malayan Nature Journal, V48, P249; Nguyen HY., 1972, J BIOL GEOLOGY, V10, P1; Nguyen NT, 1972, J BIOL GEOLOGY, V6, P155; Xuan NV, 2012, ZOOTAXA, P32; Oliverio AM, 2018, SOIL BIOL BIOCHEM, V125, P37, DOI 10.1016/j.soilbio.2018.06.026; Orgiazzi A, 2015, SOIL BIOL BIOCHEM, V80, P244, DOI 10.1016/j.soilbio.2014.10.014; Pan YT, 2010, J CAVE KARST STUD, V72, P86, DOI 10.4311/jcks2009lsc0087; Pante E, 2015, SYST BIOL, V64, P152, DOI 10.1093/sysbio/syu083; Parveen I, 2016, PLANTA MED, V82, P1225, DOI 10.1055/s-0042-111208; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Phimphan S, 2019, NUCLEUS CALCUTTA, V62, P77, DOI 10.1007/s13237-018-0260-9; Phone H, 2004, P BIOL SOC WASH, V117, P523; Pileggi LG, 2010, INVERTEBR SYST, V24, P194, DOI 10.1071/IS09043; Ponton DEV, 2020, BIODIVERS DATA J, V8, DOI 10.3897/BDJ.8.e47333; Poulin R, 2016, INT J PARASITOL, V46, P275, DOI 10.1016/j.ijpara.2015.12.002; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; QGIS Development Team, 2021, QGIS GEOGR INF SYST; Rahi ML, 2019, GENOME BIOL EVOL, V11, P1002, DOI 10.1093/gbe/evz045; Rahman MM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45379-6; Rambaut A., 2009, FIGTREE VERSION 1 3; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Robe LJ, 2012, ZOOL SCI, V29, P714, DOI 10.2108/zsj.29.714; Rocha CP, 2018, J MAR BIOL ASSOC UK, V98, P713, DOI 10.1017/S0025315416001855; Rossi N, 2020, ZOOTAXA, V4732, P177, DOI 10.11646/zootaxa.4732.1.9; Rytkonen S, 2019, ECOL EVOL, V9, P631, DOI 10.1002/ece3.4787; Saengphan N, 2019, ZOOTAXA, V4664, P274, DOI 10.11646/zootaxa.4664.2.9; Saengphan N, 2018, ZOOTAXA, V4482, P151, DOI 10.11646/zootaxa.4482.1.7; SATHIAMURTHY E., 2006, NATURAL HIST J CHULA, V2, P1; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seehausen O, 2014, ANNU REV ECOL EVOL S, V45, P621, DOI 10.1146/annurev-ecolsys-120213-091818; SHOKITA S, 1989, Bulletin of the National Science Museum Series A (Zoology), V15, P147; Siriwut W, 2020, PEERJ, V8, DOI 10.7717/peerj.10137; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spielmann G, 2019, EUR FOOD RES TECHNOL, V245, DOI 10.1007/s00217-018-3199-9; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stokkan M, 2018, MOL PHYLOGENET EVOL, V127, P988, DOI 10.1016/j.ympev.2018.07.002; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Thanh Dang Ngoc, 2012, Tap Chi Sinh Hoc, V34, P405; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Van Xuan N, 2006, CRUSTACEANA, V79, P1, DOI 10.1163/156854006776759725; von Rintelen K, 2007, MOL PHYLOGENET EVOL, V45, P1033, DOI 10.1016/j.ympev.2007.07.002; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wade NM, 2012, J EXP BIOL, V215, P343, DOI 10.1242/jeb.064592; Weigand Hannah, 2019, Sci Total Environ, V678, P499, DOI 10.1016/j.scitotenv.2019.04.247; Wowor D, 2007, RAFFLES B ZOOL, V55, P77; Wowor D, 2009, MOL PHYLOGENET EVOL, V52, P340, DOI 10.1016/j.ympev.2009.01.002; Wowor Daisy, 2008, Bulletin of Zoological Nomenclature, V65, P288; Xuan NV, 2003, CRUSTACEANA, V76, P453; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zieritz A, 2018, HYDROBIOLOGIA, V810, P29, DOI 10.1007/s10750-017-3104-8	156	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252546	10.1371/journal.pone.0252546	http://dx.doi.org/10.1371/journal.pone.0252546			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077477	gold, Green Published			2022-12-26	WOS:000664638500048
J	Deng, JZ; Yang, YS; He, JY; Xie, Z; Luo, F; Xu, JZ; Zhang, ZH				Deng, Jiezhong; Yang, Yusheng; He, Jinyue; Xie, Zhao; Luo, Fei; Xu, Jianzhong; Zhang, Zehua			Vitamin D receptor activated by vitamin D administration alleviates Mycobacterium tuberculosis-induced bone destruction by inhibiting NF kappa B-mediated aberrant osteoclastogenesis	FASEB JOURNAL			English	Article						Mycobacterium tuberculosis; osteoclastogenesis; vitamin D; VDR	SPINAL TUBERCULOSIS; IN-VITRO; EXPRESSION; RESORPTION; CELLS; MODEL	Clinically, bone destruction caused by Mycobacterium tuberculosis was serious especially in patients with vitamin D (VD) deficiency. However, the role of VD in M. tuberculosis-induced bone destruction remains clear. In this context, we investigate the role of VD and vitamin D receptor (VDR) in the M. tuberculosis-induced bone destruction. First, we infected RAW264.7 and bone marrow-derived macrophages (BMMs) with Mycobacterium bovis Bacillus Calmette-Guerin (M. bovis BCG) in vitro. Then, we activated VDR through VD administration. TRAP and FAK staining, bone resorption assays, immunofluorescence staining, qPCR, and western blot were carried out. In vivo, the M. tuberculosis-induced osteolytic model on the murine skull was established and the mu CT and histological analyses were performed. We found that VDR and TRAP were upregulated in bone tuberculosis tissue and proved that M. tuberculosis infection promoted osteoclastogenesis in RAW264.7 and BMMs. VD could inhibit osteoclasts differentiation, fusion, and bone resorption dose-dependently. However, when VDR was knocked down, the inhibitory effect of VD on osteoclasts disappeared. In mechanism, activation of VDR inhibits the phosphorylation of I kappa B alpha, thereby inhibiting NF kappa B signaling pathway and alleviating osteoclastogenesis. Furthermore, in the skull osteolysis model, VD administration reduced osteolysis, but not in VDR-/- mice. Our study, for the first time, demonstrates that activation of VDR by VD administration inhibits M. tuberculosis-induced bone destruction. Our results reveal that VD and VDR are potential therapeutic targets for M. tuberculosis-induced bone destruction, and are of great clinical significance for the development of new therapeutic strategies.	[Deng, Jiezhong; Yang, Yusheng; He, Jinyue; Xie, Zhao; Luo, Fei; Xu, Jianzhong; Zhang, Zehua] Army Med Univ, Dept Orthoped Surg, Southwest Hosp, Third Mil Med Univ, Chongqing, Peoples R China	Army Medical University	Zhang, ZH (corresponding author), Army Med Univ, Dept Orthoped Surg, Southwest Hosp, Affiliated Hosp 1, 30 Gaotanyan Zhengjie, Chongqing 400038, Peoples R China.	zhangzehuatmmu@163.com			National Natural Science Foundation of China [81772365, 81972082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (81772365, 81972082)	Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Amarasekara DS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e8; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bernardor J, 2020, J BONE MINER RES, V35, P2265, DOI 10.1002/jbmr.4122; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Chen Y, 2013, J BIOL CHEM, V288, P19450, DOI 10.1074/jbc.M113.467670; Chiu YH, 2012, J BONE MINER RES, V27, P79, DOI 10.1002/jbmr.531; Christophe T, 2010, FUTURE MED CHEM, V2, P1283, DOI [10.4155/fmc.10.223, 10.4155/FMC.10.223]; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Dou C, 2014, BBA-GENE REGUL MECH, V1839, P1084, DOI 10.1016/j.bbagrm.2014.08.002; Gu JH, 2015, J STEROID BIOCHEM, V152, P25, DOI 10.1016/j.jsbmb.2015.04.003; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hu JX, 2020, J CELL MOL MED, V24, P1893, DOI 10.1111/jcmm.14885; Jain AK, 2020, J BONE JOINT SURG AM, V102, P617, DOI 10.2106/JBJS.19.00001; Jimi E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121636; Krishnan AV, 2010, ENDOCR-RELAT CANCER, V17, pR19, DOI 10.1677/ERC-09-0139; Li LT, 2012, INT ORTHOP, V36, P277, DOI 10.1007/s00264-011-1398-0; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu XC, 2015, JPN J INFECT DIS, V68, P89, DOI 10.7883/yoken.JJID.2014.147; Meghji S, 1997, J EXP MED, V186, P1241, DOI 10.1084/jem.186.8.1241; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nakamichi Y, 2018, J STEROID BIOCHEM, V177, P70, DOI 10.1016/j.jsbmb.2017.11.005; Nakamichi Y, 2017, J BONE MINER RES, V32, P1297, DOI 10.1002/jbmr.3096; Ono T, 2018, HISTOCHEM CELL BIOL, V149, P325, DOI 10.1007/s00418-018-1636-2; Schwarz EM, 2019, J ORTHOP RES, V37, P997, DOI 10.1002/jor.24293; Starczak Y, 2018, J STEROID BIOCHEM, V177, P77, DOI 10.1016/j.jsbmb.2017.10.022; Trochoutsou AI, 2015, MINI-REV MED CHEM, V15, P953, DOI 10.2174/1389557515666150519110830; Ufimtseva E, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4325646; Verlinden L, 2019, J STEROID BIOCHEM, V195, DOI 10.1016/j.jsbmb.2019.105478; Wang XW, 2017, LIFE SCI, V188, P198, DOI 10.1016/j.lfs.2017.07.022; Zarei A, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.30	32	3	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21543	10.1096/fj.202100135R	http://dx.doi.org/10.1096/fj.202100135R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34046950				2022-12-26	WOS:000655695900050
J	Iijima, K; Kobayashi, T; Matsumoto, K; Ohara, K; Kita, H; Drake, LY				Iijima, Koji; Kobayashi, Takao; Matsumoto, Koji; Ohara, Kenzo; Kita, Hirohito; Drake, Li Y.			Transient IL-33 upregulation in neonatal mouse lung promotes acute but not chronic type 2 immune responses induced by allergen later in life	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; ASTHMA; INTERLEUKIN-33; SENSITIZATION; INFLAMMATION; POTENT; RISK	Early life respiratory insults, such as viral infections or hyperoxia, often increase asthma susceptibility later in life. The mechanisms underlying this increased susceptibility are not fully understood. IL-33 has been shown to be critically involved in allergic airway diseases. IL-33 expression in the neonatal lung can be increased by various respiratory insults associated with asthma development. Therefore, we investigated whether and how early life increases in IL-33 impact allergic airway responses later in life. Using a novel IL-33 transgenic mouse model, in which full-length IL-33 was inducible overexpressed in lung epithelial cells, we transiently upregulated lung IL-33 expression in neonatal mice for one week. After resting for 4-6 weeks, mice were intranasally exposed to a single-dose of recombinant IL-33 or the airborne allergen Alternaria. Alternatively, mice were exposed to Alternaria and ovalbumin multiple times for one month. We found that a transient increase in IL-33 expression during the neonatal period promoted IL-5 and IL-13 production when mice were later exposed to a single-dose of IL-33 or Alternaria in adulthood. However, increased IL-33 expression during the neonatal period did not affect airway inflammation, type 2 cytokine production, lung mucus production, or antigen-specific antibody responses when adult mice were exposed to Alternaria and ovalbumin multiple times. These results suggest that transient increased IL-33 expression early in life may have differential effects on allergic airway responses in later life, preferentially affecting allergen-induced acute type 2 cytokine production.	[Iijima, Koji; Kobayashi, Takao; Matsumoto, Koji; Ohara, Kenzo; Kita, Hirohito; Drake, Li Y.] Mayo Clin, Div Allerg Dis, Dept Med, Rochester, MN 55902 USA; [Iijima, Koji; Kobayashi, Takao; Matsumoto, Koji; Ohara, Kenzo; Kita, Hirohito] Div Allergy Asthma & Clin Immunol, Dept Med, Mayo Clin, Scottsdale, AZ USA; [Drake, Li Y.] Dept Anesthesiol & Perioperat Med, Mayo Clin, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic	Drake, LY (corresponding author), Mayo Clin, Div Allerg Dis, Dept Med, Rochester, MN 55902 USA.; Drake, LY (corresponding author), Dept Anesthesiol & Perioperat Med, Mayo Clin, Rochester, MN USA.	drake.li@mayo.edu		Kita, Hirohito/0000-0002-6854-2936; Drake, Li/0000-0002-4660-7647	National Institute of Health [NIH R01 HL117823]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grant from the National Institute of Health NIH R01 HL117823. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EL, 2016, ALLERGY, V71, P977, DOI 10.1111/all.12861; Barlow JL, 2013, J ALLERGY CLIN IMMUN, V132, P933, DOI 10.1016/j.jaci.2013.05.012; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Castanhinha S, 2015, J ALLERGY CLIN IMMUN, V136, P312, DOI 10.1016/j.jaci.2015.01.016; Cheon IS, 2018, J ALLERGY CLIN IMMUN, V142, P1100, DOI 10.1016/j.jaci.2017.11.025; Drake LY, 2014, ALLERGY, V69, P1300, DOI 10.1111/all.12446; Drake L, 2019, J IMMUNOL, V203, P1952, DOI 10.4049/jimmunol.1900454; Drake LY, 2017, IMMUNOL REV, V278, P173, DOI 10.1111/imr.12552; Drake LY, 2016, J IMMUNOL, V197, P1335, DOI 10.4049/jimmunol.1502669; Fujita J, 2012, ALLERGY, V67, P744, DOI 10.1111/j.1398-9995.2012.02825.x; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Iijima K, 2014, J IMMUNOL, V193, P1549, DOI 10.4049/jimmunol.1302984; Jackson DJ, 2014, AM J RESP CRIT CARE, V190, P1373, DOI 10.1164/rccm.201406-1039OC; James KM, 2013, J ALLERGY CLIN IMMUN, V132, P227, DOI 10.1016/j.jaci.2013.01.009; Kamijo S, 2013, J IMMUNOL, V190, P4489, DOI 10.4049/jimmunol.1201212; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lloyd CM, 2017, IMMUNOL REV, V278, P101, DOI 10.1111/imr.12562; Maggi L, 2017, J ALLERGY CLIN IMMUN, V139, P964, DOI 10.1016/j.jaci.2016.06.032; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Pichery M, 2012, J IMMUNOL, V188, P3488, DOI 10.4049/jimmunol.1101977; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Saravia J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005217; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Steer CA, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135961; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vogel ER, 2015, CAN J PHYSIOL PHARM, V93, P119, DOI 10.1139/cjpp-2014-0387; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252199	10.1371/journal.pone.0252199	http://dx.doi.org/10.1371/journal.pone.0252199			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048460	Green Published, gold			2022-12-26	WOS:000664636100023
J	Cacciatore, J; Thieleman, K; Fretts, R; Jackson, LB				Cacciatore, Joanne; Thieleman, Kara; Fretts, Ruth; Jackson, Lori Barnes			What is good grief support? Exploring the actors and actions in social support after traumatic grief	PLOS ONE			English	Article							LONELINESS; COVID-19; HEALTH; BEREAVEMENT; EXPERIENCE; ANXIETY; OUTCOMES; ADULTS; DEATH	Social support seems to enhance wellbeing and health in many populations. Conversely, poor social support and loneliness are a social determinant of poor health outcomes and can adversely affect physical, emotional, and mental well-being. Social support is especially important in traumatic grief. However, the ways in which grieving individuals interpret and define social support is not well understood, and little is known about what specific behaviours are perceived as helpful. Using qualitative description and content analysis, this study assessed bereaved individuals' satisfaction of social support in traumatic grief, using four categories of social support as a framework. Findings suggest inadequate satisfaction from professional, familial, and community support. Pets emerged with the most satisfactory ratings. Further, findings suggest that emotional support is the most desired type of support following traumatic loss. Implications for supporting bereaved individuals within and beyond the context of the COVID-19 pandemic are discussed.	[Cacciatore, Joanne; Thieleman, Kara; Jackson, Lori Barnes] Arizona State Univ, Sch Social Work, Phoenix, AZ 85004 USA; [Fretts, Ruth] Atrius Hlth, Boston, MA USA	Arizona State University; Arizona State University-Downtown Phoenix	Cacciatore, J (corresponding author), Arizona State Univ, Sch Social Work, Phoenix, AZ 85004 USA.	Joanne.Cacciatore@asu.edu		Thieleman, Kara/0000-0003-2893-9792; Cacciatore, Joanne/0000-0001-5803-1211				Aoun SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121101; Barlow C, 2007, SOC WORK EDUC, V26, P399, DOI 10.1080/02615470601081712; Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486; Breen LJ, 2011, J FAM THER, V33, P98, DOI 10.1111/j.1467-6427.2010.00495.x; Breen LJ, 2010, DEATH STUD, V34, P30, DOI 10.1080/07481180903372384; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Burke L.A., 2013, COMPLICATED GRIEF SC, P145; Burleson BR, 2003, PERS RELATIONSHIP, V10, P1, DOI 10.1111/1475-6811.00033; Cacioppo JT, 2018, LANCET, V391, P426, DOI 10.1016/S0140-6736(18)30142-9; Cacioppo JT, 2015, ANNU REV PSYCHOL, V66, P733, DOI 10.1146/annurev-psych-010814-015240; Cascio MA, 2019, FIELD METHOD, V31, P116, DOI 10.1177/1525822X19838237; CHINH B, 2019, EXTENDED ABSTRACTS 2, DOI DOI 10.1145/3290607.3312879; Cohen S., 1985, SOCIAL SUPPORT HLTH, P3; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Denzin NK., 1978, SOCIOLOGICAL METHODS; Dyregrov K, 2013, OMEGA-J DEATH DYING, V68, P45, DOI 10.2190/OM.68.1.c; Eisma MC, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.113031; Fried EI, 2015, J ABNORM PSYCHOL, V124, P256, DOI 10.1037/abn0000028; Gerdes KE, 2011, SOC WORK, V56, P141, DOI 10.1093/sw/56.2.141; Gijzen S, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0749-9; Harrop E, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-0532-4; Hart PL, 2014, J CLIN NURS, V23, P2223, DOI 10.1111/jocn.12500; Hartig J, 2016, OMEGA-J DEATH DYING, V73, P29, DOI 10.1177/0030222815575698; Heenan D, 2019, BRIT J SOC WORK, V49, P1741, DOI 10.1093/bjsw/bcy114; Holmgren H, 2021, OMEGA-J DEATH DYING, V84, P126, DOI 10.1177/0030222819880713; House J.S., 1985, SOCIAL SUPPORT HLTH, P83, DOI DOI 10.1016/0883-0355(88)90010-9; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; House JS, 1981, WORK STRESS SOCIAL S; Hoy J.M., 2017, RESCUING EMOTION MAR; Ikebuchi J, 2014, J TEACH SOC WORK, V34, P285, DOI 10.1080/08841233.2014.909378; Jacobson NC, 2017, J AFFECT DISORDERS, V211, P83, DOI 10.1016/j.jad.2017.01.011; Juth V, 2015, APPL PSYCHOL-HLTH WE, V7, P129, DOI 10.1111/aphw.12041; Killgore WDS, 2020, PSYCHIAT RES, V294, DOI 10.1016/j.psychres.2020.113551; Kim H, 2017, RES NURS HEALTH, V40, P23, DOI 10.1002/nur.21768; Krippendorff K., 2018, CONTENT ANAL INTRO I, V4th ed.; Laakso H, 2002, J CLIN NURS, V11, P176, DOI 10.1046/j.1365-2702.2002.00611.x; LaDonna KA, 2018, ACAD MED, V93, P347, DOI [10.1097/ACM.0000000000002046, 10.1097/ACM.0000000000002088]; Lechman C, 2009, SOC WORK HEALTH CARE, V48, P495, DOI 10.1080/00981380802619360; Lee CM, 2020, J ADOLESCENT HEALTH, V67, P714, DOI 10.1016/j.jadohealth.2020.08.009; LEHMAN DR, 1986, J CONSULT CLIN PSYCH, V54, P438, DOI 10.1037/0022-006X.54.4.438; Li LZ, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113267; MCINTOSH NJ, 1991, J ORGAN BEHAV, V12, P201, DOI 10.1002/job.4030120304; Nimer J, 2007, ANTHROZOOS, V20, P225, DOI 10.2752/089279307X224773; Palgi Y, 2020, J AFFECT DISORDERS, V275, P109, DOI 10.1016/j.jad.2020.06.036; Pitman AL, 2020, SOC PSYCH PSYCH EPID, V55, P1081, DOI 10.1007/s00127-020-01921-w; Prohaska T, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034967; Rogalla KB, 2020, OMEGA-J DEATH DYING, V81, P107, DOI 10.1177/0030222818761461; Rust J., 1999, MODERN PSYCHOMETRICS; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sasangohar F, 2020, ANESTH ANALG, V131, P106, DOI 10.1213/ANE.0000000000004866; Scott HR, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02639-4; Scragg, 2019, REFLECT PRACT, P39; Shapiro J., 2013, EUROPEAN J PERSON CT, V1, P310, DOI [10.5750/ejpch.v1i2.664, DOI 10.5750/EJPCH.V1I2.664]; Sikstrom L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224325; Simon NM, 2015, JAMA-J AM MED ASSOC, V313, P2172, DOI 10.1001/jama.2015.105; Soklaridis S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022778; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Stroebe W, 2005, J SOC CLIN PSYCHOL, V24, P1030, DOI 10.1521/jscp.2005.24.7.1030; Tonkin-Crine S, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0436-0; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; Tso IF, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113423; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Underman K, 2016, SOC SCI MED, V160, P94, DOI 10.1016/j.socscimed.2016.05.027; van der Houwen K, 2010, SOC SCI MED, V71, P1669, DOI 10.1016/j.socscimed.2010.06.047; Vanderwerker LC, 2004, J LOSS TRAUMA, V9, P45, DOI 10.1080/15325020490255304; Wago SS., 2017, SCAND PSYCHOL, V4, pe10, DOI [10.15714/scandpsychol.4.e10, DOI 10.15714/SCANDPSYCHOL.4.E10]; Waite TC, 2018, COMPLEMENT THER CLIN, V33, P49, DOI 10.1016/j.ctcp.2018.07.006; Wallace CL, 2020, J PAIN SYMPTOM MANAG, V60, pE70, DOI 10.1016/j.jpainsymman.2020.04.012; Wang Hsiu-Hung, 2003, Kaohsiung Journal of Medical Sciences, V19, P345, DOI 10.1016/S1607-551X(09)70436-X; Wang JY, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1736-5; WEST DA, 1986, COMPR PSYCHIAT, V27, P351, DOI 10.1016/0010-440X(86)90011-8; White MD, 2006, LIBR TRENDS, V55, P22, DOI 10.1353/lib.2006.0053; Yang YC, 2014, SOC SCI MED, V107, P124, DOI 10.1016/j.socscimed.2014.02.013	74	6	6	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252324	10.1371/journal.pone.0252324	http://dx.doi.org/10.1371/journal.pone.0252324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043716	gold, Green Published			2022-12-26	WOS:000664635700087
J	Hollandt, T; Baur, M; Wohr, AC				Hollandt, Tina; Baur, Markus; Woehr, Anna-Caroline			Animal-appropriate housing of ball pythons (Python regius)-Behavior-based evaluation of two types of housing systems	PLOS ONE			English	Article							REPETITIVE BEHAVIOR; STEREOTYPIES; NEUROBIOLOGY	Considering animal welfare, animals should be kept in animal-appropriate and stress-free housing conditions in all circumstances. To assure such conditions, not only basic needs must be met, but also possibilities must be provided that allow animals in captive care to express all species-typical behaviors. Rack housing systems for snakes have become increasingly popular and are widely used; however, from an animal welfare perspective, they are no alternative to furnished terrariums. In this study, we therefore evaluated two types of housing systems for ball pythons (Python regius) by considering the welfare aspect animal behavior. In Part 1 of the study, ball pythons (n = 35) were housed individually in a conventional rack system. The pythons were provided with a hiding place and a water bowl, temperature control was automatic, and the lighting in the room served as indirect illumination. In Part 2 of the study, the same ball pythons, after at least 8 weeks, were housed individually in furnished terrariums. The size of each terrarium was correlated with the body length of each python. The terrariums contained substrate, a hiding place, possibilities for climbing, a water basin for bathing, an elevated basking spot, and living plants. The temperature was controlled automatically, and illumination was provided by a fluorescent tube and a UV lamp. The shown behavior spectrum differed significantly between the two housing systems (p < 0.05). The four behaviors basking, climbing, burrowing, and bathing could only be expressed in the terrarium. Abnormal behaviors that could indicate stereotypies were almost exclusively seen in the rack system. The results show that the housing of ball pythons in a rack system leads to a considerable restriction in species-typical behaviors; thus, the rack system does not meet the requirements for animal-appropriate housing.	[Hollandt, Tina; Baur, Markus] Auffangstat Reptilien Munchen eV, Munich Rescue Ctr Reptiles, Munich, Germany; [Woehr, Anna-Caroline] Ludwig Maximilians Univ Munchen, Dept Vet Sci, Chair Anim Welf Ethol Anim Hyg & Anim Husb, Fac Vet Med, Munich, Germany	University of Munich	Hollandt, T (corresponding author), Auffangstat Reptilien Munchen eV, Munich Rescue Ctr Reptiles, Munich, Germany.	frontina2001@yahoo.de		Dr. Wohr, Anna-Caroline/0000-0001-9414-6809; Hollandt, Tina/0000-0002-3733-9935				[Anonymous], 1997, GERM EXP REP MIN REQ; Broghammer S., 2014, RACKHALTUNG REPTILIE; De Vosjoli P., 1990, GEN CARE MAINTENANCE, V1 st ed; Dupjan S, 2016, BERL MUNCH TIERARZTL, V129, P93, DOI 10.2376/0005-9366-129-93; Fraser D, 1997, ANIM WELFARE, V6, P187; Iten K., KLIMADIAGRAMME WELTW; Johnson J., FREEDOMBREEDERS; Kolle P., 2007, SCHLANGEN, V1; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P356, DOI 10.1016/j.neubiorev.2010.02.005; Langen M, 2011, NEUROSCI BIOBEHAV R, V35, P345, DOI 10.1016/j.neubiorev.2010.02.004; Longhitano F., 2010, REPTILIA; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason GJ, 2004, ANIM WELFARE, V13, pS57; McCurley K., 2011, PYTHON REGIUS KOMPEN, V2; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Rieck W, 2001, MERTENSIELLA GESCH H; Riis A., WORLD BALLPYTHONS MO; Sambraus HH., 1982, ETHOLOGISCHE AUSSAGE, P34; Schmidt D., 1994, SCHLANGEN, V2; Schmidt D., 2009, ATLAS SCHLANGEN, V1; Schrenk F., 2019, INT DVG FACHT ZUM TH, V71; Sillman AJ, 1999, J EXP BIOL, V202, P1931; Sutherland C., 2009, BALL PYTHONS, V1; Trutnau L., 1988, SCHLANGEN 1, V3; Warwick C., 2022, HLTH WELFARE CAPTIVE, V2; WECHSLER B, 1992, APPL ANIM BEHAV SCI, V33, P381, DOI 10.1016/S0168-1591(05)80074-7; WECHSLER B, 1995, APPL ANIM BEHAV SCI, V43, P123, DOI 10.1016/0168-1591(95)00557-9; Westhoff G., 2005, EXPERT REPORT SUITAB	28	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0247082	10.1371/journal.pone.0247082	http://dx.doi.org/10.1371/journal.pone.0247082			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043634	gold, Green Submitted, Green Published			2022-12-26	WOS:000664635700006
J	Hopkinson, DA; Mvukiyehe, JP; Jayaraman, SP; Syed, AA; Dworkin, MS; Mucyo, W; Cyuzuzo, T; Tuyizere, A; Mukwesi, C; Nyirigira, G; Banguti, PR; Riviello, ED				Hopkinson, Dennis A.; Mvukiyehe, Jean Paul; Jayaraman, Sudha P.; Syed, Aamer A.; Dworkin, Myles S.; Mucyo, Willy; Cyuzuzo, Thierry; Tuyizere, Anne; Mukwesi, Christian; Nyirigira, Gaston; Banguti, Paulin R.; Riviello, Elisabeth D.			Sepsis in two hospitals in Rwanda: A retrospective cohort study of presentation, management, outcomes, and predictors of mortality	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; PERITONITIS; DEFINITIONS; PREVALENCE; PROTOCOL; ADULTS	Purpose Few studies have assessed the presentation, management, and outcomes of sepsis in low-income countries (LICs). We sought to characterize these aspects of sepsis and to assess mortality predictors in sepsis in two referral hospitals in Rwanda. Materials and methods This was a retrospective cohort study in two public academic referral hospitals in Rwanda. Data was abstracted from paper medical records of adult patients who met our criteria for sepsis. Results Of the 181 subjects who met eligibility criteria, 111 (61.3%) met our criteria for sepsis without shock and 70 (38.7%) met our criteria for septic shock. Thirty-five subjects (19.3%) were known to be HIV positive. The vast majority of septic patients (92.7%) received intravenous fluid therapy (median = 1.0 L within 8 hours), and 94.0% received antimicrobials. Vasopressors were administered to 32.0% of the cohort and 46.4% received mechanical ventilation. In-hospital mortality for all patients with sepsis was 51.4%, and it was 82.9% for those with septic shock. Baseline characteristic mortality predictors were respiratory rate, Glasgow Coma Scale score, and known HIV seropositivity. Conclusions Septic patients in two public tertiary referral hospitals in Rwanda are young (median age = 40, IQR = 29, 59) and experience high rates of mortality. Predictors of mortality included baseline clinical characteristics and HIV seropositivity status. The majority of subjects were treated with intravenous fluids and antimicrobials. Further work is needed to understand clinical and management factors that may help improve mortality in septic patients in LICs.	[Hopkinson, Dennis A.; Syed, Aamer A.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA; [Mvukiyehe, Jean Paul; Banguti, Paulin R.] Univ Rwanda, Coll Med & Hlth Sci, Dept Anesthesia, Kigali, Rwanda; [Jayaraman, Sudha P.] Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23284 USA; [Dworkin, Myles S.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA; [Mucyo, Willy] King Faisal Hosp Kigali, Kigali, Rwanda; [Cyuzuzo, Thierry; Tuyizere, Anne] Univ Rwanda, Coll Med & Hlth Sci, Kigali, Rwanda; [Mukwesi, Christian] Rwanda Mil Hosp, Kigali, Rwanda; [Nyirigira, Gaston] Univ Teaching Hosp Butare, Butare, Rwanda; [Riviello, Elisabeth D.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA USA; [Riviello, Elisabeth D.] Harvard Med Sch, Boston, MA 02115 USA	Virginia Commonwealth University; University of Rwanda; Virginia Commonwealth University; Jefferson University; University of Rwanda; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hopkinson, DA (corresponding author), Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA.	Dennis.Hopkinson@vcuhealth.org		NYIRIGIRA, Gaston/0000-0002-1919-0495; Hopkinson, Dennis/0000-0002-7161-5972	Fulbright Program [PS00269093]	Fulbright Program	The study was funded through The Fulbright Program (https://eca.state.gov/fulbright) to DH [Grant number PS00269093]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews B, 2017, JAMA-J AM MED ASSOC, V318, P1233, DOI 10.1001/jama.2017.10913; Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Asiimwe SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089879; Auma MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-146; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; European Assoc Study Liver, 2017, J HEPATOL, V66, P1047, DOI 10.1016/j.jhep.2016.12.003; Giamarellos-Bourboulis EJ, 2017, CLIN MICROBIOL INFEC, V23, P104, DOI 10.1016/j.cmi.2016.11.003; Goulden R, 2018, EMERG MED J, V35, P345, DOI 10.1136/emermed-2017-207120; Halfon J, 2016, OBSTET GYNECOL, V127, p86S, DOI 10.1097/01.AOG.0000483788.70251.3e; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Koch DG, 2017, AM J GASTROENTEROL, V112, P1389, DOI 10.1038/ajg.2017.98; Lewis JM, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2501-y; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mathenge EW, 2015, KNOWLEDGE ATTITUDES; Moore CC, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000344; Munyaneza M, 2020, J SURG RES, V246, P236, DOI 10.1016/j.jss.2019.09.027; Mvukiyehe JP, 2018, AM J INFECT CONTROL, V46, pS20; National Institute of Statistics of Rwanda, 2014, POP SIZ POP CHAR; Ndayizeye L, 2016, SURGERY, V160, P1645, DOI 10.1016/j.surg.2016.08.036; Ntirenganya C, 2015, AM J TROP MED HYG, V92, P865, DOI 10.4269/ajtmh.14-0607; Papali A, 2017, J CRIT CARE, V38, P35, DOI 10.1016/j.jcrc.2016.09.031; Park HK, 2017, J CRIT CARE, V42, P12, DOI 10.1016/j.jcrc.2017.06.020; Rickard J, 2018, SURG INFECT, V19, P382, DOI 10.1089/sur.2017.158; Riviello ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155858; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Rudd KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171422; Said M., 2019, INT J CRIT CARE EMER, V5, P084; Singer AJ, 2017, ANN EMERG MED, V69, P475, DOI 10.1016/j.annemergmed.2016.10.007; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sutherland T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221121; Yapps B., 2017, SCI REP-UK, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251321	10.1371/journal.pone.0251321	http://dx.doi.org/10.1371/journal.pone.0251321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038449	gold, Green Published			2022-12-26	WOS:000664633500019
J	Tano, PF; Apiribu, F; Tano, EK; Mensah, ABB; Dzomeku, VM; Boateng, I				Tano, Priscilla Felicia; Apiribu, Felix; Tano, Emile Kouakou; Mensah, Adwoa Bemah Boamah; Dzomeku, Veronica Millicent; Boateng, Isaac			Predicting factors that determine patients' satisfaction with post-operative pain management following abdominal surgeries at Komfo Anokye Teaching Hospital, Kumasi, Ghana	PLOS ONE			English	Article							INTERNATIONAL PAIN	Introduction Poorly controlled postoperative pain has been known to be characterized by longer post-operative care, longer hospital stays with increased readmission rates, and decreased patient satisfaction. Post-operative pain has been continuously addressed in the past three (3) to four (4) decades and has been shown that 20 to 80% of post-operative patients suffer ineffective pain management. Objective The study was aimed at assessing the factors that may predict the satisfaction of patients with early postoperative pain management following abdominal surgeries at the Komfo Anokye Teaching Hospital, Kumasi. Methodology A descriptive cross-sectional study was conducted among patients who had undergone abdominal surgeries between October 2019 and December 2019 at the Komfo Anokye Teaching Hospital. Structured questionnaires based on the IPO-Q were used to obtain responses from the patients. Descriptive and Inferential statistical analysis were employed in analyzing the data obtained from the respondents of the study. Results 138 patients were involved in this study. The mean age of patients in the study was 45.81 (16.81) years. A higher percentage, 58.7% of the patients were males. 39.1% had completed their tertiary level of education. The majority (50.7%) of the patients had had persistent pain for more than three (3) months. The satisfaction of the patients with the post-operative pain management received was generally high among a significant majority of the patients. Meanwhile, among the factors that influence the satisfaction of the patients with the post-operative pain management received, type of analgesia and pain relief methods (Pearson Coefficient = 0.523, p-value <0.05), patient's ability to request more pain relief, (Pearson Coefficient = 0.29, p-value <0.05), patient's access to information about their pain treatment options from the Nurses (Pearson coefficient = -0.22, p<0.05), were the only predictors of satisfaction in patients. Conclusion This study found out that patients were generally satisfied with the post-operative pain management offered by their healthcare providers although the degree of satisfaction depended largely on the type of analgesia and pain relief methods, the ability to request for more pain relief, and access to information on pain treatment.	[Tano, Priscilla Felicia; Apiribu, Felix; Mensah, Adwoa Bemah Boamah; Dzomeku, Veronica Millicent] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Nursing, Coll Hlth Sci, Kumasi, Ghana; [Tano, Priscilla Felicia; Tano, Emile Kouakou] Komfo Anokye Teaching Hosp, Dept Surg, Kumasi, Ghana; [Boateng, Isaac] Univ Cape Coast, Dept Physiol, Cape Coast, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; University of Cape Coast	Tano, PF (corresponding author), Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Dept Nursing, Coll Hlth Sci, Kumasi, Ghana.; Tano, PF (corresponding author), Komfo Anokye Teaching Hosp, Dept Surg, Kumasi, Ghana.	pftano@gmail.com	Apiribu, Dr. Felix/AAV-5632-2021	Boateng, Isaac/0000-0002-3769-366X; Apiribu, Felix/0000-0003-4534-2568; Boamah Mensah, ADWOA Bemah/0000-0002-1114-702X; Tano, Priscilla Felicia/0000-0001-9511-6310				Ahmed Aliya, 2013, J Anaesthesiol Clin Pharmacol, V29, P472, DOI 10.4103/0970-9185.119137; Aubrun F, 2019, ANAESTH CRIT CARE PA, V38, P223, DOI 10.1016/j.accpm.2018.08.004; Batista J, 2017, OPTIMIZING POSTOPERA, V67; Behrens JA, 2019, EUR J OBSTET GYN R B, V232, P22, DOI 10.1016/j.ejogrb.2018.10.038; Drewett S, 2008, CLIN NUTR, V21, P116; Dureja GP, 2017, J PAIN RES, V10, P709, DOI 10.2147/JPR.S128655; Farooq F, 2016, INDIAN J ANAESTH, V60, P248, DOI 10.4103/0019-5049.179450; Gebremedhn Endale Gebreegziabher, 2015, BMC Res Notes, V8, P377, DOI 10.1186/s13104-015-1332-4; Geeraerts T., 2018, ANAESTH CRIT CARE PA, V37; Gerbershagen HJ, 2011, BRIT J ANAESTH, V107, P619, DOI 10.1093/bja/aer195; Hallway A, 2019, J AM COLL SURGEONS, V229, P316, DOI 10.1016/j.jamcollsurg.2019.04.020; Itisha C, 2016, WORLD ACAD SCI ENG T, V10, P285; Kesingland AC, 2000, PAIN, V86, P113, DOI 10.1016/S0304-3959(00)00233-5; Khansa I, 2017, PRS-GLOB OPEN, V5, DOI 10.1097/GOX.0000000000001400; Lemay CA, 2019, PAIN MANAG NURS, V20, P345, DOI 10.1016/j.pmn.2018.12.009; McDonall J, 2016, BMC MUSCULOSKEL DIS, V17, P1, DOI [10.1186/s12891-016-1133-5, DOI 10.1186/s12891-016-1133-5]; Meissner W, 2015, CURR MED RES OPIN, V31, P2131, DOI 10.1185/03007995.2015.1092122; Murthy S, 2013, SOUTH AFR J ANAESTH, V19, P102, DOI 10.1080/22201173.2013.10872904; Ramia E, 2017, PAIN RES MANAG, V2017, DOI 10.1155/2017/7459360; Rothaug J, 2013, J PAIN, V14, P1361, DOI 10.1016/j.jpain.2013.05.016; Schwenkglenks M, 2014, PAIN, V155, P1401, DOI 10.1016/j.pain.2014.04.021; Shigematsu-Locatelli M, 2017, JA CLIN REP, V3, DOI 10.1186/s40981-016-0075-0; Singh PK, 2016, INDIAN J ANAESTH, V60, P737, DOI 10.4103/0019-5049.191686; Stanimir M, 2016, ROM J MORPHOL EMBRYO, V57, P849; Strike E, 2019, J CARDIOTHOR VASC AN, V33, P1668, DOI 10.1053/j.jvca.2018.11.010; Ulm MA, 2018, GYNECOL ONCOL, V151, P124, DOI 10.1016/j.ygyno.2018.08.015; Umuhoza O., 2019, INT J AFR NURS SCI, V10, P145, DOI [10.1016/j.ijans.2019.04.006, DOI 10.1016/J.IJANS.2019.04.006]; Xu NF, 2019, J PEDIATR NURS, V46, pE10, DOI 10.1016/j.pedn.2019.01.014	28	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251979	10.1371/journal.pone.0251979	http://dx.doi.org/10.1371/journal.pone.0251979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033660	gold, Green Published			2022-12-26	WOS:000664633100018
J	Saidova, AA; Potashnikova, DM; Tvorogova, AV; Paklina, OV; Veliev, EI; Knyshinsky, GV; Setdikova, GR; Rotin, DL; Maly, IV; Hofmann, WA; Vorobjev, IA				Saidova, Aleena A.; Potashnikova, Daria M.; Tvorogova, Anna V.; Paklina, Oxana V.; Veliev, Evgeniy I.; Knyshinsky, Grigoriy V.; Setdikova, Galiya R.; Rotin, Daniil L.; Maly, Ivan V.; Hofmann, Wilma A.; Vorobjev, Ivan A.			Myosin 1C isoform A is a novel candidate diagnostic marker for prostate cancer	PLOS ONE			English	Article							STEM-CELL MARKERS; EXPRESSION; IDENTIFICATION; CD133; ALDH1	Early diagnosis of prostate cancer is a challenging issue due to the lack of specific markers. Therefore, a sensitive diagnostic marker that is expressed or upregulated exclusively in prostate cancer cells would facilitate diagnostic procedures and ensure a better outcome. We evaluated the expression of myosin 1C isoform A in 5 prostate cell lines, 41 prostate cancer cases, and 11 benign hyperplasias. We analyzed the expression of 12 surface molecules on prostate cancer cells by flow cytometry and analyzed whether high or low myosin 1C isoform A expression could be attributed to a distinct phenotype of prostate cancer cells. Median myosin 1C isoform A expression in prostate cancer samples and cancer cell lines was 2 orders of magnitude higher than in benign prostate hyperplasia. Based on isoform A expression, we could also distinguish clinical stage 2 from clinical stage 3. Among cell lines, PC-3 cells with the highest myosin 1C isoform A level had diminished numbers of CD10/CD13-positive cells and increased numbers of CD29 (integrin beta 1), CD38, CD54 (ICAM1) positive cells. The surface phenotype of clinical samples was similar to prostate cancer cell lines with high isoform A expression and could be described as CD10-/CD13- with heterogeneous expression of other markers. Both for cell lines and cancer specimens we observed the strong correlation of high myosin 1C isoform A mRNA expression and elevated levels of CD29 and CD54, suggesting a more adhesive phenotype for cells with high isoform A expression. Compared to normal tissue, prostate cancer samples had also reduced numbers of CD24- and CD38-positive cells. Our data suggest that a high level of myosin 1C isoform A is a specific marker both for prostate cancer cells and prostate cancer cell lines. High expression of isoform A is associated with less activated (CD24/CD38 low) and more adhesive (CD29/CD54 high) surface phenotype compared to benign prostate tissue.	[Saidova, Aleena A.; Potashnikova, Daria M.; Vorobjev, Ivan A.] Moscow MV Lomonosov State Univ, Cell Biol & Histol Dept, Sch Biol, Moscow, Russia; [Tvorogova, Anna V.; Vorobjev, Ivan A.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Paklina, Oxana V.; Knyshinsky, Grigoriy V.; Setdikova, Galiya R.; Rotin, Daniil L.] SP Botkin Clin Hosp, Pathoanat Dept, Moscow, Russia; [Veliev, Evgeniy I.] SP Botkin Clin Hosp, Urol Dept, Moscow, Russia; [Maly, Ivan V.; Hofmann, Wilma A.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Physiol & Biophys, Buffalo, NY USA; [Vorobjev, Ivan A.] Nazarbayev Univ, Sch Sci & Humanities, Dept Biol, Nur Sultan, Kazakhstan	Lomonosov Moscow State University; Lomonosov Moscow State University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Nazarbayev University	Saidova, AA (corresponding author), Moscow MV Lomonosov State Univ, Cell Biol & Histol Dept, Sch Biol, Moscow, Russia.	saidova@mail.bio.msu.ru	Saidova, Aleena/AAQ-3962-2020; Potashnikova, Daria/P-4496-2017	Saidova, Aleena/0000-0003-3294-7146; Potashnikova, Daria/0000-0002-0098-827X	NCI of the National Institutes of Health [R21CA220155]; RFBR [17-5433009]	NCI of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RFBR(Russian Foundation for Basic Research (RFBR))	This work was supported in part by the NCI of the National Institutes of Health under award number R21CA220155 to Wilma A. Hofmann and RFBR grant #17-5433009 awarded to Ivan Vorobjev. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Amaro A, 2014, CANCER METAST REV, V33, P657, DOI 10.1007/s10555-013-9470-4; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Bansal N, 2016, CLIN CANCER RES, V22, P6176, DOI 10.1158/1078-0432.CCR-15-3107; Caverly TJ, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv436; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045178; Chmielewski JP, 2018, MOL CANCER RES, V16, P1687, DOI 10.1158/1541-7786.MCR-17-0526; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dall'Era Marc A, 2007, BMC Urol, V7, P3, DOI 10.1186/1471-2490-7-3; Esfahani Maryam, 2015, Asian Pac J Cancer Prev, V16, P2601; Fujita K, 2018, INT J UROL, V25, P770, DOI 10.1111/iju.13734; Glumac PM, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-018-0198-1; Ho ME, 2013, MODERN PATHOL, V26, P849, DOI 10.1038/modpathol.2012.238; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Ihnatovych I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108609; Ihnatovych I, 2012, CYTOSKELETON, V69, P555, DOI 10.1002/cm.21040; Jaggupilli A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/708036; Johnson H, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01834-0; Kannan N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.211334; Kawachi MH, 2010, J NATL COMPR CANC NE, V8, P240, DOI 10.6004/jnccn.2010.0016; Kristiansen G, 2003, PROSTATE, V54, P34, DOI 10.1002/pros.10161; Li C, 2017, THERANOSTICS, V7, P67, DOI 10.7150/thno.16752; Li W, 2017, ONCOTARGET, V8, P65143, DOI 10.18632/oncotarget.17821; Li WZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14364-2; Liu AY, 2000, CANCER RES, V60, P3429; Liu AY, 1997, P NATL ACAD SCI USA, V94, P10705, DOI 10.1073/pnas.94.20.10705; Liu AY, 2004, AM J PATHOL, V165, P1543, DOI 10.1016/S0002-9440(10)63412-8; Liu AY, 2002, AM J PATHOL, V160, P37, DOI 10.1016/S0002-9440(10)64346-5; Loeb S, 2013, EUR UROL, V64, P876, DOI 10.1016/j.eururo.2013.05.049; Maly IV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09158-5; Mottahedeh J, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0186-3; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Saidova AA, 2018, PEERJ, V6, DOI 10.7717/peerj.5970; Scattoni V, 2010, EUR UROL, V57, P1, DOI 10.1016/j.eururo.2009.08.011; Siddique HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052993; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Sielski NL, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-8; Tang L, 2020, FEBS OPEN BIO, V10, P2678, DOI 10.1002/2211-5463.13004; Thompson IM, 2006, J NUTR, V136, p2704S, DOI 10.1093/jn/136.10.2704S; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wangerin H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/356427; Zhao HJ, 2009, PROSTATE, V69, P991, DOI 10.1002/pros.20946; Zoni E, 2019, MOL CANCER RES, V17, P1049, DOI 10.1158/1541-7786.MCR-18-1220	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251961	10.1371/journal.pone.0251961	http://dx.doi.org/10.1371/journal.pone.0251961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019593	gold, Green Published			2022-12-26	WOS:000664632300041
J	Eyring, J; Lin, CW; Ngwa, EM; Boilevin, J; Pesciullesi, G; Locher, KP; Darbre, T; Reymond, JL; Aebi, M				Eyring, Jillianne; Lin, Chia-Wei; Ngwa, Elsy Mankah; Boilevin, Jeremy; Pesciullesi, Giorgio; Locher, Kaspar P.; Darbre, Tamis; Reymond, Jean-Louis; Aebi, Markus			Substrate specificities and reaction kinetics of the yeast oligosaccharyltransferase isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-LINKED OLIGOSACCHARIDE; N-GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; OXIDOREDUCTASE ACTIVITY; LECTIN AFFINITY; PROTEIN; SUBUNITS; REVEALS; COMPLEXES; GLYCAN	Oligosaccharyltransferase (OST) catalyzes the central step in N-linked protein glycosylation, the transfer of a preassembled oligosaccharide from its lipid carrier onto asparagine residues of secretory proteins. The prototypic hetero-octameric OST complex from the yeast Saccharomyces cerevisiae exists as two isoforms that contain either Ost3p or Ost6p, both noncatalytic subunits. These two OST complexes have different protein substrate specificities in vivo. However, their detailed biochemical mechanisms and the basis for their different specificities are not clear. The two OST complexes were purified from genetically engineered strains expressing only one isoform. The kinetic properties and substrate specificities were characterized using a quantitative in vitro glycosylation assay with short peptides and different synthetic lipid-linked oligosaccharide (LLO) substrates. We found that the peptide sequence close to the glycosylation sequon affected peptide affinity and turnover rate. The length of the lipid moiety affected LLO affinity, while the lipid double-bond stereochemistry had a greater influence on LLO turnover rates. The two OST complexes had similar affinities for both the peptide and LLO substrates but showed significantly different turnover rates. These data provide the basis for a functional analysis of the Ost3p and Ost6p subunits.	[Eyring, Jillianne; Lin, Chia-Wei; Ngwa, Elsy Mankah; Aebi, Markus] Swiss Fed Inst Technol, Dept Biol, Inst Microbiol, Zurich, Switzerland; [Lin, Chia-Wei] Univ Zurich, Funct Genom Ctr Zurich, ETH Zurich, Zurich, Switzerland; [Boilevin, Jeremy; Pesciullesi, Giorgio; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Locher, Kaspar P.] Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Aebi, M (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Microbiol, Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Lin, Chia-wei/ABA-6065-2021	Lin, Chia-wei/0000-0003-4777-2916	Swiss National Science Foundation [CRSII5_171056, 31003oB_182835]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, grant numbers CRSII5_171056 and 31003oB_182835.	Atwood JA, 2006, J PROTEOME RES, V5, P3376, DOI 10.1021/pr060364b; Bai L, 2018, NATURE, V555, P328, DOI 10.1038/nature25755; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Eichler J, 2017, BBA-MOL CELL BIOL L, V1862, P589, DOI 10.1016/j.bbalip.2017.03.005; FANG XG, 1995, BIOORG MED CHEM LETT, V5, P2701, DOI 10.1016/0960-894X(95)00460-B; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Gibbs BS, 1999, BIOORGAN MED CHEM, V7, P441, DOI 10.1016/S0968-0896(98)00268-5; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guthrie C, 1991, GUIDE YEAST GENETICS; Hang I, 2015, GLYCOBIOLOGY, V25, P1335, DOI 10.1093/glycob/cwv058; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; HEESEN ST, 1991, EUR J CELL BIOL, V56, P8; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herscovics A, 1999, BBA-GEN SUBJECTS, V1426, P275, DOI 10.1016/S0304-4165(98)00129-9; Jamaluddin MFB, 2014, MOL CELL PROTEOMICS, V13, P3286, DOI 10.1074/mcp.M114.041178; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang LY, 2015, BOT STUD, V56, DOI 10.1186/s40529-015-0111-9; Kelleher DJ, 2007, J CELL BIOL, V177, P29, DOI 10.1083/jcb.200611079; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Li GT, 2005, J BIOL CHEM, V280, P1864, DOI 10.1074/jbc.M410969200; Lizak C, 2014, J BIOL CHEM, V289, P735, DOI 10.1074/jbc.M113.524751; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; Matsumoto S, 2017, BIOCHEMISTRY-US, V56, P602, DOI 10.1021/acs.biochem.6b01089; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Mueller S, 2015, MOL BIOL CELL, V26, P2596, DOI 10.1091/mbc.E15-03-0168; Murray AN, 2015, CHEM BIOL, V22, P1052, DOI 10.1016/j.chembiol.2015.06.017; Naegeli A, 2014, J BIOL CHEM, V289, P24521, DOI 10.1074/jbc.M114.579326; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Napiorkowska M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34534-0; Napiorkowska M, 2017, NAT STRUCT MOL BIOL, V24, P1100, DOI 10.1038/nsmb.3491; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Poljak K, 2018, MOL CELL PROTEOMICS, V17, P32, DOI 10.1074/mcp.RA117.000096; Ramirez AS, 2019, SCIENCE, V366, P1372, DOI 10.1126/science.aaz3505; Ramirez AS, 2017, GLYCOBIOLOGY, V27, P525, DOI 10.1093/glycob/cwx017; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarz F, 2011, J BIOL CHEM, V286, P35267, DOI 10.1074/jbc.M111.277160; Schwarz M, 2005, FEBS LETT, V579, P6564, DOI 10.1016/j.febslet.2005.10.063; Scott NE, 2012, J BIOL CHEM, V287, P29384, DOI 10.1074/jbc.M112.380212; SHARMA C, 1981, EUR J BIOCHEM, V116, P101, DOI 10.1111/j.1432-1033.1981.tb05306.x; Shrimal S, 2017, J CELL BIOL, V216, P3625, DOI 10.1083/jcb.201702159; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; Tai VWF, 2001, J ORG CHEM, V66, P6217, DOI 10.1021/jo0100345; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wong JP, 2009, J PROTEOME RES, V8, P2388, DOI 10.1021/pr801008c; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Yamasaki T, 2020, J BIOL CHEM, V295, P16072, DOI 10.1074/jbc.RA120.015013; Zacchi LF, 2016, MOL CELL PROTEOMICS, V15, P2435, DOI 10.1074/mcp.M115.056366; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	69	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100809	10.1016/j.jbc.2021.100809	http://dx.doi.org/10.1016/j.jbc.2021.100809			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34023382	Green Published, gold, Green Accepted			2022-12-26	WOS:000674717300025
J	Morales, MM; Pedowitz, NJ; Pratt, MR				Morales, Murielle M.; Pedowitz, Nichole J.; Pratt, Matthew R.			O-GlcNAc modification of MYPT1 modulates lysophosphatidic acid-induced cell contraction in fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSAMINE BIOSYNTHESIS; MYOSIN PHOSPHATASE; CROSS-TALK; GLCNACYLATION; SPHINGOSINE-1-PHOSPHATE; PHOSPHORYLATION; TRANSFERASE; METABOLISM; INSULIN; GLUCOSE	Thousands of proteins have been found to be modified by O-GlcNAc, a common glycosylation modification of serine and threonine residues throughout the cytosol and nucleus. O-GlcNAc is enzymatically added and removed from proteins, making it a potential dynamic regulator of cell signaling. However, compared with other posttranslational modifications like phosphorylation, relatively few O-GlcNAc-regulated pathways have been discovered and biochemically characterized. We previously discovered one such pathway, where O-GlcNAc controls the contraction of fibroblasts initiated by the signaling lipid sphingosine-1-phosphate. Specifically, we found that O-GlcNAc modification of the phosphatase MYPT1 maintains its activity, resulting in dephosphorylation and deactivation of the myosin light chain of the actinomyosin complex. Another signaling lipid that leads to contraction of fibroblasts is lysophosphatidic acid, and this signaling pathway also converges on MYPT1 and actinomyosin. We therefore rationalized that O-GlcNAc would also control this pathway. Here, we used a combination of small molecule inhibitors, 2D and 3D cell cultures, and biochemistry to confirm our hypothesis. Specifically, we found that O-GlcNAc levels control the sensitivity of mouse and primary human dermal fibroblasts to lysophosphatidic acid-induced contraction in culture and the phosphorylation of MLC and that MYPT1 O-GlcNAc modification is responsible. These findings further solidify the importance of O-GlcNAc in regulating the biology of fibroblasts in response to procontractile stimuli.	[Morales, Murielle M.; Pratt, Matthew R.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA; [Pedowitz, Nichole J.; Pratt, Matthew R.] Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California	Pratt, MR (corresponding author), Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA.; Pratt, MR (corresponding author), Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA.	matthew.pratt@usc.edu		Pedowitz, Nichole/0000-0001-6845-2810; Morales, Murielle/0000-0003-2955-2047; Pratt, Matthew/0000-0003-3205-5615	Anton Burg Foundation; NIGMS, National Institutes of Health [R01GM125939, T32GM118289]	Anton Burg Foundation; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Anton Burg Foundation and the NIGMS, National Institutes of Health (R01GM125939) to M. R. P. M. M. M. and N. J. P. were supported by NIGMS, National Institutes of Health T32GM118289. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balana AT, 2021, NAT CHEM, V13, P441, DOI 10.1038/s41557-021-00648-8; Banerjee PS, 2016, MOL ASPECTS MED, V51, P1, DOI 10.1016/j.mam.2016.05.005; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Chatham JC, 2021, PHYSIOL REV, V101, P427, DOI 10.1152/physrev.00043.2019; Eto Masumi, 2017, J Smooth Muscle Res, V53, P1, DOI 10.1540/jsmr.53.1; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Grassie ME, 2012, J BIOL CHEM, V287, P36356, DOI 10.1074/jbc.M112.398479; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hanover JA, 2018, J BIOENERG BIOMEMBR, V50, P155, DOI 10.1007/s10863-018-9751-2; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart G. W., 2015, PERSPECT SCI, V6, P49; Hart GW, 2019, J BIOL CHEM, V294, P2211, DOI 10.1074/jbc.AW119.003226; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jiang HM, 2008, FASEB J, V22, P2151, DOI 10.1096/fj.07-097014; Joiner CM, 2019, CURR OPIN STRUC BIOL, V56, P97, DOI 10.1016/j.sbi.2018.12.003; King DT, 2019, CURR OPIN CHEM BIOL, V53, P131, DOI 10.1016/j.cbpa.2019.09.001; Kiss A, 2019, BBA-MOL CELL RES, V1866, P2, DOI 10.1016/j.bbamcr.2018.07.023; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Levine ZG, 2016, ANNU REV BIOCHEM, V85, P631, DOI 10.1146/annurev-biochem-060713-035344; Liu CF, 2020, J BIOL CHEM, V295, P7341, DOI 10.1074/jbc.RA119.012401; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Panetti TS, 2001, PROSTAG OTH LIPID M, V64, P93, DOI 10.1016/S0090-6980(01)00102-2; Parizi M, 2000, EXP CELL RES, V254, P210, DOI 10.1006/excr.1999.4754; Pedowitz NJ, 2021, NAT CHEM BIOL, V17, P169, DOI 10.1038/s41589-020-0640-8; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Petrache I., 2016, ANNU REV PHYSIOL, V78, P1; Pinho TS, 2019, BBA-MOL BASIS DIS, V1865, P2048, DOI 10.1016/j.bbadis.2018.10.037; Rhee S, 2007, ADV DRUG DELIVER REV, V59, P1299, DOI 10.1016/j.addr.2007.08.006; Sandbo N, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1698, DOI 10.1134/S0006297916130071; Sheng XY, 2015, DEVELOPMENT, V142, P1390, DOI 10.1242/dev.121723; Shlyonsky V, 2014, PULM CIRC, V4, P471, DOI 10.1086/677362; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; TRAXINGER RR, 1991, J BIOL CHEM, V266, P10148; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Wulff-Fuentes E, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00810-4; Yanagida K, 2011, J BIOCHEM, V150, P223, DOI 10.1093/jb/mvr087; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yee HF, 2001, BIOCHEM BIOPH RES CO, V280, P1340, DOI 10.1006/bbrc.2001.4291; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2018, FEBS LETT, V592, P3950, DOI 10.1002/1873-3468.13286	56	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100800	10.1016/j.jbc.2021.100800	http://dx.doi.org/10.1016/j.jbc.2021.100800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019870	Green Published, gold			2022-12-26	WOS:000674717300020
J	Sharma, K; Singh, R; Sharma, SK; Anand, A				Sharma, Kaushal; Singh, Ramandeep; Sharma, Suresh Kumar; Anand, Akshay			Sleeping pattern and activities of daily living modulate protein expression in AMD	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; ALZHEIMERS-DISEASE; STEM-CELLS; AGE; ACCUMULATION; EPIGENETICS; MECHANISMS; RECEPTOR-3; DURATION	Degeneration of macular photoreceptors is a prominent characteristic of age-related macular degeneration (AMD) which leads to devastating and irreversible vision loss in the elderly population. In this exploratory study, the contribution of environmental factors on the progression of AMD pathology by probing the expression of candidate proteins was analyzed. Four hundred and sixty four participants were recruited in the study comprising of AMD (n = 277) and controls (n = 187). Genetics related data was analyzed to demonstrate the activities of daily living (ADL) by using regression analysis and statistical modeling, including contrast estimate, multinomial regression analysis in AMD progression. Regression analysis revealed contribution of smoking, alcohol, and sleeping hours on AMD by altered expression of IER-3, HTRA1, B3GALTL, LIPC and TIMP3 as compared to normal levels. Contrast estimate supports the gender polarization phenomenon in AMD by significant decreased expression of SLC16A8 and LIPC in control population which was found to be unaltered in AMD patients. The smoking, food habits and duration of night sleeping hours also contributed in AMD progression as evident from multinomial regression analysis. Predicted model (prediction estimate = 86.7%) also indicated the crucial role of night sleeping hours along with the decreased expression of TIMP-3, IER3 and SLC16A8. Results revealed an unambiguous role of environmental factors in AMD progression mediated by various regulatory proteins which might result in intermittent AMD phenotypes and possibly influence the outcome of anti-VEGF treatment.	[Sharma, Kaushal; Anand, Akshay] Post Grad Inst Med Educ & Res, Dept Neurol, Neurosci Res Lab, Chandigarh, India; [Sharma, Kaushal] Post Grad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Chandigarh, India; [Singh, Ramandeep] Post Grad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh, India; [Sharma, Suresh Kumar] Panjab Univ, Dept Stat, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University	Anand, A (corresponding author), Post Grad Inst Med Educ & Res, Dept Neurol, Neurosci Res Lab, Chandigarh, India.	akshay1anand@rediffmail.com		Anand, Akshay/0000-0001-9003-3532	Department of Biotechnology, New Delhi, India [BT/PR17550/MED/30/1755/2016]; CSIR-UGC, New Delhi; Indian Council of Medical Research (ICMR), New Delhi, India; Department of Science and Technology (DST), New Delhi, India	Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); CSIR-UGC, New Delhi(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India))	This study was funded by the Department of Biotechnology, New Delhi, India to AA (No. BT/PR17550/MED/30/1755/2016). We also acknowledge CSIR-UGC, New Delhi for providing fellowship during PhD to KS, Department of Science and Technology (DST), New Delhi, India and Indian Council of Medical Research (ICMR), New Delhi, India to provide the travel funds to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2012, EUR J NEUROL, V19, P788, DOI 10.1111/j.1468-1331.2011.03548.x; Anand A, 2007, BEHAV BRAIN RES, V182, P12, DOI 10.1016/j.bbr.2007.04.022; Anand A, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00115; Anand A, 2014, CURR GENOMICS, V15, P266, DOI 10.2174/1389202915666140516204512; Anand A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/635831; Anand A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/365046; Anand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049905; Anand A, 2012, CURR ALZHEIMER RES, V9, P1010, DOI 10.2174/156720512803569055; Anand A, 2010, NEUROCHEM RES, V35, P1172, DOI 10.1007/s11064-010-0171-x; Baird PN, 2013, EPIGENOMICS-UK, V5, P239, DOI [10.2217/EPI.13.19, 10.2217/epi.13.19]; Banik A, 2015, J ALZHEIMERS DIS, V47, P815, DOI 10.3233/JAD-150136; Cascella R, 2018, PROG RETIN EYE RES, V63, P132, DOI 10.1016/j.preteyeres.2017.11.004; Cascella Raffaella, 2018, Oncotarget, V9, P7812, DOI 10.18632/oncotarget.23241; Chen YH, 2011, ARCH OPHTHALMOL-CHIC, V129, P344, DOI 10.1001/archophthalmol.2011.10; English D, 2013, J CELL BIOCHEM, V114, P764, DOI 10.1002/jcb.24436; Fernandez-Robredo P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01862; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Gemenetzi M, 2020, CELL MOL LIFE SCI, V77, P807, DOI 10.1007/s00018-019-03421-w; Gemenetzi M, 2014, EYE, V28, P1407, DOI 10.1038/eye.2014.225; Gupta PK, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-114; Khurana RN, 2016, RETINA-J RET VIT DIS, V36, P255, DOI 10.1097/IAE.0000000000000706; Kunchithapautham K, 2014, J BIOL CHEM, V289, P14534, DOI 10.1074/jbc.M114.564674; Liu MM, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-13; Luu J, 2018, P NATL ACAD SCI USA, V115, P2866, DOI 10.1073/pnas.1721033115; Mathur D, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00044; Maugeri A, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020159; Maugeri A, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7532507; Perez-Canales JL, 2016, OPHTHAL EPIDEMIOL, V23, P20, DOI 10.3109/09286586.2015.1119288; Porter LF, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0608-2; Sharma K, 2017, J CELL BIOCHEM, V118, P2087, DOI 10.1002/jcb.25837; Sharma K, 2015, ANN NEUROSCI, V22, P232, DOI 10.5214/ans.0972.7531.220408; Sharma K, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00151; Sharma NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193423; Sharma NK, 2014, MOL CELL BIOCHEM, V393, P1, DOI 10.1007/s11010-014-2040-4; Sharma NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070193; Sharma NK, 2013, DNA CELL BIOL, V32, P549, DOI 10.1089/dna.2013.2072; Sharma NK, 2013, GENE, V523, P106, DOI 10.1016/j.gene.2013.03.052; Sharma NK, 2012, CURR NEUROVASC RES, V9, P256; Sharma NK, 2012, DNA CELL BIOL, V31, P1618, DOI 10.1089/dna.2012.1786; Singh T, 2012, STEM CELLS DEV, V21, P448, DOI 10.1089/scd.2011.0002; Takeuchi A, 2009, INVEST OPHTH VIS SCI, V50, P3410, DOI 10.1167/iovs.08-2299; Velilla S, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/895147; Venza I, 2012, AGING CLIN EXP RES, V24, P530, DOI 10.3275/8477; Wang Yupeng, 2010, BMC Res Notes, V3, P117, DOI 10.1186/1756-0500-3-117; Wei L, 2012, CELL REP, V2, P1151, DOI 10.1016/j.celrep.2012.10.013; Wills NK, 2008, EXP EYE RES, V86, P41, DOI 10.1016/j.exer.2007.09.005; Winkler TW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194321; Zhou JN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15512-5	48	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0248523	10.1371/journal.pone.0248523	http://dx.doi.org/10.1371/journal.pone.0248523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061866	Green Published, gold			2022-12-26	WOS:000656813600020
J	Kosir, T; Sajovic, J; Groselj, M; Fidler, A; Drevensek, G; Selic-Zupancic, P				Kosir, Tadea; Sajovic, Jakob; Groselj, Maja; Fidler, Ales; Drevensek, Gorazd; Selic-Zupancic, Polona			Real-life dental examination elicits physiological responses different to visual and auditory dental-related stimuli	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ANXIETY; FEAR; EXPOSURE	Background Previous studies on dental anxiety have examined the psychophysiological responses evoked in dentally anxious subjects by dental-related stimuli, but not during a real-life dental examination, which was achieved in the present study. Methods The heart rate, skin conductance level, and heart rate variability of 25 subjects with dental anxiety and 25 healthy controls were examined. Anxiety was determined by the Modified Dental Anxiety Scale and the Dental Anxiety Scale-Revised. The psychophysiological reactions of the two groups were compared during exposure to dental-related pictures, dental-related sounds, and an actual examination in a dental surgery. Results All the dental-related stimuli provoked an increase in heart rate, i.e. visual stimuli (p<0.001; 95% CI 0.98-3.95 bpm), auditory stimuli (p<0.001; 95% CI 1.34-4.99 bpm), and a dental examination (p<0.001; 95% CI 1.26-5.39 bpm). Dental-related pictures provoked inferior skin conductance level changes compared to dental-related sounds and the dental examination (visual modality vs auditory p<0.001; 95% CI 0.039-0.152; visual modality vs examination p<0.001; 95% CI 0.083-0.275). Heart rate variability manifested in a complex pattern of responses to the dental examination. However, when exposed to all three dental-related stimuli presentation conditions, the heart rate (F = 0.352, p = 0.556), skin conductance level (F = 0.009, p = 0.926), and heart rate variability parameters of subjects with dental anxiety did not differ in comparison to the healthy controls. Conclusions This pilot study represents an evaluation of psychophysiological reactions during a real-life dental examination compared to single modality stimuli, and shows that a real-life dental examination provokes an increase in heart rate, heart rate variability and skin conductance level. Additionally, autonomic responses did not differ between the experimental and control groups. The key issue for future studies is the effect of real-life situations on the physiological and psychological state of the subjects, which should be considered when planning new research and studied in depth.	[Kosir, Tadea; Sajovic, Jakob; Drevensek, Gorazd] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia; [Sajovic, Jakob; Groselj, Maja; Fidler, Ales] Univ Med Ctr Ljubljana, Dept Endodont, Ljubljana, Slovenia; [Groselj, Maja] Univ Ljubljana, Fac Med, Dept Dent Dis & Normal Dent Morphol, Ljubljana, Slovenia; [Drevensek, Gorazd] Univ Ljubljana, Inst Pharmacol & Expt Toxicol, Fac Med, Ljubljana, Slovenia; [Selic-Zupancic, Polona] Univ Ljubljana, Fac Med, Dept Family Med, Ljubljana, Slovenia	University of Primorska; University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana; University of Ljubljana	Drevensek, G (corresponding author), Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper, Slovenia.; Drevensek, G (corresponding author), Univ Ljubljana, Inst Pharmacol & Expt Toxicol, Fac Med, Ljubljana, Slovenia.	gorazd.drevensek@mf.uni-lj.si	Fidler, Ales/C-5722-2008	Fidler, Ales/0000-0003-3916-1111; Selic - Zupancic, Polona/0000-0002-5949-0580; Sajovic, Jakob/0000-0003-1633-5983	National Research Agency, Slovenia [P3-0293, I0-0035]; Slovenian Research Agency [P3-0339]	National Research Agency, Slovenia; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the National Research Agency, Slovenia, No. P3-0293 Periodontal Medicine and Program I0-0035. The author Polona Selic acknowledges financial support from the Slovenian Research Agency, research core funding Research in the Field of Public Health No. P3-0339. -URL of funder website: http://www.arrs.si/en/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EMOMADRID EMOTIONAL; Appukuttan DP, 2016, CLIN COSMET INVESTIG, V8, P35, DOI 10.2147/CCIDE.S63626; Bare Lyndsay C, 2004, J Dent Educ, V68, P1172; Baron-Esquivias Gonzalo, 2003, Indian Pacing Electrophysiol J, V3, P239; Camm AJ, 1996, CIRCULATION, V93, P1043; CARLSSON SG, 1986, COMMUNITY DENT ORAL, V14, P253, DOI 10.1111/j.1600-0528.1986.tb01066.x; Carter AE, 2014, WORLD J CLIN CASES, V2, P642, DOI 10.12998/wjcc.v2.i11.642; Chennafi M, 2018, 2018 IEEE ASIA PACIFIC CONFERENCE ON CIRCUITS AND SYSTEMS (APCCAS 2018), P131, DOI 10.1109/APCCAS.2018.8605674; CORAH NL, 1978, J AM DENT ASSOC, V97, P816, DOI 10.14219/jada.archive.1978.0394; Cuthbert BN, 2003, PSYCHOPHYSIOLOGY, V40, P407, DOI 10.1111/1469-8986.00043; DEGEUS EJC, 1995, BIOL PSYCHOL, V41, P205, DOI 10.1016/0301-0511(95)05137-6; El Aarbaoui T, 2017, ENVIRON POLLUT, V231, P703, DOI 10.1016/j.envpol.2017.08.031; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Friedman N, 1998, Compend Contin Educ Dent, V19, P434; Furukawa T, 2017, J ARRYTHM, V33, P568, DOI 10.1016/j.joa.2017.08.002; Gorman JM, 2000, AM HEART J, V140, P577; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Hagenaars MA, 2012, J EXP PSYCHOL GEN, V141, P98, DOI 10.1037/a0024211; Hilbert K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/196353; Humphris G, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-29; Humphris GM, 2000, INT DENT J, V50, P367, DOI 10.1111/j.1875-595X.2000.tb00570.x; Johnsen BH, 2003, J ANXIETY DISORD, V17, P75, DOI 10.1016/S0887-6185(02)00178-0; Kozlowska K, 2015, HARVARD REV PSYCHIAT, V23, P263, DOI 10.1097/HRP.0000000000000065; Kvale G, 2002, EUR J ORAL SCI, V110, P69, DOI 10.1034/j.1600-0722.2002.11204.x; Lang P. J., 2013, ATTENTION ORIENTING; Leutgeb V, 2014, INT J PSYCHOPHYSIOL, V93, P235, DOI 10.1016/j.ijpsycho.2014.05.003; Lindsay SJE, 1995, MODIFIED DENT ANXIET; Locker D, 1997, BEHAV RES THER, V35, P583, DOI 10.1016/S0005-7967(97)00016-8; Lundgren J, 2004, J BEHAV THER EXP PSY, V35, P3, DOI 10.1016/j.jbtep.2003.12.002; Macedo Paula, 2011, J Atr Fibrillation, V4, P333, DOI 10.4022/jafib.333; Miu AC, 2009, AUTON NEUROSCI-BASIC, V145, P99, DOI 10.1016/j.autneu.2008.11.010; Ninomiya T., 2017, LOCAL CHANGES BRAIN; Oosterink FMD, 2008, EUR J ORAL SCI, V116, P44, DOI 10.1111/j.1600-0722.2007.00500.x; Penders V, 2016, MOSAE VERBO; Ronis D L, 1995, J Dent Hyg, V69, P270; Ronis D L, 1994, J Dent Hyg, V68, P228; Shearer A, 2016, INT J STRESS MANAGE, V23, P232, DOI 10.1037/a0039814; Skaret E, 1998, EUR J ORAL SCI, V106, P835, DOI 10.1046/j.0909-8836.1998.eos106402.x; Tadayon R, 2018, PROCEEDINGS OF THE 3RD INTERNATIONAL WORKSHOP ON MULTIMEDIA FOR PERSONAL HEALTH AND HEALTH CARE (HEALTHMEDIA'18), P19, DOI 10.1145/3264996.3265005; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; von Rosenberg W, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00360; Wannemueller A, 2017, BEHAV RES THER, V90, P76, DOI 10.1016/j.brat.2016.12.009; Wannemuller A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00170; Wimmer S, 2019, PSYCHOL RES BEHAV MA, V12, P1031, DOI 10.2147/PRBM.S219784; Yeung AWK, 2019, ORAL DIS, V25, P34, DOI 10.1111/odi.12819	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252128	10.1371/journal.pone.0252128	http://dx.doi.org/10.1371/journal.pone.0252128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QS	34081713	gold, Green Published			2022-12-26	WOS:000664639200009
J	Ojeda, AH; Barahona-Fuentes, G; Maliqueo, SG				Huerta Ojeda, Alvaro; Barahona-Fuentes, Guillermo; Galdames Maliqueo, Sergio			Effects of a period without mandatory physical training on maximum oxygen uptake and anthropometric parameters in naval cadets	PLOS ONE			English	Article							BODY-FAT; AEROBIC CAPACITY; SPORTS-MEDICINE; FITNESS; EXERCISE; PERFORMANCE; CHILDREN; OBESITY; ADAPTATIONS; OVERWEIGHT	The effects of a period without physical training on the civilian population are well established. However, no studies show the effects of a period without mandatory physical training on maximum oxygen uptake (VO2 max) and anthropometric parameters in naval cadets. This study aimed to investigate changes in VO2 max and anthropometric parameters after 12 weeks without mandatory physical training in naval cadets. The sample was 38 healthy and physically active naval cadets. The measured variables, including VO2 max and anthropometric parameters, were evaluated through the 12-minute race test (12MRT) and the somatotype. Both variables had a separation of 12 weeks without mandatory physical training. A t-test for related samples was used to evidence changes between the test and post-test; effect size was calculated through Cohen's d-test. Distance in 12MRT and VO2 max showed significant decreases at the end of 12 weeks without mandatory physical training (p < 0.001). Likewise, the tricipital skinfold thickness and the endomorphic component showed significant increases (p < 0.05). 12 weeks without mandatory physical training significantly reduces the VO2 max in naval cadets. Simultaneously, the same period without physical training increases both the tricipital skinfold thickness and the endomorphic component in this population.	[Huerta Ojeda, Alvaro; Barahona-Fuentes, Guillermo; Galdames Maliqueo, Sergio] Univ Las Amer, Grp Invest Salud Actividad Fis & Deporte ISAFYD, Escuela Educ Fis, Sede Vina Del Mar, Chile	Universidad de Las Americas - Chile	Ojeda, AH (corresponding author), Univ Las Amer, Grp Invest Salud Actividad Fis & Deporte ISAFYD, Escuela Educ Fis, Sede Vina Del Mar, Chile.	achuertao@yahoo.es	Barahona-Fuentes, Guillermo Daniel Felipe/AAR-2833-2021; Ojeda, Alvaro Huerta/AAE-7104-2021	Barahona-Fuentes, Guillermo Daniel Felipe/0000-0003-4913-9321; Ojeda, Alvaro Huerta/0000-0001-6871-098X				Armada-de-Chile, 2014, QUIEN COMP ARM CHIL; Ato M, 2013, AN PSICOL-SPAIN, V29, P1038, DOI 10.6018/analesps.29.3.178511; Barahona-Fuentes Guillermo D., 2020, Motriz: rev. educ. fis., V26, pe10200063, DOI 10.1590/s1980-6574202000030063; Barrera A., 2004, ESTANDARES ANTROPOME; Berral F., 2004, PROTOCOLO MEDIDAS AN, P115; Carter J. L., 1990, SOMATOTYPING DEV APP, V5; Casado A, 1999, MED CLIN-BARCELONA, V112, P584; Cooper JA, 2016, PHYSIOL BEHAV, V156, P43, DOI 10.1016/j.physbeh.2015.12.028; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; Cordova A, 2012, REV ESP CARDIOL, V65, P620, DOI [10.1016/j.rec.2012.01.028, 10.1016/j.recesp.2012.01.026]; Crawford K, 2011, MIL MED, V176, P35, DOI 10.7205/MILMED-D-10-00003; Barahona-Fuentes GD, 2019, EDUC FIS CIENC, V21, DOI 10.24215/23142561e080; de Paiva PRV, 2020, BMC SPORTS SCI MED R, V12, DOI 10.1186/s13102-020-00171-2; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Dyrstad SM, 2006, MIL MED, V171, P736, DOI 10.7205/MILMED.171.8.736; Flann KL, 2011, J EXP BIOL, V214, P674, DOI 10.1242/jeb.050112; Franckle R, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130355; Gacesa JZP, 2010, CLIN PHYSIOL FUNCT I, V30, P413, DOI 10.1111/j.1475-097X.2010.00957.x; Galdames S., 2020, ARCH MED DEPORTE, V37, P220; Casas AG, 2015, CLIN INVEST ARTERIOS, V27, P239, DOI 10.1016/j.arteri.2015.01.001; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Goncalves E. C. de A., 2017, Asian Journal of Sports Medicine, V8, pe13812, DOI 10.5812/asjsm.13812; Gunter K, 2008, J BONE MINER RES, V23, P986, DOI 10.1359/JBMR.071201; Hakkinen K, 1981, SCAND J SPORT SCI, P350; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Ojeda AH, 2017, REV MED CHILE, V145, P972, DOI 10.4067/s0034-98872017000800972; Ojeda AH, 2016, J PHYS THER SCI, V28, P752, DOI [10.1589/jpts.28.752, 10.1589/jpts.28.1487]; Ingle L, 2016, EUR J SPORT SCI, V16, P1187, DOI 10.1080/17461391.2016.1183714; Izquierdo M, 2007, J STRENGTH COND RES, V21, P768; Katzmarzyk PT, 2015, MED SCI SPORT EXER, V47, P2062, DOI 10.1249/MSS.0000000000000649; Kildal CL, 2017, APPETITE, V112, P69, DOI 10.1016/j.appet.2016.12.032; Koundourakis NE, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087803, 10.1371/journal.pone.0101659]; Liguori Gary, 2012, Int J Exerc Sci, V5, P354; Lovell DI, 2012, STEROIDS, V77, P413, DOI 10.1016/j.steroids.2011.12.022; Maldonado I., 2017, REV CUBA INVESTIG BI, V36, P1; Maroto-Izquierdo S, 2017, J SCI MED SPORT, V20, P943, DOI 10.1016/j.jsams.2017.03.004; Martinez Camblor P., 2012, REV CHIL SALUD PUBLI, V16, P225, DOI [10.5354/0717-3652.2012.23127, DOI 10.5354/0717-3652.2012.23127]; Maugeri G, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04315; Mederico M, 2013, ENDOCRINOL NUTR, V60, P235, DOI 10.1016/j.endonu.2012.12.003; Miroshnichenko VM, 2020, PEDAGOG PHYS CULT SP, V24, P290, DOI 10.15561/26649837.2020.0603; Moreno JP, 2013, J SCHOOL HEALTH, V83, P473, DOI 10.1111/josh.12054; Mujika I, 2000, SPORTS MED, V30, P79, DOI 10.2165/00007256-200030020-00002; Mujika I, 1998, INT J SPORTS MED, V19, P439, DOI 10.1055/s-2007-971942; Musumeci G., 2017, J FUNCT MORPHOL KINE, V2, P40, DOI [DOI 10.3390/JFMK2040040, 10.3390/jfmk2040040]; National Health and Nutrition Examination Survey, 2005, ANTHR PROC MAN; Nelsons R, 2019, INT J OBESITY, V43, P1508, DOI 10.1038/s41366-018-0195-x; Ojeda A.H., 2016, ARCH MED DEPORTE REV, V33, P338; Ojeda AH., 2017, REV CUB MED MILITAR, V46, P1; Ormsbee MJ, 2012, J STRENGTH COND RES, V26, P2087, DOI 10.1519/JSC.0b013e31823b874c; Paoli Antonio, 2020, J Funct Morphol Kinesiol, V5, DOI 10.3390/jfmk5020030; Parpa K, 2020, INT J SPORTS MED, V41, P528, DOI 10.1055/a-1103-2038; Patel AV, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.190408; Perez-Gomez J, 2008, EUR J APPL PHYSIOL, V102, P685, DOI 10.1007/s00421-007-0648-8; Plavina Liana, 2016, Papers on Anthropology University of Tartu, V25, P27, DOI 10.12697/poa.2016.25.1.03; Prentice-Dunn H, 2012, PSYCHOL HEALTH MED, V17, P255, DOI 10.1080/13548506.2011.608806; Reinke S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004910; Sabido R, 2016, EUR J HUM MOV, V37, P109; Schneider KL, 2009, EAT BEHAV, V10, P29, DOI 10.1016/j.eatbeh.2008.10.009; Silva JR, 2016, SPORTS MED, V46, P305, DOI 10.1007/s40279-015-0419-3; Skovgaard C, 2014, J APPL PHYSIOL, V117, P1097, DOI 10.1152/japplphysiol.01226.2013; Sotiropoulos A, 2009, J STRENGTH COND RES, V23, P1697, DOI 10.1519/JSC.0b013e3181b3df69; Stebbings GK, 2013, J ATHL TRAINING, V48, P209, DOI 10.4085/1062-6050-48.1.17; Taylor MK, 2008, MIL MED, V173, P738, DOI 10.7205/MILMED.173.8.738; Thomas DT, 2016, J ACAD NUTR DIET, V116, P501, DOI 10.1016/j.jand.2015.12.006; Trowell D, 2020, SPORTS MED, V50, P133, DOI 10.1007/s40279-019-01184-9; von Hippel PT, 2016, OBESITY, V24, P2296, DOI 10.1002/oby.21613; Vrijkotte S, 2019, MIL MED, V184, pE192, DOI 10.1093/milmed/usy274; Webber BJ, 2019, MIL MED, V184, pE248, DOI 10.1093/milmed/usy418; Yanek LR, 2015, ETHNIC DIS, V25, P214	69	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251516	10.1371/journal.pone.0251516	http://dx.doi.org/10.1371/journal.pone.0251516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077447	Green Published, gold			2022-12-26	WOS:000664638500012
J	Katz-Wise, SL; Sarda, V; Austin, SB; Harris, SK				Katz-Wise, Sabra L.; Sarda, Vishnudas; Austin, S. Bryn; Harris, Sion Kim			Longitudinal effects of gender minority stressors on substance use and related risk and protective factors among gender minority adolescents	PLOS ONE			English	Article							TRANSGENDER; STIGMA; HEALTH; SCALE; RESILIENCE; SAMPLE	Purpose Gender minority (GM) adolescents, who have a different gender identity than their sex assigned at birth, may use substances as a coping strategy in response to GM-related stressors. This study examined longitudinal effects of gender minority stressors on substance use in GM adolescents, and related risk factors (internalized transphobia, depressive symptoms, anxious symptoms) and protective factors (resilience, gender-related pride, family functioning, social support, gender-related community connectedness). Methods Participants were 30 GM adolescents, ages 13-17 years, from the U.S. community-based longitudinal Trans Teen and Family Narratives Project. Participants completed an online survey every 6 months across 2 years (5 waves; data collected 2015-2019). Results Exposure to gender minority stressors was associated with higher odds of alcohol use. Across models, internalized transphobia (risk factor), resilience (protective factor), and gender-related pride (protective factor) were the most significant mediators of associations between gender minority stressors and substance use. Family functioning and social support (protective factors) significantly moderated the association between gender minority stressors and alcohol use, such that family functioning and social support were protective for alcohol use at lower levels of gender minority stress, but not at higher levels. Conclusion Results suggest that GM adolescents engage in substance use as a coping strategy in response to gender minority stressors. A number of hypothesized risk and protective factors mediated or moderated these associations. Future interventions with GM adolescents should focus efforts on addressing internalized transphobia as a risk factor and strengthening resilience, gender-related pride, and family functioning as protective factors for substance use.	[Katz-Wise, Sabra L.; Sarda, Vishnudas; Austin, S. Bryn; Harris, Sion Kim] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA 02115 USA; [Katz-Wise, Sabra L.; Austin, S. Bryn; Harris, Sion Kim] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Katz-Wise, Sabra L.; Austin, S. Bryn] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Katz-Wise, SL (corresponding author), Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA 02115 USA.; Katz-Wise, SL (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Katz-Wise, SL (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA.	sabra.katz-wise@childrens.harvard.edu	Katz-Wise, Sabra/AGY-0152-2022	Katz-Wise, Sabra/0000-0003-4825-6673; Harris, Sion/0000-0002-4618-0348	Eunice Kennedy Shriver National Institute of Child Health & Human Development [K99R00HD082340]; Boston Children's Hospital Aerosmith Endowment Fund for Prevention and Treatment of AIDS and HIV Infections; Maternal and Child Health Bureau, Health Resources and Services Administration [6T71-MC00009]	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Boston Children's Hospital Aerosmith Endowment Fund for Prevention and Treatment of AIDS and HIV Infections; Maternal and Child Health Bureau, Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	The Trans Teen and Family Narratives Project was funded by grants from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (K99R00HD082340) and the Boston Children's Hospital Aerosmith Endowment Fund for Prevention and Treatment of AIDS and HIV Infections, both awarded to SKW. SKW and SBA were also funded by the Maternal and Child Health Bureau, Health Resources and Services Administration (Leadership Education in Adolescent Health project 6T71-MC00009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, YOUTH RISK BEH SURV; Bockting WO, 2020, LGBT HEALTH, V7, P15, DOI 10.1089/lgbt.2018.0265; Bockting WO, 2013, AM J PUBLIC HEALTH, V103, P943, DOI 10.2105/AJPH.2013.301241; Centers for Disease Control and Prevention, 2019, 2019 YOUTH RISK BEH; Day JK, 2017, J ADOLESCENT HEALTH, V61, P729, DOI 10.1016/j.jadohealth.2017.06.024; Eisenberg ME, 2017, J ADOLESCENT HEALTH, V61, P521, DOI 10.1016/j.jadohealth.2017.04.014; Essau CA, 2011, J ANXIETY DISORD, V25, P19, DOI 10.1016/j.janxdis.2010.07.001; Hatzenbuehler ML, 2016, PEDIATR CLIN N AM, V63, P985, DOI 10.1016/j.pcl.2016.07.003; Hayes A., 2017, INTRO MEDIATION MODE; Hjemdal O, 2006, MEAS EVAL COUNS DEV, V39, P84, DOI 10.1080/07481756.2006.11909791; James S. E., 2016, REPORT US TRANSGENDE; Katz-Wise SL, 2018, J SEX RES, V55, P582, DOI 10.1080/00224499.2017.1415291; Kidd Jeremy D, 2018, Curr Addict Rep, V5, P158, DOI 10.1007/s40429-018-0196-9; Olson D, 2011, J MARITAL FAM THER, V37, P64, DOI 10.1111/j.1752-0606.2009.00175.x; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reisner SL, 2015, LGBT HEALTH, V2, P324, DOI 10.1089/lgbt.2015.0001; Spence SH, 1998, BEHAV RES THER, V36, P545, DOI 10.1016/S0005-7967(98)00034-5; Sterzing PR, 2017, CHILD ABUSE NEGLECT, V67, P1, DOI 10.1016/j.chiabu.2017.02.017; Testa R., PSYCHOL SEX ORIENTAT, V2, P65; Watson RJ, 2019, PREV MED REP, V15, DOI 10.1016/j.pmedr.2019.100905; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0250500	10.1371/journal.pone.0250500	http://dx.doi.org/10.1371/journal.pone.0250500			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QL	34077452	gold, Green Published			2022-12-26	WOS:000664638500006
J	Smiley-Moreno, E; Smith, D; Yu, JJ; Cao, P; Arulanandam, BP; Chambers, JP				Smiley-Moreno, Elizabeth; Smith, Douglas; Yu, Jieh-Juen; Cao, Phuong; Arulanandam, Bernard P.; Chambers, James P.			Biochemical characterization of a recombinant acid phosphatase from Acinetobacter baumannii	PLOS ONE			English	Article							ESCHERICHIA-COLI; OKADAIC ACID; CLUSTAL-W; PROTEIN; BACTERIAL; SEQUENCE; PHOSPHORYLATION; IDENTIFICATION; KINASES; COMPLEX	Genomic sequence analysis of Acinetobacter baumannii revealed the presence of a putative Acid Phosphatase (AcpA; EC 3.1.3.2). A plasmid construct was made, and recombinant protein (rAcpA) was expressed in E. coli. PAGE analysis (carried out under denaturing/reducing conditions) of nickel-affinity purified protein revealed the presence of a near-homogeneous band of approximately 37 kDa. The identity of the 37 kDa species was verified as rAcpA by proteomic analysis with a molecular mass of 34.6 kDa from the deduced sequence. The dependence of substrate hydrolysis on pH was broad with an optimum observed at 6.0. Kinetic analysis revealed relatively high affinity for PNPP (K-m = 90 mu M) with V-max, k(cat,) and K-cat/K-m values of 19.2 pmoles s(-1), 4.80 s(-1)(calculated on the basis of 37 kDa), and 5.30 x 10(4) M(-1)s(-1), respectively. Sensitivity to a variety of reagents, i.e., detergents, reducing, and chelating agents as well as classic acid phosphatase inhibitors was examined in addition to assessment of hydrolysis of a number of phosphorylated compounds. Removal of phosphate from different phosphorylated compounds is supportive of broad, i.e., 'nonspecific' substrate specificity; although, the enzyme appears to prefer phosphotyrosine and/or peptides containing phosphotyrosine in comparison to serine and threonine. Examination of the primary sequence indicated the absence of signature sequences characteristic of Type A, B, and C nonspecific bacterial acid phosphatases.	[Smiley-Moreno, Elizabeth; Yu, Jieh-Juen; Cao, Phuong; Arulanandam, Bernard P.; Chambers, James P.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA; [Smiley-Moreno, Elizabeth; Yu, Jieh-Juen; Cao, Phuong; Arulanandam, Bernard P.; Chambers, James P.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Smith, Douglas] Univ Dublin Trinity Coll, Sch Med, Dublin, Ireland	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Trinity College Dublin	Chambers, JP (corresponding author), Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX 78249 USA.; Chambers, JP (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	james.chambers@utsa.edu			UTSA [G02312]	UTSA	This study was supported by UTSA Grant G02312 (JPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACA OG, 1993, INFECT IMMUN, V61, P4232, DOI 10.1128/IAI.61.10.4232-4239.1993; BEACHAM IR, 1979, INT J BIOCHEM, V10, P877, DOI 10.1016/0020-711X(79)90117-4; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dworkin J, 2015, CURR OPIN MICROBIOL, V24, P47, DOI 10.1016/j.mib.2015.01.005; Gerlach G, 2006, J BACTERIOL, V188, P6719, DOI 10.1128/JB.00432-06; Giammanco A, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00310-16; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Ishikawa K, 2000, EMBO J, V19, P2412, DOI 10.1093/emboj/19.11.2412; Kemmer G, 2001, J BACTERIOL, V183, P3974, DOI 10.1128/JB.183.13.3974-3981.2001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LI C, 1994, J BACTERIOL, V176, P6015, DOI 10.1128/jb.176.19.6015-6022.1994; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Makde RD, 2007, BIOCHEMISTRY-US, V46, P2079, DOI 10.1021/bi062180g; Mijakovic I, 2012, FEMS MICROBIOL REV, V36, P877, DOI 10.1111/j.1574-6976.2011.00314.x; Nobeli I, 2003, J MOL BIOL, V334, P697, DOI 10.1016/j.jmb.2003.10.008; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Proudfoot M, 2004, J BIOL CHEM, V279, P54687, DOI 10.1074/jbc.M411023200; Rajagopalan K, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00225-18; Reilly TJ, 2009, APPL ENVIRON MICROB, V75, P3745, DOI 10.1128/AEM.01599-08; Reilly TJ, 1996, J BIOL CHEM, V271, P10973, DOI 10.1074/jbc.271.18.10973; Rossolini GM, 1998, CELL MOL LIFE SCI, V54, P833, DOI 10.1007/s000180050212; Singh H, 2010, J MOL BIOL, V404, P639, DOI 10.1016/j.jmb.2010.09.065; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; THALLER MC, 1994, MICROBIOL-SGM, V140, P1341, DOI 10.1099/00221287-140-6-1341; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; THALLER MC, 1995, MICROBIOL-SGM, V141, P147; Thaller MC, 1997, FEMS MICROBIOL LETT, V146, P191, DOI 10.1016/S0378-1097(96)00474-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; U Gandhi Neha, 2012, Acta Inform Med, V20, P167, DOI 10.5455/aim.2012.20.167-173; VINCENT JB, 1992, TRENDS BIOCHEM SCI, V17, P105, DOI 10.1016/0968-0004(92)90246-6	35	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252377	10.1371/journal.pone.0252377	http://dx.doi.org/10.1371/journal.pone.0252377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077475	Green Published, gold			2022-12-26	WOS:000664638500042
J	Didiya, R; Gyenwali, D; Pokhrel, TN; Devkota, S; Rai, AB; Shedain, PR; Sharma, M; Shrestha, MK; Imran, M; Kadirov, Z; Dahal, BP; Prawchan, KC; Ojha, S; Pokhrel, KN				Didiya, Rajesh; Gyenwali, Deepak; Pokhrel, Tara Nath; Devkota, Sudha; Rai, Amrit Bikram; Shedain, Purusotam Raj; Sharma, Mukunda; Shrestha, Madan Kumar; Imran, Muhammad; Kadirov, Zakir; Dahal, Bhawani Prasad; Prawchan, K. C.; Ojha, Sabir; Pokhrel, Khem Narayan			Community led testing among people who inject drugs: A community centered model to find new cases of HIV and Hepatitis C in Nepal	PLOS ONE			English	Article								Background People who inject drugs (PWIDs) have sub-optimal HIV and HCV testing as the available testing services are inadequate in low and middle-income countries. We examined a model of Community-Led Testing (CLT) in Nepal, exploring the feasibility of HIV and HCV testing by trained lay service providers who had similar backgrounds to those of PWIDs. We also assessed the prevalence of HIV and HCV within this study population and the associated risk factors among PWIDs. Methods A mix-methods cross-sectional study was conducted among 1029 PWIDs in five major districts of Nepal from July 2019 to February 2020. Trained PWID peers performed the screening for HIV and HCV using Rapid Diagnostic Test (RDT) kits. Acceptability and feasibility of the testing was assessed. The participants' sociodemographic characteristics and injecting and non-injecting risk characteristics were determined. The association of risk and prevention characteristics with testing results were assessed using multiple logistic regression. Results PWIDs shared that the test providers were friendly and competent in counseling and testing. Of total PWIDs (n = 1,029), 20.6% were HCV-positive and 0.2% were HIV-positive. HCV positivity was associated with needle sharing (AOR: 1.83, 95% CI: 1.27,2.64; p = 0.001) and reuse of syringe/needle (AOR: 2.26; 95% CI: 1.34, 3.79; p = 0.002). In addition, PWIDs were more likely to be HCV-positive who started opioid substitution therapy (OST) (AOR: 1.88, 95% CI: 1.26, 2.80, p = 0.002) and attended the rehabilitation center (AOR: 1.66, 95% CI: 1.10, 2.53, p = 0.017). Conclusions This CLT model was found to be a novel approach of testing of HIV and HCV which was acceptable to PWIDs in Nepal and showed the high prevalence of HCV and its association with injecting-related risk behaviors and being users of OST and rehabilitation. The findings highlight the need of community-led testing in hotspots, OST settings, and rehabilitation centers to screen new HIV and HCV infections.	[Didiya, Rajesh; Gyenwali, Deepak; Rai, Amrit Bikram; Ojha, Sabir; Pokhrel, Khem Narayan] Natl Assoc People Living HIV AIDS Nepal NAP N, Kathmandu, Bagmati, Nepal; [Pokhrel, Tara Nath; Devkota, Sudha; Shedain, Purusotam Raj; Shrestha, Madan Kumar] Natl Ctr AIDS & STD Control NCASC, Kathmandu, Bagmati, Nepal; [Sharma, Mukunda] Natl Publ Hlth Lab NPHL, Kathmandu, Bagmati, Nepal; [Imran, Muhammad] Save Children, Fairfield, CT USA; [Kadirov, Zakir; Dahal, Bhawani Prasad] Nepal Country Off, Save Children, KPRA Project, Kathmandu, Bagmati, Nepal; [Prawchan, K. C.] SPARSHA Nepal, Lalitpur, Bagmati, Nepal	Save the Children; Save the Children	Pokhrel, KN (corresponding author), Natl Assoc People Living HIV AIDS Nepal NAP N, Kathmandu, Bagmati, Nepal.	pratikjee@gmail.com	Shedain, Purusotam/AAC-9609-2022	KC, Prawchan/0000-0001-9519-8184; Pokhrel, Taranath/0000-0003-2560-8517; Gyenwali, Deepak/0000-0001-7322-461X	Global Fund to Fight AIDS, Tuberculosis and Malaria	Global Fund to Fight AIDS, Tuberculosis and Malaria	The study is funded by "Global Fund to Fight AIDS, Tuberculosis and Malaria for KPRA Project".	Barocas JA, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-1; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Indravudh PP, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4430-4; Kinkel HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134455; KOBO Tool Box Cambridge M, 2019, HARV HUM IN; Litwin AH, 2019, J VIRAL HEPATITIS, V26, P1094, DOI 10.1111/jvh.13119; Ministry of Health and Population and New Era ICF Inc, 2017, NEP DEM HLTH SURV 20; NCASC, 2017, NAT GUID COMM LED HI; NCASC, 2017, INT BIOL BEH SURV IB; NCASC, 2020, HIV EP UPD NEP; Ndyomugyenyi R, 2010, INT HEALTH, V2, P197, DOI 10.1016/j.inhe.2010.07.009; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Pokhrel KN, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3170-1; Poudel Krishna C, 2014, J Int Assoc Provid AIDS Care, V13, P277, DOI 10.1177/2325957413500989; Poudel KC, 2010, INT J DRUG POLICY, V21, P507, DOI 10.1016/j.drugpo.2010.03.006; Rashti R, 2020, ARCH VIROL, V165, P1947, DOI 10.1007/s00705-020-04716-1; Sharma M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002262; Swan D, 2010, AIDS PATIENT CARE ST, V24, P753, DOI 10.1089/apc.2010.0142; Nguyen VT, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25301; WHO, 2018, HLTH SYST TRANSIT, P1; WHO, REPORT NO 9241565454; World Health Organization (WHO), GLOB HLTH SECT STRAT	22	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252490	10.1371/journal.pone.0252490	http://dx.doi.org/10.1371/journal.pone.0252490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048484	gold, Green Published, Green Submitted			2022-12-26	WOS:000664636100060
J	Gros-Otero, J; Ketabi, S; Canones-Zafra, R; Garcia-Gonzalez, M; Villa-Collar, C; Casado, S; Teus, MA				Gros-Otero, Juan; Ketabi, Samira; Canones-Zafra, Rafael; Garcia-Gonzalez, Montserrat; Villa-Collar, Cesar; Casado, Santiago; Teus, Miguel A.			Corneal stromal roughness after VisuMax and Intralase femtosecond laser photodisruption: An atomic force microscopy study	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; MICROKERATOME; LASIK; BED	Purpose To compare the induced corneal stromal bed roughness measured with atomic force microscopy (AFM) after LASIK flap creation with the IntraLase 60 kHz and the VisuMax femtosecond laser platforms. Methods Three freshly enucleated porcine eyes were operated with each femtosecond laser in this experimental study. Standard LASIK treatment parameters were used for the experiment. After LASIK flap creation, the corneal stromal roughness was assessed using a JPK NanoWizard II (R) AFM in contact mode immersed in liquid. Olympus OMCL-RC800PSA commercial silicon nitride cantilever tips were used. Surface measurements were made in 10 regions of the central cornea of each sample measuring 20 x 20 microns, at 512 x 512 point resolution. Roughness was measured using the root-mean-square (RMS) value within the given regions. Results Measurements from 30 regions of the 3 eyes (10 measurements per eye) in the Intralase (FS1) group, and 30 regions of the 3 eyes (10 measurements per eye) in the VisuMax (FS2) group were analyzed. There was a statistically significant difference in mean standard deviation RMS values between the FS1 and the FS2 groups (360 +/- 120 versus 230 +/- 100 nm respectively; P< 0.00001). Conclusion This AFM study indicates that the surface of the stromal bed after LASIK flap creation is smoother in the FS2 group than the FS1 group.	[Gros-Otero, Juan; Garcia-Gonzalez, Montserrat] Clin Rementeria, Madrid, Spain; [Gros-Otero, Juan] Univ CEU San Pablo, Madrid, Spain; [Ketabi, Samira; Canones-Zafra, Rafael; Teus, Miguel A.] Hosp Univ Principe Asturias, Madrid, Spain; [Garcia-Gonzalez, Montserrat; Villa-Collar, Cesar; Teus, Miguel A.] Clin Novovision, Madrid, Spain; [Villa-Collar, Cesar] Univ Europea, Madrid, Spain; [Casado, Santiago] IMDEA Nanociencia, Madrid, Spain; [Casado, Santiago] Univ Tecnica Ambato, Fac Ciencia Ingenieria Alimentos, Ambato, Ecuador	San Pablo CEU University; Prince of Asturias University Hospital; European University of Madrid; IMDEA Nanociencia; Universidad Tecnica de Ambato	Gros-Otero, J (corresponding author), Clin Rementeria, Madrid, Spain.; Gros-Otero, J (corresponding author), Univ CEU San Pablo, Madrid, Spain.	juangros@gmail.com		Casado, Santiago/0000-0002-1473-8247; Gros-Otero, Juan/0000-0002-6410-8235; Canones-Zafra, Rafael/0000-0002-5353-0297	Abbott Medical Optics	Abbott Medical Optics	Funded in part by an unrestricted grant from Abbott Medical Optics (https://www.jnj.com/tag/abbott).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Santo MP, 2004, 2004 4TH IEEE CONFERENCE ON NANOTECHNOLOGY, P252; Farjo AA, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.08.013; Ganesh S, 2017, J REFRACT SURG, V33, P563, DOI 10.3928/1081597X-20170504-09; Gros-Otero J, 2019, GRAEF ARCH CLIN EXP, V257, P2665, DOI 10.1007/s00417-019-04497-7; Hernandez-Verdejo JL, 2007, INVEST OPHTH VIS SCI, V48, P68, DOI 10.1167/iovs.06-0192; Huhtala A, 2016, CLIN OPHTHALMOL, V10, P393, DOI 10.2147/OPTH.S99394; Kymionis GD, 2014, BRIT J OPHTHALMOL, V98, P133, DOI 10.1136/bjophthalmol-2013-304023; Marino GK, 2017, ASIA-PAC J OPHTHALMO, V6, P456, DOI 10.22608/APO.2017163; Sarayba MA, 2007, CORNEA, V26, P446, DOI 10.1097/ICO.0b013e318033e7cc; Twyman RM, 2009, ENCY NEUROSCIENCE, P595; Vetter JM, 2012, J CATARACT REFR SURG, V38, P2011, DOI 10.1016/j.jcrs.2012.05.042	11	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252449	10.1371/journal.pone.0252449	http://dx.doi.org/10.1371/journal.pone.0252449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043738	Green Published, gold			2022-12-26	WOS:000664635700103
J	Arnold, MV; Dewhurst, DR; Alshaabi, T; Minot, JR; Adams, JL; Danforth, CM; Dodds, PS				Arnold, Michael V.; Dewhurst, David Rushing; Alshaabi, Thayer; Minot, Joshua R.; Adams, Jane L.; Danforth, Christopher M.; Dodds, Peter Sheridan			Hurricanes and hashtags: Characterizing online collective attention for natural disasters	PLOS ONE			English	Article							TWITTER; INFORMATION; EVOLUTION; NETWORKS; DYNAMICS; ECONOMY; GROWTH	We study collective attention paid towards hurricanes through the lens of n-grams on Twitter, a social media platform with global reach. Using hurricane name mentions as a proxy for awareness, we find that the exogenous temporal dynamics are remarkably similar across storms, but that overall collective attention varies widely even among storms causing comparable deaths and damage. We construct 'hurricane attention maps' and observe that hurricanes causing deaths on (or economic damage to) the continental United States generate substantially more attention in English language tweets than those that do not. We find that a hurricane's Saffir-Simpson wind scale category assignment is strongly associated with the amount of attention it receives. Higher category storms receive higher proportional increases of attention per proportional increases in number of deaths or dollars of damage, than lower category storms. The most damaging and deadly storms of the 2010s, Hurricanes Harvey and Maria, generated the most attention and were remembered the longest, respectively. On average, a category 5 storm receives 4.6 times more attention than a category 1 storm causing the same number of deaths and economic damage.	[Arnold, Michael V.; Dewhurst, David Rushing; Alshaabi, Thayer; Minot, Joshua R.; Adams, Jane L.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, MassMutual Ctr Excellence Complex Syst & Data Sci, Burlington, VT 05405 USA; [Arnold, Michael V.; Dewhurst, David Rushing; Alshaabi, Thayer; Minot, Joshua R.; Adams, Jane L.; Danforth, Christopher M.; Dodds, Peter Sheridan] Vermont Complex Syst Ctr, Computat Story Lab, Burlington, VT 05405 USA; [Arnold, Michael V.; Dewhurst, David Rushing; Alshaabi, Thayer; Minot, Joshua R.; Adams, Jane L.; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Dewhurst, David Rushing] MassMutual Data Sci, Boston, MA USA	University of Vermont; University of Vermont	Arnold, MV (corresponding author), Univ Vermont, MassMutual Ctr Excellence Complex Syst & Data Sci, Burlington, VT 05405 USA.; Arnold, MV (corresponding author), Vermont Complex Syst Ctr, Computat Story Lab, Burlington, VT 05405 USA.; Arnold, MV (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA.	michael.arnold@uvm.edu	; Dodds, Peter/C-9119-2014	Arnold, Michael/0000-0002-1218-0315; Dodds, Peter/0000-0003-1973-8614; Adams, Jane/0000-0002-7826-3500				Ahmed MA, 2020, SOCIAL MEDIA COMMUNI; Allen DE, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072310; Barbera P, 2015, SOC SCI COMPUT REV, V33, P712, DOI 10.1177/0894439314558836; Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567; Bureau UC, 2019, HURR; Burnside R, 2007, SOCIOL SPECTRUM, V27, P727, DOI 10.1080/02732170701534226; Candia C, 2019, NAT HUM BEHAV, V3, P82, DOI 10.1038/s41562-018-0474-5; Citton Y., 2017, ECOLOGY ATTENTION; Cody EM, 2017, J ENVIRON STUD SCI, V7, P87, DOI 10.1007/s13412-016-0391-8; Colleoni E, 2014, J COMMUN, V64, P317, DOI 10.1111/jcom.12084; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Danforth P.S., 2020, ARXIV PREPRINT ARXIV; Dodds P. S., 2019, FAME ULTRAFAME MEASU; Dodds PS, 2020, ARXIV PREPRINT ARXIV; Dorogovtsev SN, 2000, PHYS REV E, V62, P1842, DOI 10.1103/PhysRevE.62.1842; Eisensee T, 2007, Q J ECON, V122, P693, DOI 10.1162/qjec.122.2.693; Eom YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131184; Franck G, 1999, SCIENCE, V286, P53, DOI 10.1126/science.286.5437.53; Franck G, 2019, J SOCIOL, V55, P8, DOI 10.1177/1440783318811778; Gallagher RJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195644; Garcia-Gavilanes R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602368; Golosovsky M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.098701; Gruzd A, 2014, POLICY INTERNET, V6, P28, DOI 10.1002/1944-2866.POI354; Halloran M, 2018, ANAL FINDS DISASTER; Higham KW, 2017, J INFORMETR, V11, P1190, DOI 10.1016/j.joi.2017.10.004; Higham KW, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.042309; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Housley W, 2014, BIG DATA SOC, V1, DOI 10.1177/2053951714545135; Humphreys A., 2009, ACR N AM ADV; Java Akshay, 2007, P JOINT 9 WEBKDD 1 S, P56, DOI 10.1145/1348549.1348556; Joulin A., 2017, P 15 C EUR CHAPT ASS, P427; Kiley D., 2014, CHARACTERIZING SHAPE; Ladle RJ, 2016, FRONT ECOL ENVIRON, V14, P270, DOI 10.1002/fee.1260; Lehmann J., 2012, DYNAMICAL CLASSES CO; Leskovec J, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P497; Li Q, 2016, MUCH DATA DO YOU NEE; Liu WY, 2008, PROCEEDINGS OF 2008 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-7, P857, DOI 10.1109/ICMLC.2008.4620524; Lorenz-Spreen P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09311-w; Martin Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181701; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Miller L. M., 2007, Southern Rural Sociology, V22, P45; Mislove A, 2011, P INT AAAI C WEB SOC; Mitra Tanushree, 2017, Proceedings of the ACM on Human-Computer Interaction, V1, DOI 10.1145/3134715; Newman N., 2009, RISE SOCIAL MEDIA IT; Niles MT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210484; Nowak A, 2017, UNDERST COMPLEX SYST, P45, DOI 10.1007/978-3-319-42424-8_3; Pechenick EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137041; Perrin A., 2015, PEW RES CTR, V125, P52; Roman MO, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218883; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Salinas Sara, 2019, CNBC; Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823; Scott M, 2020, HURRICANE MARIAS DEV; Shahbazi B, 2019, STORYMINER AUTOMATED; Shiller R., 2019, NARRATIVE EC STORIES; Shiller RJ, 2017, AM ECON REV, V107, P967, DOI 10.1257/aer.107.4.967; Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115545; Subrahmanian VS, 2016, COMPUTER, V49, P38, DOI 10.1109/MC.2016.183; Taylor H. T., 2010, SAFFIR SIMPSON HURRI; Tufekci Z, 2013, AM BEHAV SCI, V57, P848, DOI 10.1177/0002764213479369; Valverde S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056118; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Wang ZY, 2019, APPL GEOGR, V108, P1, DOI 10.1016/j.apgeog.2019.05.001; Weinkle J, 2018, NAT SUSTAIN, V1, P808, DOI 10.1038/s41893-018-0165-2; Wikipedia contributors, 2019, 2010 ATL HURR SEAS W; Willison CE, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001191; Wojcik Stefan, 2019, TWITTER USERS COMP G; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Wukich C, 2013, RISK HAZARDS CRISIS, V4, P83, DOI 10.1002/rhc3.12036; Zorrilla CD, 2017, NEW ENGL J MED, V377, P1801, DOI 10.1056/NEJMp1713196	70	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251762	10.1371/journal.pone.0251762	http://dx.doi.org/10.1371/journal.pone.0251762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038454	Green Submitted, gold, Green Published			2022-12-26	WOS:000664633500030
J	Ehrenberg, AJ; Moehle, EA; Brook, CE; Cate, AHD; Witkowsky, LB; Sachdeva, R; Hirsh, A; Barry, K; Hamilton, JR; Lin-Shiao, E; McDevitt, S; Valentin-Alvarado, L; Letourneau, KN; Hunter, L; Keller, A; Pestal, K; Frankino, PA; Murley, A; Nandakumar, D; Stahl, EC; Tsuchida, CA; Gildea, HK; Murdock, AG; Hochstrasser, ML; O'Brien, E; Ciling, A; Tsitsiklis, A; Worden, K; Dugast-Darzacq, C; Hays, SG; Barber, CC; McGarrigle, R; Lam, EK; Ensminger, DC; Bardet, L; Sherry, C; Harte, A; Nicolette, G; Giannikopoulos, P; Hockemeyer, D; Petersen, M; Urnov, FD; Ringeisen, BR; Boots, M; Doudna, JA				Ehrenberg, Alexander J.; Moehle, Erica A.; Brook, Cara E.; Cate, Andrew H. Doudna; Witkowsky, Lea B.; Sachdeva, Rohan; Hirsh, Ariana; Barry, Kerrie; Hamilton, Jennifer R.; Lin-Shiao, Enrique; McDevitt, Shana; Valentin-Alvarado, Luis; Letourneau, Kaitlyn N.; Hunter, Lauren; Keller, Amanda; Pestal, Kathleen; Frankino, Phillip A.; Murley, Andrew; Nandakumar, Divya; Stahl, Elizabeth C.; Tsuchida, Connor A.; Gildea, Holly K.; Murdock, Andrew G.; Hochstrasser, Megan L.; O'Brien, Elizabeth; Ciling, Alison; Tsitsiklis, Alexandra; Worden, Kurtresha; Dugast-Darzacq, Claire; Hays, Stephanie G.; Barber, Colin C.; McGarrigle, Riley; Lam, Emily K.; Ensminger, David C.; Bardet, Lucie; Sherry, Carolyn; Harte, Anna; Nicolette, Guy; Giannikopoulos, Petros; Hockemeyer, Dirk; Petersen, Maya; Urnov, Fyodor D.; Ringeisen, Bradley R.; Boots, Mike; Doudna, Jennifer A.		IGI SARS CoV 2 Testing Consortium	Launching a saliva-based SARS-CoV-2 surveillance testing program on a university campus	PLOS ONE			English	Article								Regular surveillance testing of asymptomatic individuals for SARS-CoV-2 has been center to SARS-CoV-2 outbreak prevention on college and university campuses. Here we describe the voluntary saliva testing program instituted at the University of California, Berkeley during an early period of the SARS-CoV-2 pandemic in 2020. The program was administered as a research study ahead of clinical implementation, enabling us to launch surveillance testing while continuing to optimize the assay. Results of both the testing protocol itself and the study participants' experience show how the program succeeded in providing routine, robust testing capable of contributing to outbreak prevention within a campus community and offer strategies for encouraging participation and a sense of civic responsibility.	[Ehrenberg, Alexander J.; Moehle, Erica A.; Brook, Cara E.; Cate, Andrew H. Doudna; Witkowsky, Lea B.; Sachdeva, Rohan; Hirsh, Ariana; Hamilton, Jennifer R.; Lin-Shiao, Enrique; McDevitt, Shana; Valentin-Alvarado, Luis; Letourneau, Kaitlyn N.; Hunter, Lauren; Pestal, Kathleen; Frankino, Phillip A.; Murley, Andrew; Nandakumar, Divya; Stahl, Elizabeth C.; Tsuchida, Connor A.; Gildea, Holly K.; Murdock, Andrew G.; O'Brien, Elizabeth; Ciling, Alison; Tsitsiklis, Alexandra; Worden, Kurtresha; Dugast-Darzacq, Claire; Hays, Stephanie G.; Barber, Colin C.; McGarrigle, Riley; Lam, Emily K.; Ensminger, David C.; Harte, Anna; Nicolette, Guy; Hockemeyer, Dirk; Petersen, Maya; Urnov, Fyodor D.; Ringeisen, Bradley R.; Boots, Mike; Doudna, Jennifer A.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ehrenberg, Alexander J.; Moehle, Erica A.; Brook, Cara E.; Witkowsky, Lea B.; Sachdeva, Rohan; Hirsh, Ariana; Hamilton, Jennifer R.; Lin-Shiao, Enrique; McDevitt, Shana; Valentin-Alvarado, Luis; Keller, Amanda; Nandakumar, Divya; Stahl, Elizabeth C.; Tsuchida, Connor A.; Murdock, Andrew G.; Hochstrasser, Megan L.; O'Brien, Elizabeth; Ciling, Alison; Worden, Kurtresha; McGarrigle, Riley; Bardet, Lucie; Sherry, Carolyn; Giannikopoulos, Petros; Hockemeyer, Dirk; Urnov, Fyodor D.; Ringeisen, Bradley R.; Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA; [Barry, Kerrie] Joint Genome Inst, Lawrence Berkeley Natl Lab, Berkeley, CA USA; [Harte, Anna; Nicolette, Guy] Univ Calif Berkeley, Univ Hlth Serv, Berkeley, CA 94720 USA; [Hockemeyer, Dirk] Chan Zuckerberg Biohub, San Francisco, CA USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint Genome Institute - JGI; Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA.; Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Ehrenberg, Alexander/N-9533-2019; Nandakumar, Divya/K-6250-2014; Barry, Kerrie Whitelaw/AAA-5500-2020	Ehrenberg, Alexander/0000-0003-4334-9424; Nandakumar, Divya/0000-0001-7672-0213; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Worden, Kurtresha/0000-0001-5621-7979; Hochstrasser, Megan/0000-0002-4404-078X; Lin Shiao, Enrique/0000-0001-5396-9614; Sachdeva, Rohan/0000-0001-9284-2245; Tamborski, Janina/0000-0001-9252-4319; Ensminger, David/0000-0001-5554-1638; Moehle, Erica/0000-0003-4927-0805	Packard Foundation; Curci Foundation; Julia Burke Foundation; University of California, Berkeley	Packard Foundation(The David & Lucile Packard Foundation); Curci Foundation; Julia Burke Foundation; University of California, Berkeley(University of California System)	We thank the Packard Foundation, the Curci Foundation, the Julia Burke Foundation, and other anonymous donors for their support of IGI FAST. We additionally thank the University of California, Berkeley for their financial support of IGI FAST. A.J.E. is a graduate research fellow at the Greater Good Science Center at the University of California, Berkeley (https://greatergood.berkeley.edu/). J.R.H. is a Fellow of The Jane Coffin Childs Memorial Fund for Medical Research (https://www.jccfund.org/). A.M. is a fellow of the Damon Runyon Cancer Research Foundation (https://www.damonrunyon.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amen AM, 2020, NAT BIOTECHNOL, V38, P791, DOI 10.1038/s41587-020-0583-3; Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; Bastos ML, 2021, ANN INTERN MED, V174, P501, DOI 10.7326/M20-6569; Brook CE, 2020, OPTIMIZING COVID 19; Butler-Laporte G, 2021, JAMA INTERN MED, V181, P353, DOI 10.1001/jamainternmed.2020.8876; Dellavigna S, 2017, REV ECON STUD, V84, P143, DOI 10.1093/restud/rdw056; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Hamilton JR, 2021, PLOS ONE, V16, DOI [10.1101/2021.01.10.21249151, 10.1371/journal.pone.0255690]; Hughes SR, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4211-6; Kojima N, 2021, CLIN INFECT DIS, V73, pE3106, DOI 10.1093/cid/ciaa1589; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Li N, 2020, J MED VIROL, V92, P2286, DOI 10.1002/jmv.25952; Liu Y, 2020, LANCET, V395, pE47, DOI 10.1016/S0140-6736(20)30462-1; Miranda-Rius J, 2015, INT J MED SCI, V12, P811, DOI 10.7150/ijms.12912; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Ng OT., 2020, LANCET INFECT DIS, DOI [10.1016/S1473-3099%2820%2930833-1, DOI 10.1016/S1473-3099%2820%2930833-1]; Packel L, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245765; Pasomsub E, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.05.001; Ridgway JP, 2020, INFECT CONT HOSP EP, V41, P1235, DOI 10.1017/ice.2020.307; Shah Sonalee, 2018, J Oral Maxillofac Pathol, V22, P375, DOI 10.4103/jomfp.JOMFP_171_18; Silva Julio, 2021, medRxiv, DOI 10.1101/2021.01.04.21249236; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; Warren JL., BAYESIAN NOWCASTING, V2020; Williams E, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00776-20; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Xiao AT, 2020, CLIN INFECT DIS, V71, P2249, DOI 10.1093/cid/ciaa460	26	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251296	10.1371/journal.pone.0251296	http://dx.doi.org/10.1371/journal.pone.0251296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038425	gold, Green Published, Green Submitted			2022-12-26	WOS:000664633500018
J	Falgas, N; Illan-Gala, I; Allen, IE; Mumford, P; Essanaa, YM; Le, MM; You, M; Grinberg, LT; Rosen, HJ; Neylan, TC; Kramer, JH; Walsh, CM				Falgas, Neus; Illan-Gala, Ignacio; Allen, Isabel E.; Mumford, Paige; Essanaa, Youssef M.; Le, Michael M.; You, Michelle; Grinberg, Lea T.; Rosen, Howard J.; Neylan, Thomas C.; Kramer, Joel H.; Walsh, Christine M.			Specific cortical and subcortical grey matter regions are associated with insomnia severity	PLOS ONE			English	Article							GRAY-MATTER; POOR SLEEP; WHITE-MATTER; CORTEX; DEPRIVATION; WAKEFULNESS; VALIDATION; PLASTICITY; BEHAVIOR; DISEASE	Background There is an increasing awareness that sleep disturbances are a risk factor for dementia. Prior case-control studies suggested that brain grey matter (GM) changes involving cortical (i.e, prefrontal areas) and subcortical structures (i.e, putamen, thalamus) could be associated with insomnia status. However, it remains unclear whether there is a gradient association between these regions and the severity of insomnia in older adults who could be at risk for dementia. Since depressive symptoms and sleep apnea can both feature insomnia-related factors, can impact brain health and are frequently present in older populations, it is important to include them when studying insomnia. Therefore, our goal was to investigate GM changes associated with insomnia severity in a cohort of healthy older adults, taking into account the potential effect of depression and sleep apnea as well. We hypothesized that insomnia severity is correlated with 1) cortical regions responsible for regulation of sleep and emotion, such as the orbitofrontal cortex and, 2) subcortical regions, such as the putamen. Methods 120 healthy subjects (age 74.85.7 years old, 55.7% female) were recruited from the Hillblom Healthy Aging Network at the Memory and Aging Center, UCSF. All participants were determined to be cognitively healthy following a neurological evaluation, neuropsychological assessment and informant interview. Participants had a 3T brain MRI and completed the Insomnia Severity Index (ISI), Geriatric Depression Scale (GDS) and Berlin Sleep Questionnaire (BA) to assess sleep apnea. Cortical thickness (CTh) and subcortical volumes were obtained by the CAT12 toolbox within SPM12. We studied the correlation of CTh and subcortical volumes with ISI using multiple regressions adjusted by age, sex, handedness and MRI scan type. Additional models adjusting by GDS and BA were also performed. Results ISI and GDS were predominantly mild (4.9 +/- 4.2 and 2.5 +/- 2.9, respectively) and BA was mostly low risk (80%). Higher ISI correlated with lower CTh of the right orbitofrontal, right superior and caudal middle frontal areas, right temporo-parietal junction and left anterior cingulate cortex (p<0.001, uncorrected FWE). When adjusting by GDS, right ventral orbitofrontal and temporo-parietal junction remained significant, and left insula became significant (p<0.001, uncorrected FWE). Conversely, BA showed no effect. The results were no longer significant following FWE multiple comparisons. Regarding subcortical areas, higher putamen volumes were associated with higher ISI (p<0.01). Conclusions Our findings highlight a relationship between insomnia severity and brain health, even with relatively mild insomnia, and independent of depression and likelihood of sleep apnea. The results extend the previous literature showing the association of specific GM areas (i.e, orbitofrontal, insular and temporo-parietal junction) not just with the presence of insomnia, but across the spectrum of severity itself. Moreover, our results suggest subcortical structures (i.e., putamen) are involved as well. Longitudinal studies are needed to clarify how these insomnia-related brain changes in healthy subjects align with an increased risk of dementia.	[Falgas, Neus; Illan-Gala, Ignacio] Univ Calif San Francisco, Dept Neurol, Equ Brain Hlth, San Francisco, CA 94143 USA; [Falgas, Neus; Illan-Gala, Ignacio; Allen, Isabel E.; Grinberg, Lea T.; Rosen, Howard J.; Kramer, Joel H.] Univ Calif San Francisco, Global Brain Hlth Inst, San Francisco, CA 94143 USA; [Falgas, Neus; Mumford, Paige; Essanaa, Youssef M.; Le, Michael M.; You, Michelle; Rosen, Howard J.; Neylan, Thomas C.; Kramer, Joel H.; Walsh, Christine M.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Falgas, Neus] Univ Barcelona, Hosp Clin Barcelona, Dept Neurol, Alzheimers Dis & Other Cognit Disorders Unit, Barcelona, Spain; [Illan-Gala, Ignacio] Univ Autonoma Barcelona, St Pau Memory Unit, Dept Neurol, Hosp Santa Creu & St Pau, Barcelona, Catalonia, Spain; [Allen, Isabel E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Essanaa, Youssef M.; Le, Michael M.; Neylan, Thomas C.; Kramer, Joel H.] Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Grinberg, Lea T.] Univ Sao Paulo, Dept Pathol, Med Sch, Sao Paulo, Brazil; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Neylan, Thomas C.] San Francisco VA Med Ctr, Stress & Hlth Res Program, Dept Mental Hlth, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Barcelona; Hospital Clinic de Barcelona; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade de Sao Paulo; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Walsh, CM (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, Weill Inst Neurosci, San Francisco, CA 94143 USA.	Christine.Walsh@ucsf.edu		Falgas, Neus/0000-0002-3404-2765; Illan-Gala, Ignacio/0000-0002-5418-2052; Essanaa, Youssef/0000-0001-8417-4910	UCSF Hillblom Aging Network grant, Larry L. Hillblom Network; Tau Consortium/Rainwater Charity Foundation;  [NIA R01 5R01AG03228910];  [NIA R01 AG060477];  [NIA R01 AG064314]	UCSF Hillblom Aging Network grant, Larry L. Hillblom Network; Tau Consortium/Rainwater Charity Foundation; ; ; 	This work was supported by funding from UCSF Hillblom Aging Network grant, Larry L. Hillblom Network (JHK), Biological predictors of brain aging trajectories (NIA R01 5R01AG03228910) (JHK), Clinical features and neuropathological basis of sleep-wake behavior in Alzheimer's Disease and PSP, (NIA R01 AG060477) (TCN, LTG), Linking sleep dysfunction to tau-related degeneration across AD progression (NIA R01 AG064314) (LTG, TCN), Tau Consortium/Rainwater Charity Foundation (CMW, TCN, LTG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.llhf.org/grant-seekers/grant-criteria/network-grants https://projectreporter.nih.gov/project_info_ description.cfm?aid=10052959&icde= 52636853&ddparam=&ddvalue=&ddsub=&cr= 1&csb=default&cs=ASC&pball=, https://projectreporter.nih.gov/project_info_description.cfm?aid=9932876&icde=52636818&ddparam= &ddvalue=&ddsub=&cr=1&csb=default&cs= ASC&pball= https://projectreporter.nih.gov/project_info_description.cfm?aid=9989752&icde= 52636827&ddparam=&ddvalue=&ddsub=&cr= 1&csb=default&cs=ASC&pball= https://tauconsortium.org/.	Altena E, 2010, BIOL PSYCHIAT, V67, P182, DOI 10.1016/j.biopsych.2009.08.003; Arsalidou M, 2013, HUM BRAIN MAPP, V34, P3031, DOI 10.1002/hbm.22124; Atrooz F, 2020, ADV PROTEIN CHEM STR, V119, P309, DOI 10.1016/bs.apcsb.2019.03.001; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bruck A, 2004, J NEUROL NEUROSUR PS, V75, P1467, DOI 10.1136/jnnp.2003.031237; Chao LL, 2014, SLEEP, V37, P445, DOI 10.5665/sleep.3472; Chen DW, 2018, J ALZHEIMERS DIS, V61, P645, DOI 10.3233/JAD-170032; Chen LL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00588; Chen MC, 2016, J BIOL RHYTHM, V31, P182, DOI 10.1177/0748730415627035; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cross NE, 2019, SLEEP, V42, DOI 10.1093/sleep/zsz114; Dahnke R, 2013, NEUROIMAGE, V65, P336, DOI 10.1016/j.neuroimage.2012.09.050; Dai XJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00266; Dzierzewski JM, 2018, SLEEP MED CLIN, V13, P93, DOI 10.1016/j.jsmc.2017.09.009; Elvsashagen T, 2017, NEUROIMAGE, V156, P214, DOI 10.1016/j.neuroimage.2017.05.027; Fu HJ, 2018, NAT NEUROSCI, V21, P1350, DOI 10.1038/s41593-018-0221-2; Grau-Rivera O, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-019-0547-3; Harrison TM, 2019, ANN NEUROL, V85, P229, DOI 10.1002/ana.25406; Hasegawa H, 2020, SLEEP MED REV, V52, DOI 10.1016/j.smrv.2020.101317; Holth Jerrah K., 2017, Neurobiology of Sleep and Circadian Rhythms, V2, P4, DOI 10.1016/j.nbscr.2016.08.002; Igelstrom KM, 2017, NEUROPSYCHOLOGIA, V105, P70, DOI 10.1016/j.neuropsychologia.2017.01.001; Iranzo A, 2021, LANCET NEUROL, V20, P203, DOI 10.1016/S1474-4422(20)30449-X; Joo EY, 2013, SLEEP, V36, P999, DOI 10.5665/sleep.2796; Koo DL, 2017, SLEEP MED, V35, P23, DOI 10.1016/j.sleep.2017.04.002; Lazarus M, 2012, TRENDS NEUROSCI, V35, P723, DOI 10.1016/j.tins.2012.07.001; Leng Y, 2016, SLEEP, V39, P1807, DOI 10.5665/sleep.6158; Li M, 2018, BRAIN IMAGING BEHAV, V12, P1759, DOI 10.1007/s11682-018-9844-x; Li M, 2019, BRAIN IMAGING BEHAV, V13, P1193, DOI 10.1007/s11682-018-9932-y; Lim ASP, 2016, SLEEP, V39, P227, DOI 10.5665/sleep.5354; Long ZL, 2019, NEUROREPORT, V30, P1246, DOI 10.1097/WNR.0000000000001347; Lu FM, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00214; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Minakawa EN, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040803; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Muzur A, 2002, TRENDS COGN SCI, V6, P475, DOI 10.1016/S1364-6613(02)01992-7; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Oh J, 2019, ALZHEIMERS DEMENT, V15, P1253, DOI 10.1016/j.jalz.2019.06.3916; Ohayon MM, 2009, SLEEP MED, V10, P952, DOI 10.1016/j.sleep.2009.07.008; Pak VM, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.00069; Qiu MH, 2010, EUR J NEUROSCI, V31, P499, DOI 10.1111/j.1460-9568.2009.07062.x; Raymann RJEM, 2008, SLEEP, V31, P1301; Rolls ET, 2019, NEUROPSYCHOLOGIA, V128, P14, DOI 10.1016/j.neuropsychologia.2017.09.021; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Seiger R, 2018, J NEUROIMAGING, V28, P515, DOI 10.1111/jon.12521; Sexton CE, 2017, HUM BRAIN MAPP, V38, P5465, DOI 10.1002/hbm.23739; Sexton CE, 2014, NEUROLOGY, V83, P967, DOI 10.1212/WNL.0000000000000774; Sindi S, 2018, ALZHEIMERS DEMENT, V14, P1235, DOI 10.1016/j.jalz.2018.05.012; Sprecher KE, 2017, NEUROLOGY, V89, P445, DOI 10.1212/WNL.0000000000004171; Stoffers Diederick, 2012, Front Neurol, V3, P105, DOI 10.3389/fneur.2012.00105; Wang CN, 2020, NEUROPSYCHOPHARMACOL, V45, P104, DOI 10.1038/s41386-019-0478-5; Wardle-Pinkston S, 2019, SLEEP MED REV, V48, DOI 10.1016/j.smrv.2019.07.008; Winer JR, 2020, CURR BIOL, V30, P4291, DOI 10.1016/j.cub.2020.08.017; Winkelman JW, 2013, SLEEP, V36, P991, DOI 10.5665/sleep.2794; Yan CQ, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00167; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Yu SY, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00651; Zhou FQ, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1844; Zou GY, 2021, HUM BRAIN MAPP, V42, P259, DOI 10.1002/hbm.25221	59	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252076	10.1371/journal.pone.0252076	http://dx.doi.org/10.1371/journal.pone.0252076			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038462	gold, Green Published			2022-12-26	WOS:000664633500044
J	Juliana, N; Abu Yazit, NA; Kadiman, S; Hafidz, KM; Azmani, S; Teng, NIMF; Das, S				Juliana, Norsham; Abu Yazit, Noor Anisah; Kadiman, Suhaini; Hafidz, Kamilah Muhammad; Azmani, Sahar; Teng, Nur Islami Mohd Fahmi; Das, Srijit			Intraoperative cerebral oximetry in open heart surgeries reduced postoperative complications: A retrospective study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CARDIAC-SURGERY; OXYGEN-SATURATION; ASSOCIATION; MORTALITY; OUTCOMES; STROKE	Cardiothoracic surgeries are life-saving procedures but often it results in various complications. Intraoperative cerebral oximetry monitoring used to detect regional cerebral oxygen saturation (rScO2) is a non-invasive method that provides prognostic importance in cardiac surgery. The main aim of the present study was to evaluate the association of intraoperative cerebral oxygen monitoring during cardiac surgery on postoperative complications. This was a case-controlled retrospective study conducted on adult patients, who underwent open-heart surgery in National Heart Institute, Malaysia. The case group comprised patients on protocolized cerebral oximetry monitoring. They were treated using a standardized algorithm to maintain rScO2 not lower than 20% of baseline rScO2. The control group comprised patients with matched demographic background, preoperative risk factors, and type of surgical procedures. Propensity score stratification was utilized to contend with selection bias. Retrospective analysis was performed on 240 patients (case group) while comparing it to 407 patients (control group). The non-availability of cerebral oximetry monitoring during surgery was the prominent predictor for all outcome of complications; stroke (OR: 7.66), renal failure needing dialysis (OR: 5.12) and mortality (OR: 20.51). Postoperative complications revealed that there were significant differences for risk of mortality (p<0.001, OR = 20.51), renal failure that required dialysis (p<0.001, OR = 5.12) and stroke (p <0.05, OR = 7.66). Protocolized cerebral oximetry monitoring during cardiothoracic surgeries was found to be associated with lower incidence of stroke, renal failure requiring dialysis and mortality rate.	[Juliana, Norsham; Abu Yazit, Noor Anisah; Azmani, Sahar] Univ Sains Islam Malaysia, Fac Med & Hlth Sci, Nilai, Negeri Sembilan, Malaysia; [Kadiman, Suhaini; Hafidz, Kamilah Muhammad] Natl Heart Inst, Anaesthesiol Dept & Intens Care, Kuala Lumpur, Malaysia; [Teng, Nur Islami Mohd Fahmi] Univ Teknol MARA, Fac Hlth Sci, Puncak Alam, Malaysia; [Das, Srijit] Sultan Qaboos Univ, Coll Med & Hlth Sci, Dept Human & Clin Anat, Muscat, Oman	Universiti Sains Islam Malaysia; Institute Jantung Negara; Universiti Teknologi MARA; Sultan Qaboos University	Juliana, N (corresponding author), Univ Sains Islam Malaysia, Fac Med & Hlth Sci, Nilai, Negeri Sembilan, Malaysia.	njuliana@usim.edu.my	Juliana, Norsham/V-2181-2019; Das, Srijit/E-8457-2017	Das, Srijit/0000-0001-8302-7257				Balci C, 2018, J INT MED RES, V46, P1130, DOI 10.1177/0300060517741064; Berger Miles, 2015, Anesthesiol Clin, V33, P517, DOI 10.1016/j.anclin.2015.05.008; Bush B, 2019, J NEUROSURG ANESTH, V31, P269, DOI 10.1097/ANA.0000000000000607; Colak Z, 2015, EUR J CARDIO-THORAC, V47, P447, DOI 10.1093/ejcts/ezu193; Elser HE, 2011, NEWBORN INFANT NURS, V11, P153, DOI 10.1053/j.nainr.2011.07.007; Garg AX, 2019, CAN MED ASSOC J, V191, pE247, DOI 10.1503/cmaj.181644; Gilad V, 2018, CARDIOL YOUNG, V28, P101, DOI 10.1017/S1047951117001664; Goldman S, 2004, HEART SURG FORUM, V7, pE376, DOI 10.1532/HSF98.20041062; Heller BJ, 2018, ANN CARD ANAESTH, V21, P371, DOI 10.4103/aca.ACA_105_17; Jo YY, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030840; Kunst G, 2020, J CARDIOTHOR VASC AN, V34, P1172, DOI 10.1053/j.jvca.2019.10.054; Lei L, 2017, ANAESTHESIA, V72, P1456, DOI 10.1111/anae.14056; Mazzeffi M, 2014, ANN THORAC SURG, V97, P1220, DOI 10.1016/j.athoracsur.2013.10.040; McDonagh DL, 2014, LANCET NEUROL, V13, P490, DOI 10.1016/S1474-4422(14)70004-3; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Murkin JM, 2007, ANESTH ANALG, V104, P51, DOI 10.1213/01.ane.0000246814.29362.f4; Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1; Rassen JA, 2012, PHARMACOEPIDEM DR S, V21, P69, DOI 10.1002/pds.3263; Rawat RS, 2016, ANN CARD ANAESTH, V19, P392, DOI 10.4103/0971-9784.185516; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1072; Slater JP, 2009, ANN THORAC SURG, V87, P36, DOI 10.1016/j.athoracsur.2008.08.070; Soppa G, 2013, INTERACT CARDIOV TH, V16, P750, DOI 10.1093/icvts/ivt046; Stannard B, 2021, J CLIN MONIT COMPUT, V35, P413, DOI 10.1007/s10877-020-00487-x; Steppan J, 2014, BEST PRACT RES-CLIN, V28, P429, DOI 10.1016/j.bpa.2014.09.002; Tarakji KG, 2011, JAMA-J AM MED ASSOC, V305, P381, DOI 10.1001/jama.2011.37; Uysal S, 2020, J THORAC CARDIOV SUR, V159, P943, DOI 10.1016/j.jtcvs.2019.03.036; Vranken Nousjka P A, 2017, J Extra Corpor Technol, V49, P182; Vretzakis G, 2014, J THORAC DIS, V6, pS60, DOI 10.3978/j.issn.2072-1439.2013.10.22; Yao XX, 2018, JAMA-J AM MED ASSOC, V319, P2116, DOI 10.1001/jama.2018.6024; Zheng F, 2013, ANESTH ANALG, V116, P663, DOI 10.1213/ANE.0b013e318277a255	30	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251157	10.1371/journal.pone.0251157	http://dx.doi.org/10.1371/journal.pone.0251157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038405	Green Published, gold			2022-12-26	WOS:000664633500015
J	Han, MJ; Yang, SW; Bae, SI; Moon, YM; Jeon, W; Choi, CW; Park, SK; Kim, JY				Han, Moo Jae; Yang, Seung Woo; Bae, Sang Il; Moon, Young Min; Jeon, Wan; Choi, Chul Won; Park, Sung Kwang; Kim, Jin Young			Evaluation of monoxide film-based dosimeters for surface dose detection in electron therapy	PLOS ONE			English	Article							RADIOTHERAPY	Generally, electron therapy is applied to tumors on or close to the skin surface. However, this causes a variety of skin-related side effects. To alleviate the risk of these side effects, clinical treatment uses skin dosimeters to verify the therapeutic dose. However, dosimeters suffer from poor accuracy, because their attachment sites are approximated with the help of naked eyes. Therefore, a dosimeter based on a flexible material that can adjust to the contours of the human body is required. In this study, the reproducibility, linearity, dose-rate dependence, and percentage depth ionization (PDI) of PbO and HgO film-based dosimeters are evaluated to explore their potential as large-scale flexible dosimeters. The results demonstrate that both dosimeters deliver impressive reproducibility (within 1.5%) and linearity (>= 0.9990). The relative standard deviations of the dose-rate dependence of the PbO and HgO dosimeters were 0.94% and 1.16% at 6 MeV, respectively, and 1.08% and 1.25% at 9 MeV, respectively, with the PbO dosimeter outperforming the 1.1% of existing diodes. The PDI analysis of the PbO and HgO dosimeters returned values of 0.014 cm (-0.074 cm) and 0.051 cm (-0.016 cm), respectively at 6 MeV (9 MeV) compared to the thimble chamber and R-50. Therefore, the maximum error of each dosimeter is within the allowable range of 0.1 cm. In short, the analysis reveals that the PbO dosimeter delivers a superior performance relative to its HgO counterpart and has strong potential for use as a surface dosimeter. Thus, flexible monoxide materials have the necessary qualities to be used for dosimeters that meet the requisite quality assurance standards and can satisfy a variety of radiation-related applications as flexible functional materials.	[Han, Moo Jae; Yang, Seung Woo] Inje Univ, Dept Radiat Oncol, Coll Med, Busan, South Korea; [Bae, Sang Il; Moon, Young Min; Jeon, Wan; Choi, Chul Won; Kim, Jin Young] Dongnam Inst Radiol & Med Sci, Dept Radiat Oncol, Busan, South Korea; [Park, Sung Kwang] Inje Univ, Busan Paik Hosp, Dept Radiat Oncol, Busan, South Korea	Inje University; Korea Institute of Radiological & Medical Sciences; Inje University	Kim, JY (corresponding author), Dongnam Inst Radiol & Med Sci, Dept Radiat Oncol, Busan, South Korea.	99me@nate.com		KIM, JinYoung/0000-0002-0769-9198; moon, young min/0000-0003-1780-6118	National Research Foundation of korea [NRF-2019R1C1C1008911]	National Research Foundation of korea(National Research Foundation of Korea)	The study was funded financially from 'National Research Foundation of korea (NRF-2019R1C1C1008911)'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors Moo Jae Han and Seung Woo Yang received salary support from the above support organizations.	Al-Rammah T.Y., 2013, INT J MED SCI HEALTH, V1, P1; Andreo P., 2000, IAEA TRS 398 ABSORBE; 이현직, 2017, [PROGRESS in MEDICAL PHYSICS, 의학물리], V28, P218, DOI 10.14316/pmp.2017.28.4.218; Choi JS, 2020, J KOREAN PHYS SOC, V76, P1005, DOI 10.3938/jkps.76.1005; Court LE, 2008, J APPL CLIN MED PHYS, V9, P29, DOI 10.1120/jacmp.v9i1.2792; da Rosa LAR, 1999, APPL RADIAT ISOTOPES, V50, P573, DOI 10.1016/S0969-8043(98)00068-2; Dias AG, 2019, J APPL CLIN MED PHYS, V20, P63, DOI 10.1002/acm2.12525; Hauswald H, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-118; Khan F.M., 2014, KHANS PHYS RAD THERA, P135; Kim Joong Sun, 2017, [Journal of Radiation Protection and Research, 방사선방어학회지], V42, P189, DOI 10.14407/jrpr.2017.42.4.189; Klein EE, 2009, MED PHYS, V36, P4197, DOI 10.1118/1.3190392; Kry SF, 2012, J APPL CLIN MED PHYS, V13, P20, DOI 10.1120/jacmp.v13i3.3734; Kumar R, 2014, TECHNOL CANCER RES T, V13, P361, DOI 10.7785/tcrt.2012.500388; Oh K, 2016, J NANOSCI NANOTECHNO, V16, P11473, DOI 10.1166/jnn.2016.13533; Palmans H., 2008, CODE PRACTICE ABSORB; Schieber M, 2006, IEEE T NUCL SCI, V53, P2385, DOI 10.1109/TNS.2006.877043; Semeniuk O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09168-3; Shalek RJ., 1977, MED PHYS, V4, P461, DOI [10.1118/1.594356, DOI 10.1118/1.594356]; Simon M, 2004, P SOC PHOTO-OPT INS, V5368, P188, DOI 10.1117/12.533010; Sun H, 2017, PHYS STATUS SOLIDI-R, V11, DOI 10.1002/pssr.201600397; Thrall CL, 2013, ALTERNATIVE WIDE BAN; Zhang S, 2009, J APPL CLIN MED PHYS, V10, P177, DOI 10.1120/jacmp.v10i4.2978	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251441	10.1371/journal.pone.0251441	http://dx.doi.org/10.1371/journal.pone.0251441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019553	Green Published, gold			2022-12-26	WOS:000664632300023
J	Muche, A; Melaku, MS; Amsalu, ET; Adane, M				Muche, Amare; Melaku, Mequannent Sharew; Amsalu, Erkihun Tadesse; Adane, Metadel			Using geographically weighted regression analysis to cluster under-nutrition and its predictors among under-five children in Ethiopia: Evidence from demographic and health survey	PLOS ONE			English	Article							SPATIAL-ANALYSIS; LOCAL INDICATORS; GROWTH STANDARDS; RISK-FACTORS; UNDERNUTRITION; INTERVENTION; MALNUTRITION; DISTRICT; AREAS; DETERMINANTS	Background Malnutrition among under-five children is a common public health problem and it is one of the main cause for the mortality of under-five children in developing countries, including Ethiopia. Therefore, lack of evidence about geographic heterogeneity and predictors of under-nutrition hinders for evidence-based decision-making process for the prevention and control programs of under-nutrition in Ethiopia. Thus, this study aimed to address this gap. Methods The data were obtained from the Ethiopian Demographic and Health Survey (EDHS) 2016. A total of 9,384 under-five children nested in 645 clusters were included with a stratified two-stage cluster sampling. ArcGIS version 10.5 software was used for global, local and ordinary least square analysis and mapping. The spatial autocorrelation (Global Moran's I) statistic was held in order to assess the pattern of wasting, stunting, and underweight whether it was dispersed, clustered, or randomly distributed. In addition, a Bernoulli model was used to analyze the purely spatial cluster detection of under-nutrition indicators through SaTScan version 9.6 software. Geographically weighted regression (GWR) version 4.0 software was used to model spatial relationships in the GWR analysis. Finally, a statistical decision was made at p-value<0.05 with 95%CI for ordinary least square analysis and geographically weighted regression. Main findings Childhood under-nutrition showed geographical variations at zonal levels in Ethiopia. Accordingly, Somali region (Afder, Gode, Korahe, Warder Zones), Afar region (Zone 2), Tigray region (Southern Zone), and Amhara region (Waghmira Zones) for wasting, Amhara region (West Gojam, Awi, South Gondar, and Waghmira Zones) for stunting and Amhara region (South Wollo, North Wollo, Awi, South Gondar, and Waghmira zones), Afar region (Zone 2), Tigray region (Eastern Zone, North Western Zone, Central Zone, Southern Zone, and Mekele Special Zones), and Benshangul region (Metekel and Assosa Zones) for underweight were detected as hot spot (high risk) regions. In GWR analysis, had unimproved toilet facility for stunting, wasting and underweight, father had primary education for stunting and wasting, father had secondary education for stunting and underweight, mothers age 35-49 years for wasting and underweight, having female children for stunting, having children eight and above for wasting, and mother had primary education for underweight were significant predictors at (p<0.001). Conclusions Our study showed that the spatial distribution of under-nutrition was clustered and high-risk areas were identified in all forms of under-nutrition indicators. Predictors of under-nutrition were identified in all forms of under-nutrition indicators. Thus, geographic-based nutritional interventions mainly mobilizing additional resources could be held to reduce the burden of childhood under-nutrition in hot spot areas. In addition, improving sanitation and hygiene practice, improving the life style of the community, and promotion of parent education in the identified hot spot zones for under-nutrition should be more emphasized.	[Muche, Amare; Melaku, Mequannent Sharew; Amsalu, Erkihun Tadesse] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Dessie, Ethiopia; [Melaku, Mequannent Sharew] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Informat, Gondar, Ethiopia; [Adane, Metadel] Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia	University of Gondar	Melaku, MS (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Informat, Gondar, Ethiopia.	mequsharew8@gmail.com	Tadesse, Erkihun/AAS-1819-2021; muche, amare/GNW-4693-2022; Adane, Metadel/AFQ-9478-2022	Adane, Metadel/0000-0002-7039-4768				Abdulahi A, 2017, ETHIOP J HEALTH SCI, V27, P175, DOI 10.4314/ejhs.v27i2.10; Adugna A., 2014, AYNALEM ADUGNA; Akombi BJ, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0770-z; Alemu ZA, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0480-z; Ali Zakari, 2017, BMC Nutr, V3, P31, DOI 10.1186/s40795-017-0154-2; Allen L.H., 2001, WHAT WORKS REV EFFIC; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Assefa T, 2016, RISK MANAG HEALTHC P, V9, P285, DOI 10.2147/RMHP.S117943; Ayele DG, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1602-z; Azage M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144690; Betebo B, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/6373595; Bhunia GS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-64; Bitew BD, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2797-y; BOERMA JT, 1987, STUD FAMILY PLANN, V18, P213, DOI 10.2307/1966872; Bogale GG, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2504-8; Boulom S, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1785736; BROWN KH, 1993, J PEDIATR GASTR NUTR, V17, P132, DOI 10.1097/00005176-199308000-00002; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P431, DOI 10.1111/1467-9884.00145; Charlton M, 2009, CISC VIS NETW IND GL; Chirande L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0482-9; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Commission P.C., 2008, POP SIZ AG SEX; Cressie N, 2001, NAV RES LOG, V48, P333, DOI 10.1002/nav.1022; CSA and ICF-International, 2016, ETH DEM HLTH SURV 20; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; De Valck J, 2016, LANDSCAPE URBAN PLAN, V151, P64, DOI 10.1016/j.landurbplan.2016.03.008; Deribew A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010775; Faber Jorge, 2014, Dental Press J. Orthod., V19, P27, DOI 10.1590/2176-9451.19.4.027-029.ebo; Guimaraes AGF, 2015, REV SOC BRAS MED TRO, V48, P291, DOI 10.1590/0037-8682-0001-2015; Fotheringham A.S, 2003, AM J AGR ECON; Fotheringham AS, 1998, ENVIRON PLANN A, V30, P1905, DOI 10.1068/a301905; Garenne M, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12736; Gashu D, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0155-z; Gebreyesus SH, 2016, PUBLIC HEALTH NUTR, V19, P1417, DOI 10.1017/S1368980015003377; Glover-Amengor M, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0124-1; Gupta AK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237661; Haile D, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0587-9; Hoffman D, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0095-z; Huang L, 2007, BIOMETRICS, V63, P109, DOI 10.1111/j.1541-0420.2006.00661.x; Jones JB., 1991, PLANT ANAL HDB PRACT, P127; Kandala N.B., 2001, SEMIPARAMETRIC ANAL, DOI [10.1074/jbc.M103585200 11441007, DOI 10.1074/JBC.M10358520011441007]; Kandala NB, 2009, POPUL SPACE PLACE, V15, P461, DOI 10.1002/psp.524; Khan J, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5873-z; Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kumari S, 2018, WATER SCI TECHNOL LI, V77, P87, DOI 10.1007/978-981-10-5792-2_8; Lemessa R., 2020, SPATIAL DISTRIBUTION; LeSage J. P., 2004, ADV SPATIAL ECONOMET, DOI DOI 10.1007/978-3-662-05617-2_11; Leung Y, 2000, ENVIRON PLANN A, V32, P9, DOI 10.1068/a3162; Lopez-Carr D, 2016, IEEE J-STARS, V9, P2830, DOI 10.1109/JSTARS.2016.2569411; Menezes JA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/621854; Mennis J, 2006, CARTOGR J, V43, P171, DOI 10.1179/000870406X114658; Mshida HA, 2018, AM J TROP MED HYG, V98, P1242, DOI 10.4269/ajtmh.17-0399; Newberry S.J., 2018, SODIUM POTASSIUM INT; Organization W.H, 2006, WORK TOG HLTH; Pawloski LR, 2012, PUBLIC HEALTH NUTR, V15, P2140, DOI 10.1017/S1368980012000110; Peterson I, 2009, AM J TROP MED HYG, V81, P944, DOI 10.4269/ajtmh.2009.08-0662; Sakwe N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218442; Santiago I., 2014, FUNDAMENTOS ARCGIS V; Santos CB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-399; Sisay MM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025066; Spray AL, 2013, FOOD NUTR BULL, V34, P444, DOI 10.1177/156482651303400410; Supply W.U.J.W., 2015, PROGR SANITATION DRI; Tiwari R, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-239; Turck D, 2013, J PEDIATR GASTR NUTR, V57, P258, DOI 10.1097/MPG.0b013e318298003f; Walters Stephen J, 2004, Health Qual Life Outcomes, V2, P26, DOI 10.1186/1477-7525-2-26; Wamai R.G., 2004, POPULATION MIL, V75; Wemakor Anthony, 2018, BMC Res Notes, V11, P408, DOI 10.1186/s13104-018-3528-x; Wheeler D., 2005, J GEOGRAPHICAL SYSTE, V7, P161, DOI [DOI 10.1007/S10109-005-0155-6, 10.1007/s10109-005-0155-6]; Woldemichael A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022923; Wulder M, 1998, INT J REMOTE SENS, V19, P2223, DOI 10.1080/014311698214983; Yeshiwondim AK, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-5; Yisak H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0535-0	73	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0248156	10.1371/journal.pone.0248156	http://dx.doi.org/10.1371/journal.pone.0248156			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019545	Green Published, gold			2022-12-26	WOS:000664632300005
J	Bhadra, S; Nguyen, V; Torres, JA; Kar, S; Fadanka, S; Gandini, C; Akligoh, H; Paik, I; Maranhao, AC; Molloy, J; Ellington, AD				Bhadra, Sanchita; Nguyen, Vylan; Torres, Jose-Angel; Kar, Shaunak; Fadanka, Stephane; Gandini, Chiara; Akligoh, Harry; Paik, Inyup; Maranhao, Andre C.; Molloy, Jenny; Ellington, Andrew D.			Producing molecular biology reagents without purification	PLOS ONE			English	Article							PROTEIN-PURIFICATION	We recently developed 'cellular' reagents-lyophilized bacteria overexpressing proteins of interest-that can replace commercial pure enzymes in typical diagnostic and molecular biology reactions. To make cellular reagent technology widely accessible and amenable to local production with minimal instrumentation, we now report a significantly simplified method for preparing cellular reagents that requires only a common bacterial incubator to grow and subsequently dry enzyme-expressing bacteria at 37 degrees C with the aid of inexpensive chemical desiccants. We demonstrate application of such dried cellular reagents in common molecular and synthetic biology processes, such as PCR, qPCR, reverse transcription, isothermal amplification, and Golden Gate DNA assembly, in building easy-to-use testing kits, and in rapid reagent production for meeting extraordinary diagnostic demands such as those being faced in the ongoing SARS-CoV-2 pandemic. Furthermore, we demonstrate feasibility of local production by successfully implementing this minimized procedure and preparing cellular reagents in several countries, including the United Kingdom, Cameroon, and Ghana. Our results demonstrate possibilities for readily scalable local and distributed reagent production, and further instantiate the opportunities available via synthetic biology in general.	[Bhadra, Sanchita; Kar, Shaunak; Paik, Inyup; Maranhao, Andre C.; Ellington, Andrew D.] Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA; [Bhadra, Sanchita; Kar, Shaunak; Paik, Inyup; Maranhao, Andre C.; Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA; [Nguyen, Vylan; Torres, Jose-Angel] Univ Texas Austin, DIY Diagnost Stream, Freshman Res Initiat, Austin, TX 78712 USA; [Fadanka, Stephane] Mboalab Biotech, Yaounde, Cameroon; [Gandini, Chiara; Molloy, Jenny] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Akligoh, Harry] Hive Biolab, Kumasi, Ghana	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Cambridge	Bhadra, S; Ellington, AD (corresponding author), Univ Texas Austin, Coll Nat Sci, Dept Mol Biosci, Austin, TX 78712 USA.; Bhadra, S; Ellington, AD (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	sanchitabhadra@utexas.edu; ellingtonlab@gmail.com		Akligoh, Harry/0000-0002-6949-1392; Nguyen, Vylan/0000-0002-7970-9121; Paik, Inyup/0000-0001-5938-6380; Wapouo, Stephane Fadanka/0000-0003-1807-2523	Welch Foundation [F-1654]; Bill and Melinda Gates Foundation [OPP1182120]; National Institutes of Health [1-R01EB027202-01A1]; Shuttleworth Foundation; Mozilla Foundation	Welch Foundation(The Welch Foundation); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shuttleworth Foundation; Mozilla Foundation	Work at UT Austin was supported by grants from the Welch Foundation (F-1654), the Bill and Melinda Gates Foundation (OPP1182120), and the National Institutes of Health (1-R01EB027202-01A1) to ADE. Work at University of Cambridge, Kumasi Hive and MboaLab was funded by the Shuttleworth Foundation through a fellowship to JM. Development of the DIY incubator was supported by the Mozilla Foundation under the Build Free and Open Science Hardware project. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abou Tayoun AN, 2014, AM J CLIN PATHOL, V141, P17, DOI 10.1309/AJCPA1L4KPXBJNPG; Adebamowo SN, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2017.1419033; Berninger T, 2018, MICROB BIOTECHNOL, V11, P277, DOI 10.1111/1751-7915.12880; Bhadra S, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00911-20; Bhadra S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201681; BLUEMEL K M, 1990, American Journal of Physiology, V259, pH1504; Boehm AB, 2013, WATER RES, V47, P6812, DOI 10.1016/j.watres.2012.12.046; Briand L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33037; Casini A, 2015, NAT REV MOL CELL BIO, V16, P568, DOI 10.1038/nrm4014; Castaldo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28887; Coyle BL, 2014, BIOTECHNOL BIOENG, V111, P2019, DOI 10.1002/bit.25257; Ellefson JW, 2016, SCIENCE, V352, P1590, DOI 10.1126/science.aaf5409; Ellington AD, 2020, ONE ENZYME RTQPCR AS, DOI DOI 10.1101/2020.03.29.013342; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Bueso YF, 2020, EMBO REP, V21, DOI 10.15252/embr.202050587; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green HC, 2014, APPL ENVIRON MICROB, V80, P3086, DOI 10.1128/AEM.04137-13; Harris E, 2004, EMBO REP, V5, P7, DOI 10.1038/sj.embor.7400058; Heili JM, 2018, J CHEM EDUC, V95, P1867, DOI 10.1021/acs.jchemed.7b00735; Hong J, 2008, J CHROMATOGR A, V1194, P150, DOI 10.1016/j.chroma.2008.04.048; Huang A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5105; Jiang YS, 2018, WATER RES, V131, P186, DOI 10.1016/j.watres.2017.12.023; Jiang YS, 2015, ANAL CHEM, V87, P3314, DOI 10.1021/ac504387c; Jung JK, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0571-7; Kahl L, 2018, NAT BIOTECHNOL, V36, P923, DOI 10.1038/nbt.4263; Kitney RI, 2012, SYNTHETIC BIOL PRIME; Lamb LE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234682; Lee J, 2020, CHEM COMMUN, V56, P5597, DOI 10.1039/d0cc02121k; Liljeruhm J, 2018, J BIOL ENG, V12, DOI 10.1186/s13036-018-0100-0; MACKEY BM, 1991, J GEN MICROBIOL, V137, P2361, DOI 10.1099/00221287-137-10-2361; Maranhao A., 2020, IMPROVED READILY AVA, DOI [10.1101/2020.10.02.20203356, DOI 10.1101/2020.10.02.20203356]; McFarland J, 1907, J AMER MED ASSOC, V49, P1176; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nshimyimana JP, 2014, J APPL MICROBIOL, V116, P1369, DOI 10.1111/jam.12455; Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059; Peubez I, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-65; Phillips EA, 2018, ANAL CHEM, V90, P6580, DOI 10.1021/acs.analchem.8b00269; POTTS M, 1994, MICROBIOL REV, V58, P755, DOI 10.1128/MMBR.58.4.755-805.1994; Riedel TE, 2014, J ENVIRON MANAGE, V136, P112, DOI 10.1016/j.jenvman.2014.01.029; Silverman AD, 2020, NAT REV GENET, V21, P151, DOI 10.1038/s41576-019-0186-3; Singh-Blom A, 2014, J BIOTECHNOL, V178, P12, DOI 10.1016/j.jbiotec.2014.02.009; Thavarajah W, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-0064-8; Voigt C., 2011, SYNTHETIC BIOL A; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Zhang Y., 2020, RAPID MOL DETECTION, V2, P1, DOI [10.1101/2020.02.26.20028373, DOI 10.1101/2020.02.26.20028373]	45	1	1	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252507	10.1371/journal.pone.0252507	http://dx.doi.org/10.1371/journal.pone.0252507			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061896	Green Published, gold, Green Submitted			2022-12-26	WOS:000656813600040
J	Nyarko, SH				Nyarko, Samuel H.			Socioeconomic determinants of cumulative fertility in Ghana	PLOS ONE			English	Article							WOMENS EMPLOYMENT; TRANSITION; COUNTRIES; MORTALITY; PATTERNS; OUTCOMES; DECLINE	The pace of decline in fertility rates in sub-Saharan Africa appears to have slowed or stalled in the last few decades. This study examines the socioeconomic associated with cumulative fertility in Ghana. Negative binomial regression models were used to estimate determinants of cumulative fertility using data from the Ghana Demographic and Health Surveys of 2003, 2008, and 2014. The composition of children ever born by women did not change considerably over the study periods. Socioeconomic disparities in educational attainment, household wealth, employment, and employer status are significantly associated with cumulative fertility risks in Ghana. The current age of women, age at sexual debut, and marital status, among others, are also linked to cumulative fertility levels. Place and region of residence are also linked to fertility in Ghana. Cumulative fertility levels in Ghana are underscored by considerable socioeconomic disparities among women of reproductive age. Fertility regulation policies should hinge on improving the socio-economic wellbeing of women in Ghana.	[Nyarko, Samuel H.] Univ Texas San Antonio, Coll Hlth Community & Policy, Dept Demog, San Antonio, TX 78249 USA; [Nyarko, Samuel H.] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Hohoe, Ghana	University of Texas System; University of Texas at San Antonio (UTSA)	Nyarko, SH (corresponding author), Univ Texas San Antonio, Coll Hlth Community & Policy, Dept Demog, San Antonio, TX 78249 USA.; Nyarko, SH (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Hohoe, Ghana.	samharrenson@gmail.com		Nyarko, Samuel/0000-0002-6999-351X				Adhikari R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-19; Agyei-Mensah S, 2015, J POPUL RES, V32, P157, DOI 10.1007/s12546-015-9147-7; Alaba OO, 2017, S AFR FAM PRACT, V59, P143, DOI 10.1080/20786190.2017.1292693; Askew I, 2017, POPUL DEV REV, V43, P289, DOI 10.1111/padr.12010; Azasoo MA., 2017, CURRENT J APPL SCI T, V22, P1; Benefo K, 1996, WORLD BANK ECON REV, V10, P123, DOI 10.1093/wber/10.1.123; Bongaarts J, 2003, POP STUD-J DEMOG, V57, P321, DOI 10.1080/0032472032000137835; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; Bongaarts J., 2010, VIENNA YB POPULATION, V2010, P31, DOI DOI 10.1553/POPULATIONYEARBOOK2010S31; Bongaarts J, 2013, POPUL DEV REV, V38, P153, DOI 10.1111/j.1728-4457.2013.00557.x; Brewster KL, 2000, ANNU REV SOCIOL, V26, P271, DOI 10.1146/annurev.soc.26.1.271; Byers AL, 2003, J CLIN EPIDEMIOL, V56, P559, DOI 10.1016/S0895-4356(03)00028-3; Caceres-Delpiano J, 2012, DEMOGRAPHY, V49, P151, DOI 10.1007/s13524-011-0076-6; Chandiok K., 2016, J ANTHR; Engelhardt H, 2004, POP STUD-J DEMOG, V58, P109, DOI 10.1080/0032472032000167715; Ezeh AC, 2009, PHILOS T R SOC B, V364, P2991, DOI 10.1098/rstb.2009.0166; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF International, 2015, GHAN DEM HLTH SURV 2; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF Macro, 2009, GHAN DEM HLTH SURV 2; Ghana Statistical Service (GSS) Noguchi Memorial Institute for Medical Research (NMIMR) ORC Macro, 2004, GHAN DEM HLTH SURV 2; Government of Ghana, 2015, GHAN FAM PLANN COST; Government of Ghana, 1994, NAT POP POL; GSS GHS & ICF, 2018, GHAN MAT HLTH SURV 2; Heath R, 2017, J DEV ECON, V126, P190, DOI 10.1016/j.jdeveco.2016.11.003; Heaton TB, 2011, POPUL RES POLICY REV, V30, P449, DOI 10.1007/s11113-010-9196-8; ICF International, 2012, DEM HLTH SURV SAMPL; Ifelunini I. A., 2018, African Population Studies, V32, P4125; Indongo Nelago, 2012, Afr J Reprod Health, V16, P50; Johnson-Hanks J, 2006, MED ANTHROPOL Q, V20, P12, DOI 10.1525/maq.2006.20.1.12; Kimura M, 2007, ECON LETT, V94, P228, DOI 10.1016/j.econlet.2006.06.035; Kogel T, 2004, J POPUL ECON, V17, P45, DOI 10.1007/s00148-003-0180-z; Kulu H, 2016, DEMOGR RES, V35, P1441, DOI 10.4054/DemRes.2016.35.49; Lee JW, 2020, SINGAP ECON REV, V65, P781, DOI 10.1142/S0217590819500528; Lundberg M, 2010, P 4 ANN RES C POP RE; McQuillan K, 2004, POPUL DEV REV, V30, P25, DOI 10.1111/j.1728-4457.2004.00002.x; Mekonnen W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-782; Ndahindwa V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-87; Nyarko SH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247189; Nyarko SH., 2019, GENUS, V75, P22, DOI DOI 10.1186/S41118-019-0069-7; Olatoregun O, 2014, AFR J REPROD HEALTH, V18, P36; Owoo NS, 2015, EUR J HEALTH ECON, V16, P629, DOI 10.1007/s10198-014-0615-3; R Core Team, 2020, R LANG ENV STAT COMP; Shapiro D., 2017, African Population Studies, V31, P3253; Shapiro D, 2017, DEMOGR RES, V37, P1327, DOI [10.4054/DemRes.2017.37.40, 10.4054/demres.2017.37.40]; Shapiro David, 2013, RALENTISSEMENTS RESI, P47; Stulp G, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0153; Sulemana A., 2018, INT J PROBAB STAT, V7, P31; The World Bank, 2010, DET CONS HIGH FERT S, DOI [10.1596/27497, DOI 10.1596/27497]; U.S. Census Bureau Population Division, 2019, GHAN ANN 5 YEAR AG G; United Nations Department of Economic and Social Affairs Population Division [DESA], 2017, STESASERA415 UN DESA; United Nations Department of Economic and Social Affairs Population Division [DESA], 2017, END HIGH FERT IS NEA; Van Den Broeck G, 2014, EAAE 2014 C AGR RUR; White MJ, 2008, DEMOGRAPHY, V45, P803, DOI 10.1353/dem.0.0035	52	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252519	10.1371/journal.pone.0252519	http://dx.doi.org/10.1371/journal.pone.0252519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SL3JC	34061887	gold, Green Published			2022-12-26	WOS:000656813600026
J	Tiruneh, SA; Fentie, DT; Yigizaw, ST; Abebe, AA; Gelaye, KA				Tiruneh, Sofonyas Abebaw; Fentie, Dawit Tefera; Yigizaw, Seblewongel Tigabu; Abebe, Asnakew Asmamaw; Gelaye, Kassahun Alemu			Spatial distribution and geographical heterogeneity factors associated with poor consumption of foods rich in vitamin A among children age 6-23 months in Ethiopia: Geographical weighted regression analysis	PLOS ONE			English	Article								Introduction Vitamin A deficiency is a major public health problem in poor societies. Dietary consumption of foods rich in vitamin A was low in Ethiopia. This study aimed to assess the spatial distribution and spatial determinants of dietary consumption of foods rich in vitamin A among children aged 6-23 months in Ethiopia. Methods Ethiopian 2016 demographic and health survey dataset using a total of 3055 children were used to conduct this study. The data were cleaned and weighed by STATA version 14.1 software and Microsoft Excel. Children who consumed foods rich in vitamin A (Egg, Meat, Vegetables, Green leafy vegetables, Fruits, Organ meat, and Fish) at least one food item in the last 24 hours were declared as good consumption. The Bernoulli model was fitted using Kuldorff's SaTScan version 9.6 software. ArcGIS version 10.7 software was used to visualize spatial distributions for poor consumption of foods rich in vitamin A. Geographical weighted regression analysis was employed using MGWR version 2.0 software. A P-value of less than 0.05 was used to declare statistically significant predictors spatially. Results Overall, 62% (95% CI: 60.56-64.00) of children aged 6-23 months had poor consumption of foods rich in vitamin A in Ethiopia. Poor consumption of foods rich in vitamin A highly clustered in Afar, eastern Tigray, southeast Amhara, and the eastern Somali region of Ethiopia. Spatial scan statistics identified 142 primary spatial clusters located in Afar, the eastern part of Tigray, most of Amhara and some part of the Oromia Regional State of Ethiopia. Children living in the primary cluster were 46% more likely vulnerable to poor consumption of foods rich in vitamin A than those living outside the window (RR = 1.46, LLR = 83.78, P < 0.001). Poor wealth status of the household, rural residence and living tropical area of Ethiopia were spatially significant predictors. Conclusion Overall, the consumption of foods rich in vitamin A was low and spatially non-random in Ethiopia. Poor wealth status of the household, rural residence and living tropical area were spatially significant predictors for the consumption of foods rich in vitamin A in Ethiopia. Policymakers and health planners should intervene in nutrition intervention at the identified hot spot areas to reduce the poor consumption of foods rich in vitamin A among children aged 6-23 months.	[Tiruneh, Sofonyas Abebaw] Debre Tabor Univ, Dept Publ Hlth, Coll Hlth Sci, Debre Tabor, Ethiopia; [Fentie, Dawit Tefera; Yigizaw, Seblewongel Tigabu; Abebe, Asnakew Asmamaw; Gelaye, Kassahun Alemu] Univ Gondar, Dept Epidemiol & Biostat, Inst Publ Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Tiruneh, SA (corresponding author), Debre Tabor Univ, Dept Publ Hlth, Coll Hlth Sci, Debre Tabor, Ethiopia.	zephab2@gmail.com		Abebaw Tiruneh, Sofonyas/0000-0001-5867-5105				Aemro M, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/782931; Alemu ZA, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0480-z; [Anonymous], 2012, EMPIRICAL BAYESIAN K; Baek Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213610; Beletew B., 2019, PRACTICE KEY ESSENTI, P1, DOI [10.1186/s12887-019-1814-y, DOI 10.1186/S12887-019-1814-Y]; Central Statistical Agency Addis Ababa Ethiopia, 2012, ETH DEM HLTH SURV 20; Croft TrevorN., 2018, USAID, P1; Damtie A., 2020, ADEQUATE VITAMIN RIC, V3, P1, DOI [10.1371/journal.pone.0239308, DOI 10.1371/JOURNAL.PONE.0239308]; Dangura D, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0764-x; Demissie T, 2010, FOOD NUTR BULL, V31, P234, DOI 10.1177/156482651003100206; Edris MM., 2018, PEDIAT HLTH RES, V3, P1, DOI [10.21767/2574-2817.100035, DOI 10.21767/2574-2817.100035]; FAO WHO, 2004, VIT MIN REQ HUM NUTR, P1; Fotheringham AS, 2017, ANN AM ASSOC GEOGR, V107, P1247, DOI 10.1080/24694452.2017.1352480; General AK, 2013, ETHIOPIA NATL FOOD C; Ghana Statistical Service GHS and II, 2014, GHAN HLTH DEM SURV 2; Girma A, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1595-3; Hagos S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170785; Harika R, 2017, FOOD NUTR BULL, V38, P405, DOI 10.1177/0379572117715818; IIPS, NATL FAMILY HLTH SUR; Imdad A., 2017, COCHRANE DB SYST REV, V2017, DOI [10.1002/14651858.CD008524.pub3, DOI 10.1002/14651858.CD008524.pub3]; Jemberu Y., 2017, INT J FOOD SCI NUTR, V7, P1, DOI [10.5923/j.food.20170701.01, DOI 10.5923/J.FOOD.20170701.01]; Kuche D, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.12852; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Nairobi K, 2014, DEM HLTH SURV; O'Sullivan D, 2003, GEOGR ANAL, V35, P272, DOI 10.1353/geo.2003.0008; Sartorius B., 2020, TEMPORAL TRENDS RISK, P1, DOI [10.1136/bmjopen-2019-034476, DOI 10.1136/BMJOPEN-2019-034476]; Solomon D, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0680-1; Stevens GA, 2015, LANCET GLOB HEALTH, V3, pE528, DOI 10.1016/S2214-109X(15)00039-X; Tewodros Eshete, 2018, Agriculture and Food Security, V7, DOI 10.1186/s40066-018-0219-8; Tiruneh SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244642; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; WHO, 2011, WHO TECH REP SER, V959, P1; World Health Orgnaisation, 2009, GLOB PREV VIT A DEF	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252639	10.1371/journal.pone.0252639	http://dx.doi.org/10.1371/journal.pone.0252639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081718	gold, Green Published			2022-12-26	WOS:000664639200036
J	Nathansen, J; Lukiyanchuk, V; Hein, L; Stolte, MI; Borgmann, K; Lock, S; Kurth, I; Baumann, M; Krause, M; Linge, A; Dubrovska, A				Nathansen, Jacqueline; Lukiyanchuk, Vasyl; Hein, Linda; Stolte, Maya-Isabel; Borgmann, Kerstin; Lock, Steffen; Kurth, Ina; Baumann, Michael; Krause, Mechthild; Linge, Annett; Dubrovska, Anna			Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L	ONCOGENE			English	Article							GOOD PROGNOSIS SUBGROUPS; POSTOPERATIVE RADIOCHEMOTHERAPY; HUMAN-PAPILLOMAVIRUS; MARKER EXPRESSION; DNA-DAMAGE; CANCER; CHK1; HPV; MULTICENTER; HNSCC	Head and neck squamous cell carcinoma (HNSCC) is often being diagnosed at an advanced stage, conferring a poor prognosis. The probability of local tumor control after radiotherapy depends on the eradication of cancer stem cells (CSCs) with activated DNA repair. This study provides evidence that the CSC-related transcription factor Oct4 contributes to HNSCC radioresistance by regulating DNA damage response and the CSC phenotype. Knockdown of Oct4 A isoform reduced self-renewal capacity in HNSCC and led to partial tumor cell radiosensitization caused by transcriptional downregulation of the cell cycle checkpoint kinases CHK1 and WEE1 and homologous recombination (HR) repair genes PSMC3IP and RAD54L. Besides, PARP inhibition with Olaparib selectively radiosensitized Oct4 A knockout, but not wild-type HNSCC cells. This finding links Oct4 A to the HR-mediated DNA repair mechanisms. In turn, knockdown of PSMC3IP and RAD54L reduced the HNSCC self-renewal capacity and clonogenic cell survival after irradiation, suggesting the interplay between DNA repair and the CSC phenotype. Similar to the effect of Oct4 knockdown, overexpression of Oct4 also resulted in significant HNSCC radiosensitization and increased DNA damage, suggesting that Oct4-dependent regulation of DNA repair depends on its fine-tuned expression. In line with this observation, HNSCC patients with high and low nuclear Oct4 expression at the invasive tumor front exhibited better loco-regional tumor control after postoperative radio(chemo)therapy compared to the intermediate expression subgroup. Thus, we found that the Oct4-driven transcriptional program plays a critical role in regulating HNSCC radioresistance, and a combination of radiotherapy with PARP inhibitors may induce synthetic lethality in Oct4-deregulated tumors.	[Nathansen, Jacqueline; Lukiyanchuk, Vasyl; Hein, Linda; Lock, Steffen; Kurth, Ina; Baumann, Michael; Krause, Mechthild; Linge, Annett; Dubrovska, Anna] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, OncoRay Natl Ctr Radiat Res Oncol, Fac Med, Dresden, Germany; [Nathansen, Jacqueline; Lukiyanchuk, Vasyl; Hein, Linda; Lock, Steffen; Kurth, Ina; Baumann, Michael; Krause, Mechthild; Linge, Annett; Dubrovska, Anna] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Nathansen, Jacqueline; Lukiyanchuk, Vasyl; Krause, Mechthild; Dubrovska, Anna] Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol OncoRay, Dresden, Germany; [Stolte, Maya-Isabel; Borgmann, Kerstin] Univ Med Ctr Hamburg Eppendorf, Ctr Oncol, Lab Radiobiol & Expt Radiooncol, Hamburg, Germany; [Lock, Steffen; Krause, Mechthild; Linge, Annett; Dubrovska, Anna] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany; [Lock, Steffen; Kurth, Ina; Baumann, Michael; Krause, Mechthild; Linge, Annett; Dubrovska, Anna] German Canc Res Ctr, Heidelberg, Germany; [Lock, Steffen; Baumann, Michael; Krause, Mechthild; Linge, Annett] Tech Univ Dresden, Dept Radiotherapy & Radiat Oncol, Fac Med, Dresden, Germany; [Lock, Steffen; Baumann, Michael; Krause, Mechthild; Linge, Annett] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Krause, Mechthild; Linge, Annett] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany; [Krause, Mechthild; Linge, Annett] Tech Univ Dresden, Fac Med, Dresden, Germany; [Krause, Mechthild; Linge, Annett] Helmholtz Zentrum Dresden Rossendorf HZDR, Dresden, Germany	Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR)	Linge, A; Dubrovska, A (corresponding author), Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, OncoRay Natl Ctr Radiat Res Oncol, Fac Med, Dresden, Germany.; Linge, A; Dubrovska, A (corresponding author), Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany.; Dubrovska, A (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol OncoRay, Dresden, Germany.; Linge, A; Dubrovska, A (corresponding author), German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany.; Linge, A; Dubrovska, A (corresponding author), German Canc Res Ctr, Heidelberg, Germany.; Linge, A (corresponding author), Tech Univ Dresden, Dept Radiotherapy & Radiat Oncol, Fac Med, Dresden, Germany.; Linge, A (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany.; Linge, A (corresponding author), Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany.; Linge, A (corresponding author), Tech Univ Dresden, Fac Med, Dresden, Germany.; Linge, A (corresponding author), Helmholtz Zentrum Dresden Rossendorf HZDR, Dresden, Germany.	Annett.Linge@uniklinikum-dresden.de; a.dubrovska@hzdr.de		Kurth, Ina/0000-0001-9261-5165; Linge, Annett/0000-0001-9636-1721; Baumann, Michael/0000-0002-9340-974X	Deutsche Forschungsgemeinschaft (DFG) [SPP 2084, 401326337, 416001651]; Wilhelm Sander-Stiftung [2017.106.1]; BMBF [02NUK032, 02NUK035B, 03Z1NN11]; DFG [BO1868-5]; Hubertus Wald Stiftung; Hamburger Krebsgesellschaft e.V.	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Sander-Stiftung; BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Hubertus Wald Stiftung; Hamburger Krebsgesellschaft e.V.	We greatly appreciate Liane Stolz-Kieslich for her help with immunochistochemical staining, the members of the Group of Biomarkers for Individualized Radiotherapy for their critical reading of the manuscript and the team of The Core Facilities of the Technology Platform at BIOTEC TU Dresden for their constant technical support. Work in AD lab was partially supported by grants from Deutsche Forschungsgemeinschaft (DFG) (SPP 2084: mu BONE, 401326337 and 416001651), from Wilhelm Sander-Stiftung (2017.106.1) and BMBF (03Z1NN11). Work in KB lab was partially supported by DFG (BO1868-5) and BMBF (Grant 02NUK032 and 02NUK035B), Hubertus Wald Stiftung, and Hamburger Krebsgesellschaft e.V.	Akagi K, 2014, GENOME RES, V24, P185, DOI 10.1101/gr.164806.113; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartucci M, 2012, CELL DEATH DIFFER, V19, P768, DOI 10.1038/cdd.2011.170; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bertrand G, 2014, STEM CELL REV REP, V10, P114, DOI 10.1007/s12015-013-9467-y; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Butof R, 2013, RADIOTHER ONCOL, V108, P388, DOI 10.1016/j.radonc.2013.06.002; Carpen T, 2020, CANCER IMMUNOL IMMUN, V69, P1615, DOI 10.1007/s00262-020-02570-3; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Chow LQM, 2020, NEW ENGL J MED, V382, P60, DOI 10.1056/NEJMra1715715; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Digomann D, 2019, CLIN CANCER RES, V25, P3152, DOI 10.1158/1078-0432.CCR-18-2951; Fong YW, 2013, MOL CELL, V52, P291, DOI 10.1016/j.molcel.2013.10.018; Gao Y, 2012, STEM CELLS, V30, P665, DOI 10.1002/stem.1034; Geissler C, 2012, IN VIVO, V26, P593; Hammachi F, 2012, CELL REPORTS, V1, P99, DOI 10.1016/j.celrep.2011.12.002; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Jung JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028068; Kagohara LT, 2020, BRIT J CANCER, V123, P101, DOI 10.1038/s41416-020-0851-5; Kim JY, 2018, INT J ONCOL, V53, P47, DOI 10.3892/ijo.2018.4391; Kim Ran-Ju, 2011, Lab Anim Res, V27, P147, DOI 10.5625/lar.2011.27.2.147; Kimple RJ, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.01.37; Kimple RJ, 2013, CANCER RES, V73, P4791, DOI 10.1158/0008-5472.CAN-13-0587; Koo BS, 2015, ONCOGENE, V34, P2317, DOI 10.1038/onc.2014.174; Krajewska M, 2013, ONCOGENE, V32, P3001, DOI 10.1038/onc.2012.296; Krause M, 2017, ADV DRUG DELIVER REV, V109, P63, DOI 10.1016/j.addr.2016.02.002; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Kurth I, 2015, ONCOTARGET, V6, P34494, DOI 10.18632/oncotarget.5417; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Linge A, 2016, RADIOTHER ONCOL, V121, P364, DOI 10.1016/j.radonc.2016.11.008; Linge A, 2016, CLIN CANCER RES, V22, P2639, DOI 10.1158/1078-0432.CCR-15-1990; Liu C, 2020, ORAL ONCOL, V100, DOI 10.1016/j.oraloncology.2019.104469; Lohaus F, 2014, RADIOTHER ONCOL, V113, P317, DOI 10.1016/j.radonc.2014.11.011; Manic G, 2018, GUT, V67, P903, DOI 10.1136/gutjnl-2016-312623; Meng L, 2018, ONCOL LETT, V16, P522, DOI 10.3892/ol.2018.8607; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Sullivan B, 2013, J CLIN ONCOL, V31, P543, DOI 10.1200/JCO.2012.44.0164; Peitzsch C, 2019, CANCERS, V11, DOI 10.3390/cancers11050616; Pezza RJ, 2014, NUCLEIC ACIDS RES, V42, P2346, DOI 10.1093/nar/gkt1234; Pitroda SP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008291; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Rachmadi Lisnawati, 2019, Oman Med J, V34, P224, DOI 10.5001/omj.2019.43; Razzouk S, 2014, CLIN GENET, V86, P412, DOI 10.1111/cge.12487; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Ruan ZY, 2019, CANCER MANAG RES, V11, P389, DOI 10.2147/CMAR.S180418; Schulz A, 2019, CANCERS, V11, DOI 10.3390/cancers11060862; Shao MH, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3424956; Shi GL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt39; Smith HL, 2020, EXPERT REV MOL MED, V22, DOI 10.1017/erm.2020.3; Song B, 2018, BIOCHEM BIOPH RES CO, V503, P1980, DOI 10.1016/j.bbrc.2018.07.145; Sorensen CS, 2005, NAT CELL BIOL, V7, P195, DOI 10.1038/ncb1212; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Trosko JE, 2019, CANCERS, V11, DOI 10.3390/cancers11010087; Vaddi PK, 2019, CANCERS, V11, DOI 10.3390/cancers11091331; Venkatesha VA, 2012, NEOPLASIA, V14, P519, DOI 10.1593/neo.12538; Ventela S, 2015, ONCOTARGET, V6, P144, DOI 10.18632/oncotarget.2670; Vitale I, 2017, MOL CELL, V66, P306, DOI 10.1016/j.molcel.2017.04.006; Wang X, 2009, STEM CELLS, V27, P1265, DOI 10.1002/stem.58; Wurster S, 2016, ONCOTARGET, V7, P9732, DOI 10.18632/oncotarget.6947; Yaromina A, 2007, RADIOTHER ONCOL, V83, P304, DOI 10.1016/j.radonc.2007.04.020; Zhang Y, 2019, J BONE MINER RES, V34, P2287, DOI 10.1002/jbmr.3857; Zhou YW, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0606-x	67	10	10	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4214	4228		10.1038/s41388-021-01842-1	http://dx.doi.org/10.1038/s41388-021-01842-1		JUN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34079088	Green Published, hybrid			2022-12-26	WOS:000657217400009
J	Stefani, D; Hegedues, B; Collaud, S; Zaatar, M; Ploenes, T; Valdivia, D; Elsner, C; Bleekmann, B; Widera, M; Dittmer, U; Aigner, C				Stefani, Dirk; Hegedues, Balazs; Collaud, Stephane; Zaatar, Mohamed; Ploenes, Till; Valdivia, Daniel; Elsner, Carina; Bleekmann, Barbara; Widera, Marek; Dittmer, Ulf; Aigner, Clemens			Torque Teno Virus load in lung cancer patients correlates with age but not with tumor stage	PLOS ONE			English	Article							TT-VIRUS; HIGH PREVALENCE; DNA TITER; VIREMIA; IMMUNOSUPPRESSION; HEPATITIS; INFECTION; DYNAMICS; ASSOCIATION; KINETICS	Background Torque teno virus (TTV) is a ubiquitous non-pathogenic virus, which is suppressed in immunological healthy individuals but replicates in immune compromised patients. Thus, TTV load is a suitable biomarker for monitoring the immunosuppression also in lung transplant recipients. Since little is known about the changes of TTV load in lung cancer patients, we analyzed TTV plasma DNA levels in lung cancer patients and its perioperative changes after lung cancer surgery. Material and methods Patients with lung cancer and non-malignant nodules as control group were included prospectively. TTV DNA levels were measured by quantiative PCR using DNA isolated from patients plasma and correlated with routine circulating biomarkers and clinicopathological variables. Results 47 patients (early stage lung cancer n = 30, stage IV lung cancer n = 10, non-malignant nodules n = 7) were included. TTV DNA levels were not detected in seven patients (15%). There was no significant difference between the stage IV cases and the preoperative TTV plasma DNA levels in patients with early stage lung cancer or non-malignant nodules (p = 0.627). While gender, tumor stage and tumor histology showed no correlation with TTV load patients below 65 years of age had a significantly lower TTV load then older patients (p = 0.022). Regarding routine blood based biomarkers, LDH activity was significantly higher in patients with stage IV lung cancer (p = 0.043), however, TTV load showed no correlation with LDH activity, albumin, hemoglobin, CRP or WBC. Comparing the preoperative, postoperative and discharge day TTV load, no unequivocal pattern in the kinetics were. Conclusion Our study suggest that lung cancer has no stage dependent impact on TTV plasma DNA levels and confirms that elderly patients have a significantly higher TTV load. Furthermore, we found no uniform perioperative changes during early stage lung cancer resection on plasma TTV DNA levels.	[Stefani, Dirk; Hegedues, Balazs; Collaud, Stephane; Zaatar, Mohamed; Ploenes, Till; Valdivia, Daniel; Aigner, Clemens] Univ Duisburg Essen, Dept Thorac Surg, Ruhrlandklin, Essen, Germany; [Elsner, Carina; Bleekmann, Barbara; Widera, Marek; Dittmer, Ulf] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Widera, Marek] Goethe Univ, Univ Hosp Frankfurt Main, Inst Med Virol, Frankfurt, Germany	University of Duisburg Essen; University of Duisburg Essen; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Aigner, C (corresponding author), Univ Duisburg Essen, Dept Thorac Surg, Ruhrlandklin, Essen, Germany.	clemens.aigner@rlk.uk-essen.de	Aigner, Clemens/A-7284-2019; Hegedus, Balazs/B-6076-2008; Widera, Marek/AAF-3691-2020; Plönes, Till/AAK-8208-2021; Stephane, Collaud/AAO-1978-2021	Aigner, Clemens/0000-0002-7787-991X; Hegedus, Balazs/0000-0002-4341-4153; Widera, Marek/0000-0001-5417-9307; Plönes, Till/0000-0003-4839-2130; , Stephane/0000-0002-4749-1017				Bando M, 2008, RESPIROLOGY, V13, P263, DOI 10.1111/j.1440-1843.2007.01217.x; Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260; Biagini P, 2000, TRANSFUSION, V40, P590, DOI 10.1046/j.1537-2995.2000.40050590.x; de Villiers EM, 2002, J MOL MED, V80, P44, DOI 10.1007/s001090100281; Focosi D, 2015, J GEN VIROL, V96, P115, DOI 10.1099/vir.0.070094-0; Focosi D, 2014, J INFECT DIS, V210, P667, DOI 10.1093/infdis/jiu209; Focosi D, 2010, J CLIN VIROL, V47, P189, DOI 10.1016/j.jcv.2009.11.027; Frye BC, 2019, TRANSPLANTATION, V103, P815, DOI 10.1097/TP.0000000000002436; Garbuglia AR, 2003, INT J IMMUNOPATH PH, V16, P109, DOI 10.1177/039463200301600204; Giacconi R, 2019, J GERONTOL A-BIOL; Gilles R, 2017, MED MICROBIOL IMMUN, V206, P355, DOI 10.1007/s00430-017-0511-4; Gorzer I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122975; Gorzer I, 2014, J HEART LUNG TRANSPL, V33, P320, DOI 10.1016/j.healun.2013.12.007; Haloschan M, 2014, AGE, V36, DOI 10.1007/s11357-014-9716-2; Huang LY, 2001, J MED VIROL, V64, P381, DOI 10.1002/jmv.1062; Jaksch P, 2018, J INFECT DIS, V218, P1922, DOI 10.1093/infdis/jiy452; Maggi F, 2001, J VIROL, V75, P11999, DOI 10.1128/JVI.75.24.11999-12004.2001; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Norden R, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy050; Okamoto H, 2000, J VIROL, V74, P5161, DOI 10.1128/JVI.74.11.5161-5167.2000; Ruiz P, 2019, LIVER TRANSPLANT, V25, P302, DOI 10.1002/lt.25374; Sawata T, 2018, RESPIR INVESTIG, V56, P173, DOI 10.1016/j.resinv.2017.12.004; Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9; Strassl R, 2019, J INFECT DIS, V219, P1934, DOI 10.1093/infdis/jiz039; Tokita H, 2002, J MED VIROL, V67, P501, DOI 10.1002/jmv.10129; Tyschik EA, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1007-6; Westman G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227670; Zhong S, 2001, ANN NY ACAD SCI, V945, P84; Zhong S, 2001, TRANSFUSION, V41, P1001, DOI 10.1046/j.1537-2995.2001.41081001.x	30	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252304	10.1371/journal.pone.0252304	http://dx.doi.org/10.1371/journal.pone.0252304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077485	Green Published, gold			2022-12-26	WOS:000664638500037
J	Kim, J; Kang, J; Kim, YW; Kim, A				Kim, Jiwook; Kang, Jin; Kim, Yea Woon; Kim, AeRi			The human beta-globin enhancer LCR HS2 plays a role in forming a TAD by activating chromatin structure at neighboring CTCF sites	FASEB JOURNAL			English	Article						CTCF sites; enhancer; LCR HS2; TAD; beta-globin	LOCUS-CONTROL REGION; HYPERSENSITIVE SITES; GENE-EXPRESSION; SPECIFICITY; COOPERATE; SEQUENCE; GATA-1; TARGET	The human beta-globin locus control region (LCR) hypersensitive site 2 (HS2) is one of enhancers for transcription of the beta-like globin genes in erythroid cells. Our previous study showed that the LCR HS2 has active chromatin structure before transcriptional induction of the beta-globin gene, while another enhancer LCR HS3 is activated by the induction. To compare functional difference between them, we deleted each HS (Delta HS2 and Delta HS3) from the human beta-globin locus in hybrid MEL/ch11 cells. Deletion of either HS2 or HS3 dramatically diminished the beta-globin transcription and disrupted locus-wide histone H3K27ac and chromatin interaction between LCR HSs and gene. Surprisingly, Delta HS2 weakened interactions between CTCF sites forming the beta-globin topologically associating domain (TAD), while Delta HS3 did not. CTCF occupancy and chromatin accessibility were reduced at the CTCF sites in the Delta HS2 locus. To further characterize the HS2, we deleted the maf-recognition elements for erythroid activator NF-E2 at HS2. This deletion decreased the beta-globin transcription and enhancer-promoter interaction, but did not affect interactions between CTCF sites for the TAD. In light of these results, we propose that the HS2 has a role in forming a beta-globin TAD by activating neighboring CTCF sites and this role is beyond typical enhancer activity.	[Kim, Jiwook; Kang, Jin; Kim, Yea Woon; Kim, AeRi] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea	Pusan National University	Kim, A (corresponding author), Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Busan 46241, South Korea.	kimaeri@pusan.ac.kr			National Research Foundation of Korea (NRF) [NRF-2017R1A2B4008947]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2017R1A2B4008947	Amid A, 2015, HAEMATOLOGICA, V100, DOI 10.3324/haematol.2014.117408; Bender MA, 2012, BLOOD, V119, P3820, DOI 10.1182/blood-2011-09-380485; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bottardi S, 2005, HUM MOL GENET, V14, P493, DOI 10.1093/hmg/ddi046; Bungert J, 1999, MOL CELL BIOL, V19, P3062; Cho Y, 2008, NUCLEIC ACIDS RES, V36, P4521, DOI 10.1093/nar/gkn368; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; Freese NH, 2016, BIOINFORMATICS, V32, P2089, DOI 10.1093/bioinformatics/btw069; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Huang P, 2017, GENE DEV, V31, P1704, DOI 10.1101/gad.303461.117; Im H, 2005, P NATL ACAD SCI USA, V102, P17065, DOI 10.1073/pnas.0506164102; Joly P, 2011, HEMOGLOBIN, V35, P316, DOI 10.3109/03630269.2011.571331; Kang J, 2018, BBA-GENE REGUL MECH, V1861, P637, DOI 10.1016/j.bbagrm.2018.05.005; Kang Y, 2017, BBA-GENE REGUL MECH, V1860, P416, DOI 10.1016/j.bbagrm.2017.01.013; Kim A, 2003, MOL CELL BIOL, V23, P8099, DOI 10.1128/MCB.23.22.8099-8109.2003; Kim K, 2010, INT J BIOCHEM CELL B, V42, P1517, DOI 10.1016/j.biocel.2010.05.009; Kim S, 2012, INT J BIOCHEM CELL B, V44, P505, DOI 10.1016/j.biocel.2011.12.001; Kim YW, 2020, FASEB J, V34, P14736, DOI 10.1096/fj.202001526R; Kim YW, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170976; Krivega I, 2016, ANN NY ACAD SCI, V1368, P31, DOI 10.1111/nyas.13012; Kukreti R, 2002, AM J HEMATOL, V69, P77, DOI 10.1002/ajh.10026; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levings PP, 2002, EUR J BIOCHEM, V269, P1589, DOI 10.1046/j.1432-1327.2002.02797.x; Li GL, 1998, GENES CELLS, V3, P415, DOI 10.1046/j.1365-2443.1998.00200.x; Majumder P, 2020, J EXP MED, V217, DOI 10.1084/jem.20190668; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Navas PA, 1998, MOL CELL BIOL, V18, P4188, DOI 10.1128/MCB.18.7.4188; Paliou C, 2019, P NATL ACAD SCI USA, V116, P12390, DOI 10.1073/pnas.1900672116; Patrinos GP, 2004, GENE DEV, V18, P1495, DOI 10.1101/gad.289704; Peterson KR, 2012, NUCLEIC ACIDS RES, V40, P11256, DOI 10.1093/nar/gks900; Peterson KR, 1996, P NATL ACAD SCI USA, V93, P6605, DOI 10.1073/pnas.93.13.6605; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reik A, 1998, MOL CELL BIOL, V18, P5992, DOI 10.1128/MCB.18.10.5992; Ross J, 2009, NUCLEIC ACIDS RES, V37, P5295, DOI 10.1093/nar/gkp545; Rubin AJ, 2017, NAT GENET, V49, P1522, DOI 10.1038/ng.3935; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Stees JR, 2016, MOL CELL BIOL, V36, P238, DOI 10.1128/MCB.00723-15; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Yang R, 2016, NUCLEIC ACIDS RES, V44, P3082, DOI 10.1093/nar/gkv1358	44	3	4	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21669	10.1096/fj.202002337R	http://dx.doi.org/10.1096/fj.202002337R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34033138				2022-12-26	WOS:000655695900046
J	Qaisar, SM				Qaisar, Saeed Mian			Signal-piloted processing and machine learning based efficient power quality disturbances recognition	PLOS ONE			English	Article							ARTIFICIAL-INTELLIGENCE; CLASSIFICATION	Significant losses can occur for various smart grid stake holders due to the Power Quality Disturbances (PQDs). Therefore, it is necessary to correctly recognize and timely mitigate the PQDs. In this context, an emerging trend is the development of machine learning assisted PQDs management. Based on the conventional processing theory, the existing PQDs identification is time-invariant. It can result in a huge amount of unnecessary information being collected, processed, and transmitted. Consequently, needless processing activities, power consumption and latency can occur. In this paper, a novel combination of signal-piloted acquisition, adaptive-rate segmentation and time-domain features extraction with machine learning tools is suggested. The signal-piloted acquisition and processing brings real-time compression. Therefore, a remarkable reduction can be secured in the data storage, processing and transmission requirement towards the post classifier. Additionally, a reduced computational cost and latency of classifier is promised. The classification is accomplished by using robust machine learning algorithms. A comparison is made among the k-Nearest Neighbor, Naive Bayes, Artificial Neural Network and Support Vector Machine. Multiple metrics are used to test the success of classification. It permits to avoid any biasness of findings. The applicability of the suggested approach is studied for automated recognition of the power signal's major voltage and transient disturbances. Results show that the system attains a 6.75-fold reduction in the collected information and the processing load and secures the 98.05% accuracy of classification.	[Qaisar, Saeed Mian] Effat Univ, Elect & Comp Engn Dept, Jeddah, Saudi Arabia; [Qaisar, Saeed Mian] Effat Univ, Commun & Signal Proc Lab, Energy & Technol Res Ctr, Jeddah, Saudi Arabia	Effat University; Effat University	Qaisar, SM (corresponding author), Effat Univ, Elect & Comp Engn Dept, Jeddah, Saudi Arabia.; Qaisar, SM (corresponding author), Effat Univ, Commun & Signal Proc Lab, Energy & Technol Res Ctr, Jeddah, Saudi Arabia.	sqaisar@effatuniversity.edu.sa	Mian Qaisar, Saeed/ACK-0050-2022	Mian Qaisar, Saeed/0000-0002-4268-3482	Effat University, Jeddah, KSA [9/29]	Effat University, Jeddah, KSA	S.M.Q secures funding for this project. The project is funded by the Effat University, Jeddah, KSA under the grant No. UC#9/29 April.2020/7.1-22(2)3. https://www.effatuniversity.edu.sa/English/Pages/default.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi R, 2021, SOFTWARE PRACT EXPER, V51, P645, DOI 10.1002/spe.2884; Aguera-Perez A, 2011, MEASUREMENT, V44, P1453, DOI 10.1016/j.measurement.2011.05.014; Alazab M, 2020, IEEE ACCESS, V8, P85454, DOI 10.1109/ACCESS.2020.2991067; Bonaccorso G., 2017, MACHINE LEARNING ALG; Borges FAS, 2016, IEEE T IND INFORM, V12, P824, DOI 10.1109/TII.2015.2486379; Decanini JGMS, 2011, ELECTR POW SYST RES, V81, P2057, DOI 10.1016/j.epsr.2011.07.018; Ebenuwa SH, 2019, IEEE ACCESS, V7, P24649, DOI 10.1109/ACCESS.2019.2899578; Ferreira DD, 2015, ELECTR POW SYST RES, V119, P425, DOI 10.1016/j.epsr.2014.10.028; Flores RA, 2002, INT C HARMON QUAL PO, P17; Gandhi R., 2018, SUPPORT VECTOR MACHI; IEEE Recommended Practice for Power Quality Data Interchange Format (PQDIF), 2019, 115932019 IEEE, P1, DOI [10.1109/IEEESTD.2019.8859685, 10.1109/IEEESTD.2019.8697192, DOI 10.1109/IEEESTD.2019.8697192]; Ingle V.K., 2016, CENGAGE LEARNING; Khokhar S, 2015, RENEW SUST ENERG REV, V51, P1650, DOI 10.1016/j.rser.2015.07.068; Kow KW, 2016, RENEW SUST ENERG REV, V56, P334, DOI 10.1016/j.rser.2015.11.064; Kumar V, 2016, 2016 INTERNATIONAL CONFERENCE ON EMERGING TRENDS IN ELECTRICAL ELECTRONICS & SUSTAINABLE ENERGY SYSTEMS (ICETEESES), P71, DOI 10.1109/ICETEESES.2016.7581355; Latran MB, 2015, IET POWER ELECTRON, V8, P1312, DOI 10.1049/iet-pel.2014.0531; Lgual R., 2018, 2018 18 INT C HARM Q, P1; Liu H, 2018, ELECTR POW SYST RES, V163, P1, DOI 10.1016/j.epsr.2018.05.018; Manikandan MS, 2015, IEEE T INSTRUM MEAS, V64, P27, DOI 10.1109/TIM.2014.2330493; MatLab P., 2018, 97 01190202 R2019B; Naderian S, 2017, IET GENER TRANSM DIS, V11, P133, DOI 10.1049/iet-gtd.2016.0703; Panigrahi R, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9070751; Pham Q.-V., 2021, ARXIV PREPR ARXIV210; Qaisar S.M., 2020, GREEN ENERGY SOL ENE, P191, DOI [10.1002/9781119760801.ch7, DOI 10.1002/9781119760801.CH7]; Qaisar S.M., 2020, J ELECTR ENG TECHNOL; Qaisar S.M., 2019, TIME DOMAIN IDENTIFI, P1; Qaisar SM, 2021, COMPUT METH PROG BIO, V203, DOI 10.1016/j.cmpb.2021.106034; Qaisar SM, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21041511; Qaisar SM, 2020, PROCEDIA COMPUT SCI, V168, P217, DOI 10.1016/j.procs.2020.02.266; Qaisar SM, 2020, PHYS ENG SCI MED, V43, P623, DOI 10.1007/s13246-020-00863-6; Qaisar SM, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20082252; Qaisar SM, 2019, COMPUT ELECTR ENG, V79, DOI 10.1016/j.compeleceng.2019.106462; Qaisar SM, 2014, SIGNAL PROCESS, V94, P620, DOI 10.1016/j.sigpro.2013.07.019; Rodrigues Junior W.L., 2020, INT J ENERGY RES; Rodriguez-Guerrero MA, 2017, ELECTR POW SYST RES, V143, P14, DOI 10.1016/j.epsr.2016.09.003; Ronnberg Sarah, 2016, Electricity Journal, V29, P49, DOI 10.1016/j.tej.2016.11.006; Singh U, 2018, IEEE T IND INFORM, V14, P2994, DOI 10.1109/TII.2017.2773475; Taniguchi H., 2016, IMPLEMENTATION HUMAN, P483; Ucar F, 2018, ENERGIES, V11, DOI 10.3390/en11010145; Van den Broeck G, 2018, APPL ENERG, V229, P281, DOI 10.1016/j.apenergy.2018.07.058; van Gerven Marcel, 2017, Front Comput Neurosci, V11, P114, DOI 10.3389/fncom.2017.00114; Wang Q, 2020, IEEE ACCESS, V8, P134067, DOI 10.1109/ACCESS.2020.3011032; Witten IH, 2011, MOR KAUF D, P1	43	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252104	10.1371/journal.pone.0252104	http://dx.doi.org/10.1371/journal.pone.0252104			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048442	gold, Green Published			2022-12-26	WOS:000664636100021
J	Chen, LW; Chen, PH; Yen, JH				Chen, Lee-Wei; Chen, Pei-Hsuan; Yen, Jui-Hung			Inhibiting adipose tissue M1 cytokine expression decreases DPP4 activity and insulin resistance in a type 2 diabetes mellitus mouse model	PLOS ONE			English	Article							INFLAMMATION; OBESITY; PROLIFERATION; MACROPHAGES; PROGRESSION; CELLS	Adipose tissue inflammation is a major cause of the pathogenesis of obesity and comorbidities. To study the involvement of M1/M2 cytokine expression of adipose tissue in the regulatory mechanisms of dipeptidyl peptidase 4 (DPP4) and insulin resistance in diabetes, stromal vascular fractions (SVFs) were purified from inguinal adipose tissue of diabetic (Lepr(db/db)) and non-diabetic (Lepr(+/+)) mice followed by analysis of M1/M2 cytokine expression. SVFs of Lepr(db/db) mice exhibited increased TNF-alpha, IL-6, IL-1 beta, CCL2, and DPP4 mRNA expression but decreased IL-10 mRNA expression. Plasma from Lepr(db/db) mice induced TNF-alpha, IL-6, IL-1 beta, CCL2, and DPP4 mRNA expression and plasma from Lepr(+/+) mice induced IL-10 mRNA expression in SVFs from Lepr(db/db) mice. Injection of Lepr(+/+) plasma into the adipose tissue of Lepr(db/db) mice decreased mRNA expression of TNF-alpha, IL-6, IL-1 beta, CCL2, and DPP4 and protein expression of pJNK and DPP4 in SVFs, reduced mRNA expression of ICAM, FMO3, IL-1 beta, iNOS, TNF-alpha, IL-6, and DPP4 and protein expression of ICAM, FMO3, and DPP4 in liver, and suppressed mRNA expression of TNF-alpha, IL-6, IL-1 beta, and DPP4 in Kupffer cells. Plasma from Lepr(db/db) mice did not induce M1 cytokine expression in SVFs from Lepr(db/db)-Jnk1(-/-) mice. Altogether, we demonstrate that diabetes induces M1 but decreases M2 cytokine expression in adipose tissue. Diabetic plasma-induced M1 expression is potentially through pJNK signaling pathways. Non-diabetic plasma reverses M1/M2 cytokine expression, plasma CCL2 levels, DPP4 activity, and Kupffer cell activation in diabetes. Our results suggest M1/M2 cytokine expression in adipose tissue is critical in diabetes-induced DPP4 activity, liver inflammation, and insulin resistance.	[Chen, Lee-Wei; Chen, Pei-Hsuan] Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan; [Chen, Lee-Wei] Natl Yang Ming Chiao Tung Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan; [Chen, Lee-Wei] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Yen, Jui-Hung] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; National Sun Yat Sen University; Indiana University System; Indiana University Bloomington	Chen, LW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Surg, Kaohsiung, Taiwan.; Chen, LW (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Emergency & Crit Care Med, Taipei, Taiwan.; Chen, LW (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan.; Yen, JH (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	lwchen@vghks.gov.tw; jimyen@iu.edu		Chen, Lee-Wei/0000-0002-3583-1248; Yen, Jui-Hung Jimmy/0000-0002-7325-9756	National Science Council [MOST 107-2314-B-010-043-MY3]; Kaohsiung Veterans General Hospital [VGHKS109-097]	National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Veterans General Hospital	LW Chen: National Science Council (MOST 107-2314-B-010-043-MY3) www.most.gov.tw LW Chen: Kaohsiung Veterans General Hospital (VGHKS109-097) www.vghks.gov.tw The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Bluher M, 2016, CLIN SCI, V130, P1603, DOI 10.1042/CS20160005; Braune J, 2017, J IMMUNOL, V198, P2927, DOI 10.4049/jimmunol.1600476; Casrouge A, 2018, CLIN EXP IMMUNOL, V194, P166, DOI 10.1111/cei.13163; Dregan A, 2014, CIRCULATION, V130, P837, DOI 10.1161/CIRCULATIONAHA.114.009990; Engin A, 2017, ADV EXP MED BIOL, V960, P221, DOI 10.1007/978-3-319-48382-5_9; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Furuya F, 2019, CONTRIB NEPHROL, V198, P33, DOI 10.1159/000496526; Ghorpade DS, 2018, NATURE, V555, P673, DOI 10.1038/nature26138; Guzik TJ, 2017, CARDIOVASC RES, V113, P1009, DOI 10.1093/cvr/cvx108; Hill AA, 2014, IMMUNOL REV, V262, P134, DOI 10.1111/imr.12216; Kirino Y, 2009, J ENDOCRINOL, V200, P53, DOI 10.1677/JOE-08-0424; Kirino Y, 2011, AM J PHYSIOL-ENDOC M, V300, pE372, DOI 10.1152/ajpendo.00319.2010; Kos K, 2009, DIABETES OBES METAB, V11, P285, DOI 10.1111/j.1463-1326.2008.00909.x; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lin SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177269; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Sakai N, 2012, HEPATOLOGY, V55, P888, DOI 10.1002/hep.24756; Santangelo C, 2019, ACTA DIABETOL, V56, P681, DOI 10.1007/s00592-019-01304-x; Varin EM, 2019, CELL METAB, V29, P320, DOI 10.1016/j.cmet.2018.10.001; Wronkowitz N, 2014, BBA-MOL BASIS DIS, V1842, P1613, DOI 10.1016/j.bbadis.2014.06.004; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zheng TP, 2015, ATHEROSCLEROSIS, V242, P580, DOI 10.1016/j.atherosclerosis.2015.07.042; Zhong JX, 2013, DIABETES, V62, P149, DOI 10.2337/db12-0230	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252153	10.1371/journal.pone.0252153	http://dx.doi.org/10.1371/journal.pone.0252153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043673	gold, Green Published			2022-12-26	WOS:000664635700060
J	Ezaj, MMA; Haque, MS; Syed, SB; Khan, MSA; Ahmed, KR; Khatun, MT; Nayeem, SMA; Rizvi, GR; Al-Forkan, M; Khaleda, L				Ezaj, Md. Muzahid Ahmed; Haque, Md. Sajedul; Syed, Shifath Bin; Khan, Md. Shakil Ahmed; Ahmed, Kazi Rejvee; Khatun, Mst. Tania; Nayeem, S. M. Abdul; Rizvi, Golam Rosul; Al-Forkan, Mohammad; Khaleda, Laila			Comparative proteomic analysis to annotate the structural and functional association of the hypothetical proteins of S. maltophilia k279a and predict potential T and B cell targets for vaccination	PLOS ONE			English	Article							STENOTROPHOMONAS XANTHOMONAS MALTOPHILIA; PERIPLASMIC LYSOZYME INHIBITOR; GRAM-NEGATIVE BACTERIA; OUTER-MEMBRANE; TRIMETHOPRIM-SULFAMETHOXAZOLE; ANTIGENIC DETERMINANTS; SECONDARY-STRUCTURE; CONSERVED PROTEINS; CRYSTAL-STRUCTURE; CALCIUM-BINDING	Stenotrophomonas maltophilia is a multidrug-resistant bacterium with no precise clinical treatment. This bacterium can be a vital cause for death and different organ failures in immune-compromised, immune-competent, and long-time hospitalized patients. Extensive quorum sensing capability has become a challenge to develop new drugs against this pathogen. Moreover, the organism possesses about 789 proteins which function, structure, and pathogenesis remain obscured. In this piece of work, we tried to enlighten the aforementioned sectors using highly reliable bioinformatics tools validated by the scientific community. At first, the whole proteome sequence of the organism was retrieved and stored. Then we separated the hypothetical proteins and searched for the conserved domain with a high confidence level and multi-server validation, which resulted in 24 such proteins. Furthermore, all of their physical and chemical characterizations were performed, such as theoretical isoelectric point, molecular weight, GRAVY value, and many more. Besides, the subcellular localization, protein-protein interactions, functional motifs, 3D structures, antigenicity, and virulence factors were also evaluated. As an extension of this work, 'RTFAMSSER' and 'PAAPQPSAS' were predicted as potential T and B cell epitopes, respectively. We hope our findings will help in better understating the pathogenesis and smoothen the way to the cure.	[Ezaj, Md. Muzahid Ahmed; Rizvi, Golam Rosul; Al-Forkan, Mohammad; Khaleda, Laila] Univ Chittagong, Fac Biol Sci, Dept Genet Engn & Biotechnol, Chattogram, Bangladesh; [Ezaj, Md. Muzahid Ahmed; Nayeem, S. M. Abdul] Reverse Vaccinol Res Div, Adv Bioinformat Computat Biol & Data Sci Lab, Chittagong, Bangladesh; [Haque, Md. Sajedul; Nayeem, S. M. Abdul] Univ Chittagong, Fac Sci, Dept Chem, Chattogram, Bangladesh; [Syed, Shifath Bin; Khan, Md. Shakil Ahmed; Ahmed, Kazi Rejvee; Khatun, Mst. Tania] Islamic Univ, Fac Biol Sci, Dept Biotechnol & Genet Engn, Kushtia, Bangladesh	University of Chittagong; University of Chittagong; Islamic University	Khaleda, L (corresponding author), Univ Chittagong, Fac Biol Sci, Dept Genet Engn & Biotechnol, Chattogram, Bangladesh.	lkankhi@gmail.com	Bin Syed, Shifath/ABD-6865-2021; Ezaj, Muzahid Ahmed/AAJ-5333-2021	Bin Syed, Shifath/0000-0002-4786-0337; Ezaj, Muzahid Ahmed/0000-0002-1139-985X; Khan, Md. Shakil Ahmed/0000-0003-0414-1487; Haque, Md Sajedul/0000-0002-6343-4901				Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Adegoke AA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02276; Akcakaya AA, 2011, BRIT J OPHTHALMOL, V95, P481, DOI 10.1136/bjo.2009.177709; Alexandre G, 2003, J BACTERIOL, V185, P544, DOI 10.1128/JB.185.2.544-552.2003; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amin R, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009249.pub5; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arvanitidou M, 2003, J APPL MICROBIOL, V95, P180, DOI 10.1046/j.1365-2672.2003.01966.x; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685; Batchelor AH, 1998, SCIENCE, V279, P1037, DOI 10.1126/science.279.5353.1037; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Berg G, 1999, J CLIN MICROBIOL, V37, P3594, DOI 10.1128/JCM.37.11.3594-3600.1999; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Bin Abdulhak AA, 2009, DIAGN MICR INFEC DIS, V63, P330, DOI 10.1016/j.diagmicrobio.2008.11.003; BJORNSON HS, 1984, REV INFECT DIS, V6, pS21; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Bos MP, 2004, P NATL ACAD SCI USA, V101, P9417, DOI 10.1073/pnas.0402340101; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Brooke JS, 2014, EXPERT REV ANTI-INFE, V12, P1, DOI 10.1586/14787210.2014.864553; Brun C, 2004, GENOME BIOL, V5; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Calza L, 2003, INFECTION, V31, P155, DOI 10.1007/s15010-003-3113-6; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; Chang YT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00893; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chen CC, 2006, NUCLEIC ACIDS RES, V34, pW152, DOI 10.1093/nar/gkl187; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Chen J, 2011, J CELL BIOCHEM, V112, P2694, DOI 10.1002/jcb.23219; Chimalakonda G, 2011, P NATL ACAD SCI USA, V108, P2492, DOI 10.1073/pnas.1019089108; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Oliveira-Garcia D, 2003, CELL MICROBIOL, V5, P625, DOI 10.1046/j.1462-5822.2003.00306.x; de Oliveira-Garcia D, 2002, EMERG INFECT DIS, V8, P918, DOI 10.3201/eid0809.010535; Deckers D, 2004, CELL MOL LIFE SCI, V61, P1229, DOI 10.1007/s00018-004-4066-3; DeLano W.L., 2002, CCP4 NEWSL PROTEIN C, V40, P82; Denton M, 2003, J HOSP INFECT, V55, P180, DOI 10.1016/S0195-6701(03)00299-8; Desler C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-289; Dimitrov I, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2278-5; Djordjevic S, 1998, J STRUCT BIOL, V124, P189, DOI 10.1006/jsbi.1998.4034; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Enany S, 2014, J INFECT PUBLIC HEAL, V7, P296, DOI 10.1016/j.jiph.2014.02.002; Fernandes P, 2006, NAT BIOTECHNOL, V24, P1497, DOI 10.1038/nbt1206-1497; Fujita J, 1996, RESP MED, V90, P35, DOI 10.1016/S0954-6111(96)90242-5; Furushita M, 2005, APPL ENVIRON MICROB, V71, P5598, DOI 10.1128/AEM.71.9.5598-5600.2005; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-62; Gasteiger E, 2001, Curr Issues Mol Biol, V3, P47; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gerlt JA, 2000, GENOME BIOL, V1; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Greenbaum JA, 2007, J MOL RECOGNIT, V20, P75, DOI 10.1002/jmr.815; Griswold IJ, 2002, NAT STRUCT BIOL, V9, P121, DOI 10.1038/nsb753; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hajiahmadi Z, 2020, IDENTIFICATION EVOLU; Harris NB, 2001, J VET DIAGN INVEST, V13, P255, DOI 10.1177/104063870101300313; He PQ, 2011, J INORG BIOCHEM, V105, P1259, DOI 10.1016/j.jinorgbio.2011.06.006; Hejnar P, 2007, VET MICROBIOL, V121, P357, DOI 10.1016/j.vetmic.2006.12.026; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Huedo P, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00122; HUGH R, 1963, INT B BACT NOMENCL T, V13, P133, DOI 10.1099/0096266X-13-3-133; Hutchinson GR, 1996, J CLIN MICROBIOL, V34, P584, DOI 10.1128/JCM.34.3.584-587.1996; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Ikura M, 1996, TRENDS BIOCHEM SCI, V21, P14, DOI 10.1016/0968-0004(96)80879-6; Izard T, 2001, PROTEIN SCI, V10, P1508, DOI 10.1110/ps.10.8.1508; Izard T, 2000, EMBO J, V19, P2690, DOI 10.1093/emboj/19.11.2690; Jang Tsrang-Neng, 1992, Journal of the Formosan Medical Association, V91, P1170; Johnson EH, 2003, J VET MED B, V50, P102, DOI 10.1046/j.1439-0450.2003.00643.x; Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Katayama T, 2010, INTERNAL MED, V49, P1775, DOI 10.2169/internalmedicine.49.3701; Kim YC, 2004, J BIOL CHEM, V279, P517, DOI 10.1074/jbc.M306054200; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar K, 2014, GENE, V543, P93, DOI 10.1016/j.gene.2014.03.060; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Labarca JA, 2000, CLIN INFECT DIS, V30, P195, DOI 10.1086/313591; Lai CH, 2006, CLIN MICROBIOL INFEC, V12, P986, DOI 10.1111/j.1469-0691.2006.01511.x; Lai Chung-Hsu, 2004, Journal of Microbiology Immunology and Infection, V37, P350; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Landrum ML, 2005, CLIN INFECT DIS, V40, P1551, DOI 10.1086/429730; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lidsky K, 2002, CLIN INFECT DIS, V34, P760, DOI 10.1086/338957; Lin HC, 2011, CORNEA, V30, P712, DOI 10.1097/ICO.0b013e31820007ed; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; Lubec G, 2005, PROG NEUROBIOL, V77, P90, DOI 10.1016/j.pneurobio.2005.10.001; Mahdavi M, 2012, ASIAN PAC J CANCER P, V13, P3053, DOI 10.7314/APJCP.2012.13.7.3053; Malik HS, 2000, TRENDS BIOCHEM SCI, V25, P414, DOI 10.1016/S0968-0004(00)01623-6; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marra Andrea, 2006, Drugs R D, V7, P1, DOI 10.2165/00126839-200607010-00001; Mauger TF, 2010, CLIN OPHTHALMOL, V4, P1207, DOI 10.2147/OPTH.S14507; Maurer-Stroh S, 2019, BIOINFORMATICS, V35, P3020, DOI 10.1093/bioinformatics/btz029; Metan G, 2006, SCAND J INFECT DIS, V38, P527, DOI 10.1080/00365540500452481; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Moreira D, 1999, TRENDS BIOCHEM SCI, V24, P298, DOI 10.1016/S0968-0004(99)01419-X; Nair DT, 2002, J IMMUNOL, V168, P2371, DOI 10.4049/jimmunol.168.5.2371; NESME X, 1995, SYST APPL MICROBIOL, V18, P127, DOI 10.1016/S0723-2020(11)80460-1; Neugebauer J, 2002, J COMPUT CHEM, V23, P895, DOI 10.1002/jcc.10089; Nimrod G, 2008, STRUCTURE, V16, P1755, DOI 10.1016/j.str.2008.10.017; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; Nseir S, 2006, CRIT CARE MED, V34, P2959, DOI 10.1097/01.CCM.0000245666.28867.C6; O'Donnell MJ, 2005, J HOSP INFECT, V59, P348, DOI 10.1016/j.jhin.2004.10.001; Oliver WT, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0034-z; Organization WHO, 2013, PUBL HLTH IMP ANT RE; PALLERONI NJ, 1993, INT J SYST BACTERIOL, V43, P606, DOI 10.1099/00207713-43-3-606; PAPADAKIS KA, 1995, CLIN INFECT DIS, V21, P1032, DOI 10.1093/clinids/21.4.1032; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pompilio A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-102; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; Rascon-Castelo E, 2015, VIRUSES-BASEL, V7, P873, DOI 10.3390/v7030873; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293; Rojas Pilar, 2009, J Med Case Rep, V3, P7389, DOI 10.4076/1752-1947-3-7389; Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000; Sader HS, 2005, INT J ANTIMICROB AG, V25, P95, DOI 10.1016/j.ijantimicag.2004.10.002; SAFFEN DW, 1987, J BIOL CHEM, V262, P16241; Saghatelian A, 2005, NAT CHEM BIOL, V1, P130, DOI 10.1038/nchembio0805-130; Saha Sudipto, 2006, Genomics Proteomics & Bioinformatics, V4, P42, DOI 10.1016/S1672-0229(06)60015-6; Sakhnini E, 2002, AM J MED SCI, V323, P269, DOI 10.1097/00000441-200205000-00008; SCHABLE B, 1991, INFECT CONT HOSP EP, V12, P163, DOI 10.2307/30146933; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Shahbaaz M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084263; Sinha A, 2015, LETT DRUG DES DISCOV, V12, P46; Skolnick J, 2000, TRENDS BIOTECHNOL, V18, P34, DOI 10.1016/S0167-7799(99)01398-0; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Srinivasan B., 2011, STRUCTURE FUNCTION S; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Takigawa M, 2008, CARDIOLOGY, V110, P226, DOI 10.1159/000112404; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Thiriet M., 2011, SIGNALING CELL SURFA; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Joolingen WR, 2005, COMPUT HUM BEHAV, V21, P671, DOI 10.1016/j.chb.2004.10.039; VARTIVARIAN SE, 1994, ANN INTERN MED, V121, P969, DOI 10.7326/0003-4819-121-12-199412150-00011; Vetrivel Umashankar, 2011, Hugo J, V5, P25, DOI 10.1007/s11568-011-9152-7; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Wang YL, 2014, ANTIMICROB AGENTS CH, V58, P176, DOI 10.1128/AAC.01324-13; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; WEST AH, 1995, J MOL BIOL, V250, P276, DOI 10.1006/jmbi.1995.0376; Wladis EJ, 2011, OPHTHAL PLAST RECONS, V27, pE116, DOI 10.1097/IOP.0b013e318201ca3b; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Xu D, 2000, CURR PROTEIN PEPT SC, V1, P1, DOI 10.2174/1389203003381469; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yum S, 2009, BIOCHEM BIOPH RES CO, V378, P244, DOI 10.1016/j.bbrc.2008.11.039; Zemskov EA, 2000, J VIROL, V74, P6784, DOI 10.1128/JVI.74.15.6784-6789.2000; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18	177	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252295	10.1371/journal.pone.0252295	http://dx.doi.org/10.1371/journal.pone.0252295			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043709	Green Published, gold			2022-12-26	WOS:000664635700081
J	Hao, Q; Yang, L; Fan, DY; Zeng, B; Jin, J				Hao, Qing; Yang, Lei; Fan, Dingyu; Zeng, Bin; Jin, Juan			The transcriptomic response to heat stress of a jujube (Ziziphus jujuba Mill.) cultivar is featured with changed expression of long noncoding RNAs	PLOS ONE			English	Article							GENE; IDENTIFICATION; CLASSIFICATION; TEMPERATURE; REVEALS; LNCRNAS; SEQ; DISCOVERY; INSIGHTS; TOLERANT	Long non-coding RNA (lncRNA) of plant species undergoes dynamic regulation and acts in developmental and stress regulation. Presently, there is little information regarding the identification of lncRNAs in jujube (Ziziphus jujuba Mill.), and it is uncertain whether the lncRNAs could respond to heat stress (HS) or not. In our previous study, a cultivar (Hqing1-HR) of Z. jujuba were treated by HS (45 degrees C) for 0, 1, 3, 5 and 7 days, and it was found that HS globally changed the gene expression by RNA sequencing (RNA-seq) experiments and informatics analyses. In the current study, 8260 lncRNAs were identified successfully from the previous RNA-seq data, and it indicated that lncRNAs expression was also altered globally, suggesting that the lncRNAs might play vital roles in response to HS. Furthermore, bioinformatics analyses of potential target mRNAs of lncRNAs with cis-acting mechanism were performed, and it showed that multiple differentially expressed (DE) mRNAs co-located with DElncRNAs were highly enriched in pathways associated with response to stress and regulation of metabolic process. Taken together, these findings not only provide a comprehensive identification of lncRNAs but also useful clues for molecular mechanism response to HS in jujube.	[Hao, Qing; Yang, Lei; Fan, Dingyu; Jin, Juan] Xinjiang Acad Agr Sci, Inst Hort Crops, Urumqi, Peoples R China; [Zeng, Bin] Xinjiang Agr Univ, Coll Forestry & Hort, Urumqi, Peoples R China; [Zeng, Bin] Sub Branch Natl Melon & Fruit Improvement Ctr, Dept Crop Genet & Breeding, Urumqi, Peoples R China	Xinjiang Agricultural University	Hao, Q (corresponding author), Xinjiang Acad Agr Sci, Inst Hort Crops, Urumqi, Peoples R China.	haoqingxj@sohu.com			National Natural Science Foundation of China [31801815]; Natural Science Foundation of Xinjiang China [2019D01A64]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xinjiang China	This work was supported by the "National Natural Science Foundation of China" (Grant number: 31801815) and "Natural Science Foundation of Xinjiang China" (Grant number: 2019D01A64). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashir K., 2019, F1000RES, P8, DOI [10.12688/f1000research.17047.1, DOI 10.12688/F1000RESEARCH.17047.1]; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Di C, 2014, PLANT J, V80, P848, DOI 10.1111/tpj.12679; Gao QH, 2013, J AGR FOOD CHEM, V61, P3351, DOI 10.1021/jf4007032; Gonzalez-Schain N, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv174; Hashim JH, 2016, ASIA-PAC J PUBLIC HE, V28, p8S, DOI 10.1177/1010539515599030; Huang J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006433; Jarroux J, 2017, ADV EXP MED BIOL, V1008, P1, DOI 10.1007/978-981-10-5203-3_1; Jin J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235763; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamaoui Mouna, 2018, Front Chem, V6, P26, DOI 10.3389/fchem.2018.00026; Lesk C, 2016, NATURE, V529, P84, DOI 10.1038/nature16467; Li C, 2014, ENVIRON ENTOMOL, V43, P511, DOI 10.1603/EN13317; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Liu J, 2015, PLANT BIOTECHNOL J, V13, P319, DOI 10.1111/pbi.12336; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu MJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma LN, 2013, RNA BIOL, V10, P925, DOI 10.4161/rna.24604; Ohama N, 2017, TRENDS PLANT SCI, V22, P53, DOI 10.1016/j.tplants.2016.08.015; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Richard JLC, 2018, SLAS TECHNOL, V23, P493, DOI 10.1177/2472630318780639; Rienth M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-108; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi J, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0973-y; Song LJ, 2019, MOLECULES, V24, DOI 10.3390/molecules24244528; Song S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081734; Song XM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2625-2; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang JX, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060311; Wang PF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43269-5; Xiao J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127812; Xiao L, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5895-7; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Zhang CM, 2018, PLANTA, V248, P1187, DOI 10.1007/s00425-018-2971-1; Zhang XP, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2088-0; Zhao C, 2017, P NATL ACAD SCI USA, V114, P9326, DOI 10.1073/pnas.1701762114; Zhao JG, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.01213, 10.3339/fpls.2016.01213]; Zhao XB, 2019, GENES-BASEL, V10, DOI 10.3390/genes10070536; Zhuang QW, 2020, PEERJ, V8, DOI 10.7717/peerj.8282	47	1	1	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0249663	10.1371/journal.pone.0249663	http://dx.doi.org/10.1371/journal.pone.0249663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043642	Green Published, gold			2022-12-26	WOS:000664635700011
J	Olmedilla-Alonso, B; Rodriguez-Rodriguez, E; Beltran-de-Miguel, B; Estevez-Santiago, R; Sanchez-Prieto, M				Olmedilla-Alonso, Begona; Rodriguez-Rodriguez, Elena; Beltran-de-Miguel, Beatriz; Estevez-Santiago, Rocio; Sanchez-Prieto, Milagros			Predictors of macular pigment and contrast threshold in Spanish healthy normolipemic subjects (45-65 years) with habitual food intake	PLOS ONE			English	Article							2 AGE-GROUPS; DIETARY-INTAKE; SERUM CONCENTRATIONS; ZEAXANTHIN STATUS; OPTICAL-DENSITY; VITAMIN-A; LUTEIN; CAROTENOIDS; DEGENERATION; PERFORMANCE	Introduction The dietary carotenoids lutein (L) and zeaxanthin (Z) are transported in the bloodstream by lipoproteins, sequestered by adipose tissue, and eventually captured in the retina where they constitute macular pigment. There are no L&Z dietary intake recommendations nor desired blood/tissue concentrations for the Spanish general population. Our aim was to assess the correlation of L&Z habitual dietary intake (excluding food supplements), resulting serum concentrations and lipid profile with macular pigment optical density (MPOD) as well as the contrast sensitivity (CT), as visual outcome in normolipemic subjects (n = 101) aged 45-65. Methods MPOD was measured by heterochromatic flicker photometry, serum L&Z by HPLC, the dietary intake by a 3-day food records and CT using the CGT-1000-Contrast-Glaretester at six stimulus sizes, with and without glare. Results Lutein and zeaxanthin concentrations (median) in serum: 0.361 and 0.078 mu mol/L, in dietary intake: 1.1 mg L+Z/day. MPOD: 0.34du. L+Z intake correlates with their serum concentrations (rho = 0.333, p = 0.001), which in turn correlates with MPOD (rho = 0.229, p = 0.000) and with fruit and vegetable consumption (rho = 0.202, p = 0.001), but not with lutein+zeaxanthin dietary intake. MPOD correlated with CT, with and without glare (rho ranges: -0.135, 0.160 and -0.121, -0.205, respectively). MPOD predictors: serum L+Z, L+Z/HDL-cholesterol (beta -coeficient: -0.910.2, 95%CI: -1.3,-0.5) and HDL-cholesterol (R-2 = 15.9%). CT predictors: MPOD, mainly at medium and smaller visual angles (corresponding to spatial frequencies for which sensitivity declines with age) and gender (beta -coefficients ranges: -0.95,-0.39 and -0.13,-0.39, respectively). Conclusion A higher MPOD is associated with a lower ratio of L+Z/HDL-cholesterol and with a lower CT (higher contrast sensitivity). The HDL-cholesterol would also act indirectly on the CT improving the visual function.	[Olmedilla-Alonso, Begona; Estevez-Santiago, Rocio; Sanchez-Prieto, Milagros] Technol & Nutr ICTAN CSIC, Dept Metab & Nutr, Inst Food Sci, Madrid, Spain; [Rodriguez-Rodriguez, Elena] Univ Complutense Madrid, Dept Chem Pharmaceut Sci, Fac Pharm, Madrid, Spain; [Beltran-de-Miguel, Beatriz] Univ Complutense Madrid, Dept Nutr & Food Sci, Fac Pharm, Madrid, Spain; [Estevez-Santiago, Rocio] Francisco Vitoria Univ, Fac Expt Sci, Pozuelo Alarcon, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); Complutense University of Madrid; Complutense University of Madrid; Universidad Francisco de Vitoria	Olmedilla-Alonso, B (corresponding author), Technol & Nutr ICTAN CSIC, Dept Metab & Nutr, Inst Food Sci, Madrid, Spain.	BOlmedilla@ictan.csic.es	Santiago, Rocío Estévez/K-3362-2013; Olmedilla-Alonso, Begoña/D-1337-2012	Santiago, Rocío Estévez/0000-0001-6121-7703; Olmedilla-Alonso, Begoña/0000-0002-4913-5171	Instituto de Salud Carlos III [PS09/00681, PI16/01991]; ERDF/European Social Fund; Consejo Superior de Investigaciones Cientificas (CSIC) [201970E033]; CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ERDF/European Social Fund; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI)	B.O-A, E.R-R, B.B-d-M received finantial support from the Instituto de Salud Carlos III (grants PS09/00681 and PI16/01991), co-funded by ERDF/European Social Fund. B. O-A received finantiation from the Consejo Superior de Investigaciones Cientificas (CSIC), P. intramural (grant 201970E033). The publication fee is partially supported by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuffo KO, 2017, BRIT J OPHTHALMOL, V101, P190, DOI 10.1136/bjophthalmol-2016-308418; Andersen GJ, 2012, WIRES COGN SCI, V3, P403, DOI 10.1002/wcs.1167; Arunkumar R, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158617; Beltran B, 2012, NUTR HOSP, V27, P1334, DOI 10.3305/nh.2012.27.4.5886; Bohm V, 2021, NUTR REV, V79, P544, DOI 10.1093/nutrit/nuaa008; Bovier ER, 2013, NUTRIENTS, V5, P750, DOI 10.3390/nu5030750; Broekmans WMR, 2002, AM J CLIN NUTR, V76, P595, DOI 10.1093/ajcn/76.3.595; Burke JD, 2005, J NUTR, V135, P1208, DOI 10.1093/jn/135.5.1208; Burrows T. L., 2015, Journal of Nutrition & Intermediary Metabolism, V2, P15, DOI 10.1016/j.jnim.2015.05.001; Buscemi S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091321; Cardinault N, 2005, CLIN CHIM ACTA, V357, P34, DOI 10.1016/j.cccn.2005.01.030; CLEVIDENCE BA, 1993, METHOD ENZYMOL, V214, P33; Colijn JM, 2019, OPHTHALMOLOGY, V126, P393, DOI 10.1016/j.ophtha.2018.09.045; Estevez-Santiago R, 2016, NUTR RES, V36, P719, DOI 10.1016/j.nutres.2016.02.007; Estevez-Santiago R, 2016, INT J FOOD SCI NUTR, V67, P305, DOI 10.3109/09637486.2016.1147020; Estevez-Santiago R, 2013, NUTR HOSP, V28, P823, DOI 10.3305/nh.2013.28.3.6451; Fan Q, 2017, INT J EPIDEMIOL, V46, P1891, DOI 10.1093/ije/dyx189; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Goulinet S, 1997, ARTERIOSCL THROM VAS, V17, P786, DOI 10.1161/01.ATV.17.4.786; Granado F, 2003, BRIT J NUTR, V90, P487, DOI 10.1079/BJN2003927; Granado-Lorencio F, 2006, EUR J CLIN NUTR, V60, P1000, DOI 10.1038/sj.ejcn.1602411; Hammond BR, 2002, INVEST OPHTH VIS SCI, V43, P47; Hammond BR, 1998, INVEST OPHTH VIS SCI, V39, P397; Huang YM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/564738; Jansen MCJF, 2004, EUR J CLIN NUTR, V58, P1386, DOI 10.1038/sj.ejcn.1601981; Johnson EJ, 2014, NUTR REV, V72, P605, DOI 10.1111/nure.12133; Johnson J.J., 2019, COGENT MED, V6, DOI [10.1080/2331205X.2019.1683939, DOI 10.1080/2331205X.2019.1683939]; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Leung IYF, 2005, EXP EYE RES, V81, P513, DOI 10.1016/j.exer.2005.03.009; Lien EL, 2011, PROG RETIN EYE RES, V30, P188, DOI 10.1016/j.preteyeres.2011.01.001; Loane E, 2010, INVEST OPHTH VIS SCI, V51, P5897, DOI 10.1167/iovs.09-4878; Loskutova E, 2013, NUTRIENTS, V5, P1962, DOI 10.3390/nu5061962; Mariutti LRB, 2018, ARCH BIOCHEM BIOPHYS, V648, P36, DOI 10.1016/j.abb.2018.04.005; Olmedilla B, 2003, NUTRITION, V19, P21, DOI 10.1016/S0899-9007(02)00861-4; Olmedilla-Alonso B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-52; Ortega R.M., 2008, DIAL PROGRAMA EVALUA; Putnam Christopher M, 2015, J Optom, V8, P258, DOI 10.1016/j.optom.2014.12.004; Ranard KM, 2017, EUR J NUTR, V56, P537, DOI 10.1007/s00394-017-1580-2; Renzi LM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-33; Richer Stuart, 2004, Optometry, V75, P216, DOI 10.1016/S1529-1839(04)70049-4; Rodriguez-Concepcion M, 2018, PROG LIPID RES, V70, P62, DOI 10.1016/j.plipres.2018.04.004; Rutledge GA, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01742-0; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Stahl W, 2001, BIOFACTORS, V15, P95, DOI 10.1002/biof.5520150209; Stringham JM, 2008, OPTOMETRY VISION SCI, V85, P82, DOI 10.1097/OPX.0b013e318162266e; Stringham JM, 2019, CURR DEV NUTR, V3, DOI 10.1093/cdn/nzz066; Stringham JM, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0060-8; Stringham JM, 2015, INVEST OPHTH VIS SCI, V56, P2459, DOI 10.1167/iovs.14-15716; Thomas SE, 2016, J LIPID RES, V57, P1865, DOI 10.1194/jlr.M070193; van der Made SM, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/9035745; van der Veen RLP, 2009, OPHTHAL PHYSL OPT, V29, P127, DOI 10.1111/j.1475-1313.2008.00618.x; van Leeuwen EM, 2018, PROG RETIN EYE RES, V67, P56, DOI 10.1016/j.preteyeres.2018.04.006; Vishwanathan R, 2013, NUTR NEUROSCI, V16, P21, DOI 10.1179/1476830512Y.0000000024; Wang W, 2007, AM J CLIN NUTR, V85, P762, DOI 10.1093/ajcn/85.3.762; West C. E., 1993, CAROTENOID CONTENT F; Whitehead AJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1038, DOI 10.1001/archopht.124.7.1038	56	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251324	10.1371/journal.pone.0251324	http://dx.doi.org/10.1371/journal.pone.0251324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043644	Green Published, gold			2022-12-26	WOS:000664635700016
J	Rawsthorne, H; Calahorro, F; Holden-Dye, L; O'Connor, V; Dillon, J				Rawsthorne, Helena; Calahorro, Fernando; Holden-Dye, Lindy; O'Connor, Vincent; Dillon, James			Investigating autism associated genes in C. elegans reveals candidates with a role in social behaviour	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; CAENORHABDITIS-ELEGANS; MOUSE MODELS; SPECTRUM DISORDER; NERVOUS-SYSTEM; LIFE-SPAN; GENETICS; INTEGRATION; EXPRESSION; COMMON	Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterised by a triad of behavioural impairments and includes disruption in social behaviour. ASD has a clear genetic underpinning and hundreds of genes are implicated in its aetiology. However, how single penetrant genes disrupt activity of neural circuits which lead to affected behaviours is only beginning to be understood and less is known about how low penetrant genes interact to disrupt emergent behaviours. Investigations are well served by experimental approaches that allow tractable investigation of the underpinning genetic basis of circuits that control behaviours that operate in the biological domains that are neuro-atypical in autism. The model organism C. elegans provides an experimental platform to investigate the effect of genetic mutations on behavioural outputs including those that impact social biology. Here we use progeny-derived social cues that modulate C. elegans food leaving to assay genetic determinants of social behaviour. We used the SAFRI Gene database to identify C. elegans orthologues of human ASD associated genes. We identified a number of mutants that displayed selective deficits in response to progeny. The genetic determinants of this complex social behaviour highlight the important contribution of synaptopathy and implicates genes within cell signalling, epigenetics and phospholipid metabolism functional domains. The approach overlaps with a growing number of studies that investigate potential molecular determinants of autism in C. elegans. However, our use of a complex, sensory integrative, emergent behaviour provides routes to enrich new or underexplored biology with the identification of novel candidate genes with a definable role in social behaviour.	[Rawsthorne, Helena; Calahorro, Fernando; Holden-Dye, Lindy; O'Connor, Vincent; Dillon, James] Univ Southampton, Sch Biol Sci, Highfield Campus, Southampton, Hants, England	University of Southampton	Dillon, J (corresponding author), Univ Southampton, Sch Biol Sci, Highfield Campus, Southampton, Hants, England.	j.c.dillon@soton.ac.uk	Calahorro, Fernando/H-3294-2013	Holden-Dye, Lindy/0000-0002-9704-1217; Rawsthorne-Manning, Helena/0000-0002-2284-8112; O'Connor, Vincent/0000-0003-3185-5709; Dillon, James/0000-0003-3244-7483	The Gerald Kerkut Charitable Trust	The Gerald Kerkut Charitable Trust	HR was funded by the The Gerald Kerkut Charitable Trust, http://www.kerkut-trust.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, GENETICS, V186, P1309, DOI 10.1534/genetics.110.119768; Aguirre-Chen C, 2020, G3-GENES GENOM GENET, V10, P1617, DOI 10.1534/g3.119.400925; Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Balasco L, 2020, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.01016; Barak B, 2016, NAT NEUROSCI, V19, P647, DOI 10.1038/nn.4276; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI [DOI 10.1126/SCIENCE.282.5396.2028, DOI 10.1126/science.282.5396.2028]; Bennetto L, 2007, BIOL PSYCHIAT, V62, P1015, DOI 10.1016/j.biopsych.2007.04.019; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; BRENNER S, 1974, GENETICS, V77, P71; Brisbin S, 2009, DEV CELL, V17, P459, DOI 10.1016/j.devcel.2009.08.009; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Buddell T, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008488; Calahorro F, 2013, GENES BRAIN BEHAV, V12, P453, DOI 10.1111/gbb.12046; Calahorro F, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.189423; Calahorro Fernando, 2009, J Vis Exp, DOI 10.3791/1616; Calahorro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039277; Chalasani SH, 2016, NATURE, V533, P130, DOI 10.1038/nature16515; Corominas R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4650; Crawley Jacqueline N, 2012, Dialogues Clin Neurosci, V14, P293; Dalliere N, 2016, FASEB J, V30, P836, DOI 10.1096/fj.15-279257; Das R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007038; De Arras L, 2013, J BIOL CHEM, V288, P1967, DOI 10.1074/jbc.M112.407205; De Rubeis S, 2015, HUM MOL GENET, V24, pR24, DOI 10.1093/hmg/ddv273; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Delaney CE, 2017, DEVELOPMENT, V144, P1273, DOI 10.1242/dev.145722; Endevelt-Shapira Y, 2018, NAT NEUROSCI, V21, P111, DOI 10.1038/s41593-017-0024-x; Engert CG, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007295; Faras H, 2010, ANN SAUDI MED, V30, P295, DOI 10.4103/0256-4947.65261; Feng HY, 2012, METHODS MOL BIOL, V786, P21, DOI 10.1007/978-1-61779-292-2_2; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Genc O, 2020, ELIFE, V9, DOI 10.7554/eLife.55775; Gendrel M, 2016, ELIFE, V5, DOI [10.7554/eLife.17686, 10.7554/elife.17686]; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Golden CEM, 2018, CURR OPIN NEUROBIOL, V48, P106, DOI 10.1016/j.conb.2017.11.006; Greer EL, 2014, CELL REP, V7, P113, DOI 10.1016/j.celrep.2014.02.044; Guang SQ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00470; Gyurko MD, 2015, SCI REP-UK, V5, DOI 10.1038/srep15084; Haklai-Topper L, 2011, GENE EXPR PATTERNS, V11, P144, DOI 10.1016/j.gep.2010.10.008; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431; Hukema RK, 2008, LEARN MEMORY, V15, P829, DOI 10.1101/lm.994408; Hunter JW, 2010, DIS MODEL MECH, V3, P366, DOI 10.1242/dmm.003442; Iakoucheva LM, 2019, CELL, V178, P1287, DOI 10.1016/j.cell.2019.07.037; Jee C, 2004, FEBS LETT, V561, P29, DOI 10.1016/S0014-5793(04)00107-3; Kano T, 2008, CURR BIOL, V18, P1010, DOI 10.1016/j.cub.2008.05.051; Katidou M, 2013, DEV BIOL, V373, P184, DOI 10.1016/j.ydbio.2012.10.027; Kim H, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0087-y; Kreher J, 2018, GENETICS, V210, P969, DOI 10.1534/genetics.118.301353; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Labbadia J, 2015, MOL CELL, V59, P639, DOI 10.1016/j.molcel.2015.06.027; Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703; Lee E, 2017, BIOL PSYCHIAT, V81, P838, DOI 10.1016/j.biopsych.2016.05.011; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Lee HC, 2012, MOL BIOL CELL, V23, P4689, DOI 10.1091/mbc.E12-09-0673; Lee HC, 2012, GENES CELLS, V17, P748, DOI 10.1111/j.1365-2443.2012.01624.x; Lemieux GA, 2015, CELL, V160, P119, DOI 10.1016/j.cell.2014.12.028; Li ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1780; Mack HID, 2017, AGING-US, V9, P1414, DOI 10.18632/aging.101244; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Marco EJ, 2011, PEDIATR RES, V69, p48R, DOI [10.1203/PDR.0b013e3182130c54, 10.1109/SPL.2011.5782616]; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Maro GS, 2015, NEURON, V86, P1420, DOI 10.1016/j.neuron.2015.05.015; Masse I, 2005, DEV BIOL, V286, P91, DOI 10.1016/j.ydbio.2005.07.010; McDiarmid TA, 2020, P NATL ACAD SCI USA, V117, P656, DOI 10.1073/pnas.1912049116; Metaxakis A, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180049; Mullen GP, 2006, MOL BIOL CELL, V17, P3021, DOI 10.1091/mbc.E06-02-0155; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh WC, 2011, MOL CELLS, V31, P79, DOI 10.1007/s10059-011-0007-9; Philbrook A, 2018, ELIFE, V7, DOI [10.7554/eLife.35692, 10.7554/elife.35692]; Pu MT, 2015, GENE DEV, V29, P718, DOI 10.1101/gad.254144.114; Rabaneda LG, 2014, CELL REP, V8, P337, DOI 10.1016/j.celrep.2014.06.022; Raghu P, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00208; Raich WB, 2003, GENETICS, V163, P571; Rawsthorne H, 2020, HUM MOL GENET, V29, P3546, DOI 10.1093/hmg/ddaa232; Rylaarsdam L, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00385; Sahin M, 2015, SCIENCE, V350, P890, DOI 10.1126/science.aab3897; Schmeisser K, 2018, EXP NEUROL, V299, P199, DOI 10.1016/j.expneurol.2017.04.007; Schmeisser K, 2017, EXP NEUROL, V293, P101, DOI 10.1016/j.expneurol.2017.03.022; Schroeder JC, 2017, CURR TOP BEHAV NEURO, V30, P311, DOI 10.1007/7854_2015_407; Schwarz V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-13; Scott E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09350-7; Sengupta P, 2009, CURR OPIN NEUROBIOL, V19, P637, DOI 10.1016/j.conb.2009.09.009; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sledziowska M, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0124-20.2020; St Pourcain B, 2018, MOL PSYCHIATR, V23, P263, DOI 10.1038/mp.2016.198; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; Stevenson RA, 2014, J AUTISM DEV DISORD, V44, P3161, DOI 10.1007/s10803-014-2179-6; Stevenson RA, 2014, J NEUROSCI, V34, P691, DOI 10.1523/JNEUROSCI.3615-13.2014; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tang WL, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100942; Tong XJ, 2017, NEURON, V95, P326, DOI 10.1016/j.neuron.2017.06.018; Ueoka I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174071; Verma V, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.180265; Vohra M, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002032; Volpatti JR, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.038174; Wang WK, 2018, ELIFE, V7, DOI [10.7554/eLife.34970, 10.7554/elife.34970]; Weiner DJ, 2017, NAT GENET, V49, P978, DOI 10.1038/ng.3863; Wong WR, 2019, HUM MOL GENET, V28, P2271, DOI 10.1093/hmg/ddz051; Yoo J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0143; Zuryn S, 2014, SCIENCE, V345, P826, DOI 10.1126/science.1255885	103	2	2	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0243121	10.1371/journal.pone.0243121	http://dx.doi.org/10.1371/journal.pone.0243121			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043629	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000664635700003
J	Stephan, L; Jakoby, M; Das, A; Koebke, E; Hulskamp, M				Stephan, Lisa; Jakoby, Marc; Das, Arijit; Koebke, Eva; Huelskamp, Martin			Unravelling the molecular basis of the dominant negative effect of myosin XI tails on P-bodies	PLOS ONE			English	Article							ROOT HAIR; ARABIDOPSIS; ACTIN; MOVEMENT; GROWTH; GOLGI; CELLS; DIMERIZATION; RESISTANCE; MEMBRANE	The directional movement and positioning of organelles and macromolecules is essential for regulating and maintaining cellular functions in eukaryotic cells. In plants, these processes are actin-based and driven by class XI myosins, which transport various cargos in a directed manner. As the analysis of myosin function is challenging due to high levels of redundancy, dominant negative acting truncated myosins have frequently been used to study intracellular transport processes. A comparison of the dominant negative effect of the coiled-coil domains and the GTD domains revealed a much stronger inhibition of P-body movement by the GTD domains. In addition, we show that the GTD domain does not inhibit P-body movement when driven by a hybrid myosin in which the GTD domain was replaced by DCP2. These data suggest that the dominant negative effect of myosin tails involves a competition of the GTD domains for cargo binding sites.	[Stephan, Lisa; Jakoby, Marc; Koebke, Eva; Huelskamp, Martin] Cologne Univ, Bot Inst, Bioctr, Cologne, Germany; [Das, Arijit] Univ Hosp Cologne, Inst Med Stat & Computat Biol, Fac Med, Cologne, Germany; [Das, Arijit] Univ Hosp Cologne, Inst Diagnost & Intervent Radiol, Cologne, Germany	University of Cologne; University of Cologne; University of Cologne	Hulskamp, M (corresponding author), Cologne Univ, Bot Inst, Bioctr, Cologne, Germany.	martin.huelskamp@uni-koeln.de		Stephan, Lisa/0000-0002-1296-7548; Das, Arijit/0000-0002-1108-6052; Hulskamp, Martin/0000-0003-4165-6754	International Max Planck Research School fellowship [HU 497/181]	International Max Planck Research School fellowship	This work was supported by HU 497/181 (MH) and an International Max Planck Research School fellowship (LS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Avisar D, 2012, J EXP BOT, V63, P241, DOI 10.1093/jxb/err265; Avisar D, 2009, PLANT PHYSIOL, V150, P700, DOI 10.1104/pp.109.136853; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Duan ZR, 2018, BIOCHEM BIOPH RES CO, V506, P403, DOI 10.1016/j.bbrc.2017.12.169; Feys BJ, 2005, PLANT CELL, V17, P2601, DOI 10.1105/tpc.105.033910; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Kurth EG, 2017, P NATL ACAD SCI USA, V114, pE1385, DOI 10.1073/pnas.1620577114; Li JF, 2008, TRAFFIC, V9, P290, DOI 10.1111/j.1600-0854.2007.00687.x; Li JF, 2007, J BIOL CHEM, V282, P20593, DOI 10.1074/jbc.M700645200; Li JF, 2008, PLANT J, V55, P478, DOI 10.1111/j.1365-313X.2008.03522.x; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Madison SL, 2013, CURR OPIN PLANT BIOL, V16, P710, DOI 10.1016/j.pbi.2013.10.004; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mathur J, 2004, TRENDS PLANT SCI, V9, P583, DOI 10.1016/j.tplants.2004.10.006; Mathur J, 2003, DEVELOPMENT, V130, P3137, DOI 10.1242/dev.00549; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAGAI R, 1966, J ULTRA MOL STRUCT R, V14, P571, DOI 10.1016/S0022-5320(66)80083-7; Ojangu EL, 2007, PROTOPLASMA, V230, P193, DOI 10.1007/s00709-006-0233-8; Peremyslov VV, 2008, PLANT PHYSIOL, V146, P1109, DOI 10.1104/pp.107.113654; Peremyslov VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139331; Peremyslov VV, 2013, PLANT CELL, V25, P3022, DOI 10.1105/tpc.113.113704; Peremyslov VV, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00184; Peremyslov V, 2011, PLANT PHYSIOL, V155, P1191, DOI 10.1104/pp.110.170720; Peremyslov VV, 2010, PLANT CELL, V22, P1883, DOI 10.1105/tpc.110.076315; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Reisen D, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-6; Ryan JM, 2018, PLANT PHYSIOL, V176, P119, DOI 10.1104/pp.17.01429; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Shimmen T, 2004, CURR OPIN CELL BIOL, V16, P68, DOI 10.1016/j.ceb.2003.11.009; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; Singh S, 2006, BIOCHEMISTRY-US, V45, P4927, DOI 10.1021/bi060204d; Sparkes I, 2011, MOL PLANT, V4, P805, DOI 10.1093/mp/ssr063; Sparkes IA, 2008, J EXP BOT, V59, P2499, DOI 10.1093/jxb/ern114; Sparkes IA, 2010, BIOCHEM SOC T, V38, P833, DOI 10.1042/BST0380833; STAIGER CJ, 1987, PROTOPLASMA, V141, P1, DOI 10.1007/BF01276783; Steffens A, 2014, PLANT PHYSIOL, V164, P1879, DOI 10.1104/pp.113.233031; Stephan O, 2014, PLANT CELL, V26, P4426, DOI 10.1105/tpc.114.131078; Tamura K, 2013, CURR BIOL, V23, P1776, DOI 10.1016/j.cub.2013.07.035; Tominaga M, 2003, EMBO J, V22, P1263, DOI 10.1093/emboj/cdg130; Tominaga M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00211; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Vick JK, 2012, J INTEGR PLANT BIOL, V54, P868, DOI 10.1111/j.1744-7909.2012.01180.x; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Woodhouse FG, 2013, P NATL ACAD SCI USA, V110, P14132, DOI 10.1073/pnas.1302736110; Yang L, 2014, P NATL ACAD SCI USA, V111, P13996, DOI 10.1073/pnas.1405292111; Yun BW, 2003, PLANT J, V34, P768, DOI 10.1046/j.1365-313X.2003.01773.x	51	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252327	10.1371/journal.pone.0252327	http://dx.doi.org/10.1371/journal.pone.0252327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038472	Green Published, gold			2022-12-26	WOS:000664633500072
J	Wang, Y; Zhang, X; Li, L; Zhang, Z; Wei, CX; Gong, GH				Wang, Yu; Zhang, Xuan; Li, Linger; Zhang, Zhao; Wei, Chengxi; Gong, Guohua			Ethyl ferulate contributes to the inhibition of the inflammatory responses in murine RAW 264.7 macrophage cells and acute lung injury in mice	PLOS ONE			English	Article							EXPRESSION	Background Ethyl ferulate (EF) is a derivative of ferulic acid (FA), which is a monomeric component purified from the traditional medicinal herb Ferula, but its effects have not been clear yet. The purpose of this study was to evaluate whether EF can reduce inflammation levels in macrophages by regulating the Nrf2-HO-1 and NF-kB pathway. Methods The LPS-induced raw 264.7 macrophage cells model was used to determine the anti-inflammatory and anti-oxidative stress effects of EF. The levels of IL-1 beta, IL-6, TNF-alpha and PGE2 were analyzed by ELISA. The mRNA and protein of COX-2, iNOS, TNF-alpha, IL-6, HO-1 and Nrf2 were identified by RT-PCR analysis and western blotting. Intracellular ROS levels were assessed with DCFH oxidation staining. The expressions of NF-kB p-p65 and Nrf2 were analyzed by immunofluorescence assay. The inhibitory effect of Nrf2 inhibitor ML385 (2 mu M) on mediatation of antioxidant activity by raw 264.7 macrophage cells was evaluated. The effect of EF was confirmed in acute lung injury mice model. Results In our research, EF reduced the expression of iNOS, COX2 and the production of PGE2. EF could inhibit the production of pro-inflammatory cytokines (IL-1 beta, IL-6 and TNF-alpha) in lipopolysaccharide (LPS) stimulated macrophages and decreased expression of IL-6 and TNF-alpha in LPS stimulated macrophages. Furthermore, EF inhibited NF-kB p65 from transporting to the nucleus, decreased the expression of p-IkB alpha, significantly decreased the level of intracellular reactive oxygen species (ROS) and activated Nrf2/HO-1 pathways. EF could attenuate the degree of leukocyte infiltration, reduced MPO activity, mRNA levels and secretion of TNF-alpha and IL-6 in vivo. EF exhibited potent protective effects against LPS-induced acute lung injury in mice. Conclusions Collectively, our data showed that EF relieved LPS-induced inflammatory responses by inhibiting NF-kappa B pathway and activating Nrf2/HO-1 pathway, known to be involved in the regulation of inflammatory responses by Nrf2.	[Wang, Yu; Zhang, Xuan; Li, Linger; Zhang, Zhao; Wei, Chengxi; Gong, Guohua] Inner Mongolia Univ Nationalities, Tongliao, Inner Mongolia, Peoples R China; [Wang, Yu; Zhang, Xuan; Li, Linger; Zhang, Zhao; Wei, Chengxi; Gong, Guohua] Inner Mongolia Key Lab Mongolian Med Pharmacol Ca, Tongliao, Inner Mongolia, Peoples R China; [Gong, Guohua] Inner Mongolia Univ Nationalities, Affiliated Hosp, Tongliao, Inner Mongolia, Peoples R China	Inner Mongolia University for Nationalities; Inner Mongolia University for Nationalities	Gong, GH (corresponding author), Inner Mongolia Univ Nationalities, Tongliao, Inner Mongolia, Peoples R China.; Gong, GH (corresponding author), Inner Mongolia Key Lab Mongolian Med Pharmacol Ca, Tongliao, Inner Mongolia, Peoples R China.; Gong, GH (corresponding author), Inner Mongolia Univ Nationalities, Affiliated Hosp, Tongliao, Inner Mongolia, Peoples R China.	gongguohua0211@163.com			National Natural Science Foundation of China [81760780, 81960735, 81860769]; natural science foundation of Inner Mongolia [2016BS0806]; Outstanding Youth of the natural science foundation of Inner Mongolia [2008JQ01]; Youth Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region [NJYT-19-B14]; Open subject of Inner Mongolia Provincial Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System [MDK2018074]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of Inner Mongolia; Outstanding Youth of the natural science foundation of Inner Mongolia; Youth Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region; Open subject of Inner Mongolia Provincial Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System	This work was supported by the National Natural Science Foundation of China (No. 81760780, 81960735, 81860769), the natural science foundation of Inner Mongolia (No. 2016BS0806), Outstanding Youth of the natural science foundation of Inner Mongolia (No.2008JQ01), Youth Talents of Science and Technology in Universities of Inner Mongolia Autonomous Region (NJYT-19-B14), Open subject of Inner Mongolia Provincial Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System (MDK2018074).	Anil P., 2016, NEW ENGL J MED, V375, P1800, DOI [10.1056/NEJMc1611290 27806238, DOI 10.1056/NEJMC161129027806238]; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Bajpai VK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27585-w; Bellezza I, 2012, J NUTR BIOCHEM, V23, P1583, DOI 10.1016/j.jnutbio.2011.10.012; Chen S, 2017, EXP BIOL MED, V242, P422, DOI 10.1177/1535370215625471; Fan C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181191; Islam MS, 2009, J PHARMACOL SCI, V111, P328, DOI 10.1254/jphs.09146FP; Kohno M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65673-y; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; Nazare AC, 2014, MOLECULES, V19, P8124, DOI 10.3390/molecules19068124; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Scapagnini G, 2004, ANTIOXID REDOX SIGN, V6, P811, DOI 10.1089/ars.2004.6.811; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Szwajgier D, 2013, Z NATURFORSCH C, V68, P125, DOI 10.5560/ZNC.2013.68c0125; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van Berlo D, 2010, FREE RADICAL BIO MED, V49, P1685, DOI 10.1016/j.freeradbiomed.2010.08.031; Wang QS, 2014, J BIOL CHEM, V289, P11681, DOI 10.1074/jbc.M113.517581; Wang Y, 2018, PHYTOMEDICINE, V46, P32, DOI 10.1016/j.phymed.2018.06.031; Wu YF, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105715; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yung-Chieh T., 2015, EXP MOL MED, V47, pE180; Zhang LW, 2010, INT J PHARMACEUT, V399, P44, DOI 10.1016/j.ijpharm.2010.07.054; Zhu ZX, 2016, INT IMMUNOPHARMACOL, V35, P185, DOI 10.1016/j.intimp.2016.03.044	23	5	6	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251578	10.1371/journal.pone.0251578	http://dx.doi.org/10.1371/journal.pone.0251578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038447	gold, Green Published			2022-12-26	WOS:000664633500025
J	Sarhan, A; Swift, A; Gorner, A; Rokne, J; Alhajj, R; Docherty, G; Crichton, A				Sarhan, Abdullah; Swift, Andrew; Gorner, Adam; Rokne, Jon; Alhajj, Reda; Docherty, Gavin; Crichton, Andrew			Utilizing a responsive web portal for studying disc tracing agreement in retinal images	PLOS ONE			English	Article							OPTIC DISC; GLAUCOMA; SEGMENTATION; LOCALIZATION; KAPPA	Glaucoma is a leading cause of blindness worldwide whose detection is based on multiple factors, including measuring the cup to disc ratio, retinal nerve fiber layer and visual field defects. Advances in image processing and machine learning have allowed the development of automated approached for segmenting objects from fundus images. However, to build a robust system, a reliable ground truth dataset is required for proper training and validation of the model. In this study, we investigate the level of agreement in properly detecting the retinal disc in fundus images using an online portal built for such purposes. Two Doctors of Optometry independently traced the discs for 159 fundus images obtained from publicly available datasets using a purpose-built online portal. Additionally, we studied the effectiveness of ellipse fitting in handling misalignments in tracing. We measured tracing precision, interobserver variability, and average boundary distance between the results provided by ophthalmologists, and optometrist tracing. We also studied whether ellipse fitting has a positive or negative impact on properly detecting disc boundaries. The overall agreement between the optometrists in terms of locating the disc region in these images was 0.87. However, we found that there was a fair agreement on the disc border with kappa = 0.21. Disagreements were mainly in fundus images obtained from glaucomatous patients. The resulting dataset was deemed to be an acceptable ground truth dataset for training a validation of models for automatic detection of objects in fundus images.	[Sarhan, Abdullah; Rokne, Jon; Alhajj, Reda] Univ Calgary, Dept Comp Sci, Calgary, AB, Canada; [Swift, Andrew; Gorner, Adam] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Alhajj, Reda] Istanbul Medipol Univ, Dept Comp Engn, Istanbul, Turkey; [Alhajj, Reda] Univ Southern Denmark, Dept Hlth Informat, Odense, Denmark; [Docherty, Gavin; Crichton, Andrew] Univ Calgary, Dept Ophthalmol & Visual Sci, Calgary, AB, Canada	University of Calgary; University of Calgary; Istanbul Medipol University; University of Southern Denmark; University of Calgary	Sarhan, A (corresponding author), Univ Calgary, Dept Comp Sci, Calgary, AB, Canada.	asarhan@ucalgary.ca		Sarhan, Abdullah/0000-0001-6349-2821	Calgary Eye Foundation	Calgary Eye Foundation	This study was funded by the Calgary Eye Foundation. Funding was utilized to upgrade the machine to develop the system and conduct the analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram MU, 2015, AUSTRALAS PHYS ENG S, V38, P643, DOI 10.1007/s13246-015-0377-y; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Cheplygina V, 2019, MED IMAGE ANAL, V54, P280, DOI 10.1016/j.media.2019.03.009; de la Fuente-Arriaga JA, 2014, COMPUT BIOL MED, V47, P27, DOI 10.1016/j.compbiomed.2014.01.005; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; Fu HZ, 2017, IEEE T MED IMAGING, V36, P1930, DOI 10.1109/TMI.2017.2703147; Halir R, 1998, WSCG '98, VOL 1, P125; Howe J., 2006, WIRED MAG, V14, P1; Joshi GD, 2011, IEEE T MED IMAGING, V30, P1192, DOI 10.1109/TMI.2011.2106509; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Mitry D, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.5.6; Mitry D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117401; Mookiah MRK, 2012, KNOWL-BASED SYST, V33, P73, DOI 10.1016/j.knosys.2012.02.010; Panda R, 2017, BIOCYBERN BIOMED ENG, V37, P466, DOI 10.1016/j.bbe.2017.05.008; Park SJ, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e239; Park SH, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e152; Pundir M, 2016, INT CONF CLOUD ENG, P12, DOI 10.1109/IC2E.2016.31; Sarhan A, 2019, COMPUT MED IMAG GRAP, V78, DOI 10.1016/j.compmedimag.2019.101657; Sivaswamy J, 2014, I S BIOMED IMAGING, P53, DOI 10.1109/ISBI.2014.6867807; Son J, 2018, LECT NOTES COMPUT SC, V11043, P95, DOI 10.1007/978-3-030-01364-6_11; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Thienes B, 2016, CANADIAN ASS OPTOMET; Vianna JR, 2016, INVEST OPHTH VIS SCI, V57, P3103, DOI 10.1167/iovs.16-19646; Viera AJ, 2005, FAM MED, V37, P360	25	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251703	10.1371/journal.pone.0251703	http://dx.doi.org/10.1371/journal.pone.0251703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34032798	Green Published, gold			2022-12-26	WOS:000664633100012
J	Kato, T; Tsukamoto, T; Demura, M; Kikukawa, T				Kato, Tomoya; Tsukamoto, Takashi; Demura, Makoto; Kikukawa, Takashi			Real-time identification of two substrate-binding intermediates for the light-driven sodium pump rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAMAN-SPECTROSCOPY; NA+ BINDING; HALORHODOPSIN; TEMPERATURE; PHOTOCYCLE	Membrane transport proteins undergo critical conformational changes during substrate uptake and release, as the substrate-binding site is believed to switch its accessibility from one side of the membrane to the other. Thus, at least two substrate-binding intermediates should appear during the process, that is, after uptake and before the release of the substrate. However, this view has not been verified for most transporters because of the difficulty in detecting short-lived intermediates. Here, we report real-time identification of these intermediates for the light-driven outward current-generating Na+-pump rhodopsin. We triggered the transport cycle of Na+-pump rhodopsin using a short laser pulse, and subsequent formation and decay of various intermediates was detected by time-resolved measurements of absorption changes. We used this method to analyze transport reactions and elucidated the sequential formation of the Na+-binding intermediates O1 and O2. Both intermediates exhibited redshifted absorption spectra and generated transient equilibria with short-wavelength intermediates. The equilibria commonly shifted toward O1 and O2 with increasing Na+ concentration, indicating that Na+ is bound to these intermediates. However, these equilibria were formed independently; O1 reached equilibrium with preceding intermediates, indicating Na+ uptake on the cytoplasmic side. In contrast, O2 reached equilibrium with subsequent intermediates, indicating Na+ release on the extracellular side. Thus, there is an irreversible switch in "accessibility" during the O1 to O2 transition, which could represent one of the key processes governing unidirectional Na+ transport.	[Kato, Tomoya] Hokkaido Univ, Global Inst Collaborat Res & Educ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Tsukamoto, Takashi; Demura, Makoto; Kikukawa, Takashi] Hokkaido Univ, Global Inst Collaborat Res & Educ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Tsukamoto, Takashi; Demura, Makoto; Kikukawa, Takashi] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Soft Matter, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Kikukawa, T (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan.; Kikukawa, T (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Soft Matter, Sapporo, Hokkaido, Japan.	kikukawa@sci.hokudai.ac.jp	Tsukamoto, Takashi/F-3993-2017; Kikukawa, Takashi/F-5266-2011; Demura, Makoto/F-5272-2011	Tsukamoto, Takashi/0000-0002-6348-6664; Kikukawa, Takashi/0000-0002-6185-7281; Demura, Makoto/0000-0003-0912-9284	Japan Society for the Promotion of Science KAKENHI [17K07326]; Global Station for Soft Matter, a project of the Global Institution for Collaborative Research and Education at Hokkaido University	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Station for Soft Matter, a project of the Global Institution for Collaborative Research and Education at Hokkaido University	This work was supported by the Japan Society for the Promotion of Science KAKENHI grant to Takashi Kikukawa (17K07326) and the Global Station for Soft Matter, a project of the Global Institution for Collaborative Research and Education at Hokkaido University.	Asido M, 2019, PHYS CHEM CHEM PHYS, V21, P4461, DOI 10.1039/c8cp07418f; Balashov SP, 2014, BIOCHEMISTRY-US, V53, P7549, DOI 10.1021/bi501064n; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Chen HF, 2018, PHYS CHEM CHEM PHYS, V20, P17694, DOI 10.1039/c8cp02599a; Chizhov I, 1996, BIOPHYS J, V71, P2329, DOI 10.1016/S0006-3495(96)79475-4; Chizhov I, 2001, BIOPHYS J, V81, P1600, DOI 10.1016/S0006-3495(01)75814-6; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Hasemi T, 2019, BBA-BIOENERGETICS, V1860, P136, DOI 10.1016/j.bbabio.2018.12.001; Hasemi T, 2016, J BIOL CHEM, V291, P355, DOI 10.1074/jbc.M115.688614; Hontani Y, 2016, PHYS CHEM CHEM PHYS, V18, P24729, DOI 10.1039/c6cp05240a; Iizuka A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47178-5; Inoue K, 2015, ANGEW CHEM INT EDIT, V54, P11536, DOI 10.1002/anie.201504549; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jung K. H., 2012, 244 ACS NAT M EXP 244 ACS NAT M EXP; Kajimoto K, 2017, J PHYS CHEM B, V121, P4431, DOI 10.1021/acs.jpcb.7b02421; Kandori Hideki, 2020, Biophys Rev, V12, P355, DOI 10.1007/s12551-020-00645-0; Kandori H, 2018, CHEM REV, V118, P10646, DOI 10.1021/acs.chemrev.7b00548; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kikukawa T, 2015, BBA-BIOENERGETICS, V1847, P748, DOI 10.1016/j.bbabio.2015.05.002; Kovalev K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16032-y; Kovalev K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav2671; Moradi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9393; Murabe K, 2020, J AM CHEM SOC, V142, P16023, DOI 10.1021/jacs.0c07264; Nakamizo Y, 2021, PHYS CHEM CHEM PHYS, V23, P2072, DOI 10.1039/d0cp05652a; Nakamura S, 2016, BBA-BIOENERGETICS, V1857, P1900, DOI 10.1016/j.bbabio.2016.09.006; Nishimura N, 2019, J PHYS CHEM B, V123, P3430, DOI 10.1021/acs.jpcb.9b00928; Otomo A, 2020, BIOCHEMISTRY-US, V59, P520, DOI 10.1021/acs.biochem.9b01062; Sauer DB, 2020, ELIFE, V9, DOI 10.7554/eLife.61350; Shibasaki K, 2013, BIOCHEMISTRY-US, V52, P9257, DOI 10.1021/bi401295e; Shigeta A, 2018, PHYS CHEM CHEM PHYS, V20, P8450, DOI 10.1039/c8cp00626a; Skopintsev P, 2020, NATURE, V583, P314, DOI 10.1038/s41586-020-2307-8	34	2	2	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100792	10.1016/j.jbc.2021.100792	http://dx.doi.org/10.1016/j.jbc.2021.100792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019877	gold, Green Published			2022-12-26	WOS:000674717300012
J	Ury, B; Potelle, S; Caligiore, F; Whorton, MR; Bommer, GT				Ury, Benoit; Potelle, Sven; Caligiore, Francesco; Whorton, Matthew R.; Bommer, Guido T.			The promiscuous binding pocket of SLC35A1 ensures redundant transport of CDP-ribitol to the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC ACID TRANSPORTER; ALPHA-DYSTROGLYCAN; MUSCULAR-DYSTROPHY; O-MANNOSYLATION; MUTATIONS; FAMILY; IDENTIFICATION; GLYCOSYLATION; PHOSPHATE	The glycoprotein alpha-dystroglycan helps to link the intracellular cytoskeleton to the extracellular matrix. A unique glycan structure attached to this protein is required for its interaction with extracellular matrix proteins such as laminin. Up to now, this is the only mammalian glycan known to contain ribitol phosphate groups. Enzymes in the Golgi apparatus use CDP-ribitol to incorporate ribitol phosphate into the glycan chain of alpha-dystroglycan. Since CDP-ribitol is synthesized in the cytoplasm, we hypothesized that an unknown transporter must be required for its import into the Golgi apparatus. We discovered that CDP-ribitol transport relies on the CMP-sialic acid transporter SLC35A1 and the transporter SLC35A4 in a redundant manner. These two transporters are closely related, but bulky residues in the predicted binding pocket of SLC35A4 limit its size. We hypothesized that the large binding pocket SLC35A1 might accommodate the bulky CMP-sialic acid and the smaller CDP-ribitol, whereas SLC35A4 might only accept CDP-ribitol. To test this, we expressed SLC35A1 with mutations in its binding pocket in SLC35A1 KO cell lines. When we restricted the binding site of SLC35A1 by introducing the bulky residues present in SLC35A4, the mutant transporter was unable to support sialylation of proteins in cells but still supported ribitol phosphorylation. This demonstrates that the size of the binding pocket determines the substrate specificity of SLC35A1, allowing a variety of cytosine nucleotide conjugates to be transported. The redundancy with SLC35A4 also explains why patients with SLC35A1 mutations do not show symptoms of alpha-dystroglycan deficiency.	[Ury, Benoit; Potelle, Sven; Caligiore, Francesco; Bommer, Guido T.] UCLouvain, Dept Physiol Chem, de Duve Inst, Brussels, Belgium; [Ury, Benoit; Potelle, Sven; Caligiore, Francesco; Bommer, Guido T.] Walloon Excellence Lifesci & Biotechnol WELBIO, Brussels, Belgium; [Whorton, Matthew R.] Oregon Hlth & Serv Univ OHSU, Vollum Inst, Portland, OR 97239 USA	Universite Catholique Louvain; WELBIO	Bommer, GT (corresponding author), UCLouvain, Dept Physiol Chem, de Duve Inst, Brussels, Belgium.; Bommer, GT (corresponding author), Walloon Excellence Lifesci & Biotechnol WELBIO, Brussels, Belgium.; Whorton, MR (corresponding author), Oregon Hlth & Serv Univ OHSU, Vollum Inst, Portland, OR 97239 USA.	whorton@ohsu.edu; guido.bommer@uclouvain.be	; Bommer, Guido/A-8425-2011	Caligiore, Francesco/0000-0002-4038-3136; Bommer, Guido/0000-0001-6898-4884	Belgian National Fund for Scientific Research (FNRS); Credit de recherche; FRIA fellowship; Charge de Recherche fellowship; WELBIO; E-Rare network EUROGLYCAN, Universite Catholique de Louvain (Fonds Special de Recherche); Fondation MargueriteMarie Delacroix; Prix Professeur Christian Coers; European Research Council within the Horizon 2020 program [771704]; Fonds Maurange	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Credit de recherche; FRIA fellowship(Fonds de la Recherche Scientifique - FNRS); Charge de Recherche fellowship; WELBIO(WELBIO); E-Rare network EUROGLYCAN, Universite Catholique de Louvain (Fonds Special de Recherche); Fondation MargueriteMarie Delacroix; Prix Professeur Christian Coers; European Research Council within the Horizon 2020 program; Fonds Maurange	The authors acknowledge funding from the Belgian National Fund for Scientific Research (FNRS; Credit de recherche to G. T. B.; FRIA fellowship to B. U., Charge de Recherche fellowship to S. P.; and WELBIO to G. T. B.), the E-Rare network EUROGLYCAN, Universite Catholique de Louvain (Fonds Special de Recherche), the Fondation MargueriteMarie Delacroix, the Prix Professeur Christian Coers (to S. P. and B. U.), the European Research Council within the Horizon 2020 program (consolidator grant no. 771704), and the Fonds Maurange.	Ahuja S, 2019, ELIFE, V8, DOI 10.7554/eLife.45221; Bianco G, 2016, PROTEIN SCI, V25, P295, DOI 10.1002/pro.2733; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Coulier L, 2006, ANAL CHEM, V78, P6573, DOI 10.1021/ac0607616; Cubillos-Rojas Monica, 2012, Methods Mol Biol, V869, P205, DOI 10.1007/978-1-61779-821-4_17; Ebert B, 2015, PLANT CELL, V27, P1218, DOI 10.1105/tpc.114.133827; Endo T, 2015, J BIOCHEM, V157, P1, DOI 10.1093/jb/mvu066; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Hadley B, 2019, COMPUT STRUCT BIOTEC, V17, P1123, DOI 10.1016/j.csbj.2019.08.002; Hadley B, 2014, COMPUT STRUCT BIOTEC, V10, P23, DOI 10.1016/j.csbj.2014.05.003; HOLM S, 1979, SCAND J STAT, V6, P65; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Kauskot A, 2018, HAEMATOLOGICA, V103, pE613, DOI 10.3324/haematol.2018.198028; Khoder-Agha F, 2019, CELL MOL LIFE SCI, V76, P1821, DOI 10.1007/s00018-019-03032-5; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Ma XL, 2021, HAEMATOLOGICA, V106, P759, DOI 10.3324/haematol.2019.225987; Manya H, 2016, J BIOL CHEM, V291, P24618, DOI 10.1074/jbc.M116.751917; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mohamed M, 2013, NEUROLOGY, V81, P681, DOI 10.1212/WNL.0b013e3182a08f53; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ng BG, 2017, AM J MED GENET A, V173, P2906, DOI 10.1002/ajmg.a.38412; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Parker JL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12673-w; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rautengarten C, 2014, P NATL ACAD SCI USA, V111, P11563, DOI 10.1073/pnas.1406073111; Riemersma M, 2015, HUM MOL GENET, V24, P2241, DOI 10.1093/hmg/ddu742; Schauer R, 2018, ADV CARBOHYD CHEM BI, V75, P1, DOI 10.1016/bs.accb.2018.09.001; Sosicka P, 2017, BBA-MOL CELL RES, V1864, P825, DOI 10.1016/j.bbamcr.2017.02.002; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Veiga-da-Cunha M, 2019, P NATL ACAD SCI USA, V116, P1241, DOI 10.1073/pnas.1816143116; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Willer T, 2014, ELIFE, V3, DOI 10.7554/eLife.03941; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	43	4	4	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100789	10.1016/j.jbc.2021.100789	http://dx.doi.org/10.1016/j.jbc.2021.100789			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34015330	gold, Green Published			2022-12-26	WOS:000674717300010
J	Smallwood, TB; Navarro, S; Cristofori-Armstrong, B; Watkins, TS; Tungatt, K; Ryan, RYM; Haigh, OL; Lutzky, VP; Mulvenna, JP; Rosengren, KJ; Loukas, A; Miles, JJ; Clark, RJ				Smallwood, Taylor B.; Navarro, Severine; Cristofori-Armstrong, Ben; Watkins, Thomas S.; Tungatt, Katie; Ryan, Rachael Y. M.; Haigh, Oscar L.; Lutzky, Viviana P.; Mulvenna, Jason P.; Rosengren, K. Johan; Loukas, Alex; Miles, John J.; Clark, Richard J.			Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; ANIMAL TOXINS; MOUSE MODEL; SHK TOXIN; SYSTEM; INHIBITOR; THERAPY	The prevalence of autoimmune diseases is on the rise globally. Currently, autoimmunity presents in over 100 different forms and affects around 9% of the world's population. Current treatments available for autoimmune diseases are inadequate, expensive, and tend to focus on symptommanagement rather than cure. Clinical trials have shown that live helminthic therapy can decrease chronic inflammation associated with inflammatory bowel disease and other gastrointestinal autoimmune inflammatory conditions. As an alternative and better controlled approach to live infection, we have identified and characterized two peptides, Acan1 and Nak1, from the excretory/secretory component of parasitic hookworms for their therapeutic activity on experimental colitis. WesynthesizedAcan1 andNak1 peptides fromthe Ancylostoma caninum and Necator americanus hookworms and assessed their structures and protective properties in human cell-based assays and in a mouse model of acute colitis. Acan1 and Nak1 displayed anticolitic properties via significantly reducing weight loss and colon atrophy, edema, ulceration, and necrosis in 2,4,6-trinitrobenzene sulfonic acid-exposed mice. These hookworm peptides prevented mucosal loss of goblet cells and preserved intestinal architecture. Acan1 upregulated genes responsible for the repair and restitution of ulcerated epithelium, whereas Nak1 downregulated genes responsible for epithelial cell migration and apoptotic cell signaling within the colon. These peptides were nontoxic and displayed key immunomodulatory functions in human peripheral blood mononuclear cells by suppressing CD4(+) T cell proliferation and inhibiting IL-2 and TNF production. We conclude that Acan1 and Nak1 warrant further development as therapeutics for the treatment of autoimmunity, particularly gastrointestinal inflammatory conditions.	[Smallwood, Taylor B.; Cristofori-Armstrong, Ben; Rosengren, K. Johan; Clark, Richard J.] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia; [Navarro, Severine; Watkins, Thomas S.; Tungatt, Katie; Ryan, Rachael Y. M.; Haigh, Oscar L.; Lutzky, Viviana P.; Mulvenna, Jason P.; Miles, John J.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Navarro, Severine; Ryan, Rachael Y. M.; Miles, John J.] James Cook Univ, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia; [Navarro, Severine] Queensland Univ Technol, Woolworths Ctr Child Nutr Res, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Watkins, Thomas S.; Tungatt, Katie; Ryan, Rachael Y. M.; Loukas, Alex; Miles, John J.] James Cook Univ, Ctr Mol Therapeut, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia; [Tungatt, Katie; Miles, John J.] James Cook Univ, Ctr Trop Bioinformat & Mol Biol, Douglas, Qld, Australia; [Miles, John J.] Cardiff Univ, Univ Hosp, Inst Infect & Immun, Sch Med, Cardiff, Wales	University of Queensland; QIMR Berghofer Medical Research Institute; James Cook University; Queensland University of Technology (QUT); James Cook University; James Cook University; Cardiff University	Clark, RJ (corresponding author), Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia.; Miles, JJ (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Miles, JJ (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia.; Miles, JJ (corresponding author), James Cook Univ, Ctr Mol Therapeut, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia.; Miles, JJ (corresponding author), James Cook Univ, Ctr Trop Bioinformat & Mol Biol, Douglas, Qld, Australia.; Miles, JJ (corresponding author), Cardiff Univ, Univ Hosp, Inst Infect & Immun, Sch Med, Cardiff, Wales.	john.miles@jcu.edu.au; richard.clark@uq.edu.au	Rosengren, K. Johan/P-4450-2016; Clark, Richard J/G-8848-2012; Haigh, Oscar/AAD-4324-2022; Navarro, Severine/B-7353-2014	Rosengren, K. Johan/0000-0002-5007-8434; Clark, Richard J/0000-0002-6807-5426; Haigh, Oscar/0000-0001-5022-4692; Cristofori-Armstrong, Ben/0000-0003-0235-2029; Smallwood, Taylor/0000-0002-2211-0265; Navarro, Severine/0000-0003-4568-9721; Tungatt, Katie/0000-0002-4088-3501	Australian Postgraduate Award; Australian Research Council Future Fellowship [FT100100476, FT130100890]; NCI, National Institutes of Health [R01CA155297]; National Health and Medical Research (NHMRC) [1031652, 1051627, 1117504]; Children's Hospital Foundation [RCP10317]; Australian Infectious Disease Research Centre	Australian Postgraduate Award(Australian Government); Australian Research Council Future Fellowship(Australian Research Council); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Children's Hospital Foundation; Australian Infectious Disease Research Centre	This work was supported by grants from the Australian Postgraduate Award (T. B. S., B. C. -A., T. S. W., R. Y. M. R.), Australian Research Council Future Fellowship (R. J. C.; grant number FT100100476 and K. J. R.; grant number FT130100890), Australian Infectious Disease Research Centre (R. J. C., J. J. M., and J. P. M.), NCI, National Institutes of Health (J. P. M.; grant number R01CA155297), National Health and Medical Research (NHMRC) Career Development Fellowship (J. J. M. and J. P. M.; grant numbers 1031652 and 1051627), and senior principal research fellowship (A. L.; grant 1117504), and Children's Hospital Foundation (S. N.; RCP10317). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bach JF, 2018, NAT REV IMMUNOL, V18, P105, DOI 10.1038/nri.2017.111; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Chhabra S, 2014, FASEB J, V28, P3952, DOI 10.1096/fj.14-251967; Cristofori-Armstrong B, 2015, SCI REP-UK, V5, DOI 10.1038/srep14763; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ferreira I, 2013, INFECT IMMUN, V81, P2104, DOI 10.1128/IAI.00563-12; Ferreira IB, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.42; Fung-Leung WP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170102; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hansen Lars Koch, 2014, Dan Med J, V61, pB4946; Haugaard-Kedstrom LM, 2018, J BIOL CHEM, V293, P15765, DOI 10.1074/jbc.RA118.002611; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Imam T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01212; Kazama I, 2015, MED HYPOTHESES, V85, P61, DOI 10.1016/j.mehy.2015.03.023; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lepletier A, 2019, IMMUNOL CELL BIOL, V97, P152, DOI 10.1111/imcb.12205; Levin AD, 2016, J CROHNS COLITIS, V10, P989, DOI 10.1093/ecco-jcc/jjw053; Luo XR, 2016, ANNU REV BIOMED ENG, V18, P181, DOI 10.1146/annurev-bioeng-110315-020137; Marsal J, 2012, J INTERN MED, V272, P411, DOI 10.1111/j.1365-2796.2012.02588.x; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; Mei YY, 2019, INFLAMM BOWEL DIS, V25, pE115, DOI 10.1093/ibd/izz109; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Navarro S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8807; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; Pennington MW, 2015, MAR DRUGS, V13, P529, DOI 10.3390/md13010529; Pennington MW, 1996, BIOCHEM BIOPH RES CO, V219, P696, DOI 10.1006/bbrc.1996.0297; Scheiffele Frank, 2002, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1519s49; Schroeder CI, 2020, METHODS MOL BIOL, V2068, P129, DOI 10.1007/978-1-4939-9845-6_7; Sedda S, 2015, INFLAMM BOWEL DIS, V21, P2921, DOI 10.1097/MIB.0000000000000542; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shepherd C, 2018, J ETHNOPHARMACOL, V211, P17, DOI 10.1016/j.jep.2017.09.024; Smallwood TB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00453; Smids C, 2018, J CROHNS COLITIS, V12, P465, DOI 10.1093/ecco-jcc/jjx160; Spadoni I, 2012, MUCOSAL IMMUNOL, V5, P184, DOI 10.1038/mi.2011.64; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Tarcha EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180762; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	49	3	3	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100834	10.1016/j.jbc.2021.100834	http://dx.doi.org/10.1016/j.jbc.2021.100834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051231	Green Published, Green Accepted, gold			2022-12-26	WOS:000678068400034
J	Zhang, A; Venkat, A; Taujale, R; Mull, JL; Ito, A; Kannan, N; Haltiwanger, RS				Zhang, Ao; Venkat, Aarya; Taujale, Rahil; Mull, James L.; Ito, Atsuko; Kannan, Natarajan; Haltiwanger, Robert S.			Peters plus syndrome mutations affect the function and stability of human beta 1,3-glucosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAMTS-LIKE PROTEINS; O-FUCOSYLATION; QUALITY-CONTROL; SWISS-MODEL; B3GALTL; GLYCOSYLTRANSFERASE; INSIGHTS; DATABASE; FUCOSE; GENE	Peters Plus Syndrome (PTRPLS OMIM #261540) is a severe congenital disorder of glycosylation where patients have multiple structural anomalies, including Peters anomaly of the eye (anterior segment dysgenesis), disproportionate short stature, brachydactyly, dysmorphic facial features, developmental delay, and variable additional abnormalities. PTRPLS patients and some Peters Plus-like (PTRPLS-like) patients (who only have a subset of PTRPLS phenotypes) have mutations in the gene encoding beta 1,3-glucosyltransferase (B3GLCT). B3GLCT catalyzes the transfer of glucose to O-linked fucose on thrombospondin type-1 repeats. Most B3GLCT substrate proteins belong to the ADAMTS superfamily and play critical roles in extracellular matrix. We sought to determine whether the PTRPLS or PTRPLS-like mutations abrogated B3GLCT activity. B3GLCT has two putative active sites, one in the N-terminal region and the other in the C-terminal glycosyl-transferase domain. Using sequence analysis and in vitro activity assays, we demonstrated that the C-terminal domain catalyzes transfer of glucose to O-linked fucose. We also generated a homology model of B3GLCT and identified D421 as the catalytic base. PTRPLS and PTRPLS-like mutations were individually introduced into B3GLCT, and the mutated enzymes were evaluated using in vitro enzyme assays and cell-based functional assays. Our results demonstrated that PTRPLS mutations caused loss of B3GLCT enzymatic activity and/or significantly reduced protein stability. In contrast, B3GLCT with PTRPLS-like mutations retained enzymatic activity, although some showed a minor destabilizing effect. Overall, our data supports the hypothesis that loss of glucose from B3GLCT substrate proteins is responsible for the defects observed in PTRPLS patients, but not for those observed in PTRPLS-like patients.	[Zhang, Ao; Taujale, Rahil; Mull, James L.; Ito, Atsuko; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zhang, Ao; Venkat, Aarya; Mull, James L.; Kannan, Natarajan; Haltiwanger, Robert S.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Taujale, Rahil; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA.; Haltiwanger, RS (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	rhalti@uga.edu			NIH [T32 GM107004, P41-GM103311, HD096030, GM130915]; Georgia Research Alliance	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance	We thank Dr Bernadette Holdener's group members for their discussion throughout this project, Dr Hisashi Narimatsu for providing the pcDNA3.1(+)-hB3GLCT plasmid, and Dr Kelvin Luther for comments on this article. We thank Dr Nadja Zeltner's group for facility and technical support for protein thermo shift assays. Molecular graphics and analyses NIH performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311. Supported by funding from NIH (HD096030 to R. S. H., GM130915 to N. K.) and the Georgia Research Alliance. RT was partially supported by NIH T32 GM107004. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aliferis K, 2010, OPHTHALMIC GENET, V31, P205, DOI 10.3109/13816810.2010.512355; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Benz BA, 2016, DEV BIOL, V416, P111, DOI 10.1016/j.ydbio.2016.05.038; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Dubail J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33974; Dubail J, 2015, MATRIX BIOL, V44-46, P24, DOI 10.1016/j.matbio.2015.03.001; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Haltiwanger RS., 2015, ESSENTIALS GLYCOBIOL, P151; Hao Y., 2020, J BIOL CHEM, V296; Heinonen TYK, 2003, BIOCHEM BIOPH RES CO, V309, P166, DOI 10.1016/S0006-291X(03)01540-7; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Holdener BC, 2019, HUM MOL GENET, V28, P4053, DOI 10.1093/hmg/ddz225; Holdener BC, 2019, CURR OPIN STRUC BIOL, V56, P78, DOI 10.1016/j.sbi.2018.12.005; Hubmacher D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41871; Jinek M, 2006, NAT STRUCT MOL BIOL, V13, P945, DOI 10.1038/nsmb1144; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kadirvelraj R., 2020, J BIOL CHEM, V296; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Leonhard-Melief C, 2010, METHOD ENZYMOL, V480, P401, DOI 10.1016/S0076-6879(10)80018-7; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lu SN, 2020, NUCLEIC ACIDS RES, V48, pD265, DOI 10.1093/nar/gkz991; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Neupane S., 2021, GLYCOBIOLOGY; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Petit D, 2021, GLYCOBIOLOGY, V31, P243, DOI 10.1093/glycob/cwaa086; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Righino B, 2020, J CHEM INF MODEL, V60, P3145, DOI 10.1021/acs.jcim.0c00281; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; Sun ZH, 2019, J CELL BIOL, V218, P3171, DOI 10.1083/jcb.201906047; Taujale R, 2020, ELIFE, V9, DOI 10.7554/eLife.54532; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weh E, 2014, CLIN GENET, V86, P142, DOI 10.1111/cge.12241; Zhang AO, 2020, J BIOL CHEM, V295, P15742, DOI 10.1074/jbc.RA120.014557	46	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100843	10.1016/j.jbc.2021.100843	http://dx.doi.org/10.1016/j.jbc.2021.100843			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058199	Green Published, gold			2022-12-26	WOS:000678068400043
J	Abe, T; Tominaga, K; Ando, Y; Toyama, Y; Takeda, M; Yamasaki, M; Okuyama, K; Hamano, T; Isomura, M; Nabika, T; Yano, S				Abe, Takafumi; Tominaga, Kazumichi; Ando, Yuichi; Toyama, Yuta; Takeda, Miwako; Yamasaki, Masayuki; Okuyama, Kenta; Hamano, Tsuyoshi; Isomura, Minoru; Nabika, Toru; Yano, Shozo			Number of teeth and masticatory function are associated with sarcopenia and diabetes mellitus status among community-dwelling older adults: A Shimane CoHRE study	PLOS ONE			English	Article							TOOTH LOSS; ALL-CAUSE; INSULIN; HEALTH; PERIODONTITIS; NUTRITION; APPETITE; DISEASE; GLUCOSE; ABILITY	Objectives We aimed to examine the number of teeth and masticatory function as oral health indices and clarify their roles in the pathogenesis of sarcopenia and diabetes mellitus in community-dwelling older adults. Subjects and methods This cross-sectional study was conducted with 635 older adults in Ohnan, Shimane Prefecture, in rural Japan. The number of teeth and masticatory function (measured by the number of gummy jelly pieces collected after chewing) were evaluated by dental hygienists. Sarcopenia status was assessed using handgrip strength, skeletal muscle index, calf circumference, and a possible sarcopenia diagnosis based on the Asian Working Group for Sarcopenia 2019. Diabetes mellitus status was defined as a hemoglobin A1c level >= 6.5% or self-reported diabetes. A multivariable logistic regression model was used to analyze the association between oral health, sarcopenia, and diabetes mellitus after adjusting for confounders. Results After adjusting for all confounders, logistic regression analysis showed that the number of remaining teeth was negatively associated with a low level of handgrip strength (odds ratio [OR], 0.961; 95% confidence interval [CI], 0.932-0.992) and possible sarcopenia (OR, 0.949; 95% CI, 0.907-0.992). Higher levels of masticatory function were also negatively associated with a low level of handgrip strength (OR, 0.965; 95% CI, 0.941-0.990) and possible sarcopenia (OR, 0.941; 95% CI, 0.904-0.979). Logistic regression analysis showed that the number of remaining teeth and a higher level of masticatory function were negatively associated with diabetes mellitus (OR, 0.978; 95% CI, 0.957-0.999; OR, 0.976; 95% CI, 0.960-0.992, respectively). Conclusion Our findings suggest that improvement in oral health, including the maintenance of masticatory function and remaining teeth, may contribute to the prevention of sarcopenia and diabetes mellitus in older adults.	[Abe, Takafumi; Tominaga, Kazumichi; Toyama, Yuta; Takeda, Miwako; Yamasaki, Masayuki; Okuyama, Kenta; Hamano, Tsuyoshi; Isomura, Minoru; Nabika, Toru; Yano, Shozo] Shimane Univ, Ctr Community Based Healthcare Res & Educ CoHRE, Org Res & Acad Informat, Izumo, Shimane, Japan; [Tominaga, Kazumichi] Tominaga Dent Off, Onan, Shimane, Japan; [Ando, Yuichi] Natl Inst Publ Hlth, Dept Hlth Promot, Wako, Saitama, Japan; [Yamasaki, Masayuki; Isomura, Minoru] Shimane Univ, Fac Human Sci, Matsue, Shimane, Japan; [Okuyama, Kenta] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Hamano, Tsuyoshi] Kyoto Sangyo Univ, Fac Sociol, Dept Sports Sociol & Hlth Sci, Kita Ku, Kyoto, Japan; [Nabika, Toru] Shimane Univ, Dept Funct Pathol, Fac Med, Izumo, Shimane, Japan; [Yano, Shozo] Shimane Univ, Dept Lab Med, Fac Med, Izumo, Shimane, Japan	Shimane University; National Institute of Public Health - Japan; Shimane University; Lund University; Kyoto Sangyo University; Shimane University; Shimane University	Yano, S (corresponding author), Shimane Univ, Ctr Community Based Healthcare Res & Educ CoHRE, Org Res & Acad Informat, Izumo, Shimane, Japan.; Yano, S (corresponding author), Shimane Univ, Dept Lab Med, Fac Med, Izumo, Shimane, Japan.	syano@med.shimane-u.ac.jp		Hamano, Tsuyoshi/0000-0002-6755-9138	Japan Society for the Promotion of Science (KAKENHI) [18K11143, 19K11741, 19H03996]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (KAKENHI; grant numbers 18K11143, 19K11741 and 19H03996). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen F, 2002, CLIN ORAL IMPLAN RES, V13, P320, DOI 10.1034/j.1600-0501.2002.130313.x; [Anonymous], 2019, LANCET, V394, P188, DOI 10.1016/S0140-6736(19)31639-3; Bui FQ, 2019, BIOMED J, V42, P27, DOI 10.1016/j.bj.2018.12.001; Chang Y, 2020, DIABETOLOGIA, V63, P924, DOI 10.1007/s00125-020-05112-9; Chen LK, 2020, J AM MED DIR ASSOC, V21, P300, DOI 10.1016/j.jamda.2019.12.012; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Divney AA, 2019, DIABETES CARE, V42, P1241, DOI 10.2337/dc18-2432; GLAVIND L, 1968, J PERIODONTOL, V39, P341, DOI 10.1902/jop.1968.39.6.341; Glurich I, 2019, CURR DIABETES REP, V19, DOI 10.1007/s11892-019-1228-0; Hamano T, 2015, INT J ENV RES PUB HE, V12, P7199, DOI 10.3390/ijerph120707199; Hatta K., 2020, J PROSTHODONT RES, DOI [10.2186/jpr.JPOR%5F2019%5F567, DOI 10.2186/JPR.JPOR%5F2019%5F567]; Kamdem B, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0568-3; Lee JH, 2019, J KOREAN MED SCI, V34, DOI 10.3346/jkms.2019.34.e262; Mesinovic J, 2019, DIABET METAB SYND OB, V12, P1057, DOI 10.2147/DMSO.S186600; Mihara Y, 2018, GERODONTOLOGY, V35, P214, DOI 10.1111/ger.12341; Ministry of Health Labor and Welfare, 2013, SPEC HLTH CHECK SPEC; Miquel S, 2018, PHYSIOL BEHAV, V188, P239, DOI 10.1016/j.physbeh.2018.02.018; Morais JA, 2003, J DENT RES, V82, P53, DOI 10.1177/154405910308200112; Morita K, 2018, J PROSTHODONT RES, V62, P432, DOI 10.1016/j.jpor.2018.03.007; Murakami M, 2015, GERIATR GERONTOL INT, V15, P1007, DOI 10.1111/ggi.12399; Peres MA, 2019, LANCET, V394, P249, DOI 10.1016/S0140-6736(19)31146-8; Polzer I, 2012, CLIN ORAL INVEST, V16, P333, DOI 10.1007/s00784-011-0625-9; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Ramseier CA, 2017, J CLIN PERIODONTOL, V44, P1182, DOI 10.1111/jcpe.12782; Schwahn C, 2013, INT J CARDIOL, V167, P1430, DOI 10.1016/j.ijcard.2012.04.061; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Suzuki H, 2005, METABOLISM, V54, P1593, DOI 10.1016/j.metabol.2005.06.006; Takagi D, 2017, GERODONTOLOGY, V34, P357, DOI 10.1111/ger.12274; Tanaka T, 2018, J GERONTOL A-BIOL, V73, P1661, DOI 10.1093/gerona/glx225; Tominaga K., 2007, J DENT HLTH, V57, P166, DOI 10.5834/jdh.57.3%5F166; Wakai K, 2010, COMMUNITY DENT ORAL, V38, P43, DOI 10.1111/j.1600-0528.2009.00512.x; Watt RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030797; WILLIAMS RC, 1990, NEW ENGL J MED, V322, P373, DOI 10.1056/NEJM199002083220606; Yamazaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064113; Zhu Y, 2014, PHYSIOL BEHAV, V133, P136, DOI 10.1016/j.physbeh.2014.05.011; Zhu Y, 2013, BRIT J NUTR, V110, P384, DOI 10.1017/S0007114512005053	36	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252625	10.1371/journal.pone.0252625	http://dx.doi.org/10.1371/journal.pone.0252625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077486	Green Published, gold			2022-12-26	WOS:000664638500057
J	Dorrell, MI; Kast-Woelbern, HR; Botts, RT; Bravo, SA; Tremblay, JR; Giles, S; Wada, JF; Alexander, M; Garcia, E; Villegas, G; Booth, CB; Purington, KJ; Everett, HM; Siles, EN; Wheelock, M; Silva, JA; Fortin, BM; Lowey, CA; Hale, AL; Kurz, TL; Rusing, JC; Goral, DM; Thompson, P; Johnson, AM; Elson, DJ; Tadros, R; Gillette, CE; Coopwood, C; Rausch, AL; Snowbarger, JM				Dorrell, Michael I.; Kast-Woelbern, Heidi R.; Botts, Ryan T.; Bravo, Stephen A.; Tremblay, Jacob R.; Giles, Sarah; Wada, Jessica F.; Alexander, MaryAnn; Garcia, Eric; Villegas, Gabriel; Booth, Caylor B.; Purington, Kaitlyn J.; Everett, Haylie M.; Siles, Erik N.; Wheelock, Michael; Silva, Jordan A.; Fortin, Bridget M.; Lowey, Connor A.; Hale, Allison L.; Kurz, Troy L.; Rusing, Jack C.; Goral, Dawn M.; Thompson, Paul; Johnson, Alec M.; Elson, Daniel J.; Tadros, Roujih; Gillette, Charisa E.; Coopwood, Carley; Rausch, Amy L.; Snowbarger, Jeffrey M.			A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPIES; GLIOBLASTOMA-MULTIFORME; TUMOR ANGIOGENESIS; INTERFERON-ALPHA; PHASE-II; CANCER; MODEL; GROWTH; SUNITINIB; SURVIVAL	Tumor angiogenesis is critical for the growth and progression of cancer. As such, angiostasis is a treatment modality for cancer with potential utility for multiple types of cancer and fewer side effects. However, clinical success of angiostatic monotherapies has been moderate, at best, causing angiostatic treatments to lose their early luster. Previous studies demonstrated compensatory mechanisms that drive tumor vascularization despite the use of angiostatic monotherapies, as well as the potential for combination angiostatic therapies to overcome these compensatory mechanisms. We screened clinically approved angiostatics to identify specific combinations that confer potent inhibition of tumor-induced angiogenesis. We used a novel modification of the ex ovo chick chorioallantoic membrane (CAM) model that combined confocal and automated analyses to quantify tumor angiogenesis induced by glioblastoma tumor onplants. This model is advantageous due to its low cost and moderate throughput capabilities, while maintaining complex in vivo cellular interactions that are difficult to replicate in vitro. After screening multiple combinations, we determined that glioblastoma-induced angiogenesis was significantly reduced using a combination of bevacizumab (Avastin (R)) and temsirolimus (Torisel (R)) at doses below those where neither monotherapy demonstrated activity. These preliminary results were verified extensively, with this combination therapy effective even at concentrations further reduced 10-fold with a CI value of 2.42E-5, demonstrating high levels of synergy. Thus, combining bevacizumab and temsirolimus has great potential to increase the efficacy of angiostatic therapy and lower required dosing for improved clinical success and reduced side effects in glioblastoma patients.	[Dorrell, Michael I.; Kast-Woelbern, Heidi R.] Point Loma Nazarene Univ, Dept Biol, San Diego, CA 92106 USA; [Botts, Ryan T.] Point Loma Nazarene Univ, Dept Math Informat & Comp Sci, San Diego, CA USA; [Bravo, Stephen A.; Tremblay, Jacob R.; Giles, Sarah; Wada, Jessica F.; Alexander, MaryAnn; Garcia, Eric; Villegas, Gabriel; Silva, Jordan A.; Fortin, Bridget M.; Lowey, Connor A.; Hale, Allison L.; Kurz, Troy L.; Rusing, Jack C.; Goral, Dawn M.; Thompson, Paul; Johnson, Alec M.; Elson, Daniel J.; Tadros, Roujih; Gillette, Charisa E.; Coopwood, Carley; Rausch, Amy L.; Snowbarger, Jeffrey M.] Point Loma Nazarene Univ, Dept Biol, Dr Michael Dorrells Lab, San Diego, CA USA; [Garcia, Eric; Silva, Jordan A.; Fortin, Bridget M.; Lowey, Connor A.; Hale, Allison L.; Tadros, Roujih; Gillette, Charisa E.; Coopwood, Carley; Rausch, Amy L.; Snowbarger, Jeffrey M.] Point Loma Nazarene Univ, Dept Biol, Dr Heidi R Kast Woelberns Lab, San Diego, CA USA; [Booth, Caylor B.; Purington, Kaitlyn J.; Everett, Haylie M.; Siles, Erik N.; Wheelock, Michael] Point Loma Nazarene Univ, Dept Math Informat & Comp Sci, Dr Ryan Botts Lab, San Diego, CA USA		Dorrell, MI (corresponding author), Point Loma Nazarene Univ, Dept Biol, San Diego, CA 92106 USA.	mdorrell@pointloma.edu		Silva, Jordan/0000-0002-5212-5070; Dorrell, Michael/0000-0002-7258-6288	Point Loma Nazarene University; Alumni Associates; NIH AREA grant (NIGMS) [1R15GM102995-01A1]; RASP [GR-19690, GR-20960, GR-22190, GR-20470, GR22150]	Point Loma Nazarene University; Alumni Associates; NIH AREA grant (NIGMS); RASP	Dorrell MI: Point Loma Nazarene University -Annual in-house Alumni Grants and Research and Special Projects grants. Annual funding from Alumni Associates. Botts RT: NIH AREA grant (NIGMS) #1R15GM102995-01A1. Point Loma Nazarene University -In-house Research and Special Projects grants. Annual funding from Alumni Associates. Kast-Woelbern HR: Point Loma Nazarene University -Annual inhouse Alumni Grants and Research and Special Projects grants. Annual funding from Alumni Associates. All other authors were undergraduates in MD, RB, or HK's labs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RASP grant numbers: Dorrell alumni = GR-19690 Dorrell RASP 2018 -2019 = GR-20960 Dorrell RASP 2020 -2021 = GR-22190 Heidi alumni (Angiogenesis) = GR-20470 Heidi RASP = GR22150.	Alvarez EA, 2013, GYNECOL ONCOL, V129, P22, DOI 10.1016/j.ygyno.2012.12.022; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Arrillaga-Romany I, 2014, EXPERT OPIN INV DRUG, V23, P199, DOI 10.1517/13543784.2014.856880; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Banin E, 2006, INVEST OPHTH VIS SCI, V47, P2125, DOI 10.1167/iovs.05-1096; Barnett FH, 2004, GENE THER, V11, P1283, DOI 10.1038/sj.gt.3302287; Berndsen RH, 2017, ANGIOGENESIS, V20, P245, DOI 10.1007/s10456-017-9551-z; Brooks PC, 1999, METH MOL B, V129, P257; Cao YH, 2004, SEMIN CANCER BIOL, V14, P139, DOI 10.1016/j.semcancer.2003.09.018; Caragher S, 2019, CANCERS, V11, DOI 10.3390/cancers11010044; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chang W, 2021, SHINY WEB APPL FRAME; Cheng GW, 2015, CELL BIOCHEM BIOPHYS, V73, P71, DOI 10.1007/s12013-015-0566-z; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Darefsky AS, 2012, CANCER-AM CANCER SOC, V118, P2163, DOI 10.1002/cncr.26494; Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Dong ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084236; Dorrell MI, 2007, P NATL ACAD SCI USA, V104, P967, DOI 10.1073/pnas.0607542104; Dorrell MI, 2006, PROG RETIN EYE RES, V25, P277, DOI 10.1016/j.preteyeres.2006.01.001; Dorrell MI, 2012, AM BIOL TEACH, V74, P628, DOI 10.1525/abt.2012.74.9.6; Doukas CN, 2006, 2006 28TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-15, P1690; Dragulescu AA., 2018, XLSX READ WRITE FORM; Ellis LM, 2004, HEMATOL ONCOL CLIN N, V18, P1007, DOI 10.1016/j.hoc.2004.06.002; Fasolo A, 2012, CURR PHARM DESIGN, V18, P2766, DOI 10.2174/138161212800626210; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 1992, Semin Cancer Biol, V3, P65; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622; Gravina GL, 2019, CANCERS, V11, DOI 10.3390/cancers11101604; Hatipoglu G, 2015, CANCER SCI, V106, P160, DOI 10.1111/cas.12580; Hodges TR, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1145332; Horita S, 2019, PHARMACOL RES PERSPE, V7, DOI 10.1002/prp2.545; Inampudi C, 2018, CURR OPIN PHARMACOL, V39, P60, DOI 10.1016/j.coph.2018.02.011; Irani Y, 2016, INVEST OPHTH VIS SCI, V57, P586, DOI 10.1167/iovs.15-18239; Jin X, 2011, CANCER RES, V71, P7125, DOI 10.1158/0008-5472.CAN-11-1330; Jo Jasmin, 2018, Prog Neurol Surg, V31, P180, DOI 10.1159/000467379; Kim MM, 2018, CANCER J, V24, P180, DOI 10.1097/PPO.0000000000000326; Kohen MC, 2018, MOL VIS, V24, P239; Lassen U, 2013, ANTICANCER RES, V33, P1657; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Lieberman NAP, 2018, EXPERT REV NEUROTHER, V18, P251, DOI 10.1080/14737175.2018.1425617; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Maas JWM, 2001, HUM REPROD, V16, P1557, DOI 10.1093/humrep/16.8.1557; Mascarenhas L, 2019, J CLIN ONCOL, V37, P2866, DOI 10.1200/JCO.19.00576; McCarty MF, 2003, TRENDS MOL MED, V9, P53, DOI 10.1016/S1471-4914(03)00002-9; McGranahan T, 2019, CURR TREAT OPTION ON, V20, DOI 10.1007/s11864-019-0619-4; Geraldo LHM, 2019, TRENDS CANCER, V5, P46, DOI 10.1016/j.trecan.2018.11.002; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Negrier S, 2011, LANCET ONCOL, V12, P673, DOI 10.1016/S1470-2045(11)70124-3; Nicolaou KC, 1998, BIOORGAN MED CHEM, V6, P1185, DOI 10.1016/S0968-0896(98)00090-X; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; Nienhuser H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010043; Norden AD, 2009, NAT REV NEUROL, V5, P610, DOI 10.1038/nrneurol.2009.159; Nowak-Sliwinska P, 2018, ANGIOGENESIS, V21, P425, DOI 10.1007/s10456-018-9613-x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Pedersen TL., 2019, SHINYFILES SERVER SI; R Core Team, 2020, R LANG ENV STAT COMP; Rini BI, 2014, J CLIN ONCOL, V32, P752, DOI 10.1200/JCO.2013.50.5305; Sennino B, 2012, NAT REV CANCER, V12, P699, DOI 10.1038/nrc3366; Seynhaeve ALB, 2018, JOVE-J VIS EXP, DOI 10.3791/55115; Shi P, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.106005; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Sigismund S, 2018, MOL ONCOL, V12, P3, DOI 10.1002/1878-0261.12155; Simons M, 2015, CIRC RES, V116, pE99, DOI 10.1161/RES.0000000000000054; Sperling J, 2015, CLIN EXP METASTAS, V32, P313, DOI 10.1007/s10585-015-9707-4; Tabchi S, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00052; Trujillo CA, 2007, CLIN OPHTHALMOL, V1, P393; van Kempen LCLT, 2008, INT J CANCER, V122, P1019, DOI 10.1002/ijc.23147; Viallard C, 2017, ANGIOGENESIS, V20, P409, DOI 10.1007/s10456-017-9562-9; Weiss T, 2018, CANCER RES, V78, P1031, DOI 10.1158/0008-5472.CAN-17-1788; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yihui X., 2019, DT WRAPPER JAVASCRIP; Zhang M, 2015, BRAIN TUMOR PATHOL, V32, P229, DOI 10.1007/s10014-015-0233-5; Zhao YJ, 2015, ONCOLOGIST, V20, P660, DOI 10.1634/theoncologist.2014-0465; Zhou Q, 2013, MOL MED REP, V8, P1734, DOI 10.3892/mmr.2013.1704	77	3	3	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252233	10.1371/journal.pone.0252233	http://dx.doi.org/10.1371/journal.pone.0252233			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077449	Green Published, gold			2022-12-26	WOS:000664638500034
J	Langenbucher, A; Szentmary, N; Cayless, A; Weisensee, J; Fabian, E; Wendelstein, J; Hoffmann, P				Langenbucher, Achim; Szentmary, Nora; Cayless, Alan; Weisensee, Johannes; Fabian, Ekkehard; Wendelstein, Jascha; Hoffmann, Peter			Considerations on the Castrop formula for calculation of intraocular lens power	PLOS ONE			English	Article							PREDICTION; CONSTANT	Background To explain the concept of the Castrop lens power calculation formula and show the application and results from a large dataset compared to classical formulae. Methods The Castrop vergence formula is based on a pseudophakic model eye with 4 refractive surfaces. This was compared against the SRKT, Hoffer-Q, Holladay1, simplified Haigis with 1 optimized constant and Haigis formula with 3 optimized constants. A large dataset of preoperative biometric values, lens power data and postoperative refraction data was split into training and test sets. The training data were used for formula constant optimization, and the test data for cross-validation. Constant optimization was performed for all formulae using nonlinear optimization, minimising root mean squared prediction error. Results The constants for all formulae were derived with the Levenberg-Marquardt algorithm. Applying these constants to the test data, the Castrop formula showed a slightly better performance compared to the classical formulae in terms of prediction error and absolute prediction error. Using the Castrop formula, the standard deviation of the prediction error was lowest at 0.45 dpt, and 95% of all eyes in the test data were within the limit of 0.9 dpt of prediction error. Conclusion The calculation concept of the Castrop formula and one potential option for optimization of the 3 Castrop formula constants (C, H, and R) are presented. In a large dataset of 1452 data points the performance of the Castrop formula was slightly superior to the respective results of the classical formulae such as SRKT, Hoffer-Q, Holladay1 or Haigis.	[Langenbucher, Achim; Weisensee, Johannes] Saarland Univ, Dept Expt Ophthalmol, Homburg, Saar, Germany; [Szentmary, Nora] Saarland Univ, Dr Rolf M Schwiete Ctr Limbal Stem Cell & Aniridi, Homburg, Saar, Germany; [Szentmary, Nora] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Cayless, Alan] Open Univ, Sch Phys Sci, Milton Keynes, Bucks, England; [Fabian, Ekkehard] Augenctr Rosenheim, Rosenheim, Germany; [Wendelstein, Jascha] Johannes Kepler Univ Linz, Dept Ophthalmol, Linz, Austria; [Hoffmann, Peter] Augen & Laserklin Castrop Rauxel, Castrop Rauxel, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Semmelweis University; Open University - UK; Johannes Kepler University Linz	Langenbucher, A (corresponding author), Saarland Univ, Dept Expt Ophthalmol, Homburg, Saar, Germany.	achim.langenbucher@uks.eu	Szentmary, Nora/AAE-7643-2022; Wendelstein, Jascha Armin/F-5389-2018	Wendelstein, Jascha Armin/0000-0003-4145-2559; Weisensee, Johannes/0000-0001-7741-1447				Aristodemou P, 2011, J CATARACT REFR SURG, V37, P50, DOI 10.1016/j.jcrs.2010.07.037; Cooke DL, 2019, J CATARACT REFR SURG, V45, P351, DOI 10.1016/j.jcrs.2018.12.026; Cooke DL, 2019, J CATARACT REFR SURG, V45, P284, DOI 10.1016/j.jcrs.2018.10.039; FYODOROV SN, 1975, INVEST OPHTH VISUAL, V14, P625; Gernet H., 1970, BALVE VERLAG ZIMMERM, P54; Hoffer K J, 1980, J Am Intraocul Implant Soc, V6, P370; Hoffer KJ, 2021, OPHTHALMOLOGY, V128, pE115, DOI 10.1016/j.ophtha.2020.07.005; HOFFER KJ, 1981, OPHTHALMIC SURG LAS, V12, P269; HOFFER KJ, 1993, J CATARACT REFR SURG, V19, P700, DOI 10.1016/S0886-3350(13)80338-0; HOLLADAY JT, 1988, J CATARACT REFR SURG, V14, P17, DOI 10.1016/S0886-3350(88)80059-2; Langenbucher A, 2020, KLIN MONATSBL AUGENH, V237, P1430, DOI 10.1055/a-1298-8121; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Liou HL, 1997, J OPT SOC AM A, V14, P1684, DOI 10.1364/JOSAA.14.001684; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Melles RB, 2019, OPHTHALMOLOGY, V126, P1334, DOI 10.1016/j.ophtha.2019.04.011; Norrby NES, 1997, J CATARACT REFR SURG, V23, P254, DOI 10.1016/S0886-3350(97)80350-1; Olsen T, 2006, J CATARACT REFR SURG, V32, P419, DOI 10.1016/j.jcrs.2005.12.139; Olsen T, 2014, J CATARACT REFR SURG, V40, P764, DOI 10.1016/j.jcrs.2013.10.037; RETZLAFF JA, 1990, J CATARACT REFR SURG, V16, P333, DOI 10.1016/S0886-3350(13)80705-5; SANDERS DR, 1990, J CATARACT REFR SURG, V16, P341, DOI 10.1016/S0886-3350(13)80706-7; Savini G, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-2290; Schroder S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158988; Shammas H.J., 2004, INTRAOCULAR LENS POW; Vega Y, 2021, J CLIN MED, V10, DOI 10.3390/jcm10030542; Wendelstein J, 2022, BRIT J OPHTHALMOL, V106, P795, DOI 10.1136/bjophthalmol-2020-318272; Zhang JQ, 2019, INT J OPHTHALMOL-CHI, V12, P943, DOI 10.18240/ijo.2019.06.10	26	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252102	10.1371/journal.pone.0252102	http://dx.doi.org/10.1371/journal.pone.0252102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077432	Green Published, gold, Green Accepted			2022-12-26	WOS:000664638500028
J	Rasch-Halvorsen, O; Hassel, E; Brumpton, B; Jenssen, H; Spruit, MA; Langhammer, A; Steinshamn, S				Rasch-Halvorsen, Oystein; Hassel, Erlend; Brumpton, Ben M.; Jenssen, Haldor; Spruit, Martijn A.; Langhammer, Arnulf; Steinshamn, Sigurd			Lung function and peak oxygen uptake in chronic obstructive pulmonary disease phenotypes with and without emphysema	PLOS ONE			English	Article							EXERCISE CAPACITY; DYNAMIC HYPERINFLATION; FLOW LIMITATION; COPD; DIAGNOSIS; VENTILATION; INTOLERANCE; SPIROMETRY; MORTALITY; VOLUME	Previous studies of associations of forced expiratory lung volume in one second (FEV1) with peak oxygen uptake (VO2peak) in chronic obstructive pulmonary disease (COPD) have not taken sex, age and height related variance of dynamic lung volumes into account. Nor have such demographic spread of spirometric measures been considered in studies comparing VO2peak between COPD phenotypes characterized by degree of emphysema. We aimed to assess the association of FEV1Z-score with VO2peak in COPD (n = 186) and investigate whether this association differs between emphysema (E-COPD) and non-emphysema (NE-COPD) phenotypes. Corresponding assessments using standardized percent predicted FEV1 (ppFEV(1)) were performed for comparison. Additionally, phenotype related differences in VO2peak were compared using FEV1Z-score and ppFEV(1) as alternative expressions of FEV1. E-COPD and NE-COPD were defined by transfer factor of the lung for carbon monoxide below and above lower limits of normal (LLN), respectively. The associations were assessed in linear regression models. One unit reduction in FEV1Z-score was associated with 1.9 (95% CI 1.4, 2.5) ml/kg/min lower VO2peak. In stratified analyses, corresponding estimates were 2.2 (95% CI 1.4, 2.9) and 1.2 (95% CI 0.2, 2.2) ml/kg/min lower VO2peak in E-COPD and NE-COPD, respectively. The association did not differ statistically by COPD phenotype (p-value for interaction = 0.153). Similar estimates were obtained in analyses using standardized ppFEV(1). Compared to NE-COPD, VO2peak was 2.2 (95% CI 0.8, 3.6) and 2.1 (95% CI 0.8, 3.5) ml/kg/min lower in E-COPD when adjusted for FEV1Z-score and ppFEV(1), respectively. In COPD, FEV1Z-score is positively associated with VO2peak. This association was stronger in E-COPD but did not differ statistically by phenotype. Both the association of FEV1 with VO2peak and the difference in VO2peak comparing COPD phenotypes seems independent of sex, age and height related variance in FEV1. Mechanisms leading to reduction in FEV1 may contribute to lower VO2peak in E-COPD.	[Rasch-Halvorsen, Oystein; Steinshamn, Sigurd] Norwegian Univ Sci & Technol, NTNU, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, Trondheim, Norway; [Rasch-Halvorsen, Oystein; Brumpton, Ben M.; Steinshamn, Sigurd] Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Thorac & Occupat Med, Trondheim, Norway; [Hassel, Erlend] Norwegian Armed Forces Occupat Hlth Serv, Trondheim, Norway; [Brumpton, Ben M.] Norwegian Univ Sci & Technol, NTNU, Fac Med & Hlth Sci, KG Jebsen Ctr Genet Epidemiol,Dept Publ Hlth & Nu, Trondheim, Norway; [Brumpton, Ben M.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Jenssen, Haldor] Telemark Heart Lung & Blood Inst, Skien, Norway; [Spruit, Martijn A.] CIRO, Dept Res & Dev, Horn, Netherlands; [Spruit, Martijn A.] Maastricht Univ, Dept Resp Med, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Spruit, Martijn A.] Hasselt Univ, Fac Rehabil Sci, BIOMED Biomed Res Inst, REVAL Rehabil Res Ctr, Diepenbeek, Belgium; [Langhammer, Arnulf] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, NTNU, Dept Publ Hlth & Nursing, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bristol; Maastricht University; Maastricht University Medical Centre (MUMC); Hasselt University; Norwegian University of Science & Technology (NTNU)	Rasch-Halvorsen, O (corresponding author), Norwegian Univ Sci & Technol, NTNU, Fac Med & Hlth Sci, Dept Circulat & Med Imaging, Trondheim, Norway.; Rasch-Halvorsen, O (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Thorac & Occupat Med, Trondheim, Norway.	oystein.rasch-halvorsen@ntnu.no			Dam Foundation [2015/FO5150]	Dam Foundation	OR-H received a research grant (Grant 2015/FO5150) from the Dam Foundation (https://www.dam.no/logo/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Augustin IML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201593; Bauerle O, 1995, J APPL PHYSIOL, V79, P1870, DOI 10.1152/jappl.1995.79.6.1870; Boutou AK, 2013, EUR RESPIR J, V42, P616, DOI 10.1183/09031936.00146012; Calverley PMA, 2005, EUR RESPIR J, V25, P186, DOI 10.1183/09031936.04.00113204; CAMPBELL SC, 1982, J OCCUP ENVIRON MED, V24, P531; Cooper CB, 2006, AM J MED, V119, pS21, DOI 10.1016/j.amjmed.2006.08.004; Farkhooy A, 2013, COPD, V10, P180, DOI 10.3109/15412555.2012.734873; Foglio K, 2000, RESP MED, V94, P256, DOI 10.1053/rmed.1999.0734; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Miller MR, 2011, CHEST, V139, P52, DOI 10.1378/chest.10-0189; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; Oga T, 2003, AM J RESP CRIT CARE, V167, P544, DOI 10.1164/rccm.200206-583OC; Paoletti P, 2011, RESP PHYSIOL NEUROBI, V179, P167, DOI 10.1016/j.resp.2011.07.013; PELLEGRINO R, 1993, J APPL PHYSIOL, V74, P2552, DOI 10.1152/jappl.1993.74.5.2552; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pepin Veronique, 2007, COPD, V4, P195, DOI 10.1080/15412550701480489; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Poole DC, 2017, J APPL PHYSIOL, V122, P997, DOI 10.1152/japplphysiol.01063.2016; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Quanjer PH, 2015, EUR RESPIR J, V46, P1523, DOI 10.1183/13993003.01295-2015; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rinaldo RF, 2020, MULTIDISCIP RESP MED, V15, DOI 10.4081/mrm.2020.476; Stanojevic S, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00010-2017; Vogelmeier CF, 2017, EUR RESPIR J, V49, DOI [10.1183/13993003.00214-2017, 10.1016/j.arbres.2017.02.001, 10.1111/resp.13012, 10.1164/rccm.201701-0218PP]; Vollmer WM, 2009, EUR RESPIR J, V34, P588, DOI 10.1183/09031936.00164608	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252386	10.1371/journal.pone.0252386	http://dx.doi.org/10.1371/journal.pone.0252386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043708	Green Published, gold			2022-12-26	WOS:000664635700095
J	Gregersen, T; Doran, R; Bohm, G; Poortinga, W				Gregersen, Thea; Doran, Rouven; Bohm, Gisela; Poortinga, Wouter			Outcome expectancies moderate the association between worry about climate change and personal energy-saving behaviors	PLOS ONE			English	Article							PRO-ENVIRONMENTAL INTENTIONS; COLLECTIVE EFFICACY; FEAR APPEALS; PROTECTION MOTIVATION; SELF-EFFICACY; COGNITIVE THEORY; SOCIAL NORMS; DETERMINANTS; METAANALYSIS; PERCEPTIONS	This paper explores whether efficacy beliefs can alter the relationship between worry about climate change and personal energy-saving behaviors, controlling for climate change beliefs and socio-demographics. For this purpose, we used data from 23 countries that participated in the European Social Survey Round 8 (N = 44 387). Worry about climate change, personal efficacy, personal outcome expectancy, and collective outcome expectancy were each associated with personal energy-saving behaviors concerning either energy curtailment or energy efficiency. The results further show that outcome expectancies moderate the association between worry about climate change and both types of energy behaviors. Worry was more strongly related to energy curtailment behaviors among those with high levels of personal and collective outcome expectancy. A similar pattern was found for energy efficiency behaviors, which were more strongly predicted by worry about climate change when combined with high levels of collective outcome expectancy. These findings are relevant for climate change communication, especially informational campaigns aiming to lower overall household energy use.	[Gregersen, Thea; Doran, Rouven; Bohm, Gisela] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Gregersen, Thea] Univ Bergen, Ctr Climate & Energy Transformat CET, Bergen, Norway; [Bohm, Gisela] Inland Norway Univ Appl Sci, Dept Psychol, Lillehammer, Norway; [Poortinga, Wouter] Cardiff Univ, Welsh Sch Architecture, Cardiff, Wales; [Poortinga, Wouter] Cardiff Univ, Sch Psychol, Cardiff, Wales	University of Bergen; University of Bergen; Inland Norway University of Applied Sciences; Cardiff University; Cardiff University	Gregersen, T (corresponding author), Univ Bergen, Dept Psychosocial Sci, Bergen, Norway.; Gregersen, T (corresponding author), Univ Bergen, Ctr Climate & Energy Transformat CET, Bergen, Norway.	Thea.Gregersen@uib.no	Gregersen, Thea/AAA-7655-2022	Gregersen, Thea/0000-0001-5797-1850				Abrahamse W, 2011, HUM ECOL REV, V18, P30; [Anonymous], 2013, STAT POWER ANAL BEHA; [Anonymous], 2020, TOT FIN CONS TFC SEC; B?hm G., 2010, UMWELTPSYCHOLOGIE, V14, P46; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barth M, 2016, TRANSPORT RES F-TRAF, V37, P64, DOI 10.1016/j.trf.2015.11.011; Bliese PD, 1998, ORGAN RES METHODS, V1, P355, DOI 10.1177/109442819814001; Bonniface L, 2008, AUST J SOC ISSUES, V43, P345, DOI 10.1002/j.1839-4655.2008.tb00107.x; Bostrom A., 2018, PSYCHOL PERSPECTIVES, P251, DOI [DOI 10.1007/978-3-319-92478-6_11, 10.1007/978-3-319-92478-6_11]; Bostrom A, 2019, RISK ANAL, V39, P805, DOI 10.1111/risa.13210; Boudet HS, 2016, ENERG POLICY, V92, P444, DOI 10.1016/j.enpol.2016.02.033; Bouman T, 2020, GLOBAL ENVIRON CHANG, V62, DOI 10.1016/j.gloenvcha.2020.102061; Brody S, 2012, CLIM POLICY, V12, P1, DOI 10.1080/14693062.2011.579261; Cayla JM, 2011, ENERG POLICY, V39, P7874, DOI 10.1016/j.enpol.2011.09.036; Chen MF, 2015, J ENVIRON PSYCHOL, V42, P66, DOI 10.1016/j.jenvp.2015.02.002; Clement C., 2014, INTEGRATING FACTORS, V7, DOI 10.5539/jsd.v7n6p46; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Doherty KL, 2016, NAT CLIM CHANGE, V6, P879, DOI 10.1038/NCLIMATE3025; European Commission, 2019, COMMUNICATION COMMIS; European Commission, 2018, CLEAN PLAN ALL EUR S; European Social Survey, 2018, ESS ROUND 8 2016 201; European Social Survey, 2016, DAT FIL ED 2 0; Feinberg M, 2011, PSYCHOL SCI, V22, P34, DOI 10.1177/0956797610391911; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Gardner GT, 2008, ENVIRONMENT, V50, P12, DOI 10.3200/ENVT.50.5.12-25; Geiger N., 2020, OXFORD ENCY CLIMATE; Gifford R, 2011, AM PSYCHOL, V66, P290, DOI 10.1037/a0023566; Gotz FM., 2021, SMALL EFFECTS INDISP; Gregersen T, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01573; Hamann KRS, 2020, J SOC ISSUES, V76, P35, DOI 10.1111/josi.12369; Han MS, 2020, ENERG POLICY, V140, DOI 10.1016/j.enpol.2020.111405; Hanss D, 2016, SUSTAIN DEV, V24, P357, DOI 10.1002/sd.1615; Homburg A, 2006, J ENVIRON PSYCHOL, V26, P1, DOI 10.1016/j.jenvp.2006.03.003; Hori S, 2013, ENERG POLICY, V52, P354, DOI 10.1016/j.enpol.2012.09.043; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Huang FL, 2018, SCHOOL PSYCHOL QUART, V33, P492, DOI 10.1037/spq0000272; Jugert P, 2016, J ENVIRON PSYCHOL, V48, P12, DOI 10.1016/j.jenvp.2016.08.003; Kellstedt PM, 2008, RISK ANAL, V28, P113, DOI 10.1111/j.1539-6924.2008.01010.x; KEMPTON W, 1993, ANNU REV ENERG ENV, V18, P217, DOI 10.1146/annurev.eg.18.110193.001245; Kneebone S, 2018, J ENVIRON PSYCHOL, V55, P1, DOI 10.1016/j.jenvp.2017.10.007; Koletsou A, 2011, RISK MANAG-UK, V13, P184, DOI 10.1057/rm.2011.12; Kormos C, 2014, J ENVIRON PSYCHOL, V40, P359, DOI 10.1016/j.jenvp.2014.09.003; Kothe EJ, 2019, AUST J PSYCHOL, V71, P411, DOI 10.1111/ajpy.12271; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lazarus R.S., 1984, EMOTION ADAPTATION; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Liobikiene G, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141745; Lorenzoni I, 2007, GLOBAL ENVIRON CHANG, V17, P445, DOI 10.1016/j.gloenvcha.2007.01.004; Lubell M, 2007, POLIT BEHAV, V29, P391, DOI 10.1007/s11109-006-9025-2; Lundberg DC, 2019, ENERGY RES SOC SCI, V58, DOI 10.1016/j.erss.2019.101257; MADDUX JE, 1983, J EXP SOC PSYCHOL, V19, P469, DOI 10.1016/0022-1031(83)90023-9; Maloney EK, 2011, SOC PERSONAL PSYCHOL, V5, P206, DOI 10.1111/j.1751-9004.2011.00341.x; Mead E, 2012, ATL J COMMUN, V20, P31, DOI 10.1080/15456870.2012.637027; Milfont TL, 2012, RISK ANAL, V32, P1003, DOI 10.1111/j.1539-6924.2012.01800.x; Moussaoui LS, 2016, J SOC PSYCHOL, V156, P536, DOI 10.1080/00224545.2015.1135780; Nauges C, 2017, ECOL ECON, V141, P87, DOI 10.1016/j.ecolecon.2017.05.026; O'Neill S, 2009, SCI COMMUN, V30, P355, DOI 10.1177/1075547008329201; Ogunbode CA, 2020, CLIMATIC CHANGE, V158, P361, DOI 10.1007/s10584-019-02609-0; Pelletier LG, 1999, J APPL SOC PSYCHOL, V29, P2481, DOI 10.1111/j.1559-1816.1999.tb00122.x; Poortinga W, 2003, J ECON PSYCHOL, V24, P49, DOI 10.1016/S0167-4870(02)00154-X; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI; Reese G, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020200; Reeve J., 2015, UNDERSTANDING MOTIVA, V6th ed, P268; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Smith N, 2014, RISK ANAL, V34, P937, DOI 10.1111/risa.12140; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Steg L, 2008, ENERG POLICY, V36, P4449, DOI 10.1016/j.enpol.2008.09.027; Stoll-Kleemann S, 2001, GLOBAL ENVIRON CHANG, V11, P107, DOI 10.1016/S0959-3780(00)00061-3; Tannenbaum MB, 2015, PSYCHOL BULL, V141, P1178, DOI 10.1037/a0039729; Umit R, 2019, ENERGY RES SOC SCI, V53, P206, DOI 10.1016/j.erss.2019.02.025; van der Linden S, 2017, OXFORD ENCY CLIMATE; van Valkengoed AM, 2019, NAT CLIM CHANGE, V9, P158, DOI 10.1038/s41558-018-0371-y; van Zorneren M, 2010, J ENVIRON PSYCHOL, V30, P339, DOI 10.1016/j.jenvp.2010.02.006; Verschoor M, 2020, J ENVIRON PSYCHOL, V70, DOI 10.1016/j.jenvp.2020.101435; Wang ZH, 2011, ENERG POLICY, V39, P3550, DOI 10.1016/j.enpol.2011.03.055; Whitmarsh L, 2010, J ENVIRON PSYCHOL, V30, P305, DOI 10.1016/j.jenvp.2010.01.003; Wicker P, 2013, ECOL ECON, V88, P41, DOI 10.1016/j.ecolecon.2013.01.005; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; Xue W, 2016, CLIMATIC CHANGE, V137, P43, DOI 10.1007/s10584-016-1678-1; Yang S, 2016, ENERG POLICY, V93, P196, DOI 10.1016/j.enpol.2016.02.018; Zhang CY, 2018, J CLEAN PROD, V185, P285, DOI 10.1016/j.jclepro.2018.02.303	82	7	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252105	10.1371/journal.pone.0252105	http://dx.doi.org/10.1371/journal.pone.0252105			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038456	Green Published, gold, Green Accepted			2022-12-26	WOS:000664633500050
J	Almeida, C; Azevedo, J; Gregorio, MJ; Barros, R; Severo, M; Padrao, P				Almeida, Carla; Azevedo, Jose; Gregorio, Maria Joao; Barros, Renata; Severo, Milton; Padrao, Patricia			Parental practices, preferences, skills and attitudes on food consumption of pre-school children: Results from Nutriscience Project	PLOS ONE			English	Article							COMPREHENSIVE FEEDING PRACTICES; VEGETABLE INTAKE; NUTRITION KNOWLEDGE; DIETARY-INTAKE; FRUIT; QUESTIONNAIRE; DETERMINANTS; VALIDATION; MODEL; HOME	The association between family environment and child's eating behaviors is well established but a multidimensional approach to study this relation is lacking. This study aimed to assess the proprieties of a questionnaire created to evaluate parental practices, preferences, skills and attitudes regarding fruit and vegetables (F&V), sugar and salt. Participants (n = 714) were families of pre-school children (aged 2-6 years old) of the Nutriscience Project-a web-based gamification program-who answered a questionnaire assessing socio-demographic characteristics, nutrition knowledge, and a scale evaluating parental practices, preferences, skills and attitudes, at the baseline of the project. Exploratory factorial analysis was applied to the scale: 21 items and 5 factors were extracted (52.4% of explained variance) with a Kaiser-Meyer-Olkin (KMO) value of 0.770: 1. Modelling/active promotion of F&V consumption (alpha = 0.73), 2. Skills for choosing/preparing healthy food (alpha = 0.75), 3. Food preferences and satiety perception (alpha = 0.70), 4. Awareness regarding sugar/salt intake (alpha = 0.61), 5. Allowance regarding F&V consumption (alpha = 0.55). Kruskal-Wallis and Mann-Whitney tests were conducted to compare factors according to socio-demographic characteristics. Higher scores for parental modelling and active promotion of F&V consumption were observed in older parents, those with higher nutrition knowledge and who reported to live without income difficulties. Regarding food preferences, higher scores were observed in mothers, with higher nutrition knowledge and from higher educated groups. Higher awareness regarding salt and sugar consumption were observed in older parents, with higher education, higher nutrition knowledge and with female children. Older parents and with female children also registered higher scores of skills for choosing/preparing healthy food. The scale showed satisfactory proprieties and may contribute to assess family food environment using a multidimensional approach. It also highlighted the importance of considering socio-demographic characteristics in interventions to promote healthy eating.	[Almeida, Carla; Gregorio, Maria Joao; Barros, Renata; Padrao, Patricia] Univ Porto, Fac Ciencias Nutr & Alimentacao, Porto, Portugal; [Azevedo, Jose; Barros, Renata; Severo, Milton; Padrao, Patricia] Univ Porto, EPIUnit, Inst Saude Publ, Porto, Portugal; [Azevedo, Jose; Barros, Renata; Severo, Milton; Padrao, Patricia] ITR Lab Invest Integrat & Translac Saude Populac, Porto, Portugal; [Azevedo, Jose] Univ Porto, Fac Letras, Porto, Portugal; [Severo, Milton] Univ Porto, Dept Ciencias Saude Publ & Forenses & Educ Med, Fac Med, Porto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Padrao, P (corresponding author), Univ Porto, Fac Ciencias Nutr & Alimentacao, Porto, Portugal.; Padrao, P (corresponding author), Univ Porto, EPIUnit, Inst Saude Publ, Porto, Portugal.; Padrao, P (corresponding author), ITR Lab Invest Integrat & Translac Saude Populac, Porto, Portugal.	patriciapadrao@fcna.up.pt	Barros, Renata/AGC-2171-2022; Severo, Milton/I-3497-2012; Gregorio, Maria Joao/AAI-2085-2021	Barros, Renata/0000-0002-3043-1720; Severo, Milton/0000-0002-5787-4871; Gregorio, Maria Joao/0000-0002-0380-7833; Almeida, Carla/0000-0002-5359-3319	Foundation for Science and Technology-FCT (Portuguese Ministry of Science, Technology and Higher Education) [UIDB/04750/2020, UID/QUI/50006/2020]; FCT [2020.08208.BD]; "Programa Operacional Regional Norte" (NORTE 2020/FSE) [2020.08208.BD]	Foundation for Science and Technology-FCT (Portuguese Ministry of Science, Technology and Higher Education)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); "Programa Operacional Regional Norte" (NORTE 2020/FSE)	This study was financed through national funding from the Foundation for Science and Technology-FCT (Portuguese Ministry of Science, Technology and Higher Education), under the projects UIDB/04750/2020 and UID/QUI/50006/2020. Individual PhD grants attributed to CA (2020.08208.BD) was funded by FCT and the "Programa Operacional Regional Norte" (NORTE 2020/FSE). The funders had no role in the design, analysis or writing of this paper.	Adamson M, 2014, J FAM STUD, V20, P118, DOI 10.1080/13229400.2014.11082001; Anzman-Frasca S, 2018, OBES REV, V19, P576, DOI 10.1111/obr.12658; Azevedo J, 2019, J NUTR EDUC BEHAV, V51, P326, DOI 10.1016/j.jneb.2018.10.008; Barends C, 2019, APPETITE, V137, P174, DOI 10.1016/j.appet.2019.02.003; Bere E, 2004, PUBLIC HEALTH NUTR, V7, P991, DOI 10.1079/PHN2004619; Birch LL, 1998, P NUTR SOC, V57, P617, DOI 10.1079/PNS19980090; Blanchette L, 2005, J HUM NUTR DIET, V18, P431, DOI 10.1111/j.1365-277X.2005.00648.x; Blissett J, 2008, APPETITE, V50, P477, DOI 10.1016/j.appet.2007.10.003; Blissett J, 2006, APPETITE, V47, P212, DOI 10.1016/j.appet.2006.04.002; Boavida M, 2014, REV NUTR, V21, P4; Brown MN, 2019, ERGONOMICS, V62, P1193, DOI 10.1080/00140139.2019.1623422; Campbell MWC, 2006, MED J AUSTRALIA, V184, P274, DOI 10.5694/j.1326-5377.2006.tb00236.x; Chourdakis M, 2010, APPETITE, V55, P722, DOI 10.1016/j.appet.2010.08.013; Connell PM, 2018, APPETITE, V127, P296, DOI 10.1016/j.appet.2018.05.134; Cooke LJ, 2004, PUBLIC HEALTH NUTR, V7, P295, DOI 10.1079/PHN2003527; Crowe M, 2020, EUR J NUTR, V59, P2065, DOI 10.1007/s00394-019-02056-8; Cutler GJ, 2011, J AM DIET ASSOC, V111, P230, DOI 10.1016/j.jada.2010.10.052; de Bourdeaudhuij I, 2005, PUBLIC HEALTH NUTR, V8, P189, DOI 10.1079/PHN2004673; Engler-Stringer R, 2010, CAN J DIET PRACT RES, V71, P141, DOI 10.3148/71.3.2010.141; Field AE, 2001, PEDIATRICS, V107, P54, DOI 10.1542/peds.107.1.54; Fischer C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-141; Furst T, 1996, APPETITE, V26, P247, DOI 10.1006/appe.1996.0019; Garriguet Didier, 2008, Health Rep, V19, P17; Gase LN, 2014, HEALTH EDUC BEHAV, V41, P431, DOI 10.1177/1090198114529128; Gevers DWM, 2016, PUBLIC HEALTH NUTR, V19, P83, DOI 10.1017/S1368980015000877; Gibbs H, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120267; Glanz K, 1998, J AM DIET ASSOC, V98, P1118, DOI 10.1016/S0002-8223(98)00260-0; Goncalves C, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.29442; Grimes CA, 2009, APPETITE, V53, P189, DOI 10.1016/j.appet.2009.06.007; Gupta A, 2018, APPETITE, V126, P185, DOI 10.1016/j.appet.2018.03.019; Hart CN, 2010, CHILD CARE HLTH DEV, V36, P396, DOI 10.1111/j.1365-2214.2010.01072.x; Hartmann C, 2013, APPETITE, V65, P125, DOI 10.1016/j.appet.2013.01.016; Haynes-Maslow L, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120206; Hoerr SL, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-55; Jansen E, 2018, APPETITE, V120, P115, DOI 10.1016/j.appet.2017.08.030; Jansen E, 2016, APPETITE, V100, P172, DOI 10.1016/j.appet.2016.02.031; Jansen E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0253-x; Jansen E, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-72; Javaheri Tehrani Fereshteh, 2014, Int J Community Based Nurs Midwifery, V2, P2; Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618; Lacy KE, 2019, APPETITE, V139, P95, DOI 10.1016/j.appet.2019.04.009; Lawrence W, 2009, PSYCHOL HEALTH, V24, P1003, DOI 10.1080/08870440802460426; Lyerly A.D., 2022, PREGNANCY ORIGINS IL, V399; Mantziki K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2540-5; Mantziki K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-303; Marinho AR, 2020, PUBLIC HEALTH NUTR, V23, P869, DOI 10.1017/S1368980019002519; McCurdy K, 2010, APPETITE, V54, P615, DOI 10.1016/j.appet.2010.03.004; McKinney C, 2008, J FAM ISSUES, V29, P806, DOI 10.1177/0192513X07311222; Musher-Eizenman D, 2007, J PEDIATR PSYCHOL, V32, P960, DOI 10.1093/jpepsy/jsm037; Musher-Eizenman DR, 2009, APPETITE, V52, P89, DOI 10.1016/j.appet.2008.08.007; Nicklaus S, 2013, CURR OBES REP, V2, P179, DOI 10.1007/s13679-013-0055-x; Peneau S, 2009, BRIT FOOD J, V111, P243, DOI 10.1108/00070700910941453; Pillai KG, 2019, APPETITE, V137, P267, DOI 10.1016/j.appet.2019.03.008; Pulley C, 2014, APPETITE, V80, P96, DOI 10.1016/j.appet.2014.05.001; Reinaerts E, 2007, APPETITE, V48, P248, DOI 10.1016/j.appet.2006.09.007; Rodenburg G, 2012, APPETITE, V58, P364, DOI 10.1016/j.appet.2011.11.001; Rosenkranz RR, 2008, NUTR REV, V66, P123, DOI 10.1111/j.1753-4887.2008.00017.x; Rozin P, 2004, APPETITE, V43, P147, DOI 10.1016/j.appet.2004.03.005; Sahingoz SA, 2011, APPETITE, V57, P272, DOI 10.1016/j.appet.2011.05.307; Seaman KL, 2016, PSYCHOL AGING, V31, P737, DOI 10.1037/pag0000131; Tabbakh T, 2016, APPETITE, V105, P46, DOI 10.1016/j.appet.2016.05.002; University of Porto, 2017, INQ AL NAC AT FIS IA; van Griethuijsen RALF, 2015, RES SCI EDUC, V45, P581, DOI 10.1007/s11165-014-9438-6; Van Lippevelde W, 2013, APPETITE, V61, P59, DOI 10.1016/j.appet.2012.10.019; van Stralen MM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-65; Vaughn AE, 2018, APPETITE, V126, P102, DOI 10.1016/j.appet.2018.03.025; Verbeke W, 2005, APPETITE, V44, P67, DOI 10.1016/j.appet.2004.08.006; Vidgen H.A., 2011, WHAT IS FOOD LITERAC; Wagner MG, 2016, APPETITE, V100, P94, DOI 10.1016/j.appet.2016.02.002; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wardle J, 2005, J AM DIET ASSOC, V105, P227, DOI 10.1016/j.jada.2004.11.006; Wardle J, 2003, APPETITE, V40, P155, DOI 10.1016/S0195-6663(02)00135-6; Warkentin S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3282-8; Wrieden WL, 2007, PUBLIC HEALTH NUTR, V10, P203, DOI 10.1017/S1368980007246658; Yngve A, 2005, ANN NUTR METAB, V49, P236, DOI 10.1159/000087247	75	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251620	10.1371/journal.pone.0251620	http://dx.doi.org/10.1371/journal.pone.0251620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OL	34033667	gold, Green Submitted, Green Published			2022-12-26	WOS:000664633100010
J	Li, Y; Bai, JY; You, ZW; Hou, J; Li, W				Li, Yang; Bai, Jingyi; You, Zhiwei; Hou, Jun; Li, Wei			Future changes in the intensity and frequency of precipitation extremes over China in a warmer world: Insight from a large ensemble	PLOS ONE			English	Article							TEMPERATURE; MODEL; INDEXES	Sufficient samples of extreme precipitation events are needed in order to obtain reliable estimates of the probability of their occurrence. Here, we use a large ensemble simulation with 50 members from the Canadian Earth System Model (CanESM2) under the representative concentration pathway 8.5 (RCP8.5) scenario to give future projection of the intensity and frequency of extreme precipitation events under different warming levels relative to the current climate over China. A bias-correction method based on quantile mapping is first used to remove systematic biases in the ensemble. The return value and return period are obtained by fitting enough annual maximum precipitation samples with the generalized extreme value to represent the intensity and frequency of extreme events, respectively. The results show that the average intensity of extreme precipitation in China will increase by nearly 8% per 1 degrees C of global warming, which closely follows the Clausius-Clapeyron relation. Rarer extreme events will experience greater changes in frequency, especially under higher warming. The nationally averaged extreme precipitation events, presently expected to occur every 50 years (100 years) under the current climate conditions, are expected to occur approximately every 41 years (82 years), 32 years (62 years), 22 years (42 years) and 15 years (29 years) under warming levels of 1.5, 2.0, 3.0 and 4.0 degrees C, respectively. Northwestern China (NW), southwestern China (SW) and the Yangtze River valley (YZ) exhibit the greatest increase in probability ratio (PR) under future climate condition. The risk of extreme precipitation events, currently expected to occur once every 50 years, will be nearly 11 (21) times more likely to occur under a climate warming by 3.0 degrees C (4.0 degrees C). Limiting warming to 1.5 degrees C will help avoid approximately 40%-50%, 70%-80% and over 90% of the increase in the risk of extreme events in almost all subregions if the global mean surface temperature (GMST) continues warming to 2.0 degrees C, 3.0 degrees C and 4.0 degrees C, respectively. Our study provides a useful information for the understanding the impact of climate change on the future risk of extreme events over China.	[Li, Yang; Hou, Jun] Jiangsu Meteorol Observ, Nanjing, Peoples R China; [Bai, Jingyi] Jiangsu Meteorol Serv Ctr, Nanjing, Peoples R China; [You, Zhiwei] Beijing PRESKY Technol Co Ltd, Beijing, Peoples R China; [Hou, Jun; Li, Wei] Nanjing Univ Informat Sci & Technol, Collaborat Innovat Ctr Forecast & Evaluat Meteoro, Joint Int Res Lab Climate & Environm Change, Nanjing, Peoples R China	Nanjing University of Information Science & Technology	Bai, JY (corresponding author), Jiangsu Meteorol Serv Ctr, Nanjing, Peoples R China.	nuist24yue@163.com			National Key Research and Development Program of China [2018YFC1507704]; National Natural Science Foundation of China [41905078]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	W.L is supported by the National Key Research and Development Program of China (grant 2018YFC1507704), (http://en.most.gov.cn/eng/programmes1/200610/t20061009_36224.htm) W.L is supported by the National Natural Science Foundation of China (grant 41905078), http://www.nsfc.gov.cn/english/site_1/index.html Zhiwei You works in this commercial company: Beijing PRESKY Technology Co., Ltd. The funder provided support in the form of salaries for authors [Zhiwei You], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Arora VK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046270; Chen HP, 2015, INT J CLIMATOL, V35, P2735, DOI 10.1002/joc.4168; Chen J, 2019, CLIMATIC CHANGE, V153, P361, DOI 10.1007/s10584-019-02393-x; CMA, 2014, CHIN CLIM B 2013; Coles S., 2001, INTRO STAT MODELING, DOI [10.1007/978-1-4471-3675-0, DOI 10.1007/978-1-4471-3675-0]; Huang JL, 2018, CLIM DYNAM, V50, P507, DOI 10.1007/s00382-017-3623-z; Jeffrey S, 2013, AUST METEOROL OCEAN, V63, P1; Kay JE, 2015, B AM METEOROL SOC, V96, P1333, DOI 10.1175/BAMS-D-13-00255.1; Khairoutdinov M, 2000, MON WEATHER REV, V128, P229, DOI 10.1175/1520-0493(2000)128<0229:ANCPPI>2.0.CO;2; Kharin VV, 2018, EARTHS FUTURE, V6, P704, DOI 10.1002/2018EF000813; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Kirchmeier-Young MC, 2017, J CLIMATE, V30, P553, DOI 10.1175/JCLI-D-16-0412.1; Li C, 2019, EARTHS FUTURE, V7, P11, DOI 10.1029/2018EF001001; Li J, 2005, J ATMOS SCI, V62, P286, DOI 10.1175/JAS-3396.1; Li W, 2018, GEOPHYS RES LETT, V45, P9179, DOI 10.1029/2018GL079133; Li W, 2018, SCI BULL, V63, P228, DOI 10.1016/j.scib.2017.12.021; Li W, 2016, J CLIMATE, V29, P8989, DOI 10.1175/JCLI-D-16-0377.1; Lin L, 2018, J GEOPHYS RES-ATMOS, V123, P8062, DOI 10.1029/2018JD028821; Lin L, 2016, GEOPHYS RES LETT, V43, P9860, DOI 10.1002/2016GL070869; Ma SM, 2015, J CLIMATE, V28, P6960, DOI 10.1175/JCLI-D-15-0011.1; Ma X., 2010, ATMOSPHERIC CHEM PHY, V10, P13945; Maher N, 2019, J ADV MODEL EARTH SY, V11, P2050, DOI 10.1029/2019MS001639; Qian W, 2005, METEOROL ATMOS PHYS, V90, P193, DOI 10.1007/s00703-004-0101-z; Qiu S, 2017, PROG EARTH PLANET SC, V4, DOI 10.1186/s40645-017-0148-3; Roberts MJ, 2018, B AM METEOROL SOC, V99, P2341, DOI 10.1175/BAMS-D-15-00320.1; Schmidli J, 2006, INT J CLIMATOL, V26, P679, DOI 10.1002/joc.1287; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; von Salzen K, 2005, CLIM DYNAM, V25, P671, DOI 10.1007/s00382-005-0051-2; Wang XLL, 2013, GEOPHYS RES LETT, V40, P573, DOI 10.1002/grl.50132; World Meteorlogical Organization, 2019, 1248 WMO, P1; Zhou BT, 2014, J CLIMATE, V27, P6591, DOI 10.1175/JCLI-D-13-00761.1	33	1	1	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252133	10.1371/journal.pone.0252133	http://dx.doi.org/10.1371/journal.pone.0252133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029349	Green Published, gold			2022-12-26	WOS:000664632800030
J	Maia, AG; Burney, JA; Martinez, JDM; Cesano, D				Maia, Alexandre Gori; Burney, Jennifer Anne; Morales Martinez, Jose Daniel; Cesano, Daniele			Improving production and quality of life for smallholder farmers through a climate resilience program: An experience in the Brazilian SertAo	PLOS ONE			English	Article							ADAPTATION STRATEGIES; PROPENSITY SCORE; OAXACA-BLINDER	We use a combination of economic and wellbeing metrics to evaluate the impacts of a climate resilience program designed for family farmers in the semiarid region of Brazil. Most family farmers in the region are on the verge of income and food insufficiency, both of which are exacerbated in prolonged periods of droughts. The program assisted farmers in their milk and sheepmeat production, implementing a set of climate-smart production practices and locally-adapted technologies. We find that the program under evaluation had substantive and significant impacts on production practices, land management, and quality of life in general, using several different quasi-experimental strategies to estimate the average treatment effect on the treated farmers. We highlight the strengths and limitations of each evaluation strategy and how the set of analyses and outcome indicators complement each other. The evaluation provides valuable insights into the economic and environmental sustainability of family farming in semiarid regions, which are under growing pressure from climate change and environmental degradation worldwide.	[Maia, Alexandre Gori; Morales Martinez, Jose Daniel] Univ Estadual Campinas, Ctr Appl Econ Agr & Environm Res, Rua Pitagoras, Campinas, Brazil; [Burney, Jennifer Anne] Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA 92093 USA; [Cesano, Daniele] Adapta Grp, Rio De Janeiro, Brazil	Universidade Estadual de Campinas; University of California System; University of California San Diego	Maia, AG (corresponding author), Univ Estadual Campinas, Ctr Appl Econ Agr & Environm Res, Rua Pitagoras, Campinas, Brazil.; Burney, JA (corresponding author), Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA 92093 USA.	gori@unicamp.br; jburney@ucsd.edu	Maia, Alexandre Gori/Q-5222-2019	Maia, Alexandre Gori/0000-0003-0075-5094	Inter-American Development Bank (IDB) [ATN/ME-14337-BR]; National Council for Scientific and Technological Development -Brazil (CNPq) [422778/2016-8]	Inter-American Development Bank (IDB); National Council for Scientific and Technological Development -Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The execution of the program under investigation (MAIS) was financed by the Inter-American Development Bank (IDB, grant number ATN/ME-14337-BR). The survey design, data collection and analysis were financed by the National Council for Scientific and Technological Development -Brazil (CNPq, grant number 422778/2016-8. IDB provided support in the form of salaries for author DC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri MA, 2017, CLIMATIC CHANGE, V140, P33, DOI 10.1007/s10584-013-0909-y; Andrade-Montemayor HM, 2011, SMALL RUMINANT RES, V98, P83, DOI 10.1016/j.smallrumres.2011.03.023; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Banerjee RR, 2015, NAT HAZARDS, V75, P2829, DOI 10.1007/s11069-014-1466-z; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Bedeke SB, 2020, ENVIRON DEV SUSTAIN, V22, P693, DOI 10.1007/s10668-018-0215-y; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Burney J, 2014, CLIMATIC CHANGE, V126, P45, DOI 10.1007/s10584-014-1186-0; Castro CN de., 2012, AGR NORDESTE BRASILE; Cesano D, 2017, ADAPTA SERTAO IMPROV; da Silva JMC., 2020, CAATINGA S AM ENCY W, P554, DOI [10.1016/B978-0-12-409548-9.11984%26%23x2013%3B0, DOI 10.1016/B978-0-12-409548-9.11984%26%23X2013%3B0]; Day E, 2019, CLIM POLICY, V19, P367, DOI 10.1080/14693062.2018.1517640; de Albuquerque UP, 2012, SCI WORLD J, DOI [10.1100/2012/205182, 10.1155/2012/202508]; de Araujo HFP, 2021, LAND USE POLICY, V100, DOI 10.1016/j.landusepol.2020.104913; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Diener E, 1996, KEY ISSUES IN CROSS-CULTURAL PSYCHOLOGY, P319; Diener E., 2006, APPL RES QUAL LIFE, DOI [10.1007/s11482-006-9007-x, DOI 10.1007/S10902-006-9000-Y, DOI 10.1007/S11482-006-9007-X]; Dolan P., 2011, MEASURING SUBJECTIVE; Douxchamps S, 2016, REG ENVIRON CHANGE, V16, P1305, DOI 10.1007/s10113-015-0838-6; Fortin N, 2011, HBK ECON, V4, P1, DOI 10.1016/S0169-7218(11)00407-2; Gori Maia A., 2021, LAND USE POLICY, DOI [10.1016/j.landusepol.2020.105129, DOI 10.1016/J.LANDUSEPOL.2020.105129]; Heckman J, 2004, REV ECON STAT, V86, P30, DOI 10.1162/003465304323023660; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; Hirano K., 2001, HLTH SERVICES OUTCOM, V2, P259, DOI [10.1023/A:1020371312283, DOI 10.1023/A:1020371312283]; IBGE, 2020, CENS AGR; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Independent Evaluation Group, 2011, IMP EV AGR ASS EV; Instituto Brasileiro de Geografia e Estatistica, 2017, EST POP RES MUN UN F; Issahaku G, 2020, APPL ECON PERSPECT P, V42, P559, DOI 10.1093/aepp/ppz002; Kahil MT, 2015, J HYDROL, V522, P95, DOI 10.1016/j.jhydrol.2014.12.042; Kline P, 2011, AM ECON REV, V101, P532, DOI 10.1257/aer.101.3.532; Li CY, 2013, ENVIRON MANAGE, V52, P894, DOI 10.1007/s00267-013-0139-0; Maia AG, 2018, INT J CLIM CHANG STR, V10, P729, DOI 10.1108/IJCCSM-04-2017-0088; Martinez JDM., 2018, J FAM EC ISSUES; Menezes R. S. C., 1999, Revista Brasileira de Ciencia do Solo, V23, P817, DOI 10.1590/S0100-06831999000400008; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Oh JH, 2019, AM SOCIOL REV, V84, P634, DOI 10.1177/0003122419859574; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Rosenbaum P. R., 2002, OBSERVATIONAL STUDIE; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rubin DB, 1996, BIOMETRICS, V52, P249, DOI 10.2307/2533160; Silva Filho J., 2013, AFRICAN J AGR RES, V8, P5020, DOI [10.5897/AJAR2013.6712, DOI 10.5897/AJAR2013.6712]; Sloczynski T, 2015, OXFORD B ECON STAT, V77, P588, DOI 10.1111/obes.12075; Stringer LC, 2012, ENVIRON SCI POLICY, V19-20, P121, DOI 10.1016/j.envsci.2012.02.004; Vermeulen SJ, 2012, ENVIRON SCI POLICY, V15, P136, DOI 10.1016/j.envsci.2011.09.003; Voigtlaender M, 2017, PROJETO ADAPTA SERTA; Wick B, 2000, PLANT SOIL, V222, P59, DOI 10.1023/A:1004756416281; Wooldridge JM, 2015, J HUM RESOUR, V50, P420, DOI 10.3368/jhr.50.2.420; Wossen T, 2014, ENVIRON DEV, V12, P2, DOI 10.1016/j.envdev.2014.07.003; Zhang WF, 2016, NATURE, V537, P671, DOI 10.1038/nature19368	51	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251531	10.1371/journal.pone.0251531	http://dx.doi.org/10.1371/journal.pone.0251531			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OD	34019563	Green Published, gold			2022-12-26	WOS:000664632300026
J	Stone, JK; Vukadin, L; Ahn, EYE				Stone, Joshua K.; Vukadin, Lana; Ahn, Eun-Young Erin			eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression	PLOS ONE			English	Article							NONCODING RNA; BREAST-CANCER; GROWTH; PARASPECKLES; MEDIATOR	Emerging evidence has shown that active enhancers are abundantly transcribed, generating long non-coding RNAs, called enhancer RNAs (eRNAs). While putative eRNAs are often observed from RNA sequencing, the roles of most eRNAs remain largely unknown. Previously, we identified putative enhancer regions at the MALAT1 locus that form chromatin-chromatin interactions under hypoxia, and one of these enhancers is located about 30 kb downstream of the NEAT1 gene and -20 kb upstream of the MALAT1 gene (MALAT1-20 kb enhancer). Here, we report that a novel eRNA, named eRNA of the NEAT1-MALAT1-Locus (eNEMAL), is transcribed from the MALAT1-20 kb enhancer and conserved in primates. We found that eNEMAL is upregulated in response to hypoxia in multiple breast cancer cell lines, but not in non-tumorigenic MCF10A cells. Overexpression and knockdown of eNEMAL revealed that alteration of eNEMAL level does not affect MALAT1 expression. Instead, we found that eNEMAL upregulates the long isoform of NEAT1 (NEAT1_2) without increasing the total NEAT1 transcript level in MCF7 breast cancer cells, suggesting that eNEMAL has a repressive effect on the 3'-end polyadenylation process required for generating the short isoform of NEAT1 (NEAT1_1). Altogether, we demonstrated that an eRNA transcribed from a MALAT1 enhancer regulates NEAT1 isoform expression, implicating the MALAT1-20 kb enhancer and its transcript eNEMAL in co-regulation of MALAT1 and NEAT1 in response to hypoxia in breast cancer cells.	[Stone, Joshua K.] Univ S Alabama, Mitchell Canc Inst, Mobile, AL USA; [Vukadin, Lana; Ahn, Eun-Young Erin] Univ Alabama Birmingham, Dept Pathol, Div Cellular & Mol Pathol, Birmingham, AL 35294 USA; [Ahn, Eun-Young Erin] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL 35294 USA	University of South Alabama; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ahn, EYE (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Cellular & Mol Pathol, Birmingham, AL 35294 USA.; Ahn, EYE (corresponding author), Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL 35294 USA.	eyahn@uabmc.edu		Ahn, Eun-Young Erin/0000-0001-8795-7734	NIH [R01CA190688, R21CA185818, R01CA236911]; University of Alabama at Birmingham School of Medicine; University of Alabama at Department of Pathology; University of Alabama at O'Neal Comprehensive Cancer Center	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham School of Medicine; University of Alabama at Department of Pathology; University of Alabama at O'Neal Comprehensive Cancer Center	This work was supported by the NIH grants (R01CA190688, R21CA185818, and R01CA236911 to E.E.A.) and the internal support from the University of Alabama at Birmingham School of Medicine, Department of Pathology, and O'Neal Comprehensive Cancer Center (to E.E.A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens C., 2019, LNCRNA NEAT1 1 IS SE, DOI [10.1261/rna.071456.119, DOI 10.1261/RNA.071456.119]; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Choudhry H, 2014, EMBO REP, V15, P70, DOI 10.1002/embr.201337642; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Fox AH, 2018, TRENDS BIOCHEM SCI, V43, P124, DOI 10.1016/j.tibs.2017.12.001; Gao R, 2013, J BIOL CHEM, V288, P15046, DOI 10.1074/jbc.M113.466136; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; Hsieh CL, 2014, P NATL ACAD SCI USA, V111, P7319, DOI 10.1073/pnas.1324151111; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Isobe M, 2020, RNA, V26, P251, DOI 10.1261/rna.072587.119; Kim TK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018622; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Klec C, 2019, MOL ONCOL, V13, P46, DOI 10.1002/1878-0261.12404; Knutsen E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57759-4; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Li RH, 2017, RNA, V23, P872, DOI 10.1261/rna.059477.116; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liu F, 2017, GENOM PROTEOM BIOINF, V15, P196, DOI 10.1016/j.gpb.2016.12.006; LIU XW, 1993, NUCLEIC ACIDS RES, V21, P4954, DOI 10.1093/nar/21.21.4954; Malik N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10102-6; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Melton C, 2015, NAT GENET, V47, P710, DOI 10.1038/ng.3332; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Mikhaylichenko O, 2018, GENE DEV, V32, P42, DOI 10.1101/gad.308619.117; Moreau PR, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00159; Naganuma T, 2012, EMBO J, V31, P4020, DOI 10.1038/emboj.2012.251; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Stiehl DP, 2012, ONCOGENE, V31, P2283, DOI 10.1038/onc.2011.417; Stone JK, 2019, J BIOL CHEM, V294, P11213, DOI 10.1074/jbc.RA118.006889; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tsai HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44063-z; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Yoshimoto R, 2016, BBA-GENE REGUL MECH, V1859, P192, DOI 10.1016/j.bbagrm.2015.09.012	39	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251515	10.1371/journal.pone.0251515	http://dx.doi.org/10.1371/journal.pone.0251515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019552	Green Published, gold			2022-12-26	WOS:000664632300024
J	Kotula, HJ; Peralta, G; Frost, CM; Todd, JH; Tylianakis, JM				Kotula, Hannah J.; Peralta, Guadalupe; Frost, Carol M.; Todd, Jacqui H.; Tylianakis, Jason M.			Predicting direct and indirect non-target impacts of biocontrol agents using machine-learning approaches	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; APPARENT COMPETITION; BIOLOGICAL-CONTROL; BODY-SIZE; EVOLUTIONARY HISTORY; TROPHIC INTERACTIONS; SPECIES ABUNDANCE; RISK-ASSESSMENT; PLANT; COMMUNITY	Biological pest control (i.e. 'biocontrol') agents can have direct and indirect non-target impacts, and predicting these effects (especially indirect impacts) remains a central challenge in biocontrol risk assessment. The analysis of ecological networks offers a promising approach to understanding the community-wide impacts of biocontrol agents (via direct and indirect interactions). Independently, species traits and phylogenies have been shown to successfully predict species interactions and network structure (alleviating the need to collect quantitative interaction data), but whether these approaches can be combined to predict indirect impacts of natural enemies remains untested. Whether predictions of interactions (i.e. direct effects) can be made equally well for generalists vs. specialists, abundant vs. less abundant species, and across different habitat types is also untested for consumer-prey interactions. Here, we used two machine-learning techniques (random forest and k-nearest neighbour; KNN) to test whether we could accurately predict empirically-observed quantitative host-parasitoid networks using trait and phylogenetic information. Then, we tested whether the accuracy of machine-learning-predicted interactions depended on the generality or abundance of the interacting partners, or on the source (habitat type) of the training data. Finally, we used these predicted networks to generate predictions of indirect effects via shared natural enemies (i.e. apparent competition), and tested these predictions against empirically observed indirect effects between hosts. We found that random-forest models predicted host-parasitoid pairwise interactions (which could be used to predict attack of non-target host species) more successfully than KNN. This predictive ability depended on the generality of the interacting partners for KNN models, and depended on species' abundances for both random-forest and KNN models, but did not depend on the source (habitat type) of data used to train the models. Further, although our machine-learning informed methods could significantly predict indirect effects, the explanatory power of our machine-learning models for indirect interactions was reasonably low. Combining machine-learning and network approaches provides a starting point for reducing risk in biocontrol introductions, and could be applied more generally to predicting species interactions such as impacts of invasive species.	[Kotula, Hannah J.; Peralta, Guadalupe; Tylianakis, Jason M.] Univ Canterbury, Ctr Integrat Ecol, Sch Biol Sci, Christchurch, New Zealand; [Frost, Carol M.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Todd, Jacqui H.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Tylianakis, Jason M.] Univ Canterbury, Bioprotect Res Ctr, Sch Biol Sci, Christchurch, New Zealand	University of Canterbury; University of Alberta; New Zealand Institute for Plant & Food Research Ltd; University of Canterbury	Kotula, HJ (corresponding author), Univ Canterbury, Ctr Integrat Ecol, Sch Biol Sci, Christchurch, New Zealand.	hannahkotula@gmail.com	Todd, Jacqui/H-8777-2018; Frost, Carol/AAV-9073-2021	Todd, Jacqui/0000-0001-6871-9618; Frost, Carol/0000-0003-3805-5528	Roland Stead Postgraduate Scholarship in Biology; Marsden Fund [UOC1705]; Better Border Biosecurity (B3) - New Zealand Government	Roland Stead Postgraduate Scholarship in Biology; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Better Border Biosecurity (B3) - New Zealand Government	H.J.K acknowledges support from a Roland Stead Postgraduate Scholarship in Biology. H.J.K, G.P and J.M.T were funded by the Marsden Fund (grant number UOC1705), administered by the Royal Society of New Zealand. J.H.T is funded by the Better Border Biosecurity (B3) (www.b3nz.org) research collaboration funded by the New Zealand Government. We acknowledge that one of the authors (J.H.T) is employed by a commercial company (The New Zealand Institute for Plant and Food Research Limited). Although this company does both government-funded and industry-funded work, there is no industry funding for this research. The funder provided support in the form of salaries for an author [J.H.T], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Albrecht J, 2015, J ECOL, V103, P526, DOI 10.1111/1365-2745.12375; AUSTIN A D, 1992, Invertebrate Taxonomy, V6, P1, DOI 10.1071/IT9920001; Barratt BIP, 2010, BIOL CONTROL, V52, P245, DOI 10.1016/j.biocontrol.2009.02.012; Bartomeus I, 2016, FUNCT ECOL, V30, P1894, DOI 10.1111/1365-2435.12666; Barton K., MUMIN MULTIMODEL INF; Bascompte J, 2010, SCIENCE, V329, P765, DOI 10.1126/science.1194255; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berlocher SH, 2002, ANNU REV ENTOMOL, V47, P773, DOI 10.1146/annurev.ento.47.091201.145312; Berry Jocelyn A., 1997, New Zealand Entomologist, V20, P45; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; Brousseau PM, 2018, FUNCT ECOL, V32, P192, DOI 10.1111/1365-2435.12943; Burnham KP, 2014, ECOLOGY, V95, P627, DOI 10.1890/13-1066.1; BUSH GL, 1975, ANNU REV ECOL SYST, V6, P339, DOI 10.1146/annurev.es.06.110175.002011; Canard EF, 2014, AM NAT, V183, P468, DOI 10.1086/675363; Carvalheiro LG, 2008, ECOL LETT, V11, P690, DOI 10.1111/j.1461-0248.2008.01184.x; Coux C, 2021, ECOLOGY, V102, DOI 10.1002/ecy.3239; Crawley MJ, 2014, STAT INTRO USING R; DENHOLM I, 1992, ANNU REV ENTOMOL, V37, P91, DOI 10.1146/annurev.en.37.010192.000515; Desjardins-Proulx P, 2017, PEERJ, V5, DOI 10.7717/peerj.3644; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Eklof A, 2012, P ROY SOC B-BIOL SCI, V279, P1588, DOI 10.1098/rspb.2011.2149; Eklof A, 2016, THEOR ECOL-NETH, V9, P107, DOI 10.1007/s12080-015-0273-9; Eklof A, 2013, ECOL LETT, V16, P577, DOI 10.1111/ele.12081; Emer C, 2016, DIVERS DISTRIB, V22, P841, DOI 10.1111/ddi.12458; Feder JL, 2010, ECOL ENTOMOL, V35, P67, DOI 10.1111/j.1365-2311.2009.01144.x; Frost CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12644; Garcia D, 2014, J ANIM ECOL, V83, P1441, DOI 10.1111/1365-2656.12237; Gravel D, 2019, ECOGRAPHY, V42, P401, DOI 10.1111/ecog.04006; Gravel D, 2013, METHODS ECOL EVOL, V4, P1083, DOI 10.1111/2041-210X.12103; Gul A, 2018, ADV DATA ANAL CLASSI, V12, P827, DOI 10.1007/s11634-015-0227-5; Hamerlinck G, 2016, J EVOLUTION BIOL, V29, P1766, DOI 10.1111/jeb.12909; Harrison XA, 2014, PEERJ, V2, DOI 10.7717/peerj.616; Henneman ML, 2001, SCIENCE, V293, P1314, DOI 10.1126/science.1060788; Henri DC, 2011, ADV ECOL RES, V45, P135, DOI 10.1016/B978-0-12-386475-8.00004-6; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Hood GR, 2015, P NATL ACAD SCI USA, V112, pE5980, DOI 10.1073/pnas.1424717112; HUDDLESTON T, 1986, J NAT HIST, V20, P255, DOI 10.1080/00222938600770201; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; JAGER CR, 1994, PROCEEDINGS OF THE SECTION EXPERIMENTAL AND APPLIED ENTOMOLOGY OF THE NETHERLANDS ENTOMOLOGICAL SOCIETY (N.E.V.), VOL 5, 1994, P19; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jordano P, 2016, FUNCT ECOL, V30, P1883, DOI 10.1111/1365-2435.12763; Kankare M, 2005, ANN ENTOMOL SOC AM, V98, P382, DOI 10.1603/0013-8746(2005)098[0382:GDAHCS]2.0.CO;2; Klein AM, 2006, J ANIM ECOL, V75, P315, DOI 10.1111/j.1365-2656.2006.01042.x; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Laliberte E, 2010, ECOLOGY, V91, P1740, DOI 10.1890/09-1328.1; Lefcheck JS, 2016, METHODS ECOL EVOL, V7, P573, DOI 10.1111/2041-210X.12512; Lopez-Nunez FA, 2017, ECOLOGY, V98, P782, DOI 10.1002/ecy.1701; Lopezaraiza-Mikel ME, 2007, ECOL LETT, V10, P539, DOI 10.1111/j.1461-0248.2007.01055.x; Louda SM, 2003, ANNU REV ENTOMOL, V48, P365, DOI 10.1146/annurev.ento.48.060402.102800; Louda SM, 1997, SCIENCE, V277, P1088, DOI 10.1126/science.277.5329.1088; Lynch Liam D., 2000, Biocontrol News and Information, V21, p117N; Lyon SM, 1996, J MED ENTOMOL, V33, P812, DOI 10.1093/jmedent/33.5.812; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Memmott J, 2000, NONTARGET EFFECTS OF BIOLOGICAL CONTROL, P147; Memmott J, 2009, PHILOS T R SOC B, V364, P1693, DOI 10.1098/rstb.2008.0255; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Morris RJ, 2005, ANN ZOOL FENN, V42, P449; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Munro VMW, 2002, ENVIRON ENTOMOL, V31, P388, DOI 10.1603/0046-225X-31.2.388; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Ollivier M, 2020, CURR OPIN INSECT SCI, V38, P40, DOI 10.1016/j.cois.2019.12.002; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Pearse IS, 2013, ECOL LETT, V16, P1088, DOI 10.1111/ele.12143; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peralta G, 2020, J ANIM ECOL, V89, P2145, DOI 10.1111/1365-2656.13274; Peralta G, 2020, ECOL LETT, V23, P1107, DOI 10.1111/ele.13510; Peralta G, 2018, J APPL ECOL, V55, P1265, DOI 10.1111/1365-2664.13055; Peralta G, 2017, ECOLOGY, V98, P995, DOI [10.1002/ecy.1656/suppinfo, 10.1002/ecy.1656]; Peralta G, 2016, FUNCT ECOL, V30, P1917, DOI 10.1111/1365-2435.12669; Peralta G, 2014, ECOLOGY, V95, P1888, DOI 10.1890/13-1569.1; Pichler M, 2020, METHODS ECOL EVOL, V11, P281, DOI 10.1111/2041-210X.13329; PIMENTEL D, 1992, BIOSCIENCE, V42, P750, DOI 10.2307/1311994; Pimentel D., 1997, TECHNIQUES REDUCING, P1; Poisot T, 2015, OIKOS, V124, P243, DOI 10.1111/oik.01719; R Core Team, 2020, R LANG ENV STAT COMP; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Roy HE, 2012, FUNCT ECOL, V26, P1238, DOI 10.1111/j.1365-2435.2012.02032.x; Simberloff D, 2012, BIOCONTROL, V57, P263, DOI 10.1007/s10526-011-9392-4; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Staniczenko PPA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00913-w; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Tack AJM, 2011, J ANIM ECOL, V80, P108, DOI 10.1111/j.1365-2656.2010.01744.x; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Tylianakis JM, 2014, BIOL CONTROL, V75, P77, DOI 10.1016/j.biocontrol.2013.10.003; van Achterberg C., 2004, Zoologische Mededelingen (Leiden), V78, P301; van Lenteren JC, 2006, ANNU REV ENTOMOL, V51, P609, DOI 10.1146/annurev.ento.51.110104.151129; van Lenteren JC, 2018, BIOCONTROL, V63, P39, DOI 10.1007/s10526-017-9801-4; Van Veen FJF, 2006, PROG BIOL CONTROL, V3, P145; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Veldtman R, 2011, DIVERS DISTRIB, V17, P958, DOI 10.1111/j.1472-4642.2011.00781.x; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Willis AJ, 2005, BIOL CONTROL, V35, P299, DOI 10.1016/j.biocontrol.2005.07.013; Wood TK, 1999, EVOL ECOL RES, V1, P317; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Zuur Alain F., 2009, P1	105	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252448	10.1371/journal.pone.0252448	http://dx.doi.org/10.1371/journal.pone.0252448			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061885	Green Published, Green Submitted, gold			2022-12-26	WOS:000656813600032
J	Morevati, M; Egstrand, S; Nordholm, A; Mace, ML; Andersen, CB; Salmani, R; Olgaard, K; Lewin, E				Morevati, Marya; Egstrand, Soren; Nordholm, Anders; Mace, Maria L.; Andersen, Claus B.; Salmani, Rouzbeh; Olgaard, Klaus; Lewin, Ewa			Effect of NAD(+) boosting on kidney ischemia-reperfusion injury	PLOS ONE			English	Article							NICOTINAMIDE RIBOSIDE; PROXIMAL TUBULE; ISCHEMIA/REPERFUSION INJURY; PROTEIN SIR2; ACTIVIN-A; KLOTHO; DISEASE; MITOCHONDRIAL; ACTIVATION; AUTOPHAGY	Acute kidney injury (AKI) is associated with a very high mortality and an increased risk for progression to chronic kidney disease (CKD). Ischemia-reperfusion injury (IRI) is a model for AKI, which results in tubular damage, dysfunction of the mitochondria and autophagy, and in decreased cellular nicotinamide adenine dinucleotide (NAD(+)) with progressing fibrosis resulting in CKD. NAD(+) is a co-enzyme for several proteins, including the NAD(+) dependent sirtuins. NAD(+) augmentation, e.g. by use of its precursor nicotinamide riboside (NR), improves mitochondrial homeostasis and organismal metabolism in many species. In the present investigation the effects of prophylactic administration of NR on IRI-induced AKI were studied in the rat. Bilateral IRI reduced kidney tissue NAD(+), caused tubular damage, reduced alpha-Klotho (klotho), and altered autophagy flux. AKI initiated progression to CKD, as shown by induced profibrotic Periostin (postn) and Inhibin subunit beta-A, (activin A / Inhba), both 24 hours and 14 days after surgery. NR restored tissue NAD(+) to that of the sham group, increased autophagy (reduced p62) and sirtuin1 (Sirt1) but did not ameliorate renal tubular damage and profibrotic genes in the 24 hours and 14 days IRI models. AKI induced NAD(+) depletion and impaired autophagy, while augmentation of NAD(+) by NR restored tissue NAD(+) and increased autophagy, possibly serving as a protective response. However, prophylactic administration of NR did not ameliorate tubular damage of the IRI rats nor rescued the initiation of fibrosis in the long-term AKI to CKD model, which is a pivotal event in CKD pathogenesis.	[Morevati, Marya; Egstrand, Soren; Nordholm, Anders; Mace, Maria L.; Olgaard, Klaus; Lewin, Ewa] Univ Copenhagen, Rigshosp, Nephrol Dept P, Copenhagen, Denmark; [Egstrand, Soren; Lewin, Ewa] Univ Copenhagen, Herlev Hosp, Nephrol Dept B, Copenhagen, Denmark; [Andersen, Claus B.] Univ Copenhagen, Rigshosp, Dept Forens Pathol, Copenhagen, Denmark; [Salmani, Rouzbeh] Univ Copenhagen, Roskilde Hosp, Dept Pathol, Roskilde, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen	Morevati, M (corresponding author), Univ Copenhagen, Rigshosp, Nephrol Dept P, Copenhagen, Denmark.	marya.morevati@regionh.dk			Eva and Henry Fraenkel Memorial Foundation; Helen and Ejnar Bjornow Foundation; Ruth I.E. Konig-Petersen Foundation; Kirsten and Freddy Johansen Foundation	Eva and Henry Fraenkel Memorial Foundation; Helen and Ejnar Bjornow Foundation; Ruth I.E. Konig-Petersen Foundation; Kirsten and Freddy Johansen Foundation	This project was supported by grants from The Eva and Henry Fraenkel Memorial Foundation, The Helen and Ejnar Bjornow Foundation, The Ruth I.E. Konig-Petersen Foundation and The Kirsten and Freddy Johansen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova OA, 2016, KIDNEY INT, V89, P1231, DOI 10.1016/j.kint.2016.02.002; Aman Y, 2020, MECH AGEING DEV, V185, DOI 10.1016/j.mad.2019.111194; An JN, 2019, AM J PHYSIOL-RENAL, V316, pF426, DOI 10.1152/ajprenal.00203.2018; Batlahally S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69296-1; Belayev LY, 2014, CURR OPIN NEPHROL HY, V23, P149, DOI 10.1097/01.mnh.0000441051.36783.f3; Bhatia D, 2020, PROG MOL BIOL TRANSL, V172, P107, DOI 10.1016/bs.pmbts.2020.01.008; Bian XH, 2019, BMJ OPEN DIAB RES CA, V7, DOI 10.1136/bmjdrc-2019-000720; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Black LM, 2019, J HISTOCHEM CYTOCHEM, V67, P663, DOI 10.1369/0022155419852932; Bonventre JV, 2013, CLIN J AM SOC NEPHRO, V8, P1606, DOI 10.2215/CJN.06040613; BONVENTRE JV, 1993, KIDNEY INT, V43, P1160, DOI 10.1038/ki.1993.163; Bost F, 2019, AM J CANCER RES, V9, P198; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Cea M, 2012, BLOOD, V120, P3519, DOI 10.1182/blood-2012-03-416776; CHAMBON P, 1963, BIOCHEM BIOPH RES CO, V11, P39, DOI 10.1016/0006-291X(63)90024-X; Chavez R., 2016, J HISTOL HISTOPATHOL, V3, P1, DOI [10.7243/2055-091X-3-1, DOI 10.7243/2055-091X-3-1]; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chevalier RL, 2016, AM J PHYSIOL-RENAL, V311, pF145, DOI 10.1152/ajprenal.00164.2016; Conze DB, 2016, HUM EXP TOXICOL, V35, P1149, DOI 10.1177/0960327115626254; Decuypere JP, 2015, AM J KIDNEY DIS, V66, P699, DOI 10.1053/j.ajkd.2015.05.021; Dong YJ, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/843786; Faivre A, 2021, NEPHROL DIAL TRANSPL, V36, P60, DOI 10.1093/ndt/gfaa124; Fang EF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13172-8; Fang EF, 2017, TRENDS MOL MED, V23, P899, DOI 10.1016/j.molmed.2017.08.001; Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Funk JA, 2013, TOXICOL APPL PHARM, V273, P345, DOI 10.1016/j.taap.2013.09.026; Funk JA, 2012, AM J PHYSIOL-RENAL, V302, pF853, DOI 10.1152/ajprenal.00035.2011; Funk JA, 2010, J PHARMACOL EXP THER, V333, P593, DOI 10.1124/jpet.109.161992; Galvan DL, 2017, KIDNEY INT, V92, P1051, DOI 10.1016/j.kint.2017.05.034; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Gravesen E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201936; Gravesen E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190820; Guan Y, 2017, J AM SOC NEPHROL, V28, P2337, DOI 10.1681/ASN.2016040385; Guan Y, 2016, KIDNEY DIS-BASEL, V1, P258, DOI 10.1159/000440967; Haiden A, 1906, P R SOC LOND B-CONTA, V78, P369; Hasegawa K, 2010, J BIOL CHEM, V285, P13045, DOI 10.1074/jbc.M109.067728; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Heddi A, 1999, J BIOL CHEM, V274, P22968, DOI 10.1074/jbc.274.33.22968; Horne KL, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015316; Hruska KA, 2000, AM J PHYSIOL-RENAL, V279, pF130, DOI 10.1152/ajprenal.2000.279.1.F130; Hruska KA, 2017, BONE, V100, P80, DOI 10.1016/j.bone.2017.01.023; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2010, J NEPHROL, V23, pS136; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Huang XZ, 2014, J CELL BIOCHEM, V115, P996, DOI 10.1002/jcb.24748; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Johnson K J, 1993, Curr Opin Nephrol Hypertens, V2, P625, DOI 10.1097/00041552-199307000-00014; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuro-o Makoto, 2011, Korean Journal of Internal Medicine, V26, P113, DOI 10.3904/kjim.2011.26.2.113; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lautrup S, 2019, CELL METAB, V30, P630, DOI 10.1016/j.cmet.2019.09.001; Leung KCW, 2013, NAT REV NEPHROL, V9, P77, DOI 10.1038/nrneph.2012.280; Lewin E, 2015, KIDNEY INT, V87, P1089, DOI 10.1038/ki.2015.80; Ling Q, 2017, CELL PHYSIOL BIOCHEM, V41, P2461, DOI 10.1159/000475915; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lopez-Neblina F, 2005, J INVEST SURG, V18, P335, DOI 10.1080/08941930500328862; Maeshima A, 2008, ENDOCR J, V55, P1, DOI 10.1507/endocrj.KR-113; Mehr AP, 2018, NAT MED, V24, P1351, DOI 10.1038/s41591-018-0138-z; Mencke R, 2017, ADV DRUG DELIVER REV, V121, P85, DOI 10.1016/j.addr.2017.07.009; Menn-Josephy H, 2016, AM J NEPHROL, V44, P289, DOI 10.1159/000449511; Morigi M, 2018, J AM SOC NEPHROL, V29, P1799, DOI 10.1681/ASN.2017111218; Namwanje M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021881; Nordholm A, 2019, PFLUG ARCH EUR J PHY, V471, P1079, DOI 10.1007/s00424-019-02291-2; Nordholm A, 2018, AM J PHYSIOL-RENAL, V314, pF753, DOI 10.1152/ajprenal.00528.2017; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; PALLER MS, 1994, J INVEST MED, V42, P632; Parr SK, 2016, ADV CHRONIC KIDNEY D, V23, P186, DOI 10.1053/j.ackd.2016.01.014; Rajman L, 2018, CELL METAB, V27, P529, DOI 10.1016/j.cmet.2018.02.011; Ralto KM, 2020, NAT REV NEPHROL, V16, P99, DOI 10.1038/s41581-019-0216-6; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Rodriguez E, 2018, KIDNEY BLOOD PRESS R, V43, P34, DOI 10.1159/000486744; Schmitt R, 2008, AM J KIDNEY DIS, V52, P262, DOI 10.1053/j.ajkd.2008.03.005; Sedlackova L, 2020, BIOGERONTOLOGY, V21, P381, DOI 10.1007/s10522-020-09864-0; Shi HJ, 2017, NEW ENGL J MED, V377, P544, DOI [10.1056/NEJMoa1616361, 10.1056/nejmoa1616361]; Shi MJ, 2016, J AM SOC NEPHROL, V27, P2331, DOI 10.1681/ASN.2015060613; SINGH I, 1993, MOL CELL BIOCHEM, V125, P97, DOI 10.1007/BF00936438; Sureshbabu A, 2016, AM J PHYSIOL-RENAL, V310, pF596, DOI 10.1152/ajprenal.00365.2015; Suzuki C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010155; Takaori K, 2016, J AM SOC NEPHROL, V27, P2393, DOI 10.1681/ASN.2015060647; Tang CY, 2016, J AM SOC NEPHROL, V27, P1869, DOI 10.1681/ASN.2015111277; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Tran MT, 2016, NATURE, V531, P528, DOI 10.1038/nature17184; Tsujimura T, 2016, WORLD J STEM CELLS, V8, P288, DOI 10.4252/wjsc.v8.i9.288; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Warburg O, 1936, BIOCHEM Z, V287, P291; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Yan  Q, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1008-z; Yang SY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32787; Zhang DX, 2016, METABOLISM, V65, P454, DOI 10.1016/j.metabol.2015.11.010; Zheng J, 2019, NUCLEIC ACIDS RES, V47, P4086, DOI 10.1093/nar/gkz083; Zhu JB, 2016, CELL PHYSIOL BIOCHEM, V39, P2364, DOI 10.1159/000452506	105	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252554	10.1371/journal.pone.0252554	http://dx.doi.org/10.1371/journal.pone.0252554			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061900	Green Published, gold			2022-12-26	WOS:000656813600054
J	Rennert-May, E; Leal, J; Thanh, NX; Lang, E; Dowling, S; Manns, B; Wasylak, T; Ronksley, PE				Rennert-May, Elissa; Leal, Jenine; Thanh, Nguyen Xuan; Lang, Eddy; Dowling, Shawn; Manns, Braden; Wasylak, Tracy; Ronksley, Paul E.			The impact of COVID-19 on hospital admissions and emergency department visits: A population-based study	PLOS ONE			English	Article							CARE	Background As a result of the novel coronavirus disease 2019 (COVID-19), there have been widespread changes in healthcare access. We conducted a retrospective population-based study in Alberta, Canada (population 4.4 million), where there have been approximately 1550 hospital admissions for COVID-19, to determine the impact of COVID-19 on hospital admissions and emergency department (ED visits), following initiation of a public health emergency act on March 15, 2020. Methods We used multivariable negative binomial regression models to compare daily numbers of medical/surgical hospital admissions via the ED between March 16-September 23, 2019 (pre COVID-19) and March 16-September 23, 2020 (post COVID-19 public health measures). We compared the most frequent diagnoses for hospital admissions pre/post COVID-19 public health measures. A similar analysis was completed for numbers of daily ED visits for any reason with a particular focus on ambulatory care sensitive conditions (ACSC). Findings There was a significant reduction in both daily medical (incident rate ratio (IRR) 0.86, p<0.001) and surgical (IRR 0.82, p<0.001) admissions through the ED in Alberta post COVID-19 public health measures. There was a significant decline in daily ED visits (IRR 0.65, p<0.001) including ACSC (IRR 0.75, p<0.001). The most common medical/surgical diagnoses for hospital admissions did not vary substantially pre and post COVID-19 public health measures, though there was a significant reduction in admissions for chronic obstructive pulmonary disease and a significant increase in admissions for mental and behavioral disorders due to use of alcohol. Conclusions Despite a relatively low volume of COVID-19 hospital admissions in Alberta, there was an extensive impact on our healthcare system with fewer admissions to hospital and ED visits. This work generates hypotheses around causes for reduced hospital admissions and ED visits which warrant further investigation. As most publicly funded health systems struggle with health-system capacity routinely, understanding how these reductions can be safely sustained will be critical.	[Rennert-May, Elissa; Leal, Jenine; Manns, Braden; Ronksley, Paul E.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Rennert-May, Elissa; Leal, Jenine] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Rennert-May, Elissa; Manns, Braden] Univ Calgary, Dept Med, Calgary, AB, Canada; [Rennert-May, Elissa; Leal, Jenine; Manns, Braden; Ronksley, Paul E.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Rennert-May, Elissa] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Leal, Jenine] Alberta Hlth Serv, Infect Prevent & Control, Calgary, AB, Canada; [Thanh, Nguyen Xuan; Wasylak, Tracy] Alberta Hlth Serv, Strateg Clin Networks, Calgary, AB, Canada; [Lang, Eddy; Dowling, Shawn] Univ Calgary, Dept Emergency Med, Calgary, AB, Canada; [Manns, Braden] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Ronksley, PE (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.; Ronksley, PE (corresponding author), Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada.	peronksl@ucalgary.ca		Rennert-May, Elissa/0000-0001-9884-6423				Alberta Health Services, IND DEF; Brusselaers N, 2017, METHOD INFORM MED, V56, P401, DOI 10.3414/ME17-01-0051; Canadian Institute for Health Information, DAT QUAL DOC DISCH A; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; Foulds JA, 2015, J AFFECT DISORDERS, V185, P47, DOI 10.1016/j.jad.2015.06.024; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Kadoglou NPE, 2017, HEART FAIL REV, V22, P329, DOI 10.1007/s10741-017-9614-7; Ko FW, 2016, RESPIROLOGY, V21, P1152, DOI 10.1111/resp.12780; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; MacIntyre CR, 2020, LANCET, V395, P1950, DOI 10.1016/S0140-6736(20)31183-1; Mitchell RD, 2020, EMERG MED AUSTRALAS, V32, P1027, DOI 10.1111/1742-6723.13606; Pollard MS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.22942; Sporinova B, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.9910; Lima CKT, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112915; University of Manitoba, RES INT WEIGHTS RIW; Webster P, 2020, LANCET, V395, P1180, DOI 10.1016/S0140-6736(20)30818-7; Wong LE, 2020, NEJM CATALYST INNOV, DOI DOI 10.1056/CAT.20.0193; worldometers, COVID 19 COR PAND 20	20	32	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252441	10.1371/journal.pone.0252441	http://dx.doi.org/10.1371/journal.pone.0252441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061888	Green Published, gold			2022-12-26	WOS:000656813600036
J	Absmeier, E; Vester, K; Ghane, T; Burakovskiy, D; Milon, P; Imhof, P; Rodnina, MV; Santos, KF; Wahl, MC				Absmeier, Eva; Vester, Karen; Ghane, Tahereh; Burakovskiy, Dmitry; Milon, Pohl; Imhof, Petra; Rodnina, Marina, V; Santos, Karine F.; Wahl, Markus C.			Long-range allostery mediates cooperative adenine nucleotide binding by the Ski2-like RNA helicase Brr2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD BOX HELICASES; CRYO-EM STRUCTURE; STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; KINETIC MECHANISM; TRANSLATION INITIATION; MOLECULAR-DYNAMICS; ANALYSIS REVEALS; IN-VIVO; Q-MOTIF	Brr2 is an essential Ski2-like RNA helicase that exhibits a unique structure among the spliceosomal helicases. Brr2 harbors a catalytically active N-terminal helicase cassette and a structurally similar but enzymatically inactive C-terminal helicase cassette connected by a linker region. Both cassettes contain a nucleotide-binding pocket, but it is unclear whether nucleotide binding in these two pockets is related. Here we use biophysical and computational methods to delineate the functional connectivity between the cassettes and determine whether occupancy of one nucleotide-binding site may influence nucleotide binding at the other cassette. Our results show that Brr2 exhibits high specificity for adenine nucleotides, with both cassettes binding ADP tighter than ATP. Adenine nucleotide affinity for the inactive C-terminal cassette is more than two orders of magnitude higher than that of the active N-terminal cassette, as determined by slow nucleotide release. Mutations at the intercassette surfaces and in the connecting linker diminish the affinity of adenine nucleotides for both cassettes. Moreover, we found that abrogation of nucleotide binding at the C-terminal cassette reduces nucleotide binding at the N-terminal cassette 70 A away. Molecular dynamics simulations identified structural communication lines that likely mediate these long-range allosteric effects, predominantly across the intercassette interface. Together, our results reveal intricate networks of intramolecular interactions in the complex Brr2 RNA helicase, which fine-tune its nucleotide affinities and which could be exploited to regulate enzymatic activity during splicing.	[Absmeier, Eva; Vester, Karen; Santos, Karine F.; Wahl, Markus C.] Free Univ Berlin, Struct Biochem, Berlin, Germany; [Ghane, Tahereh; Imhof, Petra] Free Univ Berlin, Computat Biophys, Berlin, Germany; [Burakovskiy, Dmitry; Rodnina, Marina, V] Max Planck Inst Biophys Chem, Dept Phys Biochem, Gottingen, Germany; [Milon, Pohl] Univ Peruana Ciencias Aplicadas, Hlth Sci Fac, Ctr Res & Innovat, Lima, Peru; [Wahl, Markus C.] Helmholtz Zentrum Berlin Mat & Energie, Macromol Crystallog, Berlin, Germany; [Absmeier, Eva] MRC Lab Mol Biol, Francis Crick Ave, Cambridge, England; [Burakovskiy, Dmitry] Evotec SE, Hamburg, Germany; [Imhof, Petra] Friedrich Alexander Univ Erlangen Nurnberg, Computat Chem Ctr, Dept Chem & Pharm, Erlangen, Germany; [Santos, Karine F.] 4TEEN4 Pharmaceut GmbH, Hennigsdorf, Germany	Free University of Berlin; Free University of Berlin; Max Planck Society; Universidad Peruana de Ciencias Aplicadas (UPC); Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); MRC Laboratory Molecular Biology; University of Erlangen Nuremberg	Absmeier, E; Santos, KF; Wahl, MC (corresponding author), Free Univ Berlin, Struct Biochem, Berlin, Germany.; Wahl, MC (corresponding author), Helmholtz Zentrum Berlin Mat & Energie, Macromol Crystallog, Berlin, Germany.; Absmeier, E (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge, England.; Santos, KF (corresponding author), 4TEEN4 Pharmaceut GmbH, Hennigsdorf, Germany.	absmeier@mrc-linb.cantac.uk; bourgeois@4teen4.de; markus.wahl@fu-berlin.de	Milon, Pohl/ABG-5423-2021; Wahl, Markus/D-6365-2017	Milon, Pohl/0000-0001-6679-5473; Wahl, Markus/0000-0002-2811-5307	Deutsche Forschungsgemeinschaft [TRR186/A15]; Dahlem International Network PostDoc Fellowship from Freie Universitat Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dahlem International Network PostDoc Fellowship from Freie Universitat Berlin	This work was funded by grant TRR186/A15 from the Deutsche Forschungsgemeinschaft to M. C. W. K. F. S. was supported by a Dahlem International Network PostDoc Fellowship from Freie Universitat Berlin.	Abraham MJ, 2011, J COMPUT CHEM, V32, P2031, DOI 10.1002/jcc.21773; Absmeier E, 2017, CELL CYCLE, V16, P100, DOI 10.1080/15384101.2016.1255384; Absmeier E, 2015, GENE DEV, V29, P2576, DOI 10.1101/gad.271528.115; Absmeier E, 2015, ACTA CRYSTALLOGR D, V71, P762, DOI 10.1107/S1399004715001005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; Bagga J, 2002, LECT NOTES COMPUT SC, V2265, P459; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Bujalowski W, 2000, BIOCHEMISTRY-US, V39, P2106, DOI 10.1021/bi992413m; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen HC, 2013, MOL CELL BIOL, V33, P514, DOI 10.1128/MCB.01093-12; Conrad KS, 2016, EMBO J, V35, P1707, DOI 10.15252/embj.201694327; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fourmann JB, 2013, GENE DEV, V27, P413, DOI 10.1101/gad.207779.112; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Goyal A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv869; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Guiraldelli MF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003383; Guy CP, 2005, NUCLEIC ACIDS RES, V33, P3678, DOI 10.1093/nar/gki685; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Halbach F, 2012, RNA, V18, P124, DOI 10.1261/rna.029553.111; Hashimoto S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60241-w; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Huang YH, 2014, MOL CELL BIOL, V34, P210, DOI 10.1128/MCB.00837-13; Johnson SJ, 2013, RNA BIOL, V10, P33, DOI 10.4161/rna.22101; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Juszkiewicz S, 2020, MOL CELL, V79, P603, DOI 10.1016/j.molcel.2020.06.006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Khalili M, 2005, J PHYS CHEM B, V109, P13798, DOI 10.1021/jp058007w; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Kudlinzki D, 2012, BIOL CHEM, V393, P1131, DOI 10.1515/hsz-2012-0158; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Lauber J, 1996, EMBO J, V15, P4001, DOI 10.1002/j.1460-2075.1996.tb00774.x; Li JQ, 2013, MBIO, V4, DOI 10.1128/mBio.00385-13; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Martegani E, 1997, YEAST, V13, P391, DOI 10.1002/(SICI)1097-0061(19970330)13:4<391::AID-YEA92>3.0.CO;2-Q; Matsuo Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00188-1; Mayerle M, 2016, RNA, V22, P793, DOI 10.1261/rna.055459.115; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; Milon P, 2007, METHOD ENZYMOL, V430, P1, DOI 10.1016/S0076-6879(07)30001-3; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; MOORE KJM, 1994, BIOCHEMISTRY-US, V33, P14565, DOI 10.1021/bi00252a024; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Noble SM, 1996, EMBO J, V15, P4368, DOI 10.1002/j.1460-2075.1996.tb00810.x; OBRIEN ET, 1989, BIOCHEMISTRY-US, V28, P1413, DOI 10.1021/bi00429a070; Oyama T, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-2; Peck ML, 2003, RNA, V9, P1180, DOI 10.1261/rna.2103703; Pena V, 2009, MOL CELL, V35, P454, DOI 10.1016/j.molcel.2009.08.006; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Resetar AM, 1995, BIOCHEMISTRY-US, V34, P16039, DOI 10.1021/bi00049a018; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Searfoss A, 2001, MOL CELL BIOL, V21, P4900, DOI 10.1128/MCB.21.15.4900-4908.2001; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Sugiyama T, 2019, CELL REP, V26, P3400, DOI 10.1016/j.celrep.2019.02.067; Talavera MA, 2005, BIOCHEMISTRY-US, V44, P959, DOI 10.1021/bi048253i; Tanaka K, 2006, DNA SEQUENCE, V17, P242, DOI 10.1080/10425170600805433; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Toseland CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038270; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Tsai RT, 2007, MOL CELL BIOL, V27, P8027, DOI 10.1128/MCB.01213-07; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Nues RW, 2001, GENETICS, V157, P1451; Vester K, 2020, J BIOL CHEM, V295, P2097, DOI 10.1074/jbc.RA119.010964; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Xu DM, 1996, NATURE, V381, P709, DOI 10.1038/381709a0; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Zhang LD, 2015, NUCLEIC ACIDS RES, V43, P3286, DOI 10.1093/nar/gkv062; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625	89	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100829	10.1016/j.jbc.2021.100829	http://dx.doi.org/10.1016/j.jbc.2021.100829			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34048711	Green Published, gold			2022-12-26	WOS:000678068400031
J	Grunkemeyer, TJ; Ghosh, S; Patel, AM; Sajja, K; Windak, J; Basrur, V; Kim, Y; Nesvizhskii, AI; Kennedy, RT; Marsh, ENG				Grunkemeyer, Timothy J.; Ghosh, Soumi; Patel, Ayesha M.; Sajja, Keerthi; Windak, James; Basrur, Venkatesha; Kim, Youngsoo; Nesvizhskii, Alexey, I; Kennedy, Robert T.; Marsh, E. Neil G.			The antiviral enzyme viperin inhibits cholesterol biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-INDUCIBLE PROTEIN; COENZYME-A REDUCTASE; E3 UBIQUITIN LIGASE; C VIRUS-REPLICATION; SQUALENE MONOOXYGENASE; MASS SPECTROMETRY; INFLUENZA-VIRUS; IDENTIFICATION; METABOLISM; EXPRESSION	Many enveloped viruses bud from cholesterol-rich lipid rafts on the cell membrane. Depleting cellular cholesterol impedes this process and results in viral particles with reduced viability. Viperin (Virus Inhibitory Protein, Endoplasmic Reticulum-associated, Interferon iNducible) is an endoplasmic reticulum membrane-associated enzyme that exerts broad-ranging antiviral effects, including inhibiting the budding of some enveloped viruses. However, the relationship between viperin expression and the retarded budding of virus particles from lipid rafts on the cell membrane is unclear. Here, we investigated the effect of viperin expression on cholesterol biosynthesis using transiently expressed genes in the human cell line human embryonic kidney 293T (HEK293T). We found that viperin expression reduces cholesterol levels by 20% to 30% in these cells. Following this observation, a proteomic screen of the viperin interactome identified several cholesterol biosynthetic enzymes among the top hits, including lanosterol synthase (LS) and squalene monooxygenase (SM), which are enzymes that catalyze key steps in establishing the sterol carbon skeleton. Coimmunoprecipitation experiments confirmed that viperin, LS, and SM form a complex at the endoplasmic reticulum membrane. While coexpression of viperin was found to significantly inhibit the specific activity of LS in HEK293T cell lysates, coexpression of viperin had no effect on the specific activity of SM, although did reduce SM protein levels by approximately 30%. Despite these inhibitory effects, the coexpression of neither LS nor SM was able to reverse the viperin-induced depletion of cellular cholesterol levels, possibly because viperin is highly expressed in transfected HEK293T cells. Our results establish a link between viperin expression and downregulation of cholesterol biosynthesis that helps explain viperin's antiviral effects against enveloped viruses.	[Grunkemeyer, Timothy J.; Ghosh, Soumi; Patel, Ayesha M.; Sajja, Keerthi; Windak, James; Kim, Youngsoo; Kennedy, Robert T.; Marsh, E. Neil G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Basrur, Venkatesha; Nesvizhskii, Alexey, I] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Nesvizhskii, Alexey, I] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Marsh, E. Neil G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Marsh, ENG (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.; Marsh, ENG (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	nmarsh@umich.edu	; Nesvizhskii, Alexey/A-5410-2012; Marsh, Neil/G-7553-2016	Patel, Ayesha/0000-0001-5037-5933; Ghosh, Soumi/0000-0001-6101-0147; Nesvizhskii, Alexey/0000-0002-2806-7819; Marsh, Neil/0000-0003-1713-1683	National Institutes of Health [GM 093088, DK 046960, GM094231]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institutes of Health grants GM 093088 to E. N. G. M., DK 046960 to R. T. K., and GM094231 to A. I. N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bajimaya S, 2017, VIROLOGY, V510, P234, DOI 10.1016/j.virol.2017.07.024; Bajimaya S, 2017, VIROLOGY, V501, P127, DOI 10.1016/j.virol.2016.11.011; Blattmann P, 2017, CELL SYST, V5, P604, DOI 10.1016/j.cels.2017.11.002; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cerqueira NMFSA, 2016, BIOCHEMISTRY-US, V55, P5483, DOI 10.1021/acs.biochem.6b00342; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Dukhovny A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26516-z; Dumbrepatil AB, 2020, J BIOL CHEM, V295, P2839, DOI 10.1074/jbc.RA119.011526; Dumbrepatil AB, 2019, J BIOL CHEM, V294, P6888, DOI 10.1074/jbc.RA119.007719; Duschene Kaitlin S, 2012, Biomol Concepts, V3, P255; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Ebrahimi KH, 2020, FEBS LETT, V594, P1624, DOI 10.1002/1873-3468.13761; Ebrahimi KH, 2020, FEBS LETT, V594, P1631, DOI 10.1002/1873-3468.13778; Eisele B, 1997, J LIPID RES, V38, P564; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; FAUST JR, 1982, P NATL ACAD SCI-BIOL, V79, P5205, DOI 10.1073/pnas.79.17.5205; Fenwick MK, 2020, BIOCHEMISTRY-US, V59, P652, DOI 10.1021/acs.biochem.9b00741; Fenwick MK, 2017, P NATL ACAD SCI USA, V114, P6806, DOI 10.1073/pnas.1705402114; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Ghosh S, 2020, J BIOL CHEM, V295, P11513, DOI 10.1074/jbc.REV120.012784; Ghosh S, 2020, BIOCHEMISTRY-US, V59, P780, DOI 10.1021/acs.biochem.9b01090; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gower TL, 2001, ANTIMICROB AGENTS CH, V45, P1231, DOI 10.1128/AAC.45.4.1231-1237.2001; Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031797; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Howe V, 2015, J BIOL CHEM, V290, P27533, DOI 10.1074/jbc.M115.675181; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; Itzhak DN, 2016, ELIFE, V5, DOI 10.7554/eLife.16950; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jiang X, 2011, IMMUNITY, V34, P285, DOI 10.1016/j.immuni.2011.03.012; Jumat MR, 2015, ANTIVIR RES, V114, P11, DOI 10.1016/j.antiviral.2014.11.007; Kim JJ, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e33; Li WL, 2020, ANTIVIR RES, V184, DOI 10.1016/j.antiviral.2020.104903; Makins C, 2016, J BIOL CHEM, V291, P26806, DOI 10.1074/jbc.M116.751040; Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015; McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mikulecky P, 2018, FEBS LETT, V592, P199, DOI 10.1002/1873-3468.12941; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mo CQ, 2005, BBA-MOL CELL BIOL L, V1737, P152, DOI 10.1016/j.bbalip.2005.11.002; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; OSBORNE TF, 1988, J BIOL CHEM, V263, P3380; Padyana AK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07928-x; Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/jvi.02054-17, 10.1128/JVI.02054-17]; Patel AM, 2021, J AM CHEM SOC, V143, P4910, DOI 10.1021/jacs.1c01045; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rabbani MAG, 2016, J VIROL, V90, P11145, DOI 10.1128/JVI.01551-16; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Upadhyay AS, 2017, J BIOL CHEM, V292, P13879, DOI 10.1074/jbc.M117.780122; Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1; Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014; Waheed AA, 2007, CELL HOST MICROBE, V2, P71, DOI 10.1016/j.chom.2007.07.005; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006; Xu CM, 2020, J MED VIROL, V92, P149, DOI 10.1002/jmv.25595; Yuan YK, 2020, MOL CELL, V77, P734, DOI 10.1016/j.molcel.2019.11.003; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13	75	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100824	10.1016/j.jbc.2021.100824	http://dx.doi.org/10.1016/j.jbc.2021.100824			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029588	gold, Green Published			2022-12-26	WOS:000678068400026
J	Krumm, CS; Xu, X; Bare, CJ; Holman, CD; Kersten, S; Dow, LE; Lee, AH; Cohen, DE				Krumm, Christopher S.; Xu, Xu; Bare, Curtis J.; Holman, Corey D.; Kersten, Sander; Dow, Lukas E.; Lee, Ann-Hwee; Cohen, David E.			Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; TRANSCRIPTION FACTOR CREBH; ELEMENT-BINDING PROTEIN; APOLIPOPROTEIN A-IV; PPAR-ALPHA; FGF21; LIVER; METABOLISM; STRESS; SENSITIVITY	Cyclic AMP-responsive element-binding protein H (CREBH encoded by Creb3l3) is a transcription factor that regulates the expression of genes that control lipid and glucose metabolism as well as inflammation. CREBH is upregulated in the liver under conditions of overnutrition, and mice globally lacking the gene (CREBH-/-) are highly susceptible to diet-induced obesity, insulin resistance, and hepatic steatosis. The net protective effects of CREBH have been attributed in large part to the activities of fibroblast growth factor (Fgf)-21 (Fgf21), a target gene that promotes weight loss, improves glucose homeostasis, and reduces hepatic lipid accumulation. To explore the possibility that activation of the CREBH-Fgf21 axis could ameliorate established effects of high-fat feeding, we generated an inducible transgenic hepatocyte-specific CREBH overexpression mouse model (Tg-rtTA). Acute overexpression of CREBH in livers of Tg-rtTA mice effectively reversed diet-induced obesity, insulin resistance, and hepatic steatosis. These changes were associated with increased activities of thermogenic brown and beige adipose tissues in Tg-rtTA mice, leading to reductions in fat mass, along with enhanced insulin sensitivity and glucose tolerance. Genetically silencing Fgf21 in Tg-rtTA mice abrogated the CREBH-mediated reductions in body weight loss, but only partially reversed the observed improvements in glucose metabolism. These findings reveal that the protective effects of CREBH activation may be leveraged to mitigate diet-induced obesity and associated metabolic abnormalities in both Fgf21-dependent and Fgf21-independent pathways.	[Krumm, Christopher S.; Xu, Xu; Bare, Curtis J.; Holman, Corey D.; Cohen, David E.] Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, Div Gastroenterol & Hepatol, New York, NY 10065 USA; [Kersten, Sander] Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Dow, Lukas E.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, Joan & Sanford I Weill Dept Med, Div Hematol & Med Oncol, New York, NY USA; [Lee, Ann-Hwee] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA	Cornell University; Wageningen University & Research; Cornell University; Cornell University	Cohen, DE (corresponding author), Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, Div Gastroenterol & Hepatol, New York, NY 10065 USA.	dcohen@med.cornell.edu	Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734; Dow, Lukas/0000-0001-7048-1418; Holman, Corey/0000-0003-1111-7442	National Institute of Diabetes and Digestive and Kidney Diseases [R37 DK048873, R01 DK103046, R01 DK056626]; National Institutes of Health (NIH) [T32 DK116970]; Weill Cornell Metabolic Phenotyping Core; NIH/National Cancer Center [P30CA016087]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell Metabolic Phenotyping Core; NIH/National Cancer Center	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK048873, R01 DK103046, and R01 DK056626 to D. E. C.). C. S. K. acknowledges support from the National Institutes of Health (NIH) T32 DK116970 (to D. E. C.). Support from the Weill Cornell Metabolic Phenotyping Core and the NIH/National Cancer Center (P30CA016087 to the Laura and Isaac Perlmutter Cancer Center; New York University Langone Health) is gratefully acknowledged. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; BonDurant LD, 2017, CELL METAB, V25, P935, DOI 10.1016/j.cmet.2017.03.005; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Cheng DM, 2016, J BIOL CHEM, V291, P23793, DOI 10.1074/jbc.M116.749283; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Dow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095236; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Henriksson E, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.601349; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jin X, 2009, J HEPATOL, V50, P1019, DOI 10.1016/j.jhep.2008.10.034; Kang HW, 2013, J BIOL CHEM, V288, P33376, DOI 10.1074/jbc.M113.481408; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Kwon MM, 2015, CELL REP, V13, P1521, DOI 10.1016/j.celrep.2015.10.021; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Nakagawa Y, 2014, ENDOCRINOLOGY, V155, P4706, DOI 10.1210/en.2014-1113; Park JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27938; Ruppert PMM, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5563-y; Samms RJ, 2015, CELL REP, V11, P991, DOI 10.1016/j.celrep.2015.04.046; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Satoh A, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100930; Scapa EF, 2008, FASEB J, V22, P2579, DOI 10.1096/fj.07-105395; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Tan MGK, 2004, J BIOL CHEM, V279, P45235, DOI 10.1074/jbc.M403683200; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Veniant MM, 2015, CELL METAB, V21, P731, DOI 10.1016/j.cmet.2015.04.019; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Wade H, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000771; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Xu X, 2014, J LIPID RES, V55, P850, DOI 10.1194/jlr.M045104; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	45	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100815	10.1016/j.jbc.2021.100815	http://dx.doi.org/10.1016/j.jbc.2021.100815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023388	Green Published, gold			2022-12-26	WOS:000678068400018
J	Kulkarni, NN; O'Neill, AM; Dokoshi, T; Luo, EWC; Wong, GCL; Gallo, RL				Kulkarni, Nikhil N.; O'Neill, Alan M.; Dokoshi, Tatsuya; Luo, Elizabeth W. C.; Wong, Gerard C. L.; Gallo, Richard L.			Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDE LL-37; DENDRITIC CELLS; ACTIVATION; COMPLEXES; KERATINOCYTES; INHIBITION; LL37	Cathelicidins such as the human 37-amino acid peptide (LL-37) are peptides that not only potently kill microbes but also trigger inflammation by enabling immune recognition of endogenous nucleic acids. Here, a detailed structure-function analysis of LL-37 was performed to understand the details of this process. Alanine scanning of 34-amino acid peptide (LL-34) showed that some variants displayed increased antimicrobial activity against Staphylococcus aureus and group A Streptococcus. In contrast, different substitutions clustered on the hydrophobic face of the LL-34 alpha helix inhibited the ability of those variants to promote type 1 interferon expression in response to U1 RNA or to present U1 to the scavenger receptor (SR) B1 on the keratinocyte cell surface. Small-angle X-ray scattering experiments of the LL-34 variants LL-34, F5A, I24A, and L31A demonstrated that these peptides form cognate supramolecular structures with U1 characterized by inter-dsRNA spacings of approximately 3.5 nm, a range that has been previously shown to activate toll-like receptor 3 by the parent peptide LL-37. Therefore, while alanine substitutions on the hydrophobic face of LL-34 led to loss of binding to SRs and the complete loss of autoinflammatory responses in epithelial and endothelial cells, they did not inhibit the ability to organize with U1 RNA in solution to associate with toll-like receptor 3. These observations advance our understanding of how cathelicidin mediates the process of innate immune self-recognition to enable inert nucleic acids to trigger inflammation. We introduce the term "innate immune vetting" to describe the capacity of peptides such as LL-37 to enable certain nucleic acids to become an inflammatory stimulus through SR binding prior to cell internalization.	[Kulkarni, Nikhil N.; O'Neill, Alan M.; Dokoshi, Tatsuya; Gallo, Richard L.] Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA; [Luo, Elizabeth W. C.; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Bioengn & Chem, Los Angeles, LA USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA.	rgallo@ucsd.edu	Dokoshi, Tatsuya/ABY-3443-2022; Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861; Luo, Elizabeth Wei-Chia/0000-0002-8663-0446; Wong, Gerard/0000-0003-0893-6383; O'Neill, Alan/0000-0002-5892-6477	National Institutes of Health [R37AI052453, R01AR076082, R01074302, U01 AI52038, R01AI153185]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant R37AI052453 to R. L. G. and G. C. L. W. R. L. G. also receives support from R01AR076082, R01074302, U01 AI52038, and R01AI153185. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Borkowski AW, 2015, J INVEST DERMATOL, V135, P569, DOI 10.1038/jid.2014.354; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Di Domizio J, 2020, NAT IMMUNOL, V21, P1034, DOI 10.1038/s41590-020-0721-6; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; Frasca L, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.02363, 10.3389/fimmu.2018.01936]; Fuentes-Duculan J, 2017, EXP DERMATOL, V26, P1075, DOI 10.1111/exd.13378; Gunasekera S, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00168; Gunasekera S, 2018, CHEMBIOCHEM, V19, P931, DOI 10.1002/cbic.201700599; Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Ilavsky J, 2012, J APPL CRYSTALLOGR, V45, P324, DOI 10.1107/S0021889812004037; Kim SH, 2017, J IMMUNOL, V198, P629, DOI 10.4049/jimmunol.1600886; Kulkarni NN, 2020, J INVEST DERMATOL, V140, P645, DOI 10.1016/j.jid.2019.08.436; Kulkarni NN, 2017, J INVEST DERMATOL, V137, P2417, DOI 10.1016/j.jid.2017.07.814; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Lee EY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08868-w; Lee EY, 2017, ACS NANO, V11, P12145, DOI 10.1021/acsnano.7b05234; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Garcia B, 2005, J INVEST DERMATOL, V125, P108, DOI 10.1111/j.0022-202X.2005.23713.x; Luo XL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00283; Murshid A, 2015, IMMUNOBIOLOGY, V220, P823, DOI 10.1016/j.imbio.2014.12.011; Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palchetti S, 2015, J BIOL CHEM, V290, P5470, DOI 10.1074/jbc.M114.601625; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Piktel E, 2016, ARCH IMMUNOL THER EX, V64, P33, DOI 10.1007/s00005-015-0359-5; Rico-Mata R, 2013, EXP PARASITOL, V133, P300, DOI 10.1016/j.exppara.2012.12.009; Salvado MD, 2013, ARTERIOSCL THROM VAS, V33, P1965, DOI 10.1161/ATVBAHA.113.301851; Scheenstra MR, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01137; Schmidt NW, 2015, NAT MATER, V14, P696, DOI [10.1038/NMAT4298, 10.1038/nmat4298]; Song Q, 2021, J INVEST DERMATOL, V141, P1428, DOI 10.1016/j.jid.2020.10.027; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Takahashi T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22409-3; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tursi SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006315; Wang GS, 2019, ADV EXP MED BIOL, V1117, P215, DOI 10.1007/978-981-13-3588-4_12; Xhindoli D, 2016, BBA-BIOMEMBRANES, V1858, P546, DOI 10.1016/j.bbamem.2015.11.003; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yu YS, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100999; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 2016, IMMUNITY, V45, P119, DOI 10.1016/j.immuni.2016.06.021	49	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100828	10.1016/j.jbc.2021.100828	http://dx.doi.org/10.1016/j.jbc.2021.100828			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34048712	gold, Green Published, Green Submitted			2022-12-26	WOS:000678068400030
J	Pires, E; Sharma, N; Selemenakis, P; Wu, B; Huang, YX; Alimbetov, DS; Zhao, WX; Wiese, C				Pires, Elena; Sharma, Neelam; Selemenakis, Platon; Wu, Bo; Huang, Yuxin; Alimbetov, Dauren S.; Zhao, Weixing; Wiese, Claudia			RAD51AP1 mediates RAD51 activity through nucleosome interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; HISTONE OCTAMER; BINDING PROTEIN; DNA-REPAIR; IN-VITRO; CHROMATIN; PROMOTION; RECONSTITUTION; ENHANCEMENT; AFFINITY	RAD51-associated protein 1 (RAD51AP1) is a key protein in the homologous recombination (HR) DNA repair pathway. Loss of RAD51AP1 leads to defective HR, genome instability, and telomere erosion. RAD51AP1 physically interacts with the RAD51 recombinase and promotes RAD51-mediated capture of donor DNA, synaptic complex assembly, and displacement-loop formation when tested with nucleosome-free DNA substrates. In cells, however, DNA is packaged into chromatin, posing an additional barrier to the complexities of the HR reaction. In this study, we show that RAD51AP1 binds to nucleosome core particles (NCPs), the minimum basic unit of chromatin in which approximately two superhelical turns of 147 bp double-stranded DNA are wrapped around one histone octamer with no free DNA ends remaining. We identified a C-terminal region in RAD51AP1, including its previously mapped DNA-binding domain, as critical for mediating the association between RAD51AP1 and both the NCP and the histone octamer. Using in vitro surrogate assays of HR activity, we show that RAD51AP1 is capable of promoting duplex DNA capture and initiating joint-molecule formation with the NCP and chromatinized template DNA, respectively. Together, our results suggest that RAD51AP1 directly assists in the RAD51-mediated search for donor DNA in chromatin. We present a model, in which RAD51AP1 anchors the DNA template through affinity for its nucleosomes to the RAD51-ssDNA nucleoprotein filament.	[Pires, Elena; Sharma, Neelam; Selemenakis, Platon; Wiese, Claudia] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Pires, Elena; Selemenakis, Platon] Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA; [Wu, Bo; Huang, Yuxin; Alimbetov, Dauren S.; Zhao, Weixing] Univ Texas Hlth San Antonio, Dept Biochem & Struct Biol, San Antonio, TX USA	Colorado State University; Colorado State University; University of Texas System; University of Texas Health San Antonio	Wiese, C (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	cwiese@colostate.edu		Wiese, Claudia/0000-0001-6844-4693; zhao, weixing/0000-0001-5746-3696; Selemenakis, Platon/0000-0002-4507-2249	National Institutes of Health [R01ES021454, R56ES021454, R03ES029206]; V Foundation Scholar Grant; Max & Minnie Tomerlin Voelcker Young Investigator Award [T32OD012201]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation Scholar Grant; Max & Minnie Tomerlin Voelcker Young Investigator Award	This work was supported by National Institutes of Health Grants R01ES021454, R56ES021454, R03ES029206 (to C. W.), a V Foundation Scholar Grant and a Max & Minnie Tomerlin Voelcker Young Investigator Award (to W. Z.). E. P. was cosupported by T32OD012201. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; Belotserkovskaya R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14563-y; Bleuyard JY, 2012, EMBO REP, V13, P135, DOI 10.1038/embor.2011.243; Crickard JB, 2019, J BIOL CHEM, V294, P490, DOI 10.1074/jbc.RA118.006146; Daley JM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a017954; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Dray E, 2011, P NATL ACAD SCI USA, V108, P3560, DOI 10.1073/pnas.1016454108; Dunlop MH, 2012, J BIOL CHEM, V287, P12343, DOI 10.1074/jbc.C112.352161; Dunlop MH, 2011, J BIOL CHEM, V286, P37328, DOI 10.1074/jbc.M111.290015; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Gottesfeld JM, 2001, BIOCHEMISTRY-US, V40, P10927, DOI 10.1021/bi0109966; Hammond CM, 2017, NAT REV MOL CELL BIO, V18, P141, DOI 10.1038/nrm.2016.159; Higgs MR, 2018, MOL CELL, V71, P25, DOI 10.1016/j.molcel.2018.05.018; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; JEONG SW, 1991, J MOL BIOL, V222, P1131, DOI 10.1016/0022-2836(91)90597-Y; Kobayashi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep24228; Kovalenko OV, 2006, NUCLEIC ACIDS RES, V34, P5081, DOI 10.1093/nar/gkl665; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Kulkarni P, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800061; Kwon Y, 2007, DNA REPAIR, V6, P1496, DOI 10.1016/j.dnarep.2007.04.012; Kwon YH, 2008, J BIOL CHEM, V283, P10445, DOI 10.1074/jbc.M800082200; Kwon Y, 2017, METHOD ENZYMOL, V591, P307, DOI 10.1016/bs.mie.2017.03.021; Liang FS, 2020, J BIOL CHEM, V295, P8186, DOI 10.1074/jbc.RA120.013714; Liang FS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10408-5; Liang FS, 2016, CELL REP, V15, P2118, DOI 10.1016/j.celrep.2016.05.007; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; Maranon DG, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201911049; Mehrotra PV, 2011, MOL CELL, V41, P46, DOI 10.1016/j.molcel.2010.12.008; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Muthurajan UM, 2014, P NATL ACAD SCI USA, V111, P12752, DOI 10.1073/pnas.1405005111; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Parplys AC, 2015, NUCLEIC ACIDS RES, V43, P9817, DOI 10.1093/nar/gkv859; Parplys AC, 2014, DNA REPAIR, V24, P87, DOI 10.1016/j.dnarep.2014.09.007; Pires E, 2017, DNA REPAIR, V59, P76, DOI 10.1016/j.dnarep.2017.09.008; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Raynard S., 2009, COLD SPRING HARB PRO, V2009; Sato K, 2012, EMBO J, V31, P3524, DOI 10.1038/emboj.2012.197; Sharma N, 2008, P NATL ACAD SCI USA, V105, P7959, DOI 10.1073/pnas.0800534105; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Strickfaden H, 2020, CELL, V183, P1772, DOI 10.1016/j.cell.2020.11.027; Tye S, 2021, SEMIN CELL DEV BIOL, V113, P14, DOI 10.1016/j.semcdb.2020.07.004; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wiese C, 2006, NUCLEIC ACIDS RES, V34, P2833, DOI 10.1093/nar/gkl366; Wilson MD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0280; Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372; Zhang ZQ, 2007, NAT STRUCT MOL BIOL, V14, P397, DOI 10.1038/nsmb1223; Zhao WX, 2015, MOL CELL, V59, P176, DOI 10.1016/j.molcel.2015.05.032	50	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100844	10.1016/j.jbc.2021.100844	http://dx.doi.org/10.1016/j.jbc.2021.100844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058198	Green Submitted, gold, Green Published			2022-12-26	WOS:000678068400044
J	Singh, RR; McNamara, JW; Sadayappan, S				Singh, Rohit R.; McNamara, James W.; Sadayappan, Sakthivel			Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPAIRS MYOFILAMENT FUNCTION; MURINE SKINNED MYOCARDIUM; SKELETAL-MUSCLE FIBERS; KINASE-A; TROPONIN-I; FORCE GENERATION; REGULATORY DOMAIN; ATPASE ACTIVITY; ATOMIC MODEL; COILED-COILS	Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disorder primarily caused by mutations in the beta-myosin heavy-chain gene. The proximal subfragment 2 region (S2), 126 amino acids of myosin, binds with the C0-C2 region of cardiac myosin-binding protein-C to regulate cardiac muscle contractility in a manner dependent on PKA-mediated phosphorylation. However, it is unknown if HCM-associated mutations within S2 dysregulate actomyosin dynamics by disrupting its interaction with C0-C2, ultimately leading to HCM. Herein, we study three S2 mutations known to cause HCM: R870H, E924K, and E930 Delta. First, experiments using recombinant proteins, solid-phase binding, and isothermal titrating calorimetry assays independently revealed that mutant S2 proteins displayed significantly reduced binding with C0C2. In addition, CD revealed greater instability of the coiledcoil structure in mutant S2 proteins compared with S2(Wt) proteins. Second, mutant S2 exhibited 5-fold greater affinity for PKA-treated C0-C2 proteins. Third, skinned papillary muscle fibers treated with mutant S2 proteins showed no change in the rate of force redevelopment as a measure of actin-myosin cross-bridge kinetics, whereas S2(Wt) showed increased the rate of force redevelopment. In summary, S2 and C0-C2 interaction mediated by phosphorylation is altered by mutations in S2, which augment the speed and force of contraction observed in HCM. Modulating this interaction could be a potential strategy to treat HCM in the future.	[Singh, Rohit R.; McNamara, James W.; Sadayappan, Sakthivel] Univ Cincinnati, Heart Lung & Vasc Inst, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45221 USA; [McNamara, James W.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [McNamara, James W.] Univ Melbourne, Sch Biomed Sci, Dept Physiol, Parkville, Vic 3010, Australia	University System of Ohio; University of Cincinnati; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Sadayappan, S (corresponding author), Univ Cincinnati, Heart Lung & Vasc Inst, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45221 USA.	sadayasl@ucmail.uc.edu		McNamara, James/0000-0003-3754-6405; Sadayappan, Sakthivel/0000-0003-2006-7678	NIH [R01 AR078001, R01 HL130356, R01 HL105826, R38 HL155775, R01 HL143490]; American Heart Association Postdoctoral Fellowship [17POST33630095]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association)	S. S. has received support from NIH Grants R01 AR078001, R01 HL130356, R01 HL105826, R38 HL155775, and R01 HL143490. J. W. M. was supported by an American Heart Association Postdoctoral Fellowship (17POST33630095). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikari AS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10555-9; Adhikari AS, 2016, CELL REP, V17, P2857, DOI 10.1016/j.celrep.2016.11.040; AL-Khayat HA, 2013, P NATL ACAD SCI USA, V110, P318, DOI 10.1073/pnas.1212708110; Armel TZ, 2009, P NATL ACAD SCI USA, V106, P6291, DOI 10.1073/pnas.0900107106; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; BARNES KP, 1972, J BIOL CHEM, V247, P1708; Blair E, 2002, CIRC RES, V90, P263, DOI 10.1161/hh0302.104532; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Brown JH, 1996, PROTEINS, V26, P134; Brunello E, 2020, P NATL ACAD SCI USA, V117, P8177, DOI 10.1073/pnas.1920632117; Chen PP, 2010, J GEN PHYSIOL, V136, P615, DOI 10.1085/jgp.201010448; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Cuello F, 2011, J BIOL CHEM, V286, P5300, DOI 10.1074/jbc.M110.202713; DAVIS JS, 1987, P NATL ACAD SCI USA, V84, P975, DOI 10.1073/pnas.84.4.975; Desjardins CL, 2012, CIRC-CARDIOVASC IMAG, V5, P127, DOI 10.1161/CIRCIMAGING.111.965772; Dias KA, 2018, J AM COLL CARDIOL, V72, P1157, DOI 10.1016/j.jacc.2018.06.054; Freeman K, 2001, AM J PHYSIOL-HEART C, V280, pH151, DOI 10.1152/ajpheart.2001.280.1.H151; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Giles J, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012782; Gillis TE, 2011, J EXP BIOL, V214, P1989, DOI 10.1242/jeb.052084; Govindan S, 2012, J MUSCLE RES CELL M, V33, P17, DOI 10.1007/s10974-012-9292-y; Gresham KS, 2016, J PHYSIOL-LONDON, V594, P669, DOI 10.1113/JP270959; Gresham KS, 2014, J PHYSIOL-LONDON, V592, P3747, DOI 10.1113/jphysiol.2014.276022; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Gundapaneni D, 2005, J STRUCT BIOL, V149, P117, DOI 10.1016/j.jsb.2004.10.005; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; Homburger JR, 2016, P NATL ACAD SCI USA, V113, P6701, DOI 10.1073/pnas.1606950113; Kensler RW, 2011, J STRUCT BIOL, V174, P44, DOI 10.1016/j.jsb.2010.12.003; Kraft T, 2013, J MOL CELL CARDIOL, V57, P13, DOI 10.1016/j.yjmcc.2013.01.001; Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MCKENNA W, 1981, AM J CARDIOL, V47, P532, DOI 10.1016/0002-9149(81)90535-X; McNally EM, 2015, CELL METAB, V21, P174, DOI 10.1016/j.cmet.2015.01.013; McNamara JW, 2019, P NATL ACAD SCI USA, V116, P11731, DOI 10.1073/pnas.1821660116; McNamara JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180064; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Nag S, 2017, NAT STRUCT MOL BIOL, V24, P525, DOI 10.1038/nsmb.3408; Najafi A, 2016, CARDIOVASC RES, V110, P200, DOI 10.1093/cvr/cvw026; Napierski NC, 2020, CIRC RES, V126, P737, DOI 10.1161/CIRCRESAHA.119.315760; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; Prajapati C, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.032896; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Previs MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400205; Rao V, 2014, BIOPHYS J, V107, P1196, DOI 10.1016/j.bpj.2014.07.027; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Robinett JC, 2019, J GEN PHYSIOL, V151, P645, DOI 10.1085/jgp.201812200; Root DD, 2006, BIOPHYS J, V90, P2852, DOI 10.1529/biophysj.105.071597; Rosas PC, 2019, JACC-BASIC TRANSL SC, V4, P817, DOI 10.1016/j.jacbts.2019.06.003; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Sarkar SS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax0069; SCHUMACHER C, 1995, N-S ARCH PHARMACOL, V351, P398; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Singh RR, 2018, DATA BRIEF, V18, P1099, DOI 10.1016/j.dib.2018.04.002; Singh RR, 2018, ARCH BIOCHEM BIOPHYS, V638, P41, DOI 10.1016/j.abb.2017.12.002; Spudich JA, 2015, BIOCHEM SOC T, V43, P64, DOI 10.1042/BST20140324; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; SUGI H, 1992, P NATL ACAD SCI USA, V89, P6134, DOI 10.1073/pnas.89.13.6134; Tanjore RR, 2006, CLIN GENET, V69, P434, DOI 10.1111/j.1399-0004.2006.00599.x; Toepfer CN, 2020, CIRCULATION, V141, P828, DOI 10.1161/CIRCULATIONAHA.119.042339; Toepfer CN, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat1199; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Trivedi Darshan V, 2018, Biophys Rev, V10, P27, DOI 10.1007/s12551-017-0274-6; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Woodhead JL, 2020, ARCH BIOCHEM BIOPHYS, V680, DOI 10.1016/j.abb.2019.108228; Xiao L, 2007, BIOCHEMISTRY-US, V46, P7054, DOI 10.1021/bi700467k; Yang SX, 2020, NATURE, V588, P521, DOI 10.1038/s41586-020-3007-0; YAZAWA Y, 1973, J BIOCHEM-TOKYO, V73, P567, DOI 10.1093/oxfordjournals.jbchem.a130115; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	83	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100836	10.1016/j.jbc.2021.100836	http://dx.doi.org/10.1016/j.jbc.2021.100836			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051236	Green Published, gold			2022-12-26	WOS:000678068400036
J	Pondugula, SR; Majrashi, M; Almaghrabi, M; Ramesh, S; Abbott, KL; Govindarajulu, M; Gill, K; Fahoury, E; Narayanan, N; Desai, D; Ren, J; Nadar, R; McElroy, T; Moore, T; Majeed, M; Kalyanam, N; Dhanasekaran, M				Pondugula, Satyanarayana R.; Majrashi, Mohammed; Almaghrabi, Mohammed; Ramesh, Sindhu; Abbott, Kodye L.; Govindarajulu, Manoj; Gill, Kristina; Fahoury, Eddie; Narayanan, Natasha; Desai, Darshini; Ren, Jun; Nadar, Rishi; McElroy, Trey; Moore, Timothy; Majeed, Muhammed; Kalyanam, Nagabhushanam; Dhanasekaran, Muralikrishnan			Oroxylum Indicum ameliorates chemotherapy induced cognitive impairment	PLOS ONE			English	Article							OXIDATIVE STRESS; WATER MAZE; NEUROTOXICITY; MECHANISMS; BRAIN; RISK; DYSFUNCTION; INDUCTION; BAICALEIN; ISCHEMIA	While chemotherapy is the most effective therapeutic approach for treating a variety of cancer patients, commonly used chemotherapeutic agents, often induce several adverse effects. Escalating evidence indicates that chemotherapeutics, particularly doxorubicin (DOX) and cyclophosphamide (CPS), induce cognitive impairment associated with central nervous system toxicity. This study was performed to determine neuroprotective effects of Oroxylum indicum extract (OIE) in regard to preventing chemotherapy induced cognitive impairment (CICI) occurring after 4 cycles of DOX (2mg/kg) and CPS (50mg/kg) combination chemotherapy in male C57BL/6J mice. OIE significantly prevented the chemotherapy impaired short-term cognitive performance, exploratory behavior associated with cognitive performance, cognitive performance, and spatial learning and memory in the Y-maze, Open-Field, Novel Object Recognition, and Morris Water Maze tests, respectively. These data suggest that OIE protects from the CICI. OIE decreased the reactive oxygen species and lipid peroxide generated by the chemotherapy treatment in the brain, while also blocking the chemotherapy-induced glutathione depletion. These results establish that OIE exhibits potent antioxidant activity in chemotherapy treated mice. Notably, OIE significantly increased the Complex-I and Complex-IV activities in the brain, indicating that OIE enhances mitochondrial function in the brain. In silico analysis of the major active chemical constituents (Oroxylin A, Baicalein and Chrysin) of OIE indicated that OIE has a favorable absorption, distribution, metabolism and excretion (ADME) profile. Taken together, our results are consistent with the conclusion that OIE prevents CICI by counteracting oxidative stress and perhaps by improving mitochondrial function.	[Pondugula, Satyanarayana R.; Abbott, Kodye L.; Gill, Kristina; Narayanan, Natasha; McElroy, Trey] Auburn Univ, Dept Anat Physiol & Pharmacol, Coll Vet Med, Auburn, AL 36849 USA; [Majrashi, Mohammed; Almaghrabi, Mohammed; Ramesh, Sindhu; Govindarajulu, Manoj; Fahoury, Eddie; Desai, Darshini; Nadar, Rishi; Moore, Timothy; Dhanasekaran, Muralikrishnan] Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, Auburn, AL 36849 USA; [Majrashi, Mohammed] Univ Jeddah, Dept Pharmacol, Fac Med, Jeddah, Saudi Arabia; [Ren, Jun] Univ Wyoming, Sch Pharm, Coll Hlth Sci, Laramie, WY USA; [Majeed, Muhammed; Kalyanam, Nagabhushanam] Sabinsa Corp, East Windsor, NJ USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Jeddah; University of Wyoming	Pondugula, SR (corresponding author), Auburn Univ, Dept Anat Physiol & Pharmacol, Coll Vet Med, Auburn, AL 36849 USA.; Dhanasekaran, M (corresponding author), Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, Auburn, AL 36849 USA.	srp0010@auburn.edu; dhanamu@auburn.edu	Majrashi, Mohammed/AAM-4998-2020; Govindarajulu, Manoj Yogish/ABB-7883-2021; ALMAGHRABI, Mohammed/AAC-1883-2022; Ren, Jun/ACG-5366-2022	Majrashi, Mohammed/0000-0001-5752-7389; Govindarajulu, Manoj Yogish/0000-0003-4739-648X; Ren, Jun/0000-0002-0275-0783; Abbott, Kodye/0000-0002-1439-1060; Almaghrabi, Mohammed/0000-0003-4929-7071; Pondugula, Satyanarayana/0000-0002-5806-0183	Sabinsa Corporation	Sabinsa Corporation	Sabinsa Corporation supplied and characterized the product and provided funding for this study. Sabinsa Corporation also provided support for this study in the form of salaries for Muhammed Majeed and Kalyanam Nagabhushanam. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Ahuja M, 2017, LIFE SCI, V177, P49, DOI 10.1016/j.lfs.2017.03.004; [Anonymous], CANC FACTS STAT 2015; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butterfield DA, 2014, FREE RADICAL BIO MED, V74, P157, DOI 10.1016/j.freeradbiomed.2014.06.006; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cheng YX, 2008, NEUROSCI LETT, V441, P16, DOI 10.1016/j.neulet.2008.05.116; Dietrich J, 2015, NEUROSCIENCE, V309, P224, DOI 10.1016/j.neuroscience.2015.06.016; Trang DHT, 2018, BRAZ J PHARM SCI, V54, DOI 10.1590/s2175-97902018000117178; Gulinello M, 2009, BEHAV BRAIN RES, V196, P220, DOI 10.1016/j.bbr.2008.09.002; Harminder, 2011, INDIAN J PHARM SCI, V73, P1, DOI 10.4103/0250-474X.98981; Karri V, 2016, ENVIRON TOXICOL PHAR, V48, P203, DOI 10.1016/j.etap.2016.09.016; Kilian J, 2018, BIOMED J, V41, P141, DOI 10.1016/j.bj.2018.06.001; Kovalchuk A, 2017, CELL CYCLE, V16, P1345, DOI 10.1080/15384101.2017.1334022; Kumar DRN, 2012, ASIAN PAC J CANCER P, V13, P2729, DOI 10.7314/APJCP.2012.13.6.2729; Lee S, 2010, NEUROCHEM RES, V35, P1725, DOI 10.1007/s11064-010-0235-y; Li H, 2003, J CHROMATOGR B, V788, P93, DOI 10.1016/S1570-0232(02)01032-2; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liao DH, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9125601; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Lu L, 2016, PHYTOTHER RES, V30, P1765, DOI 10.1002/ptr.5694; Mairuae N, 2019, MOL MED REP, V20, P1933, DOI 10.3892/mmr.2019.10411; Menon S, 2019, J AYURVEDA INTEGR ME, V10, P159, DOI 10.1016/j.jaim.2017.06.007; Miedel CJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55523; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Mohammed MB, 2018, LIFE SCI, V209, P357, DOI 10.1016/j.lfs.2018.07.052; Muralikrishnan D, 1998, FASEB J, V12, P905, DOI 10.1096/fasebj.12.10.905; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nabavi SF, 2015, NEUROCHEM INT, V90, P224, DOI 10.1016/j.neuint.2015.09.006; Pal S, 2012, FREE RADICAL RES, V46, P785, DOI 10.3109/10715762.2012.678841; Ramesh S., 2018, ALZHEIMERS DIS TREAT; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Ren GH, 2020, J SEP SCI, V43, P2290, DOI 10.1002/jssc.201901259; Roy MK, 2007, PHARMAZIE, V62, P149, DOI 10.1691/ph.2007.2.6608; Seibenhener ML, 2015, JOVE-J VIS EXP, DOI 10.3791/52434; Shewach DS, 2009, CHEM REV, V109, P2859, DOI 10.1021/cr900208x; Shinohara Moeko, 2016, Brain Nerve, V68, P421, DOI 10.11477/mf.1416200415; Siswanto S., 2016, Hayati Journal of Biosciences, V23, P51, DOI 10.1016/j.hjb.2016.02.001; Sowndhararajan K, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060104; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vichaya EG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00131; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wright ME, 2008, AM J EPIDEMIOL, V168, P1024, DOI 10.1093/aje/kwn212; Yan DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep32222; Zhang ZJ, 2005, ACTA PHARMACOL SIN, V26, P307, DOI 10.1111/j.1745-7254.2005.00051.x	46	5	5	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252522	10.1371/journal.pone.0252522	http://dx.doi.org/10.1371/journal.pone.0252522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081735	Green Published, gold			2022-12-26	WOS:000664639200024
J	Castro-Pereira, D; Peres, EA; Pinto-da-Rocha, R				Castro-Pereira, Daniel; Peres, Elen A.; Pinto-da-Rocha, Ricardo			Systematics and phylogeography of the Brazilian Atlantic Forest endemic harvestmen Neosadocus Mello-LeitAo, 1926 (Arachnida: Opiliones: Gonyleptidae)	PLOS ONE			English	Article							ALTERNATIVE REPRODUCTIVE TACTICS; MALE DIMORPHISM; RAIN-FOREST; POPULATION; DIVERSIFICATION; LANIATORES; DISPERSAL; DIVERSITY; INFERENCE; EVOLUTION	Neosadocus harvestmen are endemic to the Southern Brazilian Atlantic Forest. Although they are conspicuous and display great morphological variation, their evolutionary history and the biogeographical events underlying their diversification and distribution are still unknown. This contribution about Neosadocus includes the following: a taxonomic revision; a molecular phylogenetic analysis using mitochondrial and nuclear markers; an investigation of the genetic structure and species' diversity in a phylogeographical framework. Our results show that Neosadocus is a monophyletic group and comprises four species: N. bufo, N. maximus, N. robustus and N. misandrus (which we did not find on fieldwork and only studied the female holotype). There is astonishing male polymorphism in N. robustus, mostly related to reproductive strategies. The following synonymies have resulted from this work: "Bunoweyhia" variabilis Mello-LeitAo, 1935 = Neosadocus bufo (Mello-LeitAo, 1926); and "Bunoweyhia" minor Mello-LeitAo, 1935 = Neosadocus maximus (Giltay, 1928). Most divergences occurred during the Miocene, a geological epoch marked by intense orogenic and climatic events in the Brazilian Atlantic Forest. Intraspecific analyses indicate strong population structure, a pattern congruent with the general behavior and physiological constraints of Neotropical harvestmen.	[Castro-Pereira, Daniel; Peres, Elen A.; Pinto-da-Rocha, Ricardo] Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil	Universidade de Sao Paulo	Castro-Pereira, D (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Zool, Sao Paulo, Brazil.	daniel.castro.pereira@usp.br	Pereira, Daniel Castro/ADP-7641-2022; Peres, Elen/A-2253-2014	Pereira, Daniel Castro/0000-0003-2955-8166; Peres, Elen/0000-0002-2118-2144	PUB-USP (Programa Unificado de Bolsas de Estudo para Apoio e Formacao de Estudantes de Graduacao da Universidade de Sao Paulo); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2016/13129-0, 2013/50297-0]	PUB-USP (Programa Unificado de Bolsas de Estudo para Apoio e Formacao de Estudantes de Graduacao da Universidade de Sao Paulo); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	DCP received funding from PUB-USP (Programa Unificado de Bolsas de Estudo para Apoio e Formacao de Estudantes de Graduacao da Universidade de Sao Paulo; funder website: https://prg.usp.br/programa-unificado-de-bolsas-deestudo-para-apoio-e-formacao-de-estudantes-de-graduacao-pub-usp/) and from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), process number 2016/13129-0 (funder website: https://fapesp.br/). RPR received funding from FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo), process number 2013/50297-0 (funder website:https://fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA L., 2007, HARVESTMEN BIOL OPIL, P494; ALMEIDA FFMD, 1976, AN ACAD BRAS CIENC, V48, P15; Alvarez-Presas M, 2014, HEREDITY, V112, P656, DOI 10.1038/hdy.2014.3; Amaro RC, 2012, MOL PHYLOGENET EVOL, V62, P880, DOI 10.1016/j.ympev.2011.11.004; [Anonymous], 1945, ARQUIVOS MUSEU PARAN; [Anonymous], 1935, ARCHOS MUS NAC RIO J; [Anonymous], 2011, BIODIVERSITY HOTSPOT, DOI [10.1007/978-3-642-20992-5_21, DOI 10.1007/978-3-642-20992-5_21]; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Batalha H, 2010, APIDOLOGIE, V41, P534, DOI 10.1051/apido/2010001; Benedetti AR, 2019, ZOOTAXA, V4691, P461, DOI 10.11646/zootaxa.4691.5.3; Bragagnolo C, 2007, BIOL CONSERV, V139, P389, DOI 10.1016/j.biocon.2007.07.008; Bragagnolo C, 2015, INVERTEBR SYST, V29, P386, DOI 10.1071/IS15009; Brunes TO, 2010, MOL PHYLOGENET EVOL, V57, P1120, DOI 10.1016/j.ympev.2010.08.026; Buzatto BA, 2014, BEHAV PROCESS, V109, P2, DOI 10.1016/j.beproc.2014.06.008; Buzatto BA, 2014, EVOLUTION, V68, P1671, DOI 10.1111/evo.12395; Buzatto BA, 2011, EVOL ECOL, V25, P331, DOI 10.1007/s10682-010-9431-0; Cabanne GS, 2016, BIOL J LINN SOC, V119, P856, DOI 10.1111/bij.12844; Caetano DS, 2013, CLADISTICS, V29, P589, DOI 10.1111/cla.12009; Chelini MC, 2012, BEHAV ECOL SOCIOBIOL, V66, P1619, DOI 10.1007/s00265-012-1417-1; Chelini MC, 2014, ETHOLOGY, V120, P1147, DOI 10.1111/eth.12286; Chelini MC, 2011, THESIS U SAO PAULO; Corander J, 2004, BIOINFORMATICS, V20, P2363, DOI 10.1093/bioinformatics/bth250; Coronato-Ribeiro A, 2013, ZOOTAXA, V3637, P501, DOI 10.11646/zootaxa.3637.5.1; D'Horta FM, 2011, MOL ECOL, V20, P1923, DOI 10.1111/j.1365-294X.2011.05063.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DaSilva M.B., 2011, BIOGEOGRAFIA AM RICA, P221; DaSilva MB, 2017, CURR ZOOL, V63, P525, DOI 10.1093/cz/zow092; DaSilva MB, 2015, CLADISTICS, V31, P692, DOI 10.1111/cla.12121; DaSilva MB, 2009, INVERTEBR SYST, V23, P530, DOI 10.1071/IS09022; De Azara LN, 2013, ZOOTAXA, V 3736, P69, DOI 10.11646/zootaxa.3736.1.3; de Mello-Leitao, 1935, MEM I BUTANTAN, V9, P369; de Mello-Leitao CF., 1934, MEMORIAS I BUTANTAN, V8, P409; do Amaral FR, 2013, MOL ECOL, V22, P3996, DOI 10.1111/mec.12361; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dunlop J.A., 2007, HARVESTMEN BIOL OPIL, DOI [10.4159/9780674276833-007, DOI 10.4159/9780674276833-007]; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fiaschi P, 2009, J SYST EVOL, V47, P477, DOI 10.1111/j.1759-6831.2009.00046.x; GILTAY LOUIS, 1928, BULL ET ANN SOC ENT BELGIQUE, V68, P79; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon D, 2003, CURR PROTOC BIOINFOR, V2, P43, DOI DOI 10.1002/0471250953.BI1102S02; Grazziotin FG, 2006, MOL ECOL, V15, P3969, DOI 10.1111/j.1365-294X.2006.03057.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kury A.B., 2020, WCO LITE ONLINE WORL; Kury Adriano B., 2003, Revista Iberica de Aracnologia Volumen Especial Monografico, V1, P1; Kury AB, 2016, ZOOTAXA, V4097, P130, DOI 10.11646/zootaxa.4097.1.9; Kury AB, 2015, ZOOL J LINN SOC-LOND, V174, P1, DOI 10.1111/zoj.12225; Kury Adriano B., 1995, Papeis Avulsos de Zoologia (Sao Paulo), V39, P201; Kury AB, 2013, ZOOTAXA, V3703, P27; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Machado G, 2000, J ARACHNOL, V28, P357, DOI 10.1636/0161-8202(2000)028[0357:TUOFBT]2.0.CO;2; Machado G, 2004, SOCIOBIOLOGY, V44, P577; Machado Glauco, 2007, P400; Martins FD, 2011, PRIMATES, V52, P77, DOI 10.1007/s10329-010-0226-2; Mello-Leitao, 1926, Revista do Museu Sao Paulo, V14, P327; Mello-Leitao, 1923, Archivos do Museu Rio de Janeiro, V24, P107; Mello-Leitao C. de., 1936, Boletim do Museu Nacional Rio de Janeiro, V12, P1; Dantas GPM, 2015, J ORNITHOL, V156, P85, DOI 10.1007/s10336-014-1106-0; Menezes RST, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07776-7; Mestre LAM, 2004, J ARACHNOL, V32, P208, DOI 10.1636/M02-61; Meyer CP, 2003, BIOL J LINN SOC, V79, P401, DOI 10.1046/j.1095-8312.2003.00197.x; Mittermeier Russell A., 2004, P1; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Osses F, 2008, J ARACHNOL, V36, P518, DOI 10.1636/St06-48.1; Painting CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16368; Paz A, 2019, HEREDITY, V122, P545, DOI 10.1038/s41437-018-0155-1; Peres EA, 2019, MOL PHYLOGENET EVOL, V138, P1, DOI 10.1016/j.ympev.2019.05.028; Peres EA, 2018, SYST BIODIVERS, V16, P171, DOI 10.1080/14772000.2017.1361479; Pinto-da-Rocha R, 2005, J ARACHNOL, V33, P290, DOI 10.1636/04-114.1; Pinto-da-Rocha R, 2014, CLADISTICS, V30, P519, DOI 10.1111/cla.12065; Pinto-da-Rocha Ricardo, 2002, Arquivos de Zoologia (Sao Paulo), V36, P357; Piza S.de T. Jr., 1943, Papeis Avulsos do Departamento de Zoologia Sao Paulo, V3, P39; Powell EC, 2020, BIOL J LINN SOC, V130, P395, DOI 10.1093/biolinnean/blaa040; Resende LPA, 2012, IHERINGIA SER ZOOL, V102, P99, DOI 10.1590/S0073-47212012000100014; Riccomini C, 2004, GEOLOGIA CONTINENTE, P383; Tonini JFR, 2013, J ZOOL SYST EVOL RES, V51, P114, DOI 10.1111/jzs.12014; Rocha DFO, 2011, J NAT PROD, V74, P658, DOI 10.1021/np100719f; ROEWER C. FR, 1931, ABHANDL NATURWISS VER BREMEN, V28-1, P101; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Soares B. M., 1945, Arquivos zool S Paulo, V4, P341; Soares B. M., 1944, Papeis Avulsos do Departamento de Zoologia Sao Paulo, V4, P277; Soares B. M., 1944, Papeis Avulsos do Departamento de Zoologia Sao Paulo, V4, P243; SOARES H E M, 1984, Revista Brasileira de Entomologia, V28, P301; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suguio K, 2005, QUATERNARIO BRASIL, P114; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; Willemart RH, 2007, ITAL J ZOOL, V74, P39, DOI 10.1080/11250000601090529; Willemart RH, 2009, BEHAV PROCESS, V80, P51, DOI 10.1016/j.beproc.2008.09.006	93	2	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0249746	10.1371/journal.pone.0249746	http://dx.doi.org/10.1371/journal.pone.0249746			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077418	gold, Green Published, Green Submitted			2022-12-26	WOS:000664638500003
J	Fahim, NM; Georgieff, MK; Zhang, L; Naisbitt, S; Rao, RB; Inder, TE				Fahim, Nancy M.; Georgieff, Michael K.; Zhang, Lei; Naisbitt, Scott; Rao, Raghavendra B.; Inder, Terrie E.			Endogenous erythropoietin concentrations and association with retinopathy of prematurity and brain injury in preterm infants	PLOS ONE			English	Article							OXIDATIVE STRESS; RISK; NEUROPROTECTION; PROTEINS; SERUM; TRIAL; IRON; TERM	Background Endogenous erythropoietin (EPO) concentrations vary widely in preterm infants and may be associated with perinatal risk factors and neurological outcomes. Erythropoietin is elevated in fetal hypoxia but is also a potential neuroprotectant. Methods In a prospective study of 27 infants <= 30 weeks gestation, serum erythropoietin concentrations were measured during the first month of life, on day 1 and weeks 1, 2, and 4, and related to perinatal risk factors and outcomes including retinopathy of prematurity and cerebral injury evaluated near term-equivalent post menstrual age using magnetic resonance imaging with quantitative scoring. Results Lower birth weight was associated with higher EPO concentrations throughout the first 2 weeks of life (r = -0.6, p < 0.01). Higher day 1 and week 1 EPO concentrations were associated with lower Apgar score at 1 minute (r = - 0.5) and 5 minutes (r = -0.7), respectively (p < 0.01). Higher day 1 EPO concentrations and 2-week area under the curve were associated with increased risk (p = 0.01) and severity (r = 0.5, p < 0.02) of retinopathy of prematurity. Higher EPO concentrations at 2 weeks were associated with increased total brain injury score (r = 0.5, p < 0.05). Conclusion Elevated endogenous erythropoietin concentrations in the first two weeks of life are associated with lower birth weight and increased risk of adverse outcomes.	[Fahim, Nancy M.; Inder, Terrie E.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Fahim, Nancy M.; Georgieff, Michael K.; Rao, Raghavendra B.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Zhang, Lei] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Inder, Terrie E.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Inder, Terrie E.] Washington Univ, Dept Radiol, St Louis, MO 63110 USA; [Inder, Terrie E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pediat Newborn Med, Boston, MA 02115 USA	Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Washington University (WUSTL); Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fahim, NM (corresponding author), Washington Univ, Dept Pediat, St Louis, MO 63130 USA.; Fahim, NM (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	nfahim@umn.edu		Fahim, Nancy/0000-0002-5282-6694; Rao, Raghavendra/0000-0002-6089-5972	National Institute of Child Health and Human Development [HD057098-01]; National Center for Advancing Translational Sciences [UL1-TR002494]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	TEI (author), NICHD grant HD057098-01, National Institute of Child Health and Human Development, https://www.nichd.nih.gov/-LZ (author) and SL (acknowledged) as members of the CTSI department (Clinical and Transitional Science Institute), NCATS award UL1-TR002494, National Center for Advancing Translational Sciences, https://ncats.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benavides A, 2021, J MATERN-FETAL NEO M, V34, P3292, DOI 10.1080/14767058.2019.1683157; Bierer R, 2006, PEDIATRICS, V118, pE635, DOI 10.1542/peds.2005-3186; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; GEORGIEFF MK, 1992, AM J PHYSIOL, V262, pR485, DOI 10.1152/ajpregu.1992.262.3.R485; Holm M, 2016, ARCH DIS CHILD-FETAL, V101, pF458, DOI 10.1136/archdischild-2015-309127; Inder TE, 1997, J PEDIATR-US, V131, P541, DOI 10.1016/S0022-3476(97)70058-1; Jarjour IT, 2015, PEDIATR NEUROL, V52, P143, DOI 10.1016/j.pediatrneurol.2014.10.027; Juul SE, 2020, NEW ENGL J MED, V382, P233, DOI 10.1056/NEJMoa1907423; Juul SE, 2015, CLIN PERINATOL, V42, P469, DOI 10.1016/j.clp.2015.04.004; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; Kirpalani H, 2006, J PEDIATR-US, V149, P301, DOI 10.1016/j.jpeds.2006.05.011; Korzeniewski SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115083; Kuban KCK, 2017, J PEDIATR-US, V180, P116, DOI 10.1016/j.jpeds.2016.09.054; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Liu J, 2005, STROKE, V36, P1264, DOI 10.1161/01.STR.0000166180.91042.02; Logan JW, 2014, CYTOKINE, V69, P22, DOI 10.1016/j.cyto.2014.04.009; Lust C, 2019, J PERINATOL, V39, P393, DOI 10.1038/s41372-018-0274-9; Nardozza LMM, 2017, ARCH GYNECOL OBSTET, V295, P1061, DOI 10.1007/s00404-017-4341-9; Natalucci G, 2016, JAMA-J AM MED ASSOC, V315, P2079, DOI 10.1001/jama.2016.5504; Neubauer AP, 2010, ANN NEUROL, V67, P657, DOI 10.1002/ana.21977; Nopoulos PC, 2011, ARCH PEDIAT ADOL MED, V165, P443, DOI 10.1001/archpediatrics.2010.269; Ohls RK, 2012, J PEDIATR-US, V160, P790, DOI 10.1016/j.jpeds.2011.10.026; Ohlsson A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004863.pub4; Panfoli I, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00369; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Raffaeli G, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061554; STOCKMAN JA, 1977, NEW ENGL J MED, V296, P647, DOI 10.1056/NEJM197703242961202; Teramo KA, 2018, PEDIATR RES, V84, P807, DOI 10.1038/s41390-018-0054-4; Tsang JKW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174321; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; WIDNESS JA, 1984, AM J OBSTET GYNECOL, V148, P194, DOI 10.1016/S0002-9378(84)80175-1; WIDNESS JA, 1985, BRIT J OBSTET GYNAEC, V92, P326; YAMASHITA H, 1994, AM J PEDIAT HEMATOL, V16, P213	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252655	10.1371/journal.pone.0252655	http://dx.doi.org/10.1371/journal.pone.0252655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077474	Green Published, gold			2022-12-26	WOS:000664638500058
J	Wu, QY; Zhang, Y; An, HY; Sun, W; Wang, RZ; Liu, M; Zhang, KT				Wu, Quanyou; Zhang, Yuan; An, Haiyin; Sun, Wei; Wang, Ruozheng; Liu, Meng; Zhang, Kaitai			The landscape and biological relevance of aberrant alternative splicing events in esophageal squamous cell carcinoma	ONCOGENE			English	Article							GENE; TRANSCRIPTOME; ACCURATE; ISOFORMS; RATIO	Aberrant alternative splicing events (AASEs) are key biological processes for tumorigenesis and the rationale for designing splice-switching oligonucleotides (SSOs). However, the landscape of AASEs in esophageal squamous cell carcinoma (ESCC) remains unclear, which undermines the development of SSOs for ESCC. Here, we profiled AASEs based on 125 pairs of RNA-seq libraries. We identified 14,710 AASEs in ESCC, most of which (92.67%) affected coding genes. The first exon of transcripts was frequently changed in ESCC. We constructed a regulatory network where 74 RNA-binding proteins regulated 2142 AASEs. This network was enriched in apoptotic pathways and various adhesion/junction-related processes. Somatic mutations in ESCC regulating ASEs were mainly through trans-regulatory mode and were enriched in intron regions. Isoform switches of apoptotic genes and binding genes both tended to induce "noncoding transcripts" and "domain loss," disrupting the apoptotic and Hippo signaling pathways. All ESCC samples were grouped into three clusters with different AASEs patterns and the second cluster was identified as "cold tumor," with a low abundance of immune cells, activated immune pathways, and immunomodulators. Our work comprehensively profiled the landscape of AASEs in ESCC, revealed novel AASEs related to tumorigenesis and immune microenvironment, and suggested promising directions for designing SSOs for ESCC.	[Wu, Quanyou; Zhang, Kaitai] Chinese Acad Med Sci, State Key Lab Mol Oncol, Dept Etiol & Carcinogenesis, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China; [Wu, Quanyou; Zhang, Kaitai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Yuan; Sun, Wei; Wang, Ruozheng; Liu, Meng] Xinjiang Med Univ, Key Lab Oncol Xinjiang Uyghur Autonomous Reg, Affiliated Tumor Hosp, Urumqi, Xinjiang, Peoples R China; [An, Haiyin] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Med Oncol, Beijing 101149, Peoples R China; [Wang, Ruozheng; Liu, Meng] Chinese Acad Med Sci, Key Lab Canc Immunotherapy & Radiotherapy, Urumqi 830011, Xinjiang, Peoples R China; [Wang, Ruozheng; Liu, Meng] Xinjiang Med Univ, State Key Lab Pathogenesis Prevent & Treatment Hi, Urumqi 830011, Xinjiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Xinjiang Medical University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Xinjiang Medical University	Zhang, KT (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Dept Etiol & Carcinogenesis, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China.; Zhang, KT (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.; Liu, M (corresponding author), Xinjiang Med Univ, Key Lab Oncol Xinjiang Uyghur Autonomous Reg, Affiliated Tumor Hosp, Urumqi, Xinjiang, Peoples R China.; Liu, M (corresponding author), Chinese Acad Med Sci, Key Lab Canc Immunotherapy & Radiotherapy, Urumqi 830011, Xinjiang, Peoples R China.; Liu, M (corresponding author), Xinjiang Med Univ, State Key Lab Pathogenesis Prevent & Treatment Hi, Urumqi 830011, Xinjiang, Peoples R China.	liuxiaomeng198154@163.com; zhangkt@cicams.ac.cn		Wu, Quanyou/0000-0002-3180-8606	Research Fund of Key Laboratory of Xinjiang oncology [2017D04006]	Research Fund of Key Laboratory of Xinjiang oncology	This research was supported by the Research Fund of Key Laboratory of Xinjiang oncology (Grant no. 2017D04006). Funders only provided funding and had no role in the study design, data collection, data analysis, interpretation, and writing of the report. The authors thank Dr Wen Zhang (Department of Immunology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China) for providing technical assistance.	Aigner P, 2019, BLOOD ADV, V3, P1989, DOI 10.1182/bloodadvances.2018026385; Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BECHT E, 2016, GENOME BIOL, V17; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Bonnal SC, 2020, NAT REV CLIN ONCOL, V17, P457, DOI 10.1038/s41571-020-0350-x; Brandt AC, 2020, P NATL ACAD SCI USA, V117, P3627, DOI 10.1073/pnas.1914153117; Chabot B, 2016, J CELL BIOL, V212, P13, DOI 10.1083/jcb.201510032; Crooke ST, 2018, CELL METAB, V27, P714, DOI 10.1016/j.cmet.2018.03.004; Desterro J, 2020, NAT REV DRUG DISCOV, V19, P112, DOI 10.1038/s41573-019-0042-3; FINOTELLO F, 2019, GENOME MED, V11; Frankiw L, 2019, NAT REV IMMUNOL, V19, P675, DOI 10.1038/s41577-019-0195-7; Garrido-Martin D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20578-2; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Halloy F, 2020, NUCLEIC ACIDS RES, V48, P4658, DOI 10.1093/nar/gkaa229; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Kang YJ, 2017, NUCLEIC ACIDS RES, V45, pW12, DOI 10.1093/nar/gkx428; Khorkova O, 2017, NAT BIOTECHNOL, V35, P249, DOI 10.1038/nbt.3784; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Klausen MS, 2019, PROTEINS, V87, P520, DOI 10.1002/prot.25674; Lagergren J, 2017, LANCET, V390, P2383, DOI 10.1016/S0140-6736(17)31462-9; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li L, 2020, BRIT J CANCER, V123, P1024, DOI 10.1038/s41416-020-0951-2; Li SL, 2019, HEPATOLOGY, V69, P359, DOI 10.1002/hep.30158; Liu M, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102831; Liu YE, 2019, PATHOL RES PRACT, V215, P272, DOI 10.1016/j.prp.2018.10.036; Lucena-Araujo AR, 2015, BLOOD, V126, P2302, DOI 10.1182/blood-2015-01-623330; Mao SS, 2019, CARCINOGENESIS, V40, P121, DOI 10.1093/carcin/bgy123; Marti, 2019, TAPPAS COMPREHENSIVE, DOI 10.1101/690743; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Michaels WE, 2020, NUCLEIC ACIDS RES, V48, P7454, DOI 10.1093/nar/gkaa490; Mogilevsky M, 2018, NUCLEIC ACIDS RES, V46, P11396, DOI 10.1093/nar/gky921; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Peterson RE, 2005, DEV DYNAM, V233, P811, DOI 10.1002/dvdy.20412; Racle J, 2017, ELIFE, V6, DOI 10.7554/eLife.26476; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Ryan M, 2016, NUCLEIC ACIDS RES, V44, pD1018, DOI 10.1093/nar/gkv1288; Ryan MC, 2012, BIOINFORMATICS, V28, P2385, DOI 10.1093/bioinformatics/bts452; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soliman MA, 2008, AGING CELL, V7, P783, DOI 10.1111/j.1474-9726.2008.00427.x; Sturm G, 2019, BIOINFORMATICS, V35, pI436, DOI 10.1093/bioinformatics/btz363; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Trincado JL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1417-1; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Vanharanta S, 2014, ELIFE, V3, DOI 10.7554/eLife.02734; Vitting-Seerup K, 2019, BIOINFORMATICS, V35, P4469, DOI 10.1093/bioinformatics/btz247; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang LY, 2020, NUCLEIC ACIDS RES, V48, P5065, DOI 10.1093/nar/gkaa194; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Xie ZC, 2019, AM J TRANSL RES, V11, P4010; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	60	5	5	1	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4184	4197		10.1038/s41388-021-01849-8	http://dx.doi.org/10.1038/s41388-021-01849-8		JUN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34079089				2022-12-26	WOS:000657217400005
J	Caini, S; Paget, J; Spreeuwenberg, P; Korevaar, JC; Meijer, A; Hooiveld, M				Caini, Saverio; Paget, John; Spreeuwenberg, Peter; Korevaar, Joke C.; Meijer, Adam; Hooiveld, Mariette			Impact of influenza vaccination in the Netherlands, 2007-2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees	PLOS ONE			English	Article							TEST-NEGATIVE DESIGN; OLDER-ADULTS; METAANALYSIS; ILLNESS	Introduction We aimed to develop an innovative population-based method to estimate the health effect of influenza vaccination based on electronic medical records collected within a general practitioner (GP)-based influenza surveillance system in the Netherlands. Methods In each season between 2006/07 and 2015/16, we fitted multilevel Poisson regression models to compare GP consultation rates for clinically diagnosed influenza, acute respiratory infections (ARI), pneumonia, and lower back pain (as a control) between vaccinated vs. unvaccinated individuals. Season-specific relative risks and 95% confidence intervals (CI) were pooled into summary risk ratio (SRR) through random-effects meta-analysis models. Analyses were stratified by patient age (<45, 45-59, 60-74, <greater than or equal to>75 years) and medical indication for the vaccine (any vs. none, subjects aged <= 60 years only). Results Overall, 12.6% and 21.4% of study subjects were vaccinated because of their age only or because of an underlying medical condition. Vaccine uptake declined over time, especially among subjects aged <= 74 years with medical indications for vaccination. Vaccinated individuals had significantly higher GP consultation rates for clinically diagnosed influenza (SRR 1.24, 95% CI 1.12-1.38, p-value <0.001), ARI (SRR 1.33, 95% CI 1.27-1.39, p-value <0.001), pneumonia (SRR 1.27, 95% CI 1.19-1.36, p-value <0.001), and lower back pain (SRR 1.21, 95% CI 1.14-1.28, p-value <0.001) compared to unvaccinated individuals. Discussion Contrary to expectations, influenza vaccinees have GP consultation rates for clinically diagnosed influenza, ARI and pneumonia that are 24-33% higher compared to unvaccinated individuals. The lower back pain finding suggests that the increase in consultation rates is partially caused by confounding. Importantly, considering the data are not laboratory-confirmed, our results cannot be linked directly to influenza, but only to respiratory illnesses in general.	[Caini, Saverio; Paget, John; Spreeuwenberg, Peter; Korevaar, Joke C.; Hooiveld, Mariette] Nivel Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Meijer, Adam] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands	Netherlands Institute for Health Services Research; Netherlands National Institute for Public Health & the Environment	Hooiveld, M (corresponding author), Nivel Netherlands Inst Hlth Serv Res, Utrecht, Netherlands.	m.hooiveld@nivel.nl		Hooiveld, Mariette/0000-0002-5513-1740				Andrew MK, 2017, J INFECT DIS, V216, P405, DOI 10.1093/infdis/jix282; Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Cowling BJ, 2012, CLIN INFECT DIS, V54, P1778, DOI 10.1093/cid/cis307; Darvishian M, 2017, LANCET RESP MED, V5, P200, DOI 10.1016/S2213-2600(17)30043-7; Darvishian Maryam, 2017, PLoS One, V12, pe0169528, DOI 10.1371/journal.pone.0169528; de Hoog MLA, 2020, VACCINE, V38, P3397, DOI 10.1016/j.vaccine.2019.11.086; de Jong JC., 2016, NEDERLANDS TIJDSCHRI, V24, P181; de Jong JC., 2015, NEDERLANDS TIJDSCHRI, V23, P150; De Serres G, 2013, Euro Surveill, V18; Edmunds M, 2019, ESCAIDE EUR SCI C AP; European Centre for Disease Prevention and Control (ECDC), RISK GROUPS SEV INFL; Fukushima W, 2017, VACCINE, V35, P4796, DOI 10.1016/j.vaccine.2017.07.003; Health Council of the Netherlands, 2007, PUBLICATIONS, V0709; Heins M., 2019, WAAROM HALEN ZO WEIN; Heins M., 2019, MONITOR VACCINATIEGR; Hekimoglu CH, 2018, BALK MED J, V35, P77, DOI 10.4274/balkanmedj.2017.0487; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kalkowska DA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200813; Kissling E, 2019, EUROSURVEILLANCE, V24, P31, DOI 10.2807/1560-7917.ES.2019.24.48.1900604; Lamberts H., 1987, ICPC INT CLASSIFICAT; Lewnard JA, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6020028; Ramsay LC, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1239-8; Restivo V, 2018, HUM VACC IMMUNOTHER, V14, P724, DOI 10.1080/21645515.2017.1321722; Rikin S, 2018, VACCINE, V36, P1958, DOI 10.1016/j.vaccine.2018.02.105; Rondy M, 2017, J INFECTION, V75, P381, DOI 10.1016/j.jinf.2017.09.010; Russell K, 2018, VACCINE, V36, P1272, DOI 10.1016/j.vaccine.2018.01.045; Spronk I, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6820-3; Thompson MG, 2019, CLIN INFECT DIS, V68, P1444, DOI 10.1093/cid/ciy737; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Troeger CE, 2019, LANCET RESP MED, V7, P69, DOI [10.1016/S2213-2600(18)30496-X, 10.1016/s2213-2600(18)30496-x]; van Beek J, 2017, J INFECT DIS, V216, P415, DOI 10.1093/infdis/jix268; van der Star BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195305; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; WHO Collaborating Centre for Drug Statistics Methodology, 2009, GUIDELINES ATC CLASS; World Health Organization, REG OFF EUR INFL VAC; World Health Organization, SEAS VACC POL COV EU	36	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0249883	10.1371/journal.pone.0249883	http://dx.doi.org/10.1371/journal.pone.0249883			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048429	Green Published, gold			2022-12-26	WOS:000664636100006
J	Chisenga, CC; Bosomprah, S; Simuyandi, M; Mwila-Kazimbaya, K; Chilyabanyama, ON; Laban, NM; Bialik, A; Asato, V; Meron-Sudai, S; Frankel, G; Cohen, D; Chilengi, R				Chisenga, Caroline C.; Bosomprah, Samuel; Simuyandi, Michelo; Mwila-Kazimbaya, Katayi; Chilyabanyama, Obvious N.; Laban, Natasha M.; Bialik, Anya; Asato, Valeria; Meron-Sudai, Shiri; Frankel, Gad; Cohen, Daniel; Chilengi, Roma			Shigella-specific antibodies in the first year of life among Zambian infants: A longitudinal cohort study	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE O-ANTIGEN; GLOBAL ENTERIC MULTICENTER; DEVELOPING-COUNTRIES; SERUM ANTIBODIES; VACCINE; CHILDREN; IMMUNITY; POLYSACCHARIDE; SALMONELLA; ETIOLOGY	Introduction Shigellosis, is a leading cause of moderate-to-severe diarrhoea and related mortality in young children in low and middle income countries (LMICs). Knowledge on naturally acquired immunity can support the development of Shigella candidate vaccines mostly needed in LMICs. We aimed to quantify Shigella-specific antibodies of maternal origin and those naturally acquired in Zambian infants. Methods Plasma samples collected from infants at age 6, 14 and 52-weeks were tested for Shigella (S. sonnei and S. flexneri 2a) lipopolysaccharide (LPS) antigen specific immunoglobulin G (IgG) and A (IgA) by enzyme-linked immunosorbent assay. Results At 6 weeks infant age, the IgG geometric mean titres (GMT) against S. sonnei (N = 159) and S. flexneri 2a (N = 135) LPS were 311 (95% CI 259-372) and 446 (95% CI 343-580) respectively. By 14 weeks, a decline in IgG GMT was observed for both S. sonnei to 104 (95% CI 88-124), and S. flexneri 2a to 183 (95% CI 147-230). Both S. sonnei and S. flexneri 2a specific IgG GMT continued to decrease by 52 weeks infant age when compared to 6 weeks. In 27% and 8% of infants a significant rise in titre (4 fold and greater) against S. flexneri 2a and S. sonnei LPS, respectively, was detected between the ages of 14 and 52 weeks. IgA levels against both species LPS were very low at 6 and 14 weeks and raised significantly against S. flexneri 2a and S. sonnei LPS in 29% and 10% of the infants, respectively. Conclusion In our setting, transplacental IgG anti-Shigella LPS is present at high levels in early infancy, and begins to decrease by age 14 weeks. Our results are consistent with early exposure to Shigella and indicate naturally acquired IgG and IgA antibodies to S. flexneri 2a and S. sonnei LPS in part of infants between 14 and 52 weeks of age. These results suggest that a potential timing of vaccination would be after 14 and before 52 weeks of age to ensure early infant protection against shigellosis.	[Chisenga, Caroline C.; Bosomprah, Samuel; Simuyandi, Michelo; Mwila-Kazimbaya, Katayi; Chilyabanyama, Obvious N.; Laban, Natasha M.; Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana; [Bialik, Anya; Asato, Valeria; Meron-Sudai, Shiri; Cohen, Daniel] Tel Aviv Univ, Sackler Fac Med, Sch Publ Hlth, Tel Aviv, Israel; [Frankel, Gad] Imperial Coll London, London, England	University of Ghana; Tel Aviv University; Sackler Faculty of Medicine; Imperial College London	Chisenga, CC (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	Caroline.Chisenga@cidrz.org	Simuyandi, Michelo/I-5598-2018	Simuyandi, Michelo/0000-0002-7348-2835; Cohen, Daniel/0000-0003-2664-2303; chisenga, caroline/0000-0002-7850-7915	GCRF Networks in Vaccines Research and Development - MRC; BBSRC; BactiVac grant [BVNC P-04]; National Institutes for Health (NIH), USA [1R01AI099601]	GCRF Networks in Vaccines Research and Development - MRC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BactiVac grant; National Institutes for Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the GCRF Networks in Vaccines Research and Development which was co-funded by the MRC and BBSRC. BactiVac grant #BVNC P-04. The original cohort study was funded by the National Institutes for Health (NIH), USA, through an R01 grant 1R01AI099601.	Chilengi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150100; Chisenga CC, 2018, PEDIAT INFECT DIS, V03, P1, DOI DOI 10.21767/2573-0282.100064; Chiyangi H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2232-0; COHEN D, 1989, J CLIN MICROBIOL, V27, P162, DOI 10.1128/JCM.27.1.162-167.1989; COHEN D, 1988, J INFECT DIS, V157, P1068, DOI 10.1093/infdis/157.5.1068; COHEN D, 1991, J CLIN MICROBIOL, V29, P386, DOI 10.1128/JCM.29.2.386-389.1991; Cohen D, 1997, LANCET, V349, P155, DOI 10.1016/S0140-6736(96)06255-1; Cohen D, 2014, EPIDEMIOL INFECT, V142, P2583, DOI 10.1017/S0950268814000260; Cohen D, 2021, LANCET INFECT DIS, V21, P546, DOI 10.1016/S1473-3099(20)30488-6; Cohen D, 2019, HUM VACC IMMUNOTHER, V15, P1205, DOI 10.1080/21645515.2019.1611200; CostaCarvalho BT, 1996, BRAZ J MED BIOL RES, V29, P201; Darton TC, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01748-17; de Alwis R, 2019, J INFECT DIS, V219, P295, DOI 10.1093/infdis/jiy501; FERRECCIO C, 1991, AM J EPIDEMIOL, V134, P614, DOI 10.1093/oxfordjournals.aje.a116134; Franca EL, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/928187; Gerke C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134478; Goncalves G, 1999, EPIDEMIOL INFECT, V122, P273, DOI 10.1017/S0950268899002046; Greenland K, 2016, LANCET GLOB HEALTH, V4, pE966, DOI 10.1016/s2214-109x(16)30262-5; The HC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002055; Kotloff KL, 2017, VACCINE, V35, P6783, DOI 10.1016/j.vaccine.2017.07.036; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; LERMAN Y, 1994, J CLIN MICROBIOL, V32, P1092, DOI 10.1128/JCM.32.4.1092-1094.1994; Levine MM, 2020, LANCET GLOB HEALTH, V8, pE204, DOI 10.1016/S2214-109X(19)30541-8; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; Mani S, 2016, VACCINE, V34, P2887, DOI 10.1016/j.vaccine.2016.02.075; MANTYJARVI R, 1970, IMMUNOLOGY, V18, P449; Nyirenda TS, 2014, J INFECT DIS, V210, P56, DOI 10.1093/infdis/jiu045; Obiero CW, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01884; PASSWELL JH, 1995, PEDIATR INFECT DIS J, V14, P859, DOI 10.1097/00006454-199510000-00008; Passwell JH, 2010, VACCINE, V28, P2231, DOI 10.1016/j.vaccine.2009.12.050; Riddle MS, 2016, CLIN VACCINE IMMUNOL, V23, P908, DOI 10.1128/CVI.00224-16; ROBBINS JB, 1992, CLIN INFECT DIS, V15, P346, DOI 10.1093/clinids/15.2.346; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Talaat Kawsar R., 2017, 9 INT C VACC ENT DIS; Thompson CN, 2016, VACCINE, V34, P783, DOI 10.1016/j.vaccine.2015.12.047; Thompson CN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003708; Vilajeliu A, 2015, VACCINE, V33, P1056, DOI 10.1016/j.vaccine.2014.12.062; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Voysey M, 2017, JAMA PEDIATR, V171, P637, DOI 10.1001/jamapediatrics.2017.0638; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252222	10.1371/journal.pone.0252222	http://dx.doi.org/10.1371/journal.pone.0252222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043697	Green Published, gold			2022-12-26	WOS:000664635700072
J	Kim, J; Kim, JH; Lee, HS; Suh, SH; Lee, KY				Kim, Jinkwon; Kim, Jang Hoon; Lee, Hye Sun; Suh, Sang Hyun; Lee, Kyung-Yul			Association between longitudinal blood pressure and prognosis after treatment of cerebral aneurysm: A nationwide population-based cohort study	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; ARTERIAL-HYPERTENSION; RISK-FACTORS; J-CURVE; RUPTURE; STROKE; GUIDELINES; MANAGEMENT	Background High blood pressure is a major risk factor for the development and rupture of cerebral aneurysm. Endovascular coil embolization and surgical clipping are established procedures to treat cerebral aneurysm. However, longitudinal data of blood pressure after the treatment of cerebral aneurysm and its impact on long-term prognosis are not well known. Methods This retrospective cohort study included 1275 patients who underwent endovascular coil embolization (n = 558) or surgical clipping (n = 717) of cerebral aneurysm in 2002-2015 using the nationwide health screening database of Korea. Systolic and diastolic blood pressure of patients were repeatedly obtained from the nationwide health screening program. We performed a multivariate time-dependent Cox regression analysis of the primary composite outcome of stroke, myocardial infarction, and all-cause death. Results During the mean follow-up period of 6.13 3.41 years, 89 patients suffered the primary outcome. Among the total 3546 times of blood pressure measurement, uncontrolled high blood pressure (systolic >= 140 mmHg or diastolic >= 90 mmHg) was 22.9%. There was a significantly increased risk of primary outcome with high systolic (adjusted HR [95% CI] per 10 mmHg, 1.16 [1.01-1.35]) and diastolic (adjusted HR [95% CI] per 10 mmHg, 1.32 [1.06-1.64]) blood pressure. Conclusions High blood pressure is prevalent even in patients who received treatment for cerebral aneurysm, which is significantly associated with poor outcome. Strict control of high blood pressure may further improve the prognosis of patients with cerebral aneurysm.	[Kim, Jinkwon; Lee, Kyung-Yul] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Jinkwon] CHA Bundang Med Ctr, Dept Neurol, Seoul, South Korea; [Kim, Jang Hoon] Yonsei Univ, Coll Med, Dept Neurosurgery, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Biostatist Collaborat Unit, Seoul, South Korea; [Suh, Sang Hyun] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, KY (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.; Suh, SH (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiol, Seoul, South Korea.	suhsh11@yuhs.ac; kylee@yuhs.ac	Kim, Jinkwon/AAR-6729-2021; Lee, Hye Sun/J-2154-2015; Suh, Sang Hyun/M-5515-2015	Kim, Jinkwon/0000-0003-0156-9736; Lee, Kyung-Yul/0000-0001-5585-7739; Lee, Hye Sun/0000-0001-6328-6948; Suh, Sang Hyun/0000-0002-7098-4901	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2017R1D1A1B03033382, NRF2020R1I1A1A01060447]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.re.kr/eng/index) funded by the Ministry of Education (NRF-2017R1D1A1B03033382 to JK, NRF2020R1I1A1A01060447 to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study used the dataset of NHIS-HEALS (NHIS-2018-2-236) created by the National Health Insurance Sharing Service.	[Anonymous], EUR HEART J, DOI DOI 10.1093/EURHEARTJ/EHY339; Biffi A, 2015, JAMA-J AM MED ASSOC, V314, P904, DOI 10.1001/jama.2015.10082; Bohm M, 2017, LANCET, V389, P2226, DOI 10.1016/S0140-6736(17)30754-7; Chalouhi N, 2013, STROKE, V44, P3613, DOI 10.1161/STROKEAHA.113.002390; De Marchis GM, 2014, J NEUROL NEUROSUR PS, V85, P56, DOI 10.1136/jnnp-2013-305051; Etminan N, 2016, NAT REV NEUROL, V12, P699, DOI 10.1038/nrneurol.2016.150; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Fryar Cheryl D, 2017, NCHS Data Brief, P1; Fukuda S, 2000, CIRCULATION, V101, P2532, DOI 10.1161/01.CIR.101.21.2532; Ha KH, 2018, DIABETES METAB J, V42, P402, DOI 10.4093/dmj.2018.0014; Hasan DM, 2015, HYPERTENSION, V66, P324, DOI 10.1161/HYPERTENSIONAHA.115.05500; Inci S, 2000, SURG NEUROL, V53, P530, DOI 10.1016/S0090-3019(00)00244-5; Jeong Hae Woong, 2014, Neurointervention, V9, P63, DOI 10.5469/neuroint.2014.9.2.63; Jin DS, 2007, SURG NEUROL, V68, P11, DOI 10.1016/j.sumeu.2007.02.060; Juvela S, 2013, STROKE, V44, P2414, DOI 10.1161/STROKEAHA.113.001838; Kalkman DN, 2017, CIRCULATION, V136, P2220, DOI 10.1161/CIRCULATIONAHA.117.030342; Kim J, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0799-4; Kim J, 2018, HYPERTENSION, V72, P391, DOI 10.1161/HYPERTENSIONAHA.118.11139; Kim J, 2017, STROKE, V48, P2723, DOI 10.1161/STROKEAHA.117.018140; Kimm H, 2018, KOREAN CIRC J, V48, P36, DOI 10.4070/kcj.2017.0036; Kimm H, 2012, KOREAN CIRC J, V42, P10, DOI 10.4070/kcj.2012.42.1.10; Koyanagi M, 2018, J NEUROSURG, V129, P1492, DOI 10.3171/2017.6.JNS17174; Lee CJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007102; Lee Seung Won, 2017, Clin Hypertens, V23, P23, DOI 10.1186/s40885-017-0075-z; Lip S, 2019, HYPERTENSION, V74, P767, DOI 10.1161/HYPERTENSIONAHA.119.12787; Mayer TE, 2016, NEUROLOGY, V86, P792, DOI 10.1212/01.wnl.0000481228.68055.71; Mitsui K, 2020, HYPERTENSION, V75, P468, DOI 10.1161/HYPERTENSIONAHA.118.12595; Onal IK, 2009, EUR J INTERN MED, V20, P369, DOI 10.1016/j.ejim.2008.10.003; OSTERGAARD JR, 1985, J NEUROSURG, V63, P49, DOI 10.3171/jns.1985.63.1.0049; Park JK, 2000, KOREAN J PREV MED, V33, P76, DOI DOI 10.1161/01.STR.0000078562.82918.F6; Park TH, 2016, J CLIN NEUROL, V12, P42, DOI 10.3988/jcn.2016.12.1.42; Sandvei MS, 2009, STROKE, V40, P1958, DOI 10.1161/STROKEAHA.108.539544; Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640; Song TJ, 2020, J NEUROSURG, V133, P182, DOI 10.3171/2019.3.JNS183500; Spence JD, 2018, STROKE VASC NEUROL, V3, P69, DOI 10.1136/svn-2017-000138; Steiner T, 2013, CEREBROVASC DIS, V35, P93, DOI 10.1159/000346087; Tada Y, 2014, STROKE, V45, P579, DOI 10.1161/STROKEAHA.113.003072; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070; Walraven I, 2015, J HYPERTENS, V33, P2091, DOI 10.1097/HJH.0000000000000680; Wang YB, 2013, AFR HEALTH SCI, V13, P579, DOI 10.4314/ahs.v13i3.8; Wermer MJH, 2005, BRAIN, V128, P2421, DOI 10.1093/brain/awh587; Whelton PK, 2018, CIRCULATION, V138, pE484, DOI 10.1161/CIR.0000000000000596; Yi SW, 2016, CIRCULATION, V133, P2381, DOI 10.1161/CIRCULATIONAHA.115.020752; Yoon SS, 2015, HYPERTENSION, V65, P54, DOI 10.1161/HYPERTENSIONAHA.114.04012	45	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252042	10.1371/journal.pone.0252042	http://dx.doi.org/10.1371/journal.pone.0252042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043701	Green Published, gold			2022-12-26	WOS:000664635700047
J	Barsoe, S; Ullman, K; Leijon, M; Hedlund, KO; Klingstrom, J; Krarup, LI; Andresen, L; Quaade, ML; Hammer, AS				Barsoe, Sofie; Ullman, Karin; Leijon, Mikael; Hedlund, Kjell Olof; Klingstrom, Jonas; Krarup, Louise Iuel; Andresen, Lars; Quaade, Michelle Lauge; Hammer, Anne Sofie			RT-qPCR assay for detection of mink astrovirus in outbreaks of diarrhea on Danish mink farms	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; VIRUS; ENTERITIS; INFECTION; ROTAVIRUS; MORTALITY; DISEASE; PCR	Diarrhea in mink kits is a major cause of disease and mortality in the mink production. The etiology remains unknown in most outbreaks due to a lack of diagnostic assays. In the current study we present an RT-qPCR method to detect mink astrovirus in fecal samples from mink kits with diarrhea. All sampled animals were classified based on age and patoanatomical evaluation as having pre-weaning diarrhea, diarrhea in the growth period or as having no macroscopic signs of diarrhea. Fecal samples were analyzed for MiAstV with RT-qPCR, next generation sequencing and electron microscopy in parallel. Mink astrovirus was detected with RT-qPCR in 92 out of 203 samples. This detection was confirmed by next generation sequencing in a high proportion of samples (22/27), and by visualization of astrovirus particles with EM in some of the samples. Mink astrovirus was highly prevalent (68%) among kits in the outbreaks of pre-weaning diarrhea, in particular outbreaks from May, while less prevalent in outbreaks in June. Mink astrovirus was detected in outbreaks of diarrhea in the growth period, though in a much lesser extent than in the pre-weaning period. The role of mink astrovirus in the diarrhea disease complex of mink remain to be investigated, and for that purpose this sensitive and robust RT-qPCR can be a valuable tool in the future.	[Barsoe, Sofie; Krarup, Louise Iuel; Andresen, Lars; Quaade, Michelle Lauge; Hammer, Anne Sofie] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg C, Denmark; [Ullman, Karin; Leijon, Mikael] Natl Vet Inst, Dept Microbiol, Uppsala, Sweden; [Hedlund, Kjell Olof] Publ Hlth Agcy Sweden, Solna, Sweden; [Klingstrom, Jonas] Karolinska Inst, Karolinska Univ Hosp, Dept Med Huddinge, Ctr Infect Med, Stockholm, Sweden	University of Copenhagen; National Veterinary Institute SVA; Public Health Agency of Sweden; Karolinska Institutet; Karolinska University Hospital	Hammer, AS (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg C, Denmark.	hammer@sund.ku.dk	Ullman, Karin/HGB-8576-2022	Leijon, Mikael/0000-0001-8701-9887; Barsoe, Sofie/0000-0003-0768-8859; Andresen, Lars/0000-0002-6362-7973	Pelsdyrafgiftsfonden	Pelsdyrafgiftsfonden	The research was supported by Pelsdyrafgiftsfonden, administered by the Danish Fur breeders Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205890; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Clausen T, 2004, P 8 INT SCI C AN PRO; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Englund L, 2002, VET MICROBIOL, V85, P1, DOI 10.1016/S0378-1135(01)00472-2; GORHAM JR, 1990, CAN J VET RES, V54, P383; Guo M, 2001, ARCH VIROL, V146, P479, DOI 10.1007/s007050170157; HAVE P, 1992, VET MICROBIOL, V31, P1, DOI 10.1016/0378-1135(92)90135-G; Jensen TH, 2011, J VIROL METHODS, V171, P81, DOI 10.1016/j.jviromet.2010.10.004; Johansson O, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00645; Jorgensen M, 1996, ACTA VET SCAND, V37, P163; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LARSEN AE, 1975, VET MED SM ANIM CLIN, V70, P291; Maes RK, 2003, J CLIN MICROBIOL, V41, P290, DOI 10.1128/JCM.41.1.290-294.2003; Mittelholzer C, 2003, J CLIN MICROBIOL, V41, P5192, DOI 10.1128/JCM.41.11.5192-5194.2003; Mittelholzer C, 2003, J GEN VIROL, V84, P3087, DOI 10.1099/vir.0.19267-0; Moser LA, 2005, VIRAL IMMUNOL, V18, P4, DOI 10.1089/vim.2005.18.4; Rattenborg E, 1999, ACTA VET SCAND, V40, P307; REYNOLDS HA, 1970, CAN J COMPARAT MED, V34, P155; Slovis NM, 2014, EQUINE VET J, V46, P311, DOI 10.1111/evj.12119; Soltan MA, 2016, J VIROL METHODS, V235, P99, DOI 10.1016/j.jviromet.2016.05.006; UTTENTHAL A, 1990, J VIROL, V64, P2768, DOI 10.1128/JVI.64.6.2768-2779.1990; Vlasova AN, 2011, J GEN VIROL, V92, P1369, DOI 10.1099/vir.0.025353-0; Wilson DJ, 2015, J VET DIAGN INVEST, V27, P470, DOI 10.1177/1040638715586438; Zhao JJ, 2010, VET MICROBIOL, V140, P34, DOI 10.1016/j.vetmic.2009.07.010	25	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252022	10.1371/journal.pone.0252022	http://dx.doi.org/10.1371/journal.pone.0252022			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038467	Green Published, gold			2022-12-26	WOS:000664633500038
J	Mazzanti, S; Brescini, L; Morroni, G; Orsetti, E; Pocognoli, A; Donati, A; Cerutti, E; Munch, C; Montalti, R; Barchiesi, F				Mazzanti, Sara; Brescini, Lucia; Morroni, Gianluca; Orsetti, Elena; Pocognoli, Antonella; Donati, Abele; Cerutti, Elisabetta; Munch, Christopher; Montalti, Roberto; Barchiesi, Francesco			Candidemia in intensive care units over nine years at a large Italian university hospital: Comparison with other wards	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; CLINICAL-PRACTICE GUIDELINES; CRITICALLY-ILL PATIENTS; INVASIVE CANDIDIASIS; 2009 UPDATE; EPIDEMIOLOGY; MANAGEMENT; SURVEILLANCE; MORTALITY; ECHINOCANDIN	Purpose Candidemia is an alarming problem in critically ill patients including those admitted in intensive care units (ICUs). We aimed to describe the clinical and microbiological characteristics of bloodstream infections (BSIs) due to Candida spp. in patients admitted to ICUs of an italian tertiary referral university hospital over nine years. Methods A retrospective observational study of all cases of candidemia in adult patients was carried out from January 1, 2010 to December 31, 2018 at a 980-bedded University Hospital in Ancona, Italy, counting five ICUs. The incidence, demographics, clinical and microbiologic characteristics, therapeutic approaches and outcomes of ICU-patients with candidemia were collected. Non-ICU patients with candidemia hospitalized during the same time period were considered for comparison purposes. Early (7 days from the occurrence of the episode of Candida BSI) and late (30 days) mortality rates were calculated. Results During the study period, 188/505 (36%) episodes of candidemia occurred in ICU patients. Cumulative incidence was 9.9/1000 ICU admission and it showed to be stable over time. Candida albicans accounted for 52% of the cases, followed by C. parapsilosis (24%), and C. glabrata (14%). There was not a significant difference in species distribution between ICU and non-ICU patients. With the exception of isolates of C. tropicalis which showed to be fluconazole resistant in 25% of the cases, resistance to antifungals was not of concern in our patients. Early and late mortality rates, were 19% and 41% respectively, the latter being significantly higher than that observed in non-ICU patients. At multivariate analysis, factors associated with increased risk of death were septic shock, acute kidney failure, pulmonary embolism and lack of antifungal therapy. The type of antifungal therapy did not influence the outcome. Mortality did not increased significantly over time. Conclusion Neither cumulative incidence nor crude mortality of candidemia in ICU patients increased over time at our institution. However, mortality rate remained high and significantly associated with specific host-related factors in the majority of cases.	[Mazzanti, Sara; Brescini, Lucia; Morroni, Gianluca; Donati, Abele; Barchiesi, Francesco] Univ Politecn Marche, Dipartimento Sci Biomed & Sanita Pubbl, Azienda Osped Univ Osped Riuniti Umberto I Lancis, Ancona, Italy; [Mazzanti, Sara; Brescini, Lucia] Azienda Osped Univ Osped Riuniti Umberto I Lancis, Clin Malattie Infett, Ancona, Italy; [Orsetti, Elena] Osped Murri, Malattie Infett, Fermo, Italy; [Pocognoli, Antonella] Azienda Osped Univ Osped Riuniti Umberto I Lancis, Lab Microbiol, Ancona, Italy; [Donati, Abele] Azienda Osped Univ Osped Riuniti Umberto I Lancis, Clin Anestesia & Rianimaz, Ancona, Italy; [Cerutti, Elisabetta] Azienda Osped Univ Osped Riuniti Umberto I Lancis, Anestesia & Rianimaz, Ancona, Italy; [Munch, Christopher] Azienda Osped Univ Osped Riuniti Umberto I Lancis, Anestesia & Rianimaz Cardiochirurg, Ancona, Italy; [Montalti, Roberto] Univ Federico II, Unita Chirurg Epatobiliopancreat Mininvas & Robot, Dipartimento Sanita Pubbl, Naples, Italy; [Barchiesi, Francesco] Azienda Osped Osped Riuniti Marche Nord, Malattie Infett, Pesaro, Italy	Marche Polytechnic University; University of Naples Federico II	Barchiesi, F (corresponding author), Univ Politecn Marche, Dipartimento Sci Biomed & Sanita Pubbl, Azienda Osped Univ Osped Riuniti Umberto I Lancis, Ancona, Italy.; Barchiesi, F (corresponding author), Azienda Osped Osped Riuniti Marche Nord, Malattie Infett, Pesaro, Italy.	f.barchiesi@univpm.it		Morroni, Gianluca/0000-0003-0772-0214; BRESCINI, LUCIA/0000-0003-4533-3004; Montalti, Roberto/0000-0002-3915-3851; Munch, Christopher/0000-0001-7766-5957				Andes DR, 2012, CLIN INFECT DIS, V54, P1110, DOI 10.1093/cid/cis021; Arendrup MC, 2013, CLIN MICROBIOL INFEC, V19, pE343, DOI 10.1111/1469-0691.12212; Arendrup MC, 2017, J INFECT DIS, V216, pS445, DOI 10.1093/infdis/jix131; Bailly S, 2017, J INFECTION, V74, P408, DOI 10.1016/j.jinf.2016.12.016; Barchiesi F, 2016, INFECTION, V44, P205, DOI 10.1007/s15010-015-0845-z; Bassetti M, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2497-3; Bienvenu AL, 2020, INT J INFECT DIS, V93, P15, DOI 10.1016/j.ijid.2020.01.037; Chakrabarti A, 2015, INTENS CARE MED, V41, P285, DOI 10.1007/s00134-014-3603-2; Charles PE, 2003, INTENS CARE MED, V29, P2162, DOI 10.1007/s00134-003-2002-x; Chow JK, 2008, CRIT CARE MED, V36, P1993, DOI 10.1097/CCM.0b013e31816fc4cd; Clinical and Laboratory Standards Institute,, 2020, PERFORMANCE STANDARD; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Cortegiani A, 2019, INTENS CARE MED, V45, P512, DOI 10.1007/s00134-018-5363-x; Garnacho-Montero J, 2018, CRIT CARE MED, V46, P384, DOI 10.1097/CCM.0000000000002867; Kett DH, 2011, CRIT CARE MED, V39, P665, DOI 10.1097/CCM.0b013e318206c1ca; Kollef M, 2012, CLIN INFECT DIS, V54, P1739, DOI 10.1093/cid/cis305; Lamoth F, 2018, J ANTIMICROB CHEMOTH, V73, pi4, DOI 10.1093/jac/dkx444; Laverdiere M, 2007, J CRIT CARE, V22, P245, DOI 10.1016/j.jcrc.2006.10.038; Lockhart SR, 2012, J CLIN MICROBIOL, V50, P3435, DOI 10.1128/JCM.01283-12; Lortholary O, 2017, INTENS CARE MED, V43, P652, DOI 10.1007/s00134-017-4743-y; Lortholary O, 2014, INTENS CARE MED, V40, P1303, DOI 10.1007/s00134-014-3408-3; Macphail GLP, 2002, MYCOSES, V45, P141, DOI 10.1046/j.1439-0507.2002.00741.x; Martin-Loeches I, 2019, INTENS CARE MED, V45, P789, DOI 10.1007/s00134-019-05599-w; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Ohki S, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00450-7; Pappas PG, 2016, CLIN INFECT DIS, V62, pE1, DOI 10.1093/cid/civ933; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Puig-Asensio M, 2014, CRIT CARE MED, V42, P1423, DOI 10.1097/CCM.0000000000000221; Shields RK, 2015, CURR OPIN INFECT DIS, V28, P514, DOI 10.1097/QCO.0000000000000215; Sipsas NV, 2009, CANCER-AM CANCER SOC, V115, P4745, DOI 10.1002/cncr.24507; Wang H, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0609-x; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252165	10.1371/journal.pone.0252165	http://dx.doi.org/10.1371/journal.pone.0252165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038468	gold, Green Published			2022-12-26	WOS:000664633500058
J	Knaul, F; Arreola-Ornelas, H; Porteny, T; Touchton, M; Sanchez-Talanquer, M; Mendez, O; Chertorivski, S; Ortega, S; Chudnovsky, M; Kuri, P				Knaul, Felicia; Arreola-Ornelas, Hector; Porteny, Thalia; Touchton, Michael; Sanchez-Talanquer, Mariano; Mendez, Oscar; Chertorivski, Salomon; Ortega, Sonia; Chudnovsky, Mariana; Kuri, Pablo		Observ Containment COVID-19 Amer	Not far enough: Public health policies to combat COVID-19 in Mexico's states	PLOS ONE			English	Article								Background Mexican state governments' actions are essential to control the COVID-19 pandemic within the country. However, the type, rigor and pace of implementation of public policies have varied considerably between states. Little is known about the subnational (state) variation policy response to the COVID-19 pandemic in Mexico. Material and methods We collected daily information on public policies designed to inform the public, as well as to promote distancing, and mask use. The policies analyzed were: School Closure, Workplace Closure, Cancellation of Public Events, Restrictions on Gatherings, Stay at Home Order, Public Transit Suspensions, Information Campaigns, Internal Travel Controls, International Travel Controls, Use of Face Masks We use these data to create a composite index to evaluate the adoption of these policies in the 32 states. We then assess the timeliness and rigor of the policies across the country, from the date of the first case, February 27, 2020. Results The national average in the index during the 143 days of the pandemic was 41.1 out of a possible 100 points on our index. Nuevo Leon achieved the highest performance (50.4); San Luis Potosi the lowest (34.1). The differential between the highest versus the lowest performance was 47.4%. Conclusions The study identifies variability and heterogeneity in how and when Mexican states implemented policies to contain COVID-19. We demonstrate the absence of a uniform national response and widely varying stringency of state responses. We also show how these responses are not based on testing and do not reflect the local burden of disease. National health system stewardship and a coordinated, timely, rigorous response to the pandemic did not occur in Mexico but is desirable to contain COVID-19.	[Knaul, Felicia; Arreola-Ornelas, Hector; Porteny, Thalia; Touchton, Michael; Mendez, Oscar] Univ Miami, Inst Adv Study Amer, Miami, FL 33146 USA; [Knaul, Felicia] Univ Miami, Leonard M Miller Sch Med, Miami, FL USA; [Knaul, Felicia; Arreola-Ornelas, Hector; Ortega, Sonia] Tomatelo Pecho AC, Mexico City, DF, Mexico; [Knaul, Felicia; Arreola-Ornelas, Hector; Mendez, Oscar; Ortega, Sonia] Fdn Mexicana Salud AC, Consejo Promotor Universalidad & Competitividad S, Mexico City, DF, Mexico; [Arreola-Ornelas, Hector] Anahuac Univ, Res Ctr Hlth Sci, North Campus, Mexico City, DF, Mexico; [Porteny, Thalia] Tufts Univ, Dept Community Hlth, Medford, MA 02155 USA; [Touchton, Michael] Univ Miami, Sch Arts & Sci, Dept Polit Sci, Miami, FL 33146 USA; [Sanchez-Talanquer, Mariano] Colegio Mexico, Div Polit Sci, Mexico City, DF, Mexico; [Chertorivski, Salomon; Chudnovsky, Mariana] Ctr Econ Res & Teaching CIDE, Div Publ Adm, Mexico City, DF, Mexico; [Kuri, Pablo] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico	University of Miami; University of Miami; Universidad Anahuac; Tufts University; University of Miami; Colegio de Mexico; Centro de Investigacion y Docencia Economicas A.C. (CIDE); Universidad Nacional Autonoma de Mexico	Touchton, M (corresponding author), Univ Miami, Inst Adv Study Amer, Miami, FL 33146 USA.; Touchton, M (corresponding author), Univ Miami, Sch Arts & Sci, Dept Polit Sci, Miami, FL 33146 USA.	miketouchton@miami.edu	Arreola Ornelas, Héctor/HCG-9350-2022; Sanchez-Talanquer, Mariano/ABG-5977-2021	Arreola Ornelas, Héctor/0000-0002-7615-6218; Sanchez-Talanquer, Mariano/0000-0002-5608-3365; Touchton, Michael/0000-0001-7645-1391; Knaul, Felicia/0000-0002-0512-4788				[Anonymous], 2020, LANCET, V395, P1461, DOI 10.1016/S0140-6736(20)31095-3; [Anonymous], 2020, GUARDIAN 1026; Barrios JM, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104310; Calvo E., BOOK WILL GET COVID; Carrillo-Larco R.M, 2020, BOOK COVID 19 DATA S; Cejudo G.M., FEDERALISMO COVID C; Cruz Reyes G, 2020, MEDIDAS GOBIERNO FED; de Leon-Martinez LD, 2020, SCI TOTAL ENVIRON, V733, DOI 10.1016/j.scitotenv.2020.139357; DOF, 2020, DOF DIAR OF FED ACUE; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dyer O, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2182; Gonzalez M., 2020, GAC MED CARACAS, V128, P207; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Liu YW, 2022, J AM STAT ASSOC, V117, P897, DOI 10.1080/01621459.2020.1831926; Luchini S., 2020, SSRN ELECT J; Mathur C, 2020, DIALECT ANTHROPOL, V44, P239, DOI 10.1007/s10624-020-09611-4; Molina M.J, 2020, P NATL ACAD SCI; Munayco CV, 2020, INFECT DIS MODEL, V5, P338, DOI 10.1016/j.idm.2020.05.001; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Nuguer V., 2020, BOOK 2020 LATIN AM C; Pulejo M., 2020, BOOK ELECTORAL CONCE; Ramirezde la Cruz E.E., TRANSACTION COSTS GO, DOI [10.1111/puar.13259, DOI 10.1111/PUAR.13259]; Rios-Flores J.A., 2018, ESTUD FRONT, V19; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101613; Sanitaria I. d.E.C.y., 2020, COVID 19 INFORMACION; Schunemann H.J., 2020, LANCET; Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082932; Snyder R, 2001, STUD COMP INT DEV, V36, P93, DOI 10.1007/BF02687586; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; World Health O, 2020, BOOK ADVICE USE MASK	30	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0251722	10.1371/journal.pone.0251722	http://dx.doi.org/10.1371/journal.pone.0251722			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061864	Green Published, gold			2022-12-26	WOS:000656813600024
J	Espinosa-Vinals, CA; Masin, J; Holubova, J; Stanek, O; Jurnecka, D; Osicka, R; Sebo, P; Bumba, L				Espinosa-Vinals, Carlos Angel; Masin, Jiri; Holubova, Jana; Stanek, Ondrej; Jurnecka, David; Osicka, Radim; Sebo, Peter; Bumba, Ladislav			Almost half of the RTX domain is dispensable for complement receptor 3 binding and cell-invasive activity of the Bordetella adenylate cyclase toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; TRANSLOCATION; SECRETION; ACYLATION; MEMBRANE; DELIVERY	The whooping cough agent Bordetella pertussis secretes an adenylate cyclase toxin (CyaA) that through its large carboxy-proximal Repeat-in-ToXin (RTX) domain binds the complement receptor 3 (CR3). The RTX domain consists of five blocks (I-V) of characteristic glycine and aspartate-rich nonapeptides that fold into five Ca2+-loaded parallel beta-rolls. Previous work indicated that the CR3-binding structure comprises the interface of beta-rolls II and III. To test if further portions of the RTX domain contribute to CR3 binding, we generated a construct with the RTX block II/III interface (CyaA residues 1132-1294) linked directly to the C-terminal block V fragment bearing the folding scaffold (CyaA residues 1562-1681). Despite deletion of 267 internal residues of the RTX domain, the Ca2+-driven folding of the hybrid block III/V beta-roll still supported formation of the CR3-binding structure at the interface of beta-rolls II and III. Moreover, upon stabilization by N- and C-terminal flanking segments, the block III/V hybrid-comprising constructs competed with CyaA for CR3 binding and induced formation of CyaA toxin-neutralizing antibodies in mice. Finally, a truncated CyaA.1295- 1561 toxin bound and penetrated erythrocytes and CR3-expressing cells, showing that the deleted portions of RTX blocks III, IV, and V (residues 1295-1561) were dispensable for CR3 binding and for toxin translocation across the target cell membrane. This suggests that almost a half of the RTX domain of CyaA is not involved in target cell interaction and rather serves the purpose of toxin secretion.	[Espinosa-Vinals, Carlos Angel; Masin, Jiri; Holubova, Jana; Stanek, Ondrej; Jurnecka, David; Osicka, Radim; Sebo, Peter; Bumba, Ladislav] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Espinosa-Vinals, Carlos Angel] Univ Chem & Technol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Chemistry & Technology, Prague	Sebo, P; Bumba, L (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic.	sebo@biomed.cas.cz; bumba@biomed.cas.cz	Stanek, Ondrej/J-8407-2014; Osicka, Radim/H-6776-2014; SEBO, Peter/F-7423-2011; Jurnečka, David/ABA-2334-2021; Holubová, Jana/J-6862-2014; Jurnečka, David/L-7246-2017; Bumba, Ladislav/ABC-9943-2020; SEBO, Peter/N-2043-2019; Espinosa Vinals, Carlos Angel/T-2634-2018	Osicka, Radim/0000-0003-2626-5456; SEBO, Peter/0000-0002-9755-7715; Jurnečka, David/0000-0002-1690-8908; Holubová, Jana/0000-0002-0829-0976; Jurnečka, David/0000-0002-1690-8908; Bumba, Ladislav/0000-0001-6659-5447; SEBO, Peter/0000-0002-9755-7715; Espinosa Vinals, Carlos Angel/0000-0002-9622-2331; Masin, Jiri/0000-0001-6258-4599	Grant Agency of the Czech Republic [1915175S, 19-04607S, 19-27630X]; Ministry of Education, Youth and Sports of the Czech Republic [LM2018133]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the project 1915175S, 19-04607S, and 19-27630X of the Grant Agency of the Czech Republic and the research infrastructure project LM2018133 (EATRIS-CZ) of the Ministry of Education, Youth and Sports of the Czech Republic. The SAXS data were collected at the P12 beamline of EMBL (DESY, Hamburg, Germany). We thank Iva Marsikova, Hana Lukeova, and Sona Kozubova for excellent technical help.	Ahmad JN, 2019, MBIO, V10, DOI 10.1128/mBio.01743-19; Basar T, 1999, J BIOL CHEM, V274, P10777, DOI 10.1074/jbc.274.16.10777; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; Baumann U, 2019, TOXINS, V11, DOI 10.3390/toxins11110657; BETSOU F, 1995, INFECT IMMUN, V63, P3309, DOI 10.1128/IAI.63.9.3309-3315.1995; BETSOU F, 1993, INFECT IMMUN, V61, P3583, DOI 10.1128/IAI.61.9.3583-3589.1993; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Bumba L, 2016, MOL CELL, V62, P47, DOI 10.1016/j.molcel.2016.03.018; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; EHRMANN IE, 1991, FEBS LETT, V278, P79, DOI 10.1016/0014-5793(91)80088-K; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fedele G, 2017, TOXINS, V9, DOI 10.3390/toxins9100293; Fiser R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002580; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gray M, 1998, J BIOL CHEM, V273, P18260, DOI 10.1074/jbc.273.29.18260; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Guiso N, 2017, TOXINS, V9, DOI 10.3390/toxins9090277; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Hasan S, 2015, FEBS LETT, V589, P374, DOI 10.1016/j.febslet.2014.12.023; Holubova J, 2012, INFECT IMMUN, V80, P1181, DOI 10.1128/IAI.05711-11; IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Knapp O, 2020, TOXINS, V12, DOI 10.3390/toxins12030169; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LADANT D, 1988, J BIOL CHEM, V263, P2612; Masin J, 2020, J BIOL CHEM, V295, P9349, DOI 10.1074/jbc.RA120.013630; Masin J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09575-6; Masin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29137; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Motlova L, 2020, J MOL BIOL, V432, P5696, DOI 10.1016/j.jmb.2020.08.020; Novak J, 2017, TOXINS, V9, DOI 10.3390/toxins9100300; Osicka R, 2015, ELIFE, V4, DOI 10.7554/eLife.10766; Osickova A, 2020, J BIOL CHEM, V295, P9268, DOI 10.1074/jbc.RA120.014122; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; Stanek O, 2019, TOXINS, V11, DOI 10.3390/toxins11060336; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; Sukova A, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183310; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SZABO G, 1994, J BIOL CHEM, V269, P22496; Voegele A, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty085; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wald T, 2014, ANAL BIOCHEM, V450, P57, DOI 10.1016/j.ab.2013.10.039; Wang XZ, 2017, BIOCHEMISTRY-US, V56, P1324, DOI 10.1021/acs.biochem.6b01163; Wang XZ, 2015, J BIOL CHEM, V290, P3576, DOI 10.1074/jbc.M114.585281	46	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100833	10.1016/j.jbc.2021.100833	http://dx.doi.org/10.1016/j.jbc.2021.100833			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051233	Green Published, gold			2022-12-26	WOS:000678068400033
J	Nagashima, S; Maruyama, J; Honda, K; Kondoh, Y; Osada, H; Nawa, M; Nakahama, KI; Ishigami-Yuasa, M; Kagechika, H; Sugimura, H; Iwasa, H; Arimoto-Matsuzaki, K; Nishina, H; Hata, Y				Nagashima, Shunta; Maruyama, Junichi; Honda, Kaori; Kondoh, Yasumitsu; Osada, Hiroyuki; Nawa, Makiko; Nakahama, Ken-Ichi; Ishigami-Yuasa, Mari; Kagechika, Hiroyuki; Sugimura, Haruhiko; Iwasa, Hiroaki; Arimoto-Matsuzaki, Kyoko; Nishina, Hiroshi; Hata, Yutaka			CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTIN ALPHA; CHROMOSOME SEGREGATION; CENTER STAGE; APOPTOSIS; PROLIFERATION; GENE; EXPRESSION; TRANSPORT; COMPOUND; TARGET	The transcriptional coactivator with PDZ-binding motif (TAZ) (WWTR1) induces epithelial-mesenchymal transition and enhances drug resistance in multiple cancers. TAZ has been shown to interact with transcription factors in the nucleus, but when phosphorylated, translocates to the cytoplasm and is degraded through proteasomes. Here, we identified a compound TAZ inhibitor 4 (TI-4) that shifted TAZ localization to the cytoplasm independently of its phosphorylation. We used affinity beads to ascertain a putative target of TI-4, chromosomal segregation 1 like (CSE1L), which is known to be involved in the recycling of importin alpha and as a biomarker of cancer malignancy. We found that TI-4 suppressed TAZ-mediated transcription in a CSE1L-dependent manner. CSE1L overexpression increased nuclear levels of TAZ, whereas CSE1L silencing delayed its nuclear import. We also found via the in vitro coimmunoprecipitation experiments that TI-4 strengthened the interaction between CSE1L and importin alpha 5 and blocked the binding of importin alpha 5 to TAZ. WWTR1 silencing attenuated CSE1L-promoted colony formation, motility, and invasiveness of human lung cancer and glioblastoma cells. Conversely, CSE1L silencing blocked TAZ-promoted colony formation, motility, and invasiveness in human lung cancer and glioblastoma cells. In human cancer tissues, the expression level of CSE1L was found to correlate with nuclear levels of TAZ. These findings support that CSE1L promotes the nuclear accumulation of TAZ and enhances malignancy in cancer cells.	[Nagashima, Shunta; Maruyama, Junichi; Iwasa, Hiroaki; Arimoto-Matsuzaki, Kyoko; Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo, Japan; [Honda, Kaori; Kondoh, Yasumitsu; Osada, Hiroyuki] RIKEN Ctr Sustainable Resource Sci, Chem Biol Res Grp, Saitama, Japan; [Nawa, Makiko] Tokyo Med & Dent Univ, Lab Cytometry & Proteome Res Nanken Kyoten, Tokyo, Japan; [Nawa, Makiko] Tokyo Med & Dent Univ, RCC, Tokyo, Japan; [Nakahama, Ken-Ichi] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Tokyo, Japan; [Ishigami-Yuasa, Mari; Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Chem Biol Screening Ctr, Tokyo, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Tumor Pathol, Hamamatsu, Shizuoka, Japan; [Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo, Japan; [Hata, Yutaka] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Hamamatsu University School of Medicine; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Maruyama, J; Hata, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo, Japan.; Hata, Y (corresponding author), Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan.	jmaruyama.mbc@tmd.ac.jp; yuhammch@tmd.ac.jp	Iwasa, Hiroaki/ABG-9082-2021; Sugimura, Haruhiko/E-9048-2017	Sugimura, Haruhiko/0000-0002-0779-3088; MARUYAMA, Junichi/0000-0002-3665-2700	Japan Society for the Promotion of Sciences DC2	Japan Society for the Promotion of Sciences DC2(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	S. N. is a Research Fellow of the Japan Society for the Promotion of Sciences DC2.	Alnabulsi A, 2012, J PATHOL, V228, P471, DOI 10.1002/path.4031; Behrens P, 2001, ANTICANCER RES, V21, P2413; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; Chang CC, 2012, ANN DIAGN PATHOL, V16, P362, DOI 10.1016/j.anndiagpath.2012.02.005; Dong Q, 2018, P NATL ACAD SCI USA, V115, pE4013, DOI 10.1073/pnas.1800505115; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Jiang MC, 2016, TUMOR BIOL, V37, P13077, DOI 10.1007/s13277-016-5301-x; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kawano S, 2015, J BIOCHEM, V158, P413, DOI 10.1093/jb/mvv051; Ko fl er M., 2018, NAT COMMUN, V9, P496; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lamar JM, 2018, CANCERS, V10, DOI 10.3390/cancers10070229; Lee WR, 2016, MOL CARCINOGEN, V55, P1542, DOI 10.1002/mc.22407; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liao CF, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-15; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Lorenzato A, 2012, FASEB J, V26, P2446, DOI 10.1096/fj.11-195982; Nagashima S, 2016, CANCER SCI, V107, P791, DOI 10.1111/cas.12936; Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113; Oka M, 2018, P JPN ACAD B-PHYS, V94, P259, DOI 10.2183/pjab.94.018; Okimoto S, 2015, GENES CELLS, V20, P681, DOI 10.1111/gtc.12262; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Suvarna K, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3517; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tsai CSS, 2010, AM J PATHOL, V176, P1619, DOI 10.2353/ajpath.2010.090467; Tung MC, 2009, CANCER EPIDEM BIOMAR, V18, P1570, DOI 10.1158/1055-9965.EPI-08-0948; Wang SM, 2016, J BIOL CHEM, V291, P7926, DOI 10.1074/jbc.M115.700823; Wellmann A, 2001, INT J MOL MED, V7, P489; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Yuksel UM, 2015, TUMORI, V101, P194, DOI 10.5301/tj.5000239; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014	36	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100803	10.1016/j.jbc.2021.100803	http://dx.doi.org/10.1016/j.jbc.2021.100803			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34022224	gold, Green Published			2022-12-26	WOS:000678068400009
J	Krishnathas, GM; Strodke, B; Mittmann, L; Zech, T; Berger, LM; Reichel, CA; Rosser, S; Schmid, T; Knapp, S; Muller, S; Bracher, F; Furst, R; Bischoff-Kont, I				Krishnathas, G. Melissa; Stroedke, Benjamin; Mittmann, Laura; Zech, Thomas; Berger, Lena M.; Reichel, Christoph A.; Rosser, Silvia; Schmid, Tobias; Knapp, Stefan; Muller, Susanne; Bracher, Franz; Furst, Robert; Bischoff-Kont, Iris			C81-evoked inhibition of the TNFR1-NF kappa B pathway during inflammatory processes for stabilization of the impaired vascular endothelial barrier for leukocytes	FASEB JOURNAL			English	Article						carbazole derivative C81; endothelial cells; inflammation; protein translation; ubiquitination	NF-KAPPA-B; ADHESION MOLECULES; CELL-INTERACTIONS; ANNOMONTINE; SELECTIVITY; ACTIVATION; MECHANISMS; ALPHA	Chronic inflammation-related diseases are characterized by persistent leukocyte infiltration into the underlying tissue. The vascular endothelium plays a major role in this pathophysiological condition. Only few therapeutic strategies focus on the vascular endothelium as a major target for an anti-inflammatory approach. In this study, we present the natural compound-derived carbazole derivative C81 as chemical modulator interfering with leukocyte-endothelial cell interactions. An in vivo assay employing intravital microscopy to monitor leukocyte trafficking after C81 treatment in postcapillary venules of a murine cremaster muscle was performed. Moreover, in vitro assays using HUVECs and monocytes were implemented. The impact of C81 on cell adhesion molecules and the NF kappa B signaling cascade was analyzed in vitro in endothelial cells. Effects of C81 on protein translation were determined by incorporation of a puromycin analog-based approach and polysome profiling. We found that C81 significantly reduced TNF-activated leukocyte trafficking in postcapillary venules. Similar results were obtained in vitro when C81 reduced leukocyte-endothelial cell interactions by down-regulating cell adhesion molecules. Focusing on the NF kappa B signaling cascade, we found that C81 reduced the activation on multiple levels of the cascade through promoted I kappa B alpha recovery by attenuation of I kappa B alpha ubiquitination and through reduced protein levels of TNFR1 caused by protein translation inhibition. We suggest that C81 might represent a promising lead compound for interfering with inflammation-related processes in endothelial cells by down-regulation of I kappa B alpha ubiquitination on the one hand and inhibition of translation on the other hand without exerting cytotoxic effects.	[Krishnathas, G. Melissa; Zech, Thomas; Furst, Robert; Bischoff-Kont, Iris] Goethe Univ, Inst Pharmaceut Biol, Frankfurt, Germany; [Stroedke, Benjamin; Bracher, Franz] Ludwig Maximilians Univ Munchen, Dept Pharm, Ctr Drug Res, Munich, Germany; [Mittmann, Laura; Reichel, Christoph A.] Ludwig Maximilians Univ Munchen, Dept Otorhinolaryngol, Munich, Germany; [Mittmann, Laura; Reichel, Christoph A.] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med, Munich, Germany; [Berger, Lena M.; Knapp, Stefan; Muller, Susanne] Goethe Univ, Inst Pharmaceut Chem, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Rosser, Silvia; Schmid, Tobias] Goethe Univ, Inst Biochem, Fac Med, Frankfurt, Germany	Goethe University Frankfurt; University of Munich; University of Munich; University of Munich; Goethe University Frankfurt; Goethe University Frankfurt	Bischoff-Kont, I (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Biol, Max von Laue Str 9, D-60438 Frankfurt, Germany.	i.bischoff@em.uni-frankfurt.de	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Schmid, Tobias/0000-0002-1952-5259; Berger, Lena Marie/0000-0002-7835-8067; Furst, Robert/0000-0002-9926-7578	Deutsche Forschungsgemeinschaft (DFG) [GRK 2336]; Innovative Medicines Initiative 2 Joint Undertaking [875510]; Sonderforschungsbereich (SFB) 914 of DFG; Structural Genomics Consortium at the Goethe University Frankfurt (SGC Frankfurt)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Innovative Medicines Initiative 2 Joint Undertaking; Sonderforschungsbereich (SFB) 914 of DFG(German Research Foundation (DFG)); Structural Genomics Consortium at the Goethe University Frankfurt (SGC Frankfurt)	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: GRK 2336; Structural Genomics Consortium at the Goethe University Frankfurt (SGC Frankfurt); Innovative Medicines Initiative 2 Joint Undertaking, Grant/Award Number: 875510; Sonderforschungsbereich (SFB) 914 of DFG, Grant/Award Number: project B03 to C.A.R.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Azab A, 2016, MOLECULES, V21, DOI 10.3390/molecules21101321; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Blees JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046567; Brautigam J, 2019, J MOL CELL CARDIOL, V135, P97, DOI 10.1016/j.yjmcc.2019.08.001; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Rejon-Orantes JDC, 2011, PLANTA MED, V77, P322, DOI 10.1055/s-0030-1250406; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Frampton JE, 2018, BIODRUGS, V32, P507, DOI 10.1007/s40259-018-0307-0; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Giridharan S, 2018, J INFLAMM RES, V11, P407, DOI 10.2147/JIR.S140188; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hoffman AM, 2019, J BIOL CHEM, V294, P8942, DOI 10.1074/jbc.RA119.007996; Huang HL, 2015, ONCOTARGET, V6, P995, DOI 10.18632/oncotarget.2739; Huang MT., 1975, MOL PHARMACOL, V11, p511; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jagannath S, 2004, BRIT J HAEMATOL, V127, P165, DOI 10.1111/j.1365-2141.2004.05188.x; Jain J, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0147-4; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Laham-Karam N, 2020, FRONT CHEM, V8, DOI 10.3389/fchem.2020.00276; Lamb YN, 2017, BIODRUGS, V31, P461, DOI 10.1007/s40259-017-0240-7; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li YYY, 2008, CLIN DERMATOL, V26, P527, DOI 10.1016/j.clindermatol.2007.11.002; Mateus A, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20199232; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Newman DJ, 2020, J NAT PROD, V83, P770, DOI 10.1021/acs.jnatprod.9b01285; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Picado A, 2020, J MED CHEM, V63, P14626, DOI 10.1021/acs.jmedchem.0c01174; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Ramos GP, 2019, MAYO CLIN PROC, V94, P155, DOI 10.1016/j.mayocp.2018.09.013; READ MA, 1994, J EXP MED, V179, P503, DOI 10.1084/jem.179.2.503; Sandoo A, 2010, OPEN CARDIOVASC MED, V4, P302, DOI 10.2174/1874192401004010302; Scholz A, 2020, CELL MOL LIFE SCI, V77, P2017, DOI 10.1007/s00018-019-03265-4; Schulze-Osthoff K, 1997, IMMUNOBIOLOGY, V198, P35, DOI 10.1016/S0171-2985(97)80025-3; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Stark A, 2019, FASEB J, V33, P8771, DOI 10.1096/fj.201802440R; Strodke B, 2015, ARCH PHARM, V348, P125, DOI 10.1002/ardp.201400328; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Totzke J, 2017, CELL CHEM BIOL, V24, P1029, DOI 10.1016/j.chembiol.2017.07.011; Van Goietsenoven G, 2010, FASEB J, V24, P4575, DOI 10.1096/fj.10-162263; Vasta JD, 2018, CELL CHEM BIOL, V25, P206, DOI 10.1016/j.chembiol.2017.10.010; Verhamme P, 2006, ACTA CLIN BELG, V61, P213, DOI 10.1179/acb.2006.036; Yamaguchi T, 2007, J BIOL CHEM, V282, P33943, DOI 10.1074/jbc.M706282200; Yung R L, 2001, Curr Opin Investig Drugs, V2, P216; Zhang W, 2014, FEBS LETT, V588, P356, DOI 10.1016/j.febslet.2013.11.003	53	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21656	10.1096/fj.202100037R	http://dx.doi.org/10.1096/fj.202100037R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042211				2022-12-26	WOS:000655695900028
J	Rendina, DN; Lubach, GR; Lyte, M; Phillips, GJ; Gosain, A; Pierre, JF; Vlasova, RM; Styner, MA; Coe, CL				Rendina, Danielle N.; Lubach, Gabriele R.; Lyte, Mark; Phillips, Gregory J.; Gosain, Ankush; Pierre, Joseph F.; Vlasova, Roza M.; Styner, Martin A.; Coe, Christopher L.			Proteobacteria abundance during nursing predicts physical growth and brain volume at one year of age in young rhesus monkeys	FASEB JOURNAL			English	Article						breast feeding; gut microbiome; infant development; neuroimaging; Proteobacteria	INTESTINAL MICROBIOTA; GUT MICROBIOTA; HUMAN-MILK; VAGINAL MICROBIOME; DELIVERY MODE; INFANT; OLIGOSACCHARIDES; TRANSMISSION; ASSOCIATION; DISCOVERY	Over the last decade, multiple studies have highlighted the essential role of gut microbiota in normal infant development. However, the sensitive periods during which gut bacteria are established and become associated with physical growth and maturation of the brain are still poorly defined. This study tracked the assembly of the intestinal microbiota during the initial nursing period, and changes in community structure after transitioning to solid food in infant rhesus monkeys (Macaca mulatta). Anthropometric measures and rectal swabs were obtained at 2-month intervals across the first year of life and bacterial taxa identified by 16S rRNA gene sequencing. At 12 months of age, total brain and cortical regions volumes were quantified through structural magnetic resonance imaging. The bacterial community structure was dynamic and characterized by discrete maturational phases, reflecting an early influence of breast milk and the later transition to solid foods. Commensal microbial taxa varied with diet similar to findings in other animals and human infants; however, monkeys differ in the relative abundances of Lactobacilli and Bifidobacteria, two taxa predominant in breastfed human infants. Higher abundances of taxa in the phylum Proteobacteria during nursing were predictive of slower growth trajectories and smaller brain volumes at one year of age. Our findings define discrete phases of microbial succession in infant monkeys and suggest there may be a critical period during nursing when endogenous differences in certain taxa can shift the community structure and influence the pace of physical growth and the maturational trajectory of the brain.	[Rendina, Danielle N.; Lubach, Gabriele R.; Coe, Christopher L.] Univ Wisconsin, Harlow Ctr, Madison, WI USA; [Rendina, Danielle N.] Duke Univ, Dept Psychol & Neurosci, 210 Res Dr,3015 GSRB II, Durham, NC 27710 USA; [Lyte, Mark; Phillips, Gregory J.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Gosain, Ankush] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; [Gosain, Ankush; Pierre, Joseph F.] Le Bonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA; [Pierre, Joseph F.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Vlasova, Roza M.; Styner, Martin A.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Vlasova, Roza M.; Styner, Martin A.] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA	University of Wisconsin System; University of Wisconsin Madison; Duke University; Iowa State University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rendina, DN (corresponding author), Duke Univ, Dept Psychol & Neurosci, 210 Res Dr,3015 GSRB II, Durham, NC 27710 USA.	danielle.rendina@duke.edu	Pierre, Joseph/HCH-3993-2022; VLasova, Roza/AFQ-7077-2022	VLasova, Roza/0000-0002-6455-8949; Styner, Martin/0000-0002-8747-5118; Coe, Christopher/0000-0001-9335-9060; Lyte, Mark/0000-0001-8512-2581; Rendina, Danielle/0000-0003-0150-0886; Gosain, Ankush/0000-0002-0428-1503	HHS | NIH | National Institute of Mental Health (NIMH) [MH104198]	HHS | NIH | National Institute of Mental Health (NIMH)	HHS | NIH | National Institute of Mental Health (NIMH), Grant/Award Number: MH104198	Aakko J, 2017, BENEF MICROBES, V8, P563, DOI 10.3920/BM2016.0185; Ait-Belgnaoui A, 2012, PSYCHONEUROENDOCRINO, V37, P1885, DOI 10.1016/j.psyneuen.2012.03.024; Amaral WZ, 2017, PSYCHOSOM MED, V79, P888, DOI 10.1097/PSY.0000000000000454; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311; Bokulich NA, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00219-18; Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Browne HP, 2017, NAT REV MICROBIOL, V15, P531, DOI 10.1038/nrmicro.2017.50; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Charbonneau MR, 2016, CELL, V164, P859, DOI 10.1016/j.cell.2016.01.024; Chen Z, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35262-1; Cherel M, 2015, PROC SPIE, V9413, DOI 10.1117/12.2082209; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Cunnane SC, 2003, COMP BIOCHEM PHYS A, V136, P17, DOI 10.1016/S1095-6433(03)00048-5; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; De Leoz MLA, 2015, J PROTEOME RES, V14, P491, DOI 10.1021/pr500759e; Dettmer AM, 2019, AM J PRIMATOL, V81, DOI 10.1002/ajp.22969; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Fallani M, 2010, J PEDIATR GASTR NUTR, V51, P77, DOI 10.1097/MPG.0b013e3181d1b11e; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Georgieff MK, 2007, AM J CLIN NUTR, V85, p614S; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Goto K, 2010, GLYCOCONJUGATE J, V27, P703, DOI 10.1007/s10719-010-9315-0; Hansey CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033071; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hoban AE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.42; Jasarevic E, 2015, ENDOCRINOLOGY, V156, P3265, DOI 10.1210/en.2015-1177; Kasubuchi M, 2015, NUTRIENTS, V7, P2839, DOI 10.3390/nu7042839; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057535; Knickmeyer RC, 2010, CEREB CORTEX, V20, P1053, DOI 10.1093/cercor/bhp166; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Luczynski P, 2016, EUR J NEUROSCI, V44, P2654, DOI 10.1111/ejn.13291; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Ma Y, 2017, SAUDI J BIOL SCI, V24, P114, DOI 10.1016/j.sjbs.2016.09.004; Maathuis A, 2009, J AM COLL NUTR, V28, P657, DOI 10.1080/07315724.2009.10719798; Madan JC, 2016, JAMA PEDIATR, V170, P212, DOI 10.1001/jamapediatrics.2015.3732; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Martin R, 2007, J APPL MICROBIOL, V103, P2638, DOI 10.1111/j.1365-2672.2007.03497.x; Martin R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158498; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Moossavi S, 2019, CELL HOST MICROBE, V25, P324, DOI 10.1016/j.chom.2019.01.011; Murphy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep40597; O'Sulliyan A, 2013, J PROTEOME RES, V12, P2833, DOI 10.1021/pr4001702; Ogbonnaya ES, 2015, BIOL PSYCHIAT, V78, pE7, DOI 10.1016/j.biopsych.2014.12.023; Pannaraj PS, 2017, JAMA PEDIATR, V171, P647, DOI 10.1001/jamapediatrics.2017.0378; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rendina DN, 2019, J PEDIATR GASTR NUTR, V69, P363, DOI 10.1097/MPG.0000000000002394; Rhoades N, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1789-x; Schwarzer M, 2016, SCIENCE, V351, P854, DOI 10.1126/science.aad8588; Scott JA, 2016, BRAIN STRUCT FUNCT, V221, P2847, DOI 10.1007/s00429-015-1076-x; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shi YD, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00617; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Shirtcliff EA, 2013, DEV PSYCHOL, V49, P2005, DOI 10.1037/a0032050; Short SJ, 2010, BIOL PSYCHIAT, V67, P965, DOI 10.1016/j.biopsych.2009.11.026; Stilling RM, 2015, BRAIN BEHAV IMMUN, V50, P209, DOI 10.1016/j.bbi.2015.07.009; Stumpf RM, 2013, AM J PHYS ANTHROPOL, V152, P119, DOI 10.1002/ajpa.22395; Tao NA, 2011, J PROTEOME RES, V10, P1548, DOI 10.1021/pr1009367; Thongaram T, 2017, J DAIRY SCI, V100, P7825, DOI 10.3168/jds.2017-12753; Timmerman HM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08268-4; Valles Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004406; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007; Wright CM, 2004, ARCH DIS CHILD-FETAL, V89, pF254, DOI 10.1136/adc.2003.026906; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang MY, 2019, ANN CLIN MICROB ANTI, V18, DOI 10.1186/s12941-019-0318-9; Zou ZH, 2018, ANN CLIN MICROB ANTI, V17, DOI 10.1186/s12941-018-0264-y	74	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21682	10.1096/fj.202002162R	http://dx.doi.org/10.1096/fj.202002162R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042210				2022-12-26	WOS:000655695900056
J	Kitonsa, J; Kamacooko, O; Bahemuka, UM; Kibengo, F; Kakande, A; Wajja, A; Basajja, V; Lumala, A; Ssemwanga, E; Asaba, R; Mugisha, J; Pierce, BF; Shattock, R; Kaleebu, P; Ruzagira, E				Kitonsa, Jonathan; Kamacooko, Onesmus; Bahemuka, Ubaldo Mushabe; Kibengo, Freddie; Kakande, Ayoub; Wajja, Anne; Basajja, Vincent; Lumala, Alfred; Ssemwanga, Edward; Asaba, Robert; Mugisha, Joseph; Pierce, Benjamin F.; Shattock, Robin; Kaleebu, Pontiano; Ruzagira, Eugene			Willingness to participate in COVID-19 vaccine trials; a survey among a population of healthcare workers in Uganda	PLOS ONE			English	Article							HIGH-RISK POPULATIONS; EFFICACY TRIALS; CLINICAL-TRIAL; DETERMINANTS; MEN; SEX	Background Healthcare workers (HCWs) are at high risk of acquiring SARS-CoV-2 and COVID-19 and may therefore be a suitable population for COVID-19 vaccine trials. We conducted a survey to evaluate willingness-to-participate in COVID-19 vaccine trials in a population of HCWs at three hospitals in Uganda. Methods The survey was conducted between September and November 2020. Using a standardised questionnaire, data were collected on socio-demographics, previous participation in health research, COVID-19 information sources, underlying health conditions, and willingness-to-participate in COVID-19 vaccine trials. Data were analysed descriptively and a binomial generalised linear model with a log link function used to investigate factors associated with unwillingness to participate. Results 657 HCWs (female, 63%) were enrolled with a mean age of 33 years (Standard Deviation, 10). Overall willingness-to-participate was 70.2%. Key motivating factors for participation were: hope of being protected against COVID-19 (81.1%), altruism (73.3%), and the opportunity to get health care (26.0%). Selected hypothetical trial attributes reduced willingness-to-participate as follows: weekly-quarterly study visits over a 12-month period (70.2%-63.2%, P = 0.026); provision of approximately 50ml of blood at each study visit (70.2%-63.2%, P = 0.026); risk of mild-moderate local adverse reactions (70.2%-60.3%, P<0.001); chance of receiving candidate vaccine or placebo (70.2%-56.9%, P<0.001); and delay of pregnancy [Overall, 70.2%-57.1% P<0.001); Female, 62.8%-48.4% (P = 0.002); Male, 82.5%-71.5% (P = 0.003)]. Collectively, these attributes reduced willingness-to-participate from [70.2%-42.2% (P<0.001) overall; 82.5%-58.1% (P<0.001) in men; 62.8%-32.6% (P<0.001) in women]. Among individuals that were unwilling to participate, the commonest barriers were concerns over vaccine safety (54.6%) and fear of catching SARS-CoV-2 (31.6%). Unwillingness to participate was associated with being female (aRR 1.97, CI 1.46-2.67, P<0.001) and having university or other higher-level education (aRR 1.52, CI 1.05-2.2, P = 0.026). Conclusions Willingness-to-participate in COVID-19 vaccine trials among HCWs in Uganda is high but may be affected by vaccine trial requirements and concerns about the safety of candidate vaccines.	[Kitonsa, Jonathan; Kamacooko, Onesmus; Bahemuka, Ubaldo Mushabe; Kibengo, Freddie; Kakande, Ayoub; Wajja, Anne; Basajja, Vincent; Mugisha, Joseph; Kaleebu, Pontiano; Ruzagira, Eugene] Uganda Virus Res Inst, MRC, Entebbe, Uganda; [Kitonsa, Jonathan; Kamacooko, Onesmus; Bahemuka, Ubaldo Mushabe; Kibengo, Freddie; Kakande, Ayoub; Wajja, Anne; Basajja, Vincent; Mugisha, Joseph; Kaleebu, Pontiano; Ruzagira, Eugene] London Sch Hyg & Trop Med, Uganda Res Unit, Entebbe, Uganda; [Lumala, Alfred] Kitovu Hosp, Masaka Dist, Uganda; [Ssemwanga, Edward] Villa Maria Hosp, Kalungu Dist, Uganda; [Asaba, Robert] Our Lady Consolata Kisubi Hosp, Wakiso Dist, Uganda; [Pierce, Benjamin F.; Shattock, Robin] Imperial Coll London, Dept Infect Dis, Norfolk Pl, London, England	Uganda Virus Research Institute; Imperial College London	Kitonsa, J (corresponding author), Uganda Virus Res Inst, MRC, Entebbe, Uganda.; Kitonsa, J (corresponding author), London Sch Hyg & Trop Med, Uganda Res Unit, Entebbe, Uganda.	Jonathan.Kitonsa@mrcuganda.org	Kamacooko, Onesmus/AAY-8453-2020	kitonsa, jonathan/0000-0003-2467-4037; Bahemuka, Ubaldo/0000-0003-1092-4832; Ruzagira, Eugene/0000-0002-7291-1693	Department of Health and Social Care using UK Aid funding; Engineering and Physical Sciences Research Council (EPSRC) [EP/R013764/1]	Department of Health and Social Care using UK Aid funding; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research is funded by the Department of Health and Social Care using UK Aid funding and is managed by the Engineering and Physical Sciences Research Council (EPSRC, grant number: EP/R013764/1). The views expressed in this publication are those of the author(s) and not necessarily those of the Department of Health and Social Care.	Ali SH, 2020, JMIR PUBLIC HLTH SUR, V6, P154, DOI 10.2196/21071; Ashburn K, 2008, CLIN SCI MEETS SOCIA; Asiki G, 2013, VACCINE, V31, P5055, DOI 10.1016/j.vaccine.2013.08.080; Balfour L, 2010, AIDS CARE, V22, P1403, DOI 10.1080/09540121003693522; Barua Z, 2020, PROG DISASTER SCI, V8, DOI 10.1016/j.pdisas.2020.100119; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Buchbinder SP, 2004, JAIDS-J ACQ IMM DEF, V36, P604, DOI 10.1097/00126334-200405010-00009; Castiblanco J, 2015, CURR GENOMICS, V16, P47, DOI 10.2174/1389202916666141223220551; Chatio S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152854; Chersich MF, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00574-3; Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041; Dhanani LY, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.560828; FDA, FDA ISS EM US AUTH 3; Galvao J, 2021, LANCET INFECT DIS, V21, pE114, DOI 10.1016/S1473-3099(20)30721-0; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Hernandez AV, 2020, ANN INTERN MED, V173, pW156, DOI 10.7326/L20-1257; International Council of Nurses, ICN CONF 1500 NURS D; Jones I, 2021, LANCET, V397, P642, DOI 10.1016/S0140-6736(21)00191-4; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; Koirala A, 2020, PAEDIATR RESPIR REV, V35, P43, DOI 10.1016/j.prrv.2020.06.010; Kurupati R, 2016, ONCOTARGET, V7, P62898, DOI 10.18632/oncotarget.11704; Liu Katherine A., 2016, Pharmacy Pract (Granada), V14, DOI 10.18549/PharmPract.2016.01.708; Livingston Edward H, 2021, JAMA, V325, P1575, DOI 10.1001/jama.2021.2927; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n597; Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4347; Marchant A, 2006, J INFECT DIS, V193, P1598, DOI 10.1086/503775; Martin Amory, 2020, Econ Disaster Clim Chang, V4, P453, DOI 10.1007/s41885-020-00070-3; McCartney PR, 2020, JOGNN-J OBST GYN NEO, V49, P405, DOI 10.1016/j.jogn.2020.08.001; MOH, COVID 19 DAIL SIT RE; Nawrat A., EMA APPROVES 4 COVID; Newman PA, 2008, VACCINE, V26, P2528, DOI 10.1016/j.vaccine.2008.03.004; Newman PA, 2014, VACCINE, V32, P5854, DOI 10.1016/j.vaccine.2014.08.043; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Nyaoke BA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183788; Nyasani DK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206656; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1; Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14; Raheja D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081743; Rikin S, 2017, CONT CLIN TRIAL COMM, V7, P122, DOI 10.1016/j.conctc.2017.06.010; Ruzagira E, 2009, TROP MED INT HEALTH, V14, P196, DOI 10.1111/j.1365-3156.2008.02200.x; Sabetian G, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01532-0; Shumba CS, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2763-5; Simon AE, 2007, AM J PREV MED, V32, P370, DOI 10.1016/j.amepre.2007.01.007; Stunkel L, 2011, CONTEMP CLIN TRIALS, V32, P342, DOI 10.1016/j.cct.2010.12.003; Sugarman Jeremy, 2019, AJOB Empir Bioeth, V10, P79, DOI 10.1080/23294515.2019.1593257; Suhadev M, 2009, AIDS RES HUM RETROV, V25, P217, DOI 10.1089/aid.2007.0312; Sun SX, 2022, IEEE T FUZZY SYST, V30, P321, DOI [10.1109/TFUZZ.2020.3037959, 10.1101/2020.07.13.20152678]; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; WHO, WHO LISTS 2 ADD COVI; World Health Organization, 2021, COVID 19 VACC PROGR	54	8	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251992	10.1371/journal.pone.0251992	http://dx.doi.org/10.1371/journal.pone.0251992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043693	gold, Green Published			2022-12-26	WOS:000664635700044
J	Skorupa, M; Szczepanek, J; Mazur, J; Domagalski, K; Tretyn, A; Tyburski, J				Skorupa, Monika; Szczepanek, Joanna; Mazur, Justyna; Domagalski, Krzysztof; Tretyn, Andrzej; Tyburski, Jaroslaw			Salt stress and salt shock differently affect DNA methylation in salt-responsive genes in sugar beet and its wild, halophytic ancestor	PLOS ONE			English	Article							HISTONE H3; CYTOSINE METHYLATION; BOLTING TOLERANCE; INDUCIBLE GENES; DYNAMIC CHANGES; EXCISED LEAVES; UP-REGULATION; EXPRESSION; SALINITY; DROUGHT	Here we determined the impact of salt shock and salt stress on the level of DNA methylation in selected CpG islands localized in promoters or first exons of sixteen salt-responsive genes in beets. Two subspecies differing in salt tolerance were subjected for analysis, a moderately salt-tolerant sugar beet Beta vulgaris ssp. vulgaris cv. Huzar and a halophytic beet, Beta vulgaris ssp. maritima. The CpG island methylation status was determined. All target sequences were hyper- or hypomethylated under salt shock and/or salt stress in one or both beet subspecies. It was revealed that the genomic regions analyzed were highly methylated in both, the salt treated plants and untreated controls. Methylation of the target sequences changed in a salt-dependent manner, being affected by either one or both treatments. Under both shock and stress, the hypomethylation was a predominant response in sugar beet. In Beta vulgaris ssp. maritima, the hypermethylation occurred with higher frequency than hypomethylation, especially under salt stress and in the promoter-located CpG sites. Conversely, the hypomethylation of the promoter-located CpG sites predominated in sugar beet plants subjected to salt stress. This findings suggest that DNA methylation may be involved in salt-tolerance and transcriptomic response to salinity in beets.	[Skorupa, Monika; Szczepanek, Joanna; Mazur, Justyna; Domagalski, Krzysztof; Tretyn, Andrzej; Tyburski, Jaroslaw] Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Torun, Poland; [Skorupa, Monika; Tretyn, Andrzej; Tyburski, Jaroslaw] Nicolaus Copernicus Univ, Chair Plant Physiol & Biotechnol, Fac Biol & Vet Sci, Torun, Poland; [Domagalski, Krzysztof] Nicolaus Copernicus Univ, Dept Immunol, Fac Biol & Vet Sci, Torun, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Skorupa, M (corresponding author), Nicolaus Copernicus Univ, Ctr Modern Interdisciplinary Technol, Torun, Poland.; Skorupa, M (corresponding author), Nicolaus Copernicus Univ, Chair Plant Physiol & Biotechnol, Fac Biol & Vet Sci, Torun, Poland.	monika_skorupa@umk.pl	Skorupa, Monika/AAP-7524-2021; Domagalski, Krzysztof/G-4668-2014; Szczepanek, Joanna/G-4577-2014	Skorupa, Monika/0000-0003-1868-5370; Domagalski, Krzysztof/0000-0002-9766-8730; Szczepanek, Joanna/0000-0002-4287-5353	National Science Center, Poland [2017/01/X/NZ2/00896]	National Science Center, Poland(National Science Centre, Poland)	This project was financed through grant no. 2017/01/X/NZ2/00896 from National Science Center, Poland.	Al-Harrasi I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191492; Machado RMA, 2017, HORTICULTURAE, V3, DOI 10.3390/horticulturae3020030; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Biancardi E, 2012, BETA MARITMA: THE ORIGIN OF BEETS, P1, DOI 10.1007/978-1-4614-0842-0; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Dunajska-Ordak K, 2014, PLANT MOL BIOL REP, V32, P162, DOI 10.1007/s11105-013-0636-6; Garg R, 2015, SCI REP-UK, V5, DOI 10.1038/srep14922; Hasanuzzaman M., 2013, PLANT RESPONSE SALT; Hebrard C, 2016, J EXP BOT, V67, P207, DOI 10.1093/jxb/erv449; Hoffmann CM, 2010, J AGRON CROP SCI, V196, P243, DOI 10.1111/j.1439-037X.2009.00415.x; Kaldis A, 2011, PLANTA, V233, P749, DOI 10.1007/s00425-010-1337-0; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kim JM, 2008, PLANT CELL PHYSIOL, V49, P1580, DOI 10.1093/pcp/pcn133; Kumar S, 2018, EPIGENOMES, V2, DOI 10.3390/epigenomes2010006; Kumar S, 2017, DNA CELL BIOL, V36, P283, DOI 10.1089/dna.2016.3505; Lange W, 1999, BOT J LINN SOC, V130, P81, DOI 10.1111/j.1095-8339.1999.tb00785.x; Li H, 2014, BMC HEALTH SERV RES, V14, DOI [10.1186/1472-6963-14-158, 10.1186/1471-2229-14-105]; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li SL, 2018, BRIEF BIOINFORM, V19, P754, DOI 10.1093/bib/bbx019; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Lu X K, 2017, Genet Mol Res, V16, DOI 10.4238/gmr16029673; Luo M, 2012, BBA-GENE REGUL MECH, V1819, P129, DOI 10.1016/j.bbagrm.2011.06.008; Makarevitch I, 2015, PLOS GENET, V11, DOI [10.1371/journal.pgen.1004915, 10.1371/journal.pgen.1005566]; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Meng DZ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006141; Mousavi S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37496-5; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Niederhuth CE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1059-0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roychoudhury A., 2017, PLANT GENE, V11, P199, DOI DOI 10.1016/J.PLGENE.2017.05.011; Rozema J, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu083; Shavrukov Y, 2013, J EXP BOT, V64, P119, DOI 10.1093/jxb/ers316; Shi W, 2018, GENES GENET SYST, V93, P259, DOI 10.1266/ggs.18-00039; Skorupa M, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1661-x; Skorupa M, 2016, PLANT SCI, V243, P56, DOI 10.1016/j.plantsci.2015.11.007; Smethurst CF, 2009, PLANT SIGNAL BEHAV, V4, P39, DOI 10.4161/psb.4.1.7269; Sokol A, 2007, PLANTA, V227, P245, DOI 10.1007/s00425-007-0612-1; Takahashi S, 2018, DNA RES, V25, P511, DOI 10.1093/dnares/dsy021; Tani E, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8100231; Trap-Gentil MV, 2011, J EXP BOT, V62, P2585, DOI 10.1093/jxb/erq433; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; van Dijk K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-238; Wang BH, 2015, GENES GENOM, V37, P713, DOI 10.1007/s13258-015-0301-6; Wang Jun, 2014, PLoS One, V9, pe110357, DOI 10.1371/journal.pone.0110357; Xu JD, 2018, PLANT BIOTECHNOL J, V16, P672, DOI 10.1111/pbi.12820; Yaish MW, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4484-5; Yolcu S, 2016, PLANT PHYSIOL BIOCH, V100, P37, DOI 10.1016/j.plaphy.2015.12.019; Zakrzewski F, 2017, PLANT J, V90, P1156, DOI 10.1111/tpj.13526; Zhang HY, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1553-5; Zhang Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113298; Zhao JH, 2016, BIOCHEM BIOPH RES CO, V470, P439, DOI 10.1016/j.bbrc.2016.01.016; Zhao JH, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00764; Zhou WD, 2020, P NATL ACAD SCI USA, V117, P19359, DOI 10.1073/pnas.1921719117	56	5	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251675	10.1371/journal.pone.0251675	http://dx.doi.org/10.1371/journal.pone.0251675			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043649	Green Published, gold			2022-12-26	WOS:000664635700030
J	Bettoni, S; Stoeger, A; Rodriguez, C; Fitch, WT				Bettoni, Sabrina; Stoeger, Angela; Rodriguez, Camilo; Fitch, W. Tecumseh			Airborne vocal communication in adult neotropical otters (Lontra longicaudis)	PLOS ONE			English	Article							MOTIVATION-STRUCTURAL RULES; GIANT OTTERS; TRACT LENGTH; BODY-SIZE; REPERTOIRE; VOCALIZATIONS; MUSTELIDAE; CALLS; COMPLEXITY	Most aquatic mammals have complex social and communication systems. Interestingly, little is known about otters' vocal communication compared to other aquatic mammals. Here, for the first time, we acoustically describe vocalizations of the neotropical otter (Lontra longicaudis), a solitary and endangered New World otter species. We recorded vocalizations and behavioral contexts from six captive neotropical otters at Projeto Lontra, Santa Catarina Island, Brazil. Analysis of acoustic parameters were used to classify the vocalizations according to structure and context. We describe six call types with highly tonal as well as chaotic vocalizations with fundamental frequencies ranging from 90 to 2500 Hz. Additionally, we identified sex differences in the usage of calls. Results suggest that the neotropical river otter has a rich vocal repertoire, similar in complexity to other solitary otter species, but less complex than that of the social giant otter. Despite differences in sociality, phylogeny and ecology, L. longicaudis seems to possess vocalizations homologous to those found in other otters (e.g. hah and chirp), suggesting phylogenetic inertia in otter communicative repertoire. Otters thus offer an interesting but neglected group to explore the evolution of communication systems.	[Bettoni, Sabrina; Stoeger, Angela; Rodriguez, Camilo; Fitch, W. Tecumseh] Univ Vienna, Dept Behav & Cognit Biol, Vienna, Austria	University of Vienna	Bettoni, S; Fitch, WT (corresponding author), Univ Vienna, Dept Behav & Cognit Biol, Vienna, Austria.	Sabrina.bettoni@univie.ac.at; Tecumseh.fitch@univie.ac.at		Stoeger, Angela S/0000-0002-6714-8291	Austrian Science Fund (FWF) [W1262-B29, AP3103421]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Preparation of this paper was supported by Austrian Science Fund (FWF)(https://www.fwf.ac.at) DK Grant "Cognition & Communication" (#W1262-B29) to WTF and AS; by by Austrian Science Fund (FWF)(AP3103421) to AS.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akturk D., 2007, RES J APPL SCI, V7, P585, DOI DOI 10.3923/JAS.2007.585.588; Almonte C., 2014, ABC, V1, P502; Almonte C., 2011, VOCAL BEHAV N AM RIV; [Anonymous], 2012, ANIM BEHAV, V83, P301, DOI 10.1016/j.anbehav.2011.10.031; [Anonymous], 2017, EXPLORATORY MULTIVAR; AUGUST PV, 1987, J MAMMAL, V68, P1, DOI 10.2307/1381039; Blacher C., 1988, Boletim FBCN, V22, P105; Boersma P., PRAAT DOING PHONETIC, V37; Bradshaw J., 2000, DOMESTIC CAT BIOL IT, P67; Carvalho-Junior Oldemar, 2012, IUCN Otter Specialist Group Bulletin, V29, P95; CHIARELLO A. G., 2008, LIVRO VERMELHO FAUNA, P681; Clausen SE., 1998, APPL CORRES ANAL INT, V121; Costa Patricio Soares, 2013, J Aging Res, V2013, P302163, DOI 10.1155/2013/302163; DUPLAIX N, 1980, TERRE VIE-REV ECOL A, V34, P495; Duplaix N., 1982, CONTRIBUTION COLOGIE; Embleton TFW, 1996, J ACOUST SOC AM, V100, P31, DOI 10.1121/1.415879; EMMONS LH, 1990, NEOTROPICAL RAINFORE; FARLEY SD, 1987, J MAMMAL, V68, P413, DOI 10.2307/1381487; Feer F, 1997, NEOTROPICAL RAINFORE; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Fitch WT., 2006, VISUAL COMMUN-US, V3, P145; Foster-Turley P, 1990, OTTERS ACTION PLAN T, DOI 10.2305/IUCN.CH.1990.SSC-AP.3.en; Freeberg TM, 2012, PHILOS T R SOC B, V367, P1785, DOI 10.1098/rstb.2011.0213; Gnoli C., 1995, HYSTRIX ITALIAN J MA, V7; GREENACRE M, 1987, J AM STAT ASSOC, V82, P437, DOI 10.2307/2289445; HUFF JN, 1968, J MAMMAL, V49, P548, DOI 10.2307/1378229; Koepfli KP, 2008, CONSERV GENET, V9, P1589, DOI 10.1007/s10592-007-9498-5; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Koepfli KP, 1998, J ZOOL, V246, P401, DOI 10.1111/j.1469-7998.1998.tb00172.x; Kruuk H., 1995, WILD OTTERS PREDATIO; Kruuk H., 2006, OTTERS ECOLOGY BEHAV; Lariviere Serge, 2001, Mammalian Species, V671, P1, DOI 10.1644/1545-1410(2001)671<0001:AC>2.0.CO;2; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lemasson A, 2014, J MAMMAL, V95, P128, DOI 10.1644/12-MAMM-A-313.1; Leuchtenberger C, 2014, ETHOL ECOL EVOL, V26, P19, DOI 10.1080/03949370.2013.821673; Leuchtenberger C, 2014, J ACOUST SOC AM, V136, P2861, DOI 10.1121/1.4896518; Manser MB, 2014, ADV STUD BEHAV, V46, P281, DOI 10.1016/B978-0-12-800286-5.00006-7; McComb K, 2005, BIOL LETTERS, V1, P381, DOI 10.1098/rsbl.2005.0366; MCSHANE LJ, 1995, J MAMMAL, V76, P414, DOI 10.2307/1382352; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Mumm CAS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185733; Mumm CAS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112562; Mumm CAS, 2014, ANIM BEHAV, V88, P243, DOI 10.1016/j.anbehav.2013.12.005; Pardini R, 1999, J MAMMAL, V80, P600, DOI 10.2307/1383304; Parera A., 1993, IUCN OTTER SPEC GR, V8, P13; Plotsky K, 2013, J ZOOL, V291, P76, DOI 10.1111/jzo.12048; Quadros J., 2002, MASTOZOOLOGIA NEOTRO, V1, P54; Reby D, 2012, ANIM COGN, V15, P265, DOI 10.1007/s10071-011-0451-0; Revelle William, 2020, CRAN; Rheingantz ML, 2014, TROP CONSERV SCI, V7, P224; Riede T, 1999, J EXP BIOL, V202, P2859; SCHENCK C, 1995, Z SAUGETIERKD, V60, P310; Team R.C, R LANG ENV STAT COMP; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; Van Zyll de Jong C., 1972, SYSTEMATIC REV NEART; Wilden I., 1998, Bioacoustics, V9, P171; Wong J, 1999, J MAMMAL, V80, P570, DOI 10.2307/1383302	58	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251974	10.1371/journal.pone.0251974	http://dx.doi.org/10.1371/journal.pone.0251974			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038461	Green Published, gold			2022-12-26	WOS:000664633500035
J	Bay, V; Jafari, M; Shirzadi, MR; Bagheri, A; Asl, IM				Bay, Vahid; Jafari, Mehdi; Shirzadi, Mohammad Reza; Bagheri, Ali; Asl, Irvan Masoudi			Trend and epidemiological patterns of animal bites in Golestan province (Northern Iran) between 2017 and 2020	PLOS ONE			English	Article								Background Rabies is one of the oldest zoonosis viral diseases, which still remains as one of the most important threats to public health in the 21st century. Methods This cross-sectional study examined epidemiologic features of all 33,996 cases of persons bitten by animals and referred to the rabies prophylaxis centers in Golestan province between March 2017 and March 2020. Factors included demographic information of the victim (age, gender, and occupation), type of invasive animals (dog, cat, and other types), time of bite (year, month, and hour), place of residence (urban or rural), and injury and treatment statuses. We also obtained national and provincial animal bite incidence data for all of Iran and for Golestan province for the longer interval 2013-2020 to examine broader time trends. We used SPSS version 19, QGIS version 3.1, and Excel 2013 to generate frequency distributions and descriptive statistics. Results The incidence rates of animal bites in Golestan province and Iran as a whole both increased smoothly. The latest incidence rate of animal bites in Golestan was 652 per 100,000 people, almost three times the overall national figure for 2020. Most cases of animal bites (67.6%) occurred in rural areas, and 36% of the victims aged under 19 years old. Dog and cat bites accounted for the great majority of cases (89% and 8%, respectively). The highest rate of animal bites was reported in the spring (30.8%). The lower limb was the most commonly bitten area in these individuals (64.6%). Of note, 87% of the cases received incomplete prophylactic post-exposure treatment, and 18% received immunoglobulin. Conclusion The increasing rates of animal bites in the study area as well as the higher rate compared to the national average indicates the need for further review of animal bite control programs.	[Bay, Vahid; Jafari, Mehdi; Asl, Irvan Masoudi] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Dept Healthcare Serv Management, Tehran, Iran; [Jafari, Mehdi] Minist Hlth & Med Educ, Hlth Managers Dev Inst, Tehran, Iran; [Shirzadi, Mohammad Reza] Minist Hlth & Med Educ, Ctr Communicable Dis Control, Tehran, Iran; [Bagheri, Ali] Golestan Univ Med Sci, Infect Dis Res Ctr, Gorgan, Golestan, Iran	Iran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Ministry of Health & Medical Education (MOHME); Golestan University of Medical Sciences	Asl, IM (corresponding author), Iran Univ Med Sci, Sch Hlth Management & Informat Sci, Dept Healthcare Serv Management, Tehran, Iran.	aramiyan3@gmail.com	bay, vahid/AAB-6284-2022					Ahmad ZZ., 2019, J STUDENT RES COMMIT, V1, P23; Alaifan T., 2019, J HLTH INFORM DEV CO, V13; Amiri S, 2020, ANN GLOB HEALTH, V86, DOI 10.5334/aogh.2776; Azizi F, 2010, EPIDEMIOLOGY CONTROL; Babazadeh T, 2016, J ACUTE DIS, V5, P488, DOI 10.1016/j.joad.2016.08.019; Dehghani A, 2019, J ACUTE DIS, V8, P195, DOI 10.4103/2221-6189.268408; Esmaeilzadeh F., 2014, Tehran University Medical Journal, V72, P630; Fauci Braunwald, HARRISONS PRINCIPLES, VII, P2738; Hardanahalli RS, 2017, INDAN J COMMUNITY HE, V29, P156; Hatam N, 2014, J RES HEALTH SCI, V14, P122; Hosseini S., 2017, Journal of Community Health Research, V6, P216; Karimi A, 2019, J ACUTE DIS, V8, P265, DOI 10.4103/2221-6189.272860; Kassiri H., 2020, J PREV MED WILMINGTO, V6; Ministry of Health and Medical Education. Golestan University of Medical Sciences, 2020, MOHME1399710 MIN HLT; Raeisi A., 2012, COMPREHENSIVE GUIDEL; Salahuddin N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004448; Taylor LH, 2015, VET MED-RES REP, V6, P361, DOI 10.2147/VMRR.S51147; World Health Organization, 2020, FACTS SHEETS; World Health Organization, 2018, AN BIT	19	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252058	10.1371/journal.pone.0252058	http://dx.doi.org/10.1371/journal.pone.0252058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033653	Green Published, gold			2022-12-26	WOS:000664633100027
J	Bernardo, S; Crespo, R; Saraiva, S; Barata, R; Goncalves, S; Nogueira, P; Cortez-Pinto, H; Machado, MV				Bernardo, Sonia; Crespo, Ricardo; Saraiva, Sofia; Barata, Rui; Goncalves, Sara; Nogueira, Paulo; Cortez-Pinto, Helena; Machado, Mariana Verdelho			Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality	PLOS ONE			English	Article							RISK-FACTOR; CIRRHOSIS; CONSUMPTION; DRINKING; MEN; PROGNOSIS; FIBROSIS; SMOKING; WEIGHT; INDEX	Background Most long-term heavy drinkers do not have clinically evident chronic liver disease (CLD). However, at any time-point, their risk of developing CLD remains unknown. We aimed to evaluate the long-term outcomes of a group of heavy drinkers, without evidence of CLD at baseline. Methods A cohort of 123 long-term heavy drinkers without CLD were prospectively recruited in 2002 and retrospectively followed until 2018. Results At baseline (2002), median alcohol consumption was 271203g/day during 21.5 +/- 20 years, 65% being abstinent during the previous 1.75 +/- 5 months. Patients were followed for 14 +/- 3 years. During follow-up, 53% reported any alcohol intake. Alcohol consumption during follow-up associated weakly with either 1- or 6-months previous abstinence at baseline. Until 2018, progression to CLD occurred in 6%, associating with years of alcohol intake during follow-up (OR 1.15 [1.01-1.31]) and baseline alkaline-phosphatase (OR 1.05 [1.01-1.10]). During follow-up, being abstinent for at least 1 year positively associated with CLD-free survival. 27% died (55% of cancer-mostly oropharyngeal cancer, 27% of cardiovascular disease, and 9% of liver disease), with a mean age of 71 years [69-74] (10 years less than the expected in the Portuguese population). Achieving abstinence for at least 1 year positively associated with overall survival, while smoking, and hepatic steatosis at baseline associated negatively. Conclusion Long-term heavy drinkers seemed to have a decreased life expectancy compared with the overall Portuguese population. Cancer was the main cause of death. Our results suggest that progression to CLD depends mostly on continued alcohol intake. Alcohol abstinence, even if temporary, seems to decrease the risks of CLD and mortality.	[Bernardo, Sonia; Crespo, Ricardo; Cortez-Pinto, Helena; Machado, Mariana Verdelho] CHULN, Hosp Santa Maria, Dept Gastroenterol & Hepatol, Lisbon, Portugal; [Saraiva, Sofia] CHULC, Hosp Curry Cabral, Dept Nephrol, Lisbon, Portugal; [Barata, Rui] Portuguese Oncol Inst, Dept Gastroenterol, Lisbon, Portugal; [Goncalves, Sara] CHULN, Hosp Santa Maria, Dept Nephrol, Lisbon, Portugal; [Nogueira, Paulo] Univ Lisbon, Fac Med, Biostat Dept, Lisbon, Portugal; [Cortez-Pinto, Helena; Machado, Mariana Verdelho] Univ Lisbon, Fac Med, Nica Univ Gastrenterol, Lisbon, Portugal	Universidade de Lisboa; Hospital Santa Maria; Portuguese Institute of Oncology; Universidade de Lisboa; Hospital Santa Maria; Universidade de Lisboa; Universidade de Lisboa	Machado, MV (corresponding author), CHULN, Hosp Santa Maria, Dept Gastroenterol & Hepatol, Lisbon, Portugal.; Machado, MV (corresponding author), Univ Lisbon, Fac Med, Nica Univ Gastrenterol, Lisbon, Portugal.	mverdelhomachado@gmail.com	Nogueira, Paulo Jorge/AAR-5605-2020; Nogueira, Paulo/HDL-7482-2022	Nogueira, Paulo Jorge/0000-0001-8316-5035; Machado, Mariana/0000-0001-7769-7860; Cortez-Pinto, Helena/0000-0002-8537-8744				Aberg F, 2018, HEPATOLOGY, V67, P2141, DOI 10.1002/hep.29631; Allen AM, 2019, J HEPATOL, V71, P1229, DOI 10.1016/j.jhep.2019.08.018; [Anonymous], 2018, LANCET, DOI [DOI 10.1016/S0140-6736(18)31310-2, 10.14257/ijgdc.2018.11.9.06]; ARICO S, 1995, LIVER, V15, P202; Askgaard G, 2015, J HEPATOL, V62, P1061, DOI 10.1016/j.jhep.2014.12.005; Axley PD, 2019, CLIN LIVER DIS, V23, P39, DOI 10.1016/j.cld.2018.09.011; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Becker U, 2002, HEPATOLOGY, V35, P868, DOI 10.1053/jhep.2002.32101; Bellentani S, 1997, GUT, V41, P845, DOI 10.1136/gut.41.6.845; Bobo JK, 2000, ALCOHOL RES HEALTH, V24, P225; Estatistica INd, 2019, B I NAC EST; Fullman N, 2017, LANCET, V390, P1423, DOI 10.1016/S0140-6736(17)32336-X; Fuster D, 2018, NEW ENGL J MED, V379, P1251, DOI 10.1056/NEJMra1715733; Guha IN, 2019, CLIN GASTROENTEROL H, V17, P2330, DOI 10.1016/j.cgh.2019.01.042; Hagstrom H, 2021, GUT, V70, P170, DOI 10.1136/gutjnl-2019-320446; Hagstrom H, 2019, DIGEST DIS SCI, V64, P2014, DOI 10.1007/s10620-019-05509-6; Hart CL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1240; Holst C, 2017, ADDICTION, V112, P1358, DOI 10.1111/add.13799; Kendrick Stuart, 2013, Clin Liver Dis (Hoboken), V2, P61, DOI 10.1002/cld.145; Lackner C, 2017, J HEPATOL, V66, P610, DOI 10.1016/j.jhep.2016.11.011; Lau K, 2015, ALIMENT PHARM THER, V41, P467, DOI 10.1111/apt.13067; LELBACH WK, 1975, ANN NY ACAD SCI, V252, P85, DOI 10.1111/j.1749-6632.1975.tb19146.x; Liu B, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c912; Martins A, 2005, EUR J GASTROEN HEPAT, V17, P1099, DOI 10.1097/00042737-200510000-00014; Mitchell T, 2018, AM J GASTROENTEROL, V113, P1484, DOI 10.1038/s41395-018-0133-5; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; NISHIMURA M, 1983, KLIN WOCHENSCHR, V61, P265, DOI 10.1007/BF01497775; Pimpin L, 2018, J HEPATOL, V69, P718, DOI 10.1016/j.jhep.2018.05.011; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Singal AK, 2014, ALIMENT PHARM THER, V40, P105, DOI 10.1111/apt.12797; SORENSEN TIA, 1984, LANCET, V2, P241, DOI 10.1016/S0140-6736(84)90295-2; Spahr L, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-115; Stein E, 2016, J HEPATOL, V65, P998, DOI 10.1016/j.jhep.2016.06.018; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; TELI MR, 1995, LANCET, V346, P987, DOI 10.1016/S0140-6736(95)91685-7; UGARTE G, 1963, GASTROENTEROLOGY, V45, P182; VILSTRUP H, 1980, GUT, V21, P990, DOI 10.1136/gut.21.11.990; Weitzman ER, 2005, DRUG ALCOHOL DEPEN, V80, P377, DOI 10.1016/j.drugalcdep.2005.05.008; Westwood G, 2017, J HEPATOL, V67, P559, DOI 10.1016/j.jhep.2017.04.017	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252218	10.1371/journal.pone.0252218	http://dx.doi.org/10.1371/journal.pone.0252218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033642	gold, Green Published			2022-12-26	WOS:000664633100037
J	Jamal, A; Babazono, A; Li, YF; Fujita, T; Yoshida, S; Kim, SA				Jamal, Aziz; Babazono, Akira; Li, Yunfei; Fujita, Takako; Yoshida, Shinichiro; Kim, Sung A.			Elucidating variations in outcomes among older end-stage renal disease patients on hemodialysis in Fukuoka Prefecture, Japan	PLOS ONE			English	Article							GOODNESS-OF-FIT; REGIONAL-VARIATIONS; REGRESSION; DIALYSIS; FRAILTY	Variations in health care outcomes and services potentially indicate resource allocation inefficiency. Therefore, this study was conducted to examine variations in mortality and hospitalization cases among end-stage renal disease (ESRD) patients receiving hemodialysis (HD) care from medical facilities located in 13 secondary medical care areas (SMAs) of Fukuoka prefecture, Japan. The research was designed as a retrospective, cross-sectional study using insurance claims data. The subjects of the study were older patients (over 65 years old) insured by the Fukuoka prefecture's Latter-Stage Elderly Healthcare Insurance. Using an electronic claims database, we identified patients with chronic kidney disease (CKD) who had received HD care from April 1, 2017 to March 31, 2018. The CKD status was identified using International Classification of Disease, 10th revision code, and HD maintenance status was ascertained using specific insurance procedure codes. A total of 5,243 patients met our inclusion criteria and their records were subsequently reviewed. About 73% (n = 3,809) of patients had admission records during the period studied. Thus, the data regarding hospital length of stay (LOS) and admission costs were analyzed separately. Significant differences in terms of increased risks in hospitalization were evident in a number of SMAs. An increase in mortality risk due to heart failure and malignancy was observed in two separate SMAs. Also, analyzed LOS, total hospitalization cost, and cost per day according to SMAs showed statistically significant variations. The findings highlight the magnitude of the burden of CKD and ESRD in the community. The high prevalence of ESRD, associated mortality, and hospitalized HD patients signal the need for clinicians to assume broader roles in measures against chronic kidney disease through involvement in community awareness programs. To improve patient outcomes, improvement of regional health care provision, the level of medical care, and the development of existing human resources are needed.	[Jamal, Aziz; Babazono, Akira; Li, Yunfei; Fujita, Takako; Yoshida, Shinichiro; Kim, Sung A.] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka, Japan; [Jamal, Aziz] Univ Teknol MARA, Fac Business & Management, Hlth Adm Program, Selangor, Malaysia; [Fujita, Takako] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Fukuoka, Japan	Kyushu University; Universiti Teknologi MARA; Kyushu University	Jamal, A (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Care Adm & Management, Fukuoka, Japan.; Jamal, A (corresponding author), Univ Teknol MARA, Fac Business & Management, Hlth Adm Program, Selangor, Malaysia.	azizabduls.jamal@gmail.com	Li, Yunfei/AAY-3370-2021; Fujita, Takako/ABA-3586-2021; Jamal, Aziz/AAX-1711-2021	Li, Yunfei/0000-0002-0542-4641; Fujita, Takako/0000-0002-6890-6533; Jamal, Aziz/0000-0001-7456-7921; KIM, SUNG-A/0000-0002-3367-5763				Ansah JP., 2017, INT J HEALTHC, V3, P84, DOI [10.5430/ijh.v3n1p84, DOI 10.5430/IJH.V3N1P84]; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Blough DK., 2000, HLTH SERV OUTCOMES R, V1, P185, DOI [DOI 10.1023/A:1012597123667, 10.1023/A%3A1012597123667, DOI 10.1023/A%3A1012597123667]; Cameron AC, 1997, J ECONOMETRICS, V77, P329; CARROLL RM, 1975, EDUC PSYCHOL MEAS, V35, P541, DOI 10.1177/001316447503500304; Castelli A, 2015, EUR J HEALTH ECON, V16, P243, DOI 10.1007/s10198-014-0569-5; Doerken S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217057; Freese Jeremy., 2006, REGRESSION MODELS CA; Fukui A, 2019, CLIN EXP NEPHROL, V23, P1263, DOI 10.1007/s10157-019-01786-7; Gim THT, 2017, INT REGIONAL SCI REV, V40, P616, DOI 10.1177/0160017615626214; Hardin JW., 2018, GEN LINEAR MODELS EX, VFourth Edition; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Ikesu R, 2020, TOHOKU J EXP MED, V251, P1, DOI 10.1620/tjem.251.1; Ishikawa T, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4470-x; Jamal A, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019871; Jiang P, 2020, POPUL HEALTH MANAG, V23, P264, DOI 10.1089/pop.2019.0141; Kato S, 2008, CLIN J AM SOC NEPHRO, V3, P1526, DOI 10.2215/CJN.00950208; Kimura T., 2019, JPN J PHARMACOEPIDEM, V24, P53, DOI [10.3820/jjpe.24.e2, DOI 10.3820/JJPE.24.E2]; KURITZ SJ, 1988, ANNU REV PUBL HEALTH, V9, P123, DOI 10.1146/annurev.pu.09.050188.001011; Li YF, 2022, INT J HEALTH POLICY, V11, P489, DOI 10.34172/ijhpm.2020.190; Long J.Scott., 1997, REGRESSION MODELS CA; Maeda T, 2016, MEDICINE, V95, P1, DOI 10.1097/MD.0000000000002519; Maeda T, 2016, INT J GERIATR PSYCH, V31, P186, DOI 10.1002/gps.4310; Miraldo Marisa., 2019, OXFORD RES ENCY EC F, DOI [10.1093/acrefore/9780190625979.001.0001/acrefore-9780190625979-e-76, DOI 10.1093/ACREFORE/9780190625979.001.0001/ACREFORE-9780190625979-E-76]; Mostovaya IM, 2014, SEMIN DIALYSIS, V27, P119, DOI 10.1111/sdi.12200; National Institute of Diabetes and Digestive and Kidney Diseases, 2021, 2021 USRDS ANN DAT R; Nitta K., 2019, THER APHER DIAL, V52, P679; Nouhi M, 2019, J EDUC HEALTH PROMOT, V8, DOI 10.4103/jehp.jehp_386_18; Ogata S., 2011, J JPN SOC DIAL THER, V44, P681, DOI [10.4009/jsdt.44.681, DOI 10.4009/JSDT.44.681]; Ooba N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066116; Puhr R, 2017, STAT MED, V36, P2302, DOI 10.1002/sim.7273; Quinn MP, 2011, POSTGRAD MED J, V87, P389, DOI 10.1136/pgmj.2010.099028; Roberfroid D, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-10; Robinson BM, 2016, LANCET, V388, P294, DOI 10.1016/S0140-6736(16)30448-2; Sakai M, 2019, ENVIRON HEALTH PREV, V24, DOI 10.1186/s12199-019-0819-3; Sakamoto H., 2019, JAPAN HLTH SYSTEM RE, V8; SAKIA RM, 1992, J ROY STAT SOC D-STA, V41, P169, DOI 10.2307/2348250; Saran R, 2020, AM J KIDNEY DIS, V75, pSVI, DOI 10.1053/j.ajkd.2019.09.003; Shimizu S, 2018, NEPHRON, V140, P194, DOI 10.1159/000492083; Sinkovec H, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234658; Skidmore ST, 2013, BEHAV RES METHODS, V45, P536, DOI 10.3758/s13428-012-0257-2; Skinner J, 2012, HBK ECON, P45, DOI 10.1016/B978-0-444-53592-4.00002-5; Statistical Handbook of Japan 2020 [Internet], STAT HDB JAP; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Sutherland K, 2020, J EVAL CLIN PRACT, V26, P687, DOI 10.1111/jep.13181; Sy J, 2017, CURR OPIN NEPHROL HY, V26, P537, DOI 10.1097/MNH.0000000000000364; Takeuchi H, 2018, AGING DIS, V9, P192, DOI 10.14336/AD.2017.0429; Usami T, 2003, KIDNEY INT, V64, P1445, DOI 10.1046/j.1523-1755.2003.00221.x; Usami T, 2000, JAMA-J AM MED ASSOC, V284, P2622, DOI 10.1001/jama.284.20.2622; Usami T, 2002, CURR OPIN NEPHROL HY, V11, P343, DOI 10.1097/00041552-200205000-00012; Usvyat LA, 2014, NEPHROL DIAL TRANSPL, V29, P442, DOI 10.1093/ndt/gft219; Wakasugi M, 2013, THER APHER DIAL, V17, P298, DOI 10.1111/j.1744-9987.2012.01144.x; Wong B, 2018, AM J KIDNEY DIS, V71, P344, DOI 10.1053/j.ajkd.2017.08.028	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252196	10.1371/journal.pone.0252196	http://dx.doi.org/10.1371/journal.pone.0252196			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OL	34033671	Green Published, gold			2022-12-26	WOS:000664633100036
J	Xi, YP; Chen, AF; Ng, A				Xi, Yipeng; Chen, Anfan; Ng, Aaron			Conditional transparency: Differentiated news framings of COVID-19 severity in the pre-crisis stage in China	PLOS ONE			English	Article							NEWSPAPER COVERAGE; LOCAL-GOVERNMENTS; HEALTH CRISIS; SOCIAL MEDIA; PROMINENCE; PROXIMITY; FLU; US; MANAGEMENT; SARS	Transparency of Chinese media coverage became an international controversy when the COVID-19 outbreak initially emerged in Wuhan, the eventual crisis epicenter in China. Unlike studies characterizing mass media in authoritarian contexts as government mouthpieces during a crisis, this study aims to disaggregate Chinese media practices to uncover differences in when, where, and how the severity of COVID-19 was reported. We examine differences in how media institutions reported the severity of the COVID-19 epidemic in China during the pre-crisis period from 1 January 2020 to 20 January 2020 in terms of both the "vertical" or hierarchical positions of media institutions in the Chinese media ecosystem and the "horizontal" positions of media institutions' social proximity to Wuhan in terms of geographical human traffic flows. We find that the coverage of crisis severity is negatively associated with the media's social proximity to Wuhan, but the effect varies depending on the positional prominence of a news article and situation severity. Implications of the institutions' differentiated reporting strategies on future public health reporting in an authoritarian context are also discussed.	[Xi, Yipeng; Ng, Aaron] Natl Univ Singapore, Dept Commun & New Media, Singapore, Singapore; [Chen, Anfan] Univ Sci & Technol China, Sch Human & Social Sci, Hefei, Anhui, Peoples R China	National University of Singapore; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Ng, A (corresponding author), Natl Univ Singapore, Dept Commun & New Media, Singapore, Singapore.	e0145895@u.nus.edu	Ng, Aaron/AAN-4965-2021	Ng, Aaron/0000-0002-8349-5816; Xi, Yipeng/0000-0002-5060-4078	University of Science and Technology of China [DA2110251001]; 2019 New Humanities Funding of USTC [YD2110002015]	University of Science and Technology of China; 2019 New Humanities Funding of USTC	This research is supported by the 25th department funding of University of Science and Technology of China [grant numbers: DA2110251001]; 2019 New Humanities Funding of USTC [grant numbers: YD2110002015]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi K, 2020, J ROY SOC MED, V113, P131, DOI 10.1177/0141076820918796; Althaus SL, 2002, COMMUN RES, V29, P180, DOI 10.1177/0093650202029002004; An SK, 2009, PUBLIC RELAT REV, V35, P107, DOI 10.1016/j.pubrev.2009.01.010; Bolsen T, 2020, SCI COMMUN, V42, P562, DOI 10.1177/1075547020953603; Brady Anne-Marie., 2008, MARKETING DICTATORSH; Cheng QJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-841; Coombs W.T., 2012, ONGOING CRISIS COMMU; Cortinas-Rovira S, 2015, J CONTING CRISIS MAN, V23, P159, DOI 10.1111/1468-5973.12063; Dan V, 2018, HEALTH RISK SOC, V20, P203, DOI 10.1080/13698575.2018.1522422; Feng YJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244351; Fink S, 1986, CRISIS MANAGEMENT PL; Fu KW, 2012, HEALTH RISK SOC, V14, P71, DOI 10.1080/13698575.2011.641521; Fung TKF, 2011, J HEALTH COMMUN, V16, P889, DOI 10.1080/10810730.2011.561913; Gilbert G, 2013, S AFR J BUS MANAG, V44, P1; Guan B, 2017, J CONTEMP CHINA, V26, P233, DOI 10.1080/10670564.2016.1223105; Han EL., 2015, MICROBLOGGING MEMORI; Hong T, 2007, CYBERPSYCHOL BEHAV, V10, P696, DOI 10.1089/cpb.2007.9968; Huang YHC, 2016, PUBLIC RELAT REV, V42, P201, DOI 10.1016/j.pubrev.2015.11.015; Jia WS, 2021, GLOB MEDIA CHINA, V6, P8, DOI 10.1177/2059436421994003; Jo W, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00425; Kochenderfer MJ, 2015, MIT LINCOLN LAB, P1; Koffman J, 2020, J ROY SOC MED, V113, P211, DOI 10.1177/0141076820930665; Krippendorff K, 2004, HUM COMMUN RES, V30, P411, DOI 10.1111/j.1468-2958.2004.tb00738.x; Kwon KH, 2019, INT J COMMUN-US, V13, P2652; Kwon KH, 2017, MASS COMMUN SOC, V20, P869, DOI 10.1080/15205436.2017.1369545; Lee S, 2007, PUBLIC RELAT REV, V33, P158, DOI 10.1016/j.pubrev.2007.02.002; Lei YW, 2018, PRINCE ST CONT CHINA, P1, DOI 10.1515/9781400887941; Li Y., 2017, COMMUNICATION SOC, V39, P157; Li Z., 2020, MASS MEDIA RES, V142, P59; Lieberthal Kenneth, 2004, GOVERNING CHINA REVO; Luther CA, 2005, J MASS COMMUN Q, V82, P857, DOI 10.1177/107769900508200407; Mertha A, 2009, CHINA QUART, P995, DOI 10.1017/S0305741009990592; Myhre SL, 2002, J PUBLIC HEALTH POL, V23, P172, DOI 10.2307/3343193; National Health and Family Planning Commission of the People's Republic of China (NHFPC), 2006, MIN HLTH INF DISS PL; Ogbodo JN, 2020, HEALTH PROMOT PERSPE, V10, P257, DOI 10.34172/hpp.2020.40; Pan PL, 2016, J CONTING CRISIS MAN, V24, P95, DOI 10.1111/1468-5973.12105; Poirier W, 2020, CAN J POLIT SCI, V53, P365, DOI 10.1017/S0008423920000372; Repnikova M, 2017, MEDIA POLITICS IN CHINA: IMPROVISING POWER UNDER AUTHORITARIANISM, pCP1, DOI 10.1017/9781108164474; Roberts M.E., 2018, CENSORED DISTRACTION; Schlaeger J, 2014, CHINA INFORM, V28, P189, DOI 10.1177/0920203X14533901; Sun Y., 2020, MANY PEOPLE LEFT WUH; Thomas T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00483; Tian Z., 2005, THESIS FUDAN U CHINA; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Ungar S, 2008, SCI COMMUN, V29, P472, DOI 10.1177/1075547008316219; Vai B, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.563426; van der Meer TGLA, 2013, PUBLIC RELAT REV, V39, P229, DOI 10.1016/j.pubrev.2012.12.001; Vasterman PLM, 2013, EUR J COMMUN, V28, P436, DOI 10.1177/0267323113486235; Veil SR, 2012, PUBLIC RELAT REV, V38, P935, DOI 10.1016/j.pubrev.2012.08.004; Voltmer Katrin, 2006, MASS MEDIA POLITICAL; Wang S, 2008, MOD CHINA, V34, P56, DOI 10.1177/0097700407308169; Wicke P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240010; Xi YP, 2020, GLOB MEDIA CHINA, V5, P275, DOI 10.1177/2059436420907185; Xia Q., 2014, OPEN TIMES, V1, P190; Xiong W, 2010, THESIS SOOCHOW U CHI; Yang Z, 2010, VARIOUS DILEMMAS NEW; Zhang WY, 2020, NEW MEDIA SOC, V22, P1484, DOI 10.1177/1461444819880520; Zhao Y., 2008, COMMUNICATION CHINA; Zhao YZ, 2000, J COMMUN, V50, P3, DOI 10.1093/joc/50.2.3; Zhou XG, 2010, MOD CHINA, V36, P47, DOI 10.1177/0097700409347970	60	4	4	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252062	10.1371/journal.pone.0252062	http://dx.doi.org/10.1371/journal.pone.0252062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029357	gold, Green Published			2022-12-26	WOS:000664632800025
J	Kato, M; Ikeda, K; Sugiyama, T; Tanaka, S; Iida, K; Suga, K; Nishimura, N; Mimura, N; Kasuya, T; Kumagai, T; Furuya, H; Iwamoto, T; Iwata, A; Furuta, S; Suto, A; Suzuki, K; Kawakami, E; Nakajima, H				Kato, Manami; Ikeda, Kei; Sugiyama, Takahiro; Tanaka, Shigeru; Iida, Kazuma; Suga, Kensuke; Nishimura, Nozomi; Mimura, Norihiro; Kasuya, Tadamichi; Kumagai, Takashi; Furuya, Hiroki; Iwamoto, Taro; Iwata, Arifumi; Furuta, Shunsuke; Suto, Akira; Suzuki, Kotaro; Kawakami, Eiryo; Nakajima, Hiroshi			Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis	PLOS ONE			English	Article							SOCIETY CLASSIFICATION CRITERIA; PSORIATIC-ARTHRITIS; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; AXIAL SPONDYLOARTHRITIS; TENOSYNOVITIS; DACTYLITIS; VALIDATION; ENTHESITIS; RESOLUTION	Objectives We aimed to explore the associations of musculoskeletal inflammation patterns with peripheral blood innate lymphoid cell (ILC) populations, serum cytokines/chemokines, and treatment response to methotrexate in patients with rheumatoid arthritis (RA) and spondyloarthritis (SpA). Methods We enrolled 100 patients with either RA or SpA and performed ultrasound to evaluate power Doppler signals for synovitis (52 joint regions), tenosynovitis (20 tendons), and enthesitis (44 sites). We performed clustering analysis using unsupervised random forest based on the multi-axis ultrasound information and classified the patients into groups. We identified and counted ILC1-3 populations in the peripheral blood by flow cytometry and also measured the serum levels of 20 cytokines/chemokines. We also determined ACR20 response at 3 months in 38 patients who began treatment with methotrexate after study assessment. Results Synovitis was more prevalent and severe in RA than in SpA, whereas tenosynovitis and enthesitis were comparable between RA and SpA. Patients were classified into two groups which represented synovitis-dominant and synovitis-nondominant inflammation patterns. While peripheral ILC counts were not significantly different between RA and SpA, they were significantly higher in the synovitis-nondominant group than in the synovitis-dominant group (ILC1-3: p = 0.0007, p = 0.0061, and p = 0.0002, respectively). On the other hand, clustering of patients based on serum cytokines/chemokines did not clearly correspond either to clinical diagnoses or to synovitis-dominant/nondominant patterns. The synovitis-dominant pattern was the most significant factor that predicted clinical response to methotrexate (p = 0.0065). Conclusions Musculoskeletal inflammation patterns determined by ultrasound are associated with peripheral ILC counts and could predict treatment response to methotrexate.	[Kato, Manami; Ikeda, Kei; Sugiyama, Takahiro; Tanaka, Shigeru; Iida, Kazuma; Suga, Kensuke; Nishimura, Nozomi; Mimura, Norihiro; Kasuya, Tadamichi; Kumagai, Takashi; Furuya, Hiroki; Iwamoto, Taro; Iwata, Arifumi; Furuta, Shunsuke; Suto, Akira; Suzuki, Kotaro; Nakajima, Hiroshi] Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Chiba, Japan; [Kawakami, Eiryo] Chiba Univ, Grad Sch Med, Artificial Intelligence Med, Chiba, Chiba, Japan; [Kawakami, Eiryo] RIKEN, Med Sci Innovat Hub Program, Wako, Saitama, Japan	Chiba University; Chiba University; RIKEN	Ikeda, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Chiba, Japan.	K.Ikeda@faculty.chiba-u.jp	Iwamoto, Taro/AAW-2912-2021; Kato, Manami/AAG-6459-2021; Nakajima, Hiroshi/AFU-9313-2022; Furuya, Hiroki/GYU-8404-2022	Kato, Manami/0000-0002-0144-9606; Nakajima, Hiroshi/0000-0001-8595-9381; Suga, Kensuke/0000-0003-3107-788X; Furuya, Hiroki/0000-0002-2288-923X; Tanaka, Shigeru/0000-0002-8466-110X	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18K08405]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-inAids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (https://www.mext.go.jp/en/) (Grant number: 18K08405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing	Al-Mossawi MH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01771-2; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Altobelli E, 2017, CURR RHEUMATOL REV, V13, P170, DOI 10.2174/1573397113666170427125918; [Anonymous], 2020, UMAP UNIFORM MANIFOL; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bakewell CJ, 2013, J RHEUMATOL, V40, P1951, DOI 10.3899/jrheum.130643; Blijdorp ICJ, 2019, ARTHRITIS RHEUMATOL, V71, P392, DOI 10.1002/art.40736; Breiman L., 2001, MACH LEARN, V45, P5; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Ciccia F, 2015, ANN RHEUM DIS, V74, P1739, DOI 10.1136/annrheumdis-2014-206323; Cuthbert RJ, 2017, ARTHRITIS RHEUMATOL, V69, P1816, DOI 10.1002/art.40150; D'Agostino MA, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000428; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Gossec L, 2020, ANN RHEUM DIS, V79, P700, DOI 10.1136/annrheumdis-2020-217159; Gutierrez M, 2011, ANN RHEUM DIS, V70, P1111, DOI 10.1136/ard.2010.147272; Iwamoto T, 2014, ARTHRIT CARE RES, V66, P1576, DOI 10.1002/acr.22303; Jansen PAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004725; Kaufman L, STAT DATA ANAL BASED, P405; Kingsley GH, 2012, RHEUMATOLOGY, V51, P1368, DOI 10.1093/rheumatology/kes001; Kobayashi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166616; Kolbinger F, 2017, J ALLERGY CLIN IMMUN, V139, P923, DOI 10.1016/j.jaci.2016.06.038; Kunwar S, 2016, RHEUMATOL INT, V36, P1065, DOI 10.1007/s00296-016-3480-9; Leijten EFA, 2015, ARTHRITIS RHEUMATOL, V67, P2673, DOI 10.1002/art.39261; Lillegraven S, 2011, ANN RHEUM DIS, V70, P2049, DOI 10.1136/ard.2011.151316; Maksymowych WP, 2009, ANN RHEUM DIS, V68, P948, DOI 10.1136/ard.2007.084244; Mauro D, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0834-9; McGonagle D, 2019, NAT REV RHEUMATOL, V15, P113, DOI 10.1038/s41584-018-0147-9; Mease PJ, 2019, ARTHRITIS RHEUMATOL, V71, P1112, DOI 10.1002/art.40851; Nakagomi D, 2013, ARTHRITIS RHEUM-US, V65, P890, DOI 10.1002/art.37848; Naredo E, 2013, ANN RHEUM DIS, V72, P1328, DOI 10.1136/annrheumdis-2012-202092; Ogdie A, 2020, RHEUMATOLOGY, V59, pI37, DOI 10.1093/rheumatology/kez383; Rauber S, 2017, NAT MED, V23, P938, DOI 10.1038/nm.4373; Roan F, 2016, J IMMUNOL, V196, P2051, DOI 10.4049/jimmunol.1501491; Rodriguez-Carrio J, 2017, ARTHRITIS RHEUMATOL, V69, P70, DOI 10.1002/art.39811; Rosser EC, 2019, ARTHRITIS RHEUMATOL, V71, P460, DOI 10.1002/art.40731; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Saku A, 2020, CLIN RHEUMATOL, V39, P1091, DOI 10.1007/s10067-020-04960-5; Schett G, 2017, NAT REV RHEUMATOL, V13, P731, DOI 10.1038/nrrheum.2017.188; Shi T, 2006, J COMPUT GRAPH STAT, V15, P118, DOI 10.1198/106186006X94072; Singh JA, 2019, ARTHRITIS RHEUMATOL, V71, P5, DOI 10.1002/art.40726; Smolen JS, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-209831; Soare A, 2018, J IMMUNOL, V200, P1249, DOI 10.4049/jimmunol.1700596; Sokolova MV, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-2111-8; Tan AL, 2015, ANN RHEUM DIS, V74, P185, DOI 10.1136/annrheumdis-2014-205839; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van Steenbergen HW, 2016, ANN RHEUM DIS, V75, P1824, DOI 10.1136/annrheumdis-2015-208138; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Ward MM, 2019, ARTHRITIS RHEUMATOL, V71, P1599, DOI 10.1002/art.41042	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252116	10.1371/journal.pone.0252116	http://dx.doi.org/10.1371/journal.pone.0252116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019595	Green Submitted, gold, Green Published			2022-12-26	WOS:000664632300053
J	Proverbio, D; Kemp, F; Magni, S; Husch, A; Aalto, A; Mombaerts, L; Skupin, A; Goncalves, J; Ameijeiras-Alonso, J; Ley, C				Proverbio, Daniele; Kemp, Francoise; Magni, Stefano; Husch, Andreas; Aalto, Atte; Mombaerts, Laurent; Skupin, Alexander; Goncalves, Jorge; Ameijeiras-Alonso, Jose; Ley, Christophe			Dynamical SPQEIR model assesses the effectiveness of non-pharmaceutical interventions against COVID-19 epidemic outbreaks	PLOS ONE			English	Article								Against the current COVID-19 pandemic, governments worldwide have devised a variety of non-pharmaceutical interventions to mitigate it. However, it is generally difficult to estimate the joint impact of different control strategies. In this paper, we tackle this question with an extended epidemic SEIR model, informed by a socio-political classification of different interventions. First, we inquire the conceptual effect of mitigation parameters on the infection curve. Then, we illustrate the potential of our model to reproduce and explain empirical data from a number of countries, to perform cross-country comparisons. This gives information on the best synergies of interventions to control epidemic outbreaks while minimising impact on socio-economic needs. For instance, our results suggest that, while rapid and strong lockdown is an effective pandemic mitigation measure, a combination of social distancing and early contact tracing can achieve similar mitigation synergistically, while keeping lower isolation rates. This quantitative understanding can support the establishment of mid- and long-term interventions, to prepare containment strategies against further outbreaks. This paper also provides an online tool that allows researchers and decision makers to interactively simulate diverse scenarios with our model.	[Proverbio, Daniele; Kemp, Francoise; Magni, Stefano; Husch, Andreas; Aalto, Atte; Mombaerts, Laurent; Skupin, Alexander; Goncalves, Jorge] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Belvaux, Luxembourg; [Ameijeiras-Alonso, Jose] Univ Leuven, Dept Math, Leuven, Belgium; [Ley, Christophe] Univ Ghent, Dept Appl Math Comp Sci & Stat, Ghent, Belgium	University of Luxembourg; KU Leuven; Ghent University	Proverbio, D (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Belvaux, Luxembourg.	daniele.proverbio@uni.lu	Goncalves, Jorge M/GRN-8101-2022; Husch, Andreas Dominik/ABA-3174-2020; Proverbio, Daniele/GXH-0194-2022; Goncalves, Jorge/GYD-3756-2022; Ley, Christophe/AAA-2566-2022	Goncalves, Jorge M/0000-0002-5228-6165; Husch, Andreas Dominik/0000-0001-9404-5127; Proverbio, Daniele/0000-0002-0122-479X; Kemp, Francoise/0000-0001-5845-293X; Ley, Christophe/0000-0002-2290-8437; Magni, Stefano/0000-0001-8649-3616	FNR PRIDE DTU CriTiCS [10907093]; Luxembourg National Research Fund [PRIDE17/12244779/PARK-QC]; Fondation Cancer Luxembourg; 111 Project on Computational Intelligence and Intelligent Control [B18024]; Luxembourg National Research Fund (FNR) [13684479]; FWO research project (Flemish Science Foundation) [G.0826.15N]; Research Fund KU Leuven [GOA/12/014]; Spanish State Research Agency (AEI) [MTM201676969-P]; European Regional Development Fund (ERDF); Xunta de Galicia through the ERDF [ED431C 2017/38]	FNR PRIDE DTU CriTiCS; Luxembourg National Research Fund(Luxembourg National Research Fund); Fondation Cancer Luxembourg; 111 Project on Computational Intelligence and Intelligent Control; Luxembourg National Research Fund (FNR)(Luxembourg National Research Fund); FWO research project (Flemish Science Foundation)(FWO); Research Fund KU Leuven(KU Leuven); Spanish State Research Agency (AEI)(Spanish Government); European Regional Development Fund (ERDF)(European Commission); Xunta de Galicia through the ERDF	DP and SM's work is supported by the FNR PRIDE DTU CriTiCS, ref 10907093. FK's work is supported by the Luxembourg National Research Fund PRIDE17/12244779/PARK-QC. A. H. work was partially supported by the Fondation Cancer Luxembourg. JG is partly supported by the 111 Project on Computational Intelligence and Intelligent Control, ref B18024. AA is supported by the Luxembourg National Research Fund (FNR) (Project code: 13684479). JAA is supported by the FWO research project G.0826.15N (Flemish Science Foundation), GOA/12/014 project (Research Fund KU Leuven), Project MTM201676969-P from the Spanish State Research Agency (AEI) co-funded by the European Regional Development Fund (ERDF) and the Competitive Reference Groups 2017-2020 (ED431C 2017/38) from the Xunta de Galicia through the ERDF.	ACAPS, COVID 19 GOV MEAS DA; Alrashed Saleh, 2020, Inform Med Unlocked, V20, P100420, DOI 10.1016/j.imu.2020.100420; Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288; Altig D, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104274; Alva-Manchego F, 2020, COMPUT LINGUIST, V46, P135, DOI [10.1162/coli_a_00370, 10.1162/COLI_a_00370]; Anand N., 2020, T INDIAN NATL ACAD E, V5, P141, DOI [10.1007/s41403-020-00151-5, DOI 10.1007/S41403-020-00151-5]; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Arino J, 2005, MATH MED BIOL, V22, P129, DOI 10.1093/imammb/dqi003; Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]; Comunian A, 2020, PHYSICA D, V413, DOI 10.1016/j.physd.2020.132674; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Currie CSM, 2020, J SIMUL, V14, P83, DOI 10.1080/17477778.2020.1751570; De-Camino-Beck T., 2020, MODIFIED SEIR MODEL, DOI [10.1101/2020.05.19.20106492, DOI 10.1101/2020.05.19.20106492]; Deutsche Gesellschaft fur Epidemiologie, 2020, STELL DTSCH GES EP D; Dipartimento della Protezione Civile-Emergenza Coronavirus, DAT COVID 19 IT; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Feng Z, 2007, MATH BIOSCI ENG, V4, P675, DOI 10.3934/mbe.2007.4.675; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Google, COVID 19 COMM MOB RE; Hale T., 2020, VARIATION GOVT RESPO; Hanel R., 2020, ARXIV PREPRINT ARXIV; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Kennedy AP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243123; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Lau H, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa037; Lee KB, 2020, PHYSICA A, V559, DOI 10.1016/j.physa.2020.125090; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; Li MY, 1999, MATH BIOSCI, V160, P191, DOI 10.1016/S0025-5564(99)00030-9; Liu Xiuli, 2020, MODELING SITUATION C, DOI [10.1101/2020.03.09.20033498, DOI 10.1101/2020.03.09.20033498]; Liu Y, 2020, CMMID REPOSITORY, V2; Liu Y, 2020, LANCET, V395, pE47, DOI 10.1016/S0140-6736(20)30462-1; Liu YN, 2021, J CANCER EDUC, V36, P1014, DOI 10.1007/s13187-019-01682-4; Lopez L, 2020, NAT HUM BEHAV, V4, P746, DOI 10.1038/s41562-020-0908-8; Mancastroppa M, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.020301; Moodley K, 2020, SAMJ S AFR MED J, V110, P456, DOI [10.7196/SAMJ.2020.v110i6.14842, 10.7196/SAMJ.2020v110i6.14842]; Newville M., INGARGIOLA LMFIT NON, DOI [10.5281/ZENODO.11813, DOI 10.5281/ZENODO.11813]; Ng YX, 2020, MMWR-MORBID MORTAL W, V69, P307, DOI 10.15585/mmwr.mm6911e1; Okell LC, 2020, LANCET, V395, pE110, DOI 10.1016/S0140-6736(20)31357-X; Peak CM, 2020, LANCET INFECT DIS, V20, P1025, DOI 10.1016/S1473-3099(20)30361-3; Postnikov EB, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109841; Roda WC, 2020, INFECT DIS MODEL, V5, P271, DOI 10.1016/j.idm.2020.03.001; Roser M, 2020, WHY DID RENEWABLES B; Sjodin H, 2020, INT J EPIDEMIOL, V49, P1443, DOI 10.1093/ije/dyaa121; Stutt ROJH, 2020, P ROY SOC A-MATH PHY, V476, DOI 10.1098/rspa.2020.0376; Syafruddin S., 2012, International Journal of Modern Physics: Conference Series, V9, P380, DOI 10.1142/S2010194512005454; Taylor, 1997, INTRO ERROR ANAL U S; Vinceti M, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100457; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; WHO,, 2019, NONPH PUBL HLTH MEAS; World Health Organization, TRACK PUBL HLTH SOC; World Health Organization and others, 2020, 88 WHO, P88; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Yan P, 2006, ANZIAM J, V48, P119, DOI 10.1017/S144618110000345X	61	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252019	10.1371/journal.pone.0252019	http://dx.doi.org/10.1371/journal.pone.0252019			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019589	Green Published			2022-12-26	WOS:000664632300045
J	Serraino, GF; Provenzano, M; Jiritano, F; Michael, A; Ielapi, N; Mastroroberto, P; Andreucci, M; Serra, R				Serraino, Giuseppe Filiberto; Provenzano, Michele; Jiritano, Federica; Michael, Ashour; Ielapi, Nicola; Mastroroberto, Pasquale; Andreucci, Michele; Serra, Raffaele			Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery	PLOS ONE			English	Article							CARDIOPULMONARY BYPASS MANAGEMENT; INFLAMMATORY RESPONSE SYNDROME; AORTIC-ARCH REPLACEMENT; ACUTE-RENAL-FAILURE; CARDIOVASCULAR RISK; TRANSFUSION; DYSFUNCTION; OUTCOMES; ANEMIA; EPIDEMIOLOGY	Background Acute Kidney Injury (AKI) represents a clinical condition with poor prognosis. The incidence of AKI in hospitalized patients was about 22-57%. Patients undergoing cardiac surgery (CS) are particularly exposed to AKI because of the related oxidative stress, inflammation and ischemia-reperfusion damage. Hence, the risk profile of patients undergoing CS who develop AKI and who are consequently at increased mortality risk deserves further investigation. Methods We designed a retrospective study examining consecutive patients undergoing any type of open-heart surgery from January to December 2018. Patients with a history of AKI were excluded. AKI was diagnosed according to KDIGO criteria. Univariate associations between clinical variables and AKI were tested using logistic regression analysis. Variable thresholds maximizing the association with AKI were measured with the Youden index. Multivariable logistic regression analysis was performed to assess predictors of AKI through backward selection. Mortality risk factors were assessed through the Cox proportional hazard model. Results We studied 158 patients (mean age 51.29.7 years) of which 74.7% were males. Types of procedures performed were: isolated coronary artery bypass (CABG, 50.6%), valve (28.5%), aortic (3.2%) and combined (17.7%) surgery. Overall, incidence of AKI was 34.2%. At multivariable analysis, young age (p = 0.016), low blood glucose levels (p = 0.028), estimated Glomerular Filtration Rate (p = 0.007), pH (p = 0.008), type of intervention (p = 0.031), prolonged extracorporeal circulation (ECC, p = 0.028) and cross-clamp (p = 0.021) times were associated with AKI. The threshold for detecting AKI were 91 and 51 minutes for ECC and cross-clamp times, respectively. At survival analysis, the presence of AKI, prolonged ECC and cross-clamp times, and low blood glucose levels forecasted mortality. Conclusions AKI is common among CS patients and associates with shortened life-expectancy. Several pre-operative and intra-operative predictors are associated with AKI and future mortality. Future studies, aiming at improving prognosis in high-risk patients, by a stricter control of these factors, are awaited.	[Serraino, Giuseppe Filiberto; Jiritano, Federica; Mastroroberto, Pasquale] Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Provenzano, Michele; Serra, Raffaele] Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy; [Michael, Ashour; Andreucci, Michele] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy; [Ielapi, Nicola] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Serra, Raffaele] Magna Graecia Univ Catanzaro, Int Res & Educ Program Clin & Expt Biotechnol, Interuniv Ctr Phlebolymphol CIFL, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Sapienza University Rome; Magna Graecia University of Catanzaro	Serra, R (corresponding author), Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.; Serra, R (corresponding author), Magna Graecia Univ Catanzaro, Int Res & Educ Program Clin & Expt Biotechnol, Interuniv Ctr Phlebolymphol CIFL, Catanzaro, Italy.	rserra@unicz.it	Jiritano, Federica/ABH-1659-2020; Serra, Raffaele/AAA-6874-2022	Jiritano, Federica/0000-0002-6889-5686; Serra, Raffaele/0000-0003-4477-7412; SERRAINO, GIUSEPPE FILIBERTO/0000-0002-4804-9570				Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS144, DOI 10.2337/dc18-S014; Andreucci VE, 1998, NEPHROL DIAL TRANSPL, V13, P17, DOI 10.1093/ndt/13.suppl_7.17; Belway D, 2011, PERFUSION-UK, V26, P395, DOI 10.1177/0267659111409095; Birnie K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0606-x; Chen YM, 2020, BMC ANESTHESIOL, V20, DOI 10.1186/s12871-020-01085-9; Coppolino G, 2018, CURR PHARM DESIGN, V24, P4794, DOI 10.2174/1381612825666190112165206; Dieleman JM, 2017, BRIT J ANAESTH, V119, P637, DOI 10.1093/bja/aex239; Fischer UM, 2002, PERFUSION-UK, V17, P401, DOI 10.1191/0267659102pf610oa; Fuiano G, 2005, KIDNEY INT, V68, P2773, DOI 10.1111/j.1523-1755.2005.00748.x; Gameiro J, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061704; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; Haase M, 2013, CONTRIB NEPHROL, V182, P99, DOI 10.1159/000349969; Haase M, 2012, NEPHROL DIAL TRANSPL, V27, P153, DOI 10.1093/ndt/gfr275; Habib RH, 2005, CRIT CARE MED, V33, P1749, DOI 10.1097/01.CCM.0000171531.06133.B0; Harky A, 2020, BRAZ J CARDIOV SURG, V35, P211, DOI 10.21470/1678-9741-2019-0122; Hessel EA, 2019, J CARDIOTHOR VASC AN, V33, P2296, DOI 10.1053/j.jvca.2019.01.039; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Hogue CW, 2006, ANESTH ANALG, V103, P21, DOI 10.1213/01.ANE.0000220035.82989.79; Hoste E, 2015, INTENS CARE MED, V41, P1411, DOI 10.1007/s00134-015-3934-7; Hung AM, 2018, DIABETES CARE, V41, P503, DOI 10.2337/dc17-1237; Karkouti K, 2015, CAN J ANESTH, V62, P377, DOI 10.1007/s12630-014-0302-y; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kuitunen A, 2006, ANN THORAC SURG, V81, P542, DOI 10.1016/j.athoracsur.2005.07.047; Kumar AB, 2012, J CARDIOTHOR VASC AN, V26, P64, DOI 10.1053/j.jvca.2011.07.007; Li J, 2019, J CARDIOTHORAC SURG, V14, DOI 10.1186/s13019-019-1027-3; Machado MN, 2014, REV BRAS CIR CARDIOV, V29, P299, DOI 10.5935/1678-9741.20140049; Mehta RH, 2006, CIRCULATION, V114, P2208, DOI 10.1161/CIRCULATIONAHA.106.635573; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; Murphy GS, 2009, ANESTH ANALG, V108, P1394, DOI 10.1213/ane.0b013e3181875e2e; O'Neal JB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1352-z; Obialo C., 2017, NIGER J CARDIOVASC T, V2, P3; Palevsky PM, 2012, CLIN J AM SOC NEPHRO, V7, P844, DOI 10.2215/CJN.12791211; Presta P, 2009, NEPHRON CLIN PRACT, V111, pC229, DOI 10.1159/000208991; Provenzano M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230020; Provenzano M, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010154; Provenzano M, 2019, REV CARDIOVASC MED, V20, P209, DOI 10.31083/j.rcm.2019.04.548; Provenzano M, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00314; Rangaswami J, 2019, CIRCULATION, V139, pE840, DOI 10.1161/CIR.0000000000000664; Ng RRG, 2014, J THORAC CARDIOV SUR, V147, P1356, DOI 10.1016/j.jtcvs.2013.09.040; Rosner Mitchell H, 2008, J Intensive Care Med, V23, P3, DOI 10.1177/0885066607309998; Rosner MH, 2006, CLIN J AM SOC NEPHRO, V1, P19, DOI 10.2215/CJN.00240605; Serra R, 2020, BIOMARK MED, V14, P75, DOI 10.2217/bmm-2019-0408; Sickeler R, 2014, ANN THORAC SURG, V97, P865, DOI 10.1016/j.athoracsur.2013.09.060; SLOGOFF S, 1990, ANN THORAC SURG, V50, P911, DOI 10.1016/0003-4975(90)91118-U; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Swaminathan M, 2003, ANN THORAC SURG, V76, P784, DOI 10.1016/S0003-4975(03)00558-7; Thakar CV, 2005, J AM SOC NEPHROL, V16, P162, DOI 10.1681/ASN.2004040331; Tuttle KR, 2003, AM J KIDNEY DIS, V41, P76, DOI 10.1053/ajkd.2003.50025; Wahba A, 2020, EUR J CARDIO-THORAC, V57, P210, DOI 10.1093/ejcts/ezz267	49	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252209	10.1371/journal.pone.0252209	http://dx.doi.org/10.1371/journal.pone.0252209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019579	gold, Green Published			2022-12-26	WOS:000664632300059
J	Vaneckova, P; Wade, S; Weber, M; Murray, JM; Grogan, P; Caruana, M; Banks, E; Canfell, K				Vaneckova, Pavla; Wade, Stephen; Weber, Marianne; Murray, John M.; Grogan, Paul; Caruana, Michael; Banks, Emily; Canfell, Karen			Birth-cohort estimates of smoking initiation and prevalence in 20(th) century Australia: Synthesis of data from 33 surveys and 385,810 participants	PLOS ONE			English	Article							LUNG-CANCER MORTALITY; TOBACCO CONTROL; UNITED-STATES; TRENDS; CAMPAIGNS; FRANCE; IMPACT	The aim of our study was to quantify sex-specific patterns of smoking prevalence and initiation in 10-year birth cohorts from 1910 to 1989 in Australia. We combined individual data of 385,810 participants from 33 cross-sectional surveys conducted between 1962 and 2018. We found that age-specific smoking prevalence varied considerably between men and women within birth cohorts born before 1960. The largest difference was observed in the earliest cohort (1910-1919), with up to 37.7% point greater proportion of current smokers in men than in women. In subsequent cohorts, the proportion decreased among men, but increased among women, until there was no more than 7.4% point difference in the 1960-69 birth cohort. In the 1970-79 and 1980-89 cohorts, smoking among men marginally increased, but the proportion was at most similar to 11.0% points higher than women. Our analysis of initiation indicated that many women born before the 1930s who smoked commenced smoking after age 25 years (e.g., similar to 27% born in 1910-19); compared to at most 8% of men in any birth cohort. The earliest birth cohort (1910-1919) had the greatest difference in age at initiation between sexes; 26.6 years in women versus 19.0 in men. In later cohorts, male and female smokers initiated increasingly earlier, converging in the 1960-69 cohort (17.6 and 17.8 years, respectively). While 22.9% of men and 8.4% of women initiated smoking aged < = 15 in the 1910-1919 cohort, in the latest cohort (1980-89) the reverse was true (21.4% and 28.8% for men and women, respectively). Marked differences in smoking prevalence and age at initiation existed between birth cohorts of Australian men and women born before 1960; after this, sex-specific trends in prevalence and initiation were similar. Understanding these patterns may inform the evaluation of tobacco control policies and the targeting of potential interventions for exposed populations such as lung cancer screening.	[Vaneckova, Pavla; Wade, Stephen; Weber, Marianne; Grogan, Paul; Caruana, Michael; Canfell, Karen] Univ Sydney, Daffodil Ctr, NSW Canc Council, Sydney, NSW, Australia; [Murray, John M.] UNSW, Sch Math & Stat, Sydney, NSW, Australia; [Banks, Emily] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Banks, Emily] Sax Inst, Sydney, NSW, Australia; [Canfell, Karen] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia	Cancer Council New South Wales; University of Sydney; University of New South Wales Sydney; Australian National University; University of Sydney; University of New South Wales Sydney	Vaneckova, P (corresponding author), Univ Sydney, Daffodil Ctr, NSW Canc Council, Sydney, NSW, Australia.	pavla.vaneckova@nswcc.org.au	Murray, John/B-5481-2009	Murray, John/0000-0001-9314-2283; Wade, Stephen/0000-0002-2573-9683; Vaneckova, Pavla/0000-0001-9213-8733; Banks, Emily/0000-0002-4617-1302; Weber, Marianne/0000-0001-5731-9651; Grogan, Paul/0000-0002-7680-1811	VCS Foundation (VCS) [ACTRN12613001207707, NCT02328872]; Roche Molecular Systems USA	VCS Foundation (VCS); Roche Molecular Systems USA	KC is co-principal investigator of an unrelated investigator-initiated trial of cervical screening in Australia (Compass; ACTRN12613001207707 and NCT02328872), which is conducted and funded by the VCS Foundation (VCS), a government-funded health promotion charity. The VCS Foundation received equipment and a funding contribution from Roche Molecular Systems USA. However, neither KC nor her institution on her behalf (Cancer Council NSW) receives direct funding from industry for this trial or any other project. All the other authors received no specific funding for this work.	Alamar B, 2006, AM J PUBLIC HEALTH, V96, P1359, DOI 10.2105/AJPH.2005.069617; Anderson CM, 2012, RISK ANAL, V32, pS14, DOI 10.1111/j.1539-6924.2011.01703.x; Australian Bureau of Statistics, 2018, AUSTR DEM STAT; Australian Bureau of Statistics, HLTH SURV NAT; Australian Bureau of Statistics, 2016, AUSTR HIST POP STAT; Australian Bureau of Statistics, 4364055001 AUSTR BUR; Australian Data Archive, DATAVERSE CATALOGUE; Australian Department of Health, 2016, POST REV TOB PLAIN P; Australian Department of Health, 2016, STUD IMP TOB PLAIN P; Australian Institute of Health and Welfare, 2020, DRUG STAT SER; Australian Institute of Health and Welfare, 2017, DRUG STAT SER; Australian Institute of Health and Welfare, AUSTR HLTH SER; Australian Institute of Health and Welfare, AUSTR BURD DIS SER N; Boer R, 2012, RISK ANAL, V32, pS190, DOI 10.1111/j.1539-6924.2012.01827.x; Brandt AM., 2007, CIGARETTE CENTURY RI; Burns David, 2014, Ann Am Thorac Soc, V11, P224, DOI 10.1513/AnnalsATS.201308-258PS; Burns DM, 2011, CANCER CAUSE CONTROL, V22, P13, DOI 10.1007/s10552-010-9660-0; CDC. MMWR, 2002, REC REP WOM SMOK REP; Christopoulou R, 2011, PREV MED, V52, P66, DOI 10.1016/j.ypmed.2010.11.011; Decicca P, 2008, HEALTH ECON, V17, P733, DOI 10.1002/hec.1293; Degenhardt L, 2000, AUST NZ J PUBL HEAL, V24, P421, DOI 10.1111/j.1467-842X.2000.tb01605.x; Department of Health, 2018, TOB CONTR KEY FACTS; Greenhalgh E., 2019, TOBACCO AUSTR FACTS; Holford TR, 2016, NICOTINE TOB RES, V18, pS16, DOI 10.1093/ntr/ntv274; Holford TR, 2014, AM J PREV MED, V46, pE31, DOI 10.1016/j.amepre.2013.10.022; International Agency for Research on Cancer, 2012, REV HUM CARC PERS HA; Jeon J, 2018, ANN INTERN MED, V169, P684, DOI [10.7326/M18-1250, 10.7326/m18-1250]; Kang H, 2020, TOB CONTROL, V29, P96, DOI 10.1136/tobaccocontrol-2018-054536; Lillard DR., 2015, PATTERNS NATL CONTEX; Lillard DR., 2015, FAMILIES INCOMES JOB; Luo QW, 2019, LUNG CANCER, V130, P208, DOI 10.1016/j.lungcan.2019.02.028; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Morley KI, 2008, ADDICTION, V103, P487, DOI 10.1111/j.1360-0443.2007.02087.x; National Museum Australia, DEF MOM PILL 1961 IN; Pampel F, 2015, SOC SCI MED, V127, P41, DOI 10.1016/j.socscimed.2014.06.033; Pampel FC, 2017, POPUL RES POLICY REV, V36, P309, DOI 10.1007/s11113-016-9424-y; PIERCE JP, 1987, PREV MED, V16, P252, DOI 10.1016/0091-7435(87)90088-0; PIERCE JP, 1990, AM J PUBLIC HEALTH, V80, P565, DOI 10.2105/AJPH.80.5.565; R Core Team, 2020, R LANG ENV STAT COMP; Reitsma MB, 2017, LANCET, V389, P1885, DOI 10.1016/S0140-6736(17)30819-X; Rizzi S, 2015, AM J EPIDEMIOL, V182, P138, DOI 10.1093/aje/kwv020; Scollo M., 2021, 10 6 RETAIL VALUE VO; Scollo M, 2015, TOB CONTROL, V24, pII3, DOI 10.1136/tobaccocontrol-2014-052048; Scollo MM., 2019, TOBACCO AUSTR; U.S. National Library of Medicine, PROF SCI REP SURG GE; US Department of Health and Human Services, 1980, HLTH CONS SMOK WOM; Visalpattanasin P., 2010, COMMUNITY HEALTH ST, V11; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Whetton S., 2019, IDENTIFYING SOCIAL C; WOODWARD SD, 1984, AUST NZ J MED, V14, P405, DOI 10.1111/j.1445-5994.1984.tb03604.x; Yale University Library, 2019, SELL LIF MEN WOM GEN	51	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0250824	10.1371/journal.pone.0250824	http://dx.doi.org/10.1371/journal.pone.0250824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019558	gold, Green Published			2022-12-26	WOS:000664632300013
J	Andersen, CB; Yoshimura, Y; Nielsen, J; Otzen, DE; Mulder, FAA				Andersen, Camilla B.; Yoshimura, Yuichi; Nielsen, Janni; Otzen, Daniel E.; Mulder, Frans A. A.			How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; TRANSFER DIFFERENCE NMR; AMYLOID FIBRILS; EGCG DIMER; IN-VIVO; AGGREGATION; TOXICITY; DISEASE; FIBRILLATION; STABILITY	The intrinsically disordered human protein alpha-synuclein (alpha SN) can self-associate into oligomers and amyloid fibrils. Several lines of evidence suggest that oligomeric alpha SN is cyto-toxic, making it important to devise strategies to either prevent oligomer formation and/or inhibit the ensuing toxicity. (-)-epigallocatechin gallate (EGCG) has emerged as a molecular modulator of alpha SN self-assembly, as it reduces the flexibility of the C-terminal region of alpha SN in the oligomer and inhibits the oligomer's ability to perturb phospholipid membranes and induce cell death. However, a detailed structural and kinetic characterization of this interaction is still lacking. Here, we use liquid-state NMR spectroscopy to investigate how EGCG interacts with monomeric and oligomeric forms of alpha SN. We find that EGCG can bind to all parts of monomeric alpha SN but exhibits highest affinity for the N-terminal region. Monomeric alpha SN binds similar to 54 molecules of EGCG in total during oligomerization. Furthermore, kinetic data suggest that EGCG dimerization is coupled with the alpha SN association reaction. In contrast, preformed oligomers only bind similar to 7 EGCG molecules per protomer, in agreement with the more compact nature of the oligomer compared with the natively unfolded monomer. In previously conducted cell assays, as little as 0.36 EGCG per alpha SN reduce oligomer toxicity by 50%. Our study thus demonstrates that alpha SN cytotoxicity can be inhibited by small molecules at concentrations at least an order of magnitude below full binding capacity. We speculate this is due to cooperative binding of protein-stabilized EGCG dimers, which in turn implies synergy between protein association and EGCG dimerization.	[Andersen, Camilla B.; Yoshimura, Yuichi; Nielsen, Janni; Otzen, Daniel E.; Mulder, Frans A. A.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark; [Yoshimura, Yuichi; Mulder, Frans A. A.] Aarhus Univ, Dept Chem, Aarhus C, Denmark; [Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark; [Andersen, Camilla B.] Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, Campusvej 55, DK-5230 Odense, Denmark; [Yoshimura, Yuichi] Osaka Univ, Inst Prot Res, Yamada Oka 3-2, Suita, Osaka 5650871, Japan	Aarhus University; Aarhus University; Aarhus University; University of Southern Denmark; Osaka University	Otzen, DE; Mulder, FAA (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark.; Mulder, FAA (corresponding author), Aarhus Univ, Dept Chem, Aarhus C, Denmark.; Otzen, DE (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark.	dao@inano.au.dk; fmulder@chem.au.dk	Andersen, Camilla Bertel/Y-6856-2018; Mulder, Frans/C-7158-2017; Yoshimura, Yuichi/G-8924-2019	Andersen, Camilla Bertel/0000-0003-1298-0598; Mulder, Frans/0000-0001-9427-8406; Yoshimura, Yuichi/0000-0002-9905-453X; Otzen, Daniel/0000-0002-2918-8989	Independent Research Fund Denmark|Medical Sciences [4183-00225]	Independent Research Fund Denmark|Medical Sciences	We are grateful for the support from The Independent Research Fund Denmark|Medical Sciences (4183-00225) to D. E. O. for this project.	Ahmed R, 2018, CHEM COMMUN, V54, P4644, DOI 10.1039/c8cc01380b; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Cawood EE, 2021, BIOPHYS CHEM, V268, DOI 10.1016/j.bpc.2020.106505; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eaton JD, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170209; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fusco G, 2018, BIOPOLYMERS, V109, DOI 10.1002/bip.23117; Fusco G, 2017, SCIENCE, V358, P1440, DOI 10.1126/science.aan6160; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Hauber I, 2009, P NATL ACAD SCI USA, V106, P9033, DOI 10.1073/pnas.0811827106; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; Hudson SA, 2009, J MOL BIOL, V392, P689, DOI 10.1016/j.jmb.2009.07.031; Hyung SJ, 2013, P NATL ACAD SCI USA, V110, P3743, DOI 10.1073/pnas.1220326110; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; Korshavn KJ, 2017, J BIOL CHEM, V292, P4638, DOI 10.1074/jbc.M116.764092; Kurnik M, 2018, CELL CHEM BIOL, V25, P1389, DOI 10.1016/j.chembiol.2018.08.005; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee YH, 2019, BBA-PROTEINS PROTEOM, V1867, P529, DOI 10.1016/j.bbapap.2018.11.006; Lokappa SB, 2014, J MOL BIOL, V426, P2130, DOI 10.1016/j.jmb.2014.02.024; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Mulder FAA, 2011, J BIOMOL NMR, V51, P199, DOI 10.1007/s10858-011-9554-9; Nie RZ, 2019, J FUNCT FOODS, V52, P492, DOI 10.1016/j.jff.2018.11.018; Nie RZ, 2017, BIOPHYS CHEM, V230, P1, DOI 10.1016/j.bpc.2017.07.009; Nie RZ, 2016, BIOCHIMIE, V125, P204, DOI 10.1016/j.biochi.2016.03.011; Paslawski W, 2016, METHODS MOL BIOL, V1345, P133, DOI 10.1007/978-1-4939-2978-8_9; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Paslawski W, 2014, ANGEW CHEM INT EDIT, V53, P7560, DOI 10.1002/anie.201400491; Perissinotto F, 2020, NANOSCALE, V12, P7631, DOI 10.1039/d0nr00287a; Pieri L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24526; Sang SM, 2007, FREE RADICAL BIO MED, V43, P362, DOI 10.1016/j.freeradbiomed.2007.04.008; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Sciacca MF, 2020, ACS CHEM NEUROSCI, V11, P4336, DOI 10.1021/acschemneuro.0c00588; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Venkitakrishnan Rani Parvathy, 2012, Methods Mol Biol, V914, P47, DOI 10.1007/978-1-62703-023-6_4; Viennet T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0049-z; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wroblewski K, 2001, EUR J BIOCHEM, V268, P4384, DOI 10.1046/j.1432-1327.2001.02350.x; Xu ZX, 2017, CHEMPHYSCHEM, V18, P1611, DOI 10.1002/cphc.201700057; Zijlstra N, 2012, ANGEW CHEM INT EDIT, V51, P8821, DOI 10.1002/anie.201200813	52	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100788	10.1016/j.jbc.2021.100788	http://dx.doi.org/10.1016/j.jbc.2021.100788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019875	gold, Green Published			2022-12-26	WOS:000674717300009
J	Ozkan, M; Eskiocak, YC; Wingender, G				Ozkan, Muge; Eskiocak, Yusuf Cem; Wingender, Gerhard			Macrophage and dendritic cell subset composition can distinguish endotypes in adjuvant-induced asthma mouse models	PLOS ONE			English	Article							RESIDENT ALVEOLAR MACROPHAGES; AIRWAY INFLAMMATION; EXUDATE MACROPHAGES; MURINE MODELS; MAST-CELLS; NKT CELLS; RECRUITED MONOCYTES; LYMPHOID-TISSUE; LUNG FIBROSIS; T-CELLS	Asthma is a heterogeneous disease with neutrophilic and eosinophilic asthma as the main endotypes that are distinguished according to the cells recruited to the airways and the related pathology. Eosinophilic asthma is the treatment-responsive endotype, which is mainly associated with allergic asthma. Neutrophilic asthma is a treatment-resistant endotype, affecting 5-10% of asthmatics. Although eosinophilic asthma is well-studied, a clear understanding of the endotypes is essential to devise effective diagnosis and treatment approaches for neutrophilic asthma. To this end, we directly compared adjuvant-induced mouse models of neutrophilic (CFA/OVA) and eosinophilic (Alum/OVA) asthma side-by-side. The immune response in the inflamed lung was analyzed by multi-parametric flow cytometry and immunofluorescence. We found that eosinophilic asthma was characterized by a preferential recruitment of interstitial macrophages and myeloid dendritic cells, whereas in neutrophilic asthma plasmacytoid dendritic cells, exudate macrophages, and GL7(+) activated B cells predominated. This differential distribution of macrophage and dendritic cell subsets reveals important aspects of the pathophysiology of asthma and holds the promise to be used as biomarkers to diagnose asthma endotypes.	[Ozkan, Muge] Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst, Dept Genome Sci & Mol Biotechnol, Izmir, Turkey; [Eskiocak, Yusuf Cem; Wingender, Gerhard] Izmir Biomed & Genome Ctr IBG, Izmir, Turkey; [Wingender, Gerhard] Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst, Dept Biomed & Hlth Technol, Izmir, Turkey	Dokuz Eylul University; Dokuz Eylul University	Wingender, G (corresponding author), Izmir Biomed & Genome Ctr IBG, Izmir, Turkey.; Wingender, G (corresponding author), Dokuz Eylul Univ, Izmir Int Biomed & Genome Inst, Dept Biomed & Hlth Technol, Izmir, Turkey.	gerhard.wingender@ibg.edu.tr		Wingender, Gerhard/0000-0002-7115-298X	TUBITAK [116Z272]; Dokuz Eylul University [2016.KB.SAG.020, 2017.KB. SAG.029]; European Molecular Biology Organization (EMBO) [3073]	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Dokuz Eylul University(Dokuz Eylul University); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This work was funded by grants from TUBITAK (116Z272, GW), the Dokuz Eylul University (2016.KB.SAG.020 and 2017.KB. SAG.029, GW), and the European Molecular Biology Organization (EMBO, Installation Grant 3073; GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agache I, 2012, ALLERGY, V67, P835, DOI 10.1111/j.1398-9995.2012.02832.x; Agache I, 2018, IMPLEMENT PRECIS MED, P45; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Akbari O, 2006, NAT MED, V12, P1347, DOI 10.1038/nm1206-1347; Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Balzar S, 2011, AM J RESP CRIT CARE, V183, P299, DOI 10.1164/rccm.201002-0295OC; Bogaert P, 2011, AM J PHYSIOL-LUNG C, V300, pL679, DOI 10.1152/ajplung.00202.2010; Bratke K, 2007, THORAX, V62, P168, DOI 10.1136/thx.2006.067793; Byrne AJ, 2016, TRENDS MOL MED, V22, P303, DOI 10.1016/j.molmed.2016.02.004; Carroll NG, 2002, THORAX, V57, P677, DOI 10.1136/thorax.57.8.677; Carroll NG, 2002, EUR RESPIR J, V19, P879, DOI 10.1183/09031936.02.00275802; Cyphert-Daly JM, 2019, J ALLERGY CLIN IMMUN, V144, P1428, DOI 10.1016/j.jaci.2019.07.019; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; Dejager L, 2015, MUCOSAL IMMUNOL, V8, P1212, DOI 10.1038/mi.2015.12; Dua B, 2010, J ALLERGY CLIN IMMUN, V126, P133, DOI 10.1016/j.jaci.2010.04.006; Edwards MR, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02448-2016; Evren E, 2020, IMMUNOLOGY, V160, P126, DOI 10.1111/imm.13154; Fallon PG, 2020, J ALLERGY CLIN IMMUN, V145, P496, DOI 10.1016/j.jaci.2019.11.031; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Gelfand EW, 2017, IMMUNOL REV, V278, P63, DOI 10.1111/imr.12561; Ghosh S, 2015, CELL MOL IMMUNOL, V12, P202, DOI 10.1038/cmi.2014.103; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Global Initiative for Asthma, 2020, REV FR DALLERGOL DIM; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Haspeslagh E, 2017, METHODS MOL BIOL, V1559, P121, DOI 10.1007/978-1-4939-6786-5_10; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; He XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31663; Herbold W, 2010, INFECT IMMUN, V78, P2620, DOI 10.1128/IAI.01169-09; Hirahara K, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0067-8; Hodge S, 2016, CLIN EXP ALLERGY, V46, P60, DOI 10.1111/cea.12634; Huang YC, 2019, CLIN EXP ALLERGY, V49, P44, DOI 10.1111/cea.13248; Jang E, 2017, J IMMUNOL, V199, P3943, DOI 10.4049/jimmunol.1700211; Kalchiem-Dekel O, 2020, CHEST, V157, P26, DOI 10.1016/j.chest.2019.08.2192; Kips JC, 2003, EUR RESPIR J, V22, P374, DOI 10.1183/09031936.03.00026403; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Korosec P, 2018, CLIN EXP ALLERGY, V48, P502, DOI 10.1111/cea.13117; Kuroda E, 2016, IMMUNITY, V45, P1299, DOI 10.1016/j.immuni.2016.11.010; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Lisbonne M, 2003, J IMMUNOL, V171, P1637, DOI 10.4049/jimmunol.171.4.1637; Lynch JP, 2018, J EXP MED, V215, P537, DOI 10.1084/jem.20170298; Maazi H, 2013, ALLERGY, V68, P695, DOI 10.1111/all.12166; Maazi H, 2018, J ALLERGY CLIN IMMUN, V141, P893, DOI 10.1016/j.jaci.2017.04.043; Machado-Aranda D, 2014, J TRAUMA ACUTE CARE, V76, P982, DOI 10.1097/TA.0000000000000163; Maecker Holden T., 2009, V485, P375, DOI 10.1007/978-1-59745-170-3_25; Marin ND, 2019, J IMMUNOL, V202, P2519, DOI 10.4049/jimmunol.1801135; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; McAlees JW, 2015, MUCOSAL IMMUNOL, V8, P863, DOI 10.1038/mi.2014.117; McGrath KW, 2012, AM J RESP CRIT CARE, V185, P612, DOI 10.1164/rccm.201109-1640OC; Meziani L, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02120-2017; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Moro K, 2015, NAT PROTOC, V10, P792, DOI 10.1038/nprot.2015.047; Mould KJ, 2017, AM J RESP CELL MOL, V57, P294, DOI 10.1165/rcmb.2017-0061OC; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Osterholzer JJ, 2013, J IMMUNOL, V190, P3447, DOI 10.4049/jimmunol.1200604; Osterholzer JJ, 2011, AM J PATHOL, V178, P198, DOI 10.1016/j.ajpath.2010.11.006; Pavord ID, 2018, LANCET, V391, P350, DOI 10.1016/S0140-6736(17)30879-6; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; Radermecker C, 2019, NAT IMMUNOL, V20, P1444, DOI 10.1038/s41590-019-0496-9; Reber LL, 2015, MUCOSAL IMMUNOL, V8, P444, DOI 10.1038/mi.2014.131; Robinson DS, 2010, J ALLERGY CLIN IMMUN, V126, P1081, DOI 10.1016/j.jaci.2010.06.025; Roederer M, 2004, METHOD CELL BIOL, V75, P241; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Sadamatsu H, 2020, INFLAMM RES, V69, P139, DOI 10.1007/s00011-019-01302-3; Samitas K, 2015, EUR RESPIR REV, V24, P594, DOI 10.1183/16000617.00001715; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Shinoda K, 2017, ALLERGOL INT, V66, P369, DOI 10.1016/j.alit.2017.03.005; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Sze E, 2020, ALLERGY, V75, P311, DOI 10.1111/all.13985; Taut K, 2008, AM J RESP CELL MOL, V38, P105, DOI 10.1165/rcmb.2007-0132OC; Upham JW, 2002, CLIN EXP ALLERGY, V32, P818, DOI 10.1046/j.1365-2222.2002.01375.x; Verduyn M, 2019, J ALLER CL IMM-PRACT, V7, P1507, DOI 10.1016/j.jaip.2018.12.028; Wadhwa R, 2019, EUR RESPIR REV, V28, DOI 10.1183/16000617.0096-2019; Wakahara K, 2013, ALLERGY, V68, P180, DOI 10.1111/all.12072; Whitehead GS, 2014, ENVIRON HEALTH PERSP, V122, P34, DOI 10.1289/ehp.1307280; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Wingender G, 2015, J IMMUNOL, V195, P3838, DOI 10.4049/jimmunol.1500203; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Woo LN., 2017, 4 WEEK MODEL HOUSE D, P1; Wu W, 2014, J ALLERGY CLIN IMMUN, V133, P1280, DOI 10.1016/j.jaci.2013.11.042; Wypych TP, 2018, J ALLERGY CLIN IMMUN, V141, P1395, DOI 10.1016/j.jaci.2017.09.001; Yu QL, 2018, EXP THER MED, V15, P2492, DOI 10.3892/etm.2018.5721; Zaslona Z, 2014, J IMMUNOL, V193, P4245, DOI 10.4049/jimmunol.1400580; Zhou XF, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00103-2018	87	1	1	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0250533	10.1371/journal.pone.0250533	http://dx.doi.org/10.1371/journal.pone.0250533			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061861	Green Submitted, Green Published, gold			2022-12-26	WOS:000656813600051
J	Ji, YC; Nie, ZP; Meng, FL; Hu, CF; Chen, H; Jin, LH; Chen, MQ; Zhang, ML; Zhang, JJ; Liang, M; Wang, M; Guan, MX				Ji, Yanchun; Nie, Zhipeng; Meng, Feilong; Hu, Cuifang; Chen, Hui; Jin, Lihao; Chen, Mengquan; Zhang, Minglian; Zhang, Juanjuan; Liang, Min; Wang, Meng; Guan, Min-Xin			Mechanistic insights into mitochondrial tRNA(Ala) 3 '-end metabolism deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY OPTIC NEUROPATHY; TRANSFER-RNA SYNTHETASE; HAN CHINESE SUBJECTS; 12S RIBOSOMAL-RNA; MUTATION ALTERS; DNA MUTATION; PHENOTYPIC MANIFESTATION; M(1)G37 MODIFICATION; DISCRIMINATOR BASE; OXIDATIVE STRESS	Mitochondrial tRNA 3'-end metabolism is critical for the formation of functional tRNAs. Deficient mitochondrial tRNA 3'-end metabolism is linked to an array of human diseases, including optic neuropathy, but their pathophysiology remains poorly understood. In this report, we investigated the molecular mechanism underlying the Leber's hereditary optic neuropathy (LHON)-associated tRNA(Ala) 5587A>G mutation, which changes a highly conserved adenosine at position 73 (A73) to guanine (G73) on the 3'-end of the tRNA acceptor stem. The m.5587A>G mutation was identified in three Han Chinese families with suggested maternal inheritance of LHON. We hypothesized that the m.5587A>G mutation altered tRNA(Ala) 3'end metabolism and mitochondrial function. In vitro processing experiments showed that the m.5587A>G mutation impaired the 3'-end processing of tRNAAla precursors by RNase Z and inhibited the addition of CCA by tRNA nucleotidyltransferase (TRNT1). Northern blot analysis revealed that the m.5587A>G mutation perturbed tRNA(Ala) aminoacylation, as evidenced by decreased efficiency of aminoacylation and faster electrophoretic mobility of mutated tRNA(Ala) in these cells. The impact of m.5587A>G mutation on tRNA(Ala) function was further supported by increased melting temperature, conformational changes, and reduced levels of this tRNA. Failures in tRNA(Ala) metabolism impaired mitochondrial translation, perturbed assembly and activity of oxidative phosphorylation complexes, diminished ATP production and membrane potential, and increased production of reactive oxygen species. These pleiotropic defects elevated apoptotic cell death and promoted mitophagy in cells carrying the m.5587A>G mutation, thereby contributing to visual impairment. Our findings may provide new insights into the pathophysiology of LHON arising from mitochondrial tRNA 3'-end metabolism deficiency.	[Ji, Yanchun; Meng, Feilong; Wang, Meng; Guan, Min-Xin] Zhejiang Univ, Div Med Genet & Genom, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Ji, Yanchun; Meng, Feilong; Wang, Meng; Guan, Min-Xin] Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China; [Ji, Yanchun; Nie, Zhipeng; Meng, Feilong; Hu, Cuifang; Chen, Hui; Jin, Lihao; Wang, Meng; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Hu, Cuifang; Zhang, Juanjuan; Liang, Min] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Chen, Mengquan] Wenzhou Hosp Tradit Chinese Med, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zhang, Minglian] Hebei Prov Eye Hosp, Dept Ophthalmol, Xingtai, Hebei, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Ctr Mitochondrial Genet, Hangzhou, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Joint Inst Genet & Genome Med, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China; [Guan, Min-Xin] Univ Toronto, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University; Zhejiang University; Zhejiang University; University of Toronto	Guan, MX (corresponding author), Zhejiang Univ, Div Med Genet & Genom, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Ctr Mitochondrial Genet, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Joint Inst Genet & Genome Med, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Univ Toronto, Hangzhou, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn	Zhang, Juan/GRX-2638-2022		National Natural Science Foundation of China [31970557, 82071007]; National Key research and Development Program [2018YFC1004802]; Zhejiang Provincial Public Welfare Technology Applied Research Projects [LGF21C060001]; Zhejiang Provincial Traditional Chinese Medicine Research Projects [2019ZB072]; Zhejiang Provincial Natural Science Foundation of China [LY19H130005, LY20C060003]; Zhejiang Provincial Health Technology Project Commission [2019RC200]; Wenzhou Science and Technology Bureau [Y20190067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key research and Development Program; Zhejiang Provincial Public Welfare Technology Applied Research Projects; Zhejiang Provincial Traditional Chinese Medicine Research Projects; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Health Technology Project Commission; Wenzhou Science and Technology Bureau	This work was supported by grants from the National Natural Science Foundation of China (31970557, 82071007); the National Key research and Development Program (2018YFC1004802), Zhejiang Provincial Public Welfare Technology Applied Research Projects (LGF21C060001) and Zhejiang Provincial Traditional Chinese Medicine Research Projects (2019ZB072), Zhejiang Provincial Natural Science Foundation of China (LY19H130005 and LY20C060003), Zhejiang Provincial Health Technology Project Commission (2019RC200), and Wenzhou Science and Technology Bureau (Y20190067). We thank Ms Jiji Sun's technical assistance.	Agnew T, 2018, CELL REP, V25, P3315, DOI 10.1016/j.celrep.2018.11.080; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; Country MW, 2017, BRAIN RES, V1672, P50, DOI 10.1016/j.brainres.2017.07.025; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; Torres AG, 2019, P NATL ACAD SCI USA, V116, P8451, DOI 10.1073/pnas.1821120116; Gamper H, 2018, RNA, V24, P1878, DOI 10.1261/rna.068015.118; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gong SS, 2020, J BIOL CHEM, V295, P940, DOI 10.1074/jbc.RA119.010998; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Hou YM, 2010, IUBMB LIFE, V62, P251, DOI 10.1002/iub.301; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Ji YC, 2020, J BIOL CHEM, V295, P13224, DOI 10.1074/jbc.RA120.014603; Ji YC, 2019, HUM MOL GENET, V28, P1515, DOI 10.1093/hmg/ddy450; Ji YC, 2017, MOL MED REP, V16, P8997, DOI 10.3892/mmr.2017.7734; Ji YC, 2016, INVEST OPHTH VIS SCI, V57, P2377, DOI 10.1167/iovs.16-19243; Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158; Jin X., 2021, J BIOL CHEM, V296; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1993, J BIOL CHEM, V268, P10228; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Kuhle B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14725-y; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884; Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282; Levinger L, 2012, RNA BIOL, V9, P283, DOI 10.4161/rna.19025; Liang M, 2014, INVEST OPHTH VIS SCI, V55, P1321, DOI 10.1167/iovs.13-13011; Lovato MA, 2001, EMBO J, V20, P4846, DOI 10.1093/emboj/20.17.4846; Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Melser S, 2015, BBA-MOL CELL RES, V1853, P2812, DOI 10.1016/j.bbamcr.2015.05.010; Meng FL, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1225; Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Miao ZC, 2017, ANNU REV BIOPHYS, V46, P483, DOI 10.1146/annurev-biophys-070816-034125; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200; Nagan MC, 2000, NUCLEIC ACIDS RES, V28, P2527, DOI 10.1093/nar/28.13.2527; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003; Peng GX, 2021, NUCLEIC ACIDS RES, V49, P2816, DOI 10.1093/nar/gkab104; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Reinhard L, 2017, NUCLEIC ACIDS RES, V45, P12469, DOI 10.1093/nar/gkx902; Salinas-Giege T, 2015, INT J MOL SCI, V16, P4518, DOI 10.3390/ijms16034518; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Sasarman F, 2015, HUM MOL GENET, V24, P2841, DOI 10.1093/hmg/ddv044; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Slade A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113780; Song LY, 2017, BRAIN RES, V1657, P232, DOI 10.1016/j.brainres.2016.12.019; Suzuki T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18068-6; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wallace DC, 2017, HANDB EXP PHARMACOL, V240, P339, DOI 10.1007/164_2017_2; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang M, 2013, BIOCHEM J, V453, P455, DOI 10.1042/BJ20130294; Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811; Wedatilake Y, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0477-0; Wende S, 2015, NUCLEIC ACIDS RES, V43, P5617, DOI 10.1093/nar/gkv471; Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Xiao Y, 2020, NUCLEIC ACIDS RES, V48, P11113, DOI 10.1093/nar/gkaa860; Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965; Zeng QY, 2019, NUCLEIC ACIDS RES, V47, P3072, DOI 10.1093/nar/gkz078; Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107; Zhang QH, 2021, NUCLEIC ACIDS RES, V49, P4689, DOI 10.1093/nar/gkab228; Zhao XX, 2019, NUCLEIC ACIDS RES, V47, P10340, DOI 10.1093/nar/gkz742; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317; Zhu YS, 2014, METHOD ENZYMOL, V547, P39, DOI 10.1016/B978-0-12-801415-8.00003-5	96	9	9	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100816	10.1016/j.jbc.2021.100816	http://dx.doi.org/10.1016/j.jbc.2021.100816			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023389	Green Published, gold			2022-12-26	WOS:000678068400019
J	Strobel, EJ				Strobel, Eric J.			Preparation of E. coli RNA polymerase transcription elongation complexes by selective photoelution from magnetic beads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; IN-VITRO; BACTERIAL; MECHANISM; PROMOTER; DNA; INITIATION; DOMAIN	In vitro studies of transcription frequently require the preparation of defined elongation complexes. Defined transcription elongation complexes (TECs) are typically prepared by constructing an artificial transcription bubble from synthetic oligonucleotides and RNA polymerase. This approach is optimal for diverse applications but is sensitive to nucleic acid length and sequence and is not compatible with systems where promoter-directed initiation or extensive transcription elongation is crucial. To complement scaffold-directed approaches for TEC assembly, I have developed a method for preparing promoter-initiated Escherichia coli TECs using a purification strategy called selective photoelution. This approach combines TEC-dependent sequestration of a biotin-triethylene glycol transcription stall site with photoreversible DNA immobilization to enrich TECs from an in vitro transcription reaction. I show that selective photoelution can be used to purify TECs that contain a 273-bp DNA template and 194-nt structured RNA. Selective photoelution is a straightforward and robust procedure that, in the systems assessed here, generates precisely positioned TECs with >95% purity and >30% yield. TECs prepared by selective photoelution can contain complex nucleic acid sequences and will therefore likely be useful for investigating RNA structure and function in the context of RNA polymerases.	[Strobel, Eric J.] Univ Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Strobel, EJ (corresponding author), Univ Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	estrobel@buffalo.edu		Strobel, Eric/0000-0002-7082-2881	University at Buffalo; Arnold O. Beckman postdoctoral fellowship; Cornell University Genomics Innovation Hub Seed Grant	University at Buffalo; Arnold O. Beckman postdoctoral fellowship; Cornell University Genomics Innovation Hub Seed Grant	This work was supported by start-up funding from the University at Buffalo (to E. J. S.), an Arnold O. Beckman postdoctoral fellowship (to E. J. S.), and a Cornell University Genomics Innovation Hub Seed Grant (to John T. Lis and E. J. S.).	Artsimovitch I, 2009, METHODS, V47, P37, DOI 10.1016/j.ymeth.2008.10.006; Bae B, 2015, ELIFE, V4, DOI 10.7554/eLife.08504; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Guo XY, 2018, MOL CELL, V69, P816, DOI 10.1016/j.molcel.2018.02.008; Hein PP, 2014, NAT STRUCT MOL BIOL, V21, P794, DOI 10.1038/nsmb.2867; Henderson KL, 2017, P NATL ACAD SCI USA, V114, pE3032, DOI 10.1073/pnas.1618675114; Johnston D. E., 1976, ABORTIVE INITIATION; Kang JY, 2018, MOL CELL, V69, P802, DOI 10.1016/j.molcel.2018.01.018; Kim PB, 2015, MOL CELL, V57, P317, DOI 10.1016/j.molcel.2015.01.001; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Krupp F, 2019, MOL CELL, V74, P143, DOI 10.1016/j.molcel.2019.01.016; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; Makinen JJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21005-w; Mishanina TV, 2017, P NATL ACAD SCI USA, V114, pE5103, DOI 10.1073/pnas.1702383114; OLEJNIK J, 1995, P NATL ACAD SCI USA, V92, P7590, DOI 10.1073/pnas.92.16.7590; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Ruff EF, 2015, J MOL BIOL, V427, P2435, DOI 10.1016/j.jmb.2015.05.024; Said N, 2021, SCIENCE, V371, P44, DOI 10.1126/science.abd1673; Said N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.62; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Strobel EJ, 2020, J BIOL CHEM, V295, P6401, DOI 10.1074/jbc.RA120.012641; Strobel EJ, 2019, NAT CHEM BIOL, V15, P1067, DOI 10.1038/s41589-019-0382-7; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Wang CY, 2020, SCIENCE, V369, P1359, DOI 10.1126/science.abb5317; Widom JR, 2018, MOL CELL, V72, P541, DOI 10.1016/j.molcel.2018.08.046; YARNELL WS, 1992, CELL, V69, P1181, DOI 10.1016/0092-8674(92)90639-T; Yin Z, 2019, P NATL ACAD SCI USA, V116, P18384, DOI 10.1073/pnas.1909801116; Zhang JW, 2016, TRENDS BIOCHEM SCI, V41, P293, DOI 10.1016/j.tibs.2015.12.009; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732; Zhang SY, 2021, SCIENCE, V371, P305, DOI 10.1126/science.abf1870	35	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100812	10.1016/j.jbc.2021.100812	http://dx.doi.org/10.1016/j.jbc.2021.100812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023383	Green Published, gold			2022-12-26	WOS:000678068400015
J	Vogt, MS; Nguepbeu, RRN; Mohr, MKF; Albers, SV; Essen, LO; Banerjee, A				Vogt, Marian S.; Nguepbeu, Roi R. Ngouoko; Mohr, Michael K. F.; Albers, Sonja-Verena; Essen, Lars-Oliver; Banerjee, Ankan			The archaeal triphosphate tunnel metalloenzyme SaTTM defines structural determinants for the diverse activities in the CYTH protein family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV ADENYLYL-CYCLASE; INORGANIC POLYPHOSPHATE; RNA TRIPHOSPHATASE; MECHANISM; SIMILARITIES; SUPERFAMILY; CATALYSIS; GENE	CYTH proteins make up a large superfamily that is conserved in all three domains of life. These enzymes have a triphosphate tunnel metalloenzyme (TTM) fold, which typically results in phosphatase functions, e.g., RNA triphosphatase, inorganic polyphosphatase, or thiamine triphosphatase. Some CYTH orthologs cyclize nucleotide triphosphates to 30,50-cyclic nucleotides. So far, archaeal CYTH proteins have been annotated as adenylyl cyclases, although experimental evidence to support these annotations is lacking. To address this gap, we characterized a CYTH ortholog, SaTTM, from the crenarchaeote Sulfolobus acidocaldarius. Our in silico studies derived ten major subclasses within the CYTH family implying a close relationship between these archaeal CYTH enzymes and class IV adenylyl cyclases. However, initial biochemical characterization reveals inability of SaTTM to produce any cyclic nucleotides. Instead, our structural and functional analyses show a classical TTM behavior, i.e., triphosphatase activity, where pyrophosphate causes product inhibition. The Ca2+-inhibited Michaelis complex indicates a two-metal-ion reaction mechanism analogous to other TTMs. Cocrystal structures of SaTTM further reveal conformational dynamics in SaTTM that suggest feedback inhibition in TTMs due to tunnel closure in the product state. These structural insights combined with further sequence similarity network-based in silico analyses provide a firm molecular basis for distinguishing CYTH orthologs with phosphatase activities from class IV adenylyl cyclases.	[Vogt, Marian S.; Nguepbeu, Roi R. Ngouoko; Essen, Lars-Oliver; Banerjee, Ankan] Philipps Univ Marburg, Dept Chem, Marburg, Germany; [Mohr, Michael K. F.] Albert Ludwigs Univ Freiburg, Inst Pharmaceut Sci, Freiburg, Germany; [Albers, Sonja-Verena] Albert Ludwigs Univ Freiburg, Inst Biol 2, Mol Biol Archaea, Freiburg, Germany; [Essen, Lars-Oliver] Philipps Univ Marburg, Ctr Synthet Microbiol, Marburg, Germany; [Banerjee, Ankan] Philipps Univ Marburg, Dept Genet, Marburg, Germany	Philipps University Marburg; University of Freiburg; University of Freiburg; Philipps University Marburg; Philipps University Marburg	Essen, LO; Banerjee, A (corresponding author), Philipps Univ Marburg, Dept Chem, Marburg, Germany.; Essen, LO (corresponding author), Philipps Univ Marburg, Ctr Synthet Microbiol, Marburg, Germany.; Banerjee, A (corresponding author), Philipps Univ Marburg, Dept Genet, Marburg, Germany.	essen@chemie.uni-marburg.de; banerjee@staff.uni-marburg.de	; /A-5520-2016	Vogt, Marian/0000-0002-9867-3603; Albers, Sonja-Verena/0000-0003-2459-2226; /0000-0002-1791-252X	Volkswagen Foundation [Az96727]; Deutsche Forschungsgemeinschaft [447817670, SFB 987]	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB 987 (Collaborative Research Center 987) and Volkswagen Foundation (Az96727) to L.-O. E., M. S. V., and S.-V. A. A. B. was funded by the Deutsche Forschungsgemeinschaft (447817670).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albers SV, 2003, J BACTERIOL, V185, P3918, DOI 10.1128/JB.185.13.3918-3925.2003; Baumann A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-21; Bettendorff L, 2013, FEBS J, V280, P6443, DOI 10.1111/febs.12498; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delvaux D, 2013, BBA-GEN SUBJECTS, V1830, P4513, DOI 10.1016/j.bbagen.2013.05.014; Delvaux D, 2011, J BIOL CHEM, V286, P34023, DOI 10.1074/jbc.M111.233585; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallagher DT, 2006, J MOL BIOL, V362, P114, DOI 10.1016/j.jmb.2006.07.008; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jain Ruchi, 2008, J Biol Chem, V283, P31047, DOI 10.1074/jbc.M805392200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; Khannpnavar B, 2020, CURR OPIN STRUC BIOL, V63, P34, DOI 10.1016/j.sbi.2020.03.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEICHTLING BH, 1986, BIOCHEM BIOPH RES CO, V136, P1078, DOI 10.1016/0006-291X(86)90443-2; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Martinez J, 2015, J BIOL CHEM, V290, P23348, DOI 10.1074/jbc.M115.674473; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moeder W, 2013, PLANT J, V76, P615, DOI 10.1111/tpj.12325; Orell A, 2012, EXTREMOPHILES, V16, P573, DOI 10.1007/s00792-012-0457-9; Paula FS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53168-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Recalde A, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9010193; Remonsellez F, 2006, MICROBIOL-SGM, V152, P59, DOI 10.1099/mic.0.28241-0; SCHERER PA, 1983, CAN J MICROBIOL, V29, P1190, DOI 10.1139/m83-182; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Swieiawska B, 2014, PLANT PHYSIOL BIOCH, V80, P41, DOI 10.1016/j.plaphy.2014.03.010; Swiezawska B, 2020, FEBS LETT, V594, P1101, DOI 10.1002/1873-3468.13701; Toso DB, 2016, ARCHAEA, V2016, DOI 10.1155/2016/4706532; Toso DB, 2011, ENVIRON MICROBIOL, V13, P2587, DOI 10.1111/j.1462-2920.2011.02531.x; Ung H, 2017, PLANT PHYSIOL, V175, P473, DOI 10.1104/pp.17.00700; Ung H, 2014, PLANT PHYSIOL, V166, P1009, DOI 10.1104/pp.114.248757; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zhang Y, 2017, J BIOL CHEM, V292, P313, DOI 10.1074/jbc.M116.758896	46	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100820	10.1016/j.jbc.2021.100820	http://dx.doi.org/10.1016/j.jbc.2021.100820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029589	Green Published, gold, Green Submitted			2022-12-26	WOS:000678068400022
J	Zhang, Y; Ding, HT; Jiang, WX; Zhang, X; Cao, HY; Wang, JP; Li, CY; Huang, F; Zhang, XY; Chen, XL; Zhang, YZ; Li, PY				Zhang, Yi; Ding, Hai-Tao; Jiang, Wen-Xin; Zhang, Xia; Cao, Hai-Yan; Wang, Jing-Ping; Li, Chun-Yang; Huang, Feng; Zhang, Xi-Ying; Chen, Xiu-Lan; Zhang, Yu-Zhong; Li, Ping-Yi			Active site architecture of an acetyl xylan esterase indicates a novel cold adaptation strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE ESTERASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; FAMILY; FLEXIBILITY; PROTEIN; ENZYME; MECHANISM; LIPASE; THERMOSTABILITY	SGNH-type acetyl xylan esterases (AcXEs) play important roles in marine and terrestrial xylan degradation, which are necessary for removing acetyl side groups from xylan. However, only a few cold-adapted AcXEs have been reported, and the underlying mechanisms for their cold adaptation are still unknown because of the lack of structural information. Here, a cold-adapted AcXE, AlAXEase, from the Arctic marine bacterium Arcticibacterium luteifluviistationis SM1504(T) was characterized. AlAXEase could deacetylate xylooligosaccharides and xylan, which, together with its homologs, indicates a novel SGNH-type carbohydrate esterase family. AlAXEase showed the highest activity at 30 degrees C and retained over 70% activity at 0 degrees C but had unusual thermostability with a T-m value of 56 degrees C. To explain the cold adaption mechanism of AlAXEase, we next solved its crystal structure. AlAXEase has similar noncovalent stabilizing interactions to its mesophilic counterpart at the monomer level and forms stable tetramers in solutions, which may explain its high thermostability. However, a long loop containing the catalytic residues Asp200 and His203 in AlAXEase was found to be flexible because of the reduced stabilizing hydrophobic interactions and increased destabilizing asparagine and lysine residues, leading to a highly flexible active site. Structural and enzyme kinetic analyses combined with molecular dynamics simulations at different temperatures revealed that the flexible catalytic loop contributes to the cold adaptation of AlAXEase by modulating the distance between the catalytic His203 in this loop and the nucleophilic Ser32. This study reveals a new cold adaption strategy adopted by the thermostable AlAXEase, shedding light on the cold adaption mechanisms of AcXEs.	[Zhang, Yi; Jiang, Wen-Xin; Cao, Hai-Yan; Wang, Jing-Ping; Huang, Feng; Zhang, Xi-Ying; Chen, Xiu-Lan; Li, Ping-Yi] Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China; [Zhang, Yi; Li, Chun-Yang; Zhang, Yu-Zhong] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Zhang, Yi; Li, Chun-Yang; Zhang, Yu-Zhong] Ocean Univ China, Frontiers Sci Ctr Deep Ocean Multispheres & Earth, Qingdao, Peoples R China; [Zhang, Yi; Li, Chun-Yang; Zhang, Yu-Zhong] Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Ding, Hai-Tao] Polar Res Inst China, SOA Key Lab Polar Sci, Shanghai, Peoples R China; [Zhang, Xia] Qingdao Vland Biotech Inc, Dept Mol Biol, Qingdao, Peoples R China; [Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Qingdao, Peoples R China	Shandong University; Ocean University of China; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Polar Research Institute of China; Shandong University	Li, PY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China.; Zhang, YZ (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.; Zhang, YZ (corresponding author), Ocean Univ China, Frontiers Sci Ctr Deep Ocean Multispheres & Earth, Qingdao, Peoples R China.; Zhang, YZ (corresponding author), Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Qingdao, Peoples R China.	zhangyz@sdu.edu.cn; lipingyipeace@sdu.edu.cn	Wang, Jin/GYA-2019-2022; WANG, JINGYI/GSJ-1241-2022; wang, jing/GRS-7509-2022; wang, jing/GVT-8700-2022	Li, Chun-Yang/0000-0002-1151-4897	National Key Research and Development Program of China [2018YFC1406700, 2018YFC1406704]; National Natural Science Foundation of China [31630012, U1706207, 91851205, 91751101, 41906195, 41676180]; Major Scientific and Technological Innovation Project (MSTIP) of Shandong Province [2019JZZY010817]; Young Scholars Program of Shandong University [2017WLJH57]; Program of Shandong for Taishan Scholars [tspd20181203]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Innovation Project (MSTIP) of Shandong Province; Young Scholars Program of Shandong University; Program of Shandong for Taishan Scholars	We thank the staffs from BL17U1 and BL18U1 beamlines of the National Facility for Protein Science Shanghai and Shanghai Synchrotron Radiation Facility, for assistance during data collection. We would like to thank Jingyao Qu, Jing Zhu, and Zhifeng Li from State Key laboratory of Microbial Technology of Shandong University for help and guidance in dynamic light scattering. This work was supported by the National Key Research and Development Program of China (2018YFC1406700, 2018YFC1406704), the National Natural Science Foundation of China (31630012, U1706207, 91851205, 91751101, 41906195, and 41676180), Major Scientific and Technological Innovation Project (MSTIP) of Shandong Province (2019JZZY010817), the Program of Shandong for Taishan Scholars (tspd20181203), and the Young Scholars Program of Shandong University (2017WLJH57).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adesioye FA, 2016, ENZYME MICROB TECH, V93-94, P79, DOI 10.1016/j.enzmictec.2016.07.001; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Alalouf O, 2011, J BIOL CHEM, V286, P41993, DOI 10.1074/jbc.M111.301051; Asler IL, 2017, ACS CHEM BIOL, V12, P1928, DOI 10.1021/acschembio.6b01140; Blum DL, 1999, APPL ENVIRON MICROB, V65, P3990; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Komiya D, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01251-17; Koutaniemi S, 2013, J BIOTECHNOL, V168, P684, DOI 10.1016/j.jbiotec.2013.10.009; Kulakova L, 2004, BBA-PROTEINS PROTEOM, V1696, P59, DOI 10.1016/j.bbapap.2003.09.008; Lansky S, 2014, ACTA CRYSTALLOGR D, V70, P261, DOI 10.1107/S139900471302840X; Le LTHL, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01696-x; Lee CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169540; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; Li DD, 2017, INT J SYST EVOL MICR, V67, P664, DOI 10.1099/ijsem.0.001690; Li J, 2000, NAT STRUCT BIOL, V7, P555; Li PY, 2015, J BIOL CHEM, V290, P11188, DOI 10.1074/jbc.M115.646182; Li PY, 2014, J BIOL CHEM, V289, P19031, DOI 10.1074/jbc.M114.574913; Li Y, 2018, STAND GENOMIC SCI, V13, DOI 10.1186/s40793-018-0335-x; Lian K, 2015, FEBS OPEN BIO, V5, P107, DOI 10.1016/j.fob.2015.01.006; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martinez L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119264; Martinez-Martinez I, 2008, PROTEINS, V71, P379, DOI 10.1002/prot.21705; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Nagel ZD, 2013, J BIOL CHEM, V288, P14087, DOI 10.1074/jbc.M113.453951; Ogasahara K, 2003, J BIOL CHEM, V278, P8922, DOI 10.1074/jbc.M210893200; Papaleo E, 2006, BBA-PROTEINS PROTEOM, V1764, P1397, DOI 10.1016/j.bbapap.2006.06.005; Park SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206260; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Razeq FM, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1074-3; Rutkiewicz M, 2019, BBA-PROTEINS PROTEOM, V1867, P776, DOI 10.1016/j.bbapap.2019.06.001; Sanchez-Ruiz JM, 2001, TRENDS BIOTECHNOL, V19, P132, DOI 10.1016/S0167-7799(00)01548-1; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Soni S, 2017, EXTREMOPHILES, V21, P687, DOI 10.1007/s00792-017-0934-2; Struvay C, 2012, INT J MOL SCI, V13, P11643, DOI 10.3390/ijms130911643; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Tang MAK, 2012, PROTEIN J, V31, P337, DOI 10.1007/s10930-012-9408-7; Tian QQ, 2014, APPL MICROBIOL BIOT, V98, P2081, DOI 10.1007/s00253-013-5056-x; Till M, 2013, PROTEINS, V81, P911, DOI 10.1002/prot.24254; Wang P, 2015, MOL MICROBIOL, V98, P289, DOI 10.1111/mmi.13119; Xie BB, 2009, J BIOL CHEM, V284, P9257, DOI 10.1074/jbc.M808421200; Yang G, 2013, BIOCHIMIE, V95, P1795, DOI 10.1016/j.biochi.2013.06.008; Zhao F, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01029-19	49	5	5	6	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100841	10.1016/j.jbc.2021.100841	http://dx.doi.org/10.1016/j.jbc.2021.100841			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058201	gold, Green Published			2022-12-26	WOS:000678068400041
J	Worawichawong, S; Plumworasawat, S; Liwlompaisan, W; Sumethkul, V; Phakdeekitcharoen, B; Udomsubpayakul, U; Chalermsanyakorn, P; Kitiyakara, C				Worawichawong, Suchin; Plumworasawat, Sirithep; Liwlompaisan, Wisit; Sumethkul, Vasant; Phakdeekitcharoen, Bunyong; Udomsubpayakul, Umaporn; Chalermsanyakorn, Panus; Kitiyakara, Chagriya			Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy	PLOS ONE			English	Article							OXFORD CLASSIFICATION; LECTIN PATHWAY; COMPLEMENT; ASSOCIATION; ACTIVATION	Mesangial C4d deposits have been associated with worse outcomes in Western patients with IgA nephropathy (IgAN), but there is limited data in Asians. Previously, a high proportion of stained glomeruli was often required for the classification of C4d positive (C4d+ve). Positive staining in lower proportion of staining would be classified as C4d-ve. This retrospective study evaluated the prognostic value of C4d+ve using a less stringent definition (one C4d+ve glomerulus) in Thai patients with IgAN (n = 120). Baseline findings and outcomes were compared between those with more extensive C4d staining patterns and those with more restricted staining. Clinico-pathologic parameters and risk for kidney outcomes (kidney failure or decline GFR50%) were compared between C4d+ve versus C4d-ve, and between different patterns: Focal (< 50%) versus Diffuse (<greater than or equal to> 50% of glomeruli); or Global (>= 50) versus Segmental (< 50% of mesangial area). The hazard ratios were estimated using Cox proportional hazard models for Model 1 (Oxford score+ C4d) and Model 2 (Model 1+ clinical factors). C4d+ve (n = 81) had lower eGFR, more global sclerosis, and interstitial fibrosis than C4d-ve at baseline. The 5-year kidney survival for C4d+ve was lower (53.7%) than C4d-ve (89.7%); P = 0.0255. By univariate analysis, T1, T2, C4d+ve, eGFR<60, proteinuria were predictors of kidney outcome. By multivariate analysis, proteinuria, T1, T2 and C4d+ve were independent predictors (Model 2 HR (95% CI) C4d+ve: 3.24 (1.09-9.58), p = 0.034). Segmental had lower eGFR, higher tubulointerstitial fibrosis, and segmental sclerosis compared to Global pattern. Clinicopathological parameters were not different between Focal and Diffuse patterns. Outcomes were similar between staining patterns. In conclusion, C4d staining may be a valuable marker of poor prognosis in Asian patients with IgAN. Less stringent criteria for C4d+ve should be considered as no differences in outcomes were observed between more extensive staining with less extensive patterns. More studies are needed to identify the optimum criteria for C4d+ve.	[Worawichawong, Suchin; Plumworasawat, Sirithep; Chalermsanyakorn, Panus] Mahidol Univ, Fac Med, Dept Pathol, Ramathibodi Hosp, Bangkok, Thailand; [Liwlompaisan, Wisit; Sumethkul, Vasant; Phakdeekitcharoen, Bunyong; Kitiyakara, Chagriya] Mahidol Univ, Fac Med, Dept Med, Ramathibodi Hosp, Bangkok, Thailand; [Udomsubpayakul, Umaporn] Mahidol Univ, Fac Med, Sect Clin Epidemiol & Biostat, Ramathibodi Hosp, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University	Kitiyakara, C (corresponding author), Mahidol Univ, Fac Med, Dept Med, Ramathibodi Hosp, Bangkok, Thailand.	kitiyakc@yahoo.com	Sumethkul, Vasant/AAN-6897-2020	Sumethkul, Vasant/0000-0003-1732-1399; Kitiyakara, Chagriya/0000-0001-6340-3534	Faculty of Medicine, Ramathibodi Hospital; National Science and Technology Development Agency (NSTDA). Thailand	Faculty of Medicine, Ramathibodi Hospital; National Science and Technology Development Agency (NSTDA). Thailand	This study is supported by grants from Faculty of Medicine, Ramathibodi Hospital, and the National Science and Technology Development Agency (NSTDA). Thailand.	Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Cohen D, 2012, KIDNEY INT, V81, P628, DOI 10.1038/ki.2011.497; Coppo R, 2017, PEDIATR NEPHROL, V32, P1097, DOI 10.1007/s00467-016-3575-2; Coppo R, 2014, KIDNEY INT, V86, P828, DOI 10.1038/ki.2014.63; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Endo M, 2001, CLIN NEPHROL, V55, P185; Espinosa M, 2014, CLIN J AM SOC NEPHRO, V9, P897, DOI 10.2215/CJN.09710913; Espinosa M, 2009, NEPHROL DIAL TRANSPL, V24, P886, DOI 10.1093/ndt/gfn563; Faria B, 2015, CLIN EXP IMMUNOL, V179, P354, DOI 10.1111/cei.12461; Val-Bernal JF, 2011, HISTOL HISTOPATHOL, V26, P1391, DOI 10.14670/HH-26.1391; Fabiano RCG, 2017, PEDIATR NEPHROL, V32, P1211, DOI 10.1007/s00467-017-3610-y; Hachiya A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-78972-1; HESSING M, 1991, BIOCHEM J, V277, P581, DOI 10.1042/bj2770581; Heybeli C, 2015, RENAL FAILURE, V37, P1464, DOI 10.3109/0886022X.2015.1077319; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maeng YI, 2013, INT J CLIN EXP PATHO, V6, P904; Maillard N, 2015, J AM SOC NEPHROL, V26, P1503, DOI 10.1681/ASN.2014101000; Nasri Hamid, 2015, J Nephropathol, V4, P19, DOI 10.12860/jnp.2015.04; National High Blood Pressure Education Program, 2004, 7 REP JOINT NAT COMM; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Rodrigues JC, 2017, CLIN J AM SOC NEPHRO, V12, P677, DOI 10.2215/CJN.07420716; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Roos A, 2001, J IMMUNOL, V167, P2861, DOI 10.4049/jimmunol.167.5.2861; Roufosse C, 2018, TRANSPLANTATION, V102, P1795, DOI 10.1097/TP.0000000000002366; Sahin OZ, 2014, INT J CLIN EXP PATHO, V7, P3299; Segarra A, 2018, CLIN J AM SOC NEPHRO, V13, P258, DOI 10.2215/CJN.02530317; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Yeo SC, 2018, PEDIATR NEPHROL, V33, P763, DOI 10.1007/s00467-017-3699-z	29	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252638	10.1371/journal.pone.0252638	http://dx.doi.org/10.1371/journal.pone.0252638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081719	gold, Green Published			2022-12-26	WOS:000664639200035
J	Arumugam, A; Markham, C; Aykar, SS; Van Der Pol, B; Dixon, P; Wu, M; Wong, S				Arumugam, Arunkumar; Markham, Cole; Aykar, Saurabh S.; Van Der Pol, Barbara; Dixon, Paula; Wu, Michelle; Wong, Season			PrintrLab incubator: A portable and low-cost CO2 incubator based on an open-source 3D printer architecture	PLOS ONE			English	Article							CARBON-DIOXIDE REQUIREMENT; NEISSERIA-GONORRHOEAE; ARDUINO	Growth in open-source hardware designs combined with the decreasing cost of high-quality 3D printers have supported a resurgence of in-house custom lab equipment development. Herein, we describe a low-cost (< $400), open-source CO2 incubator. The system is comprised of a Raspberry Pi computer connected to a 3D printer controller board that has controls for a CO2 sensor, solenoid valve, heater, and thermistors. CO2 is supplied through the sublimation of dry ice stored inside a thermos to create a sustained 5% CO2 supply. The unit is controlled via G-Code commands sent by the Raspberry Pi to the controller board. In addition, we built a custom software application for remote control and used the open-source Grafana dashboard for remote monitoring. Our data show that we can maintain consistent CO2 and temperature levels for over three days without manual interruption. The results from our culture plates and real-time PCR indicate that our incubator performed equally well when compared to a much more expensive commercial CO2 incubator. We have also demonstrated that the antibiotic susceptibility assay can be performed in this low-cost CO2 incubator. Our work also indicates that the system can be connected to incubator chambers of various chamber volumes.	[Arumugam, Arunkumar; Markham, Cole; Wu, Michelle; Wong, Season] AI Biosci Inc, College Stn, TX 77845 USA; [Aykar, Saurabh S.] Iowa State Univ, Ames, IA USA; [Van Der Pol, Barbara; Dixon, Paula] Univ Alabama Birmingham, Birmingham, AL USA	Iowa State University; University of Alabama System; University of Alabama Birmingham	Wong, S (corresponding author), AI Biosci Inc, College Stn, TX 77845 USA.	season.wong@aibiosciences.com	Wu, Michelle/GRJ-2091-2022	Aykar, Saurabh/0000-0003-2885-0210	US NIH Phase I SBIR contract [75N93019C00018]	US NIH Phase I SBIR contract(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for prototype construction was supported by a US NIH Phase I SBIR contract (75N93019C00018) awarded to AI Biosciences, Inc. which employed AA, CM, SSA, and MW. SW is the cofounder of AI Biosciences, Inc. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Chan K, 2018, ANAL BIOCHEM, V545, P4, DOI 10.1016/j.ab.2018.01.008; Chan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158502; D'Ausilio A, 2012, BEHAV RES METHODS, V44, P305, DOI 10.3758/s13428-011-0163-z; Frame Mark, 2014, Surg Technol Int, V24, P314; GRIFFIN P. J., 1957, YALE JOUR BIOL AND MED, V29, P613; GRIFFIN PJ, 1956, J BACTERIOL, V71, P717, DOI 10.1128/JB.71.6.717-721.1956; Marzullo TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030837; McLimans W., 1972, GROWTH NUTR METABOLI, V1; Ng Lai-King, 2005, Can J Infect Dis Med Microbiol, V16, P15; Pineno O, 2014, BEHAV RES METHODS, V46, P196, DOI 10.3758/s13428-013-0367-5; PLATT DJ, 1976, J CLIN MICROBIOL, V4, P129; Stokes TH, 2013, 2013 35 ANN INT C IE; Tabrizi SN, 2005, SEX TRANSM DIS, V32, P199, DOI 10.1097/01.olq.0000154495.24519.bf; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x; Wadsworth CB, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00549-19; Walzik MP, 2015, BIOSENS BIOELECTRON, V64, P639, DOI 10.1016/j.bios.2014.09.061; Willbrand BN, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00696; Wittbrodt JN, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-36	18	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251812	10.1371/journal.pone.0251812	http://dx.doi.org/10.1371/journal.pone.0251812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077426	Green Published, gold			2022-12-26	WOS:000664638500017
J	Marinello, S; Leider, J; Powell, LM				Marinello, Samantha; Leider, Julien; Powell, Lisa M.			Employment impacts of the San Francisco sugar-sweetened beverage tax 2 years after implementation	PLOS ONE			English	Article							OBESITY; PACKAGE; FOOD	Introduction Sugar-sweetened beverage (SSB) taxes have been implemented worldwide to raise revenue and reduce consumption of SSBs, which is associated with health harms. Empirical evaluations have found that these taxes are successful at reducing demand for SSBs; however, SSB taxes face opposition, in part because of claims that they will lead to substantial job losses. The purpose of this study is to examine the impact of the San Francisco SSB tax, implemented on January 1st, 2018, on employment. Methods Monthly employment counts were obtained from the Bureau of Labor Statistics from January 2013 (5-years pre-tax) through December 2019 (2-years post-tax) for the overall economy, private sector, supermarkets and other grocery stores, convenience stores, limited-service restaurants, and beverage manufacturing. A synthetic control analysis was conducted for each employment outcome. The synthetic controls (i.e., estimated counterfactuals) were generated from a pool of urban control counties using pre-tax labor market-related characteristics. Results The synthetic controls had similar labor market-related characteristics and employment outcomes to those in San Francisco in the pre-tax period. Up to 2 years post-tax, differences in employment between San Francisco and the synthetic controls were small and not "statistically significant" based on placebo tests for all employment outcomes. Conclusions Up to two years post-tax, we do not find evidence that the San Francisco SSB tax negatively impacted net employment, employment in the private sector, or employment in specific SSB-related industries.	[Marinello, Samantha; Powell, Lisa M.] Univ Illinois, Sch Publ Hlth, Div Hlth Policy & Adm, Chicago, IL 60607 USA; [Marinello, Samantha; Leider, Julien; Powell, Lisa M.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Marinello, S (corresponding author), Univ Illinois, Sch Publ Hlth, Div Hlth Policy & Adm, Chicago, IL 60607 USA.; Marinello, S (corresponding author), Univ Illinois, Inst Hlth Res & Policy, Chicago, IL 60607 USA.	smarin23@uic.edu		Marinello, Samantha/0000-0002-0841-6487; Leider, Julien/0000-0002-5435-8898	Bloomberg Philanthropies' Obesity Prevention Initiative [49255]	Bloomberg Philanthropies' Obesity Prevention Initiative	This study was supported by a grant (grant number 49255 (LP)) from Bloomberg Philanthropies' Obesity Prevention Initiative (www.bloomberg.org).The contents of this publication do not necessarily reflect the views or policies of Bloomberg Philanthropies. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Abadie A, 2015, AM J POLIT SCI, V59, P495, DOI 10.1111/ajps.12116; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Abadie Alberto., 2011, SYNTH STATA MODULE I; Bank World, 2020, TAX SUG SWEET BEV SU; Bureau of Labor Statistics, Q CENS EMPL WAG; Cawley J, 2019, ANNU REV NUTR, V39, P317, DOI 10.1146/annurev-nutr-082018-124603; Chaloupka FJ, 2019, ANNU REV PUBL HEALTH, V40, P187, DOI [10.1146/annurev-publhealth-040218-043816, 10.1146/annurev-publhealth040218-043816]; Galiani S, 2017, STATA J, V17, P834, DOI 10.1177/1536867X1701700404; Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329; Guerrero-Lopez CM, 2017, PREV MED, V105, pS43, DOI 10.1016/j.ypmed.2017.09.001; Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040; Lawman HG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213218; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Marinello S, 2021, ECON HUM BIOL, V40, DOI 10.1016/j.ehb.2020.100939; Mounsey S, 2020, ECON HUM BIOL, V37, DOI 10.1016/j.ehb.2020.100854; Pan American Health Organization, 2020, SUG SWEET BEV TAX RE; Paraje G, 2021, FOOD POLICY, V100, DOI 10.1016/j.foodpol.2020.102016; Powell LM, 2014, AM J PUBLIC HEALTH, V104, P672, DOI 10.2105/AJPH.2013.301630; Teng AM, 2019, OBES REV, V20, P1187, DOI 10.1111/obr.12868	19	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252094	10.1371/journal.pone.0252094	http://dx.doi.org/10.1371/journal.pone.0252094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QL	34077430	gold, Green Published			2022-12-26	WOS:000664638500027
J	Smith, SCL; Banbury, C; Zardo, D; Cannatelli, R; Nardone, OM; Shivaji, UN; Ghosh, S; Oppenheimer, PG; Iacucci, M				Smith, Samuel C. L.; Banbury, Carl; Zardo, Davide; Cannatelli, Rosanna; Nardone, Olga M.; Shivaji, Uday N.; Ghosh, Subrata; Oppenheimer, Pola Goldberg; Iacucci, Marietta			Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease	PLOS ONE			English	Article							ULCERATIVE-COLITIS; HISTOLOGICAL REMISSION; CLINICAL RELAPSE; CROHNS-DISEASE; DIAGNOSIS; INDEX; SCORE; RISK	Background Mucosal healing (MH) is a key treatment target in the management of inflammatory bowel disease (IBD) and is defined in endoscopic terms by the newly published PICaSSO score. Raman Spectroscopy (RS) is based on the scattering of inelastic light giving spectra that are highly specific for individual molecules. We aimed to establish spectral changes before and after treatment and whether Raman Spectroscopy is able to accurately differentiate between inflammation and MH. Methods Biopsies were taken for ex vivo RS analysis alongside biopsies for histological analysis from IBD patients undergoing optical diagnosis endoscopic assessment. We compared pre- vs. post-biological treatment in IBD patients and healthy controls and active vs. MH in UC and CD. For spectral analysis, we used supervised self-organising maps for separation and classification. Results A total of 23 patients (14 IBD, 9 HC) were recruited for comparison of pre- vs. post-biologic treatment and 74 IBD patients were included for the assessment of MH in IBD, giving 9700 Raman Spectra. Spectral differences were seen between pre- and post-treatment which were observed comparing MH vs. active inflammation. Reductions in intensity at 1003cm(-1) and 1252cm(-1) when a reduction in inflammation was seen post-treatment and when MH was present. MH was associated with an increase in intensity at 1304cm(-1). The trained neural network differentiated MH from active inflammation with a sensitivity, specificity, PPV, NPV and accuracy in UC of 96.29% (sd 0.94), 95.03% (sd 1.52), 94.89% (sd 1.59), 96.33 (sd 0.97) and 95.65 (sd 0.99) and 96.19% (sd 1.46), 88% (sd 4.20), 86.60% (sd 5.39), 96.55% (sd 1.32) and 91.6% (sd 2.75) in CD respectively. Conclusion We demonstrated RS can demonstrate biochemical changes following treatment of IBD and accurately differentiates MH from active inflammation in IBD and might be a future tool to personalise therapeutic management in IBD.	[Smith, Samuel C. L.; Cannatelli, Rosanna; Nardone, Olga M.; Shivaji, Uday N.; Ghosh, Subrata; Iacucci, Marietta] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; [Banbury, Carl; Oppenheimer, Pola Goldberg] Univ Birmingham, Chem Engn, Birmingham, W Midlands, England; [Zardo, Davide; Ghosh, Subrata; Iacucci, Marietta] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England; [Shivaji, Uday N.; Ghosh, Subrata; Iacucci, Marietta] Univ Birmingham, Biomed Res Ctr, Natl Inst Hlth Res Birmingham, Birmingham, W Midlands, England; [Shivaji, Uday N.; Ghosh, Subrata; Iacucci, Marietta] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Iacucci, M (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.; Iacucci, M (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Birmingham, W Midlands, England.; Iacucci, M (corresponding author), Univ Birmingham, Biomed Res Ctr, Natl Inst Hlth Res Birmingham, Birmingham, W Midlands, England.; Iacucci, M (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.	m.iacucci@bham.ac.uk	Nardone, Olga Maria/AAW-4573-2021; Ghosh, Subrata/AAC-2676-2021	Ghosh, Subrata/0000-0002-1713-7797; Goldberg Oppenheimer, Pola/0000-0002-1014-4724; Shivaji, Uday Nagesh/0000-0002-6800-584X; Nardone, Olga Maria/0000-0002-9554-4785	NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; EPSRC	NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MI and SG are funded by the NIHR Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. CB acknowledges funding from EPSRC through a studentship from the SciPhy-4-Health Centre for Doctoral Training.	Addis J, 2016, BIOMED OPT EXPRESS, V7, P2022, DOI 10.1364/BOE.7.002022; Banbury C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47205-5; Barreiro-de Acosta M, 2016, J CROHNS COLITIS, V10, P13, DOI 10.1093/ecco-jcc/jjv158; Bielecki C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076030; Bryant RV, 2014, J CROHNS COLITIS, V8, P1582, DOI 10.1016/j.crohns.2014.08.011; Butler HJ, 2016, NAT PROTOC, V11, P664, DOI 10.1038/nprot.2016.036; Calafat M, 2017, DIGEST LIVER DIS, V49, P1327, DOI 10.1016/j.dld.2017.08.041; Cheriyadat A, 2003, INT GEOSCI REMOTE SE, P3420; Christensen B, 2017, CLIN GASTROENTEROL H, V15, P1557, DOI 10.1016/j.cgh.2017.02.016; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; Ding H, 2017, BIOMED OPT EXPRESS, V8, P3426, DOI 10.1364/BOE.8.003426; Doherty G, 2018, J CROHNS COLITIS, V12, P17, DOI 10.1093/ecco-jcc/jjx101; Gisbert JP, 2016, AM J GASTROENTEROL, V111, P632, DOI 10.1038/ajg.2016.54; Iacucci M, 2021, GASTROENTEROLOGY, V160, P1558, DOI 10.1053/j.gastro.2020.12.024; Iacucci M, 2017, GASTROINTEST ENDOSC, V86, P1118, DOI 10.1016/j.gie.2017.03.012; Iacucci M, 2015, ENDOSCOPY, V47, P726, DOI 10.1055/s-0034-1391863; Kanazawa M, 2019, ENDOSC INT OPEN, V7, pE568, DOI 10.1055/a-0869-7619; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Krafft C, 2003, VIB SPECTROSC, V32, P75, DOI 10.1016/S0924-2031(03)00049-3; Morasso C., 2020, J CROHNS COLITIS, DOI [10.1093/ecco-jcc/jjaa080, DOI 10.1093/ECCO-JCC/JJAA080]; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Murr Christian, 2014, J Amino Acids, V2014, P783730, DOI 10.1155/2014/783730; Narang V, 2018, INTEST RES, V16, P55, DOI 10.5217/ir.2018.16.1.55; Omberg KM, 2002, APPL SPECTROSC, V56, P813, DOI 10.1366/000370202760171464; Pai RK, 2019, GUT, V68, P2100, DOI 10.1136/gutjnl-2018-317547; Park S, 2016, AM J GASTROENTEROL, V111, P1692, DOI 10.1038/ajg.2016.418; Pence I, 2016, CHEM SOC REV, V45, P1958, DOI 10.1039/c5cs00581g; Pence IJ, 2017, BIOMED OPT EXPRESS, V8, P524, DOI 10.1364/BOE.8.000524; Peyrin-Biroulet L, 2015, AM J GASTROENTEROL, V110, P1324, DOI 10.1038/ajg.2015.233; Raman CV, 1928, NATURE, V121, P619, DOI 10.1038/121619b0; Rutgeerts P, 2012, GASTROENTEROLOGY, V142, P1102, DOI 10.1053/j.gastro.2012.01.035; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Shah SC, 2016, ALIMENT PHARM THER, V43, P317, DOI 10.1111/apt.13475; Shi H, 2016, WORLD J GASTROINTEST, V8, P273, DOI 10.4253/wjge.v8.i5.273; Travis SPL, 2012, GUT, V61, P535, DOI 10.1136/gutjnl-2011-300486; Trivedi PJ, 2018, GASTROINTEST ENDOSC, V88, P95, DOI 10.1016/j.gie.2018.02.044; Turner D, 2021, GASTROENTEROLOGY, V160, P1570, DOI 10.1053/j.gastro.2020.12.031; Wood JJ, 2014, COLORECTAL DIS, V16, P732, DOI 10.1111/codi.12664	38	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252210	10.1371/journal.pone.0252210	http://dx.doi.org/10.1371/journal.pone.0252210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077453	gold, Green Published			2022-12-26	WOS:000664638500033
J	Zhu, Y; Sazer, D; Miller, JS; Warmflash, A				Zhu, Ye; Sazer, Daniel; Miller, Jordan S.; Warmflash, Aryeh			Rapid fabrication of hydrogel micropatterns by projection stereolithography for studying self-organized developmental patterning	PLOS ONE			English	Article							TOOL	Self-organized patterning of mammalian embryonic stem cells on micropatterned surfaces has previously been established as an in vitro platform for early mammalian developmental studies, complimentary to in vivo studies. Traditional micropatterning methods, such as micro-contact printing (mu CP), involve relatively complicated fabrication procedures, which restricts widespread adoption by biologists. Here, we demonstrate a rapid method of micropatterning by printing hydrogel micro-features onto a glass-bottomed culture vessel. The micro-features are printed using a projection stereolithography bioprinter yielding hydrogel structures that geometrically restrict the attachment of cells or proteins. Compared to traditional and physical photomasks, a digitally tunable virtual photomask is used in the projector to generate blue light patterns that enable rapid iteration with minimal cost and effort. We show that a protocol that makes use of this method together with LN521 coating, an extracellular matrix coating, creates a surface suitable for human embryonic stem cell (hESC) attachment and growth with minimal non-specific adhesion. We further demonstrate that self-patterning of hESCs following previously published gastrulation and ectodermal induction protocols achieves results comparable with those obtained with commercially available plates.	[Zhu, Ye; Sazer, Daniel; Miller, Jordan S.; Warmflash, Aryeh] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Warmflash, Aryeh] Rice Univ, Dept Biosci, Houston, TX 77005 USA	Rice University; Rice University	Miller, JS; Warmflash, A (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.; Warmflash, A (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.	jmil@rice.edu; aryeh.warmflash@rice.edu	Warmflash, Aryeh/Y-6763-2019	Warmflash, Aryeh/0000-0002-5679-2268; Sazer, Daniel/0000-0002-1057-4353	Rice University; Welch Foundation [C-2021]; NSF [MCB-1553228]; NIH [R01GM126122]; Simons Foundation [511079]; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; Gulf Coast Consortia on the NSF IGERT: Neuroengineering from Cells to Systems [1250104]	Rice University; Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation; Gulf Coast Consortia on the NSF IGERT: Neuroengineering from Cells to Systems	This work was funded by Rice University and grants to AW from the Welch Foundation (C-2021), NSF (MCB-1553228), NIH (R01GM126122), and Simons Foundation (511079), and to DS and JM from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation, and a training fellowship to DS from the Gulf Coast Consortia on the NSF IGERT: Neuroengineering from Cells to Systems (#1250104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belisle JM, 2009, LAB CHIP, V9, P3580, DOI 10.1039/b911967a; Britton G, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.179093; Chhabra S, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000498; Deglincerti A, 2016, NAT PROTOC, V11, P2223, DOI 10.1038/nprot.2016.131; Etoc F, 2016, DEV CELL, V39, P302, DOI 10.1016/j.devcel.2016.09.016; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; Fink J, 2007, LAB CHIP, V7, P672, DOI 10.1039/b618545b; Grigoryan B., 2021, SCI REP-UK, V11, P1, DOI DOI 10.1038/S41598-021-82102-W; Grigoryan B, 2019, SCIENCE, V364, P458, DOI 10.1126/science.aav9750; Heemskerk I, 2019, ELIFE, V8, DOI 10.7554/eLife.40526; Itoga K, 2006, BIOMATERIALS, V27, P3005, DOI 10.1016/j.biomaterials.2005.12.023; Klaffky E, 2001, DEV BIOL, V239, P161, DOI 10.1006/dbio.2001.0404; Manfrin A, 2019, NAT METHODS, V16, P640, DOI 10.1038/s41592-019-0455-2; Martyn I, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.172791; Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058; Morgani SM, 2018, ELIFE, V7, DOI 10.7554/eLife.32839; Nemashkalo A, 2017, DEVELOPMENT, V144, P3042, DOI 10.1242/dev.153239; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Ruiz SA, 2007, SOFT MATTER, V3, P168, DOI 10.1039/b613349e; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Tewary M, 2017, DEVELOPMENT, V144, P4298, DOI 10.1242/dev.149658; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/nmeth.3016, 10.1038/NMETH.3016]; Yang WG, 2015, MICROMACHINES-BASEL, V6, P1903, DOI 10.3390/mi6121464	27	0	0	7	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0245634	10.1371/journal.pone.0245634	http://dx.doi.org/10.1371/journal.pone.0245634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077425	Green Submitted, gold, Green Published			2022-12-26	WOS:000664638500001
J	Caterino, C; Aragosa, F; Della Valle, G; Costanza, D; Lamagna, F; Piscitelli, A; Nieddu, A; Fatone, G				Caterino, Chiara; Aragosa, Federica; Della Valle, Giovanni; Costanza, Dario; Lamagna, Francesco; Piscitelli, Alfonso; Nieddu, Annalisa; Fatone, Gerardo			Clinical efficacy of Curcuvet and Boswellic acid combined with conventional nutraceutical product: An aid to canine osteoarthritis	PLOS ONE			English	Article							DOUBLE-BLIND; CURCUMIN; DOGS; INFLAMMATION; COMBINATION; FORMULATION; EXTRACT; SAFETY	Introduction Osteoarthritis is a progressive degenerative joint disease which is high prevalent in dogs. In the late stage of the disease, it determines chronic neuropathic pain which leads to reduced quality-of-life in affected patients. To date it has not yet been identified a specific treatment, but it has been proved that nutraceutical and dietary supplements may play an important role in controlling inflammation and pain. The aim of this study was to evaluate, by the use of force plate gait analysis, the clinical efficacy of Boswellia and Curcuvet (R) combined with conventional nutraceutical therapy compared with conventional nutraceutical alone in dogs affected by osteoarthritis. Materials and methods Twenty client-owned dogs, over 12 months old and 20 kg of body-weight, with a confirmed diagnosis of Osteoarthritis, were included in this randomized, double-blinded study. The dogs were randomly divided into two groups: the first group (A) received a conventional nutraceutical (consisted in a preparation of glucosamine, chondroitin sulfate, fish-oil containing 80% of omega 3-fatty acid, vitamin C and E, saccharomyces Cerevisiae) with a combination of acid boswellic and Curcuvet (R), while the second group (B) received a conventional nutraceutical. All the enrolled dogs underwent a washout period before starting the treatment with nutraceuticals products which were the only admitted treatment over the study period. A full orthopaedic and neurologic examination, and force plate gait analysis were performed before starting the treatment, at 45, 90, and 60 days post-treatment. Ground reaction forces were recorded and analyzed. Results Twenty dogs were enrolled in the study. In both groups there was an increasing values of ground reaction forces. These results might indicate that both nutraceutical products determined a better condition in terms of pain feeling but that effect is much more visible after 60 days from the end of the administration in treated group. Discussion In conclusion Curcuvet in combination with Boswellic acid could be considered a valid aid in a multimodal treatment for canine osteoarthritis.	[Caterino, Chiara; Aragosa, Federica; Della Valle, Giovanni; Lamagna, Francesco; Fatone, Gerardo] Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Costanza, Dario] Univ Naples Federico II, Interdepartmental Ctr Vet Radiol, Naples, Italy; [Piscitelli, Alfonso] Univ Naples Federico II, Dept Agr Sci, Portici, Italy; [Nieddu, Annalisa] Aurora Biofarma, Vet Div, Milan, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Della Valle, G (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Naples, Italy.	giovanni.dellavalle@unina.it	Fatone, Gerardo/AAE-6369-2021; Costanza, Dario/AAA-1661-2022; Caterino, Chiara/GRS-8577-2022; Della Valle, Giovanni/AAX-3735-2021	Fatone, Gerardo/0000-0003-2578-7420; Costanza, Dario/0000-0001-7310-0246; Caterino, Chiara/0000-0002-9753-5452; Della Valle, Giovanni/0000-0002-5424-6335	Aurora Biofarma	Aurora Biofarma	AN is a scientific consultant of Aurora Biofarma. Aurora Biofarma provided support in the form of nutraceutical preparation and in the form of salary to AN. The specific roles of this author are articulated in the `author contributions' section. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameye LG, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2016; Anderson MA, 1999, COMP CONT EDUC PRACT, V21, P601; Beale BS, 2004, VET CLIN N AM-SMALL, V34, P271, DOI 10.1016/j.cvsm.2003.09.008; Bennett RL, 1996, AM J VET RES, V57, P966; Beths T, 2020, AUST VET J, V98, P591, DOI 10.1111/avj.13024; Britti D, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1151-z; Colitti M, 2012, VET IMMUNOL IMMUNOP, V147, P136, DOI 10.1016/j.vetimm.2012.04.001; Comblain F, 2016, J VET PHARMACOL THER, V39, P1, DOI 10.1111/jvp.12251; Comblain F, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1317-8; Cordaro M, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-2048-y; Di Paola R, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1189-5; Filardo G, 2016, KNEE SURG SPORT TR A, V24, P1775, DOI 10.1007/s00167-016-4089-y; Haroyan A, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-017-2062-z; Henrotin Y, 2005, VET J, V170, P113, DOI 10.1016/j.tvjl.2004.08.014; Johnson KA, 2020, JAVMA-J AM VET MED A, V256, P1335, DOI 10.2460/javma.256.12.1335; Johnston SA, 1997, VET CLIN N AM-SMALL, V27, P699, DOI 10.1016/S0195-5616(97)50076-3; Kimmatkar N, 2003, PHYTOMEDICINE, V10, P3, DOI 10.1078/094471103321648593; Knebel J, 2020, VET COMP ORTHOPAED, V33, P189, DOI 10.1055/s-0040-1701502; Lascelles BDX, 2005, VET THER, V6, P237; Lee DV, 2004, J EXP BIOL, V207, P1715, DOI 10.1242/jeb.00947; Liu WD, 2016, J DRUG TARGET, V24, P694, DOI 10.3109/1061186X.2016.1157883; Loeser RF, 2013, OSTEOARTHR CARTILAGE, V21, P1436, DOI 10.1016/j.joca.2013.05.020; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; McCarthy G, 2007, VET J, V174, P54, DOI 10.1016/j.tvjl.2006.02.015; Molsa SH, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0266-8; Morgan JP, 2010, VET SURG, V39, P425, DOI 10.1111/j.1532-950X.2010.00669.x; Musco N, 2019, VET MED SCI, V5, P325, DOI 10.1002/vms3.182; Singh S, 2011, J ESSENT OIL RES, V23, P11, DOI 10.1080/10412905.2011.9712275; Vilar JM, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-131; Voss K, 2010, VET SURG, V39, P863, DOI 10.1111/j.1532-950X.2010.00729.x	30	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252279	10.1371/journal.pone.0252279	http://dx.doi.org/10.1371/journal.pone.0252279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048452	gold, Green Published			2022-12-26	WOS:000664636100028
J	Kadykalo, AN; Kelly, LA; Berberi, A; Reid, JL; Findlay, CS				Kadykalo, Andrew N.; Kelly, Lisa A.; Berberi, Albana; Reid, Jessica L.; Findlay, C. Scott			Research effort devoted to regulating and supporting ecosystem services by environmental scientists and economists	PLOS ONE			English	Article							NATURES CONTRIBUTIONS; SCIENCE; CONSERVATION; VALUES	The economic valuation of ecosystem services in part reflects the desire to use conventional economic tools (markets and economic instruments) to conserve ecosystem services. However, for regulating and supporting ecosystem services that depend on ecosystem structure and function, estimation of economic value requires estimates of the current level of underlying ecological functions first. This primary step is in principle, the job of environmental scientists, not economists. Here, we provide a coarse-level quantitative assessment of the relationship between the research effort expended by environmental scientists (on the biophysical values) and economists (on the monetary values) on 15 different regulating and supporting services in 32 ecosystem types using peer-reviewed article hits retrieved from bibliographic databases as a measure of research effort. We find a positive, moderately strong (r = 0.69) correlation between research efforts in the two domains, a result that, while encouraging, is likely to reflect serendipity rather than the deliberate design of integrated environmental science-economics research programs. Our results suggest that compared to environmental science research effort economic valuation is devoted to a smaller, less diverse set of ecosystem services but a broader, more diverse, set of ecosystem types. The two domains differed more with respect to the ecosystem services that are the major focus of research effort than they did with respect to the ecosystem types of principal research interest. For example, carbon sequestration, erosion regulation, and nutrient cycling receive more relative research effort in the environmental sciences; air quality regulation in economic valuations. For both domains, cultivated areas, wetlands, and urban/semi-urban ecosystem types received relatively large research effort, while arctic and mountain tundra, cave and subterranean, cryosphere, intertidal/littoral zone, and kelp forest ecosystem types received negligible research effort. We suggest ways and means by which the field of sustainability science may be improved by the design and implementation of a searchable database of environmental science and economic valuation literature as well as a global ecosystem service research network and repository that explicitly links research on the estimation and prediction of biophysical ecosystem functions with that of the social sciences and other knowledge systems. These suggestions would, at least in principle, facilitate a more efficient research agenda between economists and environmental scientists and aid management, regulatory and judicial decision-makers.	[Kadykalo, Andrew N.; Findlay, C. Scott] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Kadykalo, Andrew N.; Findlay, C. Scott] Univ Ottawa, Inst Environm, Ottawa, ON, Canada; [Kadykalo, Andrew N.; Kelly, Lisa A.; Berberi, Albana; Reid, Jessica L.] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [Kadykalo, Andrew N.; Berberi, Albana; Reid, Jessica L.] Carleton Univ, Inst Environm Sci, Ctr Evidence Based Conservat & Environm Managemen, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Carleton University; Carleton University	Kadykalo, AN (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.; Kadykalo, AN (corresponding author), Univ Ottawa, Inst Environm, Ottawa, ON, Canada.; Kadykalo, AN (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.; Kadykalo, AN (corresponding author), Carleton Univ, Inst Environm Sci, Ctr Evidence Based Conservat & Environm Managemen, Ottawa, ON, Canada.	andriy.kadykalo@gmail.com	kelly, Lisa/GWU-9804-2022	Berberi, Albana/0000-0001-6928-1574; Kadykalo, Andrew/0000-0002-7359-0967; Kelly, Lisa/0000-0003-2830-6493	Smart Prosperity Institute; Natural Sciences and Engineering Research Council of Canada [PGSD2-534299-2019, RGPIN170399-2001]	Smart Prosperity Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Both ANK and CSF were supported by Smart Prosperity Institute and the Natural Sciences and Engineering Research Council of Canada [ANK: PGSD2-534299-2019; CSF: RGPIN170399-2001]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abson DJ, 2014, ECOL ECON, V103, P29, DOI 10.1016/j.ecolecon.2014.04.012; Ainscough J, 2019, ECOSYST SERV, V36, DOI 10.1016/j.ecoser.2019.01.004; Aksnes DW, 2016, ICES J MAR SCI, V73, P1004, DOI 10.1093/icesjms/fsv248; Bockstael NE, 2000, ENVIRON SCI TECHNOL, V34, P1384, DOI 10.1021/es990673l; Boyd JW, 2015, RESOURCES FUTURE DIS, DOI [10.2139/ssrn.2662053, DOI 10.2139/SSRN.2662053]; Braat LC, 2012, ECOSYST SERV, V1, P4, DOI 10.1016/j.ecoser.2012.07.011; Bruins RJF, 2017, INTEGR ENVIRON ASSES, V13, P52, DOI 10.1002/ieam.1842; Chan KMA, 2020, PEOPLE NAT, V2, P1021, DOI 10.1002/pan3.10137; Chaudhary S, 2015, ENVIRON SCI POLICY, V54, P25, DOI 10.1016/j.envsci.2015.04.025; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Collins SL, 2011, FRONT ECOL ENVIRON, V9, P351, DOI 10.1890/100068; Costanza R, 2017, ECOSYST SERV, V28, P1, DOI 10.1016/j.ecoser.2017.09.008; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; De Civita P, 1997, EVRI ENV VALUATION R; De Groot R., 2010, APPENDIX C ESTIMATES; De Groot R., 2010, CHAPTER 1 INTEGRATIN; de Groot R, 2012, ECOSYST SERV, V1, P50, DOI 10.1016/j.ecoser.2012.07.005; Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826; Diaz S, 2015, CURR OPIN ENV SUST, V14, P1, DOI 10.1016/j.cosust.2014.11.002; Diaz S, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002040; Doi H, 2016, PEERJ, V4, DOI 10.7717/peerj.2173; Droste N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204749; Ehrlich P.R., 1981, EXTINCTION; Gamer M., 2012, **DATA OBJECT**; Gomez-Baggethun E, 2010, ECOL ECON, V69, P1209, DOI 10.1016/j.ecolecon.2009.11.007; Guerrero AM, 2018, ECOL SOC, V23, DOI 10.5751/ES-10232-230338; Haines-Young R, 2018, COMMON INT CLASSIFIC; Ho YS, 2014, SCIENTOMETRICS, V98, P137, DOI 10.1007/s11192-013-1014-8; Jacobs S, 2018, ECOSYST SERV, V29, P515, DOI 10.1016/j.ecoser.2017.07.011; Jacobs S, 2016, ECOSYST SERV, V22, P213, DOI 10.1016/j.ecoser.2016.11.007; Kadykalo AN, 2019, ECOSYST PEOPLE, V15, P269, DOI 10.1080/26395916.2019.1669713; Konno K, 2020, ENVIRON SCI POLICY, V114, P256, DOI 10.1016/j.envsci.2020.08.021; Liu WJ, 2019, ECOL ECON, V156, P293, DOI 10.1016/j.ecolecon.2018.09.001; Martin-Lopez B, 2014, ECOL INDIC, V37, P220, DOI 10.1016/j.ecolind.2013.03.003; McDonough K, 2017, ECOSYST SERV, V25, P82, DOI 10.1016/j.ecoser.2017.03.022; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; Molnar Z, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-3; Mongeon P, 2016, SCIENTOMETRICS, V106, P213, DOI 10.1007/s11192-015-1765-5; Newcomer-Johnson T., 2018, ECOSERVICE MODELS LI; Podlubny I, 2005, SCIENTOMETRICS, V64, P95, DOI 10.1007/s11192-005-0240-0; Potschin-Young M, 2017, ECOSYST SERV, V27, P124, DOI 10.1016/j.ecoser.2017.09.001; Ricketts, 2015, FIELD GUIDE EC CONSE; Ricketts TH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13106; Schroter M, 2014, CONSERV LETT, V7, P514, DOI 10.1111/conl.12091; Sutherland IJ, 2018, ECOL INDIC, V94, P23, DOI 10.1016/j.ecolind.2017.06.047; The Economics of Ecosystems and Biodiversity Project [TEEB], 2010, MAINSTREAMING EC NAT; Value of Nature to Canadians Study Taskforce, 2017, COMPLETING USING ECO; Van der Ploeg S., 2010, TEEB VALUATION DATAB; Vaughan L, 2005, J AM SOC INF SCI TEC, V56, P1075, DOI 10.1002/asi.20199; Wagstaff A, 2012, J HEALTH ECON, V31, P406, DOI 10.1016/j.jhealeco.2012.03.002; Wainger L.A., 2009, ECOSYSTEM BASED MANA, P92; Wainger L, 2011, ENVIRON MANAGE, V48, P710, DOI 10.1007/s00267-011-9726-0; WESTMAN WE, 1977, SCIENCE, V197, P960, DOI 10.1126/science.197.4307.960; Willer DF, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00297	54	1	1	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252463	10.1371/journal.pone.0252463	http://dx.doi.org/10.1371/journal.pone.0252463			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PN	34048482	Green Published, gold			2022-12-26	WOS:000664636100054
J	Choi, W; Yanagihara, N; Li, L; Kim, J; Lee, J				Choi, Woong; Yanagihara, Naoki; Li, Liang; Kim, Jaehyo; Lee, Jongho			Visuomotor control of intermittent circular tracking movements with visually guided orbits in 3D VR environment	PLOS ONE			English	Article							CEREBELLAR MOTOR DISORDERS; COMPLEX SPIKE ACTIVITY; PURKINJE-CELL ACTIVITY; MANUAL TRACKING; ERROR-CORRECTION; INTERNAL-MODELS; ARM MOVEMENTS; ADAPTATION; COORDINATION; ANTICIPATION	The analysis of visually guided tracking movements is important to the understanding of imitation exercises and movements carried out using the human visuomotor control system. In this study, we analyzed the characteristics of visuomotor control in the intermittent performance of circular tracking movements by applying a system that can differentiate between the conditions of invisible and visible orbits and visible and invisible target phases implemented in a 3D VR space. By applying visuomotor control based on velocity control, our study participants were able to track objects with visible orbits with a precision of approximately 1.25 times greater than they could track objects with invisible orbits. We confirmed that position information is an important parameter related to intermittent motion at low speeds (below 0.5 Hz) and that tracked target velocity information could be obtained more precisely than position information at speeds above 0.5 Hz. Our results revealed that the feedforward (FF) control corresponding to velocity was delayed under the visible-orbit condition at speeds over 0.5 Hz, suggesting that, in carrying out imitation exercises and movements, the use of visually presented 3D guides can interfere with exercise learning and, therefore, that the effects of their use should be carefully considered.	[Choi, Woong] Natl Inst Technol, Dept Informat & Comp Engn, Gunma Coll, Maebashi, Gumma, Japan; [Yanagihara, Naoki] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki, Japan; [Li, Liang] Ristumeikan Univ, Coll Informat Sci & Engn, Kusatsu, Japan; [Kim, Jaehyo] Handong Global Univ, Dept Mech & Control Engn, Pohang, South Korea; [Lee, Jongho] Komatsu Univ, Dept Clin Engn, Komatsu, Japan	University of Tsukuba; Ritsumeikan University; Handong Global University	Kim, J (corresponding author), Handong Global Univ, Dept Mech & Control Engn, Pohang, South Korea.; Kim, J; Lee, J (corresponding author), Komatsu Univ, Dept Clin Engn, Komatsu, Japan.	jhkim@handong.edu; jongho.lee@komatsu-u.ac.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology [18K11594, 20K11235]; Korea National Research Foundation (KNRF) - Korean Government (MOE) [2020R1I1A3A0403820312]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Korea National Research Foundation (KNRF) - Korean Government (MOE)	This research was supported by grants in aid from the Japan Science and Technology Agency and from the Ministry of Education, Culture, Sports, Science and Technology (No. 18K11594) to W.C. and (No. 20K11235) to J.L. This work was also supported by the Korea National Research Foundation (KNRF), grant funded by theKorean Government (MOE) (No. 2020R1I1A3A0403820312).	BEGGS WDA, 1970, NATURE, V225, P752, DOI 10.1038/225752a0; BEPPU H, 1984, BRAIN, V107, P787, DOI 10.1093/brain/107.3.787; BEPPU H, 1987, BRAIN, V110, P1, DOI 10.1093/brain/110.1.1; Choi W., 2018, SCI REP-UK, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Choi W, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10020621; Choi Woong, 2019, Biomed Res Int, V2019, P3867138, DOI 10.1155/2019/3867138; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; Desmurget M, 1996, EXP BRAIN RES, V110, P265; Engel KC, 2000, J NEUROPHYSIOL, V83, P3483, DOI 10.1152/jn.2000.83.6.3483; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field A, 2013, DISCOVERING STAT USI; Fine JM, 2014, ACTA PSYCHOL, V149, P24, DOI 10.1016/j.actpsy.2014.02.012; Flatters I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088692; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hayashi Yoshikatsu, 2010, Transactions of the Society of Instrument and Control Engineers, V46, P391, DOI 10.9746/sicetr.46.391; Hayashi Y, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022704; Ito M, 2002, ANN NY ACAD SCI, V978, P273, DOI 10.1111/j.1749-6632.2002.tb07574.x; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Kakei S, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00216; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kim J, 2017, ADV ROBOTICS, V31, P29, DOI 10.1080/01691864.2016.1266121; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Kobayashi Y, 1998, J NEUROPHYSIOL, V80, P832, DOI 10.1152/jn.1998.80.2.832; Lee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132983; Lee J, 2012, CEREBELLUM, V11, P426, DOI 10.1007/s12311-012-0370-x; MIALL RC, 1986, BEHAV BRAIN RES, V20, P185, DOI 10.1016/0166-4328(86)90003-3; MIALL RC, 1993, J MOTOR BEHAV, V25, P53, DOI 10.1080/00222895.1993.9941639; MIALL RC, 1988, BEHAV BRAIN RES, V27, P1, DOI 10.1016/0166-4328(88)90104-0; OJAKANGAS CL, 1994, J NEUROPHYSIOL, V72, P2617, DOI 10.1152/jn.1994.72.6.2617; Parker MG, 2021, EXP BRAIN RES, V239, P189, DOI 10.1007/s00221-020-05962-0; Poulton EC, 1952, B J PSYCHOL-GEN SECT, V43, P295, DOI 10.1111/j.2044-8295.1952.tb00350.x; Roitman AV, 2009, EXP BRAIN RES, V192, P241, DOI 10.1007/s00221-008-1580-9; Roitman AV, 2005, J NEUROSCI, V25, P9244, DOI 10.1523/JNEUROSCI.1886-05.2005; Roitman AV, 2004, J NEUROPHYSIOL, V91, P901, DOI 10.1152/jn.00261.2003; Saijo N, 2005, J NEUROSCI, V25, P4941, DOI 10.1523/JNEUROSCI.4143-04.2005; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Soetedjo R, 2006, J NEUROSCI, V26, P7741, DOI 10.1523/JNEUROSCI.4658-05.2006; Stepp N, 2017, J EXP PSYCHOL HUMAN, V43, P914, DOI 10.1037/xhp0000393; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; van den Dobbelsteen JJ, 2001, EXP BRAIN RES, V138, P279, DOI 10.1007/s002210100689; VIVIANI P, 1990, J MOTOR BEHAV, V22, P407; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251371	10.1371/journal.pone.0251371	http://dx.doi.org/10.1371/journal.pone.0251371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043647	Green Published, gold			2022-12-26	WOS:000664635700017
J	Hailu, L; Betemariyam, M				Hailu, Leta; Betemariyam, Mulugeta			Comparison of soil organic carbon and total nitrogen stocks between farmland treated with three and six years level soil bund and adjacent farmland without conservation measure: In the case of southwestern Ethiopia	PLOS ONE			English	Article							WATER CONSERVATION; IMPACTS	This study was conducted to examine and compare the status of soil organic carbon (SOC) and total nitrogen (TN) stocks between farmlands treated with level soil bund (LSB) of three and six years and adjacent farmland without conservation measure (control) at Somodo Watershed. Soil samples were collected from farmland treated with LSB-3 years, LSB-6 years and control using randomized complete block design. A total of 108 composite soil samples (3 treatments * 6 replications * 3 bund zones * 2 depths (0-20 and 20-40 cm) were collected for analysis and determination of the Organic Carbon fraction (OC) and Nitrogen fraction (N). OC was determined using Walkley and Black method while N was determined using the Kjeldahl digestion, distillation and titration method. The result indicated that farmland treated with LSB-6 years has insignificantly higher SOC (98.43 +/- 11.55 Mg ha(-1)) and TN (9.37 +/- 1.10 Mg ha(-1)) stock than control SOC (93.01 +/- 13.51 Mg ha(-1)) and TN (9.28 +/- 1.60 Mg ha(-1)) stock. Likely, farmland treated with LSB-6 years has insignificantly higher SOC and TN stock than farmland treated with LSB-3 years SOC (96.61 +/- 11.45 Mg ha(-1)) stock. With respect to the age of LSB, farmland treated with LSB-6 years accumulated more SOC stock (5.83%) than control. This study revealed that the age of LSB conservation measures has a critical role in enhancing soil fertility through maintaining and sequestering SOC and TN.	[Hailu, Leta] Jimma Agr Res Ctr, Jimma, Ethiopia; [Betemariyam, Mulugeta] Madda Walabu Univ, Bale Robe, Ethiopia		Hailu, L (corresponding author), Jimma Agr Res Ctr, Jimma, Ethiopia.	latahailu@gmail.com		Hailu, Leta/0000-0002-6068-1667; Betemariyam, Mulugeta/0000-0002-5581-6512	Ethiopian Institute of Agricultural Research	Ethiopian Institute of Agricultural Research	Ethiopian Institute of Agricultural Research is the institution that supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The corresponding author received a salary from the funders.	Abebayehu Aticho, 2011, International Journal of Agricultural Research, V6, P707, DOI 10.3923/ijar.2011.707.713; Adgo E, 2013, AGR WATER MANAGE, V117, P55, DOI 10.1016/j.agwat.2012.10.026; Adimassu Z, 2017, ENVIRON MANAGE, V59, P87, DOI 10.1007/s00267-016-0776-1; Amdihun A., 2014, Research Journal of Environmental Sciences, V8, P243, DOI 10.3923/rjes.2014.243.258; Artemi C., 2020, LAND-BASEL, P1, DOI [10.3390/land9010013, DOI 10.3390/LAND9010013]; Aynsau A, 2007, ECOL ECON, V61, P294, DOI 10.1016/j.ecolecon.2006.01.014; Aytenew Mulugeta, 2015, AM J SCI IND RES, P74, DOI [10.5251/ajsir.2015.6.4.74.81, DOI 10.5251/AJSIR.2015.6.4.74.81]; Berry, 2003, COMMISSIONED GM WB S; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; Challa A., 2016, INT J NATURAL RESOUR, V1, P42, DOI DOI 10.11648/J.IJNREM.20160102.15; Dagnachew M, 2020, APPL ENVIRON SOIL SC, V2020, DOI 10.1155/2020/1868792; Dejene T., 2005, E CIV ENV RES, V9, P9; Fikirie K., 2018, INT J ENV AGR RES, V4, P35, DOI [10.13140/RG.2.2.15774.79682, DOI 10.13140/RG.2.2.15774.79682]; Food and Agriculture Organization of the United Nations, 1986, ETH HIGHL RECL STUD, V1; Haileslassie A, 2005, AGR ECOSYST ENVIRON, V108, P1, DOI 10.1016/j.agee.2004.12.010; Herweg K, 1999, CATENA, V36, P99, DOI 10.1016/S0341-8162(99)00004-1; Hurni H, 2000, AGR ECOSYST ENVIRON, V81, P83, DOI 10.1016/S0167-8809(00)00182-1; Kebede Wolka, 2011, Agricultural Sciences, V2, P357, DOI 10.4236/as.2011.23047; Mekonnen M, 2017, LAND DEGRAD DEV, V28, P708, DOI 10.1002/ldr.2629; Mengistu S. L., 2012, African Journal of Food, Agriculture, Nutrition and Development, V12, P6503; Mirzabaev, 2015, EC LAND DEGRADATION, P401, DOI [10.1007/978-3-319-19168-3%5F14, DOI 10.1007/978-3-319-19168-3_14]; Pearson T.R.H., 2007, GEN TECHNICAL REPORT, V18, P42; Pennock D, 2019, SOIL EROSION GREATES; Swift R. S., 1996, Methods of soil analysis. Part 3 - chemical methods., P1011; Setegn, 2010, MODELING HYDROLOGICA; Temesgen Gashaw, 2014, Journal of Environment and Earth Science, V4, P98; Walle Jemberu, 2018, EFFECT SOIL WATER CO, DOI [10.1016/j.jenvman.2017.11.044, DOI 10.1016/J.JENVMAN.2017.11.044]; Yaekob T., 2020, RENEW AGR FOOD SYST, V35, P1, DOI [10.1017/S1742170520000010, DOI 10.1017/S1742170520000010]; Yakob T., 2018, OPEN ACCESS LIB J, V05, P1, DOI [10.4236/oalib.1104431, DOI 10.4236/OALIB.1104431]; Yimer F, 2007, FOREST ECOL MANAG, V242, P337, DOI 10.1016/j.foreco.2007.01.087	30	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252123	10.1371/journal.pone.0252123	http://dx.doi.org/10.1371/journal.pone.0252123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043684	Green Published, gold			2022-12-26	WOS:000664635700055
J	McCulloch, DJ; Jackson, ML; Hughes, JP; Lester, S; Mills, L; Freeman, B; Rasheed, MAU; Thornburg, NJ; Chu, HY				McCulloch, Denise J.; Jackson, Michael L.; Hughes, James P.; Lester, Sandra; Mills, Lisa; Freeman, Brandi; Rasheed, Mohammad Ata Ur; Thornburg, Natalie J.; Chu, Helen Y.			Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019-April 2020	PLOS ONE			English	Article								Background The first US case of SARS-CoV-2 infection was detected on January 20, 2020. However, some serology studies suggest SARS-CoV-2 may have been present in the United States prior to that, as early as December 2019. The extent of domestic COVID-19 detection prior to 2020 has not been well-characterized. Objectives To estimate the prevalence of SARS-CoV-2 antibody among healthcare users in the greater Seattle, Washington area from October 2019 through early April 2020. Study design We tested residual samples from 766 Seattle-area adults for SARS-CoV-2 antibodies utilizing an ELISA against prefusion-stabilized Spike (S) protein. Results No antibody-positive samples were found between October 2, 2019 and March 13, 2020. Prevalence rose to 1.2% in late March and early April 2020. Conclusions The absence of SARS-CoV-2 antibody-positive samples in October 2019 through mid-March, 2020, provides evidence against widespread circulation of COVID-19 among healthcare users in the Seattle area during that time. A small proportion of this metropolitan-area cohort had been infected with SARS-CoV-2 by spring of 2020.	[McCulloch, Denise J.; Chu, Helen Y.] Univ Washington, Sch Med, Seattle, WA 98115 USA; [Jackson, Michael L.] Kaiser Permanente Washington, Seattle, WA USA; [Hughes, James P.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Lester, Sandra; Rasheed, Mohammad Ata Ur] Synergy Amer Inc, Duluth, GA USA; [Mills, Lisa] Eagle Global Sci LLC, Atlanta, GA USA; [Freeman, Brandi; Thornburg, Natalie J.] Ctr Dis Control & Prevent, Atlanta, GA USA	University of Washington; University of Washington Seattle; Kaiser Permanente; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA	McCulloch, DJ (corresponding author), Univ Washington, Sch Med, Seattle, WA 98115 USA.	dmccull@uw.edu		Thornburg, Natalie/0000-0003-3523-3616; McCulloch, Denise/0000-0001-8755-6105	University of Washington Department of Medicine Scholars Award; National Institute of Allergy and Infectious Disease [5T32AI007044-43]; Kaiser Permanente; Synergy America Inc.; Eagle Global Scientific	University of Washington Department of Medicine Scholars Award; National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Kaiser Permanente; Synergy America Inc.; Eagle Global Scientific	This work was supported by the University of Washington Department of Medicine Scholars Award to HYC and by the National Institute of Allergy and Infectious Disease T32 Host Defense Training Grant (5T32AI007044-43) to DJM. Kaiser Permanente (MLJ), Synergy America Inc. (SL, MR), and Eagle Global Scientific (LM) provided support in the form of salaries for authors MLJ, SL, MR and LM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aziz NA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22351-5; Baker M., 2021, NEW YORK TIMES; Barnes E, 2020, EVALUATION ANTIBODY, DOI 10.1101/2020.04.15.20066407v1.full.pdf; Basavaraju SV, 2021, CLIN INFECT DIS, V72, pE1004, DOI 10.1093/cid/ciaa1785; Cerino P, 2021, FUTUR SCI OA, V7, DOI 10.2144/fsoa-2020-0203; Deslandes A, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.106006; Dingens AS, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-18178-1, 10.1101/2020.05.26.20114124]; Freeman Brandi, 2020, bioRxiv, DOI 10.1101/2020.04.24.057323; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Kanji Jamil N, 2021, J Assoc Med Microbiol Infect Dis Can, V6, P10, DOI 10.3138/jammi-2020-0035; La Rosa G, 2021, SCI TOTAL ENVIRON, V750, DOI 10.1016/j.scitotenv.2020.141711; Li ZJ, 2021, LANCET REG HEALTH-W, V8, DOI 10.1016/j.lanwpc.2021.100094; Nah EH, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-049837; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Rasmussen S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249733; Saeed S, 2021, TRANSFUSION, V61, P862, DOI 10.1111/trf.16296; Shakiba M, 2021, EMERG INFECT DIS, V27, P636, DOI 10.3201/eid2702.201960; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Sutton M, 2020, MMWR-MORBID MORTAL W, V69, P1100, DOI 10.15585/mmwr.mm6932a4; Washington State Department of Health, 2020, COVID 19 DAT DASHB W; Xiong Wei Ting, 2020, J Assoc Med Microbiol Infect Dis Can, V5, P235, DOI 10.3138/jammi-2020-0029	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252235	10.1371/journal.pone.0252235	http://dx.doi.org/10.1371/journal.pone.0252235			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043706	gold, Green Published, Green Submitted			2022-12-26	WOS:000664635700077
J	Cheng, CN; Huang, SY; Lien, PW; Huang, ST; Lin, FJ				Cheng, Chih-Ning; Huang, Shang-Yi; Lien, Pei-Wen; Huang, Shih-Ting; Lin, Fang-Ju			Survival, health care resource utilization and expenditures of first-line treatments for multiple myeloma patients ineligible for transplant in Taiwan	PLOS ONE			English	Article							DATABASE	Background We aimed to provide real-world information on survival, health care resource utilization (HCRU), and expenditures related to various first lines of therapy (1LOTs) in newly diagnosed multiple myeloma (NDMM) patients who were transplant ineligible (TI). Patients and methods From the Taiwan National Health Insurance Database (2008-2016), we identified 1,511 NDMM-TI patients who had received 1LOT since June 2012. We categorized 1LOT regimens into four groups: bortezomib (V)+thalidomide (T), V, T, and non-V/T. Patients' characteristics were collected. The overall survival (OS), event-free survival (EFS), frequencies of HCRU (hospitalization, visiting outpatient and emergency departments), and related expenditures within one year after commencement of the 1LOT were evaluated and compared. Results The mean age of the included patients was 71.3 (SD 10.7) years, and 40.4% of patients had a CCI score >= 3. Most patients (747; 49.4%) were in the V+T group and, after adjusting for covariates, had a significantly longer OS (median, 22.2 months) and EFS (9.1 months) than those in the T group (12.6 and 4.5 months, respectively) and the non-V/T group (12.2 and 3.2 months, respectively), but they were mostly comparable with patients in the V group (23.8 and 6.6 months, respectively). Compared to those in the V+T group, patients in the T and non-V/T groups had 29% and 39% fewer outpatient visits and 15% and 24% lower total expenditure, respectively. Conclusion Our real-world data consolidate evidence for the effectiveness of bortezomib-containing regimens as the 1LOT in NDMM-TI patients at the expense of more outpatient visits and higher total costs.	[Cheng, Chih-Ning; Lin, Fang-Ju] Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei, Taiwan; [Huang, Shang-Yi] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Lien, Pei-Wen; Huang, Shih-Ting] Takeda Pharmaceut Taiwan Ltd, Taipei, Taiwan; [Lin, Fang-Ju] Natl Taiwan Univ, Sch Pharm, Coll Med, Taipei, Taiwan; [Lin, Fang-Ju] Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Lin, FJ (corresponding author), Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei, Taiwan.; Lin, FJ (corresponding author), Natl Taiwan Univ, Sch Pharm, Coll Med, Taipei, Taiwan.; Lin, FJ (corresponding author), Natl Taiwan Univ Hosp, Dept Pharm, Taipei, Taiwan.	fjilin@ntu.edu.tw		LIN, FANG-JU/0000-0002-8249-7481	Takeda Pharmaceuticals	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceuticals. The funder provided support in the form of salaries for authors (PWL, STH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section."	Andres M, 2018, CANCER EPIDEMIOL, V53, P105, DOI 10.1016/j.canep.2018.01.015; Arikian SR, 2015, CURR MED RES OPIN, V31, P1105, DOI 10.1185/03007995.2015.1031732; Blimark CH, 2018, HAEMATOLOGICA, V103, P506, DOI 10.3324/haematol.2017.178103; Brandenburg NA, 2019, PHARMACOEPIDEM DR S, V28, P256, DOI 10.1002/pds.4711; Bringhen S, 2018, HAEMATOLOGICA, V103, P1422, DOI 10.3324/haematol.2018.191288; Chan H, 2019, BRIT J HAEMATOL, V187, P470, DOI 10.1111/bjh.16095; Chari A, 2020, CL LYMPH MYELOM LEUK, V20, P8, DOI 10.1016/j.clml.2019.09.625; Chari A, 2019, CL LYMPH MYELOM LEUK, V19, P645, DOI 10.1016/j.clml.2019.06.007; Chen Y, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-1001-7; Costello C, 2019, FUTURE ONCOL, V15, P1411, DOI 10.2217/fon-2019-0013; Cowan AJ, 2018, JAMA ONCOL, V4, P1221, DOI 10.1001/jamaoncol.2018.2128; Goto D, 2020, CANCER MED-US, V9, P626, DOI 10.1002/cam4.2698; Hsieh CY, 2019, CLIN EPIDEMIOL, V11, P349, DOI 10.2147/CLEP.S196293; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Huang TC, 2019, JAMA ONCOL, V5, P116, DOI 10.1001/jamaoncol.2018.5523; Huang TC, 2015, ANN HEMATOL, V94, P107, DOI 10.1007/s00277-014-2165-2; Knauf W, 2018, ANN HEMATOL, V97, P2437, DOI 10.1007/s00277-018-3449-8; Kumar SK, 2018, J NATL COMPR CANC NE, V16, P11, DOI 10.6004/jnccn.2018.0002; Lee Dae Hyun, 2018, Curr Treat Options Cardiovasc Med, V20, P19, DOI 10.1007/s11936-018-0618-y; Lin Chung-King, 2009, Hematol Oncol Stem Cell Ther, V2, P385; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; McPhail SM, 2016, RISK MANAG HEALTHC P, V9, P143, DOI 10.2147/RMHP.S97248; Mohty M, 2018, CL LYMPH MYELOM LEUK, V18, pE401, DOI 10.1016/j.clml.2018.06.018; Niesvizky R, 2015, J CLIN ONCOL, V33, P3921, DOI 10.1200/JCO.2014.58.7618; Palmaro A, 2017, PHARMACOEPIDEM DR S, V26, P1492, DOI 10.1002/pds.4266; Palumbo A, 2011, BLOOD REV, V25, P181, DOI 10.1016/j.blre.2011.03.005; Rajkumar SV, 2018, AM J HEMATOL, V93, P1091, DOI 10.1002/ajh.25117; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Sharpley FA, 2020, LEUKEMIA LYMPHOMA, V61, P732, DOI 10.1080/10428194.2019.1683737; Tang CH, 2020, ANN HEMATOL, V99, P321, DOI 10.1007/s00277-019-03858-w; Verelst SGR, 2018, HEMASPHERE, V2, DOI 10.1097/HS9.0000000000000045; Wu TY, 2010, LONDON J PRIM CARE, V3, P115, DOI 10.1080/17571472.2010.11493315	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252124	10.1371/journal.pone.0252124	http://dx.doi.org/10.1371/journal.pone.0252124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038463	gold, Green Published			2022-12-26	WOS:000664633500053
J	Raza, F; Babasyan, S; Larson, EM; Freer, HS; Schnabel, CL; Wagner, B				Raza, Fahad; Babasyan, Susanna; Larson, Elisabeth M.; Freer, Heather S.; Schnabel, Christiane L.; Wagner, Bettina			Peripheral blood basophils are the main source for early interleukin-4 secretion upon in vitro stimulation with Culicoides allergen in allergic horses	PLOS ONE			English	Article							INSECT-BITE HYPERSENSITIVITY; MONOCLONAL-ANTIBODIES; MAST-CELLS; FOOD ALLERGY; T-CELLS; PRODUCE INTERLEUKIN-4; ICELANDIC HORSES; MESSENGER-RNA; IGE; IL-4	Interleukin-4 (IL-4) is a key cytokine secreted by type 2 T helper (Th2) cells that orchestrates immune responses during allergic reactions. Human and mouse studies additionally suggest that basophils have a unique role in the regulation of allergic diseases by providing initial IL-4 to drive T cell development towards the Th2 phenotype. Equine Culicoides hypersensitivity (CH) is a seasonal immunoglobulin E (IgE)-mediated allergic dermatitis in horses in response to salivary allergens from Culicoides (Cul) midges. Here, we analyzed IL-4 production in peripheral blood mononuclear cells (PBMC) of CH affected (n = 8) and healthy horses (n = 8) living together in an environment with natural Cul exposure. During Cul exposure when allergic horses had clinical allergy, IL-4 secretion from PBMC after stimulation with Cul extract was similar between healthy and CH affected horses. In contrast, allergic horses had higher IL-4 secretion from PBMC than healthy horses during months without allergen exposure. In addition, allergic horses had increased percentages of IL-4(+) cells after Cul stimulation compared to healthy horses, while both groups had similar percentages of IL-4(+) cells following IgE crosslinking. The IL-4(+) cells were subsequently characterized using different cell surface markers as basophils, while very few allergen-specific CD4(+) cells were detected in PBMC after Cul extract stimulation. Similarly, IgE crosslinking by anti-IgE triggered basophils to produce IL-4 in all horses. PMA/ionomycin consistently induced high percentages of IL-4(+) Th2 cells in both groups confirming that T cells of all horses studied were capable of IL-4 production. In conclusion, peripheral blood basophils produced high amounts of IL-4 in allergic horses after stimulation with Cul allergens, and allergic horses also maintained higher basophil percentages throughout the year than healthy horses. These new findings suggest that peripheral blood basophils may play a yet underestimated role in innate IL-4 production upon allergen activation in horses with CH. Basophil-derived IL-4 might be a crucial early signal for immune induction, modulating of immune responses towards Th2 immunity and IgE production.	[Raza, Fahad; Babasyan, Susanna; Larson, Elisabeth M.; Freer, Heather S.; Schnabel, Christiane L.; Wagner, Bettina] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Schnabel, Christiane L.] Univ Leipzig, Fac Vet Med, Inst Immunol, Leipzig, Germany	Cornell University; Leipzig University	Wagner, B (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	bw73@cornell.edu		Wagner, Bettina/0000-0003-2370-6324; Simonin, Elisabeth/0000-0001-9195-5061	Harry M. Zweig Memorial Fund for Equine Research at Cornell University; Agriculture and Food Research Initiative - USDA National Institute of Food and Agriculture [2005-01812, 2015-67015-23072]	Harry M. Zweig Memorial Fund for Equine Research at Cornell University; Agriculture and Food Research Initiative - USDA National Institute of Food and Agriculture	The horses in this study were supported by research funds from the Harry M. Zweig Memorial Fund for Equine Research at Cornell University awarded to BW. The equine reagents and assays described in this article were developed with funding to BW from Agriculture and Food Research Initiative Competitive Grants no. #2005-01812 (The US Veterinary Immune Reagent Network) and #2015-67015-23072 (Equine Immune Reagents: development of monoclonal antibodies to improve the analysis of immunity in horses) supported by the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBIS DP, 1994, VET IMMUNOL IMMUNOP, V42, P103, DOI 10.1016/0165-2427(94)90093-0; Bjornsdottir S, 2006, ACTA VET SCAND, V48, DOI 10.1186/1751-0147-48-3; BROWN MA, 1987, CELL, V50, P809, DOI 10.1016/0092-8674(87)90339-4; Chirumbolo S, 2018, HUM VACC IMMUNOTHER, V14, P815, DOI 10.1080/21645515.2017.1417711; Chomarat P, 1998, Int Rev Immunol, V17, P1, DOI 10.3109/08830189809084486; Dullaers M, 2012, J ALLERGY CLIN IMMUN, V129, P635, DOI 10.1016/j.jaci.2011.10.029; Eglite S, 2000, J IMMUNOL, V165, P2183, DOI 10.4049/jimmunol.165.4.2183; Fitzsimmons CM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00061; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2000, CURR OPIN HEMATOL, V7, P32, DOI 10.1097/00062752-200001000-00007; Gandhi NA, 2017, EXPERT REV CLIN IMMU, V13, P425, DOI 10.1080/1744666X.2017.1298443; GASCAN H, 1991, J IMMUNOL, V147, P8; Gauvreau GM, 2000, AM J RESP CRIT CARE, V161, P1473, DOI 10.1164/ajrccm.161.5.9908090; Hamza E, 2008, VET IMMUNOL IMMUNOP, V122, P65, DOI 10.1016/j.vetimm.2007.10.018; Hamza E, 2010, VET IMMUNOL IMMUNOP, V133, P40, DOI 10.1016/j.vetimm.2009.07.002; Hashimoto T, 2019, EXP DERMATOL, V28, P1373, DOI 10.1111/exd.13705; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; HOWARD M, 1982, J EXP MED, V155, P914, DOI 10.1084/jem.155.3.914; Irani AMA, 1998, J ALLERGY CLIN IMMUN, V101, P354, DOI 10.1016/S0091-6749(98)70248-9; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Junttila IS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00888; Kabithe E, 2010, VET IMMUNOL IMMUNOP, V138, P149, DOI 10.1016/j.vetimm.2010.07.003; Koshino T, 1996, J ASTHMA, V33, P89, DOI 10.3109/02770909609054536; Lange S, 2005, BERL MUNCH TIERARZTL, V118, P481; Loh W, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15092043; Luna-Gomes T, 2011, J IMMUNOL, V187, P6518, DOI 10.4049/jimmunol.1101806; LUNN DP, 1991, IMMUNOLOGY, V74, P251; Mashiko S, 2017, J DERMATOL SCI, V88, P167, DOI 10.1016/j.jdermsci.2017.07.003; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Miller JE, 2019, VET DERMATOL, V30, P536, DOI 10.1111/vde.12784; Min BK, 2008, CURR OPIN HEMATOL, V15, P59, DOI 10.1097/MOH.0b013e3282f13ce8; Miyake K, 2017, ALLERGOL INT, V66, P382, DOI 10.1016/j.alit.2017.04.007; MOQBEL R, 1995, J IMMUNOL, V155, P4939; Morgan EE, 2007, VET IMMUNOL IMMUNOP, V120, P160, DOI 10.1016/j.vetimm.2007.08.007; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; NONAKA M, 1995, J IMMUNOL, V155, P3234; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Oettgen HC, 2016, J ALLERGY CLIN IMMUN, V137, P1631, DOI 10.1016/j.jaci.2016.04.009; Oliphant CJ, 2011, IMMUNOLOGY, V134, P378, DOI 10.1111/j.1365-2567.2011.03499.x; Osborne NJ, 2011, J ALLERGY CLIN IMMUN, V127, P668, DOI 10.1016/j.jaci.2011.01.039; Pilsworth RC, 2004, EQUINE VET EDUC, V16, P324, DOI 10.1111/j.2042-3292.2004.tb00321.x; Prescott S, 2011, PEDIAT ALLERG IMM-UK, V22, P155, DOI 10.1111/j.1399-3038.2011.01145.x; Raza F, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02499-w; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Schaffartzik A, 2012, VET IMMUNOL IMMUNOP, V147, P113, DOI 10.1016/j.vetimm.2012.03.017; SEDER RA, 1991, P NATL ACAD SCI USA, V88, P2835, DOI 10.1073/pnas.88.7.2835; Sheoran AS, 1998, VET IMMUNOL IMMUNOP, V62, P153, DOI 10.1016/S0165-2427(97)00162-1; SIEBENKOTTEN G, 1992, EUR J IMMUNOL, V22, P1827, DOI 10.1002/eji.1830220723; Simons FER, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1097/WOX.0b013e318211496c; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Stavnezer J, 2004, SEMIN IMMUNOL, V16, P257, DOI 10.1016/j.smim.2004.08.005; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Stone SF, 2014, BRIT J CLIN PHARMACO, V78, P1, DOI 10.1111/bcp.12297; SWAIN SL, 1990, J IMMUNOL, V145, P3796; van der Meide NMA, 2012, VET IMMUNOL IMMUNOP, V149, P245, DOI 10.1016/j.vetimm.2012.07.007; Van Grevenhof EM, 2007, EQUINE VET J, V39, P69, DOI 10.2746/042516407X153020; Wagner B, 2006, VET IMMUNOL IMMUNOP, V110, P363, DOI 10.1016/j.vetimm.2006.01.001; Wagner B, 2003, VET IMMUNOL IMMUNOP, V92, P45, DOI 10.1016/S0165-2427(03)00007-2; Wagner B., 2015, EQUINE CLIN IMMUNOLO, V1; Wagner B, 2008, VET IMMUNOL IMMUNOP, V126, P302, DOI 10.1016/j.vetimm.2008.09.001; Wagner B, 2008, VET IMMUNOL IMMUNOP, V122, P46, DOI 10.1016/j.vetimm.2007.10.013; Wagner B, 2006, VET RES, V37, P813, DOI 10.1051/vetres:2006039; Wagner B, 2010, VET RES, V41, DOI 10.1051/vetres/2010019; Wagner B, 2010, DEV COMP IMMUNOL, V34, P436, DOI 10.1016/j.dci.2009.12.002; Wagner B, 2009, VET IMMUNOL IMMUNOP, V132, P53, DOI 10.1016/j.vetimm.2009.09.015; Wagner B, 2009, VET IMMUNOL IMMUNOP, V127, P242, DOI 10.1016/j.vetimm.2008.10.313; Wilson AD, 2014, PARASITE IMMUNOL, V36, P558, DOI 10.1111/pim.12142; Wilson AD, 2001, EQUINE VET J, V33, P707, DOI 10.2746/042516401776249363; Yamanishi Y, 2016, SEMIN IMMUNOPATHOL, V38, P615, DOI 10.1007/s00281-016-0568-y; Yang YP, 1996, SCIENCE, V273, P1862, DOI 10.1126/science.273.5283.1862; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Yoshimoto T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00716; Zhu JF, 2015, CYTOKINE, V75, P14, DOI 10.1016/j.cyto.2015.05.010; Ziegler A, 2018, VET DERMATOL, V29, DOI 10.1111/vde.12493	78	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252243	10.1371/journal.pone.0252243	http://dx.doi.org/10.1371/journal.pone.0252243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038479	Green Published, gold			2022-12-26	WOS:000664633500069
J	Wurcel, AG; Reyes, J; Zubiago, J; Koutoujian, PJ; Burke, D; Knox, TA; Concannon, T; Lemon, SC; Wong, JB; Freund, KM; Beckwith, CG; LeClair, AM				Wurcel, Alysse G.; Reyes, Jessica; Zubiago, Julia; Koutoujian, Peter J.; Burke, Deirdre; Knox, Tamsin A.; Concannon, Thomas; Lemon, Stephenie C.; Wong, John B.; Freund, Karen M.; Beckwith, Curt G.; LeClair, Amy M.			"I'm not gonna be able to do anything about it, then what's the point?": A broad group of stakeholders identify barriers and facilitators to HCV testing in a Massachusetts jail	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HEALTH-SERVICES; JUSTICE SYSTEM; HIV; PRISONS; CARE; PREVENTION; TAXONOMY; OUTCOMES; PEOPLE	Background Despite national guidelines promoting hepatitis C virus (HCV) testing in prisons, there is substantial heterogeneity on the implementation of HCV testing in jails. We sought to better understand barriers and opportunities for HCV testing by interviewing a broad group of stakeholders involved in HCV testing and treatment policies and procedures in Massachusetts jails. Methods We conducted semi-structured interviews with people incarcerated in Middlesex County Jail (North Billerica, MA), clinicians working in jail and community settings, corrections administrators, and representatives from public health, government, and industry between November 2018-April 2019. Results 51/120 (42%) of people agreed to be interviewed including 21 incarcerated men (mean age 32 [IQR 25, 39], 60% non-White). Themes that emerged from these interviews included gaps in knowledge about HCV testing and treatment opportunities in jail, the impact of captivity and transience, and interest in improving linkage to HCV care after release. Many stakeholders discussed stigma around HCV infection as a factor in reluctance to provide HCV testing or treatment in the jail setting. Some stakeholders expressed that stigma often led decisionmakers to estimate a lower "worth" of incarcerated individuals living with HCV and therefore to decide against paying for HCV testing.". Conclusion All stakeholders agreed that HCV in the jail setting is a public health issue that needs to be addressed. Exploring stakeholders' many ideas about how HCV testing and treatment can be approached is the first step in developing feasible and acceptable strategies.	[Wurcel, Alysse G.; Zubiago, Julia; Burke, Deirdre] Tufts Med Ctr, Dept Med, Div Geog Med & Infect Dis, Boston, MA 02111 USA; [Wurcel, Alysse G.; Reyes, Jessica; Knox, Tamsin A.; Wong, John B.; Freund, Karen M.] Tufts Univ, Sch Med, Boston, MA 02155 USA; [Koutoujian, Peter J.] Middlesex Sheriffs Off, Medford, MA USA; [Knox, Tamsin A.; Concannon, Thomas; Wong, John B.; Freund, Karen M.; LeClair, Amy M.] Tufts Med Ctr, Dept Med, Boston, MA 02111 USA; [Lemon, Stephenie C.] Univ Massachusetts, Sch Med, Dept Populat & Quantitat Hlth Sci, Worcester, MA 01003 USA; [Freund, Karen M.; LeClair, Amy M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Dept Med, Boston, MA 02111 USA; [Beckwith, Curt G.] Brown Univ, Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA	Tufts Medical Center; Tufts University; Tufts Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Tufts Medical Center; Brown University	Wurcel, AG (corresponding author), Tufts Med Ctr, Dept Med, Div Geog Med & Infect Dis, Boston, MA 02111 USA.; Wurcel, AG (corresponding author), Tufts Univ, Sch Med, Boston, MA 02155 USA.	awurcel@tuftsmedicalcenter.org			National Institutes of Health [1KL2TR002545-01, K08HS026008-01, P30AI42853, R25DA037190]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, grants 1KL2TR002545-01 (to AGW), K08HS026008-01 (to AGW), P30AI42853 (to CB), and R25DA037190 (to CB).	Abe CM, 2019, PUBLIC HEALTH REP, V134, P626, DOI 10.1177/0033354919874081; Akiyama M., 2017, PERCEIVED BARRIERS F; Akiyama MJ, 2018, AM J PUBLIC HEALTH, V108, P607, DOI 10.2105/AJPH.2018.304362; Albertson EM, 2020, AM J PUBLIC HEALTH, V110, P317, DOI 10.2105/AJPH.2019.305400; Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; [Anonymous], 2020, HCV GUID REC TEST MA; Assoumou SA, 2020, CLIN INFECT DIS, V70, P1388, DOI 10.1093/cid/ciz383; Beckman AL, 2016, HEALTH AFFAIR, V35, P1893, DOI 10.1377/hlthaff.2016.0296; Beckwith CG, 2016, J PUBLIC HEALTH-UK, V38, P130, DOI 10.1093/pubmed/fdv023; Beckwith CG, 2015, AM J PUBLIC HEALTH, V105, P68, DOI 10.2105/AJPH.2014.302071; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Brinkley-Rubinstein L, 2019, DRUG ALCOHOL DEPEN, V205, DOI 10.1016/j.drugalcdep.2019.06.016; Candfield S, 2019, SEX TRANSM INFECT, V95, pA190, DOI 10.1136/sextrans-2019-sti.479; Cocoros N, 2014, PUBLIC HEALTH REP, V129, P5, DOI 10.1177/00333549141291S102; Concannon TW, 2012, J GEN INTERN MED, V27, P985, DOI 10.1007/s11606-012-2037-1; Conti K., 2018, BOSTON GLOBE; Crowley D, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0269-z; He TH, 2016, ANN INTERN MED, V164, P84, DOI 10.7326/M15-0617; Ho DYF, 2007, CULT PSYCHOL, V13, P377, DOI 10.1177/1354067X07080505; Kendig NE, 2019, J CORRECT HEALTH CAR, V25, P277, DOI 10.1177/1078345819857113; Khaw FM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-98; Klevens RM, 2012, CLIN INFECT DIS, V55, pS3, DOI 10.1093/cid/cis393; Kodjak A., 2018, LOUISIANAS NEW APPRO; Kohli A, 2015, ANN INTERN MED, V163, P899, DOI 10.7326/M15-0642; Lafferty L, 2018, J VIRAL HEPATITIS, V25, P1526, DOI 10.1111/jvh.12987; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Ly W, 2018, JAIDS-J ACQ IMM DEF, V78, P214, DOI 10.1097/QAI.0000000000001664; MacDonald R, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx142; Mahowald MK, 2016, J CORRECT HEALTH CAR, V22, P41, DOI 10.1177/1078345815618384; Marks JS, 2014, HEALTH AFFAIR, V33, P443, DOI 10.1377/hlthaff.2013.1350; Morey S, 2019, J VIRAL HEPATITIS, V26, P101, DOI 10.1111/jvh.13017; Morris MD, 2017, INT J PRISON HEALTH, V13, P192, DOI 10.1108/IJPH-07-2016-0028; Nguyen JT, 2015, J URBAN HEALTH, V92, P635, DOI 10.1007/s11524-015-9953-4; Pratt C, 2013, INT J FORENSIC MENT, V12, P116, DOI 10.1080/14999013.2013.791351; Prisons Bo, 2018, EVALUATION MANAGEMEN; Rich JD, 2016, LANCET, V388, P1103, DOI 10.1016/S0140-6736(16)30379-8; Rosenthal ES, 2020, CLIN INFECT DIS, V71, P1715, DOI 10.1093/cid/ciaa105; Roth A, 2012, SEX HEALTH, V9, P445, DOI 10.1071/SH11170; Saab S, 2018, HEPATOLOGY, V67, P2449, DOI 10.1002/hep.29685; Schoenbachler BT, 2016, PUBLIC HEALTH REP, V131, P98, DOI 10.1177/00333549161310S215; Spaulding AC, 2019, HEPATOLOGY, V70, P758, DOI 10.1002/hep.30636; Spaulding AC, 2019, J CORRECT HEALTH CAR, V25, P15, DOI 10.1177/1078345818805770; Spaulding AC, 2018, INFECT DIS CLIN N AM, V32, P323, DOI 10.1016/j.idc.2018.02.014; Spaulding AC, 2017, AIDS REV, V19, P134, DOI 10.24875/AIDSRev.M17000006; Spaulding AC, 2015, J PUBLIC HEALTH MAN, V21, P538, DOI 10.1097/PHH.0000000000000183; West BT, 2017, J SURV STAT METHODOL, V5, P175, DOI 10.1093/jssam/smw024; Yap L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087564	47	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0250901	10.1371/journal.pone.0250901	http://dx.doi.org/10.1371/journal.pone.0250901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038430	Green Published, gold			2022-12-26	WOS:000664633500012
J	Ricordel, C; Chaillot, L; Blondel, A; Archambeau, J; Jouan, F; Mouche, A; Tiercin, M; Burel, A; Lena, H; Desrues, B; Guillaudeux, T; Pedeux, R				Ricordel, Charles; Chaillot, Laura; Blondel, Alice; Archambeau, Jerome; Jouan, Florence; Mouche, Audrey; Tiercin, Marie; Burel, Agnes; Lena, Herve; Desrues, Benoit; Guillaudeux, Thierry; Pedeux, Remy			ING2 tumor suppressive protein translocates into mitochondria and is involved in cellular metabolism homeostasis	ONCOGENE			English	Article							INTERMEMBRANE SPACE; CYTOPLASMIC EXPRESSION; DISULFIDE RELAY; PHD FINGER; NUCLEAR; PROGRESSION; P53; P33(ING1B); TUMORIGENESIS; GENES	ING2 (Inhibitor of Growth 2) is a tumor suppressor gene that has been implicated in critical biological functions (cell-cycle regulation, replicative senescence, DNA repair and DNA replication), most of which are recognized hallmarks of tumorigenesis occurring in the cell nucleus. As its close homolog ING1 has been recently observed in the mitochondrial compartment, we hypothesized that ING2 could also translocate into the mitochondria and be involved in new biological functions. In the present study, we demonstrate that ING2 is imported in the inner mitochondrial fraction in a redox-sensitive manner in human cells and that this mechanism is modulated by 14-3-3 eta protein expression. Remarkably, ING2 is necessary to maintain mitochondrial ultrastructure integrity without interfering with mitochondrial networks or polarization. We observed an interaction between ING2 and mtDNA under basal conditions. This interaction appears to be mediated by TFAM, a critical regulator of mtDNA integrity. The loss of mitochondrial ING2 does not impair mtDNA repair, replication or transcription but leads to a decrease in mitochondrial ROS production, suggesting a detrimental impact on OXPHOS activity. We finally show using multiple models that ING2 is involved in mitochondrial respiration and that its loss confers a protection against mitochondrial respiratory chain inhibition in vitro. Consequently, we propose a new tumor suppressor role for ING2 protein in the mitochondria as a metabolic shift gatekeeper during tumorigenesis.	[Ricordel, Charles; Chaillot, Laura; Blondel, Alice; Archambeau, Jerome; Jouan, Florence; Mouche, Audrey; Lena, Herve; Desrues, Benoit; Guillaudeux, Thierry; Pedeux, Remy] Univ Rennes 1, Chem Oncogenesis Stress & Signaling, INSERM, U1242,CLCC Eugene Marquis, Rennes, France; [Ricordel, Charles; Lena, Herve; Desrues, Benoit] Univ Rennes 1, Dept Pulm Med, CHU Pontchaillou, Rennes, France; [Tiercin, Marie] Hop St Malo, Dept Pulm Med, St Malo, France; [Burel, Agnes; Guillaudeux, Thierry] Univ Rennes 1, UMS 3480, BIOSIT, MRic, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Eugene Marquis; Universite de Rennes; CHU Rennes; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Pedeux, R (corresponding author), Univ Rennes 1, Chem Oncogenesis Stress & Signaling, INSERM, U1242,CLCC Eugene Marquis, Rennes, France.	remy.pedeux@univ-rennes1.fr	PEDEUX, Rémy M/I-2603-2014	PEDEUX, Rémy M/0000-0002-2553-7934	La Ligue Contre le Cancer; Nuovo-Soldati Fundation research grant; INSERM (Institut National de la Sante et de la Recherche Medicale); La Ligue Contre le Cancer (Grand Ouest); Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale (FMR) [DEQ20180339169]; AIS Rennes Metropole; Biosit; Action Incitative Universite de Rennes 1; Region Bretagne; FHU Camin (CHU Rennes) doctoral followship	La Ligue Contre le Cancer(Ligue nationale contre le cancer); Nuovo-Soldati Fundation research grant; INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); La Ligue Contre le Cancer (Grand Ouest); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FMR)(Fondation pour la Recherche Medicale); AIS Rennes Metropole(Region Bretagne); Biosit; Action Incitative Universite de Rennes 1; Region Bretagne(Region Bretagne); FHU Camin (CHU Rennes) doctoral followship	We thank S.Manie for his participation and the technical support. We thank the photonic facility of the Microscopy Rennes Imaging Center (MRic-Photonics) of Biosit, Universite de Rennes 1. We thank Pr JA MacDonald and his team members as well as Pr K Riabowol (University of Calgary, Canada) for providing lentiviral vectors and technical support for the generation of the CrispR clones. AM was a recipient of a doctoral fellowship from La Ligue Contre le Cancer and Region Bretagne. C. Ricordel was a recipient of FHU Camin (CHU Rennes) doctoral followship and Nuovo-Soldati Fundation research grant. RP is supported by INSERM (Institut National de la Sante et de la Recherche Medicale). The work was supported by La Ligue Contre le Cancer (Grand Ouest), Association pour la Recherche sur le Cancer (ARC), Fondation pour la Recherche Medicale (FMR, DEQ20180339169), AIS Rennes Metropole, Biosit and Action Incitative Universite de Rennes 1.	Abdrabou A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010318; Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; Archambeau J, 2020, CANCERS, V12, DOI 10.3390/cancers12010058; Backes S, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00083; Bose P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.321; Dabir DV, 2013, DEV CELL, V25, P81, DOI 10.1016/j.devcel.2013.03.006; Dantas A, 2019, CANCERS, V11, DOI 10.3390/cancers11111817; Dar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09206-0; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Edwards R, 2020, BIOL CHEM, V401, P737, DOI 10.1515/hsz-2020-0114; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; Furda A, 2014, METHODS MOL BIOL, V1105, P419, DOI 10.1007/978-1-62703-739-6_31; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; Gong W, 2006, MOL CELL BIOL, V26, P2947, DOI 10.1128/MCB.26.8.2947-2954.2006; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Guerillon C, 2014, CANCER LETT, V345, P1, DOI 10.1016/j.canlet.2013.11.016; Guerillon C, 2013, CELL MOL LIFE SCI, V70, P3753, DOI 10.1007/s00018-013-1270-z; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He GHY, 2005, MOL BIOL EVOL, V22, P104, DOI 10.1093/molbev/msh256; Hilgendorf KI, 2013, GENE DEV, V27, P1003, DOI 10.1101/gad.211326.112; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Larrieu D, 2010, CELL CYCLE, V9, P3984, DOI 10.4161/cc.9.19.13208; Larrieu D, 2009, EMBO REP, V10, P1168, DOI 10.1038/embor.2009.180; Lee SR, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8060949; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li XH, 2010, J CANCER RES CLIN, V136, P1573, DOI 10.1007/s00432-010-0815-x; Longen S, 2014, DEV CELL, V28, P30, DOI 10.1016/j.devcel.2013.11.007; Ma Y, 2020, J PHYSIOL BIOCHEM, V76, P373, DOI 10.1007/s13105-020-00743-3; Marusich MF, 1997, BBA-MOL BASIS DIS, V1362, P145, DOI 10.1016/S0925-4439(97)00061-6; Mouche A, 2019, CELL DEATH DIFFER, V26, P2344, DOI 10.1038/s41418-019-0305-x; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nicolle O, 2015, TRAFFIC, V16, P893, DOI 10.1111/tra.12289; Pallotti F, 2007, METHOD CELL BIOL, V80, P3, DOI 10.1016/S0091-679X(06)80001-4; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Puleston Daniel, 2015, Cold Spring Harb Protoc, V2015, DOI 10.1101/pdb.prot086298; Quispe-Tintaya W, 2013, BIOTECHNIQUES, V55, P133, DOI 10.2144/000114077; Rosivatz E, 2011, CELL SIGNAL, V23, P478, DOI 10.1016/j.cellsig.2010.10.025; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Satoh H, 2013, CANCER RES, V73, P4158, DOI 10.1158/0008-5472.CAN-12-4499; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shiao YH, 2000, CANCER RES, V60, P2816; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Szczepanowska J, 2004, FEBS LETT, V578, P316, DOI 10.1016/j.febslet.2004.11.022; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; van Donselaar E, 2007, TRAFFIC, V8, P471, DOI 10.1111/j.1600-0854.2007.00552.x; Vogtle FN, 2012, MOL CELL PROTEOMICS, V11, P1840, DOI 10.1074/mcp.M112.021105; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang YM, 2007, CLIN CANCER RES, V13, P4111, DOI 10.1158/1078-0432.CCR-07-0408; Wang YE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074513; Weckbecker D, 2012, EMBO J, V31, P4348, DOI 10.1038/emboj.2012.263; Ythier D, 2010, ONCOGENE, V29, P5946, DOI 10.1038/onc.2010.325; Zhang JT, 2008, J CANCER RES CLIN, V134, P421, DOI 10.1007/s00432-007-0305-y; Zhu ZL, 2013, ONCOL LETT, V5, P161, DOI 10.3892/ol.2012.983; Zhuang J, 2013, P NATL ACAD SCI USA, V110, P17356, DOI 10.1073/pnas.1310908110; Zong WX, 2016, MOL CELL, V61, P667, DOI 10.1016/j.molcel.2016.02.011	60	4	4	2	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4111	4123		10.1038/s41388-021-01832-3	http://dx.doi.org/10.1038/s41388-021-01832-3		MAY 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34017078				2022-12-26	WOS:000652439200004
J	Joannides, J; Dzodzomenyo, M; Azerigyik, F; Agbosu, EE; Pratt, D; Osei, JHN; Pwalia, R; Amlalo, GK; Appawu, M; Takashi, H; Iwanaga, S; Buchwald, A; Rochford, R; Boakye, D; Koram, K; Bonney, K; Dadzie, S				Joannides, Joannitta; Dzodzomenyo, Mawuli; Azerigyik, Faustus; Agbosu, Eudocia Esinam; Pratt, Deborah; Osei, Joseph Harold Nyarko; Pwalia, Rebecca; Amlalo, Godwin Kwame; Appawu, Maxwell; Takashi, Hayashi; Iwanaga, Shiroh; Buchwald, Andrea; Rochford, Rosemary; Boakye, Daniel; Koram, Kwadwo; Bonney, Kofi; Dadzie, Samuel			Species composition and risk of transmission of some Aedes-borne arboviruses in some sites in Northern Ghana	PLOS ONE			English	Article							DIPTERA-CULICIDAE; AEGYPTI; HISTORY; DENGUE; FEVER; ZIKA; IDENTIFICATION; CHIKUNGUNYA; SPREAD	Aedes-borne viral diseases mainly Yellow Fever (YF), Dengue (DEN), Zika (ZIK) and Chikungunya (CHK) have contributed to many deaths' in the world especially in Africa. There have been major outbreaks of these diseases in West Africa. Although, YF outbreaks have occurred in Ghana over the years, no outbreak of DEN, ZIK and CHK has been recorded. However, the risk of outbreak is high due to its proximity to West African countries where outbreaks have been recently been recorded. This study surveyed the mosquito fauna to assess the risk of transmission of Yellow fever (YFV), Dengue (DENV), Chikungunya (CHKV) and Zika (ZIKV) viruses in Larabanga and Mole Game Reserve areas in Northern Ghana. The immature and adult stages of Aedes mosquitoes were collected from Larabanga and Mole Game Reserve area. There was a significant (P>0.001) number of mosquitoes collected during the rainy season than the dry season. A total of 1,930 Aedes mosquitoes were collected during the rainy season and morphologically identified. Of these, 1,915 (99.22%) were Aedes aegypti and 15 (0.22%) were Aedes vittatus. During the dry season, 27 Ae. aegypti mosquitoes were collected. A total of 415 Ae. aegypti mosquitoes were molecularly identified to subspecies level of which Ae. (Ae) aegypti aegypti was the predominant subspecies. Both Ae. aegypti aegypti and Ae aegypti formosus exist in sympatry in the area. All Aedes pools (75) were negative for DENV, ZIKV and CHKV when examined by RT- PCR. Three Larval indices namely House Index, HI (percentage of houses positive for Aedes larvae or pupae), Container Index, CI (the percentage of containers positive for Aedes larvae or pupae) and Breteau Index, BI (number of positive containers per 100 houses inspected) were assessed as a measure for risk of transmission in the study area. The HI, CI and BI for both sites were as follows; Mole Game Reserve (HI, 42.1%, CI, 23.5% and BI, 100 for rainy season and 0 for all indices for dry season) and Larabanga (39%, 15.5% and 61 for rainy season and 2.3%, 1.3% and 2.3 for dry season). The spatial distribution of Aedes breeding sites in both areas indicated that Aedes larvae were breeding in areas with close proximity to humans. Lorry tires were the main source of Aedes larvae in all the study areas. Information about the species composition and the potential role of Aedes mosquitoes in future outbreaks of the diseases that they transmit is needed to design efficient surveillance and vector control tools.	[Joannides, Joannitta; Azerigyik, Faustus; Osei, Joseph Harold Nyarko; Pwalia, Rebecca; Amlalo, Godwin Kwame; Appawu, Maxwell; Takashi, Hayashi; Boakye, Daniel; Dadzie, Samuel] Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Joannides, Joannitta; Dzodzomenyo, Mawuli] Univ Ghana, Sch Publ Hlth, Dept Environm & Occupat Hlth, Accra, Ghana; [Agbosu, Eudocia Esinam; Pratt, Deborah; Bonney, Kofi] Univ Ghana, Noguchi Mem Inst Med Res, Dept Virol, Accra, Ghana; [Takashi, Hayashi] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan; [Iwanaga, Shiroh] Tokyo Med & Dent Univ, Dept Environm Parasitol, Tokyo, Japan; [Buchwald, Andrea] Univ Colorado, Sch Publ Hlth, Dept Environm & Occupat Hlth, Aurora, CO USA; [Rochford, Rosemary] Univ Colorado, Dept Immunol & Microbiol, Aurora, CO USA; [Koram, Kwadwo] Univ Ghana, Noguchi Mem Inst Med Res, Dept Epidemiol, Accra, Ghana	University of Ghana; University of Ghana; University of Ghana; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Ghana	Dadzie, S (corresponding author), Univ Ghana, Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana.	sdadzie@noguchi.ug.edu.gh		OSEI, JOSEPH H. N./0000-0001-8143-5548; Agbosu, Esinam/0000-0001-9894-4242; Buchwald, Andrea/0000-0001-6503-6459; Dadzie, Dr Samuel Kweku/0000-0002-4105-1010	Japan Agency for Medical Research and Development (AMED)	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	We thank all the fieldworkers who assisted in the data collection as well as staff of Noguchi Memorial Institute for Medical Research for the laboratory support. The authors are grateful to Japan Agency for Medical Research and Development (AMED) for partially supporting the study as part of the collaborative project between NMIMR and Tokyo Medical and Dental University in Japan.	Abilio AP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006692; ADDY PAK, 1986, E AFR MED J, V63, P422; Amoako N, 2018, EMERG INFECT DIS, V24, P1544, DOI 10.3201/eid2408.180341; Appawu M., 2006, SURVEILLANCE VIRAL H, V40, P137, DOI [10.4314/gmj.v40i3.55269, DOI 10.4314/GMJ.V40I3.55269]; BALLINGERCRABTREE ME, 1992, AM J TROP MED HYG, V47, P893, DOI 10.4269/ajtmh.1992.47.893; Bhattacharya MK., 2013, INT J BIOMED SCI, V9, P68; Captain-Esoah M, 2020, J MED ENTOMOL, V57, P1239, DOI 10.1093/jme/tjaa024; CDC, 2017, CTR, P1; CDC, 2018, ANN TEMP TOT DEPL US; Chareonviriyaphap Theeraphap, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P529; Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2; Diallo M, 2008, T ROY SOC TROP MED H, V102, P493, DOI 10.1016/j.trstmh.2008.02.010; Fofana Diakarida, 2019, Journal of Parasitology Research, P4914137, DOI 10.1155/2019/4914137; Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780; KOhuuegh Chukwemeka, 2017, ECOLOGY DISTRIBUTION; Ndenga BA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189971; Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530; Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904; Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990; Powell JR, 2018, BIOSCIENCE, V68, P854, DOI 10.1093/biosci/biy119; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158; Rozilawati H, 2007, TROP BIOMED, V24, P83; Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1; Segbefia HA, 2015, HLTH ALERT DENGUE; Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110; Stoler J, 2015, AM J TROP MED HYG, V92, P497, DOI 10.4269/ajtmh.14-0678; Sudeep AB, 2017, J VECTOR DIS, V54, P295, DOI 10.4103/0972-9062.225833; Suzuki Takashi, 2016, Ghana Med J, V50, P136; Tarnagda Z, 2018, EMERG INFECT DIS, V24, P170, DOI 10.3201/eid2401.170973; Tinder P, 2012, VACCINE NEWS DAILY, V1; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Weetman D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020220; Were F, 2012, PAEDIATR INT CHILD H, V32, P18, DOI 10.1179/2046904712Z.00000000048; Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7; Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0234675	10.1371/journal.pone.0234675	http://dx.doi.org/10.1371/journal.pone.0234675			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061882	gold, Green Published			2022-12-26	WOS:000656813600016
J	Wu, MA; Catena, E; Castelli, A; Rech, R; Borghi, B; Ottolina, D; Fossali, T; Cogliati, C; Colombo, R				Wu, Maddalena Alessandra; Catena, Emanuele; Castelli, Antonio; Rech, Roberto; Borghi, Beatrice; Ottolina, Davide; Fossali, Tommaso; Cogliati, Chiara; Colombo, Riccardo			Autonomic biomarkers of shock in idiopathic systemic capillary leak syndrome	PLOS ONE			English	Article							HEART-RATE; ARTERIAL-PRESSURE; SPECTRAL-ANALYSIS; VARIABILITY; MARKER; EDEMA	Objective The term Idiopathic Systemic Capillary Leak Syndrome (ISCLS) refers to an uncommon condition of severe distributive shock, resulting from an abrupt shift of fluids and proteins from the intravascular to the interstitial compartment. We hypothesise that the autonomic nervous system (ANS) fails in regulating the response to hypovolemia in acute ISCLS and that ANS variables characterise the progression to the recovery. Design Prospective cohort study of patients admitted to ICU for severe ISCLS flares. Setting Single, referral center in Italy for ISCLS. Patients Analysis of cardiovascular signals recorded during seven severe ISCLS attacks and one prodromal period in five patients. Interventions ANS was studied non-invasively by means of heart rate variability (HRV) and blood pressure variability analysis, as an estimation of vagal and sympathetic modulation directed to the heart and vessels. Heart rate and systolic arterial pressure (SAP) variability were also used to assess baroreflex sensitivity. ANS variables were measured during the subsequent phases which characterise ISCLS flares, namely the acute phase, the post-acute phase, and the recovery phase. Measurements and main results HRV was severely depressed during the acute phase accounting for the loss of ANS modulation during massive capillary extravasation. This phase was characterised by shock and impaired baroreflex control, which allowed SAP to oscillate driven by respiratory activity. Impending shock and transition from shock to a post-acute phase were marked by change of baroreflex spectral variables. The baroreflex control was fully restored during recovery. Conclusions ANS modulation and baroreflex control are severely impaired during the acute haemodynamic instability which characterises ISCLS crises and their progressive restoration may be a clue of improvement. ANS indices during ISCLS flares might serve as useful biomarkers, able to timely announce the transition from one phase to the subsequent one, thus helping to adapt therapy accordingly.	[Wu, Maddalena Alessandra; Cogliati, Chiara] Univ Milan, Div Internal Med, ASST Fatebenefratelli Sacco, Luigi Sacco Hosp,Polo Univ, Milan, Italy; [Catena, Emanuele; Castelli, Antonio; Rech, Roberto; Borghi, Beatrice; Ottolina, Davide; Fossali, Tommaso; Colombo, Riccardo] Univ Milan, Div Anesthesiol & Intens Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hosp,Polo Univ, Milan, Italy	University of Milan; Luigi Sacco Hospital; University of Milan; Luigi Sacco Hospital	Colombo, R (corresponding author), Univ Milan, Div Anesthesiol & Intens Care, ASST Fatebenefratelli Sacco, Luigi Sacco Hosp,Polo Univ, Milan, Italy.	riccardo.colombo@asst-fbf-sacco.it	Catena, Emanuele/GRY-0009-2022; Fossali, Tommaso/HGD-3325-2022; Wu, Maddalena/ABF-2070-2022; Colombo, Riccardo/AAK-9081-2020	Wu, Maddalena/0000-0003-1078-1632; Colombo, Riccardo/0000-0002-9616-803X				Aroney N, 2015, CLIN CASE REP, V3, P527, DOI 10.1002/ccr3.280; Beckers F, 2004, TRANSPLANTATION, V78, P1523, DOI 10.1097/01.TP.0000141093.04132.41; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Buchman Timothy G, 2002, Curr Opin Crit Care, V8, P311, DOI 10.1097/00075198-200208000-00007; Camm AJ, 1996, EUR HEART J, V17, P354; Carrara M, 2018, SHOCK, V50, P78, DOI 10.1097/SHK.0000000000001046; CLARKSON B, 1960, AM J MED, V29, P193, DOI 10.1016/0002-9343(60)90018-8; Colombo R, 2020, RESP PHYSIOL NEUROBI, V279, DOI 10.1016/j.resp.2020.103466; Colombo R, 2020, J CRIT CARE, V57, P177, DOI 10.1016/j.jcrc.2020.02.016; Colombo R, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00111; COOK JR, 1991, J AM COLL CARDIOL, V17, P480, DOI 10.1016/S0735-1097(10)80119-6; Dick TE, 2004, AM J PHYSIOL-REG I, V286, pR1121, DOI 10.1152/ajpregu.00485.2003; Dick TE, 2014, PROG BRAIN RES, V209, P191, DOI 10.1016/B978-0-444-63274-6.00010-2; Druey KM, 2010, ANN INTERN MED, V153, P90, DOI 10.7326/0003-4819-153-2-201007200-00005; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Goldberger Ary L, 2006, Proc Am Thorac Soc, V3, P467, DOI 10.1513/pats.200603-028MS; GOLDSMITH RL, 1992, J AM COLL CARDIOL, V20, P552, DOI 10.1016/0735-1097(92)90007-A; Goldstein B, 1998, CRIT CARE MED, V26, P352, DOI 10.1097/00003246-199802000-00040; HOPF HB, 1995, ANESTHESIOLOGY, V82, P609, DOI 10.1097/00000542-199503000-00002; Kanaya N, 2003, ANESTHESIOLOGY, V98, P34, DOI 10.1097/00000542-200301000-00009; Khodadadi F, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01606-x; Korach M, 2001, CRIT CARE MED, V29, P1380, DOI 10.1097/00003246-200107000-00013; Lauscher P, 2011, MINERVA ANESTESIOL, V77, P943; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Marchi A, 2013, AUTON NEUROSCI-BASIC, V179, P166, DOI 10.1016/j.autneu.2013.08.071; Ogawa Y, 2006, J CLIN ANESTH, V18, P87, DOI 10.1016/j.jclinane.2005.06.004; Pagani M, 1997, CIRCULATION, V95, P1441; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Pichot V, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00557; Pineton M, 2017, CRIT CARE MED, V45, P1216, DOI 10.1097/CCM.0000000000002496; Pontet J, 2003, J CRIT CARE, V18, P156, DOI 10.1016/j.jcrc.2003.08.005; Porta A, 2000, AM J PHYSIOL-HEART C, V279, pH2558, DOI 10.1152/ajpheart.2000.279.5.H2558; Schmidt H, 2008, CRIT CARE CLIN, V24, P149, DOI 10.1016/j.ccc.2007.10.003; Sek AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133266; Tahirkheli NK, 1999, ANN INTERN MED, V130, P905, DOI 10.7326/0003-4819-130-11-199906010-00015; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Wu MA., 2017, ALLERGY ASTHMA CL IM, V13, P22; Wu MA, 2020, J CRIT CARE, V57, P13, DOI 10.1016/j.jcrc.2020.01.014; Wu MA, 2019, INTERN EMERG MED, V14, P723, DOI 10.1007/s11739-019-02113-4; Xie Z, 2014, J CLIN CELL IMMUNOL, V5, DOI [10.4172/2155-9899.1000213, DOI 10.4172/2155-9899.1000213]; Xie ZH, 2014, AM J RESP CRIT CARE, V189, P1145, DOI 10.1164/rccm.201310-1746LE; Xie ZH, 2012, BLOOD, V119, P4321, DOI 10.1182/blood-2011-08-375816; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0251775	10.1371/journal.pone.0251775	http://dx.doi.org/10.1371/journal.pone.0251775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061871	Green Published, gold			2022-12-26	WOS:000656813600008
J	Ge, WH; Zhao, Y; Yang, YX; Ding, Z; Xu, X; Weng, D; Wang, SM; Cheng, R; Zhang, JF				Ge, Wenhao; Zhao, Yang; Yang, Yunxia; Ding, Zhao; Xu, Xi; Weng, Dan; Wang, Shiming; Cheng, Rui; Zhang, Jianfa			An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE; DNA METHYLATION; GENE-EXPRESSION; PLASMA 5'-AMP; HYPERGLYCEMIA; HOMOCYSTEINE; SENSITIVITY; HOMEOSTASIS; METABOLISM; METHIONINE	Hepatic gluconeogenesis is the major contributor to the hyperglycemia observed in both patients and animals with type 2 diabetes. The transcription factor FOXO1 plays a dominant role in stimulating hepatic gluconeogenesis. FOXO1 is mainly regulated by insulin under physiological conditions, but liver-specific disruption of Foxo1 transcription restores normal gluconeogenesis in mice in which insulin signaling has been blocked, suggesting that additional regulatory mechanisms exist. Understanding the transcriptional regulation of Foxo1 may be conducive to the development of insulin-independent strategies for the control of hepatic gluconeogenesis. Here, we found that elevated plasma levels of adenine nucleotide in type 2 diabetes are the major regulators of Foxo1 transcription. We treated lean mice with 5'-AMP and examined their transcriptional profiles using RNA-seq. KEGG analysis revealed that the 5'-AMP treatment led to shifted profiles that were similar to db/db mice. Many of the upregulated genes were in pathways associated with the pathology of type 2 diabetes including Foxo1 signaling. As observed in diabetic db/db mice, lean mice treated with 5'-AMP displayed enhanced Foxo1 transcription, involving an increase in cellular adenosine levels and a decrease in the S-adenosylmethionine to S-adenosylhomocysteine ratio. This reduced methylation potential resulted in declining histone H3K9 methylation in the promoters of Foxo1, G6Pc, and Pepck. In mouse livers and cultured cells, 5'-AMP induced expression of more FOXO1 protein, which was found to be localized in the nucleus, where it could promote gluconeogenesis. Our results revealed that adenine nucleotide-driven Foxo1 transcription is crucial for excessive glucose production in type 2 diabetic mice.	[Ge, Wenhao; Zhao, Yang; Yang, Yunxia; Ding, Zhao; Xu, Xi; Weng, Dan; Wang, Shiming; Cheng, Rui; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Peoples R China	Nanjing University of Science & Technology	Cheng, R; Zhang, JF (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Peoples R China.	chengrui@njust.edu.cn; jfzhang@mail.njust.edu.cn	yang, yx/GZM-0464-2022		National Natural Science Foundation of China [31871178, 31861163004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation of China (numbers 31871178, 31861163004).	Antonioli L, 2015, NAT REV ENDOCRINOL, V11, P228, DOI 10.1038/nrendo.2015.10; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Becker A, 2003, ATHEROSCLEROSIS, V169, P323, DOI 10.1016/S0021-9150(03)00199-0; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Chen JP, 2015, J PHYSIOL BIOCHEM, V71, P405, DOI 10.1007/s13105-015-0420-1; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cuyas E, 2018, ONCOGENE, V37, P963, DOI 10.1038/onc.2017.367; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Friedman B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80244-x; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hawkins M, 2003, DIABETES, V52, P2748, DOI 10.2337/diabetes.52.11.2748; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; LEE CC, 1992, BRAIN, V115, P935, DOI 10.1093/brain/115.3.935; LOMBARDINI JB, 1970, MOL PHARMACOL, V6, P481; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Mozzetta C, 2015, NAT REV MOL CELL BIO, V16, P499, DOI 10.1038/nrm4029; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Pastor-Anglada M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00627; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Poirier LA, 2001, METABOLISM, V50, P1014, DOI 10.1053/meta.2001.25655; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Radovic B, 2016, DIABETOLOGIA, V59, P1743, DOI 10.1007/s00125-016-3968-6; Ratnam S, 2006, AM J PHYSIOL-ENDOC M, V290, pE933, DOI 10.1152/ajpendo.00498.2005; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Rhoads TW, 2018, CELL METAB, V27, P677, DOI 10.1016/j.cmet.2018.01.014; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Valenti L, 2008, DIABETES, V57, P1355, DOI 10.2337/db07-0714; Wu LF, 2006, ACTA PHARMACOL SIN, V27, P477, DOI 10.1111/j.1745-7254.2006.00302.x; Xia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118101; Xia L, 2015, J ENDOCRINOL, V224, P225, DOI 10.1530/JOE-14-0501; Yadav H, 2017, J BIOL CHEM, V292, P3420, DOI 10.1074/jbc.M116.764910; Yang X, 2019, DIABETOLOGIA, V62, P2106, DOI 10.1007/s00125-019-04971-1; Yang X, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00497; Yang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081866; Zhan Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.516; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527; Zhang Y, 2012, AM J PHYSIOL-ENDOC M, V302, pE325, DOI 10.1152/ajpendo.00424.2011; Zhou YF, 2018, HEPATOLOGY, V67, P21, DOI 10.1002/hep.29499	50	2	3	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100846	10.1016/j.jbc.2021.100846	http://dx.doi.org/10.1016/j.jbc.2021.100846			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058194	gold, Green Published			2022-12-26	WOS:000678068400046
J	Sun, Y; Izadi, S; Callahan, M; Deperalta, G; Wecksler, AT				Sun, Yue; Izadi, Saeed; Callahan, Matthew; Deperalta, Galahad; Wecksler, Aaron T.			Antibody-receptor interactions mediate antibody-dependent cellular cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST PHOTOCHEMICAL OXIDATION; FC-GAMMA-RIII; MOLECULAR-DYNAMICS; MASS-SPECTROMETRY; PROTEINS FPOP; THERAPEUTIC ANTIBODIES; CRYSTAL-STRUCTURE; GLYCOSYLATION; BINDING; PARAMETERS	Binding of antibodies to their receptors is a core component of the innate immune system. Understanding the precise interactions between antibodies and their Fc receptors has led to the engineering of novel mAb biotherapeutics with tailored biological activities. One of the most significant findings is that afucosylated monoclonal antibodies demonstrate increased affinity toward the receptor Fc.RIIIa, with a commensurate increase in antibody-dependent cellular cytotoxicity. Crystal structure analysis has led to the hypothesis that afucosylation in the Fc region results in reduced steric hindrance between antibody-receptor intermolecular glycan interactions, enhancing receptor affinity; however, solution-phase data have yet to corroborate this hypothesis. In addition, recent work has shown that the fragment antigen-binding (Fab) region may directly interact with Fc receptors; however, the biological consequences of these interactions remain unclear. By probing differences in solvent accessibility between native and afucosylated immunoglobulin G1 (IgG1) using hydroxyl radical footprinting-MS, we provide the first solution-phase evidence that an IgG1 bearing an afucosylated Fc region appears to require fewer conformational changes for Fc.RIIIa binding. In addition, we performed extensive molecular dynamics (MD) simulations to understand the molecular mechanism behind the effects of afucosylation. The combination of these techniques provides molecular insight into the steric hindrance from the core Fc fucose in IgG1 and corroborates previously proposed Fab-receptor interactions. Furthermore, MD-guided rational mutagenesis enabled us to demonstrate that Fab-receptor interactions directly contribute to the modulation of antibody-dependent cellular cytotoxicity activity. This work demonstrates that in addition to Fc-polypeptide and glycan-mediated interactions, the Fab provides a third component that influences IgG-Fc receptor biology.	[Sun, Yue; Callahan, Matthew; Deperalta, Galahad; Wecksler, Aaron T.] Genentech Inc, Prot Analyt Chem Dept, San Francisco, CA 94080 USA; [Izadi, Saeed] Genentech Inc, Pharmaceut Dev Dept, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Wecksler, AT (corresponding author), Genentech Inc, Prot Analyt Chem Dept, San Francisco, CA 94080 USA.	wecksler.aaron@gene.com		Callahan, Matthew/0000-0002-1854-4212				BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Case D. A., 2016, AMBER 2016; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Charvatova O, 2008, J AM SOC MASS SPECTR, V19, P1692, DOI 10.1016/j.jasms.2008.07.013; Chemical Computing Group ULC, MOL OP ENV MOE 2013 MOL OP ENV MOE 2013; Chen JW, 2012, J AM CHEM SOC, V134, P18724, DOI 10.1021/ja307606f; Chung S, 2012, MABS-AUSTIN, V4, P326, DOI 10.4161/mabs.19941; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Garcia NK, 2020, J AM SOC MASS SPECTR, V31, P1563, DOI 10.1021/jasms.0c00146; Gurjar SA, 2017, J PHARMACEUT BIOMED, V143, P188, DOI 10.1016/j.jpba.2017.06.004; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Jefferis R, 2005, ADV EXP MED BIOL, V564, P143; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Jung ST, 2011, CURR OPIN BIOTECH, V22, P858, DOI 10.1016/j.copbio.2011.03.002; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kiselar JG, 2010, J MASS SPECTROM, V45, P1373, DOI 10.1002/jms.1808; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lin M, 2018, J AM SOC MASS SPECTR, V29, P961, DOI 10.1007/s13361-017-1883-9; Louie S, 2017, BIOTECHNOL BIOENG, V114, P632, DOI 10.1002/bit.26188; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MIZUOCHI T, 1982, J IMMUNOL, V129, P2016; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Rajasekaran N, 2015, IMMUNOTARGETS THER, V4, P91, DOI 10.2147/ITT.S61292; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Reusch D, 2015, MABS-AUSTIN, V7, P167, DOI 10.4161/19420862.2014.986000; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Satoh M, 2006, EXPERT OPIN BIOL TH, V6, P1161, DOI 10.1517/14712598.6.11.1161; Saxena A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00580; Shi LQ, 2019, BIOCHEMISTRY-US, V58, P1074, DOI 10.1021/acs.biochem.8b01048; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Subedi GP, 2015, STRUCTURE, V23, P1573, DOI 10.1016/j.str.2015.06.015; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Sun Y, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2020.1802135; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; Xie B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04689-3; Yan YT, 2014, J AM SOC MASS SPECTR, V25, P2084, DOI 10.1007/s13361-014-0993-x; Yogo R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48323-w; Zhang H, 2014, FEBS LETT, V588, P308, DOI 10.1016/j.febslet.2013.11.027; Zhang Y, 2017, J AM SOC MASS SPECTR, V28, P850, DOI 10.1007/s13361-017-1601-7; Zhang Y, 2015, J AM SOC MASS SPECTR, V26, P526, DOI 10.1007/s13361-014-1055-0	51	11	11	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100826	10.1016/j.jbc.2021.100826	http://dx.doi.org/10.1016/j.jbc.2021.100826			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34044019	Green Published, gold			2022-12-26	WOS:000678068400028
J	Musarandega, R; Machekano, R; Pattinson, R; Munjanja, SP				Musarandega, Reuben; Machekano, Rhoderick; Pattinson, Robert; Munjanja, Stephen Peter		Zimbabwe Maternal & Perinatal Mor	Protocol for analysing the epidemiology of maternal mortality in Zimbabwe: A civil registration and vital statistics trend study	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; NATIONAL LEVELS; DISEASE; DEATHS; RATIO; HIV	Background Sub-Saharan Africa (SSA) carries the highest burden of maternal mortality, yet, the accurate maternal mortality ratios (MMR) are uncertain in most SSA countries. Measuring maternal mortality is challenging in this region, where civil registration and vital statistics (CRVS) systems are weak or non-existent. We describe a protocol designed to explore the use of CRVS to monitor maternal mortality in Zimbabwe-an SSA country. Methods In this study, we will collect deliveries and maternal death data from CRVS (government death registration records) and health facilities for 2007-2008 and 2018-2019 to compare MMRs and causes of death. We will code the causes of death using classifications in the maternal mortality version of the 10(th) revision to the international classification of diseases. We will compare the proportions of maternal deaths attributed to different causes between the two study periods. We will also analyse missingness and misclassification of maternal deaths in CRVS to assess the validity of their use to measure maternal mortality in Zimbabwe. Discussion This study will determine changes in MMR and causes of maternal mortality in Zimbabwe over a decade. It will show whether HIV, which was at its peak in 2007-2008, remains a significant cause of maternal deaths in Zimbabwe. The study will recommend measures to improve the quality of CRVS data for future use to monitor maternal mortality in Zimbabwe and other SSA countries of similar characteristics.	[Musarandega, Reuben] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Machekano, Rhoderick] Stellenbosch Univ, Fac Med & Hlth Sci, Biostat & Epidemiol Dept, Cape Town, South Africa; [Pattinson, Robert] Univ Pretoria, SAMRC Mat & Infant Hlth Care Strategies Res Unit, Res Ctr Maternal Fetal Newborn & Child Hlth Care, Pretoria, South Africa; [Munjanja, Stephen Peter] Univ Zimbabwe, Coll Hlth Sci, Dept Obstet & Gynaecol, Harare, Zimbabwe	University of Pretoria; Stellenbosch University; University of Pretoria; University of Zimbabwe	Musarandega, R (corresponding author), Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa.	rmusara@gmail.com	Musarandega, Reuben/AAG-3731-2022; Musarandega, Reuben/ABD-4711-2022	Musarandega, Reuben/0000-0002-0622-2195; Musarandega, Reuben/0000-0002-0622-2195	Bill & Melinda Gates Foundation [OPP1169546]; UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); Zimbabwe Ministry of Health and Child Care	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); Zimbabwe Ministry of Health and Child Care	This work is supported, in part, by the Bill & Melinda Gates Foundation through a grant to the Improving Maternal Health Measurement (IMHM) Project at the Women & Health Initiative of the Harvard T.H. Chan School of Public Health [Grant Number OPP1169546]. It is also funded from the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored programme executed by the World Health Organization (WHO). The Zimbabwe Ministry of Health and Child Care is also cosponsoring the study through funding from its partners.	Adomako J, 2016, B WORLD HEALTH ORGAN, V94, P86, DOI 10.2471/BLT.15.154849; Alkema L, 2019, TRENDS MATERNAL MORT; Alkema L, 2017, ANN APPL STAT, V11, P1245, DOI 10.1214/16-AOAS1014; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Betran AP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-131; Bradshaw D, 2012, SAJOG-S AFR J OBSTET, V18, P38; Calvert C, 2020, AIDS, V34, P1397, DOI 10.1097/QAD.0000000000002552; Cuneo CN, 2017, HEALTH HUM RIGHTS, V19, P249; D'Aquino L, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024516; Di Gennaro F, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000370; Dupont W. D., 2009, STAT MODELING BIOMED; Fowler F.J., 2009, SURV RES METHODS-GER; Geubbels Eveline, 2006, Malawi Med J, V18, P206; Geynisman J, 2011, INT J GYNECOL OBSTET, V114, P29, DOI 10.1016/j.ijgo.2011.01.011; Gnanadesikan R., 1977, METHODS STAT DATA AN; Graham WJ, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-12; Gregson S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015898; Grove J, 2015, LANCET, V386, P1511, DOI 10.1016/S0140-6736(15)00517-6; Gulmezoglu A Metin, 2004, BMC Med Res Methodol, V4, P16, DOI 10.1186/1471-2288-4-16; Hanley JA, 1996, STUD FAMILY PLANN, V27, P220, DOI 10.2307/2137955; Henkel R.E., 1976, TESTS SIGNIFICANCE; Hilbe JM, 2009, CH CRC TEXT STAT SCI, P1; ICAP, 2018, ZIMB POP BAS HIV IMP; Kassebaum NJ, 2016, LANCET, V388, P1775, DOI 10.1016/S0140-6736(16)31470-2; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Killip S, 2004, ANN FAM MED, V2, P204, DOI 10.1370/afm.141; Kumar R, 2012, INDIAN J OPHTHALMOL, V60, P582, DOI 10.4103/0301-4738.103809; Levy PS, 2008, SAMPLING POPULATIONS, V4th; Longest KC., 2015, USING STATA QUANTITA, VSecond edition; Marchant T, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002697; Marotta C, 2020, AM J TROP MED HYG, V103, P2142, DOI 10.4269/ajtmh.20-0623; Maternal Health Task Force, 2020, SUSTAINABLE DEV GOAL; Mgawadere F, 2017, BRIT MED BULL, V121, P121, DOI 10.1093/bmb/ldw056; Mgawadere F, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1084-8; Mgawadere Florence RU., 2016, BMC PREGNANCY CHILDB; Mohammed AA, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-102; Moyer Cheryl A, 2013, Afr J Reprod Health, V17, P30; Munjanja S., 2009, INT J GYNECOL OBSTET, V107, pS278; Munjanja SP, 2009, BJOG-INT J OBSTET GY, V116, P7, DOI 10.1111/j.1471-0528.2009.02337.x; Munjanja SP., 2008, ZIMB MAT PER MORT ST; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Musarandega R, 2022, INT J GYNECOL OBSTET, V156, P206, DOI 10.1002/ijgo.13695; Musarandega R, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05900-4; NAC, 2018, ZIMB NAT SUBN HIV ES; Ngwenya S, 2020, TROP DOCT, V50, P12, DOI 10.1177/0049475519884436; Ott L., 2001, INTRO STAT METHODS D; PRENTICE RL, 1978, BIOMETRICS, V34, P541, DOI 10.2307/2530374; Rabe-Hesketh S., 2007, HDB STAT ANAL USING, V4th ed.; del Aguila MMR, 2014, ALLERGOL IMMUNOPATH, V42, P485, DOI 10.1016/j.aller.2013.03.008; Rosen JE, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/958262; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Spencer NH, 2014, ESSENTIALS MULTIVARI; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wall F.J., 1986, STAT DATA ANAL HDB; Walraven G, 2000, B WORLD HEALTH ORGAN, V78, P603; WHO, 2011, WHO APPL ICD 10 DEAT, V1; World Health Organization, 2020, SUSTAINABLE DEV GOAL; World Health Organization, 2011, INT STAT CLASS DIS R, V2; Zakariah Afisah Yakubu, 2009, Reprod Health, V6, P7, DOI 10.1186/1742-4755-6-7; Zimbabwe Ministry of Health and Child Care, 2020, MAT PER DEATH SURV R; ZIMSTAT and ICF International, 2016, ZIMB DEM HLTH SURV 2; ZimStat and UNICEF, 2019, ZIMB MULT IND CLUST; ZimStat and UNICEF, 2015, ZIMB MULT IND CLUST	63	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252106	10.1371/journal.pone.0252106	http://dx.doi.org/10.1371/journal.pone.0252106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081727	Green Published, gold			2022-12-26	WOS:000664639200008
J	Ganguly, K; Dutta, SD; Jeong, MS; Patel, DK; Cho, SJ; Lim, KT				Ganguly, Keya; Dutta, Sayan Deb; Jeong, Min-Soo; Patel, Dinesh K.; Cho, Seong-Jun; Lim, Ki-Taek			Naturally-derived protein extract from Gryllus bimaculatus improves antioxidant properties and promotes osteogenic differentiation of hBMSCs	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; BONE; PEPTIDES; INSECTS; DRUGS	Naturally-derived proteins or peptides are promising biopolymers for tissue engineering applications owing to their health-promoting activity. Herein, we extracted proteins (similar to 90%) from two-spotted cricket (Gryllus bimaculatus) and evaluated their osteoinductive potential in human bone marrow-derived mesenchymal stem cells (hBMSCs) under in vitro conditions. The extracted protein isolate was analyzed for the amino acid composition and the mass distribution of the constituent peptide fraction. Fourier transform infrared (FTIR) spectroscopy was used to determine the presence of biologically significant functional groups. The cricket protein isolate (CPI) exhibited characteristic protein peaks in the FTIR spectrum. Notably, an enhanced cell viability was observed in the presence of the extracted proteins, showing their biocompatibility. The CPI also exhibited antioxidant properties in a concentration-dependent manner. More significant mineralization was observed in the CPI-treated cells than in the control, suggesting their osteoinductive potential. The upregulation of the osteogenic marker genes (Runx2, ALP, OCN, and BSP) in CPI treated media compared with the control supports their osteoinductive nature. Therefore, cricket-derived protein isolates could be used as functional protein isolate for tissue engineering applications, especially for bone regeneration.	[Ganguly, Keya; Dutta, Sayan Deb; Patel, Dinesh K.; Lim, Ki-Taek] Kangwon Natl Univ, Coll Agr & Life Sci, Dept Biosyst Engn, Inst Forest Sci, Chunchon, South Korea; [Jeong, Min-Soo; Cho, Seong-Jun] Kangwon Natl Univ, Dept Food Sci & Biotechnol, Coll Agr & Life Sci, Chunchon, South Korea	Kangwon National University; Kangwon National University	Lim, KT (corresponding author), Kangwon Natl Univ, Coll Agr & Life Sci, Dept Biosyst Engn, Inst Forest Sci, Chunchon, South Korea.; Cho, SJ (corresponding author), Kangwon Natl Univ, Dept Food Sci & Biotechnol, Coll Agr & Life Sci, Chunchon, South Korea.	sj.cho@kangwon.ac.kr; ktlim@kangwon.ac.kr	Lim, Ki-Taek/AAI-9518-2021	Lim, Ki-Taek/0000-0003-2091-788X; Ganguly, Keya/0000-0002-0235-6313; Deb Dutta, Sayan/0000-0001-9397-3140	'National Research Foundation of Korea' (NRF) - 'Ministry of Education' [NRF-2018R1A6A1A03025582, NRF-2019R1D1A3A03103828]; Ministry of Trade, Industry, and Energy (MoTIE, South Korea) [20012439]	'National Research Foundation of Korea' (NRF) - 'Ministry of Education'(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); Ministry of Trade, Industry, and Energy (MoTIE, South Korea)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	K.T.L: 'National Research Foundation of Korea' (NRF) funded by the 'Ministry of Education' (NRF-2018R1A6A1A03025582 & NRF-2019R1D1A3A03103828) S.J.C: Innovative Cultured Meat Technology Development Alchemist Project (20012439) funded by the Ministry of Trade, Industry, and Energy (MoTIE, South Korea) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkawi Ibrahim, 2018, Joints, V6, P122, DOI 10.1055/s-0038-1660790; Amarender RV, 2020, LWT-FOOD SCI TECHNOL, V125, DOI 10.1016/j.lwt.2020.109222; AOAC CP, 1999, OFFICIAL METHODS ANA, V5th; Bharadwaz A, 2020, MAT SCI ENG C-MATER, V110, DOI 10.1016/j.msec.2020.110698; Bussler S, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00218; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Chen JX, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59451-z; Chen R, 2016, ADV FUNCT MATER, V26, P8810, DOI 10.1002/adfm.201603197; Chevallier N, 2010, BIOMATERIALS, V31, P270, DOI 10.1016/j.biomaterials.2009.09.043; Chiellini C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-26; Choi BD, 2017, KOREAN J FOOD SCI AN, V37, P955, DOI 10.5851/kosfa.2017.37.6.955; Collier JH, 2010, CHEM SOC REV, V39, P3413, DOI 10.1039/b914337h; Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1; Dong YS, 2020, APPL MATER TODAY, V19, DOI 10.1016/j.apmt.2019.100548; Dutta SD, 2019, J NANOMATER, V2019, DOI 10.1155/2019/2061545; Fedchenko N, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0221-9; Ghosh S, 2017, J ASIA-PAC ENTOMOL, V20, P686, DOI 10.1016/j.aspen.2017.04.003; He R, 2012, FOOD RES INT, V49, P432, DOI 10.1016/j.foodres.2012.08.023; Hirsch A, 2019, CURR RES FOOD SCI, V1, P17, DOI 10.1016/j.crfs.2019.09.002; Huang Y., 2020, PRELIMINARY STUDY UL, DOI [DOI 10.2139/SSRN.3544750, 10.2139/ssrn.3544750]; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Kim SW, 2020, BRAIN BEHAV IMMUN, V87, P4, DOI 10.1016/j.bbi.2020.03.025; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Montowska M, 2019, FOOD CHEM, V289, P130, DOI 10.1016/j.foodchem.2019.03.062; Nandiyanto A., 2019, INDONES J SCI TECHNO, V4, P97, DOI DOI 10.17509/IJOST.V4I1.15806; Nauth A, 2011, INJURY, V42, P574, DOI 10.1016/j.injury.2011.03.034; Nwachukwu ID, 2019, J FOOD BIOCHEM, V43, DOI 10.1111/jfbc.12761; Onak G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36109-5; Otaki JM, 2010, J CHEM INF MODEL, V50, P690, DOI 10.1021/ci900452z; Patel DK, 2020, INT J BIOL MACROMOL, V162, P1429, DOI 10.1016/j.ijbiomac.2020.07.246; Pemberton RW, 1999, J ETHNOPHARMACOL, V65, P207, DOI 10.1016/S0378-8741(98)00209-8; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Roberts TT, 2012, ORGANOGENESIS, V8, P114, DOI 10.4161/org.23306; Se-Kwon K., 2020, ENCY MARINE BIOTECHN, P1209; Shim WSN, 2004, BIOCHEM BIOPH RES CO, V324, P481, DOI 10.1016/j.bbrc.2004.09.087; Udomsil N, 2019, FOOD SCI TECHNOL RES, V25, P597, DOI 10.3136/fstr.25.597; Vilcinskas A, 2005, J PEST SCI, V78, P187, DOI 10.1007/s10340-005-0114-5; Yang RW, 2017, FOOD CHEM, V219, P311, DOI 10.1016/j.foodchem.2016.09.163; Yu SH, 2020, TOXICOL REP, V7, P577, DOI 10.1016/j.toxrep.2020.04.006; Yu YL, 2019, CELL METAB, V29, P966, DOI 10.1016/j.cmet.2019.01.016; Zou TB, 2016, MOLECULES, V21, DOI 10.3390/molecules21010072	42	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0249291	10.1371/journal.pone.0249291	http://dx.doi.org/10.1371/journal.pone.0249291			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077422	gold, Green Published			2022-12-26	WOS:000664638500002
J	Shen, MQ; Zhang, RX; Jia, WZ; Zhu, ZP; Zhao, XP; Zhao, L; Huang, G; Liu, JJ				Shen, Mengqin; Zhang, Ruixue; Jia, Wenzhi; Zhu, Zongping; Zhao, Xiaoping; Zhao, Li; Huang, Gang; Liu, Jianjun			Nuclear scaffold protein p54(nrb)/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma	ONCOGENE			English	Article							LONG NONCODING RNA; LACTATE-DEHYDROGENASE; LUNG-CANCER; NONO; GROWTH	Hypoxia and related oxidative stress are closely related to the development and treatment of hepatocellular carcinoma (HCC). However, the mechanism mediated by hypoxia in HCC has not yet been elucidated. Here, we found multifunction scaffold protein p54(nrb)/NONO exerted pleiotropic effects to regulate hypoxia transcription signals, thereby enhancing the progression of liver cancer. Extensive analysis of clinical data demonstrated that NONO was significantly upregulated and represented as a poor prognostic indicator of HCC. The crucial role of NONO in driving angiogenesis and glycolysis, two well-known cancer phenotypes mediated by hypoxia, was examined in vitro an in vivo. Mechanistically, NONO interacted with and stabilized both HIF-1 and HIF-2 complexes thus activating the transcription of hypoxia-induced genes. Besides, NONO bound pre-mRNA and subsequent mRNA of these genes to facilitate them splicing and mRNA stability, respectively. Thus, NONO knockout seriously disrupted the expression of a cluster of HIF-1/2 targets and impeded hypoxia-enhanced progression in HCC. In conclusion, NONO functioned as a multipurpose scaffold that interacted with HIF-1/2 complex and their downstream transcripts to facilitate the expression of hypoxia-induced genes, allowing malignant proliferation, indicating that NONO might be a potential therapeutic target for HCC.	[Shen, Mengqin; Zhang, Ruixue; Jia, Wenzhi; Zhao, Xiaoping; Zhao, Li; Huang, Gang; Liu, Jianjun] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Inst Clin Nucl Med,Dept Nucl Med, Shanghai 200127, Peoples R China; [Zhu, Zongping] Qingdao Municipal Hosp Grp, Dept Nucl Med, Qingdao 266011, Peoples R China; [Huang, Gang] Shanghai Univ Med & Hlth Sci, Shanghai Key Lab Mol Imaging, Shanghai 201318, Peoples R China; [Liu, Jianjun] Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200127, Peoples R China	Shanghai Jiao Tong University; Qingdao Municipal Hospital; Shanghai University of Medicine & Health Sciences; Shanghai Jiao Tong University	Huang, G; Liu, JJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Inst Clin Nucl Med,Dept Nucl Med, Shanghai 200127, Peoples R China.; Huang, G (corresponding author), Shanghai Univ Med & Hlth Sci, Shanghai Key Lab Mol Imaging, Shanghai 201318, Peoples R China.; Liu, JJ (corresponding author), Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200127, Peoples R China.	huanggang2245@163.com; RInuclear@126.com		Huang, Gang/0000-0002-9245-1276	National Natural Science Foundation of China [81771858, 81530053, 81601524]; Shanghai Key Laboratory of Molecular Imaging [18DZ2260400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Laboratory of Molecular Imaging	This study was supported by grants from the National Natural Science Foundation of China (81771858, 81530053, 81601524) and Shanghai Key Laboratory of Molecular Imaging (18DZ2260400).	Albadari N, 2019, EXPERT OPIN DRUG DIS, V14, P667, DOI 10.1080/17460441.2019.1613370; Benegiamo G, 2018, CELL METAB, V27, P404, DOI 10.1016/j.cmet.2017.12.010; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Custodio N, 2016, CRIT REV BIOCHEM MOL, V51, P395, DOI 10.1080/10409238.2016.1230086; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; Feng PF, 2020, J CELL MOL MED, V24, P4368, DOI 10.1111/jcmm.15141; Fox AH, 2018, TRENDS BIOCHEM SCI, V43, P124, DOI 10.1016/j.tibs.2017.12.001; Hao XJ, 2013, HEPATOB PANCREAT DIS, V12, P617, DOI 10.1016/S1499-3872(13)60097-1; Hayashi Y, 2019, CANCER SCI, V110, P1510, DOI 10.1111/cas.13990; Hirose T, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1545; Hu ZX, 2020, HEPATOLOGY, V72, P548, DOI 10.1002/hep.31062; Hua Q, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0773-y; Huang YH, 2016, CANCER RES, V76, P1549, DOI 10.1158/0008-5472.CAN-15-2073; Ippolito D, 2014, EUR J RADIOL, V83, P1665, DOI 10.1016/j.ejrad.2014.05.040; Jankowsky E, 2015, NAT REV MOL CELL BIO, V16, P533, DOI 10.1038/nrm4032; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kessler Sonja M, 2019, Cell Physiol Biochem, V52, P787, DOI 10.33594/000000055; Kim SJ, 2020, THERANOSTICS, V10, P7974, DOI 10.7150/thno.45037; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Lapenta F, 2018, CHEM SOC REV, V47, P3530, DOI 10.1039/c7cs00822h; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mendez-Blanco C, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0159-1; Nobre AR, 2018, TRENDS CELL BIOL, V28, P941, DOI 10.1016/j.tcb.2018.06.008; Onodera T, 2019, CHEM PHARM BULL, V67, P186, DOI 10.1248/cpb.c18-00767; Pavao M, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-15; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Qin H, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00927-w; Roos M, 2016, ACS CHEM BIOL, V11, P2773, DOI 10.1021/acschembio.6b00232; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Shen MQ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0839-4; Shibuya K, 2015, ONCOTARGET, V6, P651, DOI 10.18632/oncotarget.2892; Tang WD, 2020, BIOORGAN MED CHEM, V28, DOI 10.1016/j.bmc.2019.115235; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Wu XQ, 2015, ACS CHEM BIOL, V10, P1476, DOI 10.1021/cb500851u; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Xie RH, 2021, MOL THER, V29, P291, DOI 10.1016/j.ymthe.2020.08.018; Xiong XX, 2017, MOL PHARMACOL, V92, P246, DOI 10.1124/mol.116.107706; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Zhu Z, 2016, ONCOGENE, V35, P1399, DOI 10.1038/onc.2015.197	41	3	3	3	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4167	4183		10.1038/s41388-021-01848-9	http://dx.doi.org/10.1038/s41388-021-01848-9		JUN 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34079086	Green Published, hybrid			2022-12-26	WOS:000657217400003
J	Bourget-Murray, J; Taneja, A; Naserkhaki, S; El-Rich, M; Adeeb, S; Powell, J; Johnston, K				Bourget-Murray, Jonathan; Taneja, Ashish; Naserkhaki, Sadegh; El-Rich, Marwan; Adeeb, Samer; Powell, James; Johnston, Kelly			Computational modelling of hip resurfacing arthroplasty investigating the effect of femoral version on hip biomechanics	PLOS ONE			English	Article							IMPINGEMENT; ORIENTATION; SURVIVAL; FRACTURE; MINIMUM; STRESS; SINGLE; NECK	Aim How reduced femoral neck anteversion alters the distribution of pressure and contact area in Hip Resurfacing Arthroplasty (HRA) remains unclear. The purpose of this study was to quantitatively describe the biomechanical implication of different femoral neck version angles on HRA using a finite element analysis. Materials and methods A total of sixty models were constructed to assess the effect of different femoral neck version angles on three different functional loads: 0 degrees of hip flexion, 45 degrees of hip flexion, and 90 degrees of hip flexion. Femoral version was varied between 30 degrees of anteversion to 30 degrees of retroversion. All models were tested with the acetabular cup in four different positions: (1) 40 degrees /15 degrees (inclination/version), (2) 40 degrees /25 degrees, (3) 50 degrees /15 degrees, and (4) 50 degrees /25 degrees. Differences in range of motion due to presence of impingement, joint contact pressure, and joint contact area with different femoral versions and acetabular cup positions were calculated. Results Impingement was found to be most significant with the femur in 30 degrees of retroversion, regardless of acetabular cup position. Anterior hip impingement occurred earlier during hip flexion as the femur was progressively retroverted. Impingement was reduced in all models by increasing acetabular cup inclination and anteversion, yet this consequentially led to higher contact pressures. At 90 degrees of hip flexion, contact pressures and contact areas were inversely related and showed most notable change with 30 degrees of femoral retroversion. In this model, the contact area migrated towards the anterior implant-bone interface along the femoral neck. Conclusion Femoral retroversion in HRA influences impingement and increases joint contact pressure most when the hip is loaded in flexion. Increasing acetabular inclination decreases the area of impingement but doing so causes a reciprocal increase in joint contact pressure. It may be advisable to study femoral neck version pre-operatively to better choose hip resurfacing arthroplasty candidates.	[Bourget-Murray, Jonathan; Taneja, Ashish; Powell, James; Johnston, Kelly] Univ Calgary, Sect Orthopaed Surg, Dept Surg, Calgary, AB, Canada; [Naserkhaki, Sadegh] Islamic Azad Univ, Sci & Res Branch, Dept Biomed Engn, Tehran, Iran; [El-Rich, Marwan; Adeeb, Samer] Univ Alberta, Dept Civil & Environm Engn, Edmonton, AB, Canada	University of Calgary; Islamic Azad University; University of Alberta	Bourget-Murray, J (corresponding author), Univ Calgary, Sect Orthopaed Surg, Dept Surg, Calgary, AB, Canada.	jbourgetmurray@gmail.com		Bourget-Murray, Jonathan/0000-0001-7679-233X; El-Rich, Marwan/0000-0002-0394-0079				Amstutz HC, 2015, HIP INT, V25, P330, DOI 10.5301/hipint.5000268; Amstutz HC, 2004, J BONE JOINT SURG AM, V86A, P1874, DOI 10.2106/00004623-200409000-00003; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Chang PB, 1998, CLIN ORTHOP RELAT R, P57; Chegini S, 2009, J ORTHOP RES, V27, P195, DOI 10.1002/jor.20747; Coulter G, 2012, J BONE JOINT SURG BR, V94B, P315, DOI 10.1302/0301-620X.94B3.28185; Daniel J, 2014, BONE JOINT J, V96B, P1298, DOI 10.1302/0301-620X.96B10.33695; de Smet K, 2008, J BONE JOINT SURG AM, V90A, P202, DOI 10.2106/JBJS.H.00672; Grammatopoulos G, 2010, J BONE JOINT SURG BR, V92B, P1072, DOI 10.1302/0301-620X.92B8.24194; Haddad FS, 2015, BONE JOINT J, V97B, P617, DOI 10.1302/0301-620X.97B5.34537; Hart AJ, 2013, J BONE JOINT SURG AM, V95A, P678, DOI 10.2106/JBJS.J.01447; Hart AJ, 2008, HIP INT, V18, P212, DOI 10.5301/HIP.2008.948; Hellman MD, 2019, BONE JOINT J, V101B, P32, DOI 10.1302/0301-620X.101B1.BJJ-2018-0508.R1; Holland JP, 2012, J BONE JOINT SURG BR, V94B, P471, DOI 10.1302/0301-620X.94B4.27895; Izmin NAN, 2019, INT J ENG ADV TECHNO, V9, P5879; Mehra A, 2015, J ARTHROPLASTY, V30, P1160, DOI 10.1016/j.arth.2015.01.042; Mellon SJ, 2015, J BIOMECH, V48, P318, DOI 10.1016/j.jbiomech.2014.11.027; Meyer AM, 2020, J BIOMECH, V109, DOI 10.1016/j.jbiomech.2020.109891; Miles B, 2016, P I MECH ENG H, V230, P668, DOI 10.1177/0954411916644633; Morlock MM, 2008, J BONE JOINT SURG AM, V90A, P89, DOI 10.2106/JBJS.H.00621; Murray DW, 2012, J BONE JOINT SURG BR, V94B, P1180, DOI 10.1302/0301-620X.94B9.29462; Nassutt R, 2003, CLIN ORTHOP RELAT R, P127, DOI 10.1097/01.blo.0000048133.30533.13; Oak SR, 2017, J ARTHROPLASTY, V32, P110, DOI 10.1016/j.arth.2016.06.049; Ong KL, 2006, J BONE JOINT SURG BR, V88B, P1110, DOI 10.1302/0301-620X.88B8.17567; Powell J, 2013, BONE JOINT J, V95B, P1045, DOI [10.1302/0301-620X.95B8.31811, 10.1302/0301-620X.9588.31811]; Quesada MJ, 2008, J ARTHROPLASTY, V23, P69, DOI 10.1016/j.arth.2008.06.015; Ramos A, 2019, COMPUT METHOD BIOMEC, V22, P352, DOI 10.1080/10255842.2018.1556973; Sakagoshi D, 2010, J ARTHROPLASTY, V25, P1282, DOI 10.1016/j.arth.2009.09.002; Satpathy J, 2015, J HIP PRESERV SURG, V2, P287, DOI 10.1093/jhps/hnv040; Scholes CJ, 2019, BONE JOINT J, V101B, P113, DOI 10.1302/0301-620X.101B1.BJJ-2018-0702.R1; Schuh R, 2012, INT ORTHOP, V36, P1349, DOI 10.1007/s00264-012-1502-0; Shimmin AJ, 2005, ORTHOP CLIN N AM, V36, P187, DOI 10.1016/j.ocl.2005.01.002; TONNIS D, 1991, J PEDIATR ORTHOPED, V11, P419; Woon RP, 2013, J ARTHROPLASTY, V28, P1010, DOI 10.1016/j.arth.2012.07.043	34	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252435	10.1371/journal.pone.0252435	http://dx.doi.org/10.1371/journal.pone.0252435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043721	Green Published, gold			2022-12-26	WOS:000664635700101
J	Nghiem, N; Wilson, N				Nghiem, Nhung; Wilson, Nick			Potential impact of COVID-19 related unemployment on increased cardiovascular disease in a high-income country: Modeling health loss, cost and equity	PLOS ONE			English	Article							MORTALITY; ZEALAND; STRESS	Background Cardiovascular disease (CVD) is a leading cause of health loss and health sector economic burdens in high-income countries. Unemployment is associated with increased risk of CVD, and so there is concern that the economic downturn associated with the COVID-19 pandemic will increase the CVD burden. Aims This modeling study aimed to quantify potential health loss, health cost burden and health inequities among people with CVD due to additional unemployment caused by COVID-19 pandemic-related economic disruption in one high-income country: New Zealand (NZ). Methods We adapted an established and validated multi-state life-table model for CVD in the national NZ population. We modeled indirect effects (ie, higher CVD incidence due to high unemployment rates) for various scenarios of pandemic-related unemployment projections from the NZ Treasury. Results We estimated the potential CVD-related heath loss in NZ to range from 23,300 to 36,900 health-adjusted life years (HALYs) for the different unemployment scenarios. Health inequities would be increased with the per capita health loss for Maori (Indigenous population) estimated to be 3.7 times greater than for non-Maori (49.9 vs 13.5 HALYs lost per 1000 people). The estimated additional health system costs ranged between (NZ$303 million [m] to 503m in 2019 values; or US$209m to 346m). Conclusions and policy implications Unemployment due to the COVID-19 pandemic could cause significant health loss, increase health inequities from CVD, and impose additional health system costs in this high-income country. Prevention measures should be considered by governments to reduce this risk, including additional job creation programs and measures directed towards the primary prevention of CVD.	[Nghiem, Nhung; Wilson, Nick] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Otago	Nghiem, N (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	nhung.nghiem@otago.ac.nz		Nghiem, Nhung/0000-0003-0078-4549	Health Research Council of NZ [10/248, 16/443]	Health Research Council of NZ(Health Research Council of New Zealand)	NN and NW were supported by the Health Research Council of NZ (grant 10/248 and grant 16/443, URL: https://www.hrc.govt.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MG, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2025203; Blakely T, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002716; Blakely T, 2017, EPIDEMIOLOGY, V28, P594, DOI [10.1097/EDE.0000000000000671, 10.1097/ede.0000000000000671]; Chan WC, 2008, NEW ZEAL MED J, V121, P11; Disney G, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0132-6; Fernandes N., 2020, WP1240E IESE BUS SCH, DOI [10.2139/ssrn.3557504, DOI 10.2139/SSRN.3557504]; Grey C, 2018, NEW ZEAL MED J, V131, P21; Hale T., 2020, OXF COVID 19 GOV RES; Hughes A, 2017, BRAIN BEHAV IMMUN, V64, P91, DOI 10.1016/j.bbi.2017.03.012; Johns Hopkins University, 2020, COVID 19 DASHB CTR S; Mackay S, 2017, PUBLIC HEALTH NUTR, V20, P2269, DOI [10.1017/s1368980017000805, 10.1017/S1368980017000805]; Malik MO, 2021, PROD PLAN CONTROL, V32, P1020, DOI 10.1080/09537287.2020.1784481; Ministry of Health, 2020, SUPP COVID 19 PAND R; Ministry of Health, 2013, HLTH LOSS NZ REP NZ; Ministry of Health, 2013, WAYS MEANS REP METH; Ministry of Health, 2020, POT WORS CAS HLTH IM; Ministry of Social Development, 2016, SOC REP 2016; Nghiem N, 2020, NEW ZEAL MED J, V133, P89; Nghiem N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55372-8; Nghiem N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3102-1; Nghiem N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123915; OECD, 2020, G20 GDP GROWTH 2 QUA; OECD, UN RAT 2020; Ozili P.K., 2020, SPILLOVER COVID 19 I; Roelfs DJ, 2011, SOC SCI MED, V72, P840, DOI 10.1016/j.socscimed.2011.01.005; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Ruan SG, 2020, LANCET INFECT DIS, V20, P630, DOI 10.1016/S1473-3099(20)30257-7; Statistics New Zealand, 2013, GET COM; Statistics New Zealand, INTR ETHN LAB FORC S; Statistics New Zealand, 2020, UN RAT HITS 5 3 PERC; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; The Treasury, 2020, PREEL EC FISC UPD 20; The Treasury, 2020, T2020973 TREAS; Thurston RC, 2009, PSYCHOSOM MED, V71, P836, DOI 10.1097/PSY.0b013e3181b40efc; Virtanen M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4746; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wilson N., 2020, HLTH EC IMPACTS COVI	39	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0246053	10.1371/journal.pone.0246053	http://dx.doi.org/10.1371/journal.pone.0246053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043626	Green Published, gold			2022-12-26	WOS:000664635700005
J	Shiri, N; Shiri, J; Yaseen, ZM; Kim, S; Chung, IM; Nourani, V; Zounemat-Kermani, M				Shiri, Naser; Shiri, Jalal; Yaseen, Zaher Mundher; Kim, Sungwon; Chung, Il-Moon; Nourani, Vahid; Zounemat-Kermani, Mohammad			Development of artificial intelligence models for well groundwater quality simulation: Different modeling scenarios	PLOS ONE			English	Article							NEURAL-NETWORK PREDICTION; FLUORIDE CONTAMINATION; RIVER-BASIN; RESOURCES; MACHINE; SYSTEM; PLAIN; CLASSIFICATION; INFORMATION; REMEDIATION	Groundwater is one of the most important freshwater resources, especially in arid and semi-arid regions where the annual amounts of precipitation are small with frequent drought durations. Information on qualitative parameters of these valuable resources is very crucial as it might affect its applicability from agricultural, drinking, and industrial aspects. Although geo-statistics methods can provide insight about spatial distribution of quality factors, applications of advanced artificial intelligence (AI) models can contribute to produce more accurate results as robust alternative for such a complex geo-science problem. The present research investigates the capacity of several types of AI models for modeling four key water quality variables namely electrical conductivity (EC), sodium adsorption ratio (SAR), total dissolved solid (TDS) and Sulfate (SO4) using dataset obtained from 90 wells in Tabriz Plain, Iran; assessed by k-fold testing. Two different modeling scenarios were established to make simulations using other quality parameters and the geographical information. The obtained results confirmed the capabilities of the AI models for modeling the well groundwater quality variables. Among all the applied AI models, the developed hybrid support vector machine-firefly algorithm (SVM-FFA) model achieved the best predictability performance for both investigated scenarios. The introduced computer aid methodology provided a reliable technology for groundwater monitoring and assessment.	[Shiri, Naser] Univ Tabriz, Fac Civil Engn, Tabriz, Iran; [Shiri, Jalal] Univ Tabriz, Water Engn Dept, Fac Agr, Tabriz, Iran; [Shiri, Jalal; Nourani, Vahid] Univ Tabriz, Ctr Excellence Hydroinformat, Fac Civil Engn, Tabriz, Iran; [Yaseen, Zaher Mundher] Univ Teknol Malaysia UTM, Sch Civil Engn, Fac Engn, Johor Baharu, Kagawa, Malaysia; [Kim, Sungwon] Dongyang Univ, Dept Railrd Construct & Safety Engn, Yeongju, South Korea; [Chung, Il-Moon] Korea Inst Civil Engn & Bldg Technol, Dept Land Water & Environm Res, Goyang, South Korea; [Nourani, Vahid] Near East Univ, Fac Civil & Environm Engn, Near East Blvd,Via Mersin 10, Nicosia, Turkey; [Zounemat-Kermani, Mohammad] Shahid Bahonar Univ Kerman, Water Engn Dept, Kerman, Iran	University of Tabriz; University of Tabriz; University of Tabriz; Universiti Teknologi Malaysia; Korea Institute of Civil Engineering & Building Technology (KICT); Near East University; Shahid Bahonar University of Kerman (SBUK)	Yaseen, ZM (corresponding author), Univ Teknol Malaysia UTM, Sch Civil Engn, Fac Engn, Johor Baharu, Kagawa, Malaysia.	zaheryaseen88@gmail.com	Yaseen, Zaher Mundher/G-7029-2018	Yaseen, Zaher Mundher/0000-0003-3647-7137; Shiri, Naser/0000-0002-3925-5049; Chung, Il-Moon/0000-0003-0163-7305	Korea Ministry of Environment (MOE) [146515]	Korea Ministry of Environment (MOE)(Ministry of Environment (ME), Republic of Korea)	This research was funded by the Korea Ministry of Environment (MOE) as a Demand Responsive Water Supply Service Program (146515).	Adnan RM, 2020, J HYDROL, V586, DOI 10.1016/j.jhydrol.2019.124371; Ali S.H., 2020, IRAQI J ELECT ELECT, DOI [10.37917/ijeee.sceeer.3rd.19, DOI 10.37917/IJEEE.SCEEER.3RD.19]; Alizamir M, 2020, ENERGY, V197, DOI 10.1016/j.energy.2020.117239; Arabgol R, 2016, ENVIRON MODEL ASSESS, V21, P71, DOI 10.1007/s10666-015-9468-0; Aryafar A, 2019, ENVIRON EARTH SCI, V78, DOI 10.1007/s12665-019-8092-8; Awad M, 2015, EFFICIENT LEARNING M, P67, DOI DOI 10.1007/978-1-4302-5990-9_4; Awadh SM, 2021, ENVIRON DEV SUSTAIN, V23, P1, DOI 10.1007/s10668-019-00578-z; Azimi S, 2019, J CONTAM HYDROL, V220, P6, DOI 10.1016/j.jconhyd.2018.10.010; Barzegar R, 2017, STOCH ENV RES RISK A, V31, P2705, DOI 10.1007/s00477-016-1338-z; Barzegar R, 2016, MODEL EARTH SYST ENV, V2, DOI 10.1007/s40808-015-0072-8; Barzegar R, 2017, SCI TOTAL ENVIRON, V599, P20, DOI 10.1016/j.scitotenv.2017.04.189; Benmouiza K, 2019, THEOR APPL CLIMATOL, V137, P31, DOI 10.1007/s00704-018-2576-4; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Bui DT, 2020, SCI TOTAL ENVIRON, V715, DOI 10.1016/j.scitotenv.2020.136836; Ehteram M, 2020, ENVIRON SCI POLLUT R, V27, P15278, DOI 10.1007/s11356-020-08023-9; Farjad B, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9112022; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gardner MW, 1998, ATMOS ENVIRON, V32, P2627, DOI 10.1016/S1352-2310(97)00447-0; Gholami A, 2017, J HYDROINFORM, V19, P572, DOI 10.2166/hydro.2017.200; Gholami V, 2017, APPL WATER SCI, V7, P3633, DOI 10.1007/s13201-016-0508-y; Hadi SJ, 2020, IEEE ACCESS, V8, P101993, DOI 10.1109/ACCESS.2020.2998437; Hashim ZN, 2019, TIKRIT J ENG SCI, V26, P1; Jafari R, 2019, J WATER SUPPLY RES T, V68, P573, DOI 10.2166/aqua.2019.062; Jalali M, 2009, ENVIRON GEOL, V56, P1479, DOI 10.1007/s00254-008-1245-9; Jamei M, 2020, J HYDROL, V589, DOI 10.1016/j.jhydrol.2020.125335; Jimenez-Madrid A., 2019, KARST WATER ENV, P45, DOI [10.1128/AEM.00403-19, DOI 10.1128/AEM.00403-19]; Kadam AK, 2019, MODEL EARTH SYST ENV, V5, P951, DOI 10.1007/s40808-019-00581-3; Kalhor K, 2019, GROUNDWATER SUST DEV, V8, P104, DOI 10.1016/j.gsd.2018.10.004; Kazem A, 2013, APPL SOFT COMPUT, V13, P947, DOI 10.1016/j.asoc.2012.09.024; Khaki M, 2015, CLEAN-SOIL AIR WATER, V43, P551, DOI 10.1002/clen.201400267; Kisi O, 2019, WATER RESOUR MANAG, V33, P847, DOI 10.1007/s11269-018-2147-6; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Li J, 2019, NEURAL COMPUT APPL, V31, P827, DOI 10.1007/s00521-017-3112-7; [刘建军 LIU Jian-jun], 2009, [湖南农业科学, Hunan Agricultural Sciences], P173; [罗定贵 Luo Dinggui], 2003, [地球学报, Acta Geoscientia Sinica], V24, P475; Machiwal D, 2018, EARTH-SCI REV, V185, P901, DOI 10.1016/j.earscirev.2018.08.009; Mahdavi-Meymand Amin, 2021, ISH Journal of Hydraulic Engineering, V27, P58, DOI 10.1080/09715010.2019.1574619; Maiti S, 2013, ENVIRON MONIT ASSESS, V185, P3445, DOI 10.1007/s10661-012-2802-y; Maroufpoor S, 2020, ENVIRON SCI POLLUT R, V27, P28183, DOI 10.1007/s11356-020-09188-z; Maroufpoor S, 2019, J HYDROL, V575, P544, DOI 10.1016/j.jhydrol.2019.05.045; Maroufpoor S, 2019, AGR WATER MANAGE, V215, P63, DOI 10.1016/j.agwat.2019.01.008; Naganna S.R., 2020, KNOWL BASED ENG SCI, V1, P48, DOI [DOI 10.51526/KBES.2020.1.01.48-57, 10.51526/kbes.2020.1.01.48-57]; Naganna SR, 2019, WATER-SUI, V11, DOI 10.3390/w11040742; Nathan NS., 2017, J GEOSCIENCE ENV PRO, V5, P99, DOI 10.4236/gep.2017.53008; Nourani V, 2016, J HYDROINFORM, V18, P288, DOI 10.2166/hydro.2015.143; Omran EE, 2012, WATER-SUI, V4, P545, DOI 10.3390/w4030545; Orzepowski W, 2014, AGR WATER MANAGE, V138, P45, DOI 10.1016/j.agwat.2014.02.012; Ostovari Y., 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P1983; Pan CL, 2019, ENVIRON SCI POLLUT R, V26, P5724, DOI 10.1007/s11356-018-3967-x; Sakizadeh M, 2017, INT J AGRIC ENVIRON, V8, P37, DOI [10.4018/ijaeis.2017100103, 10.4018/IJAEIS.2017100103]; Sakizadeh M, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5722-2; Salih SQ, 2021, ENVIRON DEV SUSTAIN, V23, P8027, DOI 10.1007/s10668-020-00927-3; Sepahvand Alireza, 2021, ISH Journal of Hydraulic Engineering, V27, P124, DOI 10.1080/09715010.2019.1595185; Sharafati A, 2020, J HYDROINFORM, V22, P1425, DOI 10.2166/hydro.2020.184; Sharafati A, 2020, HYDROLOG SCI J, V65, P2022, DOI 10.1080/02626667.2020.1786571; Shareef MA, 2019, TIKRIT J ENG SCI, V26, P26, DOI DOI 10.25130/TJES.26.4.04; Sinha Ray S.P., 2019, WATER GOVERNANCE CHA, P87; Smedema LK., 2004, MODERN LAND DRAINAGE; Subramani T, 2005, ENVIRON GEOL, V47, P1099, DOI 10.1007/s00254-005-1243-0; Tiyasha, 2020, J HYDROL, V585, DOI 10.1016/j.jhydrol.2020.124670; Wagh Vasant, 2018, Groundwater for Sustainable Development, V7, P436, DOI 10.1016/j.gsd.2017.12.012; Wagh VM, 2016, MODEL EARTH SYST ENV, V2, DOI 10.1007/s40808-016-0250-3; Wang LC, 2017, INT J CLIMATOL, V37, P1141, DOI 10.1002/joc.4762; Yadav KK, 2019, ECOTOX ENVIRON SAFE, V182, DOI 10.1016/j.ecoenv.2019.06.045; Yan BZ, 2019, NAT HAZARDS, V99, P735, DOI 10.1007/s11069-019-03770-6; Yang X., 2008, NATURE INSPIRED META, V2nd; Yaseen ZM, 2019, WATER-SUI, V11, DOI 10.3390/w11030502; Yesilnacar MI, 2008, ENVIRON GEOL, V56, P19, DOI 10.1007/s00254-007-1136-5; Yesilnacar MI, 2012, ENVIRON EARTH SCI, V67, P1111, DOI 10.1007/s12665-012-1555-9; Zendehboudi A, 2018, J CLEAN PROD, V199, P272, DOI 10.1016/j.jclepro.2018.07.164; Zounemat-Kermani M, 2020, ADV ENG INFORM, V43, DOI 10.1016/j.aei.2019.101030; Zounemat-Kermani M, 2019, FLOW MEAS INSTRUM, V68, DOI 10.1016/j.flowmeasinst.2019.101573	73	12	12	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251510	10.1371/journal.pone.0251510	http://dx.doi.org/10.1371/journal.pone.0251510			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043648	Green Published, gold			2022-12-26	WOS:000664635700024
J	Velazquez, FN; Zhang, LQ; Viscardi, V; Trocchia, C; Hannun, YA; Obeid, LM; Snider, AJ				Velazquez, Fabiola N.; Zhang, Leiqing; Viscardi, Valentina; Trocchia, Carolena; Hannun, Yusuf A.; Obeid, Lina M.; Snider, Ashley J.			Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer	PLOS ONE			English	Article							PERSISTENT STAT3 ACTIVATION; MESENCHYMAL TRANSITION; VASCULAR-PERMEABILITY; BARRIER INTEGRITY; 1-PHOSPHATE; EXPRESSION; TUMOR; PROGRESSION; PROLIFERATION; GROWTH	Breast cancer is a very heterogeneous disease, and similar to 30% of breast cancer patients succumb to metastasis, highlighting the need to understand the mechanisms of breast cancer progression in order to identify new molecular targets for treatment. Sphingosine kinase 1 (SK1) has been shown to be upregulated in patients with breast cancer, and several studies have suggested its involvement in breast cancer progression and/or metastasis, mostly based on cell studies. In this work we evaluated the role of SK1 in breast cancer development and metastasis using a transgenic breast cancer model, mouse mammary tumor virus-polyoma middle tumor-antigen (MMTV-PyMT), that closely resembles the characteristics and evolution of human breast cancer. The results show that SK1 deficiency does not alter tumor latency or growth, but significantly increases the number of metastatic lung nodules and the average metastasis size in the lung of MMTV-PyMT mice. Additionally, analysis of Kaplan-Meier plotter of human disease shows that high SK1 mRNA expression can be associated with a better prognosis for breast cancer patients. These results suggest a metastasis-suppressing function for SK1 in the MMTV-PyMT model of breast cancer, and that its role in regulating human breast cancer progression and metastasis may be dependent on the breast cancer type.	[Velazquez, Fabiola N.; Zhang, Leiqing; Viscardi, Valentina; Trocchia, Carolena; Hannun, Yusuf A.; Obeid, Lina M.; Snider, Ashley J.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Velazquez, Fabiola N.; Zhang, Leiqing; Viscardi, Valentina; Trocchia, Carolena; Hannun, Yusuf A.; Obeid, Lina M.; Snider, Ashley J.] SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA; [Snider, Ashley J.] Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Tucson, AZ 85721 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Arizona	Snider, AJ (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.; Snider, AJ (corresponding author), SUNY Stony Brook, Canc Ctr, Stony Brook, NY 11794 USA.; Snider, AJ (corresponding author), Univ Arizona, Coll Agr & Life Sci, Dept Nutr Sci, Tucson, AZ 85721 USA.	ashleysnider@arizona.edu		Velazquez, Fabiola Noelia/0000-0001-5692-848X; Snider, Ashley/0000-0002-1515-4171	NCI from the National Cancer Institute [P01 CA097132]	NCI from the National Cancer Institute	Funded studies. This work was supported by multiple grants and assistance programs; NCI P01 CA097132 (YAH, LMO, AJS) from the National Cancer Institute; https://www.cancer.gov/.The funders had not role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Acharya S, 2019, CANCER RES, V79, P4211, DOI 10.1158/0008-5472.CAN-18-3803; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Alshaker H, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00303; Alshaker H, 2015, BREAST CANCER RES TR, V149, P59, DOI 10.1007/s10549-014-3228-8; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Attalla S, 2021, ONCOGENE, V40, P475, DOI 10.1038/s41388-020-01560-0; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bielawski J, 2009, METHODS MOL BIOL, V579, P443, DOI 10.1007/978-1-60761-322-0_22; Buczek E, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4445-z; Datta A, 2014, ONCOTARGET, V5, P5920, DOI 10.18632/oncotarget.1874; Decock J, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0545-8; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Do SI, 2017, AM J TRANSL RES, V9, P5684; Doll F, 2007, ENDOCR-RELAT CANCER, V14, P325, DOI 10.1677/ERC-06-0050; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Ho-Tin-Noe B, 2018, BLOOD, V131, P277, DOI 10.1182/blood-2017-06-742676; Jones LM, 2016, CANCER RES, V76, P1416, DOI 10.1158/0008-5472.CAN-15-2770; Karki P, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1385573; Kile BT, 2003, MAMM GENOME, V14, P81, DOI 10.1007/s00335-002-2160-0; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Li Y, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01279-7; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu X, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008101; LO SK, 1988, AM J PHYSIOL, V254, pH763, DOI 10.1152/ajpheart.1988.254.4.H763; Long JS, 2010, MOL CELL BIOL, V30, P3827, DOI 10.1128/MCB.01133-09; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Maiti A, 2017, CELL SIGNAL, V32, P85, DOI 10.1016/j.cellsig.2017.01.021; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Nagahashi M, 2012, CANCER RES, V72, P726, DOI 10.1158/0008-5472.CAN-11-2167; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29514-3; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; O'Connell KE, 2015, COMPARATIVE MED, V65, P96; Ohotski J, 2012, BRIT J CANCER, V106, P1453, DOI 10.1038/bjc.2012.98; Peng XQ, 2004, AM J RESP CRIT CARE, V169, P1245, DOI 10.1164/rccm.200309-1258OC; Rennhack JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11236-3; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Russnes HG, 2017, AM J PATHOL, V187, P2152, DOI 10.1016/j.ajpath.2017.04.022; Sammani S, 2010, AM J RESP CELL MOL, V43, P394, DOI 10.1165/rcmb.2009-0223OC; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Sarkisyan G, 2014, AM J PHYSIOL-CELL PH, V307, pC14, DOI 10.1152/ajpcell.00043.2014; Shimizu Y, 2018, CARCINOGENESIS, V39, P47, DOI 10.1093/carcin/bgx097; Smeda M, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-1013-z; Snider AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113998; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Van Brocklyn JR, 2012, COMP BIOCHEM PHYS B, V163, P26, DOI 10.1016/j.cbpb.2012.05.006; van Hellemond IEG, 2018, CURR TREAT OPTION ON, V19, DOI 10.1007/s11864-018-0541-1; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Wada M, 2017, ONCOGENE, V36, P6649, DOI 10.1038/onc.2017.274; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Wang SS, 2018, MED SCI MONITOR, V24, P1912, DOI 10.12659/MSM.905833; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Yagoub D, 2014, MOL ENDOCRINOL, V28, P1899, DOI 10.1210/me.2013-1423; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	65	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252311	10.1371/journal.pone.0252311	http://dx.doi.org/10.1371/journal.pone.0252311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043703	Green Published, gold			2022-12-26	WOS:000664635700084
J	Echeverri-Rico, J; Petro, E; Fory, PA; Mosquera, GM; Lang, JM; Leach, JE; Lobaton, JD; Garces, G; Perafan, R; Amezquita, N; Toro, S; Mora, B; Cuasquer, JB; Ramirez-Villegas, J; Rebolledo, MC; Torres, EA				Echeverri-Rico, Johanna; Petro, Eliel; Fory, Paola A.; Mosquera, Gloria M.; Lang, Jillian M.; Leach, Jan E.; Lobaton, Juan D.; Garces, Gabriel; Perafan, Ricardo; Amezquita, Nelson; Toro, Shirley; Mora, Brayan; Cuasquer, Juan B.; Ramirez-Villegas, Julian; Rebolledo, Maria Camila; Torres, Edgar A.			Understanding the complexity of disease-climate interactions for rice bacterial panicle blight under tropical conditions	PLOS ONE			English	Article							BURKHOLDERIA-GLUMAE; GRAIN ROT; TEMPERATURE; YIELDS	Bacterial panicle blight (BPB) caused by Burkholderia glumae is one of the main concerns for rice production in the Americas since bacterial infection can interfere with the grain-filling process and under severe conditions can result in high sterility. B. glumae has been detected in several rice-growing areas of Colombia and other countries of Central and Andean regions in Latin America, although evidence of its involvement in decreasing yield under these conditions is lacking. Analysis of different parameters in trials established in three rice-growing areas showed that, despite BPB presence, severity did not explain the sterility observed in fields. PCR tests for B. glumae confirmed low infection in all sites and genotypes, only 21.4% of the analyzed samples were positive for B. glumae. Climate parameters showed that Monteria and Saldana registered maximum temperature above 34 degrees C, minimum temperature above 23 degrees C, and Relative Humidity above 80%, conditions that favor the invasion model described for this pathogen in Asia. Our study found that in Colombia, minimum temperature above 23 degrees C during 10 days after flowering is the condition that correlates with disease incidence. Therefore, this correlation, and the fact that Monteria and Saldana had a higher level of infected samples according to PCR tests, high minimum temperature, but not maximum temperature, seems to be determinant for B. glumae colonization under studied field conditions. This knowledge is a solid base line to design strategies for disease control, and is also a key element for breeders to develop strategies aimed to decrease the effect of B. glumae and high night-temperature on rice yield under tropical conditions.	[Echeverri-Rico, Johanna; Garces, Gabriel; Perafan, Ricardo; Amezquita, Nelson; Toro, Shirley] Fedearroz FNA Bogota, Bogota, Colombia; [Petro, Eliel; Fory, Paola A.; Mosquera, Gloria M.; Lobaton, Juan D.; Mora, Brayan; Cuasquer, Juan B.; Ramirez-Villegas, Julian; Rebolledo, Maria Camila; Torres, Edgar A.] Int Ctr Trop Agr CIAT, Agrobiodivers Res Area, Cali, Colombia; [Lang, Jillian M.; Leach, Jan E.] Colorado State Univ, Dept Agr Biol, Ft Collins, CO 80523 USA; [Ramirez-Villegas, Julian] CIAT, CGIAR Res Program Climate Change Agr & Food Secur, Cali, Colombia; [Rebolledo, Maria Camila] CIRAD, UMR AGAP, F-34398 Montpellier, France; [Rebolledo, Maria Camila] Univ Montpellier, AGAP, CIRAD, INRA,Montpellier SupAgro, Montpellier, France; [Torres, Edgar A.] RiceTec LTDA, Porto Alegre, RS, Brazil	Alliance; International Center for Tropical Agriculture - CIAT; Colorado State University; Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; CIRAD; Universite de Montpellier; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Mosquera, GM (corresponding author), Int Ctr Trop Agr CIAT, Agrobiodivers Res Area, Cali, Colombia.	g.m.mosquera@cgiar.org		Petro Paez, Eliel E./0000-0002-0577-6532	Colombian Ministry of Science [556-2013]; Global Rice Science Partnership (GRiSP); Climate Services for Resilient Development (CSRD)-United States Agency for International Development (USAID) Award [AIDBFS-G-11-00002-10]; CGIAR Fund [MTO 069018]; Climate Change, Agriculture and Food Security (CCAFS) project Agroclimas; CGIAR	Colombian Ministry of Science; Global Rice Science Partnership (GRiSP); Climate Services for Resilient Development (CSRD)-United States Agency for International Development (USAID) Award(CGIAR); CGIAR Fund(CGIAR); Climate Change, Agriculture and Food Security (CCAFS) project Agroclimas; CGIAR(CGIAR)	This research was supported by the Colombian Ministry of Science (formerly COLCIENCIAS), contract 556-2013, and the Global Rice Science Partnership (GRiSP). JR-V is supported by the Climate Services for Resilient Development (CSRD)-United States Agency for International Development (USAID) Award#AIDBFS-G-11-00002-10 toward the CGIAR Fund (MTO 069018), and the Climate Change, Agriculture and Food Security (CCAFS) project Agroclimas (http://bit.ly/2i3V0Nh).CCAFS is carried out with support from CGIAR Fund donors and through bilateral funding agreements (https://ccafs.cgiar.org/donors).For details, please visit https://ccafs.cgiar.org/donors.	Baek I, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9051027; Cha K.H., 2001, INFLUENCE WEATHER CO, P150; Cottyn B, 1996, PLANT DIS, V80, P429, DOI 10.1094/PD-80-0429; Cui ZQ, 2016, RICE SCI, V23, P111, DOI 10.1016/j.rsci.2016.01.007; Delerce S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161620; Diago M, 2009, REV ARROZ, V57, P30; Echeverri J., 2019, REV ARROZ, V67, P18; Echeverri J, 2017, ESTUDIO RELACION ENT; Fory PA, 2014, PHYTOPATHOLOGY, V104, P436, DOI 10.1094/PHYTO-07-13-0186-R; Goto K., 1956, ANN PHYTOPATHOL SOC, V21, P46; Goto M., 1992, FUNDAMENTALS BACTERI; Ham JH, 2011, MOL PLANT PATHOL, V12, P329, DOI 10.1111/j.1364-3703.2010.00676.x; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Jagadish SVK, 2010, CROP SCI, V50, P1633, DOI 10.2135/cropsci2009.09.0516; Juanillas V, 2019, GIGASCIENCE, V8, P1; Karim S, 2019, PLANT DIS, V103, P2893, DOI 10.1094/PDIS-10-18-1819-RE; Kurita T, 1964, ANN PHYTOPATHOL SOC, V29; Lee YH, 2015, PLANT PATHOLOGY J, V31, P350, DOI 10.5423/PPJ.OA.07.2015.0136; Mulaw T., 2018, American Journal of Plant Sciences, V9, P667, DOI 10.4236/ajps.2018.94053; Noh T, 2004, PLANT RESOUR, V7, P36; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Perez C, 2011, REV VENT CAMPO ANDIN, V15, P131; Pinson SRM, 2010, CROP SCI, V50, P1287, DOI 10.2135/cropsci2008.07.0447; Ray DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6989; Shew AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219199; Tsushima S, 1996, JARQ-JPN AGR RES Q, V30, P85; Tsushima Seiya, 1995, Annals of the Phytopathological Society of Japan, V61, P419, DOI 10.3186/jjphytopath.61.419; UEMATSU T, 1976, Annals of the Phytopathological Society of Japan, V42, P310, DOI 10.3186/jjphytopath.42.310; van Groenigen KJ, 2013, NAT CLIM CHANGE, V3, P288, DOI [10.1038/nclimate1712, 10.1038/NCLIMATE1712]; Weerakoon WMW, 2008, J AGRON CROP SCI, V194, P135, DOI 10.1111/j.1439-037X.2008.00293.x; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Yoshida S., 1981, IRRI RES PAP SER; Zeigler R. S., 1989, Plant Disease, V73, P368, DOI 10.1094/PD-73-0368B; Zhu B, 2008, RICE SCI, V15, P145, DOI 10.1016/S1672-6308(08)60033-5	34	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252061	10.1371/journal.pone.0252061	http://dx.doi.org/10.1371/journal.pone.0252061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038435	Green Published, gold			2022-12-26	WOS:000664633500043
J	Henson, JH; Samasa, B; Shuster, CB; Wikramanayake, AH				Henson, John H.; Samasa, Bakary; Shuster, Charles B.; Wikramanayake, Athula H.			The nanoscale organization of the Wnt signaling integrator Dishevelled in the vegetal cortex domain of an egg and early embryo	PLOS ONE			English	Article							SEA-URCHIN EGG; NUCLEAR BETA-CATENIN; MYOSIN-II; LIGHT-CHAIN; C-ELEGANS; AXIS; ACTIN; ENDODERM; POLARITY; SPECIFICATION	Canonical Wnt/beta -catenin (cWnt) signaling is a crucial regulator of development and Dishevelled (Dsh/Dvl) functions as an integral part of this pathway by linking Wnt binding to the Frizzled:LRP5/6 receptor complex with beta -catenin-stimulated gene expression. In many cell types Dsh has been localized to ill-defined cytoplasmic puncta, however in sea urchin eggs and embryos confocal fluorescence microscopy has shown that Dsh is localized to puncta present in a novel and development-essential vegetal cortex domain (VCD). In the present study, we used super-resolution light microscopy and platinum replica transmission electron microscopy (TEM) to provide the first views of the ultrastructural organization of Dsh within the sea urchin VCD. 3D structured illumination microscopy (SIM) imaging of isolated egg cortices demonstrated the graded distribution of Dsh in the VCD, whereas higher resolution stimulated emission depletion (STED) imaging revealed that some individual Dsh puncta consisted of more than one fluorescent source. Platinum replica immuno-TEM localization showed that Dsh puncta on the cytoplasmic face of the plasma membrane consisted of aggregates of pedestal-like structures each individually labeled with the C-terminus specific Dsh antibody. These aggregates were resistant to detergent extraction and treatment with drugs that disrupt actin filaments or inhibit myosin II contraction, and coexisted with the first cleavage actomyosin contractile ring. These results confirm and extend previous studies and reveal, for the first time in any cell type, the nanoscale organization of plasma membrane tethered Dsh. Our current working hypothesis is that these Dsh pedestals represent a prepositioned scaffold organization that is important for the localized activation of the cWnt pathway at the sea urchin vegetal pole. These observations in sea urchins may also be relevant to the submembranous Dsh puncta present in other eggs and embryos.	[Henson, John H.; Samasa, Bakary] Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA; [Henson, John H.; Samasa, Bakary; Shuster, Charles B.] Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA; [Shuster, Charles B.] New Mexico State Univ, Dept Biol, Las Cruces, NM USA; [Wikramanayake, Athula H.] Univ Miami, Dept Biol, Coral Gables, FL USA	Dickinson College; University of Washington; New Mexico State University; University of Miami	Henson, JH (corresponding author), Dickinson Coll, Dept Biol, Carlisle, PA 17013 USA.; Henson, JH (corresponding author), Univ Washington, Friday Harbor Labs, Friday Harbor, WA 98250 USA.	henson@dickinson.edu			National Science Foundation [MCB-1917976, MCB-1917983]	National Science Foundation(National Science Foundation (NSF))	Funding from collaborative National Science Foundation (www.nsf.gov) grants to J.H.H. (MCB-1917976) and C.B.S. (MCB-1917983). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer LM, 2000, DEV BIOL, V218, P1, DOI 10.1006/dbio.1999.9553; Belton RJ, 2001, MOL REPROD DEV, V59, P294, DOI 10.1002/mrd.1034; Bienz M, 2014, TRENDS BIOCHEM SCI, V39, P487, DOI 10.1016/j.tibs.2014.08.006; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Croce J, 2011, DEVELOPMENT, V138, P3297, DOI 10.1242/dev.058792; Croce JC, 2006, SEMIN CELL DEV BIOL, V17, P168, DOI 10.1016/j.semcdb.2006.04.004; Croce JC, 2006, DEV BIOL, V300, P121, DOI 10.1016/j.ydbio.2006.08.045; Gammons M, 2018, CURR OPIN CELL BIOL, V51, P42, DOI 10.1016/j.ceb.2017.10.008; Gammons MV, 2016, J CELL SCI, V129, P3892, DOI 10.1242/jcs.195685; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Henson JH, 2019, METHOD CELL BIOL, V151, P419, DOI 10.1016/bs.mcb.2019.01.005; HENSON JH, 1988, DEV BIOL, V127, P338, DOI 10.1016/0012-1606(88)90320-X; Henson JH, 2017, MOL BIOL CELL, V28, P613, DOI 10.1091/mbc.E16-06-0466; Henson JH, 2015, MOL BIOL CELL, V26, P887, DOI 10.1091/mbc.E14-07-1244; Kan W, 2020, ELIFE, V9, DOI 10.7554/eLife.55015; Kumburegama Shalika, 2008, V469, P187, DOI 10.1007/978-1-60327-469-2_14; Leonard JD, 2007, DEV BIOL, V306, P50, DOI 10.1016/j.ydbio.2007.02.041; Lhomond G, 2012, DEVELOPMENT, V139, P816, DOI 10.1242/dev.072215; Logan CY, 1999, DEVELOPMENT, V126, P345; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lucero A, 2006, MOL BIOL CELL, V17, P4093, DOI 10.1091/mbc.E06-02-0119; Ma WZ, 2020, P NATL ACAD SCI USA, V117, P16690, DOI 10.1073/pnas.1910547117; Miller JR, 1999, J CELL BIOL, V146, P427, DOI 10.1083/jcb.146.2.427; Miyoshi H, 2006, CELL MOTIL CYTOSKEL, V63, P208, DOI 10.1002/cm.20118; Mlodzik M, 2016, CURR TOP DEV BIOL, V117, P75, DOI 10.1016/bs.ctdb.2015.11.027; Moorhouse KS, 2015, DEV DYNAM, V244, P1469, DOI [10.1002/DVDY.24337, 10.1002/dvdy.24337]; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Peng CFJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080693; SARDET C, 1984, DEV BIOL, V105, P196, DOI 10.1016/0012-1606(84)90275-6; Schaefer KN, 2019, DEV CELL, V48, P429, DOI 10.1016/j.devcel.2019.01.025; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Sharma M, 2018, CELL SIGNAL, V47, P52, DOI 10.1016/j.cellsig.2018.03.004; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Snead WT, 2019, MOL CELL, V76, P295, DOI 10.1016/j.molcel.2019.09.016; Stamateris RE, 2010, GENE EXPR PATTERNS, V10, P60, DOI 10.1016/j.gep.2009.10.004; Svitkina T, 2007, METHOD CELL BIOL, V79, P295, DOI 10.1016/S0091-679X(06)79012-4; Svitkina T, 2016, METHODS MOL BIOL, V1365, P99, DOI 10.1007/978-1-4939-3124-8_5; Tadjuidje E, 2011, DEV DYNAM, V240, P1727, DOI 10.1002/dvdy.22671; TERASAKI M, 1995, J CELL SCI, V108, P2293; Torres MA, 2000, J CELL BIOL, V149, P1433, DOI 10.1083/jcb.149.7.1433; TRIMMER JS, 1986, ANNU REV CELL BIOL, V2, P1; Uehara R, 2008, CELL MOTIL CYTOSKEL, V65, P100, DOI 10.1002/cm.20246; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Weaver C, 2004, DEVELOPMENT, V131, P3491, DOI 10.1242/dev.01284; Weitzel HE, 2004, DEVELOPMENT, V131, P2947, DOI 10.1242/dev.01152; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045	51	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0248197	10.1371/journal.pone.0248197	http://dx.doi.org/10.1371/journal.pone.0248197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038442	gold, Green Published			2022-12-26	WOS:000664633500007
J	Taguchi, Y; Turki, T				Taguchi, Y-h.; Turki, Turki			Unsupervised tensor decomposition-based method to extract candidate transcription factors as histone modification bookmarks in post-mitotic transcriptional reactivation	PLOS ONE			English	Article							MITOTIC BOOKMARKING; DIFFERENTIAL PEAKS; ACTIVE GENES; BINDING; ACTIVATION; PROTEIN	The histone group added to a gene sequence must be removed during mitosis to halt transcription during the DNA replication stage of the cell cycle. However, the detailed mechanism of this transcription regulation remains unclear. In particular, it is not realistic to reconstruct all appropriate histone modifications throughout the genome from scratch after mitosis. Thus, it is reasonable to assume that there might be a type of "bookmark" that retains the positions of histone modifications, which can be readily restored after mitosis. We developed a novel computational approach comprising tensor decomposition (TD)-based unsupervised feature extraction (FE) to identify transcription factors (TFs) that bind to genes associated with reactivated histone modifications as candidate histone bookmarks. To the best of our knowledge, this is the first application of TD-based unsupervised FE to the cell division context and phases pertaining to the cell cycle in general. The candidate TFs identified with this approach were functionally related to cell division, suggesting the suitability of this method and the potential of the identified TFs as bookmarks for histone modification during mitosis.	[Taguchi, Y-h.] Chuo Univ, Dept Phys, Tokyo, Japan; [Turki, Turki] King Abdulaziz Univ, Dept Comp Sci, Jeddah, Saudi Arabia	Chuo University; King Abdulaziz University	Taguchi, Y (corresponding author), Chuo Univ, Dept Phys, Tokyo, Japan.	tag@granular.com	Taguchi, Y-h./E-1474-2011	Taguchi, Y-h./0000-0003-0867-8986	KAKENHI [19H05270, 20K12067, 20H04848]; Deanship of Scientific Research (DSR) at King Abdulazi University, Jeddah [KEP-8-611-38]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Deanship of Scientific Research (DSR) at King Abdulazi University, Jeddah	This study was supported by KAKENHI 19H05270, 20K12067, 20H04848. This project was also funded by the Deanship of Scientific Research (DSR) at King Abdulazi University, Jeddah, under grant no. KEP-8-611-38.	Allhoff M, 2014, BIOINFORMATICS, V30, P3467, DOI 10.1093/bioinformatics/btu722; Bellec Maelle, 2018, Curr Opin Syst Biol, V11, P41, DOI 10.1016/j.coisb.2018.08.003; Chen L, 2015, BIOINFORMATICS, V31, P1889, DOI 10.1093/bioinformatics/btv094; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Festuccia N, 2017, DEVELOPMENT, V144, P3633, DOI 10.1242/dev.146522; Festuccia N, 2016, NAT CELL BIOL, V18, P1139, DOI 10.1038/ncb3418; Ha GH, 2007, CANCER RES, V67, P7155, DOI 10.1158/0008-5472.CAN-06-3392; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; John S, 1998, BIOESSAYS, V20, P275, DOI 10.1002/(SICI)1521-1878(199804)20:4<275::AID-BIES1>3.3.CO;2-6; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kala K, 2009, DEVELOPMENT, V136, P253, DOI 10.1242/dev.029900; Kang Hyeseon, 2020, Genes Dev, V34, P913, DOI 10.1101/gad.335794.119; KATO R, 1994, NUCLEIC ACIDS RES, V22, P3104, DOI 10.1093/nar/22.15.3104; Kim JB, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006750; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liang K, 2012, BIOINFORMATICS, V28, P121, DOI 10.1093/bioinformatics/btr605; Liu B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S8-S3; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Mahony S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003501; Martin-Hurtado A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50356-0; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; RCore Team, 2020, R LANG ENV STAT COMP; Schweikert G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-826; Shafer MER, 2017, STEM CELL REP, V8, P1018, DOI 10.1016/j.stemcr.2017.02.004; Shandilya J, 2015, CELL CYCLE, V14, P1358, DOI 10.1080/15384101.2015.1021525; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Shen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065598; Song QA, 2011, BIOINFORMATICS, V27, P870, DOI 10.1093/bioinformatics/btr030; Stark R., 2011, R PACKAGE VERSION; Steinhauser S, 2016, BRIEF BIOINFORM, V17, P953, DOI 10.1093/bib/bbv110; Taguchi Y., 2020, UNSUPERVISED FEATURE, DOI [10.1007/978-3-030-22456-1, DOI 10.1007/978-3-030-22456-1]; Taguchi Y, 2020, GENES-BASEL, V11, DOI 10.3390/genes11121493; Taguchi YH, 2017, IEEE INT C BIOINF BI, P131, DOI 10.1109/BIBE.2017.00029; Teves SS, 2016, ELIFE, V5, DOI 10.7554/eLife.22280; Tu Shiqi, 2017, [Quantitative Biology, 定量生物学], V5, P226; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Wang FW, 2013, TRENDS CELL BIOL, V23, P175, DOI 10.1016/j.tcb.2012.11.005; Wu DY, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00169; Xing HY, 2005, SCIENCE, V307, P421, DOI 10.1126/science.1106478; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5; Zaidi SK, 2018, MOL CANCER RES, V16, P1617, DOI 10.1158/1541-7786.MCR-18-0415; Zhang YX, 2014, BIOINFORMATICS, V30, P2568, DOI 10.1093/bioinformatics/btu372; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251032	10.1371/journal.pone.0251032	http://dx.doi.org/10.1371/journal.pone.0251032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34032804	Green Submitted, Green Published, gold			2022-12-26	WOS:000664633100005
J	Zhang, FF; Tang, XF; Fan, S; Liu, X; Sun, J; Ju, C; Liang, YP; Liu, RF; Zhou, RH; Yu, B; Zhang, CH; Zhang, ZP; Kang, TB; Huang, GF; Lv, XB				Zhang, Feifei; Tang, Xiaofeng; Fan, Song; Liu, Xia; Sun, Jun; Ju, Cheng; Liang, Yiping; Liu, Renfeng; Zhou, Ruihao; Yu, Bo; Zhang, Changhua; Zhang, Zhiping; Kang, Tiebang; Huang, Guofu; Lv, Xiao-Bin			Targeting the p300/NONO axis sensitizes melanoma cells to BRAF inhibitors	ONCOGENE			English	Article							STRAND BREAK REPAIR; ACQUIRED-RESISTANCE; DRIVES RESISTANCE; RAF KINASE; NONO; MECHANISM; P54(NRB); PROTEIN; GROWTH; SWITCH	BRAF inhibitors (BRAFi) that target BRAF V600E kinase, a driver mutation found in 50% of melanomas, show a significant antitumor response, but the common emergence of acquired resistance remains a challenge. Abnormal expression of RAF isoforms CRAF and ARAF reactivates pERK1/2, which plays crucial roles in the acquisition of resistance of melanoma cells. However, the mechanisms of dysregulation of RAF isoforms in resistant melanoma cells remain unknown. Here, we identified NONO interacted with and stabilized both CRAF and ARAF in melanoma cells, and that NONO was acetylated at 198K by p300 acetyltransferase, which stabilized NONO via antagonizing its ubiquitination/degradation mediated by RNF8. The upregulation of both p300 and NONO promoted the rebound of pERK1/2 and the subsequent resistance of melanoma cells to BRAFi, and the activation of ERK1/2 in turn induced p300 to form a positive feedback loop in resistant melanoma cells. There was a positive correlation between p300 and NONO in resistant melanoma cells and clinical samples, and p300 inhibitor C646 overcame the resistance of resistant melanoma cells to BRAF inhibitors in vitro and in vivo. Our findings reveal that targeting the positive feedback loop of p300-NONO-CRAF/ARAF-pERK1/2 may be excellent strategies to overcome the resistance of BRAF inhibitors for melanoma patients.	[Zhang, Feifei; Tang, Xiaofeng; Sun, Jun; Ju, Cheng; Liang, Yiping; Liu, Renfeng; Zhou, Ruihao; Yu, Bo; Zhang, Zhiping; Lv, Xiao-Bin] Nanchang Univ, Cent Lab, Jiangxi Key Lab Canc Metastasis & Precis Treatmen, Affiliated Hosp 3, Nanchang, Jiangxi, Peoples R China; [Fan, Song] Sun Yat Sen Univ, Dept Oral & Maxillofacial Surg, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China; [Liu, Xia] South China Univ Technol, Guangzhou Peoples Hosp 1, Sch Med, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China; [Sun, Jun; Zhang, Changhua] Jiangxi Univ Tradit Chinese Med, Coll Pharm, Nanchang, Jiangxi, Peoples R China; [Ju, Cheng; Liu, Renfeng; Yu, Bo; Zhang, Zhiping] Nanchang Univ, Dept Orthoped, Affiliated Hosp 3, Nanchang, Jiangxi, Peoples R China; [Kang, Tiebang] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Huang, Guofu] Nanchang Univ, Affiliated Hosp 3, Dept Ophthalmol, Nanchang, Jiangxi, Peoples R China	Nanchang University; Sun Yat Sen University; South China University of Technology; Jiangxi University of Traditional Chinese Medicine; Nanchang University; State Key Lab Oncology South China; Sun Yat Sen University; Nanchang University	Lv, XB (corresponding author), Nanchang Univ, Cent Lab, Jiangxi Key Lab Canc Metastasis & Precis Treatmen, Affiliated Hosp 3, Nanchang, Jiangxi, Peoples R China.; Huang, GF (corresponding author), Nanchang Univ, Affiliated Hosp 3, Dept Ophthalmol, Nanchang, Jiangxi, Peoples R China.	hgf2222@sina.com; nclvxiaobin@sina.cn			National Natural Science Foundation of China [81672866, 81960501, 81560452, 81760552]; Natural Science Foundation of Jiangxi Province [20202BAB206041, 20161BAB205192, 20171ACB21073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81672866, 81960501 and 81560452 to XBL; No. 81760552 to XT); the Natural Science Foundation of Jiangxi Province (No. 20202BAB206041; Nos. 20161BAB205192 and 20171ACB21073 to XBL).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alfano L, 2016, ONCOGENE, V35, P567, DOI 10.1038/onc.2015.107; Alfano L, 2018, J CELL PHYSIOL, V233, P4338, DOI 10.1002/jcp.26269; Audrito V, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx198; Corre S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06951-2; Deshar R, 2019, NUCLEIC ACIDS RES, V47, P762, DOI 10.1093/nar/gky1166; Diaz-Martinez M, 2018, CANCER RES, V78, P1017, DOI 10.1158/0008-5472.CAN-17-1318; Feng PF, 2020, J CELL MOL MED, V24, P4368, DOI 10.1111/jcmm.15141; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Holderfield M, 2014, NAT REV CANCER, V14, P455, DOI 10.1038/nrc3760; Hu ZX, 2020, HEPATOLOGY, V72, P548, DOI 10.1002/hep.31062; Jaafar L, 2017, NUCLEIC ACIDS RES, V45, P1848, DOI 10.1093/nar/gkw1209; Janostiak R, 2019, ISCIENCE, V16, P453, DOI 10.1016/j.isci.2019.06.001; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307; Karoulia Z, 2017, NAT REV CANCER, V17, P676, DOI 10.1038/nrc.2017.79; Knott GJ, 2016, NUCLEIC ACIDS RES, V44, P3989, DOI 10.1093/nar/gkw271; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Li SY, 2014, NUCLEIC ACIDS RES, V42, P9771, DOI 10.1093/nar/gku650; Li SY, 2009, NUCLEIC ACIDS RES, V37, P6746, DOI 10.1093/nar/gkp741; Liu MH, 2016, ONCOTARGET, V7, P84951, DOI 10.18632/oncotarget.13069; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ohanna M, 2018, GENE DEV, V32, P448, DOI 10.1101/gad.305854.117; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Qin YY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw9960; Saei A, 2018, J EXP MED, V215, P1913, DOI 10.1084/jem.20171960; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Talebi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04664-0; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Zhang KX, 2016, J CANCER RES THER, V12, pC131, DOI 10.4103/0973-1482.200613; Zhu Z, 2016, ONCOGENE, V35, P1399, DOI 10.1038/onc.2015.197	38	4	5	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4137	4150		10.1038/s41388-021-01834-1	http://dx.doi.org/10.1038/s41388-021-01834-1		MAY 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34017080				2022-12-26	WOS:000652439200001
J	Qader, GQ; Seddiq, MK; Rashidi, KM; Manzoor, L; Hamim, A; Akhgar, MH; Rahman, L; Dryer, S; Boyd-Boffa, M; Somji, A; Melese, M; Suarez, PG				Qader, Ghulam Qader; Seddiq, Mohammad Khaled; Rashidi, Khakerah Mohammad; Manzoor, Lutfullah; Hamim, Azizullah; Akhgar, Mir Habibullah; Rahman, Laiqullrahman; Dryer, Sean; Boyd-Boffa, Mariah; Somji, Aleefia; Melese, Muluken; Suarez, Pedro Guillermo			Prevalence of latent tuberculosis infection among health workers in Afghanistan: A cross-sectional study	PLOS ONE			English	Article							CARE WORKERS; SKIN-TEST; ISONIAZID PROPHYLAXIS; OCCUPATIONAL RISK	Background About 26% of the world's population may have latent tuberculosis infection (LTBI). Health care workers are a high-risk category because of their professional exposure. Methods This cross-sectional study assessed the LTBI burden among health care workers in Afghanistan, a high-TB-burden country. We selected health facilities using a systematic sampling technique and invited all workers at the targeted health facilities to participate. Participants were interviewed about sociodemographic and exposure variables and received tuberculin skin tests for LTBI. Results Of the 4,648 health care workers invited to participate, 3,686 had tuberculin skin tests. The prevalence of LTBI was found to be 47.2% (1,738 workers). Multivariate analysis showed that a body mass index of >= 30 and marriage were associated with an increased risk of LTBI. Underweight (body mass index of <= 18 and below) and normal body mass index had no association with increased risk of LTBI. Conclusion LTBI is high among health care workers in Afghanistan. We recommend instituting infection control measures in health facilities and screening workers for timely TB diagnosis.	[Qader, Ghulam Qader; Rashidi, Khakerah Mohammad; Hamim, Azizullah] Challenge TB Project, Management Sci Hlth, Kabul, Afghanistan; [Seddiq, Mohammad Khaled; Manzoor, Lutfullah; Akhgar, Mir Habibullah; Rahman, Laiqullrahman] Minist Publ Hlth, Natl TB Program, Kabul, Afghanistan; [Dryer, Sean; Somji, Aleefia; Melese, Muluken; Suarez, Pedro Guillermo] Management Sci Hlth, Arlington, VA USA; [Boyd-Boffa, Mariah] Management Sci Hlth, Medford, MA USA		Qader, GQ (corresponding author), Challenge TB Project, Management Sci Hlth, Kabul, Afghanistan.	gqader@gmail.com	Suarez, Pedro G/AAD-2278-2019	Suarez, Pedro G/0000-0001-9825-1761	United States Agency for International Development (USAID) [AID-OAA-A-1400029]; Global Fund to Fight AIDS, Tuberculosis and Malaria	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Global Fund to Fight AIDS, Tuberculosis and Malaria	The United States Agency for International Development (USAID) funded this study through the Challenge TB project under cooperative agreement number AID-OAA-A-1400029, and the Global Fund to Fight AIDS, Tuberculosis and Malaria provided funding for this study. The contents of the article are the responsibility of the authors alone and do not necessarily reflect the views of USAID or the US government, or the Global Fund. The publication fee is covered by the USAID funded Sustainable Technical and Analytic Resources (STAR) project, through Public Health Institute (PHI).	Adams S, 2015, EUR RESPIR J, V45, P1364, DOI 10.1183/09031936.00138414; Agaya J, 2015, TROP MED INT HEALTH, V20, P1797, DOI 10.1111/tmi.12601; Anuradha R, 2016, CLIN VACCINE IMMUNOL, V23, P339, DOI 10.1128/CVI.00009-16; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Belo C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2516-4; Bozkanat E, 2016, J PAK MED ASSOC, V66, P270; Cauthen GM, 2002, B WORLD HEALTH ORGAN, V80, P503; Christopher DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026199; Cohn DL, 2000, AM J RESP CRIT CARE, V161, pS221; COMSTOCK GW, 1967, AM REV RESPIR DIS, V95, P935; Dubuis M, 2004, INT J TUBERC LUNG D, V8, P1065; EI-Sokkary RH, 2015, CENT EUR J PUBL HEAL, V23, P324; Fox GJ, 2017, INT J INFECT DIS, V56, P68, DOI 10.1016/j.ijid.2016.11.006; Grobler L, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1601-5; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Illowsky B, 2018, SENIOR CONTRIBUTING, P467; Janagond AB, 2017, INT J MYCOBACT, V6, P253, DOI 10.4103/ijmy.ijmy_82_17; Jesudas Christopher Devasahayam, 2013, Indian J Chest Dis Allied Sci, V55, P149; Jo KW, 2013, TUBERC RESPIR DIS, V75, P18, DOI 10.4046/trd.2013.75.1.18; Kasprowicz VO, 2011, J INFECT DIS, V204, pS1168, DOI 10.1093/infdis/jir449; Kassim S, 2000, INT J TUBERC LUNG D, V4, P321; Kayanja HK, 2005, INT J TUBERC LUNG D, V9, P686; Khawcharoenporn T, 2011, INT J TUBERC LUNG D, V15, P14; Kizza FN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0904-1; Lacerda TC, 2017, J BRAS PNEUMOL, V43, P416, DOI [10.1590/S1806-37562016000000211, 10.1590/s1806-37562016000000211]; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Nasehi M, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017002; Nasreen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164034; Ncayiyana JR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1989-x; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Rafiza S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-19; Saag LA, 2018, INT J TUBERC LUNG D, V22, P358, DOI 10.5588/ijtld.17.0558; Sawanyawisuth Kittisak, 2009, J Occup Med Toxicol, V4, P20, DOI 10.1186/1745-6673-4-20; Sherman HA, 2011, INT J TUBERC LUNG D, V15, P1050, DOI 10.5588/ijtld.10.0344; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; van Rie A, 2013, SAMJ S AFR MED J, V103, P853, DOI [10.7196/samj.7092, 10.7196/SAMJ.7092]; WHO, 2009, WHO POL TB INF CONTR; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2018, LAT TUB INF UPD CONS; Yoon CG, 2017, J KOREAN MED SCI, V32, P1251, DOI 10.3346/jkms.2017.32.8.1251; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066412; Zhou F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104673	43	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252307	10.1371/journal.pone.0252307	http://dx.doi.org/10.1371/journal.pone.0252307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061873	gold, Green Published			2022-12-26	WOS:000656813600041
J	Goswami, S; Balasubramanian, I; D'Agostino, L; Bandyopadhyay, S; Patel, R; Avasthi, S; Yu, SY; Goldenring, JR; Bonder, EM; Gao, N				Goswami, Sayantani; Balasubramanian, Iyshwarya; D'Agostino, Luca; Bandyopadhyay, Sheila; Patel, Radha; Avasthi, Shail; Yu, Shiyan; Goldenring, James R.; Bonder, Edward M.; Gao, Nan			RAB11A-mediated YAP localization to adherens and tight junctions is essential for colonic epithelial integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; SIGNALING-PATHWAY; CONTACT INHIBITION; HIPPO PATHWAY; TUMOR-SUPPRESSOR; MECHANOTRANSDUCERS YAP; SUBSTRATUM STIFFNESS; WNT/BETA-CATENIN; ALPHA-CATENIN; BETA-CATENIN	Within the intestinal epithelium, regulation of intracellular protein and vesicular trafficking is of utmost importance for barrier maintenance, immune responses, and tissue polarity. RAB11A is a small GTPase that mediates the anterograde transport of protein cargos to the plasma membrane. Loss of RAB11A-dependent trafficking in mature intestinal epithelial cells results in increased epithelial proliferation and nuclear accumulation of Yes-associated protein (YAP), a key Hippo-signaling transducer that senses cell-cell contacts and regulates tissue growth. However, it is unclear how RAB11A regulates YAP intracellular localizations. In this report, we examined the relationship of RAB11A to epithelial junctional complexes, YAP, and the associated consequences on colonic epithelial tissue repair. We found that RAB11A controls the biochemical associations of YAP with multiple components of adherens and tight junctions, including alpha-catenin, beta-catenin, and Merlin, a tumor suppressor. In the absence of RAB11A and Merlin, we observed enhanced YAP-beta-catenin complex formation and nuclear translocation. Upon chemical injury to the intestine, mice deficient in RAB11A were found to have reduced epithelial integrity, decreased YAP localization to adherens and tight junctions, and increased nuclear YAP accumulation in the colon epithelium. Thus, RAB11A-regulated trafficking regulates the Hippo-YAP signaling pathway for rapid reparative response after tissue injury.	[Goswami, Sayantani; Balasubramanian, Iyshwarya; D'Agostino, Luca; Bandyopadhyay, Sheila; Patel, Radha; Avasthi, Shail; Yu, Shiyan; Bonder, Edward M.; Gao, Nan] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Goldenring, James R.] Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, Dept Surg, Nashville, TN 37212 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Vanderbilt University	Gao, N (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA.	ngao@rutgers.edu		Bonder, Edward/0000-0001-6463-9143; Goldenring, James/0000-0002-7833-2940; Gao, Nan/0000-0003-4264-7438	National Institutes of Health (NIH) [DK102934, AT010243, DK119198]; National Science Foundation/Division of Biological Infrastructure [1952823]; Rutgers University-Newark Chancellor's Initiative for Multidisciplinary Research Teams award; Rutgers University-Newark School of Arts & Sciences-Newark research funds [DK48370]; New Jersey Commission on Cancer Research fellowships [DFHS16PPC038, DFHS17PPC036]; NIH [F31 DK121428]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation/Division of Biological Infrastructure(National Science Foundation (NSF)); Rutgers University-Newark Chancellor's Initiative for Multidisciplinary Research Teams award; Rutgers University-Newark School of Arts & Sciences-Newark research funds; New Jersey Commission on Cancer Research fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Yue Liu, Juan Flores, and Brian G. Ayee for their help with experimental procedures. This work was supported by the National Institutes of Health (NIH) grants DK102934, AT010243, DK119198 as well as National Science Foundation/Division of Biological Infrastructure grant 1952823. This work was supported by a Rutgers University-Newark Chancellor's Initiative for Multidisciplinary Research Teams award to N. G.; Rutgers University-Newark School of Arts & Sciences-Newark research funds to E. M. B.; DK48370 to J. R. G.; New Jersey Commission on Cancer Research fellowships DFHS16PPC038 to S. G.; and DFHS17PPC036 to S. B. S. B. is currently supported by an NIH F31 DK121428. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bosco EE, 2010, ONCOGENE, V29, P2540, DOI 10.1038/onc.2010.20; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; D'Agostino L, 2019, CANCER RES, V79, P4099, DOI 10.1158/0008-5472.CAN-18-4075; Das S, 2015, DEVELOPMENT, V142, P2147, DOI 10.1242/dev.121046; Deng FH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0244-8; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ehmer U, 2016, MOL CANCER RES, V14, P127, DOI 10.1158/1541-7786.MCR-15-0305; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Feng Q, 2017, J CELL SCI, V130, P2491, DOI 10.1242/jcs.201897; Feng Q, 2015, J CELL PHYSIOL, V230, P1170, DOI 10.1002/jcp.24853; Furukawa KT, 2017, CELL REP, V20, P1435, DOI 10.1016/j.celrep.2017.07.032; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kakar-Bhanot R, 2019, HUM REPROD, V34, P519, DOI 10.1093/humrep/dey365; Karaman R, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028753; Kim JH, 2009, P NATL ACAD SCI USA, V106, P11149, DOI 10.1073/pnas.0812651106; Kim M, 2014, BMB REP, V47, P540, DOI 10.5483/BMBRep.2014.47.10.177; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Knowles BC, 2015, J CELL SCI, V128, P1617, DOI 10.1242/jcs.163303; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Lapierre LA, 2012, MOL BIOL CELL, V23, P2302, DOI 10.1091/mbc.E11-08-0681; Le J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33014; Li ZQ, 2012, J BIOL CHEM, V287, P13005, DOI 10.1074/jbc.M112.347419; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; McMurray RJ, 2015, J TISSUE ENG REGEN M, V9, P528, DOI 10.1002/term.1957; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Nardone G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15321; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Pocaterra A, 2020, J CELL SCI, V133, DOI 10.1242/jcs.230425; Prahallad A, 2016, ONCOGENE, V35, P1073, DOI 10.1038/onc.2015.151; Qiao YT, 2017, CELL REP, V19, P1495, DOI 10.1016/j.celrep.2017.04.075; Radler PD, 2017, MOL CELL ENDOCRINOL, V451, P31, DOI 10.1016/j.mce.2017.04.025; Raghunathan VK, 2013, INVEST OPHTH VIS SCI, V54, P378, DOI 10.1167/iovs.12-11007; Rausch V, 2020, TRENDS CELL BIOL, V30, P32, DOI 10.1016/j.tcb.2019.10.005; Rosado-Olivieri EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09404-6; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Seo J, 2018, BMB REP, V51, P151, DOI 10.5483/BMBRep.2018.51.3.012; Sobajima T, 2015, BIOL OPEN, V4, P86, DOI 10.1242/bio.20148532; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thomasy SM, 2013, EXP EYE RES, V113, P66, DOI 10.1016/j.exer.2013.05.014; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; XU TA, 1995, DEVELOPMENT, V121, P1053; Yan ZB, 2016, ARTERIOSCL THROM VAS, V36, P339, DOI 10.1161/ATVBAHA.115.306549; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zhang Y, 2016, ONCOL REP, V36, P3619, DOI 10.3892/or.2016.5194; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	81	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100848	10.1016/j.jbc.2021.100848	http://dx.doi.org/10.1016/j.jbc.2021.100848			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058200	gold, Green Published			2022-12-26	WOS:000678068400048
J	Ilnytska, O; Lai, K; Gorshkov, K; Schultz, ML; Tran, BN; Jeziorek, M; Kunkel, TJ; Azaria, RD; McLoughlin, HS; Waghalter, M; Xu, Y; Schlame, M; Altan-Bonnet, N; Zheng, W; Lieberman, AP; Dobrowolski, R; Storch, J				Ilnytska, Olga; Lai, Kimberly; Gorshkov, Kirill; Schultz, Mark L.; Tran, Bruce Nguyen; Jeziorek, Maciej; Kunkel, Thaddeus J.; Azaria, Ruth D.; McLoughlin, Hayley S.; Waghalter, Miriam; Xu, Yang; Schlame, Michael; Altan-Bonnet, Nihal; Zheng, Wei; Lieberman, Andrew P.; Dobrowolski, Radek; Storch, Judith			Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID SPHINGOMYELINASE ACTIVITY; LYSOBISPHOSPHATIDIC ACID; IMPAIRED AUTOPHAGY; MEMBRANE-LIPIDS; C2 PROTEIN; TRAFFICKING; DISEASE; NPC1; TRANSPORT; IDENTIFICATION	Niemann-Pick C (NPC) is an autosomal recessive disorder characterized by mutations in the NPC1 or NPC2 genes encoding endolysosomal lipid transport proteins, leading to cholesterol accumulation and autophagy dysfunction. We have previously shown that enrichment of NPC1-deficient cells with the anionic lipid lysobisphosphatidic acid (LBPA; also called bis(monoacylglycerol)phosphate) via treatment with its precursor phosphatidylglycerol (PG) results in a dramatic decrease in cholesterol storage. However, the mechanisms underlying this reduction are unknown. In the present study, we showed using biochemical and imaging approaches in both NPC1-deficient cellular models and an NPC1 mouse model that PG incubation/LBPA enrichment significantly improved the compromised autophagic flux associated with NPC1 disease, providing a route for NPC1-independent endolysosomal cholesterol mobilization. PG/LBPA enrichment specifically enhanced the late stages of autophagy, and effects were mediated by activation of the lysosomal enzyme acid sphingomyelinase. PG incubation also led to robust and specific increases in LBPA species with polyunsaturated acyl chains, potentially increasing the propensity for membrane fusion events, which are critical for late-stage autophagy progression. Finally, we demonstrated that PG/LBPA treatment efficiently cleared cholesterol and toxic protein aggregates in Purkinje neurons of the NPC1(I1061T) mouse model. Collectively, these findings provide a mechanistic basis supporting cellular LBPA as a potential new target for therapeutic intervention in NPC disease.	[Ilnytska, Olga; Lai, Kimberly; Waghalter, Miriam; Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Ilnytska, Olga; Dobrowolski, Radek; Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Gorshkov, Kirill; Tran, Bruce Nguyen; Zheng, Wei] Natl Ctr Adv Translat Sci, NIH, Bethesda, MD USA; [Schultz, Mark L.; Kunkel, Thaddeus J.; Azaria, Ruth D.; Lieberman, Andrew P.] Univ Michigan, Dept Pathol, Med Sch, Ann Arbor, MI 48109 USA; [Jeziorek, Maciej; Dobrowolski, Radek] Rutgers State Univ, Dept Biol Sci, Newark, NJ USA; [McLoughlin, Hayley S.] Univ Michigan, Dept Neurol, Med Sch, Ann Arbor, MI USA; [Xu, Yang; Schlame, Michael] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Xu, Yang; Schlame, Michael] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Altan-Bonnet, Nihal] NHLBI, Lab Host Pathogen Dynam, Bldg 10, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Michigan System; University of Michigan; Rutgers State University Newark; Rutgers State University New Brunswick; University of Michigan System; University of Michigan; New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ilnytska, O; Storch, J (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA.; Ilnytska, O; Storch, J (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA.	ilnytska@sebs.rutgers.edu; storch@sebs.rutgers.edu	Zheng, Wei/GQQ-8951-2022; Zheng, Wei/GOE-5990-2022; Gorshkov, Kirill/W-2188-2019; Zheng, Wei/J-8889-2014	Gorshkov, Kirill/0000-0002-4652-8818; Zheng, Wei/0000-0003-1034-0757; Azaria, Ruth/0000-0002-1686-2591; Ilnytska, Olga/0000-0003-0807-9158; Nguyen Tran, Bruce/0000-0002-8786-1481; Schultz, Mark/0000-0002-3149-4424; McLoughlin, Hayley/0000-0003-4279-2758	Ara Parseghian Medical Research Foundation; American Heart Association [14GRNT19990014, 18CDA34110230]; Niemann-Pick Canada; U.S. National Institutes of Health [R01 NS063967, R01 AG062475, R56 AG061040, R01 GM1125866]	Ara Parseghian Medical Research Foundation; American Heart Association(American Heart Association); Niemann-Pick Canada; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funds from the Ara Parseghian Medical Research Foundation to O. I., an American Heart Association career development grant 18CDA34110230 to O. I., an American Heart Association Grant-inAid 14GRNT19990014 to J. S., Niemann-Pick Canada to M. L. S., Hope for Marian to M. L. S., and U.S. National Institutes of Health R01 NS063967 to A. P. L., R01 AG062475 and R56 AG061040 to R. D. and R01 GM1125866 to J. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdul-Hammed M, 2010, J LIPID RES, V51, P1747, DOI 10.1194/jlr.M003822; Bedia C, 2010, J LIPID RES, V51, P3542, DOI 10.1194/jlr.D010033; Bissig C, 2013, DEV CELL, V25, P364, DOI 10.1016/j.devcel.2013.04.003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borbon IA, 2011, J APPL GENET, V52, P213, DOI 10.1007/s13353-010-0021-1; BROTHERUS J, 1977, J LIPID RES, V18, P191; Carriere F, 2020, BIOCHIMIE, V179, P237, DOI 10.1016/j.biochi.2020.05.013; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chapuy-Regaud S, 2013, BIOCHIMIE, V95, P1677, DOI 10.1016/j.biochi.2013.05.019; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Corcelle-Termeau E, 2016, AUTOPHAGY, V12, P833, DOI 10.1080/15548627.2016.1159378; Dai S, 2017, AUTOPHAGY, V13, P1435, DOI 10.1080/15548627.2017.1329081; Dai S, 2016, J BIOMOL SCREEN, V21, P1112, DOI 10.1177/1087057116670068; Dany M, 2016, BLOOD, V128, P1944, DOI 10.1182/blood-2016-04-708750; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Elrick MJ, 2012, HUM MOL GENET, V21, P4876, DOI 10.1093/hmg/dds324; Falguieres T, 2009, EXP CELL RES, V315, P1567, DOI 10.1016/j.yexcr.2008.12.006; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Guan ZQ, 2007, BIOCHEMISTRY-US, V46, P14500, DOI 10.1021/bi701907g; Hoglinger D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12152-2; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P1, DOI 10.1016/j.jasms.2003.08.006; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ilnytska O, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158916; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2017, ELIFE, V6, DOI 10.7554/eLife.25466; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lee H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6514; Li J, 2017, METHODS MOL BIOL, V1583, P85, DOI 10.1007/978-1-4939-6875-6_8; Li J, 2016, ELIFE, V5, DOI 10.7554/eLife.21635; Li X, 2014, J MOL MED, V92, P473, DOI 10.1007/s00109-014-1120-y; Li XC, 2016, P NATL ACAD SCI USA, V113, P10079, DOI 10.1073/pnas.1611956113; Li XC, 2016, P NATL ACAD SCI USA, V113, P8212, DOI 10.1073/pnas.1607795113; Lim CY, 2019, NAT CELL BIOL, V21, P1206, DOI 10.1038/s41556-019-0391-5; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Maarup TJ, 2015, MOL GENET METAB, V116, P75, DOI 10.1016/j.ymgme.2015.07.001; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Maetzel D, 2014, STEM CELL REP, V2, P866, DOI 10.1016/j.stemcr.2014.03.014; Manni MM, 2018, ELIFE, V7, DOI 10.7554/eLife.34394; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McCauliff LA, 2019, ELIFE, V8, DOI 10.7554/eLife.50832; McCauliff LA, 2015, J BIOL CHEM, V290, P27321, DOI 10.1074/jbc.M115.667469; McCauliff LA, 2011, BIOCHEMISTRY-US, V50, P7341, DOI 10.1021/bi200574f; McLoughlin HS, 2018, ANN NEUROL, V84, P64, DOI 10.1002/ana.25264; Meneses-Salas E, 2020, CELL MOL LIFE SCI, V77, P2839, DOI 10.1007/s00018-019-03330-y; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mobius W, 2003, TRAFFIC, V4, P222; Moreau D, 2019, EMBO REP, V20, DOI 10.15252/embr.201847055; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nesslauer AM, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1088-2; Oninla VO, 2014, J LIPID RES, V55, P2606, DOI 10.1194/jlr.M054528; Ordonez YF, 2019, J AM CHEM SOC, V141, P7736, DOI 10.1021/jacs.8b11687; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Park H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093369; Pasqual G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002232; Pfeffer SR, 2019, J BIOL CHEM, V294, P1706, DOI 10.1074/jbc.TM118.004165; Pfisterer SG, 2016, CURR OPIN LIPIDOL, V27, P282, DOI 10.1097/MOL.0000000000000292; Pfrieger FW, 2018, J LIPID RES, V59, P2255, DOI 10.1194/jlr.R084210; Piazza GJ, 2007, J AM OIL CHEM SOC, V84, P645, DOI 10.1007/s11746-007-1081-1; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Pipalia NH, 2019, FASEB J, V33; Praggastis M, 2015, J NEUROSCI, V35, P8091, DOI 10.1523/JNEUROSCI.4173-14.2015; Reagan JM, 2000, J BIOL CHEM, V275, P38104, DOI 10.1074/jbc.M005296200; Riethmuller J, 2009, CELL PHYSIOL BIOCHEM, V24, P65, DOI 10.1159/000227814; Rosato AS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13572-w; Sanman LE, 2016, CELL CHEM BIOL, V23, P793, DOI 10.1016/j.chembiol.2016.05.019; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; STANACEV NZ, 1967, J BIOL CHEM, V242, P3018; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; THORNBURG T, 1991, J BIOL CHEM, V266, P6834; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Vats S, 2019, MOL BIOL CELL, V30, P2283, DOI 10.1091/mbc.E18-08-0482; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Ward S, 2010, PEDIATR RES, V68, P52, DOI [10.1203/PDR.0b013e3181df4623, 10.1203/00006450-201011001-00099]; Wheeler S, 2019, NEUROBIOL DIS, V127, P242, DOI 10.1016/j.nbd.2019.03.005; Wijdeven RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11808; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Xu M, 2016, FRONT BIOSCI-LANDMRK, V21, P696, DOI 10.2741/4415; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u; Yu DZ, 2014, J BIOMOL SCREEN, V19, P1164, DOI 10.1177/1087057114537378; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang XL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000252	104	9	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100813	10.1016/j.jbc.2021.100813	http://dx.doi.org/10.1016/j.jbc.2021.100813			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023384	Green Published, gold			2022-12-26	WOS:000678068400016
J	Mattila, SO; Tuhkanen, HE; Lackman, JJ; Konzack, A; Morato, X; Argerich, J; Saftig, P; Ciruela, F; Petaja-Repo, UE				Mattila, S. Orvokki; Tuhkanen, Hanna E.; Lackman, Jarkko J.; Konzack, Anja; Morato, Xavier; Argerich, Josep; Saftig, Paul; Ciruela, Francisco; Petaja-Repo, Ulla E.			GPR37 is processed in the N-terminal ectodomain by ADAM10 and furin	FASEB JOURNAL			English	Article						ADAM; GPR37; G protein-coupled receptor (GPCR); furin; shedding	PROTEIN-COUPLED RECEPTOR; CELL-SURFACE EXPRESSION; SUBCELLULAR-LOCALIZATION; PROPROTEIN CONVERTASES; CLEAVAGE; SUBSTRATE; DISINTEGRIN; METALLOPROTEASE; PROTEOLYSIS; MECHANISMS	GPR37 is an orphan G protein-coupled receptor (GPCR) implicated in several neurological diseases and important physiological pathways in the brain. We previously reported that its long N-terminal ectodomain undergoes constitutive metalloprotease-mediated cleavage and shedding, which have been rarely described for class A GPCRs. Here, we demonstrate that the protease that cleaves GPR37 at Glu167 down arrow Gln168 is a disintegrin and metalloprotease 10 (ADAM10). This was achieved by employing selective inhibition, RNAi-mediated downregulation, and genetic depletion of ADAM10 in cultured cells as well as in vitro cleavage of the purified receptor with recombinant ADAM10. In addition, the cleavage was restored in ADAM10 knockout cells by overexpression of the wild type but not the inactive mutant ADAM10. Finally, postnatal conditional depletion of ADAM10 in mouse neuronal cells was found to reduce cleavage of the endogenous receptor in the brain cortex and hippocampus, confirming the physiological relevance of ADAM10 as a GPR37 sheddase. Additionally, we discovered that the receptor is subject to another cleavage step in cultured cells. Using site-directed mutagenesis, the site (Arg54 down arrow Asp55) was localized to a highly conserved region at the distal end of the ectodomain that contains a recognition site for the proprotein convertase furin. The cleavage by furin was confirmed by using furin-deficient human colon carcinoma LoVo cells and proprotein convertase inhibitors. GPR37 is thus the first multispanning membrane protein that has been validated as an ADAM10 substrate and the first GPCR that is processed by both furin and ADAM10. The unconventional N-terminal processing may represent an important regulatory element for GPR37.	[Mattila, S. Orvokki; Tuhkanen, Hanna E.; Lackman, Jarkko J.; Konzack, Anja; Petaja-Repo, Ulla E.] Univ Oulu, Res Unit Biomed, Med Res Ctr Oulu, FI-90014 Oulu, Finland; [Morato, Xavier; Argerich, Josep; Ciruela, Francisco] Univ Barcelona, Fac Med & Ciencies Salut, Dept Patol & Terapeut Expt, Unitat Farmacol,IDIBELL, Barcelona, Spain; [Saftig, Paul] Univ Kiel, Inst Biochem, Kiel, Germany; [Ciruela, Francisco] Univ Barcelona, Inst Neurociencies, Barcelona, Spain; [Morato, Xavier] Int Univ Catalunya UIC, Inst Catala Neurociencies Aplicades, Res Ctr & Memory Clin, Fundacio ACE, Barcelona, Spain	University of Oulu; University of Barcelona; University of Kiel; University of Barcelona; Universitat Internacional de Catalunya (UIC)	Petaja-Repo, UE (corresponding author), Univ Oulu, Res Unit Biomed, Med Res Ctr Oulu, FI-90014 Oulu, Finland.	ulla.petaja-repo@oulu.fi	Petäjä-Repo, Ulla/AAV-6115-2021; Morató, Xavier/ABF-8667-2021; Saftig, Paul/A-7966-2010	Morató, Xavier/0000-0002-3012-2864; Konzack, Anja/0000-0001-9758-6164; Lackman, Jarkko/0000-0002-0422-5157	Orion Research Foundation; Finnish Concordia Fund; Magnus Ehrnrooth Foundation; Oskar Oflunds Stiftelse; FEBS; FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion [SAF2017-87349-R]; Catalan government [2017 SGR 1604]; Academy of Finland [295140]; Deutscher Forschungsgemeinschaft [SFB877-A3]	Orion Research Foundation; Finnish Concordia Fund; Magnus Ehrnrooth Foundation; Oskar Oflunds Stiftelse; FEBS; FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion(Spanish Government); Catalan government; Academy of Finland(Academy of Finland); Deutscher Forschungsgemeinschaft	Orion Research Foundation; Finnish Concordia Fund; Magnus Ehrnrooth Foundation; Oskar Oflunds Stiftelse; FEBS; Deutscher Forschungsgemeinschaft, Grant/Award Number: SFB877-A3; FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion, Grant/Award Number: SAF2017-87349-R; Catalan government, Grant/Award Number: 2017 SGR 1604; Academy of Finland, Grant/Award Number: #295140	Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Coleman JLJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76384-9; Coleman JU, 2017, CELL SIGNAL, V33, P1, DOI 10.1016/j.cellsig.2017.02.004; Cork SM, 2012, ONCOGENE, V31, P5144, DOI 10.1038/onc.2012.1; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Bernard S, 1999, J BIOL CHEM, V274, P101, DOI 10.1074/jbc.274.1.101; El Buri Ashref, 2018, Oncotarget, V9, P29453, DOI 10.18632/oncotarget.25658; Fujita-Jimbo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051155; Fukuzawa T, 2006, J BIOCHEM, V140, P445, DOI 10.1093/jb/mvj170; Gandia J, 2013, J NEUROCHEM, V125, P362, DOI 10.1111/jnc.12196; Goth CK, 2017, J BIOL CHEM, V292, P4714, DOI 10.1074/jbc.M116.730614; Grantcharova E, 2002, J BIOL CHEM, V277, P43933, DOI 10.1074/jbc.M208407200; Grantcharova E, 2006, ARTERIOSCL THROM VAS, V26, P1288, DOI 10.1161/01.ATV.0000220377.51354.30; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hartmann M, 2015, J BIOL CHEM, V290, P17041, DOI 10.1074/jbc.M114.610204; Hertz E, 2019, NEUROPHARMACOLOGY, V152, P51, DOI 10.1016/j.neuropharm.2018.11.009; Heuberger DM, 2019, THROMB J, V17, DOI 10.1186/s12959-019-0194-8; Hsia HE, 2019, CELL MOL LIFE SCI, V76, P3055, DOI 10.1007/s00018-019-03173-7; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Imai Y, 2007, NEUROSCI RES, V59, P413, DOI 10.1016/j.neures.2007.08.005; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kim W, 2015, MOL CELL BIOL, V35, P3684, DOI 10.1128/MCB.00764-15; Klenk C, 2010, J BIOL CHEM, V285, P8665, DOI 10.1074/jbc.M109.058685; KOJRO E, 1995, J BIOL CHEM, V270, P6476, DOI 10.1074/jbc.270.12.6476; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Leskela TT, 2009, TRAFFIC, V10, P116, DOI 10.1111/j.1600-0854.2008.00846.x; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Lopes JP, 2015, J NEUROCHEM, V134, P135, DOI 10.1111/jnc.13109; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Marazziti D, 2007, P NATL ACAD SCI USA, V104, P9846, DOI 10.1073/pnas.0703368104; Mattila SO, 2016, J CELL SCI, V129, P1366, DOI 10.1242/jcs.176115; Meyer RC, 2014, BRAIN RES, V1585, P1, DOI 10.1016/j.brainres.2014.08.022; Morato X, 2021, TRANSL NEURODEGENER, V10, DOI 10.1186/s40035-021-00232-7; Morato X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10147-x; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Noben JP, 2006, J PROTEOME RES, V5, P1647, DOI 10.1021/pr0504788; Noy PJ, 2016, J BIOL CHEM, V291, P3145, DOI 10.1074/jbc.M115.703058; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Petaja-Repo UE, 2006, J BIOL CHEM, V281, P15780, DOI 10.1074/jbc.M602267200; Prox J, 2013, J NEUROSCI, V33, P12915, DOI 10.1523/JNEUROSCI.5910-12.2013; Rapoport B, 2016, ENDOCR REV, V37, P114, DOI [10.1210/er.2015-1098.2016.1, 10.1210/er.2015-1098]; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Sachan V, 2019, CELL DEATH DIFFER, V26, P1942, DOI 10.1038/s41418-018-0264-7; Saftig P, 2015, PROG NEUROBIOL, V135, P1, DOI 10.1016/j.pneurobio.2015.10.003; Sebastiano M, 2017, BLOOD, V129, P883, DOI 10.1182/blood-2016-06-724245; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Sjostedt E, 2020, SCIENCE, V367, P1090, DOI 10.1126/science.aay5947; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Tafesse FG, 2014, J BIOL CHEM, V289, P24005, DOI 10.1074/jbc.M114.589275; TAKAHASHI S, 1995, J BIOL CHEM, V270, P26565, DOI 10.1074/jbc.270.44.26565; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tomita Hiroaki, 2013, Frontiers in Genetics, V4, P297, DOI 10.3389/fgene.2013.00297; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; van den Berg CW, 2012, IMMUNOBIOLOGY, V217, P935, DOI 10.1016/j.imbio.2012.01.005; Yang HJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10884	64	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21654	10.1096/fj.202002385RR	http://dx.doi.org/10.1096/fj.202002385RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042202	Green Published			2022-12-26	WOS:000655695900033
J	Demirkiran, H; Kilic, M; Tomak, Y; Dalkiran, T; Yurttutan, S; Basaranoglu, M; Tuncer, O; Derme, T; Tekeli, AE; Bahar, I; Keskin, S; Oksuz, H				Demirkiran, Hilmi; Kilic, Mehmet; Tomak, Yakup; Dalkiran, Tahir; Yurttutan, Sadik; Basaranoglu, Murat; Tuncer, Oguz; Derme, Turan; Tekeli, Arzu Esen; Bahar, Ilhan; Keskin, Siddik; Oksuz, Hafize			Evaluation of the incidence, characteristics, and outcomes of pediatric chronic critical illness	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; LONG-STAY PATIENTS; PROLONGED MECHANICAL VENTILATION; QUALITY-OF-LIFE; ILL PATIENTS; EPIDEMIOLOGY; CHILDREN; PROFILE	Our aim was to determine characteristics of children with chronic critical illness (CCI) admitted to the pediatric intensive care unit (PICU) of a tertiary care children's hospital in Turkey. The current study was a multicenter retrospective cohort study that was done from 2014 to 2017. It involved three university hospitals PICUs in which multiple criteria were set to identify pediatric CCIs. Pediatric patients staying in the ICU for at least 14 days and having at least one additional criterion, including prolonged mechanical ventilation, tracheostomy, sepsis, severe wound (burn) or trauma, encephalopathy, traumatic brain injury, status epilepticus, being postoperative, and neuromuscular disease, was accepted as CCI. In order to identify the newborn as a chronic critical patient, a stay in the intensive care unit for at least 30 days in addition to prematurity was required. Eight hundred eighty seven (11.14%) of the patients who were admitted to the PICU met the definition of CCI and 775 of them (87.3%) were discharged to their home. Of CCI patients, 289 (32.6%) were premature and 678 (76.4%) had prolonged mechanical ventilation. The total cost values for 2017 were statistically higher than the other years. As the length of ICU stay increased, the costs also increased. Interestingly, high incidence rates were observed for PCCI in our hospitals and these patients occupied 38.01% of the intensive care bed capacity. In conclusion, we observed that prematurity and prolonged mechanical ventilation increase the length of ICU stay, which also increased the costs. More work is needed to better understand PCCI.	[Demirkiran, Hilmi; Tekeli, Arzu Esen] Van Yuzuncu Yil Univ, Dept Anesthesiol & Reanimat, Fac Med, Van, Turkey; [Kilic, Mehmet] Hisar Intercontinental Hosp, Dept Pediat, Istanbul, Turkey; [Tomak, Yakup] Sakarya Univ, Anesthesiol & Intens Care Unit, Fac Med, Sakarya, Turkey; [Dalkiran, Tahir] Necip Fazil City Hosp, Pediat Intens Care Unit, Kahramanmaras, Turkey; [Yurttutan, Sadik] Kahramanmaras Sutcu Imam Univ, Div Neonatol, Dept Pediat, Fac Med, Kahramanmaras, Turkey; [Basaranoglu, Murat; Tuncer, Oguz] Van Yuzuncu Yil Univ, Div Neonatol, Dept Pediat, Fac Med, Van, Turkey; [Derme, Turan] Univ Hlth Sci, Dept Pediat, Div Neonatol, Minist Hlth Ankara City Hosp, Ankara, Turkey; [Bahar, Ilhan] Izmir Katip Celebi Univ, Ataturk Training & Res Hosp, Internal Med Crit Care Unit, Izmir, Turkey; [Keskin, Siddik] Van Yuzuncu Yil Univ, Dept Biostat, Fac Med, Van, Turkey; [Oksuz, Hafize] Kahramanmaras Sutcu Imam Univ, Dept Anesthesiol & Reanimat, Fac Med, Kahramanmaras, Turkey	Yuzuncu Yil University; Sakarya University; Kahramanmaras Necip Fazil City Hospital; Kahramanmaras Sutcu Imam University; Yuzuncu Yil University; University of Health Sciences Turkey; Izmir Ataturk Training & Research Hospital; Izmir Katip Celebi University; Yuzuncu Yil University; Kahramanmaras Sutcu Imam University	Demirkiran, H (corresponding author), Van Yuzuncu Yil Univ, Dept Anesthesiol & Reanimat, Fac Med, Van, Turkey.	h.dkiran@hotmail.com		Demirkiran, Hilmi/0000-0001-8116-3933				Bagshaw SM, 2014, CAN MED ASSOC J, V186, pE95, DOI 10.1503/cmaj.130639; Carson SS, 2006, CURR OPIN CRIT CARE, V12, P405, DOI 10.1097/01.ccx.0000244118.08753.dc; Carson SS, 2012, RESP CARE, V57, P848, DOI 10.4187/respcare.01736; Chalom R, 1999, CRIT CARE MED, V27, P2079, DOI 10.1097/00003246-199910000-00001; Conlon NP, 2009, PEDIATR CRIT CARE ME, V10, P41, DOI 10.1097/PCC.0b013e31819371f6; Donohue PK, 2018, J PALLIAT MED, V21, P940, DOI 10.1089/jpm.2017.0397; Feudtner C, 2000, PEDIATRICS, V106, P205; Hardelid P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005331; Hirschfeld RS, 2019, PEDIATR CRIT CARE ME, V20, pE546, DOI 10.1097/PCC.0000000000002150; Hsu Benson S, 2015, S D Med, V68, P341; Ishihara T, 2019, BMJ PAEDIATR OPEN, V3, DOI 10.1136/bmjpo-2019-000499; Iwashyna TJ, 2015, CRIT CARE RESUSC, V17, P215; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kirk AHP, 2018, J PEDIATR INTENSIVE, V7, P1, DOI 10.1055/s-0037-1601337; Lone NI, 2011, CRIT CARE, V15, DOI 10.1186/cc10117; Loss Sergio Henrique, 2017, Rev. bras. ter. intensiva, V29, P87, DOI [10.5935/0103-507X.20170013, 10.5935/0103-507x.20170013]; MacIntyre NR, 2012, RESP CARE, V57, P1021, DOI 10.4187/respcare.01768; Marcin JP, 2001, CRIT CARE MED, V29, P652, DOI 10.1097/00003246-200103000-00035; Naghib S, 2010, INTENS CARE MED, V36, P131, DOI 10.1007/s00134-009-1693-z; Namachivayam P, 2012, PEDIATR CRIT CARE ME, V13, P520, DOI 10.1097/PCC.0b013e31824fb989; Namachivayam SP, 2015, CRIT CARE MED, V43, P1978, DOI 10.1097/CCM.0000000000001076; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Pearson G, 2001, INTENS CARE MED, V27, P1670, DOI 10.1007/s001340101072; Peltoniemi OM, 2016, PEDIATR CRIT CARE ME, V17, pE43, DOI 10.1097/PCC.0000000000000587; Peterson-Carmichael SL, 2012, RESP CARE, V57, P993, DOI 10.4187/respcare.01738; Rennick JE, 2015, PEDIATRICS, V135, pE289, DOI 10.1542/peds.2014-2174; Rose L., 2019, CRIT CARE EXPLOR, V1, P0005, DOI [10.1097/cce.0000000000000005, 10.1097/CCE.0000000000000005]; Rose L, 2014, CAN RESPIR J, V21, P287, DOI 10.1155/2014/484835; Sauthier M, 2017, RESP CARE, V62, P49, DOI 10.4187/respcare.04881; Shapiro Miriam C, 2017, Hosp Pediatr, V7, P236, DOI 10.1542/hpeds.2016-0107; van der Heide P, 2004, ACTA PAEDIATR, V93, P1070, DOI 10.1080/08035250410027580; Walter JK, 2013, PEDIATRICS, V131, pS90, DOI 10.1542/peds.2012-1427k; Wiencek C, 2010, AACN ADV CRIT CARE, V21, P44, DOI 10.1097/NCI.0b013e3181c6a162	33	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0248883	10.1371/journal.pone.0248883	http://dx.doi.org/10.1371/journal.pone.0248883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048449	Green Published, gold			2022-12-26	WOS:000664636100004
J	Hohenberger, TL; Che, WW; Fung, JCH; Lau, AKH				Hohenberger, Tilman Leo; Che, Wenwei; Fung, Jimmy C. H.; Lau, Alexis K. H.			A proposed population-health based metric for evaluating representativeness of air quality monitoring in cities: Using Hong Kong as a demonstration	PLOS ONE			English	Article							SPATIAL REPRESENTATIVENESS; MODEL; POLLUTION; EXPOSURE; STATIONS; EMISSIONS; NETWORK; SENSORS	City air quality monitoring (AQM) network are typically sparsely distributed due to high operation costs. It is of the question of how well it can reflect public health risks to air pollution given the diversity and heterogeneity in pollution, and spatial variations in population density. Combing high-resolution air quality model, spatial population distribution and health risk factors, we proposed a population-health based metric for AQM representativeness. This metric was demonstrated in Hong Kong using hourly modelling data of PM10, PM2.5, NO2 and O-3 in 2019 with grid cells of 45m * 48m. Individual and total hospital admission risks (%AR) of these pollutants were calculated for each cell, and compared with those calculated at 16 monitoring sites using the similarity frequency (SF) method. AQM Representativeness was evaluated by SF and a population-health based network representation index (PHNI), which is population-weighted SF over the study-domain. The representativeness varies substantially among sites as well as between population- and area-based evaluation methods, reflecting heterogeneity in pollution and population. The current AQM network reflects population health risks well for PM10 (PHNI = 0.87) and PM2.5 (PHNI = 0.82), but is less able to represent risks for NO2 (PHNI = 0.59) and O-3 (PHNI (=) 0.78). Strong seasonal variability in PHNI was found for PM, increasing by >11% during autumn and winter compared to summer due to regional transport. NO2 is better represented in urban than rural, reflecting the heterogeneity of urban traffic pollution. Combined health risk (%AR(total)) is well represented by the current AQM network (PHNI = 1), which is more homogenous due to the dominance and anti-correlation of NO2 and O-3 related %AR. The proposed PHNI metric is useful to compare the health risk representativeness of AQM for individual and multiple pollutants and can be used to compare the effectiveness of AQM across cities.	[Hohenberger, Tilman Leo; Che, Wenwei; Fung, Jimmy C. H.; Lau, Alexis K. H.] Hong Kong Univ Sci & Technol, Div Environm & Sustainabil, Clear Water Bay, Hong Kong, Peoples R China; [Fung, Jimmy C. H.] Hong Kong Univ Sci & Technol, Dept Math, Clear Water Bay, Hong Kong, Peoples R China; [Lau, Alexis K. H.] Hong Kong Univ Sci & Technol, Dept Civil & Environm Engn, Clear Water Bay, Hong Kong, Peoples R China; [Lau, Alexis K. H.] Hong Kong Univ Sci & Technol, Inst Environm, Clear Water Bay, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Che, WW (corresponding author), Hong Kong Univ Sci & Technol, Div Environm & Sustainabil, Clear Water Bay, Hong Kong, Peoples R China.	wenweiche@ust.hk	Lau, Alexis K/D-7914-2013; che, Wenwei/H-1987-2018	Lau, Alexis K/0000-0003-3802-828X; Hohenberger, Tilman Leo/0000-0002-4372-8750; Fung, Jimmy/0000-0002-7859-8511; che, Wenwei/0000-0002-1337-965X	National Natural Science Foundation of China [41703104]; University Grants Committee through the Hong Kong PhD Fellowship Scheme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University Grants Committee through the Hong Kong PhD Fellowship Scheme	Che received the National Natural Science Foundation of China 41703104 (http://www.nsfc.gov.cn/english/site_1/index.html).Lau received the HSBC 150th Anniversary Charity Programme through the PRAISE-HK project (https://www.about.hsbc.com.hk/-/media/hong-kong/en/hsbc-inhong-kong/community/160902-projlionprog-brochure.pdf).Hohenberger received the University Grants Committee through the Hong Kong PhD Fellowship Scheme (https://cerg1.ugc.edu.hk/hkpfs/index.html).	Acuto M, 2016, INT AFF, V92, P1147, DOI 10.1111/1468-2346.12700; Aikawa M, 2008, ENVIRON MONIT ASSESS, V136, P411, DOI 10.1007/s10661-007-9696-0; Baldacci S, 2015, RESP MED, V109, P1089, DOI 10.1016/j.rmed.2015.05.017; Beevers SD, 2013, J EXPO SCI ENV EPID, V23, P647, DOI 10.1038/jes.2013.6; Berry B.J.L., 2008, URBAN ECOLOGY INT PE, P25, DOI [10.1007/978-0-387-73412-5_3, DOI 10.1007/978-0-387-73412-5_3]; Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf; Bibri SE, 2017, SUSTAIN CITIES SOC, V31, P183, DOI 10.1016/j.scs.2017.02.016; Binkowski FS, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001409; Che WW, 2020, SUSTAIN CITIES SOC, V54, DOI 10.1016/j.scs.2019.101986; CHP, 2020, HONG KONG ANT WHOL S; D'amato G., 2010, J INVESTIG ALLERGOL; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Douglass M, 2002, ENVIRON URBAN, V14, P53, DOI 10.1177/095624780201400105; Duyzer J, 2015, ATMOS ENVIRON, V104, P88, DOI 10.1016/j.atmosenv.2014.12.067; EU, 2008, OFF J EUR UNION, V1, P1, DOI DOI 10.2766/14352; Gan WQ, 2012, ENVIRON RES, V116, P11, DOI 10.1016/j.envres.2012.04.001; Ghazali NA, 2010, ENVIRON MONIT ASSESS, V165, P475, DOI 10.1007/s10661-009-0960-3; Giffinger R, 2010, URBAN RES PRACT, V3, P299, DOI 10.1080/17535069.2010.524420; Hagan DH, 2018, ATMOS MEAS TECH, V11, P315, DOI 10.5194/amt-11-315-2018; Han SQ, 2011, AEROSOL AIR QUAL RES, V11, P128, DOI 10.4209/aaqr.2010.07.0055; Hao YF, 2018, ATMOS ENVIRON, V177, P222, DOI 10.1016/j.atmosenv.2018.01.011; Hijmans RJ., 2019, CRAN Repository; Hong Kong Census and Statistics Department, 2012, 2011 POP CENS SUMM R; Hong Kong Census and Statistics Department, 2020, HONG KONG STAT; Hong Kong Planning Department, 2018, LAND UT HONG KONG; Houyoux MR., 1999, PROC EMISS INVENT RE; Huang XHH, 2014, AEROSOL AIR QUAL RES, V14, P237, DOI 10.4209/aaqr.2013.01.0020; Janssen S, 2012, ATMOS ENVIRON, V59, P492, DOI 10.1016/j.atmosenv.2012.05.028; Kang DW, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010151; Kousa A, 2002, ATMOS ENVIRON, V36, P2109, DOI 10.1016/S1352-2310(02)00228-5; Li JR, 2019, ATMOS ENVIRON, V215, DOI 10.1016/j.atmosenv.2019.116894; Li TX, 2018, ENVIRON TECHNOL, V39, P1271, DOI 10.1080/09593330.2017.1327557; Lin CQ, 2016, REMOTE SENS ENVIRON, V179, P13, DOI 10.1016/j.rse.2016.03.023; Louie PKK, 2005, ATMOS ENVIRON, V39, P1695, DOI 10.1016/j.atmosenv.2004.11.017; Manisalidis I, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00014; Martin F, 2014, ATMOS POLLUT RES, V5, P779, DOI 10.5094/APR.2014.087; McHugh CA, 1997, INT J ENVIRON POLLUT, V8, P666; Mocerino L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57244-7; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Nappo CJ, 1982, B AM METEOROL SOC; Nyberg F, 2000, EPIDEMIOLOGY, V11, P487, DOI 10.1097/00001648-200009000-00002; Piersanti A, 2015, ATMOS POLLUT RES, V6, P953, DOI 10.1016/j.apr.2015.04.005; Placet M, 2000, ATMOS ENVIRON, V34, P2183, DOI 10.1016/S1352-2310(99)00464-1; Postolache OA, 2009, IEEE T INSTRUM MEAS, V58, P3253, DOI 10.1109/TIM.2009.2022372; Powers JG, 2017, B AM METEOROL SOC, V98, P1717, DOI 10.1175/BAMS-D-15-00308.1; Righini G, 2014, ATMOS ENVIRON, V97, P121, DOI 10.1016/j.atmosenv.2014.08.015; Rivas E, 2019, SCI TOTAL ENVIRON, V649, P1362, DOI 10.1016/j.scitotenv.2018.08.315; Rodriguez D, 2019, ATMOS ENVIRON-X, V1, DOI 10.1016/j.aeaoa.2019.100010; Sillman S., 2002, DEV ENV SCI, V1, P339, DOI DOI 10.1016/S1474-8177(02)80015-8; Snyder EG, 2013, ENVIRON SCI TECHNOL, V47, P11369, DOI 10.1021/es4022602; Stieb DM, 2008, J AIR WASTE MANAGE, V58, P435, DOI 10.3155/1047-3289.58.3.435; Sunyer J, 2001, EUR RESPIR J, V17, P1024, DOI 10.1183/09031936.01.17510240; van der Vliet A, 2011, BBA-GEN SUBJECTS, V1810, P1035, DOI 10.1016/j.bbagen.2011.03.004; Vitali L, 2016, ATMOS POLLUT RES, V7, P990, DOI 10.1016/j.apr.2016.06.002; Wai W. T., 2012, STAT MODEL, V13, P15; Wang Y, 2017, ATMOS CHEM PHYS, V17, P10919, DOI 10.5194/acp-17-10919-2017; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Wong TW, 2013, ATMOS ENVIRON, V76, P52, DOI 10.1016/j.atmosenv.2012.06.071; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; Yang K, 2020, SUSTAIN CITIES SOC, V59, DOI 10.1016/j.scs.2020.102180; Yang K, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114878; Yu T, 2018, INT J REMOTE SENS, V39, P6463, DOI 10.1080/01431161.2018.1460505; Yuan ZB, 2006, ATMOS ENVIRON, V40, P1803, DOI 10.1016/j.atmosenv.2005.11.030	63	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252290	10.1371/journal.pone.0252290	http://dx.doi.org/10.1371/journal.pone.0252290			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048462	gold, Green Published			2022-12-26	WOS:000664636100029
J	Xu, Y; Sun, LQ; Hu, JC; Xu, S				Xu, Yan; Sun, Liqin; Hu, Juncheng; Xu, Sai			Knockdown of hsa_circ_0001275 reverses dexamethasone-induced osteoblast growth inhibition via mediation of miR-377/CDKN1B axis	PLOS ONE			English	Article							INDUCED APOPTOSIS; CELLS; INJURY; MIRNA	Background Osteoporosis affects the quality of life among middle-aged and elderly individuals. In addition, dysfunction of osteoblasts can lead to the progression of osteoporosis. Circular (circ)RNAs are involved in various types of diseases, including osteoporosis. Moreover, it has been reported that hsa_circ_0001275 expression is upregulated in osteoporosis. However, the effects of hsa_circ_0001275 on the growth of osteoblasts remain unclear. Methods In the present study, the gene and protein expression levels in hFOB1.19 cells were detected via reverse transcription-quantitative (RT-qPCR) and western blot analyses, respectively. In addition, alkaline phosphatase (ALP) activity and calcium nodules were examined by ALP and alizarin red staining, respectively. Cell proliferation was measured using the Cell Counting Kit-8 assay. Cell apoptosis and cell cycle were analyzed by flow cytometry. Furthermore, dual luciferase reporter and RNA pull-down assay were used to confirm the association among hsa_circ_0001275, microRNA (miR)-377 and CDKN1B. Results DEX-induced hFOB1.19 cell growth inhibition was significantly reversed by silencing hsa_circ_0001275. Moreover, DEX significantly increased ALP activity and calcium nodules in hFOB1.19 cells, while this effect was significantly reversed in the presence of hsa_circ_0001275 small interfering RNA. In addition, miR-377 was sponged by hsa_circ_0001275 and CDKN1B was directly targeted by miR-377 in hFOB1.19 cells. Furthermore, the therapeutic effect of hsa_circ_0001275 knockdown on osteoporosis was notably reversed by miR-377 antagomir. Conclusion The data demonstrated that knockdown of hsa_circ_0001275 reversed DEX-induced osteoblast growth inhibition via activation of the miR-377/CDKN1B axis. Therefore, this study might shed new lights on the treatment of osteoporosis.	[Xu, Yan; Sun, Liqin; Hu, Juncheng; Xu, Sai] First Peoples Hosp Fuyang Dist, Dept Endocrinol, Hangzhou, Zhejiang, Peoples R China		Xu, Y (corresponding author), First Peoples Hosp Fuyang Dist, Dept Endocrinol, Hangzhou, Zhejiang, Peoples R China.	xuyanxuyan1234@126.com						Annalisa Palmieri, 2008, J Oral Sci, V50, P301, DOI 10.2334/josnusd.50.301; Arjmand B, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00430; Bauer O, 2015, MOL CELL BIOL, V35, P1097, DOI 10.1128/MCB.01106-14; Cai FZ, 2020, CANCER BIOTHER RADIO, DOI 10.1089/cbr.2019.3538; Choi HK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030506; Das S, 2020, FASEB J, V34, P11925, DOI 10.1096/fj.202000754R; Demongeot J, 2020, CR BIOL, V343, P111, DOI 10.5802/crbiol.1; Duan LJ, 2017, BIOCHEM BIOPH RES CO, V484, P598, DOI 10.1016/j.bbrc.2017.01.145; El-Daly SM, 2020, APPL BIOCHEM BIOTECH, V192, P1208, DOI 10.1007/s12010-020-03378-8; Fan JB, 2019, MOL CELL BIOCHEM, V460, P113, DOI 10.1007/s11010-019-03575-y; Han DD, 2019, FREE RADICAL BIO MED, V137, P1, DOI 10.1016/j.freeradbiomed.2019.04.014; Hsiao CY, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00613; Ji F, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00470; Jiang CY, 2020, CANCER BIOMARK; Khalil HE, 2020, PLANTS-BASEL, V9; Li Y, 2020, GLOBAL CHANGE BIOL, V26, P3065, DOI 10.1111/gcb.15002; Lian YF, 2019, THERANOSTICS, V9, P8392, DOI 10.7150/thno.36838; Moon H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010004; Palmieri A, 2008, BIO-MED MATER ENG, V18, P91, DOI 10.3233/BME-2008-0512; Palmieri A, 2007, J BIOMED SCI, V14, P777, DOI 10.1007/s11373-007-9193-z; Palmieri Annalisa, 2008, J Oral Implantol, V34, P190, DOI 10.1563/0.869.1; Palmieri A, 2010, INT J PERIODONT REST, V30, P83; Palmieri Annalisa, 2008, J Prosthodont, V17, P522, DOI 10.1111/j.1532-849X.2008.00331.x; Suzuki T, 2020, J BONE MINER METAB, V38, P859, DOI 10.1007/s00774-020-01118-w; Tamarindo GH, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158766; Tao S, 2021, J CONTROL RELEASE, V329, P121, DOI 10.1016/j.jconrel.2020.11.059; Wang D, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152558; Wang J, 2020, AGING-US, V12, P14885, DOI 10.18632/aging.103550; Wei XX, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02857-4; Xie MW, 2020, DOSE-RESPONSE, V18, DOI 10.1177/1559325820936124; Xu GP, 2020, TECHNOL CANCER RES T, V19, DOI 10.1177/1533033820980117; Xu RY, 2018, AGING CELL, V17, DOI 10.1111/acel.12794; Xu RY, 2016, EXP GERONTOL, V84, P71, DOI 10.1016/j.exger.2016.09.001; Xu Y, 2020, NANO LETT, V20, P2558, DOI 10.1021/acs.nanolett.9b05340; Yalan Sun, 2020, Panminerva Med, DOI 10.23736/S0031-0808.20.03957-9; Yang SR, 2020, FASEB J, V34, P13284, DOI 10.1096/fj.202001326R; Yang XC, 2019, AGING-US, V11, P8777, DOI 10.18632/aging.102264; Yu DD, 2015, INT J MOL MED, V36, P345, DOI 10.3892/ijmm.2015.2258; Yuan Y, 2019, INT J SPORTS MED, V40, P931, DOI 10.1055/a-1015-0285; Zhao KW, 2018, CELL PHYSIOL BIOCHEM, V46, P2508, DOI 10.1159/000489657; Zheng JW, 2020, J CELL PHYSIOL, DOI 10.1002/jcp.29527; Zhou WY, 2020, EXP PHYSIOL, V105, P2141, DOI 10.1113/EP088399; Zhou ZW, 2020, MOL BIOL REP, V47, P5773, DOI 10.1007/s11033-020-05646-6; Zhu JW, 2019, MOL MED REP, V20, P3160, DOI 10.3892/mmr.2019.10569	44	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252126	10.1371/journal.pone.0252126	http://dx.doi.org/10.1371/journal.pone.0252126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043680	gold, Green Published			2022-12-26	WOS:000664635700056
J	Ben Lagha, A; Huacho, PM; Grenier, D				Ben Lagha, Amel; Huacho, Patricia Maquera; Grenier, Daniel			A cocoa (Theobroma cacao L.) extract impairs the growth, virulence properties, and inflammatory potential of Fusobacterium nucleatum and improves oral epithelial barrier function	PLOS ONE			English	Article							NF-KAPPA-B; ANTIINFLAMMATORY PROPERTIES; IDENTIFICATION; INTERLEUKIN-6; PATHOGENESIS; POLYPHENOLS; MODULATION; EXPRESSION; MEDIATORS; APOPTOSIS	Fusobacterium nucleatum is associated with many conditions and diseases, including periodontal diseases that affect tooth-supporting tissues. The aim of the present study was to investigate the effects of a cocoa extract (Theobroma cacao L.) on F. nucleatum with respect to growth, biofilm formation, adherence, and hydrogen sulfide (H2S) production. The anti-inflammatory properties and the effect on epithelial barrier function of the cocoa extract were also assessed. The cocoa extract, whose major phenolic compound is epicatechin, dose-dependently inhibited the growth, biofilm formation, adherence properties (basement membrane matrix, oral epithelial cells), and H2S production of F. nucleatum. It also decreased IL-6 and IL-8 production by F. nucleatum-stimulated oral epithelial cells and inhibited F. nucleatum-induced NF-kappa B activation in monocytes. Lastly, the cocoa extract enhanced the barrier function of an oral epithelial model by increasing the transepithelial electrical resistance. We provide evidence that the beneficial properties of an epicatechin-rich cocoa extract may be useful for preventing and/or treating periodontal diseases.	[Ben Lagha, Amel; Huacho, Patricia Maquera; Grenier, Daniel] Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada	Laval University	Grenier, D (corresponding author), Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Huacho, Patricia Milagros Maquera/AAG-2458-2020; Grenier, Daniel/E-5557-2015	Huacho, Patricia Milagros Maquera/0000-0002-2193-9979; Grenier, Daniel/0000-0003-0878-4674	DG 2021 Laboratoire de Controle microbiologique of Universite Laval	DG 2021 Laboratoire de Controle microbiologique of Universite Laval	DG 2021 Laboratoire de Controle microbiologique of Universite Laval The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrian E, 2004, INFECT IMMUN, V72, P4689, DOI 10.1128/IAI.72.8.4689-4698.2004; Andujar I, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/906252; Ben Lagha A, 2017, J PERIODONTAL RES, V52, P458, DOI 10.1111/jre.12411; Ben Lagha A, 2020, PHYTOTHER RES, V34, P886, DOI 10.1002/ptr.6574; Bitzer ZT, 2015, J NUTR BIOCHEM, V26, P827, DOI 10.1016/j.jnutbio.2015.02.007; Bodet C, 2006, J DENT RES, V85, P235, DOI 10.1177/154405910608500306; Brennan CA, 2019, NAT REV MICROBIOL, V17, P156, DOI 10.1038/s41579-018-0129-6; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chen WL, 2010, BIOCHEM BIOPH RES CO, V391, P645, DOI 10.1016/j.bbrc.2009.11.113; Coppenhagen-Glazer S, 2015, INFECT IMMUN, V83, P1104, DOI 10.1128/IAI.02838-14; Curtis MA, 2020, PERIODONTOL 2000, V83, P14, DOI 10.1111/prd.12296; Dahlen G, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091339; Darveau RP, 2009, DNA CELL BIOL, V28, P389, DOI 10.1089/dna.2009.0864; De Araujo QR, 2016, CRIT REV FOOD SCI, V56, P1, DOI 10.1080/10408398.2012.657921; Dixon DR, 2004, PERIODONTOL 2000, V35, P53, DOI 10.1111/j.0906-6713.2004.003556.x; Dudonne S, 2014, J AGR FOOD CHEM, V62, P3244, DOI 10.1021/jf404965z; Gaetti-Jardim E, 1999, MICROBIOLOGICA, V22, P63; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gilchrist EP, 2000, ORAL SURG ORAL MED O, V90, P340, DOI 10.1067/moe.2000.107360; Graziani F, 2017, PERIODONTOL 2000, V75, P152, DOI 10.1111/prd.12201; Groger S, 2008, J PERIODONTAL RES, V43, P604, DOI 10.1111/j.1600-0765.2007.01019.x; Groeger S, 2010, EUR J ORAL SCI, V118, P582, DOI 10.1111/j.1600-0722.2010.00782.x; Groeger SE, 2015, PERIODONTOL 2000, V69, P46, DOI 10.1111/prd.12094; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013; Han YW, 2005, J BACTERIOL, V187, P5330, DOI 10.1128/JB.187.15.5330-5340.2005; He YH, 2020, ARCH ORAL BIOL, V118, DOI 10.1016/j.archoralbio.2020.104841; Hirao C, 2010, J ORAL BIOSCI, V52, P283, DOI 10.2330/joralbiosci.52.283; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ji S, 2015, J PERIODONTAL RES, V50, P570, DOI 10.1111/jre.12248; Kang MS, 2009, J MICROBIOL, V47, P760, DOI 10.1007/s12275-009-0097-7; Kaplan CW, 2009, MOL MICROBIOL, V71, P35, DOI 10.1111/j.1365-2958.2008.06503.x; Koech R, 2013, MICROB PATHOG STRATE, V13, P971; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Lamuela-Raventos RM, 2005, FOOD SCI TECHNOL INT, V11, P159, DOI 10.1177/1082013205054498; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Mackenzie GG, 2009, BIOCHEM PHARMACOL, V78, P1252, DOI 10.1016/j.bcp.2009.06.111; Mahtout H, 2011, J PERIODONTOL, V82, P311, DOI 10.1902/jop.2010.100458; Mao T K, 2002, Dev Immunol, V9, P135; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Mori T, 2011, INT IMMUNOL, V23, P701, DOI 10.1093/intimm/dxr077; Murata T, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/1/017007; Osawa K, 2001, J DENT RES, V80, P2000, DOI 10.1177/00220345010800111001; Papapanou PN, 2018, J PERIODONTOL, V89, pS173, DOI 10.1002/JPER.17-0721; Percival RS, 2006, EUR J ORAL SCI, V114, P343, DOI 10.1111/j.1600-0722.2006.00386.x; Rahayu B, 2016, PREGNANCY HYPERTENS, V6, P42, DOI 10.1016/j.preghy.2016.01.001; Rossin D, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020280; Selmi C, 2006, J CARDIOVASC PHARM, V47, pS163, DOI 10.1097/00005344-200606001-00010; Stathopoulou PG, 2010, J CLIN PERIODONTOL, V37, P24, DOI 10.1111/j.1600-051X.2009.01505.x; TAKAHASHI K, 1994, J PERIODONTOL, V65, P147, DOI 10.1902/jop.1994.65.2.147; Tomofuji T, 2009, J PERIODONTOL, V80, P1799, DOI 10.1902/jop.2009.090270; Tonetti MS, 1998, J PERIODONTOL, V69, P1139, DOI 10.1902/jop.1998.69.10.1139; TONETTI MS, 1994, INFECT IMMUN, V62, P4005, DOI 10.1128/IAI.62.9.4005-4014.1994; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Yaegaki K, 2008, J PERIODONTAL RES, V43, P391, DOI 10.1111/j.1600-0765.2007.01052.x; Yoshida A, 2009, J PERIODONTOL, V80, P1845, DOI 10.1902/jop.2009.090012; Zeng HW, 2011, J AGR FOOD CHEM, V59, P5342, DOI 10.1021/jf2005386; Zhang JH, 2010, J PERIODONTAL RES, V45, P71, DOI 10.1111/j.1600-0765.2009.01202.x	59	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252029	10.1371/journal.pone.0252029	http://dx.doi.org/10.1371/journal.pone.0252029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029354	gold, Green Published			2022-12-26	WOS:000664632800024
J	Kouwenberg, M; Pulskens, WPC; Diepeveen, L; Bakker-van Bebber, M; Dinarello, CA; Netea, MG; Hilbrands, LB; van der Vlag, J				Kouwenberg, M.; Pulskens, W. P. C.; Diepeveen, L.; Bakker-van Bebber, M.; Dinarello, C. A.; Netea, M. G.; Hilbrands, L. B.; van der Vlag, J.			Reduced CXCL1 production by endogenous IL-37 expressing dendritic cells does not affect T cell activation	PLOS ONE			English	Article							INTERLEUKIN 37; RECEPTOR EXPRESSION; MIGRATION; CHEMOKINES; CYTOKINE; INJURY; CXCR2; TUMOR; GENE; RESPONSIVENESS	The dendritic cell (DC)-derived cytokine profile contributes to naive T cell differentiation, thereby directing the immune response. IL-37 is a cytokine with anti-inflammatory characteristics that has been demonstrated to induce tolerogenic properties in DC. In this study we aimed to evaluate the influence of IL-37 on DC-T cell interaction, with a special focus on the role of the chemokine CXCL1. DC were cultured from bone marrow of human IL-37 transgenic (hIL-37Tg) or WT mice. The phenotype of unstimulated and LPS-stimulated DC was analyzed (co-stimulatory molecules and MHCII by flow cytometry, cytokine profile by RT-PCR and ELISA), and T cell stimulatory capacity was assessed in mixed lymphocyte reaction. The role of CXCL1 in T cell activation was analyzed in T cell stimulation assays with anti-CD3 or allogeneic DC. The expression of the co-stimulatory molecules CD40, CD80 and CD86, and of MHCII in LPS-stimulated DC was not affected by endogenous expression of IL-37, whereas LPS-stimulated hIL-37Tg DC produced less CXCL1 compared to LPS-stimulated WT DC. T cell stimulatory capacity of LPS-matured hIL-37Tg DC was comparable to that of WT DC. Recombinant mouse CXCL1 did not increase T cell proliferation either alone or in combination with anti-CD3 or allogeneic DC, nor did CXCL1 affect the T cell production of interferon-gamma and IL-17. Endogenous IL-37 expression does not affect mouse DC phenotype or subsequent T cell stimulatory capacity, despite a reduced CXCL1 production. In addition, we did not observe an effect of CXCL1 in T cell proliferation or differentiation.	[Kouwenberg, M.; Pulskens, W. P. C.; Diepeveen, L.; Bakker-van Bebber, M.; Hilbrands, L. B.; van der Vlag, J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Nephrol, Nijmegen, Netherlands; [Dinarello, C. A.; Netea, M. G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Dept Internal Med, Nijmegen, Netherlands; [Dinarello, C. A.] Univ Colorado, Dept Med, Denver, CO 80202 USA	Radboud University Nijmegen; Radboud University Nijmegen; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	van der Vlag, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Nephrol, Nijmegen, Netherlands.	johan.vandervlag@radboudumc.nl	Hilbrands, Luuk/B-4921-2011; Van der Vlag, Johan/E-4636-2010	Hilbrands, Luuk/0000-0002-4935-9765; Van der Vlag, Johan/0000-0001-7843-5918	NWO ZonMw [AGIKO 92003567]	NWO ZonMw(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	JvdV; LH; MK: NWO ZonMw AGIKO 92003567, Radboud PhD program 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballak DB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5711; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Cavalli G, 2018, IMMUNOL REV, V281, P179, DOI 10.1111/imr.12605; Cavalli G, 2016, RHEUMATOLOGY, V55, P2220, DOI 10.1093/rheumatology/kew325; Chai M, 2015, J INTERF CYTOK RES, V35, P530, DOI 10.1089/jir.2014.0212; Cho KA, 2012, BIOCHEM BIOPH RES CO, V426, P558, DOI 10.1016/j.bbrc.2012.08.126; Coll-Miro M, 2016, P NATL ACAD SCI USA, V113, P1411, DOI 10.1073/pnas.1523212113; Dieker J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0617-2; Emmer PM, 2006, TRANSPLANTATION, V81, P1451, DOI 10.1097/01.tp.0000208801.51222.bd; Fairchild RL, 1997, TRANSPLANTATION, V63, P1807, DOI 10.1097/00007890-199706270-00018; Fonseca-Camarillo G, 2015, CYTOKINE, V75, P389, DOI 10.1016/j.cyto.2015.04.009; Geng S, 2013, BLOOD, V121, P1690, DOI 10.1182/blood-2012-07-445197; Gouwy M, 2014, IMMUNOBIOLOGY, V219, P218, DOI 10.1016/j.imbio.2013.10.004; Jin LL, 2014, J IMMUNOL, V193, P3549, DOI 10.4049/jimmunol.1401138; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kershaw MH, 2002, HUM GENE THER, V13, P1971, DOI 10.1089/10430340260355374; Khaw YM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017213118; Kouwenberg M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159986; Li YM, 2019, HEPATOLOGY, V70, P1564, DOI 10.1002/hep.30676; Liu L, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1167-y; Liu TX, 2019, BBA-MOL CELL BIOL L, P1338, DOI 10.1016/j.bbalip.2019.05.009; Liu YJ, 2010, NEUROBIOL AGING, V31, P175, DOI 10.1016/j.neurobiolaging.2008.03.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo YC, 2014, P NATL ACAD SCI USA, V111, P15178, DOI 10.1073/pnas.1416714111; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Megrelis L, 2014, JOVE-J VIS EXP, DOI 10.3791/52140; Michielsen AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027944; Mo R, 2003, J IMMUNOL, V170, P895, DOI 10.4049/jimmunol.170.2.895; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Morita K, 2001, J IMMUNOL, V167, P2979, DOI 10.4049/jimmunol.167.5.2979; Nanki T, 2001, CELL IMMUNOL, V214, P145, DOI 10.1006/cimm.2001.1890; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Owen JL, 2011, CELL IMMUNOL, V270, P172, DOI 10.1016/j.cellimm.2011.05.004; Peng WY, 2010, CLIN CANCER RES, V16, P5458, DOI 10.1158/1078-0432.CCR-10-0712; Sakai N, 2012, J GASTROEN HEPATOL, V27, P1609, DOI 10.1111/j.1440-1746.2012.07187.x; Sharma S, 2008, J IMMUNOL, V180, P5477, DOI 10.4049/jimmunol.180.8.5477; Shin SY, 2013, BBA-GENE REGUL MECH, V1829, P1066, DOI 10.1016/j.bbagrm.2013.07.005; Sozzani S, 1997, J IMMUNOL, V159, P1993; Takata H, 2004, J IMMUNOL, V173, P2231, DOI 10.4049/jimmunol.173.4.2231; Teng X, 2014, J IMMUNOL, V192, P1815, DOI 10.4049/jimmunol.1300047; Vecchi A, 1999, J LEUKOCYTE BIOL, V66, P489, DOI 10.1002/jlb.66.3.489; Wu B, 2014, CLIN EXP IMMUNOL, V176, P438, DOI 10.1111/cei.12284; Xu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep14478; Yang YB, 2015, KIDNEY INT, V87, P396, DOI 10.1038/ki.2014.295; Ye L, 2015, J IMMUNOL, V194, P5110, DOI 10.4049/jimmunol.1401810; Ye Z, 2014, CURR MOL MED, V14, P535, DOI 10.2174/1566524014666140414210831; Yung Raymond, 2007, Immun Ageing, V4, P8, DOI 10.1186/1742-4933-4-8; Zhu RR, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004406	51	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0251809	10.1371/journal.pone.0251809	http://dx.doi.org/10.1371/journal.pone.0251809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029331	Green Published, gold			2022-12-26	WOS:000664632800014
J	Ryu, KW; Bae, JM; Kim, EM; An, JY; Choi, MG; Lee, JH; Sohn, TS				Ryu, Kyeong-Won; Bae, Jae-Moon; Kim, Eun-Mee; An, Ji Yeong; Choi, Min-Gew; Lee, Jun Ho; Sohn, Tae Sung			Long-term effect of simplified dietary education on the nutritional status of patients after a gastrectomy	PLOS ONE			English	Article							GASTRIC-CANCER; SURGICAL COMPLICATIONS; CLASSIFICATION; MALNUTRITION	Dietary education is regarded as an important and useful tool for influencing nutritional status. Since long, dietary education has been performed to improve the nutritional status of patients after a gastrectomy. This study aimed to investigate the effect of simplified dietary education on the nutritional status of patients after a gastrectomy. A total of 1,150 patients with gastric cancer underwent surgery between March 2014 and October 2015 at the Samsung Medical Center (SMC). Of these, we used the case-control matching method (1:1 match) by stratifying the factors of age and sex and included 100 patients in each group. The clinicopathologic data of the patients for two years after the gastrectomy were prospectively collected and retrospectively analyzed. The educated group (ED, N = 100) was provided with a simplified, ordinary dietary education at regular outpatient clinic visits that occurred at 1, 3, 6, and 12 months after gastrectomy and at 1-year intervals thereafter. The clinicopathologic characteristics and nutritional parameters of the educated group (ED) (N = 100) and the non-educated group (NED) (n = 100) were compared. There were no significant differences between the two groups in terms of clinical characteristics and serological parameters. Nutritional parameters, which included body weight loss, body mass index (BMI) change, and prognostic nutritional index (PNI), were also not significantly different between the two groups. Simplified dietary education at regular outpatient clinic visits was ineffective in reducing weight loss after a subtotal gastrectomy. Further research or other methods may be needed to reduce weight loss after a gastrectomy.	[Ryu, Kyeong-Won; Kim, Eun-Mee] Samsung Med Ctr, Dept Dietet, Seoul, South Korea; [Bae, Jae-Moon; An, Ji Yeong; Choi, Min-Gew; Lee, Jun Ho; Sohn, Tae Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Upper GI,Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Bae, JM (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Upper GI,Dept Surg, Seoul, South Korea.	jmoonbae@naver.com		Bae, Jae Moon/0000-0003-3928-0743				Bae J. M., 2018, Clinical Nutrition, V37, pS160, DOI 10.1016/j.clnu.2018.06.1587; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Chen W, 2014, ASIA PAC J CLIN NUTR, V23, P607, DOI 10.6133/apjcn.2014.23.4.15; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Davis JL, 2017, SURG CLIN N AM, V97, P277, DOI 10.1016/j.suc.2016.11.005; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Fujitani K, 2012, BRIT J SURG, V99, P621, DOI 10.1002/bjs.8706; Fujiya K, 2018, ANN SURG ONCOL, V25, P974, DOI 10.1245/s10434-018-6342-8; Fukuda Y, 2015, ANN SURG ONCOL, V22, pS778, DOI 10.1245/s10434-015-4820-9; Heneghan HM, 2015, ANN SURG, V262, P803, DOI 10.1097/SLA.0000000000001445; Hong S, 2020, CANCER RES TREAT, V52, P335, DOI 10.4143/crt.2020.206; Jung KW, 2019, CANCER RES TREAT, V51, P431, DOI 10.4143/crt.2019.139; Kong SH, 2018, SURGERY, V164, P1263, DOI 10.1016/j.surg.2018.05.017; Lee HO, 2016, ANN SURG TREAT RES, V90, P79, DOI 10.4174/astr.2016.90.2.79; Nakanishi K, 2020, GASTRIC CANCER, V23, P734, DOI 10.1007/s10120-020-01048-6; Naum C, 2020, CHIRURGIA-BUCHAREST, V115, P12, DOI 10.21614/chirurgia.115.1.12; Oshima T, 2016, NUTR CLIN PRACT, V31, P432, DOI 10.1177/0884533616651754; Rosania R, 2015, GASTROINTEST TUMORS, V2, P178, DOI 10.1159/000445188; Shen L, 2013, LANCET ONCOL, V14, pE535, DOI 10.1016/S1470-2045(13)70436-4; Yasufuku I, 2020, SURG ENDOSC, V34, P5540, DOI 10.1007/s00464-019-07353-1	20	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252168	10.1371/journal.pone.0252168	http://dx.doi.org/10.1371/journal.pone.0252168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019591	gold, Green Published			2022-12-26	WOS:000664632300058
J	Rossa-Roccor, V; Richardson, CG; Murphy, RA; Gadermann, AM				Rossa-Roccor, Verena; Richardson, Chris G.; Murphy, Rachel A.; Gadermann, Anne M.			The association between diet and mental health and wellbeing in young adults within a biopsychosocial framework	PLOS ONE			English	Article							QUALITY-OF-LIFE; VEGETARIAN DIETS; ANXIETY DISORDERS; PHYSICAL-ACTIVITY; PRIMARY-CARE; DEPRESSION; STRESS; PREVALENCE; PATTERNS; PHQ-9	Objective Predominantly plant-based diets can co-benefit human physical health and the planet. Young adults appear to be on the forefront of the shift to plant-based diets. However, little is known about the relationship between plant-based diets and mental health in this population even though mental health disorders contribute substantially to the global burden of disease, particularly among this age group. Design In this cross-sectional study we utilize a biopsychosocial framework to assess the association between dietary intake and mental health and wellbeing. Mental health was assessed using self-reported measures of anxiety (GAD-7), depression (PHQ-9) and quality of life (single-item). Dietary intake in the prior month was assessed using a dietary screener (DSQ) and participants were asked to self-identify a diet preference (e.g., vegan). Setting and participants 339 university undergraduate students. Results A principal component analysis of dietary intake found three dominant dietary patterns (plant-based, animal-based, and 'junk foods'); 28.1% (n = 95) of participants self-identified as pescatarian, vegetarian, vegan, other. The association between dietary patterns, diet preference and mental health was assessed through regression analysis. After controlling for covariables, we found a significant positive association between the junk food component and depression (z-score beta = .21, p <= .001; adj. R-2 = .39) and anxiety (z-score beta = .14; p <= .001; adj. R-2 = .32) while no association was found between plant-based, animal-based or self-identified diet preference and the mental health measures. Conclusions We did not find a negative association between predominantly plant-based diet patterns and mental health and wellbeing. It is important to consider dietary composition and to conceptualize diet as a health behaviour that is embedded in a biopsychosocial framework.	[Rossa-Roccor, Verena; Richardson, Chris G.; Murphy, Rachel A.; Gadermann, Anne M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Rossa-Roccor, Verena] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada; [Richardson, Chris G.; Gadermann, Anne M.] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Providence Hlth Care Res Inst, Vancouver, BC, Canada; [Murphy, Rachel A.] BC Canc, Canc Control Res, Vancouver, BC, Canada; [Gadermann, Anne M.] Univ British Columbia, Sch Populat & Publ Hlth, Human Early Learning Partnership, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia	Rossa-Roccor, V (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.; Rossa-Roccor, V (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC, Canada.	verena.rossa-roccor@ubc.ca						AARO LE, 1995, HEALTH EDUC RES, V10, P83, DOI 10.1093/her/10.1.83; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Bailey M.J., 2011, 17633 NAT BUR EC RES; Bailey RL, 2007, J NUTR, V137, P421, DOI 10.1093/jn/137.2.421; Baines S, 2007, PUBLIC HEALTH NUTR, V10, P436, DOI 10.1017/S1368980007217938; Beard C, 2016, J AFFECT DISORDERS, V193, P267, DOI 10.1016/j.jad.2015.12.075; Beezhold B, 2015, NUTR NEUROSCI, V18, P289, DOI 10.1179/1476830514Y.0000000164; Beezhold BL, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-26; Beiter R, 2015, J AFFECT DISORDERS, V173, P90, DOI 10.1016/j.jad.2014.10.054; Beydoun MA, 2010, J AFFECT DISORDERS, V123, P52, DOI 10.1016/j.jad.2009.09.021; Blanco C, 2008, ARCH GEN PSYCHIAT, V65, P1429, DOI 10.1001/archpsyc.65.12.1429; Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Breslau J, 2008, J PSYCHIATR RES, V42, P708, DOI 10.1016/j.jpsychires.2008.01.016; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Burkert NT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088278; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Conklin AI, 2014, SOC SCI MED, V100, P167, DOI 10.1016/j.socscimed.2013.08.018; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Derbyshire EJ, 2017, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00055; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Dobersek U, 2021, CRIT REV FOOD SCI, V61, P622, DOI 10.1080/10408398.2020.1741505; Enders CK, 2010, METHODOLOGY SOCIAL S; Evans TM, 2018, NAT BIOTECHNOL, V36, P282, DOI 10.1038/nbt.4089; Fahy T, 1999, BRIT J PSYCHIAT, V175, P426, DOI 10.1192/bjp.175.5.426; Field A., 2013, DISCOVERING STAT USI; Flanagan, 2018, CTV NEWS; Gibb SJ, 2010, BRIT J PSYCHIAT, V197, P122, DOI 10.1192/bjp.bp.109.076570; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Hibbeln JR, 2018, J AFFECT DISORDERS, V225, P13, DOI 10.1016/j.jad.2017.07.051; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; Jacka FN, 2010, AM J PSYCHIAT, V167, P305, DOI 10.1176/appi.ajp.2009.09060881; Jantaratnotai N, 2017, OBES RES CLIN PRACT, V11, P1, DOI 10.1016/j.orcp.2016.07.003; Kaplan BJ, 2015, CLIN PSYCHOL SCI, V3, P964, DOI 10.1177/2167702614555413; Karatsoreos IN, 2011, TRENDS COGN SCI, V15, P576, DOI 10.1016/j.tics.2011.10.005; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Keurn BT, 2018, PSYCHOL ASSESSMENT, V30, P1096, DOI 10.1037/pas0000550; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kuehner C, 2005, J AFFECT DISORDERS, V86, P205, DOI 10.1016/j.jad.2005.01.014; Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880; Lassale C, 2019, MOL PSYCHIATR, V24, P965, DOI 10.1038/s41380-018-0237-8; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Leitzmann C, 2014, AM J CLIN NUTR, V100, p496S, DOI 10.3945/ajcn.113.071365; Li Y, 2017, PSYCHIAT RES, V253, P373, DOI 10.1016/j.psychres.2017.04.020; Logan AC, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-22; Martin W., 2017, HDB STRESS HLTH, P459, DOI [10.1002/9781118993811.ch28, DOI 10.1002/9781118993811.CH28]; McGorry PD, 2018, EVID-BASED MENT HEAL, V21, P182, DOI 10.1136/ebmental-2018-300060; Michalak J, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-67; Moubarac JC, 2014, CAN J DIET PRACT RES, V75, P15, DOI 10.3148/75.1.2014.15; Neely E, 2014, APPETITE, V82, P50, DOI 10.1016/j.appet.2014.07.005; Nettleton JA, 2006, AM J CLIN NUTR, V83, P1369, DOI 10.1093/ajcn/83.6.1369; Neumark-Sztainer D, 2006, J ADOLESCENT HEALTH, V39, P244, DOI 10.1016/j.jadohealth.2005.12.001; O'Malley PM, 2002, J STUD ALCOHOL, P23, DOI 10.15288/jsas.2002.s14.23; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Prince JP, 2015, MENT HLTH PREV, V3, P5, DOI DOI 10.1016/J.MHP.2015.03.001; Sabate J, 2003, AM J CLIN NUTR, V78, p502S, DOI 10.1093/ajcn/78.3.502S; Satija A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002039; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Somers JM, 2006, CAN J PSYCHIAT, V51, P100, DOI 10.1177/070674370605100206; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Statistics Canada, 2018, MENTAL HLTH WELL BEI; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; The Nielsen Company, 2017, NIELSEN; Thompson FE, 2017, J NUTR, V147, P1226, DOI 10.3945/jn.116.246058; Thomson A., 2018, CTV NEWS; Tiggemann Marika, 2005, Body Image, V2, P129, DOI 10.1016/j.bodyim.2005.03.006; Trautmann S, 2016, EMBO REP, V17, P1245, DOI 10.15252/embr.201642951; VanKim NA, 2013, AM J HEALTH PROMOT, V28, P7, DOI 10.4278/ajhp.111101-QUAN-395; Weersink A, 2019, CONVERSATION; Weidner G, 1996, ANXIETY STRESS COPIN, V9, P123, DOI 10.1080/10615809608249396; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4	77	2	2	7	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252358	10.1371/journal.pone.0252358	http://dx.doi.org/10.1371/journal.pone.0252358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QS	34081708	Green Published, gold			2022-12-26	WOS:000664639200016
J	Ding, H; Buzzard, GW; Huang, SS; Sehorn, MG; Marcus, RK; Wei, YZ				Ding, Hui; Buzzard, Garrett W.; Huang, Sisi; Sehorn, Michael G.; Marcus, R. Kenneth; Wei, Yanzhang			MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells	PLOS ONE			English	Article							PROLACTIN RECEPTOR; SOLUBLE MICA; NK CELLS; T-CELL; TGF-BETA; NKG2D; EXPRESSION; ANTAGONIST; LIGANDS; CHAIN	Breast cancer cells were reported to up-regulate human prolactin receptor (PRLR) to assist their growth through the utilization of prolactin (PRL) as the growth factor, which makes PRLR a potential therapeutic target for breast cancer. On the other hand, advanced cancer cells tend to down-regulate or shed off stress signal proteins to evade immune surveillance and elimination. In this report, we created a fusion protein consisting of the extracellular domain of MHC class I chain-related protein (MICA), a stress signal protein and ligand of the activating receptor NKG2D of natural killer (NK) cells, and G129R, an antagonistic variant of PRL. We hypothesize that the MICA portion of the fusion protein binds to NKG2D to activate NK cells and the G129R portion binds to PRLR on breast cancer cells, so that the activated NK cells will kill the PRLR-positive breast cancer cells. We demonstrated that the MICA-G129R fusion protein not only binds to human natural killer NK-92 cells and PRLR-positive human breast cancer T-47D cells, but also promotes NK cells to release granzyme B and IFN-gamma and enhances the cytotoxicity of NK cells specifically on PRLR-positive cells. The fusion protein, therefore, represents a new approach for the development of breast cancer specific immunotherapy.	[Ding, Hui; Wei, Yanzhang] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Buzzard, Garrett W.; Sehorn, Michael G.] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Huang, Sisi; Marcus, R. Kenneth] Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University; Clemson University; Clemson University	Wei, YZ (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	ywei@clemson.edu	Ding, Hui/GZG-7412-2022	Ding, Hui/0000-0002-2277-3894; Huang, Sisi/0000-0002-5146-9533	Clemson University Support for Early Exploration and Development (CU SEED) Grant Program	Clemson University Support for Early Exploration and Development (CU SEED) Grant Program	The study was partially supported by the Clemson University Support for Early Exploration and Development (CU SEED) Grant Program.	Bachelot A, 2007, REPRODUCTION, V133, P361, DOI 10.1530/REP-06-0299; Beck MT, 2003, CANCER RES, V63, P3598; Bernichtein S, 2010, J ENDOCRINOL, V206, P1, DOI 10.1677/JOE-10-0069; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burstein HJ, 2014, J CLIN ONCOL, V32, P2255, DOI 10.1200/JCO.2013.54.2258; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chen WY, 2015, ADV EXP MED BIOL, V846, P61, DOI 10.1007/978-3-319-12114-7_3; Chen WY, 1999, CLIN CANCER RES, V5, P3583; Crane CA, 2010, NEURO-ONCOLOGY, V12, P7, DOI 10.1093/neuonc/nop009; Ding H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010177; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Engebraaten O, 2013, AM J PATHOL, V183, P1064, DOI 10.1016/j.ajpath.2013.05.033; Faupel-Badger JM, 2014, HORM CANCER-US, V5, P42, DOI 10.1007/s12672-013-0165-7; Friese MA, 2003, CANCER RES, V63, P8996; Germain C, 2005, CLIN CANCER RES, V11, P7516, DOI 10.1158/1078-0432.CCR-05-0872; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hagemann-Jensen M, 2014, J BIOL CHEM, V289, P31576, DOI 10.1074/jbc.M114.591537; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; Hilpert J, 2012, J IMMUNOL, V189, P1360, DOI 10.4049/jimmunol.1200796; Holdenrieder S, 2006, INT J CANCER, V118, P684, DOI 10.1002/ijc.21382; Kabelitz D, 2020, CELL MOL IMMUNOL, V17, P925, DOI 10.1038/s41423-020-0504-x; Kellner C, 2012, LEUKEMIA, V26, P830, DOI 10.1038/leu.2011.288; Ko YH, 2007, LAB INVEST, V87, P241, DOI 10.1038/labinvest.3700517; Kumar V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044743; Langenheim JF, 2005, BREAST CANCER RES TR, V90, P281, DOI 10.1007/s10549-004-4816-9; Larsen Stine K., 2014, Critical Reviews in Oncogenesis, V19, P91; Levina VV, 2009, CANCER RES, V69, P5226, DOI 10.1158/0008-5472.CAN-08-4652; Liu HF, 2019, AM J CANCER RES, V9, P2064; Llovera M, 2000, EXP GERONTOL, V35, P41, DOI 10.1016/S0531-5565(99)00078-9; Marten A, 2006, INT J CANCER, V119, P2359, DOI 10.1002/ijc.22186; Martinvalet D, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9165214; Melero I, 2014, CANCER DISCOV, V4, P522, DOI 10.1158/2159-8290.CD-13-0985; Nersesian S, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2020.100930; Netter P, 2017, J IMMUNOL, V199, P2528, DOI 10.4049/jimmunol.1700394; Obeidy P, 2009, INT J BIOCHEM CELL B, V41, P2364, DOI 10.1016/j.biocel.2009.07.005; Onyeaghala G, 2017, MOL CARCINOGEN, V56, P2158, DOI 10.1002/mc.22667; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Reynolds C, 1997, ENDOCRINOLOGY, V138, P5555, DOI 10.1210/en.138.12.5555; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Scotti ML, 2008, BREAST CANCER RES TR, V111, P241, DOI 10.1007/s10549-007-9789-z; Siddharth S, 2018, CANCERS, V10, DOI 10.3390/cancers10120514; Song H, 2006, CELL IMMUNOL, V242, P39, DOI 10.1016/j.cellimm.2006.09.002; Stanelle RD, 2006, ANAL BIOANAL CHEM, V384, P250, DOI 10.1007/s00216-005-0117-3; Sun R, 2004, CELL RES, V14, P67, DOI 10.1038/sj.cr.7290204; Tamaki S, 2008, HUM IMMUNOL, V69, P88, DOI 10.1016/j.humimm.2008.01.010; Tamaki S, 2009, CLIN IMMUNOL, V130, P331, DOI 10.1016/j.clim.2008.09.004; Tan DY, 2011, CANCER LETT, V310, P101, DOI 10.1016/j.canlet.2011.06.014; Tietje A, 2017, ONCOL REP, V37, P1889, DOI 10.3892/or.2017.5375; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0; Voskoboinik I, 2015, NAT REV IMMUNOL, V15, P388, DOI 10.1038/nri3839; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Wang JN, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0069-2; Wang L, 2018, J SEP SCI, V41, P1063, DOI 10.1002/jssc.201701063; Wang T, 2016, CANCER LETT, V372, P166, DOI 10.1016/j.canlet.2016.01.001; Wen YF, 2014, CELL REP, V7, P488, DOI 10.1016/j.celrep.2014.03.009; Wensveen FM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00441; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206; Xie J, 2002, J BIOL CHEM, V277, P14020, DOI 10.1074/jbc.M112399200; Xie W, 2016, ONCOTARGET, V7, P16445, DOI 10.18632/oncotarget.7501; Zhang GR, 2002, CLIN CANCER RES, V8, P1196	64	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252662	10.1371/journal.pone.0252662	http://dx.doi.org/10.1371/journal.pone.0252662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077462	Green Published, gold			2022-12-26	WOS:000664638500061
J	Orozco-Ortiz, JM; Bauke, SL; Borgemeister, C; Lehndorff, E; Amelung, W				Orozco-Ortiz, Juan M.; Bauke, Sara L.; Borgemeister, Christian; Lehndorff, Eva; Amelung, Wulf			Bioturbation by black soldier fly larvae-Rapid soil formation with burial of ceramic artifacts	PLOS ONE			English	Article							HERMETIA-ILLUCENS; FLIES DIPTERA; DARK EARTHS; STRATIOMYIDAE; PEDOGENESIS; AMAZONIA; GROWTH; CARBON; MODEL; TIME	Bioturbation involves the incorporation of residues from the surface soil into the subsoil; however, common small soil 'bioengineers', such as earthworms or termites, are unlikely to transport human artifacts to deeper soil horizons. However, such artifacts occur in the deeper soil horizons within Amazonian Anthrosols (Terra Preta). Here we test the assumption that such tasks could be carried out by fly larvae, which could thus play a crucial role in waste decomposition and associated soil mixing under tropical conditions. We performed two greenhouse experiments with sandy substrate covered with layers of organic waste, ceramic fragments, and black soldier fly larvae (BSFL) (Hermetia illucens (L.) (Dipt.: Stratiomyidae)). We used in-situ images to assess the rate of bioturbation by BSFL, and then designed our main study to observe waste dissipation (reduction of organic carbon and phosphorus contents from waste model trials with and without charcoal) as related to larval-induced changes in soil properties. We found that the bioturbation of macroinvertebrates like BSFL was able to bury even large (> 5 cm) ceramic fragments within hours, which coincided with high soil growth rates (0.5 cm h(-1)). The sandy soil was subsequently heavily enriched with organic matter and phosphorus originating from organic waste. We conclude that BSFL, and possibly other fly species, are important, previously overlooked soil 'bioengineers', which may even contribute to the burial of artifacts in Anthrosols and other terrestrial waste dumps.	[Orozco-Ortiz, Juan M.; Bauke, Sara L.; Amelung, Wulf] Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany; [Orozco-Ortiz, Juan M.; Borgemeister, Christian] Univ Bonn, Ctr Dev Res ZEF, Bonn, Germany; [Lehndorff, Eva] Bayreuth Univ, Soil Ecol, Bayreuth, Germany	University of Bonn; University of Bonn; University of Bayreuth	Orozco-Ortiz, JM (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES, Bonn, Germany.; Orozco-Ortiz, JM (corresponding author), Univ Bonn, Ctr Dev Res ZEF, Bonn, Germany.	orozco.ortiz.juan@gmail.com	Ortiz, Juan Manuel Orozco/AAC-8073-2022	Ortiz, Juan Manuel Orozco/0000-0002-9537-1116; Bauke, Sara Louise/0000-0003-2284-9593	Colombian Department of Science, Technology, and Innovation (Convocatoria 679 de Colciencias)	Colombian Department of Science, Technology, and Innovation (Convocatoria 679 de Colciencias)	JMO received a scholarship from the Colombian Department of Science, Technology, and Innovation (Convocatoria 679 de Colciencias; https://minciencias.gov.co/).The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Acksel A, 2019, SOIL SYST, V3, DOI 10.3390/soilsystems3040072; Adani F, 2008, J ENVIRON QUAL, V37, P1608, DOI 10.2134/jeq2007.0108; Alef K., 1995, METHODS APPL SOIL MI, DOI 10.1016/B978-0-12-513840-6.X5014-9; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; ARMOURCHELU M, 1994, J ARCHAEOL SCI, V21, P433, DOI 10.1006/jasc.1994.1042; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Caligiani A, 2018, FOOD RES INT, V105, P812, DOI 10.1016/j.foodres.2017.12.012; Cheng CH, 2006, ORG GEOCHEM, V37, P1477, DOI 10.1016/j.orggeochem.2006.06.022; Cickova H, 2015, WASTE MANAGE, V35, P68, DOI 10.1016/j.wasman.2014.09.026; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; Clement CR, 2010, BIOTROPICA, V42, P534, DOI 10.1111/j.1744-7429.2010.00674.x; Conway H, 2016, AM ENTOMOL, V62, P260, DOI [10.1093/ae/tmw083, DOI 10.1093/AE/TMW083]; COWAN JA, 1985, AUST J SOIL RES, V23, P95, DOI 10.1071/SR9850095; Cunha L, 2016, SOIL SCI, V181, P110, DOI 10.1097/SS.0000000000000144; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; de Souza JG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03510-7; de Souza KW, 2009, REV BRAS CIENC SOLO, V33, P1347, DOI 10.1590/S0100-06832009000500027; Denevan WM, 1996, ANN ASSOC AM GEOGR, V86, P654, DOI 10.1111/j.1467-8306.1996.tb01771.x; Derrien D, 2011, EUR J SOIL SCI, V62, P237, DOI 10.1111/j.1365-2389.2010.01333.x; Diener S, 2011, WASTE BIOMASS VALORI, V2, P357, DOI 10.1007/s12649-011-9079-1; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Dortmans B.M.A., 2017, BLACK SOLDIER FLY BI; Downie AE, 2011, AGR ECOSYST ENVIRON, V140, P137, DOI 10.1016/j.agee.2010.11.020; EDEN MJ, 1984, AM ANTIQUITY, V49, P125, DOI 10.2307/280517; Erickson MC, 2004, J FOOD PROTECT, V67, P685, DOI 10.4315/0362-028X-67.4.685; Gabet EJ, 2003, ANNU REV EARTH PL SC, V31, P249, DOI 10.1146/annurev.earth.31.100901.141314; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Glaser B, 2012, GEOCHIM COSMOCHIM AC, V82, P39, DOI 10.1016/j.gca.2010.11.029; Gligorescu A, 2018, J INSECTS FOOD FEED, V4, P123, DOI 10.3920/JIFF2017.0080; Gligorescu A, 2019, J APPL ENTOMOL, V143, P875, DOI 10.1111/jen.12653; Golyeva A, 2016, QUATERN INT, V418, P22, DOI 10.1016/j.quaint.2015.11.093; Gunadi B, 2003, PEDOBIOLOGIA, V47, P321, DOI 10.1078/0031-4056-00196; Heckenberger MJ, 1999, LAT AM ANTIQ, V10, P353, DOI 10.2307/971962; Howard J, 2017, PROGR SOIL SCI, P1, DOI 10.1007/978-3-319-54331-4; HUMPHREYS GS, 1981, SEARCH, V12, P129; Jiang CL, 2019, MICROB BIOTECHNOL, V12, P528, DOI 10.1111/1751-7915.13393; Johnson DL, 2002, GEOARCHAEOLOGY, V17, P7, DOI 10.1002/gea.10001; JOHNSON DL, 1990, SOIL SCI, V149, P84, DOI 10.1097/00010694-199002000-00004; Kern DC, 2017, GEOARCHAEOLOGY, V32, P694, DOI 10.1002/gea.21647; Klammsteiner T, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10101578; Kroeckel S, 2012, AQUACULTURE, V364, P345, DOI 10.1016/j.aquaculture.2012.08.041; Lalander C, 2019, J CLEAN PROD, V208, P211, DOI 10.1016/j.jclepro.2018.10.017; Lalander C, 2013, SCI TOTAL ENVIRON, V458, P312, DOI 10.1016/j.scitotenv.2013.04.033; Lalander CH, 2015, AGRON SUSTAIN DEV, V35, P261, DOI 10.1007/s13593-014-0235-4; Li Q, 2011, FUEL, V90, P1545, DOI 10.1016/j.fuel.2010.11.016; Liang C, 2019, GLOBAL CHANGE BIOL, V25, P3578, DOI 10.1111/gcb.14781; Lima HN, 2002, GEODERMA, V110, P1, DOI 10.1016/S0016-7061(02)00141-6; Liu T, 2019, J ENVIRON MANAGE, V251, DOI 10.1016/j.jenvman.2019.109593; Macedo Rodrigo Santana, 2019, Bol. Mus. Para. Emílio Goeldi. Ciênc. hum., V14, P207, DOI 10.1590/1981-81222019000100013; Morales GE, 2010, REV BRAS ENTOMOL, V54, P645, DOI 10.1590/S0085-56262010000400017; Morcote-Rios, 2013, TERRAS PRETAS INDIO; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Muscolo A, 2018, J CLEAN PROD, V195, P93, DOI 10.1016/j.jclepro.2018.05.204; Myers HM, 2008, ENVIRON ENTOMOL, V37, P11, DOI 10.1603/0046-225X(2008)37[11:DOBSFD]2.0.CO;2; Myers TP, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P15, DOI 10.1007/1-4020-2597-1_2; Neves EG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P29, DOI 10.1007/1-4020-2597-1_3; Newton L., 2005, J KOREAN ENTOMOL APP; Novotny EH, 2006, NATURWISSENSCHAFTEN, V93, P447, DOI 10.1007/s00114-006-0126-x; Parsons J. W., 1981, Soil biochemistry. Volume 5, P197; Peacock E, 2002, GEOARCHAEOLOGY, V17, P91, DOI 10.1002/gea.10004; R Core Team, 2021, R LANGUAGE ENV STAT; ROOSEVELT AC, 1991, SCIENCE, V254, P1621, DOI 10.1126/science.254.5038.1621; Sagrilo E., 2015, GEODERMA REG, V6, P1, DOI DOI 10.1016/j.geodrs.2015.08.006; Sato S, 2009, J SOIL SEDIMENT, V9, P194, DOI 10.1007/s11368-009-0082-0; Schaefer CEGR, 2004, AUST J SOIL RES, V42, P401, DOI 10.1071/SR03106; Schmidt MJ, 2014, J ARCHAEOL SCI, V42, P152, DOI 10.1016/j.jas.2013.11.002; Schulz H, 2012, J PLANT NUTR SOIL SC, V175, P410, DOI 10.1002/jpln.201100143; Sheppard DC, 2002, J MED ENTOMOL, V39, P695, DOI 10.1603/0022-2585-39.4.695; Shumo M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46603-z; Shumo M, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9030079; SMITH NJH, 1980, ANN ASSOC AM GEOGR, V70, P553, DOI 10.1111/j.1467-8306.1980.tb01332.x; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Targulian VO, 2007, CATENA, V71, P373, DOI 10.1016/j.catena.2007.03.007; Tiessen H., 1993, SOIL SAMPLING METHOD, P75, DOI [10.1201/9781420005271.ch25, DOI 10.1201/9781420005271.CH25]; Tomberlin JK, 2002, J ENTOMOL SCI, V37, P345, DOI 10.18474/0749-8004-37.4.345; Tomberlin JK, 2002, ANN ENTOMOL SOC AM, V95, P379, DOI 10.1603/0013-8746(2002)095[0379:SLHTOB]2.0.CO;2; Topoliantz S, 2005, APPL SOIL ECOL, V28, P217, DOI 10.1016/j.apsoil.2004.08.003; Wilkinson MT, 2005, AUST J SOIL RES, V43, P767, DOI 10.1071/SR04158; Woods, 2004, AMAZONIAN DARK EARTH; Woods WI, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P3, DOI 10.1007/1-4020-2597-1_1; Yeton BGA, 2019, ARCH AGRON SOIL SCI, V65, P1610, DOI 10.1080/03650340.2019.1572118; Zhang M, 2000, INT J BIOL MACROMOL, V27, P99, DOI 10.1016/S0141-8130(99)00123-3; Zhang XD, 1996, SOIL BIOL BIOCHEM, V28, P1201, DOI 10.1016/0038-0717(96)00117-4	83	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252032	10.1371/journal.pone.0252032	http://dx.doi.org/10.1371/journal.pone.0252032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QL	34077440	gold, Green Published			2022-12-26	WOS:000664638500023
J	Zeinali, F; Zarch, SMA; Jahan-Mihan, A; Kalantar, SM; Mehrjardi, MYV; Fallahzadeh, H; Hosseinzadeh, M; Rahmanian, M; Mozaffari-Khosravi, H				Zeinali, Fahime; Aghaei Zarch, Seyed Mohsen; Jahan-Mihan, Alireza; Kalantar, Seyed Mehdi; Mehrjardi, Mohammad Yahya Vahidi; Fallahzadeh, Hossein; Hosseinzadeh, Mahdieh; Rahmanian, Masoud; Mozaffari-Khosravi, Hassan			Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; POTENTIAL BIOMARKER; EXPRESSION; SERUM; MECHANISMS; DIAGNOSIS; CORRELATE; MIR-146A; OBESITY	The prevalence of type 2 diabetes mellitus (T2DM) is increasing dramatically worldwide. Dysregulation of microRNA (miRNA) as key regulators of gene expression, has been reported in numerous diseases including diabetes. The aim of this study was to investigate the expression levels of miRNA-122, miRNA-126-3p and miRNA-146a in diabetic and pre-diabetic patients and in healthy individuals, and to determine whether the changes in the level of these miRNAs are reliable biomarkers in diagnosis, prognosis, and pathogenesis of T2DM. Additionally, we examined the relationship between miRNA levels and plasma concentrations of inflammatory factors including tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (Il-6) as well as insulin resistance. In this case-control study, participants (n = 90) were allocated to three groups (n = 30/group): T2DM, pre-diabetes and healthy individuals as control (males and females, age: 25-65, body mass index: 25-35). Expression of miRNA was determined by real-time polymerase chain reaction (RT-PCR). Furthermore, plasma concentrations of TNF-alpha, IL-6 and fasting insulin were measured by enzyme-linked immunosorbent assay. Homeostatic model assessment for insulin resistance (HOMA-IR) was calculated as an indicator of insulin resistance. MiRNA-122 levels were higher while miRNA-126-3p and miRNA-146a levels were lower in T2DM and pre-diabetic patients compared to control (p < 0.05). Furthermore, a positive correlation was found between miRNA-122 expression and TNF-alpha (r = 0.82), IL-6 (r = 0.83) and insulin resistance (r = 0.8). Conversely, negative correlations were observed between miRNA-126-3p and miRNA-146a levels and TNF-alpha (r = -0.7 and r = -0.82 respectively), IL-6 (r = -0.65 and r = -0.78 respectively) as well as insulin resistance (r = -0.67 and r = -0.78 respectively) (all p < 0.05). Findings of this study suggest the miRNAs can potentially contribute to the pathogenesis of T2DM. Further studies are required to examine the reproducibility of these findings.	[Zeinali, Fahime; Hosseinzadeh, Mahdieh; Mozaffari-Khosravi, Hassan] Shahid Sadoughi Univ Med Sci, Sch Publ Hlth, Dept Nutr, Yazd, Iran; [Zeinali, Fahime; Hosseinzadeh, Mahdieh; Mozaffari-Khosravi, Hassan] Shahid Sadoughi Univ Med Sci, Nutr & Food Secur Res Ctr, Yazd, Iran; [Aghaei Zarch, Seyed Mohsen; Kalantar, Seyed Mehdi] Shahid Sadoughi Univ Med Sci, Dept Genet, Fac Med, Yazd, Iran; [Jahan-Mihan, Alireza] Univ North Florida, Dept Nutr & Dietet, Jacksonville, FL USA; [Kalantar, Seyed Mehdi] Shahid Sadoughi Univ Med Sci, Yazd Clin & Res Ctr Infertil, Yazd, Iran; [Mehrjardi, Mohammad Yahya Vahidi; Rahmanian, Masoud; Mozaffari-Khosravi, Hassan] Shahid Sadoughi Univ Med Sci, Yazd Diabet Res Ctr, Yazd, Iran; [Fallahzadeh, Hossein] Shahid Sadoughi Univ Med Sci, Dept Biostat & Epidemiol, Res Ctr Prevent & Epidemiol Noncommunicable Dis, Sch Hlth, Yazd, Iran	State University System of Florida; University of North Florida	Mozaffari-Khosravi, H (corresponding author), Shahid Sadoughi Univ Med Sci, Sch Publ Hlth, Dept Nutr, Yazd, Iran.; Mozaffari-Khosravi, H (corresponding author), Shahid Sadoughi Univ Med Sci, Nutr & Food Secur Res Ctr, Yazd, Iran.; Mozaffari-Khosravi, H (corresponding author), Shahid Sadoughi Univ Med Sci, Yazd Diabet Res Ctr, Yazd, Iran.	mozaffari.kh@gmail.com	Mehrjardi, Mohammad Yahya Vahidi/V-5116-2019	Mehrjardi, Mohammad Yahya Vahidi/0000-0003-0535-1590	Shahid Sadoughi University of Medical Sciences [961024]; Iran's National Science Foundation (INSF) [96012141]; Yazd Diabetes Research Center	Shahid Sadoughi University of Medical Sciences; Iran's National Science Foundation (INSF); Yazd Diabetes Research Center	This study was supported by grants from Shahid Sadoughi University of Medical Sciences (grant number: 961024) (Email: sphealth@ssu.ac.ir) http://www.ssu.ac.ir/ and Iran's National Science Foundation (INSF) (grant number: 96012141) (Email: medicine@insf.org)https://rtms.insf.org/. H.MK. received the grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge all the participants and members who participated in this study as well as Shahid Sadoughi university of medical sciences, Iran's National Science Foundation (INSF) and Yazd Diabetes Research Center for their supports. We also acknowledge Dr Shima Abdollahi for her cooperation and assistance in laboratory services.	Abou-Zeid A, 2011, GENET TEST MOL BIOMA, V15, P807, DOI 10.1089/gtmb.2011.0026; Aghaei Zarch SM, 2019, J MAZANDARAN U MED S, V29, P195; Al-Kafaji G, 2016, EXP THER MED, V12, P815, DOI 10.3892/etm.2016.3395; Al-Kafaji G, 2015, MOL MED REP, V12, P7485, DOI 10.3892/mmr.2015.4416; Alipoor B, 2017, INT J MOL CELL MED, V6, P156, DOI 10.22088/acadpub.BUMS.6.3.156; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Amr KS, 2018, BRIT J BIOMED SCI, V75, P82, DOI 10.1080/09674845.2017.1402404; Balasubramanyam M, 2011, MOL CELL BIOCHEM, V351, P197, DOI 10.1007/s11010-011-0727-3; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bhatt K, 2016, J AM SOC NEPHROL, V27, P2277, DOI 10.1681/ASN.2015010111; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chen T, 2011, FEBS LETT, V585, P567, DOI 10.1016/j.febslet.2011.01.010; Cirillo F, 2018, CYTOKINE GROWTH F R, V39, P1, DOI 10.1016/j.cytogfr.2017.12.004; Da Silva ND, 2012, MED SCI SPORT EXER, V44, P1453, DOI 10.1249/MSS.0b013e31824e8a36; Ebrahimi R, 2019, J CELL BIOCHEM, V120, P19290, DOI 10.1002/jcb.29299; Ezzat H., 2013, AM J BIOCH, V3, P97, DOI [10.5923/j.ajb.20130304.03, DOI 10.5923/J.AJB.20130304.03]; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Hameed I, 2015, WORLD J DIABETES, V6, P598, DOI 10.4239/wjd.v6.i4.598; Henriksen EJ, 2011, FREE RADICAL BIO MED, V51, P993, DOI 10.1016/j.freeradbiomed.2010.12.005; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kamali K, 2016, BRATISL MED J, V117, P376, DOI 10.4149/BLL_2016_074; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Li YT, 2016, J VASC RES, V53, P94, DOI 10.1159/000448713; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Manfe V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029541; Matheson A, 2010, DIABETES-METAB RES, V26, P150, DOI 10.1002/dmrr.1068; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mensa E, 2019, MECH AGEING DEV, V180, P1, DOI 10.1016/j.mad.2019.03.001; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Paneni F, 2014, CARDIOVASC DIAGN THE, V4, P324, DOI 10.3978/j.issn.2223-3652.2014.08.02; Pastukh N, 2019, CLIN EXP MED, V19, P255, DOI 10.1007/s10238-019-00546-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rehman K, 2017, CRIT REV EUKAR GENE, V27, P229, DOI 10.1615/CritRevEukaryotGeneExpr.2017019712; Rezk NA, 2016, IUBMB LIFE, V68, P452, DOI 10.1002/iub.1502; Rong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073272; Roos J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38339; Sendi H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200847; Senthilkumar GP, 2018, DIABETES METAB SYND, V12, P23, DOI 10.1016/j.dsx.2017.08.005; Shah R, 2017, DIABETES CARE, V40, P546, DOI 10.2337/dc16-1354; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shibasaki M, 2003, BIOCHEM BIOPH RES CO, V309, P419, DOI 10.1016/j.bbrc.2003.07.007; Temelkova-Kurktschiev T, 2002, DIABETOLOGIA, V45, P151; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wang GF, 2012, PHYTOCHEM ANALYSIS, V23, P159, DOI 10.1002/pca.1337; Wang R, 2015, EUR J ENDOCRINOL, V172, P291, DOI 10.1530/EJE-14-0867; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wegner M, 2013, INFLAMMATION, V36, P723, DOI 10.1007/s10753-013-9598-y; Willeit P, 2017, DIABETES, V66, P347, DOI 10.2337/db16-0731; Wu Y, 2017, J PERIODONTOL, V88, pE179, DOI 10.1902/jop.2017.170091; Yang Y, 2016, IMMUNOPHARM IMMUNOT, V38, P502, DOI 10.1080/08923973.2016.1248845; Yang ZP, 2014, ACTA DIABETOL, V51, P823, DOI 10.1007/s00592-014-0617-8; Ye D, 2018, LIFE SCI, V208, P201, DOI 10.1016/j.lfs.2018.07.029; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zeinali F, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04236-y; Zhao YH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00145	61	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251697	10.1371/journal.pone.0251697	http://dx.doi.org/10.1371/journal.pone.0251697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077450	Green Published, gold			2022-12-26	WOS:000664638500013
J	Jenkins, BR; Blaseg, NA; Grifka-Walk, HM; Deuling, B; Swain, SD; Campbell, EL; Walk, ST; Kominsky, DJ				Jenkins, Brittany R.; Blaseg, Nathan A.; Grifka-Walk, Heather M.; Deuling, Benjamin; Swain, Steve D.; Campbell, Eric L.; Walk, Seth T.; Kominsky, Douglas J.			Loss of interleukin-10 receptor disrupts intestinal epithelial cell proliferation and skews differentiation towards the goblet cell fate	FASEB JOURNAL			English	Article						absorptive cells; differentiation; goblet cells; interleukin&#8208; 10 receptor; intestines	INFLAMMATORY-BOWEL-DISEASE; GENE-EXPRESSION; IL-10 RECEPTOR; MOUSE MODEL; CANCER; PROGENITORS; HOMEOSTASIS; POLYPS; MUCOSA; TARGET	Intestinal epithelial cells (IEC) are crucial for maintaining proper digestion and overall homeostasis of the gut mucosa. IEC proliferation and differentiation are tightly regulated by well described pathways, however, relatively little is known about how cytokines shape these processes. Given that the anti-inflammatory cytokine interleukin (IL)-10 promotes intestinal barrier function, and insufficient IL-10 signaling increases susceptibility to intestinal diseases like inflammatory bowel disease, we hypothesized that IL-10 signaling modulates processes underlying IEC proliferation and differentiation. This was tested using in vivo and in vitro IEC-specific IL-10 receptor 1 (IL-10R1) depletion under homeostatic conditions. Our findings revealed that loss of IL-10R1 drove lineage commitment toward a dominant goblet cell phenotype while decreasing absorptive cell-related features. Diminished IL-10 signaling also significantly elevated IEC proliferation with relatively minor changes to apoptosis. Characterization of signaling pathways upstream of proliferation demonstrated a significant reduction in the Wnt inhibitor, DKK1, increased nuclear localization of beta-catenin, and increased transcripts of the proliferation marker, OLFM4, with IL-10R1 depletion. Phosphorylated STAT3 was nearly completely absent in IL-10R1 knockdown cells and may provide a mechanistic link between our observations and the regulation of these cellular processes. Our results demonstrate a novel role for IL-10 signaling in intestinal mucosal homeostasis by regulating proper balance of proliferation and IEC lineage fate.	[Jenkins, Brittany R.; Grifka-Walk, Heather M.; Deuling, Benjamin; Swain, Steve D.; Walk, Seth T.; Kominsky, Douglas J.] Montana State Univ, Dept Microbiol & Immunol, 109 Lewis Hall, Bozeman, MT 59717 USA; [Blaseg, Nathan A.] Univ South Dakota, Sanford Sch Med, Sioux Falls, SD USA; [Campbell, Eric L.] Queens Univ Belfast, Ctr Med Expt, Belfast, Antrim, North Ireland	Montana State University System; Montana State University Bozeman; University of South Dakota; Queens University Belfast	Kominsky, DJ (corresponding author), Montana State Univ, Dept Microbiol & Immunol, 109 Lewis Hall, Bozeman, MT 59717 USA.	douglas.kominsky@montana.edu	Campbell, Eric/N-5357-2015	Campbell, Eric/0000-0003-0744-6577	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK09945]; HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [U54GM115371]; United States Department of Agriculture National Institute of Food and Agriculture Hatch Project [1015883]	HHS \ NIH \ National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); United States Department of Agriculture National Institute of Food and Agriculture Hatch Project	HHS vertical bar NIH vertical bar National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: R01DK09945; HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: U54GM115371; United States Department of Agriculture National Institute of Food and Agriculture Hatch Project, Grant/Award Number: 1015883	Akedo I, 2001, CANCER EPIDEM BIOMAR, V10, P925; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Bianco AM, 2015, WORLD J GASTROENTERO, V21, P12296, DOI 10.3748/wjg.v21.i43.12296; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Bourreille A, 1999, EUR J CLIN INVEST, V29, P48; Bousoik E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00287; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Contreras-Ruiz L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/636812; Dahan S, 2008, GASTROENTEROLOGY, V134, P192, DOI 10.1053/j.gastro.2007.10.022; Dame MK, 2014, LAB INVEST, V94, P222, DOI 10.1038/labinvest.2013.145; DELEON MP, 1988, CANCER RES, V48, P4121; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Denning TL, 2000, INT IMMUNOL, V12, P133, DOI 10.1093/intimm/12.2.133; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gassler N, 2006, GUT, V55, P1084, DOI 10.1136/gut.2005.073262; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Graham DB, 2013, TRENDS IMMUNOL, V34, P371, DOI 10.1016/j.it.2013.04.001; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hasnain SZ, 2013, GASTROENTEROLOGY, V144, P357, DOI 10.1053/j.gastro.2012.10.043; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kim TH, 2016, CELL REP, V16, P2053, DOI 10.1016/j.celrep.2016.07.056; Koch S, 2011, GASTROENTEROLOGY, V141, P259, DOI 10.1053/j.gastro.2011.03.043; Kominsky DJ, 2014, J IMMUNOL, V192, P1267, DOI 10.4049/jimmunol.1301757; Kopp ZA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00017; Kuhn KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114195; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lanis JM, 2017, MUCOSAL IMMUNOL, V10, P1133, DOI 10.1038/mi.2016.133; LEV R, 1982, GASTROENTEROLOGY, V82, P1427; Liljegren A, 2003, GUT, V52, P1140, DOI 10.1136/gut.52.8.1140; Liu XD, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0206-6; Liu ZS, 2020, DNA CELL BIOL, V39, P599, DOI 10.1089/dna.2019.5215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzon E, 2002, MOL MED, V8, P353, DOI 10.1007/BF03402016; Moor AE, 2018, CELL, V175, P1156, DOI 10.1016/j.cell.2018.08.063; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morhardt TL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38125-x; MORI M, 1993, GASTROENTEROLOGY, V105, P820, DOI 10.1016/0016-5085(93)90900-W; Navabi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068761; Noah TK, 2011, EXP CELL RES, V317, P2702, DOI 10.1016/j.yexcr.2011.09.006; Oft M, 2014, CANCER IMMUNOL RES, V2, P194, DOI 10.1158/2326-6066.CIR-13-0214; Olszak T, 2014, NATURE, V509, P497, DOI 10.1038/nature13150; Parang B, 2016, METHODS MOL BIOL, V1422, P297, DOI 10.1007/978-1-4939-3603-8_26; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Quiros M, 2017, J CLIN INVEST, V127, P3516, DOI 10.1172/JCI90229; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; SHANBHAG AG, 1994, CVGIP-GRAPH MODEL IM, V56, P414, DOI 10.1006/cgip.1994.1037; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567	58	1	1	3	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21551	10.1096/fj.202002369R	http://dx.doi.org/10.1096/fj.202002369R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042222				2022-12-26	WOS:000655695900037
J	Hubens, WHG; Kievit, MT; Berendschot, TTJM; de Coo, IFM; Smeets, HJM; Webers, CAB; Gorgels, TGMF				Hubens, Wouter H. G.; Kievit, Marielle T.; Berendschot, Tos T. J. M.; de Coo, Irenaeus F. M.; Smeets, Hubert J. M.; Webers, Carroll A. B.; Gorgels, Theo G. M. F.			Plasma GDF-15 concentration is not elevated in open-angle glaucoma	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; GROWTH; BIOMARKER; FACTOR-15; DISEASE; PREVALENCE; DYSFUNCTION; GENETICS; GDF15; CELLS	Aim Recently, the level of growth differentiation factor 15 (GDF-15) in blood, was proposed as biomarker to detect mitochondrial dysfunction. In the current study, we evaluate this biomarker in open-angle glaucoma (OAG), as there is increasing evidence that mitochondrial dysfunction plays a role in the pathophysiology of this disease. Methods Plasma GDF-15 concentrations were measured with ELISA in 200 OAG patients and 61 age-matched controls (cataract without glaucoma). The OAG patient group consisted of high tension glaucoma (HTG; n = 162) and normal tension glaucoma (NTG; n = 38). Groups were compared using the Kruskal-Wallis nonparametric test with Dunn's multiple comparison post-hoc correction. GDF-15 concentration was corrected for confounders identified with forward linear regression models. Results Before correcting for confounders, median plasma GDF-15 levels was significantly lower in the combined OAG group (p = 0.04), but not when analysing HTG and NTG patients separately. Forward linear regression analysis showed that age, gender, smoking and systemic hypertension were significant confounders affecting GDF-15 levels. After correction for these confounders, GDF-15 levels in OAG patients were no longer significantly different from controls. Subgroup analysis of the glaucoma patients did not show a correlation between disease severity and plasma GDF-15, but did reveal that for NTG patients, intake of dietary supplements, which potentially improve mitochondrial function, correlated with lower plasma GDF-15. Conclusion The present study suggests that plasma GDF-15 is not suited as biomarker of mitochondrial dysfunction in OAG patients.	[Hubens, Wouter H. G.; Kievit, Marielle T.; Berendschot, Tos T. J. M.; Webers, Carroll A. B.; Gorgels, Theo G. M. F.] Maastricht Univ, Univ Eye Clin Maastricht, Med Ctr, Maastricht, Netherlands; [Hubens, Wouter H. G.; Kievit, Marielle T.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Berendschot, Tos T. J. M.] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [de Coo, Irenaeus F. M.; Smeets, Hubert J. M.] Maastricht Univ, Dept Toxicogen, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Eindhoven University of Technology; Maastricht University	Hubens, WHG; Gorgels, TGMF (corresponding author), Maastricht Univ, Univ Eye Clin Maastricht, Med Ctr, Maastricht, Netherlands.; Hubens, WHG (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	w.hubens@maastrichtuniversity.nl; theo.gorgels@mumc.nl	Berendschot, Tos TJM/M-8509-2016	Berendschot, Tos TJM/0000-0002-8101-939X; Hubens, Wouter/0000-0001-9015-123X	Stichting Oogfonds Nederland [UZ 2019-22]; Glaucoomfonds [UZ 2019-22]	Stichting Oogfonds Nederland; Glaucoomfonds	This study was supported by Stichting Oogfonds Nederland and the Glaucoomfonds via a grant contributed through UitZicht and awarded to TG (UZ 2019-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2006, INVEST OPHTH VIS SCI, V47, P2533, DOI 10.1167/iovs.05-1639; Adela R, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/490842; Ban N, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91455; Bourouki E, 2019, J GLAUCOMA, V28, P749, DOI 10.1097/IJG.0000000000001303; Cardellach F, 2003, J TOXICOL-CLIN TOXIC, V41, P223, DOI 10.1081/CLT-120021102; Conte M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00915; Davis RL, 2016, NEUROLOGY, V86, P2010, DOI 10.1212/WNL.0000000000002705; Doerstling S, 2018, UPSALA J MED SCI, V123, P86, DOI 10.1080/03009734.2018.1460427; Farkouh A, 2016, CLIN OPHTHALMOL, V10, P2433, DOI 10.2147/OPTH.S118409; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Formichi P, 2020, NEUROL SCI, V41, P3653, DOI 10.1007/s10072-020-04422-5; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Freeman CM, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0251-1; Kalko SG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-91; Hubens WHG, 2019, CURR EYE RES, V44, P1006, DOI 10.1080/02713683.2019.1607392; Hui FR, 2020, CLIN EXP OPHTHALMOL, V48, P903, DOI 10.1111/ceo.13818; Inoue-Yanagimachi M, 2019, BRIT J OPHTHALMOL, V103, P1060, DOI 10.1136/bjophthalmol-2018-312356; Izzotti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014567; Izzotti A, 2010, ARCH OPHTHALMOL-CHIC, V128, P724, DOI 10.1001/archophthalmol.2010.87; Janssen SF, 2013, PROG RETIN EYE RES, V37, P31, DOI 10.1016/j.preteyeres.2013.09.001; Ji XB, 2017, MOL NEUROBIOL, V54, P8110, DOI 10.1007/s12035-016-0283-7; Kapetanakis VV, 2016, BRIT J OPHTHALMOL, V100, P86, DOI 10.1136/bjophthalmol-2015-307223; Khawaja AP, 2016, INVEST OPHTH VIS SCI, V57, P5046, DOI 10.1167/iovs.16-20017; Kumar P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07503-2; Lascaratos G, 2012, MITOCHONDRION, V12, P202, DOI 10.1016/j.mito.2011.11.004; Lehtonen JM, 2021, J INHERIT METAB DIS, V44, P469, DOI 10.1002/jimd.12307; Lehtonen JM, 2016, NEUROLOGY, V87, P2290, DOI 10.1212/WNL.0000000000003374; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Lind L, 2009, EUR HEART J, V30, P2346, DOI 10.1093/eurheartj/ehp261; Liu YT, 2017, EXP EYE RES, V160, P62, DOI 10.1016/j.exer.2017.05.002; Manickam AH, 2017, INDIAN J OPHTHALMOL, V65, P1087, DOI 10.4103/ijo.IJO_358_17; Mirzaei M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12858-7; Montero R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148709; Mutlu LC, 2015, INFLAMMATION, V38, P1805, DOI 10.1007/s10753-015-0158-5; Nzoughet JK, 2019, INVEST OPHTH VIS SCI, V60, P2509, DOI 10.1167/iovs.19-27099; O'Keeffe AG, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0426-1; Patel S, 2019, CELL METAB, V29, P707, DOI 10.1016/j.cmet.2018.12.016; Poulsen NS, 2020, MITOCHONDRION, V50, P35, DOI 10.1016/j.mito.2019.10.005; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; Shim MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33830; Sokmen E, 2019, FUTUR SCI OA, V5, DOI 10.2144/fsoa-2019-0029; Tanaka T, 2018, AGING CELL, V17, DOI 10.1111/acel.12799; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tsai VWW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133362; Tsygankova PG, 2019, J INHERIT METAB DIS, V42, P918, DOI 10.1002/jimd.12142; Van Bergen NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140919; Williams Pete A, 2018, Commun Integr Biol, V11, pe1356956, DOI 10.1080/19420889.2017.1356956; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Wu Q, 2012, INNATE IMMUN-LONDON, V18, P617, DOI 10.1177/1753425911429837; Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506; Zhang YH, 2017, TOXICOL APPL PHARM, V332, P8, DOI 10.1016/j.taap.2017.07.016	51	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252630	10.1371/journal.pone.0252630	http://dx.doi.org/10.1371/journal.pone.0252630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048486	gold, Green Published			2022-12-26	WOS:000664636100070
J	Priebe, JA; Horn-Hofmann, C; Wolf, D; Wolff, S; Heesen, M; Knippenberg-Bigge, K; Lang, P; Lautenbacher, S				Priebe, Janosch A.; Horn-Hofmann, Claudia; Wolf, Daniel; Wolff, Stefanie; Heesen, Michael; Knippenberg-Bigge, Katrin; Lang, Philip; Lautenbacher, Stefan			Attentional processing of pain faces and other emotional faces in chronic pain-an eye-tracking study	PLOS ONE			English	Article							SELECTIVE ATTENTION; GERMAN VERSION; INDIVIDUALS; VIGILANCE; BIAS; FEAR; RECOGNITION; EXPRESSIONS; INFORMATION; MOVEMENTS	Altered attentional processing of pain-associated stimuli-which might take the form of either avoidance or enhanced vigilance-is thought to be implicated in the development and maintenance of chronic pain. In contrast to reaction time tasks like the dot probe, eye tracking allows for tracking the time course of visual attention and thus differentiating early and late attentional processes. Our study aimed at investigating visual attention to emotional faces in patients with chronic musculoskeletal pain (N = 20) and matched pain-free controls (N = 20). Emotional faces (pain, angry, happy) were presented in pairs with a neutral face for 2000 ms each. Three parameters were determined: First fixation probabilities, fixation durations (overall and divided in four 500 ms intervals) and a fixation bias score as the relative fixation duration of emotional faces compared to neutral faces. There were no group differences in any of the parameters. First fixation probabilities were lower for pain faces than for angry faces. Overall, we found longer fixation duration on emotional compared to neutral faces ('emotionality bias'), which is in accord with previous research. However, significant longer fixation duration compared to the neutral face was detected only for happy and angry but not for pain faces. In addition, fixation durations as well as bias scores yielded evidence for vigilant-avoidant processing of pain faces in both groups. These results suggest that attentional bias towards pain-associated stimuli might not generally differentiate between healthy individuals and chronic pain patients. Exaggerated attentional bias in patients might occur only under specific circumstances, e.g., towards stimulus material specifically relating to the specific pain of the patients under study or under high emotional distress.	[Priebe, Janosch A.; Horn-Hofmann, Claudia; Wolf, Daniel; Wolff, Stefanie; Lautenbacher, Stefan] Otto Friedrich Univ Bamberg, Dept Physiol Psychol, Bamberg, Germany; [Priebe, Janosch A.] Tech Univ Munich, Ctr Interdisciplinary Pain Management Rise uP, MRI, Dept Neurol, Munich, Germany; [Heesen, Michael; Knippenberg-Bigge, Katrin; Lang, Philip] Sozialstiftung Bamberg, Dept Anesthesiol & Pain Therapy, Bamberg, Germany	Otto Friedrich University Bamberg; Technical University of Munich	Horn-Hofmann, C (corresponding author), Otto Friedrich Univ Bamberg, Dept Physiol Psychol, Bamberg, Germany.	claudia.horn-hofmann@uni-bamberg.de						Baum C, 2013, PAIN RES MANAG, V18, P191, DOI 10.1155/2013/371428; Baum C, 2013, J PAIN, V14, P223, DOI 10.1016/j.jpain.2012.11.001; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crombez G, 2013, PAIN, V154, P497, DOI 10.1016/j.pain.2012.11.013; Fashler SR, 2016, J PAIN RES, V9, P551, DOI 10.2147/JPR.S104268; Fashler SR, 2014, J PAIN RES, V7, P557, DOI 10.2147/JPR.S67431; Franklin ZC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010031; Giel KE, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00063; Jackson T, 2018, EUR J PAIN, V22, P1113, DOI 10.1002/ejp.1195; Jackson T, 2019, PAIN, V160, P2221, DOI 10.1097/j.pain.0000000000001614; Jackson T, 2018, J PAIN, V19, P649, DOI 10.1016/j.jpain.2018.01.011; Khatibi A, 2009, PAIN, V142, P42, DOI 10.1016/j.pain.2008.11.020; Kunz M, 2017, INT J BEHAV MED, V24, P260, DOI 10.1007/s12529-016-9585-4; Lee JE, 2018, PAIN RES MANAG, V2018, DOI 10.1155/2018/6038406; Liossi C, 2014, PAIN, V155, P503, DOI 10.1016/j.pain.2013.11.014; Mahmoodi-Aghdam Masoumeh, 2017, Basic Clin Neurosci, V8, P467, DOI 10.29252/nirp.bcn.8.6.467; Mazidi M., 2019, BR J PAIN, V2019; MCCRACKEN LM, 1992, PAIN, V50, P67, DOI 10.1016/0304-3959(92)90113-P; McCracken LM, 1997, BEHAV THER, V28, P271, DOI 10.1016/S0005-7894(97)80047-0; McWilliams LA, 2007, PAIN, V127, P27, DOI 10.1016/j.pain.2006.07.020; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Mogg K, 2004, COGNITION EMOTION, V18, P689, DOI 10.1080/02699930341000158; Peters ML, 2016, J POSIT PSYCHOL, V11, P258, DOI 10.1080/17439760.2015.1048816; Pincus T, 2001, PSYCHOL BULL, V127, P599, DOI 10.1037//0033-2909.127.5.599; Priebe JA, 2015, EUR J PAIN, V19, P817, DOI 10.1002/ejp.608; Schoth DE, 2015, EUR J PAIN, V19, P722, DOI 10.1002/ejp.595; Schoth DE, 2012, CLIN PSYCHOL REV, V32, P13, DOI 10.1016/j.cpr.2011.09.004; Sharpe L, 2019, PAIN, V160, P2173, DOI 10.1097/j.pain.0000000000001615; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Todd J, 2018, HEALTH PSYCHOL REV, V12, P419, DOI 10.1080/17437199.2018.1521729; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Vassilopoulos SP, 2005, BEHAV COGN PSYCHOTH, V33, P13, DOI 10.1017/S1352465804001730; Vervoort T, 2013, PAIN, V154, P836, DOI 10.1016/j.pain.2013.02.017; Walter B, 2002, SCHMERZ, V15, pS83; Yang Z, 2013, J PAIN, V14, P1148, DOI 10.1016/j.jpain.2013.04.017	36	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252398	10.1371/journal.pone.0252398	http://dx.doi.org/10.1371/journal.pone.0252398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PN	34048466	Green Published, gold			2022-12-26	WOS:000664636100045
J	Rios, S; Torres, A; Diemer, H; Collin-Faure, V; Cianferani, S; Lafanechere, L; Rabilloud, T				Rios, Sacnite Ramirez; Torres, Anaelle; Diemer, Helene; Collin-Faure, Veronique; Cianferani, Sarah; Lafanechere, Laurence; Rabilloud, Thierry			A proteomic-informed view of the changes induced by loss of cellular adherence: The example of mouse macrophages	PLOS ONE			English	Article							PDZ DOMAIN; PROTEIN; PHOSPHORYLATION; INTERACTS; CELLS; DEHYDROGENASE; COMPLEX; PHAGOCYTOSIS; COMBINATION; COFILIN	Except cells circulating in the bloodstream, most cells in vertebrates are adherent. Studying the repercussions of adherence per se in cell physiology is thus very difficult to carry out, although it plays an important role in cancer biology, e.g. in the metastasis process. In order to study how adherence impacts major cell functions, we used a murine macrophage cell line. Opposite to the monocyte/macrophage system, where adherence is associated with the acquisition of differentiated functions, these cells can be grown in both adherent or suspension conditions without altering their differentiated functions (phagocytosis and inflammation signaling). We used a proteomic approach to cover a large panel of proteins potentially modified by the adherence status. Targeted experiments were carried out to validate the proteomic results, e.g. on metabolic enzymes, mitochondrial and cytoskeletal proteins. The mitochondrial activity was increased in non-adherent cells compared with adherent cells, without differences in glucose consumption. Concerning the cytoskeleton, a rearrangement of the actin organization (filopodia vs sub-cortical network) and of the microtubule network were observed between adherent and non-adherent cells. Taken together, these data show the mechanisms at play for the modification of the cytoskeleton and also modifications of the metabolic activity between adherent and non-adherent cells.	[Rios, Sacnite Ramirez; Lafanechere, Laurence] Univ Grenoble Alpes, Inst Adv Biosci, CNRS, UMR 5309,INSERM,U1209, Grenoble, France; [Torres, Anaelle; Collin-Faure, Veronique; Rabilloud, Thierry] Univ Grenoble Alpes, CNRS, CEA, Chem & Biol Met,UMR5249,IRIG,DIESE,CBM ProMD, Grenoble, France; [Diemer, Helene; Cianferani, Sarah] Univ Strasbourg, CNRS, Lab Spectrometrie Masse BioOrgan LSMBO, IPHC,UMR 7178, Strasbourg, France; [Diemer, Helene; Cianferani, Sarah] FR2048 ProFI, Infrastruct Natl Proteom, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rabilloud, T (corresponding author), Univ Grenoble Alpes, CNRS, CEA, Chem & Biol Met,UMR5249,IRIG,DIESE,CBM ProMD, Grenoble, France.	thierry.rabilloud@cnrs.fr	TORRES, Anaelle/ABD-4920-2021	Cianferani, Sarah/0000-0003-4013-4129; Torres, Anaelle/0000-0002-0525-1787	Agence Nationale pour la Recherche, France [ANR-10-INBS-08-03]; University Grenoble Alpes; French National Centre for Scientific Research (CNRS)	Agence Nationale pour la Recherche, France(French National Research Agency (ANR)); University Grenoble Alpes; French National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Agence Nationale pour la Recherche, France in the form of a grant awarded to SC (ANR-10-INBS-08-03), as well as University Grenoble Alpes and French National Centre for Scientific Research (CNRS) in the form of recurring basic funding for the labs and research teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL G, 1991, EUR J IMMUNOGENET, V18, P239, DOI 10.1111/j.1744-313X.1991.tb00024.x; ANDERSON VE, 1984, BIOCHEMISTRY-US, V23, P2779, DOI 10.1021/bi00307a038; Anghel SI, 2012, PIGM CELL MELANOMA R, V25, P482, DOI 10.1111/j.1755-148X.2012.01018.x; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Biarc J, 2014, J PROTEOMICS, V110, P183, DOI 10.1016/j.jprot.2014.05.026; Bohlson SS, 2005, J LEUKOCYTE BIOL, V77, P80, DOI 10.1189/jlb.0504305; Boye TL., 2017, NAT COMMUN, P8, DOI [10.1038/s41467-017-00021-9, DOI 10.1038/S41467-017-00021-9]; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; D'Acquisto F, 2008, BRIT J PHARMACOL, V155, P152, DOI 10.1038/bjp.2008.252; Dalzon B, 2019, ENVIRON SCI-NANO, V6, P3133, DOI 10.1039/c9en00408d; Dalzon B, 2017, NANOSCALE, V9, P9641, DOI 10.1039/c7nr02140b; Danhier P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053324; DOMMES V, 1976, ANAL BIOCHEM, V71, P571, DOI 10.1016/S0003-2697(76)80026-7; EDDE B, 1991, J CELL BIOCHEM, V46, P134, DOI 10.1002/jcb.240460207; Eder T, 2017, METHODS MOL BIOL, V1612, P167, DOI 10.1007/978-1-4939-7021-6_12; El Mourabit H, 2002, MATRIX BIOL, V21, P207, DOI 10.1016/S0945-053X(01)00198-6; Follain G, 2020, NAT REV CANCER, V20, P107, DOI 10.1038/s41568-019-0221-x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; KAWATA M, 1991, CANCER RES, V51, P2655; LaFlamme SE, 2018, CELL MOL LIFE SCI, V75, P4177, DOI 10.1007/s00018-018-2913-x; Li G, 2016, BBA-MOL CELL RES, V1863, P572, DOI 10.1016/j.bbamcr.2015.12.021; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; MALAWISTA SE, 1971, YALE J BIOL MED, V44, P286; MALCOVATI M, 1982, METHOD ENZYMOL, V90, P170; Marcus K, 2020, PROTEOMES, V8, DOI 10.3390/proteomes8030023; Marcus K, 2020, PROTEOMES, V8, DOI 10.3390/proteomes8030017; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Mayer KM, 2002, J BIOMOL SCREEN, V7, P135, DOI 10.1089/10870570252906594; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MILLER L, 1979, ANAL BIOCHEM, V100, P166, DOI 10.1016/0003-2697(79)90127-1; Olski TM, 2001, J CELL SCI, V114, P525; Panek M, 2018, CYTOTECHNOLOGY, V70, P1085, DOI 10.1007/s10616-018-0194-8; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; PLAUT B, 1972, BIOCHEM J, V129, P311, DOI 10.1042/bj1290311; Prudent R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208979; Rabilloud T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195755; Rabilloud T, 2014, PROTEOMICS, V14, P157, DOI 10.1002/pmic.201300413; Richert S, 2004, PROTEOMICS, V4, P909, DOI 10.1002/pmic.200300642; Ritov VB, 2001, DIABETES, V50, P1253, DOI 10.2337/diabetes.50.6.1253; Sakuma M, 2012, MOL BIOL CELL, V23, P3707, DOI 10.1091/mbc.E12-01-0053; Salim M, 2001, J BIOL CHEM, V276, P10929, DOI 10.1074/jbc.M010753200; Seemann J, 1996, MOL BIOL CELL, V7, P1359, DOI 10.1091/mbc.7.9.1359; Solito E, 2006, FASEB J, V20, P1498, DOI 10.1096/fj.05-5319fje; Sridharan R, 2019, ACTA BIOMATER, V89, P47, DOI 10.1016/j.actbio.2019.02.048; Stojadinovic A, 2007, MED SCI MONITOR, V13, pBR231; SUTHERLAND EW, 1949, J BIOL CHEM, V181, P153; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Torres A, 2020, NANOMATERIALS-BASEL, V10, DOI 10.3390/nano10020215; Tracy CM, 2014, J BIOL CHEM, V289, P4490, DOI 10.1074/jbc.M113.542159; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Wang J, 2019, TOXICOL LETT, V313, P150, DOI 10.1016/j.toxlet.2019.07.002; Westbrook JA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv360; Wu D, 2010, J BIOL CHEM, V285, P28643, DOI 10.1074/jbc.M110.107649; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoshimi R, 2006, J IMMUNOL, V176, P3611, DOI 10.4049/jimmunol.176.6.3611; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107	63	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252450	10.1371/journal.pone.0252450	http://dx.doi.org/10.1371/journal.pone.0252450			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048472	Green Published, gold			2022-12-26	WOS:000664636100053
J	Kozera-Kowalska, M; Uglis, J; Lira, J				Kozera-Kowalska, Magdalena; Uglis, Jaroslaw; Lira, Jaroslaw			A framework to measure the taxonomic of economic anchor: A case study of the Three Seas Initiative countries	PLOS ONE			English	Article							GROWTH	This research is aimed at determining the characteristics of the current level of entrepreneurial potential of the Three Seas Initiative (3SI) countries, the ability to overcome the consequences of extraordinary events, such as COVID-19 and prospects for the return to an accelerated development once the destabiliser of the economic system, the coronavirus pandemic, has ceased. Eurostat, World Bank and the World Economic Forum data for 2015-2019 were used for the purpose of the research. The research was divided into three stages, i.e. assessment of economic development on the basis of a synthetic ratio of economic anchor development, for which a relative benchmark method based on spatial median (so-called L1 median or Weber point) was used, identification of conditions for the development of entrepreneurial capacity and statistical analysis showing the correlation between economic anchor measures and selected factors of the 3SI countries economic development. Our study found that the entrepreneurial capacity of the 3SI countries in 2015-2019 was determined by nine characteristics, belonging to six areas, i.e. local economy, demographic situation, social situation, trade exchange, innovation and tourism economy. The entrepreneurial potential of the 3SI countries was spatially diversified, and its development was determined, among others, by the entrepreneurial activity of residents (entrepreneurship index) and the conditions for running a business.	[Kozera-Kowalska, Magdalena; Lira, Jaroslaw] Poznan Univ Life Sci, Fac Econ, Poznan, Poland; [Uglis, Jaroslaw] Poznan Univ Life Sci, Fac Vet Med & Anim Sci, Poznan, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences	Kozera-Kowalska, M (corresponding author), Poznan Univ Life Sci, Fac Econ, Poznan, Poland.	magdalena.kozera@up.poznan.pl	Uglis, Jarosław/D-5522-2011; Kozera-Kowalska, Magdalena/U-8914-2018	Uglis, Jarosław/0000-0001-6653-2745; Kozera-Kowalska, Magdalena/0000-0002-9245-0548				Acs ZJ, 2014, RES POLICY, V43, P476, DOI 10.1016/j.respol.2013.08.016; [Anonymous], 2021, BBC WORKLIFE; Bazi?r, 2018, PRZEGLAD GEOPOLITYC, V23, P24; Bratnicki M., 2002, PRZEDSIEBIORCZO PRZE; Budner W., PRZESTRZENNY WYMIAR; Conte A., 2020, TERRITORIAL DEV JRC, P1; Czarczynska A., 2013, MANAGEMENT BUSINESS, V121, P155; Dyr T., 2012, TTS TECHNIKA TRANSPO, V19, P22; European Economic Forecast, 2020, 125 EUR EC FOR; Factsheet, FACTSH EU HELPS REB; Favero CA, 2020, RESTARTING EC SAVING, DOI [10.2139/ssrn.3580626, DOI 10.2139/SSRN.3580626]; Fernandes N., EC EFFECTS CORONAVIR; Franz H.W., 2012, CHALLENGE SOCIAL INN; Gebska M, 2020, ROCZNIK INSTYTUTU EU, V18, P171, DOI [10.36874/RIESW.2020.4.8, DOI 10.36874/RIESW.2020.4.8]; Gennaioli N, 2014, J ECON GROWTH, V19, P259, DOI 10.1007/s10887-014-9105-9; Gorka M., 2018, POLITICS CENT EUR, V14, P55, DOI [10.2478/pce-2018-0018, DOI 10.2478/PCE-2018-0018]; Harper D.A., 2002, ENTREPRENEURSHIP MAR; Holcombe Randall G., 1998, Q J AUSTRIAN EC, V1; Istok R, 2021, GEOPOLITICS, V26, P314, DOI 10.1080/14650045.2018.1551206; Klein Peter, 1999, Q J AUSTRIAN EC, V2; Klimas P., 2010, ZARZADZANIE INFORM D, P109; Kranicka T., 2002, KONCEPCJA ROZWOJU PR; Krueger N. F., 1994, ENTREP THEORY PRACT, V18, P91, DOI [10.1177/104225879401800307, DOI 10.1177/104225879401800307]; Krugman P, 1998, OXFORD REV ECON POL, V14, P7, DOI 10.1093/oxrep/14.2.7; Lira J, 2019, RELATIVE TAXONOMY ME; Lira J., 1998, ZASTOSOWANIE WYBRANY; Lira J., 2015, QUANTITATIVE METHODS, V16, P53; Mumtaz H, 2012, J EUR ECON ASSOC, V10, P716, DOI 10.1111/j.1542-4774.2012.01068.x; Orzelska-Staczek A, 2018, STUDIA POLITYCZNE, V46, P149; Orzelska-Staczek A., 2019, SPRAWY MIEDZYNARODOW, V1, P131; Panagakos G., 2015, HDB OCEAN CONTAINER, P521; Pawelek B., 2008, ZESZYTY NAUKOWE, V187; Penda I.A., 2018, ACTA EC TURISTICA, V4, P1; Raspberry A., 1997, PRZEGLAD STATYSTYCZN, V1, P11; Romisch R., 2020, COVID 19 EFFECTS CEN; Rosiek J., 2018, WIADOMOSCI STATYSTYC, V63, P28; Skrzeszewska K, 2017, EC SOC DEVELOP, P138; Sostero M., 2020, JRC WORKING PAPERS S; Strojny J., 2010, PRZEDSIEBIORCZOSC ED, V6, P176; Strulik H, 2008, J ECON GROWTH, V13, P195, DOI 10.1007/s10887-008-9033-7; Ukielski P., 2018, STUDIA EUROPEJSKIE, V86, P45; Wach K., 2015, PRZEDSIEBIORCZOSC ED, V11, P24, DOI DOI 10.24917/2729; Waligora A., 2018, STUDIA OECONOMICA PO, V6, P111; Winicki B., 2008, PERSPEKTYWY PRZEWOZO; Winiewski B., 2017, PRZEGLAD DYPLOMATYCZ, V4, P26; Wydymus S., 2013, ZESZYTY NAUKOWE U SZ, V57, P631; Xiao J, 2018, ECON GEOGR, V94, P514, DOI 10.1080/00130095.2018.1444989; Zbinkowski G, 2019, COMP ECON RES, V22, P105, DOI 10.2478/cer-2019-0015; Zieba R, 2019, POLANDS FOREIGN SECU, DOI [10.1007/978-3-030-30697-7_7, DOI 10.1007/978-3-030-30697-7_7]; Zielonka P., 2007, EFEKT ZAKOTWICZENIA	50	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252292	10.1371/journal.pone.0252292	http://dx.doi.org/10.1371/journal.pone.0252292			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043710	Green Published, gold			2022-12-26	WOS:000664635700080
J	Woon, LSC; Bin Abdullah, MFIL; Sidi, H; Mansor, NS; Jaafar, NRN				Woon, Luke Sy-Cherng; Bin Abdullah, Mohammad Farris Iman Leong; Sidi, Hatta; Mansor, Nor Shuhada; Jaafar, Nik Ruzyanei Nik			Depression, anxiety, and the COVID-19 pandemic: Severity of symptoms and associated factors among university students after the end of the movement lockdown	PLOS ONE			English	Article							MENTAL-HEALTH; IMPACT; PERSONALITY; EPIDEMIC	Background and aims This online cross-sectional study investigated the severity of depressive, anxiety, and stress symptoms among university students and determined the association between various factors and the levels of depressive and anxiety symptoms in response to the coronavirus disease 2019 (COVID-19) pandemic after the movement control order (MCO) was lifted. Methods A total of 316 participants were administered a self-report questionnaire that collected data on sociodemographic attributes, personal characteristics, COVID-19-related stressors, religious coping, and clinical characteristics. In addition, the Multidimensional Scale of Perceived Social Support (MSPSS) and the 21-item Depression, Anxiety and Stress Scale (DASS-21) were administered. Results Regarding depression, 15.5%, 11.7%, and 9.2% of the participants reported mild, moderate, and severe to extremely severe depression, respectively. For anxiety, 7.0%, 16.5%, and 13.2% of the respondents had mild, moderate, and severe to extremely severe anxiety, respectively. Moreover, 26.3% of participants had mild stress, 9.5% had moderate stress, and 6.6% had severe to extremely severe stress. The multiple linear regression model revealed that frustration because of loss of daily routine and study disruption and having preexisting medical, depressive, and anxiety disorders were associated with elevated depressive symptoms, while a greater degree of family and friends social support was associated with less depressive symptoms after adjusting for age, gender, and marital status. It was also found that frustration because of study disruption and having preexisting medical, depressive, and anxiety disorders were associated with elevated anxiety symptoms, while being enrolled in medicine-based courses and having a greater degree of family support were factors associated with less anxiety symptoms after adjusting for age, gender, and marital status. Conclusion There is a need to conduct a longitudinal study in the future to confirm the causal relationship between the significant predictive factors and depression and anxiety identified in this study, and maintenance of a persistent flow of academic activities and social interaction may be of utmost importance to safeguard the mental wellbeing of university students.	[Woon, Luke Sy-Cherng; Sidi, Hatta; Jaafar, Nik Ruzyanei Nik] Univ Kebangsaan, Malaysia Med Ctr, Dept Psychiat, Kuala Lumpur, Malaysia; [Bin Abdullah, Mohammad Farris Iman Leong; Mansor, Nor Shuhada] Univ Sains Malaysia, Adv Med & Dent Inst, Lifestyle Sci Cluster, Kepala Batas, Pulau Pinang, Malaysia	Universiti Kebangsaan Malaysia; Universiti Sains Malaysia	Bin Abdullah, MFIL (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Lifestyle Sci Cluster, Kepala Batas, Pulau Pinang, Malaysia.	farris@usm.my	Leong Abdullah, Mohammad Farris Iman/I-9583-2017	Leong Abdullah, Mohammad Farris Iman/0000-0002-7762-4052; Mansor, Nor Shuhada/0000-0003-0467-0100	Universiti Sains Malaysia [304/CIPPT/6315236]	Universiti Sains Malaysia(Universiti Sains Malaysia)	M.F.I.L.A received the research grant which funded this research project. Grant number: 304/CIPPT/6315236 Full name of funder: Short Term Grant of Universiti Sains Malaysia URL of funder: http://www.research.usm.my/default.asp? tag=22 The funder play no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, NEW STRAITS TIMES; Bagby RM, 2008, CAN J PSYCHIAT, V53, P14, DOI 10.1177/070674370805300104; Bunyan J., 2020, MALAY MAIL 0316; Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Chang Jinghui, 2020, Nan Fang Yi Ke Da Xue Xue Bao, V40, P171, DOI 10.12122/j.issn.1673-4254.2020.02.06; Chi XL, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00803; Chow SK, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9010079; Ekeland AG, 2010, INT J MED INFORM, V79, P736, DOI 10.1016/j.ijmedinf.2010.08.006; Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337; Hao FY, 2020, BRAIN BEHAV IMMUN, V87, P100, DOI 10.1016/j.bbi.2020.04.069; Hatta S, 2020, MED HEALTH-KUALA LUM, V15, P1, DOI 10.17576/MH.2020.1501.01; Hirschmann R., 2021, NUMBER STUDENTS ENRO; Islam MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238162; Kamaludin K, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05339; Kassim MAM, 2022, INT J MENT HEALTH AD, V20, P1303, DOI 10.1007/s11469-020-00444-4; Khan AH, 2020, J AFFECT DISORDERS, V277, P121, DOI 10.1016/j.jad.2020.07.135; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Li Y., 2020, CREAT ED, V11, P735, DOI [DOI 10.4236/CE.2020.115053, 10.4236/ce.2020.115053]; Li Y., 2020, PSYCHOL MED, V11, P1; Liang SW, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02231; Loo C., 2020, THE SUN DAILY; Lovibond SH., 1995, MANUAL DEPRESSION AN, V56; Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936; Manap R., 2019, J SOCIAL SCI HUMANIT, V16, P7; Moccia L, 2020, BRAIN BEHAV IMMUN, V87, P75, DOI 10.1016/j.bbi.2020.04.048; Muhammad I., 2020, SSRN, DOI [10.2139/ssrn.3720759, DOI 10.2139/SSRN.3720759]; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Ng CG, 2010, ASIAN J PSYCHIATR, V3, P3, DOI 10.1016/j.ajp.2009.12.001; Nguyen AW, 2016, J HAPPINESS STUD, V17, P959, DOI 10.1007/s10902-015-9626-8; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; Ozdin S, 2020, INT J SOC PSYCHIATR, V66, P504, DOI 10.1177/0020764020927051; Son C, 2020, J MED INTERNET RES, V22, DOI 10.2196/21279; Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206; Tafet GE, 2016, J NEUROPSYCH CLIN N, V28, P77, DOI 10.1176/appi.neuropsych.15030053; Tan WQ, 2020, BRAIN BEHAV IMMUN, V87, P84, DOI 10.1016/j.bbi.2020.04.055; van der Veen DC, 2017, AGING MENT HEALTH, V21, P1177, DOI 10.1080/13607863.2016.1202894; Wu Y, 2020, J PAIN SYMPTOM MANAG, V60, pE60, DOI 10.1016/j.jpainsymman.2020.04.008; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639; Zhang YF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072381; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	42	26	27	8	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252481	10.1371/journal.pone.0252481	http://dx.doi.org/10.1371/journal.pone.0252481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043731	Green Published, gold			2022-12-26	WOS:000664635700107
J	Sanders, MGH; Nijsten, T; Verlouw, J; Kraaij, R; Pardo, LM				Sanders, Martijn G. H.; Nijsten, Tamar; Verlouw, Joost; Kraaij, Robert; Pardo, Luba M.			Composition of cutaneous bacterial microbiome in seborrheic dermatitis patients: A cross-sectional study	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; SKIN	Background Seborrheic dermatitis (SD) is a chronic inflammatory skin disease with a multifactorial aetiology. Malassezia yeasts have been associated with the disease but the role of bacterial composition in SD has not been thoroughly investigated. Objectives To profile the bacterial microbiome of SD patients and compare this with the microbiome of individuals with no inflammatory skin disease (controls). Methods This was a cross sectional study embedded in a population-based study. Skin swabs were taken from naso-labial fold from patients with seborrheic dermatitis (lesional skin: n = 22; non-lesional skin SD: n = 75) and controls (n = 465). Sample collection began in 2016 at the research facility and is still ongoing. Shannon and Chao1 alpha- diversity metrics were calculated per group. Associations between the microbiome composition of cases and controls was calculated using multivariate statistics (permANOVA) and univariate statistics. Results We found an increased alpha -diversity between SD lesional cases versus controls (Shannon diversity: Kruskal-Wallis rank sum: Chi-squared: 19.06; global p-value = 7.7x10(-5)). Multivariate statistical analysis showed significant associations in microbiome composition when comparing lesional SD skin to controls (p-value = 0.03;R-2 = 0.1%). Seven out of 13 amplicon sequence variants (ASVs) that were significantly different between controls and lesional cases were members of the genus Staphylococcus, most of which showed increased composition in lesional cases, and were closely related to S. capitis S. caprae and S. epidermidis. Conclusion Microbiome composition differs in patients with seborrheic dermatitis and individuals without diseases. Differences were mainly found in the genus Staphylococcus.	[Sanders, Martijn G. H.; Nijsten, Tamar; Pardo, Luba M.] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands; [Verlouw, Joost; Kraaij, Robert] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Pardo, LM (corresponding author), Erasmus MC, Dept Dermatol, Rotterdam, Netherlands.	l.pardocortes@erasmusmc.nl			Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam	Erasmus Medical Center; Erasmus University Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam	The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Q, 2017, CHINESE MED J-PEKING, V130, P1662, DOI 10.4103/0366-6999.209895; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Chatzikokkinou P, 2008, ACTA DERMATOVENER CR, V16, P226; DeAngelis YM, 2005, J INVEST DERM SYMP P, V10, P295, DOI 10.1111/j.1087-0024.2005.10119.x; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Ferretti P, 2017, EXP DERMATOL, V26, P211, DOI 10.1111/exd.13210; Ghebremedhin B, 2008, J CLIN MICROBIOL, V46, P1019, DOI 10.1128/JCM.02058-07; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Gloor GB, 2016, ANN EPIDEMIOL, V26, P322, DOI 10.1016/j.annepidem.2016.03.003; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Ikram MA, 2017, EUR J EPIDEMIOL, V32, P807, DOI 10.1007/s10654-017-0321-4; Kastarinen H, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009446.pub2; Kelly BJ, 2015, BIOINFORMATICS, V31, P2461, DOI 10.1093/bioinformatics/btv183; Lally A, 2010, J EUR ACAD DERMATOL, V24, P561, DOI 10.1111/j.1468-3083.2009.03470.x; Lin QB, 2021, BIOPROC BIOSYST ENG, V44, P965, DOI 10.1007/s00449-020-02333-5; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meisel JS, 2016, J INVEST DERMATOL, V136, P947, DOI 10.1016/j.jid.2016.01.016; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Otto M, 2020, CURR OPIN MICROBIOL, V53, P71, DOI 10.1016/j.mib.2020.03.003; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Park T, 2017, EXP DERMATOL, V26, P835, DOI 10.1111/exd.13293; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanders MGH, 2018, BRIT J DERMATOL, V178, P148, DOI 10.1111/bjd.15908; Sanders MGH, 2019, J INVEST DERMATOL, V139, P108, DOI 10.1016/j.jid.2018.07.027; Sanders MGH, 2018, J INVEST DERMATOL, V138, P991, DOI 10.1016/j.jid.2017.11.020; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Soares RC, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00157; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanaka A, 2016, MICROBIOL IMMUNOL, V60, P521, DOI 10.1111/1348-0421.12398; Unna PG., 1887, MONATSH PRAKT DERMAT, V6, P827	31	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0251136	10.1371/journal.pone.0251136	http://dx.doi.org/10.1371/journal.pone.0251136			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029350	Green Published, gold			2022-12-26	WOS:000664632800004
J	Schalchli, H; Hormazabal, E; Astudillo, A; Briceno, G; Rubilar, O; Diez, MC				Schalchli, Heidi; Hormazabal, Emilio; Astudillo, Alvaro; Briceno, Gabriela; Rubilar, Olga; Diez, Maria Cristina			Bioconversion of potato solid waste into antifungals and biopigments using Streptomyces spp.	PLOS ONE			English	Article							STATE FERMENTATION; AGROINDUSTRIAL WASTE; PIGMENT PRODUCTION; TETRACYCLINE; HYDROLYSIS; PROTEIN	Potato waste was processed and used as a sole substrate for simultaneously producing antifungals and biopigments using Streptomyces spp. Out of three different Streptomyces isolates, strain SO6 stood out due to its ability to produce antifungals against economically important fungal phytopathogens and intracellular biopigments using potato waste powders without additional nutrients. This strain also showed the potential to secrete a broad range of enzymes for fermentation of eight sugars that could be involved in potato waste bioconversion. The results of the fermentation assay indicated that Streptomyces sp. strain SO6 degrades potato wastes during submerged fermentation, diminishing total dry weight and increasing reducing sugars from 0.3 to 3.6 mgmL(-1) and total proteins from 70.6 to 187.7 mu gmL(-1). The results showed that Streptomyces strain SO6 was able to convert the potato waste into 0.96 mgg(-1) of diffusible antifungals and 1.75 mgg(-1) of reddish-purple biopigments. On the contrary, an absence of pigment production was observed during the fermentation of the commercial medium used as reference. According to our results, replacement of commercial culture media with available low-cost agroindustrial wastes for producing bioactive chemicals is a real opportunity to enhance the Streptomyces pigment production and antibiotic sustainability with cost-competitiveness. To our knowledge, this is the first report on the simultaneous production of biopigments and diffusible antifungal antibiotics produced by Streptomyces spp. using potato solid waste as the sole nutrient source.	[Schalchli, Heidi; Hormazabal, Emilio; Astudillo, Alvaro; Briceno, Gabriela; Rubilar, Olga; Diez, Maria Cristina] Univ La Frontera, Biotechnol Res Ctr Appl Environm CIBAMA BIOREN, Temuco, Chile; [Schalchli, Heidi; Rubilar, Olga; Diez, Maria Cristina] Univ La Frontera, Chem Engn Dept, Temuco, Chile; [Briceno, Gabriela] Univ La Frontera, Chem Sci & Nat Resources Dept, Temuco, Chile	Universidad de La Frontera; Universidad de La Frontera; Universidad de La Frontera	Schalchli, H; Briceno, G (corresponding author), Univ La Frontera, Biotechnol Res Ctr Appl Environm CIBAMA BIOREN, Temuco, Chile.; Schalchli, H (corresponding author), Univ La Frontera, Chem Engn Dept, Temuco, Chile.; Briceno, G (corresponding author), Univ La Frontera, Chem Sci & Nat Resources Dept, Temuco, Chile.	heidi.schalchli@ufrontera.cl; gabriela.briceno@ufrontera.cl		Schalchli, Heidi/0000-0002-2624-2337	National Agency for Research and Development (ANID) / FONDECYT [11180601]; University of La Frontera DIUFRO [DI17-0126, UNT14-0009]	National Agency for Research and Development (ANID) / FONDECYT; University of La Frontera DIUFRO	This work was funded by the National Agency for Research and Development (ANID) / FONDECYT / 11180601 (HS), the University of La Frontera DIUFRO N degrees DI17-0126 (HS) and N degrees UNT14-0009 (MCD).	Alvarez A, 2017, CHEMOSPHERE, V166, P41, DOI 10.1016/j.chemosphere.2016.09.070; Anandan R, 2016, ACTINOBACTERIA BASIC, P1, DOI [10.5772/62329, DOI 10.5772/62329]; Aruldass CA, 2016, INT BIODETER BIODEGR, V113, P342, DOI 10.1016/j.ibiod.2016.01.024; Asagbra AE, 2005, WORLD J MICROB BIOT, V21, P107, DOI 10.1007/s11274-004-2778-z; Assia M., 2018, AM J MICROBIOL RES, V6, P67, DOI [10.12691/ajmr-6-3-1, DOI 10.12691/AJMR-6-3-1]; Becerra J, 2002, BOL SOC CHIL QUIM, V47, P151, DOI 10.4067/S0366-16442002000200011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bunbamrung N, 2020, PHYTOCHEMISTRY, V172, DOI 10.1016/j.phytochem.2020.112275; Castro AM, 2015, BIOCHEM ENG J, V93, P303, DOI 10.1016/j.bej.2014.10.016; Charousova I, 2015, J MICROB BIOTEC FOOD, V4, P23, DOI 10.15414/jmbfs.2015.4.special1.23-27; dos Santos ER, 2012, BRAZ ARCH BIOL TECHN, V55, P793, DOI 10.1590/S1516-89132012000500020; El-Naggar NEA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42129; Faheem M, 2015, BIOL CONTROL, V81, P101, DOI 10.1016/j.biocontrol.2014.11.012; Galal G.F., 2020, MICROBIOL RES J INT, V30, P15, DOI 10.9734/mrji/2020/v30i130186; Gmoser R, 2019, WASTE MANAGE, V97, P63, DOI 10.1016/j.wasman.2019.07.039; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; Jadon P., 2019, Environment Conservation Journal, V20, P35; Jagtap S, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113173; Javed A, 2019, AIMS AGRIC FOOD, V4, P807, DOI 10.3934/agrfood.2019.3.807; Ji Hua, 2015, Food and Nutrition Sciences, V6, P161, DOI 10.4236/fns.2015.61017; Kalaiyarasi M, 2020, J KING SAUD UNIV SCI, V32, P2134; Kassaye S, 2017, RENEW ENERG, V104, P177, DOI 10.1016/j.renene.2016.12.033; Khubber S, FERMENTATION PROCESS, V2021, P195; Kim Wan Gyu, 2008, Mycobiology, V36, P266, DOI 10.4489/MYCO.2008.36.4.266; Knoema, 2021, CROPS TRAD CROPS LIV; Landa BB, 1997, PHYTOPARASITICA, V25, P305, DOI 10.1007/BF02981094; Li QL, 2012, BIOL CONTROL, V61, P113, DOI 10.1016/j.biocontrol.2011.10.014; Long CN, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1359-z; Majumdar S, 2019, J CLEAN PROD, V211, P1389, DOI 10.1016/j.jclepro.2018.11.157; MALLADI B, 1993, WORLD J MICROB BIOT, V9, P45, DOI 10.1007/BF00656514; Manas NHA, 2020, J BIOTECHNOL, V317, P16, DOI 10.1016/j.jbiotec.2020.04.011; Meena B, 2019, MICROB PATHOGENESIS, V132, P129, DOI 10.1016/j.micpath.2019.04.043; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Minotto E., 2014, J ADV SCI RES, V5, P16; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; ODEPA, 2020, B PAP; Otero DM, 2019, BRAZ J CHEM ENG, V36, P117, DOI 10.1590/0104-6632.20190361s20170433; OZERGINULGEN K, 1993, APPL MICROBIOL BIOT, V40, P457; Panesar R, 2015, CURR OPIN FOOD SCI, V1, P70, DOI 10.1016/j.cofs.2014.12.002; Patthawaro S, 2020, WASTE BIOMASS VALORI, V11, P2375, DOI 10.1007/s12649-018-00571-z; Prat D, 2014, GREEN CHEM, V16, P4546, DOI 10.1039/c4gc01149j; Ramesh C, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040556; Rao MPN, 2017, FRONT MICROBIOL, V8, P1, DOI 10.3389/fmicb.2017.01113; Rengasamy S, 2020, SAUDI J BIOL SCI, V27, P1117, DOI 10.1016/j.sjbs.2019.12.024; Saejung C, 2021, WASTE BIOMASS VALORI, V12, P4835, DOI 10.1007/s12649-021-01351-y; Sakr AA, 2020, GEOMICROBIOL J, V37, P653, DOI 10.1080/01490451.2020.1754533; Schalchli H, 2015, CHEM ECOL, V31, P754, DOI 10.1080/02757540.2015.1094465; SCHIEBER A, 2009, FOOD, V3, P23; Sharmila G, 2013, IND CROP PROD, V44, P158, DOI 10.1016/j.indcrop.2012.11.007; Siddharth S, 2019, MICROB PATHOGENESIS, V137, DOI 10.1016/j.micpath.2019.103775; Taher NA., 2020, AL MUSTANSIRIYAH J S, V31, P6, DOI [10.23851/mjs.v31i3.93, DOI 10.23851/MJS.V31I3.93]; Torres MD, 2020, J FOOD ENG, V275, DOI 10.1016/j.jfoodeng.2019.109886; Ubando AT, 2020, BIORESOURCE TECHNOL, V299, DOI 10.1016/j.biortech.2019.122585; Usmani Z, 2020, CURR GENOMICS, V21, P80, DOI 10.2174/1389202921999200330152007; Vaithanomsat P., 2008, Kasetsart Journal, Natural Sciences, V42, P543; Venil CK, 2020, FRONT SUSTAIN FOOD S, V4, DOI 10.3389/fsufs.2020.00100; YANG SS, 1989, BIOTECHNOL BIOENG, V33, P1021, DOI 10.1002/bit.260330811; Yin HZ, 2019, SCI CHINA LIFE SCI, V62, P698, DOI 10.1007/s11427-019-9497-5; Yun TY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206497; Zezere B, 2020, SEP PURIF TECHNOL, V234, DOI 10.1016/j.seppur.2019.116046; Zhu YP, 2020, FOOD CHEM, V308, DOI 10.1016/j.foodchem.2019.125600	61	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252113	10.1371/journal.pone.0252113	http://dx.doi.org/10.1371/journal.pone.0252113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019577	gold, Green Published			2022-12-26	WOS:000664632300052
J	Furey, IM; Mehta, SC; Sankaran, B; Hu, LY; Prasad, BVV; Palzkill, T				Furey, Ian M.; Mehta, Shrenik C.; Sankaran, Banumathi; Hu, Liya; Prasad, B. V. Venkataram; Palzkill, Timothy			Local interactions with the Glu166 base and the conformation of an active site loop play key roles in carbapenem hydrolysis by the KPC-2 beta-lactamase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI STRAIN; SUBSTRATE PROFILE; CRYSTAL-STRUCTURE; ENZYME; SUBSTITUTIONS; ANTIBIOTICS; INHIBITION; EVOLUTION; INSIGHTS; ACID	The Klebsiella pneumoniae carbapenemase-2 (KPC-2) is a common source of antibiotic resistance in Gram-negative bacterial infections. KPC-2 is a class A beta-lactamase that exhibits a broad substrate profile and hydrolyzes most beta-lactam antibiotics including carbapenems owing to rapid deacylation of the covalent acyl-enzyme intermediate. However, the features that allow KPC-2 to deacylate substrates more rapidly than non-carbapenemase enzymes are not clear. The active-site residues in KPC-2 are largely conserved in sequence and structure compared with non-carbapenemases, suggesting that subtle alterations may collectively facilitate hydrolysis of carbapenems. We utilized a nonbiased genetic approach to identify mutants deficient in carbapenem hydrolysis but competent for ampicillin hydrolysis. Subsequent pre-steady-state enzyme kinetics analyses showed that the substitutions slow the rate of deacylation of carbapenems. Structure determination via X-ray diffraction indicated that a F72Y mutant forms a hydrogen bond between the tyrosine hydroxyl group and Glu166, which may lower basicity and impair the activation of the catalytic water for deacylation, whereas several mutants impact the structure of the Q214-R220 active site loop. A T215P substitution lowers the deacylation rate and drastically alters the conformation of the loop, thereby disrupting interactions between the enzyme and the carbapenem acyl-enzyme intermediate. Thus, the environment of the Glu166 general base and the precise placement and conformational stability of the Q214-R220 loop are critical for efficient deacylation of carbapenems by the KPC-2 enzyme. Therefore, the design of carbapenem antibiotics that interact with Glu166 or alter the Q214-R220 loop conformation may disrupt enzyme function and overcome resistance.	[Furey, Ian M.; Mehta, Shrenik C.; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Dept Mol Biophys & Integrated Bioimaging, Berkeley Ctr Struct Biol, Berkeley, CA USA; [Hu, Liya; Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Baylor College of Medicine	Palzkill, T (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA.; Palzkill, T (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	timothyp@bcm.edu		Mehta, Shrenik/0000-0003-3302-7069	NIH [R01 AI32956, T32 AI055449]; Welch Foundation [Q1279]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation)	This work was supported by NIH R01 AI32956 to T. P., NIH T32 AI055449 to I. M. F., and Welch Foundation Q1279 to B. V. V. P. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BICKNELL R, 1985, BIOCHEM J, V231, P83, DOI 10.1042/bj2310083; Bonomo Robert A, 2017, Cold Spring Harb Perspect Med, V7, DOI 10.1101/cshperspect.a025239; Brown CA, 2020, J BIOL CHEM, V295, P7376, DOI 10.1074/jbc.RA119.012489; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Bush K, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01076-18; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; CDC, 2013, ANTIBIOTIC RESISTANC, DOI [DOI 10.15620/CDC:82532, 10.15620/cdc:82532]; CHARNAS RL, 1981, BIOCHEMISTRY-US, V20, P2732, DOI 10.1021/bi00513a005; Dellus-Gur E, 2015, J MOL BIOL, V427, P2396, DOI 10.1016/j.jmb.2015.05.011; Dellus-Gur E, 2013, J MOL BIOL, V425, P2609, DOI 10.1016/j.jmb.2013.03.033; EASTON CJ, 1982, BIOCHEMISTRY-US, V21, P2857, DOI 10.1021/bi00541a008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Fonseca F, 2012, J AM CHEM SOC, V134, P18275, DOI 10.1021/ja304460j; Galleni Moreno, 2007, P195; Hart KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12965; HOLLAWAY MR, 1969, FEBS LETT, V4, P299, DOI 10.1016/0014-5793(69)80261-9; Kalp M, 2008, BIOCHEMISTRY-US, V47, P11830, DOI 10.1021/bi800833u; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; Ke W, 2012, ANTIMICROB AGENTS CH, V56, P2713, DOI 10.1128/AAC.06099-11; Krishnan NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136813; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282; Lohans CT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49264-0; Long SW, 2017, MBIO, V8, DOI [10.1128/mBio.00489-17, 10.1128/mbio.00489-17]; Majiduddin FK, 2005, ANTIMICROB AGENTS CH, V49, P3421, DOI 10.1128/AAC.49.8.3421-3427.2005; Malabanan MM, 2013, J AM CHEM SOC, V135, P5978, DOI 10.1021/ja401504w; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Mehta S. C., 2020, J BIOL CHEM, V296; Mehta SC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004949; Nukaga M, 2008, J AM CHEM SOC, V130, P12656, DOI 10.1021/ja7111146; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Palzkill T, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00016; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P2867, DOI 10.1128/AAC.00197-10; Patel MP, 2018, J BIOL CHEM, V293, P17971, DOI 10.1074/jbc.RA118.003792; Patel MP, 2017, BIOCHEMISTRY-US, V56, P3443, DOI 10.1021/acs.biochem.7b00176; Pemberton OA, 2017, J MED CHEM, V60, P3525, DOI 10.1021/acs.jmedchem.7b00158; Petrella S, 2008, ANTIMICROB AGENTS CH, V52, P3725, DOI 10.1128/AAC.00163-08; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pozzi C, 2016, ANTIMICROB AGENTS CH, V60, P7189, DOI 10.1128/AAC.00936-16; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Richard JP, 2016, BIOCHEMISTRY-US, V55, P3036, DOI 10.1021/acs.biochem.6b00311; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P11840, DOI 10.1021/bi901690r; Soeung V, 2020, J BIOL CHEM, V295, P18239, DOI 10.1074/jbc.RA120.016103; Stewart NK, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02191-18; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Tremblay LW, 2010, BIOCHEMISTRY-US, V49, P3766, DOI 10.1021/bi100232q; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2014, ANT RES GLOB REP SUR; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; ZAFARALLA G, 1992, J AM CHEM SOC, V114, P1505, DOI 10.1021/ja00030a070; Zhai X, 2018, J AM CHEM SOC, V140, P8277, DOI 10.1021/jacs.8b04367	64	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100799	10.1016/j.jbc.2021.100799	http://dx.doi.org/10.1016/j.jbc.2021.100799			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022225	gold, Green Published			2022-12-26	WOS:000674717300019
J	Oldach, L				Oldach, Laurel			The paper that found a third form of fat cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BROWN ADIPOSE-TISSUE; ADIPOCYTES; DISTINCT		[Oldach, Laurel] Albert Einstein Coll Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Oldach, L (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	loldach@asbmb.org		Oldach, Laurel/0000-0003-1491-608X				Berry DC, 2017, CELL METAB, V25, P166, DOI 10.1016/j.cmet.2016.10.023; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; de Jong JMA, 2019, NAT METAB, V1, P830, DOI 10.1038/s42255-019-0101-4; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Pan RP, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00185; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Wang WS, 2019, CELL METAB, V30, P174, DOI 10.1016/j.cmet.2019.05.005; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	10	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100817	10.1016/j.jbc.2021.100817	http://dx.doi.org/10.1016/j.jbc.2021.100817			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34023386	Green Published, gold			2022-12-26	WOS:000674717300026
J	Palanca, M; De Donno, G; Dall'Ara, E				Palanca, Marco; De Donno, Giulia; Dall'Ara, Enrico			A novel approach to evaluate the effects of artificial bone focal lesion on the three-dimensional strain distributions within the vertebral body	PLOS ONE			English	Article							DIGITAL VOLUME CORRELATION; METASTATICALLY INVOLVED SPINE; FINITE-ELEMENT MODELS; STRUCTURAL RESPONSE; IMAGE REGISTRATION; BURST FRACTURE; MICRO-CT; DISPLACEMENT; VALIDATION; LOCATION	The spine is the first site for incidence of bone metastasis. Thus, the vertebrae have a high potential risk of being weakened by metastatic tissues. The evaluation of strength of the bone affected by the presence of metastases is fundamental to assess the fracture risk. This work proposes a robust method to evaluate the variations of strain distributions due to artificial lesions within the vertebral body, based on in situ mechanical testing and digital volume correlation. Five porcine vertebrae were tested in compression up to 6500N inside a micro computed tomography scanner. For each specimen, images were acquired before and after the application of the load, before and after the introduction of the artificial lesions. Principal strains were computed within the bone by means of digital volume correlation (DVC). All intact specimens showed a consistent strain distribution, with peak minimum principal strain in the range -1.8% to -0.7% in the middle of the vertebra, demonstrating the robustness of the method. Similar distributions of strains were found for the intact vertebrae in the different regions. The artificial lesion generally doubled the strain in the middle portion of the specimen, probably due to stress concentrations close to the defect. In conclusion, a robust method to evaluate the redistribution of the strain due to artificial lesions within the vertebral body was developed and will be used in the future to improve current clinical assessment of fracture risk in metastatic spines.	[Palanca, Marco; De Donno, Giulia; Dall'Ara, Enrico] Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Palanca, Marco; De Donno, Giulia; Dall'Ara, Enrico] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England; [De Donno, Giulia] Univ Bologna, Dept Ind Engn, Alma Mater Studiorum, Bologna, Italy	University of Sheffield; University of Sheffield; University of Bologna	Palanca, M (corresponding author), Univ Sheffield, Dept Oncol & Metab, Sheffield, S Yorkshire, England.; Palanca, M (corresponding author), Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England.	m.palanca@sheffield.ac.uk		Dall'Ara, Enrico/0000-0003-1471-5077; Palanca, Marco/0000-0002-1231-2728	Marie Sklodowska-Curie Individual Fellowship (MetaSpine, MSCA-IF-EF-ST) [832430/2018]; H2020 Marie Sklodowska-Curie Action [EP/K03877X/1, EP/S032940/1]; Engineering and Physical Sciences Research Council (EPSRC); EPSRC [EP/S032940/1, EP/K03877X/1] Funding Source: UKRI	Marie Sklodowska-Curie Individual Fellowship (MetaSpine, MSCA-IF-EF-ST); H2020 Marie Sklodowska-Curie Action; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	MP: Marie Sklodowska-Curie Individual Fellowship (MetaSpine, MSCA-IF-EF-ST, 832430/2018), H2020 Marie Sklodowska-Curie Action, (URL: https://ec.europa.eu/research/mariecurieactions/node_en) EDA: Frontier Multisim Grant (EP/K03877X/1 and EP/S032940/1), Engineering and Physical Sciences Research Council (EPSRC), (URL: https://epsrc.ukri.org) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkalay RN, 2016, J ORTHOP RES, V34, P1808, DOI 10.1002/jor.23154; Alkalay RN, 2015, CLIN BIOMECH, V30, P121, DOI 10.1016/j.clinbiomech.2014.10.001; Aziz HN, 2008, COMPARATIVE MED, V58, P174; Barber D. C., 2005, Journal of Medical Engineering & Technology, V29, P53, DOI 10.1080/03091900412331289889; Benca E, 2017, J ORTHOP RES, V35, P2407, DOI 10.1002/jor.23550; Boulanaache Y, 2020, MED ENG PHYS, V85, P48, DOI 10.1016/j.medengphy.2020.09.009; Chen Y, 2017, J MECH BEHAV BIOMED, V65, P644, DOI 10.1016/j.jmbbm.2016.09.014; Costa MC, 2020, BONE REP, V12, DOI 10.1016/j.bonr.2020.100257; Costa MC, 2019, J MECH BEHAV BIOMED, V98, P268, DOI 10.1016/j.jmbbm.2019.06.027; Costa MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180151; Dall'Ara E, 2014, J BIOMECH, V47, P2956, DOI 10.1016/j.jbiomech.2014.07.019; Dall'Ara E, 2017, FRONT MATER, V4, DOI 10.3389/fmats.2017.00031; Danesi V, 2016, CLIN BIOMECH, V39, P14, DOI 10.1016/j.clinbiomech.2016.07.010; Danesi V, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034383; Danesi V, 2014, J BIOMECH, V47, P313, DOI 10.1016/j.jbiomech.2013.10.005; Eswaran SK, 2006, J BONE MINER RES, V21, P307, DOI 10.1359/JBMR.051027; Galbusera F, 2018, TRANSL ONCOL, V11, P639, DOI 10.1016/j.tranon.2018.03.002; Gustafson H, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4032799; Hardisty MR, 2010, ANN BIOMED ENG, V38, P2948, DOI 10.1007/s10439-010-0052-0; Hardisty MR, 2012, J ORTHOP RES, V30, P1032, DOI 10.1002/jor.22045; Hosseini HS, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026409; Hussein AI, 2013, OSTEOPOROSIS INT, V24, P979, DOI 10.1007/s00198-012-2039-1; Hussein AI, 2013, J BIOMECH, V46, P1683, DOI 10.1016/j.jbiomech.2013.04.004; Jackman TM, 2016, J BONE MINER RES, V31, P777, DOI 10.1002/jbmr.2749; Jacobs W B, 2001, Neurosurg Focus, V11, pe10; Joffre T, 2017, BIOMECH MODEL MECHAN, V16, P1349, DOI 10.1007/s10237-017-0891-9; Johnson JE, 2020, J BIOMECH, V106, DOI 10.1016/j.jbiomech.2020.109825; Kazakia GJ, 2008, MED PHYS, V35, P3170, DOI 10.1118/1.2924210; Kingma I, 2018, J BIOMECH, V70, P51, DOI 10.1016/j.jbiomech.2017.11.034; Kusins J, 2020, ANN BIOMED ENG, V48, P2859, DOI 10.1007/s10439-020-02549-2; Kusins J, 2019, J MECH BEHAV BIOMED, V97, P339, DOI 10.1016/j.jmbbm.2019.05.021; Liu L, 2007, J BIOMECH, V40, P3516, DOI 10.1016/j.jbiomech.2007.04.019; Madi K, 2020, NAT BIOMED ENG, V4, P343, DOI 10.1038/s41551-019-0477-1; Oliviero S, 2018, J MECH BEHAV BIOMED, V86, P172, DOI 10.1016/j.jmbbm.2018.06.022; Oravec D, 2019, MED PHYS, V46, P4553, DOI 10.1002/mp.13750; Palanca M, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040587; Palanca M, 2017, J BIOMECH, V58, P27, DOI 10.1016/j.jbiomech.2017.04.007; Palanca M, 2016, J BIOMECH, V49, P3882, DOI 10.1016/j.jbiomech.2016.10.018; Palanca M, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4030174; Rezaei A, 2021, J MECH BEHAV BIOMED, V119, DOI 10.1016/j.jmbbm.2021.104559; Ryan MK, 2020, MATERIALS, V13, DOI 10.3390/ma13204619; Silva M J, 1993, Eur Spine J, V2, P118, DOI 10.1007/BF00301407; Techens C, 2020, MED ENG PHYS, V84, P51, DOI 10.1016/j.medengphy.2020.07.024; Tomita K, 2001, SPINE, V26, P298, DOI 10.1097/00007632-200102010-00016; Tozzi G, 2016, STRAIN, V52, P446, DOI 10.1111/str.12202; Tschirhart CE, 2004, J BIOMECH, V37, P653, DOI 10.1016/j.jbiomech.2003.09.027; Tschirhart CE, 2007, J BIOMECH, V40, P46, DOI 10.1016/j.jbiomech.2005.11.014; Turunen MJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69850-x; Unnikrishnan GU, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031415; Whyne CM, 2000, ANN BIOMED ENG, V28, P1154, DOI 10.1114/1.1313773; Whyne CM, 2003, SPINE, V28, P652, DOI 10.1097/00007632-200304010-00007; Whyne CM, 2001, J BIOMECH, V34, P1317, DOI 10.1016/S0021-9290(01)00086-0; Windhagen HJ, 1997, CLIN ORTHOP RELAT R, P313; Wu YQ, 2020, BIOMECH MODEL MECHAN, V19, P505, DOI 10.1007/s10237-019-01225-2	54	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0251873	10.1371/journal.pone.0251873	http://dx.doi.org/10.1371/journal.pone.0251873			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061879	Green Accepted, gold, Green Published			2022-12-26	WOS:000656813600031
J	Puhl, RM; Lessard, LM; Himmelstein, MS; Foster, GD				Puhl, Rebecca M.; Lessard, Leah M.; Himmelstein, Mary S.; Foster, Gary D.			The roles of experienced and internalized weight stigma in healthcare experiences: Perspectives of adults engaged in weight management across six countries	PLOS ONE			English	Article							ANTI-FAT ATTITUDES; BIAS INTERNALIZATION; PSYCHOMETRIC PROPERTIES; GENERAL-PRACTITIONERS; WOMENS EXPERIENCES; US ADULTS; OBESITY; DISCRIMINATION; OVERWEIGHT; OUTCOMES	Background/Objectives Considerable evidence from U.S. studies suggests that weight stigma is consequential for patient-provider interactions and healthcare for people with high body weight. Despite international calls for efforts to reduce weight stigma in the medical community, cross-country research is lacking in this field. This study provides the first multinational investigation of associations between weight stigma and healthcare experiences across six Western countries. Methods Participants were 13,996 adults residing in Australia, Canada, France, Germany, the UK, and the US who were actively enrolled in an internationally available behavioral weight management program. Participants completed identical online surveys in the dominant language for their country that assessed experienced weight stigma, internalized weight bias, and healthcare behaviors and experiences including perceived quality of care, avoidance or delay of seeking care, experiences with providers, and perceived weight stigma from doctors. Results Among participants who reported a history of weight stigma (56-61%), two-thirds of participants in each country reported experiencing weight stigma from doctors. Across all six countries, after accounting for demographics, BMI, and experienced stigma, participants with higher internalized weight bias reported greater healthcare avoidance, increased perceived judgment from doctors due to body weight, lower frequency of obtaining routine checkups, less frequent listening and respect from providers, and lower quality of healthcare. Additionally, experienced weight stigma (from any source) was indirectly associated with poorer healthcare experiences through weight bias internalization, consistently across the six countries. Conclusions Weight stigma in healthcare is prevalent among adults actively engaged in weight management across different Western countries, and internalized weight bias has negative implications for healthcare even after controlling for BMI. The similar findings across all six countries underscore the negative consequences of weight stigma on healthcare behaviors and experiences, and emphasize the need for collective international efforts to address this problem.	[Puhl, Rebecca M.] Univ Connecticut, Dept Human Dev & Family Sci, Storrs, CT 06269 USA; [Puhl, Rebecca M.; Lessard, Leah M.] Univ Connecticut, Rudd Ctr Food Policy & Obes, Hartford, CT 06112 USA; [Himmelstein, Mary S.] Kent State Univ, Dept Psychol Sci, Kent, OH 44242 USA; [Foster, Gary D.] WW, New York, NY USA; [Foster, Gary D.] Univ Penn, Ctr Weight & Eating Disorders, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Connecticut; University of Connecticut; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Pennsylvania; Pennsylvania Medicine	Puhl, RM (corresponding author), Univ Connecticut, Dept Human Dev & Family Sci, Storrs, CT 06269 USA.; Puhl, RM (corresponding author), Univ Connecticut, Rudd Ctr Food Policy & Obes, Hartford, CT 06112 USA.	Rebecca.puhl@uconn.edu	Puhl, Rebecca/ABE-9260-2021	Foster, Gary/0000-0002-3960-0332	WW International	WW International	RMP received grant funding for this study fromWW International (formerly Weight Watchers). GDF is an employee and shareholder of WW(https://www.weightwatchers.com/us/), who provided input on study design and review and editing of the manuscript.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Agency for Healthcare Research and Quality (AHRQ), 2001, SURV QUEST HOUS HOLD; Ahern AL, 2017, LANCET, V389, P2214, DOI 10.1016/S0140-6736(17)30647-5; Albury C, 2020, LANCET DIABETES ENDO, V8, P447, DOI 10.1016/S2213-8587(20)30102-9; Alimoradi Z, 2020, CLIN NUTR, V39, P2001, DOI 10.1016/j.clnu.2019.10.016; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bombak AE, 2016, SOC SCI MED, V166, P94, DOI 10.1016/j.socscimed.2016.08.015; Brewis A, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-018-0337-x; Brewis AA, 2011, CURR ANTHROPOL, V52, P269, DOI 10.1086/659309; Burgess DJ, 2008, J HEALTH CARE POOR U, V19, P894, DOI 10.1353/hpu.0.0063; Cantor D., 2009, HLTH INFORM NATL TRE; Charlesworth TES, 2019, PSYCHOL SCI, V30, P174, DOI 10.1177/0956797618813087; Crandall CS, 2001, PERS SOC PSYCHOL B, V27, P30, DOI 10.1177/0146167201271003; Durso LE, 2008, OBESITY, V16, pS80, DOI 10.1038/oby.2008.448; Ferrante JM, 2016, OBES SCI PRACT, V2, P128, DOI 10.1002/osp4.40; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Gudzune KA, 2015, ANN INTERN MED, V162, P501, DOI 10.7326/M14-2238; Gudzune KA, 2014, PATIENT EDUC COUNS, V97, P128, DOI 10.1016/j.pec.2014.06.019; Gudzune KA, 2014, PREV MED, V62, P103, DOI 10.1016/j.ypmed.2014.02.001; Hargraves JL, 2003, HEALTH SERV RES, V38, P1509; Herman WH, 2015, DIABETES CARE, V38, P1449, DOI 10.2337/dc14-2459; Hilbert A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086303; Himmelstein MS, 2017, AM J PREV MED, V53, P421, DOI 10.1016/j.amepre.2017.04.003; Jung FUCE, 2016, OBES SURG, V26, P2393, DOI 10.1007/s11695-016-2104-5; Lee H, 2015, PREV MED, V70, P19, DOI 10.1016/j.ypmed.2014.11.007; Lee MS, 2016, BODY IMAGE, V17, P25, DOI 10.1016/j.bodyim.2016.01.008; Mensinger JL, 2018, BODY IMAGE, V25, P139, DOI 10.1016/j.bodyim.2018.03.001; Mold F, 2013, HEALTH EXPECT, V16, P119, DOI 10.1111/j.1369-7625.2011.00699.x; Mulherin K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-19; Newman ML, 2008, DISCOURSE PROCESS, V45, P211, DOI 10.1080/01638530802073712; Pearl RL, 2018, OBES REV, V19, P1141, DOI 10.1111/obr.12701; Pearl RL, 2018, OBESITY FACTS, V11, P157, DOI 10.1159/000488534; Pearl RL, 2018, SOC ISS POLICY REV, V12, P146, DOI 10.1111/sipr.12043; Pearl RL, 2014, BODY IMAGE, V11, P89, DOI 10.1016/j.bodyim.2013.09.005; Phelan SM, 2015, OBES REV, V16, P319, DOI 10.1111/obr.12266; Polonsky WH, 2017, DIABETES RES CLIN PR, V127, P265, DOI 10.1016/j.diabres.2017.03.016; Pont SJ, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-3034; Puhl R, 2013, INT J OBESITY, V37, P612, DOI 10.1038/ijo.2012.110; Puhl R, 2001, OBES RES, V9, P788, DOI 10.1038/oby.2001.108; Puhl RM, 2015, INT J OBESITY, V39, P1166, DOI 10.1038/ijo.2015.32; Puhl RM, 2006, OBESITY, V14, P1802, DOI 10.1038/oby.2006.208; Puhl RM, 2019, OBESITY, V27, P1906, DOI 10.1002/oby.22633; Puhl RM, 2017, ANN BEHAV MED, V51, P754, DOI 10.1007/s12160-017-9898-9; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rubino F, 2020, LANCET DIABETES ENDO, V8, P374, DOI 10.1038/s41591-020-0803-x; Sabin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048448; Schwenke M, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-01239-1; Setchell J, 2014, J PHYSIOTHER, V60, P157, DOI 10.1016/j.jphys.2014.06.020; Sutin AR, 2015, PSYCHOL SCI, V26, P1803, DOI 10.1177/0956797615601103; Tomiyama AJ, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1116-5; Tomiyama AJ, 2015, OBESITY, V23, P46, DOI 10.1002/oby.20910; Udo T, 2016, OBESITY, V24, P1366, DOI 10.1002/oby.21474; Wojtanowski AC, 2019, QUALITY OBESITY TREA, pP117, DOI DOI 10.1007/978-3-030-25173-4_13; World Health Organization Regional Office for Europe, WEIGHT BIAS OB STIGM; Wu YK, 2018, J ADV NURS, V74, P1030, DOI 10.1111/jan.13511	75	16	16	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0251566	10.1371/journal.pone.0251566	http://dx.doi.org/10.1371/journal.pone.0251566			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SL3JC	34061867	gold, Green Published			2022-12-26	WOS:000656813600022
J	Siewe, N; Friedman, A				Siewe, Nourridine; Friedman, Avner			TGF-beta inhibition can overcome cancer primary resistance to PD-1 blockade: A mathematical model	PLOS ONE			English	Article							REGULATORY T-CELLS; TUMOR-ASSOCIATED MACROPHAGES; DENDRITIC CELLS; IMMUNE; BIOMARKERS; HYPERPROGRESSION; MECHANISMS; BLOCKING; EFFICACY; EVASION	Immune checkpoint inhibitors have demonstrated, over the recent years, impressive clinical response in cancer patients, but some patients do not respond at all to checkpoint blockade, exhibiting primary resistance. Primary resistance to PD-1 blockade is reported to occur under conditions of immunosuppressive tumor environment, a condition caused by myeloid derived suppressor cells (MDSCs), and by T cells exclusion, due to increased level of T regulatory cells (Tregs). Since TGF-beta activates Tregs, TGF-beta inhibitor may overcome primary resistance to anti-PD-1. Indeed, recent mice experiments show that combining anti-PD-1 with anti-TGF-beta yields significant therapeutic improvements compared to anti-TGF-beta alone. The present paper introduces two cancer-specific parameters and, correspondingly, develops a mathematical model which explains how primary resistance to PD-1 blockade occurs, in terms of the two cancer-specific parameters, and how, in combination with anti-TGF-beta, anti-PD-1 provides significant benefits. The model is represented by a system of partial differential equations and the simulations are in agreement with the recent mice experiments. In some cancer patients, treatment with anti-PD-1 results in rapid progression of the disease, known as hyperprogression disease (HPD). The mathematical model can also explain how this situation arises, and it predicts that HPD may be reversed by combining anti-TGF-beta to anti-PD-1. The model is used to demonstrate how the two cancer-specific parameters may serve as biomarkers in predicting the efficacy of combination therapy with PD-1 and TGF-beta inhibitors.	[Siewe, Nourridine] Rochester Inst Technol, Sch Math Sci, Coll Sci, Rochester, NY 14623 USA; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Dept Math, Columbus, OH 43210 USA	Rochester Institute of Technology; University System of Ohio; Ohio State University	Siewe, N (corresponding author), Rochester Inst Technol, Sch Math Sci, Coll Sci, Rochester, NY 14623 USA.	nxssma@rit.edu		Siewe, Nourridine/0000-0002-3005-8508	College of Science at Rochester Institute of Technology [15874]; Mathematical Biosciences Institute of The Ohio State University	College of Science at Rochester Institute of Technology; Mathematical Biosciences Institute of The Ohio State University	This research was supported by the Dean's Research Initiative Grant #15874 of the College of Science at Rochester Institute of Technology. This work was also supported by the Mathematical Biosciences Institute of The Ohio State University. There was no additional external funding received for this study.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Bai XG, 2019, ONCOTARGETS THER, V12, P9527, DOI 10.2147/OTT.S224013; Cai JJ, 2019, ONCOTARGETS THER, V12, P8437, DOI 10.2147/OTT.S221340; Cantelli G, 2017, SEMIN CANCER BIOL, V42, P60, DOI 10.1016/j.semcancer.2016.08.009; Champiat S, 2018, NAT REV CLIN ONCOL, V15, P748, DOI 10.1038/s41571-018-0111-2; Champiat S, 2017, CLIN CANCER RES, V23, P1920, DOI 10.1158/1078-0432.CCR-16-1741; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chen D, 2012, B MATH BIOL, V74, P2752, DOI 10.1007/s11538-012-9776-3; Choudhry H, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9056173; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Cottrell TR, 2018, CANCER J, V24, P41, DOI 10.1097/PPO.0000000000000301; Dahmani A, 2018, CANCERS, V10, DOI 10.3390/cancers10060194; de Streel G, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17811-3; Denis M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00492; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; Fang ZX, 2017, ONCOTARGET, V8, P54173, DOI 10.18632/oncotarget.17013; Fares Charlene M, 2019, Am Soc Clin Oncol Educ Book, V39, P147, DOI 10.1200/EDBK_240837; Ganesh K, 2018, IMMUNITY, V48, P626, DOI 10.1016/j.immuni.2018.03.037; Haibe Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176176; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Janco JMT, 2015, J IMMUNOL, V194, P2985, DOI 10.4049/jimmunol.1403134; Jobe NP, 2016, HISTOCHEM CELL BIOL, V146, P205, DOI 10.1007/s00418-016-1433-8; Kamada T, 2019, P NATL ACAD SCI USA, V116, P9999, DOI 10.1073/pnas.1822001116; Kato S, 2017, CLIN CANCER RES, V23, P4242, DOI 10.1158/1078-0432.CCR-16-3133; Kawakami Y, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00136; Kumagai S, 2020, NAT IMMUNOL, V21, P1346, DOI 10.1038/s41590-020-0769-3; Labbe K, 2010, CRIT CARE, V14, DOI 10.1186/cc9295; Lei QY, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00672; Liu ZZ, 2018, INT J MOL MED, V42, P3395, DOI 10.3892/ijmm.2018.3923; Loffek S, 2018, J ONCOL, V2018, DOI 10.1155/2018/9732939; Ma Y, 2013, J CANCER, V4, P36, DOI 10.7150/jca.5046; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Martin CJ, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay8456; Nowicki TS, 2018, CANCER J, V24, P47, DOI 10.1097/PPO.0000000000000303; Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938; Oelkrug C, 2014, CLIN EXP IMMUNOL, V178, P1, DOI 10.1111/cei.12382; Perrot CY, 2013, ANN DERMATOL, V25, P135, DOI 10.5021/ad.2013.25.2.135; Popat V, 2019, J THORAC DIS, V11, pS262, DOI 10.21037/jtd.2019.01.97; Qi L, 2016, ONCOTARGET, V7, P71673, DOI 10.18632/oncotarget.12317; Ren DX, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1144-6; Sabio E, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0661-7; Sow HS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040320; Steen EH, 2020, ADV WOUND CARE, V9, P184, DOI 10.1089/wound.2019.1032; Sun JY, 2020, BIOMARK RES, V8, DOI 10.1186/s40364-020-00212-5; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; Umansky V, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4040036; Vacaflores A, 2017, MOL IMMUNOL, V81, P1, DOI 10.1016/j.molimm.2016.11.008; Wang XP, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01200-x; Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004; Whiteside TL, 2015, IMMUNOTARGETS THER, V4, P159, DOI 10.2147/ITT.S55415; Yaseen MM, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200111; Yi M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0864-3; You WJ, 2020, ONCOL REP, V44, P424, DOI 10.3892/or.2020.7643	55	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252620	10.1371/journal.pone.0252620	http://dx.doi.org/10.1371/journal.pone.0252620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061898	gold, Green Published			2022-12-26	WOS:000656813600014
J	Franco, F; Carcereny, E; Guirado, M; Ortega, AL; Lopez-Castro, R; Rodriguez-Abreu, D; Garcia-Campelo, R; del Barco, E; Juan, O; Aparisi, F; Gonzalez-Larriba, JL; Domine, M; Trigo, JM; Cobo, M; Cerezo, S; Calzas, J; Massuti, B; Bosch-Barrera, J; Coves, PG; Domenech, M; Provencio, M				Franco, Fernando; Carcereny, Enric; Guirado, Maria; Ortega, Ana L.; Lopez-Castro, Rafael; Rodriguez-Abreu, Delvys; Garcia-Campelo, Rosario; del Barco, Edel; Juan, Oscar; Aparisi, Francisco; Gonzalez-Larriba, Jose L.; Domine, Manuel; Trigo, Jose M.; Cobo, Manuel; Cerezo, Sara; Calzas, Julia; Massuti, Bartomeu; Bosch-Barrera, Joaquim; Garcia Coves, Paola; Domenech, Marta; Provencio, Mariano			Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry	PLOS ONE			English	Article							PROPHYLACTIC CRANIAL IRRADIATION; CISPLATIN-BASED CHEMOTHERAPY; STAGE; RADIOTHERAPY; 1ST-LINE; EFFICACY; TRENDS	Background Small-cell lung cancer (SCLC) is an aggressive disease with high metastatic potential and poor prognosis. Due to its low prevalence, epidemiological and clinical information of SCLC patients retrieved from lung cancer registries is scarce. Patients and methods This was an observational multicenter study that enrolled patients with lung cancer and thoracic tumors, recruited from August 2016 to January 2020 at 50 Spanish hospitals. Demographic and clinical data, treatment patterns and survival of SCLC patients included in the Thoracic Tumor Registry (TTR) were analyzed. Results With a total of 956 cases, the age of 64.7 9.1 years, 78.6% were men, 60.6% smokers, and ECOG PS 0, 1 or >= 2 in 23.1%, 53.0% and 23.8% of cases, respectively. Twenty percent of patients had brain metastases at the diagnosis. First-line chemotherapy (CT), mainly carboplatin or cisplatin plus etoposide was administered to >90% of patients. In total, 36.0% and 13.8% of patients received a second and third line of CT, respectively. Median overall survival was 9.5 months (95% CI 8.8-10.2 months), with an estimated rate of 70.3% (95% CI 67.2-73.4%), 38.9% (95% CI 35.4-42.4%), and 14.8% (95% CI 11.8-17.8%) at 6, 12 and 24 months respectively. Median progression-free survival was 6.3 months. Higher mortality and progression rates were significantly associated with male sex, older age, smoking habit, and ECOG PS 1-2. Long-term survival (> 2 years) was confirmed in 6.6% of patients, showing a positive correlation with better ECOG PS, poor smoking and absence of certain metastases at diagnosis. Conclusion This study provides an updated overview of the clinical situation and treatment landscape of ES-SCLC in Spain. Our results might assist oncologists to improve current clinical practice towards a better prognosis for these patients.	[Franco, Fernando; Provencio, Mariano] Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain; [Carcereny, Enric; Domenech, Marta] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, B ARGO, IGTP, Badalona, Spain; [Guirado, Maria; Garcia Coves, Paola] Hosp Gen Univ Elche, Elche, Spain; [Ortega, Ana L.] Hosp Univ Jaen, Jaen, Spain; [Lopez-Castro, Rafael] Hosp Clin Univ Valladolid, Valladolid, Spain; [Rodriguez-Abreu, Delvys] Hosp Univ Insular Gran Canaria, Las Palmas Gran Canaria, Spain; [Garcia-Campelo, Rosario] Complejo Hosp Univ A Coruna, La Coruna, Spain; [del Barco, Edel] Hosp Univ Salamanca, Salamanca, Spain; [Juan, Oscar] Hosp Univ & Politecn La Fe, Valencia, Spain; [Aparisi, Francisco] Hosp Gen Valencia, Valencia, Spain; [Gonzalez-Larriba, Jose L.] Hosp Univ Clin San Carlos, Madrid, Spain; [Domine, Manuel] IIS FJD, Hosp Univ Fdn Jimenez Diaz, Madrid, Spain; [Trigo, Jose M.; Cobo, Manuel] Hosp Univ Reg & Virgen Victoria, Unidad Gest Clin Interctr Oncol Med, IBIMA, Malaga, Spain; [Cerezo, Sara] Hosp Gen La Mancha Ctr, Alcazar De San Juan, Spain; [Calzas, Julia] Hosp Univ Fuenlabrada, Fuenlabrada, Spain; [Massuti, Bartomeu] Hosp Gen Univ Alicante, Alicante, Spain; [Bosch-Barrera, Joaquim] Catalan Inst Oncol, Girona, Spain	Hospital Puerta de Hierro-Majadahonda; Catalan Institute of Oncology; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Hospital Germans Trias i Pujol; Universidad de Valladolid; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; University of Salamanca; Hospital Universitari i Politecnic La Fe; Fundacion Jimenez Diaz; Universidad de Malaga; Hospital Universitario Fuenlabrada; General University Hospital of Alicante; Catalan Institute of Oncology	Provencio, M (corresponding author), Hosp Univ Puerta Hierro Majadahonda, Madrid, Spain.	mprovenciop@gmail.com	Franco, Fernando/GYD-9727-2022	Ortega Granados, Ana Laura/0000-0002-5727-3371; Bosch-Barrera, Joaquim/0000-0002-0893-7821; APARISI APARISI, FRANCISCO DE ASIS/0000-0002-1468-1375; FRANCO, FERNANDO/0000-0001-8964-5136; Rodriguez-Abreu, Delvys/0000-0003-0506-1366; Trigo, Jose/0000-0002-4489-2683; Juan, Oscar/0000-0002-7772-9030; Lopez Castro, Rafael/0000-0003-4770-4710	Fundacion GECP; AstraZeneca; Novartis; Roche; European Union's Horizon 2020 research and innovation program [CLARIFY 875160]	Fundacion GECP; AstraZeneca(AstraZeneca); Novartis(Novartis); Roche(Roche Holding); European Union's Horizon 2020 research and innovation program	The TTR registry was supported by Fundacion GECP, AstraZeneca, Novartis, Roche, the European Union's Horizon 2020 research and innovation program (CLARIFY 875160). The funders were not involved in writing the article or the decision to submit the article for publication.	Aarts MJ, 2015, CLIN LUNG CANCER, V16, P282, DOI 10.1016/j.cllc.2014.12.003; Amin MB, 2017, AJCC CANC STAGING MA, V8th, DOI [10.1007/978-3-319-40618-3_2, DOI 10.1007/978-3-319-40618-3_2, 10.1007/978-3-319-40618-3]; Bernhardt EB, 2016, CANCER TREAT RES, V170, P301, DOI 10.1007/978-3-319-40389-2_14; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Byers LA, 2015, CANCER-AM CANCER SOC, V121, P664, DOI 10.1002/cncr.29098; Choi CM, 2019, CANCER RES TREAT, V51, P1400, DOI 10.4143/crt.2018.704; Domine M, 2020, CLIN TRANSL ONCOL, V22, P245, DOI 10.1007/s12094-020-02295-w; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Foster NR, 2009, CANCER-AM CANCER SOC, V115, P2721, DOI 10.1002/cncr.24314; Fukui T, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2222-4; Griesinger F, 2019, LUNG CANCER, V135, P196, DOI 10.1016/j.lungcan.2019.07.010; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Horn L, 2018, NEW ENGL J MED, V379, P2220, DOI 10.1056/NEJMoa1809064; Kalemkerian GP, 2018, J NATL COMPR CANC NE, V16, P1171, DOI 10.6004/jnccn.2018.0079; Karachaliou N, 2016, TRANSL LUNG CANCER R, V5, P2, DOI 10.3978/j.issn.2218-6751.2016.01.02; Klein JP, 2007, STAT MED, V26, P4505, DOI 10.1002/sim.2864; Kourlaba G, 2019, CANCER EPIDEMIOL, V60, P193, DOI 10.1016/j.canep.2019.04.014; Liu SV, 2020, ANN ONCOL, V31, pS1032, DOI 10.1016/j.annonc.2020.08.1543; Manapov F, 2018, LUNG CANCER-TARGETS, V9, P49, DOI 10.2147/LCTT.S137577; Oze I, 2019, J EPIDEMIOL, V29, P347, DOI 10.2188/jea.JE20180112; Palma DA, 2016, CLIN LUNG CANCER, V17, P239, DOI 10.1016/j.cllc.2015.09.007; Paz-Ares L, 2019, LANCET, V394, P1929, DOI 10.1016/S0140-6736(19)32222-6; Provencio M, 2019, TRANSL LUNG CANCER R, V8, P461, DOI 10.21037/tlcr.2019.08.05; Reck M, 2016, J CLIN ONCOL, V34, P3740, DOI 10.1200/JCO.2016.67.6601; Rossi A, 2012, J CLIN ONCOL, V30, P1692, DOI 10.1200/JCO.2011.40.4905; Schabath MB, 2014, LUNG CANCER, V86, P14, DOI 10.1016/j.lungcan.2014.07.014; Sekine I, 2020, CANCER SCI, V111, P1685, DOI 10.1111/cas.14368; Slotman B, 2007, NEW ENGL J MED, V357, P664, DOI 10.1056/NEJMoa071780; Slotman BJ, 2015, LANCET, V385, P36, DOI 10.1016/S0140-6736(14)61085-0; Spanish Lung Cancer Group (GECP), 2016, THOR TUM REG RTT; Sun A, 2019, CURR ONCOL, V26, pE372, DOI 10.3747/co.26.4481; Wang YW, 2020, CELL BIOL INT, V44, P1564, DOI 10.1002/cbin.11359; Zhang R, 2018, CANCER MANAG RES, V10, P6525, DOI 10.2147/CMAR.S174801	33	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251761	10.1371/journal.pone.0251761	http://dx.doi.org/10.1371/journal.pone.0251761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077442	Green Published, gold			2022-12-26	WOS:000664638500016
J	Ramakrishnan, S; Baptista, RP; Asady, B; Huang, GZ; Docampo, R				Ramakrishnan, Srinivasan; Baptista, Rodrigo P.; Asady, Beejan; Huang, Guozhong; Docampo, Roberto			TbVps41 regulates trafficking of endocytic but not biosynthetic cargo to lysosomes of bloodstream forms of Trypanosoma brucei	FASEB JOURNAL			English	Article						acidocalcisome; endocytosis; HOPS; lysosome; Trypanosoma brucei; Vps41	TETHERING COMPLEXES; HOPS COMPLEX; CAENORHABDITIS-ELEGANS; AP-3 COMPLEX; LIFE-CYCLE; PROTEIN; MEMBRANE; VPS41; ACIDOCALCISOMES; SUBUNIT	The bloodstream stage of Trypanosoma brucei, the causative agent of African trypanosomiasis, is characterized by its high rate of endocytosis, which is involved in remodeling of its surface coat. Here we present evidence that RNAi-mediated expression down-regulation of vacuolar protein sorting 41 (Vps41), a component of the homotypic fusion and vacuole protein sorting (HOPS) complex, leads to a strong inhibition of endocytosis, vesicle accumulation, enlargement of the flagellar pocket ("big eye" phenotype), and dramatic effect on cell growth. Unexpectedly, other functions described for Vps41 in mammalian cells and yeasts, such as delivery of proteins to lysosomes, and lysosome-related organelles (acidocalcisomes) were unaffected, indicating that in trypanosomes post-Golgi trafficking is distinct from that of mammalian cells and yeasts. The essentiality of TbVps41 suggests that it is a potential drug target.	[Ramakrishnan, Srinivasan; Baptista, Rodrigo P.; Asady, Beejan; Huang, Guozhong; Docampo, Roberto] Ctr Trop & Emerging Global Dis, Athens, GA USA; [Docampo, Roberto] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Ramakrishnan, Srinivasan] Columbus State Univ, Dept Biol, Columbus, GA USA	University System of Georgia; University of Georgia; University System of Georgia; Columbus State University	Docampo, R (corresponding author), Univ Georgia, Dept Cellular Biol, Ctr Trop & Emerging Global Dis, Paul D Coverdell Ctr, 500 DW Brooks Dr, Athens, GA 30602 USA.	rdocampo@uga.edu		de Paula Baptista, Rodrigo/0000-0002-1806-8260; Docampo, Roberto/0000-0003-4229-8784	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [AI077538]	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI077538	Albert MA, 2005, J BIOL CHEM, V280, P28306, DOI 10.1074/jbc.M502403200; Alexander DL, 2002, J CELL SCI, V115, P3253; Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Amaya C, 2016, TRAFFIC, V17, P1181, DOI 10.1111/tra.12431; Angers CG, 2009, MOL BIOL CELL, V20, P4563, DOI 10.1091/mbc.E09-04-0272; Balderhaar HJK, 2013, J CELL SCI, V126, P1307, DOI 10.1242/jcs.107805; Cabrera M, 2010, J CELL BIOL, V191, P845, DOI 10.1083/jcb.201004092; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Darriba D, 2020, MOL BIOL EVOL, V37, P291, DOI 10.1093/molbev/msz189; Darsow T, 2001, MOL BIOL CELL, V12, P37, DOI 10.1091/mbc.12.1.37; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Demmel L, 2016, J CELL SCI, V129, P2285, DOI 10.1242/jcs.191569; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Garg S, 2011, IMMUNITY, V35, P182, DOI 10.1016/j.immuni.2011.06.009; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hao LH, 2016, P NATL ACAD SCI USA, V113, P6307, DOI 10.1073/pnas.1602757113; Harrington AJ, 2012, J NEUROSCI, V32, P2142, DOI 10.1523/JNEUROSCI.2606-11.2012; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Horn D, 2014, MOL BIOCHEM PARASIT, V195, P123, DOI 10.1016/j.molbiopara.2014.05.001; Huang GZ, 2018, MBIO, V9, DOI [10.1128/mBio.01700-18, 10.1128/mbio.01700-18]; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Huang GZ, 2011, J BIOL CHEM, V286, P36619, DOI 10.1074/jbc.M111.284661; Ibarrola-Villava M, 2015, INT J CANCER, V136, P2109, DOI 10.1002/ijc.29257; Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khatter D, 2015, J CELL SCI, V128, P1746, DOI 10.1242/jcs.162651; Klinger CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076278; Lachmann J., 2014, CELL LOGIST, V4, DOI DOI 10.4161/21592780.2014.970840; Lander N, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00068; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; Lemercier G, 2004, J BIOL CHEM, V279, P3420, DOI 10.1074/jbc.M309974200; Lin XS, 2014, SCI REP-UK, V4, DOI 10.1038/srep07282; Lu S, 2007, PARASITOLOGY, V134, P1639, DOI 10.1017/S0031182007003046; Luo SH, 2004, J BIOL CHEM, V279, P14427, DOI 10.1074/jbc.M309978200; Morlon-Guyot J, 2015, CELL MICROBIOL, V17, P1157, DOI 10.1111/cmi.12426; MUNSON BR, 1989, J BACTERIOL, V171, P3803, DOI 10.1128/jb.171.7.3803-3809.1989; O'Beirne C, 1998, MOL BIOCHEM PARASIT, V91, P165, DOI 10.1016/S0166-6851(97)00191-6; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; Pal A, 2003, BIOCHEM J, V374, P443, DOI 10.1042/BJ20030469; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; Ramakrishnan S, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020033; Rehling P, 1999, NAT CELL BIOL, V1, P346, DOI 10.1038/14037; Ruan QM, 2010, NEUROBIOL DIS, V37, P330, DOI 10.1016/j.nbd.2009.10.011; Silverman JS, 2013, TRAFFIC, V14, P1078, DOI 10.1111/tra.12094; Silverman JS, 2011, MOL MICROBIOL, V82, P664, DOI 10.1111/j.1365-2958.2011.07842.x; Sindhwani A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006700; Solinger JA, 2013, FEBS J, V280, P2743, DOI 10.1111/febs.12151; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; WEBSTER P, 1989, EUR J CELL BIOL, V49, P303; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	56	0	0	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21641	10.1096/fj.202100487R	http://dx.doi.org/10.1096/fj.202100487R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34041791	Green Accepted			2022-12-26	WOS:000655695900055
J	Vechetti, IJ; Peck, BD; Wen, Y; Walton, RG; Valentino, TR; Alimov, AP; Dungan, CM; Van Pelt, DW; von Walden, F; Alkner, B; Peterson, CA; McCarthy, JJ				Vechetti, Ivan J., Jr.; Peck, Bailey D.; Wen, Yuan; Walton, R. Grace; Valentino, Taylor R.; Alimov, Alexander P.; Dungan, Cory M.; Van Pelt, Douglas W.; von Walden, Ferdinand; Alkner, Bjorn; Peterson, Charlotte A.; McCarthy, John J.			Mechanical overload-induced muscle-derived extracellular vesicles promote adipose tissue lipolysis	FASEB JOURNAL			English	Article						adipose tissue; extracellular vesicles; lipolysis; microRNAs; skeletal muscle	ACUTE RESISTANCE EXERCISE; CYCLE ERGOMETER TEST; SKELETAL-MUSCLE; ENERGY-EXPENDITURE; BETA(3)-ADRENERGIC RECEPTOR; OXYGEN-CONSUMPTION; SATELLITE CELLS; INSULIN ACTION; BETA-AGONIST; CL 316,243	How regular physical activity is able to improve health remains poorly understood. The release of factors from skeletal muscle following exercise has been proposed as a possible mechanism mediating such systemic benefits. We describe a mechanism wherein skeletal muscle, in response to a hypertrophic stimulus induced by mechanical overload (MOV), released extracellular vesicles (EVs) containing muscle-specific miR-1 that were preferentially taken up by epidydimal white adipose tissue (eWAT). In eWAT, miR-1 promoted adrenergic signaling and lipolysis by targeting Tfap2 alpha, a known repressor of Adr beta 3 expression. Inhibiting EV release prevented the MOV-induced increase in eWAT miR-1 abundance and expression of lipolytic genes. Resistance exercise decreased skeletal muscle miR-1 expression with a concomitant increase in plasma EV miR-1 abundance, suggesting a similar mechanism may be operative in humans. Altogether, these findings demonstrate that skeletal muscle promotes metabolic adaptations in adipose tissue in response to MOV via EV-mediated delivery of miR-1.	[Vechetti, Ivan J., Jr.; Wen, Yuan] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE USA; [Vechetti, Ivan J., Jr.; Peck, Bailey D.; Walton, R. Grace; Valentino, Taylor R.; Alimov, Alexander P.; Dungan, Cory M.; Van Pelt, Douglas W.; Peterson, Charlotte A.; McCarthy, John J.] Univ Kentucky, Ctr Muscle Biol, Lexington, KY USA; [Peck, Bailey D.; Wen, Yuan; Walton, R. Grace; Dungan, Cory M.; Van Pelt, Douglas W.; Peterson, Charlotte A.] Univ Kentucky, Dept Phys Therapy, Lexington, KY USA; [Valentino, Taylor R.; Alimov, Alexander P.; McCarthy, John J.] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [von Walden, Ferdinand; Alkner, Bjorn] Karolinska Inst, Div Neuropediat, Dept Womens & Childrens Hlth, Solna, Sweden; [Alkner, Bjorn] Reg Hosp Eksjo, Dept Orthopaed Eksjo, Jonkoping, Region Jonkopin, Sweden; [Alkner, Bjorn] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden	University of Nebraska System; University of Nebraska Lincoln; University of Kentucky; University of Kentucky; University of Kentucky; Karolinska Institutet; Linkoping University	McCarthy, JJ (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA.	jjmcca2@uky.edu	Alkner, Björn/AHC-5835-2022		National Institute of Diabetes and Digestive and Kidney Diseases [R01DK119619]; Futurum-the Academy for Health and Care, Region Jonkoping County; Swedish Research Council for Sports Science	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Futurum-the Academy for Health and Care, Region Jonkoping County; Swedish Research Council for Sports Science	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (grant no. R01DK119619) to CAP and JJM and Futurum-the Academy for Health and Care, Region Jonkoping County to BA and the Swedish Research Council for Sports Science to FVW. The authors also thank Dr Beibei Zhu for his input and guidance on the 3T3-L1 cell culture.	Alberga AS, 2015, INT J OBESITY, V39, P1494, DOI 10.1038/ijo.2015.133; Aldiss P, 2018, METABOLISM, V81, P63, DOI 10.1016/j.metabol.2017.11.009; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bjorkman F, 2016, EUR J APPL PHYSIOL, V116, P1627, DOI 10.1007/s00421-016-3412-0; BLOOM JD, 1992, J MED CHEM, V35, P3081, DOI 10.1021/jm00094a025; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Broughton JP, 2016, MOL CELL, V64, P320, DOI 10.1016/j.molcel.2016.09.004; Chatzinikolaou A, 2008, DIABETES CARE, V31, P1397, DOI 10.2337/dc08-0072; CLEMENT K, 1995, NEW ENGL J MED, V333, P352, DOI 10.1056/NEJM199508103330605; COLLINS S, 1994, MOL ENDOCRINOL, V8, P518, DOI 10.1210/me.8.4.518; Rodrigues MFC, 2017, APPL PHYSIOL NUTR ME, V42, P605, DOI 10.1139/apnm-2016-0443; De Gasperi R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13105-9; Deusinger SS, 2012, PEDIATR BLOOD CANCER, V58, P135, DOI 10.1002/pbc.23368; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; DULLOO AG, 1985, METABOLISM, V34, P1061, DOI 10.1016/0026-0495(85)90080-0; Eikenberg JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148009; Ekblom-Bak E, 2014, SCAND J MED SCI SPOR, V24, P319, DOI 10.1111/sms.12014; Estrada A.L., 2020, SKELETAL MUSCLE TISS, DOI [10.1101/2020.09.27.313932, DOI 10.1101/2020.09.27.313932]; Finlin BS, 2020, J CLIN INVEST, V130, P2319, DOI 10.1172/JCI134892; Finlin BS, 2017, DIABETES, V66, P1237, DOI 10.2337/db16-1057; Forterre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084153; Fry CS, 2017, CELL STEM CELL, V20, P56, DOI 10.1016/j.stem.2016.09.010; Ghosal S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22334; GOLDBERG LR, 1968, AM PSYCHOL, V23, P483, DOI 10.1037/h0026206; Guescini M, 2010, EXP CELL RES, V316, P1977, DOI 10.1016/j.yexcr.2010.04.006; HANZLIKOVA V, 1975, CELL TISSUE RES, V160, P411; Heden T, 2011, EUR J APPL PHYSIOL, V111, P477, DOI 10.1007/s00421-010-1666-5; Hoeks J, 2003, AM J PHYSIOL-ENDOC M, V285, pE775, DOI 10.1152/ajpendo.00175.2003; Holt EH, 2001, BIOCHEM BIOPH RES CO, V288, P752, DOI 10.1006/bbrc.2001.5846; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Huh JY, 2014, MOL CELLS, V37, P365, DOI 10.14348/molcells.2014.0074; James AP, 2016, EUR J APPL PHYSIOL, V116, P2113, DOI 10.1007/s00421-016-3465-0; Jamurtas AZ, 2004, EUR J APPL PHYSIOL, V92, P393, DOI 10.1007/s00421-004-1156-8; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3467, DOI 10.1073/pnas.95.7.3467; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kim MJ, 2016, KOREAN J PARASITOL, V54, P147, DOI 10.3347/kjp.2016.54.2.147; Kirby TJ, 2016, METHODS MOL BIOL, V1460, P43, DOI 10.1007/978-1-4939-3810-0_4; Knudsen JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189301; Koopman R, 2006, EUR J APPL PHYSIOL, V96, P525, DOI 10.1007/s00421-005-0118-0; Latroche C, 2018, METHODS, V134, P50, DOI 10.1016/j.ymeth.2017.12.013; Laurens C, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131870; Le Bihan MC, 2012, J PROTEOMICS, V77, P344, DOI 10.1016/j.jprot.2012.09.008; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leonska-Duniec A, 2018, J SPORT SCI MED, V17, P134; Lin YY, 2014, MOL CELL BIOL, V34, P2339, DOI 10.1128/MCB.00042-14; Liu L, 2015, NAT PROTOC, V10, P1612, DOI 10.1038/nprot.2015.110; Lorente-Cebrian S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086800; Louis SNS, 2000, CARDIOVASC DRUG THER, V14, P565, DOI 10.1023/A:1007838125152; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Marie LS, 2003, ENDOCRINOLOGY, V144, P4427, DOI 10.1210/en.2003-0561; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; MELBY C, 1993, J APPL PHYSIOL, V75, P1847, DOI 10.1152/jappl.1993.75.4.1847; Meyers DS, 1997, J CLIN ENDOCR METAB, V82, P395, DOI 10.1210/jc.82.2.395; Murach KA, 2020, FUNCTION, V1, DOI 10.1093/function/zqaa009; Nader GA, 2005, AM J PHYSIOL-CELL PH, V289, pC1457, DOI 10.1152/ajpcell.00165.2005; Nayor M, 2015, CURR OPIN CARDIOL, V30, P543, DOI 10.1097/HCO.0000000000000206; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Ormsbee MJ, 2007, J APPL PHYSIOL, V102, P1767, DOI 10.1152/japplphysiol.00704.2006; Osterberg KL, 2000, INT J SPORT NUTR, V10, P71, DOI 10.1123/ijsnem.10.1.71; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reisi Jalil, 2016, Asian J Sports Med, V7, pe35205, DOI 10.5812/asjsm.35205; REVELLI JP, 1993, J MOL ENDOCRINOL, V10, P193, DOI 10.1677/jme.0.0100193; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SAINZ RD, 1988, BRIT J NUTR, V60, P85, DOI 10.1079/BJN19880079; SCHIAFFINO S, 1976, VIRCHOWS ARCH B, V21, P113; Seok H, 2016, MOL CELLS, V39, P375, DOI 10.14348/molcells.2016.0013; Sigal RJ, 2014, JAMA PEDIATR, V168, P1006, DOI 10.1001/jamapediatrics.2014.1392; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Pelt DW, 2020, AM J PHYSIOL-CELL PH, V319, pC419, DOI 10.1152/ajpcell.00223.2020; Vestri HS, 2007, NEUROPSYCHOPHARMACOL, V32, P765, DOI 10.1038/sj.npp.1301142; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; Walton RG, 2016, AM J PHYSIOL-ENDOC M, V311, pE69, DOI 10.1152/ajpendo.00330.2015; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555; Whitham M, 2018, CELL METAB, V27, P237, DOI 10.1016/j.cmet.2017.12.001; WILLIAMS PEV, 1987, BRIT J NUTR, V57, P417, DOI 10.1079/BJN19870049; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	80	16	16	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21644	10.1096/fj.202100242R	http://dx.doi.org/10.1096/fj.202100242R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34033143	Green Accepted, Green Submitted			2022-12-26	WOS:000655695900010
J	Artman, C; Brumfield, KD; Khanna, S; Goepp, J				Artman, Chad; Brumfield, Kyle D.; Khanna, Sahil; Goepp, Julius			Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication	PLOS ONE			English	Article							EGG-YOLK IMMUNOGLOBULIN; CLINICAL-TRIAL; INFECTIONS; PROPHYLAXIS; FIBROSIS; CHILDREN; THERAPY	Background The global pandemic of Coronavirus infectious disease 2019 (COVID-19), caused by SARS-CoV-2, has plunged the world into both social and economic disarray, with vaccines still emerging and a continued paucity of personal protective equipment; the pandemic has also highlighted the potential for rapid emergence of aggressive respiratory pathogens and the need for preparedness. Avian immunoglobulins (IgY) have been previously shown in animal models to protect against new infection and mitigate established infection when applied intranasally. We carried out a proof-of-concept study to address the feasibility of using such antibodies as mucosally-applied prophylaxis against SARS-CoV-2. Methods Hens were immunized with recombinant S1 spike glycoprotein of the virus, and the resulting IgY was evaluated for binding specificity, inhibition of glycoprotein binding to angiotensin converting enzyme-2 (ACE2) protein (the requisite binding site for the virus), and inhibition of viral replication in Vero cell culture. Results Titers of anti-S1 glycoprotein IgY were evident in yolks at 14 days post-immunization, peaking at 21 days, and at peak concentrations of 16.8 mg/ml. IgY showed strong and significant inhibition of S1/ACE2 binding interactions, and significantly inhibited viral replication at a concentration of 16.8 mg/ml. Four weeks' collection from eggs of two hens produced a total of 1.55 grams of IgY. Conclusions In this proof-of-concept study we showed that avian immunoglobulins (IgY) raised against a key virulence factor of the SARS-CoV-2 virus successfully inhibited the critical initial adhesion of viral spike glycoproteins to human ACE2 protein receptors and inhibited viral replication in vitro, in a short period using only two laying hens. We conclude that production of large amounts of IgY inhibiting viral binding and replication of SARS-CoV-2 is feasible, and that incorporation of this or similar material into an intranasal spray and/or other mucosal protecting products may be effective at reducing infection and spread of COVID-19.	[Artman, Chad; Goepp, Julius] Scaled Microbiom LLC, Hagerstown, MD 21740 USA; [Brumfield, Kyle D.] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Brumfield, Kyle D.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA; [Khanna, Sahil] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Mayo Clinic	Goepp, J (corresponding author), Scaled Microbiom LLC, Hagerstown, MD 21740 USA.	jgoepp@scaledmicrobiomics.com		Goepp, Julius/0000-0001-9449-968X; Brumfield, Kyle/0000-0002-3234-3337	Scaled Microbiomics, LLC	Scaled Microbiomics, LLC	This study was funded by Scaled Microbiomics, LLC. The funder provided support in the form of salaries for authors CA and JG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Acro Biosystems, 2020, SARS COV 2 INHIBITOR; Amirian ES, 2020, INT J INFECT DIS, V95, P363, DOI 10.1016/j.ijid.2020.04.057; Diraviyam T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097716; Giraudi V, 1997, INT J PEDIATR OTORHI, V39, P103, DOI 10.1016/S0165-5876(96)01472-3; Heikkinen T, 1998, PEDIATR INFECT DIS J, V17, P367, DOI 10.1097/00006454-199805000-00004; HEMMINGSSON P, 1993, SCAND J INFECT DIS, V25, P783, DOI 10.3109/00365549309008580; Kollberg H, 2003, PEDIATR PULM, V35, P433, DOI 10.1002/ppul.10290; Kowarik A, 2013, PACKAGE ENV STAT INC; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Lindberg K, 1996, INT J SPORTS MED, V17, P235, DOI 10.1055/s-2007-972838; Nguyen HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010152; Nilsson E, 2008, PEDIATR PULM, V43, P892, DOI 10.1002/ppul.20875; PATTERSON R, 1962, J IMMUNOL, V89, P272; Pauly D, 2011, JOVE-J VIS EXP, DOI 10.3791/3084; Rahman S, 2012, VACCINE, V30, P4661, DOI 10.1016/j.vaccine.2012.04.091; Sarker SA, 2001, J PEDIATR GASTR NUTR, V32, P19, DOI 10.1097/00005176-200101000-00009; Thomsen K, 2016, J CYST FIBROS, V15, P171, DOI 10.1016/j.jcf.2015.08.002; Tsukamoto M, 2011, MOL MED REP, V4, P209, DOI 10.3892/mmr.2011.410; Wallach MG, 2011, CLIN VACCINE IMMUNOL, V18, P1083, DOI 10.1128/CVI.05075-11; Wen JL, 2012, ANTIVIR RES, V93, P154, DOI 10.1016/j.antiviral.2011.11.005; Yang YE, 2014, J VIROL METHODS, V206, P19, DOI 10.1016/j.jviromet.2014.05.016; Zhao SQ, 2003, BIOMED ENVIRON SCI, V16, P119; Zhen YH, 2008, J APPL MICROBIOL, V105, P1529, DOI 10.1111/j.1365-2672.2008.03920.x	23	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252399	10.1371/journal.pone.0252399	http://dx.doi.org/10.1371/journal.pone.0252399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048457	Green Published, gold			2022-12-26	WOS:000664636100046
J	Fu, ZR; Akula, S; Qiao, C; Ryu, J; Chahal, G; de Garavilla, L; Kervinen, J; Thorpe, M; Hellman, L				Fu, Zhirong; Akula, Srinivas; Qiao, Chang; Ryu, Jinhye; Chahal, Gurdeep; de Garavilla, Lawrence; Kervinen, Jukka; Thorpe, Michael; Hellman, Lars			Duodenases are a small subfamily of ruminant intestinal serine proteases that have undergone a remarkable diversification in cleavage specificity	PLOS ONE			English	Article							MAST-CELL CHYMASE; EXTENDED SUBSTRATE-SPECIFICITY; STOMACH LYSOZYMES; CATHEPSIN-G; EVOLUTION; GENE; EXPRESSION; PROTEIN; MILK; SIMILARITIES	Ruminants have a very complex digestive system adapted for the digestion of cellulose rich food. Gene duplications have been central in the process of adapting their digestive system for this complex food source. One of the new loci involved in food digestion is the lysozyme c locus where cows have ten active such genes compared to a single gene in humans and where four of the bovine copies are expressed in the abomasum, the real stomach. The second locus that has become part of the ruminant digestive system is the chymase locus. The chymase locus encodes several of the major hematopoietic granule proteases. In ruminants, genes within the chymase locus have duplicated and some of them are expressed in the duodenum and are therefore called duodenases. To obtain information on their specificities and functions we produced six recombinant proteolytically active duodenases (three from cows, two from sheep and one from pigs). Two of the sheep duodenases were found to be highly specific tryptases and one of the bovine duodenases was a highly specific asp-ase. The remaining two bovine duodenases were dual enzymes with potent tryptase and chymase activities. In contrast, the pig enzyme was a chymase with no tryptase or asp-ase activity. These results point to a remarkable flexibility in both the primary and extended specificities within a single chromosomal locus that most likely has originated from one or a few genes by several rounds of local gene duplications. Interestingly, using the consensus cleavage site for the bovine asp-ase to screen the entire bovine proteome, it revealed Mucin-5B as one of the potential targets. Using the same strategy for one of the sheep tryptases, this enzyme was found to have potential cleavage sites in two chemokine receptors, CCR3 and 7, suggesting a role for this enzyme to suppress intestinal inflammation.	[Fu, Zhirong; Akula, Srinivas; Qiao, Chang; Ryu, Jinhye; Chahal, Gurdeep; Thorpe, Michael; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden; [de Garavilla, Lawrence] GDL Pharmaceut Consulting & Contracting, Downingtown, PA USA; [Kervinen, Jukka] Tosoh Biosci LLC, King Of Prussia, PA USA	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Akula, Srinivas/GYJ-1463-2022	Hellman, Lars/0000-0003-1459-3815	Knut och Alice Wallenbergs Stiftelse [KAW2017.0022]	Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation)	GDL Pharmaceutical Consulting and Contracting provided support for this study in the form of salary for LG and Tosoh Bioscience LLC provided support for this study in the form of salary for JK. The specific roles of these authors are articulated in the 'author contributions' section. Knut och Alice Wallenbergs Stiftelse provided support to LH (KAW2017.0022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143091; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Callewaert L, 2010, J BIOSCIENCES, V35, P127, DOI 10.1007/s12038-010-0015-5; CAMARA VM, 1984, AM J PHYSIOL, V247, pG19, DOI 10.1152/ajpgi.1984.247.1.G19; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Chahal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129511; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cieslak J, 2017, J SCI FOOD AGR, V97, P2174, DOI 10.1002/jsfa.8026; CROSS M, 1988, P NATL ACAD SCI USA, V85, P6232, DOI 10.1073/pnas.85.17.6232; DOBSON DE, 1984, J BIOL CHEM, V259, P1607; Edwards HM, 1999, J BIOL CHEM, V274, P30468, DOI 10.1074/jbc.274.43.30468; Fu ZR, 2019, DEV COMP IMMUNOL, V92, P160, DOI 10.1016/j.dci.2018.11.019; Fu ZR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154886; Fu ZR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131720; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Henke M, 1996, GENE, V178, P131, DOI 10.1016/0378-1119(96)00352-6; Irwin David M., 2015, Zoological Research, V36, P1, DOI 10.13918/j.issn.2095-8137.2015.1.1; Irwin DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-166; Irwin DM, 2004, GENOME, V47, P1082, DOI 10.1139/G04-075; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kervinen J, 2010, BIOCHEM PHARMACOL, V80, P1033, DOI 10.1016/j.bcp.2010.06.014; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Kornegay JR, 1996, J MOL EVOL, V42, P676, DOI 10.1007/BF02338801; Litwinczuk Z, 2011, J DAIRY SCI, V94, P684, DOI 10.3168/jds.2010-3217; McAleese SM, 1998, BIOCHEM J, V333, P801, DOI 10.1042/bj3330801; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pemberton AD, 2000, CLIN EXP ALLERGY, V30, P818, DOI 10.1046/j.1365-2222.2000.00831.x; Pemberton AD, 2002, EUR J BIOCHEM, V269, P1171, DOI 10.1046/j.1432-1033.2002.02747.x; Pemberton AD, 1997, BIOCHEM J, V321, P665, DOI 10.1042/bj3210665; Raymond WW, 2010, J IMMUNOL, V185, P5360, DOI 10.4049/jimmunol.1002292; REID JT, 1949, J DAIRY SCI, V32, P123, DOI 10.3168/jds.S0022-0302(49)92019-6; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sahoo NR., 2012, J ANIM SCI ADV, V2, P347; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Thorpe M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195077; Thorpe M, 2016, DEV COMP IMMUNOL, V63, P84, DOI 10.1016/j.dci.2016.05.013; Thorpe M, 2012, INT IMMUNOL, V24, P771, DOI 10.1093/intimm/dxs081; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje; YEH TC, 1993, MOL PHYLOGENET EVOL, V2, P65, DOI 10.1006/mpev.1993.1007; Yu M, 1996, MOL PHYLOGENET EVOL, V5, P298, DOI 10.1006/mpev.1996.0025; Zamolodchikova TS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P954, DOI 10.1134/S0006297913080130; Zamolodchikova TS, 2000, FEBS LETT, V466, P295, DOI 10.1016/S0014-5793(00)01092-9; Zamolodchikova TS, 1997, EUR J BIOCHEM, V249, P612, DOI 10.1111/j.1432-1033.1997.t01-1-00612.x; ZAMOLODCHIKOVA TS, 1995, EUR J BIOCHEM, V227, P866, DOI 10.1111/j.1432-1033.1995.tb20212.x; Zhang GC, 2014, PEDIAT ALLERG IMM-UK, V25, P544, DOI 10.1111/pai.12265	52	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252624	10.1371/journal.pone.0252624	http://dx.doi.org/10.1371/journal.pone.0252624			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048501	Green Published, gold			2022-12-26	WOS:000664636100069
J	Donoghue, OA; O'Connell, MDL; Bourke, R; Kenny, RA				Donoghue, Orna A.; O'Connell, Matthew D. L.; Bourke, Robert; Kenny, Rose Anne			Is orthostatic hypotension and co-existing supine and seated hypertension associated with future falls in community-dwelling older adults? Results from The Irish Longitudinal Study on Ageing (TILDA)	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; BLOOD-PRESSURE; POPULATION; MANAGEMENT; METAANALYSIS; MORBIDITY; MORTALITY; RECOVERY; PEOPLE	Orthostatic hypotension (OH) often co-exists with hypertension. As increasing age affects baroreflex sensitivity, it loses its ability to reduce blood pressure when lying down. Therefore, supine hypertension may be an important indicator of baroreflex function. This study examines (i) the association between OH and future falls in community-dwelling older adults and (ii) if these associations persist in those with co-existing OH and baseline hypertension, measured supine and seated. Data from 1500 community-dwelling adults aged >= 65 years from The Irish Longitudinal Study on Ageing (TILDA) were used. Continuous beat-to-beat blood pressure was measured using digital photoplethysmography during an active stand procedure with OH defined as a drop in systolic blood pressure (SBP) >= 20 mmHg and/or >= 10 mm Hg in diastolic blood pressure (DBP) within 3 minutes of standing. OH at 40 seconds (OH40) was used as a marker of impaired early stabilisation and OH sustained over the second minute (sustained OH) was used to indicate a more persistent deficit, similar to traditional OH definitions. Seated and supine hypertension were defined as SBP >= 140 mm Hg or DBP >= 90 mm Hg. Modified Poisson models were used to estimate relative risk of falls (recurrent, injurious, unexplained) and syncope occurring over four year follow-up. OH40 was independently associated with recurrent (RR = 1.30, 95% CI = 1.02,1.65), injurious (RR = 1.43, 95% CI = 1.13,1.79) and unexplained falls (RR = 1.55, 95% CI = 1.13,2.13). Sustained OH was associated with injurious (RR = 1.55, 95% CI = 1.18,2.05) and unexplained falls (RR = 1.63, 95% CI = 1.06,2.50). OH and co-existing hypertension was associated with all falls outcomes but effect sizes were consistently larger with seated versus supine hypertension. OH, particularly when co-existing with hypertension, was independently associated with increased risk of future falls. Stronger effect sizes were observed with seated versus supine hypertension. This supports previous findings and highlights the importance of assessing orthostatic blood pressure behaviour in older adults at risk of falls and with hypertension. Observed associations may reflect underlying comorbidities, reduced cerebral perfusion or presence of white matter hyperintensities.	[Donoghue, Orna A.; Kenny, Rose Anne] Trinity Coll Dublin, Irish Longitudinal Study Ageing TILDA, Dublin, Ireland; [O'Connell, Matthew D. L.] Kings Coll London, Sch Populat Hlth & Environm Sci, Dept Populat Hlth Sci, London, England; [Bourke, Robert; Kenny, Rose Anne] St James Hosp, Mercers Inst Successful Ageing MISA, Dublin, Ireland	Trinity College Dublin; University of London; King's College London; Trinity College Dublin	Donoghue, OA (corresponding author), Trinity Coll Dublin, Irish Longitudinal Study Ageing TILDA, Dublin, Ireland.	odonogh@tcd.ie		O'Connell, Matthew DL/0000-0002-9565-487X; Kenny, Rose Anne/0000-0002-9336-8124	Irish Government; Atlantic Philanthropies; Irish Life plc; Centre for Ageing Research and Development in Ireland, ageing research division of the Institute of Public Health in Ireland - American Federation for Ageing Research	Irish Government; Atlantic Philanthropies; Irish Life plc; Centre for Ageing Research and Development in Ireland, ageing research division of the Institute of Public Health in Ireland - American Federation for Ageing Research	The Irish Longitudinal Study on Ageing (TILDA) was supported by the Irish Government; the Atlantic Philanthropies; and Irish Life plc. MOC received funding from a Leadership in Ageing Research Award from the Centre for Ageing Research and Development in Ireland, which became the ageing research division of the Institute of Public Health in Ireland, sponsored by the American Federation for Ageing Research Paul B Beeson Awards for the island of Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Benetos A, 2019, CIRC RES, V124, P1045, DOI 10.1161/CIRCRESAHA.118.313236; Benvenuto LJ, 2011, AM J HYPERTENS, V24, P135, DOI 10.1038/ajh.2010.146; Biaggioni I., 2018, AM J HYPERTENS, V31, P1255, DOI DOI 10.1093/AJH/HPY089; Buckley A, 2020, JRSM CARDIOVASC DIS, V9, DOI 10.1177/2048004020954628; Ceccofiglio A, 2019, J AM MED DIR ASSOC, V20, P586, DOI 10.1016/j.jamda.2019.01.149; de Groot JC, 2000, ARCH GEN PSYCHIAT, V57, P1071, DOI 10.1001/archpsyc.57.11.1071; Donoghue OA, 2018, INT J EPIDEMIOL, V47, P1398, DOI 10.1093/ije/dyy163; Fedorowski A, 2013, J INTERN MED, V273, P322, DOI 10.1111/joim.12021; Finucane C, 2017, J AM GERIATR SOC, V65, P474, DOI 10.1111/jgs.14563; Finucane C, 2014, CIRCULATION, V130, P1780, DOI 10.1161/CIRCULATIONAHA.114.009831; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Frith J, 2017, AGE AGEING, V46, P540, DOI 10.1093/ageing/afx053; Gangavati A, 2011, J AM GERIATR SOC, V59, P383, DOI 10.1111/j.1532-5415.2011.03317.x; Ganz DA, 2005, J AM GERIATR SOC, V53, P2190, DOI 10.1111/j.1532-5415.2005.00509.x; Hu HY, 2021, NEUROSCI BIOBEHAV R, V120, P16, DOI 10.1016/j.neubiorev.2020.11.007; Jordan Jens, 2002, J Clin Hypertens (Greenwich), V4, P139, DOI 10.1111/j.1524-6175.2001.00516.x; Juraschek SP., 2020, ORTHOSTATIC HYPOTENS, V75, P660; Kamaruzzaman S, 2010, AGE AGEING, V39, P51, DOI 10.1093/ageing/afp192; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Krzesinski P, 2016, ARCH MED SCI, V12, P310, DOI 10.5114/aoms.2016.59256; Lacruz ME, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0468-7; Liguori I, 2018, J AM MED DIR ASSOC, V19, P779, DOI 10.1016/j.jamda.2018.04.018; Lipsitz L A, 1985, Clin Geriatr Med, V1, P637; Luiting S, 2019, J NUTR HEALTH AGING, V23, P330, DOI 10.1007/s12603-019-1165-2; McCrory C, 2016, CIRC RES, V119, P666, DOI 10.1161/CIRCRESAHA.116.308577; Mol A, 2019, J AM MED DIR ASSOC, V20, P589, DOI 10.1016/j.jamda.2018.11.003; Murphy CM, 2016, J PUBLIC HEALTH-UK, V38, P450, DOI 10.1093/pubmed/fdv057; Naschitz JE, 2006, POSTGRAD MED J, V82, P246, DOI 10.1136/pgmj.2005.037457; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Peeters G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201989; Privsek E, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011603; Ricci F, 2015, EUR HEART J, V36, P1609, DOI 10.1093/eurheartj/ehv093; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; RUTAN GH, 1992, HYPERTENSION, V19, P508, DOI 10.1161/01.HYP.19.6.508; Shibao C, 2010, HYPERTENSION, V56, P1042, DOI 10.1161/HYPERTENSIONAHA.110.162768; Sierra Cristina, 2011, J Aging Res, V2011, P438978, DOI 10.4061/2011/438978; Srikanth V, 2009, STROKE, V40, P175, DOI 10.1161/STROKEAHA.108.524355; Townsend RR, 2016, J AM SOC HYPERTENS, V10, P847, DOI 10.1016/j.jash.2016.08.005; Tryambake D, 2013, HYPERTENSION, V61, P1309, DOI 10.1161/HYPERTENSIONAHA.112.200972; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939	43	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252212	10.1371/journal.pone.0252212	http://dx.doi.org/10.1371/journal.pone.0252212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043698	gold, Green Published			2022-12-26	WOS:000664635700070
J	Ide, AD; Wight, EM; Damer, CK				Ide, Amber D.; Wight, Elise M.; Damer, Cynthia K.			Phosphatidylserine exposure promotes increased adhesion in Dictyostelium Copine A mutants	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; BINDING; CELLS; PHAGOCYTOSIS	The phospholipid phosphatidylserine (PS) is a key signaling molecule and binding partner for many intracellular proteins. PS is normally found on the inner surface of the cell membrane, but PS can be flipped to the outer surface in a process called PS exposure. PS exposure is important in many cell functions, yet the mechanisms that control PS exposure have not been extensively studied. Copines (Cpn), found in most eukaryotic organisms, make up a family of calcium-dependent phospholipid binding proteins. In Dictyostelium, which has six copine genes, CpnA strongly binds to PS and translocates from the cytosol to the plasma membrane in response to a rise in calcium. Cells lacking the cpnA gene (cpnA(-)) have defects in adhesion, chemotaxis, membrane trafficking, and cytokinesis. In this study we used both flow cytometry and fluorescent microscopy to show that cpnA(-) cells have increased adhesion to beads and bacteria and that the increased adhesion was not due to changes in the actin cytoskeleton or cell surface proteins. We found that cpnA(-) cells bound higher amounts of Annexin V, a PS binding protein, than parental cells and showed that unlabeled Annexin V reduced the increased cell adhesion property of cpnA(-) cells. We also found that cpnA(-) cells were more sensitive to Polybia-MP1, which binds to external PS and induces cell lysis. Overall, this suggests that cpnA(-) cells have increased PS exposure and this property contributes to the increased cell adhesion of cpnA(-) cells. We conclude that CpnA has a role in the regulation of plasma membrane lipid composition and may act as a negative regulator of PS exposure.	[Ide, Amber D.; Wight, Elise M.; Damer, Cynthia K.] Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA; [Wight, Elise M.] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA	Central Michigan University; State University System of Florida; Florida State University	Ide, AD (corresponding author), Cent Michigan Univ, Dept Biol, Mt Pleasant, MI 48859 USA.	ide1ad@cmich.edu	Wight, Elise/AAQ-4307-2021	Wight, Elise/0000-0002-7436-4128; Ide, Amber/0000-0001-8626-336X	National Institute of Health [2R15GM078089-02]; National Science Foundation [1337647]; Graduate Student Research Grant Central Michigan University	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Graduate Student Research Grant Central Michigan University	CKD, National Institute of Health 2R15GM078089-02 https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript CKD, Internal Faculty Research and Creative Endeavors Grant Central Michigan University https://www.cmich.edu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript CKD, National Science Foundation 1337647 https://www.nsf.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript ADI and EMW, Graduate Student Research Grant Central Michigan University https://www.cmich.edu/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benghezal M, 2007, CELL MICROBIOL, V9, P1336, DOI 10.1111/j.1462-5822.2006.00877.x; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; Bricogne C., 2019, SCI REP-UK, V9; Buccilli MJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070758; Cornillon S, 2006, EMBO REP, V7, P617, DOI 10.1038/sj.embor.7400701; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Daleke DL, 2007, J BIOL CHEM, V282, P821, DOI 10.1074/jbc.R600035200; Damer CK, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-46; Damer CK, 2007, EUKARYOT CELL, V6, P430, DOI 10.1128/EC.00322-06; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fisher PR., 2001, SOIL BIOL BIOCHEM, V33, P1576; Flegel KA, 2011, DEV GROWTH DIFFER, V53, P948, DOI 10.1111/j.1440-169X.2011.01300.x; Hankins HM, 2015, TRAFFIC, V16, P35, DOI 10.1111/tra.12233; Ilacqua AN, 2018, BMC CELL BIOL, V19, DOI 10.1186/s12860-018-0160-5; Kawli T, 2002, DIFFERENTIATION, V70, P272, DOI 10.1046/j.1432-0436.2002.700605.x; KNECHT DA, 1995, DEV BIOL, V170, P434, DOI 10.1006/dbio.1995.1227; Kunzelmann-Marche C, 2001, J BIOL CHEM, V276, P5134, DOI 10.1074/jbc.M007924200; Leite NB, 2015, BIOPHYS J, V109, P936, DOI 10.1016/j.bpj.2015.07.033; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Maselli A, 2002, MICROBIOL-SGM, V148, P413, DOI 10.1099/00221287-148-2-413; Oliveira CA, 1996, CHEM-BIOL INTERACT, V100, P141, DOI 10.1016/0009-2797(96)03695-2; Pelz T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191219; Reddy EC, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00015; Sharma B, 2018, SEMIN CANCER BIOL, V52, P17, DOI 10.1016/j.semcancer.2017.08.012; Smith TS, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-59; Tomsig JL, 2003, J BIOL CHEM, V278, P10048, DOI 10.1074/jbc.M212632200; Tomsig JL, 2000, BIOCHEMISTRY-US, V39, P16163, DOI 10.1021/bi0019949; Vallabhapurapu SD, 2015, ONCOTARGET, V6, P34375, DOI 10.18632/oncotarget.6045; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wight EM, 2020, FEBS OPEN BIO, V10, P979, DOI 10.1002/2211-5463.12874; Williamson Patrick, 2015, Lipid Insights, V8, P41, DOI 10.4137/LPI.S31785; Zhang Z, 2009, MOL BIOL CELL, V20, P5086, DOI 10.1091/mbc.E09-08-0691	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0250710	10.1371/journal.pone.0250710	http://dx.doi.org/10.1371/journal.pone.0250710			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043641	gold, Green Published			2022-12-26	WOS:000664635700013
J	Yuan, Y; Jagga, S; Martins, JS; Rana, R; Pajevic, PD; Liu, ES				Yuan, Ye; Jagga, Supriya; Martins, Janaina S.; Rana, Rakshya; Pajevic, Paola Divieti; Liu, Eva S.			Impaired 1,25 dihydroxyvitamin D-3 action and hypophosphatemia underlie the altered lacuno-canalicular remodeling observed in the Hyp mouse model of XLH	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; BONE-FORMATION; MICE; PHOSPHATE; OSTEOCYTES; EXPRESSION; GENE; RESORPTION; OSTEOBLAST; FIBROBLAST-GROWTH-FACTOR-23	Osteocytes remodel the perilacunar matrix and canaliculi. X-linked hypophosphatemia (XLH) is characterized by elevated serum levels of fibroblast growth factor 23 (FGF23), leading to decreased 1,25 dihydroxyvitamin D-3 (1,25D) production and hypophosphatemia. Bones from mice with XLH (Hyp) have enlarged osteocyte lacunae, enhanced osteocyte expression of genes of bone remodeling, and impaired canalicular structure. The altered lacuno-canalicular (LCN) phenotype is improved with 1,25D or anti-FGF23 antibody treatment, pointing to roles for 1,25D and/or phosphate in regulating this process. To address whether impaired 1,25D action results in LCN alterations, the LCN phenotype was characterized in mice lacking the vitamin D receptor (VDR) in osteocytes (VDRf/f;DMP1Cre+). Mice lacking the sodium phosphate transporter NPT2a (NPT2aKO) have hypophosphatemia and high serum 1,25D levels, therefore the LCN phenotype was characterized in these mice to determine if increased 1,25D compensates for hypophosphatemia in regulating LCN remodeling. Unlike Hyp mice, neither VDRf/f;DMP1Cre+ nor NPT2aKO mice have dramatic alterations in cortical microarchitecture, allowing for dissecting 1,25D and phosphate specific effects on LCN remodeling in tibial cortices. Histomorphometric analyses demonstrate that, like Hyp mice, tibiae and calvariae in VDRf/f;DMP1Cre+ and NPT2aKO mice have enlarged osteocyte lacunae (tibiae: 0.15 +/- 0.02 mu m(2)(VDRf/f;DMP1Cre-) vs 0.19 +/- 0.02 mu m(2)(VDRf/f;DMP1Cre+), 0.12 +/- 0.02 mu m(2)(WT) vs 0.18 +/- 0.0 mu m(2)(NPT2aKO), calvariae: 0.09 +/- 0.02 mu m(2)(VDRf/f;DMP1Cre-) vs 0.11 +/- 0.02 mu m(2)(VDRf/f;DMP1Cre+), 0.08 +/- 0.02 mu m(2)(WT) vs 0.13 +/- 0.02 mu m(2)(NPT2aKO), p<0.05 all comparisons) and increased immunoreactivity of bone resorption marker Cathepsin K (Ctsk). The osteocyte enriched RNA isolated from tibiae in VDRf/f;DMP1Cre+ and NPT2aKO mice have enhanced expression of matrix resorption genes that are classically expressed by osteoclasts (Ctsk, Acp5, Atp6v0d2, Nhedc2). Treatment of Ocy454 osteocytes with 1,25D or phosphate inhibits the expression of these genes. Like Hyp mice, VDRf/f;DMP1Cre+ and NPT2aKO mice have impaired canalicular organization in tibia and calvaria. These studies demonstrate that hypophosphatemia and osteocyte-specific 1,25D actions regulate LCN remodeling. Impaired 1,25D action and low phosphate levels contribute to the abnormal LCN phenotype observed in XLH.	[Yuan, Ye; Jagga, Supriya; Martins, Janaina S.; Liu, Eva S.] Harvard Med Sch, Boston, MA 02115 USA; [Yuan, Ye; Jagga, Supriya; Rana, Rakshya; Liu, Eva S.] Brigham & Womens Hosp, Div Endocrinol Diabet Hypertens, 75 Francis St, Boston, MA 02115 USA; [Martins, Janaina S.] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Pajevic, Paola Divieti] Boston Univ, Sch Dent Med, Dept Translat Dent Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Boston University	Liu, ES (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Liu, ES (corresponding author), Brigham & Womens Hosp, Div Endocrinol Diabet Hypertens, 75 Francis St, Boston, MA 02115 USA.	esliu@bwh.harvard.edu	Jagga, Supriya/AAW-5176-2020; Jagga, Supriya/HDM-9580-2022	Jagga, Supriya/0000-0003-2915-8154; Jagga, Supriya/0000-0003-2915-8154	National Institute of of Arthritis and Musculoskeletal and Skin Diseases [K08AR067854, R03 AR073899, R01 AR076973]	National Institute of of Arthritis and Musculoskeletal and Skin Diseases	EL 1) K08AR067854 Funder: National Institute of of Arthritis and Musculoskeletal and Skin Diseases URL: niams.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2) R03 AR073899 Funder: National Institute of of Arthritis and Musculoskeletal and Skin Diseases URL: niams.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 3) R01 AR076973 Funder: National Institute of of Arthritis and Musculoskeletal and Skin Diseases URL: niams.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Busse B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006286; Carpenter TO, 2011, J BONE MINER RES, V26, P1381, DOI 10.1002/jbmr.340; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; Dhawan P, 2017, ENDOCRINOLOGY, V158, P3792, DOI 10.1210/en.2017-00258; ECAROT B, 1992, J BONE MINER RES, V7, P215; Farrow EG, 2010, NAT REV NEPHROL, V6, P207, DOI 10.1038/nrneph.2010.17; Gardiner EM, 2000, FASEB J, V14, P1908, DOI 10.1096/fj.99-1075com; Goggin PM, 2016, EUR CELLS MATER, V31, P264, DOI 10.22203/eCM.v031a18; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Hemmatian H, 2017, CURR OSTEOPOROS REP, V15, P401, DOI 10.1007/s11914-017-0402-z; Holm IA, 2001, J CLIN ENDOCR METAB, V86, P3889, DOI 10.1210/jc.86.8.3889; Ito N, 2013, J STEROID BIOCHEM, V136, P183, DOI 10.1016/j.jsbmb.2012.09.029; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Juppner H, 2011, KIDNEY INT, V79, pS24, DOI 10.1038/ki.2011.27; Kaneko I, 2011, PFLUG ARCH EUR J PHY, V461, P77, DOI 10.1007/s00424-010-0888-z; Kaya S, 2017, J BONE MINER RES, V32, P688, DOI 10.1002/jbmr.3044; Ko FC, 2016, J BONE MINER RES, V31, P2204, DOI 10.1002/jbmr.2891; Levine BS, 2009, CLIN J AM SOC NEPHRO, V4, P1866, DOI 10.2215/CJN.03000509; Li AN, 2017, J BONE MINER RES, V32, P1406, DOI 10.1002/jbmr.3146; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Liu ES., 2016, J BONE MINER RES; Liu ES, 2018, ENDOCRINOLOGY, V159, P2165, DOI 10.1210/en.2018-00174; Liu ES, 2014, ENDOCRINOLOGY, V155, P3750, DOI 10.1210/en.2014-1315; Liu SG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1636, DOI 10.1152/ajpendo.00396.2007; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Martins JS, 2019, ENDOCRINOLOGY, V160, P2204, DOI 10.1210/en.2019-00186; Meyer MB, 2017, J BIOL CHEM, V292, P17541, DOI 10.1074/jbc.M117.806901; Miedlich SU, 2010, ENDOCRINOLOGY, V151, P4607, DOI 10.1210/en.2010-0354; Plotkin LI, 2016, NAT REV ENDOCRINOL, V12, P593, DOI 10.1038/nrendo.2016.71; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Rolvien T, 2017, BONE, V103, P78, DOI 10.1016/j.bone.2017.06.022; Shiraishi A, 2000, J BONE MINER RES, V15, P770, DOI 10.1359/jbmr.2000.15.4.770; Spatz JM, 2015, J BIOL CHEM, V290, P16744, DOI 10.1074/jbc.M114.628313; St John HC, 2014, MOL ENDOCRINOL, V28, P1150, DOI 10.1210/me.2014-1091; Sugawara Y, 2013, BONE, V52, P189, DOI 10.1016/j.bone.2012.09.033; Tazawa K, 2004, J BONE MINER METAB, V22, P524, DOI 10.1007/s00774-004-0519-x; Tokarz D, 2018, J BONE MINER RES, V33, P499, DOI 10.1002/jbmr.3327; Tsourdi E, 2018, J MUSCULOSKEL NEURON, V18, P292; van Tol AF, 2020, BIOMECH MODEL MECHAN, V19, P823, DOI 10.1007/s10237-019-01250-1; VERGE CF, 1991, NEW ENGL J MED, V325, P1843, DOI 10.1056/NEJM199112263252604; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; YATES AJ, 1991, J BONE MINER RES, V6, P473; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252348	10.1371/journal.pone.0252348	http://dx.doi.org/10.1371/journal.pone.0252348			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043707	gold, Green Published			2022-12-26	WOS:000664635700092
J	Dragon-Durey, MA; Chen, XY; Kirilovsky, A; Ben Hamouda, N; El Sissy, C; Russick, J; Charpentier, E; Binois, Y; Marliot, F; Meylan, M; Granier, C; Pere, H; Saldmann, A; Rance, B; Jannot, AS; Baron, S; Chebbi, M; Fayol, A; Josseaume, N; Rives-Lange, C; Tharaux, PL; Cholley, B; Diehl, JL; Arlet, JB; Azizi, M; Karras, A; Czernichow, S; Smadja, DM; Hulot, JS; Cremer, I; Tartour, E; Mousseaux, E; Pages, F				Dragon-Durey, Marie-Agnes; Chen, Xiaoyi; Kirilovsky, Amos; Ben Hamouda, Nadine; El Sissy, Carine; Russick, Jules; Charpentier, Etienne; Binois, Yannick; Marliot, Florence; Meylan, Maxime; Granier, Clemence; Pere, Helene; Saldmann, Antonin; Rance, Bastien; Jannot, Anne Sophie; Baron, Stephanie; Chebbi, Mouna; Fayol, Antoine; Josseaume, Nathalie; Rives-Lange, Claire; Tharaux, Pierre-Louis; Cholley, Bernard; Diehl, Jean-Luc; Arlet, Jean-Benoit; Azizi, Michel; Karras, Alexandre; Czernichow, Sebastien; Smadja, David M.; Hulot, Jean-Sebastien; Cremer, Isabelle; Tartour, Eric; Mousseaux, Elie; Pages, Franck			Differential association between inflammatory cytokines and multiorgan dysfunction in COVID-19 patients with obesity	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; ADIPOKINES	To investigate the mechanisms underlying the SARS-CoV-2 infection severity observed in patients with obesity, we performed a prospective study of 51 patients evaluating the impact of multiple immune parameters during 2 weeks after admission, on vital organs' functions according to body mass index (BMI) categories. High-dimensional flow cytometric characterization of immune cell subsets was performed at admission, 30 systemic cytokines/chemokines levels were sequentially measured, thirteen endothelial markers were determined at admission and at the zenith of the cytokines. Computed tomography scans on admission were quantified for lung damage and hepatic steatosis (n = 23). Abnormal BMI (> 25) observed in 72.6% of patients, was associated with a higher rate of intensive care unit hospitalization (p = 0.044). SARS-CoV-2 RNAaemia, peripheral immune cell subsets and cytokines/chemokines were similar among BMI groups. A significant association between inflammatory cytokines and liver, renal, and endothelial dysfunctions was observed only in patients with obesity (BMI > 30). In contrast, early signs of lung damage (ground-glass opacity) correlated with Th1/M1/inflammatory cytokines only in normal weight patients. Later lesions of pulmonary consolidation correlated with BMI but were independent of cytokine levels. Our study reveals distinct physiopathological mechanisms associated with SARS-CoV-2 infection in patients with obesity that may have important clinical implications.	[Dragon-Durey, Marie-Agnes; Ben Hamouda, Nadine; El Sissy, Carine; Marliot, Florence; Granier, Clemence; Saldmann, Antonin; Tartour, Eric; Pages, Franck] Lab Immunol, Paris, France; [Dragon-Durey, Marie-Agnes; Ben Hamouda, Nadine; El Sissy, Carine; Charpentier, Etienne; Binois, Yannick; Marliot, Florence; Granier, Clemence; Pere, Helene; Saldmann, Antonin; Rance, Bastien; Jannot, Anne Sophie; Baron, Stephanie; Chebbi, Mouna; Fayol, Antoine; Rives-Lange, Claire; Tharaux, Pierre-Louis; Cholley, Bernard; Diehl, Jean-Luc; Arlet, Jean-Benoit; Azizi, Michel; Karras, Alexandre; Czernichow, Sebastien; Smadja, David M.; Hulot, Jean-Sebastien; Tartour, Eric; Mousseaux, Elie; Pages, Franck] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Dragon-Durey, Marie-Agnes; El Sissy, Carine; Marliot, Florence; Granier, Clemence; Pere, Helene; Saldmann, Antonin; Rance, Bastien; Jannot, Anne Sophie; Baron, Stephanie; Chebbi, Mouna; Fayol, Antoine; Rives-Lange, Claire; Tharaux, Pierre-Louis; Cholley, Bernard; Diehl, Jean-Luc; Arlet, Jean-Benoit; Azizi, Michel; Karras, Alexandre; Czernichow, Sebastien; Smadja, David M.; Hulot, Jean-Sebastien; Tartour, Eric; Mousseaux, Elie; Pages, Franck] Univ Paris, Paris, France; [Dragon-Durey, Marie-Agnes; Russick, Jules; Meylan, Maxime; Josseaume, Nathalie; Cremer, Isabelle] INSERM, UMRS 1138, Cordeliers Res Ctr, Team Inflammat Complement & Canc, Paris, France; [Dragon-Durey, Marie-Agnes; Chen, Xiaoyi; Kirilovsky, Amos; El Sissy, Carine; Russick, Jules; Marliot, Florence; Meylan, Maxime; Josseaume, Nathalie; Cremer, Isabelle; Pages, Franck] Sorbonne Univ, Cordeliers Res Ctr, Paris, France; [Chen, Xiaoyi; Rance, Bastien; Jannot, Anne Sophie] INSERM, UMRS 1138, Cordeliers Res Ctr, Team Informat Sci Support Personalized Med, Paris, France; [Chen, Xiaoyi; Rance, Bastien; Jannot, Anne Sophie] Lab Informat Sci Support Personalized Med, Paris, France; [Kirilovsky, Amos; El Sissy, Carine; Marliot, Florence; Pages, Franck] INSERM, UMRS 1138, Cordeliers Res Ctr, Team Integrat Canc Immunol, Paris, France; [Charpentier, Etienne; Mousseaux, Elie] Dept Radiol, Paris, France; [Binois, Yannick; Karras, Alexandre] Dept Nephrol, Paris, France; [Granier, Clemence; Pere, Helene; Saldmann, Antonin; Tharaux, Pierre-Louis; Czernichow, Sebastien; Tartour, Eric] INSERM, UMR 970, Paris Cardiovasc Ctr PARCC, Paris, France; [Pere, Helene] Lab Virol, Paris, France; [Rance, Bastien; Jannot, Anne Sophie] Biostat & Publ Hlth Dept, Paris, France; [Baron, Stephanie; Chebbi, Mouna] Dept Physiol, Paris, France; [Hulot, Jean-Sebastien] Clin Investigat Ctr 1418, Paris, France; [Rives-Lange, Claire; Czernichow, Sebastien] Dept Nutr, Paris, France; [Cholley, Bernard; Diehl, Jean-Luc] Dept Intens Med, Reanimat, Paris, France; [Diehl, Jean-Luc; Smadja, David M.] INSERM, UMR S1140, Team Innovat Therapies Haemostasis, Paris, France; [Arlet, Jean-Benoit] Dept Internal Med, Paris, France; [Azizi, Michel] Dept Vasc Med, Paris, France; [Smadja, David M.] Dept Hematol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Pages, F (corresponding author), Lab Immunol, Paris, France.; Pages, F (corresponding author), Hop Europeen Georges Pompidou, AP HP, Paris, France.; Pages, F (corresponding author), Univ Paris, Paris, France.; Pages, F (corresponding author), Sorbonne Univ, Cordeliers Res Ctr, Paris, France.; Pages, F (corresponding author), INSERM, UMRS 1138, Cordeliers Res Ctr, Team Integrat Canc Immunol, Paris, France.	franck.pages@aphp.fr	, Dragon-Durey/AGM-3653-2022; Baron, Stephanie/AAY-5703-2020; Charpentier, Etienne/GYV-1121-2022; Russick, Jules/AAQ-5610-2021; CHOLLEY, Bernard/AAK-5354-2020; Hulot, Jean-Sébastien/A-2278-2016; El Sissy, Carine/AGZ-9143-2022; Tharaux, Pierre-Louis/A-9155-2009; Chen, Xiaoyi/AAN-4055-2020; Cremer, Isabelle/D-4278-2017; tartour, eric/O-7957-2017; granier, clemence/E-6114-2018	Baron, Stephanie/0000-0002-0375-6968; Russick, Jules/0000-0001-7085-7614; CHOLLEY, Bernard/0000-0001-6388-6011; Hulot, Jean-Sébastien/0000-0001-5463-6117; Tharaux, Pierre-Louis/0000-0002-6062-5905; Chen, Xiaoyi/0000-0002-7378-5158; saldmann, antonin/0000-0002-7566-8596; Cremer, Isabelle/0000-0002-0963-1031; Meylan, Maxime/0000-0002-6175-1954; tartour, eric/0000-0002-7323-468X; granier, clemence/0000-0002-4213-6438	Universite de Paris; Cancer Research for Personalized Medicine (CARPEM); National Institute of Health and Medical Research (INSERM); Assistance Publique-Hopitaux de Paris (AP-HP)	Universite de Paris; Cancer Research for Personalized Medicine (CARPEM); National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Assistance Publique-Hopitaux de Paris (AP-HP)	The funding resources were Universite ' de Paris, The Cancer Research for Personalized Medicine (CARPEM), National Institute of Health and Medical Research (INSERM), and Assistance Publique-Hopitaux de Paris (AP-HP). Study sponsors had no role in study design, data collection, analysis, interpretation, or writing of the report; and in the decision to submit the paper for publication. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Bermejo-Martin JF, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03398-0; Bernheim Adam, 2020, Radiology, V295, P200463, DOI 10.1148/radiol.2020200463; Boettler T, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100113; Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5; Caussy C, 2020, OBESITY, V28, P1175, DOI 10.1002/oby.22842; CHATENOUD L, 1989, NEW ENGL J MED, V320, P1420; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Cordeiro A, 2020, CLIN RES HEPATOL GAS, V44, P394, DOI 10.1016/j.clinre.2019.10.001; Czernichow S, 2020, OBESITY, V28, P2282, DOI 10.1002/oby.23014; Favaloro EJ, 2020, SEMIN THROMB HEMOST, V46, P379, DOI 10.1055/s-0040-1709498; Fruhbeck G, 2020, OBESITY FACTS, V13, P292, DOI 10.1159/000508082; Gao F, 2020, DIABETES CARE, V43, pE72, DOI 10.2337/dc20-0682; Gong MN, 2010, THORAX, V65, P44, DOI 10.1136/thx.2009.117572; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Graupera M, 2018, TRENDS ENDOCRIN MET, V29, P781, DOI 10.1016/j.tem.2018.09.003; Gupta S, 2021, JAMA INTERN MED, V181, P41, DOI 10.1001/jamainternmed.2020.6252; Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Jothimani D, 2020, J HEPATOL, V73, P1231, DOI 10.1016/j.jhep.2020.06.006; Kang A, 2022, INTERN MED J, V52, P808, DOI 10.1111/imj.15074; Kooistra EJ, 2021, INT J OBESITY, V45, P687, DOI 10.1038/s41366-021-00747-z; Korakas E, 2020, AM J PHYSIOL-ENDOC M, V319, pE105, DOI 10.1152/ajpendo.00198.2020; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Lambrecht J, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.634409; Lee SS, 2014, WORLD J GASTROENTERO, V20, P7392, DOI 10.3748/wjg.v20.i23.7392; Liang T, 2020, EUR RADIOL, V30, P4865, DOI 10.1007/s00330-020-06823-8; Liu YW, 2020, J INFECTION, V81, pE6, DOI 10.1016/j.jinf.2020.04.002; McInnes L, ARXIV180203426CSSTAT; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Nayak Aditi, 2020, medRxiv, DOI 10.1101/2020.04.10.20060962; Niederreiter L., 2018, LIVER RES, V2, P14, DOI [10.1016/j.livres.2018.03.003, DOI 10.1016/J.LIVRES.2018.03.003]; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Richardson P, 2020, LANCET, V395, pE30, DOI 10.1016/S0140-6736(20)30304-4; Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Singh M, 2019, INT REV IMMUNOL, V38, P157, DOI 10.1080/08830185.2019.1638921; Smadja DM, 2009, CIRCULATION, V119, P374, DOI 10.1161/CIRCULATIONAHA.108.808246; Srinivas AN, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.627424; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Virdis A, 2019, CURR HYPERTENS REP, V21, DOI 10.1007/s11906-019-0930-2; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Younossi ZM, 2018, HEPATOLOGY, V68, P349, DOI 10.1002/hep.29721; Yu Y., 2020, LANCET RESP MED, V8, P481; Zhang HB, 2020, INTENS CARE MED, V46, P586, DOI 10.1007/s00134-020-05985-9; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252026	10.1371/journal.pone.0252026	http://dx.doi.org/10.1371/journal.pone.0252026			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038475	gold, Green Published			2022-12-26	WOS:000664633500039
J	Mochioka, Y; Kinoshita, M; Tokuda, M				Mochioka, Yukari; Kinoshita, Motoaki; Tokuda, Makoto			Oviposition by a lycaenid butterfly onto old host parts is adaptive to avoid interference by conspecific larvae	PLOS ONE			English	Article							WINTER CHERRY BUG; OAK LEAF QUALITY; TEMPORAL VARIATION; PLANT SELECTION; TRADE-OFFS; PREFERENCE; PERFORMANCE; LEPIDOPTERA; FITNESS; COEVOLUTION	Oviposition site selection by herbivores can depend not only on the quality of host resources, but also on the risk of predation, parasitism and interference. Females of the lycaenid butterfly Arhopala bazalus (Lepidoptera) lay eggs primarily on old host foliage away from fresh growth, where larval offspring live and feed. Resource availability of young host leaves seems not to affect the oviposition site preference by the females. To clarify the adaptive significance of A. bazalus oviposition behavior on old foliage, we tested three hypotheses: eggs on fresh foliage are (1) easily dropped during rapid leaf expansion (bottom-up hypothesis), (2) more likely to be attacked by egg parasitoids (top-down hypothesis), and (3) frequently displaced or injured by other herbivores (interference hypothesis). In field surveys, rates of egg dropping and parasitism by egg parasitoids were not significantly different between fresh and old host parts. However, the portions of fresh leaves on which A. bazalus eggs had been laid were cut from shoots on which conspecific larvae fed. Laboratory experiments demonstrated that eggs on young leaves were displaced in the presence of conspecific larvae and we observed that fifth instar larvae actively displaced conspecific eggs by feeding on the surrounding leaf tissue. These findings indicate that eggs laid on fresh leaves are at risk of being displaced by conspecific larvae, and support the interference hypothesis. Larval behavior is a likely evolutionary force for A. bazalus to lay eggs apart from larval feeding sites on the host plant.	[Mochioka, Yukari; Kinoshita, Motoaki; Tokuda, Makoto] Saga Univ, Lab Syst Ecol, Fac Agr, Saga, Japan; [Tokuda, Makoto] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima, Japan	Saga University; Kagoshima University	Tokuda, M (corresponding author), Saga Univ, Lab Syst Ecol, Fac Agr, Saga, Japan.; Tokuda, M (corresponding author), Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima, Japan.	tokudam@cc.saga-u.ac.jp						Adar S, 2018, BEHAV PROCESS, V147, P1, DOI 10.1016/j.beproc.2017.12.002; Asou H, 2006, JPN J APPL ENTOMOL Z, V50, P241, DOI 10.1303/jjaez.2006.241; Barker AM, 1996, ECOL ENTOMOL, V21, P317, DOI 10.1046/j.1365-2311.1996.t01-1-00025.x; CHEW FS, 1977, EVOLUTION, V31, P568, DOI 10.1111/j.1558-5646.1977.tb01045.x; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; CRAIG TP, 1989, ECOLOGY, V70, P1691, DOI 10.2307/1938103; Craig TP, 2002, ECOL ENTOMOL, V27, P529, DOI 10.1046/j.1365-2311.2002.00448.x; de Castro ECP, 2018, BIOL REV, V93, P555, DOI 10.1111/brv.12357; Doak P, 2006, ECOLOGY, V87, P395, DOI 10.1890/05-0647; Edge David A., 2010, Journal of Research on the Lepidoptera, V42, P21; Forister ML, 2004, ECOL ENTOMOL, V29, P264, DOI 10.1111/j.0307-6946.2004.00596.x; FUKUDA H, 1972, INSECTS LIFE JAPAN, V3; GILBERT LE, 1982, SCI AM, V247, P110, DOI 10.1038/scientificamerican0882-110; Gripenberg S, 2007, OIKOS, V116, P592, DOI 10.1111/j.2007.0030-1299.15415.x; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Janz N, 2002, CHEMOECOLOGY OF INSECT EGGS AND EGG DEPOSITION, P349; Jaumann S, 2017, ANIM BEHAV, V123, P433, DOI 10.1016/j.anbehav.2016.11.011; Jones LC, 2019, ARTHROPOD-PLANT INTE, V13, P181, DOI 10.1007/s11829-019-09688-x; Kinoshita M, 1998, OECOLOGIA, V114, P31, DOI 10.1007/s004420050416; Kumashiro S, 2016, ENTOMOL EXP APPL, V160, P18, DOI 10.1111/eea.12455; MACNEILL CD, 1964, U CALIF PUBL ENTOMOL, V35, P1; Mayhew PJ, 2001, TRENDS ECOL EVOL, V16, P165, DOI 10.1016/S0169-5347(00)02099-1; Moon DC, 2006, ECOL ENTOMOL, V31, P236, DOI 10.1111/j.1365-2311.2006.00785.x; Nakajima Y, 2012, APPL ENTOMOL ZOOL, V47, P35, DOI 10.1007/s13355-011-0086-2; Nakajima Y, 2010, ENTOMOL EXP APPL, V137, P280, DOI 10.1111/j.1570-7458.2010.01066.x; Nomakuchi S, 2001, J INSECT BEHAV, V14, P451, DOI 10.1023/A:1011115921056; Noyes JS., 2019, WORLD WIDE WEB ELECT; R Core Team, 2020, R LANG ENV STAT COMP; RAUSHER MD, 1979, ECOLOGY, V60, P503, DOI 10.2307/1936070; Roslin T, 2009, OIKOS, V118, P1212, DOI 10.1111/j.1600-0706.2009.17322.x; ROWELLRAHIER M, 1984, OECOLOGIA, V64, P369, DOI 10.1007/BF00379135; Ruhnke H, 2009, BASIC APPL ECOL, V10, P726, DOI 10.1016/j.baae.2009.06.006; Scheirs J, 2004, ECOL ENTOMOL, V29, P375, DOI 10.1111/j.0307-6946.2004.00600.x; Shirozu T., 2006, BUTTERFLIES JAPAN CO; Sidhu JK, 2013, ENTOMOL EXP APPL, V149, P67, DOI 10.1111/eea.12111; Singer M. C., 1984, BIOL BUTTERFLIES, V13, P81; Singer MS, 2004, ECOLOGY, V85, P2747, DOI 10.1890/03-0827; Singer MS, 2003, OIKOS, V100, P554, DOI 10.1034/j.1600-0706.2003.11720.x; SUNOSE T, 1984, Kontyu, V52, P229; Teramoto N, 1993, B SHIGA AGR EXP STN, V1, P1; Teshirogi M., 1997, ILLUSTRATED BOOK JAP; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Vanderplank John, 2008, Curtis's Botanical Magazine, V25, P237, DOI 10.1111/j.1467-8748.2008.00625.x; Verdon A, 2007, ECOL ENTOMOL, V32, P62, DOI 10.1111/j.1365-2311.2006.00842.x; Videla M, 2012, OECOLOGIA, V169, P743, DOI 10.1007/s00442-011-2231-6; WIKLUND C, 1984, OECOLOGIA, V63, P23, DOI 10.1007/BF00379780; WIKLUND C, 1983, OIKOS, V40, P53, DOI 10.2307/3544198; WILLIAMS KS, 1983, OECOLOGIA, V56, P323, DOI 10.1007/BF00379707	49	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252239	10.1371/journal.pone.0252239	http://dx.doi.org/10.1371/journal.pone.0252239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038484	Green Published, gold			2022-12-26	WOS:000664633500068
J	O'Hanlon, R; Destefanis, M; Milenkovic, I; Tomsovsky, M; Janousek, J; Bellgard, SE; Weir, BS; Kudlacek, T; Jung, MH; Jung, T				O'Hanlon, Richard; Destefanis, Maria; Milenkovic, Ivan; Tomsovsky, Michal; Janousek, Josef; Bellgard, Stanley E.; Weir, Bevan S.; Kudlacek, Tomas; Jung, Marilia Horta; Jung, Thomas			Two new Nothophytophthora species from streams in Ireland and Northern Ireland: Nothophytophthora irlandica and N. lirii sp. nov.	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PHYTOPHTHORA-CINNAMOMI; NATURAL ECOSYSTEMS; MULTIPLE; FOREST; DIVERSITY; PATHOGEN; TREES; MITOCHONDRIAL; GAMETANGIA	Slow growing oomycete isolates with morphological resemblance to Phytophthora were obtained from forest streams during routine monitoring for the EU quarantine forest pathogen Phytophthora ramorum in Ireland and Northern Ireland. Internal Transcribed Spacer (ITS) sequence analysis indicated that they belonged to two previously unknown species of Nothophytophthora, a recently erected sister genus of Phytophthora. Morphological and temperature-growth studies were carried out to characterise both new species. In addition, Bayesian and Maximum-Likelihood analyses of nuclear 5-loci and mitochondrial 3-loci datasets were performed to resolve the phylogenetic positions of the two new species. Both species were sterile, formed chlamydospores and partially caducous nonpapillate sporangia, and showed slower growth than any of the six known Nothophytophthora species. In all phylogenetic analyses both species formed distinct, strongly supported clades, closely related to N. chlamydospora and N. valdiviana from Chile. Based on their unique combination of morphological and physiological characters and their distinct phylogenetic positions the two new species are described as Nothophytophthora irlandica sp. nov. and N. lirii sp. nov. Their potential lifestyle and geographic origin are discussed.	[O'Hanlon, Richard; Destefanis, Maria] Dept Agr Food & Marine, Dublin, Ireland; [O'Hanlon, Richard] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Milenkovic, Ivan; Tomsovsky, Michal; Janousek, Josef; Kudlacek, Tomas; Jung, Marilia Horta; Jung, Thomas] Mendel Univ Brno, Phytophthora Res Ctr, Fac Forestry & Wood Technol, Brno, Czech Republic; [Bellgard, Stanley E.] Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand; [Weir, Bevan S.] Landcare Res, Auckland, New Zealand; [Jung, Marilia Horta; Jung, Thomas] Phytophthora Res & Consultancy, Nussdorf, Germany	Queens University Belfast; Mendel University in Brno; Massey University; Landcare Research - New Zealand	O'Hanlon, R (corresponding author), Dept Agr Food & Marine, Dublin, Ireland.; O'Hanlon, R (corresponding author), Queens Univ Belfast, Belfast, Antrim, North Ireland.	r.ohanlon@qub.ac.uk	Jung, Thomas/F-1665-2013; Tomsovsky, Michal/B-1263-2014; Jung, Marília Horta/E-7624-2013; Weir, Bevan/B-5057-2008; Milenkovic, Ivan/M-2340-2015	Jung, Thomas/0000-0003-2034-0718; Tomsovsky, Michal/0000-0002-9505-6175; Jung, Marília Horta/0000-0003-2219-8647; Kudlacek, Tomas/0000-0002-6286-6446; Weir, Bevan/0000-0003-2580-0701; Milenkovic, Ivan/0000-0003-2792-0221; O'Hanlon, Richard/0000-0002-0595-0246	Department of Agriculture, Food and the Marine Ireland through the PHYTOFOR project; Department of Agriculture, Environment, and Rural Affairs Northern Ireland; Royal Irish Academy Charlemont scholar award; European Regional Development Fund [CZ.02.1.01/0.0/0.0/15_003/0000453]	Department of Agriculture, Food and the Marine Ireland through the PHYTOFOR project; Department of Agriculture, Environment, and Rural Affairs Northern Ireland; Royal Irish Academy Charlemont scholar award; European Regional Development Fund(European Commission)	ROH was funded by Department of Agriculture, Food and the Marine Ireland through the PHYTOFOR project, and by the Department of Agriculture, Environment, and Rural Affairs Northern Ireland. ROH also acknowledges a Royal Irish Academy Charlemont scholar award for funding part of this work. The authors TJ, MHJ, IM, MT, JJ and TK are grateful to the European Regional Development Fund for cofinancing the Project Phytophthora Research Centre Reg. No. CZ.02.1.01/0.0/0.0/15_003/0000453.	Anonymous, 2017, IR NAT FOR INV 2017; atkova H., 2020, THESIS MENDEL U BRNO; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Boutet X, 2009, MYCOL RES, V113, P110, DOI 10.1016/j.mycres.2008.09.001; Brasier C, 2004, MYCOL RES, V108, P823, DOI 10.1017/S0953756204000565; Brasier CM, 2005, MYCOL RES, V109, P853, DOI 10.1017/S0953756205003357; Brasier CM, 2003, MYCOL RES, V107, P277, DOI 10.1017/S095375620300738X; Brasier CM, 1967, THESIS U HULL UK; Brennan J, 2010, PHYTOPATHOLOGY, V100, pS17; Catala S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119311; Cooke D, 2017, 8 M INT UN FOR RES O; Cross J., 2012, IRISH FORESTRY, V69, P73; CSO, 2017, ENV IND IR 2016; Duarte S, 2015, FUNGAL DIVERS, V70, P127, DOI 10.1007/s13225-014-0300-y; Duckett DJ, 2020, PEERJ, V8, DOI 10.7717/peerj.8271; Edler D, 2021, METHODS ECOL EVOL, V12, P373, DOI 10.1111/2041-210X.13512; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Hansen EM, 2015, CURR FOR REP, V1, P16, DOI 10.1007/s40725-015-0007-7; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JEFFERS SN, 1986, PLANT DIS, V70, P1038, DOI 10.1094/PD-70-1038; Jung T, 2018, PERSOONIA, V40, P182, DOI 10.3767/persoonia.2018.40.08; Jung T, 2017, PERSOONIA, V39, P143, DOI 10.3767/persoonia.2017.39.07; Jung T, 2017, PERSOONIA, V38, P100, DOI 10.3767/003158517X693615; Jung T, 2016, FOREST PATHOL, V46, P134, DOI 10.1111/efp.12239; Jung T, 2013, FOREST PATHOL, V43, P266, DOI 10.1111/efp.12025; Jung T, 1996, EUR J FOREST PATHOL, V26, P253; Jung T, 2011, PERSOONIA, V26, P13, DOI 10.3767/003158511X557577; Jung T, 2009, PERSOONIA, V22, P95, DOI 10.3767/003158509X442612; Jung T, 2020, FORESTS, V11, DOI 10.3390/f11010093; Jung T, 2018, FOREST PATHOL, V48, DOI 10.1111/efp.12443; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Koch H, 2020, GENOME BIOL EVOL, V12, P3977, DOI 10.1093/gbe/evaa022; Kroon LPNM, 2004, FUNGAL GENET BIOL, V41, P766, DOI 10.1016/j.fgb.2004.03.007; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Magallon S, 2014, BOT SCI, V92, P1; Martin FN, 2003, MYCOLOGIA, V95, P269, DOI 10.2307/3762038; McCarren KL, 2005, AUSTRALAS PLANT PATH, V34, P333, DOI 10.1071/AP05038; MONCALVO JM, 1995, MYCOLOGIA, V87, P223, DOI 10.2307/3760908; O'Hanlon R, 2018, FOREST PATHOL, V48, DOI 10.1111/efp.12389; O'Hanlon R., 2016, Bulletin OEPP, V46, P594, DOI 10.1111/epp.12331; O'Hanlon R., 2017, EPPO WORKSH TOOLS IN; O'Hanlon R, 2016, BIOL ENVIRON, V116B, P27, DOI [10.3318/BIOE.2016.03, 10.3318/bioe.2016.03]; Perrin P, 2008, NATL SURVEY NATIVE W; Ramsfield T. D., 2009, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P47; Randall SD, 2011, THESIS U AUCKLAND NZ; Riethmuller A, 2002, MYCOLOGIA, V94, P834, DOI 10.2307/3761698; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanfuentes E, 2016, AUSTRALAS PLANT DIS, V11, DOI 10.1007/s13314-016-0205-6; Scanu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143234; Sloan DB, 2017, MOL ECOL, V26, P2212, DOI 10.1111/mec.13959; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Studholme DJ, 2019, MOL PLANT PATHOL, V20, P423, DOI 10.1111/mpp.12765; Than DJ, 2013, FOREST PATHOL, V43, P324, DOI 10.1111/efp.12034; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	56	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0250527	10.1371/journal.pone.0250527	http://dx.doi.org/10.1371/journal.pone.0250527			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038450	Green Published, gold			2022-12-26	WOS:000664633500010
J	Burgard, M; Cherbanyk, F; Nassiopoulos, K; Malekzadeh, S; Pugin, F; Egger, B				Burgard, Marie; Cherbanyk, Floryn; Nassiopoulos, Konstantinos; Malekzadeh, Sonaz; Pugin, Francois; Egger, Bernhard			An effect of the COVID-19 pandemic: Significantly more complicated appendicitis due to delayed presentation of patients!	PLOS ONE			English	Article							ADULTS	Aims of the study The novel coronavirus pandemic has affected emergency department consultations for surgical pathologies. The aim of our study was to compare the number of acute appendicitis cases and the proportion of complicated appendicitis before and during the COVID-19 pandemic. Methods We retrospectively analyzed all data collected from a multi-center database of patients presenting to the emergency department for acute appendicitis during the COVID-19 pandemic from March 12 to June 6, 2020, and compared these data with those from the same periods in 2017, 2018, and 2019. The number of acute appendicitis cases, proportion of complicated appendicitis, and pre- and postoperative patient characteristics were evaluated. Results A total of 306 patients were included in this evaluation. Sixty-five patients presented during the 2020 COVID-19 pandemic lockdown (group A), and 241 patients in previous years (group B: 2017-2019). The number of consultations for acute appendicitis decreased by almost 20 percent during the pandemic compared with previous periods, with a significant increase in complicated appendicitis (52% in group A versus 20% in group B, p < 0,001.). Comparing the two groups, significant differences were also noted in the duration of symptoms (symptoms > 48h in 61% and 26%, p < 0,001), the intervention time (77 vs 61 minutes, p = 0,002), length of hospital stay (hospitalization of > 2 days in 63% and 32%, p < 0.001) and duration of antibiotic treatment (antibiotics > 3 days in 36% and 24% p = 0.001). Conclusions The COVID-19 pandemic resulted in a decreased number of consultations for acute appendicitis, with a higher proportion of complicated appendicitis, most likely due to patient delay in consulting the emergency department at symptom onset. Patients and general practitioners should be aware of this problem to avoid a time delay from initial symptoms to consultation.	[Burgard, Marie; Cherbanyk, Floryn; Pugin, Francois; Egger, Bernhard] HFR Fribourg Cantonal Hosp Fribourg, Dept Surg, Villars Sur Glane, Switzerland; [Nassiopoulos, Konstantinos] Daler Hosp Fribourg, Dept Surg, Villars Sur Glane, Switzerland; [Malekzadeh, Sonaz] HFR Fribourg Cantonal Hosp Fribourg, Dept Diagnost & Intervent Radiol, Villars Sur Glane, Switzerland		Egger, B (corresponding author), HFR Fribourg Cantonal Hosp Fribourg, Dept Surg, Villars Sur Glane, Switzerland.	bernhard-egger@bluewin.ch		Egger, Bernhard/0000-0002-2099-3367; Burgard, Marie/0000-0002-8137-077X				Bhangu A, 2015, LANCET, V386, P1278, DOI 10.1016/S0140-6736(15)00275-5; Boserup B, 2020, AM J EMERG MED, V38, P1732, DOI 10.1016/j.ajem.2020.06.007; Collard M, 2020, J VISC SURG, V157, pS33, DOI 10.1016/j.jviscsurg.2020.04.014; Finkelstein P, 2021, J LAPAROENDOSC ADV S, V31, P243, DOI 10.1089/lap.2020.0749; Fisher JC, 2020, ANN SURG; Gao ZG, 2020, ASIAN J SURG, V43, P1002, DOI 10.1016/j.asjsur.2020.07.019; Gomes CA, 2015, WORLD J EMERG SURG, V10, DOI 10.1186/s13017-015-0053-2; Orthopoulos G, 2021, AM J SURG, V221, P1056, DOI 10.1016/j.amjsurg.2020.09.026; Perez KS, 2018, JAAPA-J AM ACAD PHYS, V31, P35, DOI 10.1097/01.JAA.0000544304.30954.40; Snapiri O, 2020, ACTA PAEDIATR, V109, P1672, DOI 10.1111/apa.15376; Tankel J, 2020, WORLD J SURG, V44, P2458, DOI 10.1007/s00268-020-05599-8; Tsioplis C, 2013, LANGENBECK ARCH SURG, V398, P857, DOI 10.1007/s00423-013-1096-z; Turanli S, 2021, WORLD J SURG, V45, P18, DOI 10.1007/s00268-020-05825-3; York TJ, 2020, BMC EMERG MED, V20, DOI 10.1186/s12873-020-00321-2	14	20	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0249171	10.1371/journal.pone.0249171	http://dx.doi.org/10.1371/journal.pone.0249171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34032800	gold, Green Submitted, Green Published			2022-12-26	WOS:000664633100003
J	de Almeida, DC; Franco, MDP; dos Santos, DRP; Santos, MC; Maltoni, IS; Mascotte, F; de Souza, AA; Pietrobom, PM; Medeiros, EA; Ferreira, PRA; Machado, FR; Goes, MA				de Almeida, Danilo Candido; Pinho Franco, Maria do Carmo; Pardo dos Santos, Davi Rettori; Santos, Marina Colella; Maltoni, Isabela Soucin; Mascotte, Felipe; de Souza, Alexandra Aparecida; Pietrobom, Paula Massaroni; Medeiros, Eduardo Alexandrino; Abrao Ferreira, Paulo Roberto; Machado, Flavia Ribeiro; Goes, Miguel Angelo			Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; CORONAVIRUS; HYDROXYCHLOROQUINE; NOREPINEPHRINE; CHLOROQUINE; EPIDEMIC; ACE2	Background COVID-19 is a multisystemic disorder that frequently causes acute kidney injury (AKI). However, the precise clinical and biochemical variables associated with AKI progression in patients with severe COVID-19 remain unclear. Methods We performed a retrospective study on 278 hospitalized patients who were admitted to the ward and intensive care unit (ICU) with COVID-19 between March 2020 and June 2020, at the University Hospital, SAo Paulo, Brazil. Patients aged >= 18 years with COVID-19 confirmed on RT-PCR were included. AKI was defined according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria. We evaluated the incidence of AKI, several clinical variables, medicines used, and outcomes in two sub-groups: COVID-19 patients with AKI (Cov-AKI), and COVID-19 patients without AKI (non-AKI). Univariate and multivariate analyses were performed. Results First, an elevated incidence of AKI (71.2%) was identified, distributed across different stages of the KDIGO criteria. We further observed higher levels of creatinine, C-reactive protein (CRP), leukocytes, neutrophils, monocytes, and neutrophil-to-lymphocyte ratio (NLR) in the Cov-AKI group than in the non-AKI group, at hospital admission. On univariate analysis, Cov-AKI was associated with older age (>62 years), hypertension, CRP, MCV, leucocytes, neutrophils, NLR, combined hydroxychloroquine and azithromycin treatment, use of mechanical ventilation, and vasoactive drugs. Multivariate analysis showed that hypertension and the use of vasoactive drugs were independently associated with a risk of higher AKI in COVID-19 patients. Finally, we preferentially found an altered erythrocyte and leukocyte cellular profile in the Cov-AKI group compared to the non-AKI group, at hospital discharge. Conclusions In our study, the development of AKI in patients with severe COVID-19 was related to inflammatory blood markers and therapy with hydroxychloroquine/azithromycin, with vasopressor requirement and hypertension considered potential risk factors. Thus, attention to the protocol, hypertension, and some blood markers may help assist doctors with decision-making for the management of COVID-19 patients with AKI.	[de Almeida, Danilo Candido; Pinho Franco, Maria do Carmo; Pardo dos Santos, Davi Rettori; Santos, Marina Colella; Maltoni, Isabela Soucin; Mascotte, Felipe; Goes, Miguel Angelo] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil; [de Souza, Alexandra Aparecida] Fed Inst Educ Sci & Technol Sao Paulo, Lab Appl Comp LABCOM, Sao Paulo, Brazil; [Pietrobom, Paula Massaroni; Medeiros, Eduardo Alexandrino; Abrao Ferreira, Paulo Roberto] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Machado, Flavia Ribeiro] Univ Fed Sao Paulo, Intens Care Unit Div, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Instituto Federal de Sao Paulo (IFSP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Goes, MA (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Sao Paulo, Brazil.	miguelpitico7@gmail.com	Medeiros, Eduardo Alexandrino/B-9825-2012; Goes, Miguel/AGG-9721-2022	Medeiros, Eduardo Alexandrino/0000-0002-6205-259X; Goes, Miguel/0000-0001-7687-3826; Pecanha Pietrobom, Paula M/0000-0003-0360-9922				Alhazzani W., 2020, INTENS CARE MED, V46, P854, DOI [DOI 10.1007/s00134-020-06022-5, 10.1007/s00134-020-06022-5]; [Anonymous], 2012, JAMA-J AM MED ASSOC, DOI 10.1001/jama.2012.5669; Aragao DS, 2011, INT J BIOL MACROMOL, V49, P79, DOI 10.1016/j.ijbiomac.2011.03.018; Arroyo-Johnson C, 2016, GASTROENTEROL CLIN N, V45, P571, DOI 10.1016/j.gtc.2016.07.012; Batlle D, 2020, J AM SOC NEPHROL, V31, P1380, DOI 10.1681/ASN.2020040419; Braun F, 2020, LANCET, V396, P597, DOI 10.1016/S0140-6736(20)31759-1; Chen QC, 2018, J NATL MED ASSOC, V110, P287, DOI 10.1016/j.jnma.2017.06.008; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Chiloff DM, 2020, AM J PHYSIOL-RENAL, V318, pF861, DOI 10.1152/ajprenal.00433.2019; Chou CY, 2011, ARTIF ORGANS, V35, pE11, DOI 10.1111/j.1525-1594.2010.01115.x; Edelstein CL, 2020, KIDNEY INT, V98, P234, DOI 10.1016/j.kint.2020.05.001; Festa BP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02536-7; Fisher M, 2020, J AM SOC NEPHROL, V31, P2145, DOI 10.1681/ASN.2020040509; Gevers S, 2020, CLIN MICROBIOL INFEC, V26, P1276, DOI 10.1016/j.cmi.2020.05.006; Goes MA, 2018, ARTIF ORGANS, V42, pE283, DOI 10.1111/aor.12019; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hanley B, 2020, LANCET MICROBE, V1, pE245, DOI 10.1016/S2666-5247(20)30115-4; Harrison AG, 2020, TRENDS IMMUNOL, V41, P1100, DOI 10.1016/j.it.2020.10.004; Hasan I, 2021, ROM J INTERN MED, V59, P10, DOI 10.2478/rjim-2020-0034; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Iba T, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03077-0; Joseph A, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00734-z; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kudose S, 2020, J AM SOC NEPHROL, V31, P1959, DOI 10.1681/ASN.2020060802; Lane JCE, 2020, LANCET RHEUMATOL, V2, pE698, DOI 10.1016/S2665-9913(20)30276-9; Lankadeva YR, 2016, KIDNEY INT, V90, P100, DOI 10.1016/j.kint.2016.02.017; Lee JR, 2021, CLIN J AM SOC NEPHRO, V16, P284, DOI 10.2215/CJN.07440520; Liu JY, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02374-0; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537; Mercuro NJ, 2020, JAMA CARDIOL, V5, P1036, DOI 10.1001/jamacardio.2020.1834; Naicker S, 2020, KIDNEY INT, V97, P824, DOI 10.1016/j.kint.2020.03.001; Organization WH, 2020, COR DIS COVID 19 DAS; Pan XW, 2020, INTENS CARE MED, V46, P1114, DOI 10.1007/s00134-020-06026-1; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Pelletier K, 2020, NEPHROL DIAL TRANSPL, V35, P1886, DOI 10.1093/ndt/gfz178; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Riva G, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03267-w; Ronco C, 2020, LANCET RESP MED, V8, P240, DOI 10.1016/S2213-2600(20)30060-6; Russo E, 2021, J NEPHROL, V34, P173, DOI 10.1007/s40620-020-00875-1; Scharte M, 2003, CRIT CARE MED, V31, pS651, DOI 10.1097/01.CCM.0000098036.90796.ED; Schurink B, 2020, LANCET MICROBE, V1, pE290, DOI 10.1016/S2666-5247(20)30144-0; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Tao ZY, 2021, J MED VIROL, V93, P1478, DOI 10.1002/jmv.26444; Weiss G, 2019, BLOOD, V133, P40, DOI 10.1182/blood-2018-06-856500; Wong J, 2019, RESPIROL CASE REP, V7, DOI 10.1002/rcr2.464; Woodruff AE, 2015, PHARMACOTHERAPY, V35, pE169, DOI 10.1002/phar.1660; Xu J., 2020, LANCET, V395, P1517, DOI [10.1016/s0140-6736(20)30920-x, DOI 10.1016/S0140-6736(20)30920-X]; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang Jiahao, 2020, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V32, P407, DOI 10.3760/cma.j.cn121430-20200302-00198; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	55	12	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251048	10.1371/journal.pone.0251048	http://dx.doi.org/10.1371/journal.pone.0251048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033655	gold, Green Published			2022-12-26	WOS:000664633100006
J	Endalie, D; Tegegne, T				Endalie, Demeke; Tegegne, Tesfa			Designing a hybrid dimension reduction for improving the performance of Amharic news document classification	PLOS ONE			English	Article							FEATURE-SELECTION	The volume of Amharic digital documents has grown rapidly in recent years. As a result, automatic document categorization is highly essential. In this paper, we present a novel dimension reduction approach for improving classification accuracy by combining feature selection and feature extraction. The new dimension reduction method utilizes Information Gain (IG), Chi-square test (CHI), and Document Frequency (DF) to select important features and Principal Component Analysis (PCA) to refine the features that have been selected. We evaluate the proposed dimension reduction method with a dataset containing 9 news categories. Our experimental results verified that the proposed dimension reduction method outperforms other methods. Classification accuracy with the new dimension reduction is 92.60%, which is 13.48%, 16.51% and 10.19% higher than with IG, CHI, and DF respectively. Further work is required since classification accuracy still decreases as we reduce the feature size to save computational time.	[Endalie, Demeke] Jimma Inst Technol, Factual Comp & Informat, Jimma, Ethiopia; [Tegegne, Tesfa] Bahir Dar Inst Technol, Factual Comp, Bahir Dar, Ethiopia		Endalie, D (corresponding author), Jimma Inst Technol, Factual Comp & Informat, Jimma, Ethiopia.	demeke.endalie@ju.edu.et						Alghamdi H, 2014, J TEKNOL, V70; Bahassine S, 2020, J KING SAUD UNIV-COM, V32, P225, DOI 10.1016/j.jksuci.2018.05.010; Basha SR, 2019, ENG TECHNOL APPL SCI, V9, P4974; Bharti KK, 2015, EXPERT SYST APPL, V42, P3105, DOI 10.1016/j.eswa.2014.11.038; chezian Manicka, 2015, P UGC SPONS NAT C AD; Chokkanathan K., 2018, INT J ENG TECHNOLOGY, V7, P31; Dzisevic R, 2019, 2019 OPEN CONFERENCE OF ELECTRICAL, ELECTRONIC AND INFORMATION SCIENCES (ESTREAM); Gasser M, 2012, SYSTEM MORPHOLOGICAL; Hailu Abraham., 2016, LANGUAGE TECHNOLOGY; Hakak S, 2021, FUTURE GENER COMP SY, V117, P47, DOI 10.1016/j.future.2020.11.022; House of people, 1994, ETH CONST; Indurkhya N, 2010, CH CRC MACH LEARN PA, pXXI; Iqbal Muhammad., 2020, INT J ADV COMPUTER R, V10, P2277; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kassa Gobena Markos, 2011, IMPLEMENTING OPEN SO; Kelemework W, 2013, ETHIOP J SCI TECHNOL, V6, P127; Ksh Nareshkumar Singh H., 2017, INT J ADV RES COMPUT, V8; Rasheed Imran., 2021, MACHINE LEARNING ALG, V907, P3; Reddy GT, 2020, IEEE ACCESS, V8, P54776, DOI 10.1109/ACCESS.2020.2980942; SPARCK-JONES K, 1973, INFORM STORAGE RET, V9, P619, DOI 10.1016/0020-0271(73)90043-0; Tegegnie A K, 2017, INT J INFORM ENG ELE, V9, P36; Tsedalu Getachew, 2010, THESIS ADDIS ABABA U; Van Hulse J, 2012, NETW MODEL ANAL HLTH, V1, P47, DOI 10.1007/s13721-012-0006-6; Yirdaw Eyob Delele, 2012, P INT C MAN EM DIG E; Zareapoor Masoumeh, 2015, International Journal of Information Engineering and Electronic Business, V7, P60, DOI 10.5815/ijieeb.2015.02.08; Zia T, 2015, MALAYS J COMPUT SCI, V28, P93; Zuh Xiong Y.F.B., 2014, MACHINE LEARNING APP	27	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251902	10.1371/journal.pone.0251902	http://dx.doi.org/10.1371/journal.pone.0251902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019571	gold, Green Published			2022-12-26	WOS:000664632300038
J	Guijo-Rubio, D; Briceno, J; Gutierrez, PA; Ayllon, MD; Ciria, R; Hervas-Martinez, C				Guijo-Rubio, David; Briceno, Javier; Antonio Gutierrez, Pedro; Dolores Ayllon, Maria; Ciria, Ruben; Hervas-Martinez, Cesar			Statistical methods versus machine learning techniques for donor-recipient matching in liver transplantation	PLOS ONE			English	Article							ALLOCATION SYSTEM; MODEL; SCORE; SURVIVAL	Donor-Recipient (D-R) matching is one of the main challenges to be fulfilled nowadays. Due to the increasing number of recipients and the small amount of donors in liver transplantation, the allocation method is crucial. In this paper, to establish a fair comparison, the United Network for Organ Sharing database was used with 4 different end-points (3 months, and 1, 2 and 5 years), with a total of 39, 189 D-R pairs and 28 donor and recipient variables. Modelling techniques were divided into two groups: 1) classical statistical methods, including Logistic Regression (LR) and Naive Bayes (NB), and 2) standard machine learning techniques, including Multilayer Perceptron (MLP), Random Forest (RF), Gradient Boosting (GB) or Support Vector Machines (SVM), among others. The methods were compared with standard scores, MELD, SOFT and BAR. For the 5-years end-point, LR (AUC = 0.654) outperformed several machine learning techniques, such as MLP (AUC = 0.599), GB (AUC = 0.600), SVM (AUC = 0.624) or RF (AUC = 0.644), among others. Moreover, LR also outperformed standard scores. The same pattern was reproduced for the others 3 end-points. Complex machine learning methods were not able to improve the performance of liver allocation, probably due to the implicit limitations associated to the collection process of the database.	[Guijo-Rubio, David; Antonio Gutierrez, Pedro; Hervas-Martinez, Cesar] Univ Cordoba, Dept Comp Sci & Numer Anal, Cordoba, Spain; [Briceno, Javier; Dolores Ayllon, Maria; Ciria, Ruben] Hosp Univ Reina Sofia, IMIBIC, Unit Hepatobiliary Surg & Liver Transplantat, Cordoba, Spain	Universidad de Cordoba	Guijo-Rubio, D (corresponding author), Univ Cordoba, Dept Comp Sci & Numer Anal, Cordoba, Spain.	dguijo@uco.es	Gutiérrez, Pedro Antonio/K-6051-2014; Guijo-Rubio, David/AAT-6335-2021	Gutiérrez, Pedro Antonio/0000-0002-2657-776X; Guijo-Rubio, David/0000-0002-8035-4057	FEDER funds; Spanish Ministry of Economy and Competitiveness [TIN2017-85887-C2-1-P]; Consejeria de Salud y Familia de la Junta de Andalucia [PS2020-780]; Consejeria de Economia, Conocimiento, Empresas y Universidad de la Junta de Andalucia [UCO-1261651]; Spanish Ministry of Education and Science, FPU Predoctoral Program [FPU16/02128]; Fundacion Publica Andaluza Progreso y Salud [PI-032-2014]; Fundacion de Investigacion Biomedica de Cordoba (FIBICO) [PI15/01570]	FEDER funds(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Consejeria de Salud y Familia de la Junta de Andalucia(Junta de Andalucia); Consejeria de Economia, Conocimiento, Empresas y Universidad de la Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Education and Science, FPU Predoctoral Program(German Research Foundation (DFG)); Fundacion Publica Andaluza Progreso y Salud; Fundacion de Investigacion Biomedica de Cordoba (FIBICO)	DGR, PAG, CHM -> FEDER funds and Spanish Ministry of Economy and Competitiveness, grant reference: TIN2017-85887-C2-1-P, webpage: https://sede.mineco.gob.es DGR, PAG, CHM -> Consejeri ' a de Salud y Familia de la Junta de Andaluci ' a, grant reference: PS2020-780, webpage: https://www.juntadeandalucia.es/organismos/saludyfamilias.html DGR, PAG, CHM -> Consejeri ' a de Economi ' a, Conocimiento, Empresas y Universidad de la Junta de Andaluci ' a, grant reference: UCO-1261651, webpage: https://www.juntadeandalucia.es/organismos/transformacioneconomicaindustriacon ocimientoyuniversidades.html DGR -> Spanish Ministry of Education and Science, FPU Predoctoral Program, grant reference: FPU16/02128, webpage: https://www.ciencia.gob.es/.JB, MDA, RC -> Fundacio ' n Pu ' blica Andaluza Progreso y Salud, grant reference: PI-032-2014, webpage: https://www.sspa.juntadeandalucia.es/fundacionprogresoysalud/es.All -> Fundacio ' n de Investigacio ' n Biome ' dica de Co ' rdoba (FIBICO), grant reference: PI15/01570, webpage: https://www.imibic.org/fibico.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2020, TRANSPL INT, V33, P1472, DOI 10.1111/tri.13695; Bertsimas D, 2019, AM J TRANSPLANT, V19, P1109, DOI 10.1111/ajt.15172; Boecker J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214221; Briceno J, 2014, J HEPATOL, V61, P1020, DOI 10.1016/j.jhep.2014.05.039; Briceno J, 2013, J HEPATOL, V58, P811, DOI 10.1016/j.jhep.2012.10.020; Bryce CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198132; Buitinck L., 2013, ECML PKDD WORKSH LAN, DOI DOI 10.48550/ARXIV.1309.0238; Christodoulou E, 2019, J CLIN EPIDEMIOL, V110, P12, DOI 10.1016/j.jclinepi.2019.02.004; Cruz-Ramirez M, 2012, EUR J OPER RES, V222, P317, DOI 10.1016/j.ejor.2012.05.013; Desai RJ, 2019, JAMA NETW OPEN, V2, DOI [10.1001/jamanetworkopen.2019.10626, 10.1001/jamanetworkopen.2019.18962]; Ayllon MD, 2018, LIVER TRANSPLANT, V24, P192, DOI 10.1002/lt.24870; Dutkowski P, 2011, ANN SURG, V254, P745, DOI 10.1097/SLA.0b013e3182365081; Frizzell JD, 2017, JAMA CARDIOL, V2, P204, DOI 10.1001/jamacardio.2016.3956; Guijo-Rubio D, 2019, LECT NOTES COMPUT SC, V11872, P97, DOI 10.1007/978-3-030-33617-2_11; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Lee J, 2017, TRANSPLANTATION, V101, pS82, DOI 10.1097/01.tp.0000525107.09342.d2; Ma YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136604; Mark E, 2019, TRANSPL INFECT DIS, V21, DOI 10.1111/tid.13181; Miller PE, 2019, J CARD FAIL, V25, P479, DOI 10.1016/j.cardfail.2019.01.018; Organ Procurement and Transplantation Network (OPTN), 2020, UN NETW ORG SHAR UNO; Parikh RB, 2017, NEW ENGL J MED, V376, P1609, DOI 10.1056/NEJMp1613224; Pawar S, 2019, J CARD FAIL, V25, P490, DOI 10.1016/j.cardfail.2019.04.010; Perez-Ortiz M, 2014, APPL SOFT COMPUT, V14, P88, DOI 10.1016/j.asoc.2013.07.017; Rana A, 2008, AM J TRANSPLANT, V8, P2537, DOI 10.1111/j.1600-6143.2008.02400.x; Sanchez-Monedero J, 2011, NEURAL PROCESS LETT, V34, P101, DOI 10.1007/s11063-011-9186-9; Shrestha S, 2016, TRANSPLANTATION, V100, P422, DOI 10.1097/TP.0000000000000844; Stahl JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002468; Stylianou N, 2015, BURNS, V41, P925, DOI 10.1016/j.burns.2015.03.016; Thuluvath PJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244744; Yu C.N., 2011, ADV NEURAL INF PROCE, V24, P1845; Zullig LL, 2019, HEALTH SERV RES, V54, P1255, DOI 10.1111/1475-6773.13200	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252068	10.1371/journal.pone.0252068	http://dx.doi.org/10.1371/journal.pone.0252068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019601	Green Published, gold			2022-12-26	WOS:000664632300049
J	Winkworth, RC; Bellgard, SE; McLenachan, PA; Lockhart, PJ				Winkworth, Richard C.; Bellgard, Stanley E.; McLenachan, Patricia A.; Lockhart, Peter J.			The mitogenome of Phytophthora agathidicida: Evidence for a not so recent arrival of the "kauri killing" Phytophthora in New Zealand	PLOS ONE			English	Article							D. DON LINDL.; AGATHIS-AUSTRALIS; MULTILOCUS PHYLOGENY; FOREST; GENUS; MITOCHONDRIAL; ARAUCARIACEAE; BIOGEOGRAPHY; GENERATION; HEMISPHERE	Phytophthora agathidicida is associated with a root rot that threatens the long-term survival of the iconic New Zealand kauri. Although it is widely assumed that this pathogen arrived in New Zealand post-1945, this hypothesis has yet to be formally tested. Here we describe evolutionary analyses aimed at evaluating this and two alternative hypotheses. As a basis for our analyses, we assembled complete mitochondrial genome sequences from 16 accessions representing the geographic range of P. agathidicida as well as those of five other members of Phytophthora clade 5. All 21 mitogenome sequences were very similar, differing little in size with all sharing the same gene content and arrangement. We first examined the temporal origins of genetic diversity using a pair of calibration schemes. Both resulted in similar age estimates; specifically, a mean age of 303.0-304.4 years and 95% HPDs of 206.9-414.6 years for the most recent common ancestor of the included isolates. We then used phylogenetic tree building and network analyses to investigate the geographic distribution of the genetic diversity. Four geographically distinct genetic groups were recognised within P. agathidicida. Taken together the inferred age and geographic distribution of the sampled mitogenome diversity suggests that this pathogen diversified following arrival in New Zealand several hundred to several thousand years ago. This conclusion is consistent with the emergence of kauri dieback disease being a consequence of recent changes in the relationship between the pathogen, host, and environment rather than a post-1945 introduction of the causal pathogen into New Zealand.	[Winkworth, Richard C.; Lockhart, Peter J.] Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand; [Winkworth, Richard C.; Bellgard, Stanley E.; McLenachan, Patricia A.; Lockhart, Peter J.] Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand	Massey University; Massey University	Winkworth, RC (corresponding author), Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand.; Winkworth, RC (corresponding author), Massey Univ, Sch Fundamental Sci, Palmerston North, New Zealand.	r.c.winkworth@massey.ac.nz		Winkworth, Richard/0000-0001-5394-3094	BioProtection Research Centre [BPRC_MU_2016_1]; Massey University [NP94607]; New Zealand Ministry of Business, Innovation and Employment Strategic Science Investment Fund [C09X1704]	BioProtection Research Centre; Massey University; New Zealand Ministry of Business, Innovation and Employment Strategic Science Investment Fund(New Zealand Ministry of Business, Innovation and Employment (MBIE))	P.J.L. and R.C.W., BPRC_MU_2016_1, BioProtection Research Centre (https://bioprotection.org.nz).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. R.C. W. and P.J.L., NP94607, Massey University (https://massey.ac.nz).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.E.B, C09X1704, New Zealand Ministry of Business, Innovation and Employment Strategic Science Investment Fund (https://www.mbie.govt.nz/science-and-technology/science-andinnovation/funding-information-and-opportunities/investmentfunds/strategic-science-investmentfund/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S., 2010, FASTQC QUALITY CONTR; ARENTZ F, 1986, Papua New Guinea Journal of Agriculture Forestry and Fisheries, V34, P9; Bassett IE, 2017, FORESTRY, V90, P640, DOI 10.1093/forestry/cpx019; Beachman J., 2017, 201752 MPI; Beever R. E., 2009, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P74; Bertram G., 1999, PESTS WEEDS NZ COSTS; Biffin E, 2010, SYST BIOL, V59, P594, DOI 10.1093/sysbio/syq030; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Bourret TB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192502; Bradshaw RE, 2020, PLANT PATHOL, V69, P3, DOI 10.1111/ppa.13104; Bregant C, 2020, FORESTS, V11, DOI 10.3390/f11080848; Brown B., 1998, PATCH DEATHS TROPICA, P41; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cai GH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231296; Corcobado T, 2020, FORESTS, V11, DOI 10.3390/f11080895; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duchene S, 2019, SYST BIOL, V68, P358, DOI 10.1093/sysbio/syy048; Enright NJ, 1999, J VEG SCI, V10, P793, DOI 10.2307/3237304; Erwin D. C., 1996, Phytophthora diseases worldwide.; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; GADGIL P D, 1974, New Zealand Journal of Forestry Science, V4, P59; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo YN, 2020, MOL PLANT PATHOL, V21, P1131, DOI 10.1111/mpp.12967; Hansen EM, 2015, CURR FOR REP, V1, P16, DOI 10.1007/s40725-015-0007-7; Hansen EM, 2012, ANNU REV PHYTOPATHOL, V50, P359, DOI 10.1146/annurev-phyto-081211-172946; Horner I. J., 2013, New Zealand Plant Protection, V66, P242; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; JEFFERS SN, 1986, PLANT DIS, V70, P1038, DOI 10.1094/PD-70-1038; Jung T, 2020, FORESTS, V11, DOI 10.3390/f11010093; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Knapp M, 2007, SYST BIOL, V56, P862, DOI 10.1080/10635150701636412; Krull CR, 2013, AUSTRAL ECOL, V38, P534, DOI 10.1111/j.1442-9993.2012.02444.x; Leslie AB, 2012, P NATL ACAD SCI USA, V109, P16217, DOI 10.1073/pnas.1213621109; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Maddison WP., 2019, CHROMASEQ MESQUITE P; Martin FN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208606; Martin FN, 2014, FUNGAL GENET BIOL, V66, P19, DOI 10.1016/j.fgb.2014.02.006; Martin MD, 2016, MOL BIOL EVOL, V33, P478, DOI 10.1093/molbev/msv241; Martin MD, 2014, MOL BIOL EVOL, V31, P1414, DOI 10.1093/molbev/msu086; McGowan J, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8050653; Miles TD, 2017, PLANT DIS, V101, P1162, DOI 10.1094/PDIS-09-16-1224-RE; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Moncalvo JM, 2008, MYCOL RES, V112, P425, DOI 10.1016/j.mycres.2007.12.001; NEWHOOK F. J., 1959, NEW ZEALAND JOUR AGRIC RES, V2, P808; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Perrie LR, 2009, MOL PHYLOGENET EVOL, V52, P774, DOI 10.1016/j.ympev.2009.05.030; Peterson KR, 2010, MYCOLOGIA, V102, P1417, DOI 10.3852/10-048; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Russel PM, 2019, SYST BIOL, V68, P219, DOI 10.1093/sysbio/syy050; Scanu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143234; Schenk JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148228; Schroers RD., 2016, 052016 CONS INT; Scott PM, 2009, PERSOONIA, V22, P1, DOI 10.3767/003158509X415450; Scott P, 2019, ENVIRON SCI POLICY, V101, P175, DOI 10.1016/j.envsci.2019.08.020; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silvester WB, 1999, NEW ZEAL J BOT, V37, P553, DOI 10.1080/0028825X.1999.9512653; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stevens R.B., 1960, PLANT PATHOLOGY ADV, V3, P357; Steward Gregory A., 2010, New Zealand Journal of Forestry Science, V40, P33; Tay ML, 2010, NEW ZEAL J BOT, V48, P205, DOI 10.1080/0028825X.2010.518318; Thomsen IM, 2009, FOREST PATHOL, V39, P56, DOI 10.1111/j.1439-0329.2008.00561.x; Verkaik E, 2006, PLANT SOIL, V287, P337, DOI 10.1007/s11104-006-9081-8; Vettraino AM, 2002, FOREST PATHOL, V32, P19, DOI 10.1046/j.1439-0329.2002.00264.x; Waipara N. W., 2013, New Zealand Plant Protection, V66, P235; Webber JF, 2012, FOREST PATHOL, V42, P136, DOI 10.1111/j.1439-0329.2011.00729.x; Weir BS, 2015, PHYTOTAXA, V205, P21, DOI 10.11646/phytotaxa.205.1.2; Winkworth RC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0224007; Woods A, 2005, BIOSCIENCE, V55, P761, DOI 10.1641/0006-3568(2005)055[0761:IAUDNB]2.0.CO;2; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Wyse SV, 2014, AUSTRAL ECOL, V39, P388, DOI 10.1111/aec.12089; Yang X, 2017, IMA FUNGUS, V8, P355, DOI 10.5598/imafungus.2017.08.02.09; Yoshida K, 2013, ELIFE, V2, DOI 10.7554/eLife.00731; YOUNG A, 1994, BIOL CONSERV, V67, P63, DOI 10.1016/0006-3207(94)90010-8; Yuan XL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01484	80	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0250422	10.1371/journal.pone.0250422	http://dx.doi.org/10.1371/journal.pone.0250422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019564	gold, Green Published			2022-12-26	WOS:000664632300010
J	Ahuja, S; Cahill, J; Hartfield, K; Whorton, MR				Ahuja, Shivani; Cahill, James; Hartfield, Kimberly; Whorton, Matthew R.			Inhibition of CMP-sialic acid transport by endogenous 5-methyl CMP	PLOS ONE			English	Article							HEALTH; FAMILY	Nucleotide-sugar transporters (NSTs) transport nucleotide-sugar conjugates into the Golgi lumen where they are then used in the synthesis of glycans. We previously reported crystal structures of a mammalian NST, the CMP-sialic acid transporter (CST) (Ahuja and Whorton 2019). These structures elucidated many aspects of substrate recognition, selectivity, and transport; however, one fundamental unaddressed question is how the transport activity of NSTs might be physiologically regulated as a means to produce the vast diversity of observed glycan structures. Here, we describe the discovery that an endogenous methylated form of cytidine monophosphate (m(5)CMP) binds and inhibits CST. The presence of m(5)CMP in cells results from the degradation of RNA that has had its cytosine bases post-transcriptionally methylated through epigenetic processes. Therefore, this work not only demonstrates that m(5)CMP represents a novel physiological regulator of CST, but it also establishes a link between epigenetic control of gene expression and regulation of glycosylation.	[Ahuja, Shivani; Cahill, James; Hartfield, Kimberly; Whorton, Matthew R.] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA	Oregon Health & Science University	Whorton, MR (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	mwhorton@gmail.com		Whorton, Matt/0000-0002-9915-7467	National Institutes of Health [R01GM130909]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (nih.gov) grant R01GM130909 to MRW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahuja S, 2019, ELIFE, V8, DOI 10.7554/eLife.45221; Bristow AWT, 2003, J AM SOC MASS SPECTR, V14, P1086, DOI 10.1016/S1044-0305(03)00403-3; Cahill J, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3551; Chen K, 2016, CELL CHEM BIOL, V23, P74, DOI 10.1016/j.chembiol.2015.11.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiaramonte M, 2001, BIOCHEMISTRY-US, V40, P14260, DOI 10.1021/bi011262w; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gkatza NA, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000297; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hadley B, 2014, COMPUT STRUCT BIOTEC, V10, P23, DOI 10.1016/j.csbj.2014.05.003; Hopkins AL., PHARMACOLOGICAL SPAC, V3rd, P521; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leung CS, 2012, J MED CHEM, V55, P4489, DOI 10.1021/jm3003697; Liu N, 2015, TRANSL RES, V165, P28, DOI 10.1016/j.trsl.2014.04.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Schrodinger L., 2020, PYMOL; Song ZW, 2013, MOL ASPECTS MED, V34, P590, DOI 10.1016/j.mam.2012.12.004; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Stanley P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005199; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Trixl L, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1510; Van Winkle LJ., 1999, BIOMEMBRANE TRANSPOR, P65; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zeng H, 2017, ANAL CHEM, V89, P4153, DOI 10.1021/acs.analchem.7b00052; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132	37	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0249905	10.1371/journal.pone.0249905	http://dx.doi.org/10.1371/journal.pone.0249905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081697	Green Published, Green Submitted			2022-12-26	WOS:000664639200003
J	Joyce, WG; Mauser, M; Evers, SW				Joyce, Walter G.; Maeuser, Matthias; Evers, Serjoscha W.			Two turtles with soft tissue preservation from the platy limestones of Germany provide evidence for marine flipper adaptations in Late Jurassic thalassochelydians	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; TROPIDEMYS-LANGII; REASSESSMENT; WATER; THALASSEMYS; TESTUDINATA; TAXONOMY; HISTORY; RECORD; EXTANT	Late Jurassic deposits across Europe have yielded a rich fauna of extinct turtles. Although many of these turtles are recovered from marine deposits, it is unclear which of these taxa are habitually marine and which may be riverine species washed into nearby basins, as adaptations to open marine conditions are yet to be found. Two new fossils from the Late Jurassic of Germany provide unusually strong evidence for open marine adaptations. The first specimen is a partial shell and articulated hind limb from the Late Jurassic (early Tithonian) platy limestones of Schernfeld near Eichstatt, which preserves the integument of the hind limb as an imprint. The skin is fully covered by flat, polygonal scales, which stiffen the pes into a paddle. Although taxonomic attribution is not possible, similarities are apparent with Thalassemys. The second specimen is a large, articulated skeleton with hypertrophied limbs referable to Thalassemys bruntrutana from the Late Jurassic (early Late Kimmeridgian) platy limestone of Wattendorf, near Bamberg. Even though the skin is preserved as a phosphatic film, the scales are not preserved. This specimen can nevertheless be inferred to have had paddles stiffened by scales based on the pose in which they are preserved, the presence of epibionts between the digits, and by full morphological correspondence to the specimen from Schernfeld. An analysis of scalation in extant turtles demonstrated that elongate flippers stiffed by scales are a marine adaptation, in contrast to the elongate but flexible flippers of riverine turtles. Phylogenetic analysis suggests that Thalassemys bruntrutana is referable to the mostly Late Jurassic turtle clade Thalassochelydia. The marine adapted flippers of this taxon therefore evolved convergently with those of later clades of marine turtles. Although thalassochelydian fossils are restricted to Europe, with one notable exception from Argentina, their open marine adaptations combined with the interconnectivity of Jurassic oceans predict that the clade must have been even more wide-spread during that time.	[Joyce, Walter G.; Evers, Serjoscha W.] Univ Freiburg, Dept Geowissensch, Fribourg, Switzerland; [Maeuser, Matthias] Nat Kunde Museum Bamberg, Staatl Nat Wissensch Sammlungen Bayerns, Bamberg, Germany		Joyce, WG (corresponding author), Univ Freiburg, Dept Geowissensch, Fribourg, Switzerland.	walter.joyce@unifr.ch			Swiss National Science Foundation [SNF 200021_178780/1]; Burgerverein Bamberg Mitte e.V.; Freunde des Naturkunde-Museums Bamberg e.V.; Landesstelle fur die nichtstaatlichen Museen in Bayern; Oberfrankenstiftung; Stiftung der Sparkasse Bamberg; Rotary Club Bamberg; VR-Bank Bamberg-Forchheim eG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Burgerverein Bamberg Mitte e.V.; Freunde des Naturkunde-Museums Bamberg e.V.; Landesstelle fur die nichtstaatlichen Museen in Bayern; Oberfrankenstiftung; Stiftung der Sparkasse Bamberg; Rotary Club Bamberg; VR-Bank Bamberg-Forchheim eG	This contribution was funded by a grant from the Swiss National Science Foundation to WGJ (SNF 200021_178780/1) and by funds from the Burgerverein Bamberg Mitte e.V., the Freunde des Naturkunde-Museums Bamberg e.V., the Landesstelle fur die nichtstaatlichen Museen in Bayern, the Oberfrankenstiftung, the Stiftung der Sparkasse Bamberg, the Rotary Club Bamberg, and the VR-Bank Bamberg-Forchheim eG to MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anquetin J, 2014, J VERTEBR PALEONTOL, V34, P1317, DOI 10.1080/02724634.2014.880449; Anquetin J, 2017, B PEABODY MUS NAT HI, V58, P317; Anquetin J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150470; Anquetin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129193; Anquetin J, 2014, PEERJ, V2, DOI 10.7717/peerj.369; Anquetin J, 2012, J SYST PALAEONTOL, V10, P3, DOI 10.1080/14772019.2011.558928; Arratia G., 2015, SOLNHOFEN FENSTER UR; Barthel KW., 1990, STUDY MESOZOIC PALAE; BENTLEY PJ, 1966, SCIENCE, V151, P1547, DOI 10.1126/science.151.3717.1547; Cadena E, 2018, SENCKENBERG-BUCH, V80, P149; Cadena E, 2015, PEERJ, V3, DOI 10.7717/peerj.1431; Cadena Edwin A., 2015, PALEOBIOS, V32, P1; Caldwell MW, 2002, AM J MED GENET, V112, P236, DOI 10.1002/ajmg.10773; Dalla Valle L, 2009, J ANAT, V214, P284, DOI 10.1111/j.1469-7580.2008.01030.x; Danilov IG, 2008, J VERTEBR PALEONTOL, V28, P306, DOI 10.1671/0272-4634(2008)28[306:AROSPK]2.0.CO;2; DAVENPORT J, 1984, PROC R SOC SER B-BIO, V220, P447, DOI 10.1098/rspb.1984.0013; DUNSON WA, 1986, COPEIA, P741, DOI 10.2307/1444958; DUNSON WA, 1980, J HERPETOL, V14, P31, DOI 10.2307/1563872; Dziomber L, 2020, PEERJ, V8, DOI 10.7717/peerj.10490; Ernst CH., 1989, TURTLES WORLD; Evers SW, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.191936; Evers SW, 2019, PEERJ, V7, DOI 10.7717/peerj.6811; Evers SW, 2019, PALAEONTOLOGY, V62, P93, DOI 10.1111/pala.12384; FERNANDEZ M S, 1988, Ameghiniana, V25, P129; Foth C, 2017, ACTA ZOOL-STOCKHOLM, V98, P310, DOI 10.1111/azo.12181; Frickhinger K.A., 1994, FOSSILS SOLNHOFEN DO; Fursich FT, 2007, NEUES JAHRB GEOL P-A, V245, P45, DOI 10.1127/0077-7749/2007/0245-0045; GAFFNEY ES, 1990, B AM MUS NAT HIST, P5; Gaffney ES, 1975, AM MUS NOVIT, V2576, P1; Gentry AD, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.191950; Gentry AD, 2017, J SYST PALAEONTOL, V15, P675, DOI 10.1080/14772019.2016.1217087; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Ruiz PG, 2020, J PALEONTOL, V94, P145, DOI 10.1017/jpa.2019.74; Grande L., 2013, LOST WORLD FOSSIL LA; Hirayama R, 1998, NATURE, V392, P705, DOI 10.1038/33669; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2021, SWISS J PALAEONTOL, V140, DOI 10.1186/s13358-020-00211-x; Joyce WG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233483; Joyce WG, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0762-5; Joyce WG, 2012, BIOL LETTERS, V8, P846, DOI 10.1098/rsbl.2012.0361; Joyce WG, 2004, P ROY SOC B-BIOL SCI, V271, P1, DOI 10.1098/rspb.2003.2523; Joyce WG, 2000, J PALEONTOL, V74, P684, DOI 10.1666/0022-3360(2000)074<0684:TFCSOS>2.0.CO;2; Joyce WG., ROY SOC OPEN SCI; Joyce WG., 2015, SOLNHOFEN FENSTER UR, P415; Kelley NP, 2015, SCIENCE, V348, DOI 10.1126/science.aaa3716; Klein I. T., 1760, KLASSIFICATION KURZE; Kosenko IN, 2016, PALEONTOL J+, V50, P578, DOI 10.1134/S0031030116060083; Li L., 2015, J VERTEBR PALEONTOL; Lillywhite H.B., 1982, Biology of Reptilia, V12, P397; Lindgren J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13187-5; Maack G.A., 1869, PALAEONTOGRAPHICA, V1868, P193; Mateus O, 2009, ACTA PALAEONTOL POL, V54, P581, DOI 10.4202/app.2008.0063; Mauser M., 2014, FRANKENLAND AM JURAS; Meyer H, 1839, BEITRAGE PETREFACTEN, V1, P75; Meyer Hvon., 1860, REPTILIEN LITHOGRAPH; Meyer Hvon., 1839, BEITR GE PETREFACTEN, V1, P59; Meyer Hvon., 1864, PALAEONTOGRAPHICA, V11, P289; Mlynarski M, 1976, TESTUDINES HDB PAL O, V7, P1; Motani R, 2021, BIOL REV, V96, P1769, DOI 10.1111/brv.12724; NIEBUHR B., 2014, SCHRIFTENREIHE DTSCH, V83, P5, DOI [10.1127/sdgg/83/2014/5, DOI 10.1127/SDGG/83/2014/5]; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Pereira AG, 2017, MOL PHYLOGENET EVOL, V113, P59, DOI 10.1016/j.ympev.2017.05.008; Perez-Garcia A, 2015, J IBER GEOL, V41, P21, DOI 10.5209/rev_JIGE.2015.v41.n1.48652; Perez-Garcia A, 2015, J IBER GEOL, V41, P11, DOI 10.5209/rev_JIGE.2015.v41.n1.48651; Perez-Garcia A, 2015, CR PALEVOL, V14, P555, DOI 10.1016/j.crpv.2015.06.003; Pictet F.-J., 1857, MATERIAUX PALEONTOLO, V1, P1; Pictet F-J., 1860, MAT RIAUX PAL ONTOLO, P15; Portis A, 1878, PALAEONTOGRAPHICA, V25, P125; Puntener C, 2015, PEERJ, V3, DOI 10.7717/peerj.1282; Puntener C, 2014, J VERTEBR PALEONTOL, V34, P353, DOI 10.1080/02724634.2013.804412; Punteneri C, 2017, PEERJ, V5, DOI 10.7717/peerj.3482; RIEPPEL O, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V171, P105; Rivera ARV, 2013, J EXP BIOL, V216, P668, DOI 10.1242/jeb.079715; Robinson NJ, 2017, J MAR BIOL ASSOC UK, V97, P1233, DOI 10.1017/S0025315416000734; Rutimeyer L., 1873, NEUE DENKSCHRIFT ALL, V25, P1; SCHMIDTN.K, 1966, SCIENCE, V154, P911, DOI 10.1126/science.154.3751.911; Schweigert G, 2015, SOLNHOFEN FENSTER JU, P63; Schweigert G, 2007, NEUES JAHRB GEOL P-A, V245, P117, DOI 10.1127/0077-7749/2007/0245-0117; SEELEY H. G., 1869, INDEX FOSSIL REMAINS; Shao S, 2018, PEERJ, V6, DOI 10.7717/peerj.5371; Szczygielski T, 2018, GEOL J, V53, P1215, DOI 10.1002/gj.2952; Tong Haiyan, 2006, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V147, P113; Viohl G., 1985, P31; Viohl G, 2015, SOLNHOFEN FENSTER JU, P515; Walther W.G, 1922, THESIS LUWDIGS U GIE, P607; Wyneken J, 2001, NMFSSEFSC470 NOAA, DOI DOI 10.1007/SPRINGERREFERENCE_; Zell P, 2014, PALAEOBIO PALAEOENV, V94, P439, DOI 10.1007/s12549-014-0154-z; Zhou CF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16299; Zhou CF, 2010, ZOOTAXA, P45; Zhou CF, 2010, ZOOTAXA, P57	92	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252355	10.1371/journal.pone.0252355	http://dx.doi.org/10.1371/journal.pone.0252355			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081728	gold, Green Published			2022-12-26	WOS:000664639200015
J	Brock, EJ; Jackson, RM; Boerner, JL; Li, QW; Tennis, MA; Sloane, BF; Mattingly, RR				Brock, Ethan J.; Jackson, Ryan M.; Boerner, Julie L.; Li, Quanwen; Tennis, Meredith A.; Sloane, Bonnie F.; Mattingly, Raymond R.			Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinoma	PLOS ONE			English	Article							PROTEIN-KINASE PATHWAY; MAP KINASE; CELL-GROWTH; XENOGRAFT MODEL; E-CADHERIN; CANCER; RAS; EXPRESSION; ACTIVATION; SUPPRESSION	Breast ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive ductal carcinoma (IDC). It is still unclear which DCIS will become invasive and which will remain indolent. Patients often receive surgery and radiotherapy, but this early intervention has not produced substantial decreases in late-stage disease. Sprouty proteins are important regulators of ERK/MAPK signaling and have been studied in various cancers. We hypothesized that Sprouty4 is an endogenous inhibitor of ERK/MAPK signaling and that its loss/reduced expression is a mechanism by which DCIS lesions progress toward IDC, including triple-negative disease. Using immunohistochemistry, we found reduced Sprouty4 expression in IDC patient samples compared to DCIS, and that ERK/MAPK phosphorylation had an inverse relationship to Sprouty4 expression. These observations were reproduced using a 3D culture model of disease progression. Knockdown of Sprouty4 in MCF10.DCIS cells increased ERK/MAPK phosphorylation as well as their invasive capability, while overexpression of Sprouty4 in MCF10.CA1d IDC cells reduced ERK/MAPK phosphorylation, invasion, and the aggressive phenotype exhibited by these cells. Immunofluorescence experiments revealed reorganization of the actin cytoskeleton and relocation of E-cadherin back to the cell surface, consistent with the restoration of adherens junctions. To determine whether these effects were due to changes in ERK/MAPK signaling, MEK1/2 was pharmacologically inhibited in IDC cells. Nanomolar concentrations of MEK162/binimetinib restored an epithelial-like phenotype and reduced pericellular proteolysis, similar to Sprouty4 overexpression. From these data we conclude that Sprouty4 acts to control ERK/MAPK signaling in DCIS, thus limiting the progression of these premalignant breast lesions.	[Brock, Ethan J.; Boerner, Julie L.; Sloane, Bonnie F.; Mattingly, Raymond R.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; [Jackson, Ryan M.; Li, Quanwen; Sloane, Bonnie F.; Mattingly, Raymond R.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Tennis, Meredith A.] Univ Colorado Denver Anschutz Med Campus, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO USA	Wayne State University; Wayne State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Mattingly, RR (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.; Mattingly, RR (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	r.mattingly@wayne.edu		Brock, Ethan/0000-0002-6502-851X	Molecular Therapeutics program of the Karmanos Cancer Institute; Wayne State University Office of the Vice-President for Research;  [R01 CA131990];  [P30 CA022453];  [T32 CA009531];  [F31 CA213807];  [R25 GM058905]	Molecular Therapeutics program of the Karmanos Cancer Institute; Wayne State University Office of the Vice-President for Research; ; ; ; ; 	This work was partially supported by R01 CA131990, the Molecular Therapeutics program of the Karmanos Cancer Institute, the Wayne State University Office of the Vice-President for Research, and aided by the Microscopy, Imaging & Cytometry Resources and Biobanking & Correlative Sciences core facilities, which are supported in part by P30 CA022453. EJB was supported by T32 CA009531 and F31 CA213807. RMJ was supported by R25 GM058905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred D. Craig, 2010, Journal of the National Cancer Institute Monographs, P134, DOI 10.1093/jncimonographs/lgq035; Ascierto PA, 2016, LANCET ONCOL, V17, P1248, DOI 10.1016/S1470-2045(16)30122-X; Ashton-Beaucage D, 2017, METHODS MOL BIOL, V1487, P1, DOI 10.1007/978-1-4939-6424-6_1; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bijker N, 2013, CURR TREAT OPTION ON, V14, P75, DOI 10.1007/s11864-012-0217-1; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Bombonati A, 2011, J PATHOL, V223, P307, DOI 10.1002/path.2808; Boxer MM, 2013, BREAST, V22, P1019, DOI 10.1016/j.breast.2013.08.012; Brewster AM, 2014, LANCET ONCOL, V15, pE625, DOI 10.1016/S1470-2045(14)70364-X; Brock EJ, 2019, J MAMMARY GLAND BIOL, V24, P1, DOI 10.1007/s10911-018-9405-3; Brock EJ, 2016, MINI-REV MED CHEM, V16, P358, DOI 10.2174/1389557515666151001154002; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Cowell CF, 2013, MOL ONCOL, V7, P859, DOI 10.1016/j.molonc.2013.07.005; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dawson PJ, 1996, AM J PATHOL, V148, P313; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Ding GX, 2015, PROSTATE, V75, P957, DOI 10.1002/pros.22978; Dummer R, 2018, LANCET ONCOL, V19, P1315, DOI 10.1016/S1470-2045(18)30497-2; Dummer R, 2018, LANCET ONCOL, V19, P603, DOI 10.1016/S1470-2045(18)30142-6; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Faratian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023772; Felfly H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02277; Gotzsche PC, 2012, CANCER CAUSE CONTROL, V23, P15, DOI 10.1007/s10552-011-9867-8; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Gum R, 1997, ONCOGENE, V14, P1481, DOI 10.1038/sj.onc.1200973; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hajra KM, 2002, CANCER RES, V62, P1613; Hanna WM, 2019, MODERN PATHOL, V32, P896, DOI 10.1038/s41379-019-0204-1; He Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep23216; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Heppner Gloria H., 1999, Breast J, V5, P122, DOI 10.1046/j.1524-4741.1999.00136.x; Horning JL, 2008, MOL PHARMACEUT, V5, P849, DOI 10.1021/mp800047v; Hwang E. Shelley, 2010, Journal of the National Cancer Institute Monographs, P197, DOI 10.1093/jncimonographs/lgq032; Jedeszko Christopher, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0420s39; Jiao QL, 2014, J THORAC DIS, V6, P1329, DOI 10.3978/j.issn.2072-1439.2014.08.13; Jing HY, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0292-7; Joannes A, 2014, MOL CANCER RES, V12, P775, DOI 10.1158/1541-7786.MCR-13-0386-T; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Kaur H, 2013, EXPERT REV MOL DIAGN, V13, P151, DOI [10.1586/ERM.13.4, 10.1586/erm.13.4]; Kaur H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050249; Kuerer HM, 2009, J CLIN ONCOL, V27, P279, DOI 10.1200/JCO.2008.18.3103; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Li QW, 2008, NEOPLASIA, V10, P314, DOI 10.1593/neo.07970; Li QW, 2010, J PHARMACOL EXP THER, V332, P821, DOI 10.1124/jpet.109.160390; Li QW, 2008, NEOPLASIA, V10, P1444, DOI 10.1593/neo.08968; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Maguire SL, 2016, J PATHOL, V240, P315, DOI 10.1002/path.4778; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Masoumi-Moghaddam S, 2014, CANCER METAST REV, V33, P695, DOI 10.1007/s10555-014-9497-1; Mattingly Raymond R, 2013, ISRN Oncol, V2013, P536529, DOI 10.1155/2013/536529; Mattingly Raymond R, 2003, Methods Mol Biol, V218, P71; McCawley LJ, 1999, J BIOL CHEM, V274, P4347, DOI 10.1074/jbc.274.7.4347; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Miller FR, 2000, J MAMMARY GLAND BIOL, V5, P379, DOI 10.1023/A:1009577811584; Moriya T, 2010, MED MOL MORPHOL, V43, P67, DOI 10.1007/s00795-010-0504-5; Najafi M, 2019, CELL BIOL INT, V43, P1206, DOI 10.1002/cbin.11187; Nam JM, 2010, CANCER RES, V70, P5238, DOI 10.1158/0008-5472.CAN-09-2319; Oldenhuis CNAM, 2008, EUR J CANCER, V44, P946, DOI 10.1016/j.ejca.2008.03.006; Patani N, 2011, SURG ONCOL, V20, pE23, DOI 10.1016/j.suronc.2010.08.007; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Polyak Kornelia, 2010, Journal of the National Cancer Institute Monographs, P210, DOI 10.1093/jncimonographs/lgq019; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sgroi DC, 2010, ANNU REV PATHOL-MECH, V5, P193, DOI 10.1146/annurev.pathol.4.110807.092306; Shah S, 2018, NEOPLASIA, V20, P951, DOI 10.1016/j.neo.2018.07.002; Sirivatanauksorn Y, 2012, J SURG ONCOL, V105, P273, DOI 10.1002/jso.22095; Solin LJ, 2013, JNCI-J NATL CANCER I, V105, P701, DOI 10.1093/jnci/djt067; Sundaram Meera V, 2013, WormBook, P1, DOI 10.1895/wormbook.1.80.2; Tennis MA, 2010, MOL CANCER RES, V8, P833, DOI 10.1158/1541-7786.MCR-09-0400; Tian YF, 2018, MOL MED REP, V18, P5603, DOI 10.3892/mmr.2018.9572; Tomao F, 2015, ONCOTARGETS THER, V8, P177, DOI 10.2147/OTT.S67673; Tsavachidou D, 2004, CANCER RES, V64, P5556, DOI 10.1158/0008-5472.CAN-04-1669; Tsumura Y, 2005, BIOCHEM J, V387, P627, DOI 10.1042/BJ20041181; Van Cleef A, 2014, FACTS VIEWS VIS OBGY, V6, P210; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Wallace MD, 2012, GENETICS, V192, P385, DOI 10.1534/genetics.112.142802; Wang JH, 2006, PROSTATE, V66, P613, DOI 10.1002/pros.20353; Wang JQ, 2019, MOL NEUROBIOL, V56, P6197, DOI 10.1007/s12035-019-1524-3; Wright CJM, 2013, DRUGS, V73, P1245, DOI 10.1007/s40265-013-0096-1; Wyganowska-Swiatkowska M, 2019, INT J MOL MED, V43, P15, DOI 10.3892/ijmm.2018.3983; Zhang H, 2016, ONCOL LETT, V11, P45, DOI 10.3892/ol.2015.3835; Zhou XL, 2016, CELL PHYSIOL BIOCHEM, V40, P1433, DOI 10.1159/000453195	91	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252314	10.1371/journal.pone.0252314	http://dx.doi.org/10.1371/journal.pone.0252314			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048471	Green Published, gold			2022-12-26	WOS:000664636100033
J	Crum, NJ; Neyman, LC; Gowan, TA				Crum, Nathan J.; Neyman, Lisa C.; Gowan, Timothy A.			Abundance estimation for line transect sampling: A comparison of distance sampling and spatial capture-recapture models	PLOS ONE			English	Article							AERIAL SURVEYS; ATLANTIC; POPULATIONS; DENSITY; INFERENCE; WHALES	Accurate and precise abundance estimation is vital for informed wildlife conservation and management decision-making. Line transect surveys are a common sampling approach for abundance estimation. Distance sampling is often used to estimate abundance from line transect survey data; however, search encounter spatial capture-recapture can also be used when individuals in the population of interest are identifiable. The search encounter spatial capture-recapture model has rarely been applied, and its performance has not been compared to that of distance sampling. We analyzed simulated datasets to compare the performance of distance sampling and spatial capture-recapture abundance estimators. Additionally, we estimated the abundance of North Atlantic right whales in the southeastern United States with two formulations of each model and compared the estimates. Spatial capture-recapture abundance estimates had lower root mean squared error than distance sampling estimates. Spatial capture-recapture 95% credible intervals for abundance had nominal coverage, i.e., contained the simulating value for abundance in 95% of simulations, whereas distance sampling credible intervals had below nominal coverage. Moreover, North Atlantic right whale abundance estimates from distance sampling models were more sensitive to model specification compared to spatial capture-recapture estimates. When estimating abundance from line transect data, researchers should consider using search encounter spatial capture-recapture when individuals in the population of interest are identifiable, when line transects are surveyed over multiple occasions, when there is imperfect detection of individuals located on the line transect, and when it is safe to assume the population of interest is closed demographically. When line transects are surveyed over multiple occasions, researchers should be aware that individual space use may induce spatial autocorrelation in counts across transects. This is not accounted for in common distance sampling estimators and leads to overly precise abundance estimates.	[Crum, Nathan J.; Neyman, Lisa C.; Gowan, Timothy A.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL 32399 USA	Florida Fish & Wildlife Conservation Commission	Crum, NJ (corresponding author), Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL 32399 USA.	nathan.crum@myfwc.com		Crum, Nathan/0000-0002-1253-7329; Neyman, Lisa/0000-0001-5538-0221; Gowan, Timothy/0000-0002-0082-1621	National Oceanic and Atmospheric Administration (NOAA) [NA14OAR4170108, NA16NMF4720319]	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA)	This study was supported by the National Oceanic and Atmospheric Administration (NOAA; grant nos. NA14OAR4170108 and NA16NMF4720319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachler E, 2007, IBIS, V149, P693, DOI 10.1111/j.1474-919X.2007.00689.x; Bischof R, 2020, WILDLIFE BIOL, V2020, DOI 10.2981/wlb.00649; Borchers DL, 2015, J AM STAT ASSOC, V110, P195, DOI 10.1080/01621459.2014.893884; Borchers D, 2012, J ORNITHOL, V152, pS435, DOI 10.1007/s10336-010-0583-z; Borchers DL, 2017, ASTA-ADV STAT ANAL, V101, P475, DOI 10.1007/s10182-016-0287-7; Borchers DL, 1998, BIOMETRICS, V54, P1221, DOI 10.2307/2533652; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; Buckland ST, 2015, METH STAT ECOL, P1, DOI 10.1007/978-3-319-19219-2; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Canadas A, 2004, J CETACEAN RES MANAG, V6, P191; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; de Valpine P, 2017, J COMPUT GRAPH STAT, V26, P403, DOI 10.1080/10618600.2016.1172487; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fewster RM, 2009, BIOMETRICS, V65, P225, DOI 10.1111/j.1541-0420.2008.01018.x; Ganley LC, 2019, ENDANGER SPECIES RES, V38, P101, DOI 10.3354/esr00938; Gardner B, 2010, ECOLOGY, V91, P3376, DOI 10.1890/09-0804.1; Gelman A., 2003, BAYESIAN DATA ANAL; Glennie R, 2019, BIOMETRICS, V75, P1345, DOI 10.1111/biom.13078; Gowan TA., ECOL EVOL; Gowan TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095126; Hain JHW, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P191; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Keller CA, 2006, MAR MAMMAL SCI, V22, P426, DOI 10.1111/j.1748-7692.2006.00033.x; Kenney RD., 2018, ENCY MARINE MAMMALS, V3; Kery M, 2015, APPL HIERARCHICAL MO, V1; Krzystan AM, 2018, ENDANGER SPECIES RES, V36, P279, DOI 10.3354/esr00902; Laake JL, 1997, J WILDLIFE MANAGE, V61, P63, DOI 10.2307/3802415; Lopez-Bao JV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20675-9; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Miller DL, 2019, J STAT SOFTW, V89, P1, DOI 10.18637/jss.v089.i01; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Minton G, 2013, RAFFLES B ZOOL, V61, P877; Noss AJ, 2012, ANIM CONSERV, V15, P527, DOI 10.1111/j.1469-1795.2012.00545.x; Oedekoven CS, 2013, J APPL ECOL, V50, P786, DOI 10.1111/1365-2664.12065; Oyster JH, 2018, J WILDLIFE MANAGE, V82, P1668, DOI 10.1002/jwmg.21541; Parks SE, 2007, MAR MAMMAL SCI, V23, P868, DOI 10.1111/j.1748-7692.2007.00154.x; Pirotta E, 2015, ANIM CONSERV, V18, P20, DOI 10.1111/acv.12132; R Core Team, 2020, R LANG ENV STAT COMP; Robertson JD, 2016, SCI REP-UK, V6, DOI [10.1038/srep27494, 10.1038/srep22615]; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2013, METHODS ECOL EVOL, V4, P520, DOI 10.1111/2041-210X.12039; Royle JA, 2011, METHODS ECOL EVOL, V2, P602, DOI 10.1111/j.2041-210X.2011.00116.x; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Russell RE, 2012, J WILDLIFE MANAGE, V76, P1551, DOI 10.1002/jwmg.412; Schaub M, 2014, METHODS ECOL EVOL, V5, P1316, DOI 10.1111/2041-210X.12134; Sedinger JS, 2019, J WILDLIFE MANAGE, V83, P627, DOI 10.1002/jwmg.21620; Straley JM, 2009, J BIOGEOGR, V36, P427, DOI 10.1111/j.1365-2699.2008.01906.x; Thompson CM, 2012, J WILDLIFE MANAGE, V76, P863, DOI 10.1002/jwmg.317; Wilton CM, 2016, J MAMMAL, V97, P266, DOI 10.1093/jmammal/gyv176	53	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252231	10.1371/journal.pone.0252231	http://dx.doi.org/10.1371/journal.pone.0252231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048456	Green Published, gold			2022-12-26	WOS:000664636100026
J	Kwizera, R; Bongomin, F; Olum, R; Worodria, W; Bwanga, F; Meya, DB; Kirenga, BJ; Gore, R; Denning, DW; Fowler, SJ				Kwizera, Richard; Bongomin, Felix; Olum, Ronald; Worodria, William; Bwanga, Freddie; Meya, David B.; Kirenga, Bruce J.; Gore, Robin; Denning, David W.; Fowler, Stephen J.			Evaluation of an Aspergillus IgG/IgM lateral flow assay for serodiagnosis of fungal asthma in Uganda	PLOS ONE			English	Article							ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; SENSITIZATION; DIAGNOSIS	Background Diagnosis of fungal allergies in asthma remains problematic in low-and middle-income countries due to non-availability of point-of-care testing. In this study, we aimed to evaluate the performance of an Aspergillus immunochromatographic technology (ICT) IgG/M lateral flow device (LFD) for the serological diagnosis of allergic bronchopulmonary aspergillosis (ABPA) and severe asthma with fungal sensitisation (SAFS) among Ugandan adult asthmatics. Methods 374 adult (aged >= 18years) asthmatics in the African Severe Asthma Program study, Ugandan site constituted the study population. ABPA and SAFS were diagnosed according to standard criteria. Asthmatics who did not meet the above criteria constituted a control group. The LFD tests were performed and read according to manufacturer's instructions. Results ABPA was found in 12/374 (3.2%) and SAFS in 60/374 (16%) participants. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for the Aspergillus ICT for the diagnosis of ABPA were 0.0%, 96.4%, 0.0% and 96.7% respectively, and for SAFS 6.7%, 97.1%, 30.8% and 84.5% respectively. False positive and negative rates were 3.5% and 3.2% for ABPA and 2.4% and 14.9% for SAFS, respectively. Patients with a positive LFD significantly had higher median Aspergillus fumigatus-specific IgE levels compared to those with negative LFD (median: 0.06 kUA/l VS 0.03 kUA/L, P = 0.011). Conclusion The Aspergillus ICT IgG/M LFD had a poor diagnostic performance for the diagnosis of both ABPA and SAFS. Its greatest value may be in distinguishing chronic and allergic aspergillosis in Africa.	[Kwizera, Richard; Meya, David B.] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Kwizera, Richard; Kirenga, Bruce J.] Makerere Univ, Lung Inst, Coll Hlth Sci, Kampala, Uganda; [Bongomin, Felix] Gulu Univ, Dept Med Microbiol, Fac Med, Gulu, Uganda; [Bongomin, Felix; Olum, Ronald; Worodria, William; Meya, David B.; Kirenga, Bruce J.] Makerere Univ, Sch Med, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Worodria, William; Kirenga, Bruce J.] Mulago Natl Referral Hosp, Div Pulmonol, Kampala, Uganda; [Bwanga, Freddie] Makerere Univ, Sch Biomed Sci, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda; [Gore, Robin] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Denning, David W.; Fowler, Stephen J.] Univ Manchester, Sch Biol Sci, Div Infect Immun & Resp Med, Fac Biol Med & Hlth, Manchester, Lancs, England; [Denning, David W.; Fowler, Stephen J.] Manchester Univ Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, Manchester, Lancs, England	Makerere University; Makerere University; Makerere University; Mulago National Referral Hospital; Makerere University; University of Cambridge; University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Kwizera, R (corresponding author), Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda.; Kwizera, R (corresponding author), Makerere Univ, Lung Inst, Coll Hlth Sci, Kampala, Uganda.	kwizerarichard@ymail.com	Olum, Ronald/AAR-4279-2020; Kwizera, Richard/I-5247-2019	Olum, Ronald/0000-0003-1289-0111; Kwizera, Richard/0000-0002-5270-3539; , David/0000-0002-8854-0321; Denning, David/0000-0001-5626-2251	DELTAS Africa Initiative grant [DEL-15-011]; New Partnership for Africa's Development Planning and Coordinating Agency NEPAD Agency; Wellcome Trust [107742/Z/15/Z]; UK government; GlaxoSmithKline (GSK) African Non-Communicable Disease (NCD) Open Lab [8019]; Manchester NIHR Biomedical Research Centre	DELTAS Africa Initiative grant; New Partnership for Africa's Development Planning and Coordinating Agency NEPAD Agency; Wellcome Trust(Wellcome Trust); UK government; GlaxoSmithKline (GSK) African Non-Communicable Disease (NCD) Open Lab; Manchester NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	RK was supported through the DELTAS Africa Initiative grant #DEL-15-011 to THRiVE-2. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency NEPAD Agency) with funding from the Wellcome Trust grant #107742/Z/15/Z and the UK government. ASAP (ClinicalTrials.gov Identifier: NCT03065920) under the Makerere University Lung Institute provided study participants, clinical data and samples to the student. ASAP provided clinical support, asthma medication and paid for all clinical and some general laboratory procedures. ASAP was funded by the GlaxoSmithKline (GSK) African Non-Communicable Disease (NCD) Open Lab (Project number: 8019) to BJK. DWD and SJF also received funding from the Manchester NIHR Biomedical Research Centre. Funders had no role in data collection, analysis or decision to publish. Authors retained control of the final content of the publication.	Agarwal R, 2013, CLIN EXP ALLERGY, V43, P850, DOI 10.1111/cea.12141; Agarwal R, 2009, INT J TUBERC LUNG D, V13, P936; Agarwal R, 2006, CHEST, V130, P442, DOI 10.1378/chest.130.2.442; Agarwal R, 2011, MED MYCOL, V49, pS150, DOI 10.3109/13693786.2010.504752; Asano K, 2021, J ALLERGY CLIN IMMUN, V147, P1261, DOI 10.1016/j.jaci.2020.08.029; Bush RK, 2004, J ALLERGY CLIN IMMUN, V113, P227, DOI 10.1016/j.jaci.2003.11.023; Denning DW, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-14; Denning DW, 2013, MED MYCOL, V51, P361, DOI 10.3109/13693786.2012.738312; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; DREBORG S, 1989, J AM ACAD DERMATOL, V21, P820, DOI 10.1016/S0190-9622(89)70256-5; Fairs A, 2010, AM J RESP CRIT CARE, V182, P1362, DOI 10.1164/rccm.201001-0087OC; Guo YQ, 2019, MEDICINE, V98, DOI [10.1097/MD.0000000000015021, 10.1097/md.0000000000015021]; HINSON KFW, 1952, THORAX, V7, P317, DOI 10.1136/thx.7.4.317; Hunter ES, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238855; Hunter ES, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00538-19; Kirenga B., 2018, AM J RESP CRIT CARE, P18; Kirenga B., 2017, RES NETWORK CHARACTE; Kirenga B, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2019-000484; Kirenga BJ, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6562-2; Kwizera R, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02747-z; Kwizera R, 2020, WORLD ALLERGY ORGAN, V13, DOI 10.1016/j.waojou.2020.100130; Kwizera R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216568; Lass-Florl C, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.08.009; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Menzies D, 2011, ALLERGY, V66, P679, DOI 10.1111/j.1398-9995.2010.02542.x; Page ID, 2015, MED MYCOL, V53, P417, DOI 10.1093/mmy/myv020; Parkes-Ratanshi R, 2015, MYCOSES, V58, P85, DOI 10.1111/myc.12387; Piarroux RP, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00012; Richardson M, 2018, CURR FUNGAL INFECT R, V12, P127, DOI 10.1007/s12281-018-0321-1; Rozaliyani A, 2020, J FUNGI, V6, DOI 10.3390/jof6040318; Sisodia J., 2020, STATPEARLS; Thornton C, 2012, JOVE-J VIS EXP, DOI 10.3791/3721; Thornton CR, 2008, CLIN VACCINE IMMUNOL, V15, P1095, DOI 10.1128/CVI.00068-08; Tillie-Leblond I, 2005, ALLERGY, V60, P1004, DOI 10.1111/j.1398-9995.2005.00887.x	35	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252553	10.1371/journal.pone.0252553	http://dx.doi.org/10.1371/journal.pone.0252553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048497	Green Published, gold			2022-12-26	WOS:000664636100067
J	Miranda, MP; Costa-Lopes, R; Freitas, G; Carvalho, CL				Miranda, Mariana P.; Costa-Lopes, Rui; Freitas, Goncalo; Carvalho, Catarina L.			Early release from prison in time of COVID-19: Determinants of unfavourable decisions towards Black prisoners	PLOS ONE			English	Article							SOCIAL-DOMINANCE ORIENTATION; PUBLIC-OPINION; RACIAL BIAS; RACE; PREJUDICE; STEREOTYPES; MERITOCRACY; CRIME; HIERARCHY; ATTITUDES	On the onset of the COVID-19 pandemic, the overcrowding in prisons led to efforts to decarcerate in order to prevent and control outbreaks in prisons. This study analyses how public support for such exceptional measures are determined by cognitive and ideological factors known to create and maintain racial biases in the criminal system. Participants were asked to express their level of agreement with the early-release of hypothetical prisoners. Results showed participants to be less favourable to the early-release of Black compared to White prisoners, when they had committed a stereotypically Black crime. As expected, the congruency between the crime stereotypicality and the colour of the prisoner's skin did not emerge for White prisoners. Moreover, the difference between the agreement with the release of the Black vs. the White prisoner when both committed a stereotypically Black crime was higher as the level of endorsement of Meritocracy increased. Contrastingly, Anti-egalitarianism only predicted an overall disagreement with prisoners' early-release. This paper highlights the cumulative explanation by different levels of analysis of this current problem and implications for the development of the public opinion on penal subjects.	[Miranda, Mariana P.; Costa-Lopes, Rui; Freitas, Goncalo] Univ Lisbon, Inst Social Sci, Lisbon, Portugal; [Carvalho, Catarina L.] Univ Porto, Fac Psychol & Educ Sci, Porto, Portugal	Institute of Social Sciences, University of Lisbon (ICS-UL); Universidade de Lisboa; Universidade do Porto	Miranda, MP (corresponding author), Univ Lisbon, Inst Social Sci, Lisbon, Portugal.	mariana.miranda@ics.ulisboa.pt	Carvalho, Catarina L./AAC-7342-2022	Carvalho, Catarina L./0000-0002-4779-5328; Freitas, Goncalo/0000-0001-5888-3000; Pires de Miranda, Mariana/0000-0003-4208-2967	Fundacao para a Ciencia e a Tecnologia [PTDC/PSI-GER/28765/2017]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The research reported here was supported by a grant (PTDC/PSI-GER/28765/2017) from the Fundacao para a Ciencia e a Tecnologia (https://www.fct.pt/) awarded to the second author (RCL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama MJ, 2020, NEW ENGL J MED, V382, P2075, DOI 10.1056/NEJMp2005687; Austin RL, 2000, J RES CRIME DELINQ, V37, P200, DOI 10.1177/0022427800037002003; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; BODENHAUSEN GV, 1987, J PERS SOC PSYCHOL, V52, P871, DOI 10.1037/0022-3514.52.5.871; BODENHAUSEN GV, 1985, J PERS SOC PSYCHOL, V48, P267, DOI 10.1037/0022-3514.48.2.267; Brewer MB, 1999, J SOC ISSUES, V55, P429, DOI 10.1111/0022-4537.00126; Burstein P, 2003, POLIT RES QUART, V56, P29, DOI 10.1177/106591290305600103; CARROLL JS, 1987, J PERS SOC PSYCHOL, V52, P107, DOI 10.1037/0022-3514.52.1.107; Castilla EJ, 2010, ADMIN SCI QUART, V55, P543, DOI 10.2189/asqu.2010.55.4.543; Christopher AN, 2003, J APPL SOC PSYCHOL, V33, P522, DOI 10.1111/j.1559-1816.2003.tb01910.x; Correll J, 2007, J PERS SOC PSYCHOL, V92, P1006, DOI 10.1037/0022-3514.92.6.1006; Costa-Lopes R., 2018, CHANGING SOC LEGACIE, P137; Darnon C, 2018, EUR J SOC PSYCHOL, V48, P523, DOI 10.1002/ejsp.2347; DeBruine Lisa, 2017, Figshare, DOI 10.6084/m9.figshare.5047666.v5; DEUTSCH M, 1975, J SOC ISSUES, V31, P137, DOI 10.1111/j.1540-4560.1975.tb01000.x; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; DOISE W, 1980, EUR J SOC PSYCHOL, V10, P213, DOI 10.1002/ejsp.2420100302; Doosje B, 1998, EUR J SOC PSYCHOL, V28, P173, DOI 10.1002/(SICI)1099-0992(199803/04)28:2<173::AID-EJSP862>3.0.CO;2-Z; Dovidio JF., 1986, PREJUDICE DISCRIMINA; Duckitt J, 2002, J PERS SOC PSYCHOL, V83, P75, DOI 10.1037//0022-3514.83.1.75; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Eberhardt JL, 2004, J PERS SOC PSYCHOL, V87, P876, DOI 10.1037/0022-3514.87.6.876; European Prison Observatory, 2019, PRIS EUR 2019 REP EU; European Prison Observatory, 2020, COVID 19 WHAT IS HAP; Eurostat, 2020, STAT REG EUR UN PART; Flanagan TJ., 1984, PRISON J, V64, P31; Foot, 1967, OXFORD REV, V5, P5, DOI DOI 10.1093/0199252866.003.0002; Foot P., 2002, MORAL DILEMMAS OTHER; Frost NA, 2010, SOCIOL COMPASS, V4, P156, DOI 10.1111/j.1751-9020.2009.00269.x; GORDON RA, 1988, J SOC PSYCHOL, V128, P191, DOI 10.1080/00224545.1988.9711362; Gordon RA, 1996, J APPL SOC PSYCHOL, V26, P148, DOI 10.1111/j.1559-1816.1996.tb01843.x; Guimond S, 2003, J PERS SOC PSYCHOL, V84, P697, DOI 10.1037/0022-3514.84.4.697; Gurman S, 2020, WALL STR J; Hamilton DL, 2014, HDB SOCIAL COGNITION, V2nd ed, P17; Hetey RC, 2014, PSYCHOL SCI, V25, P1949, DOI 10.1177/0956797614540307; Hing LSS, 2011, J PERS SOC PSYCHOL, V101, P433, DOI 10.1037/a0024618; Hirschfield PJ, 2010, CRIMINOLOGY, V48, P27, DOI 10.1111/j.1745-9125.2010.00179.x; Ho AK, 2015, J PERS SOC PSYCHOL, V109, P1003, DOI 10.1037/pspi0000033; Jones CS, 2003, BASIC APPL SOC PSYCH, V25, P1, DOI 10.1207/S15324834BASP2501_1; Jost JT, 2000, J EXP SOC PSYCHOL, V36, P209, DOI 10.1006/jesp.1999.1403; Kaeble D., 2018, CORRECTIONAL POPULAT; Kang J, 2012, UCLA LAW REV, V59, P1124; Katz D, 1933, J ABNORM SOC PSYCH, V28, P280, DOI 10.1037/h0074049; Kemmelmeier M, 2005, J APPL SOC PSYCHOL, V35, P1030, DOI 10.1111/j.1559-1816.2005.tb02158.x; Kinner SA, 2020, LANCET PUBLIC HEALTH, V5, pE188, DOI 10.1016/S2468-2667(20)30058-X; Knowles ED, 2012, SELF IDENTITY, V11, P202, DOI 10.1080/15298868.2010.542015; Kteily NS, 2017, J PERS SOC PSYCHOL, V112, P136, DOI 10.1037/pspp0000097; Lee IC, 2011, PSYCHOL BULL, V137, P1029, DOI 10.1037/a0025410; LERNER MJ, 1977, J PERS, V45, P3; Lowery BS, 2006, J PERS SOC PSYCHOL, V90, P961, DOI 10.1037/0022-3514.90.6.961; Maculan A., 2013, PRISON EUROPE OVERVI; Madeira AF, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02007; Madeira F, 2019, THESIS U LISBON; MAZZELLA R, 1994, J APPL SOC PSYCHOL, V24, P1315, DOI 10.1111/j.1559-1816.1994.tb01552.x; Mccoy SK, 2007, J EXP SOC PSYCHOL, V43, P341, DOI 10.1016/j.jesp.2006.04.009; McNamee S., 2009, MERITOCRACY MYTH; Mitchell T, 2005, LAW HUMAN BEHAV, V29, P621, DOI 10.1007/s10979-005-8122-9; Mooney CZ, 2000, J POLIT, V62, P223, DOI 10.1111/0022-3816.00011; Nellis Ashley, 2016, COLOR JUSTICE RACIAL, P3; Oldmeadow J, 2007, EUR J SOC PSYCHOL, V37, P1135, DOI 10.1002/ejsp.428; Payne BK, 2001, J PERS SOC PSYCHOL, V81, P181, DOI 10.1037/0022-3514.81.2.181; PETTIGREW TF, 1995, EUR J SOC PSYCHOL, V25, P57, DOI 10.1002/ejsp.2420250106; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; RADELET ML, 1985, LAW SOC REV, V19, P587, DOI 10.2307/3053422; Reyna C, 2005, POLIT PSYCHOL, V26, P667, DOI 10.1111/j.1467-9221.2005.00438.x; Roberts JV., 2003, RANDOM VIBRATION STA; Schuman H., 1997, RACIAL ATTITUDES AM; Seabra HM., 2006, RECLUSOS ESTRANGEIRO; Shwom R, 2010, GLOBAL ENVIRON CHANG, V20, P472, DOI 10.1016/j.gloenvcha.2010.02.003; SIDANIUS J, 1994, J APPL SOC PSYCHOL, V24, P338, DOI 10.1111/j.1559-1816.1994.tb00586.x; Sidanius J., 2006, SOC JUSTICE RES, V19, P433, DOI [DOI 10.1007/S11211-006-0026-4, 10.1007/s11211-006-0026-4]; Sidanius J., 1999, SOCIAL DOMINANCE INT; SIMON B, 1995, EUR J SOC PSYCHOL, V25, P463, DOI 10.1002/ejsp.2420250409; Simonsohn U, 2014, PERSPECT PSYCHOL SCI, V9, P666, DOI 10.1177/1745691614553988; Skorinko JL, 2013, VICTIMS OFFENDERS, V8, P278, DOI 10.1080/15564886.2012.755140; Sunnafrank M., 1983, CORNELL J SOC RELAT, V17, P1; SWEENEY LT, 1992, BEHAV SCI LAW, V10, P179, DOI 10.1002/bsl.2370100204; Thomsen L, 2008, J EXP SOC PSYCHOL, V44, P1455, DOI 10.1016/j.jesp.2008.06.011; TOOTHMAKER LE, 1994, J OPER RES SOC, V45, P119; UNODC, 2020, GLOB REP TRAFF PERS; VIDMAR N, 1980, LAW SOC REV, V14, P565, DOI 10.2307/3053193; Walmsley R., 2018, WORLD PRISON POPULAT, V12th ed; Weber M., 1958, PROTESTANT ETHIC SPI; Wellman JD, 2016, BRIT J SOC PSYCHOL, V55, P426, DOI 10.1111/bjso.12133; Young M, 1958, RISE MERITOCRACY; Yzerbyt Vincent., 2010, HDB SOCIAL PSYCHOL, V5th ed., P1024, DOI DOI 10.1002/9780470561119.SOCPSY002028	86	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252319	10.1371/journal.pone.0252319	http://dx.doi.org/10.1371/journal.pone.0252319			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043712	gold, Green Published			2022-12-26	WOS:000664635700086
J	Ranftler, C; Nagl, D; Sparer, A; Rohrich, A; Freissmuth, M; El-Kasaby, A; Shirazi, SN; Koban, F; Tschegg, C; Nizet, S				Ranftler, Carmen; Nagl, Dietmar; Sparer, Andreas; Roehrich, Andreas; Freissmuth, Michael; El-Kasaby, Ali; Shirazi, Shahrooz Nasrollahi; Koban, Florian; Tschegg, Cornelius; Nizet, Stephane			Binding and neutralization of C. difficile toxins A and B by purified clinoptilolite-tuff	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; BARRIER FUNCTION; RHO-GTPASES; CACO-2; SEQUESTRATION; VANCOMYCIN; INFECTION; TOLEVAMER; PROTEINS; COLITIS	Clostridioides difficile (C. difficile) infection is a major public health problem worldwide. The current treatment of C. difficile-associated diarrhea relies on the use of antibacterial agents. However, recurrences are frequent. The main virulence factors of C. difficile are two secreted cytotoxic proteins toxin A and toxin B. Alternative research exploring toxin binding by resins found a reduced rate of recurrence by administration of tolevamer. Hence, binding of exotoxins may be useful in preventing a relapse provided that the adsorbent is innocuous. Here, we examined the toxin binding capacity of G-PUR (R), a purified version of natural clinoptilolite-tuff. Our observations showed that the purified clinoptilolite-tuff adsorbed clinically relevant amounts of C. difficile toxins A and B in vitro and neutralized their action in a Caco-2 intestinal model. This conclusion is based on four independent sets of findings: G-PUR (R) abrogated toxin-induced (i) RAC1 glucosylation, (ii) redistribution of occludin, (iii) rarefaction of the brush border as visualized by scanning electron microscopy and (iv) breakdown of the epithelial barrier recorded by transepithelial electrical resistance monitoring. Finally, we confirmed that the epithelial monolayer tolerated G-PUR (R) over a wide range of particle densities. Our findings justify the further exploration of purified clinoptilolite-tuff as a safe agent in the treatment and/or prevention of C. difficile-associated diarrhea.	[Ranftler, Carmen; Nagl, Dietmar; Sparer, Andreas; Roehrich, Andreas; Tschegg, Cornelius; Nizet, Stephane] GLOCK Hlth Sci & Res GmbH, Deutsch Wagram, Austria; [Freissmuth, Michael; El-Kasaby, Ali; Shirazi, Shahrooz Nasrollahi; Koban, Florian] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Freissmuth, Michael; El-Kasaby, Ali; Shirazi, Shahrooz Nasrollahi; Koban, Florian] Med Univ Vienna, Ctr Physiol & Pharmacol, Gaston H Glock Res Labs Explorat Drug Dev, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Nizet, S (corresponding author), GLOCK Hlth Sci & Res GmbH, Deutsch Wagram, Austria.	stephane.nizet@glock.at		Koban, Florian/0000-0003-0912-3114; Sparer, Andreas/0000-0003-4047-2902	doctorate college CCHD (Cell Communications in Health and Disease) - FWF [W1205]; doctorate college CCHD (Cell Communications in Health and Disease) - Medical University of Vienna	doctorate college CCHD (Cell Communications in Health and Disease) - FWF(Austrian Science Fund (FWF)); doctorate college CCHD (Cell Communications in Health and Disease) - Medical University of Vienna	Shahrooz Nasrollahi-Shirazi is supported by the doctorate college CCHD (Cell Communications in Health and Disease), which is jointly funded by the FWF (W1205) and the Medical University of Vienna. Glock Health, Science and Research GmbH provided support in the form of research materials and salaries for authors C.R., D. N., A.S., A.R., C.T. and S.N., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aktories K, 2017, ANNU REV MICROBIOL, V71, P281, DOI 10.1146/annurev-micro-090816-093458; Al Adham Z, 2014, THESIS; Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Carballo RS., 2001, STUDIES SURFACE SCI, P170, DOI [10.1016/S0167-2991(01)81306-9, DOI 10.1016/S0167-2991(01)81306-9]; Chandrasekaran R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006070; Chumbler NM, 2016, INFECT IMMUN, V84, P2871, DOI 10.1128/IAI.00583-16; Cohen NA, 2018, UNITED EUR GASTROENT, V6, P773, DOI 10.1177/2050640617750809; COLUCCIO LM, 1989, J CELL BIOL, V108, P495, DOI 10.1083/jcb.108.2.495; Czepiel J, 2019, EUR J CLIN MICROBIOL, V38, P1211, DOI 10.1007/s10096-019-03539-6; Dakovic A, 2005, COLLOID SURFACE B, V46, P20, DOI 10.1016/j.colsurfb.2005.08.013; Depestel Daryl D, 2013, J Pharm Pract, V26, P464, DOI 10.1177/0897190013499521; Di Bella S, 2016, TOXINS, V8, DOI 10.3390/toxins8050134; ECDC, 2018, ANT CONS ANN EP REP; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Engevik MA, 2020, AM J PHYSIOL-GASTR L, V318, pG870, DOI 10.1152/ajpgi.00045.2020; Feltis BA, 1999, ARCH SURG-CHICAGO, V134, P1235, DOI 10.1001/archsurg.134.11.1235; Francis MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003356; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Gerhard R, 2017, CURR TOP MICROBIOL, V406, P79, DOI 10.1007/82_2016_17; Gigli S, 2017, UNITED EUR GASTROENT, V5, P1108, DOI 10.1177/2050640617698622; Gilani A, 2016, TURK J VET ANIM SCI, V40, P255, DOI 10.3906/vet-1501-103; HECHT G, 1992, GASTROENTEROLOGY, V102, P416, DOI 10.1016/0016-5085(92)90085-D; HECHT G, 1988, J CLIN INVEST, V82, P1516, DOI 10.1172/JCI113760; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; HIDALGO IJ, 1989, GASTROENTEROLOGY, V96, P736; Hinkson PL, 2008, ANTIMICROB AGENTS CH, V52, P2190, DOI 10.1128/AAC.00041-08; Hohenegger M, 1996, MOL PHARMACOL, V49, P73; Huang B, 2014, J CLIN MICROBIOL, V52, P1105, DOI 10.1128/JCM.02601-13; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; Jank T, 2015, CELL MICROBIOL, V17, P1752, DOI 10.1111/cmi.12533; Johnson S, 2014, CLIN INFECT DIS, V59, P345, DOI 10.1093/cid/ciu313; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kasendra M, 2014, J INFECT DIS, V209, P1095, DOI 10.1093/infdis/jit617; KELLY CP, 1994, J CLIN INVEST, V93, P1257, DOI 10.1172/JCI117080; KREUTZER EW, 1978, JOHNS HOPKINS MED J, V143, P67; Kristo AS, 2015, FOOD FUNCT, V6, P3818, DOI [10.1039/C5FO00116A, 10.1039/c5fo00116a]; Kurtz CB, 2001, ANTIMICROB AGENTS CH, V45, P2340, DOI 10.1128/AAC.45.8.2340-2347.2001; Lea T., 2015, IMPACT FOOD BIOACTIV, P103; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Manse JS, 2015, FEBS LETT, V589, P3945, DOI 10.1016/j.febslet.2015.11.017; MOGG GAG, 1982, BRIT J SURG, V69, P137, DOI 10.1002/bjs.1800690306; Nizet S, 2018, INFLAMM BOWEL DIS, V24, P54, DOI 10.1093/ibd/izx042; Nusrat A, 2001, INFECT IMMUN, V69, P1329, DOI 10.1128/IAI.69.3.1329-1336.2001; Padua D, 2016, EXPERT REV GASTROENT, V10, P193, DOI 10.1586/17474124.2016.1109444; Papatheodorou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010673; Pavelic K, 2001, J MOL MED-JMM, V78, P708, DOI 10.1007/s001090000176; Pavelic SK, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01350; Pfeifer G, 2003, J BIOL CHEM, V278, P44535, DOI 10.1074/jbc.M307540200; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Schneider AF, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20160344; Shahinas D, 2012, MBIO, V3, DOI 10.1128/mBio.00338-12; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stewart DB, 2013, COLORECTAL DIS, V15, P798, DOI 10.1111/codi.12134; Sturino JM, 2015, ANTIMICROB AGENTS CH, V59, P7178, DOI 10.1128/AAC.05050-14; TAYLOR NS, 1980, J INFECT DIS, V141, P92, DOI 10.1093/infdis/141.1.92; TRABER MG, 1987, J LIPID RES, V28, P1350; Tschegg C., 2019, EC GEOL PRESS; Tschegg C, 2020, J STRUCT GEOL, V138, DOI 10.1016/j.jsg.2020.104090; TVEDE M, 1989, LANCET, V1, P1156; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449	63	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252211	10.1371/journal.pone.0252211	http://dx.doi.org/10.1371/journal.pone.0252211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043688	gold, Green Published			2022-12-26	WOS:000664635700069
J	Schafer, S; Wang, K; Sundling, F; Yang, J; Liu, A; Nanan, R				Schafer, Samuel; Wang, Kevin; Sundling, Felicia; Yang, Jean; Liu, Anthony; Nanan, Ralph			Modelling maternal and perinatal risk factors to predict poorly controlled childhood asthma	PLOS ONE			English	Article							GENDER-DIFFERENCES; ALLERGIC DISEASE; LUNG DEVELOPMENT; FETAL; OBESITY; COMPLICATIONS; PREGNANCY; SIBLINGS; ECZEMA; INDEX	Asthma is the most common non-communicable pulmonary condition, affecting prepubertal boys more often than girls. This study explored how maternal and perinatal risk factors are linked to poorly controlled childhood asthma in a sex dependent manner. This single centre study was performed at a metropolitan teaching hospital in Western Sydney, Australia, using electronical obstetric records from 2000 to 2017 and electronical pediatric records from 2007 to 2018. The data of 1694 children with complete entries were retrospectively analysed. Risk factors for multiple hospital admission for asthma were selected by backward-eliminated Poisson regression modelling. Selection stability of these parameters was independently confirmed using approximated exhaustive search. Sex-specific regression models indicated that most notably parity (RR[95%CI] for parity = 3; 1.85[1.22-2.81]), birth length z-score (1.45[1.23-1.70]) and birth weight z-score (0.77[0.65-0.90]) contributed to multiple asthma admissions in girls, while boys were affected most prominently by maternal BMI (e.g. BMI 35-39.9; 1.92[1.38-2.67]) and threatened preterm labor (1.68[1.10-2.58]). Allergic status was a risk factors for both boys and girls (1.47[1.18-1.83] and 1.46[1.13-1.89]). Applying ROC analysis, the predictive modelling of risk factors for hospital admissions showed an incremental increase with an AUC of 0.84 and 0.75 for girls and boys respectively for >3 hospital admissions. Multiple hospital admissions for asthma are associated with maternal and perinatal risk factors in a sex and birth order dependent manner. Hence, prospective risk stratification studies aiming to improve childhood asthma control are warranted to test the clinical utility of these parameters. Furthermore, the influence of the early in utero environment on male-female differences in other communicable and non-communicable respiratory conditions should be considered.	[Schafer, Samuel; Sundling, Felicia; Liu, Anthony; Nanan, Ralph] Univ Sydney, Discipline Paediat & Child Hlth, Sydney Med Sch Nepean, Sydney, NSW, Australia; [Schafer, Samuel] Linkoping Univ, Ctr Personalized Med, Linkoping, Sweden; [Wang, Kevin; Yang, Jean] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia; [Yang, Jean] Univ Sydney, Charles Perkins Ctr, Judith & David Coffey Life Lab, Sydney, NSW, Australia; [Liu, Anthony; Nanan, Ralph] Univ Sydney, Charles Perkins Ctr Nepean, Sydney, NSW, Australia	University of Sydney; Linkoping University; University of Sydney; University of Sydney; University of Sydney	Nanan, R (corresponding author), Univ Sydney, Discipline Paediat & Child Hlth, Sydney Med Sch Nepean, Sydney, NSW, Australia.; Nanan, R (corresponding author), Univ Sydney, Charles Perkins Ctr Nepean, Sydney, NSW, Australia.	ralph.nanan@sydney.edu.au		Schafer, Samuel/0000-0002-3101-9367; Wang, Kevin/0000-0003-2615-6102				Annesi-Maesano I, 2001, ALLERGY, V56, P491, DOI 10.1034/j.1398-9995.2001.056006491.x; [Anonymous], 2012, INF CHILDR AC MAN AS; Arroyave WD, 2016, ANN ALLERG ASTHMA IM, V116, P18, DOI 10.1016/j.anai.2015.10.015; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bose M, 2009, CURR OPIN ENDOCRINOL, V16, P340, DOI 10.1097/MED.0b013e32832fa137; Castro-Rodriguez JA, 2011, CURR OPIN ALLERGY CL, V11, P157, DOI 10.1097/ACI.0b013e3283464c4a; Davidson R, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-14; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Duijts L, 2012, EUR J EPIDEMIOL, V27, P5, DOI 10.1007/s10654-012-9657-y; Ekstrom S, 2015, CLIN EXP ALLERGY, V45, P283, DOI 10.1111/cea.12340; Forno E, 2014, PEDIATRICS, V134, pE535, DOI 10.1542/peds.2014-0439; Fuseini H, 2017, CURR ALLERGY ASTHM R, V17, DOI 10.1007/s11882-017-0686-1; Giussani DA, 2011, PEDIATR RES, V69, P118, DOI 10.1203/PDR.0b013e3182042a20; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Harpsoe MC, 2013, J ALLERGY CLIN IMMUN, V131, P1033, DOI 10.1016/j.jaci.2012.09.008; Hon KLE, 2006, ANN ACAD MED SINGAP, V35, P882; Hong JY, 2020, CELL, V180, P847, DOI 10.1016/j.cell.2020.02.018; Kikkawa T, 2018, CLIN EXP ALLERGY, V48, P577, DOI 10.1111/cea.13100; LETTIERI L, 1993, AM J OBSTET GYNECOL, V168, P1480, DOI 10.1016/S0002-9378(11)90785-6; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; McGillick EV, 2017, PAEDIATR RESPIR REV, V21, P3, DOI 10.1016/j.prrv.2016.08.011; McKeever TM, 2001, THORAX, V56, P758, DOI 10.1136/thorax.56.10.758; Melgert BN, 2007, CURR ALLERGY ASTHM R, V7, P143, DOI 10.1007/s11882-007-0012-4; Metsala J, 2008, AM J EPIDEMIOL, V168, P170, DOI 10.1093/aje/kwn105; Murphy VE, 2003, AM J RESP CRIT CARE, V168, P1317, DOI 10.1164/rccm.200303-374OC; Ogawa K, 2017, PEDIAT ALLERG IMM-UK, V28, P746, DOI 10.1111/pai.12805; Paraboschi E.M., 2020, ACE2 TMPRSS2 VARIANT; Peretz J., 2015, SEX GENDER DIFFERENC, P183, DOI [10.1007/978-3-319-16438-0_6, DOI 10.1007/978-3-319-16438-0_6]; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; Schwindt CD, 2006, J ASTHMA, V43, P439, DOI 10.1080/02770900600758234; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Strachan DP, 2015, CLIN EXP ALLERGY, V45, P126, DOI 10.1111/cea.12349; Torday JS, 2002, AM J PHYSIOL-LUNG C, V282, pL405, DOI 10.1152/ajplung.2002.282.3.L405; Wang KYX, 2019, AUST NZ J STAT, V61, P445, DOI 10.1111/anzs.12276; Watanabe M, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0217-2; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252215	10.1371/journal.pone.0252215	http://dx.doi.org/10.1371/journal.pone.0252215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043705	gold, Green Published			2022-12-26	WOS:000664635700071
J	Slavney, AJ; Kawakami, T; Jensen, MK; Nelson, TC; Sams, AJ; Boyko, AR				Slavney, Andrea J.; Kawakami, Takeshi; Jensen, Meghan K.; Nelson, Thomas C.; Sams, Aaron J.; Boyko, Adam R.			Five genetic variants explain over 70% of hair coat pheomelanin intensity variation in purebred and mixed breed domestic dogs	PLOS ONE			English	Article							TRANSCRIPTION-FACTOR; PENDRED-SYNDROME; MOLECULAR-BASIS; COLOR; TYROSINASE; EXPRESSION; MUTATION; BLACK; ALBINISM; CATTLE	In mammals, the pigment molecule pheomelanin confers red and yellow color to hair, and the intensity of this coloration is caused by variation in the amount of pheomelanin. Domestic dogs exhibit a wide range of pheomelanin intensity, ranging from the white coat of the Samoyed to the deep red coat of the Irish Setter. While several genetic variants have been associated with specific coat intensity phenotypes in certain dog breeds, they do not explain the majority of phenotypic variation across breeds. In order to gain further insight into the extent of multigenicity and epistatic interactions underlying coat pheomelanin intensity in dogs, we leveraged a large dataset obtained via a direct-to-consumer canine genetic testing service. This consisted of genome-wide single nucleotide polymorphism (SNP) genotype data and owner-provided photos for 3,057 pheomelanic mixed breed and purebred dogs from 63 breeds and varieties spanning the full range of canine coat pheomelanin intensity. We first performed a genome-wide association study (GWAS) on 2,149 of these dogs to search for additional genetic variants that underlie intensity variation. GWAS identified five loci significantly associated with intensity, of which two (CFA15 29.8 Mb and CFA20 55.8 Mb) replicate previous findings and three (CFA2 74.7 Mb, CFA18 12.9 Mb, CFA21 10.9 Mb) have not previously been reported. In order to assess the combined predictive power of these loci across dog breeds, we used our GWAS data set to fit a linear model, which explained over 70% of variation in coat pheomelanin intensity in an independent validation dataset of 908 dogs. These results introduce three novel pheomelanin intensity loci, and further demonstrate the multigenic nature of coat pheomelanin intensity determination in domestic dogs.	[Slavney, Andrea J.; Kawakami, Takeshi; Jensen, Meghan K.; Nelson, Thomas C.; Sams, Aaron J.; Boyko, Adam R.] Embark Vet Inc, Boston, MA 02111 USA; [Boyko, Adam R.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY USA	Cornell University	Slavney, AJ (corresponding author), Embark Vet Inc, Boston, MA 02111 USA.	aslavney@embarkvet.com	Kawakami, Takeshi/B-9060-2009	Kawakami, Takeshi/0000-0002-9204-6852	Embark Veterinary, Inc.	Embark Veterinary, Inc.	This study was funded by Embark Veterinary, Inc. and the participants that provided DNA and phenotypic information via Embark's web-based platform. The funders provided support in the form of salaries for all authors (AJ Slavney, MKJ, TK, TRN, AJ Sams, and AR Boyko), but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Adhikari K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08147-0; Aigner B, 2000, MAMM GENOME, V11, P700, DOI 10.1007/s003350010120; AKC Staff, MOST POPULAR DOG BRE; Alvarez-Jarreta J., 2019, NUCLEIC ACIDS RES; Anello M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00568; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; Berryere TG, 2005, MAMM GENOME, V16, P262, DOI 10.1007/s00335-004-2445-6; Bian YM, 2019, EXP THER MED, V18, P1155, DOI 10.3892/etm.2019.7663; Broad Institute, PICARD TOOLS; Bychkova E, 2021, GENE, V769, DOI 10.1016/j.gene.2020.145212; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Crawford NG, 2017, SCIENCE, V358, P887, DOI 10.1126/science.aan8433; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Deane-Coe PE, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007648; Dreger DL, 2011, J HERED, V102, pS11, DOI 10.1093/jhered/esr042; Drogemuueller C, 2007, J HERED, V98, P468, DOI 10.1093/jhered/esm021; Durig N, 2018, ANIM GENET, V49, P284, DOI 10.1111/age.12660; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Forster, 2010, AGR 3 VOLUMES 2 RES; FUKAI K, 1995, NAT GENET, V9, P92, DOI 10.1038/ng0195-92; Grichnik JM, 1998, J INVEST DERMATOL, V111, P233, DOI 10.1046/j.1523-1747.1998.00272.x; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Hayward JJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008003; Hedan B, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050386; Hitte C, 2019, GENES-BASEL, V10, DOI 10.3390/genes10060477; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Imes DL, 2006, ANIM GENET, V37, P175, DOI 10.1111/j.1365-2052.2005.01409.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Karyadi DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003409; Kawakami T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248233; Kerns JA, 2004, MAMM GENOME, V15, P798, DOI 10.1007/s00335-004-2377-1; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Korberg IB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104363; Kunisada T, 1998, DEVELOPMENT, V125, P2915; KWON BS, 1989, BIOCHEM BIOPH RES CO, V161, P252, DOI 10.1016/0006-291X(89)91588-X; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YW, 2018, PHARMAZIE, V73, P49, DOI 10.1691/ph.2018.7634; Liao CP, 2017, GENE DEV, V31, P744, DOI 10.1101/gad.298703.117; Little C., 1957, INHERITANCE COAT COL; Liu GS, 2012, FREE RADICAL BIO MED, V52, P1835, DOI 10.1016/j.freeradbiomed.2012.02.040; Lu YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022150; Lyons LA, 2005, ANIM GENET, V36, P119, DOI 10.1111/j.1365-2052.2005.01253.x; MacLean EL, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0716; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meuwissen THE, 2001, GENETICS, V157, P1819; Nan H, 2009, J INVEST DERMATOL, V129, P2250, DOI 10.1038/jid.2009.62; National Center for Biotechnology Information, NCBI SEQUENCE READ A; Newton JM, 2000, MAMM GENOME, V11, P24, DOI 10.1007/s003350010005; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Plassais J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09373-w; Raveh E, 2005, DEV DYNAM, V233, P1478, DOI 10.1002/dvdy.20453; Reback J., 2021, PANDAS DEV PANDAS PA; Royaux IE, 2000, ENDOCRINOLOGY, V141, P839, DOI 10.1210/en.141.2.839; SARVELLA PATRICIA A., 1956, JOUR HEREDITY, V47, P123; Schmidt-Kuntzel A, 2005, J HERED, V96, P289, DOI 10.1093/jhered/esi066; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Schmutz SM, 2007, J HERED, V98, P544, DOI 10.1093/jhered/esm018; Schmutz SM, 2004, MAMM GENOME, V15, P62, DOI 10.1007/s00335-002-2249-5; Schmutz SM, 2003, J HERED, V94, P69, DOI 10.1093/jhered/esg014; Schmutz SM, 2002, MAMM GENOME, V13, P380, DOI 10.1007/s00335-001-2147-2; Seco CZ, 2015, AM J HUM GENET, V97, P647, DOI 10.1016/j.ajhg.2015.09.011; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Song XC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12754-0; Sponenberg D. P., 2001, The genetics of the dog, P61, DOI 10.1079/9780851995205.0061; Stritzel S, 2009, J ANIM BREED GENET, V126, P59, DOI 10.1111/j.1439-0388.2008.00761.x; United Kennel Club, CHESAPEAKE BAY RETRI; Wang GD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2814; Weich K, 2020, GENES-BASEL, V11, DOI 10.3390/genes11010075; Weller JI, 2014, ANIMAL, V8, P208, DOI 10.1017/S1751731113002188; Whitaker DT, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050323; Wu Stephen, 2019, APRENDIZAJE PROFUNDO, P1, DOI [DOI 10.1080/13527258.2019.1620833, 10.1093/jamia/ocz200, DOI 10.1093/JAMIA/OCZ200]; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293; Yu Y, 2019, ANIM GENET, V50, P182, DOI 10.1111/age.12765; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	81	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0250579	10.1371/journal.pone.0250579	http://dx.doi.org/10.1371/journal.pone.0250579			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043658	Green Published, gold			2022-12-26	WOS:000664635700012
J	Bai, Y; Tompkins, C; Gell, N; Dione, D; Zhang, T; Byun, W				Bai, Yang; Tompkins, Connie; Gell, Nancy; Dione, Dakota; Zhang, Tao; Byun, Wonwoo			Comprehensive comparison of Apple Watch and Fitbit monitors in a free-living setting	PLOS ONE			English	Article							WEARABLE TECHNOLOGY; PHYSICAL-ACTIVITY; INTERVENTION; ACCURACY; VALIDITY; ADULTS; TRIAL	Objectives The aim of this study was to evaluate the accuracy of three consumer-based activity monitors, Fitbit Charge 2, Fitbit Alta, and the Apple Watch 2, all worn on the wrist, in estimating step counts, moderate-to-vigorous minutes (MVPA), and heart rate in a free-living setting. Methods Forty-eight participants (31 females, 17 males; ages 18-59) were asked to wear the three consumer-based monitors mentioned above on the wrist, concurrently with a Yamax pedometer as the criterion for step count, an ActiGraph GT3X+ (ActiGraph) for MVPA, and a Polar H7 chest strap for heart rate. Participants wore the monitors for a 24-hour free-living condition without changing their usual active routine. MVPA was calculated in bouts of >= 10 minutes. Pearson correlation, mean absolute percent error (MAPE), and equivalence testing were used to evaluate the measurement agreement. Results The average step counts recorded for each device were as follows: 11,734 (Charge2), 11,922 (Alta), 11,550 (Apple2), and 10,906 (Yamax). The correlations in steps for the above monitors ranged from 0.84 to 0.95 and MAPE ranged from 17.1% to 35.5%. For MVPA minutes, the average were 76.3 (Charge2), 63.3 (Alta), 49.5 (Apple2), and 47.8 (ActiGraph) minutes accumulated in bouts of 10 or greater minutes. The correlation from MVPA estimation for above monitors were 0.77, 0.91, and 0.66. MAPE from MVPA estimation ranged from 44.7% to 55.4% compared to ActiGraph. For heart rate, correlation for Charge2 and Apple2 was higher for sedentary behavior and lower for MVPA. The MAPE ranged from 4% to 16%. Conclusion All three consumer monitors estimated step counts fairly accurately, and both the Charge2 and Apple2 reported reasonable heart rate estimation. However, all monitors substantially underestimated MVPA in free-living settings.	[Bai, Yang; Byun, Wonwoo] Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA; [Bai, Yang; Tompkins, Connie; Gell, Nancy] Univ Vermont, Dept Rehabil & Movement Sci, Burlington, VT 05405 USA; [Dione, Dakota] Arcadia Univ, Dept Phys Therapy, Glenside, PA USA; [Zhang, Tao] Univ North Texas, Dept Kinesiol Hlth Promot & Recreat, Denton, TX 76203 USA	Utah System of Higher Education; University of Utah; University of Vermont; University of North Texas System; University of North Texas Denton	Bai, Y (corresponding author), Univ Utah, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA.; Bai, Y (corresponding author), Univ Vermont, Dept Rehabil & Movement Sci, Burlington, VT 05405 USA.	Yang.Bai@utah.edu		Gell, Nancy/0000-0002-3172-8040; Bai, Yang/0000-0001-6751-3896	University of Vermont Early EXtra Promotion of REsearch and Scholarly Success	University of Vermont Early EXtra Promotion of REsearch and Scholarly Success	This work was supported by University of Vermont Early EXtra Promotion of REsearch and Scholarly Success, an internal and competitive funding program received by YB. The sponsors play no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.uvm.edu/ovpr/ovprexpress-grant-program	Alinia P, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6321; Bai Y, 2018, J SPORT SCI, V36, P1734, DOI 10.1080/02640414.2017.1412235; Bai Y, 2016, MED SCI SPORT EXER, V48, P151, DOI 10.1249/MSS.0000000000000727; Benedetto S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192691; Boudreaux BD, 2018, MED SCI SPORT EXER, V50, P624, DOI 10.1249/MSS.0000000000001471; Cadmus-Bertram LA, 2015, AM J PREV MED, V49, P414, DOI 10.1016/j.amepre.2015.01.020; Chu AHY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172535; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Collins JE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211231; Dixon PM, 2018, MED SCI SPORT EXER, V50, P837, DOI 10.1249/MSS.0000000000001481; Ellingson LD, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/10988; Feehan LM, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10527; Fukuoka Y, 2018, TRANSL BEHAV MED, V8, P714, DOI 10.1093/tbm/ibx039; Gell NM, 2020, J CANCER SURVIV, V14, P80, DOI 10.1007/s11764-019-00831-4; Gillinov S, 2017, MED SCI SPORT EXER, V49, P1697, DOI 10.1249/MSS.0000000000001284; Gorny AW, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.8233; Hartman SJ, 2018, CANCER-AM CANCER SOC, V124, P192, DOI 10.1002/cncr.30987; Jakicic JM, 2016, JAMA-J AM MED ASSOC, V316, P1161, DOI 10.1001/jama.2016.12858; Krehbiel LM, 2017, CONT CLIN TRIAL COMM, V6, P122, DOI 10.1016/j.conctc.2017.04.003; Le Masurier GC, 2003, MED SCI SPORT EXER, V35, P867, DOI 10.1249/01.MSS.0000064996.63632.10; Lee SH, 2019, TELEMED E-HEALTH, V25, P1115, DOI 10.1089/tmj.2018.0185; Liang J, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/11066; Lyden K, 2014, MED SCI SPORT EXER, V46, P386, DOI 10.1249/MSS.0b013e3182a42a2d; Mendoza JA, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26660; Mercer K, 2016, JMIR MHEALTH UHEALTH, V4, P615, DOI 10.2196/mhealth.4461; O'Driscoll R, 2020, BRIT J SPORT MED, V54, P332, DOI 10.1136/bjsports-2018-099643; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Plews DJ, 2017, INT J SPORT PHYSIOL, V12, P1324, DOI 10.1123/ijspp.2016-0668; Reddy RK, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10338; Reid RER, 2017, J SCI MED SPORT, V20, P578, DOI 10.1016/j.jsams.2016.10.015; Schoenfelder Erin, 2017, Prev Med Rep, V6, P210, DOI 10.1016/j.pmedr.2017.03.003; Sloan Robert A, 2018, BMC Res Notes, V11, P189, DOI 10.1186/s13104-018-3306-9; Stelzer EM, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00580; Sushames A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161224; Tedesco S, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/13084; Toth LP, 2018, MED SCI SPORT EXER, V50, P1315, DOI 10.1249/MSS.0000000000001569; Welk G., 2002, PHYS ACTIVITY ASSESS; Welk GJ, 2019, MED SCI SPORT EXER, V51, P1767, DOI 10.1249/MSS.0000000000001966; Xie JQ, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/mhealth.9754	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251975	10.1371/journal.pone.0251975	http://dx.doi.org/10.1371/journal.pone.0251975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038458	Green Published, gold			2022-12-26	WOS:000664633500036
J	Hernandez, A; Lan, MX; MacKinnon, NJ; Branscum, AJ; Cuadros, DF				Hernandez, Andres; Lan, Minxuan; MacKinnon, Neil J.; Branscum, Adam J.; Cuadros, Diego F.			"Know your epidemic, know your response": Epidemiological assessment of the substance use disorder crisis in the United States	PLOS ONE			English	Article							HEALTH; ABUSE; ADULTS	The United States (U.S.) is currently experiencing a substance use disorders (SUD) crisis with an unprecedented magnitude. The objective of this study was to recognize and characterize the most vulnerable populations at high risk of SUD mortality in the U.S., and to identify the locations where these vulnerable population are located. We obtained the most recent available mortality data for the U.S. population aged 15-84 (2005-2017) from the Centers for Diseases and Prevention (CDC). Our analysis focused on the unintentional substance poisoning to estimate SUD mortality. We computed health-related comorbidities and socioeconomic association with the SUD distribution. We identified the most affected populations and conducted a geographical clustering analysis to identify places with increased concentration of SUD related deaths. From 2005-2017, 463,717 SUD-related deaths occurred in the United States. White population was identified with the highest SUD death proportions. However, there was a surge of the SUD epidemic in the Black male population, with a sharp increase in the SUD-related death rate since 2014. We also found that an additional average day of mental distress might increase the relative risk of SUD-related mortality by 39%. The geographical distribution of the epidemic showed clustering in the West and Mid-west regions of the U.S. In conclusion, we found that the SUD epidemic in the U.S. is characterized by the emergence of several micro-epidemics of different intensities across demographic groups and locations within the country. The comprehensive description of the epidemic presented in this study could assist in the design and implementation of targeted policy interventions for addiction mitigation campaigns.	[Hernandez, Andres; Cuadros, Diego F.] Univ Cincinnati, Hlth Geog & Dis Modeling Lab, Cincinnati, OH USA; [Hernandez, Andres; Lan, Minxuan; Cuadros, Diego F.] Univ Cincinnati, Dept Geog & GIS, Cincinnati, OH USA; [Hernandez, Andres] Univ Twente, Fac Geoinformat Sci & Earth Observat, Dept Geoinformat Proc, Enschede, Netherlands; [MacKinnon, Neil J.] Med Coll Georgia, Dept Populat Hlth Sci, Augusta, GA 30912 USA; [MacKinnon, Neil J.; Cuadros, Diego F.] Univ Cincinnati, Geospatial Hlth Advising Grp, Cincinnati, OH USA; [Branscum, Adam J.] Oregon State Univ, Dept Biostat, Coll Publ Hlth & Human Sci, Corvallis, OR 97331 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Twente; University System of Georgia; Augusta University; University System of Ohio; University of Cincinnati; Oregon State University	Cuadros, DF (corresponding author), Univ Cincinnati, Hlth Geog & Dis Modeling Lab, Cincinnati, OH USA.; Cuadros, DF (corresponding author), Univ Cincinnati, Dept Geog & GIS, Cincinnati, OH USA.; Cuadros, DF (corresponding author), Univ Cincinnati, Geospatial Hlth Advising Grp, Cincinnati, OH USA.	diego.cuadros@uc.edu	Lan, Minxuan/AAG-3430-2020	Lan, Minxuan/0000-0002-4528-9544; mackinnon, neil/0000-0001-8111-6651				Ahluwalia IB, 2004, OBSTET GYNECOL, V104, P477, DOI 10.1097/01.AOG.0000137920.58741.26; American Society of Addiction Medicine (ASAM), 2019, PUBL POL STAT LONG D; Tran BX, 2019, SUBST ABUSE TREAT PR, V14, DOI 10.1186/s13011-019-0204-7; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Blangiardo M, 2013, SPAT SPATIO-TEMPORAL, V4, P33, DOI 10.1016/j.sste.2012.12.001; Boschetti L, 2016, REMOTE SENS ENVIRON, V186, P465, DOI 10.1016/j.rse.2016.09.016; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Disease Control and Prevention, 2016, BEH RISK FACT SURV S; Centers for Disease Control and Prevention US Department of Health and Human Services National Center for Health, 2017, MORT MULT CAUS DAT F; Chen H-Y., PREV CHRONIC DIS; Ciancio A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238341; Ciccarone D, 2019, INT J DRUG POLICY, V71, P183, DOI 10.1016/j.drugpo.2019.01.010; Drake F.L., 1995, CENTRUM WISKUNDE INF; Dunlap Eloise, 2006, J Sociol Soc Welf, V33, P115; Dwyer-Lindgren L, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0133-5; Edlund MJ, 2007, PAIN, V129, P355, DOI 10.1016/j.pain.2007.02.014; Harris KM, 2005, PSYCHIAT SERV, V56, P954, DOI 10.1176/appi.ps.56.8.954; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hawkins EH, 2009, ANNU REV PSYCHOL, V60, P197, DOI 10.1146/annurev.psych.60.110707.163456; Hedegaard Holly, 2018, NCHS Data Brief, P1; Hernandez A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61281-y; Holmes CB, 2020, B WORLD HEALTH ORGAN, V98, P87, DOI 10.2471/BLT.18.223495; Jalal H, 2018, SCIENCE, V361, P1218, DOI 10.1126/science.aau1184; Kiang MV, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0040; Kulldorff M, 2010, SATSCAN V9 0 SOFTW S; Mohammad JS, OPIOID CRISIS CONTEX; Murase H, 2009, ICES J MAR SCI, V66, P1417, DOI 10.1093/icesjms/fsp105; Norman SB, 2007, DRUG ALCOHOL DEPEN, V90, P89, DOI 10.1016/j.drugalcdep.2007.03.002; Patrick ME, 2012, J STUD ALCOHOL DRUGS, V73, P772, DOI 10.15288/jsad.2012.73.772; R Core Team, 2018, R LANG ENV STAT COMP; Rigg KK, 2018, INT J DRUG POLICY, V57, P119, DOI 10.1016/j.drugpo.2018.04.011; Rosenblatt RA, 2015, ANN FAM MED, V13, P23, DOI 10.1370/afm.1735; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Schulden JD, 2009, CURR PSYCHIAT REP, V11, P353, DOI 10.1007/s11920-009-0053-6; U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2018, NAT SURV DRUG US HLT; Unick GJ, 2017, INT J DRUG POLICY, V46, P112, DOI 10.1016/j.drugpo.2017.06.003; University of Wisconsin Population Health Institute, 2019, MED LEG PARTN; Watkins KE, 2004, AM J DRUG ALCOHOL AB, V30, P749, DOI 10.1081/ADA-200037538; Whitesell Mackenzie, 2013, J Addict, V2013, P579310, DOI 10.1155/2013/579310; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; World Health Organization, 2019, INT CLASSIFICATION D; Zaharia M, 2016, COMMUN ACM, V59, P56, DOI 10.1145/2934664	45	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251502	10.1371/journal.pone.0251502	http://dx.doi.org/10.1371/journal.pone.0251502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038441	gold, Green Published			2022-12-26	WOS:000664633500023
J	Verdam, MGE; van Ballegooijen, W; Holtmaat, CJM; Knoop, H; Lancee, J; Oort, FJ; Riper, H; van Straten, A; Verdonck-de Leeuw, IM; de Wit, M; van der Zweerde, T; Sprangers, MAG				Verdam, M. G. E.; van Ballegooijen, W.; Holtmaat, C. J. M.; Knoop, H.; Lancee, J.; Oort, F. J.; Riper, H.; van Straten, A.; Verdonck-de Leeuw, I. M.; de Wit, M.; van der Zweerde, T.; Sprangers, M. A. G.			Re-evaluating randomized clinical trials of psychological interventions: Impact of response shift on the interpretation of trial results	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; CENTERED GROUP-PSYCHOTHERAPY; INSOMNIA SEVERITY INDEX; COST-EFFECTIVENESS; CANCER SURVIVORS; SAMPLE-SIZE; DEPRESSION; LIFE; DUTCH; VALIDATION	Background Effectiveness of psychological treatment is often assessed using patient-reported health evaluations. However, comparison of such scores over time can be hampered due to a change in the meaning of self-evaluations, called 'response shift'. Insight into the occurrence of response shift seems especially relevant in the context of psychological interventions, as they often purposefully intend to change patients' frames of reference. Aims The overall aim is to gain insight into the general relevance of response shift for psychological health intervention research. Specifically, the aim is to re-analyse data of published randomized controlled trials (RCTs) investigating the effectiveness of psychological interventions targeting different health aspects, to assess (1) the occurrence of response shift, (2) the impact of response shift on interpretation of treatment effectiveness, and (3) the predictive role of clinical and background variables for detected response shift. Method We re-analysed data from RCTs on guided internet delivered cognitive behavioural treatment (CBT) for insomnia in the general population with and without elevated depressive symptoms, an RCT on meaning-centred group psychotherapy targeting personal meaning for cancer survivors, and an RCT on internet-based CBT treatment for persons with diabetes with elevated depressive symptoms. Structural equation modelling was used to test the three objectives. Results We found indications of response shift in the intervention groups of all analysed datasets. However, results were mixed, as response shift was also indicated in some of the control groups, albeit to a lesser extent or in opposite direction. Overall, the detected response shifts only marginally impacted trial results. Relations with selected clinical and background variables helped the interpretation of detected effects and their possible mechanisms. Conclusion This study showed that response shift effects can occur as a result of psychological health interventions. Response shift did not influence the overall interpretation of trial results, but provide insight into differential treatment effectiveness for specific symptoms and/or domains that can be clinically meaningful.	[Verdam, M. G. E.; Knoop, H.; Sprangers, M. A. G.] Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Med Psychol, Amsterdam, Netherlands; [Verdam, M. G. E.] Leiden Univ, Inst Psychol, Dept Methodol & Stat, Leiden, Netherlands; [van Ballegooijen, W.; Holtmaat, C. J. M.; Riper, H.; van Straten, A.; Verdonck-de Leeuw, I. M.; van der Zweerde, T.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands; [Knoop, H.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Expert Ctr Chron Fatigue,Dept Med Psychol, Amsterdam, Netherlands; [Lancee, J.] Univ Amsterdam, Fac Social & Behav Sci, Dept Clin Psychol, Amsterdam, Netherlands; [Oort, F. J.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands; [Riper, H.; van Straten, A.; Verdonck-de Leeuw, I. M.; de Wit, M.] Amsterdam Publ Hlth Res Inst, Mental Hlth, Amsterdam, Netherlands; [Verdonck-de Leeuw, I. M.] Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Verdam, MGE (corresponding author), Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Med Psychol, Amsterdam, Netherlands.; Verdam, MGE (corresponding author), Leiden Univ, Inst Psychol, Dept Methodol & Stat, Leiden, Netherlands.	m.g.e.verdam@amsterdamumc.nl	Knoop, Hans/D-3264-2009	Knoop, Hans/0000-0001-7763-3517; van Ballegooijen, Wouter/0000-0002-9189-6695; Riper, Heleen/0000-0002-8144-8901; van Straten, Annemieke/0000-0001-6875-2215	Mental Health Alliance Fund by the Amsterdam Public Health Research Institute (APH) [UMC: V.2018.29]	Mental Health Alliance Fund by the Amsterdam Public Health Research Institute (APH)	This research was supported by a grant from the Mental Health Alliance Fund provided by the Amsterdam Public Health Research Institute (APH; http://www.amsterdam-public-health.org).Grant registration number Amsterdam UMC: V.2018.29. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrykowski MA, 2009, J PAIN SYMPTOM MANAG, V37, P341, DOI 10.1016/j.jpainsymman.2008.03.015; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Blanken TF, 2019, PSYCHOTHER PSYCHOSOM, V88, P52, DOI 10.1159/000495045; Bollen KA, 1989, STRUCTURAL EQUATIONS; BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Buffart LM, 2020, CLIN PSYCHOL REV, V80, DOI 10.1016/j.cpr.2020.101882; Carlier IVE, 2019, INT J METH PSYCH RES, V28, DOI 10.1002/mpr.1785; Fokkema M, 2013, PSYCHOL ASSESSMENT, V25, P520, DOI 10.1037/a0031669; Howard GS, 1979, APPL PSYCH MEAS, V3, P1, DOI [10.1177/014662167900300101, DOI 10.1177/014662167900300101]; Ilie G, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00783; Jaarsma TA, 2007, PSYCHO-ONCOL, V16, P241, DOI 10.1002/pon.1056; Jackson DL, 2003, STRUCT EQU MODELING, V10, P128, DOI 10.1207/S15328007SEM1001_6; Jansen SJT, 2000, QUAL LIFE RES, V9, P603, DOI 10.1023/A:1008928617014; Kalter J, 2018, PSYCHO-ONCOLOGY, V27, P1150, DOI 10.1002/pon.4648; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Morin C.M., 2003, INSOMNIA CLIN GUIDE, V1; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Nolte S, 2016, QUAL LIFE RES, V25, P1339, DOI 10.1007/s11136-015-1123-3; Nolte S, 2012, QUAL LIFE RES, V21, P487, DOI 10.1007/s11136-011-9952-1; Oort FJ, 2005, QUAL LIFE RES, V14, P587, DOI 10.1007/s11136-004-0830-y; Powden CJ, 2018, J SPORT REHABIL, V27, P469, DOI 10.1123/jsr.2017-0104; Preston NJ, 2013, PALLIATIVE MED, V27, P899, DOI 10.1177/0269216313486952; R Core Team, 2020, R LANG ENV STAT COMP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Roth DL, 2008, PSYCHOL AGING, V23, P567, DOI 10.1037/a0013287; Sajobi TT, 2018, QUAL LIFE RES, V27, P1133, DOI 10.1007/s11136-017-1751-x; Smith D, 2016, J GAMBL STUD, V32, P1065, DOI 10.1007/s10899-016-9598-6; Snoek FJ, 2000, DIABETES CARE, V23, P1305, DOI 10.2337/diacare.23.9.1305; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Stegenga BT, 2012, SOC PSYCH PSYCH EPID, V47, P87, DOI 10.1007/s00127-010-0317-9; van Bastelaar KM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-9; van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248; van der Spek N, 2017, PSYCHOL MED, V47, P1990, DOI 10.1017/S0033291717000447; van der Spek N, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-22; van der Zweerde T, 2019, PSYCHOL MED, V49, P501, DOI 10.1017/S0033291718001149; Van der Zweerde T, 2020, PSYCHOTHER PSYCHOSOM, V89, P174, DOI 10.1159/000505600; van der Zweerde T, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0783-z; Verdam MGE, 2017, J CLIN EPIDEMIOL, V85, P37, DOI 10.1016/j.jclinepi.2017.02.012; Visser MRM, 2000, J PAIN SYMPTOM MANAG, V20, P12, DOI 10.1016/S0885-3924(00)00148-2; Wolf EJ, 2013, EDUC PSYCHOL MEAS, V73, P913, DOI 10.1177/0013164413495237; Wu PC, 2016, J CLIN PSYCHOL, V72, P663, DOI 10.1002/jclp.22291	44	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252035	10.1371/journal.pone.0252035	http://dx.doi.org/10.1371/journal.pone.0252035			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OL	34032803	Green Published, gold			2022-12-26	WOS:000664633100023
J	Macia, P; Barranco, M; Gorbena, S; Alvarez-Fuentes, E; Iraurgi, I				Macia, Patricia; Barranco, Mercedes; Gorbena, Susana; Alvarez-Fuentes, Esther; Iraurgi, Ioseba			Resilience and coping strategies in relation to mental health outcomes in people with cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; CONNOR-DAVIDSON RESILIENCE; BREAST-CANCER; EMOTIONAL DISTRESS; SCALED VERSION; QUESTIONNAIRE; PREDICTORS; RELIABILITY; ADJUSTMENT; DIAGNOSIS	Considering the importance of psychological variables on health-related processes, this study investigated the role of resilience and coping strategies in relation to health. The aim of this research was to explore the underlying association between these aspects for the better understanding of the effect of psychosocial variables on mental health in cancer. This information could lead to the design of adapted psychological interventions in cancer. Participants with different diagnosis of cancer were recruited (N = 170). They came from the Spanish Association Against Cancer of Biscay. Resilience was measured with the 10 items Connor-Davidson Resilience Scale, coping with the Cognitive Emotion Regulation Questionnaire and mental health was measured as a global indicator through the SF-12 and the GHQ-12. A structural equation model (SEM) was conducted to test the effects between the constructs. Results showed that resilience and coping were significantly associated. Results reflected an absence of significant correlation between adaptive and disadaptive coping strategies. Resilience was the factor that most correlated with health outcomes (beta = -.45, p < .001). However, disadaptive coping strategies did not correlate with resilience or mental health indicators. Findings in this study underscore the positive contribution of high levels of resilience and an adaptive coping on participants ' level of health. Disadaptive coping strategies did not reflect any positive relation with resilience or health indicators. Thus, promoting resilience and adaptive coping could be a significant goal for psychosocial and educational interventions in people with cancer.	[Macia, Patricia; Gorbena, Susana; Iraurgi, Ioseba] Univ Deusto, Fac Psychol & Educ, Dept Personal Evaluat & Psychol Treatments, Bilbao, Biscay, Spain; [Barranco, Mercedes; Alvarez-Fuentes, Esther] Spanish Assoc Canc, Prov Off Biscay, Bilbao, Spain	University of Deusto	Macia, P (corresponding author), Univ Deusto, Fac Psychol & Educ, Dept Personal Evaluat & Psychol Treatments, Bilbao, Biscay, Spain.	patriciamacia@deusto.es	Iraurgi, Ioseba/B-8663-2011; Gorbeña, Susana/V-2707-2019	Iraurgi, Ioseba/0000-0002-0143-9539; Macia, Patricia/0000-0003-1789-1930; Gorbena, Susana/0000-0002-5289-9850	University of Deusto	University of Deusto	The author PM was a beneficiary of a Pre-doctoral research grant given by the University of Deusto.	ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; [Anonymous], 2004, EQS STRUCTURAL EQUAT; Aschwanden D, 2019, PREV MED, V126, DOI 10.1016/j.ypmed.2019.105763; Benedict C., 2012, PSYCHOL ASPECTS CANC; Bonanno GA, 2012, SOC SCI MED, V74, P753, DOI 10.1016/j.socscimed.2011.11.022; Brunault P, 2016, PSYCHO-ONCOLOGY, V25, P513, DOI 10.1002/pon.3947; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chirico A, 2015, PEERJ, V3, DOI 10.7717/peerj.1107; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Czerw A, 2016, BREAST CANCER-TOKYO, V23, P654, DOI 10.1007/s12282-015-0620-0; Deshields TL, 2016, PSYCHO-ONCOLOGY, V25, P11, DOI 10.1002/pon.3800; Serrano-Parra MD, 2013, ENFERM CLIN, V23, P14, DOI 10.1016/j.enfcli.2012.11.006; Dubey C, 2015, EUR J ONCOL NURS, V19, P582, DOI 10.1016/j.ejon.2015.03.004; Eicher M, 2015, ONCOL NURS FORUM, V42, pE3, DOI 10.1188/15.ONF.E3-E16; Fong AJ, 2017, PSYCHO-ONCOLOGY, V26, P664, DOI 10.1002/pon.4064; Galego V., 2016, THESIS U DEUSTO BILB; Garnefski N, 2006, PERS INDIV DIFFER, V41, P1045, DOI 10.1016/j.paid.2006.04.010; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Hamilton J, 2019, PSYCHO-ONCOLOGY, V28, P61, DOI 10.1002/pon.4910; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Lai HL, 2020, EUR J CANCER CARE, V29, DOI 10.1111/ecc.13161; Lam WWT, 2017, PSYCHO-ONCOLOGY, V26, P255, DOI 10.1002/pon.4116; Lazarus R.S., 1984, EMOTION ADAPTATION; LOBO A, 1986, PSYCHOL MED, V16, P135, DOI 10.1017/S0033291700002579; Macia P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236572; Markovitz SE, 2015, PSYCHO-ONCOLOGY, V24, P1639, DOI 10.1002/pon.3834; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Mayordomo T, 2016, J PSYCHOL, V150, P809, DOI 10.1080/00223980.2016.1203276; Min JA, 2013, SUPPORT CARE CANCER, V21, P2469, DOI 10.1007/s00520-013-1807-6; Nipp RD, 2016, CANCER-AM CANCER SOC, V122, P2110, DOI 10.1002/cncr.30025; Philip EJ, 2013, PSYCHO-ONCOLOGY, V22, P987, DOI 10.1002/pon.3088; Roberts D, 2018, PSYCHO-ONCOLOGY, V27, P229, DOI 10.1002/pon.4497; Saita E., 2015, PSCYHO ONCOLOGY, V24, P334; Sanchez-Lopez MP, 2008, PSICOTHEMA, V20, P839; Seib C, 2018, PSYCHO-ONCOLOGY, V27, P1787, DOI 10.1002/pon.4728; Silva SM, 2012, PSYCHOL HEALTH, V27, P1323, DOI 10.1080/08870446.2012.676644; Smith MM, 2016, J PSYCHOL, V150, P318, DOI 10.1080/00223980.2015.1036828; Smorti M, 2012, EUR J CANCER CARE, V21, P251, DOI 10.1111/j.1365-2354.2011.01271.x; Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338; Stanton AL, 2002, PSYCHO-ONCOLOGY, V11, P93, DOI 10.1002/pon.574; Tomas JM, 2012, AGING MENT HEALTH, V16, P317, DOI 10.1080/13607863.2011.615737; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yang GM, 2018, AM J HOSP PALLIAT ME, V35, P1433, DOI 10.1177/1049909118778863; Ye ZJ, 2017, PSYCHO-ONCOLOGY, V26, P829, DOI 10.1002/pon.4237	47	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252075	10.1371/journal.pone.0252075	http://dx.doi.org/10.1371/journal.pone.0252075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OI	34029344	Green Published, gold			2022-12-26	WOS:000664632800026
J	Sridharan, V; Johnson, KA; Landes, RD; Cao, MH; Singh, P; Wagoner, G; Hayar, A; Sprick, ED; Eveld, KA; Bhattacharyya, A; Krager, KJ; Aykin-Burns, N; Weiler, H; Fernandez, JA; Griffin, JH; Boerma, M				Sridharan, Vijayalakshmi; Johnson, Kristin A.; Landes, Reid D.; Cao, Maohua; Singh, Preeti; Wagoner, Gail; Hayar, Abdallah; Sprick, Emily D.; Eveld, Kayla A.; Bhattacharyya, Anusha; Krager, Kimberly J.; Aykin-Burns, Nukhet; Weiler, Hartmut; Fernandez, Jose A.; Griffin, John H.; Boerma, Marjan			Sex-dependent effects of genetic upregulation of activated protein C on delayed effects of acute radiation exposure in the mouse heart, small intestine, and skin	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; CARDIAC-FUNCTION; RAT-HEART; IRRADIATION; THROMBOMODULIN; ANTICOAGULANT; INFLAMMATION; IMPACT; PATHOGENESIS; DYSFUNCTION	Accidental exposure to ionizing radiation may lead to delayed effects of acute radiation exposure (DEARE) in many organ systems. Activated protein C (APC) is a known mitigator of the acute radiation syndrome. To examine the role of APC in DEARE, we used a transgenic mouse model with 2- to 3-fold increased plasma levels of APC (high in APC, APCHi). Male and female APCHi mice and wild-type littermates were exposed to 9.5 Gy gamma -rays with their hind-legs (bone marrow) shielded from radiation to allow long-term survival. At 3 and 6 months after irradiation, cardiac function was measured with ultrasonography. At 3 months, radiation increased cardiac dimensions in APCHi males, while decreases were seen in wild-type females. At this early time point, APCHi mice of both sexes were more susceptible to radiation-induced changes in systolic function compared to wild-types. At 6 months, a decrease in systolic function was mainly seen in male mice of both genotypes. At 6 months, specimens of heart, small intestine and dorsal skin were collected for tissue analysis. Female APCHi mice showed the most severe radiation-induced deposition of cardiac collagens but were protected against a radiation-induced loss of microvascular density. Both male and female APCHi mice were protected against a radiation induced upregulation of toll-like receptor 4 in the heart, but this did not translate into a clear protection against immune cell infiltration. In the small intestine, the APCHi genotype had no effect on an increase in the number of myeloperoxidase positive cells (seen mostly in females) or an increase in the expression of T-cell marker CD2 (males). Lastly, both male and female APCHi mice were protected against radiation-induced epidermal thickening and increase in 3-nitrotyrosine positive keratinocytes. In conclusion, prolonged high levels of APC in a transgenic mouse model had little effects on indicators of DEARE in the heart, small intestine and skin, with some differential effects in male compared to female mice.	[Sridharan, Vijayalakshmi; Singh, Preeti; Wagoner, Gail; Bhattacharyya, Anusha; Krager, Kimberly J.; Aykin-Burns, Nukhet; Boerma, Marjan] Univ Arkansas Med Sci, Div Radiat Hlth, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Johnson, Kristin A.; Sprick, Emily D.; Eveld, Kayla A.] Univ Arkansas Med Sci, Coll Pharm, Little Rock, AR 72205 USA; [Landes, Reid D.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR 72205 USA; [Cao, Maohua] Texas A&M Univ, Coll Dent, Dallas, TX USA; [Hayar, Abdallah] Univ Arkansas Med Sci, Dept Neurobiol & Dev Sci, Little Rock, AR 72205 USA; [Weiler, Hartmut] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Fernandez, Jose A.; Griffin, John H.] Scripps Res, Dept Mol Med, La Jolla, CA USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Texas A&M University System; University of Arkansas System; University of Arkansas Medical Sciences; Medical College of Wisconsin; Scripps Research Institute	Boerma, M (corresponding author), Univ Arkansas Med Sci, Div Radiat Hlth, Dept Pharmaceut Sci, Little Rock, AR 72205 USA.	mboerma@uams.edu	Fernandez, Jose A/A-3211-2008	Fernandez, Jose A/0000-0002-0804-1865	National Institute of Allergy and Infectious Disease [U01 AI133561-01]; National Institute of General Medical Sciences [P20 GM109005]	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Allergy and Infectious Disease (https://www.niaid.nih.gov/) under grant number U01 AI133561-01 to HW, JHG and MB, and the National Institute of General Medical Sciences (https://www.nigms.nih.gov/) under grant number P20 GM109005 to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht H, 2018, RADIAT RES, V189, P441, DOI 10.1667/RR14884.1; Avlas O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120175; Baker JE, 2009, INT J RADIAT BIOL, V85, P1089, DOI 10.3109/09553000903264473; Becher PM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193844; Berg DT, 2003, P NATL ACAD SCI USA, V100, P4423, DOI 10.1073/pnas.0736918100; Bock F, 2013, P NATL ACAD SCI USA, V110, P648, DOI 10.1073/pnas.1218667110; Boerma M, 2004, ONCOL REP, V12, P213; Boerma M, 2004, STRAHLENTHER ONKOL, V180, P109, DOI 10.1007/s00066-004-1138-0; Boerma M, 2015, RADIAT RES, V183, P610, DOI 10.1667/RR13979.1; Boerma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070479; Booth C, 2015, HEALTH PHYS, V109, P399, DOI 10.1097/HP.0000000000000356; Bouwens EAM, 2013, J THROMB HAEMOST, V11, P242, DOI 10.1111/jth.12247; Brown MA, 2019, J IMMUNOL, V202, P1927, DOI 10.4049/jimmunol.1801403; Bunin DI, 2020, INT J RADIAT BIOL, V96, P145, DOI 10.1080/09553002.2019.1605465; Bupp MRG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01269; Cushman M, 2021, CIRCULATION, V143, pE239, DOI 10.1161/CIR.0000000000000907; Debo RJ, 2016, RADIAT RES, V186, P55, DOI 10.1667/RR14357.1; Dielis AWJH, 2008, J THROMB HAEMOST, V6, P125; ESMON CT, 1991, THROMB HAEMOSTASIS, V66, P160; Farese AM, 2015, DRUG TODAY, V51, P537, DOI 10.1358/dot.2015.51.9.2386730; Frantz S, 1999, J CLIN INVEST, V104, P271, DOI 10.1172/JCI6709; Garate-Carrillo A, 2020, TRANSL RES, V222, P41, DOI 10.1016/j.trsl.2020.03.008; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Gremmel T, 2014, ATHEROSCLEROSIS, V237, P692, DOI 10.1016/j.atherosclerosis.2014.10.095; Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974; Guitton C, 2011, J VASC RES, V48, P336, DOI 10.1159/000322582; Hansen RS, 2019, CLIN CHEM LAB MED, V57, P1229, DOI 10.1515/cclm-2018-1382; Healy LD, 2018, J LEUKOCYTE BIOL, V103, P1197, DOI 10.1002/JLB.3MIR0817-338R; Isermann B, 2007, NAT MED, V13, P1349, DOI 10.1038/nm1667; Jang H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051897; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kenward MG, 2009, COMPUT STAT DATA AN, V53, P2583, DOI 10.1016/j.csda.2008.12.013; Kouvari M, 2020, RISK MANAG HEALTHC P, V13, P2079, DOI 10.2147/RMHP.S264672; Lemarie J, 2014, SHOCK, V41, P522, DOI 10.1097/SHK.0000000000000148; Lyden P, 2013, CURR PHARM DESIGN, V19, P7479; Lyubimova N, 2004, BRIT J RADIOL, V77, P488, DOI 10.1259/bjr/15169876; McDonnell CJ, 2018, SEMIN THROMB HEMOST, V44, P167, DOI 10.1055/s-0037-1608910; Medzikovic L, 2019, J MOL MED, V97, P1385, DOI 10.1007/s00109-019-01833-6; Minhas N, 2017, CELL MOL LIFE SCI, V74, P1895, DOI 10.1007/s00018-016-2440-6; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2004, BLOOD, V104, P1740, DOI 10.1182/blood-2004-01-0110; Narendran N, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00260; Oneglia Andrew, 2020, Curr Heart Fail Rep, V17, P409, DOI 10.1007/s11897-020-00487-7; Pathak R, 2016, RADIAT RES, V186, P112, DOI 10.1667/RR14408.1; Pendurthi UR, 2018, CURR OPIN HEMATOL, V25, P219, DOI 10.1097/MOH.0000000000000416; Riccobono D, 2016, HEALTH PHYS, V111, P117, DOI 10.1097/HP.0000000000000515; Seawright JW, 2019, LIFE SCI SPACE RES, V20, P72, DOI 10.1016/j.lssr.2019.01.003; Seemann I, 2012, RADIOTHER ONCOL, V103, P143, DOI 10.1016/j.radonc.2011.10.011; Sennoun N, 2009, CRIT CARE MED, V37, P246, DOI 10.1097/CCM.0b013e318192fe4f; Singh VK, 2018, DRUG TODAY, V54, P679, DOI 10.1358/dot.2018.54.11.2899370; Sridharan V, 2017, RADIAT RES, V187, P361, DOI 10.1667/RR14643.1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tavener SA, 2004, CIRC RES, V95, P700, DOI 10.1161/01.RES.0000144175.70140.8c; Tower J, 2020, REDOX BIOL, V31, DOI 10.1016/j.redox.2020.101488; Unthank JL, 2015, HEALTH PHYS, V109, P511, DOI 10.1097/HP.0000000000000357; van Mens TE, 2017, BLOOD ADV, V1, P1148, DOI 10.1182/bloodadvances.2017005058; Wang JR, 2007, WORLD J GASTROENTERO, V13, P3047, DOI 10.3748/wjg.v13.i22.3047; Williams TD, 2003, CLIN EXP PHARMACOL P, V30, P769, DOI 10.1046/j.1440-1681.2003.t01-1-03808.x; Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771; Xue ML, 2015, PATHOBIOLOGY, V82, P100, DOI 10.1159/000430957; Xue ML, 2011, J BIOL CHEM, V286, P6742, DOI 10.1074/jbc.M110.181388; Xue ML, 2005, J INVEST DERMATOL, V125, P1279, DOI 10.1111/j.0022-202X.2005.23952.x; Xue ML, 2004, EXP CELL RES, V299, P119, DOI 10.1016/j.yexcr.2004.05.015	63	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252142	10.1371/journal.pone.0252142	http://dx.doi.org/10.1371/journal.pone.0252142			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029348	gold, Green Published			2022-12-26	WOS:000664632800032
J	Benedek, Z; Ferto, I; Marreiros, CG; de Aguiar, PM; Pocol, CB; Cechura, L; Poder, A; Paaso, P; Bakucs, Z				Benedek, Zsofia; Ferto, Imre; Marreiros, Cristina Galamba; de Aguiar, Pamela Mossmann; Pocol, Cristina Bianca; Cechura, Lukas; Poder, Anne; Paeaeso, Piia; Bakucs, Zoltan			Farm diversification as a potential success factor for small-scale farmers constrained by COVID-related lockdown. Contributions from a survey conducted in four European countries during the first wave of COVID-19	PLOS ONE			English	Article							FOOD-SUPPLY CHAINS; LOCAL-ACTION GROUPS; SUSTAINABILITY; PERFORMANCE; ECONOMIES; STRATEGY; SPECIALIZATION; MANAGEMENT; NETWORKS; BUSINESS	This paper explores to what extent product and marketing channel diversification contributed to the economic success of small-scale agricultural producers involved in short food supply chains after the outbreak of the COVID-19 pandemic. A survey was conducted between April and July 2020 in four countries of the European Union-Estonia, Hungary, Portugal and Romania,-resulting in a relatively large sample of farmers (N = 421). The analysis was built on a semi-nonparametric approach. Approximately 19 percent of small-scale producers were able to increase sales during the first wave of the pandemic, although country-level variation was significant. Fruits and vegetables were by far the most popular products. The importance of specific channels varied across countries, but farm gate sales were among the most important marketing channels both before and during the first wave. The importance of channels that were based on digital resources and home delivery increased. Our evidence indicates that diversification was a strategy that paid off, both in terms of marketing channels and different product categories. However, the impact appears to be nonlinear; the initial advantage generated by diversification rapidly tapered off, either temporarily (in the case of products), or permanently (in the case of marketing channels). Later research may clarify whether these findings are generalizable in other socio-economic contexts, as well as in a non-COVID situation.	[Benedek, Zsofia; Ferto, Imre; Bakucs, Zoltan] Ctr Econ & Reg Studies, Budapest, Hungary; [Ferto, Imre] Hungarian Univ Agr & Life Sci, Kaposvar, Hungary; [Marreiros, Cristina Galamba; de Aguiar, Pamela Mossmann] Univ Evora, Ctr Adv Studies Management & Econ, Evora, Portugal; [Pocol, Cristina Bianca] Univ Agr Sci & Vet Med Cluj Napoca, Cluj Napoca, Romania; [Cechura, Lukas] Czech Univ Life Sci, Prague, Czech Republic; [Poder, Anne; Paeaeso, Piia] Estonian Univ Life Sci, Tartu, Estonia; [Bakucs, Zoltan] Obuda Univ, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Economic & Regional Studies; Hungarian University of Agriculture & Life Sciences; University of Evora; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Czech University of Life Sciences Prague; Estonian University of Life Sciences; Obuda University	Benedek, Z (corresponding author), Ctr Econ & Reg Studies, Budapest, Hungary.	benedek.zsofia@krtk.hu	Cechura, Lukas/H-6694-2018; Ferto, Imre/GPS-7523-2022; Ferto, Imre/A-7371-2009; Marreiros, Cristina/AAY-2338-2021; Poder, Anne/A-9600-2014; Benedek, Zsófia/A-7923-2012	Cechura, Lukas/0000-0003-2727-1874; Ferto, Imre/0000-0002-3742-5964; Marreiros, Cristina/0000-0002-4339-6880; Poder, Anne/0000-0003-1402-1948; Benedek, Zsófia/0000-0003-3358-0702; Pocol, Cristina Bianca/0000-0001-5079-8004	Portuguese Foundation for Science and Technology [UIDB/04007/2020]; Hungarian National Research, Development and Innovation Fund [130485, 135387, 135460]; Ministry of Agriculture of the Czech Republic, Program ZEME [QK1920398]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Hungarian National Research, Development and Innovation Fund; Ministry of Agriculture of the Czech Republic, Program ZEME	This study was supported by funds from the Portuguese Foundation for Science and Technology (UIDB/04007/2020). This study was also supported by the Hungarian National Research, Development and Innovation Fund in the form of grants [IF (130485), Z. Bakucs (135387), Z. Benedek (135460)] and by the Ministry of Agriculture of the Czech Republic, Program ZEME. in the form of funds to LC (QK1920398).	Afifi A., 2003, COMPUTER AIDED MULTI; Alsos G.A., 2003, J SMALL BUSINESS ENT, V10, P435, DOI DOI 10.1108/14626000310504747; Amicarelli V, 2021, FOOD SECUR, V13, P25, DOI 10.1007/s12571-020-01121-z; Benedek Z, 2018, AGR HUM VALUES, V35, P383, DOI 10.1007/s10460-017-9834-4; Benton TG, 2020, AGR HUM VALUES, V37, P577, DOI 10.1007/s10460-020-10081-1; Blad M., 2010, EUR RURAL DEV NETW S, V7, P155; Bryman A., 2016, SOCIAL RES METHODS; Butu A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155485; Canfora I, 2016, AGRIC AGRIC SCI PROC, V8, P402, DOI 10.1016/j.aaspro.2016.02.036; Cappelli A, 2020, TRENDS FOOD SCI TECH, V99, P566, DOI 10.1016/j.tifs.2020.03.041; Chang HH, 2021, AM J AGR ECON, V103, P448, DOI 10.1111/ajae.12170; Chavas JP, 2012, J AGR ECON, V63, P25, DOI 10.1111/j.1477-9552.2011.00319.x; Culas R, 2005, 11 INT C EUR ASS AGR; Czekaj M, 2020, GLOB FOOD SECUR-AGR, V26, DOI 10.1016/j.gfs.2020.100416; Davidova S., 2014, FAMILY FARMING EUROP; De Luca G, 2008, STATA J, V8, P190, DOI 10.1177/1536867X0800800203; de Roest K, 2018, J RURAL STUD, V59, P222, DOI 10.1016/j.jrurstud.2017.04.013; Delin M, 2012, AGR ECON-CZECH, V58, P433, DOI 10.17221/148/2011-AGRICECON; GALLANT AR, 1987, ECONOMETRICA, V55, P363, DOI 10.2307/1913241; Galli F, 2020, GLOB FOOD SECUR-AGR, V26, DOI 10.1016/j.gfs.2020.100427; Gambacorta L, 2014, APPL ECON LETT, V21, P438, DOI 10.1080/13504851.2013.866196; Gao XW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237900; GARFIELD E, 1975, CURR CONTENTS, P5; Gray RS, 2020, CAN J AGR ECON, V68, P239, DOI 10.1111/cjag.12235; Gruchmann T, 2019, SUPPLY CHAIN MANAG, V24, P767, DOI 10.1108/SCM-02-2019-0073; Guarin A, 2020, GLOB FOOD SECUR-AGR, V26, DOI 10.1016/j.gfs.2020.100389; Guiomar N, 2018, LAND USE POLICY, V75, P784, DOI 10.1016/j.landusepol.2018.04.012; Hansson H, 2013, J RURAL STUD, V32, P240, DOI 10.1016/j.jrurstud.2013.07.002; Hardesty SD, 2010, RENEW AGR FOOD SYST, V25, P24, DOI 10.1017/S1742170509990196; Hoagland L, 2010, J SUSTAIN AGR, V34, P532, DOI 10.1080/10440046.2010.484697; Hobbs JE, 2020, CAN J AGR ECON, V68, P171, DOI 10.1111/cjag.12237; Hunt AR, 2012, J AGRIC FOOD SYST CO, V2, P101, DOI 10.5304/jafscd.2012.024.010; ILBERY BW, 1991, J RURAL STUD, V7, P207, DOI 10.1016/0743-0167(91)90085-7; JONES GR, 1988, STRATEGIC MANAGE J, V9, P159, DOI 10.1002/smj.4250090206; Kim K, 2012, AGR ECON-BLACKWELL, V43, P687, DOI 10.1111/j.1574-0862.2012.00612.x; Kiryluk-Dryjska E, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135276; Kneafsey M., 2013, SHORT FOOD SUPPLY CH, DOI DOI 10.2791/88784; Kolodinsky J, 2020, J AGRIC FOOD SYST CO, V9, P5, DOI 10.5304/jafscd.2020.093.013; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; Laguna L, 2020, FOOD QUAL PREFER, V86, DOI 10.1016/j.foodqual.2020.104028; Martinez S., 2010, Economic Research Report - Economic Research Service, USDA; Mastronardi L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12145709; McNally S, 2001, J RURAL STUD, V17, P247, DOI 10.1016/S0743-0167(00)00050-4; McNamara K. T., 2005, Journal of Agricultural and Applied Economics, V37, P37, DOI 10.1017/S1074070800007082; Meraner M, 2015, LAND USE POLICY, V42, P767, DOI 10.1016/j.landusepol.2014.10.013; Michel-Villarreal R, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030859; Miller A., 2020, CORRELATION UNIVERSA, DOI 10.1101 /2020.03.24.20042937; Mishra A. K., 2004, Agricultural Finance Review, V64, P151; Navarrete M, 2015, INT J AGR SUSTAIN, V13, P257, DOI 10.1080/14735903.2014.959341; Navarrete M, 2009, J SUSTAIN AGR, V33, P552, DOI 10.1080/10440040902997785; NAYYAR PR, 1992, STRATEGIC MANAGE J, V13, P219, DOI 10.1002/smj.4250130305; Oksanen Atte, 2020, JMIR Public Health Surveill, V6, pe19218, DOI 10.2196/19218; Palich LE, 2000, STRATEGIC MANAGE J, V21, P155, DOI 10.1002/(SICI)1097-0266(200002)21:2<155::AID-SMJ82>3.0.CO;2-2; PANZAR JC, 1981, AM ECON REV, V71, P268; Park K, 2012, INT J HOSP MANAG, V31, P218, DOI 10.1016/j.ijhm.2011.03.011; Printezis I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215847; Renting H, 2009, J ENVIRON MANAGE, V90, pS112, DOI 10.1016/j.jenvman.2008.11.014; Renting H, 2003, ENVIRON PLANN A, V35, P393, DOI 10.1068/a3510; Richards TJ, 2020, CAN J AGR ECON, V68, P189, DOI 10.1111/cjag.12231; Rivera M, 2020, GLOB FOOD SECUR-AGR, V26, DOI 10.1016/j.gfs.2020.100417; Ruszkai C, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042080; Salvioni C, 2013, BIO-BASED APPL ECON, V2, P257; Schmutz U, 2018, RENEW AGR FOOD SYST, V33, P518, DOI 10.1017/S1742170517000564; Sharma HB, 2020, RESOUR CONSERV RECY, V162, DOI 10.1016/j.resconrec.2020.105052; Song SJ, 2017, INT J HOSP MANAG, V61, P107, DOI 10.1016/j.ijhm.2016.11.011; Tallman S, 1996, ACAD MANAGE J, V39, P179, DOI 10.2307/256635; Ullah R, 2016, OUTLOOK AGR, V45, P199, DOI 10.1177/0030727016665440; Ullah R, 2014, OUTLOOK AGR, V43, P265, DOI 10.5367/oa.2014.0188; Volk A, 2014, AGR ECON-CZECH, V60, P364, DOI 10.17221/180/2013-AGRICECON	69	11	11	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251715	10.1371/journal.pone.0251715	http://dx.doi.org/10.1371/journal.pone.0251715			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OD	34019544	Green Published, gold, Green Accepted			2022-12-26	WOS:000664632300031
J	Xu, H; Li, N; Zhuo, QH; Lu, LR; Chen, WZ				Xu, Hong; Li, Ning; Zhuo, Qinghua; Lu, Lirong; Chen, Weizeng			Phase, microstructure and service character of as-deposited and short-time heat-treated Ni-Mo alloys with mixed state	PLOS ONE			English	Article							HYDROGEN EVOLUTION; MECHANICAL-PROPERTIES; BEHAVIOR; RESISTANCE; STABILITY; COMPOSITE; CORROSION; COATINGS	Considering the amorphous and nano-crystalline cluster structure and their activity, on the basis of the mixed structure Ni-Mo alloys, the crystallization kinetics of the alloys and the performance of the alloys after heat treatment with different mixed structure were studied. The phase structure and composition were determined by X-ray powder diffraction. The crystallization activation energy of the mixed structure was obtained by differential scanning calorimetry. The electrochemical activity of the mixed structure alloy was determined by electrochemical analysis. The experimental results show that the structural stability of the mixed-structure alloy is better, but the crystallization activation energy is much lower than that of the amorphous alloy. The crystallization process consists of a meta-stable structure transition and a new phase formation. The electrochemical properties of the alloy indicated that the alloy with the mixed structure has higher electrochemical activity, with higher hardness and better corrosion resistance, which results from the large true contact surface and the large number of active centers in this material structure.	[Xu, Hong; Li, Ning; Lu, Lirong] Zhejiang Normal Univ, Xingzhi Coll, Jinhua, Zhejiang, Peoples R China; [Li, Ning; Zhuo, Qinghua; Chen, Weizeng] Zhejiang Normal Univ, Coll Engn, Jinhua, Zhejiang, Peoples R China	Zhejiang Normal University; Zhejiang Normal University	Li, N (corresponding author), Zhejiang Normal Univ, Xingzhi Coll, Jinhua, Zhejiang, Peoples R China.; Li, N (corresponding author), Zhejiang Normal Univ, Coll Engn, Jinhua, Zhejiang, Peoples R China.	lintlt515@126.com						Berry L.G., 1973, 4850 NI; Binder Kurt., 2005, GLASSY MAT DISORDERE, V10; Carr NZ, 2004, ACTA MATER, V52, P3273, DOI 10.1016/j.actamat.2004.03.024; Chen LY, 2018, SURF COAT TECH, V350, P436, DOI 10.1016/j.surfcoat.2018.07.037; Damian A, 2006, J POWER SOURCES, V158, P464, DOI 10.1016/j.jpowsour.2005.09.007; DAS SK, 1974, PHYS STATUS SOLIDI A, V21, P177, DOI 10.1002/pssa.2210210119; Diego Luna, 2019, PLOS ONE, V14, P1; Emran KM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0187567; Evard EA, 2001, INT J HYDROGEN ENERG, V26, P457, DOI 10.1016/S0360-3199(00)00078-1; Guo W, 2017, HIGH TEMP MAT PR-ISR, V36, P677, DOI 10.1515/htmp-2015-0243; Hertsyk OM, 2014, MATER SCI+, V50, P454, DOI 10.1007/s11003-014-9742-3; Jaksic JM, 2000, ELECTROCHIM ACTA, V45, P4151, DOI 10.1016/S0013-4686(00)00549-1; Jin Shi-wei, 2016, J MATER ENG, V44, P115; Laszczynska A, 2020, INT J HYDROGEN ENERG, V45, P508, DOI 10.1016/j.ijhydene.2019.10.181; Li N, 2020, COATINGS, V10, DOI 10.3390/coatings10080767; Li N, 2018, COATINGS, V8, DOI 10.3390/coatings8090299; Li N, 2009, ACTA PHYS-CHIM SIN, V25, P735, DOI 10.3866/PKU.WHXB200904031; Li YG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153659; Luo H, 2015, SURF COAT TECH, V277, P99, DOI 10.1016/j.surfcoat.2015.07.011; Mousavi R, 2019, ANTI-CORROS METHOD M, V66, P631, DOI 10.1108/ACMM-03-2019-2087; Mukhopadhyay A, 2018, MATER TODAY-PROC, V5, P3306, DOI 10.1016/j.matpr.2017.11.573; Nagai M, 2007, APPL CATAL A-GEN, V322, P178, DOI 10.1016/j.apcata.2007.01.006; Nozaki A, 2015, APPL CATAL A-GEN, V504, P559, DOI 10.1016/j.apcata.2015.01.016; Sabzi M, 2018, CAN METALL QUART, V57, P350, DOI 10.1080/00084433.2018.1444367; Scherrer p, 1918, LEHRBUCH KOLLOIDCHEM, P98; Semenenko KI, 2016, J SURF INVESTIG, V10, P1087, DOI 10.1134/S1027451016040157; Spiller E., 2003, ENCY OPTICAL ENG, P3042; Vamsi MVN, 2017, SURF COAT TECH, V319, P403, DOI 10.1016/j.surfcoat.2017.03.074; Wang HZ, 2018, SURF ENG, V34, P468, DOI 10.1080/02670844.2017.1381374; Wang Y, 2005, SCRIPTA MATER, V52, P17, DOI 10.1016/j.scriptamat.2004.09.007; Wasekar NP, 2019, SURF COAT TECH, V370, P298, DOI 10.1016/j.surfcoat.2019.04.059; Wojewoda-Budka J, 2016, ELECTROCHIM ACTA, V209, P183, DOI 10.1016/j.electacta.2016.05.043; Yazdani A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234774; Zhou Q, 2019, CHEM J CHINESE U, V40, P1717, DOI 10.7503/cjcu20180492; Zhou SH, 2005, MAT SCI ENG A-STRUCT, V397, P288, DOI 10.1016/j.msea.2005.02.037	35	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0249875	10.1371/journal.pone.0249875	http://dx.doi.org/10.1371/journal.pone.0249875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019559	gold, Green Published			2022-12-26	WOS:000664632300008
J	Carotti, S; Zingariello, M; Francesconi, M; D'Andrea, L; Latasa, MU; Colyn, L; Fernandez-Barrena, MG; Flammia, RS; Falchi, M; Righi, D; Pedini, G; Pantano, F; Bagni, C; Perrone, G; Rana, RA; Avila, MA; Morini, S; Zalfa, F				Carotti, Simone; Zingariello, Maria; Francesconi, Maria; D'Andrea, Laura; Latasa, M. Ujue; Colyn, Leticia; Fernandez-Barrena, Maite G.; Flammia, Rocco Simone; Falchi, Mario; Righi, Daniela; Pedini, Giorgia; Pantano, Francesco; Bagni, Claudia; Perrone, Giuseppe; Rana, Rosa Alba; Avila, Matias A.; Morini, Sergio; Zalfa, Francesca			Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge	ONCOGENE			English	Article							MESSENGER-RNA TRANSPORT; HEPATOCELLULAR-CARCINOMA; MYOSIN VA; FMRP; TRANSLATION; METASTASIS; EXPRESSION; ACTIN; IDENTIFICATION; ESTABLISHMENT	Intrahepatic cholangiocarcinoma (iCCA) is a rare malignancy of the intrahepatic biliary tract with a very poor prognosis. Although some clinicopathological parameters can be prognostic factors for iCCA, the molecular prognostic markers and potential mechanisms of iCCA have not been well investigated. Here, we report that the Fragile X mental retardation protein (FMRP), a RNA binding protein functionally absent in patients with the Fragile X syndrome (FXS) and also involved in several types of cancers, is overexpressed in human iCCA and its expression is significantly increased in iCCA metastatic tissues. The silencing of FMRP in metastatic iCCA cell lines affects cell migration and invasion, suggesting a role of FMRP in iCCA progression. Moreover, we show evidence that FMRP is localized at the invasive front of human iCCA neoplastic nests and in pseudopodia and invadopodia protrusions of migrating and invading iCCA cancer cells. Here FMRP binds several mRNAs encoding key proteins involved in the formation and/or function of these protrusions. In particular, we find that FMRP binds to and regulates the expression of Cortactin, a critical regulator of invadopodia formation. Altogether, our findings suggest that FMRP could promote cell invasiveness modulating membrane plasticity and invadopodia formation at the leading edges of invading iCCA cells.	[Carotti, Simone; Zingariello, Maria; Francesconi, Maria; D'Andrea, Laura; Flammia, Rocco Simone; Morini, Sergio; Zalfa, Francesca] Campus Biomed Univ, Dept Med, Res Unit Microscop & Ultrastruct Anat, Rome, Italy; [Carotti, Simone; Righi, Daniela; Perrone, Giuseppe; Zalfa, Francesca] Campus Biomed Univ Hosp, Dept Pathol, Predict Mol Diagnost Unit, Rome, Italy; [Latasa, M. Ujue; Colyn, Leticia; Fernandez-Barrena, Maite G.; Avila, Matias A.] Univ Navarra, Hepatol Program, Ctr Appl Med Res CIMA, Pamplona, Spain; [Latasa, M. Ujue; Colyn, Leticia; Fernandez-Barrena, Maite G.; Avila, Matias A.] IdiSNA, Pamplona, Spain; [Fernandez-Barrena, Maite G.] Ctr Investigac Biomed Red Enfermedades Hepat & Di, Madrid, Spain; [Falchi, Mario] Ist Super Sanita, Natl AIDS Ctr, Rome, Italy; [Pedini, Giorgia; Bagni, Claudia] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Pantano, Francesco] Campus Biomed Univ, Med Oncol Dept, Rome, Italy; [Bagni, Claudia] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Perrone, Giuseppe] Campus Biomed Univ, Res Unit Pathol, Rome, Italy; [Rana, Rosa Alba] Univ G DAnnunzio, Med & Aging Sci Dept, Chieti, Italy	University Campus Bio-Medico - Rome Italy; University Campus Bio-Medico - Rome Italy; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; University Campus Bio-Medico - Rome Italy; University of Lausanne; University Campus Bio-Medico - Rome Italy; G d'Annunzio University of Chieti-Pescara	Morini, S; Zalfa, F (corresponding author), Campus Biomed Univ, Dept Med, Res Unit Microscop & Ultrastruct Anat, Rome, Italy.; Zalfa, F (corresponding author), Campus Biomed Univ Hosp, Dept Pathol, Predict Mol Diagnost Unit, Rome, Italy.	s.morini@unicampus.it; f.zalfa@unicampus.it	Perrone, Giuseppe/GLR-7098-2022; Avila, Matias A/Y-6342-2019; Flammia, Rocco Simone/ABC-2869-2021; Morini, Sergio/AAB-8540-2022; Pantano, Francesco/D-8459-2012	Avila, Matias A/0000-0001-6570-3557; Flammia, Rocco Simone/0000-0002-3129-0544; Morini, Sergio/0000-0001-6137-2404; Pantano, Francesco/0000-0002-2894-9686; Bagni, Claudia/0000-0002-4419-210X; Colyn, Leticia/0000-0002-7403-9149; Falchi, Mario/0000-0002-8290-5406; D'Andrea, Laura/0000-0002-2042-9782	FIRB 2010 funds [RBAP10447J_005]; Pathology Dept. and Predictive Molecular Diagnostic Division funds; Hepacare Project from Fundacion La Caixa; AECC Grant for Rare and Childhood cancers from Instituto de Salud Carlos III [FIS PI16/01126]; Gobierno de Navarra Salud [58/17]; FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion [PID2019-104878RB-100/AEI/10.13039/501100011033]; Fundacion Eugenio Rodriguez Pascual; Italian Fragile X Association; PRIN2017 89LFKB; Etat de Vaud	FIRB 2010 funds; Pathology Dept. and Predictive Molecular Diagnostic Division funds; Hepacare Project from Fundacion La Caixa; AECC Grant for Rare and Childhood cancers from Instituto de Salud Carlos III; Gobierno de Navarra Salud; FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion; Fundacion Eugenio Rodriguez Pascual; Italian Fragile X Association; PRIN2017 89LFKB; Etat de Vaud	This research was supported by FIRB 2010 funds (RBAP10447J_005) to RAR, by Pathology Dept. and Predictive Molecular Diagnostic Division funds to GP, by private funds to SM and by Hepacare Project from Fundacion La Caixa, AECC Grant for Rare and Childhood cancers 2017 call, grant FIS PI16/01126 from Instituto de Salud Carlos III, grant 58/17 from Gobierno de Navarra Salud, grant PID2019-104878RB-100/AEI/10.13039/501100011033 from FEDER/Ministerio de Ciencia, Innovacion y Universidades-Agencia Estatal de Investigacion, and Fundacion Eugenio Rodriguez Pascual to MAA and MGF-B. MGF-B is a Ramon y Cajal Fellow (RYC2018-00244475-1) and LC is a predoctoral fellow of the Gobierno de Navarra. GP was supported by the Italian Fragile X Association and PRIN2017 89LFKB and Etat de Vaud to CB. We thank Franca Abbruzzese for technical help with time lapse confocal acquisitions and Prof. R. Suzanne Zukin for the plasmid expressing human FMRP.	Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bagni C, 2019, NEURON, V101, P1070, DOI 10.1016/j.neuron.2019.02.041; Bagni C, 2013, AM J MED GENET A, V161, P2809, DOI 10.1002/ajmg.a.36241; Bagni C, 2012, J CLIN INVEST, V122, P4314, DOI 10.1172/JCI63141; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Barcena-Varela M, 2019, HEPATOLOGY, V69, P587, DOI 10.1002/hep.30168; Beaty BT, 2014, EUR J CELL BIOL, V93, P438, DOI 10.1016/j.ejcb.2014.07.003; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhogal B, 2011, NAT NEUROSCI, V14, P1517, DOI 10.1038/nn.2950; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Chen WT, 1999, ANN NY ACAD SCI, V878, P361, DOI 10.1111/j.1749-6632.1999.tb07695.x; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Clements O, 2020, J HEPATOL, V72, P95, DOI 10.1016/j.jhep.2019.09.007; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davidovic L, 2007, HUM MOL GENET, V16, P3047, DOI 10.1093/hmg/ddm263; De Rubeis S, 2010, MOL CELL NEUROSCI, V43, P43, DOI 10.1016/j.mcn.2009.09.013; Di Grazia A., 2020, CELL MOL GASTROENTER, V20, P30172; Dianat N, 2014, HEPATOLOGY, V60, P700, DOI 10.1002/hep.27165; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Elizalde M, 2014, J CLIN INVEST, V124, P2909, DOI 10.1172/JCI74382; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Filippini A, 2017, RNA BIOL, V14, P1580, DOI 10.1080/15476286.2017.1338232; Gkogkas CG, 2014, CELL REP, V9, P1742, DOI 10.1016/j.celrep.2014.10.064; Gross C, 2012, NEUROPSYCHOPHARMACOL, V37, P178, DOI 10.1038/npp.2011.137; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Janusz A, 2013, J NEUROSCI, V33, P18234, DOI 10.1523/JNEUROSCI.2207-13.2013; Kalkunte R, 2007, ARCH DIS CHILD, V92, P795, DOI 10.1136/adc.2006.103382; Kao DI, 2010, P NATL ACAD SCI USA, V107, P15601, DOI 10.1073/pnas.1010564107; Kurokawa Y, 2003, J HEPATOL, V39, P1004, DOI 10.1016/S0168-8278(03)00473-2; KUSAKA Y, 1988, RES EXP MED, V188, P367, DOI 10.1007/BF01851205; Li L, 2018, CANCER CELL, V33, P736, DOI 10.1016/j.ccell.2018.02.011; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Liao GN, 2015, WIRES RNA, V6, P1, DOI 10.1002/wrna.1265; Lindsay AJ, 2014, BIOL CELL, V106, P57, DOI 10.1111/boc.201200076; Liu YF, 2007, ONCOL REP, V18, P943; Luca R, 2013, EMBO MOL MED, V5, P1523, DOI 10.1002/emmm.201302847; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Maurin T, 2018, NUCLEIC ACIDS RES, V46, P6344, DOI 10.1093/nar/gky267; Mavros MN, 2014, JAMA SURG, V149, P565, DOI 10.1001/jamasurg.2013.5137; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Ohashi S, 2002, J BIOL CHEM, V277, P37804, DOI 10.1074/jbc.M203608200; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Rizvi S, 2018, NAT REV CLIN ONCOL, V15, P95, DOI 10.1038/nrclinonc.2017.157; Rizvi S, 2017, J HEPATOL, V67, P632, DOI 10.1016/j.jhep.2017.03.026; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schultz-Pedersen S, 2001, AM J MED GENET, V103, P226, DOI 10.1002/ajmg.1533; Sidhu H, 2014, J NEUROSCI, V34, P9867, DOI 10.1523/JNEUROSCI.1162-14.2014; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sirica AE, 2019, HEPATOLOGY, V69, P1803, DOI 10.1002/hep.30289; Srivastava A, 2015, FEBS OPEN BIO, V5, P705, DOI 10.1016/j.fob.2015.07.005; Stumpf CR, 2011, CURR OPIN GENET DEV, V21, P474, DOI 10.1016/j.gde.2011.03.007; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Vira VA., 2009, EXTRACELL MATRIX PRO, V522, P211, DOI [10.1007/978-1-59745-413-1_15, DOI 10.1007/978-1-59745-413-1_15]; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; Xing Z, 2016, ONCOTARGET, V7, P75394, DOI 10.18632/oncotarget.12215; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zach S, 2015, J STEM CELL RES TRAN, V2, P1013; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zalfa F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.521; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104	74	3	3	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 10	2021	40	23					4033	4049		10.1038/s41388-021-01824-3	http://dx.doi.org/10.1038/s41388-021-01824-3		MAY 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SQ8GV	34017076	hybrid, Green Published			2022-12-26	WOS:000652439200002
J	Junejo, IN				Junejo, Imran N.			Pedestrian attribute recognition using two-branch trainable Gabor wavelets network	PLOS ONE			English	Article								Keeping an eye on pedestrians as they navigate through a scene, surveillance cameras are everywhere. With this context, our paper addresses the problem of pedestrian attribute recognition (PAR). This problem entails recognizing attributes such as age-group, clothing style, accessories, footwear style etc. This multi-label problem is extremely challenging even for human observers and has rightly garnered attention from the computer vision community. Towards a solution to this problem, in this paper, we adopt trainable Gabor wavelets (TGW) layers and cascade them with a convolution neural network (CNN). Whereas other researchers are using fixed Gabor filters with the CNN, the proposed layers are learnable and adapt to the dataset for a better recognition. We propose a two-branch neural network where mixed layers, a combination of the TGW and convolutional layers, make up the building block of our deep neural network. We test our method on twoo challenging publicly available datasets and compare our results with state of the art.	[Junejo, Imran N.] Zayed Univ, Coll Technol Innovat, Dubai, U Arab Emirates	Zayed University	Junejo, IN (corresponding author), Zayed Univ, Coll Technol Innovat, Dubai, U Arab Emirates.	imran.junejo@zu.ac.ae						Alekseev A., 2019, PROC INT C ENG TELEC, P1; An H., 2019, PROC IEEE VIS COMMUN, P1; Bai J, 2019, IEEE IJCNN; Bekele E, 2019, IEEE INT CONF AUTOMA, P352; Bourdev L, 2011, IEEE I CONF COMP VIS, P1543, DOI 10.1109/ICCV.2011.6126413; Chang XB, 2018, PROC CVPR IEEE, P2109, DOI 10.1109/CVPR.2018.00225; Chen YQ, 2018, PROCEEDINGS OF THE 13TH INTERNATIONAL JOINT CONFERENCE ON COMPUTER VISION, IMAGING AND COMPUTER GRAPHICS THEORY AND APPLICATIONS (VISIGRAPP 2018), VOL 5: VISAPP, P114, DOI 10.5220/0006622901140122; Chikontwe P, 2018, IEEE ACCESS, V6, P60801, DOI 10.1109/ACCESS.2018.2875783; Chollet F., 2015, KERAS; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Deng YB, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P789, DOI 10.1145/2647868.2654966; Guo GD, 2009, PROC CVPR IEEE, P112, DOI 10.1109/CVPRW.2009.5206681; Guo H, 2017, PATTERN RECOGN LETT, V94, P38, DOI 10.1016/j.patrec.2017.05.012; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Joo J, 2013, IEEE I CONF COMP VIS, P721, DOI 10.1109/ICCV.2013.95; Junejo IN, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03563; Kwon HJ, 2019, IEEE IMAGE PROC, P3626, DOI 10.1109/ICIP.2019.8803442; Li DW, 2018, IEEE INT CON MULTI; Li Dangwei, 2016, ARXIV160307054; Li W, 2018, PROC CVPR IEEE, P2285, DOI 10.1109/CVPR.2018.00243; Liao SC, 2015, PROC CVPR IEEE, P2197, DOI 10.1109/CVPR.2015.7298832; Liu Pengze, 2018, BRIT MACH VIS C 2018; Liu XH, 2017, IEEE I CONF COMP VIS, P350, DOI 10.1109/ICCV.2017.46; Lowe D. G., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1150, DOI 10.1109/ICCV.1999.790410; Luan SZ, 2018, IEEE WINT CONF APPL, P1254, DOI 10.1109/WACV.2018.00142; Maji S, 2008, PROC CVPR IEEE, P2245; Nanda A, 2019, MULTIMED TOOLS APPL, V78, P3885, DOI 10.1007/s11042-017-4875-7; Oliva A, P 27 INT C NEUR INF; Qian XL, 2018, LECT NOTES COMPUT SC, V11213, P661, DOI 10.1007/978-3-030-01240-3_40; Rahman K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063503; Raudies F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053456; Sarafianos N, 2018, LECT NOTES COMPUT SC, V11215, P708, DOI 10.1007/978-3-030-01252-6_42; Sarfraz M., 2017, BMVC; Sarfraz MS, 2018, PROC CVPR IEEE, P420, DOI 10.1109/CVPR.2018.00051; Si JL, 2018, PROC CVPR IEEE, P5363, DOI 10.1109/CVPR.2018.00562; Sudowe P, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION WORKSHOP (ICCVW), P329, DOI 10.1109/ICCVW.2015.51; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wang JY, 2018, PROC CVPR IEEE, P2275, DOI 10.1109/CVPR.2018.00242; Wang XM, 2019, ADV NEUR IN, V32; Zhao Huang RH Xin, 2019, AAAI; Zhao X, 2019, AAAI CONF ARTIF INTE, P9275; Zhou Y., 2017, P BRIT MACH VIS C 20; Zhu JQ, 2015, INT CONF BIOMETR, P535, DOI 10.1109/ICB.2015.7139070	44	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0251667	10.1371/journal.pone.0251667	http://dx.doi.org/10.1371/journal.pone.0251667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061854	Green Published, gold			2022-12-26	WOS:000656813600050
J	Bammann, K; Thomson, NK; Albrecht, BM; Buchan, DS; Easton, C				Bammann, Karin; Thomson, Nicola K.; Albrecht, Birte Marie; Buchan, Duncan S.; Easton, Chris			Generation and validation of ActiGraph GT3X+accelerometer cut-points for assessing physical activity intensity in older adults. The OUTDOOR ACTIVE validation study	PLOS ONE			English	Article							ENERGY-EXPENDITURE; ACCELEROMETER; WRIST; WALKING; COMPARABILITY; PROMOTION; CHILDREN; COST	The study of physical activity in older adults is becoming more and more relevant. For evaluation of physical activity recommendations, intensity-specific accelerometer cut-points are utilized. However, research on accelerometer cut-points for older adults is still scarce. The aim of the study was to generate placement-specific cut-points of ActiGraph GT3X+ activity counts and raw measures of acceleration to determine physical activity intensity in older adults. A further aim was to compare the validity of the generated cut-points for a range of different physical activities. The study was a single experimental trial using a convenience sample. Study participants were 20 adults aged 59 to 73 years. Accelerometers were worn at six different placements (one on each wrist, one on each ankle, and two at the hip) and breath-by-breath indirect calorimetry was used as the reference for energy. The experiment comprised of two parts; a) The first required participants to walk on a treadmill at incremental speeds (3.0-5.0 kmh(-1)), and b) Five different everyday activities (reading, cleaning, shopping, cycling, aerobics) were staged in the laboratory setting. Accelerometer cut-points (activity counts, raw data) were derived for each of the investigated placements by linear regression using the treadmill part. Performance of the cut-points was assessed by applying the cut-points to the everyday activities. We provide cut-points for six placements and two accelerometer metrics in the specific age group. However, the derived cut-points did not outperform published ones. More research and innovative approaches are needed for improving internal and external validity of research results across populations and age groups.	[Bammann, Karin; Albrecht, Birte Marie] Univ Bremen, Working Grp Epidemiol Demog Change, Inst Publ Hlth & Nursing Sci IPP, Bremen, Germany; [Thomson, Nicola K.; Buchan, Duncan S.; Easton, Chris] Univ West Scotland, Inst Clin Exercise & Hlth Sci, Paisley, Lanark, Scotland	University of Bremen; University of West Scotland	Bammann, K (corresponding author), Univ Bremen, Working Grp Epidemiol Demog Change, Inst Publ Hlth & Nursing Sci IPP, Bremen, Germany.	bammann@uni-bremen.de		Albrecht, Birte/0000-0002-1072-6767; Easton, Chris/0000-0003-4808-1287; Bammann, Karin/0000-0002-5623-8160; Thomson, Nicola/0000-0002-8554-4394	German Federal Ministry of Education and Research [KB: 01EL1422B, KB: 01EL1822B]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The work for this paper has partly been funded by the German Federal Ministry of Education and Research (www.bmbf.de: KB: 01EL1422B and KB: 01EL1822B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; [Anonymous], 2010, GLOB REC PHYS ACT HL; Bammann K, 2021, AM J HEALTH PROMOT, V35, P409, DOI 10.1177/0890117120974876; Bammann K, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6124-z; Barnett A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0380-5; Buchan DS, 2020, MEAS PHYS EDUC EXERC, V24, P247, DOI 10.1080/1091367X.2020.1801441; Buchan DS, 2019, CLIN PHYSIOL FUNCT I, V39, P51, DOI 10.1111/cpf.12538; Cleland CL, 2020, J AGING PHYS ACTIV, V28, P623, DOI 10.1123/japa.2019-0244; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Crouter SE, 2006, EUR J APPL PHYSIOL, V98, P601, DOI 10.1007/s00421-006-0307-5; Crouter SE, 2013, MED SCI SPORT EXER, V45, P1403, DOI 10.1249/MSS.0b013e318285f03b; Dieu O, 2017, CLIN PHYSIOL FUNCT I, V37, P525, DOI 10.1111/cpf.12337; Doherty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169649; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Fairclough SJ, 2016, MED SCI SPORT EXER, V48, P245, DOI 10.1249/MSS.0000000000000771; Forberger S, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040379; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gil-Rey E, 2019, RES Q EXERCISE SPORT, V90, P327, DOI 10.1080/02701367.2019.1599801; Hall KS, 2013, MED SCI SPORT EXER, V45, P574, DOI 10.1249/MSS.0b013e318276c73c; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hildebrand M, 2014, MED SCI SPORT EXER, V46, P1816, DOI 10.1249/MSS.0000000000000289; Hills Andrew P, 2014, Front Nutr, V1, P5, DOI 10.3389/fnut.2014.00005; Holme I, 2015, BRIT J SPORT MED, V49, P743, DOI 10.1136/bjsports-2014-094522; Howe CCF, 2017, MEAS PHYS EDUC EXERC, V21, P127, DOI 10.1080/1091367X.2016.1271801; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Kenny GP, 2017, EUR J APPL PHYSIOL, V117, P1765, DOI 10.1007/s00421-017-3670-5; Kim DY, 2014, YONSEI MED J, V55, P1145, DOI 10.3349/ymj.2014.55.4.1145; Knaggs JD, 2011, J AM GERIATR SOC, V59, P2118, DOI 10.1111/j.1532-5415.2011.03655.x; Knowles AM, 2015, AGE, V37, DOI 10.1007/s11357-015-9763-3; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Mcminn D, 2013, INT J EXERC SCI, V6, P217; Migueles J.H., 2019, J MEAS PHYS BEHAV, V2, P188, DOI [10.1123/jmpb.2018-0063, DOI 10.1123/JMPB.2018-0063]; Migueles JH, 2022, BRIT J SPORT MED, V56, P376, DOI 10.1136/bjsports-2020-103604; Migueles JH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54267-y; Montoye AHK, 2020, J SPORT SCI, V38, P2569, DOI 10.1080/02640414.2020.1794244; Osoba MY, 2019, LARYNGOSCOPE INVEST, V4, P143, DOI 10.1002/lio2.252; Rhudy MB, 2020, J SPORT SCI, V38, P503, DOI 10.1080/02640414.2019.1707956; Rhudy Matthew B., 2018, Journal of Medical Engineering & Technology, V42, P236, DOI 10.1080/03091902.2018.1470692; Rowlands AV, 2018, MED SCI SPORT EXER, V50, P1323, DOI 10.1249/MSS.0000000000001561; Rowlands AV, 2018, PEDIATR EXERC SCI, V30, P450, DOI 10.1123/pes.2018-0201; Rowlands AV, 2018, MED SCI SPORT EXER, V50, P257, DOI 10.1249/MSS.0000000000001435; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stalling I, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09708-z; Straczkiewicz M, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19092095; Strath SJ, 2012, MED SCI SPORT EXER, V44, pS77, DOI 10.1249/MSS.0b013e3182399eb1; van Hees VT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061691; Westerterp KR, 2017, EUR J APPL PHYSIOL, V117, P1277, DOI 10.1007/s00421-017-3641-x	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252615	10.1371/journal.pone.0252615	http://dx.doi.org/10.1371/journal.pone.0252615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QS	34081715	Green Published, gold			2022-12-26	WOS:000664639200032
J	Zhang, XT; Heredia, NI; Balakrishnan, M; Thrift, AP				Zhang, Xiaotao; Heredia, Natalia I.; Balakrishnan, Maya; Thrift, Aaron P.			Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CONTROLLED ATTENUATION PARAMETER; UNITED-STATES; DIAGNOSTIC-ACCURACY; NATIONAL-HEALTH; FIBROSIS; STEATOSIS; SEVERITY; RISK	Background Non-alcoholic fatty liver disease (NAFLD) is increasingly common in the adult population. In the United States, the overall burden of NAFLD is unknown due to challenges with population-level NAFLD detection. The purpose of this study was to estimate prevalence of NAFLD and significant NAFLD fibrosis and identify factors associated with them in the U.S. Methods Data came from the 2017-2018 cycle of National Health and Nutrition Examination Survey. We defined NAFLD by controlled attenuation parameter (CAP) scores of >= 248 dB/m in absence of excessive alcohol use and viral hepatitis. We defined significant fibrosis as Vibration controlled transient elastography (VCTE) liver stiffness measurements (LSM) value >= 7.9 kPa. We calculated the adjusted odds ratio (OR) and 95% confidential intervals (CI) for associations with NAFLD and significant NAFLD fibrosis using multivariable logistic regression. Results Overall, among 4,024 individuals aged >= 20 years included in the analysis, 56.7% had NAFLD by CAP. In comparison, when defined by elevated liver enzymes, NAFLD prevalence was 12.4%. The prevalence of significant NAFLD fibrosis by VCTE LSM was 14.5%. NAFLD prevalence increased with age, was higher among men than women and among Hispanics compared with non-Hispanic whites. Individuals who were obese, had metabolic syndrome (MetS) and type 2 diabetes were more likely to have NAFLD compared to those that who were not obese or without MetS/diabetes. Inadequate physical activity (OR = 1.57, 95% CI: 1.18-2.08) was also a factor associated with NAFLD. MetS, high waist circumstance, diabetes and hypertension were independently associated with significant NAFLD fibrosis. Conclusions NAFLD and significant NAFLD fibrosis are highly prevalent in U.S. general population.	[Zhang, Xiaotao; Thrift, Aaron P.] Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX 77030 USA; [Zhang, Xiaotao] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Dept Epidemiol, Houston, TX 77030 USA; [Heredia, Natalia I.] Univ Texas Hlth Sci Ctr Houston, Dept Hlth Promot & Behav Sci, Sch Publ Hlth, Houston, TX 77030 USA; [Balakrishnan, Maya] Baylor Coll Med, Dept Med, Sect Gastroenterol & Hepatol, Houston, TX 77030 USA; [Thrift, Aaron P.] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Baylor College of Medicine	Zhang, XT (corresponding author), Baylor Coll Med, Dept Med, Sect Epidemiol & Populat Sci, Houston, TX 77030 USA.; Zhang, XT (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Dept Epidemiol, Houston, TX 77030 USA.	Xiaotao.Zhang@bcm.edu	Heredia, Natalia I./AAI-1287-2021; Zhang, Xiaotao/K-1581-2019	Heredia, Natalia I./0000-0001-8086-3700; Zhang, Xiaotao/0000-0002-3968-5030	Cancer Prevention and Research Institute of Texas (CPRIT) [RP160097]; MD Anderson's Cancer Center Support Grant - National Cancer Institute/National Institutes of Health [P30CA016672]; Prevent Cancer Foundation; Cancer Prevention and Research Institute of Texas [RP170259]	Cancer Prevention and Research Institute of Texas (CPRIT); MD Anderson's Cancer Center Support Grant - National Cancer Institute/National Institutes of Health; Prevent Cancer Foundation; Cancer Prevention and Research Institute of Texas	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. X. Zhang was supported by a research training grant from the Cancer Prevention and Research Institute of Texas (CPRIT; RP160097). N.I. Heredia was supported by supported by the Cancer Prevention and Research Institute of Texas (RP170259) and MD Anderson's Cancer Center Support Grant (P30CA016672) funded by the National Cancer Institute/National Institutes of Health, and the Prevent Cancer Foundation.	Abeysekera KWA, 2020, LANCET GASTROENTEROL, V5, P295, DOI 10.1016/S2468-1253(19)30419-4; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; [Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; [Anonymous], 2018, ASTM C33C33M 18, DOI DOI 10.1520/C0033_C0033M-18; Balakrishnan M, 2021, CLIN GASTROENTEROL H, V19, P61, DOI 10.1016/j.cgh.2020.04.067; Balakrishnan M, 2017, DIGEST DIS SCI, V62, P526, DOI 10.1007/s10620-016-4401-1; Chen TC CJ., 2020, VITAL HLTH STAT, V2; Ciardullo S, 2021, CLIN GASTROENTEROL H, V19, P384, DOI 10.1016/j.cgh.2020.06.048; Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Deweerdt S, 2017, NATURE, V551, pS92, DOI 10.1038/d41586-017-06925-2; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Eddowes PJ, 2019, GASTROENTEROLOGY, V156, P1717, DOI 10.1053/j.gastro.2019.01.042; Fabrellas N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200656; FRIEDEWA WT, 1972, CLIN CHEM, V18, P499, DOI [10.1093/clinchem/18.6.499, DOI 10.1093/clinchem/18.6.499]; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Huang T, 2020, INTERN MED J, V50, P1038, DOI 10.1111/imj.14709; Johnson C., 2013, VITAL HLTH STAT SERI; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Kim D, 2019, HEPATOL INT, V13, P205, DOI 10.1007/s12072-018-09926-z; Krasnoff JB, 2008, HEPATOLOGY, V47, P1158, DOI 10.1002/hep.22137; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Le MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173499; Lin YS, 2017, J MED ULTRASOUND, V25, P127, DOI 10.1016/j.jmu.2017.04.001; Liu Q, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-42; Lv DD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80709-z; National Health and Nutrition Examination Survey, 2020, 2017 2018 DAT DOC CO; Newsome PN, 2020, LANCET GASTROENTEROL, V5, P362, DOI 10.1016/S2468-1253(19)30383-8; Palumbo CS, 2019, INFLAMM BOWEL DIS, V25, P124, DOI 10.1093/ibd/izy200; Pu K, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-0961-9; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Ryan MC, 2005, DIABETES CARE, V28, P1222, DOI 10.2337/diacare.28.5.1222; Saab S, 2016, CLIN GASTROENTEROL H, V14, P5, DOI 10.1016/j.cgh.2015.05.001; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Sirli R, 2014, MED ULTRASON, V16, P119, DOI 10.11152/mu.201.3.2066.162.rs1is2; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Thiele M, 2018, J HEPATOL, V68, P1025, DOI 10.1016/j.jhep.2017.12.029; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Unalp-Arida A, 2017, HEPATOLOGY, V66, P84, DOI 10.1002/hep.29113; Vilar-Gomez E, 2018, GASTROENTEROLOGY, V155, P443, DOI 10.1053/j.gastro.2018.04.034; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2199, DOI 10.1016/j.jacc.2017.11.005; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zou B, 2020, J INTERN MED, V288, P139, DOI 10.1111/joim.13069	50	23	23	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252164	10.1371/journal.pone.0252164	http://dx.doi.org/10.1371/journal.pone.0252164			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081733	gold, Green Published			2022-12-26	WOS:000664639200011
J	Otagiri, R; Kawai, H; Takatsuka, M; Shinyashiki, N; Ito, A; Ikeguchi, R; Aoyama, T				Otagiri, Risa; Kawai, Hideki; Takatsuka, Masanobu; Shinyashiki, Naoki; Ito, Akira; Ikeguchi, Ryosuke; Aoyama, Tomoki			Interfacial polarization of in vivo rat sciatic nerve with crush injury studied via broadband dielectric spectroscopy	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; IMPEDANCE; REGENERATION; RECOVERY; MOTOR; AXON; PAIN	Electrical stimulation is one of the candidates for elongation-driven regeneration of damaged peripheral nerves. Different organs and tissues have an inherent cell structure and size. This leads to variation in the tissue-specific electrical properties of the frequency of interfacial polarization. Although nervous tissues have a membrane potential, the electrical reaction inside these tissues following electrical stimulation from outside remains unexplored. Furthermore, the pathophysiological reaction of an injured nerve is unclear. Here, we investigated the electrical reaction of injured and non-injured rat sciatic nerves via broadband dielectric spectroscopy. Crush injured and non-injured sciatic nerves of six 12-week-old male Lewis rats were used, 6 days after infliction of the injury. Both sides of the nerves (with and without injury) were exposed, and impedance measurements were performed at room temperature (approximately 25 degrees C) at frequencies ranging from 100 mHz to 5.5 MHz and electric potential ranging from 0.100 to 1.00 V. The measured interfacial polarization potentially originated from the polarization by ion transport around nerve membranes at frequencies between 3.2 kHz and 1.6 MHz. The polarization strength of the injured nerves was smaller than that of non-injured nerves. However, the difference in polarization between injured and non-injured nerves might be caused by inflammation and edema. The suitable frequency range of the interfacial polarization can be expected to be critical for electrical stimulation of injured peripheral nerves.	[Otagiri, Risa] Tokai Univ, Grad Sch Sci, Course Phys, Hiratsuka, Kanagawa, Japan; [Kawai, Hideki; Ito, Akira; Aoyama, Tomoki] Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Human Hlth Sci, Kyoto, Kyoto, Japan; [Takatsuka, Masanobu] Tokai Univ, Grad Sch Sci & Technol, Course Sci & Technol, Hiratsuka, Kanagawa, Japan; [Shinyashiki, Naoki] Tokai Univ, Sch Sci, Dept Phys, Hiratsuka, Kanagawa, Japan; [Ikeguchi, Ryosuke] Kyoto Univ, Dept Orthopaed Surg, Grad Sch Med, Kyoto, Kyoto, Japan	Tokai University; Kyoto University; Tokai University; Tokai University; Kyoto University	Aoyama, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Phys Therapy, Human Hlth Sci, Kyoto, Kyoto, Japan.	aoyama.tomoki.4e@kyoto-u.ac.jp	Ito, Akira/AAA-4872-2021	Ito, Akira/0000-0002-9645-9777; Shinyashiki, Naoki/0000-0003-0486-2911; Takatsuka, Masanobu/0000-0003-1307-1476	Ministry of Education, Culture, Sports, Science and Technology, Japan [KAKENHI 18H03128]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work of the lead author (T. Aoyama) was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant Number: KAKENHI 18H03128).	Al-Majed AA, 2000, EUR J NEUROSCI, V12, P4381, DOI 10.1046/j.1460-9568.2000.01341.x; Byrne K, 2011, INT ANESTHESIOL CLIN, V49, P81, DOI 10.1097/AIA.0b013e31821775a8; Chen LL, 2017, CELL BIOL INT, V41, P863, DOI 10.1002/cbin.10796; Clarke JO, 2020, ANN NY ACAD SCI, V1481, P247, DOI 10.1111/nyas.14414; Cole KS, 1939, J GEN PHYSIOL, V22, P649, DOI 10.1085/jgp.22.5.649; Gonzalez MC, 2018, CURR OPIN CLIN NUTR, V21, P366, DOI 10.1097/MCO.0000000000000496; Curtis HJ, 1938, J GEN PHYSIOL, V21, P757, DOI 10.1085/jgp.21.6.757; Fouchard Alexandre, 2016, J Physiol Paris, V110, P361, DOI 10.1016/j.jphysparis.2017.05.003; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Furst AL, 2019, CHEM REV, V119, P700, DOI 10.1021/acs.chemrev.8b00381; Gamal W, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0226; Gordon T, 2016, NEUROTHERAPEUTICS, V13, P295, DOI 10.1007/s13311-015-0415-1; Gordon T, 2016, EUR J NEUROSCI, V43, P336, DOI 10.1111/ejn.13005; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Gugliandolo E, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1303-5; Kremer F., 2003, BROADBAND DIELECTRIC; Liu QY, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00597; Low WC., 1989, HUM PHYSIOL+, P211; Mackinnon SE., 1988, NERVE REPAIR NERVE G, V1 st ed; Matsuda M, 2019, J ANESTH, V33, P131, DOI 10.1007/s00540-018-2579-4; Pan D, 2020, MUSCLE NERVE, V61, P726, DOI 10.1002/mus.26797; Peritore AF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103509; Raicu V, 2015, DIELECTRIC RELAXATION IN BIOLOGICAL SYSTEMS: PHYSICAL PRINCIPLES, METHODS, AND APPLICATIONS, P1, DOI 10.1093/acprof:oso/9780199686513.001.0001; Ravagli E, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20127-x; Camara-Lemarroy CR, 2010, NEUROIMMUNOMODULAT, V17, P314, DOI 10.1159/000292020; Ruijs ACJ, 2005, PLAST RECONSTR SURG, V116, P484, DOI 10.1097/01.prs.0000172896.86594.07; SANTOS PM, 1995, LARYNGOSCOPE, V105, P1061, DOI 10.1288/00005537-199510000-00010; SCHWAN HP, 1980, P IEEE, V68, P104, DOI 10.1109/PROC.1980.11589; Shinyashiki N., 2015, NANO MICROSCIENCE TE, P215; Smallwood RH, 2002, IEEE T MED IMAGING, V21, P708, DOI 10.1109/TMI.2002.800608; Wang TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208985; Ward LC, 2019, EUR J CLIN NUTR, V73, P194, DOI 10.1038/s41430-018-0335-3	32	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252589	10.1371/journal.pone.0252589	http://dx.doi.org/10.1371/journal.pone.0252589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077459	gold, Green Published			2022-12-26	WOS:000664638500054
J	Stadler, B; Nowell, CJ; Whittaker, MR; Arnhold, S; Pilatz, A; Wagenlehner, FM; Exintaris, B; Middendorff, R				Stadler, Beatrix; Nowell, Cameron J.; Whittaker, Michael R.; Arnhold, Stefan; Pilatz, Adrian; Wagenlehner, Florian M.; Exintaris, Betty; Middendorff, Ralf			Physiological and pharmacological impact of oxytocin on epididymal propulsion during the ejaculatory process in rodents and men	FASEB JOURNAL			English	Article						contraction; epididymis; human; noradrenaline; oxytocin; sperm transport	DUCTUS DEFERENS; IN-VITRO; SPONTANEOUS CONTRACTILITY; ADRENERGIC-INNERVATION; GENITAL ORGANS; SPERM OUTPUT; DOUBLE-BLIND; LONG-TERM; VASOPRESSIN; RECEPTORS	During the emission phase of ejaculation, the sperm is driven from the cauda epididymidis, where it is stored, through the vas deferens by strong contractions. These contractions are thought of as being mainly induced by the sympathetic nervous system and the neurotransmitter noradrenaline. In the present study, we investigated the effect of oxytocin (suggested to exert effects during ejaculation as well) on defined segments of the rat and human epididymis using live imaging. Our results indicate that it is the very last part of the epididymis, segment 19 (S19) in rat and likewise segment 9 in human, which responds in a uniquely strong and rapid manner to oxytocin (similar to noradrenaline). Because of the complex nature of this contractile response, we developed an imaging analysis method, which allowed us to quantify multidirectional contractions and to display them using heat maps. The reaction of S19 to oxytocin was concentration-dependent and could be inhibited by pretreatment with oxytocin antagonists (atosiban and cligosiban), but not with an arginine vasopressin 1(A) antagonist (SR49059). In both rat and human tissue, pretreatment with the alpha-1 adrenoreceptor antagonist tamsulosin inhibited the response to noradrenaline, whereas the effect of oxytocin was unimpaired. Our data (from men and rodents) strongly suggest that the hormone oxytocin is involved in the ejaculatory process. Thus, oxytocin-based medications might be a promising non-adrenergic treatment option for ejaculatory disorders. Additionally, we propose that S19 could be an advantageous model (detecting very low concentrations of oxytocin) to test the bioactivity of new oxytocin agonists and oxytocin antagonists.	[Stadler, Beatrix; Middendorff, Ralf] Justus Liebig Univ, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany; [Stadler, Beatrix; Nowell, Cameron J.; Exintaris, Betty] Monash Inst Pharmaceut Sci, Drug Discovery Biol, Melbourne, Vic, Australia; [Whittaker, Michael R.] Monash Inst Pharmaceut Sci, Drug Discovery Disposit & Dynam, Melbourne, Vic, Australia; [Arnhold, Stefan] Justus Liebig Univ, Inst Vet Anat Histol & Embryol, Giessen, Germany; [Pilatz, Adrian; Wagenlehner, Florian M.] Justus Liebig Univ, Dept Urol Pediat Urol & Androl, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Stadler, B (corresponding author), Justus Liebig Univ, Inst Anat & Cell Biol, Aulweg 123, D-35385 Giessen, Germany.	bea.stadler@web.de	Exintaris, Betty/ABB-8055-2021; whittaker, michael/C-2449-2008	whittaker, michael/0000-0001-5706-3932	Deutsche Forschungsgemeinschaft (DFG) [GRK 1871]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: GRK 1871	Althof S, 2019, J SEX MED, V16, P1188, DOI 10.1016/j.jsxm.2019.05.015; Alwaal A, 2015, FERTIL STERIL, V104, P1051, DOI 10.1016/j.fertnstert.2015.08.033; ARLETTI R, 1985, HORM BEHAV, V19, P14, DOI 10.1016/0018-506X(85)90002-9; BAUMGARTEN HG, 1968, Z ZELLFORSCH MIK ANA, V90, P81, DOI 10.1007/BF00496704; BAUMGARTEN HG, 1971, Z ZELLFORSCH MIK ANA, V120, P37, DOI 10.1007/BF00331243; BURNS PJ, 1981, THERIOGENOLOGY, V16, P531, DOI 10.1016/0093-691X(81)90038-8; Byrne MM, 2003, HUM REPROD, V18, P2098, DOI 10.1093/humrep/deg416; Carbone DJ, 2003, INT J IMPOT RES, V15, P299, DOI 10.1038/sj.ijir.3901017; CARMICHAEL MS, 1987, J CLIN ENDOCR METAB, V64, P27, DOI 10.1210/jcem-64-1-27; CARMICHAEL MS, 1994, ARCH SEX BEHAV, V23, P59, DOI 10.1007/BF01541618; Corona G, 2012, NAT REV UROL, V9, P508, DOI 10.1038/nrurol.2012.147; DEBACKERE M, 1961, J ENDOCRINOL, V22, P321, DOI 10.1677/joe.0.0220321; Denecke S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145051; Domeniconi RF, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.138768; Einspanier A, 1997, BIOL REPROD, V56, P416, DOI 10.1095/biolreprod56.2.416; Elfgen V, 2018, REPRODUCTION, V156, pR125, DOI 10.1530/REP-17-0754; Filippi S, 2002, MOL CELL ENDOCRINOL, V193, P89, DOI 10.1016/S0303-7207(02)00101-6; FJELLSTROM D, 1968, J REPROD FERTIL, V17, P207, DOI 10.1530/jrf.0.0170207; Frayne J, 1998, MOL HUM REPROD, V4, P527, DOI 10.1093/molehr/4.6.527; Giuliano F, 2005, EUR UROL, V48, P408, DOI 10.1016/j.eururo.2005.05.017; Goverde HJM, 1998, ARCH ANDROLOGY, V41, P17, DOI 10.3109/01485019808988540; Gupta J, 2008, BRIT J PHARMACOL, V155, P118, DOI 10.1038/bjp.2008.226; HIB J, 1974, J REPROD FERTIL, V36, P191, DOI 10.1530/jrf.0.0360191; HIB J, 1977, INT J FERTIL, V22, P63; HIB J, 1974, BIOL REPROD, V11, P436, DOI 10.1095/biolreprod11.4.436; Holstein AF., 1969, MORPHOLOGISCHE STUDI; JAAKKOLA UM, 1981, J REPROD FERTIL, V63, P47, DOI 10.1530/jrf.0.0630047; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; KIHLSTROM JE, 1963, ACTA PHYSIOL SCAND, V59, P370, DOI 10.1111/j.1748-1716.1963.tb02753.x; KNIGHT TW, 1974, J REPROD FERTIL, V40, P19, DOI 10.1530/jrf.0.0400019; KNIGHT TW, 1970, J REPROD FERTIL, V21, P523, DOI 10.1530/jrf.0.0210523; Kraft T., 2018, PHYSIOLOGIE, V8th; Kruger THC, 2003, J ENDOCRINOL, V177, P57, DOI 10.1677/joe.0.1770057; McMahon C, 2019, J SEX MED, V16, P1178, DOI 10.1016/j.jsxm.2019.05.016; MELIN P, 1970, J REPROD FERTIL, V22, P283; Mewe M, 2007, REPRODUCTION, V134, P493, DOI 10.1530/REP-07-0220; Mietens A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092603; MURPHY MR, 1987, J CLIN ENDOCR METAB, V65, P738, DOI 10.1210/jcem-65-4-738; MURPHY MR, 1990, J CLIN ENDOCR METAB, V71, P1056, DOI 10.1210/jcem-71-4-1056; Narayan P, 2001, UROLOGY, V57, P466, DOI 10.1016/S0090-4295(00)01042-6; OGAWA S, 1980, CLIN ENDOCRINOL, V13, P95, DOI 10.1111/j.1365-2265.1980.tb01027.x; Parry LJ, 1998, BIOL REPROD, V59, P1101, DOI 10.1095/biolreprod59.5.1101; PEETERS G, 1983, J ENDOCRINOL, V99, P161, DOI 10.1677/joe.0.0990161; POWERS RE, 1982, UROLOGY, V19, P523, DOI 10.1016/0090-4295(82)90610-0; Preston S, 2016, MOL CELL PROBE, V30, P13, DOI 10.1016/j.mcp.2015.08.005; Preston S, 2015, INT J PARASITOL, V45, P333, DOI 10.1016/j.ijpara.2015.01.007; Rowland D, 2010, J SEX MED, V7, P1668, DOI 10.1111/j.1743-6109.2010.01782.x; Sanbe A, 2007, BRIT J PHARMACOL, V152, P332, DOI 10.1038/sj.bjp.0707366; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SERRADEILLEGAL C, 1993, J CLIN INVEST, V92, P224, DOI 10.1172/JCI116554; Studdard PW, 2002, INT J ANDROL, V25, P65, DOI 10.1046/j.1365-2605.2002.00323.x; Sullivan R, 2019, ANDROLOGY-US, V7, P748, DOI 10.1111/andr.12633; Vignozzi L, 2008, J SEX MED, V5, P2010, DOI 10.1111/j.1743-6109.2008.00914.x; Walch K, 2001, J ASSIST REPROD GEN, V18, P655, DOI 10.1023/A:1013115301159; Wayman C, 2018, J SEX MED, V15, P1698, DOI 10.1016/j.jsxm.2018.10.008; Whittington K, 2001, REPRODUCTION, V122, P317, DOI 10.1530/reprod/122.2.317	56	1	1	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21639	10.1096/fj.202100435R	http://dx.doi.org/10.1096/fj.202100435R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34041782				2022-12-26	WOS:000655695900059
J	Kee, HJ; Lee, EJ; Han, JC; Kee, C				Kee, Hyun Joo; Lee, Eun Jung; Han, Jong Chul; Kee, Changwon			Ahmed implant coated with poly(2-methacryloyloxyethyl phosphorylcholine) inhibits foreign body reactions in rabbit eyes	PLOS ONE			English	Article							GLAUCOMA DRAINAGE DEVICE; VALVE IMPLANTATION; TREATMENT OUTCOMES; MITOMYCIN-C; TRABECULECTOMY; SURGERY; BIOCOMPATIBILITY; HYDROGELS; HYPOTONY; SAFETY	Purpose Wound healing after Ahmed glaucoma valve (AGV) implantation often entails fibrosis as a foreign body reaction to the silicone plate. Poly(2-methacryloyloxyethyl phosphorylcholine) (PMPC) forms an antifouling surface that inhibits fibrosis during wound healing. In this study, we aimed to compare the effects of the implantation of AGV coated with PMPC (wPMPC) versus AGV without PMPC (woPMPC) in rabbits. Methods Six New Zealand White rabbit does underwent AGV implantation in both eyes. For each rabbit, one eye was randomly selected for implantation of AGV wPMPC and a conventional AGV (woPMPC) was implanted in the contralateral eye. Gross conjunctival vascularity was compared between the two groups at the first, second, and fourth weeks after surgery. The eyes were enucleated in four weeks and subjected to staining with hematoxylin and eosin and Masson's trichrome stain. The fibrosis and inflammation status among the eye samples were compared by measuring the thickness of the fibrotic walls and counting the number of chronic inflammatory cells around the AGV. Counting of inflammatory cells and measuring fibrotic wall thickness were done in a blinded method to eliminate observer bias. Statistical analysis was performed using the Mann-Whitney U test. Results Gross and histological examinations revealed no toxic effects of PMPC. There were no apparent differences in overall conjunctival vascularity between the two groups at weeks 1, 2, and 4 after surgery. The average inflammatory cell counts were 14.3 5.8 per slide and 27.3 +/- 8.6 per slide in the wPMPC and woPMPC groups, respectively (p = 0.037). The average thicknesses of the fibrotic wall were 57.9 +/- 11.3 mu m and 81.5 +/- 21.3 mu m in the wPMPC and woPMPC groups, respectively (p = 0.025). Conclusion Compared to the woPMPC group, the number of inflammatory cells and fibrosis were significantly decreased in the wPMPC group.	[Kee, Hyun Joo; Lee, Eun Jung; Han, Jong Chul; Kee, Changwon] Sungkyunkwan Univ, Dept Ophthalmol, Samsung Med Ctr, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kee, C (corresponding author), Sungkyunkwan Univ, Dept Ophthalmol, Samsung Med Ctr, Sch Med, Seoul, South Korea.	ckee@skku.edu		Kee, Changwon/0000-0002-7419-0316	Korea Health 21 RD Project [HI18C0827]; Ministry of Health & Welfare, Republic of Korea	Korea Health 21 RD Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the Korea Health 21 R&D Project (HI18C0827), Ministry of Health & Welfare, Republic of Korea.	Amoozgar B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172556; Asrory VDO, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.3.20; Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409; Bozkir G, 1997, ACTA MED OKAYAMA, V51, P9; Budenz DL, 2016, AM J OPHTHALMOL, V163, P75, DOI 10.1016/j.ajo.2015.11.023; Cantor L, 1998, J GLAUCOMA, V7, P240; Cantor LB, 2003, J GLAUCOMA, V12, P266, DOI 10.1097/00061198-200306000-00015; Chen DW, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9070939; Christakis PG, 2013, OPHTHALMOLOGY, V120, P2232, DOI 10.1016/j.ophtha.2013.04.018; Cordeiro MF, 2002, PROG RETIN EYE RES, V21, P75, DOI 10.1016/S1350-9462(01)00021-0; Costa VP, 2004, OPHTHALMOLOGY, V111, P1071, DOI 10.1016/j.ophtha.2003.09.037; Dai ZX, 2017, INVEST OPHTH VIS SCI, V58, P1692, DOI 10.1167/iovs.16-21065; De Saint Jean M, 2000, CURR EYE RES, V20, P85, DOI 10.1076/0271-3683(200002)20:2;1-D;FT085; Gedde SJ, 2018, OPHTHALMOLOGY, V125, P650, DOI 10.1016/j.ophtha.2018.02.003; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Ham J, 2020, ACS APPL MATER INTER, V12, P30198, DOI 10.1021/acsami.0c07629; He MR, 2016, ACTA BIOMATER, V40, P142, DOI 10.1016/j.actbio.2016.03.038; Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231; Ishihara K, 2000, SCI TECHNOL ADV MAT, V1, P131, DOI 10.1016/S1468-6996(00)00012-7; Ishihara K, 2019, J BIOMED MATER RES A, V107, P933, DOI 10.1002/jbm.a.36635; Iwasaki Y, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064101; J Lu Louise, 2018, J Curr Glaucoma Pract, V12, P19, DOI 10.5005/jp-journals-10028-1239; Jacob JT, 1998, J BIOMED MATER RES, V43, P99, DOI 10.1002/(SICI)1097-4636(199822)43:2<99::AID-JBM3>3.0.CO;2-G; JAMPEL HD, 1992, ARCH OPHTHALMOL-CHIC, V110, P1049, DOI 10.1001/archopht.1992.01080200029011; Jung KI, 2015, ACTA OPHTHALMOL, V93, pE248, DOI 10.1111/aos.12571; Khung YL, 2015, ADV COLLOID INTERFAC, V226, P166, DOI 10.1016/j.cis.2015.10.009; Klopfleisch R, 2017, J BIOMED MATER RES A, V105, P927, DOI 10.1002/jbm.a.35958; Kook MS, 2000, OPHTHALMIC SURG LAS, V31, P100; Mandalos A, 2017, GRAEF ARCH CLIN EXP, V255, P1003, DOI 10.1007/s00417-017-3584-2; Palmerini T, 2015, J AM COLL CARDIOL, V65, P2496, DOI 10.1016/j.jacc.2015.04.017; Park JU, 2014, ACTA BIOMATER, V10, P4217, DOI 10.1016/j.actbio.2014.07.007; Parrish R, 1996, OPHTHALMOLOGY, V103, P1167, DOI 10.1016/S0161-6420(96)30527-7; Ramyashri S, 2020, INT OPHTHALMOL, V40, P1359, DOI 10.1007/s10792-020-01301-y; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; Requiao RD, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005549; Riva I, 2017, CLIN OPHTHALMOL, V11, P357, DOI 10.2147/OPTH.S104220; Safley SA, 2018, XENOTRANSPLANTATION, V25, DOI 10.1111/xen.12450; Sahiner N, 2009, ARCH OPHTHALMOL-CHIC, V127, P448, DOI 10.1001/archophthalmol.2009.19; Schlunck G, 2016, EXP EYE RES, V142, P76, DOI 10.1016/j.exer.2015.03.021; SEETNER A, 1979, CAN J OPHTHALMOL, V14, P121; Sin MC, 2014, POLYM J, V46, P436, DOI 10.1038/pj.2014.46; Suzuki R, 1999, OPHTHALMOLOGICA, V213, P135, DOI 10.1159/000027407; Than JYXL, 2018, BRIT J OPHTHALMOL, V102, P1667, DOI 10.1136/bjophthalmol-2017-311348; Tognetto D, 2005, EXPERT REV MED DEVIC, V2, P57, DOI 10.1586/17434440.2.1.57; Tsai ASH, 2015, INT J OPHTHALMOL-CHI, V8, P748, DOI 10.3980/j.issn.2222-3959.2015.04.19; Villamarin A, 2014, INVEST OPHTH VIS SCI, V55, P1848, DOI 10.1167/iovs.13-12626; Yamanaka O, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0134-8; Yang W, 2009, LANGMUIR, V25, P11911, DOI 10.1021/la9015788; Yoneyama T, 2002, BIOMATERIALS, V23, P1455, DOI 10.1016/S0142-9612(01)00268-X; Zada M, 2018, OPHTHALMOLOGY, V125, P179, DOI 10.1016/j.ophtha.2017.08.028; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	52	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252467	10.1371/journal.pone.0252467	http://dx.doi.org/10.1371/journal.pone.0252467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048489	Green Published, gold			2022-12-26	WOS:000664636100055
J	Arthur, R				Arthur, Rudy			Studying the UK job market during the COVID-19 crisis with online job ads	PLOS ONE			English	Article								The COVID-19 global pandemic and the lockdown policies enacted to mitigate it have had profound effects on the labour market. Understanding these effects requires us to obtain and analyse data in as close to real time as possible, especially as rules change rapidly and local lockdowns are enacted. This work studies the UK labour market by analysing data from the online job board Reed.co.uk, using topic modelling and geo-inference methods to break down the data by sector and geography. I also study how the salary, contract type, and mode of work have changed since the COVID-19 crisis hit the UK in March. Overall, vacancies were down by 60 to 70% in the first weeks of lockdown. By the end of the year numbers had recovered somewhat, but the total job ad deficit is measured to be over 40%. Broken down by sector, vacancies for hospitality and graduate jobs are greatly reduced, while there were more care work and nursing vacancies during lockdown. Differences by geography are less significant than between sectors, though there is some indication that local lockdowns stall recovery and less badly hit areas may have experienced a smaller reduction in vacancies. There are also small but significant changes in the salary distribution and number of full time and permanent jobs. As well as the analysis, this work presents an open methodology that enables a rapid and detailed survey of the job market in unsettled conditions and describes a web application jobtrender.com that allows others to query this data set.	[Arthur, Rudy] Univ Exeter, Dept Comp Sci, Exeter, Devon, England	University of Exeter	Arthur, R (corresponding author), Univ Exeter, Dept Comp Sci, Exeter, Devon, England.	R.Arthur@exeter.ac.uk			UK's Office for Students	UK's Office for Students	The author was supported in this work by the Institute of Coding which is funded by the UK's Office for Students.	Adams-Prassl A, 2020, CEPR DISCUSSION PAPE; [Anonymous], 2021, HLTH PROTECTION CORO; [Anonymous], 2020, SWEDISH PUBLIC HLTH; [Anonymous], 2020, POPULATION 1 JANUARY; [Anonymous], 2020, DWPS RESPONSE CORONA; [Anonymous], 2020, HLTH PROTECTION CORO; [Anonymous], 2020, UK COVID DEATHS; [Anonymous], 2020, RELATIONSHIP NUTS AR; [Anonymous], 2020, INFLATION PRICE INDI; [Anonymous], 2020, BAN CONTACT MORE 2; [Anonymous], 2020, INDEED HIRING LAB; [Anonymous], 2020, CORONAVIRUS JOB RETE; [Anonymous], 2020, WUHAN LOCKDOWN TRAVE; [Anonymous], 2020, UK UNEMPLOYMENT MAY; [Anonymous], 2020, JAPAN STATE EMERGENC; Arthur R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189327; Bartik A. W., 2020, ARE SMALL BUSINESSES; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brynjolksson E., 2020, 72344 NBER; Cajner T., 2020, US LABOR MARKET BEGI; Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464; Chetty R., 2020, 27431 NBER, V27431; Coibion O., 2020, LABOR MARKETS COVID; Costa Dias M., 2020, JOB VACANCIES COVID, DOI DOI 10.1920/BN.IFS.2020.BN0289; European Centre for the Development of Vocational Training (Cedefop), 2019, ONL JOB VACC SKILLS; Fellbaum Christiane, 1998, WORDNET ELECT DATABA; Ferreira P., 2020, IZA COVID 19 CRISIS; Forsythe E, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104238; Fujita S, 2017, AM ECON REV, V107, P3875, DOI 10.1257/aer.20131496; Giovannini A., 2019, STATE N 2019, P2019; Hensvik L, 2020, CEPR DISCUSSION PAPE; Ioannidis JPA, 2020, EUR J CLIN INVEST, V50, DOI [10.1111/eci.13222, 10.1111/eci.13223]; Islam N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2743; Le Q., 2014, 31 INT C MACH LEARN, P1188; Montenovo L., 2020, DETERMINANTS DISPARI; Nekoei A, 2020, CEPR DISCUSSION PAPE; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Ramage D., 2009, P 2009 C EMP METH NA, V1, P248, DOI DOI 10.3115/1699510.1699543; Rehurek R, 2010, P LREC 2010 WORKSHOP, P45; Roder M, 2015, WSDM'15: PROCEEDINGS OF THE EIGHTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P399, DOI 10.1145/2684822.2685324; Saltelli A, 2017, FUTURES, V91, P62, DOI 10.1016/j.futures.2016.11.012; Thurgood J., 2018, USING ONLINE JOB VAC	45	3	3	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251431	10.1371/journal.pone.0251431	http://dx.doi.org/10.1371/journal.pone.0251431			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043639	Green Published, Green Submitted, gold			2022-12-26	WOS:000664635700020
J	Mizeva, I; Potapova, E; Dremin, V; Kozlov, I; Dunaev, A				Mizeva, Irina; Potapova, Elena; Dremin, Viktor; Kozlov, Igor; Dunaev, Andrey			Spatial heterogeneity of cutaneous blood flow respiratory-related oscillations quantified via laser speckle contrast imaging	PLOS ONE			English	Article							SKIN MICROVASCULAR FUNCTION; VASOCONSTRICTOR RESPONSE; PERFUSION; MICROCIRCULATION; REFLEX; CHAOS	LSCI technique provides experimental data which can be considered in the context of spatial blood flow coherency. Analysis of vascular tone oscillations gives additional information to ensure a better understanding of the mechanisms affecting microvascular physiology. The oscillations with different frequencies are due to different physiological mechanisms. The reasons for the generation of peripheral blood flow oscillations in the 0.14-0.6 Hz frequency band are as follows: cardio-respiratory interactions, pressure variations in the venous part of the circulatory system, and the effect of the sympathetic nervous system on the vascular tone. Earlier, we described the spatial heterogeneity of around 0.3 Hz oscillations and this motivated us to continue the research to find the conditions for the occurrence of spatial phase synchronization. For this purpose, a number of physiological tests (controlled respiration, breath holder, and venous occlusion tests) which influence the blood flow oscillations of 0.14-0.6 Hz were considered, an appropriate measurement system and the required data processing algorithms were developed. At spontaneous respiration, the oscillations with frequencies around 0.3 Hz were stochastic, whereas all the performed tests induced an increase in spatial coherence. The protocols and methods proposed here can help to clarify whether the heterogeneity of respiratory-related blood flow oscillations exists on the skin surface.	[Mizeva, Irina] RAS, Inst Continuous Media Mech UrB, Perm, Russia; [Mizeva, Irina; Potapova, Elena; Dremin, Viktor; Kozlov, Igor; Dunaev, Andrey] Orel State Univ, Res & Dev Ctr Biomed Photon, Oryol, Russia; [Dremin, Viktor] Aston Univ, Coll Engn & Phys Sci, Birmingham, W Midlands, England	Russian Academy of Sciences; Perm Federal Research Center, Ural Branch, RAS; Institute of Continuous Media Mechanics of the Ural Branch, RAS; Orel State University; Aston University	Mizeva, I (corresponding author), RAS, Inst Continuous Media Mech UrB, Perm, Russia.; Mizeva, I (corresponding author), Orel State Univ, Res & Dev Ctr Biomed Photon, Oryol, Russia.	mizeva@icmm.ru	Dunaev, Andrey/AHE-8073-2022; Mizeva, Irina/D-6492-2013; Dunaev, Andrey/P-8249-2019; Dunaev, Andrey V./M-6806-2014; Potapova, Elena/H-3724-2017; Dremin, Viktor/I-9544-2019	Mizeva, Irina/0000-0002-0645-4850; Dunaev, Andrey V./0000-0003-4431-6288; Potapova, Elena/0000-0002-9227-6308; Dremin, Viktor/0000-0001-6974-3505	RFBR [19-32-90253]; European Union [839888]	RFBR(Russian Foundation for Basic Research (RFBR)); European Union(European Commission)	This study was supported by RFBR under project No. 19-32-90253. VD kindly acknowledges personal support from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 839888.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Allen J, 2013, PHYSIOL MEAS, V34, P769, DOI 10.1088/0967-3334/34/7/769; [Anonymous], 1995, OXFORD MATH MONOGRAP; Bandrivskyy A., 2004, CARDIOVASC ENG, V4, P89, DOI [10.1023/B:CARE.0000025126.63253.43, DOI 10.1023/B:CARE.0000025126.63253.43]; BOLLINGER A, 1993, PROGR APPL MICR, V20, P52; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P283, DOI 10.1111/1523-1747.ep12484917; Braverman IM, 2000, J INVEST DERM SYMP P, V5, P3, DOI 10.1046/j.1087-0024.2000.00010.x; Bricq S, 2012, MED BIOL ENG COMPUT, V50, P1017, DOI 10.1007/s11517-012-0919-3; Crandall CG, 2002, J PHYSIOL-LONDON, V538, P599, DOI 10.1113/jphysiol.2001.013060; Dremin V, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800317; Edwards CM, 1999, CLIN AUTON RES, V9, P255, DOI 10.1007/BF02319455; Estañol Bruno, 2008, Arch. Cardiol. Méx., V78, P187; Fredriksson I, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.12.126018; Frick P, 2015, BIOMED SIGNAL PROCES, V21, P1, DOI 10.1016/j.bspc.2015.04.014; Griffith TM, 1996, CARDIOVASC RES, V31, P342; HASSAN AAK, 1988, CLIN SCI, V75, P379, DOI 10.1042/cs0750379; HENRIKSEN O, 1983, ACTA PHYSIOL SCAND, V117, P171, DOI 10.1111/j.1748-1716.1983.tb07194.x; HENRIKSEN O, 1976, ACTA PHYSIOL SCAND, V98, P227, DOI 10.1111/j.1748-1716.1976.tb00240.x; HENRIKSEN O, 1991, ACTA PHYSIOL SCAND, V143, P33; Humeau A, 2007, MED BIOL ENG COMPUT, V45, P421, DOI 10.1007/s11517-007-0170-5; Humeau-Heurtier A, 2015, MICROVASC RES, V98, P54, DOI 10.1016/j.mvr.2014.12.003; Iatsenko D, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0622; Johnson PC, 2011, COMPR PHYSIOL, P409; Karavaev AS, 2019, CHAOS, V29, DOI 10.1063/1.5134833; Karavaev AS, 2009, CHAOS, V19, DOI 10.1063/1.3187794; Kirkpatrick SJ, 2008, OPT LETT, V33, P2886, DOI 10.1364/OL.33.002886; Krasnikov GV, 2013, RESP PHYSIOL NEUROBI, V185, P562, DOI 10.1016/j.resp.2012.11.007; Kvernmo HD, 1999, MICROVASC RES, V57, P298, DOI 10.1006/mvre.1998.2139; Lancaster G, 2020, J PHYSIOL-LONDON, V598, P2001, DOI 10.1113/JP278829; Lancaster G, 2018, PHYS REP, V748, P1, DOI 10.1016/j.physrep.2018.06.001; Liu GJ, 2012, BIOMED OPT EXPRESS, V3, P2669, DOI 10.1364/BOE.3.002669; Mahe G, 2012, CIRC-CARDIOVASC IMAG, V5, P155, DOI 10.1161/CIRCIMAGING.111.970418; Mayrovitz HN, 2002, MICROVASC RES, V63, P227, DOI 10.1006/mvre.2001.2391; Meredith D. J., 2012, Journal of Medical Engineering & Technology, V36, P1, DOI 10.3109/03091902.2011.638965; Mizeva I, 2020, 2020 11 C EUR STUD G, P1; Mizeva IA, 2017, IOP CONF SER-MAT SCI, V208, DOI 10.1088/1757-899X/208/1/012027; Mizeva I, 2020, IEEE T BIO-MED ENG, V67, P1882, DOI 10.1109/TBME.2019.2950323; Nikita T, 2017, RESP PHYSIOL NEUROBI, V235, P79, DOI 10.1016/j.resp.2016.10.005; Perrella A., 2018, WAVELET PHASE COHERE; Pitzalis MV, 1998, CARDIOVASC RES, V38, P332, DOI 10.1016/S0008-6363(98)00029-7; Ren YM, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0683-9; RICHARDSON JB, 1979, AM REV RESPIR DIS, V119, P785; Rosenblum M, 2019, PHILOS T R SOC A, V377, DOI 10.1098/rsta.2019.0045; Roustit M, 2012, MICROCIRCULATION, V19, P47, DOI 10.1111/j.1549-8719.2011.00129.x; Silva H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01123; SOMERS VK, 1995, J CLIN INVEST, V96, P1897, DOI 10.1172/JCI118235; Sorelli M, 2019, INT C MED BIOL ENG, P61; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; STERN MD, 1975, NATURE, V254, P56, DOI 10.1038/254056a0; Sun JF, 2012, IEEE T BIO-MED ENG, V59, P2254, DOI 10.1109/TBME.2012.2199490; Tankanag A. V., 2017, BIOPHYSICS-USSR, V62, P629, DOI DOI 10.1134/S0006350917040212; Tankanag A, 2020, MICROVASC RES, V130, DOI 10.1016/j.mvr.2020.103993; Tankanag AV, 2009, PHYS MED BIOL, V54, P5935, DOI 10.1088/0031-9155/54/19/018; Vaz Pedro G, 2016, IEEE Rev Biomed Eng, V9, P106, DOI 10.1109/RBME.2016.2532598; WARDELL K, 1994, MICROVASC RES, V48, P26, DOI 10.1006/mvre.1994.1036	56	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252296	10.1371/journal.pone.0252296	http://dx.doi.org/10.1371/journal.pone.0252296			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043720	gold, Green Published, Green Accepted			2022-12-26	WOS:000664635700082
J	Jaquetti, RK; Goncalves, JFD; Nascimento, HEM; da Costa, KCP; Maia, JMF; Schimpl, FC				Jaquetti, Roberto Kirmayr; Goncalves, Jose Francisco de Carvalho; Nascimento, Henrique Eduardo Mendonca; da Costa, Karen Cristina Pires; Maia, Jair Max Furtunato; Schimpl, Flavia Camila			Fertilization and seasonality influence on the photochemical performance of tree legumes in forest plantation for area recovery in the Amazon	PLOS ONE			English	Article							CHLOROPHYLL-A FLUORESCENCE; FREQUENTLY ASKED QUESTIONS; DROUGHT STRESS; GAS-EXCHANGE; WATER-STRESS; RAIN-FOREST; RESPONSES; PHOTOSYNTHESIS; LIGHT; TOOL	N-fixing leguminous species can reach atmospheric dinitrogen gas (N-2), having an advantage under N-limited degraded environments. These N-fixers are constantly used as facilitative species. Chlorophyll a fluorescence (ChF) acknowledges how different species take up and use light energy during photosynthesis. These techniques assess stress and performance responses to photosynthesis and are used for the selection of species with potential for reforestation. Six Fabaceae species were selected for this study: three nonfixing species (Cenostigma tocantinum, Senna reticulata and Dipteryx odorata) and three N-fixing species (Clitoria fairchildiana, Inga edulis and Acacia spp.). Variations in chlorophyll fluorescence under high vs. low water and nutrient conditions were studied. Multivariate analysis was performed to detect the effects of seasonality and fertilization on dark-adapted ChF two years after the experiment was established. The correlation among ChF variables and growth, photosynthesis and foliar nutrient concentrations was evaluated. Under high water- and nutrient-availability conditions, plants exhibited an enhanced performance index on absorption basis values correlated with electron transport fluxes. Under drought and nutrient-poor conditions, most species exhibit increased energy dissipation as photoprotection. High interspecific variation was found; therefore, species-specific responses should be considered in future ChF studies. Corroborating the ability to colonize high-light environments, N-fixers showed an increased performance index correlated with electron transport and Zn and N foliar concentrations. Negative correlations were found between photosynthesis and trapped fluxes. Diameter growth was positively correlated with electron transport fluxes. Given the different responses among species, ChF is an effective technique to screen for seasonality, fertilization and species effects and should be considered for use during forest restoration. Finally, the addition of fertilization treatments may facilitate tropical forest restoration due to the importance of nutrients in physiological processes. N-fixers showed high photochemical performance and tolerance to abiotic stress in degraded areas and therefore should be included to support ecosystem biomass restoration.	[Jaquetti, Roberto Kirmayr; Goncalves, Jose Francisco de Carvalho; Nascimento, Henrique Eduardo Mendonca] Natl Inst Amazonian Res, Lab Plant Physiol & Biochem, Manaus, Amazonas, Brazil; [da Costa, Karen Cristina Pires] Fed Univ South & Southeast, Inst Studies Agrarian & Reg Dev, Fac Agron, Maraba, Para, Brazil; [Maia, Jair Max Furtunato] Univ Amazonas State, Biol Sci Program, Manaus, Amazonas, Brazil; [Schimpl, Flavia Camila] Fed Amazonian Inst, Belem, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade do Estado do Amazonas	Jaquetti, RK (corresponding author), Natl Inst Amazonian Res, Lab Plant Physiol & Biochem, Manaus, Amazonas, Brazil.	jaquettiroberto@gmail.com	de Carvalho Gonçalves, José Francisco/V-8016-2019; Costa, Karen/GRF-5208-2022	de Carvalho Gonçalves, José Francisco/0000-0001-9197-4617; Maia, Jair/0000-0002-3967-7145; jaquetti, roberto/0000-0002-9450-2209	Coordination for the Improvement of Higher-Level Personnel (CAPES, Brazil) [52 AUXPE 3390/2013]; National Council for Scientific and Technological Development (CNPq, Brazil) [480233/2011-0]	Coordination for the Improvement of Higher-Level Personnel (CAPES, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by the: JFCG -Project Pro-Amazonia N degrees 52 AUXPE 3390/2013 -Coordination for the Improvement of Higher-Level Personnel (CAPES, Brazil). https://www.gov.br/capes/pt-br JFCG -Universal 480233/2011-0 -National Council for Scientific and Technological Development (CNPq, Brazil). http://www.cnpq.br The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00981; Adams MA, 2016, P NATL ACAD SCI USA, V113, P4098, DOI 10.1073/pnas.1523936113; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Andersson B, 2019, PLANT PHYSIOL, V181, P547, DOI 10.1104/pp.19.00480; Andrejic G, 2018, PHOTOSYNTHETICA, V56, P1249, DOI 10.1007/s11099-018-0827-3; Banks JM, 2018, ENVIRON EXP BOT, V155, P118, DOI 10.1016/j.envexpbot.2018.06.022; Banks JM, 2017, TREE PHYSIOL, V37, P1128, DOI 10.1093/treephys/tpx059; Barros FD, 2012, PLANT BIOLOGY, V14, P208, DOI 10.1111/j.1438-8677.2011.00474.x; Batterman SA, 2018, NAT ECOL EVOL, V2, P1059, DOI 10.1038/s41559-018-0583-6; Bussotti F, 2020, ECOL INDIC, V108, DOI 10.1016/j.ecolind.2019.105686; Carstensen A, 2019, PLANT SOIL, V434, P79, DOI 10.1007/s11104-018-3783-6; Chambers JQ, 2017, NAT CLIM CHANGE, V7, P175, DOI 10.1038/nclimate3238; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Gonçalves José Francisco de Carvalho, 2010, Acta Amaz., V40, P89, DOI 10.1590/S0044-59672010000100012; Dias DP, 2006, PHOTOSYNTHETICA, V44, P235, DOI 10.1007/s11099-006-0013-x; dos Santos UM, 2013, TREES-STRUCT FUNCT, V27, P193, DOI 10.1007/s00468-012-0788-2; dos Santos UM, 2006, FOREST ECOL MANAG, V226, P299, DOI 10.1016/j.foreco.2006.01.042; Eiras-Barca J, 2020, ANN NY ACAD SCI, V1472, P104, DOI 10.1111/nyas.14364; Falqueto AR, 2017, SCI HORTIC-AMSTERDAM, V224, P238, DOI 10.1016/j.scienta.2017.06.019; Favaretto VF, 2011, ENVIRON EXP BOT, V70, P20, DOI 10.1016/j.envexpbot.2010.06.003; Force L, 2003, PHOTOSYNTH RES, V78, P17, DOI 10.1023/A:1026012116709; Forrester DI, 2006, FOREST ECOL MANAG, V233, P211, DOI 10.1016/j.foreco.2006.05.012; Funk JL, 2017, BIOL REV, V92, P1156, DOI 10.1111/brv.12275; Gonçalves José Francisco de Carvalho, 2005, Braz. J. Plant Physiol., V17, P307, DOI 10.1590/S1677-04202005000300005; Gonçalves José F.C., 2007, Braz. J. Plant Physiol., V19, P171, DOI 10.1590/S1677-04202007000300001; Guo Y, 2015, PHOTOCHEM PHOTOBIOL, V91, P1, DOI 10.1111/php.12362; JAMES FC, 1990, ANNU REV ECOL SYST, V21, P129, DOI 10.1146/annurev.es.21.110190.001021; Jaquetti R. K., 2014, American Journal of Plant Sciences, V5, P2497, DOI 10.4236/ajps.2014.516264; Jaquetti RK, 2021, BMC RES NOTES, V14, DOI 10.1186/s13104-021-05552-5; Jaquetti RK, 2017, AN ACAD BRAS CIENC, V89, P1761, DOI 10.1590/0001-3765201720160734; Jaquetti RK, 2016, FORESTS, V7, DOI 10.3390/f7040076; Jaquetti RK, 2022, NEW FOREST, V53, P221, DOI 10.1007/s11056-021-09853-2; Jimenez-Munoz JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33130; Kalaji HM, 2018, PHOTOSYNTHETICA, V56, P953, DOI 10.1007/s11099-018-0766-z; Kalaji HM, 2017, PHOTOSYNTH RES, V132, P13, DOI [10.1007/s11120-016-0318-y, 10.1007/s11120-017-0356-0]; Kalaji HM, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2113-y; Kalaji HM, 2014, PHOTOSYNTH RES, V122, P121, DOI 10.1007/s11120-014-0024-6; Kalamandeen M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19358-2; Kebbas S, 2015, PHOTOSYNTHETICA, V53, P288, DOI 10.1007/s11099-015-0113-6; Kemner JE., 2021, FORESTS, V12, P1, DOI [10.3390/f12010039, DOI 10.3390/f12010039]; Lassouane N, 2013, ACTA PHYSIOL PLANT, V35, P2157, DOI 10.1007/s11738-013-1252-7; Lee TY, 2016, PHOTOSYNTHETICA, V54, P317, DOI 10.1007/s11099-015-0180-8; Liao T, 2018, PHOTOSYNTHETICA, V56, P578, DOI 10.1007/s11099-017-0704-5; Loik ME, 2001, OECOLOGIA, V127, P40, DOI 10.1007/s004420000566; Loik ME, 1999, RESTOR ECOL, V7, P382, DOI 10.1046/j.1526-100X.1999.72033.x; Loik Michael E., 2013, Rev. biol. trop, V61, P493; Maathuis FJM, 2009, CURR OPIN PLANT BIOL, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Mathur S, 2018, PHOTOSYNTHETICA, V56, P354, DOI 10.1007/s11099-018-0767-y; Meng LL, 2016, PHOTOSYNTHETICA, V54, P414, DOI 10.1007/s11099-016-0191-0; Molina-Montenegro MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076432; Navarrete AA, 2015, MOL ECOL, V24, P2433, DOI 10.1111/mec.13172; Niinemets U, 2004, PLANT BIOLOGY, V6, P254, DOI 10.1055/s-2004-817881; Nina AD, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9081047; NOYMEIR I, 1975, J ECOL, V63, P779, DOI 10.2307/2258601; Da Costa KCP, 2020, PHOTOSYNTHETICA, V58, P323, DOI 10.32615/ps.2019.146; Quesada C.A., 2009, BIOGEOSCI DISCUSS, V6, P3993, DOI DOI 10.5194/BGD-6-3993-2009; Rapacz M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00078; Robakowski P, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00742; Santiago LS, 2015, TREES-STRUCT FUNCT, V29, P1291, DOI 10.1007/s00468-015-1260-x; Schimpl FC, 2019, FLORA, V252, P10, DOI 10.1016/j.flora.2019.02.001; Schroth G, 2015, J FORESTRY RES, V26, P347, DOI 10.1007/s11676-015-0037-9; Singh JS, 2011, AGR ECOSYST ENVIRON, V140, P339, DOI 10.1016/j.agee.2011.01.017; Souza ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208512; Sprent JI, 2017, NEW PHYTOL, V215, P40, DOI 10.1111/nph.14474; Stirbet A, 2018, PHOTOSYNTHETICA, V56, P86, DOI 10.1007/s11099-018-0770-3; Swoczyna T, 2015, URBAN FOR URBAN GREE, V14, P544, DOI 10.1016/j.ufug.2015.05.005; Tariq A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24038-2; Wang XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165733; Warren CR, 2011, PLANT CELL ENVIRON, V34, P1609, DOI 10.1111/j.1365-3040.2011.02357.x; Wu ZZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18609-y; Yan BF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080770; Zivcak M, 2013, PHOTOSYNTH RES, V117, P529, DOI 10.1007/s11120-013-9885-3	72	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0243118	10.1371/journal.pone.0243118	http://dx.doi.org/10.1371/journal.pone.0243118			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019538	Green Published, gold			2022-12-26	WOS:000664632300002
J	Cresswell, P				Cresswell, Peter			CR3 ruffles Fc gamma R's claim over phagocytic cups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RECEPTORS	Phagocytosis plays diverse roles in biology, but our understanding of the purpose, interplay, and cell signaling mechanisms associated with different modes of phagocytosis is limited, without being able to capture and visualize each step in this rapid process from the beginning to end. A new study by Walbaum et al. uses stunning time-lapse 3D imaging of the engulfment of erythrocytes by macrophages via sinking, ruffling, and cup formation, unequivocally confirming a visionary 44-year-old theory derived from still electron microscopy photos that phagocytosis mediated by complement receptor CR3 occurs via a sinking mechanism and antibody-mediated phagocytosis occurs via phagocytic cup formation. The article also challenges the dogma, showing that phagocytic cup formation is not unique to antibody receptor phagocytosis, rather CR3 plays a complex role in different modes of phagocytosis. For example, inhibition of antibody-mediated phagocytosis leads to a compensatory upregulation of CR3-mediated sinking phagocytosis. These findings animate, in vivid colors, processes previously only captured as stills, exposing interactions between different phagocytic mechanisms and altering our basic understanding of this important process.	[Cresswell, Peter] Vet Greater Los Angeles HealthCare Syst, Geriatr Res Educ & Clin Ctr, Los Angeles, CA 90073 USA; [Cresswell, Peter] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Cresswell, Peter] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	Geriatric Research Education & Clinical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cresswell, P (corresponding author), Vet Greater Los Angeles HealthCare Syst, Geriatr Res Educ & Clin Ctr, Los Angeles, CA 90073 USA.; Cresswell, P (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.; Cresswell, P (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.				VA MERIT [BX003485, R01AGAG066212, AZ140160 W81XWH-15-1-0422]; Paul G Allen Foundation	VA MERIT(US Department of Veterans Affairs); Paul G Allen Foundation	VA MERIT BX003485, R01AGAG066212, AZ140160 W81XWH-15-1-0422 (DOD/CDMRP), Paul G Allen Foundation.	Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Griciuc A, 2021, CURR OPIN NEUROL, V34, P228, DOI 10.1097/WCO.0000000000000911; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Jaumouille V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01097; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; Ling GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4039; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Uribe-Querol E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01368; Walbaum S., 2021, J BIOL CHEM, V296	10	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100801	10.1016/j.jbc.2021.100801	http://dx.doi.org/10.1016/j.jbc.2021.100801			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019878	Green Published, gold			2022-12-26	WOS:000674717300021
J	Khater, M; Bryant, CN; Wu, GY				Khater, Mostafa; Bryant, Christian N.; Wu, Guangyu			G beta gamma translocation to the Golgi apparatus activates ARF1 to spatiotemporally regulate G protein-coupled receptor signaling to MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE SYNTHESIS; PHOSPHOLIPASE-D ACTIVATION; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ANGIOTENSIN-II; CHOLERA-TOXIN; GROWTH-FACTOR; CELL-SURFACE; KINASE	After activation of G protein-coupled receptors, G protein beta gamma dimers may translocate from the plasma membrane to the Golgi apparatus (GA). We recently report that this translocation activates extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) via PI3K gamma; however, how G beta gamma-PI3K gamma activates the ERK1/2 pathway is unclear. Here, we demonstrate that chemokine receptor CXCR4 activates ADP-ribosylation factor 1 (ARF1), a small GTPase important for vesicle-mediated membrane trafficking. This activation is blocked by CRISPR-Cas9-mediated knockout of the GA-translocating G gamma 9 subunit. Inducible targeting of different G beta gamma dimers to the GA can directly activate ARF1. CXCR4 activation and constitutive G beta gamma recruitment to the GA also enhance ARF1 translocation to the GA. We further demonstrate that pharmacological inhibition and CRISPR-Cas9-mediated knockout of PI3K gamma markedly inhibit CXCR4-mediated and G beta gamma translocation-mediated ARF1 activation. We also show that depletion of ARF1 by siRNA and CRISPR-Cas9 and inhibition of GA-localized ARF1 activation abolish ERK1/2 activation by CXCR4 and G beta gamma translocation to the GA and suppress prostate cancer PC3 cell migration and invasion. Collectively, our data reveal a novel function for G beta gamma translocation to the GA to activate ARF1 and identify GA-localized ARF1 as an effector acting downstream of G beta gamma-PI3K gamma to spatiotemporally regulate G protein-coupled receptor signaling to mitogen-activated protein kinases.	[Khater, Mostafa; Bryant, Christian N.; Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Wu, GY (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@augusta.edu		Bryant, Christian/0000-0002-3379-5837; Khater, Mostafa/0000-0001-7080-6534	National Institute of General Medical Sciences of the National Institutes of Health [R35GM136397, R01GM118915]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers R35GM136397 and R01GM118915 (to G. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Boal F, 2010, TRAFFIC, V11, P1537, DOI 10.1111/j.1600-0854.2010.01122.x; Boulay PL, 2011, ONCOGENE, V30, P3846, DOI 10.1038/onc.2011.100; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Casalou C, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00217; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davis JE, 2016, ONCOTARGET, V7, P39834, DOI 10.18632/oncotarget.9405; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Haines E, 2014, J BIOL CHEM, V289, P5687, DOI 10.1074/jbc.M113.516047; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jensen DD, 2016, J BIOL CHEM, V291, P11285, DOI 10.1074/jbc.M115.710681; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Karnam P, 1997, J BIOL CHEM, V272, P6136, DOI 10.1074/jbc.272.10.6136; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Klayman LM, 2017, J BIOL CHEM, V292, P1773, DOI 10.1074/jbc.M116.750430; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Lewis-Saravalli S, 2013, CELL SIGNAL, V25, P1813, DOI 10.1016/j.cellsig.2013.05.011; Li CM, 2017, CELL REP, V21, P1089, DOI 10.1016/j.celrep.2017.10.011; Li CM, 2012, J BIOL CHEM, V287, P42784, DOI 10.1074/jbc.M112.410936; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Madukwe JC, 2018, J BIOL CHEM, V293, P6387, DOI 10.1074/jbc.RA118.002354; Malik S, 2015, MOL BIOL CELL, V26, P1188, DOI 10.1091/mbc.E14-10-1476; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Mazaki Y, 2012, MOL BIOL CELL, V23, P2457, DOI 10.1091/mbc.E12-01-0062; McCulloch DA, 2001, MOL PHARMACOL, V59, P1523, DOI 10.1124/mol.59.6.1523; Mitchell R, 2003, J BIOL CHEM, V278, P33818, DOI 10.1074/jbc.M305825200; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; O'Neill PR, 2012, P NATL ACAD SCI USA, V109, pE3568, DOI 10.1073/pnas.1205345109; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Schlienger S, 2014, MOL BIOL CELL, V25, P17, DOI 10.1091/mbc.E13-06-0335; Senarath K, 2018, J BIOL CHEM, V293, P2974, DOI 10.1074/jbc.RA117.000872; Shome K, 2000, ENDOCRINOLOGY, V141, P2200, DOI 10.1210/en.141.6.2200; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Taichman RS, 2002, CANCER RES, V62, P1832; Vasudevan C, 1998, J CELL SCI, V111, P1277; Wei Z., 2021, J BIOL CHEM, V296; Wei Z, 2019, CELL REP, V28, P554, DOI 10.1016/j.celrep.2019.05.033; Weis WI, 2018, ANNU REV BIOCHEM, V87, P897, DOI 10.1146/annurev-biochem-060614-033910; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; ZHANG GF, 1995, J BIOL CHEM, V270, P21, DOI 10.1074/jbc.270.1.21; Zhou FG, 2015, CELL SIGNAL, V27, P2035, DOI 10.1016/j.cellsig.2015.06.007	56	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100805	10.1016/j.jbc.2021.100805	http://dx.doi.org/10.1016/j.jbc.2021.100805			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022220	Green Published, gold			2022-12-26	WOS:000674717300023
J	Rummun, N; Serag, A; Rondeau, P; Ramsaha, S; Bourdon, E; Bahorun, T; Farag, MA; Neergheen, VS				Rummun, Nawraj; Serag, Ahmed; Rondeau, Philippe; Ramsaha, Srishti; Bourdon, Emmanuel; Bahorun, Theeshan; Farag, Mohamed A.; Neergheen, Vidushi S.			Antiproliferative activity of Syzygium coriaceum, an endemic plant of Mauritius, with its UPLC-MS metabolite fingerprint: A mechanistic study	PLOS ONE			English	Article							APOPTOTIC INDUCTION; MASS-SPECTROMETRY; PHENOLIC CONTENTS; ANTIOXIDANT; EXTRACT; CELLS; CLASSIFICATION; MYRTACEAE; ARREST	Flowering plants from the Syzygium genus have long been used in different ethnomedicinal systems worldwide and have been under scrutiny for their biological activities. Syzygium coriaceum, an endemic plant of Mauritius has been poorly studied for its potential application against cancer. Herein, Syzygium coriaceum leaf extract has been investigated for its anticancer effect against hepatocellular carcinoma (HepG2) cells. The anticancer activity was assessed using cell proliferation assays, flow cytometry, JC-1 mitochondrial membrane potential assay, and the COMET assay. Un-targeted metabolite profiling via ultra-performance liquid chromatography coupled to high-resolution qTOF-MS (UPLC-MS) and aided by molecular networking was employed to identify the crude extract metabolites. S. coriaceum treatment induced a dose-dependent increase in lactate dehydrogenase leakage into the culture media, peaking up to 47% (p <= 0.0001), compared to untreated control. Moreover, at 40 mu g/mL, S. coriaceum led to 88.1% (p <= 0.0001) drop in mitochondrial membrane potential and 5.7% (p <= 0.001) increased in the number of the cell population in G0/G1 phase as well as increased (p < 0.05) the proportion of cells undergoing apoptotic/necrotic cell death. More so, at 10 mu g/mL, S. coriaceum induced DNA damage which was 19 folds (p < 0.001) higher than that of untreated control cells. Metabolite profiling indicated the presence of 65 metabolites, out of which 59 were identified. Tannins, flavonoids, nitrogenous compounds, and organic acids were the most predominant classes of compounds detected. Our findings showed that the presence of tannins and flavonoids in S. coriaceum leaf extract could account for the multiple mechanisms of actions underlying the antiproliferative effect against HepG2 cells.	[Rummun, Nawraj; Ramsaha, Srishti] Univ Mauritius, Fac Med & Hlth Sci, Dept Hlth Sci, Reduit, Mauritius; [Rummun, Nawraj; Ramsaha, Srishti; Bahorun, Theeshan; Neergheen, Vidushi S.] Univ Mauritius, Ctr Biomed & Biomat Res, Biopharmaceut Unit, MSIRI Bldg, Reduit, Mauritius; [Serag, Ahmed] Al Azhar Univ, Fac Pharm, Analyt Chem Dept, Cairo, Egypt; [Rondeau, Philippe; Bourdon, Emmanuel] Univ La Reunion, UMR 1188 Diabet Atherothrombose Therapies Reunion, INSERM, St Denis De La Reunion, France; [Farag, Mohamed A.] Cairo Univ, Coll Pharm, Pharmacognosy Dept, Kasr el Aini St, Cairo, Egypt; [Farag, Mohamed A.] Amer Univ Cairo, Sch Sci & Engn, Chem Dept, New Cairo, Egypt	University of Mauritius; University of Mauritius; Egyptian Knowledge Bank (EKB); Al Azhar University; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); American University Cairo	Neergheen, VS (corresponding author), Univ Mauritius, Ctr Biomed & Biomat Res, Biopharmaceut Unit, MSIRI Bldg, Reduit, Mauritius.; Farag, MA (corresponding author), Cairo Univ, Coll Pharm, Pharmacognosy Dept, Kasr el Aini St, Cairo, Egypt.; Farag, MA (corresponding author), Amer Univ Cairo, Sch Sci & Engn, Chem Dept, New Cairo, Egypt.	mohamed.alifarag@aucegypt.edu; v.neergheen@uom.ac.mu	Serag, Ahmed/O-1836-2019	Serag, Ahmed/0000-0003-1559-8079	Mauritius Research and Innovation Council under the National Research and Innovation Chair Program; Alexander von Humboldt Foundation, Germany	Mauritius Research and Innovation Council under the National Research and Innovation Chair Program; Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	This study was supported by the Mauritius Research and Innovation Council under the National Research and Innovation Chair Program studentship awarded to NR. MAF acknowledges the financial support received from the Alexander von Humboldt Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dabbagh B, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2285-7; Augustine D, 2019, TOXICOL REP, V6, P347, DOI 10.1016/j.toxrep.2019.04.005; Benhusein GM, 2010, LIBYAN J MED, V5, DOI 10.3402/ljm.v5i0.4637; Byng JW, 2015, PHYTOKEYS, V46, P61, DOI 10.3897/phytokeys.46.9039; Catan A, 2019, ATHEROSCLEROSIS, V291, P87, DOI 10.1016/j.atherosclerosis.2019.10.015; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Choi MK, 2020, J PHARM INVEST, V50, P295, DOI 10.1007/s40005-020-00475-y; Chua LK, 2019, PLANT FOOD HUM NUTR, V74, P18, DOI 10.1007/s11130-018-0704-z; Elkady AI, 2017, J BIOMATER TISS ENG, V7, P1235, DOI 10.1166/jbt.2017.1695; Farag MA, 2016, J PHARMACEUT BIOMED, V125, P292, DOI 10.1016/j.jpba.2016.03.037; Farag MA, 2015, PHYTOCHEMISTRY, V119, P41, DOI 10.1016/j.phytochem.2015.09.004; Inbathamizh L., 2017, ASIAN J PHARM CLIN R, V6, P106; Jugreet BS, 2021, CHEM BIODIVERS, V18, DOI 10.1002/cbdv.202000921; Kwan YP, 2016, PHARM BIOL, V54, P1223, DOI 10.3109/13880209.2015.1064451; Lee SY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3537471; Li J, 2019, FOOD AGR IMMUNOL, V30, P898, DOI 10.1080/09540105.2019.1642857; Mahassni SH, 2013, SAUDI J BIOL SCI, V20, P131, DOI 10.1016/j.sjbs.2012.12.002; Mahomoodally MF, 2020, IND CROP PROD, V143, DOI 10.1016/j.indcrop.2019.111948; Menyhart O, 2016, BBA-REV CANCER, V1866, P300, DOI 10.1016/j.bbcan.2016.10.002; Mery Benoite, 2017, J Cell Death, V10, p1179670717691251, DOI 10.1177/1179670717691251; Miyaji CK, 2004, GENET MOL BIOL, V27, P108, DOI 10.1590/S1415-47572004000100018; Moreira H, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6793957; Nagano T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31758; Neergheen V., 2011, U MAURITIUS RES J, V17; Neergheen VS, 2007, PHARM BIOL, V45, P9, DOI 10.1080/13880200601026242; Neergheen VS, 2006, J PLANT PHYSIOL, V163, P787, DOI 10.1016/j.jplph.2005.09.009; Ramlagan P, 2017, FOOD FUNCT, V8, P4194, DOI [10.1039/c7fo01038a, 10.1039/C7FO01038A]; Ramos AEF, 2019, NAT PROD REP, V36, P960, DOI 10.1039/c9np00006b; Ranzato E., 2014, Journal of Food Research, V3, P18; Rocchetti G, 2019, FOOD RES INT, V126, DOI 10.1016/j.foodres.2019.108715; Rummun N, 2021, S AFR J BOT, V137, P149, DOI 10.1016/j.sajb.2020.10.014; Rummun N, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13100303; Rummun N, 2018, J ETHNOPHARMACOL, V213, P111, DOI 10.1016/j.jep.2017.10.006; Rummun Nawraj, 2013, Int J Food Sci, V2013, P602312, DOI 10.1155/2013/602312; Salem MA, 2020, METABOLITES, V10, DOI 10.3390/metabo10010037; Serag A, 2020, RSC ADV, V10, P76, DOI 10.1039/c9ra07841j; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sobeh M, 2018, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2018.00566; Sobeh M, 2018, J FUNCT FOODS, V41, P223, DOI 10.1016/j.jff.2017.12.055; Sobeh M, 2018, FOOD CHEM TOXICOL, V113, P145, DOI 10.1016/j.fct.2018.01.031; Toyokuni S, 2003, FREE RADICAL RES, V37, P1215, DOI 10.1080/10715760310001598150; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Wen XY, 2009, PHYTOTHER RES, V23, P778, DOI 10.1002/ptr.2616; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Willis KJ, 2017, STATE WORLDS PLANTS; Yeh RD, 2011, ANTICANCER RES, V31, P2821; Yurdakok B, 2013, PHARM BIOL, V51, P1579, DOI 10.3109/13880209.2013.803208	47	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252276	10.1371/journal.pone.0252276	http://dx.doi.org/10.1371/journal.pone.0252276			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061874	Green Published, gold			2022-12-26	WOS:000656813600052
J	Bocharova, O; Pandit, NP; Molesworth, K; Fisher, A; Mychko, O; Makarava, N; Baskakov, IV				Bocharova, Olga; Pandit, Narayan P.; Molesworth, Kara; Fisher, Aidan; Mychko, Olga; Makarava, Natallia; Baskakov, Ilia, V			Alzheimer's disease-associated beta-amyloid does not protect against herpes simplex virus 1 infection in the mouse brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDIA-PNEUMONIAE; MICROGLIA; TYPE-1; COLOCALIZATION; ACTIVATION; RECEPTORS; NEURONS; MICE	Alzheimer's disease (AD) is a devastating fatal neurodegenerative disease. An alternative to the amyloid cascade hypothesis is that a viral infection is key to the etiology of late-onset AD, with beta-amyloid (A beta) peptides playing a protective role. In the current study, young 5XFAD mice that overexpress mutant human amyloid precursor protein with the Swedish, Florida, and London familial AD mutations were infected with one of two strains of herpes simplex virus 1 (HSV-1), 17syn+ and McKrae, at three different doses. Contrary to previous work, 5XFAD genotype failed to protect mice against HSV-1 infection. The region- and cell-specific tropisms of HSV-1 were not affected by the 5XFAD genotype, indicating that host-pathogen interactions were not altered. Seven- to ten-month-old 5XFAD animals in which extracellular A beta aggregates were abundant showed slightly better survival rate relative to their wild-type (WT) littermates, although the difference was not statistically significant. In these 5XFAD mice, HSV-1 replication centers were partially excluded from the brain areas with high densities of A beta aggregates. A beta aggregates were free of HSV-1 viral particles, and the limited viral invasion to areas with a high density of A beta aggregates was attributed to phagocytic activity of reactive microglia. In the oldest mice (12-15 months old), the survival rate did not differ between 5XFAD and WT littermates. While the current study questions the antiviral role of A beta, it neither supports nor refutes the viral etiology hypothesis of late-onset AD.	[Bocharova, Olga; Pandit, Narayan P.; Molesworth, Kara; Fisher, Aidan; Mychko, Olga; Makarava, Natallia; Baskakov, Ilia, V] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Bocharova, Olga; Pandit, Narayan P.; Molesworth, Kara; Fisher, Aidan; Mychko, Olga; Makarava, Natallia; Baskakov, Ilia, V] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.; Baskakov, IV (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	Baskakov@som.umaryland.edu	Bocharova, Olga V./J-8284-2018	Bocharova, Olga V./0000-0002-5056-1506; Fisher, Aidan/0000-0002-5706-537X	NIH [R01 NS045585]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the NIH Supplemental award for R01 NS045585 to I. V. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allnutt MA, 2020, NEURON, V105, P1027, DOI 10.1016/j.neuron.2019.12.031; Baik SH, 2016, GLIA, V64, P2274, DOI 10.1002/glia.23074; Bello-Morales R, 2018, J VIROL, V92, DOI 10.1128/JVI.00088-18; Braun E, 2006, J GEN VIROL, V87, P2827, DOI 10.1099/vir.0.81850-0; Cairns DM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay8828; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cymerys J, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2302835; De Chiara G, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007617; De Chiara G, 2012, MOL NEUROBIOL, V46, P614, DOI 10.1007/s12035-012-8320-7; Drayman N, 2019, ELIFE, V8, DOI 10.7554/eLife.46339; Duarte LF, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00046; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030; Ezzat K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10192-2; Fekete R, 2018, ACTA NEUROPATHOL, V136, P461, DOI 10.1007/s00401-018-1885-0; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Gerard HC, 2005, MICROB PATHOGENESIS, V39, P19, DOI 10.1016/j.micpath.2005.05.002; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hammond CJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-121; Harris SA, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00048; Hatton CF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02656; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hidetoshi T.-S., 2012, WIRES MEMBR TRANSP S, V1, P493, DOI [10.1002/wmts.46, DOI 10.1002/WMTS.46]; Hogestyn JM, 2018, NEURAL REGEN RES, V13, P211, DOI 10.4103/1673-5374.226380; Huang YT, 2021, NAT IMMUNOL, V22, P586, DOI 10.1038/s41590-021-00913-5; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Itzhaki RF, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00324; Janda E, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00144; Jeong HH, 2019, NEURON, V104, P1034, DOI 10.1016/j.neuron.2019.11.009; Kollias CM, 2015, J NEUROVIROL, V21, P8, DOI 10.1007/s13365-014-0302-2; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Little CS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00304; Little CS, 2004, NEUROBIOL AGING, V25, P419, DOI 10.1016/S0197-4580(03)00127-1; Makarava N, 2020, NEUROBIOL DIS, V137, DOI 10.1016/j.nbd.2020.104783; Miklossy J, 2006, NEUROBIOL AGING, V27, P228, DOI 10.1016/j.neurobiolaging.2005.01.018; Miklossy J, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00046; Moir RD, 2018, ALZHEIMERS DEMENT, V14, P1602, DOI 10.1016/j.jalz.2018.06.3040; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Piacentini R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00097; Readhead B, 2018, NEURON, V99, P64, DOI 10.1016/j.neuron.2018.05.023; Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Sawtell NM, 1998, J VIROL, V72, P5343, DOI 10.1128/JVI.72.7.5343-5350.1998; SAWTELL NM, 1992, J VIROL, V66, P2150, DOI 10.1128/JVI.66.4.2150-2156.1992; Spangenberg E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11674-z; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Theriault P, 2016, CURR BIOL, V26, pR772, DOI 10.1016/j.cub.2016.06.066; Tsai MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188490; Villalba M, 2012, MED MICROBIOL IMMUN, V201, P371, DOI 10.1007/s00430-012-0247-0; Wang H, 2013, VIRUS RES, V173, P436, DOI 10.1016/j.virusres.2013.01.001; Webre JM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/612316; Yanguas-Casas N, 2020, AGING CELL, V19, DOI 10.1111/acel.13182	55	12	12	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100845	10.1016/j.jbc.2021.100845	http://dx.doi.org/10.1016/j.jbc.2021.100845			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34052228	gold, Green Published, Green Submitted			2022-12-26	WOS:000678068400045
J	Cho, Y; Tachibana, S; Lam, K; Arita, Y; Khosrowjerdi, S; Zhang, O; Liang, AL; Li, RX; Andreyev, A; Murphy, AN; Ross, RS				Cho, Yoshitake; Tachibana, Shizuko; Lam, Kayla; Arita, Yoh; Khosrowjerdi, Shamim; Zhang, Oliver; Liang, Alex; Li, Ruixia; Andreyev, Aleksander; Murphy, Anne N.; Ross, Robert S.			Perm1 promotes cardiomyocyte mitochondrial biogenesis and protects against hypoxia/reoxygenation-induced damage in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE CAPACITY; DILATED CARDIOMYOPATHY; HEART-FAILURE; ERR-ALPHA; METABOLISM; COACTIVATOR; TRANSCRIPTION; HYPERTROPHY; TRANSLATION; GENE	Normal contractile function of the heart depends on a constant and reliable production of ATP by cardiomyocytes. Dysregulation of cardiac energy metabolism can result in immature heart development and disrupt the ability of the adult myocardium to adapt to stress, potentially leading to heart failure. Further, restoration of abnormal mitochondrial function can have beneficial effects on cardiac dysfunction. Previously, we identified a novel protein termed Perm1 (PGC- 1 and estrogen-related receptor (ERR)-induced regulator, muscle 1) that is enriched in skeletal and cardiac-muscle mitochondria and transcriptionally regulated by PGC-1 (peroxisome proliferator-activated receptor gamma coactivator 1) and ERR. The role of Perm1 in the heart is poorly understood and is studied here. We utilized cell culture, mouse models, and human tissue, to study its expression and transcriptional control, as well as its role in transcription of other factors. Critically, we tested Perm1's role in cardiomyocyte mitochondrial function and its ability to protect myocytes from stress-induced damage. Our studies show that Perm1 expression increases throughout mouse cardiogenesis, demonstrate that Perm1 interacts with PGC- 1a and enhances activation of PGC-1 and ERR, increases mitochondrial DNA copy number, and augments oxidative capacity in cultured neonatal mouse cardiomyocytes. Moreover, we found that Perm1 reduced cellular damage produced as a result of hypoxia and reoxygenation-induced stress and mitigated cell death of cardiomyocytes. Taken together, our results show that Perm1 promotes mitochondrial biogenesis in mouse cardiomyocytes. Future studies can assess the potential of Perm1 to be used as a novel therapeutic to restore cardiac dysfunction induced by ischemic injury.	[Cho, Yoshitake; Tachibana, Shizuko; Lam, Kayla; Khosrowjerdi, Shamim; Zhang, Oliver; Liang, Alex; Li, Ruixia; Andreyev, Aleksander; Ross, Robert S.] Univ Calif San Diego, Dept Med, Div Cardiovasc Med, La Jolla, CA 92093 USA; [Cho, Yoshitake; Liang, Alex; Li, Ruixia; Ross, Robert S.] Vet Adm Healthcare, Dept Med Cardiol, San Diego, CA 92161 USA; [Arita, Yoh; Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Murphy, Anne N.] Cytokinetics Inc, San Francisco, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Cho, Y (corresponding author), Univ Calif San Diego, Dept Med, Div Cardiovasc Med, La Jolla, CA 92093 USA.; Cho, Y (corresponding author), Vet Adm Healthcare, Dept Med Cardiol, San Diego, CA 92161 USA.	cyoshitake@health.ucsd.edu		Andreyev, Alexander Y./0000-0002-9246-9943; Zhang, Oliver/0000-0001-9710-9843; Ross, Robert/0000-0003-2195-8982	NHLBI, National Institute of Health (NIH) [R01HL151239]; Veterans Administration [I01 BX004897]; Tobacco-Related Disease Research Program (TRDRP) [T31IP1606]	NHLBI, National Institute of Health (NIH); Veterans Administration(US Department of Veterans Affairs); Tobacco-Related Disease Research Program (TRDRP)(University of California System)	This work is supported by NHLBI, National Institute of Health (NIH) Grant R01HL151239 (to Y. C. and R. S. R.). R. S. R was also funded by the Veterans Administration (I01 BX004897), and Y. C. was also funded by Tobacco-Related Disease Research Program (TRDRP) T31IP1606. The content is solely the responsibility of the authors and does not represent official views of the National Institute of Health.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Aravamudhan S, 2021, J MOL CELL CARDIOL, V154, P41, DOI 10.1016/j.yjmcc.2021.01.010; Arita Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5552; Camara AKS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00013; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Cho Y, 2019, MOL METAB, V23, P88, DOI 10.1016/j.molmet.2019.02.009; Cho Y, 2016, FASEB J, V30, P674, DOI 10.1096/fj.15-276360; Cho Y, 2013, J BIOL CHEM, V288, P25207, DOI 10.1074/jbc.M113.489674; Cho Y, 2009, MOL PHARMACOL, V76, P1360, DOI 10.1124/mol.109.057000; Deacon DC, 2019, NAT BIOMED ENG, V3, P147, DOI 10.1038/s41551-019-0348-9; Gantner ML, 2014, P NATL ACAD SCI USA, V111, P11870, DOI 10.1073/pnas.1406638111; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Ghosh S, 2019, IUBMB LIFE, V71, P791, DOI 10.1002/iub.2018; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Ikeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119687; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; LIU CC, 1984, NATURE, V309, P82, DOI 10.1038/309082a0; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Manso AM, 2013, J BIOL CHEM, V288, P4252, DOI 10.1074/jbc.M112.427484; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Mettauer B, 2006, PFLUG ARCH EUR J PHY, V452, P653, DOI 10.1007/s00424-006-0072-7; Oka S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234913; Papadopoulou-Legbelou K, 2017, INDIAN PEDIATR, V54, P667, DOI 10.1007/s13312-017-1131-1; Paradies G, 2018, AM J PHYSIOL-HEART C, V315, pH1341, DOI 10.1152/ajpheart.00028.2018; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Piquereau J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00959; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rose AJ, 2003, J PHYSIOL-LONDON, V553, P303, DOI 10.1113/jphysiol.2003.054171; Sharov VG, 1998, J MOL CELL CARDIOL, V30, P1757, DOI 10.1006/jmcc.1998.0739; Sharov VG, 2000, J MOL CELL CARDIOL, V32, P2361, DOI 10.1006/jmcc.2000.1266; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Tachibana S, 2019, JOVE-J VIS EXP, DOI 10.3791/59052; Taegtmeyer H, 2016, CIRC RES, V118, P1659, DOI 10.1161/RES.0000000000000097; de Carvalho AETS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15656-3; Vasquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wende AR, 2017, AM J PHYSIOL-HEART C, V313, pH1098, DOI 10.1152/ajpheart.00101.2017; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Yeh CH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000508; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849	62	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100825	10.1016/j.jbc.2021.100825	http://dx.doi.org/10.1016/j.jbc.2021.100825			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029594	Green Published, gold			2022-12-26	WOS:000678068400027
J	Guo, CX; Fordjour, FK; Tsai, SJ; Morrell, JC; Gould, SJ				Guo, Chenxu; Fordjour, Francis K.; Tsai, Shang Jui; Morrell, James C.; Gould, Stephen J.			Choice of selectable marker affects recombinant protein expression in cells and exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENE EXPRESSION; LENTIVIRAL VECTORS; SLEEPING-BEAUTY; GENE; RESISTANCE; ENHANCER; CLONING; VIRUS; ELEMENT	Transgenic mammalian cells are used for numerous research, pharmaceutical, industrial, and clinical purposes, and dominant selectable markers are often used to enable the selection of transgenic cell lines. Using HEK293 cells, we show here that the choice of selectable marker gene has a significant impact on both the level of recombinant protein expression and the cell-to-cell variability in recombinant protein expression. Specifically, we observed that cell lines generated with the NeoR or BsdR selectable markers and selected in the antibiotics G418 or blasticidin, respectively, displayed the lowest level of recombinant protein expression as well as the greatest cell-to-cell variability in transgene expression. In contrast, cell lines generated with the BleoR marker and selected in zeocin yielded cell lines that expressed the highest levels of linked recombinant protein, approximately 10-fold higher than those selected using the NeoR or BsdR markers, as well as the lowest cell-tocell variability in recombinant protein expression. Intermediate yet still-high levels of expression were observed in cells generated with the PuroR- or HygR-based vectors and that were selected in puromycin or hygromycin, respectively. Similar results were observed in the African green monkey cell line COS7. These data indicate that each combination of selectable marker and antibiotic establishes a threshold below which no cell can survive and that these thresholds vary significantly between different selectable markers. Moreover, we show that choice of selectable marker also affects recombinant protein expression in cell-derived exosomes, consistent with the hypothesis that exosome protein budding is a stochastic rather than determinative process.	[Guo, Chenxu; Fordjour, Francis K.; Tsai, Shang Jui; Morrell, James C.; Gould, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	sgould@jhmi.edu		Guo, Chenxu/0000-0002-9651-4203; Tsai, Shang-Jui/0000-0002-9602-2823	National Institutes of Health [5U19CA179563]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Gould lab and the Department of Biological Chemistry for their suggestions during the course of this study and particularly Dr Michael Caterina. We thank Zhaolin Chen and Yiyan Lin for expert technical assistance, Hao Zhang for flow cytometric analysis, and Nazar Filonov and Nadia Filonov for assistance with NTA analysis. This work was supported, in part, by the National Institutes of Health (grant number 5U19CA179563). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachurski D, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1596016; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; CANAANI D, 1982, P NATL ACAD SCI-BIOL, V79, P5166, DOI 10.1073/pnas.79.17.5166; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fonseca JP, 2019, ACS SYNTH BIOL, V8, P2593, DOI 10.1021/acssynbio.9b00322; Gaspar V, 2015, EXPERT OPIN BIOL TH, V15, P353, DOI 10.1517/14712598.2015.996544; GATIGNOL A, 1988, FEBS LETT, V230, P171, DOI 10.1016/0014-5793(88)80665-3; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GRUSS P, 1979, P NATL ACAD SCI USA, V76, P4317, DOI 10.1073/pnas.76.9.4317; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; HUMPHRIES RK, 1982, CELL, V30, P173; Hunter Molly, 2019, Curr Protoc Protein Sci, V95, pe77, DOI 10.1002/cpps.77; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; JOYNER A, 1982, P NATL ACAD SCI-BIOL, V79, P1573, DOI 10.1073/pnas.79.5.1573; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KASTER KR, 1983, NUCLEIC ACIDS RES, V11, P6895, DOI 10.1093/nar/11.19.6895; KIMURA M, 1994, MOL GEN GENET, V242, P121, DOI 10.1007/BF00391004; Li MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4031; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; MULSANT P, 1988, SOMAT CELL MOLEC GEN, V14, P243, DOI 10.1007/BF01534585; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Pegtel DM, 2019, ANNU REV BIOCHEM, V88, P487, DOI 10.1146/annurev-biochem-013118-111902; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Stokowa-Soltys K, 2019, J INORG BIOCHEM, V195, P71, DOI 10.1016/j.jinorgbio.2019.03.010; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Tipanee J, 2017, HUM GENE THER, V28, P1087, DOI 10.1089/hum.2017.128; Trastoy MO, 2005, MUTAGENESIS, V20, P111, DOI 10.1093/mutage/gei016; Turan S, 2013, GENE, V515, P1, DOI 10.1016/j.gene.2012.11.016; VARA J, 1985, GENE, V33, P197, DOI 10.1016/0378-1119(85)90094-0; Vernia M, 2003, ANN NY ACAD SCI, V983, P170, DOI 10.1111/j.1749-6632.2003.tb05972.x; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814	42	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100838	10.1016/j.jbc.2021.100838	http://dx.doi.org/10.1016/j.jbc.2021.100838			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051235	Green Published, gold			2022-12-26	WOS:000678068400038
J	Larson-Casey, JL; Gu, LL; Kang, J; Dhyani, A; Carter, AB				Larson-Casey, Jennifer L.; Gu, Linlin; Kang, Jungsoon; Dhyani, Ashish; Carter, A. Brent			NOX4 regulates macrophage apoptosis resistance to induce fibrotic progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY-FIBROSIS; NADPH OXIDASE; ALTERNATIVE ACTIVATION; LUNG FIBROBLASTS; EXPRESSION; MICE; INHIBITION; SURVIVAL; STRESS; CELLS	Pulmonary fibrosis is a progressive lung disease often occurring secondary to environmental exposure. Asbestos exposure is an important environmental mediator of lung fibrosis and remains a significant cause of disease despite strict regulations to limit exposure. Lung macrophages play an integral role in the pathogenesis of fibrosis induced by asbestos (asbestosis), in part by generating reactive oxygen species (ROS) and promoting resistance to apoptosis. However, the mechanism by which macrophages acquire apoptosis resistance is not known. Here, we confirm that macrophages isolated from asbestosis subjects are resistant to apoptosis and show they are associated with enhanced mitochondrial content of NADPH oxidase 4 (NOX4), which generates mitochondrial ROS generation. Similar results were seen in chrysotile-exposed WT mice, while macrophages from Nox4(-/-) mice showed increased apoptosis. NOX4 regulated apoptosis resistance by activating Akt1-mediated Bcl-2-associated death phosphorylation. Demonstrating the importance of NOX4-mediated apoptosis resistance in fibrotic remodeling, mice harboring a conditional deletion of Nox4 in monocyte-derived macrophages exhibited increased apoptosis and were protected from pulmonary fibrosis. Moreover, resolution occurred when Nox4 was deleted in monocyte-derived macrophages in mice with established fibrosis. These observations suggest that NOX4 regulates apoptosis resistance in monocyte-derived macrophages and contributes to the pathogenesis of pulmonary fibrosis. Targeting NOX4-mediated apoptosis resistance in monocyte-derived macrophages may provide a novel therapeutic target to protect against the development and/or progression of pulmonary fibrosis.	[Larson-Casey, Jennifer L.; Gu, Linlin; Kang, Jungsoon; Dhyani, Ashish; Carter, A. Brent] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Carter, A. Brent] Birmingham Vet Adm Med Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.; Carter, AB (corresponding author), Birmingham Vet Adm Med Ctr, Birmingham, AL 35233 USA.	bcarter1@uab.edu		Carter, A. Brent/0000-0001-6002-4715; Larson-Casey, Jennifer L./0000-0001-7238-7986	National Institutes of Health [2R01 ES015981-13, P42 ES027723-2]; Department of Veteran Affairs Merit Review [1 I01 CX001715-2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs Merit Review(US Department of Veterans Affairs)	Research reported in this publication was supported by the National Institutes of Health grants 2R01 ES015981-13 and P42 ES027723-2 and Department of Veteran Affairs Merit Review 1 I01 CX001715-2 to A. B. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attfield M. D., 2004, Morbidity and Mortality Weekly Report, V53, P627; Bernard K, 2017, J BIOL CHEM, V292, P3029, DOI 10.1074/jbc.M116.752261; Campa CC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07698-6; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Gu LL, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101307; Guidotti TL, 2004, AM J RESP CRIT CARE, V170, P691, DOI 10.1164/rccm.200310-1436ST; Hagimoto N, 1997, AM J RESP CELL MOL, V17, P272, DOI 10.1165/ajrcmb.17.3.2893; HAMILTON RF, 1995, AM J PHYSIOL-LUNG C, V269, pL318, DOI 10.1152/ajplung.1995.269.3.L318; He C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126551; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Jacobsen K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00450-6; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Larson-Casey JL, 2019, J CLIN INVEST, V129, P4962, DOI [10.1172/JCl127959, 10.1172/JCI127959]; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Larson-Casey JL, 2014, J BIOL CHEM, V289, P36204, DOI 10.1074/jbc.M114.593285; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; McCubbrey AL, 2018, AM J RESP CELL MOL, V58, P66, DOI 10.1165/rcmb.2017-0154OC; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Palmieri M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14338; Plataki M, 2005, CHEST, V127, P266, DOI 10.1378/chest.127.1.266; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Sancho P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045285; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Spadoni T, 2015, ARTHRITIS RHEUMATOL, V67, P1611, DOI 10.1002/art.39084; Tanaka T, 2002, EUR RESPIR J, V20, P359, DOI 10.1183/09031936.02.00252602; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Wang LY, 2006, AM J PHYSIOL-LUNG C, V290, pL695, DOI 10.1152/ajplung.00245.2005; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.551; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang M, 2020, THORAX, V75, P798, DOI 10.1136/thoraxjnl-2020-214822; Zhao QD, 2015, CIRCULATION, V131, P643, DOI 10.1161/CIRCULATIONAHA.114.011079; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	47	4	4	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100810	10.1016/j.jbc.2021.100810	http://dx.doi.org/10.1016/j.jbc.2021.100810			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023385	gold, Green Published			2022-12-26	WOS:000678068400013
J	Sugiyama, T; Sugiyama, M; Mavoa, S; Barnett, A; Kamruzzaman, M; Turrell, G				Sugiyama, Takemi; Sugiyama, Masaaki; Mavoa, Suzanne; Barnett, Anthony; Kamruzzaman, Md.; Turrell, Gavin			Neighborhood environmental attributes and walking mobility decline: A longitudinal ecological study of mid-to-older aged Australian adults	PLOS ONE			English	Article							BUILT ENVIRONMENT; PHYSICAL-ACTIVITY; FUNCTIONAL LIMITATIONS; HEALTH; CONTEXT; ONSET	Objectives Cross-sectional studies have found some built environmental attributes to be associated with residents' lower levels of mobility (functional capacity to walk outside the home). However, less is known about what environmental attributes are related to mobility decline. This longitudinal study examined area-level associations of specific environmental attributes with mid-to-older aged adults' changes in walking mobility. Methods Data collected from 4,088 adults (aged 46-71 years at baseline) who participated in a cohort study in Brisbane, Australia were used. The outcome was the change in self-reported mobility score (SF-36) from 2013 to 2016, which were aggregated at the neighborhood (N = 156) and suburb (N = 99) levels, due to the known lack of sensitivity in SF-36 subscales to individual changes. Linear regression analysis examined associations of mobility change with seven environmental attributes measured at baseline (residential density, intersection density, land use mix, density of walking/bike paths, park density, bus stop density, density of social incivilities), adjusting for confounding variables. Results Participants on average reported 4% of mobility decline during the 3-year study period. It was found that greater land use diversity was consistently associated with less decline in walking mobility, while greater density of social incivilities was associated with more decline in walking mobility. The latter finding was significant only at the neighborhood level. No consistent associations were observed for residential density, intersection density, density of walking/bike paths, park density, and bus stop density. Discussion Our findings suggest that mid-to-older aged adults who live in areas with lower land use diversity and more social incivilities may be at risk of developing mobility limitations. Recommended policies to slow residents' mobility decline and to achieve aging in place include improving these environmental attributes where needed and advising older adults to relocate to safer, mixed-use neighborhoods.	[Sugiyama, Takemi] Swinburne Univ Technol, Ctr Urban Transit, Hawthorn, Vic, Australia; [Sugiyama, Takemi; Sugiyama, Masaaki; Mavoa, Suzanne; Barnett, Anthony] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Sugiyama, Takemi] Baker Heart & Diabet Inst, Melbourne, Vic, Australia; [Sugiyama, Masaaki] Osaka City Univ, Grad Sch Human Life Sci, Osaka, Japan; [Mavoa, Suzanne] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Kamruzzaman, Md.] Monash Univ, Monash Urban Planning & Design, Caulfield, Vic, Australia; [Turrell, Gavin] Univ Canberra, Hlth Res Inst, Ctr Res & Act Publ Hlth, Canberra, ACT, Australia	Swinburne University of Technology; Australian Catholic University; Baker Heart and Diabetes Institute; Osaka Metropolitan University; University of Melbourne; Monash University; University of Canberra	Sugiyama, T (corresponding author), Swinburne Univ Technol, Ctr Urban Transit, Hawthorn, Vic, Australia.; Sugiyama, T (corresponding author), Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia.; Sugiyama, T (corresponding author), Baker Heart & Diabet Inst, Melbourne, Vic, Australia.	tsugiyama@swin.edu.au	; Sugiyama, Takemi/F-4013-2013	Turrell, Gavin/0000-0002-3576-8744; Sugiyama, Masaaki/0000-0002-0312-2850; Sugiyama, Takemi/0000-0002-8859-5269; Kamruzzaman, Md./0000-0001-7113-942X	Australian National Health and Medical Research Council (NHMRC) Grants [1047453, 497236, 339718]; Brisbane City Council; Australian National Health and Medical Research Council Early Career Fellowship [1121035]	Australian National Health and Medical Research Council (NHMRC) Grants(National Health and Medical Research Council (NHMRC) of Australia); Brisbane City Council; Australian National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The HABITAT study was supported by the Australian National Health and Medical Research Council (NHMRC) Grants #1047453, #497236, and #339718, with support from the Brisbane City Council. Mavoa is supported by an Australian National Health and Medical Research Council Early Career Fellowship (#1121035).	Amiard V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211853; Australian Bureau of Statistics, 2008, SOCIO EC INDEXES ARE; Australian Bureau of Statistics, 2007, STAT GEOGR; Australian Bureau of Statistics, 2020, REG POP; Barnett DW, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0558-z; Beard JR, 2015, J SOC WORK PRACT, V29, P5, DOI 10.1080/02650533.2014.993944; Beaton K, 2015, GERIATR GERONTOL INT, V15, P133, DOI 10.1111/ggi.12379; Burton NW, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-76; Busija L, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-55; Carmichael L, 2019, LAND USE POLICY, V84, P154, DOI 10.1016/j.landusepol.2019.02.043; Castrucci BC, 2015, J PUBLIC HEALTH MAN, V21, pS38, DOI 10.1097/PHH.0000000000000169; Chen BI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222268; Chomik R., 2014, AGED CARE AUSTR 1; Clarke PJ, 2014, J GERONTOL B-PSYCHOL, V69, pS8, DOI 10.1093/geronb/gbu121; Etman A, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0070-8; Foster S, 2021, ENVIRON BEHAV, V53, P3, DOI 10.1177/0013916519853300; Gabriel KP, 2017, PREV MED, V105, P287, DOI 10.1016/j.ypmed.2017.10.005; Hand CL, 2019, J GERONTOL B-PSYCHOL, V74, P546, DOI 10.1093/geronb/gbw215; Judd B., 2014, 150 AHURI; Judd B., 2010, 144 AHURI; Kanamori S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099638; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Latham K, 2015, J AGING HEALTH, V27, P1415, DOI 10.1177/0898264315584328; Manini TM, 2013, EXERC SPORT SCI REV, V41, P2, DOI 10.1097/JES.0b013e318279fdc5; Mavoa S, 2018, J TRANSP LAND USE, V11, P681, DOI 10.5198/jtlu.2018.1132; Michael YL, 2011, J AGING HEALTH, V23, P1246, DOI 10.1177/0898264311412597; Nguyen TT, 2016, J EPIDEMIOL COMMUN H, V70, P1017, DOI 10.1136/jech-2016-207241; Openshaw S., 1983, MODIFIABLE AREAL UNI; Organization WH, 2015, SUMM WORLD REP AG HL; Patel KV, 2006, AM J PREV MED, V31, P217, DOI 10.1016/j.amepre.2006.05.005; Peeters G, 2013, B WORLD HEALTH ORGAN, V91, P661, DOI 10.2471/BLT.13.123075; Perchoux C, 2019, J TRANSP HEALTH, V13, P170, DOI 10.1016/j.jth.2019.04.002; Rachele JN, 2019, HEALTH PLACE, V58, DOI 10.1016/j.healthplace.2019.05.015; Rantakokko M, 2013, EXERC SPORT SCI REV, V41, P19, DOI 10.1097/JES.0b013e3182556f1e; Rosso Andrea L, 2011, J Aging Res, V2011, P816106, DOI 10.4061/2011/816106; Satariano WA, 2012, AM J PUBLIC HEALTH, V102, P1508, DOI 10.2105/AJPH.2011.300631; Schootman M, 2012, ANN EPIDEMIOL, V22, P568, DOI 10.1016/j.annepidem.2012.04.020; Sugiyama T, 2018, GERONTOLOGIST, V58, P121, DOI 10.1093/geront/gnx088; Walsh K, 2011, J SOCIO-ECON, V40, P631, DOI 10.1016/j.socec.2011.05.001; Zhang M, 2020, J PLAN EDUC RES, V40, P304, DOI 10.1177/0739456X18755495; Zhang WJ, 2020, TRANSPORT RES D-TR E, V86, DOI 10.1016/j.trd.2020.102445	41	0	0	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252017	10.1371/journal.pone.0252017	http://dx.doi.org/10.1371/journal.pone.0252017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QS	34081707	Green Published, gold			2022-12-26	WOS:000664639200007
J	Dayton, KA; Bril, F; Barb, D; Lai, JP; Kalavalapalli, S; Cusi, K				Dayton, Kristin Alexandra; Bril, Fernando; Barb, Diana; Lai, Jinping; Kalavalapalli, Srilaxmi; Cusi, Kenneth			Severity of non-alcoholic steatohepatitis is not linked to testosterone concentration in patients with type 2 diabetes	PLOS ONE			English	Article							FATTY LIVER-DISEASE; HORMONE-BINDING GLOBULIN; INSULIN SENSITIVITY; HEPATIC STEATOSIS; MEN; ASSOCIATION; HYPOGONADISM; PREVALENCE; OBESITY; DIAGNOSIS	Background Hypogonadism is reported to occur in non-alcoholic fatty liver disease (NAFLD), but earlier studies used low-sensitivity diagnostic techniques (CT, ultrasound), for NAFLD diagnosis. We hypothesized that if hypogonadism was due to NAFLD, and not solely attributable to underlying obesity/diabetes, it would be more severe in the presence of steatohepatitis (NASH). To examine the influence of liver disease on testosterone in males with type 2 diabetes mellitus (T2DM), we used gold-standard liver imaging with MR-spectroscopy (H-1-MRS), and performed liver biopsies to grade/stage the NAFLD. Methods In this cross-sectional study, we measured in 175 males with T2DM total and free testosterone, markers of insulin resistance, and intrahepatic triglyceride content (IHTG) by H-1-MRS. Those with NAFLD on imaging underwent a liver biopsy. Results Total testosterone was higher in the group without NAFLD ("No-NAFLD"; n = 48) compared to isolated steatosis (IS; n = 62) or NASH (n = 65) (385 116 vs. 339 +/- 143 vs. 335 +/- 127 ng/ml, p(trend) 0.03). Testosterone was also lower in obese vs. non-obese subjects in both the No-NAFLD and IS groups (p = 0.06 and p = 0.11, respectively), but not in obese vs. non-obese patients with NASH (p = 0.81). IHTG was independently associated with total testosterone (ss = -4.8, p = 0.004). None of the liver histology characteristics were associated with lower testosterone. Conclusions NAFLD is linked to lower total testosterone in patients with T2DM, but likely given a common soil of insulin resistance/obesity and not from the severity of liver necroinflammation or fibrosis. Nevertheless, clinicians should consider screening patients with T2DM and NAFLD for hypogonadism.	[Dayton, Kristin Alexandra] Univ Florida, Div Pediat Endocrinol, Dept Pediat, Gainesville, FL USA; [Bril, Fernando; Barb, Diana; Kalavalapalli, Srilaxmi; Cusi, Kenneth] Univ Florida, Div Endocrinol Diabet & Metab, Dept Med, Gainesville, FL 32611 USA; [Bril, Fernando; Cusi, Kenneth] Malcom Randall Vet Adm Med Ctr, Gainesville, FL 32608 USA; [Lai, Jinping] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cusi, K (corresponding author), Univ Florida, Div Endocrinol Diabet & Metab, Dept Med, Gainesville, FL 32611 USA.; Cusi, K (corresponding author), Malcom Randall Vet Adm Med Ctr, Gainesville, FL 32608 USA.	Kenneth.Cusi@medicine.ufl.edu	Bril, Fernando/E-3430-2017; Lai, Jinping/AAZ-6861-2021	Bril, Fernando/0000-0001-5570-4396; Dayton, Kristin/0000-0003-1872-7753	American Diabetes Association [1-08-CR-08]; U.S. Department of Veterans Affairs, VA Merit Award [1 I01 CX000167-01]	American Diabetes Association(American Diabetes Association); U.S. Department of Veterans Affairs, VA Merit Award(US Department of Veterans Affairs)	This study was partially funded by the American Diabetes Association (1-08-CR-08 [K. C.]) https://www.diabetes.org/and the U.S. Department of Veterans Affairs, VA Merit Award (1 I01 CX000167-01 [K. C.]), https://www.research.va.gov/funding/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbonetti A, 2016, J SPINAL CORD MED, V39, P443, DOI 10.1179/2045772314Y.0000000288; Bhasin S, 2018, J CLIN ENDOCR METAB, V103, P1715, DOI 10.1210/jc.2018-00229; Bril F, 2015, LIVER INT, V35, P2139, DOI 10.1111/liv.12840; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Cooper LA, 2015, CLIN ENDOCRINOL, V83, P828, DOI 10.1111/cen.12768; Corona G, 2015, MOL CELL ENDOCRINOL, V418, P120, DOI 10.1016/j.mce.2015.06.031; Dhindsa S, 2018, DIABETES CARE, V41, P1516, DOI 10.2337/dc17-2510; Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177; Guechot J, 1987, GASTROENTEROLOGY, V92, P203, DOI 10.1016/0016-5085(87)90860-2; Hackett G, 2019, BJU INT, V123, P519, DOI 10.1111/bju.14536; Hua XM, 2014, CLIN ENDOCRINOL, V80, P877, DOI 10.1111/cen.12360; Isidori AM, 1999, J CLIN ENDOCR METAB, V84, P3673, DOI 10.1210/jc.84.10.3673; Kapoor D, 2007, DIABETES CARE, V30, P911, DOI 10.2337/dc06-1426; Kim S, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-69; Kim WR, 2018, AM J TRANSPLANT, V18, P172, DOI 10.1111/ajt.14559; Lazo M, 2015, CLIN GASTROENTEROL H, V13, P1686, DOI 10.1016/j.cgh.2014.12.033; Leite NC, 2011, LIVER INT, V31, P700, DOI 10.1111/j.1478-3231.2011.02482.x; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Mintziori G, 2017, MINERVA ENDOCRINOL, V42, P145, DOI 10.23736/S0391-1977.16.02570-0; Mody A, 2015, CARDIOVASC ENDOCRINO, V4, P83, DOI 10.1097/XCE.0000000000000057; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Schiffer L, 2017, EUR J ENDOCRINOL, V177, pR125, DOI 10.1530/EJE-17-0124; Seo NK, 2015, J GASTROEN HEPATOL, V30, P1211, DOI 10.1111/jgh.12935; Volzke H, 2010, INT J ANDROL, V33, P45, DOI 10.1111/j.1365-2605.2009.00953.x; Williamson RM, 2011, DIABETES CARE, V34, P1139, DOI 10.2337/dc10-2229; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yialamas MA, 2007, J CLIN ENDOCR METAB, V92, P4254, DOI 10.1210/jc.2007-0454; Yim JY, 2018, LIVER INT, V38, P2051, DOI 10.1111/liv.13735; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	30	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251449	10.1371/journal.pone.0251449	http://dx.doi.org/10.1371/journal.pone.0251449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077443	Green Published, gold			2022-12-26	WOS:000664638500011
J	Schonning, MJ; Koh, S; Sun, RW; Richter, GT; Edwards, AK; Shawber, CJ; Wu, JK				Schonning, Michael J.; Koh, Seung; Sun, Ravi W.; Richter, Gresham T.; Edwards, Andrew K.; Shawber, Carrie J.; Wu, June K.			Venous malformation vessels are improperly specified and hyperproliferative	PLOS ONE			English	Article							VASCULAR MALFORMATIONS; GROWTH-FACTOR; VE-CADHERIN; STEM-CELL; PERICYTES; NOTCH3; GENE; DIFFERENTIATION; SPECIALIZATION; ANGIOGENESIS	Venous malformations (VMs) are slow-flow malformations of the venous vasculature and are the most common type of vascular malformation with a prevalence of 1%. Germline and somatic mutations have been shown to contribute to VM pathogenesis, but how these mutations affect VM pathobiology is not well understood. The goal of this study was to characterize VM endothelial and mural cell expression by performing a comprehensive expression analysis of VM vasculature. VM specimens (n = 16) were stained for pan-endothelial, arterial, venous, and endothelial progenitor cell proteins; proliferation was assessed with KI67. Endothelial cells in the VM vessels were abnormally orientated and improperly specified, as seen by the misexpression of both arterial and endothelial cell progenitor proteins not observed in control vessels. Consistent with arterialization of the endothelial cells, VM vessels were often surrounded by multiple layers of disorganized mural cells. VM endothelium also had a significant increase in proliferative endothelial cells, which may contribute to the dilated channels seen in VMs. Together the expression analysis indicates that the VM endothelium is misspecified and hyperproliferative, suggesting that VMs are biologically active lesions, consistent with clinical observations of VM progression over time.	[Schonning, Michael J.; Koh, Seung; Edwards, Andrew K.; Shawber, Carrie J.; Wu, June K.] Columbia Univ Vagelos Coll Phys & Surg, Dept Surg, New York, NY 10032 USA; [Sun, Ravi W.; Richter, Gresham T.] Univ Arkansas Med Sci, Dept Otolaryngol Head & Neck Surg, Little Rock, AR 72205 USA; [Shawber, Carrie J.] Columbia Univ Vagelos Coll Phys & Surg, Dept Ob Gyn, New York, NY USA; [Schonning, Michael J.] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ USA	University of Arkansas System; University of Arkansas Medical Sciences; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wu, JK (corresponding author), Columbia Univ Vagelos Coll Phys & Surg, Dept Surg, New York, NY 10032 USA.	jw92@cumc.columbia.edu			DOD [W81XWH1910267, P30CA013696]	DOD(United States Department of Defense)	Funding was provided by DOD W81XWH1910266 (CJS) and DOD W81XWH1910267 (JKW). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. These studies used the resources of the Herbert Irving Comprehensive Cancer Center Pathology Shared Resources funded in part through Center Grant P30CA013696.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Behravesh S, 2016, CARDIOVASC DIAGN THE, V6, P557, DOI 10.21037/cdt.2016.11.10; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Boscolo E, 2015, J CLIN INVEST, V125, P3491, DOI 10.1172/JCI76004; Brouillard P, 2003, CLIN GENET, V63, P340, DOI 10.1034/j.1399-0004.2003.00092.x; Brouillard P, 2007, HUM MOL GENET, V16, pR140, DOI 10.1093/hmg/ddm211; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Castel P, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1164; Castillo SD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9982; Couto JA, 2015, AM J HUM GENET, V96, P480, DOI 10.1016/j.ajhg.2015.01.007; Diehl S, 2005, PEDIATR RES, V57, P537, DOI 10.1203/01.PDR.0000155761.70710.C4; Edwards AK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93764; Eifert S, 2000, J VASC SURG, V31, P462, DOI 10.1067/mva.2000.101464; Falati S, 2006, BLOOD, V107, P535, DOI 10.1182/blood-2005-04-1512; Fish JE, 2015, DEV DYNAM, V244, P391, DOI 10.1002/dvdy.24252; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Greene AK, 2018, PLAST RECONSTR SURG, V141, p709E, DOI 10.1097/PRS.0000000000004294; Hassanein AH, 2012, ANN PLAS SURG, V68, P198, DOI 10.1097/SAP.0b013e31821453c8; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Jadeja S, 2013, INVEST OPHTH VIS SCI, V54, P3569, DOI 10.1167/iovs.12-11125; Kofler NM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16449; LANGILLE BL, 1981, CIRC RES, V48, P481, DOI 10.1161/01.RES.48.4.481; Limaye N, 2015, AM J HUM GENET, V97, P914, DOI 10.1016/j.ajhg.2015.11.011; Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272; Lin SH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16074; Liu H, 2010, CIRC RES, V107, P860, DOI 10.1161/CIRCRESAHA.110.218271; Mulliken J B, 2000, Curr Probl Surg, V37, P517, DOI 10.1016/S0011-3840(00)80013-1; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Olivieri B, 2016, AM J ROENTGENOL, V206, P952, DOI 10.2214/AJR.15.15794; Potente M, 2017, NAT REV MOL CELL BIO, V18, P477, DOI 10.1038/nrm.2017.36; Rocha SF, 2009, ANGIOGENESIS, V12, P139, DOI 10.1007/s10456-009-9132-x; Rolny C, 2006, BLOOD, V108, P1877, DOI 10.1182/blood-2006-04-014894; Schulz GB, 2015, STROKE, V46, P1337, DOI 10.1161/STROKEAHA.114.007512; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sinha R, 2016, SCI REP-UK, V6, DOI 10.1038/srep29510; Soblet J, 2013, MOL SYNDROMOL, V4, P179, DOI 10.1159/000348327; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Uranishi R, 2001, NEUROSURGERY, V49, P671, DOI 10.1097/00006123-200109000-00027; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vikkula M, 1998, TRENDS CARDIOVAS MED, V8, P281, DOI 10.1016/S1050-1738(98)00024-3; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Vikkula M, 2001, MATRIX BIOL, V20, P327, DOI 10.1016/S0945-053X(01)00150-0; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030503; Wassef M, 2015, PEDIATRICS, V136, pE203, DOI 10.1542/peds.2014-3673; Wu JK, 2010, ANGIOGENESIS, V13, P15, DOI 10.1007/s10456-009-9161-5; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Zhang G, 2008, FEBS LETT, V582, P2957, DOI 10.1016/j.febslet.2008.07.031; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868	48	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252342	10.1371/journal.pone.0252342	http://dx.doi.org/10.1371/journal.pone.0252342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043714	Green Published, gold			2022-12-26	WOS:000664635700090
J	Grewar, JD; Kotze, JL; Parker, BJ; van Helden, LS; Weyer, CT				Grewar, John D.; Kotze, Johann L.; Parker, Beverly J.; van Helden, Lesley S.; Weyer, Camilla T.			An entry risk assessment of African horse sickness virus into the controlled area of South Africa through the legal movement of equids	PLOS ONE			English	Article								South Africa is endemic for African horse sickness (AHS), an important health and trade-sensitive disease of equids. The country is zoned with movement control measures facilitating an AHS-free controlled area in the south-west. Our objective was to quantitatively establish the risk of entry of AHS virus into the AHS controlled area through the legal movement of horses. Outcomes were subcategorised to evaluate movement pathway, temporal, and spatial differences in risk. A 'no-control' scenario allowed for evaluation of the impact of control measures. Using 2019 movement and AHS case data, and country-wide census data, a stochastic model was developed establishing local municipality level entry risk of AHSV at monthly intervals. These were aggregated to annual probability of entry. Sensitivity analysis evaluated model variables on their impact on the conditional means of the probability of entry. The median monthly probability of entry of AHSV into the controlled area of South Africa ranged from 0.75% (June) to 5.73% (February), with the annual median probability of entry estimated at 20.21% (95% CI: 15.89%-28.89%). The annual risk of AHSV entry compared well with the annual probability of introduction of AHS into the controlled area, which is similar to 10% based on the last 20 years of outbreak data. Direct non-quarantine movements made up most movements and accounted for most of the risk of entry. Spatial analysis showed that, even though reported case totals were zero throughout 2019 in the Western Cape, horses originating from this province still pose a risk that should not be ignored. Control measures decrease risk by a factor of 2.8 on an annual basis. Not only do the outcomes of this study inform domestic control, they can also be used for scientifically justified trade decision making, since in-country movement control forms a key component of export protocols.	[Grewar, John D.; Kotze, Johann L.] Univ Pretoria, Dept Prod Anim Studies, Pretoria, Gauteng, South Africa; [Grewar, John D.; Parker, Beverly J.; Weyer, Camilla T.] South African Equine Hlth & Protocols NPC, Cape Town, Western Cape Pr, South Africa; [van Helden, Lesley S.] Western Cape Dept Agr, Vet Serv, Elsenburg, Western Cape Pr, South Africa; [Weyer, Camilla T.] Univ Pretoria, Dept Vet Trop Dis, Pretoria, Gauteng, South Africa	University of Pretoria; University of Pretoria	Grewar, JD (corresponding author), Univ Pretoria, Dept Prod Anim Studies, Pretoria, Gauteng, South Africa.; Grewar, JD (corresponding author), South African Equine Hlth & Protocols NPC, Cape Town, Western Cape Pr, South Africa.	jdgrewar@gmail.com		Grewar, John/0000-0002-4496-8051	National Research Foundation of South Africa [120319]	National Research Foundation of South Africa(National Research Foundation - South Africa)	This work is based on the research supported in part by the National Research Foundation of South Africa (Grant Number: 120319 -University of Pretoria Community of Practice in Sanitary and Phytosanitary Risk Assessment). The opinions, findings, conclusions and/or recommendations expressed in this publication are the authors alone. South African Equine Health and Protocols NPC (SAEHP) is a registered non-profit company in South Africa (registration number 2017/528099/08). It is privately funded, and the funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Backer JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023066; BARNARD BJH, 1994, ONDERSTEPOORT J VET, V61, P391; BOSMAN P, 1995, REV SCI TECH OIE, V14, P645, DOI 10.20506/rst.14.3.866; Coetzer J. A. W., 2004, Infectious diseases of livestock. Volume Two, P1231; de Vos CJ, 2012, PREV VET MED, V106, P108, DOI 10.1016/j.prevetmed.2012.01.019; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Durr PA, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00098; Faverjon C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0435-4; Fischer EAJ, 2016, PREV VET MED, V131, P48, DOI 10.1016/j.prevetmed.2016.07.005; Gilbert M, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.227; Grewar JD., 2020, AFRICAN HORSE SICKNE, DOI [10.5281/ZENODO.4316352, DOI 10.5281/ZENODO.4316352]; Grewar JD., 2020, AFRICAN HORSE SICKNE, DOI [10.5281/ZENODO.4316375, DOI 10.5281/ZENODO.4316375]; Grewar JD, 2020, TRANSBOUND EMERG DIS, V67, P2146, DOI 10.1111/tbed.13566; Grewar JD, 2019, TRANSBOUND EMERG DIS, V66, P743, DOI 10.1111/tbed.13077; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Lubroth J., 1988, Equine Practice, V10, P26; R Core Team, 2020, R LANG ENV STAT COMP; Sellers RF., 1977, J HYG-CAMBRIDGE, DOI 10.1017/S0022172400053109; Sergeant ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151757; South African Government, 2016, FIN 2016 AFR HORS SI; Weyer CT, 2016, EMERG INFECT DIS, V22, P2087, DOI 10.3201/eid2212.160718; World Organisation for Animal Health, 2019, TERR AN HLTH COD; World Organisation for Animal Health (OIE), 2020, 34 OIE; Zientara S, 2015, REV SCI TECH OIE, V34, P315, DOI 10.20506/rst.34.2.2359	24	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252117	10.1371/journal.pone.0252117	http://dx.doi.org/10.1371/journal.pone.0252117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038466	Green Published, gold			2022-12-26	WOS:000664633500052
J	Konishi, T				Konishi, Tomokazu			SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans	PLOS ONE			English	Article								SARS-CoV-2 infection in minks has become a serious problem, as the virus may mutate and reinfect humans; some countries have decided to cull minks. Here, the virus sequencing data in minks were analysed and compared to those of human-virus. Although the mink-virus maintained the characteristics of human-virus, some variants rapidly mutated, adapting to minks. Some mink-derived variants infected humans, which accounted for 40% of the total SARS-CoV-2 cases in the Netherlands. These variants appear to be less lethal and infective compared to those in humans. Variants that have mutated further among minks were not found in humans. Such mink-viruses might be suitable for vaccination for humans, such as in the case of the smallpox virus, which is less infective and toxic to humans.	[Konishi, Tomokazu] Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita, Japan	Akita Prefectural University	Konishi, T (corresponding author), Akita Prefectural Univ, Grad Sch Bioresource Sci, Akita, Japan.	konishi@akita-pu.ac.jp	Konishi, Tomokazu/K-8067-2012	Konishi, Tomokazu/0000-0003-4826-6265				BBC, 2020, DENM CULL 17 MILL MI; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Elbe S, 2017, GLOB CHALL, V1, P33, DOI 10.1002/gch2.1018; Hikita S., 2020, ASAHHI NEWS; International Fur Trade Federation, 2009, SOC IMP INT FARM; ipj/sri (dpa Reuters AP AFP)., 2020, LITH MINK ALS COR IN; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; Konishi T, 2020, DATASET FIGSHARE, DOI [10.6084/m9.figshare.13385192.v1, DOI 10.6084/M9.FIGSHARE.13385192.V1]; Konishi T., 2021, FIGSHARE, DOI [10.6084/m9.figshare.12365777.v1, DOI 10.6084/M9.FIGSHARE.12365777.V1]; Konishi T., 2021, PROGR ADAPTATION SAR, DOI [10.1101/2020.12.18.413344, DOI 10.1101/2020.12.18.413344]; Konishi T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55253-0; Mallapaty S, 2020, NATURE, V587, P340, DOI 10.1038/d41586-020-03218-z; Mossburg C, 2020, 10000 MINK ARE DEAD; Munnink BBO, 2021, SCIENCE, V371, P172, DOI 10.1126/science.abe5901; R Core Team, 2020, R LANG ENV STAT COMP; Wang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02806-4; WHO, 2020, MINK STRAIN COVID 19; World Health Organization, 2021, **NON-TRADITIONAL**; Wright ES, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0749-z; Zhou P, 2021, SCIENCE, V371, P120, DOI 10.1126/science.abf6097	21	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0247626	10.1371/journal.pone.0247626	http://dx.doi.org/10.1371/journal.pone.0247626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038423	Green Published, Green Submitted, gold			2022-12-26	WOS:000664633500005
J	Ng, DY; Car, LT; Ng, MJM; Lu, J; Leung, J; Goo, TT; Chia, CLK				Ng, Ding Yi; Car, Lorraine Tudor; Ng, Marcus Jia Ming; Lu, Junde; Leung, Joelle; Goo, Tiong Thye; Chia, Clement Luck Khng			Identifying barriers to early presentation in patients with locally advanced breast cancer (LABC) in Northern Singapore: Qualitative study	PLOS ONE			English	Article								Introduction Breast cancer is the leading cause of death in Singaporean women, with advanced stage rendering a poorer prognosis. This study aims to explore the barriers to early presentation, information needs and sources in patients with locally advanced breast cancer (LABC). Materials & methods A convenience sample of patients who presented with locally advanced breast cancer to the Department of General Surgery in a teaching tertiary hospital were recruited for the study. We conducted semi-structured interviews face to face with the recruited patients. We recorded the interviews, transcribed them verbatim and analysed using thematic content analysis. Results Twenty-three participants were recruited of which 12 were Chinese and 11 were Malay women. Mean age was 60 years ( 13 SD). The most common knowledge barrier resulting in delay was the misconception that a breast lump must be painful to be malignant. Other knowledge barriers include the lack of knowledge and misinformation from the internet or other social media platforms. Some perceived barriers include fear of diagnosis, fear of treatment and fear of imposing financial burden on family members. A significant proportion of participants were also not aware of a national breast screening programme. Conclusions Our study has found that barriers to early presentation of women with locally advanced breast cancer remain similar and have persisted over the years despite targeted efforts. There is a need for a rethink of existing strategies and to develop new innovative ways to reach out to this group of patients.	[Ng, Ding Yi; Car, Lorraine Tudor; Lu, Junde] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Car, Lorraine Tudor] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Ng, Marcus Jia Ming] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Leung, Joelle; Goo, Tiong Thye; Chia, Clement Luck Khng] Khoo Teck Puat Hosp, Dept Gen Surg, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; National University of Singapore	Chia, CLK (corresponding author), Khoo Teck Puat Hosp, Dept Gen Surg, Singapore, Singapore.	clemchia84@gmail.com	Car, Lorainne Tudor/E-1205-2017	Car, Lorainne Tudor/0000-0001-8414-7664; NG, DING YI/0000-0003-1024-0211; Lu, Junde/0000-0001-9502-2306	Alexandra Health Enabling Grant (AHEG), Singapore [AHEG1815]	Alexandra Health Enabling Grant (AHEG), Singapore	Yes. C. LK Chia was given the grant of $10,000 under the Alexandra Health Enabling Grant (AHEG), Singapore (Grant number: AHEG1815). The grant is subsumed under the local government hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, SINGAPORE CANC REGIS; [Anonymous], 2010, MIN HLTH PRACT GUID; Breast Cancer Foundation S, WHAT IS BREAST CANC; Burnard P, 2008, BRIT DENT J, V204, P429, DOI 10.1038/sj.bdj.2008.292; Chang GH, 2011, ASIAN PAC J CANCER P, V12, P1635; Chiou CP, 2012, J CLIN NURS, V21, P1223, DOI 10.1111/j.1365-2702.2011.03793.x; Data.gov.sg, SING RES AG GROUP ET; Department of Statistics Ministry of Trade and Industry R of S, 2010, SING CENS POP 2010, P71; Epidemiology and Disease Control Division Ministry of Health Singapore, 2010, NAT HLTH SURV; Fusch PI, 2015, QUAL REP, V20, P1408; HealthHub, 2020, BREAST CANC INF; Ho PJ, 2020, CANCER MED-US, V9, P2435, DOI 10.1002/cam4.2830; Jones CEL, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006944; Kerr-Cresswell DM., 2005, J CLIN ONCOL; Lim JNW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009863; Malhotra C., 2016, ASIAN PAC J CANCER P; Merrick EL., 2015, AM J MANAG CARE; National Cancer Centre Singapore, MED LIF PAYM OPT; National Cancer Centre Singapore, BREAST CANC WHAT IT; National Comprehensive Cancer Network (NCCN), BREAST CANCER-TOKYO; Seetoh T., 2014, ANN ACAD MED SINGAPO; Singapore Cancer Society, BREAST CANC; Singhealth, 2016, LANDSC BREAST CANC S; Teufel-Shone Nicolette I, 2005, Prev Chronic Dis, V2, pA20; Vondeling GT, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4158-3; Xin WR., 2017, J BREAST CANCER	26	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252008	10.1371/journal.pone.0252008	http://dx.doi.org/10.1371/journal.pone.0252008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34032802	Green Published, gold			2022-12-26	WOS:000664633100019
J	Jaatinen, J; Veija, T; Salmikangas, M; Bohling, T; Sihto, H; Koljonen, V				Jaatinen, Jenni; Veija, Tuukka; Salmikangas, Marko; Bohling, Tom; Sihto, Harri; Koljonen, Virve			ALK is frequently phosphorylated in Merkel cell carcinoma and associates with longer survival	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; LARGE T-ANTIGEN; POLYOMAVIRUS INFECTION; MUTATIONS; IDENTIFICATION; EXPRESSION; REARRANGEMENTS; CANCERS; PROTEIN; GENE	Merkel cell carcinoma (MCC) is a rare skin cancer with only limited therapeutic options for advanced disease. We previously showed that oncogene ALK is frequently expressed at the RNA level in MCC and further that ALK positivity by immunohistochemistry is frequent and correlates strongly with Merkel cell polyomavirus (MCPyV) positivity. In this study, we investigated whether ALK receptor is active in MCC tumor samples and MCC cell lines, and whether ALK would be a prospective treatment target in MCC. We utilized tissue microarrays constructed from 136 primary MCC tumor samples as well as nine previously established MCC cell lines to determine the presence of ALK and phosphorylated ALK (p-ALK) via immunohistochemistry. Almost half of the analyzed MCC tumors displayed ALK phosphorylation (47.8%). Analysis of MCC tumor samples revealed that the presence of p-ALK correlated to MCPyV positivity, younger age, nonexistence of metastases at diagnosis and ultimately to better MCC-specific survival. In contrast to MCC tumor samples only two out of nine MCC cell lines showed only low ALK phosphorylation by immunohistochemistry. Our study reveals clear disparity in ALK activity between patient derived tumors and cell line samples and therefore, more advanced disease models such as xenografts are necessary to resolve whether ALK is a useful treatment target in MCC.	[Jaatinen, Jenni; Veija, Tuukka; Salmikangas, Marko; Bohling, Tom; Sihto, Harri] Univ Helsinki, Dept Pathol, Helsinki, Finland; [Koljonen, Virve] Univ Helsinki, Dept Plast Surg, Helsinki, Finland; [Koljonen, Virve] Helsinki Univ Hosp, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Veija, T (corresponding author), Univ Helsinki, Dept Pathol, Helsinki, Finland.	tuukka.veija@helsinki.fi	; Sihto, Harri/B-3432-2015	Koljonen, Virve/0000-0003-0398-4829; Sihto, Harri/0000-0001-5265-5509	Jane and Aatos Erkko Foundation [4706147]; Hospital district of Helsinki and Uusimaa [TYH2019225]	Jane and Aatos Erkko Foundation; Hospital district of Helsinki and Uusimaa	This study was funded by the Jane and Aatos Erkko Foundation (TB, Grant number 4706147, URL: https://jaes.fi) and the Hospital district of Helsinki and Uusimaa. (VK, Grant number TYH2019225, URL: https://www.hus.fi/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Cao S, 2017, CANCERS, V9, DOI 10.3390/cancers9090123; Conklin CMJ, 2013, J THORAC ONCOL, V8, P45, DOI 10.1097/JTO.0b013e318274a83e; Filtenborg-Barnkob BE, 2013, HUM PATHOL, V44, P1656, DOI 10.1016/j.humpath.2012.11.021; Guan J, 2016, DIS MODEL MECH, V9, P941, DOI 10.1242/dmm.024448; Guastafierro A, 2013, J VIROL METHODS, V187, P6, DOI 10.1016/j.jviromet.2012.10.001; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Higaki-Mori H, 2012, HUM PATHOL, V43, P2282, DOI 10.1016/j.humpath.2012.04.002; Houben R, 2013, J INVEST DERMATOL, V133, P2453, DOI 10.1038/jid.2013.169; Jaeger T, 2012, J SKIN CANCER, V2012, DOI 10.1155/2012/983421; Kaufman HL, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-017-0310-x; Kim MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120320; LEONARD JH, 1995, INT J CANCER, V60, P100, DOI 10.1002/ijc.2910600115; LEONARD JH, 1993, INT J CANCER, V55, P803, DOI 10.1002/ijc.2910550519; Leroux-Kozal V, 2015, HUM PATHOL, V46, P443, DOI 10.1016/j.humpath.2014.12.001; Lin E, 2009, MOL CANCER RES, V7, P1466, DOI 10.1158/1541-7786.MCR-08-0522; Liu JH, 2016, ONCOL LETT, V11, P213, DOI 10.3892/ol.2015.3859; MARTIN EME, 1991, BONE MINER, V14, P113, DOI 10.1016/0169-6009(91)90088-H; Moshiri AS, 2017, J INVEST DERMATOL, V137, P819, DOI 10.1016/j.jid.2016.10.028; Murugan AK, 2011, CANCER RES, V71, P4403, DOI 10.1158/0008-5472.CAN-10-4041; Nghiem P, 2019, J CLIN ONCOL, V37, P693, DOI 10.1200/JCO.18.01896; Ning H, 2013, ONCOTARGET, V4, P2237, DOI 10.18632/oncotarget.1357; RONAN SG, 1993, J AM ACAD DERMATOL, V29, P715, DOI 10.1016/0190-9622(93)70236-M; ROSEN ST, 1987, LAB INVEST, V56, P302; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Sihto H, 2011, CLIN CANCER RES, V17, P4806, DOI 10.1158/1078-0432.CCR-10-3363; Sihto H, 2009, JNCI-J NATL CANCER I, V101, P938, DOI 10.1093/jnci/djp139; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Van Gele M, 2002, INT J CANCER, V101, P137, DOI 10.1002/ijc.10591; Veija T, 2019, HISTOPATHOLOGY, V74, P829, DOI 10.1111/his.13815; Veija T, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3233-5; Wang YW, 2011, NEOPLASIA, V13, P704, DOI 10.1593/neo.11222; Wu T, 2017, CANCER LETT, V387, P61, DOI 10.1016/j.canlet.2016.01.043; Xiong WM, 2017, ONCOTARGET, V8, P96419, DOI 10.18632/oncotarget.21682; Yang JJ, 2014, CLIN CANCER RES, V20, P1383, DOI 10.1158/1078-0432.CCR-13-0699; Yu Z, 2018, ANTI-CANCER DRUG, V29, P513, DOI 10.1097/CAD.0000000000000616	36	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252099	10.1371/journal.pone.0252099	http://dx.doi.org/10.1371/journal.pone.0252099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029351	Green Published, gold			2022-12-26	WOS:000664632800029
J	Kiragga, AN; Twinomuhwezi, E; Banturaki, G; Achieng, M; Nampala, J; Bagaya, I; Kigozi, J; Castelnuovo, B; Musick, BS; Hazra, R; Yiannoutsos, CT; Wools-Kaloustian, KK				Kiragga, Agnes N.; Twinomuhwezi, Ellon; Banturaki, Grace; Achieng, Marion; Nampala, Juliet; Bagaya, Irene; Kigozi, Joanita; Castelnuovo, Barbara; Musick, Beverly S.; Hazra, Rohan; Yiannoutsos, Constantin T.; Wools-Kaloustian, Kara K.			Outcomes of retained and disengaged pregnant women living with HIV in Uganda	PLOS ONE			English	Article							OPTION B PLUS; ANTIRETROVIRAL THERAPY; FOLLOW-UP; INFECTED PATIENTS; INCOME COUNTRIES; MIDDLE-INCOME; PATIENTS LOST; RETENTION; PROGRAMS; CARE	Introduction Loss-to-follow-up among women living with HIV (WLWHIV) may lead to unfavorable outcomes for both mother and exposed infant. This study traced WLWHIV disengaged from care and their infants and compared their outcomes with those retained in care. Methods The study included WLWHIV who initiated ART during pregnancy at six public clinics in Uganda. A woman was defined as disengaged (DW) if she had not attended her 6-week post-partum visit by 10 weeks after her estimated date of delivery. DW were matched with retained women (RW) by age and duration on ART. Nurse counselors traced all selected DW via telephone and community visits to assess vital status, infant HIV sero-status and maternal HIV viral load through blood draws. Results Between July 2017 and July 2018, 734 women (359 DW and 375 RW) were identified for the study. Tracing was attempted on 349 DW and 160 (44.6%) were successfully located and enrolled in the study. They were matched with 162 RW. Among DW, 52 (32.5%) transferred to another health facility. Very few DW, 39.0% were HIV virally suppressed (<1000 copies/ml) compared to RW 89.5%, P<0.001). Among 138 babies born to DW, 4.3% tested positive for HIV compared to 1.4% among babies born to RW (P = 0.163). Conclusion Pregnant and breastfeeding WLWHIV who disengage from care are difficult to find in urban environments. Many have detectable viral loads, leading to the potential for an increased risk of MTCT. Efforts to reduce disengagement from care are critical for the successful elimination of MTCT in resource-limited settings.	[Kiragga, Agnes N.; Twinomuhwezi, Ellon; Banturaki, Grace; Achieng, Marion; Nampala, Juliet; Bagaya, Irene; Kigozi, Joanita; Castelnuovo, Barbara] Makerere Univ, Infect Dis Inst, Res Dept, Coll Hlth Sci, Kampala, Uganda; [Musick, Beverly S.; Wools-Kaloustian, Kara K.] Indiana Univ, Sch Med, Indianapolis, IN USA; [Hazra, Rohan] Natl Inst Child Hlth & Human Dev NICHD, NIH, Bethesda, MD USA; [Yiannoutsos, Constantin T.] Indiana Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA	Makerere University; Indiana University System; Indiana University-Purdue University Indianapolis; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Indiana University System; Indiana University-Purdue University Indianapolis	Kiragga, AN (corresponding author), Makerere Univ, Infect Dis Inst, Res Dept, Coll Hlth Sci, Kampala, Uganda.	akiragga@idi.co.ug		Kiragga, Agnes/0000-0002-0969-0699	National Institutes of Health (NIH) [U01 AI069911]; Fogarty International Center grant HIV co-infections [D43 TW009771]; EDCTP [100448 TMA 2015 CDF -1036]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center grant HIV co-infections; EDCTP	This work was supported by the National Institutes of Health (NIH) under the U01 AI069911 Eastern Africa International epidemiology Databases to Evaluate AIDS (IeDEA). Salary support for ANK was provided from the Fogarty International Center grant HIV co-infections (D43 TW009771) and the EDCTP (100448 TMA 2015 CDF -1036.	Anglewicz Philip, 2012, Demography, V49, P239, DOI 10.1007/s13524-011-0072-x; [Anonymous], 2019, J INT AIDS SOC, V22, P1, DOI 10.1002/jia2.25327; [Anonymous], 2016, THAIL IS 1 COUNTR AS; [Anonymous], 2012, NATL BUSINESS REV; [Anonymous], 2019, UGANDA EMR; Barr BAT, 2018, LANCET HIV, V5, pE688, DOI 10.1016/S2352-3018(18)30316-3; Chi BH, 2018, PEDIATR INFECT DIS J, V37, P1137, DOI 10.1097/INF.0000000000001997; Clouse K, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25121; Commission UA, 2017, UG HIV AIDS COUNTR P; Geldsetzer P, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20679; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Geng EH, 2016, CLIN INFECT DIS, V62, P935, DOI 10.1093/cid/civ1004; Geng EH, 2015, LANCET HIV, V2, pE107, DOI 10.1016/S2352-3018(15)00002-8; Geng EH, 2012, AM J EPIDEMIOL, V175, P1080, DOI 10.1093/aje/kwr444; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Haas AD, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21947; Haas AD, 2016, CLIN INFECT DIS, V63, P1227, DOI 10.1093/cid/ciw500; Huerga H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2740-y; Kim MH, 2015, JAIDS-J ACQ IMM DEF, V68, pE77, DOI 10.1097/QAI.0000000000000517; Kiwanuka G, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3450-9; Kyaw KWY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184426; Landes M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25290; Marotta C, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5646-8; MOH U, 2008, NAT ANT TREATM CAR G; Mooney AC, 2018, AIDS BEHAV, V22, P2368, DOI 10.1007/s10461-018-2155-9; Muhumuza S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187605; Nachega JB, 2012, AIDS, V26, P2039, DOI 10.1097/QAD.0b013e328359590f; Phillips TK, 2020, AIDS, V34, P749, DOI 10.1097/QAD.0000000000002478; Pricilla RA, 2018, MATERN CHILD HLTH J, V22, P1685, DOI 10.1007/s10995-018-2612-0; Reidy W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222959; Sagay AS, 2015, CURR HIV RES, V13, P193, DOI 10.2174/1570162X1303150506182534; Schuyler AC, 2017, GLOB PUBLIC HEALTH, V12, P1033, DOI 10.1080/17441692.2015.1074715; Sikazwe I, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002811; Tweya H, 2014, TROP MED INT HEALTH, V19, P1360, DOI 10.1111/tmi.12369; UNAIDS, 2017, START FREE STAY FREE; UNAIDS, 2018, UNAIDS DAT 2018; UNAIDS, 2017, START FREE STAY AIDS; UNAIDS, 2020, START FREE STAY AIDS; Vogt F, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20022; WHO, 2014, IMPL OPT B PREV MOTH, P37; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434; Woelk GB, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20837	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251413	10.1371/journal.pone.0251413	http://dx.doi.org/10.1371/journal.pone.0251413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019568	Green Published, gold			2022-12-26	WOS:000664632300022
J	Jiang, Y; Wang, ZL; Ying, CT; Hu, JF; Zeng, T; Gao, L				Jiang, Yang; Wang, Zhenlin; Ying, Chenting; Hu, Jiangfeng; Zeng, Tao; Gao, Liang			FMR1/circCHAF1A/miR-211-5p/HOXC8 feedback loop regulates proliferation and tumorigenesis via MDM2-dependent p53 signaling in GSCs	ONCOGENE			English	Article							CIRCULAR RNAS; STEM-CELL; CANCER; PHOSPHORYLATION; ANGIOGENESIS; EXPRESSION; APOPTOSIS; CHAF1A; GROWTH	Glioma is the most common and fatal primary malignant brain tumor. Glioma stem cells (GSCs) may be an important factor in glioma cell proliferation, invasion, chemoradiotherapy tolerance, and recurrence. Therefore, discovering novel GSCs related circular RNAs (circRNAs) may finds out a prospective target for the treatment of glioma. A novel circRNA-CHAF1A (circCHAF1A) was first found in our study. CircCHAF1A was overexpressed in glioma and related to the low survival rate. Functionally, it was found that no matter in vitro or in vivo, circCHAF1A can facilitate the proliferation and tumorigenesis of TP53wt GSCs. Mechanistically, circCHAF1A upregulated transcription factor HOXC8 expression in GSCs through miR-211-5p sponging. Then, HOXC8 can transcriptionally upregulate MDM2 expression and inhibited the antitumor effect of p53. Furtherly, the RNA binding protein FMR1 can bind to and promoted the expression of circCHAF1A via maintaining its stability, while HOXC8 also transcribed the FMR1 expression to form a feedback loop, which may be involved in the malignant transformation of glioma. The novel feedback loop among FMR1, circCHAF1A, miR-211-5p, and HOXC8 in GSCs can facilitate the proliferation and tumorigenesis of glioma and GSCs. It also provided a helpful biomarker for diagnosis and prognostic evaluation of glioma and may be applied to molecular targeted therapy.	[Jiang, Yang; Zeng, Tao; Gao, Liang] Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, Sch Med, Shanghai, Peoples R China; [Wang, Zhenlin; Ying, Chenting] Shanghai Jiao Tong Univ, Dept Surg, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China; [Hu, Jiangfeng] Shanghai Jiao Tong Univ, Dept Gastroenterol, Shanghai Gen Hosp, Sch Med, Shanghai, Peoples R China	Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Gao, L (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Dept Neurosurg, Sch Med, Shanghai, Peoples R China.	lianggaoh@126.com			National Natural Science Foundation of China [81900544]; Key disciplines-B neurosurgery of Shanghai Tenth People's Hospital [DS04! 02! 18014]; Shanghai Sailing Program [19YF1439000, 21YF1449900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key disciplines-B neurosurgery of Shanghai Tenth People's Hospital; Shanghai Sailing Program	We thank Zhitao Jing at the Department of Neurosurgery, The First Affiliated Hospital of China Medical University for molecular experimental technical support. This work was supported by the National Natural Science Foundation of China (81900544), Key disciplines-B neurosurgery of Shanghai Tenth People's Hospital (DS04! 02! 18014), and the Shanghai Sailing Program (No. 19YF1439000, No. 21YF1449900).	Arnold A, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00940-7; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Ebert MS, 2010, RNA, V16, P2043, DOI 10.1261/rna.2414110; Gong C, 2019, MOL CARCINOGEN, V58, P1863, DOI 10.1002/mc.23079; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; He JH, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1120-1; He QR, 2018, MOL THER-NUCL ACIDS, V10, P331, DOI 10.1016/j.omtn.2017.12.014; He ZW, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1065-7; Hsu PJ, 2019, J BIOL CHEM, V294, P19889, DOI 10.1074/jbc.AC119.010078; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang TZ, 2017, CANCER CELL, V32, P840, DOI 10.1016/j.ccell.2017.11.005; Jiang Y, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01691-y; Jiang Y, 2020, EBIOMEDICINE, V52, DOI 10.1016/j.ebiom.2020.102651; Jiang Y, 2019, EBIOMEDICINE, V48, P36, DOI 10.1016/j.ebiom.2019.09.037; Jiang Y, 2018, EBIOMEDICINE, V37, P78, DOI 10.1016/j.ebiom.2018.10.053; Jiang Y, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0210-1; Kosti A, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02115-y; Lapointe S, 2018, LANCET, V392, P432, DOI 10.1016/S0140-6736(18)30990-5; Li X, 2018, MOL CELL, V71, P428, DOI 10.1016/j.molcel.2018.06.034; Liang Tingyu, 2018, Chin Neurosurg J, V4, P24, DOI 10.1186/s41016-018-0132-9; Lin J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2474-4; Liu HL, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0016-4; Liu TZ, 2017, EXP THER MED, V14, P4681, DOI 10.3892/etm.2017.5201; Liu XB, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01625-8; Luo Z, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01203-8; Lyu DB, 2017, RNA BIOL, V14, P1000, DOI 10.1080/15476286.2016.1227904; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Quail DF, 2017, CANCER CELL, V31, P326, DOI 10.1016/j.ccell.2017.02.009; Sadik A, 2020, CELL, V182, P1252, DOI 10.1016/j.cell.2020.07.038; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Shao LQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1845-1; Shen LY, 2019, CANCER SCI, V110, P1735, DOI 10.1111/cas.13993; Sun JK, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1121-0; Suva ML, 2020, CANCER CELL, V37, P630, DOI 10.1016/j.ccell.2020.04.001; Wang ZL, 2021, ONCOGENE, V40, P1458, DOI 10.1038/s41388-020-01635-y; Wu PQ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1771-2; Xia DD, 2017, BIOCHEM BIOPH RES CO, V486, P191, DOI 10.1016/j.bbrc.2017.03.026; Xing Z, 2016, ONCOTARGET, V7, P75394, DOI 10.18632/oncotarget.12215; Yang XS, 2018, ONCOGENE, V37, P6399, DOI 10.1038/s41388-018-0416-8; Yang YB, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx166; Yu J, 2018, J HEPATOL, V68, P1214, DOI 10.1016/j.jhep.2018.01.012; Zalfa F, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.521; Zang JK, 2020, J NEUROSCI RES, V98, P87, DOI 10.1002/jnr.24356; Zeng Y, 2017, THERANOSTICS, V7, P3842, DOI 10.7150/thno.19764; Zhang J, 2019, INT J BIOCHEM CELL B, V114, DOI 10.1016/j.biocel.2019.06.005; Zhang J, 2017, J NEURO-ONCOL, V133, P553, DOI 10.1007/s11060-017-2464-2; Zhang LG, 2019, CANCER CELL, V36, P302, DOI 10.1016/j.ccell.2019.07.009; Zheng LX, 2018, EBIOMEDICINE, V38, P69, DOI 10.1016/j.ebiom.2018.11.009; Zhu ZL, 2019, THERANOSTICS, V9, P8294, DOI 10.7150/thno.36256	50	13	14	3	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4094	4110		10.1038/s41388-021-01833-2	http://dx.doi.org/10.1038/s41388-021-01833-2		MAY 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34017077				2022-12-26	WOS:000652439200005
J	Ishak, SNH; Kamarudin, NHA; Ali, MSM; Leow, ATC; Shariff, FM; Abd Rahman, RNZR				Ishak, Siti Nor Hasmah; Kamarudin, Nor Hafizah Ahmad; Ali, Mohd Shukuri Mohamad; Leow, Adam Thean Chor; Shariff, Fairolniza Mohd; Abd Rahman, Raja Noor Zaliha Raja			Structure elucidation and docking analysis of 5M mutant of T1 lipase Geobacillus zalihae	PLOS ONE			English	Article							THERMOSTABLE LIPASE; CRYSTAL-STRUCTURE; PROTEIN STRUCTURES; CRYSTALLIZATION; SIMULATION; TRANSESTERIFICATION; OPTIMIZATION; DYNAMICS; ENZYMES; MODELS	5M mutant lipase was derived through cumulative mutagenesis of amino acid residues (D43E/T118N/E226D/E250L/N304E) of T1 lipase from Geobacillus zalihae. A previous study revealed that cumulative mutations in 5M mutant lipase resulted in decreased thermostability compared to wild-type T1 lipase. Multiple amino acids substitution might cause structural destabilization due to negative cooperation. Hence, the three-dimensional structure of 5M mutant lipase was elucidated to determine the evolution in structural elements caused by amino acids substitution. A suitable crystal for X-ray diffraction was obtained from an optimized formulation containing 0.5 M sodium cacodylate trihydrate, 0.4 M sodium citrate tribasic pH 6.4 and 0.2 M sodium chloride with 2.5 mg/mL protein concentration. The three-dimensional structure of 5M mutant lipase was solved at 2.64 angstrom with two molecules per asymmetric unit. The detailed analysis of the structure revealed that there was a decrease in the number of molecular interactions, including hydrogen bonds and ion interactions, which are important in maintaining the stability of lipase. This study facilitates understanding of and highlights the importance of hydrogen bonds and ion interactions towards protein stability. Substrate specificity and docking analysis on the open structure of 5M mutant lipase revealed changes in substrate preference. The molecular dynamics simulation of 5M-substrates complexes validated the substrate preference of 5M lipase towards long-chain p-nitrophenyl-esters.	[Ishak, Siti Nor Hasmah; Kamarudin, Nor Hafizah Ahmad; Ali, Mohd Shukuri Mohamad; Leow, Adam Thean Chor; Shariff, Fairolniza Mohd; Abd Rahman, Raja Noor Zaliha Raja] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Enzyme & Microbial Technol Res Ctr, Serdang, Selangor, Malaysia; [Ishak, Siti Nor Hasmah; Shariff, Fairolniza Mohd; Abd Rahman, Raja Noor Zaliha Raja] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Serdang, Selangor, Malaysia; [Kamarudin, Nor Hafizah Ahmad] Univ Putra Malaysia, Ctr Fdn Studies Agr Sci, Serdang, Selangor, Malaysia; [Ali, Mohd Shukuri Mohamad] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Biochem, Serdang, Selangor, Malaysia; [Leow, Adam Thean Chor] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia; [Leow, Adam Thean Chor; Abd Rahman, Raja Noor Zaliha Raja] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia; [Abd Rahman, Raja Noor Zaliha Raja] Univ Putra Malaysia, Halal Prod Res Inst, Lab Halal Sci Res, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Abd Rahman, RNZR (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Enzyme & Microbial Technol Res Ctr, Serdang, Selangor, Malaysia.; Abd Rahman, RNZR (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Microbiol, Serdang, Selangor, Malaysia.; Abd Rahman, RNZR (corresponding author), Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia.; Abd Rahman, RNZR (corresponding author), Univ Putra Malaysia, Halal Prod Res Inst, Lab Halal Sci Res, Serdang, Selangor, Malaysia.	rnzaliha@upm.edu.my		Raja Abd. Rahman, Raja Noor Zaliha/0000-0002-6316-6177; Ishak, Siti Nor Hasmah/0000-0002-8392-2443	Ministry of Science, Technology, and Innovation, Malaysia [09-05-MGI-GMB001]	Ministry of Science, Technology, and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	Rahman RNZRA received funding by the Ministry of Science, Technology, and Innovation, Malaysia (09-05-MGI-GMB001).	Abdalla M., 2016, GLOB J BIOTECHNOL BI, V2, P25, DOI [10.17352/gjbbs.000008, DOI 10.17352/GJBBS.000008]; Abdullah A, 2019, RSC ADV, V9, P5599, DOI 10.1039/c8ra09418g; Abed SM, 2018, LWT-FOOD SCI TECHNOL, V93, P306, DOI 10.1016/j.lwt.2018.03.057; Carugo O, 2003, J APPL CRYSTALLOGR, V36, P125, DOI 10.1107/S0021889802020502; Chen G, 2017, INNOV FOOD SCI EMERG, V41, P267, DOI 10.1016/j.ifset.2017.03.016; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Damm KL, 2006, BIOPHYS J, V90, P4558, DOI 10.1529/biophysj.105.066654; Declerck N, 2002, BIOLOGIA, V57, P203; Duarte JG, 2016, FUEL, V177, P123, DOI 10.1016/j.fuel.2016.02.079; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hasan F, 2010, AFR J BIOTECHNOL, V9, P4836; Hussain CH., 2017, THESIS U PUTRA MALAY; Ishak SNH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102561; Ishak SNH, 2017, MOLECULES, V22, DOI 10.3390/molecules22101574; Jana S, 2002, PHOTOCH PHOTOBIO SCI, V1, P323, DOI 10.1039/c1pp05180f; Kanmani P, 2015, ELECTRON J BIOTECHN, V18, P20, DOI 10.1016/j.ejbt.2014.11.003; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kumari A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-1; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Latip W, 2016, PEERJ, V4, DOI 10.7717/peerj.2420; Leow TC, 2007, CRYST GROWTH DES, V7, P406, DOI 10.1021/cg050506z; Liu L, 2014, APPL ENVIRON MICROB, V80, P798, DOI 10.1128/AEM.03045-13; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matsumura H, 2008, PROTEINS, V70, P592, DOI 10.1002/prot.21799; Mazlan SNHS, 2018, INT J BIOL MACROMOL, V119, P1188, DOI 10.1016/j.ijbiomac.2018.08.022; McPherson A, 2014, ACTA CRYSTALLOGR F, V70, P1445, DOI 10.1107/S2053230X14019670; Moharana TR, 2019, BIOCHEM BIOPH RES CO, V508, P145, DOI 10.1016/j.bbrc.2018.11.105; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Omar KA, 2016, J FOOD SCI TECH MYS, V53, P1035, DOI 10.1007/s13197-015-2158-8; Sangeetha R., 2011, Research Journal of Microbiology, V6, P1, DOI 10.3923/jm.2011.1.24; Sani HA, 2018, MOL BIOTECHNOL, V60, P1, DOI 10.1007/s12033-017-0038-3; Shariff FM, 2011, INT J MOL SCI, V12, P2917, DOI 10.3390/ijms12052917; Sharma A, 2018, INT J BIOL MACROMOL, V107, P2131, DOI 10.1016/j.ijbiomac.2017.10.092; Souza IM., 2018, J BIOTECHNOL BIORES, V10, P1; Tirunagari H., 2018, PROCESS BIOCHEM, V65, P109, DOI [10.1016/j.procbio.2017.11.008, DOI 10.1016/J.PROCBIO.2017.11.008]; Tiwari GJ, 2016, J CEREAL SCI, V71, P43, DOI 10.1016/j.jcs.2016.07.008; Torpenholt S, 2015, COMPUT STRUCT BIOTEC, V13, P256, DOI 10.1016/j.csbj.2015.03.010; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Tyndall JDA, 2002, J MOL BIOL, V323, P859, DOI 10.1016/S0022-2836(02)01004-5; Uppada Sita Ramyasree, 2017, Journal of Genetic Engineering and Biotechnology, V15, P331, DOI 10.1016/j.jgeb.2017.07.008; Wu ZW, 2016, ENVIRON TOXICOL PHAR, V41, P259, DOI 10.1016/j.etap.2015.12.017; YIP KSP, 1995, STRUCTURE, V3, P1147, DOI 10.1016/S0969-2126(01)00251-9; Yuan DJ, 2016, BIOTECHNOL APPL BIOC, V63, P41, DOI 10.1002/bab.1338; Zhang LY, 2017, PROTEIN PEPTIDE LETT, V24, P643, DOI 10.2174/0929866524666170502151429; Zhao XB, 2015, RENEW SUST ENERG REV, V44, P182, DOI 10.1016/j.rser.2014.12.021; Zhao ZX, 2017, FEBS J, V284, P3506, DOI 10.1111/febs.14211	48	1	1	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0251751	10.1371/journal.pone.0251751	http://dx.doi.org/10.1371/journal.pone.0251751			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061877	gold, Green Published			2022-12-26	WOS:000656813600037
J	Bunch, TA; Guhathakurta, P; Lepak, VC; Thompson, AR; Kanassatega, RS; Wilson, A; Thomas, DD; Colson, BA				Bunch, Thomas A.; Guhathakurta, Piyali; Lepak, Victoria C.; Thompson, Andrew R.; Kanassatega, Rhye-Samuel; Wilson, Anna; Thomas, David D.; Colson, Brett A.			Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; REGULATORY DOMAIN; PHOSPHORYLATION; FRET; ACTIVATION; MODULATORS; MUTATIONS; MOTILITY	Cardiac myosin-binding protein C (cMyBP-C) interacts with actin and myosin to modulate cardiac muscle contractility. These interactions are disfavored by cMyBP-C phosphorylation. Heart failure patients often display decreased cMyBP-C phosphorylation, and phosphorylation in model systems has been shown to be cardioprotective against heart failure. Therefore, cMyBP-C is a potential target for heart failure drugs that mimic phosphorylation or perturb its interactions with actin/myosin. Here we have used a novel fluorescence lifetime-based assay to identify small-molecule inhibitors of actin-cMyBP-C binding. Actin was labeled with a fluorescent dye (Alexa Fluor 568, AF568) near its cMyBP-C binding sites; when combined with the cMyBP-C N-terminal fragment, C0-C2, the fluorescence lifetime of AF568-actin decreases. Using this reduction in lifetime as a readout of actin binding, a high-throughput screen of a 1280-compound library identified three reproducible hit compounds (suramin, NF023, and aurintricarboxylic acid) that reduced C0C2 binding to actin in the micromolar range. Binding of phosphorylated C0-C2 was also blocked by these compounds. That they specifically block binding was confirmed by an actin-C0-C2 time-resolved FRET (TR-FRET) binding assay. Isothermal titration calorimetry (ITC) and transient phosphorescence anisotropy (TPA) confirmed that these compounds bind to cMyBP-C, but not to actin. TPA results were also consistent with these compounds inhibiting C0-C2 binding to actin. We conclude that the actin-cMyBP-C fluorescence lifetime assay permits detection of pharmacologically active compounds that affect cMyBP-C-actin binding. We now have, for the first time, a validated high-throughput screen focused on cMyBP-C, a regulator of cardiac muscle contractility and known key factor in heart failure.	[Bunch, Thomas A.; Lepak, Victoria C.; Kanassatega, Rhye-Samuel; Colson, Brett A.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Guhathakurta, Piyali; Thompson, Andrew R.; Wilson, Anna; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	University of Arizona; University of Minnesota System; University of Minnesota Twin Cities	Colson, BA (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA.	bcolson@arizona.edu		Kanassatega, Rhye-Samuel/0000-0001-9007-6524; Thompson, Andrew/0000-0001-8537-6776; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [R37 AG26160, R01 HL141564]; University of Arizona Sarver Heart Center "Novel Research Project Award in the Area of Cardiovascular Disease and Medicine"	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arizona Sarver Heart Center "Novel Research Project Award in the Area of Cardiovascular Disease and Medicine"	This work was supported by National Institutes of Health grants R37 AG26160 (to D. D. T.) and R01 HL141564 (to B. A. C.) and a University of Arizona Sarver Heart Center "Novel Research Project Award in the Area of Cardiovascular Disease and Medicine" (to B. A. C). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arimura T, 2011, HUM MUTAT, V32, P1481, DOI 10.1002/humu.21603; Bunch TA, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012707; Bunch TA, 2019, J BIOL CHEM, V294, P16228, DOI 10.1074/jbc.RA119.009543; Bunch TA, 2018, J MOL CELL CARDIOL, V125, P140, DOI 10.1016/j.yjmcc.2018.10.009; Colson B. A., 2012, P NATL ACAD SCI USA; Colson BA, 2016, P NATL ACAD SCI USA, V113, P3233, DOI 10.1073/pnas.1521281113; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Guhathakurta P, 2018, J BIOL CHEM, V293, P12288, DOI 10.1074/jbc.RA118.002702; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; McNamara JW, 2019, P NATL ACAD SCI USA, V116, P11731, DOI 10.1073/pnas.1821660116; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; Mun JY, 2014, P NATL ACAD SCI USA, V111, P2170, DOI 10.1073/pnas.1316001111; Nag S, 2017, NAT STRUCT MOL BIOL, V24, P525, DOI 10.1038/nsmb.3408; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Previs MJ, 2016, P NATL ACAD SCI USA, V113, P3239, DOI 10.1073/pnas.1522236113; Previs MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400205; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Rebbeck RT, 2017, SLAS DISCOV, V22, P176, DOI 10.1177/1087057116674312; Risi C, 2018, STRUCTURE, V26, P1604, DOI 10.1016/j.str.2018.08.007; Robinett JC, 2019, J GEN PHYSIOL, V151, P645, DOI 10.1085/jgp.201812200; Rosas PC, 2015, CIRC-HEART FAIL, V8, P582, DOI 10.1161/CIRCHEARTFAILURE.114.001550; Schaaf T. M., 2018, BIOSENSORS-BASEL, P8; Schaaf TM, 2017, SLAS DISCOV, V22, P262, DOI 10.1177/1087057116680151; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Spudich JA, 2019, PFLUG ARCH EUR J PHY, V471, P701, DOI 10.1007/s00424-019-02259-2; Walcott S, 2015, BIOPHYS J, V108, P10, DOI 10.1016/j.bpj.2014.11.1852; Wang C, 2016, J MOL CELL CARDIOL, V96, P2, DOI 10.1016/j.yjmcc.2015.10.007; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	38	2	2	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100840	10.1016/j.jbc.2021.100840	http://dx.doi.org/10.1016/j.jbc.2021.100840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34052227	Green Published, gold			2022-12-26	WOS:000678068400040
J	Sohn, HB; Kim, SJ; Hong, SY; Park, SG; Oh, DH; Lee, S; Nam, HY; Nam, JH; Kim, YH				Sohn, Hwang-Bae; Kim, Su-Jeong; Hong, Su-Young; Park, Sin-Gi; Oh, Dong-Ha; Lee, Sunghoon; Nam, Hwa Yeun; Nam, Jung Hwan; Kim, Yul-Ho			Development of 50 InDel-based barcode system for genetic identification of tartary buckwheat resources	PLOS ONE			English	Article							FAGOPYRUM-ESCULENTUM MOENCH; CULTIVATED COMMON BUCKWHEAT; UV-B RADIATION; PHYLOGENETIC-RELATIONSHIPS; TATARICUM GAERTN.; WILD ANCESTOR; MANTEN-KIRARI; RUTIN CONTENT; RICE-TARTARY; EXPRESSION	Tartary buckwheat (Fagopyrum tataricum Gartn.) is a highly functional crop that is poised to be the target of many future breeding efforts. The reliable ex situ conservation of various genetic resources is essential for the modern breeding of tartary buckwheat varieties. We developed PCR-based co-dominant insertion/deletion (InDel) markers to discriminate tartary buckwheat genetic resources. First, we obtained the whole genome from 26 accessions across a superscaffold-scale reference genome of 569.37 Mb for tartary buckwheat cv. "Daegwan 3-7." Next, 171,926 homogeneous and 53,755 heterogeneous InDels were detected by comparing 26 accessions with the "Daegwan 3-7" reference sequence. Of these, 100 candidate InDels ranging from 5-20 bp in length were chosen for validation, and 50 of them revealed polymorphisms between the 26 accessions and "Daegwan 3-7." The validated InDels were further tested through the assessment of their likelihood to give rise to a single or a few PCR products in 50 other accessions, covering most tartary buckwheat genome types. The major allele frequencies ranged from 0.5616 at the TB42 locus to 0.9863 at the TB48 locus, with the average PIC value of 0.1532 with a range of 0.0267-0.3712. To create a user-friendly system, the homology of the genotypes between and among the accessions were visualized in both one- (1D) and two-dimensional (2D) barcode types by comparing amplicon polymorphisms with the reference variety, "Daegwan 3-7." A phylogenetic tree and population structure of the 76 accessions according to amplicon polymorphisms for the 50 InDel markers corresponded to those using non-synonymous single nucleotide polymorphism variants, indicating that the barcode system based on the 50 InDels was a useful tool to improve the reliability of identification of tartary buckwheat accessions in the germplasm stocks.	[Sohn, Hwang-Bae; Kim, Su-Jeong; Hong, Su-Young; Nam, Hwa Yeun; Nam, Jung Hwan; Kim, Yul-Ho] Natl Inst Crop Sci, Highland Agr Res Inst, Pyeongchang, Gangwon Do, South Korea; [Park, Sin-Gi] TherageneEtex Inc, TheragenEtex Bio Inst, Suwon, South Korea; [Oh, Dong-Ha] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Lee, Sunghoon] EONE DIAGNOMICS Genome Ctr Co Ltd, Incheon, South Korea	Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Louisiana State University System; Louisiana State University	Kim, YH (corresponding author), Natl Inst Crop Sci, Highland Agr Res Inst, Pyeongchang, Gangwon Do, South Korea.	kimyuh77@korea.kr	Oh, Dong-Ha/O-7591-2019	Oh, Dong-Ha/0000-0003-1526-9814	Co-operative Research Program for Agriculture Science and Technology Development - Rural Development Administration (RDA), Republic of Korea [PJ01189401]; TheragenEtex Inc.	Co-operative Research Program for Agriculture Science and Technology Development - Rural Development Administration (RDA), Republic of Korea; TheragenEtex Inc.	This study was financially supported by grants from Co-operative Research Program for Agriculture Science and Technology Development funded by the Rural Development Administration (RDA), Republic of Korea to YHK (Project No. PJ01189401) and TheragenEtex Inc. provided support for this study in the form of salaries for SGK. The specific role of this authors is articulated in the `author contributions' section. The RDA evaluated the project every year for 5 years (2016 similar to 2020) and had a role in decision to submit for publication, but the funders had no additional role in study design, data collection and analysis, or preparation of the manuscript.	Ahmed S, 2013, CONSERV LETT, V6, P28, DOI 10.1111/j.1755-263X.2012.00269.x; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Attaran E, 2008, MOL PLANT MICROBE IN, V21, P1482, DOI 10.1094/MPMI-21-11-1482; Bansal V, 2019, ISCIENCE, V18, P37, DOI 10.1016/j.isci.2019.06.035; Bellucci E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083891; Bevan MW, 2017, NATURE, V543, P346, DOI 10.1038/nature22011; Bhandari H.R., 2017, ADV PLANTS AGR RES, V7, P00255, DOI DOI 10.15406/APAR.2017.07.00255; Bisht IS, 2007, GENET RESOUR CROP EV, V54, P345, DOI 10.1007/s10722-005-5562-5; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bonafaccia G, 2003, FOOD CHEM, V80, P9, DOI 10.1016/S0308-8146(02)00228-5; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Chun Jae-Buhm, 2019, [Korean Journal of Plant Reources., 한국자원식물학회지], V32, P519, DOI 10.7732/kjpr.2019.32.5.519; Deletre M, 2011, P NATL ACAD SCI USA, V108, P18249, DOI 10.1073/pnas.1106259108; EGGUM BO, 1980, QUAL PLANT, V30, P175, DOI 10.1007/BF01094020; Ericksen PJ, 2008, GLOBAL ENVIRON CHANG, V18, P234, DOI 10.1016/j.gloenvcha.2007.09.002; Fabjan N, 2003, J AGR FOOD CHEM, V51, P6452, DOI 10.1021/jf034543e; Germ M, 2013, CEREAL RES COMMUN, V41, P97, DOI 10.1556/CRC.2012.0031; Gupta N, 2011, J PLANT PHYSIOL, V168, P2117, DOI 10.1016/j.jplph.2011.06.018; Halbrecq B, 2005, EUR J AGRON, V23, P209, DOI 10.1016/j.eja.2004.11.006; Hollister JD, 2010, MOL BIOL EVOL, V27, P409, DOI 10.1093/molbev/msp249; Hou SY, 2016, PLANT MOL BIOL REP, V34, P233, DOI 10.1007/s11105-015-0907-5; Hou XH, 2010, PLANT J, V63, P880, DOI 10.1111/j.1365-313X.2010.04277.x; Hu YY, 2016, FOOD FUNCT, V7, P1523, DOI 10.1039/c5fo01467k; Huang SF, 2017, BIOINFORMATICS, V33, P2577, DOI 10.1093/bioinformatics/btx220; Huang WJ, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101806; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Reyes-Valdes MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079936; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Islam MS, 2009, BMB REP, V42, P611, DOI 10.5483/BMBRep.2009.42.9.611; Jackson L, 2010, CURR OPIN ENV SUST, V2, P80, DOI 10.1016/j.cosust.2010.02.007; Janwan M., 2013, Journal of Plant Sciences, V8, P24; Jiang P, 2007, FOOD RES INT, V40, P356, DOI 10.1016/j.foodres.2006.10.009; Jones MK, 2009, SCIENCE, V324, P730, DOI 10.1126/science.1172082; Joshi B. K., 2005, Fagopyrum, V22, P77; Katsu K, 2019, FOOD CHEM, V295, P51, DOI 10.1016/j.foodchem.2019.05.087; Kim Su Jeong, 2017, [Korean Journal of Food Science and Technology, 한국식품과학회지], V49, P258, DOI 10.9721/KJFST.2017.49.3.258; Kim YH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-477; Kreft I., 2003, Fagopyrum, V20, P7; Kreft I, 2006, FOOD CHEM, V98, P508, DOI 10.1016/j.foodchem.2005.05.081; Kreft S, 2002, J EXP BOT, V53, P1801, DOI 10.1093/jxb/erf032; Langlois-Meurinne M, 2005, PLANT PHYSIOL, V139, P1890, DOI 10.1104/pp.105.067223; LEISHMAN MR, 1995, J ECOL, V83, P517, DOI 10.2307/2261604; Li CH, 2019, BREEDING SCI, V69, P464, DOI 10.1270/jsbbs.18081; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SQ, 2001, CRIT REV FOOD SCI, V41, P451, DOI 10.1080/20014091091887; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu MY, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5036-8; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Matsuura A, 2005, PLANT PROD SCI, V8, P533, DOI 10.1626/pps.8.533; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng HT, 2015, SCI REP-UK, V5, DOI 10.1038/srep08260; Moghaddam SM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00185; Murai M, 1996, GENES GENET SYST, V71, P211, DOI 10.1266/ggs.71.211; Ohnishi O, 1998, ECON BOT, V52, P123, DOI 10.1007/BF02861199; Ohnishi O, 1996, GENES GENET SYST, V71, P383, DOI 10.1266/ggs.71.383; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Pandey V, 2014, PLANTA, V239, P1217, DOI 10.1007/s00425-014-2046-x; Perrier X., 2006, DARWIN SOFTWARE; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; [屈洋 Qu Yang], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P2049; Rogers SO, 1994, PLANT MOL BIOL MANUA, P1; Singh SP, 2001, CROP SCI, V41, P1659, DOI 10.2135/cropsci2001.1659; Sohn HB, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00520; Sohn HwangBae, 2018, Korean Journal of Breeding Science, V50, P396, DOI 10.9787/KJBS.2018.50.4.396; Spengler RN, 2020, TRENDS PLANT SCI, V25, P340, DOI 10.1016/j.tplants.2020.01.005; Steadman KJ, 2001, J SCI FOOD AGR, V81, P1094, DOI 10.1002/jsfa.914; Suzuki T, 2014, BREEDING SCI, V64, P344, DOI 10.1270/jsbbs.64.344; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Tsuji K, 2000, GENET RESOUR CROP EV, V47, P431, DOI 10.1023/A:1008741513277; Tsuji K, 2001, GENES GENET SYST, V76, P47, DOI 10.1266/ggs.76.47; Tsuji K, 2001, GENET RESOUR CROP EV, V48, P63, DOI 10.1023/A:1011286326401; Vali U, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-8; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Vigouroux Y, 2011, CR BIOL, V334, P450, DOI 10.1016/j.crvi.2011.03.003; Wang LJ, 2013, IND CROP PROD, V49, P312, DOI 10.1016/j.indcrop.2013.04.039; Wang YJ, 2007, EUPHYTICA, V156, P399, DOI 10.1007/s10681-007-9389-3; Yasui Y, 1998, GENES GENET SYST, V73, P201, DOI 10.1266/ggs.73.201; Yasui Y, 2016, DNA RES, V23, P215, DOI 10.1093/dnares/dsw012; Zhang LJ, 2020, GENES-BASEL, V11, DOI 10.3390/genes11040459; Zhang LJ, 2017, MOL PLANT, V10, P1224, DOI 10.1016/j.molp.2017.08.013; Zhang ZW, 2013, ACTA HORTIC, V979, P407	82	3	3	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0250786	10.1371/journal.pone.0250786	http://dx.doi.org/10.1371/journal.pone.0250786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081692	gold, Green Published			2022-12-26	WOS:000664639200004
J	Rodriguez-Reyes, O; Estrada-Ruiz, E; Dussan, CM; Brito, LD; Terrazas, T				Rodriguez-Reyes, Oris; Estrada-Ruiz, Emilio; Dussan, Camila Monje; Brito, Lilian de Andrade; Terrazas, Teresa			A new Oligocene-Miocene tree from Panama and historical Anacardium migration patterns	PLOS ONE			English	Article							FOSSIL WOODS; EOCENE; BIOGEOGRAPHY; EVOLUTION; REVEAL; FAMILY; FRUITS	Migration of Boreotropical megathermal taxa during the Oligocene and Miocene played a key role in assembling diversity in tropical regions. Despite scattered fossil reports, the cashew genus Anacardium offers an excellent example of such migration. The fossil woods described here come from localities in Veraguas, Panama mapped as Oligocene-Miocene. We studied, described, and identified two well-preserved specimens using wood anatomical characteristics and completed extensive comparisons between fossil and extant material. The studied fossil woods share several diagnostic features with the modern Anacardium genus, including large solitary vessels, large intervessel-pitting, a simple vessel-ray pitting pattern, and mostly 1-3 seriate rays with large rhomboidal solitary crystals. We propose a new fossil species named Anacardium gassonii sp. nov., that adds an essential piece to the understanding of the historical biogeography of the genus. In addition, our findings confirm previous interpretations of this species' migration from Europe to North America and its crossing through Panama, leading to subsequent diversification in South America. This discovery provides an important link to the historical migration patterns of the genus, supporting the notion of an Eocene migration to the Neotropics via Boreotropical bridges, as well as an Oligocene-Miocene crossing of Central America followed by diversification in South America.	[Rodriguez-Reyes, Oris] Univ Panama, Estafeta Univ, Inst Ciencias Ambientales & Biodiversidad, Panama City, Panama; [Rodriguez-Reyes, Oris] Smithsonian Trop Res Inst, Panama City, Panama; [Estrada-Ruiz, Emilio] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Lab Ecol, Dept Zool, Mexico City, DF, Mexico; [Dussan, Camila Monje] Univ Sao Paulo, Dept Bot, Inst Biociencias, Rua Matao,Cidade Univ, Sao Paulo, SP, Brazil; [Brito, Lilian de Andrade] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Dept Bot, Rio De Janeiro, RJ, Brazil; [Terrazas, Teresa] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City, DF, Mexico	Universidad de Panama; Smithsonian Institution; Smithsonian Tropical Research Institute; Instituto Politecnico Nacional - Mexico; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidad Nacional Autonoma de Mexico	Rodriguez-Reyes, O (corresponding author), Univ Panama, Estafeta Univ, Inst Ciencias Ambientales & Biodiversidad, Panama City, Panama.; Rodriguez-Reyes, O (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	oris.rodriguez@up.ac.pa		Rodriguez Reyes, Oris/0000-0002-2976-0017	Secretaria Nacional de Ciencia, Tecnologia e Innovacion [ITE16-R1-023]	Secretaria Nacional de Ciencia, Tecnologia e Innovacion	Specimens described and analyzed in this work were obtained during field work sponsored by the Secretaria Nacional de Ciencia, Tecnologia e Innovacion grant ITE16-R1-023 to Oris Rodriguez. SENACYT did not play any role in the study design, data analysis, or decision to publish.	[Anonymous], 2021, NATURAL EARTH; Buchs DM, 2011, GEOLOGY, V39, P335, DOI 10.1130/G31703.1; DONG ZM, 1993, IAWA J, V14, P87, DOI 10.1163/22941932-90000580; Estrada-Ruiz E, 2010, AM J BOT, V97, P1179, DOI 10.3732/ajb.0900234; Gupta S, 2008, IAWA J, V29, P79, DOI 10.1163/22941932-90000172; Hernandez-Damian AL, 2019, EARTH ENV SCI T R SO, V108, P471, DOI 10.1017/S1755691018000701; Herrera F, 2019, INT J PLANT SCI, V180, P479, DOI 10.1086/703551; Herrera F, 2012, REV PALAEOBOT PALYNO, V175, P10, DOI 10.1016/j.revpalbo.2012.02.007; Hooghiemstra H, 2006, ANN MO BOT GARD, V93, P297, DOI 10.3417/0026-6493(2006)93[297:TPROCI]2.0.CO;2; Jud NA, 2017, IAWA J, V38, P366, DOI 10.1163/22941932-20170176; Kolarsky R.A., 1995, GEOL S AM S, P159, DOI 10.1130/spe295-p159; Kruse H.O., 1954, OHIO J SCI, V54, P243; Leon H. W. J., 2014, Pittieria, P1; Leon H. Williams J., 2003, Acta Botanica Venezuelica, V26, P1; Mabberley D. J., 2008, MABBERLEYS PLANT BOO; Madel E., SENCKENBERG LETHAEA, V43, P283; Manchester SR, 2007, INT J PLANT SCI, V168, P1199, DOI 10.1086/520728; Martinez-Cabrera HI, 2004, IAWA J, V25, P103, DOI 10.1163/22941932-90000353; MITCHELL J D, 1987, Memoirs of the New York Botanical Garden, V42, P1; Montes C., 2020, GEOLOGY COLOMBIA PAL, V3, P451, DOI [10.32685/pub.esp.37.2019.15, DOI 10.32685/PUB.ESP.37.2019.15]; Muellner-Riehl AN, 2016, TAXON, V65, P1019, DOI 10.12705/655.5; Ogata K., IDENTIFICATION TIMBE; Pell S. K., 2011, V10, P7; Perez-Lara DK, 2017, IAWA J, V38, P543, DOI 10.1163/22941932-20170179; Pons D, 2007, B GEOSCI, V82, P343, DOI 10.3140/bull.geosci.2007.04.343; Poole I., 2009, IAWA J, V6, P1; Pujana RR., REV MUSEO ARGENTINO, V13, P183; QGIS.org, 2020, QGIS VERSION 31416 S; Rodriguez-Reyes O, 2020, BOL SOC GEOL MEX, V72, DOI [10.18268/BSGM2020v72n2a300719, 10.18268/bsgm2020v72n2a300719]; Shukla A, 2016, J GEOL SOC INDIA, V87, P520, DOI 10.1007/s12594-016-0425-6; Terrazas, 1999, B SOC BOT MEX, V64, P103, DOI [10.17129/botsci.1587, DOI 10.17129/BOTSCI.1587]; Terrazas T.S., 1994, WOOD ANATOMY ANACARD; Weeks A, 2005, MOL PHYLOGENET EVOL, V35, P85, DOI 10.1016/j.ympev.2004.12.021; Weeks A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00409; Wheeler EA, 2002, IAWA J, P4; Wheeler EA, 2011, IAWA J, V32, P199, DOI 10.1163/22941932-90000051; Woodcock DW, 2017, IAWA J, V38, P313, DOI 10.1163/22941932-20170175; Xie L, 2014, MOL PHYLOGENET EVOL, V77, P136, DOI 10.1016/j.ympev.2014.04.006; Yang YY, 2016, S AFR J BOT, V106, P129, DOI 10.1016/j.sajb.2016.05.021; Yi TS, 2004, MOL PHYLOGENET EVOL, V33, P861, DOI 10.1016/j.ympev.2004.07.006; Yusnizar J., 2003, B GEOL SOC MALAYS, V46, P401; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	42	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0250721	10.1371/journal.pone.0250721	http://dx.doi.org/10.1371/journal.pone.0250721			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077439	Green Published, gold			2022-12-26	WOS:000664638500007
J	Lior, C; Hodge, F; De-Souza, EA; Bourboulia, D; Calderwood, SK; David, D; Drummond, DA; Edkins, A; Morimoto, RI; Prahlad, V; Rechavi, O; Sistonen, L; Wilson, M; Wiseman, RL; Zanetti, M; Taylor, R; Scherz-Shouval, R; van Oosten-Hawle, P				Lior, Chen; Hodge, Francesca; De-Souza, Evandro A.; Bourboulia, Dimitra; Calderwood, Stuart K.; David, Della; Allan Drummond, D.; Edkins, Adrienne; Morimoto, Richard I.; Prahlad, Veena; Rechavi, Oded; Sistonen, Lea; Wilson, Mark; Wiseman, R. Luke; Zanetti, Maurizio; Taylor, Rebecca; Scherz-Shouval, Ruth; van Oosten-Hawle, Patricija			The 2021 FASEB Virtual Catalyst Conference on Extracellular and Organismal Proteostasis in Health and Disease, February 3-4, 2021	FASEB JOURNAL			English	Editorial Material							STRESS; INFLAMMATION; CHAPERONES		[Lior, Chen; Scherz-Shouval, Ruth] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel; [Hodge, Francesca; van Oosten-Hawle, Patricija] Univ Leeds, Sch Mol & Cell Biol, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [De-Souza, Evandro A.; Taylor, Rebecca] Med Res Council Lab Mol Biol, Div Neurobiol, Cambridge, England; [Bourboulia, Dimitra] SUNY Upstate Med Univ, Dept Urol, Dept Biochem & Mol Biol, Upstate Canc Ctr, Syracuse, NY 13210 USA; [Calderwood, Stuart K.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiat Oncol, Boston, MA 02115 USA; [David, Della] Univ Tubingen, German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Allan Drummond, D.] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA; [Edkins, Adrienne] Rhodes Univ, Dept Biochem & Microbiol, Biomed Biotechnol Res Unit, Grahamstown, South Africa; [Morimoto, Richard I.] Northwestern Univ, Dept Mol Biosci, Evanston, IL USA; [Prahlad, Veena] Univ Iowa, Dept Biol, Aging Mind & Brain Initiat, Iowa City, IA 52242 USA; [Rechavi, Oded] Tel Aviv Univ, Dept Neurobiol, Wise Fac Life Sci, Tel Aviv, Israel; [Rechavi, Oded] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Sistonen, Lea] Abo Akad Univ, Dept Cell Biol, Turku, Finland; [Sistonen, Lea] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Sistonen, Lea] Abo Akad Univ, Turku, Finland; [Wilson, Mark] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Wiseman, R. Luke] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Zanetti, Maurizio] Univ Calif San Diego, Dept Med, Immunol Lab, La Jolla, CA 92093 USA; [Zanetti, Maurizio] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Weizmann Institute of Science; University of Leeds; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Chicago; Rhodes University; Northwestern University; University of Iowa; Tel Aviv University; Tel Aviv University; Abo Akademi University; University of Turku; Abo Akademi University; University of Wollongong; Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Scherz-Shouval, R (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel.; van Oosten-Hawle, P (corresponding author), Univ Leeds, Sch Mol & Cell Biol, Leeds LS2 9JT, W Yorkshire, England.; van Oosten-Hawle, P (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	ruth.shouval@weizmann.ac.il; p.vanoosten-hawle@leeds.ac.uk	de Souza, Evandro Araujo/G-3696-2014; Edkins, Adrienne L/C-8704-2012; van Oosten-Hawle, Patricija/GVS-1791-2022; Wilson, Mark R/B-3254-2018	de Souza, Evandro Araujo/0000-0002-9080-3864; Edkins, Adrienne L/0000-0002-3615-6651; Wilson, Mark R/0000-0002-9551-7445; Sistonen, Lea/0000-0003-1341-2867; Prahlad, Veena/0000-0002-0413-6074; Taylor, Rebecca/0000-0003-3429-3123	Medical Research Council [MC_UP_1201/7] Funding Source: Medline; NIA NIH HHS [RF1 AG057296, R37 AG026647, P01 AG049665, P01 AG054407] Funding Source: Medline; NIGMS NIH HHS [R01 GM139932] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker-Williams AJ, 2019, CELL REP, V28, P1894, DOI 10.1016/j.celrep.2019.07.045; Chakraborty A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020272; Das S, 2020, ELIFE, V9, DOI 10.7554/eLife.55246; Gallotta I, 2020, NATURE, V584, P410, DOI 10.1038/s41586-020-2461-z; Grunberg N, 2021, CANCER RES, V81, P1639, DOI 10.1158/0008-5472.CAN-20-2756; Levi-Galibov O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20054-x; Luoto J.C., 2020, IN VIVO MIMICKING 3D, DOI [10.1101/2020.12.22.423913, DOI 10.1101/2020.12.22.423913]; O'Brien D, 2018, CELL REP, V23, P3905, DOI 10.1016/j.celrep.2018.05.093; Ozbey NP, 2020, DEV CELL, V55, P754, DOI 10.1016/j.devcel.2020.10.024; Posner R, 2019, CELL, V177, P1814, DOI 10.1016/j.cell.2019.04.029; Riback JA, 2017, CELL, V168, P1028, DOI 10.1016/j.cell.2017.02.027; Rodvold JJ, 2016, CANCER LETT, V380, P227, DOI 10.1016/j.canlet.2015.09.009; Romine Isabelle C, 2020, Biochem J, V477, P1721, DOI 10.1042/BCJ20190312; Sala AJ, 2020, GENE DEV, V34, P678, DOI 10.1101/gad.335422.119; Sanchez-Pozo J, 2018, ISCIENCE, V1, P87, DOI 10.1016/j.isci.2018.02.004; Vihervaara A, 2021, MOL CELL, V81, P1715, DOI 10.1016/j.molcel.2021.03.007; Wyatt AR, 2013, ANNU REV BIOCHEM, V82, P295, DOI 10.1146/annurev-biochem-072711-163904	17	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21631	10.1096/fj.202100566	http://dx.doi.org/10.1096/fj.202100566			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34046940	Green Accepted			2022-12-26	WOS:000655695900063
J	Vasantha, M; Muniyandi, M; Ponnuraja, C; Srinivasan, R; Venkatesan, P				Vasantha, Mahalingam; Muniyandi, Malaisamy; Ponnuraja, Chinnaiyan; Srinivasan, Ramalingam; Venkatesan, Perumal			Bayesian structural equation modeling for post treatment health related quality of life among tuberculosis patients	PLOS ONE			English	Article							IMPACT	Background The use of Bayesian Structural Equation Model (BSEM) to evaluate the impact of TB on self-reported health related quality of life (HRQoL) of TB patients has been not studied. Objective To identify the factors that contribute to the HRQoL of TB patients using BSEM. Methods This is a latent variable modeling with Bayesian approach using secondary data. HRQoL data collected after one year from newly diagnosed 436 TB patients who were registered and successfully completed treatment at Government health facilities in Tiruvallur district, south India under the National TB Elimination Programme (NTEP) were used for this analysis. In this study, the four independent latent variables such as physical well-being (PW = PW1-7), mental well-being (MW = MW1-7), social well-being (SW = SW1-4) and habits were considered. The BSEM was constructed using Markov Chain Monte Carlo algorithm for identifying the factors that contribute to the HRQoL of TB patients who completed treatment. Results Bayesian estimates were obtained using 46,300 observations after convergence and the standardized structural regression estimate of PW, MW, SW on HRQoL were 0.377 (p<0.001), 0.543 (p<0.001) and 0.208 (p<0.001) respectively. The latent variables PW, MW and SW were significantly associated with HRQoL of TB patients. The age was found to be significantly negatively associated with HRQoL of TB patients. Conclusions The current study demonstrated the application of BSEM in evaluating HRQoL. This methodology may be used to study precise estimates of HRQoL of TB patients in different time points.	[Vasantha, Mahalingam; Ponnuraja, Chinnaiyan; Srinivasan, Ramalingam; Venkatesan, Perumal] Indian Council Med Res, ICMR Natl Inst Res TB, Dept Stat, Chennai, Tamil Nadu, India; [Muniyandi, Malaisamy] Indian Council Med Res, ICMR Natl Inst Res TB, Dept Hlth Econ, Chennai, Tamil Nadu, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT)	Vasantha, M (corresponding author), Indian Council Med Res, ICMR Natl Inst Res TB, Dept Stat, Chennai, Tamil Nadu, India.	vasantha_m@nirt.res.in		Mahalingam, Vasantha/0000-0003-0390-346X				Ansari A, 2002, PSYCHOMETRIKA, V67, P49, DOI 10.1007/BF02294709; Atif M, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-19; Bauer M, 2013, QUAL LIFE RES, V22, P2213, DOI 10.1007/s11136-012-0329-x; Dujaili JA, 2015, INT J INFECT DIS, V31, P4, DOI 10.1016/j.ijid.2014.12.004; Guo N, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-14; Jenatabadi HS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182311; Kastien-Hilka T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174605; Lee S.-Y., 2007, STRUCTURAL EQUATION; Lee SY, 2000, STRUCT EQU MODELING, V7, P411, DOI 10.1207/S15328007SEM0703_3; Lee SY, 2004, BRIT J MATH STAT PSY, V57, P131, DOI 10.1348/000711004849204; Li CT, 2017, J INT MED RES, V45, P610, DOI 10.1177/0300060517694491; Muniyandi M, 2007, INT J TUBERC LUNG D, V11, P887; Oort FJ, 2005, QUAL LIFE RES, V14, P599, DOI 10.1007/s11136-004-0831-x; Radzi CWJBWM, 2016, SYMMETRY-BASEL, V8, DOI 10.3390/sym8120141; Rajeswari R, 2005, SOC SCI MED, V60, P1845, DOI 10.1016/j.socscimed.2004.08.024; Scheines R, 1999, PSYCHOMETRIKA, V64, P37, DOI 10.1007/BF02294318; Staquet MJ, 1998, OX MED PUBL, P337; Stenling A, 2015, J SPORT EXERCISE PSY, V37, P410, DOI 10.1123/jsep.2014-0330; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	20	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252205	10.1371/journal.pone.0252205	http://dx.doi.org/10.1371/journal.pone.0252205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PN	34048437	gold, Green Published, Green Accepted			2022-12-26	WOS:000664636100024
J	Cheza, A; Tlou, B; Zhou, DT				Cheza, Alexander; Tlou, Boikhutso; Zhou, Danai Tavonga			Incidence of non-communicable diseases (NCDs) in HIV patients on ART in a developing country: Case of Zimbabwe's Chitungwiza Central Hospital-A retrospective cohort study (2010-2019)	PLOS ONE			English	Article							BURDEN	Introduction The incidence of non-communicable diseases (NCDs) has been reported to be rising over the years leading up to 2010. In Zimbabwe, there are few studies done to examine the incidence of NCDs in people living with HIV (PLHIV) on anti-retroviral treatment (ART). Objective To determine the incidence of NCDs in HIV patients on ART at the Chitungwiza Central Hospital over ten years and the associated risk factors. Methods This was a retrospective cohort study using data from 203 patients enrolled on ART at the Chitungwiza Central Hospital between 2010 and 2019. All 500 records were considered and the selection was based on participants' consenting to the study and their strict adherence to ART without absconding. The incidence of NCDs was determined and generalized estimating equations (GEE) were used to estimate the association between NCDs and the selected risk factors. Findings Data collected at the study's baseline (2010) showed that the most prevalent NCD was hypertension, found in (18/203) 8.9% of the study participants, followed by diabetes (6.9%), then followed by cardiovascular diseases (CVD) (3.9%), and the least common NCD was cancer (1.9%). Incidences of all of these NCDs showed an increasing trend as the time of follow-up progressed. The factors found to be significantly associated with the development of NCDs were gender (p = 0.002) and follow-up time (p<0.001). Geographical location was a significant risk factor as urban patients were more likely to develop hypertension as compared to the peri-urban patients (p = 0.001). Conclusions NCDs and HIV comorbidity is common with women more likely than males to develop NCDs as they advance in age. There is need to devise targeted intervention approach to the respective NCDs and risk factors since they affect differently in relation to the demographic details of the participants. Recommendations This paper recommends a multi-stakeholder approach to the management of NCDs, with researchers, clinicians and the government and its various arms taking a leading role.	[Cheza, Alexander; Tlou, Boikhutso] Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Durban, South Africa; [Zhou, Danai Tavonga] Univ Zimbabwe, Coll Hlth Sci, Dept Med Lab Sci, Harare, Zimbabwe	University of Kwazulu Natal; University of Zimbabwe	Cheza, A (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Sch Nursing & Publ Hlth, Durban, South Africa.	218086530@stu.ukzn.ac.za	TLOU, BOIKHUTSO/AEA-3161-2022	Cheza, Alexander/0000-0002-4730-3151				Achwoka D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235606; Achwoka D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6716-2; Amuche N. J., 2017, Asian Pacific Journal of Tropical Disease, V7, P239, DOI 10.12980/apjtd.7.2017D6-366; Bigna JJ, 2019, LANCET GLOB HEALTH, V7, pE1295, DOI 10.1016/S2214-109X(19)30370-5; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; George S, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3956-9; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Haregu TN., 2015, INT J HEALTHCARE, V1, P21, DOI [10.5430/ijh.v1n1p21, DOI 10.5430/IJH.V1N1P21]; Heneghan C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003298; Kansiime S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221022; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; Megerso A, 2016, HIV AIDS-RES PALLIAT, V8, P83, DOI 10.2147/HIV.S98137; Mudie K, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020409; Ndlovu Q., 14 ZIM AD HIV POS ZI; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Smit M, 2018, AIDS, V32, P773, DOI [10.1097/QAD.0000000000001754, 10.1097/qad.0000000000001754]; UNAIDS, 2020, GLOB AIDS UPD SEIZ M; World Health Organisation, 2018, NONC DIS FACT SHEET; World Health Organization, GLOB DAT BOD MASS IN	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252180	10.1371/journal.pone.0252180	http://dx.doi.org/10.1371/journal.pone.0252180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043718	gold, Green Published			2022-12-26	WOS:000664635700065
J	Davies, N; De Souza, T; Rait, G; Meehan, J; Sampson, EL				Davies, Nathan; De Souza, Tanisha; Rait, Greta; Meehan, Jessica; Sampson, Elizabeth L.			Developing an applied model for making decisions towards the end of life about care for someone with dementia	PLOS ONE			English	Article							PEOPLE; SUPPORT	Background Many people with dementia reach the end-of-life without an advance care plan. Many are not ready to have conversations about end-of-life, and decision-making is left to their families and professionals when they no longer have capacity. Carers may benefit from further support with decision-making. To develop this support, it is important to understand the decision-making process. Aim Explore with family carers and people living with dementia the decision-making process and factors that influence decision-making in dementia end of life care, to produce a model of decision-making in the context of dementia end-of-life care. Methods Semi-structured interviews with 21 family carers and 11 people with dementia in England (2018-2019) from memory clinics, general practice and carer organisations. Interviews were analysed using thematic analysis and findings were mapped onto the Interprofessional Shared Decision Making model, refined to produce a modified model of decision-making in dementia. Results Participants described five key decisions towards the end-of-life as examples of decision making. We used these experiences to produce a modified model of decision-making in dementia end-of-life-care. The model considers the contextual factors that influence the decision-making process, including: personal preferences; advance care planning and Lasting Power of Attorney; capacity and health and wellbeing of the person with dementia; support from others and clarity of roles. The decision-making process consists of seven inter-linked stages: 1) identifying the decision maker or team; 2) sharing and exchanging information; 3) clarifying values and preferences; 4) managing and considering emotions; 5) considering the feasibility of options; 6) balancing preferred choice and the actual choice; and 7) implementation and reflecting on outcomes. Conclusions The modified model breaks down the decision-making process and attempts to simplify the process while capturing the subtle nuances of decision making. It provides a framework for conversations and supporting decisions by carers.	[Davies, Nathan; De Souza, Tanisha; Rait, Greta; Meehan, Jessica] UCL, Res Dept Primary Care & Populat Hlth, Ctr Ageing Populat Studies, London, England; [Davies, Nathan; Sampson, Elizabeth L.] UCL, Marie Curie Palliat Care Res Dept, Div Psychiat, Ctr Dementia Palliat Care Res, London, England; [Sampson, Elizabeth L.] North Middlesex Univ Hosp, Barnet Enfield & Haringey Mental Hlth Trust Liais, London, England	University of London; University College London; University of London; University College London	Davies, N (corresponding author), UCL, Res Dept Primary Care & Populat Hlth, Ctr Ageing Populat Studies, London, England.; Davies, N (corresponding author), UCL, Marie Curie Palliat Care Res Dept, Div Psychiat, Ctr Dementia Palliat Care Res, London, England.	n.m.davies@ucl.ac.uk	Meehan, Jessica/HHS-2638-2022; Sampson, Elizabeth L/B-8647-2009	Sampson, Elizabeth L/0000-0001-8929-7362; Davies, Nathan/0000-0001-7757-5353	Alzhiemer's Society [AS-JF-16b-012]	Alzhiemer's Society	This work was supported by Alzhiemer's Society [grant number: AS-JF-16b-012]. ND, GR, ELS received the award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.alzheimers.org.uk/.	Anantapong K, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01931-y; Arcand M, 2005, COMFORT CARE END LIF; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cooper C, 2010, AM J GERIAT PSYCHIAT, V18, P193, DOI 10.1097/JGP.0b013e3181bf9caf; Davies N., 2020, SUPPORTING YOU MAKE; Davies N, 2019, INT PSYCHOGERIATR, V31, P1403, DOI 10.1017/S1041610219000826; Davies N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206422; Davies N, 2017, PALLIATIVE MED, V31, P726, DOI 10.1177/0269216316673552; Davies N, 2014, PALLIATIVE MED, V28, P919, DOI 10.1177/0269216314526766; Davies N, 2014, AGING MENT HEALTH, V18, P400, DOI 10.1080/13607863.2013.843157; de Boer ME., 2012, AJOB PRIMARY RES, V3, P14, DOI [10.1080/21507716.2011.636784, DOI 10.1080/21507716.2011.636784]; Dening KH, 2013, PALLIATIVE MED, V27, P409, DOI 10.1177/0269216312464094; Dening KH, 2017, INT J PALLIAT NURS, V23, P4, DOI 10.12968/ijpn.2017.23.1.4; Donnelly S, 2019, DEMENTIA-LONDON, V18, P2985, DOI 10.1177/1471301218763180; Fetherstonhaugh D, 2019, DEMENTIA-LONDON, V18, P1601, DOI 10.1177/1471301217721862; Fetherstonhaugh D, 2013, J AGING STUD, V27, P143, DOI 10.1016/j.jaging.2012.12.007; Forbes S, 2000, J NURS SCHOLARSHIP, V32, P251, DOI 10.1111/j.1547-5069.2000.00251.x; Frost J, 2018, HEALTH EXPECT, V21, P1111, DOI 10.1111/hex.12814; Garvelink MM, 2016, HEALTH AFFAIR, V35, P619, DOI 10.1377/hlthaff.2015.1375; Garvelink MM, 2019, GERONTOLOGIST, V59, P822, DOI 10.1093/geront/gny073; Herrmann LK, 2018, AM J GERIAT PSYCHIAT, V26, P316, DOI 10.1016/j.jagp.2017.09.006; Hill SR, 2017, INT J GERIATR PSYCH, V32, P1037, DOI 10.1002/gps.4564; Hughes R, 2002, J ADV NURS, V37, P382, DOI 10.1046/j.1365-2648.2002.02100.x; Jones K, 2019, DEMENTIA-LONDON, V18, P825, DOI 10.1177/1471301216676121; Lamahewa K, 2018, HEALTH EXPECT, V21, P118, DOI 10.1111/hex.12593; Legare F, 2011, J EVAL CLIN PRACT, V17, P554, DOI 10.1111/j.1365-2753.2010.01515.x; Lewis F., 2014, TRAJECTORY DEMENTIA; Livingston G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4184; Mathew R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010416; McCleary L, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1882-9; Miller LM, 2016, DEMENTIA-LONDON, V15, P1141, DOI 10.1177/1471301214555542; Moore KJ, 2020, INT PSYCHOGERIATR, V32, P1245, DOI 10.1017/S1041610220000745; Moore KJ, 2020, INT PSYCHOGERIATR, V32, P753, DOI 10.1017/S1041610220000289; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; National Institute for Health and Care Excellence, DEM ASS MAN SUPP PEO; NHS England and Improvement, 2020, DEM WELLB COVID 19 P; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Rietjens JAC, 2017, LANCET ONCOL, V18, pE543, DOI 10.1016/S1470-2045(17)30582-X; Saini G, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0127-2; Sellars M, 2019, PALLIATIVE MED, V33, P274, DOI 10.1177/0269216318809571; The Stationery Office, 2005, MENTAL CAPACITY ACT; Van den Block L, 2019, PALLIATIVE MED, V33, P259, DOI 10.1177/0269216319826411; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685	43	4	4	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252464	10.1371/journal.pone.0252464	http://dx.doi.org/10.1371/journal.pone.0252464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043728	Green Published, gold			2022-12-26	WOS:000664635700105
J	Kim, JY; Park, YM; Lee, GN; Song, HC; Ahn, YB; Han, K; Ko, SH				Kim, Ji-Youn; Park, Yong-Moon; Lee, Gyu-Na; Song, Hyun Chul; Ahn, Yu-Bae; Han, Kyungdo; Ko, Seung-Hyun			Association between toothbrushing and non-alcoholic fatty liver disease	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; KOREA NATIONAL-HEALTH; NUTRITION EXAMINATION SURVEY; METABOLIC SYNDROME; MATRIX METALLOPROTEINASE-8; EXTERNAL VALIDATION; DIABETES-MELLITUS; PERIODONTITIS; PREVALENCE; SMOKING	Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome. Periodontitis, as chronic inflammatory destructive disease, is associated metabolic syndromes bidirectionally. Toothbrushing is an essential and important way to manage periodontitis through mechanical removal of biofilm at periodontal tissue. We aimed to assess the association between toothbrushing frequency and the prevalent NAFLD in nationally representative Korean adults. Among adults aged 19 years and older who participated in the Korea National Health and Nutrition Examination Survey in 2010, a total of 6,352 subjects were analyzed. NAFLD was defined as fatty liver index >= 60. Multiple logistic regression analysis was used to estimate multivariable-adjusted odds ratios (ORs) and 95% confidence intervals (CIs). An inverse association between toothbrushing frequency and NAFLD was found. The adjusted ORs (95% CIs) of NALFD was 0.56 (0.35-0.91) in the group who performed toothbrushing >= 3 per day compared to the group that performed toothbrushing <= 1 per day. For those with toothbrushing frequency <= 1 per day, the adjusted OR (95% CIs) of NAFLD was 2.26 (1.22-4.19) in smokers and 4.52 (1.97-10.38) in subjects with diabetes mellitus (DM), compared to those without the disease and with toothbrushing frequency >= 2 per day, respectively. Our results indicate that higher frequency of toothbrushing is inversely associated with NAFLD. As a modifiable oral habit, regular toothbrushing may be recommended to lower risk of NAFLD, especially in high risk groups such as smokers and diabetic patients.	[Kim, Ji-Youn; Song, Hyun Chul] Catholic Univ Korea, St Vincents Hosp, Coll Med, Div Oral & Maxillofacial Surg,Dept Dent, Seoul, South Korea; [Park, Yong-Moon] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Lee, Gyu-Na; Han, Kyungdo] Soongsil Univ, Stat & Actuarial Sci, Seoul, South Korea; [Ahn, Yu-Bae; Ko, Seung-Hyun] Catholic Univ Korea, St Vincents Hosp, Div Endocrinol & Metab, Dept Internal Med,Coll Med, Seoul, South Korea	Catholic University of Korea; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Soongsil University; Catholic University of Korea	Han, K (corresponding author), Soongsil Univ, Stat & Actuarial Sci, Seoul, South Korea.; Ko, SH (corresponding author), Catholic Univ Korea, St Vincents Hosp, Div Endocrinol & Metab, Dept Internal Med,Coll Med, Seoul, South Korea.	hkd917@naver.com; kosh@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879; Ko, Seung-Hyun/0000-0003-3703-1479	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI18C0275]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0275). The funding acquisition was performed by S.K. The funder had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Alakhali MS, 2018, CLIN ORAL INVEST, V22, P2965, DOI 10.1007/s00784-018-2726-1; Alexander M, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1321-x; Arweiler NB, 2018, PERIODONTOL 2000, V76, P164, DOI 10.1111/prd.12152; Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1; Ban MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191148; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Butt K., 2019, DENT UPDATE, V46, P907, DOI [10.12968/denu.2019.46.10.907, DOI 10.12968/DENU.2019.46.10.907]; Cardoso EM, 2018, POSTGRAD MED, V130, P98, DOI 10.1080/00325481.2018.1396876; Choi HM, 2015, J PERIODONTOL, V86, P866, DOI 10.1902/jop.2015.150025; Drinda S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112601; Forlani G, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2931985; Giannopoulou C, 2003, J CLIN PERIODONTOL, V30, P145, DOI 10.1034/j.1600-051X.2003.300201.x; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Han K, 2018, EXP THER MED, V15, P3865, DOI 10.3892/etm.2018.5880; Han K, 2018, GAC SANIT, V32, P143, DOI 10.1016/j.gaceta.2017.01.013; Han K, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001839; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Jennison E, 2019, POSTGRAD MED J, V95, P314, DOI 10.1136/postgradmedj-2018-136316; Jung HS, 2019, AM J GASTROENTEROL, V114, P453, DOI 10.1038/s41395-018-0283-5; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kim BY, 2019, DIABETES METAB J, V43, P487, DOI 10.4093/dmj.2019.0067; Kim EJ, 2011, J PERIODONTOL, V82, P533, DOI 10.1902/jop.2010.100274; Kim JY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60797-7; Kim YH, 2014, CLIN ORAL INVEST, V18, P1517, DOI 10.1007/s00784-013-1112-2; Kim Y, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014002; Ko SH, 2018, DIABETES METAB J, V42, P93, DOI 10.4093/dmj.2018.42.2.93; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Kwak MS, 2018, KOREAN J INTERN MED, V33, P64, DOI 10.3904/kjim.2017.343; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee HY, 2019, KOREAN J INTERN MED, V34, P296, DOI 10.3904/kjim.2017.194; Lee SH, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081755; Lee YH, 2019, DIABETES METAB J, V43, P31, DOI 10.4093/dmj.2019.0011; Leite FRM, 2018, AM J PREV MED, V54, P831, DOI 10.1016/j.amepre.2018.02.014; Leite NC, 2014, WORLD J GASTROENTERO, V20, P8377, DOI 10.3748/wjg.v20.i26.8377; Liu KZ, 2006, BBA-MOL BASIS DIS, V1762, P775, DOI 10.1016/j.bbadis.2006.05.014; Liu PY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181497; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Mealey BL, 2007, PERIODONTOL 2000, V44, P127, DOI 10.1111/j.1600-0757.2006.00193.x; Meffert PJ, 2014, AM J GASTROENTEROL, V109, P1404, DOI 10.1038/ajg.2014.155; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Pan YY, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170917; Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263; Rana JS, 2007, DIABETES OBES METAB, V9, P218, DOI 10.1111/j.1463-1326.2006.00594.x; Reis C, 2014, EXP THER MED, V8, P323, DOI 10.3892/etm.2014.1724; Rietman A, 2018, EUR J CLIN NUTR, V72, P117, DOI 10.1038/ejcn.2017.148; Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370; Shchipkova AY, 2010, J DENT RES, V89, P1247, DOI 10.1177/0022034510377203; Soder B, 2006, J PERIODONTAL RES, V41, P411, DOI 10.1111/j.1600-0765.2006.00888.x; Soder B, 2002, J CLIN PERIODONTOL, V29, P384, DOI 10.1034/j.1600-051X.2002.290502.x; Song SJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008694; Soresi M, 2013, ACTA DIABETOL, V50, P241, DOI 10.1007/s00592-012-0406-1; Sun K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047791; Yoneda M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-16; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2004, CLIN GASTROENTEROL H, V2, P262, DOI 10.1016/S1542-3565(04)00014-X	55	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0243686	10.1371/journal.pone.0243686	http://dx.doi.org/10.1371/journal.pone.0243686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043630	gold, Green Submitted, Green Published			2022-12-26	WOS:000664635700004
J	Yen, HH; Su, PY; Huang, SP; Wu, L; Hsu, TC; Zeng, YH; Chen, YY				Yen, Hsu-Heng; Su, Pei-Yuan; Huang, Siou-Ping; Wu, Lisha; Hsu, Tsui-Chun; Zeng, Ya-Huei; Chen, Yang-Yuan			Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study	PLOS ONE			English	Article							CONSENSUS GUIDELINE; HEPATIC STEATOSIS; CROHNS-DISEASE; MANAGEMENT; DIAGNOSIS; FIBROSIS; SOCIETY	Background/purpose An increased prevalence of non-alcoholic fatty liver disease (NAFLD) is observed in patients with inflammatory bowel disease (IBD) in Western countries. Both intestinal inflammation and metabolic factors contribute to the pathogenesis of IBD-associated NAFLD. The burden of NAFLD is not clear in the Asian population. This study aimed to evaluate the prevalence of NAFLD and liver fibrosis in a cohort of Taiwanese patients with IBD. Methods From January to December 2019, patients with IBD who underwent ultrasound examination were enrolled. Hepatic steatosis and fibrosis were measured with liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) using FibroScan. Patients with a history of excessive alcohol or recent steroid use were excluded. Univariate and multivariate analysis were performed. Results A total of 81 consecutive patients were enrolled and included in the analysis (45 with ulcerative colitis, 36 with Crohn's disease). The median age was 42 years old. The patients were classified in terms of body mass index as normal weight (54.3%), underweight (11.1%), overweight (28.4%), and obese (6.2%). The mean CAP increased to 162.22 dB/m in the underweight group, 210.86 dB/m in the normal weight group, 260.7 dB/m in the overweight group, and 274.0 dB/m in the obese group. NAFLD was observed in 29.6% of the patients, 1.2% of which had significant fibrosis. Increased body mass index (odds ratio [OR] 1.33, 95% confidence interval [CI] 1.1-1.62) and older age at IBD diagnosis (OR: 1.05, 95% CI 1-1.11) was found to be associated with the presence of NAFLD. Conclusion In this study, the prevalence of NAFLD was lower (29.6%) in IBD patients than in the Western population. Higher BMI and older age were associated with NAFLD in our study.	[Yen, Hsu-Heng; Su, Pei-Yuan; Huang, Siou-Ping; Wu, Lisha; Hsu, Tsui-Chun; Zeng, Ya-Huei; Chen, Yang-Yuan] Changhua Christian Hosp, Dept Internal Med, Div Gastroenterol, Changhua, Taiwan; [Yen, Hsu-Heng] Chung Yuan Christian Univ, Dept Elect Engn, Taoyuan, Taiwan; [Yen, Hsu-Heng] Chien Kuo Technol Univ, Gen Educ Ctr, Changhua, Taiwan; [Yen, Hsu-Heng; Chen, Yang-Yuan] Taiwan Assoc Study Small Intestinal Dis TASSID, Taipei, Taiwan; [Chen, Yang-Yuan] MingDao Univ, Dept Hospitality Management, Changhua, Taiwan	Changhua Christian Hospital; Chung Yuan Christian University; Chienkuo Technology University; Mingdao University	Yen, HH (corresponding author), Changhua Christian Hosp, Dept Internal Med, Div Gastroenterol, Changhua, Taiwan.; Yen, HH (corresponding author), Chung Yuan Christian Univ, Dept Elect Engn, Taoyuan, Taiwan.; Yen, HH (corresponding author), Chien Kuo Technol Univ, Gen Educ Ctr, Changhua, Taiwan.; Yen, HH (corresponding author), Taiwan Assoc Study Small Intestinal Dis TASSID, Taipei, Taiwan.	91646@cch.org.tw	Su, Pei yuan/ABA-5312-2021	Su, Pei yuan/0000-0002-6860-1051; Yen, Hsu-Heng/0000-0002-3494-2245	Changhua Christian Hospital [109-IRPCCH-008, 108-CCHIRP-018]	Changhua Christian Hospital	The authors received funding for this manuscript from Changhua Christian Hospital (109-IRPCCH-008 and 108-CCHIRP-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206450; Allocca M, 2020, CLIN GASTROENTEROL H, V18, P1309, DOI 10.1016/j.cgh.2019.11.052; Amorim VB, 2020, WORLD J HEPATOL, V12, P661, DOI 10.4254/wjh.v12.i9.661; Arieira C, 2019, EUR J GASTROEN HEPAT, V31, P998, DOI 10.1097/MEG.0000000000001319; Barbero-Villares A, 2012, SCAND J GASTROENTERO, V47, P575, DOI 10.3109/00365521.2011.647412; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chao CY, 2016, WORLD J GASTROENTERO, V22, P7727, DOI 10.3748/wjg.v22.i34.7727; Cheon JH, 2013, J GASTROEN HEPATOL, V28, P220, DOI 10.1111/jgh.12053; Ciccone MM, 2015, J CARDIOVASC MED, V16, P11, DOI 10.2459/JCM.0000000000000149; Dasarathy S, 2009, J HEPATOL, V51, P1061, DOI 10.1016/j.jhep.2009.09.001; Estes C, 2020, ALIMENT PHARM THER, V51, P801, DOI 10.1111/apt.15673; Huang JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139796; Kang MK, 2020, DIGEST DIS, V38, P507, DOI 10.1159/000506938; Karaivazoglou K, 2020, EUR J GASTROEN HEPAT, V32, P903, DOI 10.1097/MEG.0000000000001679; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Li J, 2019, LANCET GASTROENTEROL, V4, P389, DOI 10.1016/S2468-1253(19)30039-1; Lin A, 2021, INFLAMM BOWEL DIS, V27, P947, DOI 10.1093/ibd/izaa189; Lin WC, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-02164-3; Lin YJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111775; Maaser C, 2019, J CROHNS COLITIS, V13, P144, DOI 10.1093/ecco-jcc/jjy113; Mak WY, 2020, J GASTROEN HEPATOL, V35, P380, DOI 10.1111/jgh.14872; McGowan CE, 2012, INFLAMM BOWEL DIS, V18, P49, DOI 10.1002/ibd.21669; Palumbo CS, 2019, INFLAMM BOWEL DIS, V25, P124, DOI 10.1093/ibd/izy200; Ritaccio G, 2021, DIGEST DIS SCI, V66, P3186, DOI 10.1007/s10620-020-06588-6; Sagami S, 2017, HEPATOL RES, V47, P872, DOI 10.1111/hepr.12828; Tien YC, 2017, CLIN EXP RHEUMATOL, V35, P831; Wei SC, 2017, INTEST RES, V15, P285, DOI 10.5217/ir.2017.15.3.285; Wei SC, 2017, INTEST RES, V15, P266, DOI 10.5217/ir.2017.15.3.266; Wong VWS, 2010, HEPATOLOGY, V51, P454, DOI 10.1002/hep.23312; Yen HH, 2021, BMC GASTROENTEROL, V21, DOI 10.1186/s12876-021-01792-8; Yen HH, 2021, PEERJ, V9, DOI 10.7717/peerj.10944; Yen HH, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000025090; Yen HH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237582; Yen HH, 2020, PEERJ, V8, DOI 10.7717/peerj.9537; Yen HH, 2019, INTEST RES, V17, P54, DOI 10.5217/ir.2018.00096; Yen YH, 2018, TRANSPL P, V50, P3533, DOI 10.1016/j.transproceed.2018.06.039; Yen YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176027; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zhou F, 2019, HEPATOLOGY, V70, P1119, DOI 10.1002/hep.30702; Zou ZY, 2019, INFLAMM BOWEL DIS, V25, P1764, DOI 10.1093/ibd/izz043	40	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252286	10.1371/journal.pone.0252286	http://dx.doi.org/10.1371/journal.pone.0252286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043691	gold, Green Published			2022-12-26	WOS:000664635700078
J	Kobori, A; Miyashita, M; Miyano, Y; Suzuki, K; Toriumi, K; Niizato, K; Oshima, K; Imai, A; Nagase, Y; Yoshikawa, A; Horiuchi, Y; Yamasaki, S; Nishida, A; Usami, S; Takizawa, S; Itokawa, M; Arai, H; Arai, M				Kobori, Akiko; Miyashita, Mitsuhiro; Miyano, Yasuhiro; Suzuki, Kazuhiro; Toriumi, Kazuya; Niizato, Kazuhiro; Oshima, Kenichi; Imai, Atsushi; Nagase, Yukihiro; Yoshikawa, Akane; Horiuchi, Yasue; Yamasaki, Syudo; Nishida, Atsushi; Usami, Satoshi; Takizawa, Shunya; Itokawa, Masanari; Arai, Heii; Arai, Makoto			Advanced glycation end products and cognitive impairment in schizophrenia	PLOS ONE			English	Article							ENHANCED CARBONYL STRESS; WORK OUTCOMES; SUPPORTED EMPLOYMENT; METABOLIC SYNDROME; NEGATIVE SYMPTOMS; MENTAL-ILLNESS; REMEDIATION; METAANALYSIS; ASSOCIATION; SUBPOPULATION	Advanced glycation end products play a key role in the pathophysiology of schizophrenia. Cognitive impairment is one of the central features of schizophrenia; however, the association between advanced glycation end products and cognitive impairment remains unknown. This study investigated whether advanced glycation end products affect the cognitive domain in patients with schizophrenia. A total of 58 patients with chronic schizophrenia were included in this cross-sectional study. Plasma advanced glycation end products were measured using high-performance liquid chromatography (HPLC). Neuropsychological and cognitive functions were assessed using the Wechsler Adult Intelligence Scale, Third Version, and the Wisconsin Card Sorting Test Keio-FS version. Multiple regression analysis adjusted for age, sex, body mass index, educational years, daily dose of antipsychotics, and psychotic symptoms revealed that processing speed was significantly associated with plasma pentosidine, a representative advanced glycation end product (standardized beta = -0.425; p = 0.009). Processing speed is the cognitive domain affected by advanced glycation end products. Considering preceding evidence that impaired processing speed is related to poor functional outcome, interventions targeted at reducing advanced glycation end products may contribute to promoting recovery of patients with schizophrenia as well as cognitive function improvement.	[Kobori, Akiko; Miyashita, Mitsuhiro; Miyano, Yasuhiro; Suzuki, Kazuhiro; Toriumi, Kazuya; Yoshikawa, Akane; Horiuchi, Yasue; Itokawa, Masanari; Arai, Makoto] Tokyo Metropolitan Inst Med Sci, Schizophrenia Res Project, Dept Psychiat & Behav Sci, Setagaya Ku, Tokyo, Japan; [Kobori, Akiko; Arai, Heii] Juntendo Univ, Grad Sch Med, Dept Psychiat & Behav Sci, Bunkyo Ku, Tokyo, Japan; [Miyashita, Mitsuhiro; Miyano, Yasuhiro; Niizato, Kazuhiro; Oshima, Kenichi; Imai, Atsushi; Itokawa, Masanari] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Setagaya Ku, Tokyo, Japan; [Miyashita, Mitsuhiro; Suzuki, Kazuhiro; Nagase, Yukihiro] Takatsuki Hosp, Dept Psychiat, Hachioji, Tokyo, Japan; [Yamasaki, Syudo; Nishida, Atsushi] Tokyo Metropolitan Inst Med Sci, Res Ctr Social Sci & Med, Setagaya Ku, Tokyo, Japan; [Usami, Satoshi] Univ Tokyo, Grad Sch Educ, Bunkyo Ku, Tokyo, Japan; [Takizawa, Shunya] Tokai Univ, Sch Med, Dept Internal Med, Div Neurol, Isehara, Kanagawa, Japan	Tokyo Metropolitan Institute of Medical Science; Juntendo University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; Tokai University	Arai, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Schizophrenia Res Project, Dept Psychiat & Behav Sci, Setagaya Ku, Tokyo, Japan.	arai-mk@igakuken.or.jp	Horiuchi, Yasue/ABC-6248-2021; Andoh, Akira/AAB-9303-2022	Horiuchi, Yasue/0000-0003-0597-2514; Toriumi, Kazuya/0000-0002-8593-3269; Takizawa, Shunya/0000-0002-4567-6384	Japan Society for the Promotion of Science (JSPS) KAKENHI [15K21648, 18K07579, 16H05380, 17H05930, 19H04887, 20H03608]; Japan Agency for Medical Research and Development (AMED) [JP20dm0107088]; Uehara Memorial Foundation; SENSHIN Medical Research Foundation; Sumitomo Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Uehara Memorial Foundation(Uehara Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Sumitomo Foundation	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI (15K21648 to AK; 18K07579 to MM; 16H05380, 17H05930, 19H04887, and 20H03608 to MA); the Japan Agency for Medical Research and Development (AMED) (JP20dm0107088 to MI); the Uehara Memorial Foundation (to MA); SENSHIN Medical Research Foundation (to MA); and the Sumitomo Foundation (to MA). The JSPS, AMED, the Uehara Foundation, and the Sumitomo Foundation had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Adamowicz K, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00359; Akhter F, 2020, J ALZHEIMERS DIS, V76, P165, DOI 10.3233/JAD-191236; Arai M, 2010, ARCH GEN PSYCHIAT, V67, P589, DOI 10.1001/archgenpsychiatry.2010.62; Cella M, 2020, PSYCHOL MED, V50, P1062, DOI 10.1017/S0033291720000872; Cella M, 2017, CLIN PSYCHOL REV, V52, P43, DOI 10.1016/j.cpr.2016.11.009; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Fatouros-Bergman H, 2014, SCHIZOPHR RES, V158, P156, DOI 10.1016/j.schres.2014.06.034; Firth J, 2017, SCHIZOPHRENIA BULL, V43, P546, DOI 10.1093/schbul/sbw115; Forbes NF, 2009, PSYCHOL MED, V39, P889, DOI 10.1017/S0033291708004558; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 2016, J CLIN PSYCHIAT, V77, P8, DOI 10.4088/JCP.14074su1c.02; Hanssen NMJ, 2015, DIABETES, V64, P257, DOI 10.2337/db13-1864; Hogarty GE, 2004, ARCH GEN PSYCHIAT, V61, P866, DOI 10.1001/archpsyc.61.9.866; Huang XX, 2020, PSYCHONEUROENDOCRINO, V119, DOI 10.1016/j.psyneuen.2020.104748; Hwang WJ, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00356; HYDE CE, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P45; Ikebuchi E, 2017, PSYCHIAT CLIN NEUROS, V71, P301, DOI 10.1111/pcn.12486; Isami F, 2018, J INT MED RES, V46, P1043, DOI 10.1177/0300060517736914; Itokawa M, 2018, PSYCHIAT CLIN NEUROS, V72, P35, DOI 10.1111/pcn.12613; Karbasforoushan H, 2015, PSYCHOL MED, V45, P109, DOI 10.1017/S0033291714001111; Knowles EEM, 2010, AM J PSYCHIAT, V167, P828, DOI 10.1176/appi.ajp.2010.09070937; Kochunov P, 2016, P NATL ACAD SCI USA, V113, P13504, DOI 10.1073/pnas.1608246113; Magistro D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136386; McGurk SR, 2003, PSYCHIAT SERV, V54, P1129, DOI 10.1176/appi.ps.54.8.1129; McGurk SR, 2007, AM J PSYCHIAT, V164, P1791, DOI 10.1176/appi.ajp.2007.07060906; McGurk SR, 2006, ADM POLICY MENT HLTH, V33, P598, DOI 10.1007/s10488-006-0070-2; McGurk SR, 2015, AM J PSYCHIAT, V172, P852, DOI 10.1176/appi.ajp.2015.14030374; McGurk SR, 2009, SCHIZOPHRENIA BULL, V35, P319, DOI 10.1093/schbul/sbn182; Meli M, 2002, J ALZHEIMERS DIS, V4, P93, DOI 10.3233/JAD-2002-4203; Michel NM, 2013, ASSESSMENT, V20, P462, DOI 10.1177/1073191113478153; Milev P, 2005, AM J PSYCHIAT, V162, P495, DOI 10.1176/appi.ajp.162.3.495; Miyashita M, 2014, SCHIZOPHRENIA BULL, V40, P1040, DOI 10.1093/schbul/sbt129; Miyashita M, 2014, PSYCHIAT CLIN NEUROS, V68, P83, DOI 10.1111/pcn.12081; Miyata T, 1996, P NATL ACAD SCI USA, V93, P2353, DOI 10.1073/pnas.93.6.2353; Miyata T, 1999, KIDNEY INT, V55, P389, DOI 10.1046/j.1523-1755.1999.00302.x; Mu L, 2020, J PSYCHIATR RES, V131, P194, DOI 10.1016/j.jpsychires.2020.09.003; Pothier W, 2019, SCHIZOPHR RES-COGN, V18, DOI 10.1016/j.scog.2019.100158; Son S, 2020, SCHIZOPHR RES, V223, P242, DOI 10.1016/j.schres.2020.08.007; Thai ML, 2019, PSYCHIAT RES, V272, P230, DOI 10.1016/j.psychres.2018.12.088; Uribarri J, 2015, J CLIN ENDOCR METAB, V100, P1957, DOI 10.1210/jc.2014-3925; Van Eck RM, 2018, SCHIZOPHRENIA BULL, V44, P631, DOI 10.1093/schbul/sbx088; Wetzels S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00855; Wexler BE, 2005, SCHIZOPHRENIA BULL, V31, P931, DOI 10.1093/schbul/sbi038; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855	44	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251283	10.1371/journal.pone.0251283	http://dx.doi.org/10.1371/journal.pone.0251283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038433	Green Published, gold			2022-12-26	WOS:000664633500017
J	Haddad, D; John, SE; Mohammad, A; Hammad, MM; Hebbar, P; Channanath, A; Nizam, R; Al-Qabandi, S; Al Madhoun, A; Alshukry, A; Ali, H; Thanaraj, TA; Al-Mulla, F				Haddad, Dania; John, Sumi Elsa; Mohammad, Anwar; Hammad, Maha M.; Hebbar, Prashantha; Channanath, Arshad; Nizam, Rasheeba; Al-Qabandi, Sarah; Al Madhoun, Ashraf; Alshukry, Abdullah; Ali, Hamad; Thanaraj, Thangavel Alphonse; Al-Mulla, Fahd			SARS-CoV-2: Possible recombination and emergence of potentially more virulent strains	PLOS ONE			English	Article								COVID-19 is challenging healthcare preparedness, world economies, and livelihoods. The infection and death rates associated with this pandemic are strikingly variable in different countries. To elucidate this discrepancy, we analyzed 2431 early spread SARS-CoV-2 sequences from GISAID. We estimated continental-wise admixture proportions, assessed haplotype block estimation, and tested for the presence or absence of strains' recombination. Herein, we identified 1010 unique missense mutations and seven different SARS-CoV-2 clusters. In samples from Asia, a small haplotype block was identified, whereas samples from Europe and North America harbored large and different haplotype blocks with nonsynonymous variants. Variant frequency and linkage disequilibrium varied among continents, especially in North America. Recombination between different strains was only observed in North American and European sequences. In addition, we structurally modelled the two most common mutations, Spike_D614G and Nsp12_P314L, which suggested that these linked mutations may enhance viral entry and replication, respectively. Overall, we propose that genomic recombination between different strains may contribute to SARS-CoV-2 virulence and COVID-19 severity and may present additional challenges for current treatment regimens and countermeasures. Furthermore, our study provides a possible explanation for the substantial second wave of COVID-19 presented with higher infection and death rates in many countries.	[Haddad, Dania; John, Sumi Elsa; Hebbar, Prashantha; Channanath, Arshad; Nizam, Rasheeba; Al Madhoun, Ashraf; Ali, Hamad; Thanaraj, Thangavel Alphonse; Al-Mulla, Fahd] Dasman Diabet Inst, Dept Genet & Bioinformat, Kuwait, Kuwait; [Mohammad, Anwar; Hammad, Maha M.] Dasman Diabet Inst, Dept Biochem & Mol Biol, Kuwait, Kuwait; [Al-Qabandi, Sarah] Minist Hlth, Publ Hlth Lab, Kuwait, Kuwait; [Alshukry, Abdullah] Jaber AlAhmad Hosp, Minist Hlth, Dept Otolaryngol & Head & Neck Surg, Kuwait, Kuwait; [Ali, Hamad] Kuwait Univ, Hlth Sci Ctr, Dept Med Lab Sci, Fac Allied Hlth Sci, Kuwait, Kuwait	Kuwait University	Thanaraj, TA; Al-Mulla, F (corresponding author), Dasman Diabet Inst, Dept Genet & Bioinformat, Kuwait, Kuwait.	alphonse.thangavel@dasmaninstitute.org; fahd.almulla@dasmaninstitute.org	Ali, Hamad/AAA-2192-2021; Al-Mulla, Fahd/E-2068-2015	Al-Mulla, Fahd/0000-0001-5409-3829; Haddad, Dania/0000-0001-6687-6361	Coronavirus emergency resilience grant from Kuwait Foundation for the Advancement of Sciences	Coronavirus emergency resilience grant from Kuwait Foundation for the Advancement of Sciences	This work was supported by Coronavirus emergency resilience grant from Kuwait Foundation for the Advancement of Sciences.	Adhikari P, 2020, PHYS CHEM CHEM PHYS, V22, P18272, DOI 10.1039/d0cp03145c; Al-Mulla F, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06133; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bai Y, 2020, EVOLUTION MOL CHARAC, DOI [10.1101/2020.04.24.058933, DOI 10.1101/2020.04.24.058933, 10.1101/2020.04.24.058933.]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Eaaswarkhanth M, 2020, INT J INFECT DIS, V96, P459, DOI 10.1016/j.ijid.2020.05.071; Fung TS, 2019, ANNU REV MICROBIOL, V73, P529, DOI 10.1146/annurev-micro-020518-115759; Gao Y, 2020, SCIENCE, V368, P779, DOI 10.1126/science.abb7498; Guan Q, 2020, GENOMIC VARIATION LA; Holland LA, 2020, J VIROL, V94, DOI 10.1128/JVI.00711-20; Jakobsen IB, 1996, COMPUT APPL BIOSCI, V12, P291; Kasibhatla SM, 2020, J MED VIROL, V92, P1932, DOI 10.1002/jmv.25909; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Martin DP, 2017, METHODS MOL BIOL, V1525, P433, DOI 10.1007/978-1-4939-6622-6_17; Mohammad A, 2021, INT J INFECT DIS, V103, P611, DOI 10.1016/j.ijid.2020.10.033; Ovsyannikova IG, 2020, IMMUNOL REV, V296, P205, DOI 10.1111/imr.12897; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000056; Poland GA, 2020, MAYO CLIN PROC, V95, P2172, DOI 10.1016/j.mayocp.2020.07.021; Poland GA, 2020, MAYO CLIN PROC, V95, P1838, DOI 10.1016/j.mayocp.2020.06.044; Poland GA, 2020, LANCET INFECT DIS, V20, P531, DOI 10.1016/S1473-3099(20)30250-4; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Shaminur Rahman M, 2020, COMPREHENSIVE ANNOTA, DOI [10.1101/2020.06.29.177238, DOI 10.1101/2020.06.29.177238]; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; SMITH JM, 1992, J MOL EVOL, V34, P126; Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260; Velthuis AJWT, 2010, NUCLEIC ACIDS RES, V38, P203, DOI 10.1093/nar/gkp904; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943; Xi J., 2020, EMERGING MICROBES IN, DOI 10.1101/2020.03.10.20033944; Xia S, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0184-0; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhou HX, 2018, CHEM REV, V118, P1691, DOI 10.1021/acs.chemrev.7b00305	40	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251368	10.1371/journal.pone.0251368	http://dx.doi.org/10.1371/journal.pone.0251368			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033650	Green Submitted, gold, Green Published			2022-12-26	WOS:000664633100008
J	Stewart, T; Wolfe, BE; Fuchs, SM				Stewart, Taylor; Wolfe, Benjamin E.; Fuchs, Stephen M.			Defining the role of the polyasparagine repeat domain of the S. cerevisiae transcription factor Azf1p	PLOS ONE			English	Article							RNA-BINDING PROTEINS; PRION-LIKE DOMAINS; SEQUENCE FEATURES; CLOCK GENE; INHERITANCE; AGGREGATION; REGULATOR; EMERGENCE	Across eukaryotes, homopolymeric repeats of amino acids are enriched in regulatory proteins such as transcription factors and chromatin remodelers. These domains play important roles in signaling, binding, prion formation, and functional phase separation. Azf1p is a prion-forming yeast transcription factor that contains two homorepeat domains, a polyglutamine and a polyasparagine domain. In this work, we report a new phenotype for Azf1p and identify a large set of genes that are regulated by Azf1p during growth in glucose. We show that the polyasparagine (polyN) domain plays a subtle role in transcription but is dispensable for Azf1p localization and prion formation. Genes upregulated upon deletion of the polyN domain are enriched in functions related to carbon metabolism and storage. This domain may therefore be a useful target for engineering yeast strains for fermentation applications and small molecule production. We also report that both the polyasparagine and polyglutamine domains vary in length across strains of S. cerevisiae and propose a model for how this variation may impact protein function.	[Stewart, Taylor; Wolfe, Benjamin E.; Fuchs, Stephen M.] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Fuchs, Stephen M.] Inst Prot Innovat, Boston, MA 02115 USA; [Fuchs, Stephen M.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	Tufts University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Fuchs, SM (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.; Fuchs, SM (corresponding author), Inst Prot Innovat, Boston, MA 02115 USA.; Fuchs, SM (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.	stephen.fuchs@proteininnovation.org		Fuchs, Stephen/0000-0001-7261-9214; Stewart, Taylor/0000-0002-0744-2309	Army Research Office [W911NF-16-1-0175, W911NF19-1-0299, W911NF-20-1-0083]	Army Research Office	This work was supported by the Army Research Office [W911NF-16-1-0175, W911NF19-1-0299, and W911NF-20-1-0083 to S.M.F.]	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babokhov M., 2018, TANDEM REPEATS DRIVE, DOI [10.1101/339663, DOI 10.1101/339663]; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Cascarina SM, 2014, CELL MOL LIFE SCI, V71, P2047, DOI 10.1007/s00018-013-1543-6; Chakrabortee S, 2016, CELL, V167, P369, DOI 10.1016/j.cell.2016.09.017; Chakravarty AK, 2020, MOL CELL, V77, P251, DOI 10.1016/j.molcel.2019.10.028; Chen RB, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100879; Chernova TA, 2017, PRION, V11, P151, DOI 10.1080/19336896.2017.1328342; Collinge J, 2016, NATURE, V539, P217, DOI 10.1038/nature20415; Ebisawa T, 2001, EMBO REP, V2, P342, DOI 10.1093/embo-reports/kve070; Faux NG, 2005, GENOME RES, V15, P537, DOI 10.1101/gr.3096505; Fidalgo M, 2008, YEAST, V25, P879, DOI 10.1002/yea.1642; Franzmann TM, 2019, J BIOL CHEM, V294, P7128, DOI 10.1074/jbc.TM118.001190; Gemayel R, 2015, MOL CELL, V59, P615, DOI 10.1016/j.molcel.2015.07.003; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Harvey ZH, 2018, MOL CELL, V69, P195, DOI 10.1016/j.molcel.2017.10.030; Holmes DL, 2013, CELL, V153, P153, DOI 10.1016/j.cell.2013.02.026; Howson R, 2005, COMP FUNCT GENOM, V6, P2, DOI 10.1002/cfg.449; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Itakura AK, 2020, MOL CELL, V77, P266, DOI 10.1016/j.molcel.2019.10.027; Jarosz DF, 2014, CELL, V158, P1072, DOI 10.1016/j.cell.2014.07.024; Jarosz DF, 2014, CELL, V158, P1083, DOI 10.1016/j.cell.2014.07.025; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Kolaczkowska A, 2002, MOL GENET GENOMICS, V267, P96, DOI 10.1007/s00438-002-0642-0; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Laughery MF, 2015, YEAST, V32, P711, DOI 10.1002/yea.3098; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/NCHEMBIO.970, 10.1038/nchembio.970]; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Lu XM, 2014, J PEPT SCI, V20, P860, DOI 10.1002/psc.2677; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Newby GA, 2013, TRENDS CELL BIOL, V23, P251, DOI 10.1016/j.tcb.2013.01.007; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Paul KR, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00652-16; Peters TW, 2007, PRION, V1, P144, DOI 10.4161/pri.1.2.4630; Press MO, 2017, GENETICS, V205, P455, DOI 10.1534/genetics.116.193359; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Slattery MG, 2006, EUKARYOT CELL, V5, P313, DOI 10.1128/EC.5.2.313-320.2006; Strope PK, 2015, GENOME RES, V25, P762, DOI 10.1101/gr.185538.114; Tank EMH, 2007, MOL CELL BIOL, V27, P5445, DOI 10.1128/MCB.02127-06; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Zhang YP, 2017, FEMS YEAST RES, V17, DOI 10.1093/femsyr/fox080	55	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0247285	10.1371/journal.pone.0247285	http://dx.doi.org/10.1371/journal.pone.0247285			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019539	Green Submitted, gold, Green Published			2022-12-26	WOS:000664632300003
J	Xu, F; Qin, YK; He, WJ; Huang, GY; Lv, J; Xie, XX; Diao, CL; Tang, F; Jiang, L; Lan, RS; Cheng, XH; Xiao, XL; Zeng, SM; Chen, Q; Cui, L; Li, M; Tang, NN				Xu, Fan; Qin, Yikun; He, Wenjing; Huang, Guangyi; Lv, Jian; Xie, Xinxin; Diao, Chunli; Tang, Fen; Jiang, Li; Lan, Rushi; Cheng, Xiaohui; Xiao, Xiaolin; Zeng, Siming; Chen, Qi; Cui, Ling; Li, Min; Tang, Ningning			A deep transfer learning framework for the automated assessment of corneal inflammation on in vivo confocal microscopy images	PLOS ONE			English	Article							DIAGNOSIS	Purpose Infiltration of activated dendritic cells and inflammatory cells in cornea represents an important marker for defining corneal inflammation. Deep transfer learning has presented a promising potential and is gaining more importance in computer assisted diagnosis. This study aimed to develop deep transfer learning models for automatic detection of activated dendritic cells and inflammatory cells using in vivo confocal microscopy images. Methods A total of 3453 images was used to train the models. External validation was performed on an independent test set of 558 images. A ground-truth label was assigned to each image by a panel of cornea specialists. We constructed a deep transfer learning network that consisted of a pre-trained network and an adaptation layer. In this work, five pre-trained networks were considered, namely VGG-16, ResNet-101, Inception V3, Xception, and Inception-ResNet V2. The performance of each transfer network was evaluated by calculating the area under the curve (AUC) of receiver operating characteristic, accuracy, sensitivity, specificity, and G mean. Results The best performance was achieved by Inception-ResNet V2 transfer model. In the validation set, the best transfer system achieved an AUC of 0.9646 (P<0.001) in identifying activated dendritic cells (accuracy, 0.9319; sensitivity, 0.8171; specificity, 0.9517; and G mean, 0.8872), and 0.9901 (P<0.001) in identifying inflammatory cells (accuracy, 0.9767; sensitivity, 0.9174; specificity, 0.9931; and G mean, 0.9545). Conclusions The deep transfer learning models provide a completely automated analysis of corneal inflammatory cellular components with high accuracy. The implementation of such models would greatly benefit the management of corneal diseases and reduce workloads for ophthalmologists.	[Xu, Fan; He, Wenjing; Huang, Guangyi; Lv, Jian; Xie, Xinxin; Diao, Chunli; Tang, Fen; Jiang, Li; Zeng, Siming; Chen, Qi; Cui, Ling; Li, Min; Tang, Ningning] Peoples Hosp Guangxi Zhuang Autonomous Reg, Guangxi Hlth Commiss Key Lab Ophthalmol & Related, Dept Ophthalmol, Nanning, Guangxi, Peoples R China; [Qin, Yikun] China ASEAN Informat Harbor, Nanning, Guangxi, Peoples R China; [Lan, Rushi] Guilin Univ Elect Technol, Guangxi Coll & Univ Key Lab Intelligent Proc Comp, Guilin, Guangxi, Peoples R China; [Cheng, Xiaohui] Guilin Univ Technol, Guangxi Key Lab Embedded Technol & Intelligent Sy, Guilin, Guangxi, Peoples R China; [Xiao, Xiaolin] South China Univ Technol, Sch Comp Sci & Engn, Guangzhou, Guangdong, Peoples R China	Guilin University of Electronic Technology; Guilin University of Technology; South China University of Technology	Li, M; Tang, NN (corresponding author), Peoples Hosp Guangxi Zhuang Autonomous Reg, Guangxi Hlth Commiss Key Lab Ophthalmol & Related, Dept Ophthalmol, Nanning, Guangxi, Peoples R China.	eyeminli@163.com; oph_tangnn@163.com			Guangxi Promotion of Appropriate Health Technologies Project; Guangxi clinical ophthalmic research center [GuikeAD19245193]	Guangxi Promotion of Appropriate Health Technologies Project; Guangxi clinical ophthalmic research center	All authors report grants from Guangxi Promotion of Appropriate Health Technologies Project (No.S2019084) and Guangxi clinical ophthalmic research center (No. GuikeAD19245193).	Aggarwal S, 2021, OCUL SURF, V19, P183, DOI 10.1016/j.jtos.2020.05.012; [Anonymous], 2009, HDB RES MACHINE LEAR; Bengio Y., 2017, ADAPT COMPUT MACH LE, V1; Chidambaram JD, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00193; Chidambaram JD., 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Cruzat A, 2011, INVEST OPHTH VIS SCI, V52, P5136, DOI 10.1167/iovs.10-7048; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Duchi J, 2011, J MACH LEARN RES, V12, P2121; Fukuda Ken, 2010, Cornea, V29 Suppl 1, pS62; Hanlon SD, 2014, EXP EYE RES, V120, P61, DOI 10.1016/j.exer.2014.01.004; He KM, 2016, LECT NOTES COMPUT SC, V9908, P630, DOI 10.1007/978-3-319-46493-0_38; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kamel JT, 2020, OCUL IMMUNOL INFLAMM, V28, P884, DOI 10.1080/09273948.2019.1643028; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kwon MS, 2018, SURV OPHTHALMOL, V63, P565, DOI 10.1016/j.survophthal.2017.11.001; Labbe A, 2009, OCUL SURF, V7, P41, DOI 10.1016/S1542-0124(12)70291-4; Li LJ, 2009 IEEE C COMP VIS, P248; Lv J, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.03.134; Matsumoto Y, 2018, INVEST OPHTH VIS SCI, V59, DOI 10.1167/iovs.17-23602; Niederer RL, 2010, PROG RETIN EYE RES, V29, P30, DOI 10.1016/j.preteyeres.2009.11.001; Patel DV, 2019, CLIN EXP OPHTHALMOL, V47, P334, DOI 10.1111/ceo.13512; Scarpa F, 2020, CORNEA, V39, P342, DOI 10.1097/ICO.0000000000002181; Simonyan K., 2014, COMPUTER SCI, DOI DOI 10.48550/ARXIV.1409.1556; Smedowski A, 2017, ACTA OPHTHALMOL, V95, P405, DOI 10.1111/aos.13363; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tan CQ, 2018, LECT NOTES COMPUT SC, V11141, P270, DOI 10.1007/978-3-030-01424-7_27; Torrey L., 2010, HDB RES MACHINE LEAR, P242, DOI DOI 10.4018/978-1-60566-766-9.CH011; Wei SS, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.2.32; Williams BM, 2020, DIABETOLOGIA, V63, P419, DOI 10.1007/s00125-019-05023-4; Yosinski J, 2014, ADV NEUR IN, V27	32	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252653	10.1371/journal.pone.0252653	http://dx.doi.org/10.1371/journal.pone.0252653			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081736	Green Published, gold			2022-12-26	WOS:000664639200039
J	Kang, HM; Hasanuzzaman, M; Kim, SW; Koh, HJ; Lee, SC				Kang, Hae Min; Hasanuzzaman, Md.; Kim, So Won; Koh, Hyoung Jun; Lee, Sung Chul			Significant elevation of aqueous endothelin-1 in central retinal vein occlusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; BIG ENDOTHELIN-1; NITRIC-OXIDE; INJECTION; INJURY; MODEL; HUMOR; DOGS	Purpose To investigate aqueous humor concentrations of endothelin-1 (ET-1) in patients with central retinal vein occlusion (CRVO) compared with patients with branch retinal vein occlusion (BRVO) and a normal control group. Methods A total 80 subjects were included in this prospective study, including 15 patients with CRVO, 20 patients with BRVO, and 45 patients who underwent cataract surgery and had no concomitant ocular disease. Aqueous humor levels of ET-1 were obtained before intravitreal bevacizumab injection (IVB) and after 1 month. Results At baseline, the mean aqueous ET-1 level was 12.73.6 pg/mL in the CRVO group, 8.0 +/- 2.3 pg/mL in the BRVO group, and 2.0 +/- 0.9 pg/mL in the control group (P<0.001). After IVB, the mean aqueous level of ET-1 was 3.4<plus/minus>1.9 pg/mL (0.5-6.9 pg/mL) in the CRVO group and 1.8 +/- 1.0 pg/mL (0.3-3.2 pg/mL) in the BRVO group (P = 0.008). The mean aqueous ET-1 level was significantly reduced in both the patients with CRVO and those with BRVO (P<0.001). Conclusion The mean aqueous humor ET-1 level was significant higher in the patients with CRVO than those with BRVO and in the control group. After IVB, the mean level was significantly reduced in both the patients with CRVO and those with BRVO.	[Kang, Hae Min] Catholic Kwandong Univ, Coll Med, Dept Ophthalmol, Intl St Marys Hosp, Incheon, South Korea; [Hasanuzzaman, Md.; Kim, So Won] Univ Ulsan, Coll Med, Dept Pharmacol, Asan Med Ctr, Seoul, South Korea; [Koh, Hyoung Jun] Yonsei Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Lee, Sung Chul] Konyang Univ Hosp, Dept Ophthalmol, Daejeon, South Korea	Catholic Kwandong University; University of Ulsan; Yonsei University; Yonsei University Health System; Konyang University; Konyang University Hospital	Kang, HM (corresponding author), Catholic Kwandong Univ, Coll Med, Dept Ophthalmol, Intl St Marys Hosp, Incheon, South Korea.	liebe05@naver.com		Koh, Hyoung Jun/0000-0002-5932-8516	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2018R1C1B5085620]	National Research Foundation of Korea (NRF) - Korea government (MSIT)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2018R1C1B5085620). This paper has not been presented at a scientific meeting. None of the authors have a proprietary interest in this work.	Brown G, 2017, OPHTHALMOL RETINA, V1, P404, DOI 10.1016/j.oret.2017.01.018; Desai D, 2004, BIOCHEM BIOPH RES CO, V318, P642, DOI 10.1016/j.bbrc.2004.04.073; Green W R, 1981, Retina, V1, P27; Grieshaber MC, 2007, SURV OPHTHALMOL, V52, pS115, DOI 10.1016/j.survophthal.2007.08.005; Iannaccone A, 1998, BRIT J OPHTHALMOL, V82, P498, DOI 10.1136/bjo.82.5.498; Kallberg ME, 2002, J GLAUCOMA, V11, P105; Kida T, 2018, EXP EYE RES, V176, P207, DOI 10.1016/j.exer.2018.07.016; Kida T, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0066-2; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P513, DOI 10.1001/archopht.126.4.513; Kurata H, 2005, EUR J PHARMACOL, V517, P232, DOI 10.1016/j.ejphar.2005.05.026; Kurata H, 2004, J CARDIOVASC PHARM, V44, pS455, DOI 10.1097/01.fjc.0000166314.38258.a8; MASAKI T, 1991, CIRCULATION, V84, P1457, DOI 10.1161/01.CIR.84.4.1457; Masuzawa K, 2006, EXP BIOL MED, V231, P1085; Matsuura A, 1998, HYPERTENSION, V32, P89, DOI 10.1161/01.HYP.32.1.89; Mendrinos E, 2011, INVEST OPHTH VIS SCI, V52, P3215, DOI 10.1167/iovs.10-6888; MIYAUCHI T, 1989, LANCET, V2, P53, DOI 10.1016/S0140-6736(89)90303-6; Morgan WH, 2004, OPHTHALMOLOGY, V111, P1489, DOI 10.1016/j.ophtha.2003.12.053; Oellers P, 2018, RYANS RETINA, V2, P1166; Ooi KGJ, 2006, INVEST OPHTH VIS SCI, V47, P272, DOI 10.1167/iovs.05-0790; RADER J, 1994, AM J OPHTHALMOL, V117, P72, DOI 10.1016/S0002-9394(14)73017-X; ROSENBERG N, 1986, ARCH OPHTHALMOL-CHIC, V104, P34; SAITO Y, 1990, NEW ENGL J MED, V322, P205; Sin BH, 2013, J GLAUCOMA, V22, P104, DOI 10.1097/IJG.0b013e3182312047; TAKEI K, 1993, GRAEF ARCH CLIN EXP, V231, P476, DOI 10.1007/BF02044235; Vago H, 2004, J CARDIOVASC PHARM, V44, pS376; Wollensak G, 1998, CURR EYE RES, V17, P541, DOI 10.1076/ceyr.17.5.541.5187; YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yu DY, 2016, INVEST OPHTH VIS SCI, V57, P412, DOI 10.1167/iovs.15-18358	29	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252530	10.1371/journal.pone.0252530	http://dx.doi.org/10.1371/journal.pone.0252530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077461	gold, Green Published			2022-12-26	WOS:000664638500047
J	Luan, D; Zhao, MJ; Zhao, QR; Wang, N				Luan, Di; Zhao, Mingjing; Zhao, Qianru; Wang, Nan			Modelling of integrated scheduling problem of capacitated equipment systems with a multi-lane road network	PLOS ONE			English	Article							GENETIC ALGORITHM; ROUTING-PROBLEMS; TABU SEARCH; YARD CRANE; CONTAINER; OPTIMIZATION; STORAGE; STRATEGY; VEHICLES; AGVS	The coordination of different container-handling equipment is an important method for improving the overall efficiency of automated container terminals. In the real terminal, we should consider many real-life issues, such as the equipment capacity, the equipment collision, changing lanes in the multi-lane road, and choosing one of container-handling lanes for each container. This paper proposes the integrated scheduling problem of three container-handling equipment with the capacity constraint and the dual-cycle strategy, for simultaneously solving the equipment scheduling problem, the assignment problem of the container-handling lane and the conflict-free route planning problem of automated guided vehicles (AGVs). With the objective of minimizing the ship's berth time, we propose a mixed-integer programming model based on the space-time network representation method and two bilevel optimization algorithms based on conflict resolution rules. Finally, numerical experiments are conducted to verify the effectiveness of the proposed model and two bilevel optimization algorithms.	[Luan, Di; Zhao, Mingjing] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Zhao, Qianru] Beijing Jiaotong Univ, Haibin Coll, Cangzhou, Peoples R China; [Wang, Nan] Beijing Jiaotong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; Beijing Jiaotong University	Zhao, MJ (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.	17114218@bjtu.edu.cn		Luan, Di/0000-0002-4020-007X	National Key R&D Program of China [2017YFE0134600]	National Key R&D Program of China	The research is supported by grants from National Key R&D Program of China (No. 2017YFE0134600).	Bala A, 2015, 2015 THIRD INTERNATIONAL CONFERENCE ON IMAGE INFORMATION PROCESSING (ICIIP), P281, DOI 10.1109/ICIIP.2015.7414781; Ben Ticha H, 2018, NETWORKS, V72, P393, DOI 10.1002/net.21808; Carlo HJ, 2015, COMPUT IND ENG, V89, P23, DOI 10.1016/j.cie.2015.04.026; Carlo HJ, 2012, INT J PROD ECON, V140, P844, DOI 10.1016/j.ijpe.2012.06.035; Chen L, 2007, EUR J OPER RES, V181, P40, DOI 10.1016/j.ejor.2006.06.033; Chu YL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180370; Dell RF, 2009, J IND MANAG OPTIM, V5, P285, DOI 10.3934/jimo.2009.5.285; Duinkerken MB, 2015, INT C COMP SUPP COOP, P401, DOI 10.1109/CSCWD.2015.7230993; Fazlollahtabar H, 2015, J INTELL ROBOT SYST, V77, P525, DOI 10.1007/s10846-013-0003-8; Gen M, 2006, OR SPECTRUM, V28, P337, DOI [10.1007/s00291-005-0029-9, 10.1007/S00291-005-0029-9]; Ghasemzadeh H, 2009, ROBOT AUTON SYST, V57, P738, DOI 10.1016/j.robot.2008.10.016; GLOVER F, 1995, COMPUT OPER RES, V22, P111, DOI 10.1016/0305-0548(93)E0023-M; Goodchild AV, 2006, TRANSPORT SCI, V40, P473, DOI 10.1287/trsc.1060.0148; Gorman MF, 1998, ANN OPER RES, V78, P51, DOI 10.1023/A:1018906301828; He JL, 2015, EXPERT SYST APPL, V42, P2464, DOI 10.1016/j.eswa.2014.11.016; Ji S., 2020, TRANSP LETT, P1; Kizilay D, 2020, EUR J OPER RES, V286, P945, DOI 10.1016/j.ejor.2020.04.025; Lau HYK, 2008, ANN OPER RES, V159, P373, DOI 10.1007/s10479-007-0262-5; Li Q, 2016, INT J ADV ROBOT SYST, V13, DOI 10.5772/62685; Li ZN, 2019, TRANSPORT RES C-EMER, V104, P234, DOI 10.1016/j.trc.2019.05.003; Luo JB, 2020, COMPUT IND ENG, V149, DOI 10.1016/j.cie.2020.106848; Luo JB, 2016, COMPUT IND ENG, V94, P32, DOI 10.1016/j.cie.2016.01.010; Luo JB, 2015, TRANSPORT RES E-LOG, V79, P49, DOI 10.1016/j.tre.2015.03.006; Martin-Soberon AM, 2014, PROCD SOC BEHV, V160, P195, DOI 10.1016/j.sbspro.2014.12.131; Meersmans Albert P. M, 2001, EFFECTIVE ALGORITHMS; Miyamoto T, 2016, COMPUT IND ENG, V91, P1, DOI 10.1016/j.cie.2015.10.017; Nguyen VD, 2009, COMPUT IND ENG, V56, P1002, DOI 10.1016/j.cie.2008.09.009; Qiu L, 2002, INT J PROD RES, V40, P745, DOI 10.1080/00207540110091712; Schmidt J, 2015, RES TRANSP BUS MANAG, V17, P99, DOI 10.1016/j.rtbm.2015.09.002; Spears W.M., 1991, FDN GENETIC ALGORITH, P301; SteadieSeifi M, 2017, TRANSPORT RES B-METH, V106, P321, DOI 10.1016/j.trb.2017.07.007; Steenken D, 2004, OR SPECTRUM, V26, P3, DOI 10.1007/s00291-003-0157-z; TAGHABONI F, 1988, INT J PROD RES, V26, P173, DOI 10.1080/00207548808947852; Umar UA, 2015, INT J ADV MANUF TECH, V81, P2123, DOI 10.1007/s00170-015-7329-2; Vis IFA, 2006, EUR J OPER RES, V170, P677, DOI 10.1016/j.ejor.2004.09.020; Vis IFA, 2003, EUR J OPER RES, V147, P1, DOI 10.1016/S0377-2217(02)00293-X; Xiao J, 2018, TRANSPORT RES C-EMER, V86, P124, DOI 10.1016/j.trc.2017.10.006; Yang CX, 2012, COMPUT IND ENG, V63, P243, DOI 10.1016/j.cie.2012.03.004; Yang XM, 2015, IEEE T INTELL TRANSP, V16, P2889, DOI 10.1109/TITS.2015.2425547; Yang Y, 2018, COMPUT IND ENG, V126, P482, DOI 10.1016/j.cie.2018.10.007; Yu F, 2014, APPL ENERG, V134, P102, DOI 10.1016/j.apenergy.2014.07.104; Zeng QC, 2009, COMPUT OPER RES, V36, P1935, DOI 10.1016/j.cor.2008.06.010; Zhang XJ, 2019, TRANSPORT RES E-LOG, V122, P181, DOI 10.1016/j.tre.2018.12.003; Zhang XJ, 2016, TRANSPORT RES E-LOG, V94, P171, DOI 10.1016/j.tre.2016.08.002; Zhao J, 2020, TRANSPORT RES B-METH, V138, P1, DOI 10.1016/j.trb.2020.04.001; Zhong MS, 2020, COMPUT IND ENG, V142, DOI 10.1016/j.cie.2020.106371; Zhou CH, 2020, TRANSPORT RES E-LOG, V138, DOI 10.1016/j.tre.2020.101966	47	0	0	9	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251875	10.1371/journal.pone.0251875	http://dx.doi.org/10.1371/journal.pone.0251875			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077456	gold, Green Published			2022-12-26	WOS:000664638500018
J	Saha, A; Kent, M; Hauser, L; Drinan, DP; Nielsen, EE; Westgaard, JI; Lien, S; Johansen, T				Saha, Atal; Kent, Matthew; Hauser, Lorenz; Drinan, Daniel P.; Nielsen, Einar E.; Westgaard, Jon-Ivar; Lien, Sigbjorn; Johansen, Torild			Hierarchical genetic structure in an evolving species complex: Insights from genome wide ddRAD data in Sebastes mentella	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; ATLANTIC COD ECOTYPES; DEEP-WATER REDFISH; POPULATION-STRUCTURE; BEAKED REDFISH; NORTH-ATLANTIC; IRMINGER-SEA; LOCI; DIVERGENCE; SOFTWARE	The diverse biology and ecology of marine organisms may lead to complex patterns of intraspecific diversity for both neutral and adaptive genetic variation. Sebastes mentella displays a particular life-history as livebearers, for which existence of multiple ecotypes has been suspected to complicate the genetic population structure of the species. Double digest restriction-site associated DNA was used to investigate genetic population structure in S. mentella and to scan for evidence of selection. In total, 42,288 SNPs were detected in 277 fish, and 1,943 neutral and 97 tentatively adaptive loci were selected following stringent filtration. Unprecedented levels of genetic differentiation were found among the previously defined 'shallow pelagic', 'deep pelagic' and 'demersal slope' ecotypes, with overall mean F-ST = 0.05 and 0.24 in neutral and outlier SNPs, respectively. Bayesian computation estimated a concurrent and historical divergence among these three ecotypes and evidence of local adaptation was found in the S. mentella genome. Overall, these findings imply that the depth-defined habitat divergence of S. mentella has led to reproductive isolation and possibly adaptive radiation among these ecotypes. Additional sub-structuring was detected within the 'shallow' and 'deep' pelagic ecotypes. Population assignment of individual fish showed more than 94% agreement between results based on SNP and previously generated microsatellite data, but the SNP data provided a lower estimate of hybridization among the ecotypes than that by microsatellite data. We identified a SNP panel with only 21 loci to discriminate populations in mixed samples based on a machine-learning algorithm. This first SNP based investigation clarifies the population structure of S. mentella, and provides novel and high-resolution genomic tools for future investigations. The insights and tools provided here can readily be incorporated into the management of S. mentella and serve as a template for other exploited marine species exhibiting similar complex life history traits.	[Saha, Atal] Stockholm Univ, Div Populat Genet, Dept Zool, Stockholm, Sweden; [Saha, Atal; Westgaard, Jon-Ivar; Johansen, Torild] Inst Marine Res, Tromso Dept, Tromso, Norway; [Kent, Matthew; Lien, Sigbjorn] Norwegian Univ Life Sci, Fac Biosci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet, As, Norway; [Hauser, Lorenz; Drinan, Daniel P.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Nielsen, Einar E.] DTU Aqua Natl Inst Aquat Resources, Charlottenlund, Denmark	Stockholm University; Institute of Marine Research - Norway; Norwegian University of Life Sciences; University of Washington; University of Washington Seattle; Technical University of Denmark	Saha, A (corresponding author), Stockholm Univ, Div Populat Genet, Dept Zool, Stockholm, Sweden.; Saha, A; Johansen, T (corresponding author), Inst Marine Res, Tromso Dept, Tromso, Norway.	atal.saha@zoologi.su.se; torild.johansen@hi.no	Nielsen, Einar/AAT-1737-2021	Nielsen, Einar/0000-0002-7009-9814; Saha, Atal/0000-0003-1334-928X	Norwegian Institute of Marine Research; Research Council of Norway [NFR-196691]	Norwegian Institute of Marine Research; Research Council of Norway(Research Council of Norway)	The project was funded by the Norwegian Institute of Marine Research and Research Council of Norway (NFR-196691, SNIPFISK).	Anderson EC, 2010, MOL ECOL RESOUR, V10, P701, DOI 10.1111/j.1755-0998.2010.02846.x; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2018, R LANG ENV STAT COMP, DOI DOI 10.18637/JSS.V028.I05; Artamonova VS, 2013, J NAT HIST, V47, P1791, DOI 10.1080/00222933.2012.752539; Benjamini Y, 2001, ANN STAT, V29, P1165; Berg PR, 2017, HEREDITY, V119, P418, DOI 10.1038/hdy.2017.54; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bohling JH, 2013, MOL ECOL, V22, P74, DOI 10.1111/mec.12109; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cadrin SX, 2011, ICES J MAR SCI, V68, P2016, DOI 10.1093/icesjms/fsr134; Cadrin SX, 2010, ICES J MAR SCI, V67, P1617, DOI 10.1093/icesjms/fsq046; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Danielsdottir AK, 2008, T AM FISH SOC, V137, P1723, DOI 10.1577/T07-240.1; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Derycke Sp, 2012, THESIS GHENT U GHENT; Drevetnyak K, 2009, MAR BIOL RES, V5, P86, DOI 10.1080/17451000802534865; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Geweke J.F., 1991, EVALUATING ACCURACY; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; HEDRICK PW, 1982, BIOSCIENCE, V32, P845, DOI 10.2307/1309007; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Holliday JA, 2012, G3-GENES GENOM GENET, V2, P1085, DOI 10.1534/g3.112.002733; Johannesson, 1995, DISTRIBUTION ABUNDAN; Johansen T, 2000, FISH RES, V49, P179, DOI 10.1016/S0165-7836(00)00193-4; Johansen T., 2003, GENETIC STUDY GENUS; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kjaerner-Semb E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2867-z; Knutsen H, 2018, EVOL APPL, V11, P1527, DOI 10.1111/eva.12640; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; MAGNUSSON J, 1995, SCI MAR, V59, P241; Makhrov AA, 2011, ICES J MAR SCI, V68, P2013, DOI 10.1093/icesjms/fsr132; Malmstrom M, 2017, SCI DATA, V4, DOI 10.1038/sdata.2016.132; Moore JS, 2014, MOL ECOL, V23, P5680, DOI 10.1111/mec.12972; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Nielsen EE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1845; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Pampoulie C, 2008, FISH RES, V93, P54, DOI 10.1016/j.fishres.2008.02.007; Pardo-Diaz C, 2015, METHODS ECOL EVOL, V6, P445, DOI 10.1111/2041-210X.12324; Perrier C, 2019, EVOL LETT, V3, P240, DOI 10.1002/evl3.86; Planque B, 2013, AQUAT LIVING RESOUR, V26, P293, DOI 10.1051/alr/2013062; Pomerantz A, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy033; Pritchard JK, 2000, GENETICS, V155, P945; Riginos C, 2011, ECOGRAPHY, V34, P566, DOI 10.1111/j.1600-0587.2010.06511.x; Rikhter V.A., 1996, Northwest Atlantic Fisheries Organization Scientific Council Studies, V27, P49; Roques S, 2002, MAR BIOL, V140, P297, DOI 10.1007/s002270100705; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; RYMAN N, 1995, REV FISH BIOL FISHER, V5, P417, DOI 10.1007/BF01103814; Saha A, 2017, EVOL APPL, V10, P77, DOI 10.1111/eva.12429; Saha A, 2015, ICES J MAR SCI, V72, P2732, DOI 10.1093/icesjms/fsv139; Salmenkova EA, 2011, RUSS J GENET+, V47, P1279, DOI 10.1134/S1022795411110159; Schwenke PL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194068; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Seeb LW, 2000, T AM FISH SOC, V129, P1223, DOI 10.1577/1548-8659(2000)129&lt;1223:GDOSSO&gt;2.0.CO;2; Shum P, 2015, MOL ECOL, V24, P3652, DOI 10.1111/mec.13262; Shum P, 2014, PEERJ, V2, DOI 10.7717/peerj.525; Stefansson MO, 2009, HEREDITY, V102, P514, DOI 10.1038/hdy.2009.10; Stefansson MO, 2009, ICES J MAR SCI, V66, P680, DOI 10.1093/icesjms/fsp059; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whiting JR, 2018, MOL ECOL, V27, P3174, DOI 10.1111/mec.14772; Whitlock MC, 2015, AM NAT, V186, pS24, DOI 10.1086/682949; Zueva KJ, 2018, MAR GENOM, V39, P26, DOI 10.1016/j.margen.2018.01.001	69	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251976	10.1371/journal.pone.0251976	http://dx.doi.org/10.1371/journal.pone.0251976			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043665	Green Published, gold			2022-12-26	WOS:000664635700041
J	Sato, H; Ichikawa, D; Okada, E; Suzuki, T; Watanabe, S; Shirai, S; Shibagaki, Y				Sato, Hirotaka; Ichikawa, Daisuke; Okada, Eri; Suzuki, Tomo; Watanabe, Shiika; Shirai, Sayuri; Shibagaki, Yugo			Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy	PLOS ONE			English	Article							OXFORD CLASSIFICATION; PROGNOSTIC-FACTORS; NATURAL-HISTORY; OUTCOMES; DISEASE; HEMATURIA	Background There are few studies describing the clinical course and spontaneous remission of IgA nephropathy (IgAN) in adult patients receiving conservative treatment. Method Data from 62 adult patients with biopsy-diagnosed IgAN, who received conservative treatment at least 5 years prior, were retrospectively investigated. No patients received corticosteroids, other immunosuppressants, or tonsillectomy. Remission of proteinuria and hematuria were defined as proteinuria <0.3 g/gCr and urine red blood cells (RBC) <5 / high power field (HPF) on three consecutive urinalyses obtained during an observation period of >= 6 months. Result Thirty-eight (61.3%) patients had remission of hematuria, 24 (38.7%) had remission of proteinuria, and 19 (30.6%) had remission of both. Remission rates increased in patients with proteinuria <0.5 g/g Cr at diagnosis. The median time to remission of hematuria was 2.8 years and that of proteinuria was 2.6 years. Patients who showed renal function decline (defined as 30% decline of estimated glomerular filtration rate [eGFR] from baseline) were older, had significantly lower eGFR, and higher proteinuria at diagnosis. Two patients with preserved renal function and normal proteinuria at diagnosis experienced renal function decline. Renal function did not decline within 3 years of diagnosis in patients with proteinuria <1 g/gCr at diagnosis. Conclusions Relatively high rates of spontaneous remission were observed. Remission of both hematuria and proteinuria were frequent within 3 years after diagnosis, and renal function was well preserved during this period. These data indicate that it is rational to use conservative treatment for 3 years after the diagnosis instead of aggressive treatments.	[Sato, Hirotaka; Ichikawa, Daisuke; Watanabe, Shiika; Shibagaki, Yugo] St Marianna Univ, Dept Internal Med, Div Nephrol & Hypertens, Sch Med, Kawasaki, Kanagawa, Japan; [Okada, Eri] Chiba East Hosp, Kidney Ctr, Natl Hosp Org, Chiba, Japan; [Suzuki, Tomo] Kameda Med Ctr, Dept Nephrol, Chiba, Japan; [Shirai, Sayuri] St Marianna Univ, Div Nephrol & Hypertens, Dept Internal Med, Sch Med,Yokohama City Seibu Hosp, Kawasaki, Kanagawa, Japan	Saint Marianna University; Saint Marianna University	Ichikawa, D (corresponding author), St Marianna Univ, Dept Internal Med, Div Nephrol & Hypertens, Sch Med, Kawasaki, Kanagawa, Japan.	ichikawa6008@gmail.com						Ai Z, 2020, CLIN NEPHROL, V94, P290, DOI 10.5414/CN110192; Baigent C, 2017, KIDNEY INT, V92, P297, DOI 10.1016/j.kint.2017.04.019; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; CHAUVEAU D, 1993, CONTRIB NEPHROL, V104, P1; Chen D, 2018, KIDNEY BLOOD PRESS R, V43, P318, DOI 10.1159/000487901; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Duan ZY, 2013, AM J NEPHROL, V38, P241, DOI 10.1159/000354646; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Han SH, 2011, NEPHROL DIAL TRANSPL, V26, P1570, DOI 10.1093/ndt/gfq559; Higa A, 2015, PEDIATR NEPHROL, V30, P2121, DOI 10.1007/s00467-015-3176-5; Ieiri N, 2012, CLIN EXP NEPHROL, V16, P122, DOI 10.1007/s10157-011-0530-1; Imai N, 2016, Indian J Nephrol, V26, P107, DOI 10.4103/0971-4065.157010; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lee H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-94; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lv JC, 2017, JAMA-J AM MED ASSOC, V318, P432, DOI 10.1001/jama.2017.9362; Moriyama T, 2019, CLIN EXP NEPHROL, V23, P1089, DOI 10.1007/s10157-019-01735-4; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Rodrigues JC, 2017, CLIN J AM SOC NEPHRO, V12, P677, DOI 10.2215/CJN.07420716; Selvaskandan H, 2019, CLIN EXP NEPHROL, V23, P577, DOI 10.1007/s10157-019-01700-1; Sevillano AM, 2017, J AM SOC NEPHROL, V28, P3089, DOI 10.1681/ASN.2017010108; Shen P, 2008, NETH J MED, V66, P242; Shen PC, 2007, NEPHRON CLIN PRACT, V106, P157, DOI 10.1159/000104426; Shima Y, 2019, PEDIATR NEPHROL, V34, P837, DOI 10.1007/s00467-018-4099-8; Shima Y, 2013, PEDIATR NEPHROL, V28, P71, DOI 10.1007/s00467-012-2294-6; Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P481, DOI 10.1007/s10157-013-0849-x; Tang YY, 2018, MOL MED REP, V18, P4103, DOI 10.3892/mmr.2018.9413	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251294	10.1371/journal.pone.0251294	http://dx.doi.org/10.1371/journal.pone.0251294			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043669	gold, Green Published			2022-12-26	WOS:000664635700015
J	Syversen, IF; Elschot, M; Sandsmark, E; Bertilsson, H; Bathen, TF; Goa, PE				Syversen, Ingrid Framas; Elschot, Mattijs; Sandsmark, Elise; Bertilsson, Helena; Bathen, Tone Frost; Goa, Pal Erik			Exploring the diagnostic potential of adding T2 dependence in diffusion-weighted MR imaging of the prostate	PLOS ONE			English	Article							CANCER	Background Magnetic resonance imaging (MRI) is essential in the detection and staging of prostate cancer. However, improved tools to distinguish between low-risk and high-risk cancer are needed in order to select the appropriate treatment. Purpose To investigate the diagnostic potential of signal fractions estimated from a two-component model using combined T2- and diffusion-weighted imaging (T2-DWI). Material and methods 62 patients with prostate cancer and 14 patients with benign prostatic hyperplasia (BPH) underwent combined T2-DWI (TE = 55 and 73 ms, b-values = 50 and 700 s/mm(2)) following clinical suspicion of cancer, providing a set of 4 measurements per voxel. Cancer was confirmed in post-MRI biopsy, and regions of interest (ROIs) were delineated based on radiology reporting. Signal fractions of the slow component (SFslow) of the proposed two-component model were calculated from a model fit with 2 free parameters, and compared to conventional bi- and mono-exponential apparent diffusion coefficient (ADC) models. Results All three models showed a significant difference (p<0.0001) between peripheral zone (PZ) tumor and normal tissue ROIs, but not between non-PZ tumor and BPH ROIs. The area under the receiver operating characteristics curve distinguishing tumor from prostate voxels was 0.956, 0.949 and 0.949 for the two-component, bi-exponential and mono-exponential models, respectively. The corresponding Spearman correlation coefficients between tumor values and Gleason Grade Group were fair (0.370, 0.499 and -0.490), but not significant. Conclusion Signal fraction estimates from a two-component model based on combined T2-DWI can differentiate between tumor and normal prostate tissue and show potential for prostate cancer diagnosis. The model performed similarly to conventional diffusion models.	[Syversen, Ingrid Framas] Norwegian Univ Sci & Technol, NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway; [Elschot, Mattijs; Bathen, Tone Frost] Norwegian Univ Sci & Technol, NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Elschot, Mattijs; Sandsmark, Elise] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Bertilsson, Helena] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Urol, Trondheim, Norway; [Bertilsson, Helena] Norwegian Univ Sci & Technol, NTNU, Dept Clin & Mol Med, Trondheim, Norway; [Goa, Pal Erik] Norwegian Univ Sci & Technol, NTNU, Dept Phys, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Syversen, IF (corresponding author), Norwegian Univ Sci & Technol, NTNU, Kavli Inst Syst Neurosci, Trondheim, Norway.	ingrid.f.syversen@ntnu.no	Elschot, Mattijs/AAD-4362-2021; Syversen, Ingrid Framås/GPK-8219-2022	Elschot, Mattijs/0000-0002-8056-9103; Syversen, Ingrid Framås/0000-0001-5832-1702; Bathen, Tone/0000-0002-8582-6965	Norwegian University of Science and Technology [81850040, 90265300]; Central Norway Regional Health Authority [90265300]; Research Council of Norway [295013]	Norwegian University of Science and Technology; Central Norway Regional Health Authority; Research Council of Norway(Research Council of Norway)	IFS: Norwegian University of Science and Technology, https://www.ntnu.no/(project number 81850040). -ME: The liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology, https://helse-midt.no/samarbeidsorganet (grant number 90265300). TFB: The Research Council of Norway, https://www.forskningsradet.no/(grant number 295013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin O, 2011, EUR RADIOL, V21, P1970, DOI 10.1007/s00330-011-2130-6; Barentsz JO, 2016, EUR UROL, V69, P41, DOI 10.1016/j.eururo.2015.08.038; Chatterjee A, 2018, RADIOLOGY, V287, P864, DOI 10.1148/radiol.2018171130; Egnell L, 2020, J MAGN RESON IMAGING, V51, P1868, DOI 10.1002/jmri.27018; Futterer JJ, 2015, EUR UROL, V68, P1045, DOI 10.1016/j.eururo.2015.01.013; Hoeks CMA, 2013, RADIOLOGY, V266, P207, DOI 10.1148/radiol.12120281; Issa B, 2002, J MAGN RESON IMAGING, V16, P196, DOI 10.1002/jmri.10139; Karunamuni RA, 2018, ACTA RADIOL, V59, P1523, DOI 10.1177/0284185118770889; Kim S, 2005, MAGN RESON MED, V54, P1387, DOI 10.1002/mrm.20676; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Kobus T, 2012, RADIOLOGY, V265, P457, DOI 10.1148/radiol.12111744; MA X, 2017, 10 INT C IM SIGN PRO, P1, DOI DOI 10.1109/CISP-BMEI.2017.8302193; Mazaheri Y, 2011, J MAGN RESON IMAGING, V33, P258, DOI 10.1002/jmri.22420; Mulkern RV, 2006, MAGN RESON IMAGING, V24, P563, DOI 10.1016/j.mri.2005.12.008; Sadinski M, 2016, AM J ROENTGENOL, V207, P592, DOI 10.2214/AJR.15.15626; Shamonin DP, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00050; ShinMoto H, 2009, MAGN RESON IMAGING, V27, P355, DOI 10.1016/j.mri.2008.07.008; SYVERSEN IF, 2020, ISMRM SMRT VIRT C EX; Wang SY, 2014, J MAGN RESON IMAGING, V39, P781, DOI 10.1002/jmri.24212; Westphalen AC, 2020, RADIOLOGY, V296, P76, DOI 10.1148/radiol.2020190646; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252387	10.1371/journal.pone.0252387	http://dx.doi.org/10.1371/journal.pone.0252387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043735	gold, Green Published			2022-12-26	WOS:000664635700096
J	Gebremedhin, S; Bekele, T				Gebremedhin, Samson; Bekele, Tilahun			Gestational weight gain in sub-Saharan Africa: Estimation based on pseudo-cohort design	PLOS ONE			English	Article							PREGNANCY; BIRTH	Background Inadequate or excess gestational weight gain (GWG) leads to multiple undesirable birth outcomes. Yet, in sub-Saharan Africa (SSA) little is known about the weight gain pattern in pregnancy. The purpose of the study is to estimate the average gestational weight gain (GWG) in sub-Saharan Africa (SSA) and to examined whether there had been recent improvements or not. Methods Based on cross-sectional anthropometric data extracted from multiple Demographic and Health Surveys conducted in SSA, we estimated the average GWG in the region. Pseudo-cohort design was used to reconstruct GWG trajectories based on aggregated data of 110,482 women extracted from 30 recent surveys. Trend in GWG between 2000 and 2015 was determined using the data of 11 SSA countries. Pre-pregnancy weight was estimated based on the weight of non-pregnant women at risk of conception. Results On average, women in SSA gain inadequate weight (6.6 kg, 95% confidence interval, 6.0-7.2) over pregnancy. No meaningful gain was observed in the first trimester; whereas, women in the second and third trimesters put on 2.2 and 3.2 kg, respectively. The highest weight gain (10.5, 8.2-12.9 kg) was observed in Southern African sub-region and the lowest in Western Africa (5.8, 5.0-6.6 kg). The GWG among women who had secondary or above education (9.5, 8.2-10.9 kg) was higher than women with lower education (5.0, 4.3-5.8 kg). Likewise, GWG in women from richest households (9.0, 7.2-10.7 kg) was superior to those from poorest households (6.1, 5.3-7.0 kg). The estimated recent (2015-20) mean GWG (6.6, 5.8-7.4 kg) was not significantly different from what had been at beginning of the new millennium (6.7, 5.9-7.5 kg). Conclusion In SSA GWG is extremely low and is not showing improvements.	[Gebremedhin, Samson] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Bekele, Tilahun] Addis Ababa Univ, Ctr Food Sci & Nutr, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Gebremedhin, S (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.	samsongmgs@yahoo.com						African Union, MEMB STAT; Arora P, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/3849596; Asefa F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231889; Austin PC, 2002, J VASC SURG, V36, P194, DOI 10.1067/mva.2002.125015; Bank World, COUNTR LEND GROUPS C; Bhavadharini Balaji, 2017, Indian J Endocrinol Metab, V21, P588, DOI 10.4103/ijem.IJEM_557_16; Chung JGY, 2013, EUR J OBSTET GYN R B, V167, P149, DOI 10.1016/j.ejogrb.2012.11.020; Coffey D, 2015, P NATL ACAD SCI USA, V112, P3302, DOI 10.1073/pnas.1416964112; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Doctor HV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5695-z; Dolatian M, 2020, NURS OPEN, V7, P1568, DOI 10.1002/nop2.539; Galal M, 2012, FACTS VIEWS VIS OBGY, V4, P175; Goldstein RF, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1128-1; Kleinman KP, 2007, INT J EPIDEMIOL, V36, P1275, DOI 10.1093/ije/dym156; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; MEASURE DHS/ICF International, 2012, DEM HLTH SURV METH S; Meng Y, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/5080492; Nomura K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53809-8; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Fraga ACSA, 2014, CAD SAUDE PUBLICA, V30, P633, DOI 10.1590/0102-311X00085313; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Strauss RS, 1999, J NUTR, V129, P988, DOI 10.1093/jn/129.5.988; Truong YN, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.027; Tucker J, 2004, BRIT MED J, V329, P675, DOI 10.1136/bmj.329.7467.675; Ukah UV, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1003009; United Nations Population Division, WORLD POP PROSP; Wang DQ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003423; Wie JH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181164	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252247	10.1371/journal.pone.0252247	http://dx.doi.org/10.1371/journal.pone.0252247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038488	gold, Green Published			2022-12-26	WOS:000664633500070
J	Lee, KEM; Lum, WHD; Coleman, JL				Lee, Kenneth Ee Meng; Lum, W. H. Deon; Coleman, Joanna L.			Ecological impacts of the LED-streetlight retrofit on insectivorous bats in Singapore	PLOS ONE			English	Article							LIGHT-EMITTING DIODE; ARTIFICIAL-LIGHT; TRAFFIC NOISE; REPRODUCTIVE PHENOLOGY; FRUGIVOROUS BATS; PRESSURE SODIUM; URBAN; POLLUTION; CHIROPTERA; INSECTS	Cities around the world are transitioning to more efficient lighting schemes, especially retrofitting traditional, high-pressure sodium (HPS) streetlights with light-emitting diode (LED) lights. Although these initiatives aim to address the problems of urban sustainability and save money, the ecological impacts of these retrofits remain poorly understood, especially in brightly lit cities and in the tropics, where urbanisation is most rapid. We performed an experimental study of the retrofit in Singapore-focusing on insectivorous bats, whose activity we monitored acoustically along paired control (HPS-lit) and treatment (LED-lit) streets. We recorded seven species along these streets, but only obtained enough recordings to measure the effect of light type for three of them-all of which can reasonably be described as urban adapters. The strongest predictor of bat activity (an index of habitat use) was rainfall-it has a positive effect. Light type did not influence bat activity or species composition of the bat assemblage along these streets, though it did interact with the effects of rainfall and traffic noise for one bat species. Ultimately, the retrofit may be ecologically meaningless to urban-adapted, tropical insectivores that already experience high levels of light pollution as they do in Singapore. However, while our findings may appear reassuring to those concerned with such retrofits in other tropical and/or brightly-lit cities, they also highlight the contextual nature of ecological impacts. We point out that they should not be prematurely generalised to other locales and systems. In particular, they do not imply no impact on species that are less urban-adapted, and there is a clear need for further studies, for example, on responses of other foraging guilds and of bats (and insects) throughout the tropics.	[Lee, Kenneth Ee Meng; Lum, W. H. Deon; Coleman, Joanna L.] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	National University of Singapore	Coleman, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	joanna.coleman.2000@gmail.com		Lum, Deon/0000-0002-6072-4807				Adams AM, 2012, METHODS ECOL EVOL, V3, P992, DOI 10.1111/j.2041-210X.2012.00244.x; Aziz SA, 2017, ECOL EVOL, V7, P8670, DOI 10.1002/ece3.3213; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bonsen G, 2015, ACTA CHIROPTEROL, V17, P347, DOI 10.3161/15081109ACC2015.17.2.010; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Bunkley JP, 2015, ETHOLOGY, V121, P1116, DOI 10.1111/eth.12428; Chaiyarat R, 2020, URBAN ECOSYST, V23, P97, DOI 10.1007/s11252-019-00919-w; Chan AAQ, 2021, URBAN ECOSYST, V24, P251, DOI 10.1007/s11252-020-01034-x; Chattopadhyay B, 2019, CURR BIOL, V29, pR1299, DOI 10.1016/j.cub.2019.11.013; Ciach M, 2019, URBAN ECOSYST, V22, P513, DOI 10.1007/s11252-019-00840-2; Coleman JL, 2013, J MAMMAL, V94, P1111, DOI 10.1644/12-MAMM-A-217.1; CORLETT RT, 1992, J BIOGEOGR, V19, P411, DOI 10.2307/2845569; MacSwiney MC, 2009, ACTA CHIROPTEROL, V11, P139, DOI 10.3161/150811009X465758; Cumming GS, 1997, OECOLOGIA, V111, P309, DOI 10.1007/s004420050240; Davies TW, 2013, GLOBAL CHANGE BIOL, V19, P1417, DOI 10.1111/gcb.12166; DSS, POP TRENDS 2017; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; Falchi F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600377; FENTON MB, 1981, J MAMMAL, V62, P233, DOI 10.2307/1380701; Ffrench-Constant RH, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0813; Finch D, 2020, ENVIRON POLLUT, V263, DOI 10.1016/j.envpol.2020.114405; Fox J., 2019, R COMPANION APPL REG, VThird; Furey NM, 2011, ACTA CHIROPTEROL, V13, P341, DOI 10.3161/150811011X624811; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Gaw LYF, 2019, DATA, V4, DOI 10.3390/data4030116; GEGGIE JF, 1985, CAN J ZOOL, V63, P263, DOI 10.1139/z85-040; Gil-De-Castro A, 2013, LIGHTING RES TECHNOL, V45, P710, DOI 10.1177/1477153512450866; Goerlitz HR, 2018, ECOL EVOL, V8, P5090, DOI 10.1002/ece3.4088; Haddock JK, 2019, AUSTRAL ECOL, V44, P1052, DOI 10.1111/aec.12772; Hartig F., 2022, DHARMA RESIDUAL DIAG; Hoyos-Díaz José M, 2018, Mastozool. neotrop., V25, P473, DOI 10.31687/saremMN.18.25.2.0.22; Jiang Y, 2015, J TRAFFIC TRANSP ENG, V2, P158, DOI 10.1016/j.jtte.2015.03.004; Kerbiriou C, 2020, DIVERSITY-BASEL, V12, DOI 10.3390/d12040165; Kingston T, 2010, BIODIVERS CONSERV, V19, P471, DOI 10.1007/s10531-008-9458-5; Kishimoto-Yamada K, 2015, ENTOMOL SCI, V18, P407, DOI 10.1111/ens.12134; Kyba CCM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701528; Lane DJW, 2006, BIOL CONSERV, V131, P584, DOI 10.1016/j.biocon.2006.03.005; Lewanzik D, 2017, J APPL ECOL, V54, P264, DOI 10.1111/1365-2664.12758; Lewanzik D, 2014, J APPL ECOL, V51, P388, DOI 10.1111/1365-2664.12206; LTA, 2017, SMART MOR EN EFF STR; Luarte T, 2016, ENVIRON POLLUT, V218, P1147, DOI 10.1016/j.envpol.2016.08.068; Luo JH, 2015, GLOBAL CHANGE BIOL, V21, P3278, DOI 10.1111/gcb.12997; Ma T, 2012, REMOTE SENS ENVIRON, V124, P99, DOI 10.1016/j.rse.2012.04.018; Meyer CH, 2016, DEV OPHTHALMOL, V55, P63, DOI 10.1159/000431143; Meyer CFJ, 2004, J TROP ECOL, V20, P397, DOI 10.1017/S0266467404001373; MSS, CLIM SING; NEA, RAINF MONTHL TOT; Nurul-Ain E, 2017, BIOTROPICA, V49, P382, DOI 10.1111/btp.12430; Oksanen J., **DATA OBJECT**; Pawson SM, 2014, ECOL APPL, V24, P1561, DOI 10.1890/14-0468.1; Polak T, 2011, J ZOOL, V285, P21, DOI 10.1111/j.1469-7998.2011.00808.x; Pottie SA, 2005, ACTA CHIROPTEROL, V7, P237, DOI 10.3161/1733-5329(2005)7[237:TMBFOS]2.0.CO;2; Pu GZ, 2020, ECOTOX ENVIRON SAFE, V191, DOI 10.1016/j.ecoenv.2019.110014; QGIS.org, QGIS GEOGR INF SYST; R Core Team, 2020, R LANG ENV STAT COMP; Rich C, 2006, ECOLOGICAL CONSEQUEN, P458; Rowse EG, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180205; Rowse EG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150884; RYDELL J, 1992, FUNCT ECOL, V6, P744, DOI 10.2307/2389972; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Senawi J, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.203950; Siemers BM, 2011, P ROY SOC B-BIOL SCI, V278, P1646, DOI 10.1098/rspb.2010.2262; SLA, TOT LAND AR SING; Smokorowski KE, 2017, FACETS, V2, P212, DOI 10.1139/facets-2016-0058; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; Stone EL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0127; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; Tahkamo L, 2015, J CLEAN PROD, V93, P234, DOI 10.1016/j.jclepro.2015.01.025; Trikootam SC, 2019, BUILD ENVIRON, V149, P561, DOI 10.1016/j.buildenv.2018.11.037; UN DESA,, 2019, STESASERA420 UN DESA; van Grunsven RHA, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11226198; Vaughan N, 1997, J APPL ECOL, V34, P716, DOI 10.2307/2404918; Wakefield A, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150291; Willig MR, 2003, BAT ECOLOGY, P580; Zalipah MN, 2016, BIOTROPICA, V48, P425, DOI 10.1111/btp.12335	77	1	1	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0247900	10.1371/journal.pone.0247900	http://dx.doi.org/10.1371/journal.pone.0247900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038438	Green Published, gold			2022-12-26	WOS:000664633500006
J	Pan, Y; Zhao, X; Wu, XL; Wang, Y; Tan, J; Chen, DX				Pan, Yuan; Zhao, Xiao; Wu, Xiao-li; Wang, Yu; Tan, Jun; Chen, Da-xia			Transcriptomic and metabolomic analyses provide insights into the biosynthesis of chlorogenic acids in Lonicera macranthoides Hand.-Mazz	PLOS ONE			English	Article							JAPONICA THUNB.; REVEALS; HYDROXYCINNAMOYLTRANSFERASE; IDENTIFICATION; ANNOTATION; ARTICHOKE; GENES; KEGG	Lonicera macranthoides Hand.-Mazz (L. macranthoides) is a medicinal herb that is widely distributed in South China. The developmental stage and corolla dehiscence of the flower are the important factors affecting the quality of medicinal ingredients. However, neither the regulatory mechanism controlling chlorogenic acids biosynthesis in L. macranthoides nor the molecular basis of effect of corolla dehiscence on the quality of medicinal materials is fully understood. In this study, metabolomics and transcriptomics were used to analyze the metabolic and transcriptional differences of two different cultivars closed bud type (Bt), and flowering type (Ft), as well as the effect of jasmonic acid methyl ester (MeJA) on chlorogenic acids (CGAs) biosynthesis. In total, large number of differentially expressed genes (DEGs) and differentially accumulated metabolites (DAMs) were filtered among three lines of samples. Gene metabolite correlation analyses revealed a 'core set' of 30 genes and 54 genes that were strongly correlated with CGAs biosynthesis and regulating the flowering, respectively. Quantitative real-time polymerase chain reaction results proved the alterations in the expression levels of genes encoding the pathways involved in CGAs biosynthesis. The ion abundances of CGAs were most significantly increased, while some of the CGAs derived and Caffeoyl-CoA-derived substances showed the most largely reduced abundances in the closed bud type (Bt) compared to the flowering type (Ft). MeJA may leads to the activation of downstream genes in CGAs biosynthesis pathway. Overall, there were significant differences in the transcriptional and metabolic levels of CGAs biosynthesis pathway in flower buds of different flowering cultivars. The redirection of metabolic flux may contribute to increased accumulation of CGAs. However, whether MeJA and flowering have direct effects on the accumulation of CGAs needs further studied. These researches effectively expanded the functional genomic library and provide new insights into CGAs biosynthesis in L. macranthoides.	[Pan, Yuan; Zhao, Xiao; Wu, Xiao-li; Wang, Yu; Tan, Jun; Chen, Da-xia] Chongqing Acad Chinese Mat Med, Chongqing, Peoples R China; [Pan, Yuan; Zhao, Xiao; Wu, Xiao-li; Wang, Yu; Tan, Jun; Chen, Da-xia] Chongqing Engn Res Ctr Fine Variety Breeding Tech, Chongqing, Peoples R China; [Pan, Yuan; Zhao, Xiao; Wu, Xiao-li; Wang, Yu; Tan, Jun; Chen, Da-xia] China Acad Chinese Med Sci, Chongqing Sub Ctr, Natl Resource Ctr Chinese Mat Med, Chongqing, Peoples R China	China Academy of Chinese Medical Sciences	Chen, DX (corresponding author), Chongqing Acad Chinese Mat Med, Chongqing, Peoples R China.; Chen, DX (corresponding author), Chongqing Engn Res Ctr Fine Variety Breeding Tech, Chongqing, Peoples R China.; Chen, DX (corresponding author), China Acad Chinese Med Sci, Chongqing Sub Ctr, Natl Resource Ctr Chinese Mat Med, Chongqing, Peoples R China.	17837@163.com			Natural Science Foundation of Chongqing province of China [cstc2018jcyjAX0381]	Natural Science Foundation of Chongqing province of China(Natural Science Foundation of Chongqing)	Funded studies.This work was supported by the Natural Science Foundation of Chongqing province of China (No. cstc2018jcyjAX0381). The by sponsor is Daxia Chen.	Abdulrazzak N, 2006, PLANT PHYSIOL, V140, P30, DOI 10.1104/pp.105.069690; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2020, BMC PLANT BIOL, DOI DOI 10.1186/S12870-020-02546-6; Chen J, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02554-6; Chen J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4946-9; Chen Qiu-Zhu, 2010, Zhong Yao Cai, V33, P920; Chen ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137212; Clifford MN, 2004, PLANTA MED, V70, P1103, DOI 10.1055/s-2004-835835; Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI [10.1002/(SICI)1097-0010(20000515)80:7&lt;1033::AID-JSFA595&gt;3.0.CO;2-T, 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T]; Colombo M, 2008, PLANT J, V54, P1037, DOI 10.1111/j.1365-313X.2008.03485.x; Comino C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-30; Comino C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-14; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Gao J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051869; Geng Shi-Lei, 2005, Acta Botanica Yunnanica, V27, P279; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han JM, 2015, PHYTOTHER RES, V29, P1616, DOI 10.1002/ptr.5413; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062922; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Howles PA, 1996, PLANT PHYSIOL, V112, P1617, DOI 10.1104/pp.112.4.1617; Jie Meng, 2019, Journal of Agricultural and Food Chemistry, V67, P3284, DOI 10.1021/acs.jafc.8b06355; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kishimoto Noriaki, 2005, Biocontrol Science, V10, P155; Kong DX, 2017, PLANT PHYSIOL BIOCH, V112, P87, DOI 10.1016/j.plaphy.2016.12.027; Li YQ, 2018, REV BRAS FARMACOGN, V28, P533, DOI 10.1016/j.bjp.2018.06.007; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547; Park C, 2018, PHYTOTHER RES, V32, P504, DOI 10.1002/ptr.5996; Park KI, 2017, ONCOL LETT, V13, P2521, DOI 10.3892/ol.2017.5771; Rai A, 2017, J NAT MED-TOKYO, V71, P1, DOI 10.1007/s11418-016-1041-x; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Sonnante G, 2010, PLANT PHYSIOL, V153, P1224, DOI 10.1104/pp.109.150144; STRACK D, 1990, PLANT PHYSIOL, V92, P41, DOI 10.1104/pp.92.1.41; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Tian, 2011, CHINA J CHINESE MAT, V3, P1406; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wan LY, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02383-7; Wang ZR, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01990; WOLTERING EJ, 1988, J EXP BOT, V39, P1605, DOI 10.1093/jxb/39.11.1605; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yuan HJ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9415409; Yuan Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-195; Zhang B, 2019, J PHARMACEUT BIOMED, V170, P83, DOI 10.1016/j.jpba.2019.03.035; Zhang Cong, 2009, Zhongguo Zhong Yao Za Zhi, V34, P3051; Zhang T, 2020, INT J BIOL MACROMOL, V151, P1058, DOI 10.1016/j.ijbiomac.2019.10.147; Zhang Z, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02344-0; Zhou LK, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00197-3	48	0	0	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251390	10.1371/journal.pone.0251390	http://dx.doi.org/10.1371/journal.pone.0251390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038434	Green Published, gold			2022-12-26	WOS:000664633500021
J	Rabaglino, MB; O'Doherty, A; Secher, JBM; Lonergan, P; Hyttel, P; Fair, T; Kadarmideen, HN				Rabaglino, Maria B.; O'Doherty, Alan; Secher, Jan Bojsen-Moller; Lonergan, Patrick; Hyttel, Poul; Fair, Trudee; Kadarmideen, Haja N.			Application of multi-omics data integration and machine learning approaches to identify epigenetic and transcriptomic differences between in vitro and in vivo produced bovine embryos	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGIES; FOCAL ADHESION KINASE; GENE-EXPRESSION; DNA METHYLATION; GENOME; PROGESTERONE; CONCEPTUSES; BLASTOCYST; PREGNANCY; ENVIRONMENT	Pregnancy rates for in vitro produced (IVP) embryos are usually lower than for embryos produced in vivo after ovarian superovulation (MOET). This is potentially due to alterations in their trophectoderm (TE), the outermost layer in physical contact with the maternal endometrium. The main objective was to apply a multi-omics data integration approach to identify both temporally differentially expressed and differentially methylated genes (DEG and DMG), between IVP and MOET embryos, that could impact TE function. To start, four and five published transcriptomic and epigenomic datasets, respectively, were processed for data integration. Second, DEG from day 7 to days 13 and 16 and DMG from day 7 to day 17 were determined in the TE from IVP vs. MOET embryos. Third, genes that were both DE and DM were subjected to hierarchical clustering and functional enrichment analysis. Finally, findings were validated through a machine learning approach with two additional datasets from day 15 embryos. There were 1535 DEG and 6360 DMG, with 490 overlapped genes, whose expression profiles at days 13 and 16 resulted in three main clusters. Cluster 1 (188) and Cluster 2 (191) genes were down-regulated at day 13 or day 16, respectively, while Cluster 3 genes (111) were up-regulated at both days, in IVP embryos compared to MOET embryos. The top enriched terms were the KEGG pathway "focal adhesion" in Cluster 1 (FDR = 0.003), and the cellular component: "extracellular exosome" in Cluster 2 (FDR<0.0001), also enriched in Cluster 1 (FDR = 0.04). According to the machine learning approach, genes in Cluster 1 showed a similar expression pattern between IVP and less developed (short) MOET conceptuses; and between MOET and DKK1-treated (advanced) IVP conceptuses. In conclusion, these results suggest that early conceptuses derived from IVP embryos exhibit epigenomic and transcriptomic changes that later affect its elongation and focal adhesion, impairing post-transfer survival.	[Rabaglino, Maria B.; Kadarmideen, Haja N.] Tech Univ Denmark, Quantitat Genet Bioinformat & Computat Biol Grp, Dept Appl Math & Comp Sci, Lyngby, Denmark; [O'Doherty, Alan; Lonergan, Patrick; Fair, Trudee] Univ Coll Dublin, Sch Agr & Food Sci, Dublin, Ireland; [Secher, Jan Bojsen-Moller; Hyttel, Poul] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg C, Denmark	Technical University of Denmark; University College Dublin; University of Copenhagen	Kadarmideen, HN (corresponding author), Tech Univ Denmark, Quantitat Genet Bioinformat & Computat Biol Grp, Dept Appl Math & Comp Sci, Lyngby, Denmark.	hajak@dtu.dk		Kadarmideen, Haja/0000-0001-6294-382X; Rabaglino, Maria/0000-0002-0099-045X; Secher, Jan Ole Bertelsen/0000-0002-7399-7142	MBR's appointment at the Technical University of Denmark (DTU) - Innovation Fund Denmark [7045-00013B]	MBR's appointment at the Technical University of Denmark (DTU) - Innovation Fund Denmark	MBR's appointment at the Technical University of Denmark (DTU) and the research conducted in this study was part of the EliteOVA project funded by a grant from Innovation Fund Denmark (7045-00013B).	Anastasiadi D, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0205-1; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barnwell CV, 2015, DOMEST ANIM ENDOCRIN, V52, P75, DOI 10.1016/j.domaniend.2015.03.004; Barnwell CV, 2016, MOL REPROD DEV, V83, P424, DOI 10.1002/mrd.22640; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bauersachs S, 2009, P NATL ACAD SCI USA, V106, P5681, DOI 10.1073/pnas.0811841106; Bazer FW, 2017, REPRODUCTION, V154, pF11, DOI 10.1530/REP-17-0257; Bertolini M, 2002, MOL REPROD DEV, V63, P318, DOI 10.1002/mrd.90015; Betsha S, 2013, MOL REPROD DEV, V80, P315, DOI 10.1002/mrd.22165; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Block J, 2009, THERIOGENOLOGY, V71, P1063, DOI 10.1016/j.theriogenology.2008.11.007; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Bridi A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031163; Clemente M, 2009, REPRODUCTION, V138, P507, DOI 10.1530/REP-09-0152; Corcoran D, 2006, REPRODUCTION, V131, P651, DOI 10.1530/rep.1.01015; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Denicol AC, 2014, FASEB J, V28, P3975, DOI 10.1096/fj.14-253112; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Ealy AD, 2019, J ANIM SCI, V97, P2555, DOI 10.1093/jas/skz116; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrlich M, 2013, EPIGENOMICS-UK, V5, P553, DOI 10.2217/epi.13.43; Fair T, 2016, ANIM REPROD, V13, P250, DOI 10.21451/1984-3143-AR880; Gad A, 2011, HUM REPROD, V26, P1693, DOI 10.1093/humrep/der110; Hansen PJ, 2020, ANNU REV ANIM BIOSCI, V8, P395, DOI 10.1146/annurev-animal-021419-084010; Hansen PJ, 2004, REPROD FERT DEVELOP, V16, P1, DOI 10.1071/RD03073; Heras S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2393-z; Hornung R, 2017, BIOINFORMATICS, V33, P397, DOI 10.1093/bioinformatics/btw650; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber W., 2003, STAT APPL GENET MOL, V2, pARTICL, DOI [10.2202/1544-6115.1008, DOI 10.2202/1544-6115.1008]; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaneko Y, 2012, J MORPHOL, V273, P639, DOI 10.1002/jmor.20010; Karatzoglou A, 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i09, DOI 10.18637/JSS.V011.I09]; Kues WA, 2008, P NATL ACAD SCI USA, V105, P19768, DOI 10.1073/pnas.0805616105; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kusama K, 2018, BIOCHEM BIOPH RES CO, V495, P1370, DOI 10.1016/j.bbrc.2017.11.176; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Lonergan P, 2008, THERIOGENOLOGY, V69, P17, DOI 10.1016/j.theriogenology.2007.09.007; Lonergan P, 2007, REPROD FERT DEVELOP, V19, P861, DOI 10.1071/RD07089; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma L, 2020, J CELL PHYSIOL, V235, P6711, DOI 10.1002/jcp.29566; Mamo S, 2011, BIOL REPROD, V85, P1143, DOI 10.1095/biolreprod.111.092643; Mansouri-Attia N, 2009, P NATL ACAD SCI USA, V106, P5687, DOI 10.1073/pnas.0812722106; Mathew DJ, 2019, BIOL REPROD, V100, P365, DOI 10.1093/biolre/ioy199; Mellisho EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178306; Merino F, 2020, SEMIN CELL DEV BIOL, V102, P51, DOI 10.1016/j.semcdb.2019.11.018; Moore SG, 2017, J DAIRY SCI, V100, P10314, DOI 10.3168/jds.2017-13138; Nakamura K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158278; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; O'Doherty AM, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4818-3; R Core Team, 2020, R LANG ENV STAT COMP; Renshaw MW, 1999, J CELL BIOL, V147, P611, DOI 10.1083/jcb.147.3.611; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Saadi HAS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-451; Saeed-Zidane M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223753; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salilew-Wondim D, 2018, BMC GENOMICS, V19, DOI [10.1186/s12864-018-4826-3, 10.1186/S12864-018-4826-3]; Salilew-Wondim D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140467; Sanchez JM, 2019, BIOL REPROD, V101, P26, DOI 10.1093/biolre/ioz060; Shawky JH, 2015, DEV BIOL, V401, P152, DOI 10.1016/j.ydbio.2014.12.005; Smyth GK, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-165; Thibier M, 2002, LIVEST PROD SCI, V74, P203, DOI 10.1016/S0301-6226(01)00291-3; Tribulo P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48374-z; Urrego R, 2014, EPIGENETICS-US, V9, P803, DOI 10.4161/epi.28711; Viana J., 2019, EMBRYO TECHNOL NEWSL, V37, P7; Wiltbank MC, 2016, THERIOGENOLOGY, V86, P239, DOI 10.1016/j.theriogenology.2016.04.037; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Wrighton KH, 2013, NAT REV MOL CELL BIO, V14, DOI 10.1038/nrm3708; Wu CY, 2020, THERIOGENOLOGY, V144, P122, DOI 10.1016/j.theriogenology.2019.12.020; Wu CT, 2001, SCIENCE, V293, P1103, DOI 10.1126/science.293.5532.1103; Wu J., 2017, GCRMA BACKGROUND ADJ; Zolini AM, 2020, CELL TISSUE RES, V382, P665, DOI 10.1007/s00441-020-03257-y; Zolini AM, 2020, BIOL REPROD, V102, P292, DOI 10.1093/biolre/ioz190	74	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252096	10.1371/journal.pone.0252096	http://dx.doi.org/10.1371/journal.pone.0252096			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029343	Green Published, gold			2022-12-26	WOS:000664632800028
J	MacKay, EJ; Stubna, MD; Chivers, C; Draugelis, ME; Hanson, WJ; Desai, ND; Groeneveld, PW				MacKay, Emily J.; Stubna, Michael D.; Chivers, Corey; Draugelis, Michael E.; Hanson, William J.; Desai, Nimesh D.; Groeneveld, Peter W.			Application of machine learning approaches to administrative claims data to predict clinical outcomes in medical and surgical patient populations	PLOS ONE			English	Article							MODELS	Objective This study aimed to develop and validate a claims-based, machine learning algorithm to predict clinical outcomes across both medical and surgical patient populations. Methods This retrospective, observational cohort study, used a random 5% sample of 770,777 fee-for-service Medicare beneficiaries with an inpatient hospitalization between 2009-2011. The machine learning algorithms tested included: support vector machine, random forest, multilayer perceptron, extreme gradient boosted tree, and logistic regression. The extreme gradient boosted tree algorithm outperformed the alternatives and was the machine learning method used for the final risk model. Primary outcome was 30-day mortality. Secondary outcomes were: rehospitalization, and any of 23 adverse clinical events occurring within 30 days of the index admission date. Results The machine learning algorithm performance was evaluated by both the area under the receiver operating curve (AUROC) and Brier Score. The risk model demonstrated high performance for prediction of: 30-day mortality (AUROC = 0.88; Brier Score = 0.06), and 17 of the 23 adverse events (AUROC range: 0.80-0.86; Brier Score range: 0.01-0.05). The risk model demonstrated moderate performance for prediction of: rehospitalization within 30 days (AUROC = 0.73; Brier Score: = 0.07) and six of the 23 adverse events (AUROC range: 0.74-0.79; Brier Score range: 0.01-0.02). The machine learning risk model performed comparably on a second, independent validation dataset, confirming that the risk model was not overfit. Conclusions and relevance We have developed and validated a robust, claims-based, machine learning risk model that is applicable to both medical and surgical patient populations and demonstrates comparable predictive accuracy to existing risk models.	[MacKay, Emily J.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [MacKay, Emily J.] Univ Penn, Penn Ctr Perioperat Outcomes Res & Transformat CP, Philadelphia, PA 19104 USA; [MacKay, Emily J.; Desai, Nimesh D.; Groeneveld, Peter W.] Univ Penn, Penns Cardiovasc Outcomes Qual & Evaluat Res Ctr, Philadelphia, PA 19104 USA; [Stubna, Michael D.; Chivers, Corey; Draugelis, Michael E.] Univ Penn, Penn Predict Healthcare, Penn Med, Philadelphia, PA 19104 USA; [Hanson, William J.; Desai, Nimesh D.] Univ Penn, Div Cardiovasc Surg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Desai, Nimesh D.; Groeneveld, Peter W.] Univ Penn, Leonard Davis Inst Hlth Econ LDI, Philadelphia, PA 19104 USA; [Groeneveld, Peter W.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Groeneveld, Peter W.] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	MacKay, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.; MacKay, EJ (corresponding author), Univ Penn, Penn Ctr Perioperat Outcomes Res & Transformat CP, Philadelphia, PA 19104 USA.; MacKay, EJ (corresponding author), Univ Penn, Penns Cardiovasc Outcomes Qual & Evaluat Res Ctr, Philadelphia, PA 19104 USA.	Emily.mackay@pennmedicine.upenn.edu	MacKay, Emily/HGC-4619-2022	Groeneveld, Peter/0000-0002-7374-4292; MACKAY, EMILY/0000-0001-9865-419X	Penn Medicine, University of Pennsylvania Health System	Penn Medicine, University of Pennsylvania Health System	This work was supported by grant funding from: Penn Medicine, University of Pennsylvania Health System to E.J.M and M.D.S. https://www.pennmedicine.org Data for this work was supplied by the Centers for Medicare and Medicaid Services (CMS), as a part of the Artificial Intelligence (AI) Health Outcomes Challenge. https://innovation.cms.gov/innovation-models/artificial-intelligence-health-outcomes-challenge.	AHRQ) HCaUPHaAfHRaQ, CLIN CLASS SOFTW CCS; ARKES HR, 1995, MED DECIS MAKING, V15, P120; Bilimoria KY, 2013, J AM COLL SURGEONS, V217, P833, DOI 10.1016/j.jamcollsurg.2013.07.385; Buitinck L, 2013, ARXIV PREPRINT ARXIV; Bzdok D, 2018, NAT METHODS, V15, P5, DOI 10.1038/nmeth.4551; Cheng JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24454; CMS) CfMMS, ICD 10 CMPCS MS DRG; Donze J, 2013, JAMA INTERN MED, V173, P632, DOI 10.1001/jamainternmed.2013.3023; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fried TR, 2016, NEW ENGL J MED, V374, P104, DOI 10.1056/NEJMp1510020; Gadekallu TR, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9020274; Geron A, 2017, HANDS ON MACHINE LEA; Golas SB, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0620-z; Karen Aldana AD, CMS ART INT HLTH OUT; Khan RU, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9112375; Krumholz HM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8406; Krumholz HM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7314; Language PP, PYTH V3 7 6; Lash TL, 2001, EPIDEMIOLOGY, V12, P259, DOI 10.1097/00001648-200103000-00021; LeDell E, 2015, ELECTRON J STAT, V9, P1583, DOI 10.1214/15-EJS1035; Magnimind, 2019, APPL MACHINE LEARNIN; O'Brien SM, 2018, ANN THORAC SURG, V105, P1419, DOI 10.1016/j.athoracsur.2018.03.003; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pencina MJ, 2015, JAMA-J AM MED ASSOC, V314, P1063, DOI 10.1001/jama.2015.11082; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Pope GC, 2000, HEALTH CARE FINANC R, V21, P93; Reddy GT, 2022, MULTIMED TOOLS APPL, V81, P41429, DOI 10.1007/s11042-020-09988-y; Sahni N, 2018, J GEN INTERN MED, V33, P921, DOI 10.1007/s11606-018-4316-y; Services CfMaM, CTR MED MED SERV CMS; Shahian DM, STS RISK CALC SOC TH; Shen L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48995-4; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Thomalla G, 2018, NEW ENGL J MED, V379, P611, DOI 10.1056/NEJMoa1804355; van Walraven Carl, 2012, Open Med, V6, pe80; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252585	10.1371/journal.pone.0252585	http://dx.doi.org/10.1371/journal.pone.0252585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081720	gold, Green Published			2022-12-26	WOS:000664639200030
J	Yamanaka, H; Takata, Y; Nakagawa, H; Isosaka-Yamanaka, T; Yamashita, T; Takada, M				Yamanaka, Hajime; Takata, Yu; Nakagawa, Hiroshi; Isosaka-Yamanaka, Tomoko; Yamashita, Toshihide; Takada, Masahiko			An enhanced therapeutic effect of repetitive transcranial magnetic stimulation combined with antibody treatment in a primate model of spinal cord injury	PLOS ONE			English	Article							GUIDANCE MOLECULE-A; RGMA INHIBITION; MOTOR; RECOVERY; EXCITABILITY	Repetitive transcranial magnetic stimulation (rTMS) targeting the primary motor cortex (MI) is expected to provide a therapeutic impact on spinal cord injury (SCI). On the other hand, treatment with antibody against repulsive guidance molecule-a (RGMa) has been shown to ameliorate motor deficits after SCI in rodents and primates. Facilitating activity of the corticospinal tract (CST) by rTMS following rewiring of CST fibers by anti-RGMa antibody treatment may exert an enhanced effect on motor recovery in a primate model of SCI. To address this issue, we examined whether such a combined therapeutic strategy could contribute to accelerating functional restoration from SCI. In our SCI model, unilateral lesions were made between the C6 and the C7 level. Two macaque monkeys were used for each of the combined therapy and antibody treatment alone, while one monkey was for rTMS alone. The antibody treatment was continuously carried out for four weeks immediately after SCI, and rTMS trials applying a thermoplastic mask and a laser distance meter lasted ten weeks. Behavioral assessment was performed over 14 weeks after SCI to investigate the extent to which motor functions were restored with the antibody treatment and/or rTMS. While rTMS without the preceding antibody treatment produced no discernible sign for functional recovery, a combination of the antibody and rTMS exhibited a greater effect, especially at an early stage of rTMS trials, on restoration of dexterous hand movements. The present results indicate that rTMS combined with anti-RGMa antibody treatment may exert a synergistic effect on motor recovery from SCI.	[Yamanaka, Hajime; Takata, Yu; Nakagawa, Hiroshi; Isosaka-Yamanaka, Tomoko; Takada, Masahiko] Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Dept Neurosci, Inuyama, Aichi, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Nakagawa, Hiroshi] Osaka Univ, Dept Mol Neurosci, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka, Japan	Kyoto University; Osaka University; Osaka University	Yamanaka, H (corresponding author), Kyoto Univ, Primate Res Inst, Syst Neurosci Sect, Dept Neurosci, Inuyama, Aichi, Japan.	yamanaka.hajime.8x@kyoto-u.ac.jp		YAMANAKA, Hajime/0000-0001-6748-9179	Strategic Research Program for Brain Sciences from the Agency for Medical Research and Development (AMED), Japan [17dm0107117h0002]; Mitsubishi Tanabe Pharma Corporation (Tokyo, Japan)	Strategic Research Program for Brain Sciences from the Agency for Medical Research and Development (AMED), Japan; Mitsubishi Tanabe Pharma Corporation (Tokyo, Japan)	This work was supported by the Strategic Research Program for Brain Sciences from the Agency for Medical Research and Development (AMED), Japan in the form of a grant (17dm0107117h0002) and Mitsubishi Tanabe Pharma Corporation (Tokyo, Japan) in the form of the anti-RGMa antibody used in the study, funding for the expendables, and a stipend awarded to HY and MT. The funders had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belci M, 2004, SPINAL CORD, V42, P417, DOI 10.1038/sj.sc.3101613; Benito J, 2012, Top Spinal Cord Inj Rehabil, V18, P106, DOI 10.1310/sci1802-106; Bunday KL, 2012, CURR BIOL, V22, P2355, DOI 10.1016/j.cub.2012.10.046; Drucker CB, 2015, J NEUROSCI METH, V253, P90, DOI 10.1016/j.jneumeth.2015.06.013; Ellaway PH, 2007, J REHABIL RES DEV, V44, P69, DOI 10.1682/JRRD.2005.08.0140; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fitzgerald PB, 2020, J AFFECT DISORDERS, V276, P90, DOI 10.1016/j.jad.2020.06.067; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; Harada K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18362-2; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Kuppuswamy A, 2011, CLIN NEUROPHYSIOL, V122, P2452, DOI 10.1016/j.clinph.2011.04.022; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; Mothe AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10987-7; Nakagawa H, 2019, CEREB CORTEX, V29, P561, DOI 10.1093/cercor/bhx338; Nakagawa H, 2018, NEURAL REGEN RES, V13, P981, DOI 10.4103/1673-5374.233437; Nakagawa H, 2015, SCI REP-UK, V5, DOI 10.1038/srep11986; Nakanishi T, 2019, NEUROSCI LETT, V709, DOI 10.1016/j.neulet.2019.134329; Rosenzweig ES, 2009, J COMP NEUROL, V513, P151, DOI 10.1002/cne.21940; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Shabanzadeh AP, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.109; Siebold C, 2017, TRENDS CELL BIOL, V27, P365, DOI 10.1016/j.tcb.2016.11.009; Tanabe S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1118-4; Tazoe T, 2015, ARCH PHYS MED REHAB, V96, pS145, DOI 10.1016/j.apmr.2014.07.418; Wassermann EM, 1996, ELECTROMYOGR MOTOR C, V101, P412	26	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252023	10.1371/journal.pone.0252023	http://dx.doi.org/10.1371/journal.pone.0252023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077429	gold, Green Published			2022-12-26	WOS:000664638500022
J	Yang, X; Chen, Y; Zhou, Y; Wu, C; Li, Q; Wu, J; Hu, WW; Zhao, WQ; Wei, W; Wu, CP; Jiang, JT; Ji, M				Yang, Xin; Chen, Yan; Zhou, You; Wu, Chen; Li, Qing; Wu, Jun; Hu, Wen Wei; Zhao, Wei Qing; Wei, Wei; Wu, Chang Ping; Jiang, Jing Ting; Ji, Mei			GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion	ONCOGENE			English	Article							ANTITUMOR IMMUNITY; TUMOR-GROWTH; GLYPICAN-5; GENE; MICRORNAS; NICHE; MECHANISMS; TRANSITION; EXPRESSION; SMOKERS	Lung cancer is the leading cause of cancer-related death worldwide. Glypican-5 (GPC5) is a member of heparan sulfate proteoglycans, and its biological importance in initiation and progression of lung cancer remains controversial. In the present study, we revealed that GPC5 transcriptionally enhanced the expression of CTDSP1 (miR-26b host gene) via AhR-ARNT pathway, and such up-regulation of CTDSP1 intracellularly contributed to the inhibited proliferation of lung cancer cells. Moreover, exosomes derived from GPC5-overexpressing human lung cancer cells (GPC5-OE-derived exosomes) had an extracellular repressive effect on human lymphatic endothelial cells (hLECs), leading to decreased tube formation and migration. Comparison between GPC5-WT- and GPC5-OE-derived exosomes showed that miR-26b (embedded within introns of CTDSP1 gene) was significantly up-regulated in GPC5-OE-derived exosomes and critical to the influence on hLECs. On the mechanism, we demonstrated that miR-26b transferred into hLECs directly targeted to PTK2 3'-UTR and led to PTK2 down-regulation, resulting in defects in tube formation and migration of hLECs. By uncovering the regulation network among GPC5, miR-26b, miR-26b host gene (CTDSP1), and target gene (PTK2), our findings demonstrated that GPC5 functioned as a tumor suppressor in human lung cancer.	[Yang, Xin; Chen, Yan; Wu, Chen; Wu, Jun; Hu, Wen Wei; Zhao, Wei Qing; Wei, Wei; Wu, Chang Ping; Ji, Mei] Soochow Univ, Dept Oncol, Affiliated Hosp 3, Changzhou, Peoples R China; [Yang, Xin; Zhou, You; Jiang, Jing Ting] Jiangsu Engn Res Ctr Tumor Immunotherapy, Changzhou, Peoples R China; [Yang, Xin; Zhou, You; Jiang, Jing Ting] Soochow Univ, Inst Cell Therapy, Changzhou, Peoples R China; [Zhou, You; Jiang, Jing Ting] Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Peoples R China; [Li, Qing] Soochow Univ, Affiliated Hosp 3, Dept Pathol, Changzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Yang, X; Ji, M (corresponding author), Soochow Univ, Dept Oncol, Affiliated Hosp 3, Changzhou, Peoples R China.; Yang, X; Jiang, JT (corresponding author), Jiangsu Engn Res Ctr Tumor Immunotherapy, Changzhou, Peoples R China.; Yang, X; Jiang, JT (corresponding author), Soochow Univ, Inst Cell Therapy, Changzhou, Peoples R China.; Jiang, JT (corresponding author), Soochow Univ, Affiliated Hosp 3, Dept Tumor Biol Treatment, Changzhou, Peoples R China.	yangxindoctor@163.com; jiangjingting@suda.edu.cn; zlkjimei@163.com	Zhou, You/GMW-4434-2022		Natural Science Foundation of China [82072561]; Natural Science Youth Foundation of China [81501971, 31701111, 31700792]; China Postdoctoral Science Foundation [2018M630603]; Natural Science Youth Foundation of Jiangsu Province [BK20150252, BK20170295]; Human Resource Summit Grant of Jiangsu Province [WSW-142]; Youth Medical Professionals Foundation of Jiangsu Province [QNRC2016279]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Youth Foundation of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Youth Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Human Resource Summit Grant of Jiangsu Province; Youth Medical Professionals Foundation of Jiangsu Province	This work was supported by grants from the Natural Science Foundation of China (82072561), the Natural Science Youth Foundation of China (81501971, 31701111, 31700792), Project funded by China Postdoctoral Science Foundation (2018M630603), the Natural Science Youth Foundation of Jiangsu Province (BK20150252, BK20170295), the Human Resource Summit Grant of Jiangsu Province (WSW-142), and the Youth Medical Professionals Foundation of Jiangsu Province (QNRC2016279).	Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Broekman ML, 2018, NAT REV NEUROL, V14, P482, DOI 10.1038/s41582-018-0025-8; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Chen Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11420; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Devarakonda S, 2015, LANCET ONCOL, V16, pE342, DOI 10.1016/S1470-2045(15)00077-7; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kruspig B, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao2565; LeBleu VS, 2019, IMMUNITY, V50, P547, DOI 10.1016/j.immuni.2019.02.019; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; Li YF, 2011, J THORAC ONCOL, V6, P2, DOI 10.1097/JTO.0b013e3181fd6b04; Li YF, 2010, LANCET ONCOL, V11, P321, DOI 10.1016/S1470-2045(10)70042-5; Li Y, 2013, ONCOL LETT, V6, P1565, DOI 10.3892/ol.2013.1622; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Nishimura R, 2013, CANCER SCI, V104, P856, DOI 10.1111/cas.12173; Noone A, 2017, SEER CANC STAT REV C; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Ovrevik J, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0048-8; Poggio M, 2019, CELL, V177, P414, DOI 10.1016/j.cell.2019.02.016; Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2; Tian YA, 2009, BIOCHEM PHARMACOL, V77, P670, DOI 10.1016/j.bcp.2008.10.023; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Veugelers M, 1997, GENOMICS, V40, P24, DOI 10.1006/geno.1996.4518; Wang SW, 2016, ONCOTARGET, V7, P79722, DOI 10.18632/oncotarget.12945; Wang Z, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1056-9; Williamson D, 2007, CANCER RES, V67, P57, DOI 10.1158/0008-5472.CAN-06-1650; Xu R, 2018, NAT REV CLIN ONCOL, V15, P617, DOI 10.1038/s41571-018-0036-9; Yang X, 2013, CANCER LETT, V341, P265, DOI 10.1016/j.canlet.2013.08.020; Yuan S, 2016, ONCOGENE, V35, P6120, DOI 10.1038/onc.2016.149; Zhang CW, 2016, TUMOR BIOL, V37, P6413, DOI 10.1007/s13277-015-4499-3; Zhang CW, 2011, MOL GENET METAB, V103, P104, DOI 10.1016/j.ymgme.2011.02.005; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	48	5	5	1	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2021	40	25					4307	4323		10.1038/s41388-021-01837-y	http://dx.doi.org/10.1038/s41388-021-01837-y		JUN 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SY4AZ	34079082				2022-12-26	WOS:000657217400004
J	Dulay, RM; Valdez, BC; Li, Y; Chakrabarti, S; Dhillon, B; Kalaw, SP; Reyes, RG; Cabrera, EC				Dulay, Rich Milton; Valdez, Benigno C.; Li, Yang; Chakrabarti, Seemanti; Dhillon, Braham; Kalaw, Sofronio P.; Reyes, Renato G.; Cabrera, Esperanza C.			Cytotoxicity of Gymnopilus purpureosquamulosus extracts on hematologic malignant cells through activation of the SAPK/JNK signaling pathway	PLOS ONE			English	Article							METABOLIC OXIDATIVE STRESS; KINASE; APOPTOSIS; MUSHROOM; DEATH; LINES; ASK1; JNK	Treatment of hematologic malignancies is a formidable challenge for hematologists and there is an urgent need to identify safe and efficacious agents either via synthesis in the laboratory or isolation from natural products. Here, we report the cytotoxicity of extracts from mushroom Gymnopilus purpureosquamulosus HOil (G. pps) and describe its molecular mechanisms. Using leukemia, lymphoma and multiple myeloma cell lines, 28-35 ppm G. pps extract inhibited cell proliferation by similar to 46-79%, which correlates with activation of apoptosis as indicated by increase in annexin V-positive cells (similar to 5-8-fold), production of reactive oxygen species (similar to 2-3-fold), cells in sub G0/G1 phase (similar to 3-13-fold), caspase 3 enzymatic activity (similar to 1.6-2.9-fold), DNA fragmentation, PARP1 cleavage and down-regulation of prosurvival proteins. Mitochondrial membrane potential decreased and leakage of pro-apoptotic factors to cytoplasm was observed, consistent with the activation of intrinsic apoptosis. Western blot analysis showed activation of the ASK1-MEK-SAPK/JNK and ASK1-P38 MAPK pathways possibly due to changes in the cellular redox status as suggested by decreased protein levels of peroxiredoxin, thioredoxin and thioredoxin reductase. Moreover, antioxidant N-acetylcysteine alleviated the cytotoxicity of G. pps. Pharmacological inhibition of SAPK/JNK and P38 alleviated the G. pps-mediated cytotoxicity. The extract activated apoptosis in leukemia and lymphoma patient cell samples but not in mononuclear cells from healthy donors further supporting the therapeutic values of G. pps for hematologic malignancies.	[Dulay, Rich Milton; Kalaw, Sofronio P.; Reyes, Renato G.] Cent Luzon State Univ, Coll Sci, Ctr Trop Mushroom Res & Dev, Dept Biol Sci, Sci City Of Munoz, Nueva Ecija, Philippines; [Dulay, Rich Milton; Cabrera, Esperanza C.] De La Salle Univ, Coll Sci, Dept Biol, Manila, Philippines; [Valdez, Benigno C.; Li, Yang] UT MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Chakrabarti, Seemanti; Dhillon, Braham] Univ Florida, Ft Lauderdale Res & Educ Ctr, Dept Plant Pathol, Davie, FL USA	Central Luzon State University; De La Salle University; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Florida	Valdez, BC (corresponding author), UT MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA.	bvaldez@mdanderson.org		Dulay, Rich Milton/0000-0002-5438-878X	Philippine Department of Science and Technology-Science Education Institute scholarship grant; National Institutes of Health through M.D. Anderson's Cancer Center Support Grant [CA016672]	Philippine Department of Science and Technology-Science Education Institute scholarship grant; National Institutes of Health through M.D. Anderson's Cancer Center Support Grant	RMD was supported by the Philippine Department of Science and Technology-Science Education Institute scholarship grant. Part of this research was performed in the Flow Cytometry & Cellular Imaging Facility, which is supported in part by the National Institutes of Health through M.D. Anderson's Cancer Center Support Grant CA016672.	Al-Kandari N, 2019, MOLECULES, V24, DOI 10.3390/molecules24183333; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; American Cancer Society, 2020, CANC FACTS FIG 2020; Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Arnante MES, 2017, P DLSU RES C 2017 SA; Badalyan SM, 2014, P 8 INT C MUSHR BIOL; Bharali DJ, 2009, INT J NANOMED, V4, P1; Boukes GJ, 2017, S AFR J BOT, V113, P62, DOI 10.1016/j.sajb.2017.07.010; Buniel PAS, 2018, INT J PHARM SCI RES, V9, P4201, DOI 10.13040/IJPSR.0975-8232.9(10).4201-09; Chaitanya MVNL, 2019, ASIAN PAC J TROP MED, V12, P531, DOI 10.4103/1995-7645.272482; Culala JM., 2018, INT J BIOL PHARM ALL, V7, P1890, DOI DOI 10.31032/IJBPAS/2018/7.10.4565; De Leon A., 2016, CURR RES ENVIRON APP, V6, P61; Dhanasekaran Danny N, 2017, Genes Cancer, V8, P682, DOI 10.18632/genesandcancer.155; Dulay RMR, 2020, BIOCATAL AGR BIOTECH, V27, DOI 10.1016/j.bcab.2020.101666; Dulay RMR., 2017, INT J BIOL PHARM ALL, V6, P1459; Durgo K, 2013, INT J MED MUSHROOMS, V15, P435, DOI 10.1615/IntJMedMushr.v15.i5.20; Fang EF, 2016, NAT REV MOL CELL BIO, V17, P308, DOI 10.1038/nrm.2016.14; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Florea Ana-Maria, 2011, Cancers (Basel), V3, P1351, DOI 10.3390/cancers3011351; Hseu YC, 2019, FOOD CHEM TOXICOL, V124, P30, DOI 10.1016/j.fct.2018.11.043; Joseph TP, 2018, INTEGR CANCER THER, V17, P200, DOI 10.1177/1534735417736861; Kim HS, 2005, MOL CELL BIOL, V25, P6821, DOI 10.1128/MCB.25.15.6821-6833.2005; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Liwanag JMG., 2017, INT J BIOL PHARM ALL, V6, P1060; Manikanta K, 2020, HAEMATOLOGICA, V105, pE419, DOI 10.3324/haematol.2019.233908; Matsuzawa A, 2001, J BIOCHEM-TOKYO, V130, P1; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; MEG DE CASTRO, 2015, J CHEM BIOL PHYS SCI, V5, P1646; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Papadakis ES, 2006, FEBS LETT, V580, P1320, DOI 10.1016/j.febslet.2006.01.053; Patel S, 2012, 3 BIOTECH, V2, P1, DOI 10.1007/s13205-011-0036-2; Psenakova K, 2020, FEBS J, V287, P1626, DOI 10.1111/febs.15101; Ragasa C.Y., 2020, ASIAN J CHEM, V32, P1197, DOI [10.14233/ajchem.2020.22591, DOI 10.14233/AJCHEM.2020.22591]; Sadi G, 2015, PHARMACOGN MAG, V11, pS6, DOI 10.4103/0973-1296.157665; Saha P, 2020, MOL CELL NEUROSCI, V108, DOI 10.1016/j.mcn.2020.103551; Sak Katrin, 2012, Chemother Res Pract, V2012, P282570, DOI 10.1155/2012/282570; Soethoudt M, 2014, FREE RADICAL BIO MED, V77, P331, DOI 10.1016/j.freeradbiomed.2014.09.025; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Valdez BC, 2008, LEUKEMIA RES, V32, P1684, DOI 10.1016/j.leukres.2008.01.016; Wasser SP, 2010, INT J MED MUSHROOMS, V12, P1, DOI 10.1615/IntJMedMushr.v12.i1.10; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; World Health Organization, WHO REP CANC SETT PR; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xu R, 2015, J BIOMED INFORM, V55, P64, DOI 10.1016/j.jbi.2015.03.009; Zhang JF, 2016, ONCOL LETT, V12, P413, DOI 10.3892/ol.2016.4659; Zhang M, 2019, PROG MOL BIOL TRANSL, V163, P297, DOI 10.1016/bs.pmbts.2019.02.013; Zheng L, 2018, MOL MED REP, V18, P938, DOI 10.3892/mmr.2018.9035	48	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252541	10.1371/journal.pone.0252541	http://dx.doi.org/10.1371/journal.pone.0252541			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048499	Green Published, gold			2022-12-26	WOS:000664636100065
J	Ward, AB; Stephen, K; Argo, CM; Harris, PA; Watson, CA; Neacsu, M; Russell, W; Grove-White, DH; Morrison, PK				Ward, Ashley B.; Stephen, Kate; Argo, Caroline McGregor; Harris, Patricia A.; Watson, Christine A.; Neacsu, Madalina; Russell, Wendy; Grove-White, Dai H.; Morrison, Philippa K.			COVID-19 impacts equine welfare: Policy implications for laminitis and obesity	PLOS ONE			English	Article							RISK-FACTORS; MANAGEMENT-PRACTICES; INSULIN SENSITIVITY; HORSE OWNERS; PERCEPTIONS; INFORMATION; INFLUENZA; ATTITUDES; EXERCISE; DIETARY	The COVID-19 pandemic continues to impact human health and welfare on a global level. In March 2020, stringent national restrictions were enforced in the UK to protect public health and slow the spread of the SARS-CoV-2 virus. Restrictions were likely to have resulted in collateral consequences for the health and welfare of horses and ponies, especially those at risk of obesity and laminitis and this issue warranted more detailed exploration. The current study utilised qualitative methodology to investigate the implications of COVID-19 related policies upon equine management and welfare with a focus on horses and ponies at risk of laminitis and obesity. Twenty-four interviews with five sub-groups of key equestrian welfare stakeholders in the UK were conducted between May and July of 2020 to understand the challenges facing equine welfare in the context of laminitis and obesity susceptible animals. Thematic analysis revealed lockdown-associated factors with the potential to compromise welfare of horses and ponies at risk of obesity and laminitis. These included: disparate information and guidance, difficulties enacting public health measures in yard environments, and horses having reduced exercise during the pandemic. Positive examples of clear and consistent information sharing by farriers were reported to have improved horse owner understanding of routine hoof care during lockdown. Analysis suggested that the recommendations for supporting the management-based needs of horses under reduced supervision were not clearly defined, or were not sufficiently disseminated, across the equine industry. These findings support the development of guidelines specific to the care of horses and ponies at risk of obesity and laminitis through collaborative input from veterinary and welfare experts, to reduce the negative impacts of future lockdown events in the UK.	[Ward, Ashley B.; Stephen, Kate; Argo, Caroline McGregor; Watson, Christine A.; Morrison, Philippa K.] Scotlands Rural Coll, Aberdeen, Scotland; [Ward, Ashley B.; Neacsu, Madalina; Russell, Wendy] Univ Aberdeen, Rowett Inst, Foresterhill, Aberdeen, Scotland; [Harris, Patricia A.] WALTHAM Petcare Sci Inst, Equine Stud Grp, Melton Mowbray, Leics, England; [Grove-White, Dai H.] Univ Liverpool, Fac Hlth & Life Sci, Wirral, Merseyside, England	Scotland's Rural College; University of Aberdeen; Mars; WALTHAM Petcare Science Institute; University of Liverpool	Morrison, PK (corresponding author), Scotlands Rural Coll, Aberdeen, Scotland.	Philippa.Morrison@sruc.ac.uk	Lamont, Kate/N-9071-2018; Watson, Christine/I-2135-2012	Lamont, Kate/0000-0003-3258-7355; Watson, Christine/0000-0002-3758-9483; Ward, Ashley/0000-0003-1906-7515; Morrison, Philippa/0000-0003-4187-0371	Mars Petcare; Scottish Funding Council Research Excellence Grant (REG)	Mars Petcare; Scottish Funding Council Research Excellence Grant (REG)	This study was funded by Mars Petcare and is part of a PhD studentship funded by the Scottish Funding Council Research Excellence Grant (REG). Authors WR and MN receive salary support from the Rural and Environment Science and Analytical Services Division (RESAS). With the exception of PH (employed by the funding organization), the funding organization did not have any additional role in the conceptualization, methodology, investigation, data curation, formal analysis, decision to publish, or preparation of the manuscript. PH was involved in study design, data interpretation, and manuscript preparation.	[Anonymous], NATL PET CHARITY BLU; [Anonymous], VET TIMES; Bamford NJ, 2019, J VET INTERN MED, V33, P280, DOI 10.1111/jvim.15374; BEVA, 2020, BEVA LAUNCH COL COD; BHS.org, REP YOUR HORS RID IN; Biggs A, 2020, VET REC, V186, DOI 10.1136/vr.m1648; Bird Stephen R, 2016, BMJ Open Sport Exerc Med, V2, pe000143, DOI 10.1136/bmjsem-2016-000143; Boden LA, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-188; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; British Equestrian, BRIT EQ US MEMB BOD; British Equine Veterinary Association, OB RES GUID; British Veterinary Association, BVA RESP AN WELF COM; Carter RA, 2010, AM J VET RES, V71, P314, DOI 10.2460/ajvr.71.3.314; Celadine T, JBEP; Coleman MC, 2018, JAVMA-J AM VET MED A, V253, P470, DOI 10.2460/javma.253.4.470; de Laat MA, 2019, J VET INTERN MED, V33, P1456, DOI 10.1111/jvim.15419; Durham A, 2013, EQUINE APPL CLIN NUT, P568; Egan M., 2020, BLOG YOU UND GUID 4; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Finlay L, 2013, J HUMANIST PSYCHOL, V53, P172, DOI 10.1177/0022167812453877; Fisher R, 2013, J RURAL STUD, V31, P13, DOI 10.1016/j.jrurstud.2013.02.006; Forge and farrier, 2020, BFBA ADV FARR 24 03; Frank N, 2014, EQUINE VET J, V46, P103, DOI 10.1111/evj.12169; Furtado T., GRASS IS GREENER EQU; Garforth CJ, 2013, PREV VET MED, V110, P456, DOI 10.1016/j.prevetmed.2013.02.018; Geor RJ., 2013, EQUINE APPL CLIN NUT, P469; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; GOV.UK, PRIM MIN STAT COR CO; Greene EA, 2020, TRANSL ANIM SCI, V4, DOI 10.1093/tas/txaa085; Harris P., 2017, Equine laminitis, P436; Hii C, 2020, PREV VET MED, V179, DOI 10.1016/j.prevetmed.2020.104988; Hockenhull J, 2010, J VET BEHAV, V5, P52, DOI [10.1016/j.jveb.2009.09.019, DOI 10.1016/J.JVEB.2009.09.019]; Hothersall B, 2012, EQUINE VET EDUC, V24, P479, DOI 10.1111/j.2042-3292.2011.00296.x; Lesimple C, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10020294; Lesniak K, 2017, ANIMALS, V7, DOI 10.3390/ani7040029; Liburt NR., 2011, J EQUINE VET SCI, P237, DOI [10.1016/j.jevs.2011.03.034, DOI 10.1016/J.JEVS.2011.03.034]; Lofgren EA, 2016, J EQUINE VET SCI, V37, P58, DOI 10.1016/j.jevs.2015.10.005; Longland AC, 2006, J NUTR, V136, p2099S, DOI 10.1093/jn/136.7.2099S; Luthersson N, 2017, J EQUINE VET SCI, V53, P68, DOI 10.1016/j.jevs.2016.03.006; Mair TS, 2021, EQUINE VET EDUC, V33, P15, DOI 10.1111/eve.13399; McCann Terence V, 2003, Nurse Res, V11, P19; McGregor-Argo C, 2009, VET J, V179, P158, DOI 10.1016/j.tvjl.2008.04.007; Menzies-Gow NJ, 2017, EQUINE VET J, V49, P300, DOI 10.1111/evj.12606; Menzies-Gow NJ, 2014, EQUINE VET J, V46, P317, DOI 10.1111/evj.12132; Menzies-Gow NJ, 2010, VET REC, V167, P690, DOI 10.1136/vr.c5177; Micoud N., 2015, SCOPING STUDY EQUINE; Morrison PK, 2017, J EQUINE VET SCI, V53, P19, DOI 10.1016/j.jevs.2017.01.006; Petplan Charitable Trust, COVID 19 EQ RESC EM; Pollard D, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1798-8; Potter SJ, 2017, AUST VET J, V95, P370, DOI [10.1111/avj.12635, 10.1111/avj.12623]; Rennie DL, 1998, THEOR PSYCHOL, V8, P101, DOI 10.1177/0959354398081006; Schemann K, 2012, PREV VET MED, V106, P97, DOI 10.1016/j.prevetmed.2012.01.013; Scottish Government, EM HELP THOS WORS AF; Scottish Government, COR COVID 19 SUPP PE; Scottish Government, SUPP BUS PAN; Smith J. A., 2003, QUALITATIVE PSYCHOL, P51; Spence KL, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2120-5; Stewart-Hunt L, 2010, EQUINE VET J, V42, P355, DOI 10.1111/j.2042-3306.2010.00255.x; Teti M, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406920920962; The Small Animal Veterinary Surveillance Network, 2020, 1 SMALL AN VET SURV; Thirkell J, 2017, J EQUINE VET SCI, V59, P88, DOI 10.1016/j.jevs.2017.10.005; van Dobbenburgh R, 2020, VET REC, V187, DOI 10.1136/vr.m3265; van Rijnsoever FJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181689; WAITE R, 1953, J SCI FOOD AGR, V4, P197, DOI 10.1002/jsfa.2740040408; Weller SC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198606; Wiethoelter AK, 2017, PREV VET MED, V140, P67, DOI 10.1016/j.prevetmed.2017.03.003; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Williams JM, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10101862; World Health Organisation, TIM WHOS RESP COVID; World Health Organisation, WHO DIR GEN OP REM M; World Horse Welfare, RIGHT WEIGHT; Wylie CE, 2013, VET J, V198, P57, DOI 10.1016/j.tvjl.2013.08.028; Cuan-Baltazar JY, 2020, JMIR PUBLIC HLTH SUR, V6, P176, DOI 10.2196/18444	73	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252340	10.1371/journal.pone.0252340	http://dx.doi.org/10.1371/journal.pone.0252340			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PN	34048478	Green Published, gold			2022-12-26	WOS:000664636100037
J	Carrillo-Hernandez, MY; Ruiz-Saenz, J; Jaimes-Villamizar, L; Robledo-Restrepo, SM; Martinez-Gutierrez, M				Yelitza Carrillo-Hernandez, Marlen; Ruiz-Saenz, Julian; Jaimes-Villamizar, Lucy; Maria Robledo-Restrepo, Sara; Martinez-Gutierrez, Marlen			Phylogenetic and evolutionary analysis of dengue virus serotypes circulating at the Colombian-Venezuelan border during 2015-2016 and 2018-2019	PLOS ONE			English	Article							POPULATION-DYNAMICS; CO-CIRCULATION; ENDEMIC AREA; HISTORY; LINEAGES; TYPE-1; TIME	Dengue is an endemic disease in Colombia. Norte de Santander is a region on the border of Colombia and Venezuela and has reported the co-circulation and simultaneous co-infection of different serotypes of the dengue virus (DENV). This study aimed to conduct a phylogenetic analysis on the origin and genetic diversity of DENV strains circulating in this bordering region. Serum samples were collected from patients who were clinically diagnosed with febrile syndrome associated with dengue during two periods. These samples were tested for DENV and serotyping was performed using reverse transcriptase-polymerase chain reaction. Subsequently, positive samples were amplified and the envelope protein gene of DENV was sequenced. Phylogenetic and phylogeographic analyses were performed using the sequences obtained. Basic local alignment search tool analysis confirmed that six and eight sequences belonged to DENV-1 and DENV-2, respectively. The phylogenetic analysis of DENV-1 showed that the sequences belonged to genotype V and clade I; they formed two groups: in the first group, two sequences showed a close phylogenetic relationship with strains from Ecuador and Panama, whereas the other four sequences were grouped with strains from Venezuela and Colombia. In the case of DENV-2, the analysis revealed that the sequences belonged to the Asian-American genotype and clade III. Furthermore, they formed two groups; in the first group, three sequences were grouped with strains from Colombia and Venezuela, whereas the other five were grouped with strains from Venezuela, Colombia and Honduras. This phylogenetic analysis suggests that the geographical proximity between Colombia and Venezuela is favourable for the export and import of different strains among serotypes or clades of the same DENV serotype, which could favour the spread of new outbreaks caused by new strains or genetic variants of this arbovirus. Therefore, this information highlights the importance of monitoring the transmission of DENV at border regions.	[Yelitza Carrillo-Hernandez, Marlen; Ruiz-Saenz, Julian; Martinez-Gutierrez, Marlen] Univ Cooperat Colombia, Grp Invest Ciencias Anim GRICA, Bucaramanga, Colombia; [Yelitza Carrillo-Hernandez, Marlen; Maria Robledo-Restrepo, Sara] Univ Antioquia, Programa Estud & Control Enfermedades Trop, Medellin, Colombia; [Jaimes-Villamizar, Lucy] ESE Hosp Jorge Cristo Sahium, Lab Clin, Norte Santander, Colombia	Universidad Cooperativa de Colombia; Universidad de Antioquia	Martinez-Gutierrez, M (corresponding author), Univ Cooperat Colombia, Grp Invest Ciencias Anim GRICA, Bucaramanga, Colombia.	marlen.martinezg@campusucc.edu.co	Ruiz, Julian/GWU-9801-2022	Ruiz, Julian/0000-0002-1447-1458; Martinez-Gutierrez, Marlen/0000-0002-9429-0058	CONADI of the Universidad Cooperativa de Colombia [1882-2017]; Ministerio de Ciencia Tecnologia e Innovacion [573-2016]	CONADI of the Universidad Cooperativa de Colombia; Ministerio de Ciencia Tecnologia e Innovacion	This work was funded by CONADI of the Universidad Cooperativa de Colombia (Grant 1882-2017) and the Ministerio de Ciencia Tecnologia e Innovacion that provided to Marlen Carrilllo Hernandez a scholarship (Announcement 573-2016).	Fernandez-Nino JA, 2016, BIOMEDICA, V36, P44, DOI 10.7705/biomedica.v36i0.2869; Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499; [Anonymous], 2014, TRACER V1 6; BERRY I, 2020, BMC EVOL BIOL, V20, P1, DOI DOI 10.1186/S12862-019-1549-2; Black A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4566-2; Boshell J., 1986, Biomedica, V6, P101; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; de Pernia AMB, 2013, DESAFIOS, V25, P165; Carreno MF, 2019, TROP MED INT HEALTH, V24, P1400, DOI 10.1111/tmi.13311; Castrillon JC, 2015, REV CHIL INFECTOL, V32, P142, DOI 10.4067/S0716-10182015000300002; Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006; Coloma J, 2018, ACI AVANCES CIENCIAS, V10; Colombia M, 2019, INF VEN COL; Costa RL, 2012, INFECT GENET EVOL, V12, P309, DOI 10.1016/j.meegid.2011.12.011; Cuypers L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100569; D.C B, 2019, B EP SEM; DdVyAdRe S, 2017, PROT VIG SAL PUBL CO; de Bruycker-Nogueira F, 2016, INFECT GENET EVOL, V45, P454, DOI 10.1016/j.meegid.2016.09.025; Domingo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000833; Franco L, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.03.016; Gotuzzo H Eduardo, 2018, Acta méd. Peru, V35, P143; Houldcroft CJ, 2017, NAT REV MICROBIOL, V15, P183, DOI 10.1038/nrmicro.2016.182; INS, 2019, B EP SEM; Jimeaez-Silva CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203090; Kukreti H, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-1; Laiton-Donato K, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1170-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin Y, 2019, INT J INFECT DIS, V79, P152, DOI 10.1016/j.ijid.2018.11.370; Londono-Renteria B, 2015, BIOMEDICA, V35, P572, DOI 10.7705/biomedica.v35i4.2530; Mendez JA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-64; Mendez JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-226; MigracionColombia, 2017, INF VEN COL; Mir Daiana, 2014, PLoS One, V9, pe98519, DOI 10.1371/journal.pone.0098519; Noor R, 2020, TZU CHI MED J, V32, P227, DOI 10.4103/tcmj.tcmj_193_19; Ocazionez RE, 2006, MEM I OSWALDO CRUZ, V101, P725, DOI 10.1590/S0074-02762006000700004; Ocazionez RE., 2007, REV CUBA MED TROP, V59; Ocazionez-Jimenez RE, 2013, BIOMEDICA, V33, P22, DOI 10.7705/biomedica.v33i0.717; OMS, 2019, ACT EP SAR; OMS TDR OPS, 2009, DENG GUIAS DIAGN TRA; Organization WH Research SPf Diseases TiT Diseases WHODoCoNT Epidemic WHO Alert P, 2009, DENG GUID DIAGN TREA; Ospina MC, 2010, AM J TROP MED HYG, V83, P672, DOI 10.4269/ajtmh.2010.09-0766; Padilla J.C., 2012, DENGUE COLOMBIA EPID; PAHO, 2018, EP UPD MEASL; Perez-Ramirez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-260; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2016, FIGTREE 1 4 3; Ramirez A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-329; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; Salud OPdl, 2016, DENG GUIAS AT ENF RE; Sang SW, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007592; Stewart-Ibarra AM, 2018, AM J TROP MED HYG, V98, P1444, DOI 10.4269/ajtmh.17-0762; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Torres MC., 2018, SCI REP-UK, V8, P1, DOI DOI 10.1038/S41598-017-17765-5; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; Vicente CR, 2018, EPIDEMIOL INFECT, V146, P100, DOI 10.1017/S0950268817002618; Waman VP, 2016, PEERJ, V4, DOI 10.7717/peerj.2326; Wang BH, 2018, EMERG INFECT DIS, V24, P1756, DOI 10.3201/eid2409.180252; WHO, 2011, COMPR GUID PREV CONT; Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1; Wilson M.E., 2002, DENGUE AM; World Health Organization, 2012, GLOB STRAT DENG PREV; Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1	63	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252379	10.1371/journal.pone.0252379	http://dx.doi.org/10.1371/journal.pone.0252379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048474	gold, Green Published			2022-12-26	WOS:000664636100041
J	Lu, ML; Wyman, CE				Lu, May Ling; Wyman, Charles E.			Elucidation of native California Agave americana and Agave deserti biofuel potential: Compositional analysis	PLOS ONE			English	Article							TEQUILANA; PLANTS; LEAVES; METABOLISM; FEEDSTOCK; SUCCULENT; FRUCTANS	Because biofuels have the unique potential to be rapidly deployed in existing transportation fuel infrastructures, they should play a major role in helping California quickly meet its aggressive goals to substantially reduce greenhouse gas contributions by this major sector. Furthermore, energy crops are vital to significantly impact the State's large and burgeoning need for sustainable fuels. Among crops amenable to be grown in California to support fuel production, agave pose a particularly promising prospect, given their drought tolerance and high productivity on marginal land in a State prone to drought and limited water resources. This study focuses on measuring compositional profiles of wild A. deserti and cultivated A. americana, two agaves native to California, to elucidate their potential for biological conversion to fuels that can help meet the huge State need for low-carbon transportation. Results from this study indicate that these two California agave species can be rich in fructans, ranging from 96-314 g/L of equivalent fructose and glucose in their leaf bases. In addition, structural and water-soluble sugar contents exceeding 63 wt.% show that these plants are amenable to fermentation to ethanol and other biofuels. Moreover, because the low K-lignin content of agave leaf bases bagasse of only about 12-18 wt.% suggests low recalcitrance and the negligible acid insoluble ash content should facilitate pretreatment prior to fermentations, the agave species native to the State hold considerable promise as potential biofuel feedstocks.	[Lu, May Ling; Wyman, Charles E.] Univ Calif Riverside, Bourns Coll Engn, Ctr Environm Res & Technol, Riverside, CA 92521 USA; [Lu, May Ling; Wyman, Charles E.] Univ Calif Riverside, Bourns Coll Engn, Dept Chem & Environm Engn, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Wyman, CE (corresponding author), Univ Calif Riverside, Bourns Coll Engn, Ctr Environm Res & Technol, Riverside, CA 92521 USA.; Wyman, CE (corresponding author), Univ Calif Riverside, Bourns Coll Engn, Dept Chem & Environm Engn, Riverside, CA 92521 USA.	cewyman@engr.ucr.edu			Ford Motor Company; University of California Center on Economic Competitiveness in Transportation (UCCONNECT) [00008347]; UCR Bourns College of Engineering	Ford Motor Company; University of California Center on Economic Competitiveness in Transportation (UCCONNECT); UCR Bourns College of Engineering	The project was funded in part by the Ford Motor Company, which established a chair in Environmental Engineering at the Center for Environmental Research and Technology (CE_CERT), Bourns College of Engineeering at the University of California, Riverside (UCR), for Charles E. Wyman (CEW). In addition, a 2014 University of California Center on Economic Competitiveness in Transportation (UCCONNECT) (Award No.: 00008347) graduate fellowship was awarded to May Ling Lu (MLL) to support her effort on agave compositional analysis. Link to the UCCONNECT website can be found at http://ucconnect.berkeley.edu/.Finally, the authors are grateful for the provision of the 2014 UCR Graduate Fellowship by the UCR Bourns College of Engineering to May Ling Lu (MLL), which also facilitated this study. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrete-Herrera PI, 2019, FOODS, V8, DOI 10.3390/foods8090404; Arrizon J, 2010, FOOD CHEM, V122, P123, DOI 10.1016/j.foodchem.2010.02.028; Avila-Gaxiola E, 2017, J FOOD PROCESS ENG, V40, DOI 10.1111/jfpe.12455; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Bernardino-Nicanor A., 2012, African Journal of Agricultural Research, V7, P3550; Boguslavsky A., 2008, 5th International Symposium on New Crops and Uses: their role in a rapidly changing world, University of Southampton, Southampton, UK, 3-4 September 2007, P381; Borland AM, 2009, J EXP BOT, V60, P2879, DOI 10.1093/jxb/erp118; California Air Resources Board, 2019, DAT DASHB; Chand N., 1993, MET MATER PROCESS, V5, P51; Close D, 2017, BIOMASS BIOENERG, V106, P176, DOI 10.1016/j.biombioe.2017.08.032; Corbin KR, 2016, BIOENERG RES, V9, P1142, DOI 10.1007/s12155-016-9755-x; Corbin KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135382; Davis SC, 2011, GCB BIOENERGY, V3, P68, DOI 10.1111/j.1757-1707.2010.01077.x; DeMartini JD, 2011, BIOTECHNOL BIOENG, V108, P306, DOI 10.1002/bit.22937; Escamilla-Trevino LL, 2012, BIOENERG RES, V5, P1, DOI 10.1007/s12155-011-9159-x; Escobar-Guzman RE, 2008, BOTANY, V86, P1343, DOI 10.1139/B08-099; Gentry HS., 1982, AGAVES CONTINENTAL N; Gonzalez-Llanes MD, 2018, CAN J CHEM ENG, V96, P639, DOI 10.1002/cjce.22959; Humbird D., 2011, TECHNICAL REPORT NRE, DOI DOI 10.2172/1107470; Jepson Flora Project, 2020, JEPS EFLORA; Li HJ, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-50; Li HJ, 2012, RSC ADV, V2, P4951, DOI 10.1039/c2ra20557b; Lowe M., 2008, VALUE CHAIN ANAL SEL; Mancilla-Margalli NA, 2006, J AGR FOOD CHEM, V54, P7832, DOI 10.1021/jf060354v; Marques WL, 2016, FEMS YEAST RES, V16, DOI 10.1093/femsyr/fov107; Matiz A., 2013, PHOTOSYNTHESIS, V1, P91, DOI DOI 10.5772/56219; Mellado-Mojica E, 2012, J AGR FOOD CHEM, V60, P11704, DOI 10.1021/jf303332n; Michel-Cuello C, 2008, J AGR FOOD CHEM, V56, P5753, DOI 10.1021/jf800158p; Mielenz JR, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0261-8; Mohd Azhar Siti Hajar, 2017, Biochem Biophys Rep, V10, P52, DOI 10.1016/j.bbrep.2017.03.003; National Integrated Drought Information System NIDIS-Drought.gov-U.S. Drought Portal, 2000, DROUGHT CAL 2000 202; National Plant Data Team, 2020, PLANTS DAT AG L AG D; Nguyen SK, 2009, APPL BIOCHEM BIOTECH, V158, P352, DOI 10.1007/s12010-009-8596-x; NOBEL PS, 1990, ECON BOT, V44, P488, DOI 10.1007/BF02859785; NOBEL PS, 1984, OECOLOGIA, V64, P1, DOI 10.1007/BF00377535; Nobel PS., 1994, REMARKABLE AGAVES CA; Ortega Z, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1022-2; Oudiani EA., 2015, ADV MAT, V4, P15; Pedroso GM, 2011, CALIF AGR, V65, P168, DOI 10.3733/ca.E.v065n03p168; Perez-Pimienta JA, 2017, BIOFUEL BIOPROD BIOR, V11, P732, DOI 10.1002/bbb.1776; Queensland Government, 2016, WEEDS AUSTR BIOS QUE; Reveal JL., 2020, AGAVE UTAHESIS VAR N; Rijal D, 2016, IND CROP PROD, V84, P263, DOI 10.1016/j.indcrop.2016.02.011; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Shelef O, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02069; Singh AK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58277-z; Sluiter A., 2008, NATL RENEWABLE ENERG, P18; Sluiter A., 2008, LAB ANAL PROCEDURE L; SMITH JAC, 1986, J EXP BOT, V37, P1044; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Tan LL, 2013, ENERGIES, V6, P3734, DOI 10.3390/en6083734; The State of Queensland Department of Agriculture and Fishery, 2020, AG CENT PLANT SIS AG; U. S. Department of Agriculture U. S. Department of Forest Services, 2020, NAT GARD WHY GARD NA; U. S. Environmental Protection Agency Office of Research and Development National Center for Environmental Assessment, 2010, EPA600R08086F; Wang M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045905; Williams CL, 2016, BIOENERG RES, V9, P1, DOI 10.1007/s12155-015-9694-y; Witcover J., 2018, UCDITSRR1825; Yang LS, 2015, BIOMASS BIOENERG, V76, P43, DOI 10.1016/j.biombioe.2015.03.004; Yang Q, 2012, BIORESOURCE TECHNOL, V126, P336, DOI 10.1016/j.biortech.2012.10.018	59	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252201	10.1371/journal.pone.0252201	http://dx.doi.org/10.1371/journal.pone.0252201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043690	Green Published, gold			2022-12-26	WOS:000664635700067
J	Yan, YJ; Zhang, DF				Yan, Yingjing; Zhang, Defu			Multi-scale U-like network with attention mechanism for automatic pancreas segmentation	PLOS ONE			English	Article							MRI; CT	In recent years, the rapid development of deep neural networks has made great progress in automatic organ segmentation from abdominal CT scans. However, automatic segmentation for small organs (e.g., the pancreas) is still a challenging task. As an inconspicuous and small organ in the abdomen, the pancreas has a high degree of anatomical variability and is indistinguishable from the surrounding organs and tissues, which usually leads to a very vague boundary. Therefore, the accuracy of pancreatic segmentation is sometimes below satisfaction. In this paper, we propose a 2.5D U-net with an attention mechanism. The proposed network includes 2D convolutional layers and 3D convolutional layers, which means that it requires less computational resources than 3D segmentation models while it can capture more spatial information along the third dimension than 2D segmentation models. Then We use a cascaded framework to increase the accuracy of segmentation results. We evaluate our network on the NIH pancreas dataset and measure the segmentation accuracy by the Dice similarity coefficient (DSC). Experimental results demonstrate a better performance compared with state-of-the-art methods.	[Yan, Yingjing; Zhang, Defu] Xiamen Univ, Sch Informat, Xiamen, Fujian, Peoples R China	Xiamen University	Yan, YJ (corresponding author), Xiamen Univ, Sch Informat, Xiamen, Fujian, Peoples R China.	23020181154286@stu.xmu.edu.cn						Asaturyan H, 2019, COMPUT MED IMAG GRAP, V75, P1, DOI 10.1016/j.compmedimag.2019.04.004; Cai J, 2018, ARXIV PREPRINT ARXIV; Cai JZ, 2019, ADV COMPUT VIS PATT, P3, DOI 10.1007/978-3-030-13969-8_1; Chen SH, 2018, LECT NOTES COMPUT SC, V11213, P236, DOI 10.1007/978-3-030-01240-3_15; Chu X, 2017, PROC CVPR IEEE, P5669, DOI 10.1109/CVPR.2017.601; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Farag A, 2017, IEEE T IMAGE PROCESS, V26, P386, DOI 10.1109/TIP.2016.2624198; Fu J, 2019, PROC CVPR IEEE, P3141, DOI 10.1109/CVPR.2019.00326; Fu M, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0572-z; Gupta A, 2018, ICMI'18: PROCEEDINGS OF THE 20TH ACM INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P611, DOI 10.1145/3242969.3264985; Havaei M, 2017, MED IMAGE ANAL, V35, P18, DOI 10.1016/j.media.2016.05.004; Huang ZL, 2019, IEEE I CONF COMP VIS, P603, DOI 10.1109/ICCV.2019.00069; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Karasawa K, 2017, MED IMAGE ANAL, V39, P18, DOI 10.1016/j.media.2017.03.006; Kingma DP., 2014, ADAM METHOD STOCHAST; Lee CY, 2015, JMLR WORKSH CONF PRO, V38, P562; Li J., 2019, ARXIV PREPRINT ARXIV; Long J., 2015, P IEEE C COMP VIS PA, P3431; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; Nie D, 2018, LECT NOTES COMPUT SC, V11073, P370, DOI 10.1007/978-3-030-00937-3_43; Oktay O., 2018, ARXIV180403999; Ronneberger O., 2015, P MICCAI MUN GERM 5, P234, DOI DOI 10.1007/978-3-319-24574-4_28; Roth HR, 2018, MED IMAGE ANAL, V45, P94, DOI 10.1016/j.media.2018.01.006; Roth HR, 2015, LECT NOTES COMPUT SC, V9349, P556, DOI 10.1007/978-3-319-24553-9_68; Song MC, 2017, INT S HIGH PERF COMP, P1, DOI 10.1109/HPCA.2017.52; Yu QH, 2018, PROC CVPR IEEE, P8280, DOI 10.1109/CVPR.2018.00864; Zeng GD, 2018, I S BIOMED IMAGING, P136; Zhang Y, 2021, MED IMAGE ANAL, V68, DOI 10.1016/j.media.2020.101884; Zhou Y, 2017, INT C MED IM COMP CO, P222, DOI DOI 10.1007/978-3-319-66179-7_26; Zhou Y., LNCS, V10433, P693	30	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252287	10.1371/journal.pone.0252287	http://dx.doi.org/10.1371/journal.pone.0252287			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043732	Green Published, gold			2022-12-26	WOS:000664635700079
J	Lee, Y; Kim, N; Roh, H; Kim, A; Han, HJ; Cho, M; Kim, DH				Lee, Yoonhang; Kim, Nameun; Roh, HyeongJin; Kim, Ahran; Han, Hyun-Ja; Cho, Miyoung; Kim, Do-Hyung			Transcriptome analysis unveils survival strategies of Streptococcus parauberis against fish serum	PLOS ONE			English	Article							PENICILLIN RESISTANCE; VIRULENCE FACTORS; ESCHERICHIA-COLI; HYALURONIC-ACID; PROTEIN; STRESS; FAMILY; TRANSPORTER; EXPRESSION; TOLERANCE	Streptococcus parauberis is an important bacterial fish pathogen that causes streptococcosis in a variety of fish species including the olive flounder. Despite its importance in the aquaculture industry, little is known about the survival strategy of S. parauberis in the host. Therefore, the objective of this study was to produce genome-wide transcriptome data and identify key factors for the survival of S. parauberis SPOF3K in its host. To this end, S. parauberis SPOF3K was incubated in olive flounder serum and nutrient-enriched media as a control. Although S. parauberis SPOF3K proliferated in both culture conditions, the transcriptomic patterns of the two groups were very different. Interestingly, the expression levels of genes responsible for the replication of an S. parauberis plasmid in the presence of olive flounder serum were higher than those in the absence of olive flounder serum, indicating that this plasmid may play an important role in the survival and proliferation of S. parauberis in the host. Several ATP-binding cassette transporters known to transport organic substrates (e.g., biotin and osmoprotectants) that are vital for bacterial survival in the host were significantly up-regulated in S. parauberis cultured in serum. In addition, groEL, dnaK operon, and members of the clp protease family, which are known to play important roles in response to various stressors, were up-regulated in S. parauberis incubated in serum, thus limiting damage and facilitating cellular recovery. Moreover, important virulence factors including the hyaluronic acid capsule (has operon), sortase A (srtA), C5a peptidase (scp), and peptidoglycan O-acetyltransferase (oatA) were significantly upregulated in S. paraubers in serum. These results indicate that S. paraubers can resist and evade the humoral immune responses of fish. The transcriptomic data obtained in this study provide a better understanding of the mode of action of S. parauberis in fish.	[Lee, Yoonhang; Kim, Nameun; Roh, HyeongJin; Kim, Do-Hyung] Pukyong Natl Univ, Dept Aquat Life Med, Busan, South Korea; [Kim, Ahran; Han, Hyun-Ja; Cho, Miyoung] Natl Inst Fisheries Sci, Pathol Res Div, Busan, South Korea	Pukyong National University; National Institute of Fisheries Science	Kim, DH (corresponding author), Pukyong Natl Univ, Dept Aquat Life Med, Busan, South Korea.	dhkim@pknu.ac.kr		Kim, Do-Hyung/0000-0001-7315-1297	National Institute of Fisheries Science (NIFS), Republic of Korea [R2021065]	National Institute of Fisheries Science (NIFS), Republic of Korea	DH Kim received support for this study from the National Institute of Fisheries Science (NIFS), Republic of Korea, grant number R2021065. [http://nifs.go.kr/] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DS, 2004, J BACTERIOL, V186, P6220, DOI 10.1128/JB.186.18.6220-6229.2004; Andrews S., 2010, FASTQC QUALITY CONTR; Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007; Ashbaugh CD, 1998, J BACTERIOL, V180, P4955, DOI 10.1128/JB.180.18.4955-4959.1998; Aubry C, 2011, J INFECT DIS, V204, P731, DOI 10.1093/infdis/jir396; Augimeri RV, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01282; Austin B., 2012, BACTERIAL FISH PATHO; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Chimalapati S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041393; Chun Won-Kyong, 2019, [Korean Journal of Fisheries and Aquatic Sciences, 한국수산과학회지], V52, P382, DOI 10.5657/KFAS.2019.0382; CLEARY PP, 1992, INFECT IMMUN, V60, P5219, DOI 10.1128/IAI.60.12.5219-5223.1992; Coker PR, 2003, J CLIN MICROBIOL, V41, P1212, DOI 10.1128/JCM.41.3.1212-1218.2003; Filipe SR, 2001, MICROB DRUG RESIST, V7, P303, DOI 10.1089/10766290152773310; Fiser A, 2003, TRENDS MICROBIOL, V11, P547, DOI 10.1016/j.tim.2003.10.003; Franca A, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv125; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Frees D, 2014, INT J MED MICROBIOL, V304, P142, DOI 10.1016/j.ijmm.2013.11.009; Garai P, 2017, VIRULENCE, V8, P297, DOI 10.1080/21505594.2016.1221025; Ge SX, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2486-6; Gupta P, 2016, ARCH MICROBIOL, V198, P1, DOI 10.1007/s00203-015-1148-6; Harvey KL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02351; Hu YL, 2019, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00452; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Huja S, 2014, MBIO, V5, DOI 10.1128/mBio.01460-14; 심재동, 2019, [JOURNAL OF FISH PATHOLOGY, 한국어병학회지], V32, P029, DOI 10.7847/jfp.2019.32.1.029; Isom CE., 2016, BMC MICROBIOL, V16, P1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kijek TM, 2019, MICROB PATHOGENESIS, V137, DOI 10.1016/j.micpath.2019.103742; Kotrba P, 2001, J BIOSCI BIOENG, V92, P502, DOI 10.1263/jbb.92.502; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomeA.00248-18, 10.1128/genomea.00248-18]; Lemos JA, 2007, J BACTERIOL, V189, P1582, DOI 10.1128/JB.01655-06; Li GW, 2011, INFECT IMMUN, V79, P1951, DOI 10.1128/IAI.01230-10; Liu GYH, 2004, FRONT BIOSCI-LANDMRK, V9, P1794, DOI 10.2741/1296; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malachowa N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018617; Maleki F, 2016, J CLIN DIAGN RES, V10, pBE1, DOI 10.7860/JCDR/2016/14568.7444; Meng F, 2009, FISH PATHOL, V44, P40, DOI 10.3147/jsfp.44.40; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; Moses AE, 1997, INFECT IMMUN, V65, P64, DOI 10.1128/IAI.65.1.64-71.1997; Nguyen CT, 2015, J MICROBIOL, V53, P741, DOI 10.1007/s12275-015-5432-6; Nguyen TL, 2016, J FISH DIS, V39, P31, DOI 10.1111/jfd.12322; Nho SW, 2011, J BACTERIOL, V193, P3356, DOI 10.1128/JB.00182-11; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Park SS, 2015, FEBS J, V282, P1352, DOI 10.1111/febs.13228; Park SB, 2016, AQUACULTURE, V461, P25, DOI 10.1016/j.aquaculture.2016.04.022; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Pena-Gonzalez A, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00065-18; Truong QL, 2014, CLIN VACCINE IMMUNOL, V21, P1573, DOI 10.1128/CVI.00164-14; Richards VP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-920; Rieux V, 2001, J INFECT DIS, V184, P66, DOI 10.1086/320992; Roh H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239198; Sabet C, 2005, INFECT IMMUN, V73, P6912, DOI 10.1128/IAI.73.10.6912-6922.2005; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Tran TDH, 2011, ANTIMICROB AGENTS CH, V55, P2714, DOI 10.1128/AAC.01383-10; Torres-Corral Y, 2020, APPL MICROBIOL BIOT, V104, P6211, DOI 10.1007/s00253-020-10683-z; Uribe C, 2011, VET MED-CZECH, V56, P486, DOI 10.17221/3294-VETMED; Verhagen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089541; Wang H, 2016, SCIENCE, V353, P492, DOI 10.1126/science.aaf7501; Wang J, 2014, FISH SHELLFISH IMMUN, V40, P392, DOI 10.1016/j.fsi.2014.07.028; Wawrzyniak P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02353; Wessels MR, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0050-2018; Williams TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114376; Won KM, 2010, FISHERIES SCI, V76, P991, DOI 10.1007/s12562-010-0287-6; Woo JE, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00351; Woodbury R, 2003, BIOCHEM BIOPH RES CO, V302, P722, DOI 10.1016/S0006-291X(03)00254-7; Zhang XY, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1441-7; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	71	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252200	10.1371/journal.pone.0252200	http://dx.doi.org/10.1371/journal.pone.0252200			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038483	gold, Green Published			2022-12-26	WOS:000664633500065
J	Roos, LE; Salisbury, M; Penner-Goeke, L; Cameron, EE; Protudjer, JLP; Giuliano, R; Afifi, TO; Reynolds, K				Roos, Leslie E.; Salisbury, Marlee; Penner-Goeke, Lara; Cameron, Emily E.; Protudjer, Jennifer L. P.; Giuliano, Ryan; Afifi, Tracie O.; Reynolds, Kristin			Supporting families to protect child health: Parenting quality and household needs during the COVID-19 pandemic	PLOS ONE			English	Article							POSTNATAL-DEPRESSION-SCALE; INTERPARENTAL CONFLICT; MATERNAL SENSITIVITY; SELF-REGULATION; STRESS; RISK; INTERVENTION; ADVERSITY; SYMPTOMS; VALIDITY	Background Supportive parenting is critical for promoting healthy child development in the face of stressors, such as those occurring during COVID-19. Here, we address a knowledge gap regarding specific household risk factors associated with parenting quality during the pandemic and incorporate first-person accounts of family challenges and needs. Methods Mixed methods were applied to data collected between April 14th - 28th, 2020 from the "Parenting During the Pandemic" survey. Participants included 656 primary caregivers (e.g., mothers, fathers, foster parents) of least one child age 1.5-8 years of which 555 (84.6%) responded to at least one parenting questionnaire. Parenting quality was assessed across stressful, negative, and positive parenting dimensions. Household risk was examined across pandemic- linked (e.g., caregiver depression, unmet childcare needs) and stable factors (i.e., annual income, mental illness history). Significant correlates were examined with regressions in Mplus. Thematic analysis identified caregiver challenges and unmet needs from open-ended questions. Findings Caregiver depression, higher child parity, unmet childcare needs, and relationship distress predicted lower-quality parenting. Caregiver depression was the most significant predictor across every parenting dimension, with analyses indicating medium effect sizes, ds = .39 - .73. Qualitative findings highlighted severe strains on parent capacities including managing psychological distress, limited social supports, and too much unstructured time. Interpretations Lower quality parenting during COVID-19 is associated with multiple household and pandemic risk factors, with caregiver depression consistently linked to parent- child relationship disruptions. Focused efforts are needed to address caregiver mental health to protect child health as part of the pandemic response.	[Roos, Leslie E.; Salisbury, Marlee; Penner-Goeke, Lara; Cameron, Emily E.; Giuliano, Ryan; Afifi, Tracie O.; Reynolds, Kristin] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada; [Roos, Leslie E.; Protudjer, Jennifer L. P.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Roos, Leslie E.; Protudjer, Jennifer L. P.; Giuliano, Ryan] Childrens Hosp Res Inst Manitoba, Winnipeg, MB R3E 3P4, Canada; [Penner-Goeke, Lara] Univ Winnipeg, Dept Psychol, Winnipeg, MB, Canada; [Afifi, Tracie O.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Afifi, Tracie O.] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Winnipeg; University of Manitoba; University of Manitoba	Roos, LE (corresponding author), Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada.; Roos, LE (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada.; Roos, LE (corresponding author), Childrens Hosp Res Inst Manitoba, Winnipeg, MB R3E 3P4, Canada.	leslie.roos@umanitoba.ca		Roos, Leslie/0000-0001-7083-4017	Children's Hospital Research Institute of Manitoba (CHRIM), Winnipeg, MB; Research Manitoba, Winnipeg, MB; Research Manitoba -2020 Manitoba COVID-19 Rapid Response;  [CHRIM MG2020-3]	Children's Hospital Research Institute of Manitoba (CHRIM), Winnipeg, MB; Research Manitoba, Winnipeg, MB; Research Manitoba -2020 Manitoba COVID-19 Rapid Response; 	Initials of funded authors: LR; RG; JP; MS; LPG; KR Grants: 1) Research Manitoba -2020 Manitoba COVID-19 Rapid Response 2) CHRIM MG2020-3 -Match for project titled "The PACT Program: Parenting Apart while Coming Together Research Grant Funders Name: 1) The Children's Hospital Research Institute of Manitoba (CHRIM), Winnipeg, MB 2) Research Manitoba, Winnipeg, MB URL of Funders Website: https://researchmanitoba.ca/https://www.chrim.ca/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin R.R., 1990, PARENTING STRESS IND; Arnold D.S., 1993, PSYCHOL ASSESSMENT, V9, P137, DOI [10.1037/1040-3590.5.2.137, DOI 10.1037/1040-3590.5.2.137]; Azhari A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47810-4; Baker BL, 2005, J INTELL DISABIL RES, V49, P575, DOI 10.1111/j.1365-2788.2005.00691.x; Bauer NS, 2013, JAMA PEDIATR, V167, P341, DOI 10.1001/jamapediatrics.2013.780; Baumel A, 2018, COGN BEHAV PRACT, V25, P538, DOI 10.1016/j.cbpra.2017.10.001; BOYD JH, 1982, ARCH GEN PSYCHIAT, V39, P1195; Breitenstein SM, 2016, JMIR MHEALTH UHEALTH, V4, P536, DOI 10.2196/mhealth.5202; Brennan PA, 2000, DEV PSYCHOL, V36, P759, DOI 10.1037/0012-1649.36.6.759; Bronte-Tinkew J, 2007, J NUTR, V137, P2160, DOI 10.1093/jn/137.9.2160; BUSBY DM, 1995, J MARITAL FAM THER, V21, P289, DOI 10.1111/j.1752-0606.1995.tb00163.x; Cameron EE, 2020, J AFFECT DISORDERS, V276, P765, DOI 10.1016/j.jad.2020.07.081; Canada Statistics, MEAS LAB MARK IS NOT; Chase SK, 2011, CHILD MALTREATMENT, V16, P33, DOI 10.1177/1077559510387659; Cluver L, 2020, LANCET, V395, pE64, DOI 10.1016/S0140-6736(20)30736-4; Coe JL, 2020, DEV PSYCHOPATHOL, V32, P257, DOI 10.1017/S0954579418001736; CONGER RD, 1994, CHILD DEV, V65, P541, DOI 10.1111/j.1467-8624.1994.tb00768.x; Cowan PA, 2019, ATTACH HUM DEV, V21, P532, DOI 10.1080/14616734.2019.1582600; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cuijpers P, 2008, EUR CHILD ADOLES PSY, V17, P32, DOI 10.1007/s00787-007-0631-2; Davis RN, 2011, PEDIATRICS, V127, P612, DOI 10.1542/peds.2010-1779; de Joode JW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218512; Di Giorgio E, 2021, EUR CHILD ADOLES PSY, V30, P1401, DOI 10.1007/s00787-020-01631-3; Eaton WW, 2004, CTR EPIDEMIOLOGIC ST; Elgar FJ, 2007, J ABNORM CHILD PSYCH, V35, P943, DOI 10.1007/s10802-007-9145-0; EREL O, 1995, PSYCHOL BULL, V118, P108, DOI 10.1037/0033-2909.118.1.108; Espeleta HC, 2018, CHILD ABUSE NEGLECT, V82, P92, DOI 10.1016/j.chiabu.2018.05.027; Fernandes N., 2020, WP1240E IESE BUS SCH, DOI [10.2139/ssrn.3557504, DOI 10.2139/SSRN.3557504]; Fisher PA, 2016, ANNU REV CLIN PSYCHO, V12, P331, DOI 10.1146/annurev-clinpsy-032814-112855; Flannery J.E., DIGITAL PARENTING TR, DOI [10.31234/osf.io/cpd9b, DOI 10.31234/OSF.IO/CPD9B]; Flouri E, 2015, EUR CHILD ADOLES PSY, V24, P745, DOI 10.1007/s00787-014-0619-7; Garbe A., 2020, AM J QUALITATIVE RES, V4, P45, DOI [10.29333/ajqr/8471, DOI 10.29333/AJQR/8471]; Gardner F, 2003, SOC DEV, V12, P361, DOI 10.1111/1467-9507.00238; Gutman LM, 2010, EARLY CHILD DEV CARE, V180, P535, DOI 10.1080/03004430802113042; Hagan MJ, 2016, PSYCHOSOM MED, V78, P998, DOI 10.1097/PSY.0000000000000379; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Haskett ME, 2006, J CLIN CHILD ADOLESC, V35, P302, DOI 10.1207/s15374424jccp3502_14; Hostinar CE, 2014, PSYCHOL BULL, V140, P256, DOI 10.1037/a0032671; Hughes K, 2017, LANCET PUBLIC HEALTH, V2, pE356, DOI 10.1016/S2468-2667(17)30118-4; Hughes SO, 2015, APPETITE, V92, P337, DOI 10.1016/j.appet.2015.06.002; Hutchings J, 2007, BMJ-BRIT MED J, V334, P678, DOI 10.1136/bmj.39126.620799.55; International QSR, 1999, NVIVO QUAL DAT AN SO; JARVIS PA, 1991, INFANT BEHAV DEV, V14, P383, DOI 10.1016/0163-6383(91)90029-R; Kaplan J., 2020, BUSINESS INSIDER; Karreman A, 2006, INFANT CHILD DEV, V15, P561, DOI 10.1002/icd.478; Liang LL, 2020, PSYCHIAT QUART, V91, P841, DOI 10.1007/s11126-020-09744-3; Luby J, 2013, JAMA PEDIATR, V167, P1135, DOI 10.1001/jamapediatrics.2013.3139; McEachern AD, 2012, J CHILD FAM STUD, V21, P498, DOI 10.1007/s10826-011-9503-y; Moran TE, 2006, ARCH WOMEN MENT HLTH, V9, P173, DOI 10.1007/s00737-006-0136-x; Neppl TK, 2016, J FAM PSYCHOL, V30, P12, DOI 10.1037/fam0000168; Newland RP, 2013, J FAM PSYCHOL, V27, P96, DOI 10.1037/a0031112; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Oh DL, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1037-7; Patel R, 2020, CBC NEWS; Patrick SW, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-016824; Pereira J, 2012, CHILD ABUSE NEGLECT, V36, P433, DOI 10.1016/j.chiabu.2012.01.006; Perry NB, 2014, DEV PSYCHOL, V50, P784, DOI 10.1037/a0033819; Prasso, 2020, BLOOMBERG BUSINESSWE; Prinzie P, 2007, EUR J PSYCHOL ASSESS, V23, P24, DOI 10.1027/1015-5759.23.1.24; PROOF Food Insecurity Policy Research, HOUSEHOLD FOOD INSEC, V2018, P1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rapoport Eli, 2021, Child Abuse Negl, V116, P104719, DOI 10.1016/j.chiabu.2020.104719; Rhoades KA, 2007, J CLIN CHILD ADOLESC, V36, P137, DOI 10.1080/15374410701274157; Rhoades KA, 2008, CHILD DEV, V79, P1942, DOI 10.1111/j.1467-8624.2008.01235.x; Riegler LJ, 2020, J PSYCHOTHER INTEGR, V30, P290, DOI 10.1037/int0000220; Rodriguez CM, 2021, CHILD MALTREATMENT, V26, P139, DOI 10.1177/1077559520982066; Rodriguez CM, 2010, VIOLENCE VICTIMS, V25, P728, DOI 10.1891/0886-6708.25.6.728; Romero E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17196975; Shelton KH, 2008, J FAM PSYCHOL, V22, P712, DOI 10.1037/a0013515; Shen HY, 2016, JAMA PSYCHIAT, V73, P239, DOI 10.1001/jamapsychiatry.2015.2917; Shonkoff JP, 2013, DEV PSYCHOPATHOL, V25, P1635, DOI 10.1017/S0954579413000813; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Somerville S, 2014, ARCH WOMEN MENT HLTH, V17, P443, DOI 10.1007/s00737-014-0425-8; Spencer CM, 2020, J FAM PSYCHOL, V34, P364, DOI 10.1037/fam0000605; Spieker SJ, 2018, INFANT MENT HEALTH J, V39, P5, DOI 10.1002/imhj.21685; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Statista, MED ANN FAM INC CAN; Statistics Canada, CAR THEIR CHILDR IMP; STEINBERG LD, 1981, CHILD DEV, V52, P975; Teissedre F, 2004, CAN J PSYCHIAT, V49, P51, DOI 10.1177/070674370404900108; Thanhauser M, 2017, CURR OPIN PSYCHIATR, V30, P283, DOI 10.1097/YCO.0000000000000342; United Nations, 2020, ENS FOOD SEC ER COVI; World Health Organization, 2020, DIR GEN OP REM MED B; Ye JC, 2020, JMIR PEDIATR PARENT, V3, DOI 10.2196/19867; Zarra-Nezhad M, 2019, CHILD YOUTH CARE FOR, V48, P865, DOI 10.1007/s10566-019-09510-y	85	33	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0251720	10.1371/journal.pone.0251720	http://dx.doi.org/10.1371/journal.pone.0251720			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029311	Green Submitted, gold, Green Published			2022-12-26	WOS:000664632800010
J	Dang, XD; Zhao, WH; Li, C; Yang, H; Li, DZ; Zhang, SS; Jin, TB				Dang, Xiaodong; Zhao, Wenhui; Li, Chen; Yang, Hua; Li, Dianzhen; Zhang, Shanshan; Jin, Tianbo			Impact of COL6A4P2 gene polymorphisms on the risk of lung cancer: A case-control study	PLOS ONE			English	Article							COLLAGEN; SUSCEPTIBILITY; POPULATION; VARIANTS	Lung cancer (LC) is a malignant tumor that poses the greatest threat to human health and life. Most studies suggested that the occurrence of LC is associated with environmental and genetic factors. We aimed to explore the association between COL6A4P2 single nucleotide polymorphisms (SNPs) and CHD risk in the Chinese Southern Han population. Based on the 'case-control' experimental design (510 cases and 495 controls), we conducted an association study between five candidate COL6A4P2 SNPs and the corresponding LC risk. Odds ratio (OR) and 95% confidence intervals (CIs) were calculated by logistic regression to analyze the LC susceptibility under different genetic models. The results showed that COL6A4P2 rs34445363 was significantly associated with LC risk under alleles model (OR = 1.26, 95%CI: 1.01-1.58, p = 0.038). In addition, rs34445363 was also significantly associated with LC risk under the log-additive model (OR = 1.26, 95%CI: 1.01-1.58, p = 0.041). The results of subgroup analysis showed that rs34445363 (OR = 1.42, 95%CI: 1.03-1.95, p = 0.033) and rs61733464 (OR = 0.72, 95%CI: 0.52-0.99, p = 0.048) were both significantly associated with LC risk in the log-additive model among participants who were <= 61 years old. We also found that the variation of rs34445363 (GA vs. GG, OR = 1.73, 95%CI: 1.04-2.86, p = 0.034) and rs77941834 (TA vs. TT, OR = 1.88, 95%CI: 1.06-3.34, p = 0.032) were associated with LC risk in the codominant model among female participants. Our study is the first to find that COL6A4P2 gene polymorphism is associated with LC risk in the Chinese Han population. Our study provides a basic reference for individualized LC prevention.	[Dang, Xiaodong; Zhao, Wenhui] Shaanxi Prov Canc Hosp, Dept Anesthesiol, Xian, Shaanxi, Peoples R China; [Li, Chen; Yang, Hua; Li, Dianzhen; Zhang, Shanshan] Xian 21st Century Biol Sicence & Technol Co Ltd, Xian, Shaanxi, Peoples R China; [Jin, Tianbo] Xizang Minzu Univ, Sch Med, Key Lab Mol Mech & Intervent Res Plateau Dis Tibe, Xianyang, Shaanxi, Peoples R China; [Jin, Tianbo] Northwest Univ, Sch Life Sci, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Shaanxi, Peoples R China	Xizang Minzu University; Northwest University Xi'an	Jin, TB (corresponding author), Xizang Minzu Univ, Sch Med, Key Lab Mol Mech & Intervent Res Plateau Dis Tibe, Xianyang, Shaanxi, Peoples R China.; Jin, TB (corresponding author), Northwest Univ, Sch Life Sci, Minist Educ, Key Lab Resource Biol & Biotechnol Western China, Xian, Shaanxi, Peoples R China.	jintianbo@gmail.com						Aareleid T, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3605-x; Albarqouni L, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0302-4; Bhimji S S., 2018, STATPEARLS; Cao M., 2018, THORAC CANCER; Chaudhary N, 2013, CHEM-BIOL INTERACT, V204, P125, DOI 10.1016/j.cbi.2013.05.004; Chiu KH, 2011, J PROTEOME RES, V10, P1110, DOI 10.1021/pr1008724; Dai ZJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002466; de Groot PM, 2018, TRANSL LUNG CANCER R, V7, P220, DOI 10.21037/tlcr.2018.05.06; Dimitrakopoulos FID, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23324-3; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; He J, 2018, MOL THER-NUCL ACIDS, V11, P1, DOI 10.1016/j.omtn.2018.01.003; Huang CY, 2015, AM J CANCER RES, V5, P3241; Kou Y, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/5326909; Li H, 2018, CANCER MANAG RES, V10, P5209, DOI 10.2147/CMAR.S175961; Li Y, 2018, EXP CELL RES, V363, P121, DOI 10.1016/j.yexcr.2017.12.020; Liu D, 2018, J THORAC DIS, V10, P5545, DOI 10.21037/jtd.2018.08.91; Lynn H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200916; Mohamed S, 2018, MULTIDISCIP RESP MED, V13, DOI 10.1186/s40248-018-0150-7; Oh JY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011683; Shea MP, 2018, CANCER LETT, V433, P1, DOI 10.1016/j.canlet.2018.06.025; Sun K X, 2018, Zhonghua Zhong Liu Za Zhi, V40, P805, DOI 10.3760/cma.j.issn.0253-3766.2018.11.002; Voiles L, 2014, ONCOL REP, V32, P1897, DOI 10.3892/or.2014.3438; Wei CC, 2017, ONCOTARGET, V8, P5233, DOI 10.18632/oncotarget.14125; Wu C, 2018, FEBS LETT, V592, P973, DOI 10.1002/1873-3468.13011	26	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252082	10.1371/journal.pone.0252082	http://dx.doi.org/10.1371/journal.pone.0252082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019596	gold, Green Published			2022-12-26	WOS:000664632300050
J	Fernandez-Perez, J; Madden, PW; Brady, RT; Nowlan, PF; Ahearne, M				Fernandez-Perez, Julia; Madden, Peter W.; Brady, Robert Thomas; Nowlan, Peter F.; Ahearne, Mark			The effect of prior long-term recellularization with keratocytes of decellularized porcine corneas implanted in a rabbit anterior lamellar keratoplasty model	PLOS ONE			English	Article							NERVE REGENERATION; EPITHELIAL-CELLS; STROMAL CELLS; STEM-CELLS; TISSUE; MATRIX; CONSTRUCTION; SCAFFOLD; MYOFIBROBLASTS; GENERATION	Decellularized porcine corneal scaffolds are a potential alternative to human cornea for keratoplasty. Although clinical trials have reported promising results, there can be corneal haze or scar tissue. Here, we examined if recellularizing the scaffolds with human keratocytes would result in a better outcome. Scaffolds were prepared that retained little DNA (14.89 +/- 5.56 ng/mg) and demonstrated a lack of cytotoxicity by in vitro. The scaffolds were recellularized using human corneal stromal cells and cultured for between 14 in serum-supplemented media followed by a further 14 days in either serum free or serum-supplemented media. All groups showed full-depth cell penetration after 14 days. When serum was present, staining for ALDH3A1 remained weak but after serum-free culture, staining was brighter and the keratocytes adopted a native dendritic morphology with an increase (p < 0.05) of keratocan, decorin, lumican and CD34 gene expression. A rabbit anterior lamellar keratoplasty model was used to compare implanting a 250 mu m thick decellularized lenticule against one that had been recellularized with human stromal cells after serum-free culture. In both groups, host rabbit epithelium covered the implants, but transparency was not restored after 3 months. Post-mortem histology showed under the epithelium, a less-compact collagen layer, which appeared to be a regenerating zone with some alpha-SMA staining, indicating fibrotic cells. In the posterior scaffold, ALDH1A1 staining was present in all the acellular scaffold, but in only one of the recellularized lenticules. Since there was little difference between acellular and cell-seeded scaffolds in our in vivo study, future scaffold development should use acellular controls to determine if cells are necessary.	[Fernandez-Perez, Julia; Madden, Peter W.; Ahearne, Mark] Univ Dublin, Trinity Coll Dublin, Sch Engn, Dept Mech Mfg & Biomed Engn, Dublin, Ireland; [Fernandez-Perez, Julia; Madden, Peter W.; Ahearne, Mark] Univ Dublin, Trinity Coll Dublin, Trinity Ctr Biomed Engn, Trinity Biomed Sci Inst, Dublin, Ireland; [Brady, Robert Thomas] Mater Misericordiae Univ Hosp, Dept Ophthalmol, Dublin, Ireland; [Nowlan, Peter F.] Univ Dublin, Trinity Coll Dublin, Sch Nat Sci, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Mater Misericordiae University Hospital; University College Dublin; Trinity College Dublin	Ahearne, M (corresponding author), Univ Dublin, Trinity Coll Dublin, Sch Engn, Dept Mech Mfg & Biomed Engn, Dublin, Ireland.; Ahearne, M (corresponding author), Univ Dublin, Trinity Coll Dublin, Trinity Ctr Biomed Engn, Trinity Biomed Sci Inst, Dublin, Ireland.	ahearnm@tcd.ie	Fernández-Pérez, Julia/S-8960-2019	Fernández-Pérez, Julia/0000-0002-8375-2907; Brady, Robert Thomas/0000-0001-5839-8566; Ahearne, Mark/0000-0002-4540-4434	European Research Council [637460]; Science Foundation Ireland [15/ERC/3269]	European Research Council(European Research Council (ERC)European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	MA received funding from European Research Council, grant number 637460 (https://erc.europa.eu/) and Science Foundation Ireland, grant number 15/ERC/3269 (https://www.sfi.ie/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamdani MSS, 2010, J PROTEOME RES, V9, P963, DOI 10.1021/pr900844q; Del Barrio JLA, 2018, AM J OPHTHALMOL, V186, P47, DOI 10.1016/j.ajo.2017.10.026; del Barrio JLA, 2015, EXP EYE RES, V132, P91, DOI 10.1016/j.exer.2015.01.020; Brady RT., 2020, CORNEAL REGENERATION; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Darwish T, 2007, CORNEA, V26, P935, DOI 10.1097/ICO.0b013e3180de493f; Diao JM, 2015, EXP EYE RES, V132, P216, DOI 10.1016/j.exer.2015.01.015; Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x; Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006; Fernandez-Perez J, 2020, TISSUE ENG PT A, V26, P1030, DOI [10.1089/ten.TEA.2020.0019, 10.1089/ten.tea.2020.0019]; Fernandez-Perez J, 2020, METHODS, V171, P86, DOI 10.1016/j.ymeth.2019.05.009; Fernandez-Perez J, 2019, CURR EYE RES, V44, P135, DOI 10.1080/02713683.2018.1536216; Fernandez-Perez J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06898-2; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; Friedrich EE, 2018, J TISSUE ENG REGEN M, V12, pE1704, DOI 10.1002/term.2604; GOLDMAN JEROME N., 1967, INVEST OPHTHALMOL, V6, P574; Gonzalez-Andrades M, 2011, INVEST OPHTH VIS SCI, V52, P215, DOI 10.1167/iovs.09-4773; Gouveia RM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09331-6; Guyette JP, 2014, NAT PROTOC, V9, P1451, DOI 10.1038/nprot.2014.097; Hashimoto Y, 2019, MAT SCI ENG C-MATER, V102, P238, DOI 10.1016/j.msec.2019.04.024; Hashimoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131989; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Huang YH, 2017, ACTA BIOMATER, V58, P238, DOI 10.1016/j.actbio.2017.05.060; Ignat'eva NY, 2007, J ANAL CHEM+, V62, P51, DOI 10.1134/S106193480701011X; Islam MM, 2018, NPJ REGEN MED, V3, DOI 10.1038/s41536-017-0038-8; Jeon KI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30964-y; Jester JV, 2005, INVEST OPHTH VIS SCI, V46, P2369, DOI 10.1167/iovs.04-1225; Kafienah W, 2003, METH MOL B, V238, P217; Kim MK, 2015, INT J SURG, V23, P255, DOI 10.1016/j.ijsu.2015.07.685; Koivusalo L, 2019, BIOMATERIALS, V225, DOI 10.1016/j.biomaterials.2019.119516; Lee W, 2014, INT J OPHTHALMOL-CHI, V7, P587, DOI 10.3980/j.issn.2222-3959.2014.04.01; Li SQ, 2020, XENOTRANSPLANTATION, V27, DOI 10.1111/xen.12566; Lin YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08207-3; Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011; Luo HL, 2013, BIOMATERIALS, V34, P6748, DOI 10.1016/j.biomaterials.2013.05.045; Lynch AP, 2016, EXP EYE RES, V151, P26, DOI 10.1016/j.exer.2016.07.015; Lynch AP, 2016, TISSUE ENG PART C-ME, V22, P561, DOI [10.1089/ten.tec.2016.0017, 10.1089/ten.TEC.2016.0017]; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; MAURICE DM, 1957, J PHYSIOL-LONDON, V136, P263, DOI 10.1113/jphysiol.1957.sp005758; Medeiros CS, 2018, INVEST OPHTH VIS SCI, V59, P4044, DOI 10.1167/iovs.18-24428; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Netto MV, 2006, EXP EYE RES, V82, P788, DOI 10.1016/j.exer.2005.09.021; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066; Richter A, 1997, GER J OPHTHALMOL, V5, P513; Sasaki S, 2009, MOL VIS, V15, P2022; Shafiq MA, 2012, TISSUE ENG PART C-ME, V18, P340, DOI [10.1089/ten.tec.2011.0072, 10.1089/ten.TEC.2011.0072]; Shi Y, 2017, XENOTRANSPLANTATION, V24, DOI 10.1111/xen.12338; Sorkio A, 2018, BIOMATERIALS, V171, P57, DOI 10.1016/j.biomaterials.2018.04.034; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Torricelli AAM, 2016, EXP EYE RES, V142, P110, DOI 10.1016/j.exer.2014.09.012; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; Wilson SL, 2012, J FUNCT BIOMATER, V3, P642, DOI 10.3390/jfb3030642; Wilson SL, 2012, ADV FUNCT MATER, V22, P3641, DOI 10.1002/adfm.201200655; Wu J, 2014, EXP EYE RES, V120, P71, DOI 10.1016/j.exer.2014.01.005; Xu B, 2017, ARTIF ORGANS, V41, P1004, DOI 10.1111/aor.12878; Yam GHF, 2017, SCI REP-UK, V7, DOI 10.1038/srep45396; Yoeruek E, 2012, ACTA OPHTHALMOL, V90, pe125, DOI 10.1111/j.1755-3768.2011.02261.x; Zhang MC, 2015, AM J TRANSPLANT, V15, P1068, DOI 10.1111/ajt.13096; Zheng J, 2019, XENOTRANSPLANTATION, V26, DOI 10.1111/xen.12509; Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170	61	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0245406	10.1371/journal.pone.0245406	http://dx.doi.org/10.1371/journal.pone.0245406			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061862	Green Submitted, Green Published, gold			2022-12-26	WOS:000656813600002
J	Marakasova, E; Olivares, P; Karnaukhova, E; Chun, H; Hernandez, NE; Kurasawa, JH; Hassink, GU; Shestopal, SA; Strickland, DK; Sarafanov, AG				Marakasova, Ekaterina; Olivares, Philip; Karnaukhova, Elena; Chun, Haarin; Hernandez, Nancy E.; Kurasawa, James H.; Hassink, Gabriela U.; Shestopal, Svetlana A.; Strickland, Dudley K.; Sarafanov, Andrey G.			Molecular chaperone RAP interacts with LRP1 in a dynamic bivalent mode and enhances folding of ligand-binding regions of other LDLR family receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; HIGH-AFFINITY BINDING; CONSERVED ACIDIC RESIDUE; PROTEIN-PROTEIN DOCKING; CIRCULAR-DICHROISM; VLDL RECEPTOR; I-TASSER; RECOGNITION; COMPLEX; EXPRESSION	The low-density lipoprotein receptor (LDLR) family of receptors are cell-surface receptors that internalize numerous ligands and play crucial role in various processes, such as lipoprotein metabolism, hemostasis, fetal development, etc. Previously, receptor-associated protein (RAP) was described as a molecular chaperone for LDLR-related protein 1 (LRP1), a prominent member of the LDLR family. We aimed to verify this role of RAP for LRP1 and two other LDLR family receptors, LDLR and vLDLR, and to investigate the mechanisms of respective interactions using a cell culture model system, purified system, and in silico modelling. Upon coexpression of RAP with clusters of the ligand-binding complement repeats (CRs) of the receptors in secreted form in insect cells culture, the isolated proteins had increased yield, enhanced folding, and improved binding properties compared with proteins expressed without RAP, as determined by circular dichroism and surface plasmon resonance. Within LRP1 CR-clusters II and IV, we identified multiple sites comprised of adjacent CR doublets, which provide alternative bivalent binding combinations with specific pairs of lysines on RAP. Mutational analysis of these lysines within each of isolated RAP D1/D2 and D3 domains having high affinity to LRP1 and of conserved tryptophans on selected CR-doublets of LRP1, as well as in silico docking of a model LRP1 CR-triplet with RAP, indicated a universal role for these residues in interaction of RAP and LRP1. Consequently, we propose a new model of RAP interaction with LDLR family receptors based on switching of the bivalent contacts between molecules over time in a dynamic mode.	[Marakasova, Ekaterina; Olivares, Philip; Karnaukhova, Elena; Chun, Haarin; Hernandez, Nancy E.; Kurasawa, James H.; Hassink, Gabriela U.; Shestopal, Svetlana A.; Sarafanov, Andrey G.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Marakasova, Ekaterina] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Kurasawa, James H.] AstraZeneca, R&D, Antibody Discovery & Prot Engn, Gaithersburg, MD USA; [Hassink, Gabriela U.] GSK Slaoui Ctr Vaccines Res, Rockville, MD USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland Baltimore; US Food & Drug Administration (FDA); AstraZeneca	Sarafanov, AG (corresponding author), US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Andrey.Sarafanov@fda.hhs.gov		Marakasova, Ekaterina/0000-0002-6505-4726; Sarafanov, Andrey/0000-0001-6124-9713; Hernandez, Nancy/0000-0002-8307-4704; Shestopal, Svetlana/0000-0003-0725-5885; Olivares, Philip/0000-0003-3182-5884; Chun, Haarin/0000-0002-2668-6296	Center for Biologics Evaluation and Research of the US Food and Drug Administration	Center for Biologics Evaluation and Research of the US Food and Drug Administration	This work was supported by funds from the Center for Biologics Evaluation and Research of the US Food and Drug Administration by appointments to the research program administered by the Oak Ridge Institute for Science and Education through an interagency agreement with the US Department of Energy. This study used the computational resources of the High Performance Computing clusters of the FDA, Center for Devices and Radiological Health. The authors are thankful to Dr. Rong Fong Shen and Dr. Wells Wu (US FDA), who contributed to protein characterization. These contributions are an informal communication and represent the best judgment of the authors and do not bind or obligate the US Food and Drug Administration.	Dato VA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061780; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Andersen OM, 2001, BIOCHEMISTRY-US, V40, P15408, DOI 10.1021/bi0110692; Au DT, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8356537; Bajari TM, 1998, BIOL CHEM, V379, P1053, DOI 10.1515/bchm.1998.379.8-9.1053; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Chagas R, 2018, FOOD CHEM, V259, P166, DOI 10.1016/j.foodchem.2018.03.115; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Cooper JM, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100715; De Nardis C, 2017, J BIOL CHEM, V292, P912, DOI 10.1074/jbc.M116.758862; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Dlugosz P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103090; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guo Y, 2004, J BIOL CHEM, V279, P16629, DOI 10.1074/jbc.M400157200; HERZ J, 1991, J BIOL CHEM, V266, P21232; HIDER RC, 1988, BIOPHYS CHEM, V31, P45, DOI 10.1016/0301-4622(88)80007-3; HIDER RC, 1988, BIOPOLYMERS, V27, P113, DOI 10.1002/bip.360270109; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Khalili M, 2004, PROTEIN SCI, V13, P2725, DOI 10.1110/ps.04878904; Kurasawa JH, 2015, BIOCHEMISTRY-US, V54, P481, DOI 10.1021/bi5011688; Kurasawa JH, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.468108; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Martinez-Olivan J, 2015, FEBS LETT, V589, P3534, DOI 10.1016/j.febslet.2015.10.014; Marze NA, 2017, PROTEINS, V85, P479, DOI 10.1002/prot.25168; MEDH JD, 1995, J BIOL CHEM, V270, P536, DOI 10.1074/jbc.270.2.536; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; Migliorini M, 2020, J BIOL CHEM, V295, P212, DOI 10.1074/jbc.RA119.010449; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Prasad JM, 2016, J BIOL CHEM, V291, P18430, DOI 10.1074/jbc.M116.744904; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Sarafanov A, 2004, ANAL BIOCHEM, V328, P98, DOI 10.1016/j.ab.2003.11.028; Sarafanov AG, 2006, BIOCHEMISTRY-US, V45, P1829, DOI 10.1021/bi0520380; Sarafanov AG, 2007, THROMB HAEMOSTASIS, V98, P1170, DOI 10.1160/TH07-05-0353; Sato A, 1999, BIOCHEM J, V341, P377, DOI 10.1042/0264-6021:3410377; Schasfoort R, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, pX, DOI 10.1039/9781847558220-FP010; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Tang N, 2016, J AGR FOOD CHEM, V64, P4376, DOI 10.1021/acs.jafc.6b01534; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Yakovlev S, 2017, BIOCHEMISTRY-US, V56, P2518, DOI 10.1021/acs.biochem.7b00087; Yamamoto T, 2008, ANAL BIOCHEM, V372, P222, DOI 10.1016/j.ab.2007.09.005; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; Young PA, 2016, J BIOL CHEM, V291, P26035, DOI 10.1074/jbc.M116.754622	67	2	2	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100842	10.1016/j.jbc.2021.100842	http://dx.doi.org/10.1016/j.jbc.2021.100842			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058195	Green Submitted, gold, Green Published			2022-12-26	WOS:000678068400042
J	James, A; Plank, MJ; Hendy, S; Binny, R; Lustig, A; Steyn, N; Nesdale, A; Verrall, A				James, A.; Plank, M. J.; Hendy, S.; Binny, R.; Lustig, A.; Steyn, N.; Nesdale, A.; Verrall, A.			Successful contact tracing systems for COVID-19 rely on effective quarantine and isolation	PLOS ONE			English	Article								Models of contact tracing often over-simplify the effects of quarantine and isolation on disease transmission. We develop a model that allows us to investigate the importance of these factors in reducing the effective reproduction number. We show that the reduction in onward transmission during quarantine and isolation has a bigger effect than tracing coverage on the reproduction number. We also show that intuitively reasonable contact tracing performance indicators, such as the proportion of contacts quarantined before symptom onset, are often not well correlated with the reproduction number. We conclude that provision of support systems to enable people to quarantine and isolate effectively is crucial to the success of contact tracing.	[James, A.; Plank, M. J.] Univ Canterbury, Sch Math & Stat, Christchurch, New Zealand; [James, A.; Plank, M. J.; Hendy, S.; Binny, R.; Lustig, A.; Steyn, N.] Te Punaha Matatini, Auckland, New Zealand; [Hendy, S.] Univ Auckland, Dept Phys, Auckland, New Zealand; [Binny, R.; Lustig, A.] Manaaki Whenua, Lincoln, New Zealand; [Nesdale, A.] Hutt Valley Dist Hlth Board, Lower Hutt, New Zealand; [Verrall, A.] Univ Otago, Dept Pathol & Mol Med, Dunedin, New Zealand	University of Canterbury; University of Auckland; Landcare Research - New Zealand; University of Otago	James, A (corresponding author), Univ Canterbury, Sch Math & Stat, Christchurch, New Zealand.; James, A (corresponding author), Te Punaha Matatini, Auckland, New Zealand.	alex.james@canterbury.ac.nz	Hendy, Shaun/A-9776-2008	Hendy, Shaun/0000-0003-3468-6517; Steyn, Nicholas/0000-0001-8904-2941	Ministry of Business, Innovation and Employment, New Zealand; Te Punaha Matatini, the New Zealand Centre of Research Excellence for Complex Systems	Ministry of Business, Innovation and Employment, New Zealand(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Te Punaha Matatini, the New Zealand Centre of Research Excellence for Complex Systems	This work was funded by the Ministry of Business, Innovation and Employment, New Zealand and Te Punaha Matatini, the New Zealand Centre of Research Excellence for Complex Systems.	Aleta Alberto, 2020, medRxiv, DOI 10.1101/2020.05.06.20092841; Ali ST, 2020, SCIENCE, V369, P1106, DOI 10.1126/science.abc9004; [Anonymous], 2020, BMC MED, DOI 10.1186/s12916-020-01597-8; Baker MG, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMc2025203; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Centre for Disease Control, 2020, SELF IS SELF QUAR HO; Chau NVV., 2020, CLIN INFECT DIS, V71, P2679, DOI 10.1093/cid/ciaa711; Chen SM, 2020, LANCET, V395, P1305, DOI 10.1016/S0140-6736(20)30744-3; Compass Research Centre, 2018, INT SOCIAL SURVEY PR; Cousins S, 2020, LANCET, V395, P1474, DOI 10.1016/S0140-6736(20)31097-7; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Endo Akira, 2020, Wellcome Open Res, V5, P239, DOI 10.12688/wellcomeopenres.16344.1; European Centre for Disease Prevention and Control, 2020, SKY POST; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Firth JA, 2020, NAT MED, V26, P1616, DOI 10.1038/s41591-020-1036-8; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Ganyani T, 2020, EUROSURVEILLANCE, V25, P12, DOI 10.2807/1560-7917.ES.2020.25.17.2000257; Group, 2020, LANCET PUBLIC HEALTH, DOI [10.1016/S2468-2667(20)30308-X 33484644, DOI 10.1016/S2468-2667(20)30308-X33484644]; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hall, 2020, EFFECTIVE CONFIGURAT, V2020, P29; Hellewell J., 2020, LANCET GLOB HEALTH, V8, pE488, DOI [10.1016/S2214-109X(20)30074-7, DOI 10.1101/2020.02.08.20021162, 10.1016/S2214-109X%2820%2930074-7, DOI 10.1016/S2214-109X(20)30074-7]; Hendy, 2020, STRUCTURED MODEL COV; Ienca M, 2020, NAT MED, V26, P463, DOI 10.1038/s41591-020-0832-5; Kang M, 2016, EMERG INFECT DIS, V22, P1644, DOI 10.3201/eid2209.152116; Kretzschmar ME, 2020, LANCET PUBLIC HEALTH, V5, pE452, DOI 10.1016/S2468-2667(20)30157-2; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lavezzo E., 2020, SUPPRESSION COVID 1, DOI [10.1101/2020.04.17.20053157v1, DOI 10.1101/2020.04.17.20053157V1, 10.1038/s41586-020-2488-1]; Liu YN, 2021, J CANCER EDUC, V36, P1014, DOI 10.1007/s13187-019-01682-4; Nishiura H, 2020, INT J INFECT DIS, V93, P284, DOI 10.1016/j.ijid.2020.02.060; O'Dowd A, 2020, BMJ-BRIT MED J, V369; Obadia T, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-147; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Stockdale JE, 2020, TRANSMISSION INTERVA, DOI [10.1101/2020.03.03.20029983, DOI 10.1101/2020.03.03.20029983, 10.1101/2020.03.03.20029983v1]; Sun KY, 2020, LANCET INFECT DIS, V20, P876, DOI 10.1016/S1473-3099(20)30357-1; Verrall A., 2020, SUPP REG TOWN WAT IN; World Health Organization, 2020, TECH REP; World Health Organization, 2020, DIG TOOLS COVID 19 C; World Health Organization Centers for Disease Control Prevention, 2015, IMPL MAN CONT TRAC E	40	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252499	10.1371/journal.pone.0252499	http://dx.doi.org/10.1371/journal.pone.0252499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081709	gold, Green Published, Green Submitted			2022-12-26	WOS:000664639200022
J	Ma, L; Jiang, T; Liu, XY; Xiao, HJ; Peng, YC; Zhang, WN				Ma, Long; Jiang, Ting; Liu, Xiangya; Xiao, Haijun; Peng, Yingchuan; Zhang, Wanna			Evaluation of candidate reference genes for gene expression analysis in the brassica leaf beetle, Phaedon brassicae (Coleoptera: Chrysomelidae)	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; BACILLUS-THURINGIENSIS; QRT-PCR; RT-QPCR; IDENTIFICATION; VALIDATION; SELECTION; NORMALIZATION	The brassica leaf beetle Phaedon brassicae is a notorious defoliator of cruciferous vegetables. However, few molecular studies of this pest have been conducted due to limited sequence data. Recently, RNA sequencing has offered a powerful platform to generate numerous transcriptomic data, which require RT-qPCR to validate target gene expression. The selection of reliable reference genes to normalize RT-qPCR data is a prerequisite for gene expression analysis. In the present study, the expression stabilities of eight candidate reference genes under biotic conditions (development stages and various tissues) and abiotic perturbations (thermal stress and pesticide exposure) were evaluated using four different statistical algorithms. The optimal suites of reference genes were recommended for the respective experimental conditions. For tissue expression analysis, RPL32 and EF-1 alpha were recommended as the suitable reference genes. RPL19 and TBP were the optimal reference genes across different developmental stages. RPL32 and TBP were identified as the most suitable references for thermal stress. Furthermore, RPL32 and RPL19 were ranked as the best references for insecticide exposure. This work provides a systematic exploration of the optimal reference genes for the respective experimental conditions, and our findings would facilitate molecular studies of P. brassicae.	[Ma, Long; Zhang, Wanna] Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China; [Jiang, Ting; Liu, Xiangya; Xiao, Haijun; Peng, Yingchuan; Zhang, Wanna] Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China	Jiangxi Science & Technology Normal University; Jiangxi Agricultural University	Zhang, WN (corresponding author), Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China.	zhangwanna880210@yeah.net	Xiao, Haijun/HGE-3088-2022	Xiao, Haijun/0000-0002-0832-0493	National Natural Science Foundation of China [31960543, 32060642]; Natural Science Foundation of Jiangxi Province [20202BABL203046, 20202ACBL205004]; Science and Technology Program of Department of Education of Jiangxi Province [GJJ201106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Science and Technology Program of Department of Education of Jiangxi Province	This research was supported by National Natural Science Foundation of China (31960543, 32060642), Natural Science Foundation of Jiangxi Province (20202BABL203046, 20202ACBL205004), and Science and Technology Program of Department of Education of Jiangxi Province (GJJ201106).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Basu S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47020-y; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chen X, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59197-8; Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152; Ferguson BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015208; Gao XK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188477; Gao YL, 2011, PEST MANAG SCI, V67, P1076, DOI 10.1002/ps.2149; Kim E, 2015, J ECON ENTOMOL, V108, P2556, DOI 10.1093/jee/tov245; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kristensen R, 2005, MYCOL RES, V109, P173, DOI 10.1017/S0953756204002114; Li HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195096; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01614; Matsubara S, 2018, APPL ENTOMOL ZOOL, V53, P501, DOI [10.1007/s13355-018-0582-8, 10.1]; Morales MA, 2016, INT J BIOL SCI, V12, P1129, DOI 10.7150/ijbs.16319; Nagy NA, 2017, PEERJ, V5, DOI 10.7717/peerj.4047; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129482; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Sang W, 2015, ENVIRON ENTOMOL, V44, P418, DOI 10.1093/ee/nvv010; Shakeel M, 2018, BIOTECHNOL LETT, V40, P227, DOI 10.1007/s10529-017-2465-4; Shi Xiao-Qin, 2013, BMC Res Notes, V6, P93, DOI 10.1186/1756-0500-6-93; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Singh S, 2019, J ECON ENTOMOL, V112, P371, DOI 10.1093/jee/toy328; Tan QQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118693; TATSUKA M, 1992, NATURE, V359, P333, DOI 10.1038/359333a0; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XP, 2007, EUR J ENTOMOL, V104, P693, DOI 10.14411/eje.2007.087; Wang Xiao-Ping, 2009, Chinese Bulletin of Entomology, V46, P403; Wang XP, 2007, PAN-PAC ENTOMOL, V83, P143, DOI 10.3956/0031-0603-83.2.143; Wang Y, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.94; Wang Z, 2020, J INSECT SCI, V20, DOI 10.1093/jisesa/iez130; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xie J, 2019, INSECT SCI, V26, P263, DOI 10.1111/1744-7917.12543; Yang XW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20612-w; Zhang JW, 2018, ARCH INSECT BIOCHEM, V99, DOI 10.1002/arch.21516; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014	41	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0251920	10.1371/journal.pone.0251920	http://dx.doi.org/10.1371/journal.pone.0251920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081693	gold, Green Published			2022-12-26	WOS:000664639200006
J	Molinos-Senante, M; Maziotis, A				Molinos-Senante, Maria; Maziotis, Alexandros			Productivity growth, economies of scale and scope in the water and sewerage industry: The Chilean case	PLOS ONE			English	Article							OPERATIONAL ENVIRONMENT; SANITATION UTILITIES; TECHNICAL EFFICIENCY; COMPUTING ECONOMIES; ELECTRIC-POWER; COST FUNCTION; BENCHMARKING; INTEGRATION; COMPANIES; PERFORMANCE	Evaluating the performance and analyzing the cost drivers of water utilities is of great interest for water regulators and water sector managers. This study uses a quadratic cost function to investigate the existence of economies of scale and scope in the Chilean water and sewerage industry over the period 2010-2017. We also estimate and decompose productivity growth into technical change and scale efficiency change. Technical change is further broken into pure, non-neutral and scale-augmenting technical change. The results indicate that cost savings can be achieved by increases in the scale of production and the separation of water and sewerage services. Productivity progressed favorably throughout the whole period at an annual rate of 8.4%, which was attributed to the scale effect, the adoption of new technologies and a good allocation of resources. Some policy implications are finally discussed based on our findings.	[Molinos-Senante, Maria; Maziotis, Alexandros] Pontificia Univ Catolica Chile, Dept Ingn Hidraul & Ambiental, Santiago, Chile; [Molinos-Senante, Maria] Ctr Desarrollo Urbano Sustentable CONICYT FONDAP, Santiago, Chile; [Maziotis, Alexandros] New York Coll, Dept Business, Athens, Greece	Pontificia Universidad Catolica de Chile	Molinos-Senante, M (corresponding author), Pontificia Univ Catolica Chile, Dept Ingn Hidraul & Ambiental, Santiago, Chile.; Molinos-Senante, M (corresponding author), Ctr Desarrollo Urbano Sustentable CONICYT FONDAP, Santiago, Chile.	mmolinos@uc.cl	Maziotis, Alexandros/AAB-5477-2020; Molinos-Senante, Maria/A-8523-2016	Maziotis, Alexandros/0000-0001-9817-1470; Molinos-Senante, Maria/0000-0002-6689-6861				Abbott M, 2009, UTIL POLICY, V17, P233, DOI 10.1016/j.jup.2009.05.001; Arocena P, 2012, J IND ECON, V60, P434, DOI 10.1111/j.1467-6451.2012.00486.x; BALTAGI BH, 1988, J POLIT ECON, V96, P20, DOI 10.1086/261522; Baumol W. J., 1982, CONTESTABLE MARKETS; Berg SV, 2011, WATER POLICY, V13, P591, DOI 10.2166/wp.2011.041; Bottasso A, 2011, INT J PROD ECON, V130, P112, DOI 10.1016/j.ijpe.2010.12.002; Carvaho P, 2012, UTIL POLICY, V21, P40, DOI 10.1016/j.jup.2011.12.005; Carvalho P, 2016, WATER-SUI, V8, DOI 10.3390/w8030082; Carvalho P, 2016, SCI TOTAL ENVIRON, V544, P574, DOI 10.1016/j.scitotenv.2015.11.169; Carvalho P, 2015, ENG ECON, V60, P109, DOI 10.1080/0013791X.2013.873507; Carvalho P, 2014, EUR J OPER RES, V234, P292, DOI 10.1016/j.ejor.2013.09.022; Carvalho P, 2011, J ENVIRON MANAGE, V92, P2698, DOI 10.1016/j.jenvman.2011.06.008; CAVES DW, 1980, REV ECON STAT, V62, P477, DOI 10.2307/1927120; Cetrulo TB, 2019, WATER RES, V161, P372, DOI 10.1016/j.watres.2019.05.044; Coelli T., 2003, WBI DEV STUDIES; De Witte K, 2009, INT T OPER RES, V16, P257, DOI 10.1111/j.1475-3995.2009.00675.x; Donoso G, 2015, GLOB ISS WATER POL, V9, P83, DOI 10.1007/978-3-319-16465-6_5; Ferro G, 2016, UTIL POLICY, V43, P97, DOI 10.1016/j.jup.2016.04.016; Fraquelli G, 2005, J REGUL ECON, V28, P289, DOI 10.1007/s11149-005-3959-x; Goh KH, 2021, J CLEAN PROD, V284, DOI 10.1016/j.jclepro.2020.124711; Guerrini A, 2018, UTIL POLICY, V52, P103, DOI 10.1016/j.jup.2018.04.003; Jara-Diaz S, 2004, ENERG ECON, V26, P995, DOI 10.1016/j.eneco.2004.05.001; Kwoka JE, 2002, INT J IND ORGAN, V20, P653, DOI 10.1016/S0167-7187(00)00114-4; Marques RC, 2008, WATER POLICY, V10, P25, DOI 10.2166/wp.2007.033; Marques RC, 2014, J WATER RES PLAN MAN, V140, P562, DOI 10.1061/(ASCE)WR.1943-5452.0000366; Martinez-Budria E, 2003, J PROD ANAL, V20, P213, DOI 10.1023/A:1025184306832; Martinez-Budria E, 2007, CONTRIB ECON, P127, DOI 10.1007/978-3-7908-1765-2_10; Mellah T, 2016, UTIL POLICY, V38, P18, DOI 10.1016/j.jup.2015.11.001; Molinos-Senante M, 2019, URBAN WATER J, V16, P353, DOI 10.1080/1573062X.2019.1669196; Molinos-Senante M, 2020, ENVIRON SCI POLLUT R, V27, P13155, DOI 10.1007/s11356-020-07918-x; Molinos-Senante M, 2020, INT J WATER RESOUR D, V36, P972, DOI 10.1080/07900627.2019.1702000; Molinos-Senante M, 2019, UTIL POLICY, V61, DOI 10.1016/j.jup.2019.100971; Molinos-Senante M, 2018, GLOB ISS WATER POL, V21, P131, DOI 10.1007/978-3-319-76702-4_9; Molinos-Senante M, 2018, J CLEAN PROD, V183, P908, DOI 10.1016/j.jclepro.2018.02.227; Molinos-Senante M, 2018, ENVIRON SCI POLLUT R, V25, P14158, DOI 10.1007/s11356-018-1638-6; Molinos-Senante M, 2017, J WATER RES PLAN MAN, V143, DOI [10.1061/(asce)wr.1943-5452.0000833, 10.1061/(ASCE)WR.1943-5452.0000833]; Molinos-Senante M, 2015, ENVIRON SCI POLICY, V50, P166, DOI 10.1016/j.envsci.2015.02.015; Mydland O, 2020, ECON MODEL, V88, P39, DOI 10.1016/j.econmod.2019.09.008; Pinto FS, 2017, URBAN WATER J, V14, P773, DOI 10.1080/1573062X.2016.1254254; Porcher S, 2019, PALGRAVE STUDIES WAT; Ramos-Real FJ, 2010, J TRANSP ECON POLICY, V44, P231; Saal D., 2000, MANAG DECIS ECON, V21, P253; Saal DS, 2007, J PROD ANAL, V28, P127, DOI 10.1007/s11123-007-0040-z; Saal DS, 2013, REV NETW ECON, V12, P93, DOI 10.1515/rne-2012-0004; Sala-Garrido R, 2019, J CLEAN PROD, V216, P597, DOI 10.1016/j.jclepro.2018.12.034; Sala-Garrido R, 2018, URBAN WATER J, V15, P626, DOI 10.1080/1573062X.2018.1529807; Sauer J, 2004, 63 IAMO; See KF, 2015, WATER RESOUR ECON, V9, P23, DOI 10.1016/j.wre.2014.11.002; SISS (Superintendencia de Servicios Sanitarios, 2015, MAN REP CHIL WAT SEW; Stone Webster Consultants, 2004, FINAL REPORT, P1; Thomas S, 2012, WHY WATER IS PUBLIC; Triebs TP, 2016, J PROD ANAL, V45, P173, DOI 10.1007/s11123-016-0467-1	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0251874	10.1371/journal.pone.0251874	http://dx.doi.org/10.1371/journal.pone.0251874			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PN	34048446	Green Published, gold			2022-12-26	WOS:000664636100018
J	Busingye, D; Pollack, A; Chidwick, K				Busingye, Doreen; Pollack, Allan; Chidwick, Kendal			Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study	PLOS ONE			English	Article							CROHNS-DISEASE; NEW-ZEALAND; INSIGHTS	The burden of inflammatory bowel disease (IBD) in Australia is increasing but national data about the current prevalence are limited. We aimed to estimate the prevalence of IBD (including Crohn's disease, ulcerative colitis and unspecified IBD) as well as Crohn's disease and ulcerative colitis separately in a general practice population in Australia. We also assessed risk factors associated with Crohn's disease and ulcerative colitis. We conducted a cross-sectional study using data from MedicineInsight, a national database of general practice electronic health records, from 1 July 2017 to 30 June 2019. The prevalence of IBD was calculated and stratified by sociodemographic characteristics. Logistic regression analysis was conducted to assess risk factors associated with Crohn's disease and ulcerative colitis. The study comprised 2,428,461 regular patients from 481 practices. The estimated crude prevalence of IBD was 653 per 100,000 patients; Crohn's disease was 306 per 100,000 and ulcerative colitis was 334 per 100,000. Males were independently associated with a lower risk of Crohn's disease (OR: 0.86; 95% CI: 0.81, 0.90) but a greater risk of ulcerative colitis (OR: 1.12; 95% CI: 1.06, 1.17) than females. Compared to non-smokers, patients who were current smokers were associated with a greater risk of Crohn's disease (OR: 1.13; 95% CI: 1.04, 1.23) but a lower risk of ulcerative colitis (OR: 0.52; 95% CI: 0.47, 0.57). Other factors positively associated with both Crohn's disease and ulcerative colitis were age (>= 25 years), non-Indigenous status and socioeconomic advantage. Our findings provide a current estimate of the prevalence of IBD, Crohn's disease and ulcerative colitis in a large national general practice population in Australia and an assessment of the factors associated with Crohn's disease and ulcerative colitis. These data can assist in estimating the health burden and costs, and planning for health services.	[Busingye, Doreen; Pollack, Allan; Chidwick, Kendal] NPS MedicineWise, Hlth Intelligence, Sydney, NSW, Australia		Busingye, D (corresponding author), NPS MedicineWise, Hlth Intelligence, Sydney, NSW, Australia.	dbusingye@nps.org.au		Chidwick, Kendal/0000-0003-4901-4182	Australian Government Department of Health for the MedicineInsight program; Australian Government Department of Health	Australian Government Department of Health for the MedicineInsight program; Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing)	NPS MedicineWise receives funding from the Australian Government Department of Health for the MedicineInsight program and the study was also funded by the Australian Government Department of Health. The Australian Government Department of Health did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatab S, 2020, LANCET GASTROENTEROL, V5, P17, DOI 10.1016/S2468-1253(19)30333-4; Australian Bureau of Statistics, 2018, NAT HLTH SURV 1 RES; Australian Bureau of Statistics, 2015, IND STAT STAND 2014; Australian Bureau of Statistics, 2018, AUSTR STAT GEOGR STA; Australian Bureau of Statistics, 2018, 31010 ABS; Australian Bureau of Statistics, 2018, SOCIO EC INDEXES ARE; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bhatia R, 2019, INTERN MED J, V49, P622, DOI 10.1111/imj.14111; Busingye D, 2019, INT J EPIDEMIOL, V48, P1741, DOI 10.1093/ije/dyz147; Cavanaugh JA, 2003, ANN HUM GENET, V67, P35, DOI 10.1046/j.1469-1809.2003.00006.x; Crohn's and Colitis Australia,, 2013, IMPR INFL BOW DIS CA; Deloitte Access economics, 2007, EC COSTS CROHNS DIS; Engel MA, 2010, J GASTROENTEROL, V45, P571, DOI 10.1007/s00535-010-0219-3; Gearry RB, 2006, GUT, V55, P580, DOI 10.1136/gut.2005.085464; Gearry RB, 2006, INFLAMM BOWEL DIS, V12, P936, DOI 10.1097/01.mib.0000231572.88806.b9; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Greuter T, 2020, DIGESTION, V101, P98, DOI 10.1159/000504701; Hein R, 2014, SCAND J GASTROENTERO, V49, P1325, DOI 10.3109/00365521.2014.962605; Jacobsen BA, 2006, EUR J GASTROEN HEPAT, V18, P601, DOI 10.1097/00042737-200606000-00005; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Ko Y, 2015, CLIN GASTROENTEROL H, V13, P1453, DOI 10.1016/j.cgh.2015.02.045; Krzywinski M, 2013, NAT METHODS, V10, P921, DOI 10.1038/nmeth.2659; Leach ST, 2014, J PAEDIATR CHILD H, V50, P328, DOI 10.1111/jpc.12535; NPS MedicineWise, 2019, US MED DAT MED DAT; NPS MedicineWise, 2020, GEN PRACT INS REP JU; Ooi CJ, 2016, J GASTROEN HEPATOL, V31, P45, DOI 10.1111/jgh.12956; Parkes GC, 2014, J CROHNS COLITIS, V8, P717, DOI 10.1016/j.crohns.2014.02.002; Pasvol TJ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036584; Studd C, 2016, J GASTROEN HEPATOL, V31, P81, DOI 10.1111/jgh.13050	29	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252458	10.1371/journal.pone.0252458	http://dx.doi.org/10.1371/journal.pone.0252458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043730	gold, Green Published			2022-12-26	WOS:000664635700104
J	Doidge, C; Lima, E; Lovatt, F; Hudson, C; Kaler, J				Doidge, Charlotte; Lima, Eliana; Lovatt, Fiona; Hudson, Chris; Kaler, Jasmeet			From the other perspective: Behavioural factors associated with UK sheep farmers' attitudes towards antibiotic use and antibiotic resistance	PLOS ONE			English	Article							COGNITIVE-DISSONANCE; ANTIMICROBIAL USE; DAIRY FARMERS; USAGE; LAMENESS; ABORTION; TRAVEL; HABIT; RISK	Research suggests that many sheep farmers continue to carry out traditional antibiotic use practices despite new 'good practice' recommendations. The aim of this study was to group farmers depending on their attitudes around antibiotic use and antibiotic resistance, and determine the behaviours that are associated with the farmers in these groups. In 2017, a flock health survey was sent to British sheep farmers. K-means cluster analysis was used to identify groups of farmers with similar attitudes towards antibiotic use and resistance. A multivariable logistic regression model was built to determine the associations between farmers' past behaviours and their antibiotic attitude group. There were 461 responses. Two groups of farmers were identified based on their antibiotic attitudes. Cluster 1 were defined as the "discordant" group who had positive views of using antibiotics prophylactically and negative views of reducing antibiotic use. Cluster 2 were defined as the "concordant" group who were positive about reducing antibiotic use and had negative views about using antibiotics prophylactically. Using antibiotics in all lambs (OR = 2.689, CI = 1.571, 4.603), using antibiotics in all ewes (OR = 3.388, CI = 1.318, 8.706), always trimming diseased feet over the past three years (OR = 2.487, CI = 1.459, 4.238), not using a computer to record information over the past three years (OR = 1.996, CI = 1.179, 3.381), not changing worming practices over the past three years (OR = 1.879, CI = 1.144, 3.087), and farmers' perceptions that their sheep flock did not make a financial loss in the past three years (OR = 2.088, CI = 1.079, 4.040) were significantly associated with belonging to the discordant group. Talking to their veterinarian about antibiotic use or the frequency of veterinary visits were not associated with antibiotic attitude group. These results suggest that farmers who had attitudes relating to antibiotic use that did not align with current recommendations carried out more traditional practices, which were strengthened by their positive perceptions of profitability.	[Doidge, Charlotte; Lima, Eliana; Lovatt, Fiona; Hudson, Chris; Kaler, Jasmeet] Univ Nottingham, Sch Vet Med & Sci, Sutton, Surrey, England	University of Nottingham	Kaler, J (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Sutton, Surrey, England.	jasmeet.kaler@nottingham.ac.uk	; Hudson, Chris/G-5561-2011	Doidge, Charlotte/0000-0003-1344-7808; Hudson, Chris/0000-0003-4777-062X	Agriculture and Horticulture Development Board [61110063]	Agriculture and Horticulture Development Board	CD was funded by the Agriculture and Horticulture Development Board (61110063) (website: https://ahdb.org.uk/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHDB, 2018, UK YB 2018 SHEEP; AHDB, RED LAMB LOSS BETT R; AHDB, MED HUB SHEEP CATTLE; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bem DJ, 1972, ADV EXPT SOCIAL PSYC, V6, P1, DOI DOI 10.1016/S0065-2601(08)60024-6; Best CM, 2020, PREV VET MED, V181, DOI 10.1016/j.prevetmed.2020.105064; Bourdieu P., 1997, ED CULTURE EC SOC, P46; Burton RJF, 2008, SOCIOL RURALIS, V48, P16, DOI 10.1111/j.1467-9523.2008.00452.x; Butler D, 2016, SOCIOL RURALIS, V56, P513, DOI 10.1111/soru.12103; Clements RH, 2014, VET REC, V175, P225, DOI 10.1136/vr.102161; Clifton R, 2020, J RURAL STUD, V74, P67, DOI 10.1016/j.jrurstud.2019.11.014; de Leeuw RNH, 2008, ADDICTION, V103, P1713, DOI 10.1111/j.1360-0443.2008.02293.x; De Vaus D, 2013, SURVEYS SOCIAL RES, V5th; De Vos J, 2020, TRANSPORT RES A-POL, V138, P525, DOI 10.1016/j.tra.2020.06.014; DEFRA, FARM STAT FIN LAND U; DEFRA, FARM BUS INC TYP FAR; DEFRA, 2014, SHEEP GOATS TYP COMB; Doidge C, 2021, PREV VET MED, V186, DOI 10.1016/j.prevetmed.2020.105226; Doidge C, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00524; Doidge C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213855; Dunn H, 2018, WESTERN J NURS RES, V40, P1658, DOI 10.1177/0193945917707705; Essig A, 2015, CURR CLIN MICROBIOL, V2, P22, DOI 10.1007/s40588-015-0014-2; Etienne J., 2017, EFSA Supporting Publications, V14, pEN, DOI 10.2903/sp.efsa.2017.en-1183; Festinger L., 1957, THEORY COGNITIVE DIS, Vxi; Gama H, 2009, PHARMACOEPIDEM DR S, V18, P175, DOI 10.1002/pds.1703; Gardner B., 2019, OXFORD RES ENCY PSYC, DOI [10.1093/acrefore/9780190236557.013.129, DOI 10.1093/ACREFORE/9780190236557.013.129]; Gardner B, 2019, BRIT J HEALTH PSYCH, V24, P241, DOI 10.1111/bjhp.12369; Goff DA, 2017, LANCET INFECT DIS, V17, pE56, DOI 10.1016/S1473-3099(16)30386-3; Gonzalez SM, 2010, PREV VET MED, V95, P50, DOI 10.1016/j.prevetmed.2010.03.004; Gorton M, 2008, J RURAL STUD, V24, P322, DOI 10.1016/j.jrurstud.2007.10.001; Green L, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00161; Guillem EE, 2012, J ENVIRON MANAGE, V110, P226, DOI 10.1016/j.jenvman.2012.06.020; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Harmon-Jones E, 2002, PERS SOC PSYCHOL B, V28, P711, DOI 10.1177/0146167202289001; Hidano A, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00137; Jager W., 2003, HUMAN DECISION MAKIN; Jermias J, 2001, ACCOUNT ORG SOC, V26, P141, DOI 10.1016/S0361-3682(00)00008-8; Jones Christopher R, 2019, Front Psychol, V10, P2701, DOI 10.3389/fpsyg.2019.02701; Jones PJ, 2015, PREV VET MED, V121, P30, DOI 10.1016/j.prevetmed.2015.05.010; Kaler J, 2010, J VET INTERN MED, V24, P420, DOI 10.1111/j.1939-1676.2009.0450.x; Kaler J, 2009, PREV VET MED, V92, P52, DOI 10.1016/j.prevetmed.2009.08.001; Kaler J, 2019, PREV VET MED, V170, DOI 10.1016/j.prevetmed.2019.104715; Kramer T, 2017, PREV VET MED, V147, P142, DOI 10.1016/j.prevetmed.2017.08.023; Kroesen M, 2017, TRANSPORT RES A-POL, V101, P190, DOI 10.1016/j.tra.2017.05.013; Kurz T, 2015, WIRES CLIM CHANGE, V6, P113, DOI 10.1002/wcc.327; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Learmount J, 2016, VET PARASITOL, V226, P116, DOI 10.1016/j.vetpar.2016.06.037; Lima E, 2019, ANIMAL, V13, P2630, DOI 10.1017/S1751731119001058; Lima E, 2020, PREV VET MED, V174, DOI 10.1016/j.prevetmed.2019.104851; Lokhorst AM, 2011, APPL PSYCHOL-INT REV, V60, P337, DOI 10.1111/j.1464-0597.2011.00438.x; Longbottom D, 2013, VET J, V195, P257, DOI 10.1016/j.tvjl.2012.06.018; McDougall S, 2017, NEW ZEAL VET J, V65, P84, DOI 10.1080/00480169.2016.1246214; O'Neill J., 2016, REV ANTIMICROBIAL RE; Olson M.A., 2008, ATTITUDES ATTITUDE C; Oyserman D, 2010, COUNS PSYCHOL, V38, P1001, DOI 10.1177/0011000010374775; Prosser NS, 2019, PREV VET MED, V173, DOI 10.1016/j.prevetmed.2019.104801; RCVS, COD PROF COND VET SU; Red Tractor Assurance, BEEF LAMB STAND 2020; Red Tractor Assurance, 2018, COD REC WELF LIV; Ritter C, 2017, J DAIRY SCI, V100, P3329, DOI 10.3168/jds.2016-11977; RUMA, TARG TASK FORC REP 2; *RUMA, 2019, COL IS GOLD; Scherpenzeel CGM, 2016, J DAIRY SCI, V99, P8259, DOI 10.3168/jds.2016-11349; Shortall O, 2018, SOCIOL RURALIS, V58, P583, DOI 10.1111/soru.12205; Stubbings L., 2012, TECHNICAL MANUAL VET; Swinkels JM, 2015, J DAIRY SCI, V98, P2369, DOI 10.3168/jds.2014-8488; van der Zwaluw CS, 2013, ADDICT BEHAV, V38, P2110, DOI 10.1016/j.addbeh.2013.01.012; van Dijk WFA, 2016, LAND USE POLICY, V59, P207, DOI 10.1016/j.landusepol.2016.09.003; van Rijn M, 2019, PUBLIC UNDERST SCI, V28, P486, DOI 10.1177/0963662518823701; Velde FV, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00255; VMD, UK VET ANT RES SAL S; VMD, UK VARSS 2019 SUPPL; Whitmarsh L., 2012, ENGAGING PUBLIC CLIM, DOI 10.4324/9781849775243; Winter JR, 2015, PREV VET MED, V122, P121, DOI 10.1016/j.prevetmed.2015.09.014	74	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251439	10.1371/journal.pone.0251439	http://dx.doi.org/10.1371/journal.pone.0251439			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043635	Green Published, gold			2022-12-26	WOS:000664635700021
J	Ke, Q; Liao, CC; Tan, XH; Guo, BP; Cen, H; Li, LQ				Ke, Qing; Liao, Cheng-Cheng; Tan, Xiao-Hong; Guo, Bao-Ping; Cen, Hong; Li, Le-Qun			Diagnostic accuracy of pelvic magnetic resonance imaging for the assessment of bone marrow involvement in diffuse large B-cell lymphoma	PLOS ONE			English	Article							WHOLE-BODY MRI; POSITRON-EMISSION-TOMOGRAPHY; COMPUTED TOMOGRAPHY; RESPONSE ASSESSMENT; HODGKIN-LYMPHOMA; FDG-PET/CT; PERFORMANCE; BIOPSY; PROVIDES; UTILITY	Purpose We investigated the efficacy of pelvic magnetic resonance imaging (MRI) in the diagnosis of bone marrow involvement (BMinv) in diffuse large B-cell lymphoma (DLBCL) patients. Patients and methods This was a retrospective study of data from a previous study (NCT02733887). We included 171 patients who underwent bone marrow biopsy (BMB) and bone marrow smear (BMS), pelvic MRI, and whole-body positron emission tomography-computed tomography (PET/CT) from January 2016 to December 2019 at a single center. BMB/BMS and whole-body PET/CT results were used as reference standards against which we calculated the diagnostic value of pelvic MRI for BMinv in DLBCL patients. A chi-square test was used to compare detection rates, and a receiver operating characteristic curve was used to evaluate diagnostic value of pelvic MRI. Propensity-score matching was performed according to clinical information, and Kaplan-Meier curves were constructed to compare progression-free survival (PFS) and overall survival (OS) of patients. Results The BMinv detection rate of pelvic MRI (42/171) was higher (P = 0.029) than that of BMB/BMS (25/171), and similar to that of PET/CT (44/171; P = 0.901). The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of pelvic MRI were 83.33%, 98.37%, 94.15%, 95.24%, and 93.80%, respectively. Median PFS values were as follows: BMB/BMS-positive, 17.8 months vs. BMB/BMS-negative, 26.9 months (P = 0.092); PET/CT-positive, 24.8 months vs. PET/CT-negative, 33.0 months (P = 0.086); pelvic MRI-positive, 24.9 months vs. pelvic MRI-negative, 33.1 months (P<0.001). Median OS values were as follows: BMB/BMS-positive, 22.3 months vs. BMB/BMS-negative, 29.8 months (P = 0.240); PET/CT-positive, 27.9 months vs. PET/CT-negative, 33.9 months (P = 0.365); pelvic MRI-positive, 27.3 months vs. pelvic MRI-negative, 35.8 months (P = 0.062). Conclusion Pelvic MRI is effective for detecting BMinv in DLBCL patients, providing a more accurate indication of PFS than BMB/BMS and PET/CT do. It may ultimately be used to improve the accuracy of clinical staging, guide patient treatment, and evaluate prognosis.	[Ke, Qing; Liao, Cheng-Cheng; Tan, Xiao-Hong; Guo, Bao-Ping; Cen, Hong] Guangxi Med Univ, Canc Hosp, Dept Hematol Oncol, Nanning, Peoples R China; [Li, Le-Qun] Guangxi Med Univ, Canc Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University	Cen, H (corresponding author), Guangxi Med Univ, Canc Hosp, Dept Hematol Oncol, Nanning, Peoples R China.; Li, LQ (corresponding author), Guangxi Med Univ, Canc Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China.	cenhong0771@163.com; lequnli1110@163.com			Guangxi Natural Science Foundation Program [2016GXNSFDA380029, 2018GXNSFBA281026, 14124003-4]; Fellowship of China Postdoctoral Science Foundation [2020M673555XB]; Self-financed Scientific Research Project of Guangxi Zhuang Autonomous Region Health and Family Planning Commission [Z2016504]; Guangxi Science and Technology Foundation [GK2013-13-B-01]	Guangxi Natural Science Foundation Program(National Natural Science Foundation of Guangxi Province); Fellowship of China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Self-financed Scientific Research Project of Guangxi Zhuang Autonomous Region Health and Family Planning Commission; Guangxi Science and Technology Foundation	This work was supported by grants from the Guangxi Natural Science Foundation Program (2016GXNSFDA380029, 2018GXNSFBA281026, and 14124003-4), Fellowship of China Postdoctoral Science Foundation (2020M673555XB),the Self-financed Scientific Research Project of Guangxi Zhuang Autonomous Region Health and Family Planning Commission (Z2016504) and the Guangxi Science and Technology Foundation (GK2013-13-B-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HJA, 2013, CLIN RADIOL, V68, P750, DOI 10.1016/j.crad.2013.01.022; Adams HJA, 2014, EUR J NUCL MED MOL I, V41, P565, DOI 10.1007/s00259-013-2623-4; Albano D, 2017, J MAGN RESON IMAGING, V45, P1082, DOI 10.1002/jmri.25439; Albano D, 2016, MAGN RESON IMAGING, V34, P922, DOI 10.1016/j.mri.2016.04.023; Albano D, 2016, EUR J RADIOL, V85, P313, DOI 10.1016/j.ejrad.2015.12.006; Alonso-Alvarez S, 2020, CANCERS, V12, DOI 10.3390/cancers12020474; [Anonymous], 2009, NEOPLASIA, V11, P102, DOI 10.1593/neo.81328; Armitage JO, 2017, LANCET, V390, P298, DOI 10.1016/S0140-6736(16)32407-2; Atkinson W, 2016, ABDOM RADIOL, V41, P1338, DOI 10.1007/s00261-016-0638-6; Avigdor A, 2013, BLOOD, V122, P4, DOI 10.1182/blood-2013-05-502575; Bachtiar V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214921; Badr S, 2018, CLIN NUCL MED, V43, pE428, DOI 10.1097/RLU.0000000000002315; Balbo-Mussetto A, 2017, RADIOL MED, V122, P623, DOI 10.1007/s11547-017-0762-6; Bane O, 2018, MAGN RESON MED, V79, P2564, DOI 10.1002/mrm.26903; Barrington SF, 2014, J CLIN ONCOL, V32, P3048, DOI 10.1200/JCO.2013.53.5229; Berthet L, 2013, J NUCL MED, V54, P1244, DOI 10.2967/jnumed.112.114710; Cheson BD, 2014, J CLIN ONCOL, V32, P3059, DOI 10.1200/JCO.2013.54.8800; Daldrup-Link HE, 2007, EUR RADIOL, V17, P743, DOI 10.1007/s00330-006-0404-1; Galia M, 2018, EUR RADIOL, V28, P1187, DOI 10.1007/s00330-017-5071-x; Hamilton R, 2014, LEUKEMIA LYMPHOMA, V55, P1049, DOI 10.3109/10428194.2013.821201; Ho DE, 2011, J STAT SOFTW, V42; Khan AB, 2013, BLOOD, V122, P61, DOI 10.1182/blood-2012-12-473389; Koh DM, 2012, AM J ROENTGENOL, V199, P252, DOI 10.2214/AJR.11.7866; Kwee TC, 2011, THESCIENTIFICWORLDJO, V11, P391, DOI 10.1100/tsw.2011.40; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; Munakata W, 2019, JPN J CLIN ONCOL, V49, P895, DOI 10.1093/jjco/hyz111; Muslimani AA, 2008, AM J CLIN ONCOL-CANC, V31, P409, DOI 10.1097/COC.0b013e318168d90b; Petralia G, 2018, MAGN RESON IMAGING C, V26, P495, DOI 10.1016/j.mric.2018.06.003; Ponisio MR, 2016, PEDIATR RADIOL, V46, P1258, DOI 10.1007/s00247-016-3601-3; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schaefer NG, 2007, EUR J NUCL MED MOL I, V34, P60, DOI 10.1007/s00259-006-0238-8; Sekine T, 2018, RADIOLOGY, V286, P249, DOI 10.1148/radiol.2017162305; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Sok M, 2019, SUPPORT CARE CANCER, V27, P3793, DOI 10.1007/s00520-018-4597-z; Sun MT, 2016, J MAGN RESON IMAGING, V44, P1522, DOI 10.1002/jmri.25300; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Tilly H, 2015, ANN ONCOL, V26, pV116, DOI 10.1093/annonc/mdv304; Wolach O, 2014, ACTA HAEMATOL-BASEL, V131, P239, DOI 10.1159/000354842; Yao Z, 2018, LEUKEMIA, V32, P353, DOI 10.1038/leu.2017.222	40	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252226	10.1371/journal.pone.0252226	http://dx.doi.org/10.1371/journal.pone.0252226			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043683	Green Published, gold			2022-12-26	WOS:000664635700074
J	Malamba, SS; Muyinda, H; Ogwang, DM; Katamba, A; Zamar, DS; Jongbloed, K; Sewankambo, NK; Schechter, MT; Spittal, PM				Malamba, Samuel S.; Muyinda, Herbert; Ogwang, D. Martin; Katamba, Achilles; Zamar, David S.; Jongbloed, Kate; Sewankambo, Nelson K.; Schechter, Martin T.; Spittal, Patricia M.			Cango Lyec (Healing the Elephant): Chronic Hepatitis B Virus among post-conflict affected populations living in mid-Northern Uganda	PLOS ONE			English	Article							HIV-INFECTION	Background The legacy of war in Northern Uganda continues to impact people's health and wellbeing in the Acholi region. Despite increasing attention to Hepatitis B Virus (HBV) in Uganda and globally, concerns remain that unique drivers of infection, and barriers to screening, and treatment, persist among those affected by conflict. Methods Cango Lyec (Healing the Elephant) cohort survey involved conflict-affected adults aged 13-49 in three mid-Northern Uganda districts (Gulu, Amuru and Nwoya). Baseline (2011-2012) samples were tested for HBV surface antigen (HBsAg), HBV e-antigen (HBeAg), antibodies to HBV surface antigen (HBsAb), antibodies to HBV e-antigen (HBeAb), and antibodies to HBV core antigen (HBcAb). All HBsAg positive samples were tested for IgM antibodies to HBV B core antigen (HBc-IgM) and where available, >6-month follow-up samples were tested for HBeAg and HBV DNA. Data were analyzed using STATA 15 software. Logistic regression accounted for variance due to complex two-stage sampling that included stratification, unequal selection probabilities and community clustering. Odds ratios measured effect potential risk factors associated with chronic HBV infection. Results Among 2,421 participants, 45.7% were still susceptible to HBV infection. HBsAg seropositivity was 11.9% (10.9-13.0), chronic HBV was 11.6% (10.4-12.8), acquired immunity resulting from vaccination was 10.9%, and prior natural infection was 31.5%. Older age (OR:0.570; 95%CI:0.368-0.883) and higher education (OR:0.598; 95%CI:0.412-0.868) were associated with reduced odds of chronic HBV infection. Being male (OR:1.639; 95%CI:1.007-2.669) and having been abducted (OR:1.461; 95%CI:1.055-2.023) were associated with increased odds of infection. Among women, having 1 or 2 pregnancies (compared to none or >2) was associated with increased odds of infection (OR:1.764; 95%CI:1.009-3.084). Conclusion Chronic HBV is endemic in Gulu, Amuru and Nwoya districts. Recommended strategies to reduce post-conflict prevalence include establishment of Northern Uganda Liver Wellness Centres, integration of screening and treatment into antenatal care, and roll out of birth-dose vaccination.	[Malamba, Samuel S.] Uganda Virus Res Inst UVRI, HIV Reference Lab Program, Entebbe, Uganda; [Muyinda, Herbert] Makerere Univ, Child Hlth Dev Ctr, Kampala, Uganda; [Ogwang, D. Martin] St Marys Hospital Lacor, Gulu, Uganda; [Ogwang, D. Martin] Northern Uganda Program Hlth Sci, Gulu, Uganda; [Katamba, Achilles; Sewankambo, Nelson K.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Zamar, David S.; Jongbloed, Kate; Schechter, Martin T.; Spittal, Patricia M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Zamar, David S.; Spittal, Patricia M.] BC Childrens Hosp Res Inst, Vancouver, BC, Canada	Makerere University; Makerere University; University of British Columbia	Spittal, PM (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.; Spittal, PM (corresponding author), BC Childrens Hosp Res Inst, Vancouver, BC, Canada.	patricia.spittal@ubc.ca		Jongbloed, Kate/0000-0001-9903-5630	Canadian Institutes for Health Research Operating Grant [106621]	Canadian Institutes for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	The Cango Lyec Project was funded through a Canadian Institutes for Health Research Operating Grant (106621). https://cihr-irsc.gc.ca/e/193.html The funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Bayo P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005889; Bigna JJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015298; Bwogi J, 2009, AFR HEALTH SCI, V9, P98; Carlson C., 2004, CASE STUDY 6 REV HLT; Chiesa A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242278; Gatanaga H, 2013, CLIN INFECT DIS, V56, P1812, DOI 10.1093/cid/cit145; Hepatitis DoV Centers for Disease Control and Prevention, INT HEP B SER TEST R; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Katamba A, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100408; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Malamba SS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2030-0; McNaughton AL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003068; Nankya-Mutyoba J., 2019, BMC HEALTH SERV RES, V19, P1, DOI [10.1186/s12913-018-3827-x, DOI 10.1186/S12913-018-3827-X]; Ochola E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-727; Ogwang DM., 2019, CONVERSATION P SPITT; Okongo F, 2019, INT J CANCER, V144, P2985, DOI 10.1002/ijc.32053; Opendi S, 2018, WORLD HEPATITIS DAY; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Spearman CW, 2017, LANCET GASTROENTEROL, V2, P900, DOI 10.1016/S2468-1253(17)30295-9; Spittal PM, 2018, JAIDS-J ACQ IMM DEF, V78, P257, DOI 10.1097/QAI.0000000000001671; Stabinski L, 2011, ANTIVIR THER, V16, P405, DOI 10.3851/IMP1783; Streiner DL, 2015, AM J CLIN NUTR, V102, P721, DOI 10.3945/ajcn.115.113548; Uganda Ministry of Health, 2019, UG POP BAS HIV IMP A; Uganda National Expanded Program on Immunisation (UNEPI), IMM GUID UNEPI; World Health Organization (WHO), GLOB HLTH SECT STRAT	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251573	10.1371/journal.pone.0251573	http://dx.doi.org/10.1371/journal.pone.0251573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043637	Green Published, gold			2022-12-26	WOS:000664635700027
J	McKay, JL; Lang, KC; Bong, SM; Hackney, ME; Factor, SA; Ting, LH				McKay, J. Lucas; Lang, Kimberly C.; Bong, Sistania M.; Hackney, Madeleine E.; Factor, Stewart A.; Ting, Lena H.			Abnormal center of mass feedback responses during balance: A potential biomarker of falls in Parkinson's disease	PLOS ONE			English	Article							MONTREAL COGNITIVE ASSESSMENT; DANCE-BASED REHABILITATION; MUSCLE-ACTIVITY; RATING-SCALE; STRETCH REFLEXES; MINI-BESTEST; GAIT; ACCELERATION; RELIABILITY; INDIVIDUALS	Although Parkinson disease (PD) causes profound balance impairments, we know very little about how PD impacts the sensorimotor networks we rely on for automatically maintaining balance control. In young healthy people and animals, muscles are activated in a precise temporal and spatial organization when the center of body mass (CoM) is unexpectedly moved that is largely automatic and determined by feedback of CoM motion. Here, we show that PD alters the sensitivity of the sensorimotor feedback transformation. Importantly, sensorimotor feedback transformations for balance in PD remain temporally precise, but become spatially diffuse by recruiting additional muscle activity in antagonist muscles during balance responses. The abnormal antagonist muscle activity remains precisely time-locked to sensorimotor feedback signals encoding undesirable motion of the body in space. Further, among people with PD, the sensitivity of abnormal antagonist muscle activity to CoM motion varies directly with the number of recent falls. Our work shows that in people with PD, sensorimotor feedback transformations for balance are intact but disinhibited in antagonist muscles, likely contributing to balance deficits and falls.	[McKay, J. Lucas; Ting, Lena H.] Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA 30322 USA; [McKay, J. Lucas; Factor, Stewart A.] Emory Univ, Sch Med, Dept Neurol, Jean & Paul Amos PD & Movement Disorders Program, Atlanta, GA 30322 USA; [McKay, J. Lucas; Bong, Sistania M.] Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA; [McKay, J. Lucas; Bong, Sistania M.] Georgia Tech, Atlanta, GA 30332 USA; [Lang, Kimberly C.] Emory Univ, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Hackney, Madeleine E.] Emory Univ, Sch Med, Dept Med, Div Gen Med & Geriatr, Atlanta, GA USA; [Hackney, Madeleine E.] Atlanta VA Med Ctr, Rehabil R&D Ctr, Decatur, GA USA; [Ting, Lena H.] Emory Univ, Div Phys Therapy, Dept Rehabil Med, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; Emory University	McKay, JL (corresponding author), Emory Univ, Sch Med, Dept Biomed Informat, Atlanta, GA 30322 USA.; McKay, JL (corresponding author), Emory Univ, Sch Med, Dept Neurol, Jean & Paul Amos PD & Movement Disorders Program, Atlanta, GA 30322 USA.; McKay, JL (corresponding author), Emory Univ, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30322 USA.; McKay, JL (corresponding author), Georgia Tech, Atlanta, GA 30332 USA.	lucas@dbmi.emory.edu		Hackney, Madeleine/0000-0003-1833-0051	National Institutes of Health [K25HD086276, R01HD046922, R21HD075612, UL1TR002378, UL1TR000454]; Department of Veterans Affairs R&D Service Career Development Awards [E7108M, N0870W]; Consolidated Anti-Aging Foundation; APDA center for Advanced Research at Emory University; Sartain Lanier Family Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs R&D Service Career Development Awards; Consolidated Anti-Aging Foundation; APDA center for Advanced Research at Emory University; Sartain Lanier Family Foundation	This study was supported in part by National Institutes of Health grants K25HD086276, R01HD046922, R21HD075612, UL1TR002378, UL1TR000454; Department of Veterans Affairs R&D Service Career Development Awards E7108M and N0870W, The Consolidated Anti-Aging Foundation, the APDA center for Advanced Research at Emory University, and the Sartain Lanier Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JL, 2017, J NEUROPHYSIOL, V118, P363, DOI 10.1152/jn.00813.2016; ANGEL RW, 1978, J NEUROL NEUROSUR PS, V41, P919, DOI 10.1136/jnnp.41.10.919; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Bloem BR, 2001, J NEUROL, V248, P950, DOI 10.1007/s004150170047; BLOXHAM CA, 1987, J NEUROL NEUROSUR PS, V50, P1178, DOI 10.1136/jnnp.50.9.1178; Blum KP, 2020, ELIFE, V9, DOI 10.7554/eLife.55177; Blum KP, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005767; Bohnen NI, 2009, NEUROLOGY, V73, P1670, DOI 10.1212/WNL.0b013e3181c1ded6; Bohnen NI, 2019, ANN NEUROL, V85, P538, DOI 10.1002/ana.25430; Bong SM, 2020, GAIT POSTURE, V76, P44, DOI 10.1016/j.gaitpost.2019.10.029; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Carpenter MG, 2004, J NEUROPHYSIOL, V92, P3255, DOI 10.1152/jn.01139.2003; Carpenter MG, 2004, J NEUROL NEUROSUR PS, V75, P1245, DOI 10.1136/jnnp.2003.021147; Chvatal SA, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00048; CLARK RD, 1993, GERONTOLOGY, V39, P117; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CRONE C, 1994, ACTA PHYSIOL SCAND, V152, P351, DOI 10.1111/j.1748-1716.1994.tb09817.x; Curtze C, 2015, MOVEMENT DISORD, V30, P1361, DOI 10.1002/mds.26269; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dimitrova D, 2004, J NEUROPHYSIOL, V91, P489, DOI 10.1152/jn.00094.2003; Drucker JH, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00537; Duncan RP, 2013, PHYS THER, V93, P542, DOI 10.2522/ptj.20120302; Duncan RP, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/237673; EVARTS EV, 1981, BRAIN, V104, P167, DOI 10.1093/brain/104.1.167; Finley JM, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.51; Foreman KB, 2011, PARKINSONISM RELAT D, V17, P166, DOI 10.1016/j.parkreldis.2010.12.007; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Getz EB, 1998, BIOPHYS J, V75, P2971, DOI 10.1016/S0006-3495(98)77738-0; Giladi N, 2000, PARKINSONISM RELAT D, V6, P165, DOI 10.1016/S1353-8020(99)00062-0; Gill DP, 2009, ANN EPIDEMIOL, V19, P523, DOI 10.1016/j.annepidem.2009.03.012; Godi M, 2013, PHYS THER, V93, P158, DOI 10.2522/ptj.20120171; Goetz CG, 2012, MOVEMENT DISORD, V27, P1239, DOI 10.1002/mds.25122; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; HALLETT M, 1980, BRAIN, V103, P301, DOI 10.1093/brain/103.2.301; HENATSCH HD, 1971, B SCHWEIZ AKAD MED, V27, P266; HOLM S, 1979, SCAND J STAT, V6, P65; Honeycutt C., 2009, MECH UNDERLYING MUSC; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Horak FB, 1996, J NEUROPHYSIOL, V75, P2380, DOI 10.1152/jn.1996.75.6.2380; Hornykiewicz O, 1987, Adv Neurol, V45, P19; Horslen BC, 2013, J NEUROPHYSIOL, V110, P899, DOI 10.1152/jn.00065.2013; Hoskovcova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139849; Islam A, 2020, NPJ PARKINSONS DIS, V6, DOI 10.1038/s41531-020-00119-w; Ivanenko Y, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00171; Kesar TM, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/5190671; Kwon DY, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/848035; Lang KC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211137; Langley J, 2017, MOVEMENT DISORD, V32, P441, DOI 10.1002/mds.26883; Lockhart DB, 2007, NAT NEUROSCI, V10, P1329, DOI 10.1038/nn1986; MACKEL R, 1992, J NEUROPHYSIOL, V67, P132, DOI 10.1152/jn.1992.67.1.132; MACPHERSON JM, 1988, J NEUROPHYSIOL, V60, P218, DOI 10.1152/jn.1988.60.1.218; Macpherson JM, 2013, PRINCIPLES NEURAL SC, P935; Manckoundia P, 2008, CLIN INTERV AGING, V3, P667; McKay JL, 2019, NPJ PARKINSON DIS, V5, DOI 10.1038/s41531-019-0099-z; McKay JL, 2019, MOV DISORD CLIN PRAC, V6, P446, DOI 10.1002/mdc3.12784; Mckay JL, 2018, GAIT POSTURE, V62, P220, DOI 10.1016/j.gaitpost.2018.02.027; McKay JL, 2016, J NEUROL PHYS THER, V40, P257, DOI 10.1097/NPT.0000000000000150; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nazem S, 2009, J AM GERIATR SOC, V57, P304, DOI 10.1111/j.1532-5415.2008.02096.x; Park JH, 2015, J MOV DISORD, V8, P109, DOI 10.14802/jmd.15018; Pasquereau B, 2016, BRAIN, V139, P127, DOI 10.1093/brain/awv312; Petersen N, 1998, J PHYSIOL-LONDON, V512, P267, DOI 10.1111/j.1469-7793.1998.267bf.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445; Safavynia SA, 2013, J NEUROPHYSIOL, V110, P1278, DOI 10.1152/jn.00609.2012; Schlenstedt C, 2016, PHYS THER, V96, P494, DOI 10.2522/ptj.20150249; Seki K, 2012, J NEUROSCI, V32, P890, DOI 10.1523/JNEUROSCI.4958-11.2012; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Simpson CS, 2015, J BIOMECH, V48, P2990, DOI 10.1016/j.jbiomech.2015.07.037; Simpson LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019431; Snijders AH, 2016, ANN NEUROL, V80, P644, DOI 10.1002/ana.24778; Sohn MH, 2013, J BIOMECH, V46, P1363, DOI 10.1016/j.jbiomech.2013.01.020; St George RJ, 2012, J NEUROSURG, V116, P1347, DOI 10.3171/2012.2.JNS11847; Stack E, 1999, Physiother Res Int, V4, P190, DOI 10.1002/pri.165; Stebbins GT, 2013, MOVEMENT DISORD, V28, P668, DOI 10.1002/mds.25383; Ting LH, 2004, J NEUROPHYSIOL, V92, P808, DOI 10.1152/jn.00773.2003; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Ullah S, 2010, ACCIDENT ANAL PREV, V42, P384, DOI 10.1016/j.aap.2009.08.018; Weaver TB, 2016, J AM GERIATR SOC, V64, P96, DOI 10.1111/jgs.13878; Welch TDJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096440; Welch TDJ, 2009, J NEUROPHYSIOL, V101, P3294, DOI 10.1152/jn.90775.2008; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Willard AM, 2015, NEUROSCIENCE, V301, P254, DOI 10.1016/j.neuroscience.2015.05.068; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Zaback M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48722-z	87	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252119	10.1371/journal.pone.0252119	http://dx.doi.org/10.1371/journal.pone.0252119			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043678	Green Published, gold			2022-12-26	WOS:000664635700054
J	Trefzer, R; Elpeleg, O; Gabrusskaya, T; Stepensky, P; Mor-Shaked, H; Grosse, R; Brandt, DT				Trefzer, Raphael; Elpeleg, Orly; Gabrusskaya, Tatyana; Stepensky, Polina; Mor-Shaked, Hagar; Grosse, Robert; Brandt, Dominique T.			Characterization of a L136P mutation in Formin-like 2 (FMNL2) from a patient with chronic inflammatory bowel disease	PLOS ONE			English	Article							DOWNSTREAM; MACROPHAGES; ASSOCIATION; ACTIVATION; MIGRATION; FILOPODIA; MOTILITY; LOCI	Diaphanous related formins are highly conserved proteins regulated by Rho-GTPases that act as actin nucleation and assembly factors. Here we report the functional characterization of a non-inherited heterozygous FMNL2 p.L136P mutation carried by a patient who presented with severe very early onset inflammatory bowel disease (IBD). We found that the FMNL2 L136P protein displayed subcellular mislocalization and deregulated protein autoinhibition indicating gain-of-function mechanism. Expression of FMNL2 L136P impaired cell spreading as well as filopodia formation. THP-1 macrophages expressing FMNL2 L136P revealed dysregulated podosome formation and a defect in matrix degradation. Our data indicate that the L136P mutation affects cellular actin dynamics in fibroblasts and immune cells such as macrophages.	[Trefzer, Raphael; Grosse, Robert; Brandt, Dominique T.] Univ Marburg, Inst Pharmacol, Marburg, Germany; [Elpeleg, Orly] Hadassah Hebrew Univ Med Ctr, Dept Genet, Jerusalem, Israel; [Gabrusskaya, Tatyana] St Petersburg State Pediat Med Univ, Dept Gastroenterol, St Petersburg, Russia; [Stepensky, Polina] Hadassah Hebrew Univ Med Ctr, Dept Bone Marrow Transplantat & Canc Immunotherap, Jerusalem, Israel; [Mor-Shaked, Hagar] Hadassah Hebrew Univ Med Ctr, Dept Genet, Jerusalem, Israel; [Grosse, Robert] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Freiburg, Germany	Philipps University Marburg; Hebrew University of Jerusalem; Saint Petersburg State Pediatric Medical University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Freiburg	Brandt, DT (corresponding author), Univ Marburg, Inst Pharmacol, Marburg, Germany.	brandtd@staff.uni-marburg.de		Trefzer, Raphael/0000-0003-3687-9830	Deutsche Forschungsgemeinschaft [GR 2111/8-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	this work was supported by the Deutsche Forschungsgemeinschaft"(GR 2111/8-1 to R.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applewhite DA, 2007, MOL BIOL CELL, V18, P2579, DOI 10.1091/mbc.e06-11-0990; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Block J, 2012, CURR BIOL, V22, P1005, DOI 10.1016/j.cub.2012.03.064; Boyer O, 2011, NEW ENGL J MED, V365, P2377, DOI 10.1056/NEJMoa1109122; Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058; Davies JM, 2015, SCAND J GASTROENTERO, V50, P24, DOI 10.3109/00365521.2014.966321; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gardberg M, 2016, J PATHOL CLIN RES, V2, P41, DOI 10.1002/cjp2.34; Gardberg M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-55; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Graham DB, 2020, NATURE, V578, P527, DOI 10.1038/s41586-020-2025-2; Gren ST, 2016, INFLAMM BOWEL DIS, V22, P1992, DOI 10.1097/MIB.0000000000000824; Grikscheit K, 2015, J CELL BIOL, V209, P367, DOI 10.1083/jcb.201412015; Grobe H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194716; GUZZO AV, 1965, BIOPHYS J, V5, P809, DOI 10.1016/S0006-3495(65)86753-4; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang HL, 2017, NATURE, V547, P173, DOI 10.1038/nature22969; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Jiang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13875; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kuhn S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8088; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Lund ME, 2016, J IMMUNOL METHODS, V430, P64, DOI 10.1016/j.jim.2016.01.012; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Mersich AT, 2010, CYTOSKELETON, V67, P573, DOI 10.1002/cm.20468; Momozawa Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04365-8; Moriya K, 2012, BIOSCI BIOTECH BIOCH, V76, P1201, DOI 10.1271/bbb.120069; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Panzer L, 2016, J CELL SCI, V129, P298, DOI 10.1242/jcs.177691; Ren XL, 2018, CANCER LETT, V419, P245, DOI 10.1016/j.canlet.2018.01.023; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Starnes TW, 2011, METHODS MOL BIOL, V769, P111, DOI 10.1007/978-1-61779-207-6_9; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; van den Dries K, 2019, J CELL SCI, V132, DOI 10.1242/jcs.236828; Wang Y, 2015, DEV CELL, V34, P475, DOI 10.1016/j.devcel.2015.06.015; Wong S, 2014, P NATL ACAD SCI USA, V111, P17176, DOI 10.1073/pnas.1412285111; Zhu XL, 2008, INT J COLORECTAL DIS, V23, P1041, DOI 10.1007/s00384-008-0520-2	44	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252428	10.1371/journal.pone.0252428	http://dx.doi.org/10.1371/journal.pone.0252428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043722	gold, Green Published			2022-12-26	WOS:000664635700099
J	Zhang, J; Wang, XJ; Wu, LJ; Yang, L; Yang, YT; Zhang, D; Hong, J; Li, XY; Dong, XQ; Guo, XC; Han, R; Ma, XP				Zhang, Ji; Wang, Xue-jun; Wu, Li-jie; Yang, Ling; Yang, Yan-ting; Zhang, Dan; Hong, Jue; Li, Xi-ying; Dong, Xiao-qing; Guo, Xiao-cong; Han, Rong; Ma, Xiaopeng			Herb-partitioned moxibustion alleviates colonic inflammation in Crohn's disease rats by inhibiting hyperactivation of the NLRP3 inflammasome via regulation of the P2X7R-Pannexin-1 signaling pathway	PLOS ONE			English	Article							NF-KAPPA-B; P2X7 RECEPTOR; PANNEXIN-1 CHANNELS; ULCERATIVE-COLITIS; A20 EXPRESSION; MOUSE MODEL; CELLS; ACTIVATION; BLOCKADE	Crohn's disease is a chronic inflammatory bowel disease and the NLRP3 inflammasome plays an important role in Crohn's disease. Previous studies have shown that Herb-partitioned moxibustion treating (at Qihai (CV 6) and Tianshu (ST 25)) prevented the excessive activation of the NLRP3 inflammasome and repaired damaged colonic mucosa in Crohn's disease. However, the mechanism by which Herb-partitioned moxibustion (at CV 6 and ST 25) regulates NLRP3 remains unclear. In this study, we treated Crohn's disease rats with herb-partitioned moxibustion (at CV 6 and ST 25) to investigate the mechanism by which Herb-partitioned moxibustion regulates the colonic NLRP3 inflammasome by observing colon length, the colon macroscopic damage indexes, and the expression of ATP, P2X7R, Pannexin-1, NF-kappa Bp65, NLRP3, ASC, caspase-1, IL-1 beta and IL-18 in the colon in Crohn's disease. Here, this study shows that herb-partitioned moxibustion (at CV 6 and ST 25) can reduce colon macroscopic damage indexes and colon histopathological scores, alleviate colon shortening and block the abnormal activation of the NLRP3 inflammasome by inhibiting the ATP content and the expression of P2X7R, Pannexin-1 and NF-kappa Bp65, thereby reducing the release of the downstream inflammatory cytokine IL-1 beta and ultimately suppressing colonic inflammation in Crohn's disease rats. This study for the first time identifies the mechanism by which herb-partitioned moxibustion (at CV 6 and ST 25) may inhibit the abnormal activation of the NLRP3 inflammasome by inhibiting the P2X7R-Pannexin-1 signaling pathway in Crohn's disease rats.	[Zhang, Ji; Wang, Xue-jun; Wu, Li-jie; Li, Xi-ying; Dong, Xiao-qing; Guo, Xiao-cong; Han, Rong; Ma, Xiaopeng] Shanghai Univ Tradit Chinese Med, Yueyang Clin Med Sch, Shanghai, Peoples R China; [Wu, Li-jie] Zhejiang Prov Hosp Tradit Chinese Med, Acupuncture & Moxibust Dept, Hangzhou, Zhejiang, Peoples R China; [Yang, Ling; Yang, Yan-ting; Zhang, Dan; Hong, Jue; Ma, Xiaopeng] Shanghai Univ Tradit Chinese Med, Key Lab Acupuncture Moxibust & Immunol, Shanghai Res Inst Acupuncture & Meridian, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Zhejiang Chinese Medical University; Shanghai University of Traditional Chinese Medicine	Ma, XP (corresponding author), Shanghai Univ Tradit Chinese Med, Yueyang Clin Med Sch, Shanghai, Peoples R China.; Ma, XP (corresponding author), Shanghai Univ Tradit Chinese Med, Key Lab Acupuncture Moxibust & Immunol, Shanghai Res Inst Acupuncture & Meridian, Shanghai, Peoples R China.	pengpengma@163.com		ma, xiaopeng/0000-0002-9532-4870	National Natural Science Foundation of China [81674073, 81273843]; Natural Science Foundation of Shanghai [20ZR1453000]; Training Project for Outstanding Discipline Leaders of Shanghai Municipal Commission of Health and Family Planning [2017BR047]; National Key Basic Research Program of China (973 Program) [2015CB554501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Training Project for Outstanding Discipline Leaders of Shanghai Municipal Commission of Health and Family Planning; National Key Basic Research Program of China (973 Program)(National Basic Research Program of China)	This research was supported by the National Natural Science Foundation of China, No. 81674073 and 81273843, Natural Science Foundation of Shanghai, No. 20ZR1453000, Training Project for Outstanding Discipline Leaders of Shanghai Municipal Commission of Health and Family Planning, No. 2017BR047 and National Key Basic Research Program of China (973 Program), No. 2015CB554501.	Adinolfi E, 2018, BIOCHEM PHARMACOL, V151, P234, DOI 10.1016/j.bcp.2017.12.021; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Argollo M, 2019, CURR DRUG TARGETS, V20, P1327, DOI 10.2174/1389450120666190320110809; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Cheifetz AS, 2013, JAMA-J AM MED ASSOC, V309, P2150, DOI 10.1001/jama.2013.4466; Ciccocioppo R, 2019, JGH OPEN, V3, P249, DOI 10.1002/jgh3.12141; Dassopoulos T, 2012, GASTROENTEROL CLIN N, V41, P393, DOI 10.1016/j.gtc.2012.01.004; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Diezmos EF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00865; Diezmos EF, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00311; Dotlacil V, 2020, EUR J PEDIATR SURG, V30, P27, DOI 10.1055/s-0039-1697909; Elia PP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/936193; Ferrero Maria E, 2009, Recent Pat Antiinfect Drug Discov, V4, P108; Gajendran M, 2018, DM-DIS MON, V64, P20, DOI 10.1016/j.disamonth.2017.07.001; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Han CL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1139-z; Inami A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082371; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kirchgesner J, 2018, GASTROENTEROLOGY, V155, P337, DOI 10.1053/j.gastro.2018.04.012; Kirk RGW, 2018, SCI TECHNOL HUM VAL, V43, P622, DOI 10.1177/0162243917726579; Korcok J, 2004, J BONE MINER RES, V19, P642, DOI 10.1359/JBMR.040108; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lazaridis LD, 2017, DIGEST DIS SCI, V62, P2348, DOI 10.1007/s10620-017-4609-8; Li Shuang, 2019, Zhongguo Zhong Yao Za Zhi, V44, P2433, DOI 10.19540/j.cnki.cjcmm.20190221.004; Li YQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15836-2; Lightner Amy L, 2019, Curr Gastroenterol Rep, V21, P16, DOI 10.1007/s11894-019-0672-y; Lim KH, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03035-2; Liu YH, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00084; Mao LM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02566; Mao LM, 2018, J CLIN INVEST, V128, P1793, DOI 10.1172/JCI98642; Marques CC, 2014, BBA-MOL BASIS DIS, V1842, P65, DOI 10.1016/j.bbadis.2013.10.012; Mehta N, 2014, BIOORGAN MED CHEM, V22, P54, DOI 10.1016/j.bmc.2013.10.054; Mehto S, 2019, MOL CELL, V73, P429, DOI 10.1016/j.molcel.2018.11.018; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Mousseau M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aas9846; Nakao S, 2017, J ANUS RECTUM COLON, V1, P56, DOI 10.23922/jarc.2016-006; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Ozen M, 2020, PEDIATR RES, V87, P463, DOI 10.1038/s41390-019-0557-7; Pellegatti P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002599; Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045; Silva PARE, 2021, CLIN SCI, V135, P687, DOI 10.1042/CS20201419; Shen XY, 2006, COMPLEMENT THER MED, V14, P213, DOI 10.1016/j.ctim.2005.09.003; Shi Y., 2003, JIANGXI J TCM, V34, P16; Shi Y., 2011, SHANGHAI J TCM, V45, P45; Shi Y, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109149; Shteingart S, 2009, GUT, V58, P790, DOI 10.1136/gut.2008.153981; Sun Yi, 2019, Zhen Ci Yan Jiu, V44, P1, DOI 10.13702/j.1000-0607.180512; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Tourkochristou E, 2019, WORLD J GASTROENTERO, V25, P4796, DOI 10.3748/wjg.v25.i33.4796; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1982, DOI 10.1097/MIB.0000000000000392; WALLACE JL, 1992, GASTROENTEROLOGY, V102, P18, DOI 10.1016/0016-5085(92)91779-4; Wang Hong-Yun, 2014, Zhong Yao Cai, V37, P1391; Wang XM, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/949065; Wilhelm K, 2010, NAT MED, V16, P1434, DOI 10.1038/nm.2242; Wu LY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00175; Xu J, 2018, J CELL PHYSIOL, V233, P2075, DOI 10.1002/jcp.25906; Yao YK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15402; Yu Y, 2019, CYTOKINE, V119, P175, DOI 10.1016/j.cyto.2019.03.019; Zhang Chuan-Ying, 2018, Zhen Ci Yan Jiu, V43, P687, DOI 10.13702/j.1000-0607.180229; Zhang D, 2018, WORLD J GASTROENTERO, V24, P3384, DOI 10.3748/wjg.v24.i30.3384; Zhang J, 2019, SHANGHAI ZHEN JIU ZA, V38, P119, DOI DOI 10.3969/j.issn.1004-5589.2019.01.011; Zhao JM, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3405146; Zhou J, 2019, WORLD J GASTROENTERO, V25, P2071, DOI 10.3748/wjg.v25.i17.2071; Zhou JT, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/7956274	66	2	2	10	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252334	10.1371/journal.pone.0252334	http://dx.doi.org/10.1371/journal.pone.0252334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043726	gold, Green Published			2022-12-26	WOS:000664635700089
J	Wu, H; Eungpinichpong, W; Ruan, H; Zhang, XD; Dong, XJ				Wu, Hua; Eungpinichpong, Wichai; Ruan, Hui; Zhang, Xinding; Dong, Xiujuan			Relationship between motor fitness, fundamental movement skills, and quality of movement patterns in primary school children	PLOS ONE			English	Article							2016 PHYSICAL-ACTIVITY; HEALTH-RELATED FITNESS; FUNCTIONAL MOVEMENT; PROFICIENCY BARRIER; WEIGHT STATUS; COMPETENCE; PREVALENCE; AGE; INTERVENTIONS; ADOLESCENTS	Seefeldt`s classic motor development pyramid model recognizes the significance of fundamental movement skills (FMS) in physical activities and proposes a "proficiency barrier" between FMS and higher-level specific sports skills during middle childhood. However, the relationship between the layers of the conceptual model has not been empirically tested. This study investigated motor fitness (MF), FMS, and quality of movement patterns (QMP) in 7-10 years old children and evaluated the relationships among them. A total of 117 children were randomly selected to take tests of MF, the Test of Gross Motor Development-2 (TGMD-2), and the Functional Movement Screen (FMS (TM)). MF and FMS levels were classified according to percentile ranges. Two multiple (RxC) Chi-Square tests were applied to analyze the relationships between MF, FMS, and QMP. Post-hoc testing estimated the possibility of FMS and QMP to predict MF. The results showed that boys scored significantly higher on the object-control subtest and on the TGMD-2 compared to girls (p<0.001), while girls scored significantly higher on the FMS<(TM)> (p = 0.001). FMS score and QMP level were weakly correlated with MF (FMS: chi (2) = 14.605, p = 0.006, Cramer`s V = 0.25; QMP: chi (2) = 13.943, p = 0.007, Cramer`s V = 0.24). Thus, 60.5% of children with "excellent" FMS and 59.6% with "high" QMP were categorized as having a "good" MF. In contrast, only 23.1% of children with "poor" FMS and 24.3% with "low" QMP were classified as having a "good" MF. Our results confirm MF, FMS, and QMP are correlated with each other, although this relationship is weak. Further, a possible motor skill proficiency barrier exists already in children 7-10 years old. The study results support the promotion of physical activity and motor skill development in primary school children.	[Wu, Hua; Eungpinichpong, Wichai] Khon Kaen Univ, Fac Associated Med Sci, Khon Kaen, Thailand; [Wu, Hua; Ruan, Hui; Zhang, Xinding; Dong, Xiujuan] Hainan Normal Univ, Fac Phys Educ, Haikou, Hainan, Peoples R China; [Eungpinichpong, Wichai] Khon Kaen Univ, Fac Associated Med Sci, BNOJHP Res Ctr, PT Div Phys Therapy, Khon Kaen, Thailand	Khon Kaen University; Hainan Normal University; Khon Kaen University	Eungpinichpong, W (corresponding author), Khon Kaen Univ, Fac Associated Med Sci, BNOJHP Res Ctr, PT Div Phys Therapy, Khon Kaen, Thailand.	wiceun@gmail.com	Eungpinichpong, Wichai/C-6039-2015	Eungpinichpong, Wichai/0000-0001-7014-1448; Wu, hua/0000-0002-0966-3068	national office for philosophy and social sciences [16BTY058]	national office for philosophy and social sciences	The study was supported by national office for philosophy and social sciences (16BTY058).	[Anonymous], 2014, CHINESE NATL STUDENT; Barnett L, 2013, J SCI MED SPORT, V16, P332, DOI 10.1016/j.jsams.2012.08.011; Barnett LM, 2016, J TEACH PHYS EDUC, V35, P219, DOI 10.1123/jtpe.2014-0209; Barnett LM, 2009, J ADOLESCENT HEALTH, V44, P252, DOI 10.1016/j.jadohealth.2008.07.004; Batra M., 2011, POSTURAL REACTIONS E, V22, P134, DOI [10.5463/DCID.V22I2.30, DOI 10.5463/DCID.V22I2.30]; Brian A, 2020, SPORTS MED, V50, P1889, DOI 10.1007/s40279-020-01332-6; Bryant ES, 2014, J SPORT SCI, V32, P1775, DOI 10.1080/02640414.2014.918644; Burns RD, 2017, MED SCI SPORT EXER, V49, P746, DOI [10.1249/MSS.0000000000001147, 10.1249/mss.0000000000001147]; Cai YJ, 2017, J SPORT HEALTH SCI, V6, P404, DOI 10.1016/j.jshs.2017.09.002; Capio CM, 2018, J INTELL DISABIL RES, V62, P225, DOI 10.1111/jir.12458; Capio CM, 2015, J SPORT HEALTH SCI, V4, P235, DOI 10.1016/j.jshs.2014.08.001; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Chen WY, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4105-2; Chorba Rita S, 2010, N Am J Sports Phys Ther, V5, P47; Clark J.E., 2002, MOTOR DEV RES REV, V2, P62; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; Cohen KE, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-49; Cook G., 2010, MOVEMENT G COOK MOVE, P29; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P62; Cook G, 2014, INT J SPORTS PHYS TH, V9, P396; Cook Gray, 2006, N Am J Sports Phys Ther, V1, P132; De Meester A, 2018, J SCI MED SPORT, V21, P58, DOI 10.1016/j.jsams.2017.05.007; Duncan MJ, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-11; Duncan MJ, 2012, J OBES, V2012, DOI 10.1155/2012/697563; Fan X, 2017, J SPORT HEALTH SCI, V6, P388, DOI 10.1016/j.jshs.2017.09.006; Ferreira L, 2018, CHILD CARE HLTH DEV, V44, P801, DOI 10.1111/cch.12606; Fisher A, 2005, MED SCI SPORT EXER, V37, P684, DOI 10.1249/01.MSS.0000159138.48107.7D; Flores FS, 2019, PERCEPT MOTOR SKILL, V126, P366, DOI 10.1177/0031512519829271; Gallahue D, 2007, DEV PHYS ED ALL CHIL, V4th; Gallahue DL., 2011, UNDERSTANDING MOTOR; Garcia-Pinillos F, 2018, NUTR HOSP, V35, P805, DOI 10.20960/nh.1670; Hardy LL, 2013, MED SCI SPORT EXER, V45, P1965, DOI 10.1249/MSS.0b013e318295a9fc; Hardy LL, 2012, PEDIATRICS, V130, pE390, DOI 10.1542/peds.2012-0345; Hilbert P, 2010, ANAESTHESIST, V59, P700, DOI 10.1007/s00101-010-1742-6; Kelly L, 2019, J SPORT SCI, V37, P1055, DOI 10.1080/02640414.2018.1543833; Kiesel Kyle, 2007, N Am J Sports Phys Ther, V2, P147; Lester D, 2017, SPORTS, V5, DOI 10.3390/sports5040077; Li J., 2007, CHIN 1 PHYS ED, V14, P37, DOI [10.16237/j.cnki.cn44-1404/g8.2007.03.011, DOI 10.16237/J.CNKI.CN44-1404/G8.2007.03.011]; Lima RA, 2017, SCAND J MED SCI SPOR, V27, P1638, DOI 10.1111/sms.12850; Lima RA, 2019, J PEDIAT-BRAZIL, V95, P482, DOI 10.1016/j.jped.2018.02.010; Lloyd M, 2014, ADAPT PHYS ACT Q, V31, P67, DOI [10.1123/apaq:2013-0048, 10.1123/apaq.2013-0048]; Lloyd RS, 2012, STRENGTH COND J, V34, P61, DOI 10.1519/SSC.0b013e31825760ea; Logan SW, 2012, CHILD CARE HLTH DEV, V38, P305, DOI 10.1111/j.1365-2214.2011.01307.x; Lubans DR, 2010, SPORTS MED, V40, P1019, DOI 10.2165/11536850-000000000-00000; Ma H., 2006, ANAL RELIABILITY VAL; Malina RM, 1996, RES Q EXERCISE SPORT, V67, pS48, DOI 10.1080/02701367.1996.10608853; Minick KI, 2010, J STRENGTH COND RES, V24, P479, DOI 10.1519/JSC.0b013e3181c09c04; Ministry of Education of the People's Republic of China, 2014, NOT MIN ED TEST REP; Ministry of Education of the People's Republic of China, 2014, NOT MIN ED ISS NAT S; Mukherjee S, 2017, PERCEPT MOTOR SKILL, V124, P584, DOI 10.1177/0031512517703005; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Okada T, 2011, J STRENGTH COND RES, V25, P252, DOI 10.1519/JSC.0b013e3181b22b3e; Ortega FB, 2015, SPORTS MED, V45, P533, DOI 10.1007/s40279-014-0281-8; Parchmann CJ, 2011, J STRENGTH COND RES, V25, P3378, DOI 10.1519/JSC.0b013e318238e916; Rey E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236070; Roberts G.C., 1980, PSYCHOL MOTOR BEHAV, P314; Spessato BC, 2013, EARLY CHILD DEV CARE, V183, P916, DOI 10.1080/03004430.2012.689761; Stodden DF, 2008, QUEST, V60, P290, DOI 10.1080/00336297.2008.10483582; Stodden DF, 2014, PEDIATR EXERC SCI, V26, P231, DOI 10.1123/pes.2013-0027; Stodden DF, 2013, RES Q EXERCISE SPORT, V84, P397, DOI 10.1080/02701367.2013.814910; THOMAS JR, 1985, PSYCHOL BULL, V98, P260, DOI 10.1037/0033-2909.98.2.260; Tompsett C, 2017, SPORTS MED, V47, P1795, DOI 10.1007/s40279-017-0697-z; Ulrich D. A., 2019, TEST GROSS MOTOR DEV; van Beurden E, 2002, J SCI MED SPORT, V5, P244, DOI 10.1016/S1440-2440(02)80010-X; Veldman SLC, 2017, J SCI MED SPORT, V20, P50, DOI 10.1016/j.jsams.2016.04.009; World Health Organization, WHO CHILDH OV OB; Yi XR, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6420-2; Yildiz S., 2018, UNIVERSAL J ED RES, V6, P1647; Yildiz S., 2018, J ED TRAIN STUD, V6, P66, DOI [DOI 10.11114/JETS.V6I8.3352, 10.11114/jets.v6i8.3352]; Zeng N, 2019, J SPORT HEALTH SCI, V8, P122, DOI 10.1016/j.jshs.2019.01.001; Zhang X., 2017, CHINESE J CHILD HLTH, V25, P935; Zhu Z, 2017, J SPORT HEALTH SCI, V6, P395, DOI 10.1016/j.jshs.2017.09.003	72	4	4	9	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0237760	10.1371/journal.pone.0237760	http://dx.doi.org/10.1371/journal.pone.0237760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038427	Green Submitted, gold, Green Published			2022-12-26	WOS:000664633500001
J	Zhang, NX; Guo, Y; Li, H; Yang, XQ; Gao, CX; Hui, CY				Zhang, Nai-Xing; Guo, Yan; Li, Hui; Yang, Xue-Qin; Gao, Chao-Xian; Hui, Chang-Ye			Versatile artificial mer operons in Escherichia coli towards whole cell biosensing and adsorption of mercury	PLOS ONE			English	Article							SURFACE DISPLAY; GENETIC-ANALYSIS; FAMILY PROTEINS; DESIGN; TRANSCRIPTION; BIOSORPTION; HG(II)	Mercury exists naturally and mainly as a man-made pollutant in the environment, where it exerts adverse effects on local ecosystems and living organisms. It is important to develop an appropriate synthetic biological device that recognizes, detects and removes the bioavailable fraction of environmental mercury. Both single-signal and double-signal output mercury biosensors were assembled using a natural mer operon as a template. Selectivity and sensitivity of whole-cell biosensors based on artificial mer operons were determined. Three whole-cell biosensors were highly stable at very high concentrations of mercuric chloride, and could detect bioavailable Hg(II) in the concentration range of 6.25-200 mu M HgCl2. A novel Hg(II) bioadsorption coupled with biosensing artificial mer operon was assembled. This would allow Hg(II)-induced Hg(II) binding protein cell surface display and green fluorescence emission to be achieved simultaneously while retaining the linear relationship between fluorescent signal and Hg(II) exposure concentration. The present study provides an innovative way to simultaneously detect, quantify, and remove bioavailable heavy metal ions using an artificially reconstructed heavy metal resistance operon.	[Zhang, Nai-Xing; Guo, Yan; Li, Hui] Shenzhen Prevent & Treatment Ctr Occupat Dis, Natl Key Clin Specialty Occupat Dis, Shenzhen, Peoples R China; [Yang, Xue-Qin; Gao, Chao-Xian; Hui, Chang-Ye] Shenzhen Prevent & Treatment Ctr Occupat Dis, Dept Toxicol & Pathol, Shenzhen, Peoples R China		Hui, CY (corresponding author), Shenzhen Prevent & Treatment Ctr Occupat Dis, Dept Toxicol & Pathol, Shenzhen, Peoples R China.	hcy_sypu@hotmail.com			National Natural Science Foundation of China [82073517]; Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties [SZGSP015, JCYJ20180306170237563, JCYJ20190808175205480]; Shenzhen Science and Technology Innovation Commission; Department of Science and Technology of Guangdong Province [2019A1515011989, 2021A1515012472]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties; Shenzhen Science and Technology Innovation Commission; Department of Science and Technology of Guangdong Province	This research was partly supported by a grant (82073517) from the National Natural Science Foundation of China (www.nsfc.gov.cn) to Hui CY, the Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties (SZGSP015), grant (JCYJ20180306170237563; JCYJ20190808175205480) from Shenzhen Science and Technology Innovation Commission (http://stic.sz.gov.cn/) to Hui CY and Guo Y, respectively, and grant (2019A1515011989; 2021A1515012472) from Department of Science and Technology of Guangdong Province (http://gdstc.gd.gov.cn/) to Guo Y and Hui CY, respectively. There was no additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae W, 2003, APPL ENVIRON MICROB, V69, P3176, DOI 10.1128/AEM.69.6.3176-3180.2003; Bernhoft RA, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/460508; Cai S, 2018, ANALYST, V143, P630, DOI 10.1039/c7an00587c; Chang CC, 2015, NUCLEIC ACIDS RES, V43, P7612, DOI 10.1093/nar/gkv681; Chen H, 2020, ANAL CHIM ACTA, V1093, P131, DOI 10.1016/j.aca.2019.09.062; Guo MZ, 2020, BIOSENS BIOELECTRON, V150, DOI 10.1016/j.bios.2019.111899; Guo MZ, 2019, J BIOL ENG, V13, DOI 10.1186/s13036-019-0202-3; Guo Y, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.585617; Guo Y, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01454; Hansen LH, 2000, FEMS MICROBIOL LETT, V193, P123; He W, 2010, APPL MICROBIOL BIOT, V87, P981, DOI 10.1007/s00253-010-2548-9; Huang CC, 2007, ANGEW CHEM INT EDIT, V46, P6824, DOI 10.1002/anie.200700803; Hui CY, 2020, RSC ADV, V10, P28106, DOI 10.1039/d0ra04815a; Hui CY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228456; Hui CY, 2019, BIOTECHNOL LETT, V41, P763, DOI 10.1007/s10529-019-02676-4; Hui CY, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0612-5; Hui CY, 2018, BIOTECHNOL LETT, V40, P837, DOI 10.1007/s10529-018-2533-4; Hui CY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24134-3; Jiang T, 2015, ANAL CHIM ACTA, V876, P77, DOI 10.1016/j.aca.2015.03.026; Mathema VB, 2011, ARCH MICROBIOL, V193, P837, DOI 10.1007/s00203-011-0751-4; McNerney MP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13454-1; Mei HC, 2013, CHEM COMMUN, V49, P164, DOI 10.1039/c2cc36416f; Mendoza JI, 2020, CHEM COMMUN, V56, P6590, DOI 10.1039/d0cc01323d; Ndu U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138333; PARK SJ, 1992, J BACTERIOL, V174, P2160, DOI 10.1128/JB.174.7.2160-2171.1992; Priyadarshi H, 2012, J ENVIRON SCI-CHINA, V24, P963, DOI 10.1016/S1001-0742(11)60820-6; Qi X, 2019, BIOSENS BIOELECTRON, V142, DOI 10.1016/j.bios.2019.111500; Qin J, 2006, MICROBIOL-SGM, V152, P709, DOI 10.1099/mic.0.28474-0; Regnell O, 2019, ENVIRON SCI TECHNOL, V53, P4, DOI 10.1021/acs.est.8b02709; ROSS W, 1989, J BACTERIOL, V171, P4009, DOI 10.1128/jb.171.7.4009-4018.1989; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Song LY, 2004, J BACTERIOL, V186, P1861, DOI 10.1128/JB.186.6.1861-1868.2004; Suvarapu LN, 2017, INT J ANAL CHEM, V2017, DOI 10.1155/2017/3624015; Tao HC, 2013, BIOTECHNOL LETT, V35, P1253, DOI 10.1007/s10529-013-1216-4; Tao RK, 2018, FREE RADICAL BIO MED, V121, P26, DOI 10.1016/j.freeradbiomed.2018.04.562; Tauriainen S, 1999, ANAL BIOCHEM, V272, P191, DOI 10.1006/abio.1999.4193; Wang D, 2020, J BIOSCI BIOENG, V129, P223, DOI 10.1016/j.jbiosc.2019.08.005; Wang W, 2019, APPL MICROBIOL BIOT, V103, P6797, DOI 10.1007/s00253-019-09984-9; Watstein DM, 2018, ACS SYNTH BIOL, V7, P267, DOI 10.1021/acssynbio.7b00292; Wegner SV, 2007, J AM CHEM SOC, V129, P3474, DOI 10.1021/ja068342d; Wei QG, 2018, MOL BIOTECHNOL, V60, P12, DOI 10.1007/s12033-017-0039-2; Wei W, 2014, ENVIRON SCI TECHNOL, V48, P3363, DOI 10.1021/es4046567; Yan L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123741; Yang S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13152-y	44	7	7	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252190	10.1371/journal.pone.0252190	http://dx.doi.org/10.1371/journal.pone.0252190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038487	gold, Green Published			2022-12-26	WOS:000664633500063
J	Chenillat, F; Riviere, P; Ohman, MD				Chenillat, Fanny; Riviere, Pascal; Ohman, Mark D.			On the sensitivity of plankton ecosystem models to the formulation of zooplankton grazing	PLOS ONE			English	Article							CALIFORNIA CURRENT SYSTEM; SOUTHERN CALIFORNIA; FEEDING-BEHAVIOR; BODY-SIZE; PHYTOPLANKTON GROWTH; FUNCTIONAL-RESPONSES; FLORAL PATTERNS; ACARTIA-TONSA; DYNAMICS; NUTRIENT	Model representations of plankton structure and dynamics have consequences for a broad spectrum of ocean processes. Here we focus on the representation of zooplankton and their grazing dynamics in such models. It remains unclear whether phytoplankton community composition, growth rates, and spatial patterns in plankton ecosystem models are especially sensitive to the specific means of representing zooplankton grazing. We conduct a series of numerical experiments that explicitly address this question. We focus our study on the form of the functional response to changes in prey density, including the formulation of a grazing refuge. We use a contemporary biogeochemical model based on continuum size-structured organization, including phytoplankton diversity, coupled to a physical model of the California Current System. This region is of particular interest because it exhibits strong spatial gradients. We find that small changes in grazing refuge formulation across a range of plausible functional forms drive fundamental differences in spatial patterns of plankton concentrations, species richness, pathways of grazing fluxes, and underlying seasonal cycles. An explicit grazing refuge, with refuge prey concentration dependent on grazers' body size, using allometric scaling, is likely to provide more coherent plankton ecosystem dynamics compared to classic formulations or size-independent threshold refugia. We recommend that future plankton ecosystem models pay particular attention to the grazing formulation and implement a threshold refuge incorporating size-dependence, and we call for a new suite of experimental grazing studies.	[Chenillat, Fanny; Riviere, Pascal] Univ Brest, IFREMER, IRD, IUEM,Lab Sci Environm Marin LEMAR, Brest, France; [Ohman, Mark D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of California System; University of California San Diego; Scripps Institution of Oceanography	Chenillat, F (corresponding author), Univ Brest, IFREMER, IRD, IUEM,Lab Sci Environm Marin LEMAR, Brest, France.	fanny.chenillat@univ-brest.fr	Chenillat, Fanny/E-5278-2018	Chenillat, Fanny/0000-0002-6233-0377; Ohman, Mark D./0000-0001-8136-3695	LabexMer grant [ANR-10-LABX-19-01]; People Programme (Marie Curie Actions -PRESTIGE program coordinated -by Campus France via the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant) [PRESTIGE-2015-3-0017, PCOFUND-GA-2013-609102]; Gordon and Betty Moore Foundation [GBMF3576, GBMF5479]; U.S. NSF grants [1637632]	LabexMer grant; People Programme (Marie Curie Actions -PRESTIGE program coordinated -by Campus France via the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. NSF grants(National Science Foundation (NSF))	This work was supported by four grants: (1) F.C. received a LabexMer grant ANR-10-LABX-19-01 (www.labexmer.eu), (2) F.C. received a the PRESTIGE-2015-3-0017 grant from the People Programme (Marie Curie Actions -PRESTIGE program coordinated -by Campus France via the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement n. PCOFUND-GA-2013-609102) (www.campusfrance.org); (3) M.D.O. received support from the Gordon and Betty Moore Foundation (Grant id GBMF3576 and GBMF5479) (www.moore.org) (4) M.D.O. received a U.S. NSF grants to the California Current Ecosystem LTER site (#1637632) (www.nsf.gov/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeda R, 2010, J EXP MAR BIOL ECOL, V387, P24, DOI 10.1016/j.jembe.2010.03.002; Anderson TR, 2010, PROG OCEANOGR, V87, P201, DOI 10.1016/j.pocean.2010.06.003; ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; Aumont O, 2015, GEOSCI MODEL DEV, V8, P2465, DOI 10.5194/gmd-8-2465-2015; Ayata SD, 2013, J MARINE SYST, V125, P29, DOI 10.1016/j.jmarsys.2012.12.010; Baird ME, 2007, ECOL MODEL, V203, P185, DOI 10.1016/j.ecolmodel.2006.11.025; Banas NS, 2011, ECOL MODEL, V222, P2663, DOI 10.1016/j.ecolmodel.2011.05.018; Boyd PW, 2019, NATURE, V568, P327, DOI 10.1038/s41586-019-1098-2; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; Capet X, 2008, J PHYS OCEANOGR, V38, P29, DOI 10.1175/2007JPO3671.1; CAPRIULO GM, 1982, MAR BIOL, V71, P73, DOI 10.1007/BF00396994; CARON DA, 1985, MAR ECOL PROG SER, V24, P243, DOI 10.3354/meps024243; Chabert P., 2021, JGR OCEANS, DOI [10.1029/2020JC016308, DOI 10.1029/2020JC016308]; Chenillat F, 2018, OCEAN DYNAM, V68, P761, DOI 10.1007/s10236-018-1158-4; Chenillat F, 2016, GEOPHYS RES LETT, V43, P5812, DOI 10.1002/2016GL068945; Chenillat F, 2015, J GEOPHYS RES-OCEANS, V120, P5566, DOI 10.1002/2015JC010826; Chenillat F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062281; DROOP MR, 1968, J MAR BIOL ASSOC UK, V48, P689, DOI 10.1017/S0025315400019238; DURBIN AG, 1992, LIMNOL OCEANOGR, V37, P379, DOI 10.4319/lo.1992.37.2.0379; Dutkiewicz S, 2021, GLOBAL CHANGE BIOL, V27, P1196, DOI 10.1111/gcb.15493; Dutkiewicz S, 2020, BIOGEOSCIENCES, V17, P609, DOI 10.5194/bg-17-609-2020; Edwards CA, 2000, J MAR RES, V58, P37, DOI 10.1357/002224000321511197; EVANS GT, 1977, AM NAT, V111, P799, DOI 10.1086/283210; FERNANDEZ F, 1979, Journal of Plankton Research, V1, P313, DOI 10.1093/plankt/1.4.313; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Flynn KJ, 2008, J PLANKTON RES, V30, P423, DOI 10.1093/plankt/fbn007; Flynn KJ, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00165; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; FRANKS PJS, 1986, MAR BIOL, V91, P121, DOI 10.1007/BF00397577; Franks PJS, 2002, J OCEANOGR, V58, P379, DOI 10.1023/A:1015874028196; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; FROST BW, 1975, LIMNOL OCEANOGR, V20, P263, DOI 10.4319/lo.1975.20.2.0263; FROST BW, 1992, MAR ECOL PROG SER, V83, P291, DOI 10.3354/meps083291; FROST BW, 1983, DEEP-SEA RES, V30, P1, DOI 10.1016/0198-0149(83)90029-8; Frouin R, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00003; Fussmann GF, 2005, BIOL LETTERS, V1, P9, DOI 10.1098/rsbl.2004.0246; Gao KS, 2012, MAR ECOL PROG SER, V470, P167, DOI 10.3354/meps10043; Geider RJ, 1998, LIMNOL OCEANOGR, V43, P679, DOI 10.4319/lo.1998.43.4.0679; Gentleman W, 2003, DEEP-SEA RES PT II, V50, P2847, DOI 10.1016/J.DSR2.2003.07.001; Gentleman WC, 2008, J PLANKTON RES, V30, P1215, DOI 10.1093/plankt/fbn078; Goebel NL, 2013, ECOL MODEL, V264, P37, DOI 10.1016/j.ecolmodel.2012.11.008; Goebel NL, 2010, J MARINE SYST, V83, P221, DOI 10.1016/j.jmarsys.2010.05.002; Gorsky G, 2010, J PLANKTON RES, V32, P285, DOI 10.1093/plankt/fbp124; Hansen PJ, 1997, LIMNOL OCEANOGR, V42, P687, DOI 10.4319/lo.1997.42.4.0687; Houghton IA, 2018, NATURE, V556, P497, DOI 10.1038/s41586-018-0044-z; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Ivlev VS., 1955, PISCHEPROMIZDAT; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Kahru M, 1999, INT J REMOTE SENS, V20, P3423, DOI 10.1080/014311699211453; Kenitz KM, 2019, ECOSYSTEMS, V22, P968, DOI 10.1007/s10021-018-0314-5; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kiorboe T., 2008, MECH APPROACH PLANKT, DOI [10.1007/s00442-007-0893-x, DOI 10.1007/S00442-007-0893-X]; Kiorboe T, 2018, ICES J MAR SCI, V75, P1849, DOI 10.1093/icesjms/fsy090; Kwiatkowski L, 2018, GLOBAL BIOGEOCHEM CY, V32, P516, DOI 10.1002/2017GB005799; Lavaniegos BE, 2007, PROG OCEANOGR, V75, P42, DOI 10.1016/j.pocean.2007.07.002; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; Leising AW, 2003, DEEP-SEA RES PT II, V50, P2877, DOI 10.1016/j.dsr2.2003.07.002; Lessard EJ, 1998, AQUAT MICROB ECOL, V16, P173, DOI 10.3354/ame016173; Levy M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07059-3; Levy M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0481; Litchman E, 2006, BIOGEOSCIENCES, V3, P585, DOI 10.5194/bg-3-585-2006; Litchman E, 2007, ECOL LETT, V10, P1170, DOI 10.1111/j.1461-0248.2007.01117.x; Martini S, 2021, LIMNOL OCEANOGR, V66, P965, DOI 10.1002/lno.11655; Martz T, 2014, GEOPHYS RES LETT, V41, P2496, DOI 10.1002/2014GL059332; MOLONEY CL, 1991, J PLANKTON RES, V13, P1003, DOI 10.1093/plankt/13.5.1003; Moore JK, 2001, DEEP-SEA RES PT II, V49, P403, DOI 10.1016/S0967-0645(01)00108-4; Myerscough MR, 1996, ECOL MODEL, V89, P31, DOI 10.1016/0304-3800(95)00117-4; Ohman MD, 2016, LIMNOL OCEANOGR, V61, P765, DOI 10.1002/lno.10251; Ohman MD, 2001, NATURE, V412, P638, DOI 10.1038/35088068; OHMAN MD, 1984, MAR ECOL PROG SER, V19, P125, DOI 10.3354/meps019125; Olivares M, 2019, MAR ECOL PROG SER, V616, P25, DOI 10.3354/meps12928; PAFFENHOFER GA, 1988, MAR ECOL PROG SER, V42, P33, DOI 10.3354/meps042033; Pahlow M, 2010, MAR ECOL PROG SER, V403, P129, DOI 10.3354/meps08466; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; RUNGE JA, 1988, HYDROBIOLOGIA, V167, P61, DOI 10.1007/BF00026294; Saage A, 2009, J SEA RES, V62, P16, DOI 10.1016/j.seares.2009.01.002; Shchepetkin AF, 2005, OCEAN MODEL, V9, P347, DOI 10.1016/j.ocemod.2004.08.002; STEELE JH, 1992, J PLANKTON RES, V14, P157, DOI 10.1093/plankt/14.1.157; Steele JH, 1974, STRUCTURE MARINE ECO; Stoecker DK, 2017, ANNU REV MAR SCI, V9, P311, DOI 10.1146/annurev-marine-010816-060617; Strom SL, 2000, MAR ECOL PROG SER, V193, P19, DOI 10.3354/meps193019; STROM SL, 1991, MAR ECOL PROG SER, V78, P103, DOI 10.3354/meps078103; Takahashi K, 2005, MAR ECOL PROG SER, V303, P213, DOI 10.3354/meps303213; Taylor AG, 2018, MAR ECOL PROG SER, V592, P1, DOI 10.3354/meps12526; Venrick EL, 2009, J MAR RES, V67, P89, DOI 10.1357/002224009788597917; Venrick EL, 2002, J MAR RES, V60, P171, DOI 10.1357/002224002762341294; VIDAL J, 1980, MAR BIOL, V56, P111, DOI 10.1007/BF00397129; Ward BA, 2012, LIMNOL OCEANOGR, V57, P1877, DOI 10.4319/lo.2012.57.6.1877; WLODARCZYK E, 1992, MAR ECOL PROG SER, V85, P93, DOI 10.3354/meps085093	90	8	8	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252033	10.1371/journal.pone.0252033	http://dx.doi.org/10.1371/journal.pone.0252033			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033649	Green Submitted, Green Published, gold			2022-12-26	WOS:000664633100022
J	Roumen, RMH; Schuurman, MS; Aarts, MJ; Maaskant-Braat, AJG; Vreugdenhil, G; Louwman, WJ				Roumen, R. M. H.; Schuurman, M. S.; Aarts, M. J.; Maaskant-Braat, A. J. G.; Vreugdenhil, G.; Louwman, W. J.			Survival of sentinel node biopsy versus observation in intermediate-thickness melanoma: A Dutch population-based study	PLOS ONE			English	Article							CUTANEOUS MELANOMA; PROGNOSTIC-SIGNIFICANCE; STAGE-I; DISSECTION; MANAGEMENT; ASSOCIATION; MULTICENTER; METASTASIS	Background The Multicenter Selective Lymphadenectomy Trial (MSLT-1) comparing survival after a sentinel lymph node biopsy (SLNB) versus nodal observation in melanoma patients did not show a significant benefit favoring SLNB. However, in subgroup analyses melanoma-specific survival among patients with nodal metastases seemed better. Aim To evaluate the association of performing a SLNB with overall survival in intermediate thickness melanoma patients in a Dutch population-based daily clinical setting. Methods Survival, excess mortality adjusted for age, gender, Breslow-thickness, ulceration, histological subtype, location, co-morbidity and socioeconomic status were calculated in a population of 1,989 patients diagnosed with malignant cutaneous melanoma (1.2-3.5 mm) on the trunk or limb between 2000-2016 in ten hospitals in the South East area, The Netherlands. Results A SLNB was performed in 51% of the patients (n = 1008). Ten-year overall survival after SLNB was 75% (95%CI, 71%-78%) compared to 61% (95%CI 57%-64%) following observation. After adjustment for risk factors, a lower risk on death (HR = 0.80, 95%CI 0.66-0.96) was found after SLNB compared to observation only. Conclusions SLNB in patients with intermediate-thickness melanoma on trunk or limb resulted in a 14% absolute and significant 10-year survival difference compared to those without SLNB.	[Roumen, R. M. H.; Maaskant-Braat, A. J. G.] Maxima Med Ctr, Dept Surg, Eindhoven, Netherlands; [Roumen, R. M. H.] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Schuurman, M. S.; Aarts, M. J.; Louwman, W. J.] Netherlands Comprehens Canc Org, IKNL, Utrecht, Netherlands; [Vreugdenhil, G.] Maxima Med Ctr, Dept Med Oncol, Eindhoven, Netherlands	Maxima Medical Center; Maastricht University; Maxima Medical Center	Roumen, RMH (corresponding author), Maxima Med Ctr, Dept Surg, Eindhoven, Netherlands.; Roumen, RMH (corresponding author), Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands.	r.roumen@mmc.nl	Louwman, Marieke WJ/N-5267-2018	Louwman, Marieke WJ/0000-0001-9011-6741				Balch CM, 2014, NEW ENGL J MED, V370, P663, DOI 10.1056/NEJMe1313690; Bichakjian CK, 2011, J AM ACAD DERMATOL, V65, P1032, DOI 10.1016/j.jaad.2011.04.031; Bilimoria KY, 2009, J CLIN ONCOL, V27, P1857, DOI 10.1200/JCO.2008.18.7567; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; Brown RE, 2010, ANN SURG ONCOL, V17, P3330, DOI 10.1245/s10434-010-1208-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen J, 2016, ONCOTARGET, V7, P45671, DOI 10.18632/oncotarget.10140; Duijn C, 2002, MAANDSTATISTIEK BEVO, V50, P32; Eriksson H, 2013, EUR J CANCER, V49, P2705, DOI 10.1016/j.ejca.2013.03.013; Faries MB, 2017, NEW ENGL J MED, V376, P2211, DOI 10.1056/NEJMoa1613210; Faries MB, 2018, CLIN EXP METASTAS, V35, P431, DOI 10.1007/s10585-018-9898-6; Gonzalez A, 2018, AM J CLIN DERMATOL, V19, P24, DOI 10.1007/s40257-018-0379-0; Grange F, 2008, ARCH DERMATOL, V144, P629, DOI 10.1001/archderm.144.5.629; Huismans AM, 2014, ANN SURG ONCOL, V21, P3395, DOI 10.1245/s10434-014-3764-9; Kim J, 2016, J PEDIATR SURG, V51, P986, DOI 10.1016/j.jpedsurg.2016.02.067; Leiter U, 2016, LANCET ONCOL, V17, P757, DOI 10.1016/S1470-2045(16)00141-8; Leung AM, 2013, JAMA SURG, V148, P879, DOI 10.1001/jamasurg.2013.3044; Lyth J, 2016, EUR J CANCER, V59, P171, DOI 10.1016/j.ejca.2016.02.029; Mandala M, 2011, MAYO CLIN PROC, V86, P113, DOI 10.4065/mcp.2010.0671; Marsden JR, 2010, BRIT J DERMATOL, V163, P238, DOI [10.1111/j.1365-2133.2010.09883.x, 10.1016/j.bjps.2010.07.006]; Martinez SR, 2012, J SURG ONCOL, V106, P807, DOI 10.1002/jso.23169; McGregor JM, 2015, BRIT J DERMATOL, V172, P552, DOI 10.1111/bjd.13666; Mohrle M, 2004, DERMATOLOGY, V209, P5, DOI 10.1159/000078580; Morton DL, 2014, NEW ENGL J MED, V370, P599, DOI 10.1056/NEJMoa1310460; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; Mosquera C, 2017, ANN SURG ONCOL, V24, P127, DOI 10.1245/s10434-016-5460-4; Murtha TD, 2018, ANN SURG ONCOL, V25, P903, DOI 10.1245/s10434-018-6348-2; Rivard J, 2015, J SURG ONCOL, V112, P173, DOI 10.1002/jso.23981; Sabel MS, 2015, ANN SURG ONCOL, V22, P2112, DOI 10.1245/s10434-015-4539-7; Satzger I, 2011, ANN SURG ONCOL, V18, P514, DOI 10.1245/s10434-010-1318-3; SCHOUTEN LJ, 1993, INT J EPIDEMIOL, V22, P369, DOI 10.1093/ije/22.3.369; Sobin LH., 2012, CANC IUA, V6; Swetter SM, 2019, J AM ACAD DERMATOL, V80, P208, DOI 10.1016/j.jaad.2018.08.055; Tanis PJ, 2008, HEAD NECK-J SCI SPEC, V30, P380, DOI 10.1002/hed.20749; Torjesen I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8645; van Akkooi ACJ, 2019, BRIT J DERMATOL, V180, P5, DOI 10.1111/bjd.17143; van den Broek FJ, 2013, INT J CLIN ONCOL, V18, P428, DOI 10.1007/s10147-012-0399-3; van der Ploeg APT, 2011, ANN SURG ONCOL, V18, P3300, DOI 10.1245/s10434-011-1741-0; van der Ploeg APT, 2014, ANN SURG, V260, P149, DOI 10.1097/SLA.0000000000000500; van der Ploeg APT, 2014, EUR J CANCER, V50, P111, DOI 10.1016/j.ejca.2013.08.023; Veerbeek Laetitia, 2013, Ned Tijdschr Geneeskd, V157, pA6136; Verstijnen J, 2017, SURG ONCOL, V26, P431, DOI 10.1016/j.suronc.2017.08.006; Vist GE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000009.pub3; WorldHealthOrganization, INT CLASSIFICATION D, V3	44	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252021	10.1371/journal.pone.0252021	http://dx.doi.org/10.1371/journal.pone.0252021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033662	gold, Green Published			2022-12-26	WOS:000664633100021
J	Sutar, J; Deshpande, S; Mullick, R; Hingankar, N; Patel, V; Bhattacharya, J				Sutar, Jyoti; Deshpande, Suprit; Mullick, Ranajoy; Hingankar, Nitin; Patel, Vainav; Bhattacharya, Jayanta			Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LINKED GLYCOSYLATION SITES; CLADE-C; ENV CLONES; EPIDEMIC; DETERMINANTS; RESISTANCE; PROGRESS; LINEAGE; REGION	Evolving diversity in globally circulating HIV-1 subtypes presents a formidable challenge in defining and developing neutralizing antibodies for prevention and treatment. HIV-1 subtype C is responsible for majority of global HIV-1 infections. In the present study, we examined the diversity in genetic signatures and attributes that differentiate region-specific HIV-1 subtype C gp120 sequences associated with virus neutralization outcomes to key bnAbs having distinct epitope specificities. A total of 1814 full length HIV-1 subtype C gp120 sequence from 37 countries were retrieved from Los Alamos National Laboratory HIV database (www.hiv.lanl.gov). The amino acid sequences were assessed for their phylogenetic association, variable loop lengths and prevalence of potential N-linked glycosylation sites (pNLGS). Responses of these sequences to bnAbs were predicted with a machine learning algorithm 'bNAb-ReP' and compared with those reported in the CATNAP database. Subtype C sequences from Asian countries including India differed phylogenetically when compared with that from African countries. Variable loop lengths and charges within Indian and African clusters were also found to be distinct from each other, specifically for V1, V2 and V4 loops. Pairwise analyses at each of the 25 pNLG sites indicated distinct country specific profiles. Highly significant differences (p<0.001***) were observed in prevalence of four pNLGS (N130, N295, N392 and N448) between South Africa and India, having most disease burden associated with subtype C. Our findings highlight that distinctly evolving clusters within global intra-subtype C gp120 sequences are likely to influence the disparate region-specific sensitivity of circulating HIV-1 subtype C to bnAbs.	[Sutar, Jyoti; Deshpande, Suprit; Mullick, Ranajoy; Hingankar, Nitin; Bhattacharya, Jayanta] Translat Hlth Sci Technol Inst, HIV Vaccine Translat Res Lab, NCR Biotech Sci Cluster, Faridabad, Haryana, India; [Sutar, Jyoti; Mullick, Ranajoy; Bhattacharya, Jayanta] Int AIDS Vaccine Initiat, New Delhi, India; [Patel, Vainav] ICMR Natl Inst Res Reprod Hlth, Mumbai, Maharashtra, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); International AIDS Vaccine Initiative; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Reproductive Health (NIRRH)	Bhattacharya, J (corresponding author), Translat Hlth Sci Technol Inst, HIV Vaccine Translat Res Lab, NCR Biotech Sci Cluster, Faridabad, Haryana, India.; Bhattacharya, J (corresponding author), Int AIDS Vaccine Initiat, New Delhi, India.	JBhattacharya@iavi.org		Patel, Vainav/0000-0001-6661-3238; BHATTACHARYA, JAYANTA/0000-0002-1531-3822; Sutar, Jyoti/0000-0002-5869-2156	Wellcome Trust/DBT India Alliance Team Science Grant [IA/TSG/19/1/600019]; Science & Engineering Research Board, Department of Science & Technology, Government of India [CRG/2019/002939]; Department of Biotechnology, Government of India [BT/PR24520/MED/29/1222/2017]; Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); Irish Aid	Wellcome Trust/DBT India Alliance Team Science Grant; Science & Engineering Research Board, Department of Science & Technology, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Irish Aid(CGIAR)	The authors wish to acknowledge the funding support from the Wellcome Trust/DBT India Alliance Team Science Grant (IA/TSG/19/1/600019), Science & Engineering Research Board, Department of Science & Technology, Government of India (CRG/2019/002939) and Department of Biotechnology, Government of India (BT/PR24520/MED/29/1222/2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our laboratory members for providing valuable inputs and suggestions. ICMRNIRRH is acknowledged for server support for computation analysis. IAVI's work was made possible by generous support from many donors, including the Bill & Melinda Gates Foundation, the Ministry of Foreign Affairs of Denmark, Irish Aid, the Ministry of Finance of Japan, the Ministry of Foreign Affairs of the Netherlands, the Norwegian Agency for Development Cooperation (NORAD), the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. The contents are the responsibility of the International AIDS Vaccine Initiative and do not necessarily reflect the views of USAID or the United States Government. We thank Prof Gagandeep Kang, Translational Health Science & Technology Institute for support.	[Anonymous], 2015, RSTUD; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Bai HJ, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007056; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Blish CA, 2008, PLOS MED, V5, P90, DOI 10.1371/journal.pmed.0050009; Bouvin-Pley M, 2014, J VIROL, V88, P13910, DOI 10.1128/JVI.02083-14; Bouvin-Pley M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003477; Bunnik EM, 2010, NAT MED, V16, P995, DOI 10.1038/nm.2203; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Burnie J, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010085; Caskey M, 2019, NAT MED, V25, P547, DOI 10.1038/s41591-019-0412-8; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Corey L, 2021, NEW ENGL J MED, V384, P1003, DOI 10.1056/NEJMoa2031738; DeLeon O, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001549; Deshpande S, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0297-2; Doores KJ, 2015, J VIROL, V89, P1105, DOI 10.1128/JVI.02905-14; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Gnanakaran S, 2007, J VIROL, V81, P4886, DOI 10.1128/JVI.01954-06; Hake A, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005789; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han C., 2020, MBIO, P11; Hemelaar J, 2019, LANCET INFECT DIS, V19, P143, DOI 10.1016/S1473-3099(18)30647-9; Hraber P, 2014, J VIROL, V88, P12623, DOI 10.1128/JVI.01705-14; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Kumar Rajesh, 2018, Ther Adv Vaccines Immunother, V6, P61, DOI 10.1177/2515135518800689; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Lynch RM, 2009, AIDS RES HUM RETROV, V25, P237, DOI 10.1089/aid.2008.0219; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Nishimura Y, 2017, CELL HOST MICROBE, V22, P207, DOI 10.1016/j.chom.2017.07.010; Novitsky V, 2002, J VIROL, V76, P5435, DOI 10.1128/JVI.76.11.5435-5451.2002; Ogert RA, 2001, J VIROL, V75, P5998, DOI 10.1128/JVI.75.13.5998-6006.2001; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; R Core Team, 2013, R LANG ENV STAT COMP; Rademeyer C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005742; Rawi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50635-w; Ringe R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037157; Ringe R, 2012, VIROLOGY, V426, P34, DOI 10.1016/j.virol.2012.01.011; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Sok D, 2018, NAT IMMUNOL, V19, P1179, DOI 10.1038/s41590-018-0235-7; Sok D, 2016, IMMUNITY, V45, P958, DOI 10.1016/j.immuni.2016.10.033; Sutar Jyoti, 2020, VirusDisease, V31, DOI 10.1007/s13337-020-00595-x; Sutar J, 2019, VIRUS RES, V273, DOI 10.1016/j.virusres.2019.197763; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; Walker BD., NEW ENGL J MED, V384, P1068, DOI [10.1056/NEJMe2101131 33730459, DOI 10.1056/NEJME210113133730459]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	56	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0251969	10.1371/journal.pone.0251969	http://dx.doi.org/10.1371/journal.pone.0251969			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029329	gold, Green Published			2022-12-26	WOS:000664632800019
J	Cui, CQ; Liu, YY; Liu, Y; Cui, XH; Sun, ZY; Du, ZW; Wu, K; Jiang, XL; Mei, HX; Zheng, YZ				Cui, Chengqi; Liu, Yanyang; Liu, Yan; Cui, Xianghua; Sun, Zhiyu; Du, Zhenwei; Wu, Ke; Jiang, Xiaolin; Mei, Hongxian; Zheng, Yongzhan			Genome-wide association study of seed coat color in sesame (Sesamum indicum L.)	PLOS ONE			English	Article							GENETIC-MAP CONSTRUCTION; FLAVONOID 3',5'-HYDROXYLASE; MARKER DEVELOPMENT; AGRONOMIC TRAITS; ARABIDOPSIS; IDENTIFICATION; BIOSYNTHESIS; ENCODES; ANTHOCYANIN; DISCOVERY	Sesame (Sesamum indicum L.) is an important and ancient oilseed crop. Sesame seed coat color is related to biochemical functions involved in protein and oil metabolism, and antioxidant content. Because of its complication, the genetic basis of sesame seed coat color remains poorly understood. To elucidate the factors affecting the genetic architecture of seed coat color, 366 sesame germplasm lines were evaluated for seed coat color in 12 environments. The genome-wide association studies (GWAS) for three seed coat color space values, best linear unbiased prediction (BLUP) values from a multi-environment trial analysis and principal component scores (PCs) of three seed coat color space values were conducted. GWAS for three seed coat color space values identified a total of 224 significant single nucleotide polymorphisms (SNPs, P < 2.34x10(-7)), with phenotypic variation explained (PVE) ranging from 1.01% to 22.10%, and 35 significant SNPs were detected in more than 6 environments. Based on BLUP values, 119 significant SNPs were identified, with PVE ranging from 8.83 to 31.98%. Comparing the results of the GWAS using phenotypic data from different environments and the BLUP values, all significant SNPs detected in more than 6 environments were also detected using the BLUP values. GWAS for PCs identified 197 significant SNPs, and 30 were detected in more than 6 environments. GWAS results for PCs were consistent with those for three color space values. Out of 224 significant SNPs, 22 were located in the confidence intervals of previous reported quantitative trait loci (QTLs). Finally, 92 candidate genes were identified in the vicinity of the 4 SNPs that were most significantly associated with sesame seed coat color. The results in this paper will provide new insights into the genetic basis of sesame seed coat color, and should be useful for molecular breeding in sesame.	[Cui, Chengqi; Liu, Yanyang; Du, Zhenwei; Wu, Ke; Jiang, Xiaolin; Mei, Hongxian; Zheng, Yongzhan] Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China; [Liu, Yan] Nanyang Acad Agr Sci, Nanyang, Henan, Peoples R China; [Cui, Xianghua] Zhumadian Acad Agr Sci, Zhumadian, Henan, Peoples R China; [Sun, Zhiyu] South China Normal Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Henan Academy of Agricultural Sciences; South China Normal University	Mei, HX; Zheng, YZ (corresponding author), Henan Acad Agr Sci, Henan Sesame Res Ctr, Zhengzhou, Henan, Peoples R China.	meihx2003@126.com; sesame168@163.com			Agriculture Research System of China [CARS-14-1-01]; Key Project of Science and Technology of Henan Province [201300110600]; Key R&D and Promotion Projects of Henan Province [202102110026]; Science-Technology Foundation for Outstanding Young Scientists [2020YQ26]; Science & Technology Innovation and Creative Projects of Henan Academy of Agricultural Sciences [2020CX25]; Henan Academy of Agricultural Sciences [2020JC008, 2021JC013, 2021ZC69]	Agriculture Research System of China; Key Project of Science and Technology of Henan Province; Key R&D and Promotion Projects of Henan Province; Science-Technology Foundation for Outstanding Young Scientists; Science & Technology Innovation and Creative Projects of Henan Academy of Agricultural Sciences; Henan Academy of Agricultural Sciences	This study was supported by Agriculture Research System of China (CARS-14-1-01) to Yongzhan Zheng; the Key Project of Science and Technology of Henan Province (201300110600), and the Key R&D and Promotion Projects of Henan Province (202102110026) to Hongxian Mei; the Science-Technology Foundation for Outstanding Young Scientists (2020YQ26), and the Science & Technology Innovation and Creative Projects (2020CX25) of Henan Academy of Agricultural Sciences to Chengqi Cui; and the Basic Scientific Research Projects (2020JC008, 2021JC013, 2021ZC69) of Henan Academy of Agricultural Sciences to Yanyang Liu. The funders had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ashri A., 1998, Plant Breeding Reviews, V16, P179; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baydar Hasan, 2000, Turkish Journal of Biology, V24, P503; BEDIGIAN D, 1986, ECON BOT, V40, P137, DOI 10.1007/BF02859136; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Champa WAH, 2014, POSTHARVEST BIOL TEC, V91, P57, DOI 10.1016/j.postharvbio.2013.12.014; Chen F, 2017, CRIT REV PLANT SCI, V36, P311, DOI 10.1080/07352689.2018.1441103; Cui CQ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01189; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; de Vetten N, 1999, P NATL ACAD SCI USA, V96, P778, DOI 10.1073/pnas.96.2.778; Dong Y, 2014, BIOCHEM BIOPH RES CO, V450, P453, DOI 10.1016/j.bbrc.2014.05.139; Dossa K, 2019, PLANT BIOTECHNOL J, V17, P1788, DOI 10.1111/pbi.13100; Falusi OA, 2007, AFR J BIOTECHNOL, V6, P2780; Gonzalez A, 2016, DEV BIOL, V419, P54, DOI 10.1016/j.ydbio.2016.03.031; Guo BH, 2013, THEOR APPL GENET, V126, P1419, DOI 10.1007/s00122-013-2100-2; Guo Y, 2013, THEOR APPL GENET, V126, P1445, DOI 10.1007/s00122-013-2063-3; Gutierrez E, 1999, AGRONOMIA TROP, V44, P513; Huang C, 2017, PLANT BIOTECHNOL J, V15, P1374, DOI 10.1111/pbi.12722; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kaler AS, 2017, THEOR APPL GENET, V130, P2203, DOI 10.1007/s00122-017-2951-z; Li C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105757; Li DH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1099-y; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li PH, 2016, NEW PHYTOL, V210, P905, DOI 10.1111/nph.13816; Liu LZ, 2012, THEOR APPL GENET, V124, P1573, DOI 10.1007/s00122-012-1811-0; Makkena S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24140; Matsubara K, 2005, GENE, V358, P121, DOI 10.1016/j.gene.2005.05.031; Mei HX, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00636; Mei HongXian, 2013, China Oils and Fats, V38, P87; Meng L, 2015, CROP J, V3, P269, DOI 10.1016/j.cj.2015.01.001; Moazzami AA, 2006, J AM OIL CHEM SOC, V83, P719, DOI 10.1007/s11746-006-5029-7; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Pandey S. K., 2013, African Journal of Biotechnology, V12, P6061; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Pourcel L, 2007, TRENDS PLANT SCI, V12, P29, DOI 10.1016/j.tplants.2006.11.006; R Core Team, 2020, R LANG ENV STAT COMP; Shin J.-H., 2006, J STAT SOFTWARE, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Tanaka Y, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0432; Turlapati PV, 2011, PLANTA, V233, P439, DOI 10.1007/s00425-010-1298-3; Turner S.D., 2018, BIORXIV, V3, P731, DOI [10.1101/005165, 10.21105/joss.00731, DOI 10.1101/005165.V1]; Wang LH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2316-4; Wang LH, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r39; Wang Q, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090701; Wei X, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01169; Wei X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9609; Wu K, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0274-7, 10.1186/s12870-014-0277-4]; Xu WJ, 2015, TRENDS PLANT SCI, V20, P176, DOI 10.1016/j.tplants.2014.12.001; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yano K, 2019, P NATL ACAD SCI USA, V116, P21262, DOI 10.1073/pnas.1904964116; Yano K, 2016, NAT GENET, V48, P927, DOI 10.1038/ng.3596; Yu CY, 2013, J APPL GENET, V54, P135, DOI 10.1007/s13353-012-0132-y; Zhang HY, 2016, SCI REP-UK, V6, DOI 10.1038/srep31556; Zhang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063898; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; Zhou QH, 2018, DNA RES, V25, P229, DOI 10.1093/dnares/dsx052; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096	60	8	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251526	10.1371/journal.pone.0251526	http://dx.doi.org/10.1371/journal.pone.0251526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019554	gold, Green Submitted, Green Published			2022-12-26	WOS:000664632300025
J	Manfio, VM; Tasca, KI; Garcia, JL; Gois, JD; Correa, CR; de Souza, LD				Manfio, Vanessa Martinez; Tasca, Karen Ingrid; Garcia, Jessica Leite; Gois, Janaina de Oliveira; Correa, Camila Renata; de Souza, Lenice do Rosario			Redox imbalance is related to HIV and pregnancy	PLOS ONE			English	Article							OXIDATIVE STRESS; MARKERS	Redox imbalance may compromise the homeostasis of physiological processes indispensable to gestational development in HIV-infected women. The present study aims to evaluate markers of the redox system in the development of pregnancy of these women. HIV-positive pregnant women, HIV-negative pregnant women and non-pregnant were studied. Redox markers superoxide dismutase (SOD), catalase (CAT), protein carbonylation and malondialdehyde (MDA) were assessed at first or second trimester, third trimester and postpartum from pregnant and from non-pregnant women. According to the longitudinal analysis model, CAT activity was increased in the postpartum in HIV-positive women and before delivery in HIV-negative women. Increased carbonylation was observed in the pre-delivery period of HIV-negative pregnant women and MDA concentrations were higher in HIV-positive pregnant women compared to those non-infected by HIV at all times. According to the factorial model, higher SOD and CAT activities were observed in HIV-positive women in the initial months of pregnancy and in non-pregnant women. Carbonylation at third trimester was more evident in HIV-negative pregnant women. MDA levels were higher in HIV-positive pregnant women. Increased oxidative stress may occur in HIV-infected pregnant women. Nevertheless, the HIV virus is not solely responsible for this process; instead, mechanisms inherent to the pregnancy seem to play a role in this imbalance.	[Manfio, Vanessa Martinez; Gois, Janaina de Oliveira; de Souza, Lenice do Rosario] Sao Paulo State Univ UNESP Botucatu Brazil, Dept Trop Dis, Botucatu, SP, Brazil; [Tasca, Karen Ingrid] Sao Paulo State Univ UNESP Botucatu Brazil, Dept Microbiol & Immunol, Botucatu, SP, Brazil; [Garcia, Jessica Leite; Correa, Camila Renata] Sao Paulo State Univ UNESP Botucatu Brazil, Dept Med Clin, Botucatu, SP, Brazil		Manfio, VM (corresponding author), Sao Paulo State Univ UNESP Botucatu Brazil, Dept Trop Dis, Botucatu, SP, Brazil.	vanessamanfio@hotmail.com	Garcia, Jessica/Q-8779-2018; Tasca, Karen Ingrid/L-5062-2014; martinez manfio, vanessa/C-8224-2019	Garcia, Jessica/0000-0002-3670-243X; Tasca, Karen Ingrid/0000-0002-3664-3978; do Rosario de Souza, Lenice/0000-0003-1948-5071; martinez manfio, vanessa/0000-0003-2996-0526; Correa, Camila Renata/0000-0001-8493-5329	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP and Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior - CAPES.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Anderson SM, 2018, ENVIRON INT, V121, P1, DOI 10.1016/j.envint.2018.08.042; Aquaro S., 2008, FUT HIV THER, V2, P327, DOI DOI 10.2217/17469600.2.4.327; Basu J, 2015, OBSTET GYNECOL INT, V2015, DOI 10.1155/2015/276095; Bilbis LS, 2010, ANN AFR MED, V9, P235, DOI 10.4103/1596-3519.70963; CROUCH RK, 1991, J OCUL PHARMACOL, V7, P253, DOI 10.1089/jop.1991.7.253; Ramos BRD, 2016, CELL STRESS CHAPERON, V21, P755, DOI 10.1007/s12192-016-0715-3; de Lucca L, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010018; DelmasBeauvieux MC, 1996, AM J CLIN NUTR, V64, P101, DOI 10.1093/ajcn/64.1.101; Drain PK, 2007, AM J CLIN NUTR, V85, P333, DOI 10.1093/ajcn/85.2.333; Ekun OA, 2018, MED SCI MONIT BASIC, V24, P225, DOI 10.12659/MSMBR.910660; Gil L, 2003, PHARMACOL RES, V47, P217, DOI 10.1016/S1043-6618(02)00320-1; Gonzalez BI., 2014, BIOMEDICINE AGING PA, V4, P235; Gupta S, 2005, OBSTET GYNECOL SURV, V60, P807, DOI 10.1097/01.ogx.0000193879.79268.59; Hernandez S, 2017, JAIDS-J ACQ IMM DEF, V75, pE113, DOI 10.1097/QAI.0000000000001334; Hulgan T, 2003, CLIN INFECT DIS, V37, P1711, DOI 10.1086/379776; Ibeh BO, 2008, INT J STD AIDS, V19, P536, DOI 10.1258/ijsa.2008.008031; Ivanov AV, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8910396; Korovay S, 2019, Georgian Med News, P20; Kumar A, 2010, INDIAN J CLIN BIOCHE, V25, P411, DOI 10.1007/s12291-010-0067-1; Li HW, 2016, OBSTET GYNECOL INT, V2016, DOI 10.1155/2016/3865454; Mandas A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/749575; Martin JA, 2001, JAMA-J AM MED ASSOC, V285, P1444, DOI 10.1001/jama.285.11.1444; Mert I, 2012, J OBSTET GYNAECOL RE, V38, P658, DOI 10.1111/j.1447-0756.2011.01771.x; Mesquita CS, 2014, ANAL BIOCHEM, V458, P69, DOI 10.1016/j.ab.2014.04.034; Ngondi Judith L, 2006, AIDS Res Ther, V3, P19, DOI 10.1186/1742-6405-3-19; Osuji FN., 2018, J BIOMED SCI, V3, P53; Ramiro-Cortijo D, 2016, PLACENTA, V47, P37, DOI 10.1016/j.placenta.2016.08.090; Samarghandian S, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/2645237; Sharma B, 2014, CURR HIV RES, V12, P13, DOI 10.2174/1570162X12666140402100959; Smith Reuben L., 2013, Frontiers in Genetics, V3, P328, DOI 10.3389/fgene.2012.00328; Stark MJ, 2013, REPRODUCTION, V146, P243, DOI 10.1530/REP-13-0239; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; Taravati A, 2018, TAIWAN J OBSTET GYNE, V57, P779, DOI 10.1016/j.tjog.2018.10.002; Tasca KI, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9834803; Yuksel S, 2015, TURK J MED SCI, V45, P454, DOI 10.3906/sag-1311-72	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251619	10.1371/journal.pone.0251619	http://dx.doi.org/10.1371/journal.pone.0251619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019550	Green Published, gold			2022-12-26	WOS:000664632300027
J	Usumura, M; Kishimoto, R; Ishii, K; Hotta, E; Kershaw, J; Higashi, T; Obata, T; Suga, M				Usumura, Masashi; Kishimoto, Riwa; Ishii, Koki; Hotta, Eika; Kershaw, Jeff; Higashi, Tatsuya; Obata, Takayuki; Suga, Mikio			Longitudinal stability of a multimodal visco-elastic polyacrylamide gel phantom for magnetic resonance and ultrasound shear-wave elastography	PLOS ONE			English	Article							FIBROSIS	We evaluated the long-term stability of a newly developed viscoelastic phantom made of polyacrylamide (PAAm) gel for magnetic resonance elastography (MRE) and ultrasound-based shear-wave elastography (US SWE). The stiffness of the cylindrical phantom was measured at 0, 13 and 18 months. Storage and loss moduli were measured with MRE, and shear-wave speed (SWS) was measured with US SWE. Long-term stability was evaluated in accordance with the Quantitative Imaging Biomarker Alliance (QIBA) profiles for each modality. The initial storage and loss moduli of the phantom were 5.01 +/- 0.22 and 1.11 +/- 0.15 respectively, and SWS was 2.57 +/- 0.04 m/s. The weight of the phantom decreased by 0.6% over the 18 months. When measured with MRE, the stiffness of the phantom decreased and changes to the storage and loss moduli were -3.0% and -4.6% between 0 and 13 months, and -4.3% and 0.0% between 0 and 18 months. The US measurements found that SWS decreased by 2.4% over the first 13 months and 3.6% at 18 months. These changes were smaller than the tolerances specified in the QIBA profiles, so the viscoelastic PAAm gel phantom fulfilled the condition for long-term stability. This new phantom has the potential to be used as a quality assurance and quality control phantom for MRE and US SWE.	[Usumura, Masashi; Kishimoto, Riwa; Ishii, Koki] Chiba Univ, Grad Sch Sci & Engn, Dept Med Engn, Chiba, Japan; [Kishimoto, Riwa; Hotta, Eika] QST Hosp, Natl Inst Quantum, Chiba, Japan; [Kishimoto, Riwa; Hotta, Eika] QST Hosp, Natl Inst Radiol Sci & Technol, Chiba, Japan; [Kershaw, Jeff; Obata, Takayuki] Natl Inst Radiol Sci, Appl MRI Res, Chiba, Japan; [Kershaw, Jeff; Obata, Takayuki] Natl Inst Quantum, Chiba, Japan; [Kershaw, Jeff; Obata, Takayuki] Natl Inst Radiol Sci & Technol, Chiba, Japan; [Higashi, Tatsuya] Natl Inst Radiol Sci, Dept Mol Imaging & Theranost, Chiba, Japan; [Higashi, Tatsuya] Natl Inst Radiol Sci, Chiba, Japan; [Higashi, Tatsuya] Natl Inst Quantum, Chiba, Japan; [Higashi, Tatsuya] Natl Inst Radiol Sci & Technol, Chiba, Japan; [Suga, Mikio] Chiba Univ, Ctr Frontier Med Engn, Chiba, Japan	Chiba University; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Chiba University	Kishimoto, R (corresponding author), QST Hosp, Natl Inst Quantum, Chiba, Japan.; Kishimoto, R (corresponding author), QST Hosp, Natl Inst Radiol Sci & Technol, Chiba, Japan.	kishimoto.riwa@qst.go.jp		Obata, Takayuki/0000-0001-7678-5033; Suga, Mikio/0000-0003-1663-7092	MEXT; JSPS [JP17H02115, JP17H05279, JP19K08242]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by MEXT and JSPS Grants-in-Aid for Scientific Research on Innovative Areas, Grant No. JP17H02115, No. JP17H05279 and No. JP19K08242. There was no additional external funding received for this study.	Asbach P, 2010, RADIOLOGY, V257, P80, DOI 10.1148/radiol.10092489; Barr RG, 2015, RADIOLOGY, V276, P845, DOI 10.1148/radiol.2015150619; Barr RG, 2015, ULTRASOUND MED BIOL, V41, P1148, DOI 10.1016/j.ultrasmedbio.2015.03.008; Charrier EE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02906-9; Cosgrove D, 2017, ULTRASOUND MED BIOL, V43, P4, DOI 10.1016/j.ultrasmedbio.2016.06.022; Glaser KJ, 2003, MAGNET RESON MED, V50, P1256, DOI 10.1002/mrm.10641; Goertz RS, 2011, EUR J RADIOL, V80, pE226, DOI 10.1016/j.ejrad.2010.09.025; Hall TJ, 2013, IEEE INT ULTRA SYM, P397, DOI 10.1109/ULTSYM.2013.0103; Kershaw J., 2014, JOINT ANN M ISMRM ES, P3237; Kishimoto R, 2019, EUR RADIOL, V29, P5999, DOI 10.1007/s00330-019-06195-8; Kishimoto R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013925; Mansy HA, 2008, PHYS MED BIOL, V53, P2115, DOI 10.1088/0031-9155/53/8/008; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Palmeri M, 2015, 2015 IEEE INT ULTR S, P1; Palmeri ML, 2008, ULTRASOUND MED BIOL, V34, P546, DOI 10.1016/j.ultrasmedbio.2007.10.009; Quantitative Imaging Biomarkers Alliance, ULTR SWS BIOM COMM; Quantitative Imaging Biomarkers Alliance, MR EL BIOM COMM; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Suga M, 2020, IEEE INT ULTRA SYM; Sullivan DC, 2015, RADIOLOGY, V277, P813, DOI 10.1148/radiol.2015142202; Uffmann K, 2008, IEEE ENG MED BIOL, V27, P28, DOI 10.1109/EMB.2007.910268; Urban Matthew, 2017, 2017 IEEE International Ultrasonics Symposium (IUS), DOI 10.1109/ULTSYM.2017.8091625; Yu, 2009, P INT SOC MAGN RES M, P2506; Zhou BR, 2018, J MECH BEHAV BIOMED, V85, P109, DOI 10.1016/j.jmbbm.2018.05.041	24	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0250667	10.1371/journal.pone.0250667	http://dx.doi.org/10.1371/journal.pone.0250667			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019551	gold, Green Published			2022-12-26	WOS:000664632300012
J	Frenster, JD; Stephan, G; Ravn-Boess, N; Bready, D; Wilcox, J; Kieslich, B; Wilde, C; Straeter, N; Wiggin, GR; Liebscher, I; Schoeneberg, T; Placantonakis, DG				Frenster, Joshua D.; Stephan, Gabriele; Ravn-Boess, Niklas; Bready, Devin; Wilcox, Jordan; Kieslich, Bjoern; Wilde, Caroline; Straeter, Norbert; Wiggin, Giselle R.; Liebscher, Ines; Schoeneberg, Torsten; Placantonakis, Dimitris G.			Functional impact of intramolecular cleavage and dissociation of adhesion G protein-coupled receptor GPR133 (ADGRD1) on canonical signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LATROTOXIN CIRL; CONSTITUTIVE ACTIVITY; ACTIVATION MECHANISM; PROTEOLYTIC CLEAVAGE; TETHERED AGONISM; ANGIOGENESIS; BINDING; DOMAIN; VASCULOSTATIN; MIGRATION	GPR133 (ADGRD1), an adhesion G protein-coupled receptor (GPCR) whose canonical signaling activates GaS-mediated generation of cytosolic cAMP, has been shown to be necessary for the growth of glioblastoma (GBM), a brain malignancy. The extracellular N terminus of GPR133 is thought to be autoproteolytically cleaved into N-terminal and C-terminal fragments (NTF and CTF, respectively). However, the role of this cleavage in receptor activation remains unclear. Here, we used subcellular fractionation and immunoprecipitation approaches to show that the WT GPR133 receptor is cleaved shortly after protein synthesis and generates significantly more canonical signaling than an uncleavable point mutant GPR133 (H543R) in patient-derived GBM cultures and HEK293T cells. After cleavage, the resulting NTF and CTF remain noncovalently bound to each other until the receptor is trafficked to the plasma membrane, where we demonstrated NTF-CTF dissociation occurs. Using a fusion of the CTF of GPR133 and the N terminus of thrombin-activated human protease-activated receptor 1 as a controllable proxy system to test the effect of intramolecular cleavage and dissociation, we also showed that thrombin-induced cleavage and shedding of the human protease-activated receptor 1 NTF increased intracellular cAMP levels. These results support a model wherein dissociation of the NTF from the CTF at the plasma membrane promotes GPR133 activation and downstream signaling. These findings add depth to our understanding of the molecular life cycle and mechanism of action of GPR133 and provide critical insights that will inform therapeutic targeting of GPR133 in GBM.	[Frenster, Joshua D.; Stephan, Gabriele; Ravn-Boess, Niklas; Bready, Devin; Wilcox, Jordan; Placantonakis, Dimitris G.] NYU, Dept Neurosurg, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Frenster, Joshua D.; Placantonakis, Dimitris G.] NYU, Kimmel Ctr Stem Cell Biol, Grossman Sch Med, New York, NY 10003 USA; [Kieslich, Bjoern; Straeter, Norbert] Univ Leipzig, Ctr Biotechnol & Biomed, Inst Bioanalyt Chem, Leipzig, Germany; [Wilde, Caroline; Liebscher, Ines; Schoeneberg, Torsten] Univ Leipzig, Med Fac, Rudolf Schonheimer Inst Biochem, Leipzig, Germany; [Wiggin, Giselle R.] Heptares Therapeut Ltd, Cambridge, England; [Placantonakis, Dimitris G.] NYU, Laura & Isaac Perlmutter Canc Ctr, Grossman Sch Med, New York, NY 10003 USA; [Placantonakis, Dimitris G.] NYU, Brain & Spine Tumor Ctr, Grossman Sch Med, New York, NY 10003 USA; [Placantonakis, Dimitris G.] NYU, Grossman Sch Med, Neurosci Inst, New York, NY 10003 USA	New York University; New York University; Leipzig University; Leipzig University; Heptares Therapeutics Ltd.; New York University; New York University; New York University	Placantonakis, DG (corresponding author), NYU, Dept Neurosurg, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU, Kimmel Ctr Stem Cell Biol, Grossman Sch Med, New York, NY 10003 USA.; Placantonakis, DG (corresponding author), NYU, Laura & Isaac Perlmutter Canc Ctr, Grossman Sch Med, New York, NY 10003 USA.; Placantonakis, DG (corresponding author), NYU, Brain & Spine Tumor Ctr, Grossman Sch Med, New York, NY 10003 USA.; Placantonakis, DG (corresponding author), NYU, Grossman Sch Med, Neurosci Inst, New York, NY 10003 USA.	dimitris.placantonakis@nyulangone.org		Wilde, Caroline/0000-0003-4548-1760; Frenster, Joshua/0000-0003-2401-1575; Wiggin, Giselle/0000-0003-4436-9208; Placantonakis, Dimitris/0000-0003-1950-2978	NYSTEM Stem Cell Biology training grant [C322560GG]; DFG postdoctoral fellowship [STE 2843/1-1]; T32 Cell Biology training Grant [T32GM136542]; DFG [266022790 P4, 209933838 B6, 421152132]; NIH/NINDS [R01 NS102665]; NYSTEM (NY State Stem Cell Science) [IIRP C32595GG]; NIH/NIBIB [R01 EB028774]; DFG (German Research Foundation) FOR2149; NYU Perlmutter Cancer Center Support Grant [P30CA016087]; NYU Grossman School of Medicine	NYSTEM Stem Cell Biology training grant; DFG postdoctoral fellowship(German Research Foundation (DFG)); T32 Cell Biology training Grant; DFG(German Research Foundation (DFG)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NYSTEM (NY State Stem Cell Science); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); DFG (German Research Foundation) FOR2149(German Research Foundation (DFG)); NYU Perlmutter Cancer Center Support Grant; NYU Grossman School of Medicine	J. D. F. was supported by a NYSTEM Stem Cell Biology training grant to NYU Grossman School of Medicine (#C322560GG). G. S. was supported by a DFG postdoctoral fellowship (STE 2843/1-1). N. R. -B. was supported by a T32 Cell Biology training Grant (T32GM136542) to NYU Grossman School of Medicine. I. L. and T. S. were supported by DFG FOR2149 (project numbers 266022790 P4 to T. S. and P5 to I. L.), CRC1052 (project number 209933838 B6), and CRC1423 (project number 421152132). D. G. P. was supported by NIH/NINDS R01 NS102665, NYSTEM (NY State Stem Cell Science) IIRP C32595GG, NIH/NIBIB R01 EB028774 (to Dr Steven Baete at NYU Grossman School of Medicine), NYU Grossman School of Medicine, and DFG (German Research Foundation) FOR2149 as a Mercator fellow. The NYU Microscopy Core facility was supported by the NYU Perlmutter Cancer Center Support Grant P30CA016087. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe J, 2002, J BIOL CHEM, V277, P23391, DOI 10.1074/jbc.M110877200; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bayin NS, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.63; Bayin NS, 2017, ONCOTARGET, V8, P64932, DOI 10.18632/oncotarget.18117; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Bruser A, 2016, J BIOL CHEM, V291, P508, DOI 10.1074/jbc.M115.701102; Cork SM, 2012, ONCOGENE, V31, P5144, DOI 10.1038/onc.2012.1; Frenster J. D., 2020, NEUROONCOL ADV, V2; Frenster JD, 2018, METHODS MOL BIOL, V1741, P63, DOI 10.1007/978-1-4939-7659-1_4; Frenster JD, 2017, NEUROSURGERY, V64, P177, DOI 10.1093/neuros/nyx227; Gray JX, 1996, J IMMUNOL, V157, P5438; Hovelson DH, 2015, NEOPLASIA, V17, P385, DOI 10.1016/j.neo.2015.03.004; Hsiao CC, 2015, INT J BIOCHEM CELL B, V65, P197, DOI 10.1016/j.biocel.2015.06.007; Hsiao CC, 2011, FEBS LETT, V585, P313, DOI 10.1016/j.febslet.2010.12.005; Hsiao CC, 2009, FEBS LETT, V583, P3285, DOI 10.1016/j.febslet.2009.09.001; Huang YS, 2012, MOL CELL BIOL, V32, P1408, DOI 10.1128/MCB.06557-11; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kishore A, 2016, J BIOL CHEM, V291, P3385, DOI 10.1074/jbc.M115.689349; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Krasnoperov V, 1999, J BIOL CHEM, V274, P3590, DOI 10.1074/jbc.274.6.3590; Langenhan T, 2020, BASIC CLIN PHARMACOL, V126, P5, DOI 10.1111/bcpt.13223; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Liebscher I, 2016, HANDB EXP PHARMACOL, V234, P111, DOI 10.1007/978-3-319-41523-9_6; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Lin HH, 2010, ADV EXP MED BIOL, V706, P49; Maser RL, 2020, CELL SIGNAL, V72, DOI 10.1016/j.cellsig.2020.109637; Mathiasen S, 2020, NAT CHEM BIOL, V16, P1343, DOI 10.1038/s41589-020-0617-7; Mehrotra M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181968; Morgan RK, 2019, ANN NY ACAD SCI, V1456, P5, DOI 10.1111/nyas.14094; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Patra C, 2013, P NATL ACAD SCI USA, V110, P16898, DOI 10.1073/pnas.1304837110; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Salzman GS, 2017, P NATL ACAD SCI USA, V114, P10095, DOI 10.1073/pnas.1708810114; Schoneberg T, 2016, PHARMACOL RES, V108, P9, DOI 10.1016/j.phrs.2016.03.027; Scholz N, 2016, HANDB EXP PHARMACOL, V234, P221, DOI 10.1007/978-3-319-41523-9_10; Schulze A, 2020, FASEB J, V34, P11243, DOI 10.1096/fj.202000100R; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Vallon M, 2006, J BIOL CHEM, V281, P34179, DOI 10.1074/jbc.M605291200; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Wilde C, 2016, FASEB J, V30, P666, DOI 10.1096/fj.15-276220; Yang LY, 2017, ACTA PHARMACOL SIN, V38, P56, DOI 10.1038/aps.2016.89; Zhu BK, 2019, J BIOL CHEM, V294, P19246, DOI 10.1074/jbc.RA119.008234	48	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100798	10.1016/j.jbc.2021.100798	http://dx.doi.org/10.1016/j.jbc.2021.100798			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022221	Green Published, gold			2022-12-26	WOS:000674717300018
J	Maitra, D; Pinsky, BM; Soherawardy, A; Zheng, HY; Banerjee, R; Omary, MB				Maitra, Dhiman; Pinsky, Benjamin M.; Soherawardy, Amenah; Zheng, Haiyan; Banerjee, Ruma; Omary, M. Bishr			Protein-aggregating ability of different protoporphyrin-IX nanostructures is dependent on their oxidation and protein-binding capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM; SUBCELLULAR-LOCALIZATION; LIGAND-BINDING; SINGLET OXYGEN; PORPHYRIN NANOSTRUCTURES; SCLEROSING CHOLANGITIS; QUANTUM YIELD; MECHANISM; ALBUMIN; MODEL	Porphyrias are rare blood disorders caused by genetic defects in the heme biosynthetic pathway and are associated with the accumulation of high levels of porphyrins that become cytotoxic. Porphyrins, due to their amphipathic nature, spontaneously associate into different nanostructures, but very little is known about the cytotoxic effects of these porphyrin nanostructures. Previously, we demonstrated the unique ability of fluorescent biological porphyrins, including protoporphyrin-IX (PP-IX), to cause organelle-selective protein aggregation, which we posited to be a major mechanism by which fluorescent porphyrins exerts their cytotoxic effect. Herein, we tested the hypothesis that PP-IX-mediated protein aggregation is modulated by different PP-IX nanostructures via a mechanism that depends on their oxidizing potential and protein-binding ability. UV-visible spectrophotometry showed pH-mediated reversible transformations of PP-IX nanostructures. Biochemical analysis showed that PP-IX nanostructure size modulated PP-IX-induced protein oxidation and protein aggregation. Furthermore, albumin, the most abundant serum protein, preferentially binds PP-IX dimers and enhances their oxidizing ability. PP-IX binding quenched albumin intrinsic fluorescence and oxidized His-91 residue to Asn/Asp, likely via a previously described photo-oxidation mechanism for other proteins. Extracellular albumin protected from intracellular porphyrinogenic stress and protein aggregation by acting as a PP-IX sponge. This work highlights the importance of PP-IX nanostructures in the context of porphyrias and offers insights into potential novel therapeutic approaches.	[Maitra, Dhiman; Soherawardy, Amenah; Zheng, Haiyan; Omary, M. Bishr] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Pinsky, Benjamin M.; Banerjee, Ruma; Omary, M. Bishr] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA; [Banerjee, Ruma] Dept Biol Chem, Ann Arbor, MI USA	Rutgers State University New Brunswick; University of Michigan System; University of Michigan	Maitra, D (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	dm1401@cabm.rutgers.edu		, dhiman/0000-0002-8775-2963; Zheng, Haiyan/0000-0003-1955-1817	National Institutes of Health [DK116548, GM130183]; Honors Summer Fellowship (College of Literature, Science, and the Arts); Summer Undergraduate Research Fellowship (Department of Molecular and Integrative Physiology) at the University of Michigan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Honors Summer Fellowship (College of Literature, Science, and the Arts); Summer Undergraduate Research Fellowship (Department of Molecular and Integrative Physiology) at the University of Michigan	This work was supported by National Institutes of Health R01 grants DK116548 (M. B. O.) and GM130183 (R. B.); an Honors Summer Fellowship (College of Literature, Science, and the Arts), and a Summer Undergraduate Research Fellowship (Department of Molecular and Integrative Physiology) at the University of Michigan (B. M. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Badminton M. N., 2014, CLIN BIOCH METABOLIC, P533; Baral A, 2017, NEW J CHEM, V41, P8130, DOI 10.1039/c7nj01227f; Belcher J, 2009, J PHYS CHEM B, V113, P6020, DOI 10.1021/jp900957d; Bissell DM., 2015, ROSENBERGS MOL GENET, V5th, P731, DOI DOI 10.1016/B978-0-12-410529-4.00066-8; Brancaleon L, 2002, BIOPHYS CHEM, V96, P77, DOI 10.1016/S0301-4622(02)00035-2; BRUN A, 1991, J PHOTOCH PHOTOBIO B, V10, P285, DOI 10.1016/1011-1344(91)80015-A; Camilloni C, 2008, BIOPHYS J, V94, P4654, DOI 10.1529/biophysj.107.125799; Carter EL, 2017, J BIOL CHEM, V292, P11280, DOI 10.1074/jbc.M117.783118; Chen YZ, 2014, NANOSCALE, V6, P978, DOI 10.1039/c3nr04908f; Constantin C, 2010, NANOMEDICINE-UK, V5, P307, DOI 10.2217/NNM.09.111; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Cunha JB, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88668-9; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Dayan FE, 2011, AM SCI, V99, P236, DOI 10.1511/2011.90.236; Dini F, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055502; La DD, 2017, PHOTOCH PHOTOBIO SCI, V16, P151, DOI 10.1039/c6pp00335d; Elemans JAAW, 2006, ADV MATER, V18, P1251, DOI 10.1002/adma.200502498; Elenbaas JS, 2016, FASEB J, V30, P1798, DOI 10.1096/fj.201500111R; Evans TW, 2002, ALIMENT PHARM THER, V16, P6, DOI 10.1046/j.1365-2036.16.s5.2.x; Ezzeddine R, 2013, J BIOL CHEM, V288, P36579, DOI 10.1074/jbc.M113.511642; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Fernandez NF, 2008, J PHYS CHEM B, V112, P7592, DOI 10.1021/jp710249d; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; Gotardo F, 2017, CHEM PHYS LETT, V674, P48, DOI 10.1016/j.cplett.2017.02.055; Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276; GUNDRY RL, 2007, CLIN PROTEOMICS DIAG, P263, DOI DOI 10.1002/9783527622153.CH18; Hasobe T, 2005, J AM CHEM SOC, V127, P1216, DOI 10.1021/ja047768u; Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Imahori H, 2004, ADV FUNCT MATER, V14, P525, DOI 10.1002/adfm.200305172; INAMURA I, 1991, B CHEM SOC JPN, V64, P2005, DOI 10.1246/bcsj.64.2005; Jin CS, 2014, ADV HEALTHC MATER, V3, P1240, DOI 10.1002/adhm.201300651; Jin CS, 2013, ACS NANO, V7, P2541, DOI 10.1021/nn3058642; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Kim S, 2014, J AM CHEM SOC, V136, P11707, DOI 10.1021/ja504279r; LEHN JM, 1993, SCIENCE, V260, P1762, DOI 10.1126/science.8511582; Liu Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09563-w; Lyoumi S, 2011, GASTROENTEROLOGY, V141, P1509, DOI 10.1053/j.gastro.2011.06.078; Magna G, 2019, MOLECULES, V24, DOI 10.3390/molecules24234307; Maitra D, 2019, CELL MOL GASTROENTER, V8, P535, DOI 10.1016/j.jcmgh.2019.06.006; Maitra D, 2019, CELL MOL GASTROENTER, V8, P659, DOI 10.1016/j.jcmgh.2019.05.010; Maitra D, 2015, J BIOL CHEM, V290, P23711, DOI 10.1074/jbc.M114.636001; MARGALIT R, 1983, BIOCHEM J, V209, P547, DOI 10.1042/bj2090547; Medforth CJ, 2009, CHEM COMMUN, P7261, DOI 10.1039/b914432c; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; Rabbani G, 2019, INT J BIOL MACROMOL, V123, P979, DOI 10.1016/j.ijbiomac.2018.11.053; Saggi H, 2019, J HEPATOL, V70, P108, DOI 10.1016/j.jhep.2018.09.023; Sansaloni-Pastor S, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12040148; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Scolaro LM, 2002, J PHYS CHEM B, V106, P2453, DOI 10.1021/jp013155h; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Seo J, 2016, J AM CHEM SOC, V138, P16315, DOI 10.1021/jacs.6b08700; Shaw AK, 2008, J PHOTOCH PHOTOBIO B, V90, P187, DOI 10.1016/j.jphotobiol.2008.01.001; Singla A, 2013, J CELL SCI, V126, P3105, DOI 10.1242/jcs.123026; Sulkowski L, 2016, MOLECULES, V21, DOI 10.3390/molecules21111519; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; Takeshita K, 2004, J INVEST DERMATOL, V122, P1463, DOI 10.1111/j.0022-202X.2004.22601.x; Tanielian C, 2001, FREE RADICAL BIO MED, V30, P208, DOI 10.1016/S0891-5849(00)00460-3; Teiten MH, 2003, BRIT J CANCER, V88, P146, DOI 10.1038/sj.bjc.6600664; Tene KW, 2019, J PHYS CHEM B, V123, P5832, DOI 10.1021/acs.jpcb.9b01913; TOMITA M, 1969, BIOCHEMISTRY-US, V8, P5149, DOI 10.1021/bi00840a069; TSAI CS, 1985, BIOCHEM J, V225, P203, DOI 10.1042/bj2250203; Walter MG, 2010, J PORPHYR PHTHALOCYA, V14, P759, DOI 10.1142/S1088424610002689; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wang ZC, 2004, J AM CHEM SOC, V126, P15954, DOI 10.1021/ja045068j; Wang ZC, 2006, ADV MATER, V18, P2557, DOI 10.1002/adma.200600539; WOODBURN KW, 1991, PHOTOCHEM PHOTOBIOL, V54, P725, DOI 10.1111/j.1751-1097.1991.tb02081.x; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Zhang HB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5418; Zhang N, 2018, NANO LETT, V18, P560, DOI 10.1021/acs.nanolett.7b04701; Zhou J, 2017, BIOMATERIALS, V129, P1, DOI 10.1016/j.biomaterials.2017.03.014	76	3	3	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100778	10.1016/j.jbc.2021.100778	http://dx.doi.org/10.1016/j.jbc.2021.100778			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023387	Green Submitted, gold, Green Published			2022-12-26	WOS:000678068400006
J	White, CJ; Ellis, JM; Wolfgang, MJ				White, Cory J.; Ellis, Jessica M.; Wolfgang, Michael J.			The role of ethanolamine phosphate phospholyase in regulation of astrocyte lipid homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL PROFILING APPROACH; FATTY-ACID-METABOLISM; GENE-EXPRESSION; MESSENGER-RNA; DOCOSAHEXAENOIC ACID; ARACHIDONIC-ACID; BETA-OXIDATION; INBORN-ERRORS; BRAIN UPTAKE; PHOSPHOETHANOLAMINE	Dietary lipid composition has been shown to impact brain morphology, brain development, and neurologic function. However, how diet uniquely regulates brain lipid homeostasis compared with lipid homeostasis in peripheral tissues remains largely uncharacterized. To evaluate the lipid response to dietary changes in the brain, we assessed actively translating mRNAs in astrocytes and neurons across multiple diets. From this data, ethanolamine phosphate phospholyase (Etnppl) was identified as an astrocyte-specific fasting-induced gene. Etnppl catabolizes phosphoethanolamine (PEtN), a prominent headgroup precursor in phosphatidylethanolamine (PE) also found in other classes of neurologically relevant lipid species. Altered Etnppl expression has also previously been associated with humans with mood disorders. We evaluated the relevance of Etnppl in maintaining brain lipid homeostasis by characterizing Etnppl across development and in coregulation with PEtN-relevant genes, as well as determining the impact to the brain lipidome after Etnppl loss. We found that Etnppl expression dramatically increased during a critical window of early brain development in mice and was also induced by glucocorticoids. Using a constitutive knockout of Etnppl (Etnppl(KO)), we did not observe robust changes in expression of PEtN-related genes. However, loss of Etnppl altered the phospholipid profile in the brain, resulting in increased total abundance of PE and in polyunsaturated fatty acids within PE and phosphatidylcholine species in the brain. Together, these data suggest that brain phospholipids are regulated by the phospholyase action of the enzyme Etnppl, which is induced by dietary fasting in astrocytes.	[White, Cory J.; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Ellis, Jessica M.] East Carolina Univ, East Carolina Diabet & Obes Inst, Dept Physiol, Greenville, NC 27858 USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; University of North Carolina; East Carolina University; Johns Hopkins University	Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.; Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	mwolfga1@jhmi.edu		White, Cory/0000-0003-3350-2835	National Institutes of Health (NIH) [R01NS072241, R01DK116746, R01DK125812, F31NS102151, F99NS118713]; NIH [T32GM007445]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health (NIH) grants R01NS072241 and R01DK116746 to M. J. W., R01DK125812 to J. M. E., as well as F31NS102151 and F99NS118713 to C. J. W. C. J. W. was additionally supported by the NIH T32GM007445 training grant to the Biochemistry, Cellular and Molecular Biology Graduate Program at Johns Hopkins School of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguado-Llera D, 2011, NEUROCHEM INT, V58, P22, DOI 10.1016/j.neuint.2010.10.005; Ahmed AT, 2020, J AFFECT DISORDERS, V264, P90, DOI 10.1016/j.jad.2019.11.122; Ahmed MY, 2017, BRAIN, V140, P547, DOI 10.1093/brain/aww318; Ao MRB, 2008, AUST NZ J PSYCHIAT, V42, P995, DOI 10.1080/00048670802512073; Barone R, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00636; Borowsky AD, 2012, J LIPID RES, V53, P1920, DOI 10.1194/jlr.M028084; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; Brenna JT, 2007, PROSTAG LEUKOTR ESS, V77, P247, DOI 10.1016/j.plefa.2007.10.016; Brenna JT, 2014, J HUM EVOL, V77, P99, DOI 10.1016/j.jhevol.2014.02.017; Carter BS, 2012, PHYSIOL GENOMICS, V44, P1188, DOI 10.1152/physiolgenomics.00097.2012; Cho K. H., 2017, CLIN GENET, V113, P1; Clark-Taylor T, 2004, MED HYPOTHESES, V62, P970, DOI 10.1016/j.mehy.2004.01.011; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Crawford M. A., 2008, NOVARTIS FOUND S, P267, DOI [10.1002/9780470719862.ch16, DOI 10.1002/9780470719862.CH16]; Davis-Bruno K, 2011, BIRTH DEFECTS RES B, V92, P240, DOI 10.1002/bdrb.20311; Ding QS, 2016, J CLIN PATHOL, V69, P215, DOI 10.1136/jclinpath-2015-203042; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dutta DJ, 2018, P NATL ACAD SCI USA, V115, P11832, DOI 10.1073/pnas.1811013115; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Ellis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116587; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Ferris HA, 2017, P NATL ACAD SCI USA, V114, P1189, DOI 10.1073/pnas.1620506114; Fleshood H. L., 2016, ARCH BIOCHEM BIOPHYS, V141, P423; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heiman M, 2014, NAT PROTOC, V9, P1282, DOI 10.1038/nprot.2014.085; Horibata Y, 2018, J LIPID RES, V59, P1015, DOI 10.1194/jlr.P081620; Huigen MCDG, 2015, MOL GENET METAB, V114, P51, DOI 10.1016/j.ymgme.2014.10.016; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Jemberg JN, 2017, J NEUROCHEM, V142, P407, DOI 10.1111/jnc.14072; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kroll JR, 2013, J COMP NEUROL, V521, P3500, DOI 10.1002/cne.23364; Lamari F, 2015, J INHERIT METAB DIS, V38, P3, DOI 10.1007/s10545-014-9764-x; Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062; Lee J, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-23; Leishman E, 2016, BBA-MOL CELL BIOL L, V1861, P491, DOI 10.1016/j.bbalip.2016.03.003; Leventoux N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62145-1; Lin LE, 2015, J LIPID RES, V56, P390, DOI 10.1194/jlr.M055590; Magomedova L, 2016, HANDB EXP PHARMACOL, V233, P73, DOI 10.1007/164_2015_1; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; Merritt JL, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.57; Mitchell RW, 2011, PROSTAG LEUKOTR ESS, V85, P293, DOI 10.1016/j.plefa.2011.04.007; Murphy Robert C, 2011, Biochim Biophys Acta, V1811, P635, DOI 10.1016/j.bbalip.2011.09.003; Norton WT., 1984, MYELIN, P147, DOI DOI 10.1007/978-1-4757-1830-0_5; PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; Roberts SJ, 2004, BIOCHEM J, V382, P59, DOI 10.1042/BJ20040511; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Salvati S, 2000, DEV NEUROSCI-BASEL, V22, P481, DOI 10.1159/000017479; Schiroli D, 2015, BBA-PROTEINS PROTEOM, V1854, P1200, DOI 10.1016/j.bbapap.2015.02.023; Schiroli D, 2015, FEBS J, V282, P183, DOI 10.1111/febs.13122; Schiroli D, 2013, IUBMB LIFE, V65, P645, DOI 10.1002/iub.1178; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Schroeder FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071323; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Shao L, 2008, BIOL PSYCHIAT, V64, P89, DOI 10.1016/j.biopsych.2007.11.010; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; Stankiewicz AM, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0130-6; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Tyni T, 1999, ACTA PAEDIATR, V88, P237, DOI 10.1080/08035259950169954; Tyni T, 1997, J PEDIATR-US, V130, P67, DOI 10.1016/S0022-3476(97)70312-3; Vasconcelos AR, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00009; Vaz FM, 2019, BRAIN, V142, P3382, DOI 10.1093/brain/awz291; Veiga-da-Cunha M, 2012, J BIOL CHEM, V287, P7246, DOI 10.1074/jbc.M111.323485; Watkins PA, 2001, J MOL NEUROSCI, V16, P87, DOI 10.1385/JMN:16:2-3:87; White CJ, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00037-20; Xie ZG, 2016, CELL REP, V14, P991, DOI 10.1016/j.celrep.2016.01.004; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zheng L, 2019, ADV NUTR, V10, P1163, DOI 10.1093/advances/nmz051; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	81	3	3	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100830	10.1016/j.jbc.2021.100830	http://dx.doi.org/10.1016/j.jbc.2021.100830			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	TQ1SY	34048714	Green Published, gold			2022-12-26	WOS:000678068400032
J	Bonaparte, SC; Adams, L; Bakamutumaho, B; Costa, GB; Cleaton, JM; Gilbert, AT; Osinubi, M; Pieracci, EG; Recuenco, S; Tugumizemu, V; Wamala, J; Wallace, RM				Bonaparte, Sarah C.; Adams, Laura; Bakamutumaho, Barnabas; Costa, Galileu Barbosa; Cleaton, Julie M.; Gilbert, Amy T.; Osinubi, Modupe; Pieracci, Emily G.; Recuenco, Sergio; Tugumizemu, Victor; Wamala, Joseph; Wallace, Ryan M.			Rabies post-exposure healthcare-seeking behaviors and perceptions: Results from a knowledge, attitudes, and practices survey, Uganda, 2013	PLOS ONE			English	Article							ANIMAL BITE INJURIES; CANINE RABIES; VACCINATION; ELIMINATION; PREVENTION; MANAGEMENT; INFECTION; DEATHS; BURDEN	Background Rabies is a viral disease of animals and people causing fatal encephalomyelitis if left untreated. Although effective pre- and post-exposure vaccines exist, they are not widely available in many endemic countries within Africa. Since many individuals in these countries remain at risk of infection, post-exposure healthcare-seeking behaviors are crucial in preventing infection and warrant examination. Methodology A rabies knowledge, attitudes, and practices survey was conducted at 24 geographically diverse sites in Uganda during 2013 to capture information on knowledge concerning the disease, response to potential exposure events, and vaccination practices. Characteristics of the surveyed population and of the canine-bite victim sub-population were described. Post-exposure healthcare-seeking behaviors of canine-bite victims were examined and compared to the related healthcare-seeking attitudes of non-bite victim respondents. Wealth scores were calculated for each household, rabies knowledge was scored for each non-bitten survey respondent, and rabies exposure risk was scored for each bite victim. Logistic regression was used to determine the independent associations between different variables and healthcare-seeking behaviors among canine-bite victims as well as attitudes of non-bitten study respondents. Results A total of 798 households were interviewed, capturing 100 canine-bite victims and a bite incidence of 2.3 per 100 person-years. Over half of bite victims actively sought medical treatment (56%), though very few received rabies post-exposure prophylaxis (3%). Bite victims who did not know or report the closest location where PEP could be received were less likely to seek medical care (p = 0.05). Respondents who did not report having been bitten by a dog with higher knowledge scores were more likely to respond that they would both seek medical care (p = 0.00) and receive PEP (p = 0.06) after a potential rabies exposure event. Conclusions There was varying discordance between what respondents who did not report having been bitten by a dog said they would do if bitten by a dog when compared to the behaviors exhibited by canine-bite victims captured in the KAP survey. Bite victims seldom elected to wash their wound or receive PEP. Having lower rabies knowledge was a barrier to theoretically seeking care and receiving PEP among not bitten respondents, indicating a need for effective and robust educational programs in the country.	[Bonaparte, Sarah C.; Costa, Galileu Barbosa; Cleaton, Julie M.; Gilbert, Amy T.; Osinubi, Modupe; Pieracci, Emily G.; Recuenco, Sergio; Wallace, Ryan M.] US Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Bonaparte, Sarah C.; Costa, Galileu Barbosa; Cleaton, Julie M.] US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Adams, Laura] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Bakamutumaho, Barnabas] Uganda Virus Res Inst, Kampala, Uganda; [Tugumizemu, Victor] Minist Hlth, Vet Publ Hlth Div, Kampala, Uganda; [Wamala, Joseph] WHO, Kampala, Uganda	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Uganda Virus Research Institute; World Health Organization	Bonaparte, SC (corresponding author), US Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.; Bonaparte, SC (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	sarahcbonaparte@gmail.com	Costa, Galileu/C-3319-2014	Costa, Galileu/0000-0001-7360-6722; Bonaparte, Sarah/0000-0002-2809-1720; Gilbert, Amy T./0000-0002-8256-0081; Pieracci, Emily/0000-0002-7735-6051	USAID	USAID(United States Agency for International Development (USAID))	Fieldwork funded by USAID Emerging Pandemic Threats contract to the CDC National Center for Emerging and Zoonotic Infectious Diseases in Atlanta, Georgia, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alie A., 2015, INT J BASIC APPL VIR, V4, P28, DOI [10.5829/idosi.ijbav.2015.4.1.94266, DOI 10.5829/IDOSI.IJBAV.2015.4.1.94266]; Awah Ndukum J, 2003, J CAMEROON ACAD SCI, V3, P7; Costa GB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197330; Davlin SL, 2014, EPIDEMIOL INFECT, V142, P1476, DOI 10.1017/S0950268813002513; Digafe Reta T, 2015, BMC Res Notes, V8, P400, DOI 10.1186/s13104-015-1357-8; Etheart MD, 2017, LANCET GLOB HEALTH, V5, pE1017, DOI 10.1016/S2214-109X(17)30321-2; Fenelon N, 2017, EPIDEMIOL INFECT, V145, P1624, DOI 10.1017/S0950268816003125; Fevre EM, 2005, TROP MED INT HEALTH, V10, P790, DOI 10.1111/j.1365-3156.2005.01447.x; Fooks AR, 2014, LANCET, V384, P1389, DOI 10.1016/S0140-6736(13)62707-5; Frey J, 2013, TROP MED INT HEALTH, V18, P1555, DOI 10.1111/tmi.12202; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jackson C, 2019, KNOWLEDGE MANAGEMENT; Jibat T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003447; Johnson N, 2010, VET MICROBIOL, V142, P151, DOI 10.1016/j.vetmic.2010.02.001; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Launiala A, 2009, ANTHR MATTERS J, V11; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Masiira B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198568; Meslin FX, 2013, ANTIVIR RES, V98, P291, DOI 10.1016/j.antiviral.2013.03.011; Ministry of Health Uganda, ANN HLTH SECT PERF R; Monje F, 2020, ONE HEALTH OUTLOOK, V2, DOI 10.1186/s42522-020-00031-6; Mucheru GM, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.255.4745; Nantima N, 2019, REV SCI TECH OIE, V38, P315, DOI 10.20506/rst.38.1.2963; Nel LH, 2013, EMERG INFECT DIS, V19, P529, DOI 10.3201/eid1904.120185; Omodo M, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4934-y; Ravallion M, 2009, WORLD BANK ECON REV, V23, P163, DOI 10.1093/wber/lhp007; Ren MH, 2018, LANCET GLOB HEALTH, V6, pE828, DOI 10.1016/S2214-109X(18)30302-4; Sambo M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003310; Schildecker S, 2017, TRANSBOUND EMERG DIS, V64, P1433, DOI 10.1111/tbed.12531; Tran CH, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006955; Wallace RM, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00009; Wallace RM, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0306-2; Warrell MJ, 2015, CLIN MED, V15, P78, DOI 10.7861/clinmedicine.14-6-78; WHO, 2018, RAB FACT SHEET; World Health Organization, 2018, AN BIT	36	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251702	10.1371/journal.pone.0251702	http://dx.doi.org/10.1371/journal.pone.0251702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077427	Green Published, gold			2022-12-26	WOS:000664638500014
J	Cobiac, LJ; Scarborough, P				Cobiac, Linda J.; Scarborough, Peter			Modelling future trajectories of obesity and body mass index in England	PLOS ONE			English	Article							TRENDS	Background Obesity is a leading risk for poor health outcomes in England. We examined best- and worst-case scenarios for the future trajectory of the obesity epidemic. Methods Taking the last 27 years of Health Survey for England data, we determined both position and shape of the adult body mass index (BMI) distribution and projected these parameters 20 years forward in time. For the best-case scenario, we fitted linear models, allowing for a quadratic relationship between the outcome variable and time, to reflect a potential reversal in upwards trends. For the worst-case scenario, we fitted non-linear models that applied an exponential function to reflect a potential flattening of trends over time. Best-fitting models were identified using Monte Carlo cross-validation on 1991-2014 data, and predictions of population prevalence across five BMI categories were then validated using 2015-17 data. Results Both linear and non-linear models showed a close fit to observed data (mean absolute error <2%). In the best-case scenario, the proportion of the population at increased risk (BMI<greater than or equal to>25kg/m(2)) is predicted to fall from 66% in 2017 to 53% (95% confidence interval: 41% to 64%) in 2035. In the worst-case scenario, this proportion is likely to remain relatively stable overall- 64% (37% to 90%) in 2035 -but with an increasing proportion of the population at highest risk (BMI >= 35kg/m(2)). Conclusions While obesity prediction depends on chosen modelling methods, even under optimistic assumptions it is likely that the majority of the English population will still be at increased risk of disease due to their weight until at least 2035, without greater allocation of resources to effective interventions.	[Cobiac, Linda J.; Scarborough, Peter] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England	University of Oxford	Cobiac, LJ (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.	linda.cobiac@ndph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944	National Institute for Health Research Biomedical Research Centre at Oxford [BRC-1215-20008]; British Heart Foundation [FS/15/34/31656]	National Institute for Health Research Biomedical Research Centre at Oxford; British Heart Foundation(British Heart Foundation)	This work was supported by the National Institute for Health Research (www.nihr.ac.uk) Biomedical Research Centre at Oxford (BRC-1215-20008). PS is supported by a British Heart Foundation (www.bhf.org.uk) Intermediate Basic Science Fellowship (FS/15/34/31656). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancej C, 2015, HEALTH PROMOT CHRON, V35, P109, DOI 10.24095/hpcdp.35.7.02; Conolly A, 2017, HLTH SURVEY ENGLAND; Cullen AC, 1999, PROBABILISTIC TECHNI; Davies SC., 2018, ANN REPORT CHIEF MED; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Haby MM, 2012, HEALTH PROMOT INT, V27, P250, DOI 10.1093/heapro/dar036; Hastie T., 2015, STAT LEARNING SPARSI; Keaver L, 2020, SCAND J PUBLIC HEALT, V48, P422, DOI 10.1177/1403494818794814; Majer IM, 2013, STAT MED, V32, P1561, DOI 10.1002/sim.5558; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; Marmot M., 2008, MARMOT REV LONDON 20; McPherson K, 2007, FORESIGHT TACKLING O; Pell D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026698; Pineda E, 2018, OBESITY FACTS, V11, P360, DOI 10.1159/000492115; Scarborough P, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003025; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; White J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147614; Wilson R, 2018, AUST NZ J PUBL HEAL, V42, P396, DOI 10.1111/1753-6405.12804; Yamada G., 2019, INT J EPIDEMIOL; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305	22	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252072	10.1371/journal.pone.0252072	http://dx.doi.org/10.1371/journal.pone.0252072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077469	Green Published, gold			2022-12-26	WOS:000664638500025
J	Wang, Y; Yu, HT; Xie, XZ; Deng, T; Ye, LY; Wu, LJ; Ding, XW; Yang, Z; Zhu, QD; Li, JJ; Zheng, YH; Yu, ZP; Chen, G				Wang, Yi; Yu, Haitao; Xie, Xiaozai; Deng, Tuo; Ye, Longyun; Wu, Lijun; Ding, Xiwei; Yang, Zhen; Zhu, Qiandong; Li, Junjian; Zheng, Yihu; Yu, Zhengping; Chen, Gang			Plasmalemma vesicle-associated protein promotes angiogenesis in cholangiocarcinoma via the DKK1/CKAP4/PI3K signaling pathway	ONCOGENE			English	Article							GROWTH-FACTOR; INTRAHEPATIC CHOLANGIOCARCINOMA; GALLBLADDER CARCINOMA; PROGNOSTIC-FACTORS; PHASE-II; VEGF; GEMCITABINE; EXPRESSION; RECEPTOR; ENDOTHELIUM	Cholangiocarcinoma (CCA) is aggressive and has poor clinical outcomes because of typically delayed diagnosis and a lack of effective non-surgical therapeutic options. Recent studies have shown that plasmalemma vesicle-associated protein (PLVAP) is related to angiogenesis in various tumors, and in vivo PLVAP targeting therapy has been proven effective against hepatocellular carcinoma and pancreatic cancer. The goal of this study was to determine the potential therapeutic utility of targeting PLVAP and thus angiogenesis in CCA and explore the underlying molecular mechanisms. We found that the PLVAP expression levels were significantly higher in CCA tissues when compared with matched adjacent non-tumor tissues obtained from a total of 90 CCA patients; higher expression levels of PLVAP were associated with shorter overall survival of patients. In addition, overexpression of PLVAP was associated with higher micro-vessel density in CCA tissues. In a PLVAP overexpressing CCA patient-derived xenograft model, a novel humanized anti-PLVAP antibody in combination with Gemcitabine plus Cisplatin was significantly inhibited tumor growth. Molecular analysis of CCA cells co-cultured with human umbilical vascular endothelial cells or human hepatic sinusoidal endothelial cells showed that Dickkopf-related protein 1 (DKK1) secreted by CCA cells activated the PI3K/Akt pathway after binding to its receptor, cytoskeleton-associated protein 4 (CKAP4), resulting in the upregulation of PLVAP. Thus, CCA cells increased the angiogenic potency of endothelial cells in a paracrine fashion. Consistently, patients bearing CKAP4 and PLVAP overexpressing tumors had a poor prognosis. In conclusion, the DKK1/CKAP4/PI3K/PLVAP pathway increases angiogenesis in CCA and is therefore a potential anti-angiogenic target.	[Wang, Yi] Wenzhou Med Univ, Sch Publ Hlth & Management, Div Prevent Med, Wenzhou, Peoples R China; [Yu, Haitao; Xie, Xiaozai; Deng, Tuo; Ye, Longyun; Wu, Lijun; Zhu, Qiandong; Li, Junjian; Zheng, Yihu; Yu, Zhengping; Chen, Gang] Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Di, Affiliated Hosp 1, Wenzhou, Peoples R China; [Yu, Haitao; Xie, Xiaozai; Deng, Tuo; Ye, Longyun; Wu, Lijun; Zhu, Qiandong; Li, Junjian; Zheng, Yihu; Yu, Zhengping; Chen, Gang] Wenzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Wenzhou, Peoples R China; [Ding, Xiwei] Nanjing Univ, Dept Gastroenterol, Affiliated Hosp, Med Sch,Nanjing Drum Tower Hosp, Nanjing, Jiangsu, Peoples R China; [Yang, Zhen] Shandong Univ, Dept Infect Dis, Shandong Prov Hosp, Jinan, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Nanjing University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Wang, Y (corresponding author), Wenzhou Med Univ, Sch Publ Hlth & Management, Div Prevent Med, Wenzhou, Peoples R China.; Chen, G (corresponding author), Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Di, Affiliated Hosp 1, Wenzhou, Peoples R China.; Chen, G (corresponding author), Wenzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Wenzhou, Peoples R China.	wang.yi@wmu.edu.cn; chen.gang@wmu.edu.cn	Chen, Gang/ABG-9894-2021	Wang, Yi/0000-0002-0558-7491	National Natural Science Foundation of China [81201953, 81772628, 82072685, 81703310]; Project of National Health Council [WKJ-ZJ-1706]; Project of Zhejiang Province [WKJ-ZJ-1706]; Natural Science Foundation of Zhejiang Province [LY17H160047]; Public Projects of Zhejiang Province [2016C37127, 2018C37114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of National Health Council; Project of Zhejiang Province; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Public Projects of Zhejiang Province	We thank Jungang Zhao, Yifan Tong, Ziyan Chen, and Mingxun Wang for discussing the paper. We also appreciate Sina Zhang for her help with statistical analysis and bioinformatics analysis. We are deeply thankful to Prof Lewis R.Roberts (Mayo Clinic, USA) for valuable advice and discussions on the paper. This work was supported by the National Natural Science Foundation of China (Grant No. 81201953, 81772628, 82072685 to GC and 81703310 to YW); the Joint Projects of National Health Council and Zhejiang Province (No.WKJ-ZJ-1706 to GC); the Natural Science Foundation of Zhejiang Province (No.LY17H160047 to GC); the Public Projects of Zhejiang Province (No.2016C37127 to ZPY and 2018C37114 to YW).	Aparicio S, 2015, NAT REV CANCER, V15, P311, DOI 10.1038/nrc3944; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Bengala C, 2010, BRIT J CANCER, V102, P68, DOI 10.1038/sj.bjc.6605458; Brechon M, 2018, INVEST NEW DRUG, V36, P156, DOI 10.1007/s10637-017-0492-6; Cassidy JW, 2015, CANCER RES, V75, P2963, DOI 10.1158/0008-5472.CAN-15-0727; Cavalloni G, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2136-1; Deharvengt SJ, 2012, J CELL MOL MED, V16, P2690, DOI 10.1111/j.1582-4934.2012.01587.x; El-Khoueiry AB, 2014, BRIT J CANCER, V110, P882, DOI 10.1038/bjc.2013.801; El-Khoueiry AB, 2012, INVEST NEW DRUG, V30, P1646, DOI 10.1007/s10637-011-9719-0; Hall C, 2017, CANCER LETT, V386, P179, DOI 10.1016/j.canlet.2016.11.025; Ioannidou S, 2006, P NATL ACAD SCI USA, V103, P16770, DOI 10.1073/pnas.0603501103; Kennedy L, 2018, HEPATOLOGY, V68, P1042, DOI 10.1002/hep.29898; Kim JH, 2008, CANCER-AM CANCER SOC, V113, P1614, DOI 10.1002/cncr.23787; Kimura H, 2019, CLIN CANCER RES, V25, P1936, DOI 10.1158/1078-0432.CCR-18-2124; Kimura H, 2016, J CLIN INVEST, V126, P2689, DOI 10.1172/JCI84658; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Matsuyama M, 2015, INVEST NEW DRUG, V33, P490, DOI 10.1007/s10637-014-0197-z; Mittal K, 2014, SEMIN ONCOL, V41, P235, DOI 10.1053/j.seminoncol.2014.02.007; Mobius C, 2007, EJSO-EUR J SURG ONC, V33, P1025, DOI 10.1016/j.ejso.2007.02.020; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Paes KT, 2011, INVEST OPHTH VIS SCI, V52, P6452, DOI 10.1167/iovs.10-7146; Peng H, 2016, ONCOTARGET, V7, P17220, DOI 10.18632/oncotarget.7948; Phoenix TN, 2016, CANCER CELL, V29, P508, DOI 10.1016/j.ccell.2016.03.002; Rantakari P, 2016, NATURE, V538, P392, DOI 10.1038/nature19814; Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101; Rizvi S, 2013, GASTROENTEROLOGY, V145, P1215, DOI 10.1053/j.gastro.2013.10.013; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Shi RY, 2013, CANCER-AM CANCER SOC, V119, P993, DOI 10.1002/cncr.27788; Shi XD, 2016, ONCOTARGET, V7, P70378, DOI 10.18632/oncotarget.11859; Shinno N, 2018, ONCOGENE, V37, P3471, DOI 10.1038/s41388-018-0179-2; Shirabe K, 2004, AM J SURG, V187, P538, DOI 10.1016/j.amjsurg.2003.12.044; Shirota T, 2015, MOL CANCER THER, V14, P1985, DOI 10.1158/1535-7163.MCT-15-0069; Shroff RT, 2017, BRIT J CANCER, V116, P1402, DOI 10.1038/bjc.2017.119; Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003; Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805; Tichauer KM, 2014, MOL IMAGING BIOL, V16, P372, DOI 10.1007/s11307-013-0692-1; Valle Juan, 2010, N Engl J Med, V362, P1273, DOI 10.1056/NEJMoa0908721; Wang YY, 2009, CLIN CANCER RES, V15, P5784, DOI 10.1158/1078-0432.CCR-09-0814; Wang Y, 2016, CANCER LETT, V380, P163, DOI 10.1016/j.canlet.2016.05.017; Xu YF, 2019, ONCOGENE, V38, P868, DOI 10.1038/s41388-018-0485-8; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Zhang JQ, 2013, AM J PATHOL, V182, P1629, DOI 10.1016/j.ajpath.2013.01.045	44	6	6	1	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2021	40	25					4324	4337		10.1038/s41388-021-01844-z	http://dx.doi.org/10.1038/s41388-021-01844-z		JUN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SY4AZ	34079085				2022-12-26	WOS:000657217400001
J	Dansako, H; Ueda, Y; Satoh, S; Kato, N				Dansako, Hiromichi; Ueda, Youki; Satoh, Shinya; Kato, Nobuyuki			Extracellular vesicles activate ATM-Chk2 signaling pathway through the intercellular transfer of mitochondrial DNA in HBV-infected human hepatocytes	FASEB JOURNAL			English	Article						ATM&#8208; Chk2 signaling pathway; extracellular vesicles; hepatitis B virus; mitochondrial DNA	CANCER; INFLAMMATION; HEPATITIS; EXOSOMES; DAMAGE; CELLS	Hepatitis B virus (HBV) is a human hepatotropic pathogen causing hepatocellular carcinoma. We recently obtained HBV-susceptible immortalized human hepatocyte NKNT-3 by exogenously expressing NTCP and its derived cell clones, #28.3.8 and #28.3.25.13 exhibiting different levels of HBV susceptibility. In the present study, we showed that HBV infection activated the ATM-Chk2 signaling pathway in #28.3.25.13 cells but not in #28.3.8 cells. Both the cell culture supernatant and extracellular vesicles (EVs) derived from HBV-infected #28.3.25.13 cells also activated the ATM-Chk2 signaling pathway in naive #28.3.25.13 cells. Interestingly, EVs derived from HBV-infected #28.3.25.13 cells included higher level of mitochondrial DNA (mtDNA) than those from HBV-infected #28.3.8 cells. Based on our results, we propose the novel model that EVs mediate the activation of ATM-Chk2 signaling pathway by the intercellular transfer of mtDNA in HBV-infected human hepatocyte.	[Dansako, Hiromichi; Ueda, Youki; Satoh, Shinya; Kato, Nobuyuki] Okayama Univ, Dept Tumor Virol, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008558, Japan	Okayama University	Dansako, H (corresponding author), Okayama Univ, Dept Tumor Virol, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	dansako@md.okayama-u.ac.jp	Dansako, Hiromichi/B-2025-2011	Dansako, Hiromichi/0000-0002-2353-3024	Japan Agency for Medical Research and Development (AMED) [JP20fk0310103, JP20fk0310107]; Wesco Foundation; Okayama Medical Foundation	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Wesco Foundation; Okayama Medical Foundation	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP20fk0310103 and JP20fk0310107; Wesco Foundation; Okayama Medical Foundation	Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862; Alminana C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020979; Chapman J, 2019, FEBS LETT, V593, P1566, DOI 10.1002/1873-3468.13498; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Dansako H, 2019, FASEB BIOADV, V1, P67, DOI 10.1096/fba.1022; Dansako H, 2016, FEBS J, V283, P144, DOI 10.1111/febs.13563; Dansako H, 2014, VIROLOGY, V462, P166, DOI 10.1016/j.virol.2014.05.017; Dansako H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003345; de Galarreta MR, 2017, NAT CELL BIOL, V19, P1008, DOI 10.1038/ncb3603; Desrochers LM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11958; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Guenat D, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080211; Haraszti RA, 2016, J EXTRACELL VESICLES, V5, DOI 10.3402/jev.v5.32570; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712; Honegger A, 2013, INT J CANCER, V133, P1631, DOI 10.1002/ijc.28164; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Imai H, 2018, BIOCHEM BIOPH RES CO, V504, P672, DOI 10.1016/j.bbrc.2018.08.195; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Kobayashi N, 2000, SCIENCE, V287, P1258, DOI 10.1126/science.287.5456.1258; Koczor CA, 2009, J BIOL CHEM, V284, P36191, DOI 10.1074/jbc.M109.036020; Maekawa H, 2019, CELL REP, V29, P1261, DOI 10.1016/j.celrep.2019.09.050; Maybury BD, 2013, ANTICANCER RES, V33, P3543; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Takasugi M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15728; Torresi J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5916-6; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Zhang L, 2019, BBA-REV CANCER, V1871, P455, DOI 10.1016/j.bbcan.2019.04.004	36	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21680	10.1096/fj.202002678R	http://dx.doi.org/10.1096/fj.202002678R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042225				2022-12-26	WOS:000655695900057
J	Li, P; Liu, CL; Qian, L; Zheng, ZY; Li, CL; Lian, ZN; Liu, J; Zhang, ZM; Wang, L				Li, Peng; Liu, Chunlei; Qian, Lei; Zheng, Zhenyu; Li, Chenglong; Lian, Zhengnan; Liu, Jie; Zhang, Zhongmin; Wang, Liang			miR-10396b-3p inhibits mechanical stress-induced ligamentum flavum hypertrophy by targeting IL-11	FASEB JOURNAL			English	Article						ligamentum flavum hypertrophy; lumbar spinal stenosis; mechanical stress; miR&#8208; 10396b&#8208; 3p	LUMBAR SPINAL STENOSIS; FIBROSIS; REGULATOR; APOPTOSIS; CELLS	Ligamentum flavum hypertrophy (LFH) leads to lumbar spinal stenosis (LSS) caused by LF tissue inflammation and fibrosis. Emerging evidence has indicated that dysregulated microRNAs (miRNAs) have an important role in inflammation and fibrosis. Mechanical stress (MS) has been explored as an initiating step in LFH pathology progression; the inflammation-related miRNAs induced after mechanical stress have been implicated in fibrosis pathology. However, the pathophysiological mechanism of MS-miRNAs-LFH remains to be elucidated. Using miRNAs sequencing analysis and subsequent confirmation with qRT-PCR assays, we identified the decreased expression of miR-10396b-3p and increased expression of IL-11 (interleukin-11) as responses to the development of LSS in hypertrophied LF tissues. We also found that IL-11 is positively correlated with fibrosis indicators of collagen I and collagen III. The up-regulation of miR-10396b-3p significantly decreased the level of IL-11 expression, whereas miR-10396b-3p down-regulation increased IL-11 expression in vitro. Luciferase reporter assay indicates that IL-11 is a direct target of miR-10396b-3p. Furthermore, cyclic mechanical stress inhibits miR-10396b-3p and induces IL-11, collagen I, and collagen III in vitro. Our results showed that overexpression of miR-10396b-3p suppresses MS-induced LFH by inhibiting collagen I and III via the inhibition of IL-11. These data suggest that the MS-miR-10396b-3p-IL-11 axis plays a key role in the pathological progression of LFH.	[Li, Peng; Liu, Chunlei; Zheng, Zhenyu; Li, Chenglong; Lian, Zhengnan; Liu, Jie; Zhang, Zhongmin; Wang, Liang] Southern Med Univ, Acad Orthoped, Affiliated Hosp 3, Dept Orthoped, Guangzhou, Guangdong, Peoples R China; [Qian, Lei] Southern Med Univ, Dept Anat, Guangdong Prov Key Lab Med Biomech, Guangzhou, Peoples R China; [Zhang, Zhongmin] Southern Med Univ, Nanfang Hosp, Div Spine Surg, Dept Orthopad, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhang, ZM; Wang, L (corresponding author), Southern Med Univ, Acad Orthoped, Affiliated Hosp 3, Dept Orthoped, Guangzhou, Guangdong, Peoples R China.	nfzzm@163.com; liang091@aliyun.com		Li, Peng/0000-0002-5027-5526	National Natural Science Foundation of China [81874013, 81702199, 31801012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81874013, 81702199, and 31801012).	Bagnato G, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0125-2016; Chang ML, 2017, J CELL PHYSIOL, V232, P3762, DOI 10.1002/jcp.25856; Chao YH, 2012, CONNECT TISSUE RES, V53, P422, DOI 10.3109/03008207.2012.685132; Chen JW, 2016, J SPINAL CORD MED, V39, P450, DOI 10.1080/10790268.2016.1141470; Chen JW, 2014, DIS MARKERS, V2014, P1, DOI 10.1155/2014/786543; Cook SA, 2020, ANNU REV MED, V71, P263, DOI 10.1146/annurev-med-041818-011649; Fernandez-Ruiz I, 2018, NAT REV CARDIOL, V15, P1, DOI 10.1038/nrcardio.2017.197; Han TS, 2019, GASTROENTEROLOGY, V156, P1140, DOI 10.1053/j.gastro.2018.11.059; Hayashi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13360-w; Hur JW, 2015, NEUROSURGERY, V77, P274, DOI 10.1227/NEU.0000000000000755; Jezek J, 2020, SPINE J, V20, P1125, DOI 10.1016/j.spinee.2020.03.002; Kim YU, 2017, PAIN PHYSICIAN, V20, pE419; Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220; Metcalfe RD, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01424; Mori T, 2017, SPINE SURG RELAT RES, V1, P211, DOI 10.22603/ssrr.1.2017-0023; Nakamura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085542; Nakatani T, 2002, J ORTHOP RES, V20, P1380, DOI 10.1016/S0736-0266(02)00046-3; Negahdaripour M, 2016, CYTOKINE GROWTH F R, V32, P41, DOI 10.1016/j.cytogfr.2016.06.002; Nguyen PM, 2019, GROWTH FACTORS, V37, P1, DOI 10.1080/08977194.2019.1620227; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Park JO, 2013, J SPINAL DISORD TECH, V26, pE6, DOI 10.1097/BSD.0b013e3182698501; Powers JC, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.119.006426; Sakai Y, 2017, J ORTHOP SCI, V22, P27, DOI 10.1016/j.jos.2016.08.007; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Shafaq N, 2012, J SPINAL DISORD TECH, V25, P107, DOI 10.1097/BSD.0b013e31820bb76e; Shojaati G, 2019, STEM CELL TRANSL MED, V8, P1192, DOI 10.1002/sctm.18-0297; Sidon E, 2019, J CELL BIOCHEM, V120, P11716, DOI 10.1002/jcb.28451; Stienen MN, 2019, SPINE J, V19, P1276, DOI 10.1016/j.spinee.2019.02.014; Sun C, 2020, FASEB J, V34, P9854, DOI 10.1096/fj.202000635R; Sun C, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171214; Sun C, 2017, BIOCHEM BIOPH RES CO, V490, P1106, DOI 10.1016/j.bbrc.2017.06.182; Wang J, 2015, CELL MOL LIFE SCI, V72, P2091, DOI 10.1007/s00018-015-1853-y; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xu YQ, 2016, SPINE, V41, P275, DOI 10.1097/BRS.0000000000001226; Yan B, 2018, CELL PHYSIOL BIOCHEM, V48, P293, DOI 10.1159/000491729; Ye S, 2019, J ORTHOP RES, V37, P2634, DOI 10.1002/jor.24425; Yuan J, 2018, THERANOSTICS, V8, P2565, DOI 10.7150/thno.22878; Zheng ZY, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00858	38	2	2	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21676	10.1096/fj.202100169RR	http://dx.doi.org/10.1096/fj.202100169RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042220				2022-12-26	WOS:000655695900067
J	Berra, TZ; Gomes, D; Ramos, ACV; Alves, YM; Bruce, ATI; Arroyo, LH; dos Santos, FL; Souza, LLL; Crispim, JD; Arcencio, RA				Berra, Thais Zamboni; Gomes, Dulce; Vieira Ramos, Antonio Carlos; Alves, Yan Mathias; Inomata Bruce, Alexandre Tadashi; Arroyo, Luiz Henrique; dos Santos, Felipe Lima; Limirio Souza, Ludmilla Leideanne; Crispim, Juliane de Almeida; Arcencio, Ricardo Alexandre			Effectiveness and trend forecasting of tuberculosis diagnosis after the introduction of GeneXpert in a city in south-eastern Brazil	PLOS ONE			English	Article							XPERT MTB/RIF ASSAY; MYCOBACTERIUM-TUBERCULOSIS; SOLID CULTURE; PERFORMANCE; LIQUID; SYSTEM; POINT; COST; TB	Background To evaluate the effectiveness of a rapid molecular test for the detection of tuberculosis (TB) and to predict the rates of disease in a municipality of Brazil where TB is endemic. Methods An ecological study was carried out in RibeirAo Preto-SP on a population of TB cases notified between 2006 and 2017. Monthly TB incidence rates and the average monthly percentage change (AMPC) were calculated. In order to identify changes in the series, the breakpoint technique was performed; the rates were modelled and predictions of the incidence of TB until 2025 were made. Results AMPC showed a fall of 0.69% per month in TB and human immunodeficiency virus (TB-HIV) co-infection, a fall of 0.01% per month in general and lung TB and a fall of 0.33% per month in extrapulmonary TB. With the breakpoint technique, general and pulmonary TB changed in structure in late 2007, and extrapulmonary TB and TB-HIV co-infection changed in structure after 2014, which is considered the cut-off point. The IMA(3) models were adjusted for general and pulmonary TB and TB-HIV co-infection, and the AR(5) models for extrapulmonary TB, and predictions were performed. Conclusions The rapid molecular test for TB is the method currently recommended by the WHO for the diagnosis of the disease and its main advantage is to provide faster, more accurate results and to already check for drug resistance. It is necessary that professionals encourage the use of this technology in order to optimize the diagnosis so that the treatment begins as quickly as possible and in an effective way. Only by uniting professionals from all areas with health policies aimed at early case identification and rapid treatment initiation it is possible to break the chain of TB transmission so that its rates decrease and the goals proposed by the WHO are achieved.	[Berra, Thais Zamboni; Vieira Ramos, Antonio Carlos; Alves, Yan Mathias; Inomata Bruce, Alexandre Tadashi; Arroyo, Luiz Henrique; dos Santos, Felipe Lima; Limirio Souza, Ludmilla Leideanne; Crispim, Juliane de Almeida; Arcencio, Ricardo Alexandre] Univ Sao Paulo, Ribeirao Preto Coll Nursing, Dept Maternal Infant & Publ Hlth Nursing, Ribeirao Preto, SP, Brazil; [Gomes, Dulce] Univ Evora, Dept Math, Evora, Portugal	Universidade de Sao Paulo; University of Evora	Berra, TZ (corresponding author), Univ Sao Paulo, Ribeirao Preto Coll Nursing, Dept Maternal Infant & Publ Hlth Nursing, Ribeirao Preto, SP, Brazil.	thaiszamboni@live.com	Inomata Bruce, Alexandre Tadashi/GPK-2777-2022; Santos, Felipe Lima dos/AAC-3102-2021; Inomata Bruce, Alexandre Tadashi/ABA-8987-2021; Alves, Yan Mathias/GLU-0281-2022	Inomata Bruce, Alexandre Tadashi/0000-0002-7008-8023; Santos, Felipe Lima dos/0000-0001-5606-9478; Alves, Yan Mathias/0000-0002-5596-0047; Berra, Thais Zamboni/0000-0002-4163-8719; Gomes, Dulce/0000-0001-8085-1945	Sao Paulo State Research Support Foundation (FAPESP) [2018/03700-7]; National Council for Scientific and Technological Development (CNPq) [04483/2018-4]	Sao Paulo State Research Support Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	TZB received funding from the Sao Paulo State Research Support Foundation (FAPESP) [Process FAPESP no 2018/03700-7] and RAA received funding from the National Council for Scientific and Technological Development (CNPq) Scholarship research productivity [Process No. 04483/2018-4].	Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10; Becketti S., 2013, INTRO TIME SERIES US; Box G., 1970, TIME SERIES ANAL; Brasil. Agencia Nacional de Vigilancia Sanitaria, 2011, B BRAS AV TECN SAUD; Brasil. Ministerio da Saude, 2020, COM NAC INC TECN SUS; Brasil. Ministerio da Saude . Secretaria de Vigil6ancia em Saude . Departamento de Vigilancia Epidemiologica, 2008, MANUAL NACL VIGIL NC; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2019, PROGR NAC CONTR TUB; Brockwell PJ, 2006, INTRO TIME SERIES FO; Cepheid, SUNN CA CEPH NEW GEN; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Choi HW, 2013, INT J TUBERC LUNG D, V17, P1328, DOI 10.5588/ijtld.13.0095; Clementino FS., 2016, TEXTO CONTEXTO, V25; Costa JD, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000399, 10.11606/s1518-8787.2018052000399]; de Lima TM., 2017, REV PAN-AMAZ SAUDE, V8, P65, DOI [10.5123/s2176-62232017000200008, DOI 10.5123/S2176-62232017000200008]; de Souza HC, 2019, REV BRAS ENFERM, V72, P1295, DOI 10.1590/0034-7167-2018-0115; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Antunes JLF, 2015, EPIDEMIOL SERV SAUDE, V24, P565, DOI 10.5123/S1679-49742015000300024; Feyzioglu B, 2014, INT J CLIN EXP MED, V7, P1084; Seidl EMF, 2007, CAD SAUDE PUBLICA, V23, P2305, DOI 10.1590/S0102-311X2007001000006; Galesi Vera Maria Neder, 2007, Rev. Saúde Pública, V41, P121, DOI 10.1590/S0034-89102007000800017; Garcia-Basteiro AL, 2018, PULMONOLOGY, V24, P73, DOI 10.1016/j.rppnen.2017.12.002; KLEINBAUM J, 1982, J CLIN ENDOCR METAB, V55, P787, DOI 10.1210/jcem-55-4-787; Kohli M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012768.pub2; Kritski A, 2018, REV SOC BRAS MED TRO, V51, P2, DOI 10.1590/0037-8682-0349-2017; Malacarne J, 2019, J BRAS PNEUMOL, V45, DOI 10.1590/1806-3713/e20180185; Mathewos B, 2015, ASIAN PAC J TROP MED, V8, P35, DOI 10.1016/S1995-7645(14)60184-X; Mechal Y, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4687-7; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; Opota O, 2019, CLIN MICROBIOL INFEC, V25, P1370, DOI 10.1016/j.cmi.2019.03.021; Opota O, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01717-18; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Phillips PPJ, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0955-9; Rageade F, 2014, EUR J CLIN MICROBIOL, V33, P867, DOI 10.1007/s10096-014-2105-z; Rufai SB, 2015, J CLIN MICROBIOL, V53, P3636, DOI 10.1128/JCM.02182-15; Scheffer D., 2014, BLUCHER P, V1; Secretaria Municipal de Saude (Ribeirao Preto), 2021, REL UN SAUD; Sehgal IS, 2016, J CLIN MICROBIOL, V54, P1133, DOI 10.1128/JCM.03205-15; Sekadde MP, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-133; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10; VALLEJO V PATRICIO, 2015, Rev. chil. enferm. respir., V31, P127; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2013, US XPERT MTB RIF ASS; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6; Zeileis A., 2019, CRAN REPOSITORY; Zhao P, 2016, J INT MED RES, V44, P1055, DOI 10.1177/0300060516655243	48	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252375	10.1371/journal.pone.0252375	http://dx.doi.org/10.1371/journal.pone.0252375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048490	Green Published, gold			2022-12-26	WOS:000664636100040
J	Hiol, AN; von Hurst, PR; Conlon, CA; Mugridge, O; Beck, KL				Hiol, Anne N.; von Hurst, Pamela R.; Conlon, Cathryn A.; Mugridge, Owen; Beck, Kathryn L.			Body composition associations with muscle strength in older adults living in Auckland, New Zealand	PLOS ONE			English	Article							SKELETAL-MUSCLE; REFERENCE VALUES; MASS INDEX; SARCOPENIA; OBESITY; EPIDEMIOLOGY; HEALTH; FALLS; MEN; WEAKNESS	Background Aging is associated with decreases in muscle strength and simultaneous changes in body composition, including decreases in muscle mass, muscle quality and increases in adiposity. Methods Adults (n = 369; 236 females) aged 65-74 years living independently were recruited from the cross-sectional Researching Eating Activity and Cognitive Health (REACH) study. Body fat percentage and appendicular skeletal muscle mass (ASM) (sum of lean mass in the arms and legs) were assessed using Dual-energy X-ray Absorptiometry (Hologic, QDR Discovery A). The ASM index was calculated by ASM (kilograms) divided by height (meters) squared. Isometric grip strength was measured using a hand grip strength dynamometer (JAMAR HAND). Results Linear regression analyses revealed that muscle strength was positively associated with the ASM index (R-2 = 0.431, p < 0.001). When exploring associations between muscle strength and muscle mass according to obesity classifications (obesity <greater than or equal to>30% males; >= 40% females), muscle mass was a significant predictor of muscle strength in non-obese participants. However, in participants with obesity, muscle mass was no longer a significant predictor of muscle strength. Conclusions Body fat percentage should be considered when measuring associations between muscle mass and muscle strength in older adults.	[Hiol, Anne N.; von Hurst, Pamela R.; Conlon, Cathryn A.; Mugridge, Owen; Beck, Kathryn L.] Massey Univ, Sch Sport Exercise & Nutr, North Shore City, New Zealand	Massey University	Beck, KL (corresponding author), Massey Univ, Sch Sport Exercise & Nutr, North Shore City, New Zealand.	k.l.beck@massey.ac.nz		HIOL, Anne Nadine/0000-0002-3979-7948	Health Research Council of New Zealand Emerging Researcher Grant [17/566]	Health Research Council of New Zealand Emerging Researcher Grant	Funding is provided by a Health Research Council of New Zealand Emerging Researcher Grant 17/566 - Beck: Optimising cognitive function: the role of dietary and lifestyle patterns. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbat-Artigas S, 2013, J AM MED DIR ASSOC, V14, DOI 10.1016/j.jamda.2013.06.003; Batsis JA, 2016, INT J OBESITY, V40, P761, DOI 10.1038/ijo.2015.243; Batsis JA, 2018, MED CLIN N AM, V102, P65, DOI 10.1016/j.mcna.2017.08.007; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Beliaeff S, 2008, J AGING PHYS ACTIV, V16, P484, DOI 10.1123/japa.16.4.484; Bernardi M, 2004, J ELECTROMYOGR KINES, V14, P401, DOI 10.1016/j.jelekin.2003.09.001; Bertoni M, 2018, EXP GERONTOL, V108, P87, DOI 10.1016/j.exger.2018.04.001; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Borges VS, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311x00107319, 10.1590/0102-311X00107319]; Chatindiara I, 2019, AUST NZ J PUBL HEAL, V43, P56, DOI 10.1111/1753-6405.12848; Chen L, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-74; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Rodriguez-Garcia WD, 2018, EUR GERIATR MED, V9, P219, DOI 10.1007/s41999-018-0032-8; Duchowny KA, 2018, J NUTR HEALTH AGING, V22, P501, DOI 10.1007/s12603-017-0951-y; Fragala MS, 2015, SPORTS MED, V45, P641, DOI 10.1007/s40279-015-0305-z; Gallagher D, 2000, AM J PHYSIOL-ENDOC M, V279, pE366, DOI 10.1152/ajpendo.2000.279.2.E366; Goodpaster BH, 2001, J APPL PHYSIOL, V90, P2157, DOI 10.1152/jappl.2001.90.6.2157; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Hayashida I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111810; Health Quality & Safety Commission, 2016, FALLS PEOPL AG 50 OV; Heymsfield SB, 1997, ANNU REV NUTR, V17, P527, DOI 10.1146/annurev.nutr.17.1.527; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209; Keevil VL, 2015, J NUTR HEALTH AGING, V19, P3, DOI 10.1007/s12603-014-0492-6; Kim S, 2017, INNOV AGING, V1, DOI 10.1093/geroni/igx008; Lee K, 2019, KOREAN J RADIOL, V20, P205, DOI 10.3348/kjr.2018.0479; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; Ministry of Health, 2020, ANN UPD KEY RES 2019; Ministry of Health, 2019, ANN DAT EXPLOR 2018; Ministry of Social Development, 2016, SOC REP 2016; Mumme KD, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6900-4; Nana A, 2012, MED SCI SPORT EXER, V44, P180, DOI 10.1249/MSS.0b013e318228b60e; REED RL, 1991, J AM GERIATR SOC, V39, P555, DOI 10.1111/j.1532-5415.1991.tb03592.x; ROBBINS AS, 1989, ARCH INTERN MED, V149, P1628, DOI 10.1001/archinte.1989.00390070138022; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Robertson MC., 2012, REPORT HLTH QUALITY; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Rubenstein LZ, 2002, CLIN GERIATR MED, V18, P141, DOI 10.1016/S0749-0690(02)00002-2; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Schlussel MM, 2008, CLIN NUTR, V27, P601, DOI 10.1016/j.clnu.2008.04.004; Shafiee G, 2018, INT J PREVENTIVE MED, V9, DOI 10.4103/ijpvm.IJPVM_295_17; Statistics New Zealand, 2007, NEW ZEAL 65 PLUS POP; Thurlow S, 2018, J CLIN DENSITOM, V21, P375, DOI 10.1016/j.jocd.2017.03.003; United Nations Department of Economic and Social Affairs, 2019, WORLD POP AG 2019 HI; Visser M GB., 2005, J GERONTOL A; Waters DL, 2010, OSTEOPOROSIS INT, V21, P351, DOI 10.1007/s00198-009-0947-5; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Yoo JJ, 2014, ARTHRITIS RHEUMATOL, V66, P3511, DOI 10.1002/art.38861	49	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0250439	10.1371/journal.pone.0250439	http://dx.doi.org/10.1371/journal.pone.0250439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PN	34048458	gold, Green Published			2022-12-26	WOS:000664636100008
J	Chaiwattanarungruengpaisan, S; Thongdee, M; Anuntakarun, S; Payungporn, S; Arya, N; Punchukrang, A; Ramasoota, P; Singhakaew, S; Atithep, T; Sariya, L				Chaiwattanarungruengpaisan, Somjit; Thongdee, Metawee; Anuntakarun, Songtham; Payungporn, Sunchai; Arya, Nlin; Punchukrang, Apichart; Ramasoota, Pongrama; Singhakaew, Sombat; Atithep, Thassanant; Sariya, Ladawan			A new species of Chlamydia isolated from Siamese crocodiles (Crocodylus siamensis)	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; FAMILY CHLAMYDIACEAE; PROPOSAL; GENUS; BACTERIA; GENES	Chlamydia is a known pathogen in both saltwater and freshwater crocodiles. However, the exact species/strain has not been clearly identified. In this study, we successfully cultivated Siamese crocodile Chlamydia in McCoy cells at a temperature of 30 degrees C. Electron microscopy; phylogeny based on nine conserved taxonomically informative markers, on ompA, or on seven housekeeping genes; and whole-genome sequencing and analysis of the isolate confirmed the identity of the isolate as a new member of the genus Chlamydia, a new species that we name Chlamydia crocodili.	[Chaiwattanarungruengpaisan, Somjit; Thongdee, Metawee; Sariya, Ladawan] Mahidol Univ, Monitoring & Surveillance Ctr Zoonot Dis Wildlife, Fac Vet Sci, Salaya, Nakhon Pathom, Thailand; [Anuntakarun, Songtham; Payungporn, Sunchai] Chulalongkorn Univ, Fac Med, Res Affairs, Ctr Excellence Syst Biol, Bangkok, Thailand; [Payungporn, Sunchai] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok, Thailand; [Arya, Nlin] Mahidol Univ, Fac Vet Sci, Dept Preclin & Appl Anim Sci, Salaya, Nakhon Pathom, Thailand; [Punchukrang, Apichart] Songkhla Rajabhat Univ, Fac Agr Technol, Songkhla, Thailand; [Ramasoota, Pongrama] Mahidol Univ, Ctr Excellence Antibody Res, Bangkok, Thailand; [Ramasoota, Pongrama] Mahidol Univ, Dept Social & Environm Med, Fac Trop Med, Bangkok, Thailand; [Singhakaew, Sombat] Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand; [Atithep, Thassanant] Vidyasirimedhi Inst Sci & Technol, Frontier Res Ctr, Rayong, Thailand	Mahidol University; Chulalongkorn University; Chulalongkorn University; Mahidol University; Songkhla Rajabhat University; Mahidol University; Mahidol University; Mahidol University; Vidyasirimedhi Institute of Science & Technology	Sariya, L (corresponding author), Mahidol Univ, Monitoring & Surveillance Ctr Zoonot Dis Wildlife, Fac Vet Sci, Salaya, Nakhon Pathom, Thailand.	ladawan.sar@mahidol.edu	Arya, Nlin/HDO-6236-2022	sariya, ladawan/0000-0002-2803-5067	Thailand Research Fund (RGJ Advanced Programme) [RAP59K0012]	Thailand Research Fund (RGJ Advanced Programme)	This project was financially supported by the Thailand Research Fund (RGJ Advanced Programme) project code RAP59K0012.	Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Cheong HC, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7050146; Condon K, 2007, LETT APPL MICROBIOL, V45, P121, DOI 10.1111/j.1472-765X.2007.02169.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hayat MA, 2000, PRINCIPLES AND TECHNIQUES OF ELECTRON MICROSCOPY: BIOLOGICAL APPLICATIONS, FOURTH EDITION, P1; Huchzermeyer FW, 2008, J S AFR VET ASSOC, V79, P99; HUCHZERMEYER FW, 1994, J S AFR VET ASSOC, V65, P20; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McElnea CL, 1999, AUST VET J, V77, P516, DOI 10.1111/j.1751-0813.1999.tb12123.x; Meier-Kolthoff JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10210-3; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pillonel T, 2015, INT J SYST EVOL MICR, V65, P1381, DOI 10.1099/ijs.0.000090; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Sachse K, 2015, SYST APPL MICROBIOL, V38, P99, DOI 10.1016/j.syapm.2014.12.004; Sachse K, 2014, SYST APPL MICROBIOL, V37, P79, DOI 10.1016/j.syapm.2013.12.004; Sariya L, 2015, JPN J VET RES, V63, P5; Seebacher F, 1997, COPEIA, P549; Shilton CM, 2016, J VET DIAGN INVEST, V28, P279, DOI 10.1177/1040638716642268; Srinon V, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00063; Staub E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23897-z; Taylor-Brown A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10757-5; Taylor-Brown A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3055-x; Thongkamkoon P, 2018, VET PATHOL, V55, P736, DOI 10.1177/0300985818768382; Tindall BJ, 2010, INT J SYST EVOL MICR, V60, P249, DOI 10.1099/ijs.0.016949-0	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252081	10.1371/journal.pone.0252081	http://dx.doi.org/10.1371/journal.pone.0252081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043689	Green Published, gold			2022-12-26	WOS:000664635700050
J	Heilbroner, SP; Xanthopoulos, EP; Buono, D; Carrier, D; Durkee, BY; Corradetti, M; Wang, TJC; Neugut, AI; Hershman, DL; Cheng, SK				Heilbroner, Samuel P.; Xanthopoulos, Eric P.; Buono, Donna; Carrier, Daniel; Durkee, Ben Y.; Corradetti, Michael; Wang, Tony J. C.; Neugut, Alfred I.; Hershman, Dawn L.; Cheng, Simon K.			Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; RADIATION-THERAPY; IMAGE-GUIDANCE; PROSTATE-CANCER; RADIOTHERAPY; OUTCOMES; IMPACT; ASSOCIATION; BREAST; MOTION	Background High-frequency image-guided radiotherapy (hfIGRT) is ubiquitous but its benefits are unproven. We examined the cost effectiveness of hfIGRT in stage III non-small-cell lung cancer (NSCLC). Methods We selected stage III NSCLC patients >= 66 years old who received definitive radiation therapy from the Surveillance, Epidemiology, and End-Results-Medicare database. Patients were stratified by use of hfIGRT using Medicare claims. Predictors for hfIGRT were calculated using a logistic model. The impact of hfIGRT on lung toxicity free survival (LTFS), esophageal toxicity free survival (ETFS), cancer-specific survival (CSS), overall survival (OS), and cost of treatment was calculated using Cox regressions, propensity score matching, and bootstrap methods. Results Of the 4,430 patients in our cohort, 963 (22%) received hfIGRT and 3,468 (78%) did not. By 2011, 49% of patients were receiving hfIGRT. Predictors of hfIGRT use included treatment with intensity-modulated radiotherapy (IMRT) (OR = 7.5, p < 0.01), recent diagnosis (OR = 51 in 2011 versus 2006, p < 0.01), and residence in regions where the Medicare intermediary allowed IMRT (OR = 1.50, p < 0.01). hfIGRT had no impact on LTFS (HR 0.97; 95% CI 0.86-1.09), ETFS (HR 1.05; 95% CI 0.93-1.18), CSS (HR 0.94; 95% CI 0.84-1.04), or OS (HR 0.95; 95% CI 0.87-1.04). Mean radiotherapy and total medical costs six months after diagnosis were $17,330 versus $15,024 (p < 0.01) and $71,569 versus $69,693 (p = 0.49), respectively. Conclusion hfIGRT did not affect clinical outcomes in elderly patients with stage III NSCLC but did increase radiation cost. hfIGRT deserves further scrutiny through a randomized controlled trial.	[Heilbroner, Samuel P.; Carrier, Daniel; Wang, Tony J. C.; Cheng, Simon K.] New York Presbyterian Hosp, Dept Radiat Oncol, New York, NY 10032 USA; [Xanthopoulos, Eric P.] Univ Wisconsin, Beloit Hlth Canc Ctr, Beloit, WI USA; [Buono, Donna; Neugut, Alfred I.; Hershman, Dawn L.] Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Durkee, Ben Y.] Univ Wisconsin, Dept Radiat Oncol, Madison, WI USA; [Corradetti, Michael] Duke Canc Ctr, Raleigh, NC USA	NewYork-Presbyterian Hospital; University of Wisconsin System; University of Wisconsin System; University of Wisconsin Madison	Cheng, SK (corresponding author), New York Presbyterian Hosp, Dept Radiat Oncol, New York, NY 10032 USA.	sc2335@cumc.columbia.edu		Heilbroner, Samuel/0000-0003-0036-5440				Bissonnette JP, 2009, INT J RADIAT ONCOL, V73, P927, DOI 10.1016/j.ijrobp.2008.08.059; Boero IJ, 2016, J CLIN ONCOL, V34, P684, DOI 10.1200/JCO.2015.63.9898; CHARLSON ME, 1986, J CHRON DIS, V39, P439, DOI 10.1016/0021-9681(86)90111-6; Chen AB, 2014, SEMIN RADIAT ONCOL, V24, P25, DOI 10.1016/j.semradonc.2013.08.003; Chetty IJ, 2003, MED PHYS, V30, P1776, DOI 10.1118/1.1581412; Chung PWM, 2004, INT J RADIAT ONCOL, V60, P329, DOI 10.1016/j.ijrobp.2004.03.038; Cms, CHRON COND DAT WAR C; Craig T, 2003, INT J RADIAT ONCOL, V57, P833, DOI 10.1016/S0360-3016(03)00638-2; de Crevoisier R, 2018, INT J RADIAT ONCOL, V102, P1420, DOI 10.1016/j.ijrobp.2018.07.2006; Deek MP, 2016, J THORAC DIS, V8, P2602, DOI 10.21037/jtd.2016.08.95; Du XL, 2007, CANCER, V110, P660, DOI 10.1002/cncr.22826; Guckenberger M, 2007, RADIOTHER ONCOL, V83, P57, DOI 10.1016/j.radonc.2007.01.012; Hawkins MA, 2006, INT J RADIAT ONCOL, V66, P610, DOI 10.1016/j.ijrobp.2006.03.026; Kilburn JM, 2016, PRACT RADIAT ONCOL, V6, pE73, DOI 10.1016/j.prro.2015.10.004; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Kong F.-M.S, 2018, WHAT HAPPENS PROTON; Kupelian PA, 2008, INT J RADIAT ONCOL, V70, P1151, DOI 10.1016/j.ijrobp.2007.07.2371; Li W, 2010, MED DOSIM, V35, P287, DOI 10.1016/j.meddos.2009.09.003; Meyer J, 2007, INT J RADIAT ONCOL, V67, P1220, DOI 10.1016/j.ijrobp.2006.11.010; Nabavizadeh N, 2016, INT J RADIAT ONCOL, V94, P850, DOI 10.1016/j.ijrobp.2015.09.035; Sethi RA, 2007, INT J RADIAT ONCOL, V69, pS341, DOI 10.1016/j.ijrobp.2007.07.1420; Shirvani SM, 2013, LUNG CANCER, V82, P252, DOI 10.1016/j.lungcan.2013.08.015; Smith BD, 2011, JNCI-J NATL CANCER I, V103, P798, DOI 10.1093/jnci/djr100; Song WY, 2006, INT J RADIAT ONCOL, V64, P289, DOI 10.1016/j.ijrobp.2005.08.037; Sonke JJ, 2009, INT J RADIAT ONCOL, V74, P567, DOI 10.1016/j.ijrobp.2008.08.004; Tondel H, 2018, RADIOTHER ONCOL, V126, P229, DOI 10.1016/j.radonc.2017.10.029; van Haaren PMA, 2009, RADIOTHER ONCOL, V90, P291, DOI 10.1016/j.radonc.2008.12.021; Velec M, 2011, INT J RADIAT ONCOL, V80, P265, DOI 10.1016/j.ijrobp.2010.05.023; Warren JL, 2002, MED CARE, V40, P55; Zeidan OA, 2007, INT J RADIAT ONCOL, V67, P670, DOI 10.1016/j.ijrobp.2006.09.040	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252053	10.1371/journal.pone.0252053	http://dx.doi.org/10.1371/journal.pone.0252053			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043677	Green Submitted, gold, Green Published			2022-12-26	WOS:000664635700049
J	Kritly, L; Sluyts, Y; Pelegrin-Garcia, D; Glorieux, C; Rychtarikova, M				Kritly, Leopold; Sluyts, Yannick; Pelegrin-Garcia, David; Glorieux, Christ; Rychtarikova, Monika			Discrimination of 2D wall textures by passive echolocation for different reflected-to-direct level difference configurations	PLOS ONE			English	Article							AUDIBILITY THRESHOLDS; BLIND; SOUND; ABILITY; PERFORMANCE; PERCEPTION; SIMULATION; HUMANS; SIZE	In this work, we study people's ability to discriminate between different 2D textures of walls by passive listening to a pre-recorded tongue click in an auralized echolocation scenario. In addition, the impact of artificially enhancing the early reflection magnitude by 6dB and of removing the direct component while equalizing the loudness was investigated. Listening test results for different textures, ranging from a flat wall to a staircase, were assessed using a 2 Alternative-Forced-Choice (2AFC) method, in which 14 sighted, untrained participants were indicating 2 equally perceived stimuli out of 3 presented stimuli. The average performance of the listening subjects to discriminate between different textures was found to be significantly higher for walls at 5m distance, without overlap between the reflected and direct sound, compared to the same walls at 0.8m distance. Enhancing the reflections as well as removing the direct sound were found to be beneficial to differentiate textures. This finding highlights the importance of forward masking in the discrimination process. The overall texture discriminability was found to be larger for the walls reflecting with a higher spectral coloration.	[Kritly, Leopold; Sluyts, Yannick; Rychtarikova, Monika] Katholieke Univ Leuven, Res Dept Architecture Bldg & Room Acoust, Fac Architecture, Brussels, Belgium; [Kritly, Leopold] EPF, Sch Engn, Sceaux, France; [Pelegrin-Garcia, David; Glorieux, Christ] Katholieke Univ Leuven, ZMB Lab Acoust, Dept Phys & Astron, Heverlee, Belgium; [Rychtarikova, Monika] Slovak Univ Technol Bratislava, Fac Civil Engn, Bratislava, Slovakia; [Pelegrin-Garcia, David] WS Audiol Denmark A S, Lynge, Denmark	KU Leuven; KU Leuven; Slovak University of Technology Bratislava	Kritly, L (corresponding author), Katholieke Univ Leuven, Res Dept Architecture Bldg & Room Acoust, Fac Architecture, Brussels, Belgium.; Kritly, L (corresponding author), EPF, Sch Engn, Sceaux, France.	leopold.kritly@kuleuven.be	; Rychtarikova, Monika/B-3445-2017	Kritly, Leopold/0000-0003-1608-4520; Glorieux, Christ/0000-0001-7740-5215; Rychtarikova, Monika/0000-0001-5678-7218	Faculty of Architecture of KU Leuven; EU project ACI (Erasmus+ program Strategic partnerships) [2017-1-PL01-KA202-038577]; EU project Asknow (Erasmus+ Knowledge Alliances) [2018-1-PL01-KA202-050820]; European Union [690970]; EPF France	Faculty of Architecture of KU Leuven; EU project ACI (Erasmus+ program Strategic partnerships); EU project Asknow (Erasmus+ Knowledge Alliances); European Union(European Commission); EPF France	The research has been performed under support of Faculty of Architecture of KU Leuven, the EPF France, EU project ACI (Erasmus+ program Strategic partnerships -Grant No 2017-1-PL01-KA202-038577) and EU project Asknow (Erasmus+ Knowledge Alliances -Grant No 2018-1-PL01-KA202-050820). This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 690970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advanced CAE Research, 2012, FASTBEM AC 3 0 US GU; Beranek L, 1996, J ACOUST SOC AM, V99, P2647, DOI 10.1121/1.414808; Bernschutz B., 2013, FORTSCHRITTE AKUSTIK, P592; Boullet I., 2005, SONIE SONS IMPULSION; Brinkmann F, 2019, J ACOUST SOC AM, V145, P2746, DOI 10.1121/1.5096178; Buchholz JM, 2011, HEARING RES, V277, P192, DOI 10.1016/j.heares.2011.01.002; Cabrera D, 2009, ACOUST AUST, V37, P98; Calleri C, 2016, SUSTAIN CITIES SOC, V27, P346, DOI 10.1016/j.scs.2016.05.016; Claes N., 2016, P EUROREGIO 2016 POR; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; de Vos R, 2018, ACTA ACUST UNITED AC, V104, P131, DOI 10.3813/AAA.919153; de Vos R, 2017, ACTA ACUST UNITED AC, V103, P1106, DOI 10.3813/AAA.919138; Devlieger P., 2006, BLINDNESS MULTISENSO; Dodsworth C, 2020, COGNITION, V197, DOI 10.1016/j.cognition.2020.104185; Dujardin M., 2010, END USER DRIVEN ARCH, P2; Fletcher NH, 2014, SPRINGER HANDBOOK OF ACOUSTICS, 2ND EDITION, P821; Garcia S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134369; Gay J., 2020, ASSETS 2020 22 INT A, P8, DOI [10.1145/3373625.3418048, DOI 10.1145/3373625.3418048]; Genesis S., 2018, LOUDNESS ONLINE; Griffin Donald R., 1944, SCIENCE, V100, P589, DOI 10.1126/science.100.2609.589; Hugo Fast HZ., 2007, PSYCHOACOUSTICS FACT; Jicol C, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01443; Kish D, 2009, NEW SCI, V202, P31, DOI 10.1016/S0262-4079(09)60997-0; Kolarik AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175750; Kolarik AJ, 2014, HEARING RES, V310, P60, DOI 10.1016/j.heares.2014.01.010; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; Rojas JAM, 2009, ACTA ACUST UNITED AC, V95, P325, DOI 10.3813/AAA.918155; Milne JL, 2014, ATTEN PERCEPT PSYCHO, V76, P1828, DOI 10.3758/s13414-014-0695-2; Norouzian R, 2018, SECOND LANG RES, V34, P257, DOI 10.1177/0267658316684904; Paulsen RR, 2010, IEEE T VIS COMPUT GR, V16, P636, DOI 10.1109/TVCG.2009.208; Pelegrin-Garcia D, 2018, APPL ACOUST, V139, P82, DOI 10.1016/j.apacoust.2018.04.018; Pelegrin-Garcia D, 2017, ACTA ACUST UNITED AC, V103, P492, DOI 10.3813/AAA.919078; Pelegrin-Garcia D, 2016, ACTA ACUST UNITED AC, V102, P530, DOI 10.3813/AAA.918970; Poulsen T., 2002, LECT NOTE DENMARK OS; RICE CE, 1965, J EXP PSYCHOL, V70, P246, DOI 10.1037/h0022215; Robinson PW, 2013, J ACOUST SOC AM, V134, P2755, DOI 10.1121/1.4820890; Robinson PW, 2013, J ACOUST SOC AM, V133, P3940, DOI 10.1121/1.4803846; Rowan D, 2013, HEARING RES, V300, P56, DOI 10.1016/j.heares.2013.03.005; Rychtarikova M, 2011, APPL ACOUST, V72, P196, DOI 10.1016/j.apacoust.2010.11.012; Schenkman BN, 2010, PERCEPTION, V39, P483, DOI 10.1068/p6473; Schornich S, 2012, JARO-J ASSOC RES OTO, V13, P673, DOI 10.1007/s10162-012-0338-z; Shtrepi L., 2012, 41 INT C EXP NOIS CO, P7394; Shtrepi L, 2019, J ACOUST SOC AM, V145, pEL215, DOI 10.1121/1.5092821; Shtrepi L, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7030224; Shtrepi L, 2016, J ACOUST SOC AM, V140, P3651, DOI 10.1121/1.4966267; Shtrepi L, 2015, J ACOUST SOC AM, V138, P1485, DOI 10.1121/1.4929743; Teng S, 2011, J VISUAL IMPAIR BLIN, V105, P20, DOI 10.1177/0145482X1110500103; Thaler L, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2735; Thaler L, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005670; Thaler L, 2016, WIRES COGN SCI, V7, P382, DOI 10.1002/wcs.1408; Thaler L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154868; Thaler L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00098; Tim J., 2012, BEGINNERS GUIDE ECOL; Tonelli A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156654; Torres RR, 2000, ACUSTICA, V86, P919; Vitale R., 2015, PERCEPTUAL ASPECTS S; Wallmeier L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115363; Wallmeier L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1428; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409	59	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251397	10.1371/journal.pone.0251397	http://dx.doi.org/10.1371/journal.pone.0251397			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043655	Green Published, gold			2022-12-26	WOS:000664635700018
J	Naraba, H; Goto, T; Shirakawa, T; Sonoo, T; Kanda, N; Nakano, H; Takahashi, Y; Hashimoto, H; Nakamura, K				Naraba, Hiromu; Goto, Tadahiro; Shirakawa, Toru; Sonoo, Tomohiro; Kanda, Naoki; Nakano, Hidehiko; Takahashi, Yuji; Hashimoto, Hideki; Nakamura, Kensuke			Time in blood glucose range 70 to 180 mg/dL and survival rate in critically ill patients: A retrospective cohort study	PLOS ONE			English	Article							INTENSIVE INSULIN THERAPY; GUIDELINES; EXPRESSION; MORTALITY; HYPERGLYCEMIA; MANAGEMENT; CELLS	Background While time in targeted blood glucose range (TIR) 70-140 mg/dL is a known factor associated with mortality in critically ill patients, it remains unclear whether TIR is associated with 28-day mortality under the glycemic control with a less tight target glucose range of 70-180 mg/dL. We aimed to examine whether TIR 70-180 mg/dL was associated with 28-day mortality. Methods This is a retrospective cohort study using data from a tertiary care center in Japan collected from January 2016 through October 2019. We included adult patients (aged >= 20 years) admitted to the ICU. We excluded patients 1) with diabetic ketoacidosis patients, 2) discharged within 48 hours, 3) with repeated ICU admissions. We calculated TIR 70-180 mg/dL using the measured blood glucose values (>= 3 times per day). The primary outcome was 28-day mortality. We examined the association between TIR and 28-day mortality using a logistic regression and Cox proportional hazard models with a stratification by glycosylated hemoglobin (HbA1c) level of 6.5%. Additionally, we repeated the analyses using the TIR category to assess the optimal TIR. For the sensitivity analysis, we repeated the primary analysis using TIR during the first three days from ICU admission. Results Of 1,230 patients, the median age was 72 years, 65% were male, and 250 patients (20%) had HbA1c >= 6.5% on admission. In patients with HbA1c <6.5%, TIR <80% was associated with an increased risk of 28-day mortality, with an adjusted odds ratio (OR) of 1.88 (95%CI: 1.36-2.61). Likewise, when using 10% incremental TIR as a categorical variable, lower TIR was associated with a worse 28-day mortality compared with TIR >= 90% (e.g., adjusted OR of TIR <60%, 3.62 [95%CI 2.36-5.53]). Similar associations were found in the analyses using Cox proportional hazards model and using TIR during the first three days. By contrast, in patients with HbA1c <greater than or equal to>6.5%, there was no consistent association of TIR with 28-day mortality. Conclusions We found that lower TIR 70-180 mg/dL was associated with a higher 28-day mortality in critically ill patients with HbA1c <6.5%, whereas there was no consistent association in patients with HbA1c <greater than or equal to>6.5%.	[Naraba, Hiromu; Sonoo, Tomohiro; Kanda, Naoki; Nakano, Hidehiko; Takahashi, Yuji; Hashimoto, Hideki; Nakamura, Kensuke] Hitachi Gen Hosp, Dept Emergency & Crit Care Med, Hitachi, Ibaraki, Japan; [Naraba, Hiromu; Goto, Tadahiro; Shirakawa, Toru; Sonoo, Tomohiro] TXP Med Co Ltd, Bunkyo Ku, Tokyo, Japan; [Goto, Tadahiro] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, Tokyo, Japan; [Shirakawa, Toru] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka, Japan	University of Tokyo; Osaka University	Naraba, H (corresponding author), Hitachi Gen Hosp, Dept Emergency & Crit Care Med, Hitachi, Ibaraki, Japan.; Naraba, H (corresponding author), TXP Med Co Ltd, Bunkyo Ku, Tokyo, Japan.	naraba-hok@umin.ac.jp		Takahashi, Yuji/0000-0002-9776-2647	TXP Medical	TXP Medical	The funder, TXP Medical, was not involved in the study design, data analysis, publication decisions, or manuscript preparation and provided support only in the form of authors' salaries and research materials. This study was not conducted in partnership with a commercial organization.	Aljada A, 2004, AM J CLIN NUTR, V80, P51; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS99, DOI 10.2337/dc16-S016; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Chettab K, 2002, THROMB HAEMOSTASIS, V87, P141; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Goto T, 2020, ACUTE MED SURG, V7, DOI 10.1002/ams2.554; Hermanides J, 2010, CRIT CARE MED, V38, P1430, DOI 10.1097/CCM.0b013e3181de562c; Jacobi J, 2012, CRIT CARE MED, V40, P3251, DOI 10.1097/CCM.0b013e3182653269; KLIP A, 1994, FASEB J, V8, P43, DOI 10.1096/fasebj.8.1.8299889; Krinsley JS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0908-7; Krinsley James S, 2012, Hosp Pract (1995), V40, P31, DOI 10.3810/hp.2012.04.967; Lanspa MJ, 2019, CHEST, V156, P878, DOI 10.1016/j.chest.2019.05.016; Lanspa MJ, 2013, CHEST, V143, P1226, DOI 10.1378/chest.12-2072; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Omar AS, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/1471-2253-15-14; Penning S, 2014, J CRIT CARE, V29, P374, DOI 10.1016/j.jcrc.2014.01.013; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Qaseem A, 2014, AM J MED QUAL, V29, P95, DOI 10.1177/1062860613489339; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Sechterberger MK, 2014, DIABETES TECHNOL THE, V16, P72, DOI 10.1089/dia.2013.0138; Signal Matthew, 2012, J Diabetes Sci Technol, V6, P1030; Stevens RD, 2007, INTENS CARE MED, V33, P1876, DOI 10.1007/s00134-007-0772-2; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Yorek MA, 2002, METABOLISM, V51, P225, DOI 10.1053/meta.2002.29958	27	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252158	10.1371/journal.pone.0252158	http://dx.doi.org/10.1371/journal.pone.0252158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043681	Green Published, gold, Green Submitted			2022-12-26	WOS:000664635700062
J	Whisson, DA; McKinnon, F; Lefoe, M; Rendall, AR				Whisson, Desley A.; McKinnon, Freya; Lefoe, Matthew; Rendall, Anthony R.			Passive acoustic monitoring for detecting the Yellow-bellied Glider, a highly vocal arboreal marsupial	PLOS ONE			English	Article							PETAURUS-AUSTRALIS; FORAGING BEHAVIOR; POPULATION; HABITAT; SYSTEM; COST	Passive acoustic monitoring (PAM) is increasingly being used for the survey of vocalising wildlife species that are otherwise cryptic and difficult to survey. Our study aimed to develop PAM guidelines for detecting the Yellow-bellied Glider, a highly vocal arboreal marsupial that occurs in native Eucalyptus forests in eastern and south-eastern Australia. To achieve this, we considered the influence of background noise, weather conditions, lunar illumination, time since sunset and season on the probability of detecting vocalisations. We deployed Autonomous Recording Units (ARUs) at 43 sites in the Central Highlands of Victoria during two periods: spring/summer (October 2018 to January 2019), and autumn/winter (May to August 2019). ARUs were programmed to record for 11 hours from sunset for 14 consecutive days during each period. Background noise resulted from inclement weather (wind and rain) and masked vocalisations in spectrograms of the recordings, thus having the greatest influence on detection probability. Vocalisations were most common in the four hours after sunset. Rainfall negatively influenced detection probability, especially during the autumn/winter sampling period. Detection of Yellow-bellied Gliders with PAM requires deploying ARUs programmed to record for four hours after sunset, for a minimum of six nights with minimal inclement weather (light or no wind or rain). The survey period should be extended to 12 nights when rain or wind are forecast. Because PAM is less labour intensive than active surveys (i.e., spotlighting and call playbacks with multiple observers and several nights' survey per site), its use will facilitate broad-scale surveys for Yellow-bellied Gliders.	[Whisson, Desley A.; McKinnon, Freya; Lefoe, Matthew; Rendall, Anthony R.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia	Deakin University	Whisson, DA (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic, Australia.	dwhisson@deakin.edu.au	Whisson, Desley/H-9578-2013	Whisson, Desley/0000-0002-4221-0706; Rendall, Anthony/0000-0002-7286-9288				[Anonymous], 2019, MODEL SELECTION MULT; BAILEY WJ, 1981, J NAT HIST, V15, P693, DOI 10.1080/00222938100770491; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Bureau of Meteorology, 2020, SUMM STAT S E WAL RE; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Campos-Cerqueira M, 2016, METHODS ECOL EVOL, V7, P1340, DOI 10.1111/2041-210X.12599; Comazzi C, 2016, BIOACOUSTICS, V25, P267, DOI 10.1080/09524622.2016.1152564; CRAIG SA, 1985, AUST WILDLIFE RES, V12, P1; Department of Sustainability and Environment, 2011, SURV STAND YELL BELL; Enari H, 2019, ECOL INDIC, V98, P753, DOI 10.1016/j.ecolind.2018.11.062; Eyre TJ, 2003, WILDLIFE RES, V30, P229, DOI 10.1071/WR02020; Fine ML, 2008, T AM FISH SOC, V137, P627, DOI 10.1577/T04-134.1; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Garden JG, 2007, WILDLIFE RES, V34, P218, DOI 10.1071/WR06111; Gibb R, 2019, METHODS ECOL EVOL, V10, P169, DOI 10.1111/2041-210X.13101; GOLDINGAY RL, 1993, WILDLIFE RES, V20, P387, DOI 10.1071/WR9930387; GOLDINGAY RL, 1992, AUST J ZOOL, V40, P267, DOI 10.1071/ZO9920267; GOLDINGAY RL, 1989, AUST WILDLIFE RES, V16, P105; GOLDINGAY RL, 1990, OECOLOGIA, V85, P191, DOI 10.1007/BF00319401; GOLDINGAY RL, 1994, AUST J ZOOL, V42, P279, DOI 10.1071/ZO9940279; Goldingay RL, 1989, BEHAV ECOLOGY; Goldingay RL, 2018, AUST MAMMAL, V40, P214, DOI 10.1071/AM17029; Goldingay Ross L., 2004, P369; Goldingay RL, 2016, AUST J ZOOL, V64, P413, DOI 10.1071/ZO17002; Gonzalez LF, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16010097; Goold JC, 1996, J MAR BIOL ASSOC UK, V76, P811, DOI 10.1017/S0025315400031477; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Hagens SV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199396; Hedley RW, 2017, AVIAN CONSERV ECOL, V12, DOI 10.5751/ACE-00963-120106; Heinicke S, 2015, METHODS ECOL EVOL, V6, P753, DOI 10.1111/2041-210X.12384; Henry S.R., 1984, P331; Incoll RD, 2001, BIOL CONSERV, V98, P77, DOI 10.1016/S0006-3207(00)00144-0; Kaiwi A., 2020, N QUEENSL NAT, V50, P65; Kalan AK, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0167-8; KAVANAGH R P, 1982, Australian Mammalogy, V5, P95; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Lambert KTA, 2014, AUSTRAL ECOL, V39, P779, DOI 10.1111/aec.12143; Law BS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205075; Lazaridis E., 2014, LUNAR LUNAR PHASE DI; Lindenmayer D, 2002, GLIDERS AUSTR NATURA; Lindenmayer DB, 2006, CONSERV BIOL, V20, P1005, DOI 10.1111/j.1523-1739.2006.00501.x; MacKenzie D. I., 2018, OCCUPANCY ESTIMATION, DOI DOI 10.1016/C2012-0-01164-7; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; Murphy A., 1997, Australian Forestry, V60, P90; Perez-Granados C, 2019, IBIS, V161, P901, DOI 10.1111/ibi.12728; R Core Team, 2013, R LANG ENV STAT COMP; Rogers TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052542; Skalak SL, 2012, METHODS ECOL EVOL, V3, P490, DOI 10.1111/j.2041-210X.2011.00177.x; Thompson ME, 2010, AFR J ECOL, V48, P654, DOI 10.1111/j.1365-2028.2009.01161.x; Towsey M, 2012, BIOACOUSTICS, V21, P107, DOI 10.1080/09524622.2011.648753; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Wimmer J, 2013, ECOL APPL, V23, P1419, DOI 10.1890/12-2088.1; Wintle BA, 2005, J WILDLIFE MANAGE, V69, P905, DOI 10.2193/0022-541X(2005)069[0905:EADWDI]2.0.CO;2; Woinarski J., 2014, PETAURUS AUSTRALIS I, DOI [10.2305/iucn.uk.2016-1.rlts.t16730a21959641.en, DOI 10.2305/IUCN.UK.2016-1.RLTS.T16730A21959641.EN]; Wood S., 2014, GAMM4 GEN ADDITIVE M; Zuur Alain F., 2009, P1	58	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252092	10.1371/journal.pone.0252092	http://dx.doi.org/10.1371/journal.pone.0252092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033663	gold, Green Published			2022-12-26	WOS:000664633100029
J	van Loon, FHJ; Korsten, HHM; Dierick-van Daele, ATM; Bouwman, ARA				van Loon, Fredericus H. J.; Korsten, Hendrikus H. M.; Dierick-van Daele, Angelique T. M.; Bouwman, Arthur R. A.			The impact of the catheter to vein ratio on peripheral intravenous cannulation success, a post-hoc analyses	PLOS ONE			English	Article							RATES; PICC	Background Intravenous cannulation is usually the first procedure performed in modern healthcare, although establishing peripheral intravenous access is challenging in some patients. The impact of the ratio between venous diameter and the size of the inserted catheter (catheter to vein ratio, CVR) on the first attempt success rate can be of added value in clinical. This study tries to give insight into the consideration that must be made when selecting the target vein and the type of catheter, and proved the null hypothesis that an optimal CVR would not be associated with increased first attempt cannulation success. Methods This was a post-hoc analyses on adult patients admitted for peripheral intravenous cannulation. Intravenous cannulation was performed according to practice guidelines, by applying the traditional landmark approach. The CVR was calculated afterwards for each individual patient by dividing the external diameter of the inserted catheter by the diameter of the target vein, which was multiplied by 100%. Results In total, 610 patients were included. The median CVR was 0.39 (0.15) in patients with a successful first attempt, whereas patients with an unsuccessful first attempt had a median CVR of 0.55 (0.20) (P<0.001). The optimal cut-off point of the CVR was 0.41. First attempt cannulation was successful in 92% of patients with a CVR<0.41, whereas as those with a CVR>0.41 had a first attempt success rate of 65% (P<0.001). Conclusion This first introduction of the CVR in relation to cannulation success should be further investigated. Although, measuring the venous diameter or detection of a vein with a specific diameter prior to cannulation may increase first attempt cannulation success.	[van Loon, Fredericus H. J.] Catharina Hosp, Dept Anesthesiol Intens Care & Pain Med, Eindhoven, Netherlands; [van Loon, Fredericus H. J.] Fontys Univ Appl Sci, Dept Sci & Technol Anesthesia Nursing Practice, Eindhoven, Netherlands; [Korsten, Hendrikus H. M.; Bouwman, Arthur R. A.] TUe Univ Technol, Dept Signal Proc Syst & Elect Engn, Eindhoven, Netherlands; [Dierick-van Daele, Angelique T. M.] Fontys Univ Appl Sci, Dept People & Hlth Sci, Eindhoven, Netherlands; [Dierick-van Daele, Angelique T. M.] Catharina Hosp, Dept Res & Educ, Eindhoven, Netherlands; [Bouwman, Arthur R. A.] Catharina Hosp, Dept Anesthesiol Intens Care & Pain Med, Eindhoven, Netherlands	Catharina Hospital; Catharina Hospital; Catharina Hospital	van Loon, FHJ (corresponding author), Catharina Hosp, Dept Anesthesiol Intens Care & Pain Med, Eindhoven, Netherlands.; van Loon, FHJ (corresponding author), Fontys Univ Appl Sci, Dept Sci & Technol Anesthesia Nursing Practice, Eindhoven, Netherlands.	rick.v.loon@catharinaziekenhuis.nl	van Loon, Fredericus HJ/ABG-7427-2021	van Loon, F.H.J./0000-0003-3854-6976; Bouwman, R. Arthur/0000-0002-2051-5947				Adams Debra, 2012, Nurs Stand, V26, P49, DOI 10.7748/ns.26.37.49.s54; Barton Andrew, 2017, Br J Nurs, V26, pS28, DOI 10.12968/bjon.2017.26.8.S28; Bodenham A, 2016, ANAESTHESIA, V71, P573, DOI 10.1111/anae.13360; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Dychter SS, 2012, J INFUS MURS, V35, P84, DOI 10.1097/NAN.0b013e31824237ce; Gorski Lisa A, 2017, Home Healthc Now, V35, P10; Infusion Nurses Society (INS), 2021, J INFUS NURS S1, V44, pS1, DOI [DOI 10.1097/NAN.0000000000000396, 10.1097/NAN.0000000000000396, DOI 10.1097/NHH.0000000000000481]; Klebanoff MA, 2018, AM J OBSTET GYNECOL, V219, P447, DOI 10.1016/j.ajog.2018.08.044; Melamed A, 2018, BJOG-INT J OBSTET GY, V125, P1776, DOI 10.1111/1471-0528.15203; Nifong TP, 2011, CHEST, V140, P48, DOI 10.1378/chest.10-2637; Rivera AM, 2007, ACTA ANAESTH BELG, V58, P19; Santos-Costa P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207552; Sharp R, 2015, J INFUS MURS, V38, P351, DOI 10.1097/NAN.0000000000000125; Sharp R, 2015, INT J NURS STUD, V52, P677, DOI 10.1016/j.ijnurstu.2014.12.002; van Loon FH., 2021, MINERVA ANESTESIOL, DOI [10.23736/S0375-9393.21.15291-5, DOI 10.23736/S0375-9393.21.15291-5]; van Loon FHJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020144; van Loon FHJ, 2018, J VASC ACCESS, V19, P258, DOI 10.1177/1129729817747531; Witting MD, 2010, J EMERG MED, V39, P70, DOI 10.1016/j.jemermed.2009.01.003; Yin JJ, 2014, STAT MED, V33, P985, DOI 10.1002/sim.5992	19	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0252166	10.1371/journal.pone.0252166	http://dx.doi.org/10.1371/journal.pone.0252166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029356	Green Published, gold			2022-12-26	WOS:000664632800033
J	Han, S; Jin, S; Yoo, SH; Lee, HS; Lee, SH; Jeon, MJ; Ryu, JS				Han, Sangwon; Jin, Soyoung; Yoo, Seon Hee; Lee, Hyo Sang; Lee, Suk Hyun; Jeon, Min Ji; Ryu, Jin-Sook			A practical individualized radiation precaution based on the dose rate at release time after inpatient I-131 ablation therapy	PLOS ONE			English	Article							THYROID-CANCER; MANAGEMENT GUIDELINES; IODINE BIOKINETICS; SAFETY; THYROGLOBULIN; HORMONE; CARCINOMA; EXPOSURE; DISEASES; NODULES	Introduction Retained radioactivity of I-131 after ablation therapy largely differs in each patient according to factors including the amount of remnant thyroid tissue, renal function, and use of recombinant human thyroid-stimulating hormone. To reduce unnecessary restriction of patient's daily life after inpatient I-131 ablation therapy, we propose a practical individualized method for radiation precaution based on dose rate at release time. Methods We evaluated 215 patients with differentiated thyroid cancer who underwent inpatient I-131 ablation therapy following total thyroidectomy. Effective dose equivalent rates at 1-m distance were measured upon release (EDRR) on day 2 and during delayed whole-body scan (EDRD) visits on day 68 after I-131 administration. The biexponential model was designed to estimate total effective dose equivalent to others. To assess conservativeness of our model, EDRD estimated by our model was compared with measured EDRD. EDRR-based periods of precaution not to receiving 1 mSv of radiation exposure were estimated and compared with those based on administered radioactivities on American Thyroid Association (ATA) recommendations. Results The EDRR ranged from 1.0-48.9 mu Sv/hr. The measured EDRD were equal to or lower than estimated EDRD in all patients, except for one, indicating that our model is sufficiently conservative. According to our model, no subjects needed additional daytime restriction after release. The maximum permissible times for public transportation use were longer in all patients compared with those based on administered radioactivities. Nighttime restriction periods were significantly shorter than those based on administered radioactivity; median periods requiring sleeping apart were 0 (range, 05), 4 (range, 114), and 3 (range, 213) days after release in patients treated with radioactivity doses of 2.96, 5.50, and 7.40 GBq, respectively, needing 8, 16, and 19 additional days, respectively, based on administered radioactivity. Conclusions Radiation safety instructions using proposed method based on EDRR of individual patient could safely reduce the burden of radiation precaution.	[Han, Sangwon; Yoo, Seon Hee; Ryu, Jin-Sook] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea; [Jin, Soyoung] Eulji Univ, Sch Med, Nowon Eulji Med Ctr, Dept Nucl Med, Seoul, South Korea; [Lee, Hyo Sang] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Nucl Med, Kangnung, South Korea; [Lee, Suk Hyun] Hallym Univ, Div Nucl Med, Dept Radiol, Kangnam Sacred Heart Hosp,Coll Med, Seoul, South Korea; [Jeon, Min Ji] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Endocrinol, Seoul, South Korea	University of Ulsan; Asan Medical Center; Eulji University; University of Ulsan; Hallym University; University of Ulsan; Asan Medical Center	Ryu, JS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea.	jsryu2@amc.seoul.kr						Barrington SF, 1996, EUR J NUCL MED, V23, P123, DOI 10.1007/BF01731834; Carey JE, 1995, J NUCL MED TECHNOL, V23, P144; Choi S, 2015, NUCL MED MOLEC IMAG, V49, P115, DOI 10.1007/s13139-014-0308-y; CULVER CM, 1992, J NUCL MED, V33, P1402; Greenlee C, 2011, THYROID, V21, P151, DOI 10.1089/thy.2010.0090; Grigsby PW, 2000, JAMA-J AM MED ASSOC, V283, P2272, DOI 10.1001/jama.283.17.2272; Hanscheid H, 2006, J NUCL MED, V47, P648; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hong CM, 2018, NUCL MED MOLEC IMAG, V52, P247, DOI 10.1007/s13139-018-0522-0; Howe DB., 2008, NUREG1556; Huang CC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232480; IAEA publications, 2009, SAFETY REPORT SERIES, V63; JEEVANRAM RK, 1982, CANCER, V49, P2281, DOI 10.1002/1097-0142(19820601)49:11<2281::AID-CNCR2820491113>3.0.CO;2-1; Jeon MJ, 2015, THYROID, V25, P410, DOI 10.1089/thy.2014.0544; Jeon MJ, 2013, J CLIN ENDOCR METAB, V98, P153, DOI 10.1210/jc.2012-2369; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liu B, 2014, RADIOLOGY, V273, P211, DOI 10.1148/radiol.14132234; Nabhan F, 2017, ENDOCR-RELAT CANCER, V24, pR13, DOI 10.1530/ERC-16-0432; Siegel JA, 1998, J NUCL MED, V39, p28S; Siegel JA, 2002, J NUCL MED, V43, P1241; Siegel JA, 2007, HEALTH PHYS, V93, P667, DOI 10.1097/01.HP.0000270300.34270.44; Silberstein EB, 2012, J NUCL MED, V53, P1633, DOI 10.2967/jnumed.112.105148; Sisson JC, 2011, THYROID, V21, P335, DOI 10.1089/thy.2010.0403; Song JSA, 2018, HEAD NECK-J SCI SPEC, V40, P2129, DOI 10.1002/hed.25204; St Germain J, 2006, 155 NCRP; Taieb D, 2010, J CLIN ENDOCR METAB, V95, P3283, DOI 10.1210/jc.2009-2528; Wang XF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234843; Yap BK, 2013, EUR THYROID J, V2, P275, DOI 10.1159/000355911; Zanzonico PB, 1997, THYROID, V7, P199, DOI 10.1089/thy.1997.7.199; Zanzonico PB, 2000, HEALTH PHYS, V78, P648, DOI 10.1097/00004032-200006000-00007	30	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251627	10.1371/journal.pone.0251627	http://dx.doi.org/10.1371/journal.pone.0251627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019555	gold, Green Published			2022-12-26	WOS:000664632300028
J	Wang, XH; Yang, Q; Liu, MZ; Ma, XJ				Wang, Xiaohua; Yang, Qing; Liu, Meizhen; Ma, Xiaojian			Comprehensive influence of topological location and neighbor information on identifying influential nodes in complex networks	PLOS ONE			English	Article							RANKING; SPREADERS; COMMUNITY; IDENTIFICATION; CENTRALITY; MODEL	Identifying the influential nodes of complex networks is now seen as essential for optimizing the network structure or efficiently disseminating information through networks. Most of the available methods determine the spreading capability of nodes based on their topological locations or the neighbor information, the degree of node is usually used to denote the neighbor information, and the k-shell is used to denote the locations of nodes, However, k-shell does not provide enough information about the topological connections and position information of the nodes. In this work, a new hybrid method is proposed to identify highly influential spreaders by not only considering the topological location of the node but also the neighbor information. The percentage of triangle structures is employed to measure both the connections among the neighbor nodes and the location of nodes, the contact distance is also taken into consideration to distinguish the interaction influence by different step neighbors. The comparison between our proposed method and some well-known centralities indicates that the proposed measure is more highly correlated with the real spreading process, Furthermore, another comprehensive experiment shows that the top nodes removed according to the proposed method are relatively quick to destroy the network than other compared semi-local measures. Our results may provide further insights into identifying influential individuals according to the structure of the networks.	[Wang, Xiaohua; Yang, Qing; Ma, Xiaojian] Wuhan Univ Technol, Sch Safety Sci & Emergency Management, Wuhan, Peoples R China; [Liu, Meizhen] Shandong Womens Univ, Sch Data & Comp Sci, Jinan, Peoples R China; [Ma, Xiaojian] Wuhan Univ Technol, Sch Management, Wuhan, Peoples R China	Wuhan University of Technology; Shandong Womens University; Wuhan University of Technology	Ma, XJ (corresponding author), Wuhan Univ Technol, Sch Management, Wuhan, Peoples R China.	xiaojianma0813@whut.edu.cn						Bae J, 2014, PHYSICA A, V395, P549, DOI 10.1016/j.physa.2013.10.047; Batagelj V, USAIR; Boguna M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056122; Borgatti S. P., 2006, Computational & Mathematical Organization Theory, V12, P21, DOI 10.1007/s10588-006-7084-x; Borge-Holthoefer J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026116; Cantwell GT, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.042306; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Gao S, 2014, PHYSICA A, V403, P130, DOI 10.1016/j.physa.2014.02.032; Ghalmane Z, 2018, IEEE WORKS COMPLEX; Ghalmane Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46507-y; Ghalmane Z, 2019, EPJ DATA SCI, V8, DOI 10.1140/epjds/s13688-019-0195-7; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Han ZM, 2016, ACTA PHYS SIN-CH ED, V65, DOI 10.7498/aps.65.168901; Havlin S, 2012, EUR PHYS J-SPEC TOP, V214, P273, DOI 10.1140/epjst/e2012-01695-x; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Krebs V, USPOLBOOKS; Li Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44930-9; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Liu F, 2020, KNOWL-BASED SYST, V193, DOI 10.1016/j.knosys.2019.105464; Liu Y, 2016, CHAOS SOLITON FRACT, V86, P1, DOI 10.1016/j.chaos.2016.01.030; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Lu LY, 2016, PHYS REP, V650, P1, DOI 10.1016/j.physrep.2016.06.007; Lu L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10168; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Ma LL, 2016, PHYSICA A, V451, P205, DOI 10.1016/j.physa.2015.12.162; Medo M, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38005; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Rajeh S, 2020, IEEE ACCESS, V8, P129717, DOI 10.1109/ACCESS.2020.3009525; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Subelj L, 2011, EUR PHYS J B, V81, P353, DOI 10.1140/epjb/e2011-10979-2; Wang ZX, 2016, PHYSICA A, V461, P171, DOI 10.1016/j.physa.2016.05.048; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen T, 2020, KNOWL-BASED SYST, V195, DOI 10.1016/j.knosys.2020.105717; Zareie A, 2018, EXPERT SYST APPL, V93, P200, DOI 10.1016/j.eswa.2017.10.018; Zeng A, 2013, PHYS LETT A, V377, P1031, DOI 10.1016/j.physleta.2013.02.039; Zhao J, 2021, CONNECT SCI, V33, P201, DOI 10.1080/09540091.2020.1806203; Zhao ZY, 2015, ENTROPY-SWITZ, V17, P2228, DOI 10.3390/e17042228	49	4	4	13	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251208	10.1371/journal.pone.0251208	http://dx.doi.org/10.1371/journal.pone.0251208			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019580	gold, Green Published			2022-12-26	WOS:000664632300019
J	Barile, A; Battista, T; Fiorillo, A; di Salvo, ML; Malatesta, F; Tramonti, A; Ilari, A; Contestabile, R				Barile, Anna; Battista, Theo; Fiorillo, Annarita; di Salvo, Martino Luigi; Malatesta, Francesco; Tramonti, Angela; Ilari, Andrea; Contestabile, Roberto			Identification and characterization of the pyridoxal 5 '-phosphate allosteric site in Escherichia coli pyridoxine 5 '-phosphate oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; BIOSYNTHESIS; BINDING	Pyridoxal 5'-phosphate (PLP), the catalytically active form of vitamin B6, plays a pivotal role in metabolism as an enzyme cofactor. PLP is a very reactive molecule and can be very toxic unless its intracellular concentration is finely regulated. In Escherichia coli, PLP formation is catalyzed by pyridoxine 5'-phosphate oxidase (PNPO), a homodimeric FMN-dependent enzyme that is responsible for the last step of PLP biosynthesis and is also involved in the PLP salvage pathway. We have recently observed that E. coli PNPO undergoes an allosteric feedback inhibition by PLP, caused by a strong allosteric coupling between PLP binding at the allosteric site and substrate binding at the active site. Here we report the crystallo-graphic identification of the PLP allosteric site, located at the interface between the enzyme subunits and mainly circum-scribed by three arginine residues (Arg23, Arg24, and Arg215) that form an "arginine cage" and efficiently trap PLP. The crystal structure of the PNPO-PLP complex, characterized by a marked structural asymmetry, presents only one PLP molecule bound at the allosteric site of one monomer and sheds light on the allosteric inhibition mechanism that makes the enzyme-substrate-PLP ternary complex catalytically incompetent. Site-directed mutagenesis studies focused on the arginine cage validate the identity of the allosteric site and provide an effective means to modulate the allosteric properties of the enzyme, from the loosening of the allosteric coupling (in the R23L/R24L and R23L/R215L variants) to the complete loss of allosteric properties (in the R23L/R24L/R21L variant).	[Barile, Anna; Battista, Theo; Fiorillo, Annarita; Tramonti, Angela; Ilari, Andrea] CNR, Ist Biol & Patol Mol, Rome, Italy; [Barile, Anna; Battista, Theo; Fiorillo, Annarita; di Salvo, Martino Luigi; Malatesta, Francesco; Tramonti, Angela; Contestabile, Roberto] Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ist Pasteur Italia, Fdn Cenci Bolognetti, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Fondazione Cenci Bolognetti; Sapienza University Rome	Contestabile, R (corresponding author), Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ist Pasteur Italia, Fdn Cenci Bolognetti, Rome, Italy.	roberto.contestabile@uniroma1.it	Battista, Theo/GSN-8769-2022; Ilari, Andrea/AAC-7670-2022; Tramonti, Angela/K-5325-2019	Ilari, Andrea/0000-0002-7754-399X; Tramonti, Angela/0000-0002-5625-1170; FIORILLO, Annarita/0000-0002-8966-8554; Contestabile, Roberto/0000-0002-5235-9993; Barile, Anna/0000-0002-0929-3378	Istituto Pasteur Italia -Fondazione Cenci Bolognetti; Sapienza Universita di Roma [RM11916B51484C08, RM120172A76E4B78]; CNR Italy-Russia bilateral project [CUPB86C17000270001]	Istituto Pasteur Italia -Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Sapienza Universita di Roma; CNR Italy-Russia bilateral project	This research was supported by grants from Istituto Pasteur Italia -Fondazione Cenci Bolognetti (Research Grant "Anna Tramontano" 2018 to R. C.), from Sapienza Universita di Roma (RM11916B51484C08 and RM120172A76E4B78 to R. C.), and the CNR Italy-Russia bilateral project (Grant CUPB86C17000270001 to A. T.).	Barile A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70598-7; Barile A, 2019, J BIOL CHEM, V294, P15593, DOI 10.1074/jbc.RA119.009697; Battista T., 2020, PROTEIN DATA BANK; Battista T., 2020, PROTEIN DATA BANK; Denesyuk AI, 2002, J MOL BIOL, V316, P155, DOI 10.1006/jmbi.2001.5310; Di Salvo M, 1998, PROTEIN EXPRES PURIF, V13, P349, DOI 10.1006/prep.1998.0904; di Salvo ML, 2017, MOL GENET METAB, V122, P135, DOI 10.1016/j.ymgme.2017.08.003; di Salvo ML, 2011, BBA-PROTEINS PROTEOM, V1814, P1597, DOI 10.1016/j.bbapap.2010.12.006; di Salvo ML, 2002, J MOL BIOL, V315, P385, DOI 10.1006/jmbi.2001.5254; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Ito T, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00056-20; KWON O, 1991, J BIOL CHEM, V266, P22136; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Safo MK, 2001, J MOL BIOL, V310, P817, DOI 10.1006/jmbi.2001.4734; Yang ES, 2000, ARCH BIOCHEM BIOPHYS, V377, P109, DOI 10.1006/abbi.2000.1737; Yang Y, 1998, J BACTERIOL, V180, P1814, DOI 10.1128/JB.180.7.1814-1821.1998; ZHAO GS, 1995, J BACTERIOL, V177, P883, DOI 10.1128/jb.177.4.883-891.1995	20	1	1	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100795	10.1016/j.jbc.2021.100795	http://dx.doi.org/10.1016/j.jbc.2021.100795			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019876	Green Published, gold			2022-12-26	WOS:000674717300015
J	Otzen, DE				Otzen, Daniel E.			Driving forces in amyloidosis: How does a light chain make a heavy heart?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Light-chain amyloidosis (AL) is a fatal disorder wherein the immunoglobulin light chain misfolds and aggregates, leading to amyloid plaques in various organs. Patient-specific mutations in the light chain variable domain (V-L) are tightly linked to amyloidosis, but how these mutations drive AL is unknown. In recent work, Rottenaicher et al. analyze fivemutations found in the V-L of a patient with cardiac AL. Their data suggest that decreased V-L stability and increased flexibility in the core of the V-L, causedby mutations outside of this core, could be key to aggregation and highlight the delicate balancing act required for antibody maturation to enable antigen recognition while not altering protein biophysics.	[Otzen, Daniel E.] Aarhus Univ, iNANO, Aarhus C, Denmark	Aarhus University	Otzen, DE (corresponding author), Aarhus Univ, iNANO, Aarhus C, Denmark.	dao@inano.au.dk		Otzen, Daniel/0000-0002-2918-8989				Annamalai K, 2017, ANGEW CHEM INT EDIT, V56, P7510, DOI 10.1002/anie.201701761; Gertz MA, 2018, AM J HEMATOL, V93, P1169, DOI 10.1002/ajh.25149; Lecoq L, 2019, CHEMBIOCHEM, V20, P1027, DOI 10.1002/cbic.201800732; Merlini G, 2017, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2017.1.1; Morgan GJ, 2016, J MOL BIOL, V428, P4280, DOI 10.1016/j.jmb.2016.08.021; Pradhan T, 2020, J BIOL CHEM, V295, P18474, DOI 10.1074/jbc.RA120.016006; Radamaker L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09032-0; Rottenaicher GJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100334	8	1	1	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100785	10.1016/j.jbc.2021.100785	http://dx.doi.org/10.1016/j.jbc.2021.100785			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019874	Green Published, gold			2022-12-26	WOS:000674717300007
J	Raja, A; Malik, MFA; Haq, F				Raja, Aroosha; Malik, Muhammad Faraz Arshad; Haq, Farhan			Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer	PLOS ONE			English	Article							GROWTH; IDENTIFICATION; PROLIFERATION; AMPLIFICATION; PROGRESSION; METASTASIS; EXPRESSION; RESISTANCE; CARCINOMA; PACKAGE	Background Fibroblast (FGFs) and insulin (IGF) growth factor pathways are among 10 most recurrently altered genomic pathways in pancreatic ductal adenocarcinoma (PDAC). However, the prognostic and therapeutic relevance of FGF and IGF pathways in PDAC is largely unknown. Methods We investigated the relationship between fibroblast and insulin pathway gene expression and clinicopathological features in three independent transcriptomic cohorts of 532 PDAC patients. Furthermore, we have examined the coexpressed genes specific to the prognostic marker identified from these cohorts. Statistical tests including Fisher-exact\Chi-square, Kaplan-Meier, Pearson Correlation and cox regression analyses were performed. Additionally, pathway analysis of gene-specific co-expressed genes was also performed. Results The dysregulation of six genes including FGF9, FGF14, FGFR1, FGFR4, IGF2BP2 and IGF2BP3 were significantly associated with different clinical characteristics (including grade, stage, recurrence and nodes) in PDAC cohorts. 11 genes (including FGF9, FGF13, FGF14, FGF17, FGFR1, FGFRL1, FGFBP3, IGFBP3, IGF2BP2, IGF2BP3 and IGFBPL1) showed association with overall survival in different PDAC cohorts. Interestingly, overexpression of FGF14 was found associated with better overall survival (OS) in all three cohorts. Of note, multivariate analysis also revealed FGF14 as an independent prognostic marker for better OS in all three cohorts. Furthermore, FMN2 and PGR were among the top genes that correlated with FGF14 in all 3 cohorts. Of note, overexpression of FMN2 and PGR was found significantly associated with good overall survival in PDAC patients, suggesting FMN2 and PGR can also act as potential markers for the prediction of prognosis in PDAC patients. Conclusion FGF14 may define a distinct subset of PDAC patients with better prognosis. Moreover, FGF14-based sub-classification of PDAC suggests that FMN2 and PGR can be employed as good prognostic markers in PDAC and this classification may lead to new therapeutic approaches.	[Raja, Aroosha; Malik, Muhammad Faraz Arshad; Haq, Farhan] COMSATS Univ, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Haq, F (corresponding author), COMSATS Univ, Islamabad, Pakistan.	farhan.haq@comsats.edu.pk	; Haq, Farhan/Q-3067-2017	Raja, Aroosha/0000-0002-1041-6638; Haq, Farhan/0000-0001-9190-4360	Higher Education Commission (HEC) of Pakistan; COMSATS University Islamabad	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); COMSATS University Islamabad	We are grateful to Higher Education Commission (HEC) of Pakistan and COMSATS University Islamabad for facilitating this research.	Bach LA, 2015, J CELL COMMUN SIGNAL, V9, P189, DOI 10.1007/s12079-015-0288-4; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Becker AE, 2014, WORLD J GASTROENTERO, V20, P11182, DOI 10.3748/wjg.v20.i32.11182; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Brannmark C, 2013, J BIOL CHEM, V288, P9867, DOI 10.1074/jbc.M112.432062; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Fang Q, 2018, ONCOTARGET, V9, P2475, DOI 10.18632/oncotarget.23504; Glass M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114190; Goggins M, 2005, J CLIN ONCOL, V23, P4524, DOI 10.1200/JCO.2005.19.711; Hagihara A, 2004, ONCOGENE, V23, P8705, DOI 10.1038/sj.onc.1207783; Haq F, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1743-9; Kawano M, 2019, CLIN TRANSL RAD ONCO, V14, P8, DOI 10.1016/j.ctro.2018.10.004; Khalid A., 2016, J CANC SCI THERAPY, V08, DOI [10.4172/1948-5956.1000413, DOI 10.4172/1948-5956.1000413]; Kopantzev EP, 2017, MOL GENET MICROBIOL+, V32, P131, DOI 10.3103/S0891416817030041; Kukreja M, 2012, J PROTEOM BIOINFORM, DOI [10.4172/jpb.S6-001, DOI 10.4172/JPB.S6-001]; Lehnen NC, 2013, HISTOPATHOLOGY, V63, P157, DOI 10.1111/his.12115; Li DJ, 2018, WORLD J GASTROENTERO, V24, P5013, DOI 10.3748/wjg.v24.i44.5013; Li XL, 2017, ONCOL RES, V25, P579, DOI 10.3727/97818823455816X14760504645779; Liu FY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.46; Liu MY, 2016, ONCOL LETT, V12, P473, DOI 10.3892/ol.2016.4658; Long J, 2014, CANCER LETT, V346, P273, DOI 10.1016/j.canlet.2014.01.004; Motoda N, 2011, INT J ONCOL, V38, P133, DOI 10.3892/ijo_00000832; Neid M, 2004, J BIOL CHEM, V279, P3941, DOI 10.1074/jbc.M303975200; Oberstein PE, 2013, THER ADV GASTROENTER, V6, P321, DOI 10.1177/1756283X13478680; Ozawa F, 2001, TERATOGEN CARCIN MUT, V21, P27, DOI 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9; Pour Parviz M, 2003, Mol Cancer, V2, P13, DOI 10.1186/1476-4598-2-13; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Reiter JG, 2017, NAT REV GASTRO HEPAT, V14, P7, DOI 10.1038/nrgastro.2016.190; Samovski D, 2018, DIABETES, V67, P1272, DOI 10.2337/db17-1226; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Su TH, 2019, GUT, V68, pA15, DOI 10.1136/gutjnl-2019-IDDFabstracts.28; Taniuchi K, 2014, ONCOTARGET, V5, P6832, DOI 10.18632/oncotarget.2257; Turkowski K, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081755; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Vescarelli E., 2015, PANCREATIC DISORDERS, V5, P3, DOI DOI 10.4172/2165-7092.1000164; Wang Q, 2017, CANCER MED-US, V6, P1323, DOI 10.1002/cam4.1026; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wu Z, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.921430; Yamada K, 2013, MOL CELL, V49, P922, DOI 10.1016/j.molcel.2012.12.023; Yang SH, 2016, CANCER RES, V76, P3838, DOI 10.1158/0008-5472.CAN-15-2841; Ye S, 2016, FEBS LETT, V590, P1641, DOI 10.1002/1873-3468.12205; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang PP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1224-3; Zou BJ, 2018, CANCER MANAG RES, V10, P5303, DOI 10.2147/CMAR.S176152	44	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252344	10.1371/journal.pone.0252344	http://dx.doi.org/10.1371/journal.pone.0252344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061869	gold, Green Published			2022-12-26	WOS:000656813600012
J	Razmi, P; Asl, MG; Canarella, G; Emami, AS				Razmi, Peyman; Asl, Mahdi Ghaemi; Canarella, Giorgio; Emami, Afsaneh Sadat			Topology identification in distribution system via machine learning algorithms	PLOS ONE			English	Article							ERRORS	This paper contributes to the literature on topology identification (TI) in distribution networks and, in particular, on change detection in switching devices' status. The lack of measurements in distribution networks compared to transmission networks is a notable challenge. In this paper, we propose an approach to topology identification (TI) of distribution systems based on supervised machine learning (SML) algorithms. This methodology is capable of analyzing the feeder's voltage profile without requiring the utilization of sensors or any other extraneous measurement device. We show that machine learning algorithms can track the voltage profile's behavior in each feeder, detect the status of switching devices, identify the distribution system's typologies, reveal the kind of loads connected or disconnected in the system, and estimate their values. Results are demonstrated under the implementation of the ANSI case study.	[Razmi, Peyman] Ferdowsi Univ Mashhad, Fac Engn, Mashhad, Razavi Khorasan, Iran; [Asl, Mahdi Ghaemi] Kharazmi Univ, Fac Econ, Tehran, Iran; [Canarella, Giorgio] Univ Nevada, Dept Econ, Las Vegas, NV 89154 USA; [Canarella, Giorgio] Univ Nevada, CBER, Las Vegas, NV 89154 USA; [Emami, Afsaneh Sadat] Islamic Azad Univ Tabriz, Fac Elect & Comp Engn, East Azerbaijan, Tabriz, Iran	Ferdowsi University Mashhad; Kharazmi University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; US Food & Drug Administration (FDA); Islamic Azad University	Asl, MG (corresponding author), Kharazmi Univ, Fac Econ, Tehran, Iran.	m.ghaemi@khu.ac.ir	Ghaemi Asl, Mahdi/GLU-8608-2022; Ghaemi Asl, Mahdi/GZK-2341-2022; Ghaemi Asl, Mahdi/GLT-5925-2022	Ghaemi Asl, Mahdi/0000-0002-2246-2914; Ghaemi Asl, Mahdi/0000-0002-2246-2914; Ghaemi Asl, Mahdi/0000-0002-2246-2914				Arghandeh Reza, 2015, 2015 IEEE Power & Energy Society General Meeting, P1, DOI 10.1109/PESGM.2015.7286053; Barattini Mariana, 2009, Polis, V8, P17; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Bernards R, 2018, SMART PLANNING INTEG; Bolognani S, 2013, IEEE DECIS CONTR P, P1659, DOI 10.1109/CDC.2013.6760120; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L., 1996, 460 U CAL STAT DEP, V460; Cavraro G, 2015, ARXIV150405926; Chang C.-C., 2011, ACM T INTEL SYST TEC, V2, P1, DOI [10.1145/1961189.1961199, DOI 10.1145/1961189.1961199]; [陈艳波 Chen Yanbo], 2012, [电网技术, Power System Technology], V36, P95; Chen Yanbo, 2010, Automation of Electric Power Systems, V34, P20; Clement-Nyns K, 2010, IEEE T POWER SYST, V25, P371, DOI 10.1109/TPWRS.2009.2036481; CLEMENTS KA, 1988, IEEE T POWER SYST, V3, P1748, DOI 10.1109/59.192991; Clements KA, 1998, IEEE T POWER SYST, V13, P347, DOI 10.1109/59.667350; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Deka D, 2015, ARXIV150104131; Dorostkar-Ghamsari MR, 2016, IEEE T POWER SYST, V31, P1879, DOI 10.1109/TPWRS.2015.2457954; Duan KB, 2005, LECT NOTES COMPUT SC, V3541, P278; Edwards DD., 2003, ARTIF INTELL, V2; Farza M, 2009, AUTOMATICA, V45, P2292, DOI 10.1016/j.automatica.2009.06.008; Gao Y., 2013, PROC IEEE OCEANS 13, P1, DOI [10.1109/OCEANS-Bergen.2013.6608044, DOI 10.1109/OCEANS-BERGEN.2013.6608044]; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Huang J, 2012, PROCEEDINGS OF THE 10TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA 2012), P1, DOI 10.1109/WCICA.2012.6357827; KEARNS M, 1994, J ACM, V41, P67, DOI 10.1145/174644.174647; Kearns M., 1988, THOUGHTS HYPOT UNPUB, V45, P105; Korres GN, 2012, IEEE POW ENER SOC GE; Lavorato M, 2012, IEEE T POWER SYST, V27, P172, DOI 10.1109/TPWRS.2011.2161349; LUGTU RL, 1980, IEEE T POWER AP SYST, V99, P2406, DOI 10.1109/TPAS.1980.319807; Ma Jing, 2014, Automation of Electric Power Systems, V38, P74, DOI 10.7500/AEPS20131212003; Maimon O.Z., 2014, DATA MINING DECISION; Mehta P, 2019, PHYS REP, V810, P1, DOI 10.1016/j.physrep.2019.03.001; Mili L, 1999, IEEE T POWER SYST, V14, P1469, DOI 10.1109/59.801932; Nielsen M.A., 2015, NEURAL NETWORKS DEEP; Opitz D., 1999, J ARTIF INTELL RES, V11, P169, DOI [10.1613/jair.614, DOI 10.1613/JAIR.614]; Pappu SJ., 2017, IEEE T SMART GRID; Lopes JAP, 2011, P IEEE, V99, P168, DOI 10.1109/JPROC.2010.2066250; Polikar R., 2006, IEEE Circuits and Systems Magazine, V6, P21, DOI 10.1109/MCAS.2006.1688199; Provost F, 1998, MACH LEARN, V30, P127, DOI 10.1023/A:1007442505281; Sharon Y., 2012, 2012 IEEE PES INNOVA, P1; Simon Phil, 2013, TOO BIG IGNORE BUSIN; SINGH N, 1994, IEEE T POWER SYST, V9, P841, DOI 10.1109/59.317631; SINGH N, 1991, IEEE T POWER SYST, V6, P324, DOI 10.1109/59.131079; Singh R, 2010, IEEE T POWER SYST, V25, P1329, DOI 10.1109/TPWRS.2010.2040294; Souza JCS, 1998, IEEE T POWER SYST, V13, P796, DOI 10.1109/59.708645; Sun XF, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON POWER AND RENEWABLE ENERGY (ICPRE), P456; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Taylor JA, 2012, IEEE T POWER SYST, V27, P1407, DOI 10.1109/TPWRS.2012.2184307; Vapnik V., 1998, STAT LEARNING THEORY; [王晶 Wang Jing], 2012, [电网技术, Power System Technology], V36, P166; Xu SC, 2013, 2013 IEEE 5TH INTERNATIONAL WORKSHOP ON COMPUTATIONAL ADVANCES IN MULTI-SENSOR ADAPTIVE PROCESSING (CAMSAP 2013), P420, DOI 10.1109/CAMSAP.2013.6714097; Yao Y., 2011, POWER SYSTEM PROTECT, V39, P31; Zhang QH, 2002, IEEE T AUTOMAT CONTR, V47, P525, DOI 10.1109/9.989154; Zhou Q, 2007, IET GENER TRANSM DIS, V1, P492, DOI 10.1049/iet-gtd:20060246; Zhou Z.-H, 2012, ENSEMBLE METHODS FDN, DOI DOI 10.1201/B12207	56	1	1	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252436	10.1371/journal.pone.0252436	http://dx.doi.org/10.1371/journal.pone.0252436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061910	gold, Green Published			2022-12-26	WOS:000656813600047
J	Banholzer, N; van Weenen, E; Lison, A; Cenedese, A; Seeliger, A; Kratzwald, B; Tschernutter, D; Salles, JP; Bottrighi, P; Lehtinen, S; Feuerriegel, S; Vach, W				Banholzer, Nicolas; van Weenen, Eva; Lison, Adrian; Cenedese, Alberto; Seeliger, Arne; Kratzwald, Bernhard; Tschernutter, Daniel; Salles, Joan Puig; Bottrighi, Pierluigi; Lehtinen, Sonja; Feuerriegel, Stefan; Vach, Werner			Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave	PLOS ONE			English	Article								The novel coronavirus (SARS-CoV-2) has rapidly developed into a global epidemic. To control its spread, countries have implemented non-pharmaceutical interventions (NPIs), such as school closures, bans of small gatherings, or even stay-at-home orders. Here we study the effectiveness of seven NPIs in reducing the number of new infections, which was inferred from the reported cases of COVID-19 using a semi-mechanistic Bayesian hierarchical model. Based on data from the first epidemic wave of n = 20 countries (i.e., the United States, Canada, Australia, the EU-15 countries, Norway, and Switzerland), we estimate the relative reduction in the number of new infections attributed to each NPI. Among the NPIs considered, bans of large gatherings were most effective, followed by venue and school closures, whereas stay-at-home orders and work-from-home orders were least effective. With this retrospective cross-country analysis, we provide estimates regarding the effectiveness of different NPIs during the first epidemic wave.	[Banholzer, Nicolas; van Weenen, Eva; Lison, Adrian; Cenedese, Alberto; Seeliger, Arne; Kratzwald, Bernhard; Tschernutter, Daniel; Salles, Joan Puig; Bottrighi, Pierluigi; Feuerriegel, Stefan] Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland; [Lehtinen, Sonja] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Vach, Werner] Basel Acad Qual & Res Med, Basel, Switzerland; [Vach, Werner] Univ Basel, Dept Environm Sci, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Banholzer, N (corresponding author), Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland.	nbanholzer@ethz.ch	Vach, Werner/F-2512-2011; Feuerriegel, Stefan/ABD-6599-2021	Vach, Werner/0000-0003-1865-8399; Feuerriegel, Stefan/0000-0001-7856-8729; Banholzer, Nicolas/0000-0003-0138-6120; van Weenen, Eva/0000-0001-5500-2108; Lehtinen, Sonja/0000-0002-4236-828X; Lison, Adrian/0000-0002-6822-8437	Swiss National Science Foundation (SNSF) [186932]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	NB, EvW and SF acknowledge funding from the Swiss National Science Foundation (SNSF) as part of the Eccellenza grant 186932 on "Data-driven health management". The funding bodies had no control over design, conduct, data, analysis, review, reporting, or interpretation of the research conducted.	Adam DC, 2020, NAT MED, V26, P1714, DOI 10.1038/s41591-020-1092-0; Auger KA, 2020, JAMA-J AM MED ASSOC, V324, P859, DOI 10.1001/jama.2020.14348; Bottrighi P., 2020, ESTIMATING IMPACT NO, DOI [10.1101/2020.04.16.20062141v3, DOI 10.1101/2020.04.16.20062141V3]; Brauner J.M., 2020, SCIENCE; Carpenter B., BAYESIAN WORKFLOW; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Cereda D., EARLY PHASE COVID 19; Cevik M, 2020, J INFECT DIS, DOI [32743609, DOI 10.1093/INFDIS/JIAA691/5943164]; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Davies NG, 2020, LANCET PUBLIC HEALTH, V5, pE375, DOI 10.1016/S2468-2667(20)30133-X; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ferretti L., 2020, TIMING COVID 19 TRAN, DOI [DOI 10.1101/2020.09.04.20188516, 10.1101/2020.09.04.20188516, 10.2139/ssrn.3716879, DOI 10.1101/2020.09.04.20188516V2]; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Haug N, 2020, NAT HUM BEHAV, V4, DOI 10.1038/s41562-020-01009-0; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; John J, 2020, SCIENCE, V370, P663, DOI 10.1126/science.abe9707; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Lemieux JE, 2021, SCIENCE, V371, P588, DOI 10.1126/science.abe3261; Levinson M, 2020, NEW ENGL J MED, V383, P981, DOI 10.1056/NEJMms2024920; Li Y, 2021, LANCET INFECT DIS, V21, P193, DOI 10.1016/S1473-3099(20)30785-4; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; McAloon C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039652; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Soltesz K, 2020, NATURE, V588, pE26, DOI 10.1038/s41586-020-3025-y; Stan Development Team, 2020, PRIOR CHOIC REC; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Wang L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18836-4; WHO, 2020, WHO COR COVID 19 DAS	34	20	20	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252827	10.1371/journal.pone.0252827	http://dx.doi.org/10.1371/journal.pone.0252827			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077448	Green Submitted, Green Published, gold			2022-12-26	WOS:000664638500062
J	Chen, KS; Lawhn-Heath, C; Behr, S; Juarez, R; Whitman, J; Paciorek, A; Nakakura, EK; Fidelman, N; Feng, MUS; Bergsland, EK; Anwar, M				Chen, Katherine S.; Lawhn-Heath, Courtney; Behr, Spencer; Juarez, Roxanna; Whitman, Julia; Paciorek, Alan; Nakakura, Eric K.; Fidelman, Nicholas; Feng, Mary Uan-Sian; Bergsland, Emily K.; Anwar, Mekhail			Outcomes after high-dose radiation in the management of neuroendocrine neoplasms	PLOS ONE			English	Article							RECEPTOR RADIONUCLIDE THERAPY; SOMATOSTATIN ANALOGS; TUMORS; GRADE	Background Neuroendocrine neoplasms (NENs) comprise a rare and heterogenous group of cancers, for which the role of radiation therapy continues to evolve. The purpose of this study is to analyze oncologic outcomes after the use of high-dose radiation in management of NENs at a tertiary hospital. Materials and methods We performed a retrospective review of patients who received high-dose radiation with intent to cure or provide durable local control (defined as biologically effective dose (BED) >= 40, alpha/beta = 10) for a localized or metastatic NEN from 2006 to 2019. Evaluation of disease status after radiation was performed according to Response Evaluation Criteria in Solid Tumors (RECIST) criteria when possible. Patients were grouped by differentiation (well-differentiated (WD) or poorly-differentiated (PD)) and stage (localized/locally advanced disease (L) or metastatic (M)) in analysis of probabilities of progression after radiation. Results 45 patients completed a radiation course with BED >= 40 for a NEN (median BED 72). With a median follow-up of 24 months after radiation, the 2-year actuarial rates of local relapse-free survival, new metastasis-free survival, progression-free survival, and overall survival after radiation were 98%, 45%, 41%, and 69%, respectively. 25 patients (56%) developed new metastases after completion of radiation, including 33% (n = 3) of patients with WD-L disease, 44% (n = 8) of WD-M, 77% (n = 10) of PD-L, and 80% (n = 4) of PD-M, with progressively shorter median times to progression (26, 9, 8, and 3 months, respectively; p = 0.093). Of the 25 patients evaluable by RECIST, 68% (n = 17) achieved either a complete or partial best response in the irradiated lesion. Conclusions These data suggest that focal, high-dose radiation has a role in the management of selected patients with NENs. Local failure is rare in patients with both well-differentiated and poorly-differentiated disease, although the predominant pattern of failure remains development of new metastases.	[Chen, Katherine S.; Feng, Mary Uan-Sian; Anwar, Mekhail] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94115 USA; [Lawhn-Heath, Courtney; Behr, Spencer; Juarez, Roxanna; Fidelman, Nicholas] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Whitman, Julia] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Paciorek, Alan] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Nakakura, Eric K.] Univ Calif San Francisco, Dept Surg, Dept Surg, San Francisco, CA USA; [Bergsland, Emily K.] Univ Calif San Francisco, Div Hematol Oncol, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chen, KS; Anwar, M (corresponding author), Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94115 USA.	Katherine.chen5@ucsf.edu; Mekhail.anwar@ucsf.edu		Lawhn-Heath, Courtney/0000-0002-1088-3463				Barker JL, 2003, CANCER-AM CANCER SOC, V98, P2322, DOI 10.1002/cncr.11795; Carter JN, 2016, INT J RADIAT ONCOL, V96, pE202, DOI 10.1016/j.ijrobp.2016.06.1100; Chan DL, 2018, CLIN ONCOL-UK, V30, P400, DOI 10.1016/j.clon.2018.03.006; Contessa JN, 2009, INT J RADIAT ONCOL, V75, P1196, DOI 10.1016/j.ijrobp.2008.12.044; Dasari A, 2017, JAMA ONCOL, V3, P1335, DOI 10.1001/jamaoncol.2017.0589; Delaunoit T, 2005, MAYO CLIN PROC, V80, P502, DOI 10.4065/80.4.502; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Eriksson B, 1999, ANN ONCOL, V10, pS31, DOI 10.1093/annonc/10.suppl_2.S31; Grozinsky-Glasberg S, 2008, ENDOCR-RELAT CANCER, V15, P701, DOI 10.1677/ERC-07-0288; Guan M, 2019, ADV RADIAT ONCOL, V4, P513, DOI 10.1016/j.adro.2019.03.014; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Hope TA, 2019, J NUCL MED, V60, P937, DOI 10.2967/jnumed.118.230607; Kim SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-448; Kunz PL, 2013, PANCREAS, V42, P557, DOI 10.1097/MPA.0b013e31828e34a4; Lee JS, 2013, RADIAT ONCOL J, V31, P125, DOI 10.3857/roj.2013.31.3.125; National Comprehensive Cancer Network, NCCN CLIN PRACTICE G; Saif MW, 2013, ANTICANCER RES, V33, P2175; SCHUPAK KD, 1991, INT J RADIAT ONCOL, V20, P489; Strosberg J, 2017, NEW ENGL J MED, V376, P125, DOI 10.1056/NEJMoa1607427; US Department of Health and Human Services, 2017, COMMON TERMINOLOGY C; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zagar TM, 2012, INT J RADIAT ONCOL, V83, P1126, DOI 10.1016/j.ijrobp.2011.09.041; Zaknun JJ, 2013, EUR J NUCL MED MOL I, V40, P800, DOI 10.1007/s00259-012-2330-6	23	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252574	10.1371/journal.pone.0252574	http://dx.doi.org/10.1371/journal.pone.0252574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077464	Green Published, gold			2022-12-26	WOS:000664638500051
J	Khalil, DM; Elmorsy, E; Arafa, A; Nafady, HA; Saleh, L				Khalil, Doaa Mahmoud; Elmorsy, Elmorsy; Arafa, Ahmed; Nafady, Hesham Ahmed; Saleh, Lamiaa			Factors affecting prehospital time delay of the injured patients arriving at the Emergency Department of Beni-Suef University Hospital in Egypt: A cross-sectional study	PLOS ONE			English	Article							LEVEL; CARE; SERVICES	Purpose This study aimed to assess the factors affecting the prehospital time delay of the injured patients arriving at the Emergency Department of Beni-Suef University Hospital in Upper Egypt. Materials and methods In this cross-sectional study, the following data were retrieved from the hospital records of 632 injured patients between 1/1/2018 and 31/3/2018: age, sex, residence, means of transportation to the hospital, prehospital time delay, consciousness level on admission, source of injury, and type of worst injury. Results The prehospital time delay (>one hour) of the injured patients was positively associated with age >60 years and rural residence but inversely associated with consciousness level with odds ratios (95% confidence intervals) of 5.14 (2.26-11.68), 3.49 (2.22-5.48), and 0.56 (0.32-0.96), respectively. Conclusion The prehospital time delay of the injured patients arriving at the Emergency Department of Beni-Suef University Hospital in Egypt was associated with old age, rural residence, and consciousness level.	[Khalil, Doaa Mahmoud; Elmorsy, Elmorsy; Arafa, Ahmed; Saleh, Lamiaa] Beni Suef Univ, Dept Publ Hlth & Community Med, Fac Med, Bani Suwayf, Egypt; [Arafa, Ahmed] Osaka Univ, Dept Social Med, Publ Hlth, Grad Sch Med, Osaka, Japan; [Nafady, Hesham Ahmed] Beni Suef Univ, Dept Gen Surg, Fac Med, Bani Suwayf, Egypt	Egyptian Knowledge Bank (EKB); Beni Suef University; Osaka University; Egyptian Knowledge Bank (EKB); Beni Suef University	Khalil, DM (corresponding author), Beni Suef Univ, Dept Publ Hlth & Community Med, Fac Med, Bani Suwayf, Egypt.	doaamahmoud@med.bsu.edu.eg	Arafa, Ahmed/GNH-2073-2022; , Ahmed/AAJ-3610-2020	, Ahmed/0000-0002-3335-2243; Mahmoud, Doaa/0000-0002-9003-0136				Arafa A, 2019, INT J INJ CONTROL SA, V26, P372, DOI 10.1080/17457300.2019.1638419; Boutayeb A, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-23; CAPMAS. Central Agency for Public Mobilization and Statistics, 2018, EG STAT FIN RES 2017; Chang KC, 2004, STROKE, V35, P700, DOI 10.1161/01.STR.0000117236.90827.17; Chiang CF, 2013, NAGOYA J MED SCI, V75, P225; Elgazzar H, 2009, HEALTH ECON POLICY L, V4, P445, DOI 10.1017/S1744133109004939; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; James SL, 2020, INJURY PREV; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McCoy CE, 2013, ANN EMERG MED, V61, P167, DOI 10.1016/j.annemergmed.2012.08.026; McNarry AF, 2004, ANAESTHESIA, V59, P34, DOI 10.1111/j.1365-2044.2004.03526.x; Mohan B, 2018, INDIAN HEART J, V70, pS194, DOI 10.1016/j.ihj.2018.10.395; Newgard CD, 2015, ANN EMERG MED, V66, P30, DOI 10.1016/j.annemergmed.2014.12.004; Nguyen HL, 2010, CIRC-CARDIOVASC QUAL, V3, P82, DOI 10.1161/CIRCOUTCOMES.109.884361; Raj R, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-67; Rouleau DM, 2009, CAN FAM PHYSICIAN, V55, P1006; Sakran JV, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-64; Saleh HM, 2018, EUR J TRAUMA EMERG S, V44, P225, DOI 10.1007/s00068-017-0762-1; WHO, 2018, GLOB HLTH EST 2019 D; WHO, 2014, VIOL INJ PREV; Yu WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176907	21	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252044	10.1371/journal.pone.0252044	http://dx.doi.org/10.1371/journal.pone.0252044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077438	Green Published, gold			2022-12-26	WOS:000664638500024
J	Guo, HL; Ni, MM; Xu, J; Chen, F; Yao, ZY; Yao, YQ; Liu, C; Du, QM				Guo, Hongli; Ni, Mingming; Xu, Jing; Chen, Feng; Yao, Zhaoying; Yao, Yiqin; Liu, Chao; Du, Qianming			Transcriptional enhancement of GBP-5 by BATF aggravates sepsis-associated liver injury via NLRP3 inflammasome activation	FASEB JOURNAL			English	Article						acute liver injury; BATF; GBP-5; inflammation; NLRP3 inflammasome	INTERFERON-INDUCIBLE GTPASES; GUANYLATE-BINDING PROTEINS	Strong inflammatory response triggered by the activation of the innate immune system is one typical characteristic of sepsis-associated liver injury (SALI). Guanylate-binding protein 5 (GBP-5) is a component of cell-autonomous immunity and known to be associated with inflammation. Currently, whether GBP-5 participates in SALI and its roles in this disease are yet to be investigated. Using a lipopolysaccharide (LPS)-induced SALI mouse model, we found GBP-5 was highly expressed in LPS-treated mice, and its expression was tightly related to the serum concentrations of live injury markers and inflammatory cytokines, liver damage scores by H&E staining, and amounts of apoptotic hepatocytes by TUNEL staining. Moreover, GBP-5 overexpression was found to aggravate LPS-induced SALI by promoting the activation of NLR family pyrin domain containing 3 (NLRP3) inflammasome, then facilitated the production of pro-inflammatory cytokines, eventually induced hepatocyte cell death. Direct transcriptional activation of GBP-5 by basic leucine zipper ATF-like transcription factor (BATF) was identified and further validated. This study unveils a transcriptional upregulation of GBP-5 by interacting with BATF, which promotes the progression of LPS-induced SALI through NLRP3 inflammasome activation, and provides novel therapeutic insights for halting the progression of liver injury in various liver diseases.	[Guo, Hongli; Ni, Mingming; Xu, Jing; Chen, Feng] Nanjing Med Univ, Dept Pharm, Childrens Hosp, 72 Guanzhou Rd, Nanjing 210008, Peoples R China; [Du, Qianming] Nanjing Med Univ, Nanjing First Hosp, Gen Clin Res Ctr, 68 Changle Rd, Nanjing 210006, Peoples R China; [Liu, Chao] Nanjing Med Univ, Nanjing First Hosp, Dept Pharm, Nanjing, Peoples R China; [Yao, Zhaoying; Liu, Chao; Du, Qianming] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Clin Pharm, Nanjing, Peoples R China; [Yao, Yiqin] Xinjiang Med Univ, Coll Pharm, Urumqi, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; China Pharmaceutical University; Xinjiang Medical University	Guo, HL (corresponding author), Nanjing Med Univ, Dept Pharm, Childrens Hosp, 72 Guanzhou Rd, Nanjing 210008, Peoples R China.; Du, QM (corresponding author), Nanjing Med Univ, Nanjing First Hosp, Gen Clin Res Ctr, 68 Changle Rd, Nanjing 210006, Peoples R China.	guohongli@njmu.edu.cn; duqianming@njmu.edu.cn	Ming-ming, Ni/AAD-1301-2022	Ming-ming, Ni/0000-0003-3809-0614; Guo, Hongli/0000-0002-6660-8145	National Natural Science Foundation of China [81800530]; Natural Science Foundation of Jiangsu Province [BK20170149]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	National Natural Science Foundation of China, Grant/Award Number: 81800530; Natural Science Foundation of Jiangsu Province, Grant/Award Number: BK20170149	Alvisi G, 2020, J CLIN INVEST, V130, P3137, DOI 10.1172/JCI130426; Bian XB, 2019, J SCI FOOD AGR, V99, P3283, DOI 10.1002/jsfa.9541; Cerqueira DM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007519; Chen LY, 2019, DIGEST DIS SCI, V64, P773, DOI 10.1007/s10620-018-5392-x; Chen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044890; Cho HI, 2016, BRIT J PHARMACOL, V173, P980, DOI 10.1111/bph.13397; Delacher M, 2020, IMMUNITY, V52, P295, DOI 10.1016/j.immuni.2019.12.002; Fellenberg F, 2004, J INVEST DERMATOL, V122, P1510, DOI 10.1111/j.0022-202X.2004.22613.x; Finethy R, 2017, MBIO, V8, DOI 10.1128/mBio.01188-17; Fujiwara Y, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.59; Groslambert M, 2018, J INFLAMM RES, V11, P359, DOI 10.2147/JIR.S141220; Inzaugarat ME, 2019, HEPATOLOGY, V69, P845, DOI 10.1002/hep.30252; Jiang ZY, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/5871431; Jimenez-Castro MB, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101131; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Liu EH, 2020, J BIOL REG HOMEOS AG, V34, P1719, DOI 10.23812/20-326-A; Liu LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121383; Liu Q, 2020, ACTA PHARMACOL SIN, V41, P771, DOI 10.1038/s41401-019-0335-4; Luan JY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02201; Meunier E, 2016, CELL MICROBIOL, V18, P168, DOI 10.1111/cmi.12546; Meunier E, 2015, NAT IMMUNOL, V16, P476, DOI 10.1038/ni.3119; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Pilla-Moffett D, 2016, J MOL BIOL, V428, P3495, DOI 10.1016/j.jmb.2016.04.032; Punkenburg E, 2016, GUT, V65, P1139, DOI 10.1136/gutjnl-2014-308227; Sakai N, 2012, J GASTROEN HEPATOL, V27, P1609, DOI 10.1111/j.1440-1746.2012.07187.x; Shao BZ, 2019, INFLAMMATION, V42, P1147, DOI 10.1007/s10753-019-01008-y; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Szabo G, 2015, NAT REV GASTRO HEPAT, V12, P387, DOI 10.1038/nrgastro.2015.94; 't Hart NA, 2004, AM J TRANSPLANT, V4, P1836, DOI 10.1111/j.1600-6143.2004.00580.x; Wang LY, 2018, CLIN EXP MED, V18, P263, DOI 10.1007/s10238-017-0480-3; Woznica EA, 2018, ADV CLIN EXP MED, V27, P547, DOI 10.17219/acem/68363; Yan J, 2014, INT REV IMMUNOL, V33, P498, DOI 10.3109/08830185.2014.889129; Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224	34	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21672	10.1096/fj.202100234R	http://dx.doi.org/10.1096/fj.202100234R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042221				2022-12-26	WOS:000655695900038
J	Yang, CC; Sung, PH; Chiang, JY; Chai, HT; Chen, CH; Chu, YC; Li, YC; Yip, HK				Yang, Chih-Chao; Sung, Pei-Hsun; Chiang, John Y.; Chai, Han-Tan; Chen, Chih-Hung; Chu, Yi-Ching; Li, Yi-Chen; Yip, Hon-Kan			Combined tacrolimus and melatonin effectively protected kidney against acute ischemia-reperfusion injury	FASEB JOURNAL			English	Article						acute kidney injury; inflammation; kidney ischemia-reperfusion; melatonin; oxidative stress; tacrolimus	CRITICALLY-ILL PATIENTS; MESENCHYMAL STEM-CELL; ACUTE-RENAL-FAILURE; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; HOSPITALIZED-PATIENTS; RIFLE CRITERIA; SEPSIS; CARE; THERAPY	Acute kidney injury (AKI) is commonly encountered and causes high mortality in hospitalized patients; however, effective therapies for AKI have still not been established. Accordingly, we performed a rodent model with acute renal ischemia-reperfusion (IR) and tested the hypothesis that combined tacrolimus and melatonin therapy could be superior to either one for protecting the kidney against IR injury. Adult-male SD rat (n = 30) were equally categorized into group 1 (receiving laparotomy only), group 2 (IR treated by 3.0 cc/normal-saline), group 3 [IR + tacrolimus/0.5 mg/kg by intravenous administration at 30 minutes and at days 1/2/3 after IR], group 4 (IR + melatonin/50 mg/kg by intra-peritoneal administration at 30 minutes and 25 mg/kg at days 1/2/3 after IR] and group 5 (IR + tacrolimus +melatonin). By day 3 after IR, the creatinine/BUN levels and ratio of urine protein to urine creatinine were highest in group 2, lowest in group 1 and significantly lower in group 5 than in groups 3/4 (all P < .0001), but they did not differ between the groups 3/4. The protein expressions of oxidative-stress (p47phox/NOX-1/NOX-2/NOX-4), upstream (TLR4/MAL/MyD88/TRAF6/ASK1/MKK4/MKK7/NF-kappa B) and downstream (IL-6/INF-gamma/MMP-9/IL-1ss) inflammatory signaling, MAPK-family-signaling cascades(ERK1/2, JNK/p38/c-JUN), apoptotic/autophagic (p53/caspase 3/mitochondrial-Bax, ratio of LC3B-II/LC3B-I), and mitochondrial-damaged (cyclophilin D/cytochrome C/DRP1) biomarkers, and the expressions of inflammatory-immune cells (F4/80, CD14/CD3/CD8) as well as the kidney injured score exhibited an identical pattern of creatinine level (all P < .0001). In conclusion, combined tacrolimus and melatonin therapy was better than either single one on protecting the kidney functional and anatomical integrity against IR injury through suppressing inflammation and the generation of oxidative stress.	[Yang, Chih-Chao] Kaohsiung Chang Gung Mem Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Yang, Chih-Chao; Sung, Pei-Hsun; Chai, Han-Tan; Chen, Chih-Hung; Chu, Yi-Ching; Li, Yi-Chen; Yip, Hon-Kan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Sung, Pei-Hsun; Chai, Han-Tan; Chu, Yi-Ching; Li, Yi-Chen; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, 123 Ta Pei Rd, Kaohsiung, Taiwan; [Sung, Pei-Hsun; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Ctr Shockwave Med & Tissue Engn, Kaohsiung, Taiwan; [Sung, Pei-Hsun; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Kaohsiung, Taiwan; [Chiang, John Y.] Natl Sun Yat Sen Univ, Dept Comp Sci & Engn, Kaohsiung, Taiwan; [Chiang, John Y.] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Chen, Chih-Hung] Kaohsiung Chang Gung Mem Hosp, Div Gen Med, Dept Internal Med, Kaohsiung, Taiwan; [Yip, Hon-Kan] Asia Univ, Dept Nursing, Taichung, Taiwan; [Yip, Hon-Kan] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Yip, Hon-Kan] Xiamen Chang Gung Hosp, Dept Internal Med, Div Cardiol, Xiamen, Peoples R China	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Sun Yat Sen University; Kaohsiung Medical University; Chang Gung Memorial Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Li, YC; Yip, HK (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Cardiol, Dept Internal Med, 123 Ta Pei Rd, Kaohsiung, Taiwan.	han.gung@msa.hinet.net; han.gung@msa.hinet.net		Sung, Pei-Hsun/0000-0002-1989-9752; Yip, Hon-Kan/0000-0002-6305-5717	Chang Gung Memorial Hospital, Chang Gung University [CMRPG8H0741]	Chang Gung Memorial Hospital, Chang Gung University(Chang Gung Memorial Hospital)	This study was supported by a program grant from Chang Gung Memorial Hospital, Chang Gung University (Grant number: CMRPG8H0741).	Bagshaw SM, 2008, CRIT CARE, V12, DOI [10.1186/cc6863, 10.1186/cc6268]; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Chen HH, 2016, J PINEAL RES, V61, P52, DOI 10.1111/jpi.12326; Chen HH, 2014, J PINEAL RES, V57, P16, DOI 10.1111/jpi.12140; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Chen YT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-270; Chen YT, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt212; Clec'h C, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-31; Damman J, 2011, AM J TRANSPLANT, V11, P660, DOI 10.1111/j.1600-6143.2011.03475.x; Fernandez A, 2015, J PINEAL RES, V59, P292, DOI 10.1111/jpi.12264; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Garcia JJ, 2014, J PINEAL RES, V56, P225, DOI 10.1111/jpi.12128; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Jin SA, 2016, TRANSPL P, V48, P199, DOI 10.1016/j.transproceed.2015.12.018; Jones SL, 2013, NEPHROL DIAL TRANSPL, V28, P1186, DOI 10.1093/ndt/gft015; Joslin J, 2015, CLIN MED, V15, P431, DOI 10.7861/clinmedicine.15-5-431; Kang JW, 2011, J PINEAL RES, V50, P403, DOI 10.1111/j.1600-079X.2011.00858.x; Kim MH, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0008-x; Li YJ, 2015, CELL PHYSIOL BIOCHEM, V37, P14, DOI 10.1159/000430329; Mesropian PD, 2016, NEPHROLOGY, V21, P729, DOI 10.1111/nep.12751; Moriyama T, 2016, J SURG RES, V201, P213, DOI 10.1016/j.jss.2015.10.036; Pickering JW, 2015, AM J KIDNEY DIS, V65, P283, DOI 10.1053/j.ajkd.2014.09.008; Rajapakse S, 2009, SAUDI J KIDNEY DIS T, V20, P553; RATYCH R E, 1986, Journal of Free Radicals in Biology and Medicine, V2, P311, DOI 10.1016/S0748-5514(86)80030-7; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Sheu JJ, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-82; Sun CK, 2017, AM J TRANSL RES, V9, P1543; Sun CK, 2015, J PINEAL RES, V58, P137, DOI 10.1111/jpi.12199; Sung PH, 2018, ONCOTARGET, V9, P3531, DOI 10.18632/oncotarget.23180; Sung PH., 2020, ACTA CARDIOL SIN, V39, P689; Tapper EB, 2016, AM J MED, V129, P461, DOI 10.1016/j.amjmed.2015.12.006; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; UK National Clinical Guideline Centre, 2013, ACUTE KIDNEY INJURY; Wonnacott A, 2014, CLIN J AM SOC NEPHRO, V9, P1007, DOI 10.2215/CJN.07920713; Yang CH, 2013, J ATHEROSCLER THROMB, V20, P9, DOI 10.5551/jat.14316; Yang JH, 2020, FASEB J, V34, P12324, DOI 10.1096/fj.202001252R; ZAGER RA, 1992, CIRC RES, V70, P20, DOI 10.1161/01.RES.70.1.20; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhao HY, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8219287	41	2	3	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21661	10.1096/fj.202100174R	http://dx.doi.org/10.1096/fj.202100174R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34029398	hybrid			2022-12-26	WOS:000655695900017
J	Niner, MD; Stepien, CA; Gorgoglione, B; Leaman, DW				Niner, Megan D.; Stepien, Carol A.; Gorgoglione, Bartolomeo; Leaman, Douglas W.			Genomic and immunogenic changes of Piscine novirhabdovirus (Viral Hemorrhagic Septicemia Virus) over its evolutionary history in the Laurentian Great Lakes	PLOS ONE			English	Article							FLOUNDER PARALICHTHYS-OLIVACEUS; HEMATOPOIETIC NECROSIS VIRUS; SNAKEHEAD RHABDOVIRUS SHRV; NON-VIRION PROTEIN; ST-LAWRENCE-RIVER; NV PROTEIN; GENOTYPE IVB; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; NUCLEOTIDE-SEQUENCE	A unique and highly virulent subgenogroup (-IVb) of Piscine novirhabdovirus, also known as Viral Hemorrhagic Septicemia Virus (VHSV), suddenly appeared in the Laurentian Great Lakes, causing large mortality outbreaks in 2005 and 2006, and affecting >32 freshwater fish species. Periods of apparent dormancy have punctuated smaller and more geographically-restricted outbreaks in 2007, 2008, and 2017. In this study, we conduct the largest whole genome sequencing analysis of VHSV-IVb to date, evaluating its evolutionary changes from 48 isolates in relation to immunogenicity in cell culture. Our investigation compares genomic and genetic variation, selection, and rates of sequence changes in VHSV-IVb, in relation to other VHSV genogroups (VHSV-I, VHSV-II, VHSV-III, and VHSV-IVa) and with other Novirhabdoviruses. Results show that the VHSV-IVb isolates we sequenced contain 253 SNPs (2.3% of the total 11,158 nucleotides) across their entire genomes, with 85 (33.6%) of them being non-synonymous. The most substitutions occurred in the non-coding region (NCDS; 4.3%), followed by the Nv- (3.8%), and M- (2.8%) genes. Proportionally more M-gene substitutions encoded amino acid changes (52.9%), followed by the Nv- (50.0%), G- (48.6%), N- (35.7%) and L- (23.1%) genes. Among VHSV genogroups and subgenogroups, VHSV-IVa from the northeastern Pacific Ocean has shown the fastest substitution rate (2.01x10(-3)), followed by VHSV-IVb (6.64x10(-5)) and by the VHSV-I, -II and-III genogroups from Europe (4.09x10(-5)). A 2016 gizzard shad (Dorosoma cepedianum) from Lake Erie possessed the most divergent VHSV-IVb sequence. The in vitro immunogenicity analysis of that sample displayed reduced virulence (as did the other samples from 2016), in comparison to the original VHSV-IVb isolate (which had been traced back to 2003, as an origin date). The 2016 isolates that we tested induced milder impacts on fish host cell innate antiviral responses, suggesting altered phenotypic effects. In conclusion, our overall findings indicate that VHSV-IVb has undergone continued sequence change and a trend to lower virulence over its evolutionary history (2003 through present-day), which may facilitate its long-term persistence in fish host populations.	[Niner, Megan D.] Univ Toledo, Dept Environm Sci, Toledo, OH USA; [Stepien, Carol A.] Washington Univ, Sch Oceanog, St Louis, MO 14263 USA; [Stepien, Carol A.] NOAA Pacific Marine Environm Lab, Genet & Genom Grp, Seattle, WA 98115 USA; [Gorgoglione, Bartolomeo; Leaman, Douglas W.] Univ Toledo, Dept Biol Sci, Toledo, OH USA; [Leaman, Douglas W.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Gorgoglione, Bartolomeo] CVM, Dept Pathobiol & Diagnost Invest, Aquat Anim Hlth Lab, E Lansing, MI USA; [Leaman, Douglas W.] Michigan State Univ, CANR, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Leaman, Douglas W.] Auburn Univ, Montgomery, AL USA	University System of Ohio; University of Toledo; Washington University (WUSTL); National Oceanic Atmospheric Admin (NOAA) - USA; University System of Ohio; University of Toledo; University System of Ohio; Wright State University Dayton; Michigan State University; Auburn University System; Auburn University	Stepien, CA (corresponding author), Washington Univ, Sch Oceanog, St Louis, MO 14263 USA.; Stepien, CA (corresponding author), NOAA Pacific Marine Environm Lab, Genet & Genom Grp, Seattle, WA 98115 USA.	cstepien@uw.edu	Stepien, Carol Ann/GWU-8631-2022	Gorgoglione, Bartolomeo/0000-0001-9458-6249; Stepien, Carol/0000-0002-5544-4333	USDA-ARS CRIS [58-3655-9-748, 3655-31320-002-00D];  [NSF-DBI-1354806]	USDA-ARS CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); 	Research funding was provided by grants to CAS and DWL, including NSF-DBI-1354806 for "Gene diversity of the VHS fish virus: Evolution of cellular immune response and pathogenesis" and USDA-ARS CRIS #3655-31320-002-00D, under specific cooperative agreement #58-3655-9-748, "VHS fish virus in yellow perch aquaculture".	Abbadi M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01306; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Alonso M, 2004, J VIROL, V78, P5875, DOI 10.1128/JVI.78.11.5875-5882.2004; Alves JM, 2019, SCIENCE, V363, P1319, DOI 10.1126/science.aau7285; Ammayappan A, 2011, J VIROL, V85, P8393, DOI 10.1128/JVI.00597-11; Ammayappan A, 2011, MAR BIOTECHNOL, V13, P672, DOI 10.1007/s10126-010-9329-4; Ammayappan A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-171; Andino R, 2015, VIROLOGY, V479, P46, DOI 10.1016/j.virol.2015.03.022; [Anonymous], 2013, PREPRINTS; Baillon L, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.574231; Baillon L, 2017, J GEN VIROL, V98, P1181, DOI 10.1099/jgv.0.000830; Bayliss SC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00121; Bernard Hans-Ulrich, 1994, Trends in Microbiology, V2, P140, DOI 10.1016/0966-842X(94)90602-5; Betts AM, 2000, VIRUS GENES, V20, P259, DOI 10.1023/A:1008148813746; Biacchesi S, 2010, J VIROL, V84, P10038, DOI 10.1128/JVI.00343-10; Bourhy H, 2005, J GEN VIROL, V86, P2849, DOI 10.1099/vir.0.81128-0; Brunson R., 1989, AM FISH SOC FISH HLT, V17, P3; Burkett E. M., 2018, RECREATIONAL FISHING; Campbell S, 2009, DIS AQUAT ORGAN, V86, P205, DOI 10.3354/dao02127; Cano I, 2016, VET MICROBIOL, V187, P31, DOI 10.1016/j.vetmic.2016.02.012; Chinchilla B, 2017, FISH SHELLFISH IMMUN, V70, P343, DOI 10.1016/j.fsi.2017.09.021; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coffee LL, 2017, J GREAT LAKES RES, V43, P119, DOI 10.1016/j.jglr.2017.03.013; Collet B, 2001, EUR J BIOCHEM, V268, P1577, DOI 10.1046/j.1432-1033.2001.02021.x; Cornwell ER, 2015, J GREAT LAKES RES, V41, P520, DOI 10.1016/j.jglr.2015.01.002; Cornwell ER, 2014, J GREAT LAKES RES, V40, P1002, DOI 10.1016/j.jglr.2014.09.006; Dale OB, 2009, DIS AQUAT ORGAN, V85, P93, DOI 10.3354/dao02065; Duesund H, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-19; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; East ML, 2001, P NATL ACAD SCI USA, V98, P15026, DOI 10.1073/pnas.261411898; Eckerlin GE, 2011, T AM FISH SOC, V140, P529, DOI 10.1080/00028487.2011.581975; Einer-Jensen K, 2014, J GEN VIROL, V95, P307, DOI 10.1099/vir.0.057448-0; Escobar LE, 2018, REV FISH BIOL FISHER, V28, P637, DOI 10.1007/s11160-018-9524-3; Faisal M, 2012, VIRUSES-BASEL, V4, P734, DOI 10.3390/v4050734; Faisal M, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-2; Faisal M, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-45; Fetzer WW, 2011, T AM FISH SOC, V140, P1460, DOI 10.1080/00028487.2011.630281; Gagne N, 2007, J FISH DIS, V30, P213, DOI 10.1111/j.1365-2761.2007.00802.x; Getchell RG., 2019, J FISH DIS, P1, DOI [10.1111/jfd.13085, DOI 10.1111/JFD.13085]; Getchell RG, 2017, DIS AQUAT ORGAN, V126, P211, DOI 10.3354/dao03171; Ghorani M, 2016, VET MICROBIOL, V186, P97, DOI 10.1016/j.vetmic.2016.02.019; Gorgoglione B, THESIS U ABERDEEN SC; Gorgoglione B, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01372-4; Groocockl GH, 2007, DIS AQUAT ORGAN, V76, P187, DOI 10.3354/dao076187; Gudmundsdottir S, 2019, J FISH DIS, V42, P47, DOI 10.1111/jfd.12910; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; He M, 2014, MOL PHYLOGENET EVOL, V77, P34, DOI 10.1016/j.ympev.2014.04.002; Hedrick RP, 2003, DIS AQUAT ORGAN, V55, P211, DOI 10.3354/dao055211; Holmes E., 2009, EVOLUTION EMERGENCE; Hopper K., 1989, AM FISH SOC FISH HLT, V17, P1; Hughes AL, 2007, GENE, V404, P117, DOI 10.1016/j.gene.2007.09.013; Hwang JY, 2018, AQUACULTURE, V484, P242, DOI 10.1016/j.aquaculture.2017.11.038; Hwang JY, 2016, VET MICROBIOL, V193, P72, DOI 10.1016/j.vetmic.2016.05.024; Imanse SM, 2014, J GREAT LAKES RES, V40, P879, DOI 10.1016/j.jglr.2014.08.004; Ito T, 2018, DIS AQUAT ORGAN, V128, P51, DOI 10.3354/dao03215; Ito T, 2012, J GEN VIROL, V93, P2546, DOI 10.1099/vir.0.043091-0; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jia P, 2014, INFECT GENET EVOL, V27, P418, DOI 10.1016/j.meegid.2014.08.013; Johnson MC, 1999, VIRUS RES, V64, P95, DOI 10.1016/S0168-1702(99)00071-4; Johnson MC, 2000, J VIROL, V74, P2343, DOI 10.1128/JVI.74.5.2343-2350.2000; Kane-Sutton M, 2010, J GREAT LAKES RES, V36, P37, DOI 10.1016/j.jglr.2009.11.004; Karsiotis SI, 2012, J GREAT LAKES RES, V38, P121, DOI 10.1016/j.jglr.2011.12.010; Ke Q, 2017, J VIROL, V91, DOI 10.1128/JVI.00279-17; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kennedy DA, 2016, EVOL APPL, V9, P344, DOI 10.1111/eva.12342; Kerr PJ, 2017, P NATL ACAD SCI USA, V114, P9397, DOI 10.1073/pnas.1710336114; Kesterson SP, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050499; Kim DH, 2005, VIRUS RES, V107, P1, DOI 10.1016/j.virusres.2004.06.004; Kim JO, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00681-13; Kim MS, 2013, FISH SHELLFISH IMMUN, V34, P1315, DOI 10.1016/j.fsi.2013.02.026; Kim MS, 2012, FISH SHELLFISH IMMUN, V32, P459, DOI 10.1016/j.fsi.2011.12.014; Kim R, 2010, J FISH DIS, V33, P83, DOI 10.1111/j.1365-2761.2009.01093.x; Kim SH, 2015, VIRUS RES, V195, P203, DOI 10.1016/j.virusres.2014.10.013; Kitchen A, 2011, P NATL ACAD SCI USA, V108, P238, DOI 10.1073/pnas.1011090108; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumin IV, 2009, INFECT GENET EVOL, V9, P541, DOI 10.1016/j.meegid.2009.02.005; Kurath G, 2012, RHABDOVIRUSES MOL TA, P89, DOI DOI 10.1128/JVI.01960-08; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Vazquez C, 2015, DIS AQUAT ORGAN, V114, P99, DOI 10.3354/dao02840; Lumsden JS, 2007, DIS AQUAT ORGAN, V76, P99, DOI 10.3354/dao076099; Meyers Theodore R., 1995, Annual Review of Fish Diseases, V5, P3, DOI 10.1016/0959-8030(95)00002-X; MEYERS TR, 1992, DIS AQUAT ORGAN, V12, P167, DOI 10.3354/dao012167; MILLER ROBERT RUSH, 1960, U S FISH WILDLIFE SERV FISH BULL, V60, P371; MORZUNOV SP, 1995, VIRUS RES, V38, P175, DOI 10.1016/0168-1702(95)00056-V; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Niner MD., 2019, EVOLUTIONARY PATTERN; Oh WT, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040200; Panzarin V, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01984; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Pereira F., 2013, BRENNERS ENCY GENETI, P566, DOI [10.1016/B978-0-12-374984-0.00499-X, DOI 10.1016/B978-0-12-374984-0.00499-X]; Pierce LR, 2012, MOL PHYLOGENET EVOL, V63, P327, DOI 10.1016/j.ympev.2011.12.024; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quer J, 1996, J MOL BIOL, V264, P465, DOI 10.1006/jmbi.1996.0654; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rude NP, 2017, J APPL ICHTHYOL, V33, P1166, DOI 10.1111/jai.13499; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Schonherz AA, 2016, VET RES, V47, DOI 10.1186/s13567-015-0298-5; Schutze H, 1999, VIRUS GENES, V19, P59, DOI 10.1023/A:1008140707132; Stepien CA., CLIMATE CHANGE INFEC; Stepien CA, 2020, ECOL EVOL, V10, P9740, DOI 10.1002/ece3.6611; Stepien CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135146; Stone DM, 1997, J GEN VIROL, V78, P1319, DOI 10.1099/0022-1317-78-6-1319; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Takano R, 2000, B EUR ASSOC FISH PAT, V20, P186; Thompson TM, 2011, DIS AQUAT ORGAN, V96, P29, DOI 10.3354/dao02362; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Thoulouze MI, 2004, J VIROL, V78, P4098, DOI 10.1128/JVI.78.8.4098-4107.2004; Throckmorton E, 2015, N AM J FISH MANAGE, V35, P503, DOI 10.1080/02755947.2015.1020077; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; VANVALEN L, 1974, J MOL EVOL, V3, P89, DOI 10.1007/BF01796554; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Walker PJ, 2018, J GEN VIROL, V99, P447, DOI 10.1099/jgv.0.001020; Wang C, 2016, VIRUS RES, V220, P193, DOI 10.1016/j.virusres.2016.04.015; Wolf K., 1988, FISH VIRUSES FISH VI, P217, DOI [10.7591/9781501746383, DOI 10.7591/9781501746383]; Xu LM, 2019, MOL PHYLOGENET EVOL, V131, P19, DOI 10.1016/j.ympev.2018.10.030; Yingjie S, 2011, J FISH DIS, V34, P167, DOI 10.1111/j.1365-2761.2010.01218.x; Yusuff S, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1139-3; Zhang JL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0742-4; Zhu RL, 2014, ARCH VIROL, V159, P817, DOI 10.1007/s00705-013-1716-5; Zou J, 2014, J IMMUNOL, V193, P2273, DOI 10.4049/jimmunol.1301796	126	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0232923	10.1371/journal.pone.0232923	http://dx.doi.org/10.1371/journal.pone.0232923			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048438	gold, Green Published			2022-12-26	WOS:000664636100001
J	Bhattacharya, D; Kshatri, JS; Choudhary, HR; Parai, D; Shandilya, J; Mansingh, A; Pattnaik, M; Mishra, K; Padhi, SP; Padhi, A; Pati, S				Bhattacharya, Debdutta; Kshatri, Jaya Singh; Choudhary, Hari Ram; Parai, Debaprasad; Shandilya, Jyoti; Mansingh, Asit; Pattnaik, Matrujyoti; Mishra, Kaushik; Padhi, Shakti Prakash; Padhi, Arun; Pati, Sanghamitra			One Health approach for elimination of human anthrax in a tribal district of Odisha: Study protocol	PLOS ONE			English	Article								Background Anthrax is a major but neglected zoonotic disease of public health concern in India with Odisha contributing a major share to the disease burden. Bacillus anthracis spores can be found naturally in soil and commonly affect both animals and humans around the world. Domestic and wild animals such as cattle, sheep, goats, and deer can become infected when they inhale or ingest spores from contaminated soil, plants, or water. Anthrax can be fatal if patients are not treated promptly with antibiotics. This protocol aims to describe the implementation and evaluation of the 'One Health' intervention model based on the principles of Theory of Change (ToC) to eliminate human anthrax from a tribal district in Odisha, India. Methods This study would test the effectiveness of a complex public health intervention package developed using the ToC framework for the elimination of human anthrax in Koraput district by a comparative analysis of baseline and end-line data. We plan to enroll 2640 adults across 14 geographically divided blocks in Koraput district of Odisha for baseline and end-line surveys. After baseline, we would provide capacity building training to stakeholders from the department of health, veterinary, forest, academic and allied health institutions followed by workshops on sensitization and awareness through IEC (Information Education Communication)/BCC (Behavior Change Communication) activities in the community. We would establish a state-level laboratory facility as a robust system for timely diagnosis and management of human anthrax cases. Surveillance network will be strengthened to track the cases in early stage and risk zoning will be done for focused surveillance in endemic areas. Advocacy with district level administration will be done for maximizing the coverage of livestock vaccination in the entire district. Interdepartmental coordination would be established for the effective implementation of the intervention package. Conclusion This would be a first study applying One Health concept for the elimination of human anthrax in India. The findings from this study will offer important insights for policy-making and further replication in other endemic regions of the state and country. Trial registration The authors confirm that all ongoing and related trials for this intervention are prospectively registered with the Clinical Trials Registry of India [CTRI/2020/05/025325] on 22 May 2020.	[Bhattacharya, Debdutta; Kshatri, Jaya Singh; Choudhary, Hari Ram; Parai, Debaprasad; Shandilya, Jyoti; Mansingh, Asit; Pattnaik, Matrujyoti; Pati, Sanghamitra] ICMR Reg Med Res Ctr, Bhubaneswar, Odisha, India; [Mishra, Kaushik] Saheed Laxman Nayak Med Coll & Hosp, Koraput, Odisha, India; [Padhi, Shakti Prakash] Govt Odisha, Dept Publ Hlth, Bhubaneswar, Odisha, India; [Padhi, Arun] Dept Publ Hlth, Koraput, Odisha, India	Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar	Bhattacharya, D; Pati, S (corresponding author), ICMR Reg Med Res Ctr, Bhubaneswar, Odisha, India.	drdebduttab.rmrc-od@gov.in; drsanghamitra12@gmail.com	BHATTACHARYA, DEBDUTTA/J-7148-2019	BHATTACHARYA, DEBDUTTA/0000-0001-5199-5288; Pattnaik, Matrujyoti/0000-0001-8614-2920; Mansingh, Asit/0000-0001-5832-0881; Choudhary, Hari Ram/0000-0001-6457-7202	Indian Council of Medical Research New Delhi [ZON/33/1/2018-ECD-II]; Indian Council of Medical Research New Delhi, India	Indian Council of Medical Research New Delhi(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research New Delhi, India(Indian Council of Medical Research (ICMR))	Dr. Sanghamitra Pati (PI) is the recipient and this research was funded by the Indian Council of Medical Research New Delhi to (Grant Number ZON/33/1/2018-ECD-II). The funding body was not involved in the design of the study and collection, analysis, and interpretation of data, or in writing the manuscript. URL of funding agency is https://main.icmr.nic.in/.; We would like to acknowledge and thank our field research staff including Biren Kumar Padhy, Subrat Kumar Sahoo, Padma Mohan Pradhan, and Annalisha Peter. We also acknowledge all the stakeholders from different departments who contributed their time and efforts for the effective implementation of our interventions. Thanks to all the study participants who have participated in our study and are willing to share their experiences and time with us. Finally, we are grateful to our funders; the Indian Council of Medical Research New Delhi, India.	[Anonymous], 2016, J PHARMACOVIGILANCE, DOI DOI 10.4172/2329-6887.S3-002; Balachandrudu B., 2018, J NTR U HLTH SCI, V7, P49; Bengis RG, 2014, REV SCI TECH OIE, V33, P593, DOI 10.20506/rst.33.2.2309; Bhat P, 1989, SALISBURY MED B S, V68, P8; Datta V, 2019, INT HEALTH, V11, P52, DOI 10.1093/inthealth/ihy062; Dutta T K, 2011, J Assoc Physicians India, V59, P573; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Kock R, 2019, LANCET PLANET HEALTH, V3, pE285, DOI 10.1016/S2542-5196(19)30111-1; Lal S., 2005, ZOONOTIC DIS PUBLIC; Maini R, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000617; Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067; Nayak P, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6787-0; Nyatanyi T, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000121; Park K., 2015, PARKS TXB PREVENTIVE, V23rd; Pati S., 2019, POLICY; Patil Rajan R, 2010, Indian J Community Med, V35, P189, DOI 10.4103/0970-0218.62573; Pavani G., 2014, INT J BASIC APPL MED, V4, P73; Sahoo KC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093094; Spencer RC, 2003, J CLIN PATHOL, V56, P182, DOI 10.1136/jcp.56.3.182; Turnbull PCB, 2008, ONDERSTEPOORT J VET, V75, P95; WHO/DFID-AHP FAO OIE, 2006, CONTR NEGL ZOON DIS; Yin WW, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-23; Zumla A, 2016, INT J INFECT DIS, V47, P5, DOI 10.1016/j.ijid.2016.06.012	23	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251041	10.1371/journal.pone.0251041	http://dx.doi.org/10.1371/journal.pone.0251041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043627	gold, Green Published			2022-12-26	WOS:000664635700014
J	Dass, SC; Kwok, WM; Gibson, GJ; Gill, BS; Sundram, BM; Singh, S				Dass, Sarat C.; Kwok, Wai M.; Gibson, Gavin J.; Gill, Balvinder S.; Sundram, Bala M.; Singh, Sarbhan			A data driven change-point epidemic model for assessing the impact of large gathering and subsequent movement control order on COVID-19 spread in Malaysia	PLOS ONE			English	Article								The second wave of COVID-19 in Malaysia is largely attributed to a four-day mass gathering held in Sri Petaling from February 27, 2020, which contributed to an exponential rise of COVID-19 cases in the country. Starting from March 18, 2020, the Malaysian government introduced four consecutive phases of a Movement Control Order (MCO) to stem the spread of COVID-19. The MCO was implemented through various non-pharmaceutical interventions (NPIs). The reported number of cases reached its peak by the first week of April and then started to reduce, hence proving the effectiveness of the MCO. To gain a quantitative understanding of the effect of MCO on the dynamics of COVID-19, this paper develops a class of mathematical models to capture the disease spread before and after MCO implementation in Malaysia. A heterogeneous variant of the Susceptible-Exposed-Infected-Recovered (SEIR) model is developed with additional compartments for asymptomatic transmission. Further, a change-point is incorporated to model disease dynamics before and after intervention which is inferred based on data. Related statistical analyses for inference are developed in a Bayesian framework and are able to provide quantitative assessments of (1) the impact of the Sri Petaling gathering, and (2) the extent of decreasing transmission during the MCO period. The analysis here also quantitatively demonstrates how quickly transmission rates fall under effective NPI implementation within a short time period. The models and methodology used provided important insights into the nature of local transmissions to decision makers in the Ministry of Health, Malaysia.	[Dass, Sarat C.; Kwok, Wai M.] Heriot Watt Univ Malaysia, Sch Math & Comp Sci, Putrajaya, Wilayah Perseku, Malaysia; [Gibson, Gavin J.] Heriot Watt Univ, Sch Math & Comp Sci, Edinburgh, Midlothian, Scotland; [Gill, Balvinder S.; Sundram, Bala M.; Singh, Sarbhan] Minist Hlth, Inst Med Res, Shah Alam, Selangor, Malaysia	Heriot Watt University; Heriot Watt University; Kementerian Kesihatan Malaysia	Dass, SC (corresponding author), Heriot Watt Univ Malaysia, Sch Math & Comp Sci, Putrajaya, Wilayah Perseku, Malaysia.	s.dass@hw.ac.uk		Dass, Sarat/0000-0002-7376-0436	FRGS grant from the Ministry of Higher Education, Malaysia [FRGS/1/2020/STG06/HWUM/02/1]; Global Challenges Research Fund (GCRF) by the Scottish Funding Council [831077/SFC-GCRF 2019-2020 COVID-19 Round]; Heriot-Watt University	FRGS grant from the Ministry of Higher Education, Malaysia; Global Challenges Research Fund (GCRF) by the Scottish Funding Council; Heriot-Watt University	This research is mainly funded by an FRGS grant (FRGS/1/2020/STG06/HWUM/02/1) from the Ministry of Higher Education, Malaysia, and supported by a Global Challenges Research Fund (GCRF) (Award no. 831077/SFC-GCRF 2019-2020 COVID-19 Round) by the Scottish Funding Council (http://www.sfc.ac.uk/) and Heriot-Watt University (https://www.hw.ac.uk/).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Wahaibi A, 2020, INT J INFECT DIS, V99, P466, DOI 10.1016/j.ijid.2020.08.039; Babulal V, 2020, NEW STRAITS TIMES; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Blackwood JC., 2018, LETT BIOMATH, V5, P195, DOI [10.30707/LiB5.1Blackwood, DOI 10.30707/LIB5.1BLACKWOOD]; Bottrighia, 2020, ESTIMATED IMPACT NON; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Dass, 2020, MODELING IMPACT LOCK, DOI [10.1101/2020.07.17.208371, DOI 10.1101/2020.07.17.208371]; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Efron B, 2014, STAT SCI, V29, P285, DOI 10.1214/13-STS455; Frasso G, 2016, BIOSTATISTICS, V17, P779, DOI 10.1093/biostatistics/kxw027; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Hu, 2020, ESTIMATED TIME VARYI; Hwang J, 2020, MEDRXIV; Imai Natsuko, 2020, Wellcome Open Res, V5, P59, DOI 10.12688/wellcomeopenres.15808.1; Kementerian Kesihatan Malaysia, 2020, ANN 2 MAN SUSP PROB; Kementerian Kesihatan Malaysia, MIN HLTH MAL FAC DAT; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Leon C., 2020, B WORLD HEALTH ORGAN; McCaw J., 2006, USING MATH MODELS AS; Ngonghala CN, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108364; Novozhilov AS, 2012, MATH MODEL NAT PHENO, V7, P147, DOI 10.1051/mmnp/20127310; Novozhilov AS, 2008, MATH BIOSCI, V215, P177, DOI 10.1016/j.mbs.2008.07.010; Organization WH, 2020, WHO DIRECTOR GEN OPE; Romero-Severson EO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236776; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; Thompson RN, 2019, EPIDEMICS-NETH, V29, DOI 10.1016/j.epidem.2019.100356; Angulo MT, 2018, EPIDEMICS-NETH, V24, P98, DOI 10.1016/j.epidem.2018.03.001; Wei WE, 2020, MMWR-MORBID MORTAL W, V69, P411, DOI 10.15585/mmwr.mm6914e1; WHO, 2020, 73 WHO; Xu XG, 2016, BIOSTATISTICS, V17, P619, DOI 10.1093/biostatistics/kxw011; Yu P, 2020, J INFECT DIS, V221, P1757, DOI 10.1093/infdis/jiaa077; Zainul Emil., 2020, MALAYSIA BOOST VIRUS	33	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252136	10.1371/journal.pone.0252136	http://dx.doi.org/10.1371/journal.pone.0252136			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043676	Green Published, gold, Green Submitted			2022-12-26	WOS:000664635700058
J	Safari, D; Gultom, SM; Tafroji, W; Azzahidah, A; Soesanti, F; Khoeri, MM; Prayitno, A; Pimenta, FC; Carvalho, MD; Uiterwaal, CSPM; Putri, ND				Safari, Dodi; Gultom, Septiani Madonna; Tafroji, Wisnu; Azzahidah, Athiya; Soesanti, Frida; Khoeri, Miftahuddin Majid; Prayitno, Ari; Pimenta, Fabiana C.; Carvalho, Maria da Gloria; Uiterwaal, Cuno S. P. M.; Putri, Nina Dwi			Prevalence, serotype and antibiotic susceptibility of Group B Streptococcus isolated from pregnant women in Jakarta, Indonesia	PLOS ONE			English	Article							MATERNAL COLONIZATION; DISEASE WORLDWIDE; RESISTANCE; STILLBIRTHS	Group B Streptococcus (GBS) is a bacterial pathogen which is a leading cause of neonatal infection. Currently, there are limited GBS data available from the Indonesian population. In this study, GBS colonization, serotype distribution and antimicrobial susceptibility profile of isolates were investigated among pregnant women in Jakarta, Indonesia. Demographics data, clinical characteristics and vaginal swabs were collected from 177 pregnant women (mean aged: 28.7 years old) at 29-40 weeks of gestation. Bacterial culture identification tests and latex agglutination were performed for GBS. Serotyping was done by conventional multiplex PCR and antibiotic susceptibility testing by broth microdilution. GBS colonization was found in 53 (30%) pregnant women. Serotype II was the most common serotype (30%) followed by serotype III (23%), Ia and IV (13% each), VI (8%), Ib and V (6% each), and one non-typeable strain. All isolates were susceptible to vancomycin, penicillin, ampicillin, cefotaxime, daptomycin and linezolid. The majority of GBS were resistant to tetracycline (89%) followed by clindamycin (21%), erythromycin (19%), and levofloxacin (6%). The serotype III was more resistant to erythromycin, clindamycin, and levofloxacin and these isolates were more likely to be multidrug resistant (6 out of 10) compared to other serotypes. This report provides demographics of GBS colonization and isolate characterization in pregnant women in Indonesia. The results may facilitate preventive strategies to reduce neonatal GBS infection and improve its treatment.	[Safari, Dodi; Tafroji, Wisnu; Khoeri, Miftahuddin Majid] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Gultom, Septiani Madonna; Soesanti, Frida; Prayitno, Ari; Putri, Nina Dwi] Univ Indonesia, Fac Med, Dept Child Hlth, Cipto Mangunkusumo Gen Hosp, Jakarta, Indonesia; [Azzahidah, Athiya] Aix Marseille Univ, Marseille, France; [Pimenta, Fabiana C.; Carvalho, Maria da Gloria] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Uiterwaal, Cuno S. P. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands	Eijkman Institute; University of Indonesia; UDICE-French Research Universities; Aix-Marseille Universite; Centers for Disease Control & Prevention - USA; Utrecht University; Utrecht University Medical Center	Putri, ND (corresponding author), Univ Indonesia, Fac Med, Dept Child Hlth, Cipto Mangunkusumo Gen Hosp, Jakarta, Indonesia.	ninadwip@gmail.com		Putri, Nina Dwi/0000-0003-0153-9852; Soesanti, Frida/0000-0002-4319-5528	Partnerships for Enhanced Engagement in Research (PEER) program - the U.S. Agency for International Development [161463]; Ministry of Research and Technology, Republic of Indonesia/National Research and Innovation Agency; U.S. Global Health Security funds; Publikasi Terindeks Internasional (PUTI) Universitas Indonesia	Partnerships for Enhanced Engagement in Research (PEER) program - the U.S. Agency for International Development; Ministry of Research and Technology, Republic of Indonesia/National Research and Innovation Agency; U.S. Global Health Security funds; Publikasi Terindeks Internasional (PUTI) Universitas Indonesia	This study was partly funded by Partnerships for Enhanced Engagement in Research (PEER) program - the U.S. Agency for International Development (Grant Number: 161463), Ministry of Research and Technology, Republic of Indonesia/National Research and Innovation Agency, the U.S. Global Health Security funds, and Publikasi Terindeks Internasional (PUTI) Universitas Indonesia. The funder had no role in study design, data analysis, decision to publish and preparation of the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Africa CWJ, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00356; Ambarwati W., 2018, GLOB MED HLTH COMMUN, V6, P226, DOI [10.29313/gmhc.v6i3.3618, DOI 10.29313/GMHC.V6I3.3618]; [Anonymous], MANUAL CLIN MICROBIO, V12th; At Thobari J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219097; Boswihi SS, 2012, J MED MICROBIOL, V61, P126, DOI 10.1099/jmm.0.035477-0; Botelho ACN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196925; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Clinical and Laboratory Standards Institute, 2016, M100S26 CLSI; Edwards James M, 2019, Infect Dis Obstet Gynecol, V2019, P5430493, DOI 10.1155/2019/5430493; Festin MR, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-17; Gizachew M, 2019, ANN CLIN MICROB ANTI, V18, DOI 10.1186/s12941-019-0313-1; Gomi Y, 2019, TAIWAN J OBSTET GYNE, V58, P805, DOI 10.1016/j.tjog.2019.09.014; Hadi U, 2008, INT J INFECT DIS, V12, P622, DOI 10.1016/j.ijid.2008.01.002; Hayes K, 2020, CRIT REV MICROBIOL, V46, P253, DOI 10.1080/1040841X.2020.1758626; Huang JY, 2016, J GLOB ANTIMICROB RE, V7, P169, DOI 10.1016/j.jgar.2016.08.010; Imperi M, 2010, J MICROBIOL METH, V80, P212, DOI 10.1016/j.mimet.2009.11.010; Kobayashi M, 2019, VACCINE, V37, P7307, DOI 10.1016/j.vaccine.2016.12.029; Kobayashi Miwako, 2016, F1000Res, V5, P2355; Kovavisarach Ekachai, 2007, Journal of the Medical Association of Thailand, V90, P1710; Kwatra G, 2016, LANCET INFECT DIS, V16, P1076, DOI 10.1016/S1473-3099(16)30055-X; Lawn JE, 2017, CLIN INFECT DIS, V65, pS89, DOI 10.1093/cid/cix653; Le Doare K, 2016, J INFECTION, V72, P283, DOI 10.1016/j.jinf.2015.12.014; Lu B, 2014, CLIN MICROBIOL INFEC, V20, pO370, DOI 10.1111/1469-0691.12416; Patras KA, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00027; Pujowaty D., 2002, INCIDENCE GROUP B ST; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Regan JA, 1996, AM J OBSTET GYNECOL, V174, P1354, DOI 10.1016/S0002-9378(96)70684-1; Russell NJ, 2017, CLIN INFECT DIS, V65, pS100, DOI 10.1093/cid/cix658; Saha SK, 2017, J CLIN MICROBIOL, V55, P2406, DOI 10.1128/JCM.00380-17; Seale AC, 2017, CLIN INFECT DIS, V65, pS200, DOI 10.1093/cid/cix664; Sigauque B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191193; Sri-Budayanti N, 2013, BALI MED J, V2, P17; Teatero S, 2014, J CLIN MICROBIOL, V52, P1441, DOI 10.1128/JCM.03554-13; Tsai MH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00264; Wang P, 2015, INT J INFECT DIS, V37, P115, DOI 10.1016/j.ijid.2015.06.019; WIBAWAN IWT, 1992, ZBL BAKT-INT J MED M, V277, P260	36	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252328	10.1371/journal.pone.0252328	http://dx.doi.org/10.1371/journal.pone.0252328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043711	Green Published, gold			2022-12-26	WOS:000664635700088
J	Wang, LQ; Li, JP; Wang, ZZ; Du, Y; Sun, T; Na, L; Niu, Y				Wang, Liqun; Li, Jiangping; Wang, Zhizhong; Du, Yong; Sun, Ting; Na, Li; Niu, Yang			Social capital and cognitive decline: Does sleep duration mediate the association?	PLOS ONE			English	Article							POPULATION; IMPAIRMENT; DEMENTIA; NETWORK; CHINESE; HEALTH; RISK; PREVALENCE; BIOMARKERS; SUPPORT	Background Studies have found that social capital (SC) is associated with the risk of cognitive decline; however, the mechanism explaining how SC leads to cognitive decline is unclear. The current study examines the mediation effect of sleep duration on the relationship between SC and cognitive decline in Chinese older adults. Methods A cross-sectional study of 955 community-dwelling aged 60 or over was conducted. The mini-mental state examination (MMSE), self-report sleep duration questionnaire, and social capital scales were administered during the face-to-face survey. The Bootstrap methods PROCESS program is employed to test the mediation model. Results After controlling for covariates, both social cohesion and social interaction were positively correlated with the MMSE score (p<0.001), and social cohesion was negatively correlated with sleep duration (p = 0.009); On the contrary, sleep duration was negatively correlated with MMSE score (p<0.001). Linear regression analysis showed social cohesion was positively associated with the MMSE score (beta = 0.16, p = 0.005), while sleep duration was associated with an increased risk of cognitive decline (beta = -0.72, p<0.001). Sleep duration has mediated the relationship between social cohesion and cognitive decline (explaining 21.7% of the total variance). Conclusions Social capital negatively associated with the risk of cognitive decline in this Chinese population, and sleep duration may partly explain this relationship. It may be a suggestive clue to identify those at a higher risk of progressing to cognitive impairment. Further prospective study in need to confirm this finding due to the cross-sectional design.	[Wang, Liqun; Li, Jiangping] Ningxia Med Univ, Sch Publ Hlth & Management, Dept Epidemiol & Stat, Yinchuan, Ningxia, Peoples R China; [Wang, Zhizhong] Guangdong Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Dongguan, Peoples R China; [Du, Yong; Sun, Ting; Na, Li] Ningxia Med Univ, Gen Hosp, Surg Lab, Yinchuan, Ningxia, Peoples R China; [Du, Yong] Ningxia Med Univ, Sch Clin Med, Yinchuan, Ningxia, Peoples R China; [Niu, Yang] Ningxia Med Univ, Minist Educ, Key Lab Ningxia Ethnomed Modernizat, Yinchuan, Ningxia, Peoples R China; [Niu, Yang] Ningxia Med Univ, Sch Tradit Chinese Med, Yinchuan, Ningxia, Peoples R China	Ningxia Medical University; Guangdong Medical University; Ningxia Medical University; Ningxia Medical University; Ningxia Medical University; Ningxia Medical University	Wang, ZZ (corresponding author), Guangdong Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Dongguan, Peoples R China.; Niu, Y (corresponding author), Ningxia Med Univ, Minist Educ, Key Lab Ningxia Ethnomed Modernizat, Yinchuan, Ningxia, Peoples R China.; Niu, Y (corresponding author), Ningxia Med Univ, Sch Tradit Chinese Med, Yinchuan, Ningxia, Peoples R China.	wzhzh_lion@126.com; niuyang0227@163.com		Wang, zhizhong/0000-0002-0612-3218	Research and Development Plan of the 13th five-year plan of Ningxia autonomous region (the major ST projects) [2016BZ02]; National Natural Science Foundation of China [81860599]	Research and Development Plan of the 13th five-year plan of Ningxia autonomous region (the major ST projects); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the Research and Development Plan of the 13th five-year plan of Ningxia autonomous region (the major S&T projects.) (grant number 2016BZ02) and the National Natural Science Foundation of China (grant number 81860599).	[Anonymous], DEM PUBL HLTH PRIOR; Auyeung TW, 2013, AGE, V35, P479, DOI 10.1007/s11357-011-9366-6; BEDARD MA, 1991, J CLIN EXP NEUROPSYC, V13, P950, DOI 10.1080/01688639108405110; Benito-Leon J, 2013, J PSYCHIATR RES, V47, P1998, DOI 10.1016/j.jpsychires.2013.09.007; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Berkman LF, 2000, LANCET, V355, P1291, DOI 10.1016/S0140-6736(00)02107-3; Bian YJ, 1997, AM SOCIOL REV, V62, P366, DOI 10.2307/2657311; Blackwell T, 2011, SLEEP, V34, P1347, DOI 10.5665/SLEEP.1276; BLIWISE DL, 1994, J CLIN EPIDEMIOL, V47, P35, DOI 10.1016/0895-4356(94)90031-0; Bloom DE, 2015, LANCET, V385, P649, DOI 10.1016/S0140-6736(14)61464-1; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Buerger K, 2002, NEUROLOGY, V59, P627, DOI 10.1212/WNL.59.4.627; Chen JC, 2016, ALZHEIMERS DEMENT, V12, P21, DOI 10.1016/j.jalz.2015.03.004; Cheng GHL, 2018, INT PSYCHOGERIATR, V30, P893, DOI 10.1017/S1041610217001041; Crooks VC, 2008, AM J PUBLIC HEALTH, V98, P1221, DOI 10.2105/AJPH.2007.115923; Cui GH, 2011, ACTA NEUROL SCAND, V124, P361, DOI 10.1111/j.1600-0404.2010.01484.x; Dai W, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2385-y; Ellwardt L, 2015, SOC SCI MED, V125, P107, DOI 10.1016/j.socscimed.2014.05.007; Faubel R, 2009, J SLEEP RES, V18, P427, DOI 10.1111/j.1365-2869.2009.00759.x; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Grandner MA, 2013, SLEEP, V36, P769, DOI 10.5665/sleep.2646; Hang L., 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0231318, DOI 10.1371/JOURNAL.PONE.0231318]; Holtzman RE, 2004, J GERONTOL B-PSYCHOL, V59, pP278, DOI 10.1093/geronb/59.6.P278; Ihle A, 2018, DEMENT GERIATR COGN, V45, P190, DOI 10.1159/000488052; Kawachi I, 2004, INT J EPIDEMIOL, V33, P682, DOI 10.1093/ije/dyh177; Kimura D, 2017, PSYCHOGERIATRICS, V17, P9, DOI 10.1111/psyg.12182; Li X, 2013, J AM GERIATR SOC, V61, P2111, DOI 10.1111/jgs.12552; Liang Y, 2019, AGING CLIN EXP RES, V31, P309, DOI 10.1007/s40520-018-1005-y; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Loerbroks A, 2010, INT J GERIATR PSYCH, V25, P100, DOI 10.1002/gps.2305; MacKinnon DP, 2007, BEHAV RES METHODS, V39, P384, DOI 10.3758/BF03193007; Malek-Ahmadi M, 2016, AGING CLIN EXP RES, V28, P333, DOI 10.1007/s40520-015-0388-2; MASON CH, 1991, J MARKETING RES, V28, P268, DOI 10.2307/3172863; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Ramos AR, 2013, J CLIN SLEEP MED, V9, P669, DOI 10.5664/jcsm.2834; Sanchez-Espinosa MP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08292-4; Schmutte Timothy, 2007, Behav Sleep Med, V5, P39; Song QF, 2017, BIOMED ENVIRON SCI, V30, P749, DOI 10.3967/bes2017.100; Takahashi M, 2014, J SLEEP RES, V23, P458, DOI 10.1111/jsr.12136; Uchino BN, 1999, ANN BEHAV MED, V21, P135, DOI 10.1007/BF02908294; van Oostrom SH, 2018, SLEEP MED, V41, P78, DOI 10.1016/j.sleep.2017.07.029; Verhaeghe PP, 2012, SOC SCI MED, V75, P349, DOI 10.1016/j.socscimed.2012.02.057; Virta JJ, 2013, SLEEP, V36, P1533, DOI 10.5665/sleep.3052; Wang BY, 2015, ARCH GERONTOL GERIAT, V60, P522, DOI 10.1016/j.archger.2015.01.002; Wang C, 2016, ASIA-PAC J PUBLIC HE, V28, P717, DOI 10.1177/1010539516640351; Wang LQ, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08516-9; Wang LQ., 2017, NEUROPSYCHIATRY-LOND, V07, P659, DOI [10.4172/Neuropsychiatry.1000262, DOI 10.4172/NEUROPSYCHIATRY.1000262]; Win T, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5204-4; Windham BG, 2014, J AM GERIATR SOC, V62, P2303, DOI 10.1111/jgs.13165; Wu L, 2018, SLEEP BREATH, V22, P805, DOI 10.1007/s11325-017-1527-0; Xu L, 2011, SLEEP, V34, P575, DOI 10.1093/sleep/34.5.575; Yeh SCJ, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-9; Zhang JY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186560; Zhang ZX, 2006, NEUROEPIDEMIOLOGY, V27, P177, DOI 10.1159/000096131; Ziersch AM, 2005, SOC SCI MED, V61, P2119, DOI 10.1016/j.socscimed.2005.01.015	56	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252208	10.1371/journal.pone.0252208	http://dx.doi.org/10.1371/journal.pone.0252208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043692	Green Published, gold			2022-12-26	WOS:000664635700068
J	Loshchilov, I; Del Dottore, E; Mazzolai, B; Floreano, D				Loshchilov, Ilya; Del Dottore, Emanuela; Mazzolai, Barbara; Floreano, Dario			Conditions for the emergence of circumnutations in plant roots	PLOS ONE			English	Article							ALPI ET-AL; AUXIN TRANSPORT; ARABIDOPSIS ROOTS; ELONGATION ZONE; CELL-DIVISION; TIP ROTATION; GROWTH; NEUROBIOLOGY; GRAVITY; GRAVITROPISM	The plant root system shows remarkably complex behaviors driven by environmental cues and internal dynamics, whose interplay remains largely unknown. A notable example is circumnutation growth movements, which are growth oscillations from side to side of the root apex. Here we describe a model capable of replicating root growth behaviors, which we used to analyze the role of circumnuntations, revealing their emergence I) under gravitropic stress, as a combination of signal propagation and sensitivity to the signal carriers; II) as a result of the interplay between gravitropic and thigmotropic responses; and III) as a behavioral strategy to detect and react to resource gradients. The latter function requires the presence of a hypothetical internal oscillator whose parameters are regulated by the perception of environmental resources.	[Loshchilov, Ilya; Floreano, Dario] Ecole Polytech Fed Lausanne, Lab Intelligent Syst, Lausanne, Switzerland; [Del Dottore, Emanuela; Mazzolai, Barbara] Ist Italiano Tecnol, Ctr Microbiorobot, Pontedera, Italy	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Istituto Italiano di Tecnologia - IIT	Del Dottore, E (corresponding author), Ist Italiano Tecnol, Ctr Microbiorobot, Pontedera, Italy.	emanuela.deldottore@iit.it		Del Dottore, Emanuela/0000-0001-6874-1970; Floreano, Dario/0000-0002-5330-4863	Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET [293431]	Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET	This work was supported by the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission, under FET-Open grant number: 293431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abel S, 2011, CURR OPIN PLANT BIOL, V14, P303, DOI 10.1016/j.pbi.2011.04.007; Agostinelli D, 2020, J MECH PHYS SOLIDS, V136, DOI 10.1016/j.jmps.2019.103702; Ahmed MA, 2018, J EXP BOT, V69, P1199, DOI 10.1093/jxb/erx439; Alpi A, 2007, TRENDS PLANT SCI, V12, P135, DOI 10.1016/j.tplants.2007.03.002; Baluska F, 2010, PLANT SIGNAL BEHAV, V5, P87, DOI 10.4161/psb.5.2.11237; Band LR, 2014, PLANT CELL, V26, P862, DOI 10.1105/tpc.113.119495; Bastien R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00136; Bastien R, 2013, P NATL ACAD SCI USA, V110, P755, DOI 10.1073/pnas.1214301109; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; BEER RD, 1995, ADAPT BEHAV, V3, P469, DOI 10.1177/105971239500300405; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Brenner ED, 2007, TRENDS PLANT SCI, V12, P285, DOI 10.1016/j.tplants.2007.06.005; Brenner ED, 2006, TRENDS PLANT SCI, V11, P413, DOI 10.1016/j.tplants.2006.06.009; Brooks TLD, 2010, PLANT PHYSIOL, V152, P206, DOI 10.1104/pp.109.145292; BROWN AH, 1993, PLANT PHYSIOL, V101, P345, DOI 10.1104/pp.101.2.345; Buer CS, 2003, PLANT PHYSIOL, V132, P1085, DOI 10.1104/pp.102.019182; Chavarria-Krauser A, 2008, NEW PHYTOL, V177, P811, DOI 10.1111/j.1469-8137.2007.02299.x; Chelakkot R, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0001; Choi WG, 2014, P NATL ACAD SCI USA, V111, P6497, DOI 10.1073/pnas.1319955111; Crisp PA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501340; Darwin C., 1897, POWER MOVEMENT PLANT; Davies P.J., 2004, PLANT HORMONES BIOSY; Del Dottore E, 2018, BIOINSPIR BIOMIM, V13, DOI 10.1088/1748-3190/aa9998; Del Dottore E, 2016, IEEE INT CONF ROBOT, P4722, DOI 10.1109/ICRA.2016.7487673; Di Mambro R, 2017, P NATL ACAD SCI USA, V114, pE7641, DOI 10.1073/pnas.1705833114; Dunbabin VM, 2013, PLANT SOIL, V372, P93, DOI 10.1007/s11104-013-1769-y; Dupuy L, 2010, J EXP BOT, V61, P2131, DOI 10.1093/jxb/erp389; Dyson RJ, 2014, NEW PHYTOL, V202, P1212, DOI 10.1111/nph.12764; Eapen D, 2005, TRENDS PLANT SCI, V10, P44, DOI 10.1016/j.tplants.2004.11.004; Esmon CA, 2005, INT J DEV BIOL, V49, P665, DOI 10.1387/ijdb.052028ce; Evans M, 2003, TRENDS PLANT SCI, V8, P312, DOI 10.1016/S1360-1385(03)00133-X; FISHER JOHN E., 1964, CANADIAN JOUR BOT, V42, P293, DOI 10.1139/b64-024; Freschet GT, 2017, FUNCT ECOL, V31, P1506, DOI 10.1111/1365-2435.12883; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Godin C, 2005, NEW PHYTOL, V166, P705, DOI 10.1111/j.1469-8137.2005.01445.x; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hayashi Y, 2004, PLANT CELL PHYSIOL, V45, P351, DOI 10.1093/pcp/pch042; Hochholdinger F, 2004, ANN BOT-LONDON, V93, P359, DOI 10.1093/aob/mch056; Inoue N, 1999, ECOL RES, V14, P31, DOI 10.1046/j.1440-1703.1999.141282.x; ISRAELSS.D, 1967, PHYSIOL PLANTARUM, V20, P957, DOI 10.1111/j.1399-3054.1967.tb08383.x; Izquierdo EJ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002890; JOHNSSON A, 1968, PHYSIOL PLANTARUM, V21, P282, DOI 10.1111/j.1399-3054.1968.tb07251.x; Julkowska MM, 2015, TRENDS PLANT SCI, V20, P586, DOI 10.1016/j.tplants.2015.06.008; Kramer EM, 2011, TRENDS PLANT SCI, V16, P461, DOI 10.1016/j.tplants.2011.05.003; Lopez-Bucio J, 2005, PLANT PHYSIOL, V137, P681, DOI 10.1104/pp.104.049577; Loughman BC., 1981, STRUCTURE FUNCTION P, P9, DOI [10.1007/978-94-009-8314-4_2, DOI 10.1007/978-94-009-8314-4_2]; Mahonen AP, 2014, NATURE, V515, P125, DOI 10.1038/nature13663; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Massa GD, 2003, PLANT J, V33, P435, DOI 10.1046/j.1365-313X.2003.01637.x; Meroz Y, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0038; Migliaccio F, 2001, TRENDS PLANT SCI, V6, P561, DOI 10.1016/S1360-1385(01)02152-5; Migliaccio F, 2013, AM J BOT, V100, P4, DOI 10.3732/ajb.1200314; Mugnai S, 2015, RHYTHMS IN PLANTS, P19, DOI DOI 10.1007/978-3-319-20517-5_2; Mullen JL, 1998, PLANTA, V206, P598, DOI 10.1007/s004250050437; Mullen JL, 2000, PLANT PHYSIOL, V123, P665, DOI 10.1104/pp.123.2.665; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Niinuma K, 2005, PLANT CELL PHYSIOL, V46, P1423, DOI 10.1093/pcp/pci127; OKADA K, 1990, SCIENCE, V250, P274, DOI 10.1126/science.250.4978.274; Oliva M, 2007, NEW PHYTOL, V176, P37, DOI 10.1111/j.1469-8137.2007.02184.x; Pouliquen O, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa6876; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rubio V, 2009, PLANT MOL BIOL, V69, P361, DOI 10.1007/s11103-008-9380-y; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Scheres B, 2017, NATURE, V543, P337, DOI 10.1038/nature22010; Schuster J, 1997, BIOL RHYTHM RES, V28, P422, DOI 10.1076/brhm.28.4.422.13117; Shabala SN, 1997, PHYSIOL PLANTARUM, V100, P917, DOI 10.1034/j.1399-3054.1997.1000418.x; Shabala SN, 1997, PHYSIOL PLANTARUM, V101, P770, DOI 10.1111/j.1399-3054.1997.tb01062.x; Sharp RE, 2004, J EXP BOT, V55, P2343, DOI 10.1093/jxb/erh276; Shimura Y., 1994, MODULATION ROOT GROW, P665; Stolarz M, 2009, PLANT SIGNAL BEHAV, V4, P380, DOI 10.4161/psb.4.5.8293; Sun FF, 2008, PLANT PHYSIOL, V146, P178, DOI 10.1104/pp.107.109413; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Taiz L, 2019, TRENDS PLANT SCI, V24, P677, DOI 10.1016/j.tplants.2019.05.008; TAKANO M, 1995, PLANTA, V197, P410, DOI 10.1007/BF00202664; Taylor I, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018940118; Thitamadee S, 2002, NATURE, V417, P193, DOI 10.1038/417193a; Trewavas A, 2007, TRENDS PLANT SCI, V12, P231, DOI 10.1016/j.tplants.2007.04.006; Tsutsumi D, 2003, SOIL SCI SOC AM J, V67, P387, DOI 10.2136/sssaj2003.0387; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Verbelen JP, 2006, PLANT SIGNAL BEHAV, V1, P296, DOI 10.4161/psb.1.6.3511; Waisel Y, 2002, PLANT ROOTS HIDDEN H, P157, DOI DOI 10.1201/9780203909423; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Wolters H, 2009, NAT REV GENET, V10, P305, DOI 10.1038/nrg2558; Zieschang HE, 1997, J THEOR BIOL, V184, P237, DOI 10.1006/jtbi.1996.0259	89	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252202	10.1371/journal.pone.0252202	http://dx.doi.org/10.1371/journal.pone.0252202			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038485	Green Published, gold			2022-12-26	WOS:000664633500066
J	Paul, P; Arra, B; Hakobyan, M; Hovhannisyan, MG; Kauhanen, J				Paul, Pavitra; Arra, Bhanu; Hakobyan, Mihran; Hovhannisyan, Marine G.; Kauhanen, Jussi			The determinants of under-5 age children malnutrition and the differences in the distribution of stunting-A study from Armenia	PLOS ONE			English	Article							NUTRITIONAL-STATUS; CENTRAL REGION; RISK-FACTORS; HEALTH; UNDERNUTRITION; GROWTH; POVERTY; CONSEQUENCES; PREVALENCE; EDUCATION	Stunting undermines economic growth by perpetuating the vicious cycle of poverty and labour market performance. Studies have captured the trend in stunting and present distributional evidence of policy effects in the country contexts. We identify the determinants of U5 (under 5 years of age) malnutrition for the poor and the Nonpoor and compare the distribution of stunting at four time points (2000, 2005, 2010 and 2015) over a 15-year period between different groups of population. Further, we decompose the gap in malnutrition into causes of differences in stunting between worse-off and better-off socioeconomic groups of the population and estimate the magnitude of distributional differences in stunting between two socioeconomic groups. We also present the inequality trend over time that provides insights into the dynamicity of the effect of different determinants on stunting at different time points. Using 35,490 observations from Armenian Demographic and Health Survey Data [four waves: Year2015,9533; Year2010,8644; Year2005,8919; Year2000,8334], we apply regression-based decomposition method and inequality measures to identify the determinants of malnutrition and distribution of stunting between and within socioeconomic groups. Although the proportional difference in prevalence of stunting between worse-off and better-off children of 13 months and above are reduced by 9.5% in 2015 compared to 2000, the association between socioeconomic position and stunting is statistically significant among children aged 13 months and above in 2000, as well as among children of 36 months and above in 2015. This study demonstrates that the less of socioeconomic distribution of the population, but rather more of the effect from in-country region and settlement of residence are significantly associated with stunting. The approach of our analysis is potentially also a useful tool to generate evidence for decision making towards achieving SDGs 2.2. We conclude that development in childhood is not independent from the distributional effect of region specific development initiatives. Understanding the regional characteristics and resources allocated for the maternal and child health is the necessity to address stunting.	[Paul, Pavitra; Arra, Bhanu; Kauhanen, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Hakobyan, Mihran] United Nations Childrens Fund, Yerevan, Armenia; [Hovhannisyan, Marine G.] Yerevan State Med Univ, Fac Publ Hlth, Yerevan, Armenia	University of Eastern Finland; Yerevan State Medical University	Paul, P (corresponding author), Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland.	paulpavitra@icloud.com	Kauhanen, Jussi/ABC-4064-2021; PAUL, Pavitra/K-2761-2015	PAUL, Pavitra/0000-0003-1428-6882				A Balalian Arin, 2017, BMC Nutr, V3, P85, DOI 10.1186/s40795-017-0204-9; Alderman H, 2006, OXFORD ECON PAP, V58, P450, DOI 10.1093/oep/gpl008; Aryastami NK, 2017, BMC NUTR, V3, P16, DOI [10.1186/s40795-017-0130-x, DOI 10.1186/S40795-017-0130-X]; Assis AMO, 2005, EUR J CLIN NUTR, V59, P1317, DOI 10.1038/sj.ejcn.1602245; BERG A, 1972, AM J CLIN NUTR, V25, P186; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Buzasi K, 2020, J DEV STUD, V56, P87, DOI 10.1080/00220388.2018.1554209; Chirande L, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0482-9; Chopra M, 2003, PUBLIC HEALTH NUTR, V6, P645, DOI 10.1079/PHN2003477; Croft, 2018, GUIDE DHS STAT; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Dewey KG, 1998, AM J CLIN NUTR, V67, P10, DOI 10.1093/ajcn/67.1.10; Fenske N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078692; Frongillo EA, 1997, J NUTR, V127, P2302, DOI 10.1093/jn/127.12.2302; Cruz LMG, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050491; Garcia M., 1989, Pakistan Development Review, V28, P891; Hien Nguyen Ngoc, 2008, J Prev Med Public Health, V41, P232, DOI 10.3961/jpmph.2008.41.4.232; HILL MS, 1995, CHILD YOUTH SERV REV, V17, P91, DOI 10.1016/0190-7409(95)00005-W; HJORT NL, 1992, INT STAT REV, V60, P355, DOI 10.2307/1403683; Hovhannisyan L, 2014, PUBLIC HEALTH NUTR, V17, P1046, DOI 10.1017/S1368980013001171; Ikeda N, 2013, B WORLD HEALTH ORGAN, V91, P341, DOI 10.2471/BLT.12.113381; JAMISON DT, 1986, J DEV ECON, V20, P299, DOI 10.1016/0304-3878(86)90026-X; Janevic T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-509; Jann B, 2008, STATA J, V8, P453, DOI 10.1177/1536867X0800800401; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MALDONADO G, 1993, EPIDEMIOLOGY, V4, P310, DOI 10.1097/00001648-199307000-00006; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Martorell R, 2012, PAEDIATR PERINAT EP, V26, P302, DOI 10.1111/j.1365-3016.2012.01298.x; Menezes Risia Cristina Egito de, 2011, Rev. Saúde Pública, V45, P1079, DOI 10.1590/S0034-89102011000600010; Mercedes de Onis BlossnerMonika., 2011, PUBLIC HEALTH NUTR, P1, DOI [10.1017/S1368980010003198, DOI 10.1017/S1368980010003198]; Mkhitaryan M, 2009, B WORLD HEALTH ORGAN, V87, P489, DOI 10.2471/BLT.09.010709; National Statistical Service [Armenia] Ministry of Health [Armenia] and ORC Macro, 2001, ARMENIA DEMOGRAPHIC; Olofin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064636; Reyes H, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-57; Rossi L, 2005, SOZ PRAVENTIV MED, V50, P166, DOI 10.1007/s00038-005-3158-7; Rutstein Shea O., 2004, DHS WEALTH INDEX DHS; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Strauss J, 1998, J ECON LIT, V36, P766; Suliman E., 2007, SOCIO EC DIFFERENCES; Svedberg P., 1987, WORKING PAPER NO 15; Torosyan A, 2008, J PUBLIC HEALTH-HEID, V16, P183, DOI 10.1007/s10389-007-0160-y; UNICEF WHO World Bank Group (WB), 2018, LEVELS TRENDS CHILD; VELLA V, 1994, INT J EPIDEMIOL, V23, P782, DOI 10.1093/ije/23.4.782; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WATERLOW JC, 1994, EUR J CLIN NUTR, V48, pS1; World Health Assembly, 2014, WHA GLOBAL NUTR TARG; World Health Organisation, 2017, FACT SHEETS MALNUTRI; World Health Organization, REDUCING STUNTING CH; World Health Organization-WHO, 2018, WHO CHILD GROWTH STA; Zopunyan V, 2013, HEALTH HUM RIGHTS, V15, P41	53	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0249776	10.1371/journal.pone.0249776	http://dx.doi.org/10.1371/journal.pone.0249776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038415	gold, Green Published			2022-12-26	WOS:000664633500008
J	Pokhrel, S; Kraemer, BR; Lee, L; Samardzic, K; Mochly-Rosen, D				Pokhrel, Suman; Kraemer, Benjamin R.; Lee, Lucia; Samardzic, Kate; Mochly-Rosen, Daria			Increased elastase sensitivity and decreased intramolecular interactions in the more transmissible 501Y.V1 and 501Y.V2 SARS-CoV-2 variants' spike protein-an in silico analysis	PLOS ONE			English	Article							NEUTROPHIL ELASTASE; SIFT	Two SARS-CoV-2 variants of concern showing increased transmissibility relative to the Wuhan virus have recently been identified. Although neither variant appears to cause more severe illness nor increased risk of death, the faster spread of the virus is a major threat. Using computational tools, we found that the new SARS-CoV-2 variants may acquire an increased transmissibility by increasing the propensity of its spike protein to expose the receptor binding domain via proteolysis, perhaps by neutrophil elastase and/or via reduced intramolecular interactions that contribute to the stability of the closed conformation of spike protein. This information leads to the identification of potential treatments to avert the imminent threat of these more transmittable SARS-CoV-2 variants.	[Pokhrel, Suman; Kraemer, Benjamin R.; Lee, Lucia; Samardzic, Kate; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Mochly-Rosen, D (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mochly@stanford.edu		Mochly-Rosen, Daria/0000-0002-6691-8733; Samardzic, Kate/0000-0001-6177-5561; POKHREL, SUMAN/0000-0003-2258-8768	SPARK at Stanford community; 2020 COVID-19 Response: Drug and Vaccine Prototyping Grant from the Innovative Medicines Accelerator, Stanford University	SPARK at Stanford community; 2020 COVID-19 Response: Drug and Vaccine Prototyping Grant from the Innovative Medicines Accelerator, Stanford University	Supported in part by the 2020 COVID-19 Response: Drug and Vaccine Prototyping Grant from the Innovative Medicines Accelerator, Stanford University to D. M.-R. and by the SPARK at Stanford community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgun E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240012; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Benton DJ, 2020, NATURE, V588, DOI 10.1038/s41586-020-2772-0; Callaway E, 2021, NATURE, V589, P177, DOI 10.1038/d41586-021-00031-0; Centers for Disease Control and Prevention, 2020, INT IMPL EMERG SARS; Chemical Computing Group ULC, 2019, MOL OPER ENV MOE, V01; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Fu ZR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02387; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111; Ke ZL, 2020, NATURE, V588, P498, DOI 10.1038/s41586-020-2665-2; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Loes AN., 2021, COMPREHENSIVE MAPPIN; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mishra SK, 2021, ACTA TROP, V214, DOI 10.1016/j.actatropica.2020.105778; Mustafa Z, 2021, ACS OMEGA, V6, P7181, DOI 10.1021/acsomega.1c00363; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Pokhrel S., 2021, NATURAL VARIANTS SAR; Ramanathan Muthukumar, 2021, Lancet Infect Dis, V21, P1070, DOI [10.1101/2021.02.22.432359, 10.1016/S1473-3099(21)00262-0]; Rambaut A., 2020, COVID 19 GENOMICS CO; Roberts M., 2021, BBC NEWS ONLINE; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Seyran M, 2021, FEBS J, V288, P5010, DOI 10.1111/febs.15651; Tang JLW, 2021, J INFECTION, V82, pE27, DOI 10.1016/j.jinf.2020.12.024; Tegally H., 2020, NATURE, DOI [DOI 10.1038/S41586-021-03402-9, 10.1101/2020.12.21.20248640]; Thierry AR, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092942; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Toelzer C, 2020, SCIENCE, V370, P725, DOI 10.1126/science.abd3255; Tomazic PV, 2014, J ALLERGY CLIN IMMUN, V133, P741, DOI 10.1016/j.jaci.2013.09.040; van Dorp CH., 2021, ESTIMATING STRENGTH, DOI [10.1101/2021.03.29.21254233, DOI 10.1101/2021.03.29.21254233]; Vaser R, 2016, NAT PROTOC, V11, P1, DOI 10.1038/nprot.2015.123; Volz E, 2021, CELL, V184, P64, DOI 10.1016/j.cell.2020.11.020; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312; Weissman D, 2021, CELL HOST MICROBE, V29, P23, DOI 10.1016/j.chom.2020.11.012; World Health Organization, 2020, SARS COV 2 VAR WHO; World Health Organization, 2020, SARS COV 2 VAR UN KI; Xiong XL, 2020, NAT STRUCT MOL BIOL, V27, P934, DOI 10.1038/s41594-020-0478-5; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zahradnik J, 2021, SARS COV 2 RBD VITRO, DOI 10.1101/2021.01.06.425392; Zhu X., 2021, CRYO EM STRUCTURE N5	49	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251426	10.1371/journal.pone.0251426	http://dx.doi.org/10.1371/journal.pone.0251426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038453	Green Published, gold			2022-12-26	WOS:000664633500022
J	Oliver, GR; Marcano-Bonilla, S; Quist, J; Tolosa, EJ; Iguchi, E; Swanson, AA; Hoppman, NL; Schwab, T; Sigafoos, A; Prodduturi, N; Voss, JS; Knight, SM; Zhang, J; Fadra, N; Urrutia, R; Zimmerman, M; Egan, JB; Bilyeu, AG; Jen, J; Veras, E; Al-Safi, R; Block, M; Kerr, S; Fernandez-Zapico, ME; Schoolmeester, JK; Klee, EW				Oliver, Gavin R.; Marcano-Bonilla, Sofia; Quist, Jonathan; Tolosa, Ezequiel J.; Iguchi, Eriko; Swanson, Amy A.; Hoppman, Nicole L.; Schwab, Tanya; Sigafoos, Ashley; Prodduturi, Naresh; Voss, Jesse S.; Knight, Shannon M.; Zhang, Jin; Fadra, Numrah; Urrutia, Raul; Zimmerman, Michael; Egan, Jan B.; Bilyeu, Anthony G.; Jen, Jin; Veras, Ema; Al-Safi, Rema'a; Block, Matthew; Kerr, Sarah; Fernandez-Zapico, Martin E.; Schoolmeester, John K.; Klee, Eric W.			LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; TERT PROMOTER MUTATIONS; TELOMERASE REVERSE-TRANSCRIPTASE; DIFFERENTIAL-DIAGNOSIS; DISEASE; TISSUE	Gestational trophoblastic disease (GTD) is a heterogeneous group of lesions arising from placental tissue. Epithelioid trophoblastic tumor (ETT), derived from chorionic-type trophoblast, is the rarest form of GTD with only approximately 130 cases described in the literature. Due to its morphologic mimicry of epithelioid smooth muscle tumors and carcinoma, ETT can be misdiagnosed. To date, molecular characterization of ETTs is lacking. Furthermore, ETT is difficult to treat when disease spreads beyond the uterus. Here using RNA-Seq analysis in a cohort of ETTs and other gestational trophoblastic lesions we describe the discovery of LPCAT1-TERT fusion transcripts that occur in ETTs and coincide with underlying genomic deletions. Through cell-growth assays we demonstrate that LPCAT1-TERT fusion proteins can positively modulate cell proliferation and therefore may represent future treatment targets. Furthermore, we demonstrate that TERT upregulation appears to be a characteristic of ETTs, even in the absence of LPCAT1-TERT fusions, and that it appears linked to copy number gains of chromosome 5. No evidence of TERT upregulation was identified in other trophoblastic lesions tested, including placental site trophoblastic tumors and placental site nodules, which are thought to be the benign chorionic-type trophoblast counterpart to ETT. These findings indicate that LPCAT1-TERT fusions and copy-number driven TERT activation may represent novel markers for ETT, with the potential to improve the diagnosis, treatment, and outcome for women with this rare form of GTD.	[Oliver, Gavin R.; Marcano-Bonilla, Sofia; Quist, Jonathan; Prodduturi, Naresh; Fadra, Numrah; Zimmerman, Michael; Egan, Jan B.; Block, Matthew; Klee, Eric W.] Mayo Clin, Ctr Individualized Med, Rochester, MI USA; [Oliver, Gavin R.; Marcano-Bonilla, Sofia; Quist, Jonathan; Prodduturi, Naresh; Fadra, Numrah; Urrutia, Raul; Zimmerman, Michael; Fernandez-Zapico, Martin E.] Mayo Clin, Div Hlth Sci Res, Rochester, MI USA; [Tolosa, Ezequiel J.; Iguchi, Eriko; Fernandez-Zapico, Martin E.] Mayo Clin, Dept Oncol, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MI USA; [Swanson, Amy A.; Hoppman, Nicole L.; Voss, Jesse S.; Knight, Shannon M.; Zhang, Jin; Bilyeu, Anthony G.; Jen, Jin; Kerr, Sarah; Schoolmeester, John K.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MI USA; [Schwab, Tanya; Sigafoos, Ashley] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MI USA; [Veras, Ema] Sibley Mem Hosp, Johns Hopkins Med, Washington, DC USA; [Al-Safi, Rema'a] Matern Hosp, Histopathol & Cytol Units, Gynecol Pathol, Kuwait, Kuwait	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine	Oliver, GR (corresponding author), Mayo Clin, Ctr Individualized Med, Rochester, MI USA.; Oliver, GR (corresponding author), Mayo Clin, Div Hlth Sci Res, Rochester, MI USA.	oliver.gavin@mayo.edu	Tolosa, Ezequiel J/AAD-9799-2019	Tolosa, Ezequiel J/0000-0001-5167-0782; Oliver, Gavin/0000-0002-9948-3799	Mayo Clinic Center for Individualized Medicine; Mayo Clinic Department of Laboratory Medicineand Pathology; Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS	Mayo Clinic Center for Individualized Medicine; Mayo Clinic Department of Laboratory Medicineand Pathology; Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We wish to acknowledge Mayo Clinic Center for Individualized Medicine and the Department of Laboratory Medicineand Pathology for supporting this study. GTEx data used for the analyses described in this manuscript were obtained from dbGaP accession number phs000424.v7.p2. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS.	Almarzooqi S, 2014, ACTA CYTOL, V58, P198, DOI 10.1159/000357966; Amezcua CA, 2001, AM J OBSTET GYNECOL, V184, P1441, DOI 10.1067/mob.2001.114862; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bae SN, 1999, AM J OBSTET GYNECOL, V180, P328, DOI 10.1016/S0002-9378(99)70208-5; Bi JF, 2019, CELL METAB, V30, P525, DOI 10.1016/j.cmet.2019.06.014; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Chen RJ, 2002, HUM REPROD, V17, P463, DOI 10.1093/humrep/17.2.463; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; Cheung ANY, 1999, J CLIN PATHOL, V52, P588, DOI 10.1136/jcp.52.8.588; Cho EJ, 2020, GYNECOL ONCOL, V157, P151, DOI 10.1016/j.ygyno.2019.09.022; Colebatch AJ, 2019, J CLIN PATHOL, V72, P281, DOI 10.1136/jclinpath-2018-205653; Dholakia J, 2020, INT J GYNECOL PATHOL, V39, P238, DOI 10.1097/PGP.0000000000000598; Frijstein MM, 2019, GYNECOL ONCOL, V152, P361, DOI 10.1016/j.ygyno.2018.11.015; Haines K, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.PEDCA15-A33; Horowitz NS, 2017, GYNECOL ONCOL, V144, P208, DOI 10.1016/j.ygyno.2016.10.024; Hrdlickova R, 2012, MOL CELL BIOL, V32, P4283, DOI 10.1128/MCB.00550-12; Hu X, 2018, NUCLEIC ACIDS RES, V46, pD1144, DOI 10.1093/nar/gkx1018; Hui P, 2004, MODERN PATHOL, V17, P248, DOI 10.1038/modpathol.3800025; Juratli TA, 2017, ONCOTARGET, V8, P109228, DOI 10.18632/oncotarget.22650; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kim Ji-Hye, 2017, Obstet Gynecol Sci, V60, P124, DOI 10.5468/ogs.2017.60.1.124; Kim P, 2019, NUCLEIC ACIDS RES, V47, pD994, DOI 10.1093/nar/gky1067; Kurman R.J., 2014, WHO CLASSIFICATION T, V4th; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludlow AT, 2019, CANCERS, V11, DOI 10.3390/cancers11050666; McGregor SM, 2020, INT J GYNECOL PATHOL, V39, P8, DOI 10.1097/PGP.0000000000000563; Mizukoshi E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081823; Moessinger C, 2014, BMC CELL BIOL, V15, DOI 10.1186/s12860-014-0043-3; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Morgan JM, 2008, CURR ONCOL REP, V10, P497, DOI 10.1007/s11912-008-0075-y; Nishi H, 1998, INT J ONCOL, V12, P81; Oliver GR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223337; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Segal-Bendirdjian E, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00332; Shi JX, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002162; Shih IM, 2007, ANN DIAGN PATHOL, V11, P228, DOI 10.1016/j.anndiagpath.2007.04.001; Shih IM, 1998, AM J SURG PATHOL, V22, P1393, DOI 10.1097/00000478-199811000-00010; Spiegl-Kreinecker S, 2018, NEURO-ONCOLOGY, V20, P1584, DOI 10.1093/neuonc/noy104; Thompson CAH, 2020, CURR TOP MED CHEM, V20, P498, DOI 10.2174/1568026620666200131125110; Tsai HW, 2008, HISTOPATHOLOGY, V53, P601, DOI 10.1111/j.1365-2559.2008.03145.x; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Wang RF, 2017, CELL RES, V27, P11, DOI 10.1038/cr.2016.155; Wei CH, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1092-4; Xu ML, 2009, MODERN PATHOL, V22, P232, DOI 10.1038/modpathol.2008.165; Xue WC, 2002, CANCER, V94, P2288, DOI 10.1002/cncr.10424; Yang JJ, 2019, J CANCER, V10, P11, DOI 10.7150/jca.28134; Zaloudek CJ, 2016, AJSP-REV REP, V21, P93, DOI 10.1097/PCR.0000000000000136	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0250518	10.1371/journal.pone.0250518	http://dx.doi.org/10.1371/journal.pone.0250518			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033669	gold, Green Published			2022-12-26	WOS:000664633100004
J	Congly, SE; Shaheen, AA; Swain, MG				Congly, Stephen E.; Shaheen, Abdel Aziz; Swain, Mark G.			Modelling the cost effectiveness of non-alcoholic fatty liver disease risk stratification strategies in the community setting	PLOS ONE			English	Article							TRANSIENT ELASTOGRAPHY; UNITED-STATES; FIBROSIS; FIB-4	Background Non-alcoholic fatty liver disease (NAFLD) is highly prevalent worldwide. Identifying high-risk patients is critical to best utilize limited health care resources. We established a community-based care pathway using 2D ultrasound shear wave elastography (SWE) to identify high risk patients with NAFLD. Our objective was to assess the cost-effectiveness of various non-invasive strategies to correctly identify high-risk patients. Methods A decision-analytic model was created using a payer's perspective for a hypothetical patient with NAFLD. FIB-4 [>= 1.3], NAFLD fibrosis score (NFS) [>= -1.455], SWE [>= 8 kPa], transient elastography (TE) [>= 8 kPa], and sequential strategies with FIB-4 or NFS followed by either SWE or TE were compared to identify patients with either significant (>= F2) or advanced fibrosis (>= F3). Model inputs were obtained from local data and published literature. The cost/correct diagnosis of advanced NAFLD was obtained and univariate sensitivity analysis was performed. Results For >= F2 fibrosis, FIB-4/SWE cost $148.75/correct diagnosis while SWE cost $276.42/correct diagnosis, identifying 84% of patients correctly. For >= F3 fibrosis, using FIB-4/SWE correctly identified 92% of diagnoses and dominated all other strategies. The ranking of strategies was unchanged when stratified by normal or abnormal ALT. For >= F3 fibrosis, the cost/correct diagnosis was less in the normal ALT group. Conclusions SWE based strategies were the most cost effective for diagnosing >= F2 fibrosis. For >= F3 fibrosis, FIB-4 followed by SWE was the most effective and least costly strategy. Further evaluation of the timing of repeating non-invasive strategies are required to enhance the cost-effective management of NAFLD.	[Congly, Stephen E.; Shaheen, Abdel Aziz; Swain, Mark G.] Univ Calgary, Cumming Sch Med, Dept Med, Div Gastroenterol & Hepatol, Calgary, AB, Canada; [Congly, Stephen E.] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Shaheen, Abdel Aziz] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Congly, SE (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med, Div Gastroenterol & Hepatol, Calgary, AB, Canada.; Congly, SE (corresponding author), Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada.	secongly@ucalgary.ca	Shaheen, Abdel Aziz/AAX-3773-2021	Shaheen, Abdel Aziz/0000-0002-2940-897X				Alvarez CS, 2020, HEPATOLOGY, V72, P430, DOI 10.1002/hep.31040; Bank of Canada, INFL CAL; Bernal-Reyes R, 2019, REV GASTROENTEROL ME, V84, P69, DOI 10.1016/j.rgmx.2018.11.007; Blake L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010507; Boursier J, 2019, J HEPATOL, V71, P389, DOI 10.1016/j.jhep.2019.04.020; Castera L, 2019, GASTROENTEROLOGY, V156, P1264, DOI 10.1053/j.gastro.2018.12.036; Center for Medicare and Medicaid Services, 2020, PHYS FEE SCHED SEARC; Centers for Medicare & Medicaid Services, 2019, FY 2020 FIN RUL CORR; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chan WK, 2019, CLIN GASTROENTEROL H, V17, P2570, DOI 10.1016/j.cgh.2019.03.006; Davyduke T, 2019, HEPATOL COMMUN, V3, P1322, DOI 10.1002/hep4.1411; Eddowes PJ, 2018, ALIMENT PHARM THER, V47, P631, DOI 10.1111/apt.14469; Herrmann E, 2018, HEPATOLOGY, V67, P260, DOI 10.1002/hep.29179; Husereau D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1049; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Libman H, 2019, ANN INTERN MED, V171, P199, DOI 10.7326/M19-1125; LiverScan Direct, FIBROSCAN SERV; Ma XF, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-1165-z; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Nones RB, 2017, ARCH ENDOCRIN METAB, V61, P276, DOI 10.1590/2359-3997000000233; Paik JM, 2019, HEPATOL COMMUN, V3, P1459, DOI 10.1002/hep4.1419; Pandyarajan Vijay, 2019, Gastroenterol Hepatol (N Y), V15, P357; Serra-Burriel M, 2019, J HEPATOL, V71, P1141, DOI 10.1016/j.jhep.2019.08.019; Shaheen Abdel Aziz, 2020, CMAJ Open, V8, pE370, DOI 10.9778/cmajo.20200009; Siddiqui MS, 2016, GASTROENTEROLOGY, V150, P1849, DOI 10.1053/j.gastro.2016.02.077; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Srivastava A, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-1039-4; Srivastava A, 2019, J HEPATOL, V71, P371, DOI 10.1016/j.jhep.2019.03.033; Steadman R, 2013, CAN J GASTROENTEROL, V27, P149, DOI 10.1155/2013/684982; Swain Mark G, 2020, CMAJ Open, V8, pE429, DOI 10.9778/cmajo.20190212; Tanajewski L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015659; Tapper EB, 2018, NAT REV GASTRO HEPAT, V15, P274, DOI 10.1038/nrgastro.2018.10; Tapper EB, 2016, AM J GASTROENTEROL, V111, P677, DOI 10.1038/ajg.2016.49; Tapper EB, 2015, AM J GASTROENTEROL, V110, P1298, DOI 10.1038/ajg.2015.241; Vilar-Gomez E, 2020, CLIN GASTROENTEROL H, V18, P2305, DOI 10.1016/j.cgh.2020.04.017; Xiao GQ, 2017, HEPATOLOGY, V66, P1486, DOI 10.1002/hep.29302; Younossi ZM, 2016, HEPATOLOGY, V64, P1577, DOI 10.1002/hep.28785; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	38	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251741	10.1371/journal.pone.0251741	http://dx.doi.org/10.1371/journal.pone.0251741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019560	gold, Green Published			2022-12-26	WOS:000664632300034
J	Snigdha, K; Singh, A; Kango-Singh, M				Snigdha, Kirti; Singh, Amit; Kango-Singh, Madhuri			Yorkie-Cactus (I kappa B alpha)-JNK axis promotes tumor growth and progression in Drosophila	ONCOGENE			English	Article							CELL POLARITY; ONCOGENIC RAS; MATRIX METALLOPROTEINASES; TISSUE OVERGROWTH; IMMUNE-RESPONSE; NECROSIS-FACTOR; HIPPO PATHWAY; JNK; RECEPTOR; CANCER	Presence of inflammatory factors in the tumor microenvironment is well-documented yet their specific role in tumorigenesis is elusive. The core inflammatory pathways like the Toll-Like Receptor (TLR) and the Tumor Necrosis Factor (TNF) pathway are conserved in Drosophila. We induced GFP-marked epithelial tumors by expressing activated oncogenic forms of Ras(V12) or Yorkie (Yki(3SA), mammalian YAP) in scribble deficient cells (scrib(RNAi), mammalian SCRIB) to study the role of inflammatory factors in tumorigenesis. Similar to Ras(V12)scrib(RNAi), we found that Yki(3SA)scrib(RNAi) form invasive neoplastic lethal tumors that induce a systemic inflammatory response. We identified Cactus (Cact, mammalian I kappa B alpha), the negative regulator of TLR, as a key player in tumor growth. Cact accumulates in the cytoplasm in Drosophila tumor models, similar to squamous cell carcinoma in mice models and human patients where cytoplasmic I kappa B alpha favors oncogenic transformation. Further, cact is transcriptionally upregulated in tumors, and downregulation of Cact affects tumor growth. We investigated if TLR or TNF pathway affect tumor growth through activation of Jun N-terminal Kinase (JNK) pathway and its target Matrix Metalloprotease1 (MMP1). Genetically manipulating levels of TLR components or TNF receptors showed that Cact acts upstream of JNK signaling and regulates JNK via a non-canonical mechanism during tumorigenesis. Further, Hippo coactivator Yki transcriptionally regulates cact expression, and downregulation of Yki or Cact is sufficient to cause downregulation of JNK-mediated signaling that promotes tumorigenesis. Here, we report a link between Hippo, I kappa B alpha and JNK signaling that may induce inflammation and innate immune response in tumorigenesis.	[Snigdha, Kirti; Singh, Amit; Kango-Singh, Madhuri] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Singh, Amit; Kango-Singh, Madhuri] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA; [Singh, Amit; Kango-Singh, Madhuri] Univ Dayton, Premed Programs, Dayton, OH 45469 USA; [Singh, Amit; Kango-Singh, Madhuri] Univ Dayton, Integrat Sci & Engn Ctr ISE, Dayton, OH 45469 USA	University of Dayton; University of Dayton; University of Dayton; University of Dayton	Kango-Singh, M (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.; Kango-Singh, M (corresponding author), Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dayton, OH 45469 USA.; Kango-Singh, M (corresponding author), Univ Dayton, Premed Programs, Dayton, OH 45469 USA.; Kango-Singh, M (corresponding author), Univ Dayton, Integrat Sci & Engn Ctr ISE, Dayton, OH 45469 USA.	mkangosingh1@udayton.edu		Kango-Singh, Madhuri/0000-0003-2447-6997; Singh, Amit/0000-0002-2962-2255; SNIGDHA, KIRTI/0000-0002-8618-1628	Graduate Program of University of Dayton; Schuellein Endowed Chair in Biology from University of Dayton; NIH [1R15 GM124654-1, R01CA183991]; University of Dayton	Graduate Program of University of Dayton; Schuellein Endowed Chair in Biology from University of Dayton; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Dayton	We would like to thank the anonymous reviewers for their helpful comments that have helped make this manuscript better. We thank Dr. A. Bergmann, Dr. Stephen Cohen, the Bloomington Drosophila Stock Center, and the Drosophila Studies Hybridoma Bank for flies and antibodies. KS acknowledges the Teaching Assistantship and Graduate Student Summer Fellowship from the Graduate Program of University of Dayton. AS is supported by funding from Start-up research funds, the Schuellein Endowed Chair in Biology from the University of Dayton, and NIH 1R15 GM124654-1. MKS is supported by start-up research funds from the University of Dayton, and a subaward from NIH grant R01CA183991 (PI Nakano).	Andersen DS, 2015, NATURE, V522, P482, DOI 10.1038/nature14298; Arefin B, 2017, G3-GENES GENOM GENET, V7, P2139, DOI 10.1534/g3.117.039487; Atkins M, 2016, CURR BIOL, V26, P2101, DOI 10.1016/j.cub.2016.06.035; Beaucher M, 2007, DEV BIOL, V303, P625, DOI 10.1016/j.ydbio.2006.12.001; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bergmann A, 1996, MECH DEVELOP, V60, P109, DOI 10.1016/S0925-4773(96)00607-7; BIREMBAUT P, 1985, J PATHOL, V145, P283, DOI 10.1002/path.1711450402; Bretscher AJ, 2015, BIOL OPEN, V4, P355, DOI 10.1242/bio.201410595; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Bunker BD, 2015, ELIFE, V4, DOI 10.7554/eLife.03189; Byun PK, 2019, CURR BIOL, V29, P2790, DOI 10.1016/j.cub.2019.07.012; Mulero MC, 2013, CANCER CELL, V24, P151, DOI 10.1016/j.ccr.2013.06.003; Cellurale C, 2011, MOL CELL BIOL, V31, P1565, DOI 10.1128/MCB.01122-10; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Dominguez M, 2014, SEMIN CELL DEV BIOL, V28, P78, DOI 10.1016/j.semcdb.2014.04.012; Enomoto M, 2015, DEV BIOL, V403, P162, DOI 10.1016/j.ydbio.2015.05.001; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; GEISLER R, 1992, CELL, V71, P613, DOI 10.1016/0092-8674(92)90595-4; Germani F, 2018, GENETICS, V208, P473, DOI 10.1534/genetics.117.300256; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hauling T, 2014, BIOL OPEN, V3, P250, DOI 10.1242/bio.20146494; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hong X, 2014, EMBO J, V33, P2447, DOI 10.15252/embj.201489385; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Ito K, 1997, DEVELOPMENT, V124, P761; Kanda H, 2002, J BIOL CHEM, V277, P28372, DOI 10.1074/jbc.C200324200; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Kango-Singh M, 2003, DEV BIOL, V256, P48, DOI 10.1016/S0012-1606(02)00123-9; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kauppila S, 2003, ONCOGENE, V22, P4860, DOI 10.1038/sj.onc.1206715; Kulshammer E, 2015, DIS MODEL MECH, V8, P1279, DOI 10.1242/dmm.020719; La Marca JE, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00042; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Ma X, 2016, ONCOGENE, V35, P846, DOI 10.1038/onc.2015.137; Ma XJ, 2015, P NATL ACAD SCI USA, V112, P1065, DOI 10.1073/pnas.1415020112; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mao YP, 2017, ONCOTARGET, V8, P110877, DOI 10.18632/oncotarget.22865; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Martinelli C, 2005, J ENDOTOXIN RES, V11, P243, DOI 10.1179/09680510SX37411; Mishra-Gorur K, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.039727; Morimoto Kenta, 2017, J Vis Exp, DOI 10.3791/55901; Muzzopappa M, 2017, P NATL ACAD SCI USA, V114, pE7291, DOI 10.1073/pnas.1701791114; Villegas SN, 2018, CELL REP, V22, P2541, DOI 10.1016/j.celrep.2018.02.049; Oh H, 2009, DEV BIOL, V335, P188, DOI 10.1016/j.ydbio.2009.08.026; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Parisi F, 2014, CELL REP, V6, P855, DOI 10.1016/j.celrep.2014.01.039; Parvy JP, 2019, ELIFE, V8, DOI 10.7554/eLife.45061; Patel PH, 2015, NAT CELL BIOL, V17, P1182, DOI 10.1038/ncb3214; Ramet M, 2002, DEV BIOL, V241, P145, DOI 10.1006/dbio.2001.0502; ROTH S, 1991, DEVELOPMENT, V112, P371; Rudrapatna VA, 2014, ONCOGENE, V33, P2801, DOI 10.1038/onc.2013.232; Shaukat Z, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/369286; Snigdha K, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00085; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Tournier Cathy, 2013, Genes Cancer, V4, P397, DOI 10.1177/1947601913486349; Tremmel DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067789; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; van Hogerlinden M, 1999, CANCER RES, V59, P3299; Verghese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047173; Vidal M, 2007, CANCER RES, V67, P10278, DOI 10.1158/0008-5472.CAN-07-1376; Waghmare I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158081; Wang X, 2008, ACTA PHARMACOL SIN, V29, P1275, DOI 10.1111/j.1745-7254.2008.00889.x; Willsey HR, 2016, ELIFE, V5, DOI 10.7554/eLife.11491; Yang CC, 2015, P NATL ACAD SCI USA, V112, P1785, DOI 10.1073/pnas.1420850112; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049	80	1	1	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4124	4136		10.1038/s41388-021-01831-4	http://dx.doi.org/10.1038/s41388-021-01831-4		MAY 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34017079				2022-12-26	WOS:000652439200003
J	Ibekwe, AM; Ors, S; Ferreira, JFS; Liu, X; Suarez, DL				Ibekwe, Abasiofiok M.; Ors, Selda; Ferreira, Jorge F. S.; Liu, Xuan; Suarez, Donald L.			Influence of seasonal changes and salinity on spinach phyllosphere bacterial functional assemblage	PLOS ONE			English	Article							COMMUNITIES; MICROBIOTA; DIVERSITY; INSIGHTS; DEGRADATION; HALOMONAS; PATHOGEN; FOREST	The phyllosphere is the aerial part of plants that is exposed to different environmental conditions and is also known to harbor a wide variety of bacteria including both plant and human pathogens. However, studies on phyllosphere bacterial communities have focused on bacterial composition at different stages of plant growth without correlating their functional capabilities to bacterial communities. In this study, we examined the seasonal effects and temporal variabilities driving bacterial community composition and function in spinach phyllosphere due to increasing salinity and season and estimated the functional capacity of bacterial community16S V4 rRNA gene profiles by indirectly inferring the abundance of functional genes based on metagenomics inference tool Piphillin. The experimental design involved three sets of spinach (Spinacia oleracea L., cv. Racoon) grown with saline water during different seasons. Total bacteria DNA from leaf surfaces were sequenced using MiSeq (R) Illumina platform. About 66.35% of bacteria detected in the phyllosphere were dominated by four phyla- Proteobacteria, Firmicutes, Bacteroidetes, and Actinobacteria. Permutational analysis of variance (PERMANOVA) showed that phyllosphere microbiomes were significantly (P < 0.003) affected by season, but not salinity (P = 0.501). The most abundant inferred functional pathways in leaf samples were the amino acids biosynthesis, ABC transporters, ribosome, aminoacyl-tRNA biosynthesis, two-component system, carbon metabolism, purine metabolism, and pyrimidine metabolism. The photosynthesis antenna proteins pathway was significantly enriched in June leaf samples, when compared to March and May. Several genes related to toxin co-regulated pilus biosynthesis proteins were also significantly enriched in June leaf samples, when compared to March and May leaf samples. Therefore, planting and harvesting times must be considered during leafy green production due to the influence of seasons in growth and proliferation of phyllosphere microbial communities.	[Ibekwe, Abasiofiok M.; Ferreira, Jorge F. S.; Liu, Xuan; Suarez, Donald L.] USDA ARS, US Salin Lab, 4500 Glenwood Dr, Riverside, CA 92501 USA; [Ors, Selda] Ataturk Univ, Dept Agr Struct & Irrigat, Erzurum, Turkey	United States Department of Agriculture (USDA); Ataturk University	Ibekwe, AM (corresponding author), USDA ARS, US Salin Lab, 4500 Glenwood Dr, Riverside, CA 92501 USA.	Mark.ibekwe@ars.usda.go		ORS, Selda/0000-0001-6789-8642; Ibekwe, Abasiofiok/0000-0003-3352-759X	AMI USDA-ARS Project USDA-ARS [036012036505]	AMI USDA-ARS Project USDA-ARS	AMI USDA-ARS Project #036012036505 USDA-ARS The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Arjunekumar K., 2020, PLANT MICROBIOMES SU, V25; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Baldwin HE, 2017, J DRUGS DERMATOL, V16, P12; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Beattie GA, 2011, ANNU REV PHYTOPATHOL, V49, P533, DOI 10.1146/annurev-phyto-073009-114436; Bodenhausen N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004283; Bringel F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00486; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chhabra R., 1996, SOIL SALINITY WATER; Coince A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100668; Cordier T, 2012, NEW PHYTOL, V196, P510, DOI 10.1111/j.1469-8137.2012.04284.x; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Dias NS, 2016, IND CROP PROD, V94, P1009, DOI 10.1016/j.indcrop.2016.09.029; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Froelich BA, 2012, APPL ENVIRON MICROB, V78, P3885, DOI 10.1128/AEM.07855-11; Furnkranz M, 2008, ISME J, V2, P561, DOI 10.1038/ismej.2008.14; Guron GKP, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00239-19; Hellberg RS, 2016, CRIT REV MICROBIOL, V42, P548, DOI 10.3109/1040841X.2014.972335; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Hossain MJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00631; Ibekwe AM, 2010, SOIL BIOL BIOCHEM, V42, P567, DOI 10.1016/j.soilbio.2009.11.033; Ibekwe AM, 2020, SCI TOTAL ENVIRON, V717, DOI 10.1016/j.scitotenv.2020.137207; Ibekwe AM, 2017, SCI TOTAL ENVIRON, V579, P1485, DOI 10.1016/j.scitotenv.2016.11.151; Iwai S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166104; Kecskemeti E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160852; Kohler J, 2010, J SOIL SEDIMENT, V10, P1585, DOI 10.1007/s11368-010-0259-6; Koike S.T., 2011, AGR NATURAL RES PUB, P7212; Koo H, 2017, J MICROBIOL METH, V140, P15, DOI 10.1016/j.mimet.2017.06.017; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lehmann S, 2015, PHYTOCHEMISTRY, V112, P54, DOI 10.1016/j.phytochem.2014.08.027; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Lolans K, 2006, ANTIMICROB AGENTS CH, V50, P2941, DOI 10.1128/AAC.00116-06; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meiners SJ, 2017, OECOLOGIA, V183, P1155, DOI 10.1007/s00442-017-3833-4; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Ors S, 2016, HORTIC SCI, V43, P33, DOI 10.17221/114/2015-HORTSCI; Penuelas J, 2012, PLANT BIOLOGY, V14, P565, DOI 10.1111/j.1438-8677.2011.00532.x; Poret-Peterson AT, 2019, FRONT ENV SCI-SWITZ, V6, DOI 10.3389/fenvs.2018.00160; Poss JA, 2004, COMPUT ELECTRON AGR, V43, P55, DOI 10.1016/j.compag.2003.10.001; Rastogi G, 2013, FEMS MICROBIOL LETT, V348, P1, DOI 10.1111/1574-6968.12225; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Rawat SR, 2012, FEMS MICROBIOL ECOL, V82, P341, DOI 10.1111/j.1574-6941.2012.01381.x; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Remus-Emsermann MNP, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00036-13; Ren GD, 2014, APPL MICROBIOL BIOT, V98, P9459, DOI 10.1007/s00253-014-5915-0; Rico L, 2014, PLANT BIOLOGY, V16, P586, DOI 10.1111/plb.12082; Rochaix JD, 2019, BIOCHEM J, V476, P581, DOI 10.1042/BCJ20180718; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schonherr J, 2006, J EXP BOT, V57, P2471, DOI 10.1093/jxb/erj217; Sokol NW, 2019, NAT GEOSCI, V12, P46, DOI 10.1038/s41561-018-0258-6; Stevens DA, 2009, MEDICINE, V88, P244, DOI 10.1097/MD.0b013e3181aede29; Suarez D.L., 2012, EXTRACTCHEM; Trouvelot S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00592; USEPA, 2004, 625R04108 USEPA; Vacher C, 2016, ANNU REV ECOL EVOL S, V47, P1, DOI 10.1146/annurev-ecolsys-121415-032238; van Elsas JD, 2011, ISME J, V5, P173, DOI 10.1038/ismej.2010.80; Van Elsas JD, 2007, MODERN SOIL MICROBIO; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; VREELAND RH, 1980, INT J SYST BACTERIOL, V30, P485, DOI 10.1099/00207713-30-2-485; Wang CY, 2018, AMB EXPRESS, V8, DOI [10.4236/ape.2018.81001, 10.1186/s13568-018-0594-3]; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; Williams TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068642; Yamazaki A, 2011, APPL ENVIRON MICROB, V77, P156, DOI 10.1128/AEM.01079-10; Yan N, 2015, INT SOIL WATER CONSE, V3, P316, DOI 10.1016/j.iswer.2015.11.003; Yang CH, 2001, P NATL ACAD SCI USA, V98, P3889, DOI 10.1073/pnas.051633898	76	2	2	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252242	10.1371/journal.pone.0252242	http://dx.doi.org/10.1371/journal.pone.0252242			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061881	Green Published, gold			2022-12-26	WOS:000656813600030
J	Di Tomo, P; Alessio, N; Falone, S; Pietrangelo, L; Lanuti, P; Cordone, V; Santini, SJ; Di Pietrantonio, N; Marchisio, M; Protasi, F; Di Pietro, N; Formoso, G; Amicarelli, F; Galderisi, U; Pandolfi, A				Di Tomo, Pamela; Alessio, Nicola; Falone, Stefano; Pietrangelo, Laura; Lanuti, Paola; Cordone, Valeria; Santini, Silvano Junior; Di Pietrantonio, Nadia; Marchisio, Marco; Protasi, Feliciano; Di Pietro, Natalia; Formoso, Gloria; Amicarelli, Fernanda; Galderisi, Umberto; Pandolfi, Assunta			Endothelial cells from umbilical cord of women affected by gestational diabetes: A suitable in vitro model to study mechanisms of early vascular senescence in diabetes	FASEB JOURNAL			English	Article						endothelium; gestational diabetes; mitochondria; oxidative stress; senescence	NF-KAPPA-B; OXIDATIVE STRESS; HIGH-GLUCOSE; SUPEROXIDE-DISMUTASE; CELLULAR SENESCENCE; LIPID-PEROXIDATION; GENE-EXPRESSION; DYSFUNCTION; HYPERGLYCEMIA; MELLITUS	Human umbilical cord endothelial cells (HUVECs) obtained from women affected by gestational diabetes (GD-HUVECs) display durable pro-atherogenic modifications and might be considered a valid in vitro model for studying chronic hyperglycemia effects on early endothelial senescence. Here, we demonstrated that GD- compared to C-HUVECs (controls) exhibited oxidative stress, altered both mitochondrial membrane potential and antioxidant response, significant increase of senescent cells characterized by a reduced NAD-dependent deacetylase sirtuin-1 (SIRT1) activity together with an increase in cyclin-dependent kinase inhibitor-2A (P16), cyclin-dependent kinase inhibitor-1 (P21), and tumor protein p53 (P53) acetylation. This was associated with the p300 activation, and its silencing significantly reduced the GD-HUVECs increased protein levels of P300 and Ac-P53 thus indicating a persistent endothelial senescence via SIRT1/P300/P53/P21 pathway. Overall, our data suggest that GD-HUVECs can represent an "endothelial hyperglycemic memory" model to investigate in vitro the early endothelium senescence in cells chronically exposed to hyperglycemia in vivo.	[Di Tomo, Pamela; Di Pietrantonio, Nadia; Di Pietro, Natalia; Pandolfi, Assunta] Univ G dAnnunzio, Dept Med & Oral Sci & Biotechnol, Chieti, Italy; [Di Tomo, Pamela; Pietrangelo, Laura; Lanuti, Paola; Di Pietrantonio, Nadia; Marchisio, Marco; Protasi, Feliciano; Di Pietro, Natalia; Formoso, Gloria; Pandolfi, Assunta] Univ G dAnnunzio, Ctr Adv Studies & Technol CAST ex CeSI MeT, Chieti, Italy; [Alessio, Nicola; Galderisi, Umberto] Univ Campania L Vanvitelli, Dept Expt Med, Naples, Italy; [Falone, Stefano; Santini, Silvano Junior; Amicarelli, Fernanda] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Pietrangelo, Laura; Lanuti, Paola; Marchisio, Marco; Protasi, Feliciano; Formoso, Gloria] Univ G dAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Cordone, Valeria] Univ Ferrara, Dept Biomed & Specialist Surg Sci, Ferrara, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Universita della Campania Vanvitelli; University of L'Aquila; G d'Annunzio University of Chieti-Pescara; University of Ferrara	Pandolfi, A (corresponding author), Univ G dAnnunzio, Dept Med & Oral Sci & Biotechnol, Ctr Adv Studies & Technol CAST ex CeSIMeT, Room 421, I-66100 Chieti, Italy.	assunta.pandolfi@unich.it	Cordone, Valeria/HGB-2367-2022; Santini, Silvano Junior/L-6688-2019; Falone, Stefano/D-8692-2017	Cordone, Valeria/0000-0003-2791-8121; Santini, Silvano Junior/0000-0001-6577-5892; Falone, Stefano/0000-0002-5978-0545	POR FESR ABRUZZO 2014-2020 Asse I Determinazione (SANI) [39 DPG013/12222017]; Italian Telethon ONLUS Foundation [GGP19231]; Italian MIUR [2015ZZR4W3]; Italian Society of Nephrology (SIN) [10122016]	POR FESR ABRUZZO 2014-2020 Asse I Determinazione (SANI); Italian Telethon ONLUS Foundation(Fondazione Telethon); Italian MIUR(Ministry of Education, Universities and Research (MIUR)); Italian Society of Nephrology (SIN)	This study was partially supported by grants from: POR FESR ABRUZZO 2014-2020 Asse I Determinazione (SANI, number: 39 DPG013/12222017) to Assunta Pandolfi; Italian Telethon ONLUS Foundation (GGP19231) and Italian MIUR (PRIN #2015ZZR4W3) to Feliciano Protasi; Italian Society of Nephrology (SIN, 10122016) to Natalia Di Pietro.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alessio N, 2017, NEOPLASIA, V19, P781, DOI 10.1016/j.neo.2017.06.005; Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; Angulo J, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101271; Aronson D, 2014, CARDIOL CLIN, V32, P439, DOI 10.1016/j.ccl.2014.04.001; Baskin SI., 2017, OXIDANTS ANTIOXIDANT, DOI [10.1201/9780203744673, DOI 10.1201/9780203744673]; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Bonfigli A, 2006, INT J BIOCHEM CELL B, V38, P2196, DOI 10.1016/j.biocel.2006.06.011; Capone V, 2018, BBA-MOL BASIS DIS, V1864, P3164, DOI 10.1016/j.bbadis.2018.07.003; Ceriello A, 2009, J CLIN ENDOCR METAB, V94, P410, DOI 10.1210/jc.2008-1824; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1729, DOI 10.1152/ajpheart.01103.2005; Chen YH, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.04.29; Cheng XH, 2013, DIABETES, V62, P4088, DOI 10.2337/db13-0169; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Coco C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20122949; Conti V, 2015, AGING CLIN EXP RES, V27, P547, DOI 10.1007/s40520-015-0357-9; Cossarizza A, 1996, EXP CELL RES, V222, P84, DOI 10.1006/excr.1996.0011; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; DEHAAN JB, 1995, BIOCHEM MOL BIOL INT, V35, P1281; Di Fulvio P, 2014, NUTR METAB CARDIOVAS, V24, P1337, DOI 10.1016/j.numecd.2014.06.005; Di Tomo P, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2925; Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018; Donato AJ, 2018, CIRC RES, V123, P825, DOI 10.1161/CIRCRESAHA.118.312563; El Assar M, 2016, J PHYSIOL-LONDON, V594, P3045, DOI 10.1113/JP271836; Feng YH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00748; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gui J, 2016, PEDIATR RES, V79, P788, DOI 10.1038/pr.2015.269; HA HJ, 1994, KIDNEY INT, V46, P1620, DOI 10.1038/ki.1994.461; Hayashi T, 2014, P NATL ACAD SCI USA, V111, P1168, DOI 10.1073/pnas.1322153111; Herbert KJ, 2014, TOXICOL APPL PHARM, V277, P288, DOI 10.1016/j.taap.2014.04.001; Hill Michael D, 2014, Handb Clin Neurol, V126, P167, DOI 10.1016/B978-0-444-53480-4.00012-6; Ihnat MA, 2007, DIABETOLOGIA, V50, P1523, DOI 10.1007/s00125-007-0684-2; Iskender H, 2017, BIOMED PHARMACOTHER, V90, P500, DOI 10.1016/j.biopha.2017.03.102; Jia GH, 2019, BBA-MOL BASIS DIS, V1865, P1802, DOI 10.1016/j.bbadis.2018.08.008; Katsuumi G, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00018; Ksiazek K, 2008, BIOCHEM BIOPH RES CO, V366, P793, DOI 10.1016/j.bbrc.2007.12.021; Kuki S, 2006, CIRC J, V70, P1076, DOI 10.1253/circj.70.1076; La Sala L, 2019, EUR J PREV CARDIOL, V26, P15, DOI 10.1177/2047487319878373; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manohar SM, 2013, J RES MED SCI, V18, P89; Marchetti C, 2004, HUM REPROD, V19, P2267, DOI 10.1093/humrep/deh416; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Masoud S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010197; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Morley JE, 2018, CLIN GERIATR MED, V34, pIX, DOI 10.1016/j.cger.2018.08.013; Nigro C, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070749; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; Orimo M, 2009, ARTERIOSCL THROM VAS, V29, P889, DOI 10.1161/ATVBAHA.109.185694; Ortega-Camarillo C, 2006, MOL CELL BIOCHEM, V281, P163, DOI 10.1007/s11010-006-0829-5; Ozuguz U, 2011, DIABETES RES CLIN PR, V94, P426, DOI 10.1016/j.diabres.2011.08.024; Palmer AK, 2019, DIABETOLOGIA, V62, P1835, DOI 10.1007/s00125-019-4934-x; Pandolfi A, 2007, GENES NUTR, V2, P195, DOI 10.1007/s12263-007-0050-5; Patel H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-142; Pluvinet R, 2008, BLOOD, V112, P3624, DOI 10.1182/blood-2008-03-143305; RAJESWARI P, 1991, J CELL PHYSIOL, V149, P100, DOI 10.1002/jcp.1041490113; Santini S, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090346; Santos AN, 2017, MECH AGEING DEV, V166, P24, DOI 10.1016/j.mad.2017.07.009; Schisano B, 2011, DIABETOLOGIA, V54, P1219, DOI 10.1007/s00125-011-2049-0; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Sivandzade F, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3128; Sobrevia L, 2015, EXP PHYSIOL, V100, P231, DOI 10.1113/expphysiol.2014.082743; SUN M, 1978, ANAL BIOCHEM, V90, P81, DOI 10.1016/0003-2697(78)90010-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ucci M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8184656; Villalobos-Labra R, 2019, PLACENTA, V86, P35, DOI 10.1016/j.placenta.2019.07.007; Wang XL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36911-1; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xu WL, 2010, DIABETES, V59, P2928, DOI 10.2337/db10-0539; Yagi K, 1998, Methods Mol Biol, V108, P101; Yang JH, 2011, ARCH MED RES, V42, P354, DOI 10.1016/j.arcmed.2011.07.005; Yerra VG, 2013, REDOX BIOL, V1, P394, DOI 10.1016/j.redox.2013.07.005; Yessoufou A, 2011, EXP DIABETES RES, DOI 10.1155/2011/218598; Yiu KH, 2014, ARTERIOSCL THROM VAS, V34, P1136, DOI 10.1161/ATVBAHA.114.302192; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; Yokoyama M, 2019, J MOL CELL CARDIOL, V129, P105, DOI 10.1016/j.yjmcc.2019.02.010; Yu YX, 2010, CHINESE MED J-PEKING, V123, P1915, DOI 10.3760/cma.j.issn.0366-6999.2010.14.016; Zhang EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143814; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	81	5	5	6	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21662	10.1096/fj.202002072RR	http://dx.doi.org/10.1096/fj.202002072RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34046935				2022-12-26	WOS:000655695900013
J	Andersson-Hall, U; Svedin, P; Mallard, C; Blennow, K; Zetterberg, H; Holmang, A				Andersson-Hall, Ulrika; Svedin, Pernilla; Mallard, Carina; Blennow, Kaj; Zetterberg, Henrik; Holmang, Agneta			Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy	PLOS ONE			English	Article							AGOUTI-RELATED PROTEIN; INHIBITORY CYTOKINE-1; AREA POSTREMA; RECEPTOR; HYPEREMESIS; LEPTIN; GDF15; SEX; MIC-1/GDF15; PROMOTES	Aim Growth differentiation factor 15 (GDF15) increases in serum during pregnancy to levels not seen in any other physiological state and is suggested to be involved in pregnancy-induced nausea, weight regulation and glucose metabolism. The main action of GDF15 is regulated through a receptor of the brainstem, i.e., through exposure of GDF15 in both blood and cerebrospinal fluid (CSF). The aim of the current study was to measure GDF15 in both CSF and serum during pregnancy, and to compare it longitudinally to non-pregnant levels. Methods Women were sampled at elective caesarean section (n = 45, BMI = 28.15.0) and were followed up 5 years after pregnancy (n = 25). GDF15, insulin and leptin were measured in CSF and serum. Additional measurements included plasma glucose, and serum adiponectin and Hs-CRP. Results GDF15 levels were higher during pregnancy compared with follow-up in both CSF (385 +/- 128 vs. 115 +/- 32 ng/l, P<0.001) and serum (73789 +/- 29198 vs. 404 +/- 102 ng/l, P<0.001). CSF levels correlated with serum levels during pregnancy (P<0.001), but not in the non-pregnant state (P = 0.98). Both CSF and serum GDF15 were highest in women carrying a female fetus (P<0.001). Serum GDF15 correlated with the homeostatic model assessment for beta-cell function and placental weight, and CSF GDF15 correlated inversely with CSF insulin levels. Conclusion This, the first study to measure CSF GDF15 during pregnancy, demonstrated increased GDF15 levels in both serum and CSF during pregnancy. The results suggest that effects of GDF15 during pregnancy can be mediated by increases in both CSF and serum levels.	[Andersson-Hall, Ulrika; Svedin, Pernilla; Mallard, Carina; Holmang, Agneta] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England	University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; University of London; University College London; University of London; University College London	Andersson-Hall, U (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Gothenburg, Sweden.	ulrika.andersson.hall@gu.se			Swedish Research Council [12206, 2017-00915, VR-2017-01409, 2018-02532]; Swedish Diabetes Association Research Foundation [2015-08]; Swedish government; ALF [720851, 715986, 720931, ALFGBG-722491]; Alzheimer Drug Discovery Foundation (ADDF), USA [RDAPB-201809-2016615, 201809-2016862]; Swedish Alzheimer Foundation [AF-742881]; Swedish brain foundation [FO2017-0243, FO2019-0270]; European Union Joint Program for Neurodegenerative Disorders [JPND2019-466-236]; European Research Council [681712]; Emil and Wera Cornell Foundation; Ahlen Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association Research Foundation; Swedish government; ALF; Alzheimer Drug Discovery Foundation (ADDF), USA; Swedish Alzheimer Foundation; Swedish brain foundation; European Union Joint Program for Neurodegenerative Disorders; European Research Council(European Research Council (ERC)European Commission); Emil and Wera Cornell Foundation; Ahlen Foundation	The original cesarean and follow-up studies were supported by the Swedish Research Council (12206, 2017-00915, 2018-02532), the Swedish Diabetes Association Research Foundation (2015-08), the Swedish state under the agreement between the Swedish government and the country councils, the ALF-agreement (720851, 715986, 720931), the Alzheimer Drug Discovery Foundation (ADDF), USA (#RDAPB-201809-2016615, 201809-2016862), the Swedish Alzheimer Foundation (#AF-742881), the Swedish brain foundation (#FO2017-0243), and European Union Joint Program for Neurodegenerative Disorders (JPND2019-466-236). HZ is a Wallenberg Scholar also supported by the European Research Council (#681712). The GDF15 measurements were supported by the Emil and Wera Cornell Foundation, the Swedish Research Council (VR-2017-01409), Ahlen Foundation, the Swedish state under the agreement between the Swedish government and the country councils, the ALF-agreement (ALFGBG-722491) and Swedish Brain Foundation (FO2019-0270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson-Hall U, 2021, CLIN ENDOCRINOL, V95, P92, DOI 10.1111/cen.14433; Andersson-Hall U, 2020, INT J OBESITY, V44, P675, DOI 10.1038/s41366-019-0452-7; Andersson-Hall U, 2018, CLIN ENDOCRINOL, V88, P263, DOI 10.1111/cen.13520; Askling J, 1999, LANCET, V354, P2053, DOI 10.1016/S0140-6736(99)04239-7; Coll AP, 2020, NATURE, V578, P444, DOI 10.1038/s41586-019-1911-y; Day EA, 2019, NAT METAB, V1, P1202, DOI 10.1038/s42255-019-0146-4; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Fejzo MS, 2019, GEBURTSH FRAUENHEILK, V79, P382, DOI 10.1055/a-0830-1346; Fejzo MS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03258-0; Gustavsson C, 2016, OBESITY, V24, P1299, DOI 10.1002/oby.21502; Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042; KALLEN B, 1987, EUR J OBSTET GYN R B, V26, P291; Kampmann U, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/5320156; Klein AB., 2021, NAT COMMUN, V12, P1, DOI [10.1038/s41467-020-20314-w, DOI 10.1038/S41467-020-20314-W]; Kosa P, 2020, MULT SCLER RELAT DIS, V45, DOI 10.1016/j.msard.2020.102434; Ladyman SR, 2010, J NEUROENDOCRINOL, V22, P805, DOI 10.1111/j.1365-2826.2010.02017.x; LINDROOS AK, 1993, EUR J CLIN NUTR, V47, P461; Maetzler W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149349; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Michelsen TM, 2019, FASEB J, V33, P2944, DOI 10.1096/fj.201801193R; MILLER AD, 1994, FRONT NEUROENDOCRIN, V15, P301, DOI 10.1006/frne.1994.1012; Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781; Mullican SE, 2018, TRENDS ENDOCRIN MET, V29, P560, DOI 10.1016/j.tem.2018.05.002; Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392; Nakayasu ES, 2020, CELL METAB, V31, P363, DOI 10.1016/j.cmet.2019.12.005; Page-Wilson G, 2013, J CLIN ENDOCR METAB, V98, P264, DOI 10.1210/jc.2012-2309; Petry CJ., 2018, WELLCOME OPEN RES, P3, DOI [10.12688/wellcomeopenres.13488.1, DOI 10.12688/WELLCOMEOPENRES.13488.1]; Rashid M, 2012, J OBSTET GYNAECOL, V32, P475, DOI 10.3109/01443615.2012.666580; Rosenfeld CS, 2015, ENDOCRINOLOGY, V156, P3422, DOI 10.1210/en.2015-1227; Schernthaner-Reiter MH, 2019, NUTR METAB CARDIOVAS, V29, P334, DOI 10.1016/j.numecd.2018.12.008; Schiff MA, 2004, BJOG-INT J OBSTET GY, V111, P27, DOI 10.1046/j.1471-0528.2003.00005.x; Shnaper S, 2009, INT J CANCER, V125, P2624, DOI 10.1002/ijc.24639; Sjostedt E, 2020, SCIENCE, V367, P1090, DOI 10.1126/science.aay5947; Strelau J, 2000, J NEUROSCI, V20, P8597; Tang MY, 2019, DIABETES RES CLIN PR, V156, DOI 10.1016/j.diabres.2019.107823; Tsai VW, 2018, INT J OBESITY, V42, P561, DOI 10.1038/ijo.2017.258; Tsai VWW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100370; Tsai VW-W., 2019, INT J OBESITY, P1; Wang QP, 2008, NEUROCHEM RES, V33, P2035, DOI 10.1007/s11064-008-9676-y; Wischhusen J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00951; Worth AA, 2020, ELIFE, V9, DOI 10.7554/eLife.55164; Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394; Zhang H, 2019, AM J PHYSIOL-ENDOC M, V316, pE829, DOI 10.1152/ajpendo.00439.2018	44	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0248980	10.1371/journal.pone.0248980	http://dx.doi.org/10.1371/journal.pone.0248980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043633	Green Published, Green Submitted, gold			2022-12-26	WOS:000664635700009
J	Hoenink, JC; Galenkamp, H; Beune, EJ; Hartman, MA; Snijder, MB; Dijkshoorn, H; Peters, RJG; Bal, E; Stronks, K; Nicolaou, M				Hoenink, Jody C.; Galenkamp, Henrike; Beune, Erik J.; Hartman, Marieke A.; Snijder, Marieke B.; Dijkshoorn, Henriette; Peters, Ron J. G.; Bal, Ellen; Stronks, Karien; Nicolaou, Mary			Body size ideals and body satisfaction among Dutch-origin and African-origin residents of Amsterdam: The HELIUS study	PLOS ONE			English	Article							WEIGHT STATUS; NUTRITIONAL TRANSITION; UNITED-STATES; YOUNG-ADULTS; IMAGE; DISSATISFACTION; ACCULTURATION; OBESITY; WOMEN; ETHNICITY	Objective Obesity is highly prevalent among ethnic minorities and acceptance of larger body sizes may put these ethnic minorities at risk of obesity. This study aimed to examine body size ideals and body satisfaction in relation to body weight, in two Sub-Saharan African (SSA)-origin groups in the Netherlands compared to the Dutch. Additionally, in the two SSA-origin groups, this study assessed the mediating role of acculturation in the relation between ethnicity and body size ideals and body satisfaction. Methods Dutch, African Surinamese and Ghanaians living in Amsterdam, the Netherlands, participated in the observational HELIUS study (n = 10,854). Body size ideals were assessed using a validated nine figure scale. Body satisfaction was calculated as the concordance of current with ideal figure. Acculturation was only assessed among SSA-origin participants and acculturation proxies included age of migration, residence duration, ethnic identity and social network. Weight and height were measured using standardised protocols. Results SSA-origin women and Ghanaian men had larger body size ideals compared to the Dutch; e.g. Surinamese and Ghanaian women had 0.37 (95%CI 0.32; 0.43) and 0.70 (95%CI 0.63; 0.78) larger body size ideals compared to Dutch women. SSA-origin participants were more often satisfied with their weight compared to the Dutch. Similarly, SSA-origin participants had more than twice the odds of being satisfied/preferring a larger figure compared to the Dutch (e.g. B-Surinamese men 2.44, 95%CI 1.99; 2.99). Within the two SSA-origin groups, most acculturation proxies mediated the relation between ethnicity and body size ideals in women. Limited evidence of mediation was found for the outcome body satisfaction. Conclusion Public health strategies promoting a healthy weight may need to be differentiated according to sex and ethnic differences in body weight perception. Factors other than acculturation may underlie the ethnic differences between African Surinamese and Ghanaians in obesity.	[Hoenink, Jody C.] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Amsterdam, Netherlands; [Galenkamp, Henrike; Beune, Erik J.; Snijder, Marieke B.; Stronks, Karien; Nicolaou, Mary] Univ Amsterdam, Dept Publ Hlth, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Amsterdam, Netherlands; [Hartman, Marieke A.] Erasmus Univ, Erasmus Univ Coll, Dept Life Sci, Rotterdam, Netherlands; [Snijder, Marieke B.] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Amsterdam, Netherlands; [Dijkshoorn, Henriette] Publ Hlth Serv Amsterdam, Dept Epidemiol Hlth Promot & Healthcare Innovat, Amsterdam, Netherlands; [Peters, Ron J. G.] Univ Amsterdam, Dept Cardiol, Amsterdam UMC, Amsterdam, Netherlands; [Bal, Ellen] Vrije Univ Amsterdam, Dept Social & Cultural Anthropol, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Public Health Service Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Hoenink, JC (corresponding author), Vrije Univ Amsterdam, Dept Epidemiol & Biostat, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Amsterdam, Netherlands.	j.c.hoenink@amsterdamumc.nl	Hoenink, Jody/AAC-3606-2019	Hoenink, Jody/0000-0003-0303-4540; Bal, Ellen/0000-0002-2893-0977; Stronks, Karien/0000-0002-0921-2232	Academic Medical Center (AMC) of Amsterdam; Dutch Heart Foundation (Hartstichting) [2010T084]; Netherlands Organization for Health Research and Development (ZonMw) [200500003]; European Integration Fund (EIF) [2013EIF013]; European Union [278901]; Public Health Service of Amsterdam (GGD Amsterdam)	Academic Medical Center (AMC) of Amsterdam; Dutch Heart Foundation (Hartstichting); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Integration Fund (EIF); European Union(European Commission); Public Health Service of Amsterdam (GGD Amsterdam)	The Academic Medical Center (AMC) of Amsterdam and the Public Health Service of Amsterdam (GGD Amsterdam) provided core financial support for HELIUS. The HELIUS study is also funded by research grants of the Dutch Heart Foundation (Hartstichting; grant no. 2010T084), the Netherlands Organization for Health Research and Development (ZonMw; grant no. 200500003), the European Integration Fund (EIF; grant no. 2013EIF013) and the European Union (Seventh Framework Programme, FP-7; grant no. 278901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo IY, 2019, ETHNIC HEALTH, DOI 10.1080/13557858.2019.1607261; Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Aikins AD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214501; [Anonymous], 2016, BIJLM CENTR STAD ZUI; Broesch J, 2012, SOC SCI J, V49, P375, DOI 10.1016/j.soscij.2012.02.004; Cachelin Fary M, 2006, Body Image, V3, P67, DOI 10.1016/j.bodyim.2005.10.006; CASH TF, 1995, J PERS ASSESS, V64, P466, DOI 10.1207/s15327752jpa6403_6; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen E., 2018, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V30, P59, DOI 10.3166/bmsap-2018-0006; Cohen E, 2013, SOC SCI MED, V96, P24, DOI 10.1016/j.socscimed.2013.07.004; Davison TE., 2012, ENCY BODY IMAGE HUMA, P243, DOI [10.1016/B978-0-12-384925-0.00023-7, DOI 10.1016/B978-0-12-384925-0.00023-7]; De-Graft Aikins A., 2011, FATNESS MATERNAL BOD; Delavari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-458; Demarest J, 2000, J SOC PSYCHOL, V140, P465, DOI 10.1080/00224540009600485; Flahaux M.-L., 2016, COMP MIGR STUD, V4, P1, DOI [10.1186/s40878-015-0015-6, DOI 10.1186/S40878-015-0015-6]; Flannery WP, 2001, PERS SOC PSYCHOL B, V27, P1035, DOI 10.1177/0146167201278010; Fox M, 2017, AM ANTHROPOL, V119, P405, DOI 10.1111/aman.12867; Frederick David A, 2006, Body Image, V3, P413, DOI 10.1016/j.bodyim.2006.08.002; Gordon KH, 2010, CULT DIVERS ETHN MIN, V16, P135, DOI 10.1037/a0018671; Grabe S, 2006, PSYCHOL BULL, V132, P622, DOI 10.1037/0033-2909.132.4.622; Gramaglia C., 2018, Body image, eating, and weight: a guide to assessment, treatment, and prevention, P427; Hartman MA, 2013, HLTH PROMOTION MULTI; Kimber M, 2014, INT J EAT DISORDER, V47, P892, DOI 10.1002/eat.22295; Kronenfeld LW, 2010, BODY IMAGE, V7, P131, DOI 10.1016/j.bodyim.2009.11.002; Leesberg, 2012, THE NEW HOLLSTEIN, V1, plvi; Lynch E, 2007, AM J EPIDEMIOL, V165, P1055, DOI 10.1093/aje/kwk114; McClure S ., 2012, ENCY BODY IMAGE HUMA, P89; Nicolaou M, 2008, PUBLIC HEALTH NUTR, V11, P1332, DOI 10.1017/S1368980008002966; Nolan LJ, 2016, APPETITE, V102, P15, DOI 10.1016/j.appet.2016.01.027; Overstreet NM, 2010, SEX ROLES, V63, P91, DOI 10.1007/s11199-010-9792-4; Petti YM, 2011, J AM ACAD NURSE PRAC, V23, P84, DOI 10.1111/j.1745-7599.2010.00581.x; Pulvers K, 2013, EAT BEHAV, V14, P437, DOI 10.1016/j.eatbeh.2013.07.005; Pulvers KM, 2004, OBES RES, V12, P1641, DOI 10.1038/oby.2004.204; Renzaho AMN, 2012, QUAL HEALTH RES, V22, P740, DOI 10.1177/1049732311425051; Robinson E, 2017, OBES REV, V18, P1200, DOI 10.1111/obr.12570; Robinson E, 2015, INT J OBESITY, V39, P1721, DOI 10.1038/ijo.2015.143; RStudio Team, 2018, RSTUDIO INT DEV R; Schumann M, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2020.100539; Smith DE, 1999, INT J EAT DISORDER, V25, P71, DOI 10.1002/(SICI)1098-108X(199901)25:1&lt;71::AID-EAT9&gt;3.0.CO;2-3; Snijder MB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017873; Snooks Margaret K, 2002, Health Care Women Int, V23, P460, DOI 10.1080/073993302760190065; Sonneville KR, 2016, INT J EAT DISORDER, V49, P937, DOI 10.1002/eat.22565; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Swami V, 2012, BODY IMAGE, V9, P559, DOI 10.1016/j.bodyim.2012.05.006; Tingley D., 2014, MEDIATION R PACKAGE; Toselli S, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0184-6; Turkson-Ocran RAN, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.013220; Vertovec S., 2010, INT SOC SCI J, V199, P83, DOI DOI 10.1111/J.1468-2451.2010.01749.X; Yates A, 2004, J ADOLESCENT HEALTH, V34, P300, DOI 10.1016/j.jadohealth.2003.07.014	49	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252054	10.1371/journal.pone.0252054	http://dx.doi.org/10.1371/journal.pone.0252054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038446	gold, Green Published			2022-12-26	WOS:000664633500041
J	Richard, E; Bourhy, P; Picardeau, M; Moulin, L; Wurtzer, S				Richard, Elise; Bourhy, Pascale; Picardeau, Mathieu; Moulin, Laurent; Wurtzer, Sebastien			Effect of disinfection agents and quantification of potentially viable Leptospira in fresh water samples using a highly sensitive integrity-qPCR assay	PLOS ONE			English	Article							REAL-TIME PCR; ESCHERICHIA-COLI; PROPIDIUM MONOAZIDE; INACTIVATION; MECHANISMS; OUTBREAK; SURFACE; GROWTH; SPP.	Leptospirosis is an emerging worldwide zoonotic disease, but the general biology of the causative agents is still poorly understood. Humans are an occasional host. The main risk factors are water-associated exposure during professional or recreational activities or during outbreaks in endemic areas. Detecting the presence of pathogenic bacteria in aquatic environments and their capacity to resist various inactivation processes are research fields that need to be further developed. In addition, the methods used for detecting and enumerating Leptospira still need to be improved. We aimed to describe a new quantitative polymerase chain reaction coupled to propidium monoazide treatment (PMAqPCR) that targets not only total Leptospira but also discriminates pathogenic from non-pathogenic Leptospira while also addressing PCR inhibitors, a frequently encountered problem when studying environmental water. In a second step, the killing efficiency of Leptospira to different treatments was tested and PMAqPCR compared to culture-based enumeration. This provided information about the effects of temperature, as well as ultraviolet and chlorine disinfection, that are both related to water treatment processes, in particular for the production of drinking water, on the persistence of both saprophytic and pathogenic Leptospira. Finally, PMAqPCR was used for the detection of Leptospira in freshwater samples for a proof-of-concept. In conclusion, our method could be used for routine freshwater monitoring and allows better evaluation of the presence of Leptospira, allowing evaluation of the bacterial dynamics in a designated area or assessment of the efficacy of water disinfection processes.	[Richard, Elise; Moulin, Laurent; Wurtzer, Sebastien] Eau Paris, DRDQE, Ivry, France; [Richard, Elise; Bourhy, Pascale; Picardeau, Mathieu] Inst Pasteur, Unite Biol Spirochetes, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Moulin, L (corresponding author), Eau Paris, DRDQE, Ivry, France.; Picardeau, M (corresponding author), Inst Pasteur, Unite Biol Spirochetes, Paris, France.	mathieu.picardeau@pasteur.fr; laurent.moulin@eaudeparis.fr		wurtzer, sebastien/0000-0002-9628-1075; Moulin, Laurent/0000-0001-5162-7215	DIM 1Health 2017 from Ile-de-France region	DIM 1Health 2017 from Ile-de-France region	This work is part of the PhD thesis of E. R., who received financial support from the "DIM 1Health 2017 from Ile-de-France region". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulmawjood A, 2002, MOL CELL PROBE, V16, P335, DOI 10.1006/mcpr.2002.0431; Abgueguen P, 2008, J INFECTION, V57, P171, DOI 10.1016/j.jinf.2008.06.010; Adler B, 2015, CURR TOP MICROBIOL, V387, P1, DOI 10.1007/978-3-662-45059-8; Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Ali MRM, 2018, MOL CELL PROBE, V38, P1, DOI 10.1016/j.mcp.2018.03.001; Andre-Fontaine G, 2015, CURR MICROBIOL, V71, P136, DOI 10.1007/s00284-015-0836-4; [Anonymous], 2003, LANCET INFECT DIS, DOI DOI 10.1016/S1473-3099(03)00830-2; Barragan VA, 2011, CURR MICROBIOL, V62, P1802, DOI 10.1007/s00284-011-9931-3; Bierque E, 2020, CURR MICROBIOL, V77, P3035, DOI 10.1007/s00284-020-02128-7; Biscornet L., OBSERVATIONAL STUDY, V10; Bourhy P., DIAGNOSTIC SURVEILLA, V7; Bouscaren N., 2019, New Microbes and New Infections, V29, P100518, DOI 10.1016/j.nmni.2019.100518; Bridges DF, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00888; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CACCIAPUOTI B, 1987, AM J EPIDEMIOL, V126, P535, DOI 10.1093/oxfordjournals.aje.a114686; Casanovas-Massana A, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/aem.00507-18, 10.1128/AEM.00507-18]; Chakraborty A, 2011, MICROBIOL IMMUNOL, V55, P494, DOI 10.1111/j.1348-0421.2011.00347.x; CHANG SL, 1948, J INFECT DIS, V82, P256, DOI 10.1093/infdis/82.3.256; Cho M, 2010, WATER RES, V44, P3410, DOI 10.1016/j.watres.2010.03.017; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Coudray-Meunier C, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-216; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Faine S., 1999, MEDISCI; FUKUNAGA M, 1989, J BACTERIOL, V171, P5763, DOI 10.1128/jb.171.11.5763-5767.1989; Gensberger ET, 2014, WATER RES, V67, P367, DOI 10.1016/j.watres.2014.09.022; Goarant C, 2016, RES REP TROP MED, V7, P49, DOI 10.2147/RRTM.S102543; Gokmen TG, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658064; Golpayegani Abdolali, 2019, J Environ Health Sci Eng, V17, P407, DOI 10.1007/s40201-019-00359-w; Guillois Y, 2018, EUROSURVEILLANCE, V23, P12, DOI 10.2807/1560-7917.ES.2018.23.48.1700848; Huang KL, 2014, ECOTOX ENVIRON SAFE, V109, P15, DOI 10.1016/j.ecoenv.2014.07.029; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Joshi YP, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2506-6; Karim MR, 2015, J VIROL METHODS, V219, P51, DOI 10.1016/j.jviromet.2015.02.020; Kazama S., 2013, J WATER ENV TECHNOL, V11, P507, DOI [10.2965/jwet.2013.507, DOI 10.2965/JWET.2013.507]; Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Loureiro AP, 2015, LETT APPL MICROBIOL, V61, P603, DOI 10.1111/lam.12501; Mizozoe M, 2019, WATER-SUI, V11, DOI 10.3390/w11102156; Morgan J, 2002, CLIN INFECT DIS, V34, P1593, DOI 10.1086/340615; Munoz-Zanzi C, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.78; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Palaniappan RUM, 2005, MOL CELL PROBE, V19, P111, DOI 10.1016/j.mcp.2004.10.002; Pappas G, 2008, INT J INFECT DIS, V12, P351, DOI 10.1016/j.ijid.2007.09.011; Perez LJ, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00457; Pijnacker R, 2016, EUROSURVEILLANCE, V21, P23, DOI 10.2807/1560-7917.ES.2016.21.17.30211; Podgorsek D, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01744-4; Prevost B, 2016, WATER RES, V91, P68, DOI 10.1016/j.watres.2015.12.049; Prevost B, 2015, ENVIRON INT, V79, P42, DOI 10.1016/j.envint.2015.03.004; Ramakrishnan R, 2003, J Commun Dis, V35, P1; Roussel C, 2018, APPL MICROBIOL BIOT, V102, P9793, DOI 10.1007/s00253-018-9380-z; Schaechter M, 2001, MICROBIOL MOL BIOL R, V65, P119, DOI 10.1128/MMBR.65.1.119-130.2001; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; Stoddard RA, 2009, DIAGN MICR INFEC DIS, V64, P247, DOI 10.1016/j.diagmicrobio.2009.03.014; Thibeaux R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005414; Tique V, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6473851; Vincent AT, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007270; Virto R, 2005, APPL ENVIRON MICROB, V71, P5022, DOI 10.1128/AEM.71.9.5022-5028.2005; Waggoner JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112356; Wurtzer S, 2014, J VIROL METHODS, V209, P47, DOI 10.1016/j.jviromet.2014.08.016; Xu LM, 2018, J ENVIRON SCI-CHINA, V65, P356, DOI 10.1016/j.jes.2017.07.006	61	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251901	10.1371/journal.pone.0251901	http://dx.doi.org/10.1371/journal.pone.0251901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038443	gold, Green Published			2022-12-26	WOS:000664633500032
J	Dohi, T; Ohmura, Y; Yoshimura, K; Sasaki, T; Fujiwara, K; Kanaizuka, S; Nakama, S; Iijima, K				Dohi, Terumi; Ohmura, Yoshihito; Yoshimura, Kazuya; Sasaki, Takayuki; Fujiwara, Kenso; Kanaizuka, Seiichi; Nakama, Shigeo; Iijima, Kazuki			Radiocaesium accumulation capacity of epiphytic lichens and adjacent barks collected at the perimeter boundary site of the Fukushima Dai-ichi Nuclear Power Station	PLOS ONE			English	Article							NATURAL RADIONUCLIDES; HEAVY-METALS; 3 REGIONS; PLANT; CHERNOBYL; CS-137; BIOMONITORS; CLADONIA; SOIL; CESIUM-137	We investigated the radiocaesium content of nine epiphytic foliose lichens species and the adjacent barks of Zelkova serrata (Ulmaceae, "Japanese elm") and Cerasus sp. (Rosaceae, "Cherry tree") at the boundary of the Fukushima Dai-ichi Nuclear Power Station six years after the accident in 2011. Caesium-137 activities per unit area (the Cs-137-inventory) were determined to compare radiocaesium retentions of lichens (65 specimens) and barks (44 specimens) under the same growth conditions. The Cs-137-inventory of lichens collected from Zelkova serrata and Cerasus sp. were respectively 7.9- and 3.8-times greater than the adjacent barks. Furthermore, we examined the radiocaesium distribution within these samples using autoradiography and on the surfaces with an electron probe micro analyzer (EPMA). Autoradiographic results showed strong local spotting and heterogeneous distributions of radioactivity in both the lichen and bark samples, although the intensities were lower in the barks. The electron microscopy analysis demonstrated that particulates with similar sizes and compositions were distributed on the surfaces of the samples. We therefore concluded that the lichens and barks could capture fine particles, including radiocaesium particles. In addition, radioactivity was distributed more towards the inwards of the lichen samples than the peripheries. This suggests that lichen can retain Cs-137 that is chemically immobilised in particulates intracellularly, unlike bark.	[Dohi, Terumi; Fujiwara, Kenso; Iijima, Kazuki] Japan Atom Energy Agcy, Sect Fukushima Res & Dev, Fukushima, Japan; [Ohmura, Yoshihito] Natl Museum Nat & Sci, Dept Bot, Ibaraki, Japan; [Yoshimura, Kazuya; Nakama, Shigeo] Japan Atom Energy Agcy, Sect Fukushima Res & Dev, Minamisoma, Fukushima, Japan; [Sasaki, Takayuki] Kyoto Univ, Dept Nucl Engn, Kyoto, Japan; [Kanaizuka, Seiichi] Nucl Engn Co Ltd, Ibaraki, Japan	Japan Atomic Energy Agency; National Museum of Nature and Science; Japan Atomic Energy Agency; Kyoto University	Dohi, T (corresponding author), Japan Atom Energy Agcy, Sect Fukushima Res & Dev, Fukushima, Japan.	dohi.terumi@jaea.go.jp	Yoshimura, Kazuya/N-9508-2015; Iijima, Kazuki/AFV-1268-2022	Yoshimura, Kazuya/0000-0001-5256-2679; Ohmura, Yoshihito/0000-0003-2557-2761	Japan Atomic Energy Agency; MEXT Nuclear Energy SAMP;T and Human Resource Development Project through Concentrating Wisdom Grant [JPMX15D15664655]; JSPS [16K12627]	Japan Atomic Energy Agency(Japan Atomic Energy Agency); MEXT Nuclear Energy SAMP;T and Human Resource Development Project through Concentrating Wisdom Grant; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by an internal budget of Japan Atomic Energy Agency for the Fukushima reconstruction research activity. This research was supported by the MEXT Nuclear Energy S&T and Human Resource Development Project through Concentrating Wisdom Grant Number JPMX15D15664655 operated by KI, and Grant-in-Aid for Challenging Exploratory Research of JSPS (no.16K12627) operated by TD. These funders did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. They provided only financial support in the research materials in this study. Nuclear Engineering Co., Ltd. employed SK, this commercial affiliation did not play a role in this study.	Adachi K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02554; [Anonymous], 2002, NATO SCI S SS IV EAR; Aoki D, 2017, SCI TOTAL ENVIRON, V584, P88, DOI 10.1016/j.scitotenv.2017.01.159; Armstrong RA, 1997, SYMBIOSIS, V22, P293; Backor M, 2009, BIOL PLANTARUM, V53, P214, DOI 10.1007/s10535-009-0042-y; Belivermis M, 2010, APPL RADIAT ISOTOPES, V68, P2433, DOI 10.1016/j.apradiso.2010.07.010; Belivermis M, 2010, J ENVIRON RADIOACTIV, V101, P945, DOI 10.1016/j.jenvrad.2010.06.012; BIAZROV LG, 1994, SCI TOTAL ENVIRON, V157, P25, DOI 10.1016/0048-9697(94)90561-4; BROWNRIDGE JD, 1985, B ENVIRON CONTAM TOX, V35, P193, DOI 10.1007/BF01636498; Burger A, 2018, SCI TOTAL ENVIRON, V618, P1459, DOI 10.1016/j.scitotenv.2017.09.298; Chant LA, 1996, APPL RADIAT ISOTOPES, V47, P933, DOI 10.1016/S0969-8043(96)00090-5; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; COLLINS CR, 1978, NEW PHYTOL, V81, P71, DOI 10.1111/j.1469-8137.1978.tb01605.x; Dohi T., 2019, ENV RADIOCHEMICAL AN, P58; Dohi T, 2015, J ENVIRON RADIOACTIV, V146, P125, DOI 10.1016/j.jenvrad.2015.04.013; ECKL P, 1984, NORD J BOT, V4, P521, DOI 10.1111/j.1756-1051.1984.tb02058.x; Fukushima Prefecture, 2012, ENV RAD LEV NUCL POW; Galhardi JA, 2017, J ENVIRON RADIOACTIV, V167, P43, DOI 10.1016/j.jenvrad.2016.11.009; GARTY J, 1979, NEW PHYTOL, V82, P159, DOI 10.1111/j.1469-8137.1979.tb07571.x; Garty J, 2001, CRIT REV PLANT SCI, V20, P309, DOI 10.1016/S0735-2689(01)80040-X; Godoy JM, 1998, J ENVIRON RADIOACTIV, V41, P33, DOI 10.1016/S0265-931X(97)00084-2; Hale M.E., 1973, LICHENS, P473; Heinrich G, 1999, J ENVIRON RADIOACTIV, V45, P13, DOI 10.1016/S0265-931X(98)00069-1; HVINDEN T, 1961, NATURE, V192, P1144, DOI 10.1038/1921144a0; Imamura N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08261-x; Jahnke, 1990, BIBLIOTHECA LICHENOL, V38, P63; JEMIMA/JSA, Z45042008 JIS JEMIMA; JERAN Z, 1995, LICHENOLOGIST, V27, P375, DOI 10.1006/lich.1995.0035; Kaduka AV, 2016, RADIATSIONNAYA GYGIE, V9, P14, DOI [10.21514/1998-426, DOI 10.21514/1998-426X-2016-9-3-14-27]; Kato H, 2019, J ENVIRON RADIOACTIV, V210, DOI 10.1016/j.jenvrad.2018.09.015; Kirchner G, 2002, ENVIRON POLLUT, V120, P145, DOI 10.1016/S0269-7491(02)00139-2; Kubota A., 2011, RES IMPROVEMENT URBA, V623, P41; Lindahl P, 2004, J ENVIRON RADIOACTIV, V73, P73, DOI 10.1016/j.jenvrad.2003.08.003; MATTSSON LJ, 1975, HEALTH PHYS, V28, P233, DOI 10.1097/00004032-197503000-00008; Meessen J, 2013, ORIGINS LIFE EVOL B, V43, P283, DOI 10.1007/s11084-013-9337-2; Mukai H, 2014, ENVIRON SCI TECHNOL, V48, P13053, DOI 10.1021/es502849e; Nash, 1996, LICHEN BIOL, V4, P42; Nash T. H, 1996, LICHEN BIOL, V12, P236; Nimis PL, 2002, NATO SCI S SS IV EAR, V7, P1; Nuclear Emergency Response Headquarters, 2011, JAP GOV IAEA MIN C N; Ohmura Y, 2015, J ENVIRON RADIOACTIV, V141, P38, DOI 10.1016/j.jenvrad.2014.11.014; Ohmura Y, 2013, LICHENOLOGIST, V45, P685, DOI 10.1017/S0024282913000431; Okumura T, 2019, CHEM LETT, V48, P1336, DOI 10.1246/cl.190581; Onda Y, 2015, J ENVIRON RADIOACTIV, V139, P300, DOI 10.1016/j.jenvrad.2014.06.002; Orange A., 2001, MICROCHEMICAL METHOD; Paatero J, 1998, J ENVIRON RADIOACTIV, V38, P223, DOI 10.1016/S0265-931X(97)00024-6; PAPASTEFANOU C, 1992, ENVIRON INT, V18, P397, DOI 10.1016/0160-4120(92)90071-B; Purvis OW, 2014, BOT STUD, V55, DOI 10.1186/1999-3110-55-23; Purvis OW, 2000, NEW PHYTOL, V147, P591, DOI 10.1046/j.1469-8137.2000.00719.x; Ramzaev V, 2014, J ENVIRON RADIOACTIV, V138, P177, DOI 10.1016/j.jenvrad.2014.09.001; RICHARDSON DHS, 1995, SYMBIOSIS, V18, P119; Sasaki Y, 2016, J ENVIRON RADIOACTIV, V161, P58, DOI 10.1016/j.jenvrad.2015.12.001; Savino F, 2017, J ENVIRON RADIOACTIV, V172, P201, DOI 10.1016/j.jenvrad.2017.03.002; Sawidis T, 1997, CAN J BOT, V75, P2216, DOI 10.1139/b97-931; Sawidis T, 2010, ECOTOX ENVIRON SAFE, V73, P1789, DOI 10.1016/j.ecoenv.2010.07.011; Sawidis T, 2009, J ENVIRON MANAGE, V90, P2620, DOI 10.1016/j.jenvman.2009.02.010; SEAWARD MRD, 1988, J ENVIRON RADIOACTIV, V7, P123, DOI 10.1016/0265-931X(88)90003-3; Shukla V., 2014, LICHENS BIOMONITOR E, P97; SLOOF JE, 1992, J ENVIRON RADIOACTIV, V16, P229, DOI 10.1016/0265-931X(92)90002-B; Steinhauser G, 2014, SCI TOTAL ENVIRON, V470, P800, DOI 10.1016/j.scitotenv.2013.10.029; Su PP, 2013, WOOD SCI TECHNOL, V47, P1083, DOI 10.1007/s00226-013-0562-7; Suchara I, 2011, SCI TOTAL ENVIRON, V409, P1927, DOI 10.1016/j.scitotenv.2011.02.019; Suno H, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87617-w; TOPCUOGLU S, 1995, J ENVIRON RADIOACTIV, V29, P157, DOI 10.1016/0265-931X(94)00069-9; VANDENBERG GJ, 1992, J ENVIRON RADIOACTIV, V17, P115, DOI 10.1016/0265-931X(92)90021-K; Wang W, 2019, RADIOCESIUM DYNAMICS, V4, P105, DOI [DOI 10.1007/978-981-13-8606-0_4, 10.1007/978-981-13-8606-0_4]; Yasukawa C, 2019, FORESTS, V10, DOI 10.3390/f10080652	67	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0251828	10.1371/journal.pone.0251828	http://dx.doi.org/10.1371/journal.pone.0251828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029330	gold, Green Published			2022-12-26	WOS:000664632800015
J	Gaudilliere, M; Marsot, C; Balaire, L; Groisne, L; Moret, M; Villar-Fimbel, S; Douek, P; Moulin, P; Charriere, S				Gaudilliere, Melanie; Marsot, Charlotte; Balaire, Laetitia; Groisne, Laure; Moret, Myriam; Villar-Fimbel, Sylvie; Douek, Philippe; Moulin, Philippe; Charriere, Sybil			Higher prevalence of incidental findings identified upon coronary calcium score assessment in type 2 and type 3 diabetes versus type 1 diabetes	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; SIGNIFICANT NONCARDIAC FINDINGS; PROGNOSTIC VALUE; ARTERY-DISEASE; CANCER	Aim Noninvasive assessment of infraclinic coronary atherosclerosis by coronary artery calcium score (CAC) measurement leads to the identification of incidental findings. The aim of this study was to determine the prevalence of incidental findings following systematic CAC assessment in diabetic patients with high cardiovascular risk, to identify the determinants, and to assess the midterm consequences of these findings in patient care. Methods 732 consecutive asymptomatic patients (187 type 1 diabetes (TD1), 482 type 2 diabetes (TD2) and 63 type 3 diabetes (TD3)) aged 60.60.7 years who had a CAC assessment by Multiple Detector Computed Tomography between 2015 and 2017 were systematically included. Clinical and biological data were collected from medical electronic files. Results 117/732 diabetic patients (16.0%) had incidental findings of which 105 (14.3%) were unknown. Incidental findings were more frequent in TD3 (23.8%) and TD2 (17.0%) than in TD1 (10.7%) (p = 0.05). 76 diabetic patients (10.4%) had lung abnormalities, mainly pulmonary nodules (31 patients, 4.2%). The other incidental finding were pericardial (1.5%), vascular (1.2%), thymic (0.7%) and digestive diseases (0.5%). 42.6% of patients with incidental findings had an additional TDM and 56.8% a specialized medical advice. In 10 patients (9.3% of incidental findings), the identification of incidental finding led to a specific treatment of the underlying disease. In multivariate analysis, microalbuminuria, type of diabetes (TD2/TD3 vs TD1) and smoking were significantly associated with incidental findings (p = 0.003; p = 0.026; p = 0.050 respectively). Conclusions Incidental findings are not rare in diabetic patients upon CAC assessment. A fraction of them are accessible to specific treatment. These findings raise the question if a systematic low dose chest TDM should be conducted in TD2 or TD3 patients and in any diabetic smokers by enlarging the window used for CAC assessment.	[Gaudilliere, Melanie; Douek, Philippe; Moulin, Philippe; Charriere, Sybil] Univ Lyon 1 Claude Bernard, Fac Med Lyon EST, Lyon, France; [Gaudilliere, Melanie; Marsot, Charlotte; Balaire, Laetitia; Groisne, Laure; Moret, Myriam; Villar-Fimbel, Sylvie; Moulin, Philippe; Charriere, Sybil] Hosp Civils Lyon, Hop Cardiovasc Louis Pradel, Malad Metabol, Fed Encolol,Diabete Nutr, Bron, France; [Douek, Philippe] Hosp Civils Lyon, Hop Louis Pradel, Serv Radiol, Bron, France; [Douek, Philippe] Univ Claude Bernard Lyon 1, CNRS, UMR 5220, Lab Carmen, Villeurbanne, France; [Moulin, Philippe; Charriere, Sybil] Univ Lyon 1, Ctr Rech Nutr Humaine Rhone Alpes, INSA Lyon, CENS,INRA U1235,INSERM U1060, Villeurbanne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Charriere, S (corresponding author), Univ Lyon 1 Claude Bernard, Fac Med Lyon EST, Lyon, France.; Charriere, S (corresponding author), Hosp Civils Lyon, Hop Cardiovasc Louis Pradel, Malad Metabol, Fed Encolol,Diabete Nutr, Bron, France.; Charriere, S (corresponding author), Univ Lyon 1, Ctr Rech Nutr Humaine Rhone Alpes, INSA Lyon, CENS,INRA U1235,INSERM U1060, Villeurbanne, France.	sybil.charriere@chu-lyon.fr	Carmen, Team2/Y-7383-2019; douek, philippe c/C-3993-2019	Carmen, Team2/0000-0001-9867-5724; Lab, Carmen/0000-0002-5935-3236; charriere, sybil/0000-0002-7695-077X	Hospices Civils de Lyon	Hospices Civils de Lyon	The authors thank Hospices Civils de Lyon for their support, the imaging department (Dr Delphine Gamondes), the nurses of the endocrinology department of Hopital Louis Pradel and Caroline Moulin for her expert editorial assistance.	Aldrovandi A, 2009, EUR RADIOL, V19, P1653, DOI 10.1007/s00330-009-1344-3; Andreini D, 2013, DIABETES CARE, V36, P1834, DOI 10.2337/dc12-2123; Becker N, 2020, INT J CANCER, V146, P1503, DOI 10.1002/ijc.32486; Brodersen J, 2020, BREATHE, V16, DOI 10.1183/20734735.0013-2020; Chow BJW, 2011, CIRC-CARDIOVASC IMAG, V4, P463, DOI 10.1161/CIRCIMAGING.111.964155; Cosentino F., 2020, EUR HEART J, V41, P255, DOI [10.1093/eurheartj/ehz486, DOI 10.1093/eurheartj/ehz486]; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P272, DOI 10.1001/jama.2018.8359; d'Othee BJ, 2008, EUR J RADIOL, V65, P449, DOI 10.1016/j.ejrad.2007.05.003; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Elgin EE, 2002, AM J CARDIOL, V90, P543, DOI 10.1016/S0002-9149(02)02533-X; Elicker BM, 2019, SEMIN ULTRASOUND CT, V40, P229, DOI 10.1053/j.sult.2018.11.010; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Gil BN, 2007, J COMPUT ASSIST TOMO, V31, P1, DOI 10.1097/01.rct.0000233125.83184.33; Greenland P, 2018, J AM COLL CARDIOL, V72, P434, DOI 10.1016/j.jacc.2018.05.027; Hadamitzky M, 2010, DIABETES CARE, V33, P1358, DOI 10.2337/dc09-2104; Haller S, 2006, AM J ROENTGENOL, V187, P105, DOI 10.2214/AJR.04.1988; Horton KM, 2002, CIRCULATION, V106, P532, DOI 10.1161/01.CIR.0000027136.56615.DE; Hunold P, 2001, EUR HEART J, V22, P1748, DOI 10.1053/euhj.2000.2586; Jacobs PCA, 2008, J COMPUT ASSIST TOMO, V32, P214, DOI 10.1097/RCT.0b013e3181585ff2; Onuma Y, 2006, J AM COLL CARDIOL, V48, P402, DOI 10.1016/j.jacc.2006.04.071; Rao VRALBV, 2019, DIABETES METAB SYND, V13, P754, DOI 10.1016/j.dsx.2018.11.054; Schragin JG, 2004, J THORAC IMAG, V19, P82, DOI 10.1097/00005382-200404000-00004; Tsilidis KK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7607; Valensi P, 2021, DIABETES METAB, V47, DOI 10.1016/j.diabet.2020.08.002; Valensi P, 2011, ARCH CARDIOVASC DIS, V104, P178, DOI 10.1016/j.acvd.2010.11.013; Van JAD, 2017, J AM SOC NEPHROL, V28, P1050, DOI 10.1681/ASN.2016091018; van Werkhoven JM, 2010, RADIOLOGY, V256, P83, DOI 10.1148/radiol.1090600	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0251693	10.1371/journal.pone.0251693	http://dx.doi.org/10.1371/journal.pone.0251693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029335	Green Published, gold			2022-12-26	WOS:000664632800009
J	Ahonkhai, AA; Aliyu, MH; Audet, CM; Bravo, M; Simmons, M; Claquin, G; Memiah, P; Fernando, AN; Carlucci, JG; Shepherd, BE; Van Rompaey, S; Yu, ZH; Gong, W; Vermund, SH; Wester, CW				Ahonkhai, Aima A.; Aliyu, Muktar H.; Audet, Carolyn M.; Bravo, Magdalena; Simmons, Melynda; Claquin, Gael; Memiah, Peter; Fernando, Anibal N.; Carlucci, James G.; Shepherd, Bryan E.; Van Rompaey, Sara; Yu, Zhihong; Gong, Wu; Vermund, Sten H.; Wester, C. William			Poor retention and care-related sex disparities among youth living with HIV in rural Mozambique	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; YOUNG-ADULTS; ADOLESCENTS; ADHERENCE; WOMEN; ENGAGEMENT; INFECTION; PREGNANCY; SERVICES	Background There are few studies that characterize sex-related differences in HIV outcomes among adolescents and young adults (AYA) 15-24 years of age. Methods We conducted a retrospective cohort study among AYA who enrolled in a comprehensive HIV program in Mozambique between 2012-2016. We assessed patients by sex and pregnancy/lactation status, comparing time to combination antiretroviral therapy (ART) initiation using Cox proportional hazard models. We employed multivariable logistic regression to investigate pre- and post-ART retention. Patients were defined as 'retained pre-ART' if they attended at least 3 of 4 required visits or started ART in the 6 months after enrollment, and 'retained post-ART' if they had any ART pickup or clinical visit during the last 90 days of the one-year follow-up period. Results Of 47,702 patients in the cohort, 81% (n = 38,511) were female and 19% (n = 9,191) were male. Of the females, 57% (n = 21,770) were non-pregnant and non-lactating (NPNL) and 43% (n = 16,741) were pregnant or lactating (PL). PL (aHR 2.64, 95%CI:2.47-2.81) and NPNL females (aHR 1.36, 95%CI:1.30-1.42) were more likely to initiate ART than males. PL females had higher odds of pre-ART retention in care (aOR 3.56, 95%CI: 3.30-3.84), as did NPNL females (aOR 1.71, 95%CI: 1.62-1.81), compared to males. This was also true for retention post-ART initiation, with higher odds for both PL (aOR 1.78, 95%CI:1.63-1.94) and NPNL females (aOR 1.50, 95%CI:1.35-1.65) compared to males. Conclusions PL females were most likely to initiate ART and remain in care post-ART in this AYA cohort, likely reflecting expansion of Option B+. Despite pregnancy and policy driven factors, we observed important sex-related disparities in this cohort. NPNL females were more likely to initiate ART and be retained in care before and after ART initiation than males. These data suggest that young males need targeted interventions to improve these important care continuum outcomes.	[Ahonkhai, Aima A.; Wester, C. William] Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37235 USA; [Ahonkhai, Aima A.; Aliyu, Muktar H.; Audet, Carolyn M.; Simmons, Melynda; Carlucci, James G.; Wester, C. William] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Aliyu, Muktar H.; Audet, Carolyn M.] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA; [Audet, Carolyn M.; Bravo, Magdalena; Claquin, Gael; Van Rompaey, Sara] Friends Global Hlth FGH, Maputo, Mozambique; [Audet, Carolyn M.] Univ Witwatersrand, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Memiah, Peter] Univ Maryland, Sch Med, Div Epidemiol & Prevent, Baltimore, MD 21201 USA; [Fernando, Anibal N.] Prov Hlth Directorate Zambezia, Quelimane, Mozambique; [Carlucci, James G.] Vanderbilt Univ, Med Ctr, Div Pediat Infect Dis, Nashville, TN USA; [Shepherd, Bryan E.; Yu, Zhihong; Gong, Wu] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN USA; [Vermund, Sten H.] Yale Univ, Yale Sch Publ Hlth, New Haven, CT USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Witwatersrand; University System of Maryland; University of Maryland Baltimore; Vanderbilt University; Vanderbilt University; Yale University	Ahonkhai, AA (corresponding author), Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37235 USA.; Ahonkhai, AA (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA.	aimalohi.a.ahonkhai@vumc.org		Ahonkhai, Aimalohi/0000-0003-0666-4767; Carlucci, James/0000-0002-3969-8544; CLAQUIN, Gael/0000-0002-5833-7461	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [U2GGH002071, U2GGH001943]; National Institute of Allergy and Infectious Diseases [K23AI106406]; National Institute of Mental Health [R25MH080665]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) in the form of Cooperative Agreements for CWW [U2GGH002071; U2GGH001943]. This study was also supported by The National Institute of Allergy and Infectious Diseases (K23AI106406) and the National Institute of Mental Health (R25MH080665) in the form of grants to AAA.	Agwu AL, 2012, J ADOLESCENT HEALTH, V50, P471, DOI 10.1016/j.jadohealth.2011.09.001; Ahonkhai AA, 2016, J ADOLESCENT HEALTH, V59, P298, DOI 10.1016/j.jadohealth.2016.05.002; [Anonymous], 2015, AVERT; [Anonymous], 2015, AVERT; [Anonymous], R LANG ENV STAT COMP; Audet CM, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0582-z; Audet CM, 2016, AIDS BEHAV, V20, P2090, DOI 10.1007/s10461-016-1341-x; Auld AF, 2014, MMWR-MORBID MORTAL W, V63, P1097; Birungi J, 2010, LANCET, V376, P1302, DOI 10.1016/S0140-6736(10)61918-6; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Chammartin F, 2018, CLIN INFECT DIS, V67, P1643, DOI 10.1093/cid/ciy347; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Kariminia Azar, 2018, J Int AIDS Soc, V21, pe25215, DOI 10.1002/jia2.25215; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Llenas-Garcia J, 2016, TROP MED INT HEALTH, V21, P1003, DOI 10.1111/tmi.12728; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Manders EJ, 2010, STUD HEALTH TECHNOL, V160, P411, DOI 10.3233/978-1-60750-588-4-411; Mane P., 2001, GENDER HIV AIDS WHAT, DOI [10.1177/0011392101496005, DOI 10.1177/0011392101496005]; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mills EJ, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001167; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Ministerio da Saude (MISAU) Instituto Nacional de Estatistica (INE) ICF, 2019, SURV IND IMM MAL HIV; Mozambique (moz)-demographics health & infant mortality, UNICEF DATA; Murphy DA, 2001, AIDS CARE, V13, P27, DOI 10.1080/09540120020018161; Myer L, 2017, JAIDS-J ACQ IMM DEF, V75, pS115, DOI [10.1097/QAI.0000000000001343, 10.1097/qai.0000000000001343]; Nuwagaba-Biribonwoha H, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25178; Porth T, 2014, DISPARITIES TRENDS A; Psaros C, 2015, CURR HIV-AIDS REP, V12, P1, DOI 10.1007/s11904-014-0252-6; Ruel TD, 2011, CLIN INFECT DIS, V53, P592, DOI 10.1093/cid/cir484; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Tenthani L, 2014, AIDS, V28, P589, DOI 10.1097/QAD.0000000000000143; UNAIDS, ENS AD LIV HIV AR LE; UNAIDS, 2015, ALL ENDADOLESCENTAID; UNPF, AD YOUTH DASHB; WHO, 2018, AD HLTH RISKS SOL; WHO, 2014, HLTH WORLDS AD 2 CHA	39	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0250921	10.1371/journal.pone.0250921	http://dx.doi.org/10.1371/journal.pone.0250921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019582	gold, Green Published			2022-12-26	WOS:000664632300016
J	Zabel, J; Przekoracka-Krawczyk, A; Olszewski, J; Michalak, KP				Zabel, Jacek; Przekoracka-Krawczyk, Anna; Olszewski, Jan; Michalak, Krzysztof Piotr			Variability of Rayleigh and Moreland test results using anomaloscope in young adults without color vision disorders	PLOS ONE			English	Article							NAGEL ANOMALOSCOPE; DEFICIENCY; GREEN; RED	Aim To validate the reference ranges proposed by the manufacturer of the Oculus HMC Anomaloscope MR for Rayleigh and Moreland tests in healthy young adults. Method The manual Rayleigh (red-green) and the Moreland (blue-green) anomaloscope tests were performed on 90 healthy subjects (54 female, 36 male, 178 eyes) residing in Poland, aged between 18-45 years, and without color vision disorders (assessed with HRR test). The analyzed parameters for both the Rayleigh and the Moreland tests were as follows: the lower (R-1/M-1) and the upper (R-2/M-2) limits; the center (R-C/M-C) and the width (R-W/M-W) of the matching ranges. Results The results of the Rayleigh test were similar to the values proposed in the anomaloscope user's manual, however, with a small shift of R-C and R-2 towards the red color. The double-peak distribution of R-2 with a small second peak (approximately at R-2 = 52) was mainly due to the measurements in male subjects (n(male) = 8, n(female) = 2), which suggests that this group might be diagnosed with subtle protanomaly. The results of the Moreland test showed a high M-W which did not correspond to the reference range described in the anomaloscope user's manual. The observed significant correlations between R-1 and M-1 suggest that the M-1 parameter seems to be the best indicator of blue vision quality. Conclusions Oculus HMC Anomaloscope MR is a sensitive tool for detection of prot-deuteranomalies but the reference ranges for young adults require a certain adjustment towards the red color. The parameters obtained for the Moreland test varied significantly between the subjects and therefore the test should not be used as is to diagnose color vision deficits in the green-blue area (tritanomaly).	[Zabel, Jacek; Przekoracka-Krawczyk, Anna; Michalak, Krzysztof Piotr] Adam Mickiewicz Univ, Fac Phys, Lab Vis Sci & Optometry, Poznan, Poland; [Zabel, Jacek; Olszewski, Jan] Univ Med Sci, Dept Bion & Bioimpendance, Lab Bion & Expt Med Biol, Poznan, Poland; [Przekoracka-Krawczyk, Anna; Michalak, Krzysztof Piotr] Adam Mickiewicz Univ, NanoBioMed Ctr, Lab Vis & Neurosci, Poznan, Poland	Adam Mickiewicz University; Adam Mickiewicz University	Michalak, KP (corresponding author), Adam Mickiewicz Univ, Fac Phys, Lab Vis Sci & Optometry, Poznan, Poland.; Michalak, KP (corresponding author), Adam Mickiewicz Univ, NanoBioMed Ctr, Lab Vis & Neurosci, Poznan, Poland.	kmichalak@amu.edu.pl	Michalak, Krzysztof Piotr/O-7865-2018	Michalak, Krzysztof Piotr/0000-0002-0267-5605; Zabel, Jacek/0000-0002-6657-8687; Przekoracka-Krawczyk, Anna/0000-0003-2401-4135; Olszewski, Jan/0000-0002-6032-3077				Bailey JE, 2004, VISUAL NEUROSCI, V21, P431, DOI 10.1017/S0952523804213463; Bimler DL, 2004, COLOR RES APPL, V29, P128, DOI 10.1002/col.10232; Drum B, 1993, COLOUR VISION DEFICI; French A., 2008, AUST ORTHOPTIC J, V40, P7; GERI GA, 1988, BEHAV RES METH INSTR, V20, P27, DOI 10.3758/BF03202598; GmbH OO., 2011, HMS AN MR I MAN, P1; Grosvenor T, 2011, OPTOMETRIA; HURVICH LM, 1957, PSYCHOL REV, V64, P384, DOI 10.1037/h0041403; Jagle H, 2005, GRAEF ARCH CLIN EXP, V243, P26, DOI 10.1007/s00417-004-0893-z; Jaint Nidhi, 2010, Indian J Physiol Pharmacol, V54, P366; JORDAN G, 1993, NATURE, V363, P546, DOI 10.1038/363546a0; Katz B, 1995, Trans Am Ophthalmol Soc, V93, P685; KOZAK LC, 1994, OPTOMETRY VISION SCI, V71, P557, DOI 10.1097/00006324-199409000-00003; Langina-Jansone Z, 2020, J OPT SOC AM A, V37, pA212, DOI 10.1364/JOSAA.382397; LUTZE M, 1990, VISION RES, V30, P149, DOI 10.1016/0042-6989(90)90134-7; MENAGE MJ, 1993, BRIT J OPHTHALMOL, V77, P68, DOI 10.1136/bjo.77.2.68; Neitz M, 2020, J OPT SOC AM A, V37, pA26, DOI 10.1364/JOSAA.381919; Niwa Y, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14079; Ong GL, 2003, BRIT J OPHTHALMOL, V87, P747, DOI 10.1136/bjo.87.6.747; Papaconstantinou D, 2009, CLIN OPHTHALMOL, V3, P251; Pohlen B, 2018, INT J PROSTHODONT, V31, P239, DOI 10.11607/ijp.5563; POKORNY J, 1981, J OPT SOC AM, V71, P1327, DOI 10.1364/JOSA.71.001327; Raman R., 2018, GMS OPJTHALMOL CASES, V8, P1; Sharpe LT, 1998, J NEUROSCI, V18, P10053; SMITH VC, 1976, VISION RES, V16, P1087, DOI 10.1016/0042-6989(76)90247-9; Squire TJ, 2005, AVIAT SPACE ENVIR MD, V76, P421; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Tibber MS, 2006, INVEST OPHTH VIS SCI, V47, P5125, DOI 10.1167/iovs.06-0393; Truksa R., 2012, MAT SCI, V18	29	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251903	10.1371/journal.pone.0251903	http://dx.doi.org/10.1371/journal.pone.0251903			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019572	Green Published, gold			2022-12-26	WOS:000664632300039
J	Hartmann, AM; Fu, LF; Ziegler, C; Winklhofer, M; Nothwang, HG				Hartmann, Anna-Maria; Fu, Lifei; Ziegler, Christine; Winklhofer, Michael; Nothwang, Hans Gerd			Structural changes in the extracellular loop 2 of the murine KCC2 potassium chloride cotransporter modulate ion transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; CRYO-EM STRUCTURES; PHYSIOLOGY; HYPEREXCITABILITY; IDENTIFICATION; DISRUPTION; MECHANISM; TERMINUS; ISOFORM; BRAIN	K+-Cl- cotransporters (KCCs) play important roles in physiological processes such as inhibitory neurotransmission and cell-volume regulation. KCCs exhibit significant variations in K+ affinities, yet recent atomic structures demonstrated that K+- and Cl--binding sites are highly conserved, raising the question of whether additional structural elements may contribute to ion coordination. The termini and the large extracellular domain (ECD) of KCCs exhibit only low sequence identity and were already discussed as modulators of transport activity. Here, we used the extracellular loop 2 (EL2) that links transmembrane helices (TMs) 3 and 4, as a mechanism to modulate ECD folding. We compared consequences of point mutations in the K+-binding site on the function of WT KCC2 and in a KCC2 variant, in which EL2 was structurally altered by insertion of a IFYPYDVPDYAGYPYDVPDYAGSY-PYDVPDYAAHAAA (3xHA) tag (36 amino acids). In WT KCC2, individual mutations of five residues in the K+-binding site resulted in a 2- to 3-fold decreased transport rate. However, the same mutations in the KCC2 variant with EL2 structurally altered by insertion of a 3xHA tag had no effect on transport activity. Homology models of mouse KCC2 with the 3xHA tag inserted into EL2 using ab initio prediction were generated. The models suggest subtle conformational changes occur in the ECD upon EL2 modification. These data suggest that a conformational change in the ECD, for example, by interaction with EL2, might be an elegant way to modulate the K+ affinity of the different isoforms in the KCC subfamily.	[Hartmann, Anna-Maria; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Div Neurogenet, Sch Med & Hlth Sci, Oldenburg, Germany; [Hartmann, Anna-Maria; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany; [Fu, Lifei; Ziegler, Christine] Univ Regensburg, Fac Biol & Preclin Med, Biophys 2, Biophys 2 Struct Biol, Regensburg, Germany; [Winklhofer, Michael] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, IBU, Oldenburg, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Ctr Excellence Hearing4all, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; University of Regensburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Div Neurogenet, Sch Med & Hlth Sci, Oldenburg, Germany.; Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany.	anna.maria.hartmann@uol.de	Winklhofer, Michael/B-7349-2009	Winklhofer, Michael/0000-0003-1352-9723; Ziegler, Christine Maria/0000-0003-3439-7213; Nothwang, Hans Gerd/0000-0001-7695-6437	Deutsche Forschungsgemeinschaft [HA 6338/2-1, NO428/14-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants HA 6338/2-1 to A. -M. H. and NO428/14-1 to H. G. N.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Acton BA, 2012, J NEUROSCI, V32, P8746, DOI 10.1523/JNEUROSCI.6089-11.2012; Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Chew TA, 2019, NATURE, V572, P488, DOI 10.1038/s41586-019-1438-2; Chi X., 2020, MOLECULAR BASIS REGU, DOI [10.1101/2020.02.22.960815, DOI 10.1101/2020.02.22.960815]; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Cordshagen A, 2018, J BIOL CHEM, V293, P16984, DOI 10.1074/jbc.RA118.004349; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 2020, AM J PHYSIOL-CELL PH, V318, pC225, DOI 10.1152/ajpcell.00465.2019; Di Fulvio M, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P169; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gerelsaikhan T, 2000, J BIOL CHEM, V275, P40471, DOI 10.1074/jbc.M007751200; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Hartmann AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179968; Hartmann AM, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00470; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Liu S, 2019, SCIENCE, V366, P505, DOI 10.1126/science.aay3129; Markkanen M, 2014, J COMP NEUROL, V522, P1897, DOI 10.1002/cne.23510; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Merner ND, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00386; Arroyo JP, 2013, MOL ASPECTS MED, V34, P288, DOI 10.1016/j.mam.2012.05.002; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Puskarjov M., 2014, NEUROPHARMACOLOGY, V32, P11356; R Core Team, 2021, R LANGUAGE ENV STAT; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Reid MS, 2020, ELIFE, V9, DOI 10.7554/eLife.52505; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Weber M, 2014, J BIOL CHEM, V289, P18668, DOI 10.1074/jbc.M114.567834; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Xie Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5883; Yang X., 2020, NAT COMMUN, V11, P1; Zhang S., 2021, COMMUN BIOL, V4, P1; Zhao BB, 2008, CELL SIGNAL, V20, P1769, DOI 10.1016/j.cellsig.2008.06.011; Zhao Y., 2020, BIORXIV, P1, DOI [10.1101/2020.07.26.221770, DOI 10.1101/2020.07.26.221770]	59	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100793	10.1016/j.jbc.2021.100793	http://dx.doi.org/10.1016/j.jbc.2021.100793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019872	gold, Green Published			2022-12-26	WOS:000674717300013
J	Kamm, DR; Pyles, KD; Sharpe, MC; Healy, LN; Colca, JR; McCommis, KS				Kamm, Dakota R.; Pyles, Kelly D.; Sharpe, Martin C.; Healy, Laura N.; Colca, Jerry R.; McCommis, Kyle S.			Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PYRUVATE CARRIER; PANCREATIC BETA-CELL; NONALCOHOLIC STEATOHEPATITIS; MOUSE MODEL; PPAR-GAMMA; PIOGLITAZONE; GLUCOSE; METABOLISM; SECRETION; THIAZOLIDINEDIONES	Insulin sensitizers and incretin mimetics are antidiabetic agents with vastly different mechanisms of action. Thiazolidinedione (TZD) insulin sensitizers are associated with weight gain, whereas glucagon-like peptide-1 receptor agonists can induce weight loss. We hypothesized that combination of a TZD insulin sensitizer and the glucagon-like peptide-1 receptor agonist liraglutide would more significantly improve mouse models of diabetes and nonalcoholic steatohepatitis (NASH). Diabetic db/db and MS-NASH mice were treated with the TZD MSDC-0602K by oral gavage, liraglutide (Lira) by s.c. injection, or combination 0602K+Lira. Lira slightly reduced body weight and modestly improved glycemia in db/db mice. Comparatively, 0602K-treated and 0602K+Lira-treated mice exhibited slight weight gain but completely corrected glycemia and improved glucose tolerance. 0602K reduced plasma insulin, whereas Lira further increased the hyperinsulinemia of db/db mice. Surprisingly, 0602K+Lira treatment reduced plasma insulin and C-peptide to the same extent as mice treated with 0602K alone. 0602K did not reduce glucose-stimulated insulin secretion in vivo, or in isolated islets, indicating the reduced insulinemia was likely compensatory to improved insulin sensitivity. In MS-NASH mice, both 0602K or Lira alone improved plasma alanine aminotransferase and aspartate aminotransferase, as well as liver histology, but more significant improvements were observed with 0602K+Lira treatment. 0602K or 0602K+Lira also increased pancreatic insulin content in both db/db and MS-NASH mice. In conclusion, MSDC-0602K corrected glycemia and reduced insulinemia when given alone, or in combination with Lira. However, 0602K+Lira combination more significantly improved glucose tolerance and liver histology, suggesting that this combination treatment may be an effective therapeutic strategy for diabetes and NASH.	[Kamm, Dakota R.; Pyles, Kelly D.; Sharpe, Martin C.; McCommis, Kyle S.] St Louis Univ, Sch Med, Biochem & Mol Biol, St Louis, MO 63104 USA; [Healy, Laura N.] LNH Tox Path Consulting LLC, Newbury Pk, CA USA; [Colca, Jerry R.] Cirius Therapeut, Kalamazoo, MI USA; [Colca, Jerry R.] Cirius Therapeut, San Diego, CA USA	Saint Louis University	McCommis, KS (corresponding author), St Louis Univ, Sch Med, Biochem & Mol Biol, St Louis, MO 63104 USA.	kyle.mccommis@health.slu.edu		Colca, Jerry/0000-0003-3933-8626; Pyles, Kelly/0000-0001-9478-3365; Kamm, Dakota/0000-0003-3096-8429; McCommis, Kyle/0000-0003-2381-1589	NIH [R00 HL136658]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K. S. M. is supported by NIH R00 HL136658. The db/db study and analyses received no specific grant funding from any public or commercial agency. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdulreda MH, 2016, CELL METAB, V23, P541, DOI 10.1016/j.cmet.2016.01.009; Adams MD, 1998, BIOCHEM PHARMACOL, V55, P1915, DOI 10.1016/S0006-2952(98)00052-5; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Buganova M, 2017, J ENDOCRINOL, V233, P93, DOI 10.1530/JOE-16-0478; Campbell IW, 2007, DIABETES RES CLIN PR, V76, P163, DOI 10.1016/j.diabres.2006.08.015; Chareyron I, 2020, DIABETOLOGIA, V63, P2628, DOI 10.1007/s00125-020-05275-5; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Colca JR, 2013, CLIN PHARMACOL THER, V93, P352, DOI 10.1038/clpt.2013.10; Colca JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061551; Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Diani AR, 2004, AM J PHYSIOL-ENDOC M, V286, pE116, DOI 10.1152/ajpendo.00331.2003; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Duparc T, 2019, AM J PHYSIOL-GASTR L, V317, pG508, DOI 10.1152/ajpgi.00139.2019; Eguchi Y, 2015, HEPATOL RES, V45, P269, DOI 10.1111/hepr.12351; Fukunaga T, 2015, J BONE MINER RES, V30, P508, DOI 10.1002/jbmr.2364; Harrison SA, 2020, J HEPATOL, V72, P613, DOI 10.1016/j.jhep.2019.10.023; Kalavalapalli S, 2018, AM J PHYSIOL-ENDOC M, V315, pE163, DOI 10.1152/ajpendo.00023.2018; Kimura T, 2015, MOL CELL ENDOCRINOL, V400, P78, DOI 10.1016/j.mce.2014.11.018; Lamontagne J, 2013, DIABETES, V62, P2122, DOI 10.2337/db12-0428; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Larsen PJ, 2008, DIABETES OBES METAB, V10, P301, DOI 10.1111/j.1463-1326.2008.00865.x; Matsui J, 2004, DIABETES, V53, P2844, DOI 10.2337/diabetes.53.11.2844; McCommis KS, 2017, HEPATOLOGY, V65, P1543, DOI 10.1002/hep.29025; McCommis KS, 2016, MOL METAB, V5, P602, DOI 10.1016/j.molmet.2016.06.016; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; Miyazaki Y, 2002, DIABETES CARE, V25, P517, DOI 10.2337/diacare.25.3.517; Musso G, 2017, JAMA INTERN MED, V177, P633, DOI 10.1001/jamainternmed.2016.9607; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, V8th; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V38, P1008, DOI 10.1053/jhep.2003.50420; Newsome PN, 2021, NEW ENGL J MED, V384, P1113, DOI 10.1056/NEJMoa2028395; Patterson JN, 2014, J BIOL CHEM, V289, P13335, DOI 10.1074/jbc.M113.521666; Qian X, 2018, DIABETES THER, V9, P815, DOI 10.1007/s13300-018-0401-9; Raman P, 2000, EUR J PHARMACOL, V409, P19, DOI 10.1016/S0014-2999(00)00806-2; Raman P, 1998, LIFE SCI, V62, pPL89, DOI 10.1016/S0024-3205(97)01177-6; Rohatgi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062012; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Somm E, 2021, TRANSL RES, V227, P75, DOI 10.1016/j.trsl.2020.07.008; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tozzo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126642; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593	44	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100807	10.1016/j.jbc.2021.100807	http://dx.doi.org/10.1016/j.jbc.2021.100807			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022222	gold, Green Published			2022-12-26	WOS:000674717300024
J	Eaves, ER; Barber, J; Whealy, R; Clancey, SA; Wright, R; Cocking, JH; Spadafino, J; Hepp, CM				Eaves, Emery R.; Barber, Jarrett; Whealy, Ryann; Clancey, Sara A.; Wright, Rita; Cocking, Jill Hager; Spadafino, Joseph; Hepp, Crystal M.			Characterization of neonatal opioid withdrawal syndrome in Arizona from 2010-2017	PLOS ONE			English	Article							ABSTINENCE SYNDROME; PREGNANT-WOMEN; MAINTENANCE THERAPY; SUBSTANCE USE; PREDICTORS; MANAGEMENT; MEDICATION; ANALGESIA; SMOKING; COCAINE	In this paper, we describe a population of mothers who are opioid dependent at the time of giving birth and neonates exposed to opioids in utero who experience withdrawal following birth. While there have been studies of national trends in this population, there remains a gap in studies of regional trends. Using data from the Arizona Department of Health Services Hospital Discharge Database, this study aimed to characterize the population of neonates with neonatal opioid withdrawal syndrome (NOWS) and mothers who were opioid dependent at the time of giving birth, in Arizona. We analyzed approximately 1.2 million electronic medical records from the Arizona Department of Health Services Hospital Discharge Database to identify patterns and disparities across socioeconomic, ethnic, racial, and/or geographic groupings. In addition, we identified comorbid conditions that are differentially associated with NOWS in neonates or opioid dependence in mothers. Our analysis was designed to assess whether indicators such as race/ethnicity, insurance payer, marital status, and comorbidities are related to the use of opioids while pregnant. Our findings suggest that women and neonates who are non-Hispanic White and economically disadvantaged, tend be part of our populations of interest more frequently than expected. Additionally, women who are opioid dependent at the time of giving birth are unmarried more often than expected, and we suggest that marital status could be a proxy for support. Finally, we identified comorbidities associated with neonates who have NOWS and mothers who are opioid dependent not previously reported.	[Eaves, Emery R.] No Arizona Univ, Dept Anthropol, Flagstaff, AZ 86011 USA; [Eaves, Emery R.] No Arizona Univ, Ctr Hlth Equity Res, Flagstaff, AZ 86011 USA; [Eaves, Emery R.; Barber, Jarrett; Hepp, Crystal M.] No Arizona Univ, Southwest Hlth Equity Res Collaborat, Flagstaff, AZ 86011 USA; [Barber, Jarrett; Whealy, Ryann; Cocking, Jill Hager; Hepp, Crystal M.] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA; [Whealy, Ryann; Cocking, Jill Hager; Hepp, Crystal M.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA; [Clancey, Sara A.] No Arizona Univ, Inst Human Dev, Flagstaff, AZ 86011 USA; [Wright, Rita] No Arizona Univ, Dept Social Work, Flagstaff, AZ 86011 USA; [Spadafino, Joseph] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA	Northern Arizona University; Northern Arizona University; Northern Arizona University; Northern Arizona University; Northern Arizona University; Northern Arizona University; Northern Arizona University; Arizona Department of Health Services	Hepp, CM (corresponding author), No Arizona Univ, Southwest Hlth Equity Res Collaborat, Flagstaff, AZ 86011 USA.; Hepp, CM (corresponding author), No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA.; Hepp, CM (corresponding author), No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA.	crystal.hepp@nau.edu		Hepp, Crystal/0000-0002-0612-3648; Whealy, Ryann/0000-0002-8113-411X	NIH/NIMHD RCMI [U54MD012388]	NIH/NIMHD RCMI	This work was supported by a Pilot grant project to Crystal Hepp, Ph.D. as part of the NIH/NIMHD RCMI U54MD012388 (Julie Baldwin, Ph.D. PI). The authors acknowledge the contributions of Arizona Department of Health Services staff members Kyle Gardner and Timothy Flood for assistance defining the data request, the Northern Arizona University Information Technology Services for managing data security issues, and the Southwest Health Equity Research Collaborative Research Infrastructure Core for analytical assistance.	Admon LK, 2019, AM J PUBLIC HEALTH, V109, P148, DOI [10.2105/AJPH.2018.304771, 10.2105/ajph.2018.304771]; Akerman SC, 2015, J SUBST ABUSE TREAT, V52, P40, DOI 10.1016/j.jsat.2014.12.002; [Anonymous], 2016, DATA DOCUMENTATION S; Arizona Department of Health Services, 2019, OP EP; Arizona Department of Health Services, 2016, AR OP REP; Atwell Karina A, 2016, WMJ, V115, P287; Azuine RE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6405; Bagley SM, 2014, ADDICT SCI CLIN PRAC, V9, DOI 10.1186/1940-0640-9-19; Bagwell GA, 2016, NEONATAL NETW, V35, P1, DOI 10.1891/0730-0832.35.S1.1; Beattie MC, 1997, ADDICTION, V92, P1507; Bersani I., 2013, EARLY HUM DEV, V89, pS85, DOI [10.1016/S0378-3782(13)70112-9, DOI 10.1016/S0378-3782(13)70112-9]; Brown JD, 2018, RES SOC ADMIN PHARM, V14, P617, DOI 10.1016/j.sapharm.2018.03.001; Brown Joshua D, 2018, J Rural Health, V34, P6, DOI 10.1111/jrh.12251; Burnette T, 2019, J MATERN-FETAL NEO M, V32, P3415, DOI 10.1080/14767058.2018.1465038; Cassidy B, 2004, ANAESTH INTENS CARE, V32, P494, DOI 10.1177/0310057X0403200406; Chen C, 2004, TECH REPORT USING RA; Chisolm MS, 2013, NICOTINE TOB RES, V15, P1297, DOI 10.1093/ntr/nts274; Cleveland C., 2018, PREGNANT ADDICTED OP; Corr TE, 2017, ADDICTION, V112, P1590, DOI 10.1111/add.13842; Coyle MG, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0045-0; Dobkin PL, 2002, ADDICTION, V97, P347, DOI 10.1046/j.1360-0443.2002.00083.x; Farr A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1003-z; Filippelli Amanda C, 2012, Glob Adv Health Med, V1, P48; Gomez-Pomar E, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00033; HAVASSY BE, 1995, ADDICTION, V90, P699, DOI 10.1046/j.1360-0443.1995.90569911.x; Heinz AJ, 2009, ADDICT BEHAV, V34, P258, DOI 10.1016/j.addbeh.2008.10.020; Hoyt MR, 2018, INT J OBSTET ANESTH, V34, P67, DOI 10.1016/j.ijoa.2018.01.001; Hussaini KS, 2018, MATERN CHILD HLTH J, V22, P1352, DOI 10.1007/s10995-018-2517-y; Ishwaran H., 2020, FAST UNIFIED RANDOM; Ishwaran H, 2010, J AM STAT ASSOC, V105, P205, DOI 10.1198/jasa.2009.tm08622; Jansson Lauren M, 2009, J Opioid Manag, V5, P47; Jones HE, 2009, AM J DRUG ALCOHOL AB, V35, P375, DOI 10.1080/00952990903125235; Kaltenbach K., 2018, NEONATAL ABSTINENCE; Kelly LE, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1666-9; Kocherlakota P., 2019, INFECT DIS PHARM, P243; Koppell J., 2014, ARIZONAS VULNERABLE; Maalouf FI, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2017-4183; McCarthy JJ, 2017, AM J OBSTET GYNECOL, V216, P226, DOI 10.1016/j.ajog.2016.10.003; Merline AC, 2004, AM J PUBLIC HEALTH, V94, P96, DOI 10.2105/AJPH.94.1.96; Moos RH, 2002, ADDICTION, V97, P75, DOI 10.1046/j.1360-0443.2002.00063.x; National Institute on Drug Abuse, 2018, AR OP SUMM; Patrick SW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3835; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Prabhu M, 2018, OBSTET GYNECOL, V132, P459, DOI 10.1097/AOG.0000000000002741; R Core Team, 2020, R LANG ENV STAT COMP; Robinson JN, 1999, OBSTET GYNECOL, V94, P259, DOI 10.1016/S0029-7844(99)00259-8; Sanlorenzo LA, 2018, CURR OPIN PEDIATR, V30, P182, DOI 10.1097/MOP.0000000000000589; Segal D, 2017, NEW YORK TIMES; Smith MV, 2015, MATERN CHILD HLTH J, V19, P548, DOI 10.1007/s10995-014-1536-6; Stabler ME, 2017, J RURAL HEALTH, V33, P92, DOI 10.1111/jrh.12174; Stone W., 2016, PRESCOTT GRAPPLING C; Strahan AE, 2020, JAMA PEDIATR, V174, P200, DOI 10.1001/jamapediatrics.2019.4791; Villapiano NLG, 2017, JAMA PEDIATR, V171, P194, DOI 10.1001/jamapediatrics.2016.3750; Winkelman TNA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3520	54	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0248476	10.1371/journal.pone.0248476	http://dx.doi.org/10.1371/journal.pone.0248476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QS	34081702	gold, Green Published			2022-12-26	WOS:000664639200002
J	Herbut, A				Herbut, Aneta			Wave generator as an alternative for classic and innovative wave transmission path vibration mitigation techniques	PLOS ONE			English	Article							GROUND VIBRATIONS; SCREENING EFFECTIVENESS; SEISMIC METAMATERIALS; RAYLEIGH-WAVES; IMPEDING BLOCK; REDUCTION; BARRIERS; NOISE; ATTENUATION; PROPAGATION	In this paper the author proposes an approach in the form of an active wave generator for ground surface vibration reduction. The idea is compared to classic and innovative vibration mitigation techniques. The solution is mainly addressed to prevent people and structures against the destructive effects of anthropogenic vibrations. The efficiency of the presented idea is verified in the paper for two types of excitation-harmonic and impact loads, for points located on the ground surface and below it. The vibration reduction effect for structures is presented in the paper in the case of a three-story building. The advantages and disadvantages of the presented solutions are summarized. Moreover, this paper presents a wide and up-to-date literature review on the vibration control of the ground surface. Classical well-known technologies in the form of ground obstacles are compared with innovative ideas such as metamaterials.	[Herbut, Aneta] Wroclaw Univ Sci & Technol, Fac Civil Engn, Wybrzeze Wyspianskiego 27, Wroclaw, Poland	Wroclaw University of Science & Technology	Herbut, A (corresponding author), Wroclaw Univ Sci & Technol, Fac Civil Engn, Wybrzeze Wyspianskiego 27, Wroclaw, Poland.	aneta.herbut@pwr.edu.pl	Herbut, Aneta/G-6467-2018	Herbut, Aneta/0000-0001-7106-9652	WCSS Computer Centre [437]	WCSS Computer Centre	The results of numerical calculations presented in this paper have been obtained with the support of the WCSS Computer Centre, within the frame of Grant No 437.	Achaoui Y, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/aa6e21; Adam M, 2005, COMPUT STRUCT, V83, P11, DOI 10.1016/j.compstruc.2004.08.010; Albino C, 2019, ENG STRUCT, V196, DOI 10.1016/j.engstruct.2019.109340; Alzawi A, 2011, SOIL DYN EARTHQ ENG, V31, P306, DOI 10.1016/j.soildyn.2010.08.010; Andersen L, 2005, SOIL DYN EARTHQ ENG, V25, P701, DOI 10.1016/j.soildyn.2005.04.007; Ang LYL, 2017, APPL ACOUST, V122, P16, DOI 10.1016/j.apacoust.2017.02.005; [Anonymous], 1999, 41503 DIN; [Anonymous], 1992, 522841992 BS; [Anonymous], 2016, PNB02170201612; [Anonymous], 1993, 738521993 BS; Athanasopoulos GA, 2000, SOIL DYN EARTHQ ENG, V19, P371, DOI 10.1016/S0267-7261(00)00008-7; Brule S, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.133901; Buckmann T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5130; Cacciola P, 2015, SOIL DYN EARTHQ ENG, V77, P47, DOI 10.1016/j.soildyn.2015.04.006; Capolino F., 2009, THEORY PHENOMENA MET; Carcione J.M, 2001, WAVE FIELDS REAL MED; Chen XJ, 2014, SOIL DYN EARTHQ ENG, V65, P243, DOI 10.1016/j.soildyn.2014.06.019; Chen Y, 2019, MANCHUKUO PERSPECTIVES, P175, DOI 10.1016/j.matdes.2019.107813; CHOUW N, 1991, ENG ANAL BOUND ELEM, V8, P125, DOI 10.1016/0955-7997(91)90021-K; Chouw N, 1991, BAUINGENIEUR-GERMANY, V66, P215; Colombi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07151-6; Colombi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27717; Colombi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25320; Colombi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19238; Coulier P, 2015, SOIL DYN EARTHQ ENG, V77, P238, DOI 10.1016/j.soildyn.2015.04.007; Dasgupta B., 1990, COMPUT MECH, V6, P129, DOI [10.1007/BF00350518, DOI 10.1007/BF00350518]; Diatta A, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4887454; Diatta A, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/44/445101; Dijckmans A, 2016, SOIL DYN EARTHQ ENG, V84, P55, DOI 10.1016/j.soildyn.2016.02.001; Duggal SK, 2013, EARTHQUAKE RESISTANT, V13; EDWIN L, 2009, NATURE, V462, P990, DOI DOI 10.1038/462990A; Gao GY, 2006, SOIL DYN EARTHQ ENG, V26, P1015, DOI 10.1016/j.soildyn.2006.02.005; Gao GY, 2018, SOIL DYN EARTHQ ENG, V115, P507, DOI 10.1016/j.soildyn.2018.09.015; Gao GY, 2017, SOIL DYN EARTHQ ENG, V93, P99, DOI 10.1016/j.soildyn.2016.12.006; Geng Q, 2018, SOIL DYN EARTHQ ENG, V107, P264, DOI 10.1016/j.soildyn.2018.01.028; Herbut A, 2017, SOIL DYN EARTHQ ENG, V100, P573, DOI 10.1016/j.soildyn.2017.07.005; Herbut A, 2016, SOIL DYN EARTHQ ENG, V88, P328, DOI 10.1016/j.soildyn.2016.06.015; Huang JK, 2013, J SOUND VIB, V332, P4423, DOI 10.1016/j.jsv.2013.03.028; Jung W, 2019, MECH SYST SIGNAL PR, V121, P144, DOI 10.1016/j.ymssp.2018.11.003; KUSHWAHA MS, 1993, PHYS REV LETT, V71, P2022, DOI 10.1103/PhysRevLett.71.2022; Kushwaha MS, 1997, APPL PHYS LETT, V70, P3218, DOI 10.1063/1.119130; Lysmer J, 1969, J ENG MECH DIV ASCE, V95, P859, DOI 10.1061/JMCEA3.0001144; MABSOUT ME, 1994, INT J NUMER METH ENG, V37, P257, DOI 10.1002/nme.1620370206; Majumder M, 2016, KSCE J CIV ENG, V20, P2308, DOI 10.1007/s12205-015-0267-6; MARTINEZSALA R, 1995, NATURE, V378, P241, DOI 10.1038/378241a0; Mehrabi MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176480; Meseguer F, 1999, PHYS REV B, V59, P12169, DOI 10.1103/PhysRevB.59.12169; Milton GW, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/248; Mirshekarloo MS, 2018, APPL ACOUST, V137, P90, DOI 10.1016/j.apacoust.2018.03.017; Muhammad, 2019, ENG STRUCT, V188, P440, DOI 10.1016/j.engstruct.2019.03.046; Nunez IJC, 2019, APPL ACOUST, V152, P41, DOI 10.1016/j.apacoust.2019.03.024; Palermo A, 2018, SOIL DYN EARTHQ ENG, V113, P265, DOI 10.1016/j.soildyn.2018.05.035; Palermo A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39356; Peplow AT, 1999, APPL ACOUST, V56, P283, DOI 10.1016/S0003-682X(98)00031-0; Persson P, 2014, SOIL DYN EARTHQ ENG, V60, P31, DOI 10.1016/j.soildyn.2014.01.009; Pu XB, 2018, SOIL DYN EARTHQ ENG, V104, P228, DOI 10.1016/j.soildyn.2017.10.022; Ramana, 2011, PRINCIPLES SOIL DYNA; Reinhorn, 2005, ACTIVE HYBRID SEMIAC; Roux P, 2018, SEISMOL RES LETT, V89, P582, DOI 10.1785/0220170196; Rybak J, 2010, NDE FOR SAFETY: DEFEKTOSKOPIE 2010, P237; Rybak J, 2014, INT MULTI SCI GEOCO, P1043; Saikia A, 2014, EARTHQ ENG ENG VIB, V13, P545, DOI 10.1007/s11803-014-0261-x; Shamonina E., 2009, WAVES METAMATERIALS; Takemiya H, 2004, SOIL DYN EARTHQ ENG, V24, P69, DOI 10.1016/j.soildyn.2003.07.005; Tanveer M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224436; Tombari A, 2018, MECH SYST SIGNAL PR, V101, P219, DOI 10.1016/j.ymssp.2017.08.034; Tombari A, 2016, PROBABILIST ENG MECH, V44, P183, DOI 10.1016/j.probengmech.2015.11.002; Tsai PH, 2009, SOIL DYN EARTHQ ENG, V29, P865, DOI 10.1016/j.soildyn.2008.09.005; Turan A, 2013, SOIL DYN EARTHQ ENG, V55, P225, DOI 10.1016/j.soildyn.2013.09.003; Ulgen D, 2015, CONSTR BUILD MATER, V86, P12, DOI 10.1016/j.conbuildmat.2015.03.098; Verruijt A, 2010, INTRO SOIL DYNAMICS, DOI [10.1007/s10439-010-9938-0, DOI 10.1007/S10439-010-9938-0]; Woods RD, 1968, J SOIL MECH FDN DIV, V94, P951, DOI [10.1061/JSFEAQ.0001180, DOI 10.1061/JSFEAQ.0001180]; Wrana B, 2016, COMPUTATION MODELS; Wyjadlowski M, 2017, STUD GEOTECH MECH, V39, P121, DOI 10.1515/sgem-2017-0042; Xu F.H., 2016, INTELLIGENT VIBRATIO; Xu YL., 2017, SMART CIVIL STRUCTUR, DOI [10.1201/9781315368917, DOI 10.1201/9781315368917]	76	1	1	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252088	10.1371/journal.pone.0252088	http://dx.doi.org/10.1371/journal.pone.0252088			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077446	gold, Green Published			2022-12-26	WOS:000664638500026
J	Pandey, KR; Subedee, A; Khanal, B; Koirala, B				Pandey, Kiran Raj; Subedee, Anup; Khanal, Bishesh; Koirala, Bhagawan			COVID-19 control strategies and intervention effects in resource limited settings: A modeling study	PLOS ONE			English	Article							INFLUENZA; CHINA	Introduction Many countries with weaker health systems are struggling to put together a coherent strategy against the COVID-19 epidemic. We explored COVID-19 control strategies that could offer the greatest benefit in resource limited settings. Methods Using an age-structured SEIR model, we explored the effects of COVID-19 control interventions-a lockdown, physical distancing measures, and active case finding (testing and isolation, contact tracing and quarantine)-implemented individually and in combination to control a hypothetical COVID-19 epidemic in Kathmandu (population 2.6 million), Nepal. Results A month-long lockdown will delay peak demand for hospital beds by 36 days, as compared to a base scenario of no intervention (peak demand at 108 days (IQR 97-119); a 2 month long lockdown will delay it by 74 days, without any difference in annual mortality, or healthcare demand volume. Year-long physical distancing measures will reduce peak demand to 36% (IQR 23%-46%) and annual morality to 67% (IQR 48%-77%) of base scenario. Following a month long lockdown with ongoing physical distancing measures and an active case finding intervention that detects 5% of the daily infection burden could reduce projected morality and peak demand by more than 99%. Conclusion Limited resource settings are best served by a combination of early and aggressive case finding with ongoing physical distancing measures to control the COVID-19 epidemic. A lockdown may be helpful until combination interventions can be put in place but is unlikely to reduce annual mortality or healthcare demand.	[Pandey, Kiran Raj; Subedee, Anup] Hosp Adv Med & Surg, Kathmandu, Nepal; [Khanal, Bishesh] Nepal Appl Math & Informat Inst Res NAAMII, Kathmandu, Nepal; [Koirala, Bhagawan] Tribhuvan Univ, Inst Med, Kathmandu, Nepal	Tribhuvan University; Institute of Medicine (IoM) - Nepal	Pandey, KR (corresponding author), Hosp Adv Med & Surg, Kathmandu, Nepal.	kiran.krp@gmail.com		Khanal, Bishesh/0000-0002-2775-4748				Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Biswas S., 2020, BBC NEWS; Blackwood JC., 2018, LETT BIOMATH, V5, P195, DOI [10.30707/LiB5.1Blackwood, DOI 10.30707/LIB5.1BLACKWOOD]; Brauer F, 2008, LECT NOTES MATH, V1945, P19; Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9; Chung D, 2020, KOREA RESPONSE COVID; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Del Valle SY, 2013, MATH BIOSCI ENG, V10, P1475, DOI 10.3934/mbe.2013.10.1475; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Greenberg A., 2020, WIRED; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Health Emergency Operation Center, 2020, 69 HLTH EM OP CTR; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hu Y, 2020, 101056NEJMOA2001282P, DOI DOI 10.1056/NEJMOA2001282; Inseconline, 2020, COR STAT UPD SUD PAS; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Makoni M, 2020, LANCET, V395, P483, DOI 10.1016/S0140-6736(20)30355-X; New Spotlight, 2020, NEP BARS US RAP TEST; Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5; Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013574; Nyugen HK., 2020, VIETNAM LOW COST COV; Paneru H, 2020, JSAN, V7; Parmet WE, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2004211; Pradhan TR., 2020, NEPAL GOES LOCKDOWN; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Roberts M, 2015, EPIDEMICS-NETH, V10, P49, DOI [10.1016/j.epidem.2014.09.006, 10.1016/j.]; Saunders-Hastings P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179315; Schafer H, 2020, COVID 19 WILL HIT S; Singh R, 2020, AGE STRUCTURED IMPAC, DOI DOI 10.48550/ARXIV.2003.12055; The World Bank, 2020, HOSP BEDS PER 1000 P; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Vu M., 2020, SECRET VIETNAM COVID; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; WHO, 2020, COR COVID 19 EV THEY; WHO, 2020, COVID 19 STRAT UPD; Woelfel R, 2020, MEDRXIV, DOI 10.1101/2020.03.05.20030502; World Health Organization, 2020, CRIT PREP READ RESP; World Health Organization (WHO), 2020, COR DIS COVID 19 SIT; Worldometer, 2020, REP CAS DEATHS COUNT; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zastrow Mark, 2020, Nature, DOI 10.1038/d41586-020-00740-y; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	48	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252570	10.1371/journal.pone.0252570	http://dx.doi.org/10.1371/journal.pone.0252570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077483	Green Published, Green Submitted, gold			2022-12-26	WOS:000664638500050
J	Radtke, T; Rodriguez, M; Braun, J; Dressel, H				Radtke, Thomas; Rodriguez, Manuel; Braun, Julia; Dressel, Holger			Criterion validity of the ActiGraph and activPAL in classifying posture and motion in office-based workers: A cross-sectional laboratory study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BEHAVIOR; MONITORS; BREAKS	Background The ActiGraph and activPAL monitors are the most frequently used thigh-worn devices to measure motion and posture, but the criterion validity to measure sitting, standing and postural transfer in the office setting is not known. Research question: To examine the criterion validity of the ActiGraph and activPAL activity monitors in repeatedly measuring a variety of different postures and motion in the office setting. Methods Twenty office workers from the University of Zurich wore an ActiGraph and activPAL during two identical laboratory experiments lasting approximately 60 minutes each, within a maximum of 7 days. The experimental setting consisted of a standard computer office workstation with an electrically powered height-adjustable desk, a swivel chair without arm rests, a standard chair, a footrest, and a bookcase. The protocol consisted of 24 pre-defined tasks mimicking sitting, standing, stepping, and postural transitions around the workplace. All tasks were supervised and observed by the same experimenter. Results In repeated measurements (40 individual experiments), the percentages of correctly classified tasks for the ActiGraph and activPAL were, respectively, 100% vs. 85% for sitting, 87% vs. 100% for standing, and 100% vs. 73% for postural transitions. Both monitors correctly identified all stepping tasks. The activPAL misclassified sitting with legs outstretched, and sitting with both feet placed beneath the chair, as standing similar to 25-70% and 45% of the time, respectively. The ActiGraph misclassified standing with the right foot on a footrest as sitting in 65% of events. Conclusions The ActiGraph appears to be slightly more sensitive than the activPAL with respect to the measurement of sitting and postural transitions of short duration, whereas the activPAL seems to be slightly more accurate in capturing standing postures. This knowledge will help guide researchers to choose the best suitable monitor for their research setting.	[Radtke, Thomas; Rodriguez, Manuel; Dressel, Holger] Univ Zurich, Div Occupat & Environm Med Epidemiol Biostat & Pr, Zurich, Switzerland; [Radtke, Thomas; Rodriguez, Manuel; Dressel, Holger] Univ Hosp Zurich, Zurich, Switzerland; [Braun, Julia] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich	Radtke, T (corresponding author), Univ Zurich, Div Occupat & Environm Med Epidemiol Biostat & Pr, Zurich, Switzerland.; Radtke, T (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	thomas.radtke@uzh.ch		Radtke, Thomas/0000-0002-1723-1070				Actigraph, IS INCL DET THIGH WE; An HS, 2017, GAIT POSTURE, V51, P174, DOI 10.1016/j.gaitpost.2016.10.014; Bassett DR, 2014, MED SCI SPORT EXER, V46, P2025, DOI 10.1249/MSS.0000000000000326; Biddle SJH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3307-3; Clark BK, 2011, MED SCI SPORT EXER, V43, P1907, DOI 10.1249/MSS.0b013e31821820a2; Crowley P, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0835-0; Dowd KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047633; Edwardson CL, 2017, J SPORT HEALTH SCI, V6, P162, DOI 10.1016/j.jshs.2016.02.002; Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI [10.1016/s2214-109x(18)30357-7, 10.1016/S2214-109X(18)30357-7]; Koster A, 2016, MED SCI SPORT EXER, V48, P1514, DOI 10.1249/MSS.0000000000000924; Kuster RP, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10387-7; Lyden K, 2012, MED SCI SPORT EXER, V44, P2243, DOI 10.1249/MSS.0b013e318260c477; Mok A, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2323; Pfister Ted, 2017, BMJ Open Sport Exerc Med, V3, pe000227, DOI 10.1136/bmjsem-2017-000227; Prince SA, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0790-9; Shrestha N, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010912.pub4; Smith L, 2015, BMC PUBLIC HEALTH, V15, DOI [10.1186/s12889-014-1338-1, 10.1186/s12889-015-1459-1]; Stamatakis E, 2019, J AM COLL CARDIOL, V73, P2062, DOI 10.1016/j.jacc.2019.02.031; Steeves JA, 2015, MED SCI SPORT EXER, V47, P952, DOI 10.1249/MSS.0000000000000497; Sudholz B, 2018, J SCI MED SPORT, V21, P697, DOI 10.1016/j.jsams.2017.10.030; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; World Health Organization, 2013, GLOB ACT PLAN PREV C	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252659	10.1371/journal.pone.0252659	http://dx.doi.org/10.1371/journal.pone.0252659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077463	Green Published, gold			2022-12-26	WOS:000664638500060
J	Huang, LP; Ma, YL; Chen, L; Chang, J; Zhong, M; Wang, ZJ; Sun, Y; Chen, X; Sun, F; Xiao, L; Chen, JI; Lai, YJ; Yan, CM; Yue, XJ				Huang, Liping; Ma, Yanlin; Chen, Lu; Chang, Jiang; Zhong, Mei; Wang, Zhijian; Sun, Ying; Chen, Xia; Sun, Fei; Xiao, Lu; Chen, Jianing; Lai, Yingjun; Yan, Chuming; Yue, Xiaojing			Maternal RND3/RhoE deficiency impairs placental mitochondrial function in preeclampsia by modulating the PPAR gamma-UCP2 cascade	FASEB JOURNAL			English	Article						mitochondrion; oxidative stress; PPAR gamma; preeclampsia; Rnd3	ACTIVATED RECEPTOR-GAMMA; OXIDATIVE STRESS; PPAR-GAMMA; UNCOUPLING PROTEIN-2; THERAPEUTIC TARGET; GENETIC DELETION; UP-REGULATION; TROPHOBLAST; RND3; PATHOPHYSIOLOGY	Preeclampsia (PE) is a life-threatening disease of pregnant women associated with severe hypertension, proteinuria, or multi-organ injuries. Mitochondrial-mediated placental oxidative stress plays a key role in the pathogenesis of PE. However, the underlying mechanism remains to be revealed. Here, we identify Rnd3, a small Rho GTPase, regulating placental mitochondrial reactive oxygen species (ROS). We showed that Rnd3 is down-regulated in primary trophoblasts isolated from PE patients. Loss of Rnd3 in trophoblasts resulted in excessive ROS generation, cell apoptosis, mitochondrial injury, and proton leakage from the respiratory chain. Moreover, Rnd3 overexpression partially rescues the mitochondrial defects and oxidative stress in human PE primary trophoblasts. Rnd3 physically interacts with the peroxisome proliferators-activated receptor gamma (PPAR gamma) and promotes the PPAR gamma-mitochondrial uncoupling protein 2 (UCP2) cascade. Forced expression of PPAR gamma rescues deficiency of Rnd3-mediated mitochondrial dysfunction. We conclude that Rnd3 acts as a novel protective factor in placental mitochondria through PPAR gamma-UCP2 signaling and highlight that downregulation of Rnd3 is a potential factor involved in PE pathogenesis.	[Huang, Liping; Chen, Lu; Zhong, Mei; Wang, Zhijian; Chen, Xia; Sun, Fei; Xiao, Lu; Chen, Jianing; Lai, Yingjun; Yan, Chuming; Yue, Xiaojing] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1023 South Shatai Rd, Guangzhou 510515, Peoples R China; [Ma, Yanlin] Hainan Med Univ, Hainan Prov Key Lab Human Reprod Med & Genet Res, Reprod Med Ctr, Affiliated Hosp 1, Haikou, Hainan, Peoples R China; [Chang, Jiang] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Sun, Ying] Southern Med Univ, Dept Obstet & Gynecol, Affiliated Shenzhen Matern & Child Healthcare Hos, Shenzhen, Peoples R China	Southern Medical University - China; Hainan Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Southern Medical University - China	Yue, XJ (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1023 South Shatai Rd, Guangzhou 510515, Peoples R China.	yuexj1986@163.com	WANG, JINGYI/GSJ-1241-2022; Ma, Yanlin/CAH-2185-2022; wang, jie/GRS-0942-2022	Ma, Yanlin/0000-0001-9668-0204; 	Major Science and Technology Program of Hainan Province [ZDKJ2017007]; National Natural Science Foundation of China [81771609, 81601317, 81960283, 81971415]; Natural Science Foundation of Guangdong Province [2017A030313584, 2019A1515010290, 2019A1515010019]; Special Fund for Cooperative Innovation and Platform Environment Construction [2015B050501006]; Outstanding Youth Development Scheme of Nanfang Hospital Southern Medical University [2018J010]	Major Science and Technology Program of Hainan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Special Fund for Cooperative Innovation and Platform Environment Construction; Outstanding Youth Development Scheme of Nanfang Hospital Southern Medical University	This study was supported by the following funding sources: the Major Science and Technology Program of Hainan Province (ZDKJ2017007), the National Natural Science Foundation of China (81771609, 81601317, 81960283, and 81971415), the Natural Science Foundation of Guangdong Province (2017A030313584, 2019A1515010290 and 2019A1515010019), the Special Fund for Cooperative Innovation and Platform Environment Construction (2015B050501006), the Outstanding Youth Development Scheme of Nanfang Hospital Southern Medical University (2018J010)	Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Cadenas S, 2018, BBA-BIOENERGETICS, V1859, P940, DOI 10.1016/j.bbabio.2018.05.019; Collett GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030453; Corona JC, 2016, FREE RADICAL BIO MED, V100, P153, DOI 10.1016/j.freeradbiomed.2016.06.023; D'Souza V, 2016, CLIN EXP HYPERTENS, V38, P225, DOI 10.3109/10641963.2015.1081226; Dai Y, 2019, CIRCULATION, V139, P1185, DOI 10.1161/CIRCULATIONAHA.118.033700; Fang YN, 2018, EUR REV MED PHARMACO, V22, P6583, DOI 10.26355/eurrev_201810_16132; Hladunewich M, 2007, CLIN J AM SOC NEPHRO, V2, P543, DOI 10.2215/CJN.03761106; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Jie W, 2016, COMPR PHYSIOL, V6, P169, DOI 10.1002/cphy.c150018; Kohan-Ghadr HR, 2019, BIOL REPROD, V100, P479, DOI 10.1093/biolre/ioy186; Lin X, 2013, P NATL ACAD SCI USA, V110, P8236, DOI 10.1073/pnas.1219995110; Liu BH, 2015, CANCER MED-US, V4, P1404, DOI 10.1002/cam4.484; McCarthy FP, 2011, HYPERTENSION, V58, P280, DOI 10.1161/HYPERTENSIONAHA.111.172627; Medvedev AV, 2001, J BIOL CHEM, V276, P10817, DOI 10.1074/jbc.M010587200; Moses E, 2012, Pregnancy Hypertens, V2, P219, DOI 10.1016/j.preghy.2012.04.078; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Rana S, 2019, CIRC RES, V124, P1094, DOI 10.1161/CIRCRESAHA.118.313276; Salgado SS, 2011, JCPSP-J COLL PHYSICI, V21, P482, DOI 08.2011/JCPSP.482486; Juan-Reyes SS, 2020, ARCH BIOCHEM BIOPHYS, V681, DOI 10.1016/j.abb.2020.108255; Sanchez-Aranguren LC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00372; Saso J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094698; Schaiff WT, 2000, J CLIN ENDOCR METAB, V85, P3874, DOI 10.1210/jc.85.10.3874; Shi ZJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078533, 10.1371/journal.pone.0064351]; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; TORBERGSEN T, 1989, ACTA OBSTET GYN SCAN, V68, P145, DOI 10.3109/00016348909009902; Vishnyakova PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32410; Waite LL, 2000, J CLIN ENDOCR METAB, V85, P3808, DOI 10.1210/jc.85.10.3808; Waite LL, 2005, J CLIN ENDOCR METAB, V90, P620, DOI 10.1210/jc.2004-0849; Wang Y, 1998, PLACENTA, V19, P581, DOI 10.1016/S0143-4004(98)90018-2; Xu YT, 2018, MOL THER-NUCL ACIDS, V12, P195, DOI 10.1016/j.omtn.2018.05.007; Xu YT, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.503; Yang XS, 2015, CIRC RES, V116, pE1, DOI 10.1161/CIRCRESAHA.116.304940; Yiallourides M, 2009, REPRODUCTION, V138, P601, DOI 10.1530/REP-09-0043; Yue X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.235; Yue XJ, 2018, PLACENTA, V62, P43, DOI 10.1016/j.placenta.2017.12.009; Yue XJ, 2016, HYPERTENSION, V67, P597, DOI 10.1161/HYPERTENSIONAHA.115.06412	39	2	2	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21555	10.1096/fj.202002639RRR	http://dx.doi.org/10.1096/fj.202002639RRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34046947	Green Submitted			2022-12-26	WOS:000655695900068
J	Dunne, JJ; Uchida, TK; Besier, TF; Delp, SL; Seth, A				Dunne, James J.; Uchida, Thomas K.; Besier, Thor F.; Delp, Scott L.; Seth, Ajay			A marker registration method to improve joint angles computed by constrained inverse kinematics	PLOS ONE			English	Article							GAIT; REPEATABILITY; OPTIMIZATION; PATIENT; MODEL	Accurate computation of joint angles from optical marker data using inverse kinematics methods requires that the locations of markers on a model match the locations of experimental markers on participants. Marker registration is the process of positioning the model markers so that they match the locations of the experimental markers. Markers are typically registered using a graphical user interface (GUI), but this method is subjective and may introduce errors and uncertainty to the calculated joint angles and moments. In this investigation, we use OpenSim to isolate and quantify marker registration-based error from other sources of error by analyzing the gait of a bipedal humanoid robot for which segment geometry, mass properties, and joint angles are known. We then propose a marker registration method that is informed by the orientation of anatomical reference frames derived from surface-mounted optical markers as an alternative to user registration using a GUI. The proposed orientation registration method reduced the average root-mean-square error in both joint angles and joint moments by 67% compared to the user registration method, and eliminated variability among users. Our results show that a systematic method for marker registration that reduces subjective user input can make marker registration more accurate and repeatable.	[Dunne, James J.; Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Dunne, James J.; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Dunne, James J.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Crawley, WA, Australia; [Uchida, Thomas K.] Univ Ottawa, Dept Mech Engn, Ottawa, ON, Canada; [Besier, Thor F.] Univ Auckland, Auckland Bioengn Inst, Dept Engn Sci, Auckland, New Zealand; [Seth, Ajay] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands	Stanford University; Stanford University; University of Western Australia; University of Ottawa; University of Auckland; Delft University of Technology	Uchida, TK (corresponding author), Univ Ottawa, Dept Mech Engn, Ottawa, ON, Canada.	tuchida@uottawa.ca		Delp, Scott/0000-0002-9643-7551; Seth, Ajay/0000-0003-4217-1580; Uchida, Thomas/0000-0002-7700-7476	National Institutes of Health (NIH) [R24 HD065690, P2C HD065690]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JJD, TKU, SLD, and AS received funding from National Institutes of Health (NIH; www.nih.gov) grants R24 HD065690 and P2C HD065690 (NIH National Center for Simulation in Rehabilitation Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MS, 2010, COMPUT METHOD BIOMEC, V13, P171, DOI 10.1080/10255840903067080; Ayusawa K, 2014, MECH MACH THEORY, V74, P274, DOI 10.1016/j.mechmachtheory.2013.12.015; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; Clement J, 2015, J BIOMECH, V48, P3796, DOI 10.1016/j.jbiomech.2015.09.040; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Dembia CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180320; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Hicks JL, 2011, GAIT POSTURE, V34, P197, DOI 10.1016/j.gaitpost.2011.04.009; Jackson RW, 2017, J EXP BIOL, V220, P2082, DOI 10.1242/jeb.150011; Kainz H, 2016, J BIOMECH, V49, P1658, DOI 10.1016/j.jbiomech.2016.03.052; KEPPLE TM, 1994, J BIOMECH, V27, P365, DOI 10.1016/0021-9290(94)90012-4; Lathrop RL, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005409; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Sartori M, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1368; Seth A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006223; Spong M.W., 1989, ROBOT DYNAMICS CONTR, V1st ed., DOI 10.5555/534552; Steele KM, 2012, J PEDIATR REHAB MED, V5, P99, DOI 10.3233/PRM-2012-0201; Taddei F, 2012, CLIN BIOMECH, V27, P273, DOI 10.1016/j.clinbiomech.2011.09.006; Uchida TK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163417	27	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252425	10.1371/journal.pone.0252425	http://dx.doi.org/10.1371/journal.pone.0252425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048476	Green Published, gold			2022-12-26	WOS:000664636100050
J	Hailu, L; Tesfaye, G; Fikirie, K; Debebe, Y				Hailu, Leta; Tesfaye, Gizaw; Fikirie, Kalkidan; Debebe, Yalemtsehay			Effect of land-use practices on species diversity and selected soil property in Somodo Watershed South-Western Ethiopia	PLOS ONE			English	Article							AGROFORESTRY SYSTEMS	This study was conducted in Somodo Watershed to investigate the land-use practices and its effect on species diversity and selected soil properties. Field observation was carried out to identify existing land-use practices following a transect line. A total of 20 plots (10 x 10) m(2) were sampled from plots exhibiting different land-use practices found in the watershed in order to evaluate species richness and diversity. Soil samples were also collected from each plot. The soil samples were analyzed following standard laboratory procedures. The result of the analysis showed that there was a significant difference (p<0.05) in species diversity and richness among different land-use practices. Coffea arabica was dominant in homestead gardens and natural forests while Grevillea robusta showed had maximum richness in plantations and farm forests in the Watershed. Furthermore, home garden agroforestry practice was significantly (p<0.05) affected soil pH compared to other land-use systems (cultivated land, natural forest, and plantation forest. While Organic carbon (OC), Total nitrogen (TN), and Carbon to Nitrogen ratio (C: N) did not show significance difference among land-use systems in the watershed. The study has concluded that different land-use practices had a positive impact on sustaining species diversity, richness, and improve soil properties. Therefore, the study suggests that improving and expanding home garden agroforestry practices in the area are indispensable for environmental protection and soil fertility enhancement.	[Hailu, Leta; Debebe, Yalemtsehay] Jimma Agr Res Ctr, Jimma, Ethiopia; [Tesfaye, Gizaw] Melkasa Agr Res Ctr, Adama, Ethiopia; [Fikirie, Kalkidan] Holeta Agr Res Ctr, Holeta, Ethiopia		Hailu, L (corresponding author), Jimma Agr Res Ctr, Jimma, Ethiopia.	latahailu@gmail.com		Hailu, Leta/0000-0002-6068-1667	Ethiopian Institute of Agricultural Research	Ethiopian Institute of Agricultural Research	The study was supported by Ethiopian Institute of Agricultural Research.	Aredehey G, 2019, COGENT FOOD AGR, V5, DOI 10.1080/23311932.2019.1708683; Brady NC, 2002, NATURE PROPERTY SOIL, V13; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; de Jong R., 2013, ECOSYSTEM SERVICES C, P357, DOI DOI 10.1007/978-94-007-6455-2_15; Elias E, 2016, SOIL ETHIOPIAN HIGHL; Ewuketu Linger Mekonnen, 2014, International Journal of Biodiversity and Conservation, V6, P301; FAO (Food and Agricultural Organization), 2017, AGR FOR LANDSC REST, DOI [10.4060/i7374e, DOI 10.4060/I7374E]; Fasika A., 2019, AFR J AGR RES, V14, P102, DOI [10.5897/ajar2018.13672, DOI 10.5897/AJAR2018.13672]; Hart DA., 2011, OREGON STATE U EXTEN; Islam M., 2017, J NATURAL SCI RES, V7, P56; Jackson M.L., 1958, SOIL CHEM ANAL, DOI DOI 10.1002/JPLN.19590850311; Jegora T., 2019, INT J FORESTRY RES, P1, DOI [10.1155/2019/3697047, DOI 10.1155/2019/3697047]; Julie, 2001, STEP STEP GUIDE DATA; Kassa H, 2018, AGROECOL SUST FOOD, V42, P149, DOI 10.1080/21683565.2017.1382425; Leta Hailu, 2020, Journal of Degraded and Mining Lands Management, V8, P2491, DOI 10.15243/jdmlm.2020.081.2491; Lipper L, 2012, INT ASS AGR EC IAAE, P18, DOI [10.22004/ag.econ.126251, DOI 10.22004/AG.ECON.126251]; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Mikrewongel TT., 2016, INT J ENV AGR RES; Mirzabaev, 2014, ZEF WORKING PAPER SE, V128; Mirzabaev A, 2016, EC LAND DEGRADATION, V10, P978; Misra PK, 2011, INT J BIOTECHNOLOGY, V7, P637; Mulugeta G., 2017, J RESOUR DEV MANAG, V30, P68; Nyssen J., 2015, WORLD GEOMORPHOLOGIC, P369, DOI [10.1007/978-94-017-8026-1, DOI 10.1007/978-94-017-8026-1_21, 10.1007/978-94-017-8026-1_, DOI 10.1007/978-94-017-8026-1]; Tadesse E, 2019, FORESTS, V10, DOI 10.3390/f10030266; Tefera MT., 2016, INT J ENV AGR RES, V2; Temesgen Gashaw, 2014, Journal of Environment and Earth Science, V4, P98; Tesfaye G., 2018, INT J EARTH ENV SCI, V3, P1; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003	29	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252305	10.1371/journal.pone.0252305	http://dx.doi.org/10.1371/journal.pone.0252305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048492	gold, Green Published			2022-12-26	WOS:000664636100032
J	Murakami, S; Shimada, M; Harada, Y; Hara, Y				Murakami, Sawako; Shimada, Masakazu; Harada, Yasuji; Hara, Yasushi			Examination of the proximodistal patellar position in small dogs in relation to anatomical features of the distal femur and medial patellar luxation	PLOS ONE			English	Article							PATELLOTROCHLEAR INDEX; JOINT; ALTA	Objective To determine the influence of anatomical features of the distal femur on the proximodistal patellar position and compare the proximodistal patellar position between dogs with and without medial patellar luxation (MPL). Study design Retrospective case series (n = 71). Methods Mediolateral-view radiographs of clinical cases of dogs weighing less than 15 kg were obtained. The stifle joint angle, patellar ligament length, patellar length, size of the femoral condyle, trochlear length, and trochlear angle were measured and included in multiple linear regression analyses to ascertain their effects on the proximodistal patellar position. Radiographs were divided into MPL and control groups. The effects of MPL on the proximodistal patellar position and morphological factors were also examined. Results The final model for the proximodistal patellar position revealed that the patella became distal as the ratio of the patellar ligament length to patellar length decreased, the trochlear angle relative to the femur increased, the trochlear length relative to the patellar length increased, or the trochlear length relative to the femoral condyle width decreased. The proximodistal patellar position in the MPL group was not significantly different from that in the control group despite the trend towards a distally positioned patella (p = 0.073). The MPL group showed a significantly shorter trochlea (p<0.001) and greater trochlear angle relative to the femur (p = 0.029) than the control group. Conclusion The proximodistal patellar position depends on multiple factors, and its determination based on PLL/PL alone may not be appropriate. Dogs with MPL did not have a proximally positioned patella compared with dogs without MPL. Although hindlimbs with MPL had a shorter trochlea than those without patellar luxation, this difference did not appear to be sufficient to displace the patellar position proximally in small dogs, possibly compensated by increased trochlear angle relative to the femur.	[Murakami, Sawako; Shimada, Masakazu; Harada, Yasuji; Hara, Yasushi] Nippon Vet & Life Sci Univ, Div Vet Sci, Sect Vet Med, Dept Vet Surg, Tokyo, Japan	Nippon Veterinary & Life Science University	Murakami, S (corresponding author), Nippon Vet & Life Sci Univ, Div Vet Sci, Sect Vet Med, Dept Vet Surg, Tokyo, Japan.	muracarmin@gmail.com		Murakami, Sawako/0000-0003-2558-595X; Shimada, Masakazu/0000-0002-9233-2496				Ahmad M, 2019, SKELETAL RADIOL, V48, P387, DOI 10.1007/s00256-018-3040-3; Ali SA, 2009, AM J ROENTGENOL, V193, P1361, DOI 10.2214/AJR.09.2729; Allberg CM, 2020, VET COMP ORTHOPAED, V33, P96, DOI 10.1055/s-0039-3400230; Biedert RM, 2006, KNEE SURG SPORT TR A, V14, P707, DOI 10.1007/s00167-005-0015-4; Biedert Roland M, 2017, Am J Orthop (Belle Mead NJ), V46, P290; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Harasen G, 2006, CAN VET J, V47, P1037; Heinze G, 2017, TRANSPL INT, V30, P6, DOI 10.1111/tri.12895; Hulse DA., 1993, DIS MECH SMALL ANIMA, P808; Johnson AL, 2006, VET SURG, V35, P78, DOI 10.1111/j.1532-950X.2005.00115.x; Johnson AL, 2002, AM J VET RES, V63, P42, DOI 10.2460/AJVR.2002.63.42; Kalff S, 2014, VET COMP ORTHOPAED, V27, P130, DOI 10.3415/VCOT-13-05-0064; Knazovicky D, 2012, ACTA VET BRNO, V81, P403, DOI 10.2754/avb201281040403; Magnussen RA, 2014, KNEE SURG SPORT TR A, V22, P2545, DOI 10.1007/s00167-013-2445-8; Miles JE, 2012, VET J, V193, P529, DOI 10.1016/j.tvjl.2012.01.003; Mostafa AA, 2008, VET SURG, V37, P201, DOI 10.1111/j.1532-950X.2008.00367.x; Murakami S, 2020, VET COMP ORTHOPAED, V33, P279, DOI 10.1055/s-0040-1702235; Neyret P, 2002, KNEE, V9, P3, DOI 10.1016/S0968-0160(01)00136-3; Ocal MK, 2020, VET COMP ORTHOPAED, V33, P110, DOI 10.1055/s-0039-3400232; ROUSH JK, 1993, VET CLIN N AM-SMALL, V23, P855, DOI 10.1016/S0195-5616(93)50087-6; Wangdee C, 2015, VET COMP ORTHOPAED, V28, P270, DOI 10.3415/VCOT-15-02-0028; Yasukawa S, 2016, VET COMP ORTHOPAED, V29, P29, DOI 10.3415/VCOT-15-05-0089	22	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252531	10.1371/journal.pone.0252531	http://dx.doi.org/10.1371/journal.pone.0252531			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048507	gold, Green Published			2022-12-26	WOS:000664636100064
J	Sankaran, S; Derechin, J; Christakis, NA				Sankaran, Soham; Derechin, Jacob; Christakis, Nicholas A.			CurmElo: The theory and practice of a forced-choice approach to producing preference rankings	PLOS ONE			English	Article							ATTITUDE MEASUREMENT; LIKERT; DISCRIMINATION; WORDLIKENESS; VALIDITY; NUMBER; SCALES; TESTS; MODEL	We introduce CurmElo, a forced-choice approach to producing a preference ranking of an arbitrary set of objects that combines the Elo algorithm with novel techniques for detecting and correcting for (1) preference heterogeneity induced polarization in preferences among raters, and (2) intransitivity in preference rankings. We detail the application of CurmElo to the problem of generating approximately preference-neutral identifiers, in this case four-letter and five-letter nonsense words patterned on the phonological conventions of the English language, using a population of Amazon Mechanical Turk workers. We find evidence that human raters have significant non-uniform preferences over these nonsense words, and we detail the consequences of this finding for social science work that utilizes identifiers without accounting for the bias this can induce. In addition, we describe how CurmElo can be used to produce rankings of arbitrary features or dimensions of preference of a set of objects relative to a population of raters.	[Sankaran, Soham; Derechin, Jacob; Christakis, Nicholas A.] Yale Univ, Yale Inst Network Sci, New Haven, CT 06520 USA; [Derechin, Jacob; Christakis, Nicholas A.] Yale Univ, Sociol, New Haven, CT 06520 USA; [Sankaran, Soham] Cornell Univ, Comp Sci, Ithaca, NY USA; [Sankaran, Soham] Pashi, San Francisco, CA USA	Yale University; Yale University; Cornell University	Derechin, J (corresponding author), Yale Univ, Yale Inst Network Sci, New Haven, CT 06520 USA.; Derechin, J (corresponding author), Yale Univ, Sociol, New Haven, CT 06520 USA.	jacob.derechin@yale.edu			Tata Sons Private Limited; Tata Consultancy Services Limited; Tata Chemicals Limited; NIH National Institute on Aging [P30AG034420]	Tata Sons Private Limited; Tata Consultancy Services Limited; Tata Chemicals Limited; NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Author NC received funding from: 1) Tata Sons Private Limited (https://www.tata.com/business/tata-sons); 2) Tata Consultancy Services Limited (https://www.tcs.com/); 3) Tata Chemicals Limited (https://www.tatachemicals.com/); and 4) NIH National Institute on Aging, Grant no. P30AG034420, (https://www.nia.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright A., 2008, 82 LSA CHIC; Aldous D, 2017, STAT SCI, V32, P616, DOI 10.1214/17-STS628; Alwin DF, 1997, SOCIOL METHOD RES, V25, P318, DOI 10.1177/0049124197025003003; ALWIN DF, 1991, SOCIOL METHOD RES, V20, P139, DOI 10.1177/0049124191020001005; Bailey TM, 2001, J MEM LANG, V44, P568, DOI 10.1006/jmla.2000.2756; BARTLETT CJ, 1960, EDUC PSYCHOL MEAS, V20, P699, DOI 10.1177/001316446002000405; Bartram D, 2007, INT J SELECT ASSESS, V15, P263, DOI 10.1111/j.1468-2389.2007.00386.x; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Bi J, 2006, J SENS STUD, V21, P584, DOI 10.1111/j.1745-459X.2006.00084.x; BILLIG M, 1973, EUR J SOC PSYCHOL, V3, P27, DOI 10.1002/ejsp.2420030103; Block HD., 1959, COWLES FDN RES EC; Bonneau J, 2012, P IEEE S SECUR PRIV, P538, DOI 10.1109/SP.2012.49; Booth AL, 2012, OXFORD B ECON STAT, V74, P547, DOI 10.1111/j.1468-0084.2011.00664.x; Brockhoff PB, 2010, FOOD QUAL PREFER, V21, P330, DOI 10.1016/j.foodqual.2009.04.003; BROOME J, 1991, ECON PHILOS, V7, P1, DOI 10.1017/S0266267100000882; BROWN J, 1974, BRIT J PSYCHOL, V65, P13, DOI 10.1111/j.2044-8295.1974.tb02766.x; Carifio J, 2008, MED EDUC, V42, P1150, DOI 10.1111/j.1365-2923.2008.03172.x; Carpusor AG, 2006, J APPL SOC PSYCHOL, V36, P934, DOI 10.1111/j.0021-9029.2006.00050.x; Cattelan M, 2012, STAT SCI, V27, P412, DOI 10.1214/12-STS396; Chomsky Noam, 1968, SOUND PATTERN ENGLIS; Coleman J, 1997, COMPLG9707017 ARXIV; Diehl M., 1990, EUROPEAN REV SOCIAL, V1, P263, DOI [https://doi.org/10.1080/14792779108401864, DOI 10.1080/14792779108401864]; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; Edelman B, 2017, AM ECON J-APPL ECON, V9, P1, DOI 10.1257/app.20160213; Elo A. E., 1978, RATING CHESSPLAYERS; Frisch SA, 2000, J MEM LANG, V42, P481, DOI 10.1006/jmla.1999.2692; Fryer RG, 2004, Q J ECON, V119, P767, DOI 10.1162/0033553041502180; Gliem JA., 2003, MIDW RES PRACT C AD; Green DM, 1966, SIGNAL DETECTION THE; Hammond M., 2004, INT J ENGLISH STUDIE, V4, P1; Hammond Michael, 1999, PHONOLOGY ENGLISH PR; HEYWOOD S, 1972, PERCEPT MOTOR SKILL, V34, P357, DOI 10.2466/pms.1972.34.2.357; Jabin PE, 2015, SIAM J APPL MATH, V75, P420, DOI 10.1137/140969324; Jackson DN, 2000, HUM PERFORM, V13, P371, DOI 10.1207/S15327043HUP1304_3; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; Kam CCS, 2018, SOCIOL METHOD RES, V47, P574, DOI 10.1177/0049124115626177; KUBOVY M, 1976, J EXP PSYCHOL HUMAN, V2, P291, DOI 10.1037/0096-1523.2.2.291; LIEBERSON S, 1992, AM J SOCIOL, V98, P511, DOI 10.1086/230048; Lieberson S, 1995, AM SOCIOL REV, V60, P928, DOI 10.2307/2096433; Likert Rensis, 1932, ARCH PSYCHOL; Lupyan G, 2015, LANG COGN, V7, P167, DOI 10.1017/langcog.2014.21; Mas-Colell A., 1995, MICROECONOMIC THEORY; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; NUTTIN JM, 1985, EUR J SOC PSYCHOL, V15, P353, DOI 10.1002/ejsp.2420150309; O'Mahony M., 1992, J SENS STUD, V7, P1, DOI [DOI 10.1111/J.1745-459X.1992.TB00519.X, 10.1111/j.1745-459X.1992.tb00519.x]; O'Mahony M, 2017, TRENDS FOOD SCI TECH, V66, P146, DOI 10.1016/j.tifs.2017.05.017; Ohala J., 1986, EXPT PHONOLOGY, P239; RAY JJ, 1980, J SOC PSYCHOL, V111, P63, DOI 10.1080/00224545.1980.9924273; Revilla MA, 2014, SOCIOL METHOD RES, V43, P73, DOI 10.1177/0049124113509605; Riddle B. L., 1989, Computers & Security, V8, P569, DOI 10.1016/0167-4048(89)90049-7; Roettgers J., 2017, VARIETY; Kreitchmann RS, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02309; Seabold S., 2010, P 9 PYTHON SCI C, P92, DOI [DOI 10.25080/MAJORA-92BF1922-011, 10.25080/MAJORA-92BF1922-011]; Starns JJ, 2017, J MEM LANG, V93, P55, DOI 10.1016/j.jml.2016.09.001; STERN H, 1992, MATH SOC SCI, V23, P103, DOI 10.1016/0165-4896(92)90040-C; Stolk E, 2019, VALUE HEALTH, V22, P23, DOI 10.1016/j.jval.2018.05.010; Sturgis P, 2014, SOCIOL METHOD RES, V43, P15, DOI 10.1177/0049124112452527; TAJFEL H, 1970, SCI AM, V223, P96, DOI 10.1038/scientificamerican1170-96; Watrin L, 2019, J INDIVID DIFFER, V40, P134, DOI 10.1027/1614-0001/a000285; Wright R., 2004, PHONETICALLY BASED P, P34, DOI DOI 10.1017/CBO9780511486401.002	62	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252145	10.1371/journal.pone.0252145	http://dx.doi.org/10.1371/journal.pone.0252145			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043666	Green Submitted, Green Published, gold			2022-12-26	WOS:000664635700059
J	Zeigler, DF; Gage, E; Clegg, CH				Zeigler, David F.; Gage, Emily; Clegg, Christopher H.			Epitope-targeting platform for broadly protective influenza vaccines	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; VIRUS HEMAGGLUTININ; PROVIDES PROTECTION; CELL EPITOPES; PEPTIDE; NEURAMINIDASE; M2; COMBINATION; CHALLENGE; PROGRESS	Seasonal influenza vaccines are often ineffective because they elicit strain-specific antibody responses to mutation-prone sites on the hemagglutinin (HA) head. Vaccines that provide long-lasting immunity to conserved epitopes are needed. Recently, we reported a nanoparticle-based vaccine platform produced by solid-phase peptide synthesis (SPPS) for targeting linear and helical protein-based epitopes. Here, we illustrate its potential for building broadly protective influenza vaccines. Targeting known epitopes in the HA stem, neuraminidase (NA) active site, and M2 ectodomain (M2e) conferred 50-75% survival against 5LD(50) influenza B and H1N1 challenge; combining stem and M2e antigens increased survival to 90%. Additionally, protein sequence and structural information were employed in tandem to identify alternative epitopes that stimulate greater protection; we report three novel HA and NA sites that are highly conserved in type B viruses. One new target in the HA stem stimulated 100% survival, highlighting the value of this simple epitope discovery strategy. A candidate influenza B vaccine targeting two adjacent HA stem sites led to >10(4)-fold reduction in pulmonary viral load. These studies describe a compelling platform for building vaccines that target conserved influenza epitopes.	[Zeigler, David F.; Gage, Emily; Clegg, Christopher H.] TRIA Biosci Corp, Seattle, WA 98102 USA; [Zeigler, David F.; Gage, Emily] Lonza Pharma & Biotech, Bend, OR USA		Clegg, CH (corresponding author), TRIA Biosci Corp, Seattle, WA 98102 USA.	cclegg@triabio.com			Center of Disease Control [R43IP001108]	Center of Disease Control	This research was supported in its entirety by the Center of Disease Control (www.cdc.gov) under award number R43IP001108 (CC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are employed by TRIA Bioscience Corp, which provided support in the form of salaries but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. There was no additional external funding received for this study.	Allen JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204284; An YM, 2019, J VIROL, V93, DOI 10.1128/JVI.01693-18; Angeletti D, 2019, P NATL ACAD SCI USA, V116, P13474, DOI 10.1073/pnas.1816300116; Atsmon J, 2012, J CLIN IMMUNOL, V32, P595, DOI 10.1007/s10875-011-9632-5; Bajic G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40175-8; Beerli RR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-224; Bernstein DI, 2020, LANCET INFECT DIS, V20, P80, DOI 10.1016/S1473-3099(19)30393-7; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Broecker F, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0126-4; Carter DM, 2016, J VIROL, V90, P4720, DOI 10.1128/JVI.03152-15; Cauwelaert ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146372; Cho KJ, 2016, J VIROL, V90, P611, DOI 10.1128/JVI.02105-15; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Coughlan L, 2018, CELL HOST MICROBE, V24, P18, DOI 10.1016/j.chom.2018.06.016; Deng L, 2018, P NATL ACAD SCI USA, V115, pE7758, DOI 10.1073/pnas.1805713115; Doyle TM, 2013, BIOCHEM BIOPH RES CO, V441, P226, DOI 10.1016/j.bbrc.2013.10.041; Doyle TM, 2013, ANTIVIR RES, V100, P567, DOI 10.1016/j.antiviral.2013.09.018; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eggink D, 2014, J VIROL, V88, P699, DOI 10.1128/JVI.02608-13; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Escuret V, 2014, J INFECT DIS, V210, P1260, DOI 10.1093/infdis/jiu244; Estrada LD, 2019, J IMMUNOL, V202, P392, DOI 10.4049/jimmunol.1801054; Falugi F, 2001, EUR J IMMUNOL, V31, P3816, DOI 10.1002/1521-4141(200112)31:12<3816::AID-IMMU3816>3.0.CO;2-K; Frasch CE, 2009, VACCINE, V27, P6468, DOI 10.1016/j.vaccine.2009.06.013; Gravel C, 2010, VACCINE, V28, P5774, DOI 10.1016/j.vaccine.2010.06.075; GREENSTEIN JL, 1992, J IMMUNOL, V148, P3970; Herbert JA, 2018, VACCINE, V36, P3809, DOI 10.1016/j.vaccine.2018.05.036; Hutchinson EC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5816; Jang YH, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00344; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031; Kolpe A, 2017, EXPERT REV VACCINES, V16, P123, DOI 10.1080/14760584.2017.1240041; Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y; Kumar A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00600; Li QA, 2010, CHEMBIOCHEM, V11, P1686, DOI 10.1002/cbic.201000235; Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515; Liu WL, 2003, FEMS IMMUNOL MED MIC, V35, P141, DOI 10.1016/S0928-8244(03)00009-9; Malonis RJ, 2020, CHEM REV, V120, P3210, DOI 10.1021/acs.chemrev.9b00472; Mathew NR, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02997; McCluskie MJ, 2016, IMMUNOPHARM IMMUNOT, V38, P184, DOI 10.3109/08923973.2016.1165246; McCluskie MJ, 2015, INT IMMUNOPHARMACOL, V25, P518, DOI 10.1016/j.intimp.2015.02.030; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Mezhenskaya D, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0572-3; Miller KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114366; Ni FY, 2013, VIROLOGY, V446, P112, DOI 10.1016/j.virol.2013.07.035; Nobusawa E, 2006, J VIROL, V80, P3675, DOI 10.1128/JVI.80.7.3675-3678.2006; Oscherwitz J, 2016, HUM VACC IMMUNOTHER, V12, P2113, DOI 10.1080/21645515.2016.1160977; Paget J, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020421; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Paterson RG, 2003, VIROLOGY, V306, P7, DOI 10.1016/S0042-6822(02)00083-1; Ramamurthy M, 2019, J CELL BIOCHEM, V120, P17534, DOI 10.1002/jcb.29017; Saelens X, 2019, J INFECT DIS, V219, pS68, DOI 10.1093/infdis/jiz003; Salazar G, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0019-3; Sautto GA, 2018, VIROL J, V15, DOI 10.1186/s12985-017-0918-y; Schepens B, 2018, CURR OPIN IMMUNOL, V53, P22, DOI 10.1016/j.coi.2018.03.024; Schotsaert M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24402; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Stepanova LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119520; Sullivan SG, 2019, LANCET RESP MED, V7, P8, DOI 10.1016/S2213-2600(18)30511-3; Sun WN, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030117; Sun WN, 2019, J VIROL, V93, DOI 10.1128/JVI.00333-19; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Tsybalova LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201429; Viboud C, 2016, J INFECT DIS, V213, P738, DOI 10.1093/infdis/jiv534; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang Y, 2020, ADV HEALTHC MATER, V9, DOI 10.1002/adhm.201901176; Wu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8708; Yusuf M, 2013, J CHEM INF MODEL, V53, P2423, DOI 10.1021/ci400421e; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zeigler DF, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0125-5; Zeigler DF, 2019, VACCINE, V37, P1584, DOI 10.1016/j.vaccine.2019.02.003; Zeigler DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178835; Zhang Y, 2017, NUCLEIC ACIDS RES, V45, pD466, DOI 10.1093/nar/gkw857	78	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252170	10.1371/journal.pone.0252170	http://dx.doi.org/10.1371/journal.pone.0252170			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043704	Green Published, gold			2022-12-26	WOS:000664635700064
J	Lowen, C; Kchouri, B; Lehnert, T				Lowen, Celina; Kchouri, Bilal; Lehnert, Thorsten			Is this time really different? Flight-to-safety and the COVID-19 crisis	PLOS ONE			English	Article							VOLATILITY; STOCKS; BONDS; GOLD	During periods of market stress, risk-averse investors reallocate their investments from stocks to gold in a bid to hedge risks. Market participants interpret the induced gold price increase as an indication of safe-haven purchases and a signal of increased uncertainty in the general economic and financial conditions, thereby causing higher gold price volatility. The aim of this paper is to analyze whether this flight to safety effect can be observed during the COVID-19 crisis, which is considered to be a one-of-a-kind crisis and obviously of different origin compared to previous (financial) crises. By examining the interactions between the (option-implied) volatilities of the stock market (VIX) and of the gold (GVZ) and oil (OVX) markets, the main findings indicate that there is a granger causality in general between the equity market and the gold as well as the oil market. During the COVID-19 crisis, a stronger influence of the equity market on the oil market can be observed. Based on symmetric causality tests that are typically employed in the literature, this cannot be observed for the gold market. However, once we control for asymmetric causal interactions, we find that positive shocks in VIX cause positive shocks in GVZ. Hence, the typical flight to safety effect, similar to the one observed during other (financial) crises can also be identified for the COVID-19 crisis. The causality between the equity and oil market is triggered by political factors as well as the economic impact of the crisis which induces a sharp drop in demand for oil.	[Lowen, Celina; Kchouri, Bilal; Lehnert, Thorsten] Univ Luxembourg, Dept Finance, Luxembourg, Luxembourg	University of Luxembourg	Lehnert, T (corresponding author), Univ Luxembourg, Dept Finance, Luxembourg, Luxembourg.	thorsten.lehnert@uni.lu	Lehnert, Thorsten/GLR-2903-2022	Lehnert, Thorsten/0000-0002-0470-0851				[Anonymous], 2020, WORLD HLTH ORG, DOI DOI 10.1080/09639284.2021.1971095; [Anonymous], 2011, PRUEBA SOLEDAD PAISA; Baele L, 2020, REV FINANC STUD, V33, P689, DOI 10.1093/rfs/hhz055; Bali TG, 2016, J FINANC QUANT ANAL, V51, P707, DOI 10.1017/S0022109016000417; Bams D, 2017, J EMPIR FINANC, V44, P270, DOI 10.1016/j.jempfin.2017.07.003; BARSKY RB, 1989, AM ECON REV, V79, P1132; Basta M, 2018, FINANC RES LETT, V26, P204, DOI 10.1016/j.frl.2018.02.001; Baur DG, 2010, FINAN REV, V45, P217, DOI 10.1111/j.1540-6288.2010.00244.x; Bekaert G, 2009, J FINANC ECON, V91, P59, DOI 10.1016/j.jfineco.2008.01.005; Brunnermeier MK, 2009, REV FINANC STUD, V22, P2201, DOI 10.1093/rfs/hhn098; Caballero RJ, 2008, J FINANC, V63, P2195, DOI 10.1111/j.1540-6261.2008.01394.x; CBOE Holdings, 2008, CBOE INTR NEW CRUD O; Connolly R, 2005, J FINANC QUANT ANAL, V40, P161, DOI 10.1017/S0022109000001782; Fernandez-Aviles G, 2020, EUR J FINANC, V26, P1207, DOI 10.1080/1351847X.2020.1724171; Fernandez-Aviles G, 2016, EXPERT SYST APPL, V60, P280, DOI 10.1016/j.eswa.2016.05.008; Gallagher LA, 1998, ECON SOC REV, V29, P341; Gardebroek C., 2014, IFPRI DISCUSSION PAP; Gokmenoglu KK, 2015, PROC ECON FINANC, V25, P478, DOI 10.1016/S2212-5671(15)00760-1; Groth J., 2016, FONDS FOKUS SPDR GOL; Hatemi-J A, 2016, APPL ECON, V48, P4033, DOI 10.1080/00036846.2016.1150950; Hatemi-J A, 2012, EMPIR ECON, V43, P447, DOI 10.1007/s00181-011-0484-x; Huang W, 2012, J BANK FINANC, V36, P1492, DOI 10.1016/j.jbankfin.2011.12.014; IEA, 2020, WORLD EN OUTL, DOI DOI 10.1787/CO2_FUEL-2016-EN; Jubinski D, 2012, J FUTURES MARKETS, V32, P480, DOI 10.1002/fut.20521; Kapetanios G, 2005, J TIME SER ANAL, V26, P123, DOI 10.1111/j.1467-9892.2005.00393.x; Patel V, 2020, J FINANC MARK, V47, DOI 10.1016/j.finmar.2019.100524; Rapach DE, 2013, J FINANC, V68, P1633, DOI 10.1111/jofi.12041; Sarwar G, 2017, FINANC RES LETT, V20, P118, DOI 10.1016/j.frl.2016.09.015; Thomas JM, 2015, J PORTFOLIO MANAGE, V42, P135, DOI 10.3905/jpm.2015.42.1.135; Turner C, 2019, INDEX OPTIONS EXPLAI; USCF, 2020, USO US OIL FUND; Vayanos D., 2004, FLIGHT QUALITY FLIGH, P1, DOI [10.3386/w10327, DOI 10.3386/W10327]; Wang YS, 2013, ECON MODEL, V30, P792, DOI 10.1016/j.econmod.2012.09.052; Zaiontz C, 2017, REAL STAT USING EXCE	34	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251752	10.1371/journal.pone.0251752	http://dx.doi.org/10.1371/journal.pone.0251752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038444	Green Published, gold			2022-12-26	WOS:000664633500028
J	Lam, S; Kommadath, A; Lopez-Campos, O; Prieto, N; Aalhus, J; Juarez, M; Dugan, MER; Vahmani, P				Lam, Stephanie; Kommadath, Arun; Lopez-Campos, Oscar; Prieto, Nuria; Aalhus, Jennifer; Juarez, Manuel; Dugan, Michael E. R.; Vahmani, Payam			Evaluation of RNA quality and functional transcriptome of beef longissimus thoracis over time post-mortem	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; SKELETAL-MUSCLE; MEAT; TRAITS; MITOCHONDRIA; STABILITY; CARCASS; OXYGEN; ACID; PH	Evaluating RNA quality and transcriptomic profile of beef muscle over time post-mortem may provide insight into RNA degradation and underlying biological and functional mechanisms that accompany biochemical changes occurring post-mortem during transformation of muscle to meat. RNA was extracted from longissimus thoracis (LT) sampled from British Continental crossbred heifer carcasses (n = 7) stored at 4 degrees C in an abattoir drip cooler at 5 time points post-mortem, i.e., 45 min (0 h), 6 h, 24 h, 48 h, and 72 h. Following RNA-Sequencing, processed reads were aligned to the ARS-UCD1.2 bovine genome assembly. Subsequent differential expression (DE) analysis identified from 51 to 1434 upregulated and 27 to 2256 downregulated DE genes at individual time points compared to time 0 h, showing a trend for increasing counts of both upregulated and downregulated genes over time. Gene ontology and biological pathway term enrichment analyses on sets of DE genes revealed several processes and their timelines of activation/deactivation that accompanied or were involved with muscle transformation to meat. Although the quality of RNA in refrigerated LT remained high for several days post-mortem, the expression levels of several known biomarker genes for meat quality began to change from 24 h onwards. Therefore, to ensure accuracy of predictions on meat quality traits based on the expression levels of those biomarker genes in refrigerated beef muscle tissue, it is crucial that those expression measurements be made on RNA sampled within 24 h post-mortem. The present study also highlighted the need for more research on the roles of mitochondrial genes and non-coding genes in orchestrating muscle tissue processes after death, and how pre-mortem immune status might influence post-mortem meat quality.	[Lam, Stephanie; Kommadath, Arun; Lopez-Campos, Oscar; Prieto, Nuria; Aalhus, Jennifer; Juarez, Manuel; Dugan, Michael E. R.] Agr & Agri Food Canada, Lacombe Res & Dev Ctr, Lacombe, AB, Canada; [Vahmani, Payam] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA	Agriculture & Agri Food Canada; University of California System; University of California Davis	Vahmani, P (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	pvahmani@ucdavis.edu		Kommadath, Arun/0000-0003-3587-6670	Agriculture and Agri-Food Canada (AAFC)	Agriculture and Agri-Food Canada (AAFC)(Agriculture & Agri Food Canada)	The financial and material support for this study was provided by Agriculture and Agri-Food Canada (AAFC). Please note that AAFC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A., 2017, Meat and Muscle Biology, V1, P18, DOI 10.22175/mmb2016.12.0007; Bahar B, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-108; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bauer M, 2007, FORENSIC SCI INT-GEN, V1, P69, DOI 10.1016/j.fsigen.2006.11.002; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen D, 2015, ASIAN AUSTRAL J ANIM, V28, P158, DOI 10.5713/ajas.14.0394; Damsteegt EL, 2016, ANAL BIOCHEM, V511, P92, DOI 10.1016/j.ab.2016.08.005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; England EM, 2018, MEAT SCI, V139, P97, DOI 10.1016/j.meatsci.2017.12.008; Ferreira PG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02772-x; Fontanesi L, 2008, MEAT SCI, V80, P1345, DOI 10.1016/j.meatsci.2008.06.014; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Habets PEMH, 1999, J HISTOCHEM CYTOCHEM, V47, P995, DOI 10.1177/002215549904700803; Hart SN, 2013, J COMPUT BIOL, V20, P970, DOI 10.1089/cmb.2012.0283; Huang CY, 2020, TRENDS FOOD SCI TECH, V105, P416, DOI 10.1016/j.tifs.2020.09.030; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Lawrie R. A., 2014, LAWRIES MEAT SCI; Leal-Gutierrez JD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240895; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Muniz MMM, 2020, FUNCT INTEGR GENOMIC, V20, P609, DOI 10.1007/s10142-020-00738-9; Matarneh S. K., 2017, LAWRIES MEAT SCI WOO, V8th, P159, DOI DOI 10.1016/B978-0-08-100694-8.00005-4; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGovern F, 2018, ANIM BIOTECHNOL, V29, P269, DOI 10.1080/10495398.2017.1378226; Neath KE, 2007, MEAT SCI, V75, P499, DOI 10.1016/j.meatsci.2006.08.016; Nery RA, 2015, ABCD-ARQ BRAS CIR DI, V28, P290, DOI [10.1590/S0102-6720201500040018, 10.1590/s0102-6720201500040018]; Pas MFWT, 2010, J ANIM SCI, V88, P4044, DOI 10.2527/jas.2010-2952; Pastsart U, 2013, MEAT SCI, V93, P681, DOI 10.1016/j.meatsci.2012.11.008; Pozhitkov AE, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160267; Prager I, 2019, J LEUKOCYTE BIOL, V105, P1319, DOI 10.1002/JLB.MR0718-269R; Ramanathan R, 2010, MEAT SCI, V86, P738, DOI 10.1016/j.meatsci.2010.06.014; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Ropka-Molik K, 2018, ASIAN AUSTRAL J ANIM, V31, P1565, DOI 10.5713/ajas.17.0714; Rosen BD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa021; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Tang JL, 2005, J AGR FOOD CHEM, V53, P1223, DOI 10.1021/jf048646o; Vahmani P, 2020, CAN J ANIM SCI, V100, P570, DOI 10.1139/cjas-2019-0164; Vennemann M, 2010, FORENSIC SCI INT, V203, P71, DOI 10.1016/j.forsciint.2010.07.006; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Yu QQ, 2019, FOOD CHEM, V301, DOI 10.1016/j.foodchem.2019.125262; Zhang YF, 2019, MEAT SCI, V150, P47, DOI 10.1016/j.meatsci.2018.12.008; Zhu YZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05882-0	46	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0251868	10.1371/journal.pone.0251868	http://dx.doi.org/10.1371/journal.pone.0251868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033656	gold, Green Published			2022-12-26	WOS:000664633100014
J	Pinzon, MA; Ortiz, S; Holguin, H; Betancur, JF; Arango, DC; Laniado, H; Arias, CA; Munoz, B; Quiceno, J; Jaramillo, D; Ramirez, Z				Pinzon, Miguel Alejandro; Ortiz, Santiago; Holguin, Hector; Betancur, Juan Felipe; Arango, Doris Cardona; Laniado, Henry; Arias, Carolina Arias; Munoz, Bernardo; Quiceno, Julian; Jaramillo, Daniel; Ramirez, Zoraida			Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia	PLOS ONE			English	Article								Background There is no effective therapy for the severe acute respiratory syndrome by coronavirus 2 (SARS-CoV2) responsible for the Coronavirus disease 2019 (Covid-19). To date, dexamethasone has shown a decrease in mortality in patients who require oxygen, especially those with invasive mechanical ventilation. However, it is unknown if another corticosteroid can be used, the optimal dose and its duration, to achieve a better clinical outcome. The objective of the study was to compare the differences in clinical outcome and laboratory results in hospitalized patients with severe SARS-CoV2 Pneumonia treated with dexamethasone at 6 mg doses versus patients treated with high-dose methylprednisolone. Materials and methods Ambispective cohort study with survival analysis of 216 patients diagnosed with severe Covid-19 pneumonia confirmed by polymerase chain reaction for SARS-CoV2 by Berlin protocol, who were hospitalized in a high-complexity clinic in Medellin, Colombia. The patients should also have supplementary oxygen and radiological confirmation of Pneumonia by chest tomography. Sample size was not calculated since the total population that met the inclusion criteria was evaluated. 111 patients were treated with the institutional protocol with intravenous dexamethasone 6 mg QD for seven to 10 days if they required oxygen. Since September 15, 2020, the hospitalization protocol of the clinic was modified by the Infectious Diseases and Pulmonology service, recommending a high dose of methylprednisolone of 250 to 500 mg every day for three days with a subsequent change to oral prednisone 50 mg every day for 14 days. The protocol was not applied in the intensive care unit, where dexamethasone continued to be administered. The clinical outcome and differences in laboratory results of the patients who received dexamethasone vs. the prospective cohort that received methylprednisolone from September 15 to October 31, 2020, were evaluated. Follow-up was carried out by outpatient consultation one month after discharge or by telephone, inquiring about readmission or living-dead status. Results 216 patients had Covid-19 pneumonia documented by ground-glass imaging and alveolar pressure / inspired oxygen fraction (PaFi) less than 300. 111 patients received dexamethasone (DXM) and 105 received methylprednisolone (MTP). Patients in the DXM group evolved to severe ARDS in a higher proportion (26.1% vs 17.1% than the MTP group). Upon completion 4 days of treatment with parenteral corticosteroid, laboratory markers of severity decreased significantly in the group that received MTP, CRP 2.85 (2.3-3.8) vs 7.2 (5.4-9.8), (p-value < 0.0001), D-dimer 691 (612-847) vs 1083 (740-1565) (p-value = 0.04) and DHL 273 (244-289) vs 355 (270.6-422) (p-value = 0.01). After starting the corticosteroid, transfer to the intensive care unit (4.8% vs. 14.4%) and mortality (9,5% vs. 17.1%) was lower in the group that received MTP. Recovery time was shorter in patients treated with MTP, three days (3-4) vs. DXM 6 days (5-8) (p-value < 0.0001). At 30-day follow-up, 88 (92.6%) were alive in MTP vs 58 (63.1%) of those who received dexamethasone. Conclusions In this study, the treatment of severe Covid-19 Pneumonia with high-dose methylprednisolone for three days followed by oral prednisone for 14 days, compared with 6 mg dexamethasone for 7 to 10 days, statistically significantly decreased the recovery time, the need for transfer to intensive care and the severity markers C-reactive protein (CRP), D-dimer and LDH. Randomized controlled studies with methylprednisolone are required to corroborate its effect, and studies in a population hospitalized in intensive care wards.	[Pinzon, Miguel Alejandro] Clin Medellin, Grp Quironsalud, Dept Infect Dis, Medellin, Antioquia, Colombia; [Ortiz, Santiago; Laniado, Henry] Univ EAFIT, Dept Math Sci, Medellin, Antioquia, Colombia; [Holguin, Hector] Clin Medellin, Grp Quironsalud, Pharmaceut Serv, Medellin, Antioquia, Colombia; [Betancur, Juan Felipe; Quiceno, Julian; Ramirez, Zoraida] Clin Medellin, Grp Quironsalud, Dept Internal Med, Medellin, Antioquia, Colombia; [Arango, Doris Cardona] CES Univ, Dept Publ Hlth, Medellin, Antioquia, Colombia; [Arias, Carolina Arias] CES Univ, Dept Epidemiol, Medellin, Antioquia, Colombia; [Munoz, Bernardo] Clin Medellin, Grp Quironsalud, Dept Pulmonol, Medellin, Antioquia, Colombia; [Jaramillo, Daniel] CES Univ, Clin Leon XIII, Dept Rheumatol & Autoimmune Dis, Medellin, Antioquia, Colombia	Universidad EAFIT	Pinzon, MA (corresponding author), Clin Medellin, Grp Quironsalud, Dept Infect Dis, Medellin, Antioquia, Colombia.	alejandropinzon01@yahoo.es	Ortiz, Santiago/ABD-3604-2021	Ortiz, Santiago/0000-0002-9121-3807	Universidad EAFIT	Universidad EAFIT	This study was partially supported by Universidad EAFIT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, CORONAVIRUS UPDATE L; Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099; Bednarski T., 2006, COXROBUST ROBUST EST; Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787; COX DR, 1972, J R STAT SOC B, V34, P187; Deftereos SG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13136; Edalatifard M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02808-2020; Fan E, 2020, LANCET RESP MED, V8, P816, DOI 10.1016/S2213-2600(20)30304-0; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Kory P, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000724; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m641; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Minder CE, 1996, STAT MED, V15, P1033, DOI 10.1002/(SICI)1097-0258(19960530)15:10<1033::AID-SIM215>3.0.CO;2-Y; R Core Team, 2021, R LANGUAGE ENV STAT; Ragab D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01446; Ruiz-Irastorza G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239401; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Scarsi M, 2020, ANN RHEUM DIS, V79, P1286, DOI 10.1136/annrheumdis-2020-217712; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Therneau T., 2021, PACKAGE SURVIVAL ANA, DOI DOI 10.1198/TECH.2004.S740; Villar J, 2020, LANCET RESP MED, V8, P267, DOI 10.1016/S2213-2600(19)30417-5; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang RR, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13412; Yao TT, 2020, J MED VIROL, V92, P556, DOI 10.1002/jmv.25729; Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237; Zhao Z, 2003, J MED MICROBIOL, V52, P715, DOI 10.1099/jmm.0.05320-0; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	29	57	58	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252057	10.1371/journal.pone.0252057	http://dx.doi.org/10.1371/journal.pone.0252057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033648	gold, Green Published			2022-12-26	WOS:000664633100026
J	Giles, JW; Broden, C; Tempelaere, C; Emery, RJH; Baena, FRY				Giles, Joshua W.; Broden, Cyrus; Tempelaere, Christine; Emery, Roger J. H.; Rodriguez y Baena, Ferdinando			Development and ex-vivo assessment of a novel patient specific guide and instrumentation system for minimally invasive total shoulder arthroplasty	PLOS ONE			English	Article							GLENOID COMPONENT POSITION; INTRAOPERATIVE NAVIGATION; SUBSCAPULARIS TENDON; GLENOHUMERAL JOINT; ANTERIOR SHOULDER; AXILLARY NERVE; OSTEOARTHRITIS; HEMIARTHROPLASTY; REPLACEMENT; ACCURACY	Objective To develop and assess a novel guidance technique and instrumentation system for minimally invasive short-stemmed total shoulder arthroplasty that will help to reduce the complications associated with traditional open replacement such as poor muscle healing and neurovascular injury. We have answered key questions about the developed system including (1) can novel patient-specific guides be accurately registered and used within a minimally invasive environment?; (2) can accuracy similar to traditional techniques be achieved? Methods A novel intra-articular patient-specific guide was developed for use with a new minimally invasive posterior surgical approach that guides bone preparation without requiring muscle resection or joint dislocation. Additionally, a novel set of instruments were developed to enable bone preparation within the minimally invasive environment. The full procedure was evaluated in six cadaveric shoulders, using digitizations to assess accuracy of each step. Results Patient-specific guide registration accuracy in 3D translation was 2.21.2mm (RMSE1 SD; p = 0.007) for the humeral component and 2.7 +/- 0.7mm (p<0.001) for the scapula component. Final implantation accuracy was 2.9 +/- 3.0mm (p = 0.066) in translation and 5.7-6.8 +/- 2.2-4.0 degrees (0.001<p<0.009) across the humerus implants' three rotations. Similarly, the glenoid component's implantation accuracy was 3.0 +/- 1.7mm (p = 0.008) in translation and 2.3-4.3 +/- 2.2-4.4 degrees (0.008<p<0.09) in rotation. Conclusion This system achieves minimally invasive shoulder replacement with accuracy similar to traditional open techniques while avoiding common causes of complications. Significance This novel technique could lead to a paradigm shift in shoulder arthroplasty for patients with moderate arthritis, which could significantly improve rehabilitation and functional outcomes.	[Giles, Joshua W.] Univ Victoria, Dept Mech Engn, Victoria, BC, Canada; [Giles, Joshua W.; Rodriguez y Baena, Ferdinando] Imperial Coll London, Dept Mech Engn, London, England; [Broden, Cyrus; Tempelaere, Christine; Emery, Roger J. H.] Imperial Coll London, Dept Surg & Canc, London, England	University of Victoria; Imperial College London; Imperial College London	Giles, JW (corresponding author), Univ Victoria, Dept Mech Engn, Victoria, BC, Canada.; Giles, JW; Baena, FRY (corresponding author), Imperial Coll London, Dept Mech Engn, London, England.	jwgiles@uvic.ca; f.rodriguez@imperial.ac.uk	Giles, Joshua W/I-2783-2019; Rodriguez y Baena, Ferdinando M/C-5627-2009	Giles, Joshua W/0000-0001-6997-8873; Rodriguez y Baena, Ferdinando M/0000-0002-5199-9083	Leverhulme Trust; Wellcome Trust Translation Fund award [098269/Z/12/Z]	Leverhulme Trust(Leverhulme Trust); Wellcome Trust Translation Fund award	Author FRyB received a Career Award from the Leverhulme Trust (https://www.leverhulme.ac.uk/).Authors FRyB and RJHE received funding through a Wellcome Trust Translation Fund award (Grant #098269/Z/12/Z; https://wellcome.org/grant-funding/schemes/translation-fund).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirthanayagam TD, 2017, J SHOULDER ELB SURG, V26, P512, DOI 10.1016/j.jse.2016.08.011; Anderl W, 2015, KNEE SURG SPORT TR A, V23, P1563, DOI 10.1007/s00167-014-2981-x; Bellamy JL, 2014, J SHOULDER ELB SURG, V23, P895, DOI 10.1016/j.jse.2013.09.013; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bohsali KI, 2006, J BONE JOINT SURG AM, V88A, P2279, DOI 10.2106/JBJS.F.00125; Briem D, 2011, COMPUT AIDED SURG, V16, P93, DOI 10.3109/10929088.2010.546076; Bryant D, 2005, J BONE JOINT SURG AM, V87A, P1947, DOI 10.2106/JBJS.D.02854; Carter Michael J, 2012, J Bone Joint Surg Am, V94, pe127; Denard PJ, 2013, J SHOULDER ELB SURG, V22, P894, DOI 10.1016/j.jse.2012.09.016; Favre P, 2008, CLIN BIOMECH, V23, P175, DOI 10.1016/j.clinbiomech.2007.09.009; Gregory TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075791; Hendel MD, 2012, J BONE JOINT SURG AM, V94A, P2167, DOI 10.2106/JBJS.K.01209; Hopkins AR, 2004, J SHOULDER ELB SURG, V13, P668, DOI 10.1016/j.jse.2004.04.008; Iannotti Joseph, 2014, J Bone Joint Surg Am, V96, pe71, DOI 10.2106/JBJS.L.01346; Iannotti JP, 2015, J BONE JOINT SURG AM, V97A, P651, DOI 10.2106/JBJS.N.00493; Iannotti JP., 2017, SEMIN ARTHROPLASTY, V28, P25, DOI [10.1053/j.sart.2017.05.005, DOI 10.1053/J.SART.2017.05.005]; Ives EP, 2013, J CLIN ULTRASOUND, V41, P129, DOI 10.1002/jcu.21980; Karelse A, 2014, J SHOULDER ELB SURG, V23, P1120, DOI 10.1016/j.jse.2013.11.023; Kircher J, 2009, J SHOULDER ELB SURG, V18, P515, DOI 10.1016/j.jse.2009.03.014; Lafosse L, 2009, J SHOULDER ELB SURG, V18, P864, DOI 10.1016/j.jse.2009.03.017; Lapner PLC, 2015, J SHOULDER ELB SURG, V24, P223, DOI 10.1016/j.jse.2014.06.042; Levy JC, 2014, J SHOULDER ELB SURG, V23, P1563, DOI 10.1016/j.jse.2014.01.051; Lo IKY, 2005, J BONE JOINT SURG AM, V87A, P2178, DOI 10.2106/JBJS.D.02198; Mathys Ltd. Affinis, SHORT SHORT STEMM TO; Maynou C, 2005, J BONE JOINT SURG BR, V87B, P1096, DOI 10.1302/0301-620X.87B8.14605; McFarland EG, 2002, AM J SPORT MED, V30, P601, DOI 10.1177/03635465020300042101; Miller BS, 2005, J SHOULDER ELB SURG, V14, P492, DOI 10.1016/j.jse.2005.02.013; Miller SL, 2003, J SHOULDER ELB SURG, V12, P29, DOI 10.1067/mse.2003.128195; Mole D, 2011, CLIN ORTHOP RELAT R, V469, P2461, DOI 10.1007/s11999-011-1861-7; Nagda SH, 2007, J SHOULDER ELB SURG, V16, p2S, DOI 10.1016/j.jse.2006.01.016; Patel RB, 2019, J SHOULDER ELB SURG, V28, P861, DOI 10.1016/j.jse.2018.09.029; Prince EJ, 2004, J ORTHOP TRAUMA, V18, P585, DOI 10.1097/00005131-200410000-00001; Rasmussen JV, 2014, ACTA ORTHOP, V85, P117, DOI [10.3109/17453674.2014.893497, 10.3109/17453674.2014.922007]; Roberson TA, 2017, J SHOULDER ELB SURG, V26, P1298, DOI 10.1016/j.jse.2016.12.069; Sachs RA, 2005, AM J SPORT MED, V33, P1458, DOI 10.1177/0363546505275350; Sadoghi P, 2015, ARCH ORTHOP TRAUM SU, V135, P41, DOI 10.1007/s00402-014-2126-1; Savoie FH, 2015, J SHOULDER ELB SURG, V24, P606, DOI 10.1016/j.jse.2014.07.020; Simovitch R, 2013, BULL HOSP JT DIS, V71, pS94; Streit J.J., 2011, SEMIN ARTHROPLAST, V22, P132, DOI [10.1053/j.sart.2011.01.010, DOI 10.1053/J.SART.2011.01.010]; Suero EM, 2013, KNEE SURG SPORT TR A, V21, P2860, DOI 10.1007/s00167-012-2177-1; Terrier A, 2010, J SHOULDER ELB SURG, V19, P1184, DOI 10.1016/j.jse.2010.06.006; Throckmorton TW, 2015, J SHOULDER ELB SURG, V24, P965, DOI 10.1016/j.jse.2014.10.013; Van den Broeck J, 2015, COMPUT METHOD BIOMEC, V18, P38, DOI 10.1080/10255842.2013.774383; Villatte G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201759; Walch G, 2015, J SHOULDER ELB SURG, V24, P302, DOI 10.1016/j.jse.2014.05.029	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251880	10.1371/journal.pone.0251880	http://dx.doi.org/10.1371/journal.pone.0251880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019573	Green Published, gold			2022-12-26	WOS:000664632300037
J	Adhikari, B; Ghimire, A; Jha, N; Karkee, R; Shrestha, A; Dhakal, R; Niraula, A; Majhi, S; Pandit, AK; Bhandari, N				Adhikari, Bikram; Ghimire, Anup; Jha, Nilambar; Karkee, Rajendra; Shrestha, Archana; Dhakal, Roshan; Niraula, Aarju; Majhi, Sangita; Pandit, Antesh Kumar; Bhandari, Niroj			Factors associated with low back pain among construction workers in Nepal: A cross-sectional study	PLOS ONE			English	Article							PSYCHOSOCIAL RISK-FACTORS; NECK-SHOULDER PAIN; HEALTH; EPIDEMIOLOGY; PREVALENCE; DEPRESSION; DISORDERS; DISTRESS; ANXIETY	Background Low back pain (LBP) is the commonest cause of disability throughout the world. This study aimed to determine the prevalence and factors associated with LBP among the construction workers in Nepal. Methods A community-based cross-sectional study was conducted among the construction workers working in Banepa and Panauti municipalities of Kavre district, from September 2019 to February 2020. Data was collected purposively by face-to-face interview from 402 eligible participants from the both municipalities using semi-structured questionnaire. Mobile-based data collection was done using KoboCollect. Data were exported to and analysed using R-programming software (R-3.6.2). Univariate and multivariate logistic regressions were performed. All tests were two tailed and performed at 95% confidence interval (CI). Result One-year prevalence of LBP among construction workers were 52.0% (95%CI: 47.0-57.0). The higher odds of LBP was reported among females [adjusted odds ratio (aOR) = 2.42; 95%CI: 1.12-5.23], those living below poverty-line (aOR = 2.35; 95%CI: 1.32-4.19), participants with more than five years of work experience (aOR = 1.66; 95%CI: 1.01-2.73) and those with intermediate sleep quality (aOR = 2.06; CI: 1.03-4.11). About 80.0% of construction workers with LBP never seek healthcare services due to: a) time constraints (90.9%), b) financial constraints (18.1%) and c) fear of losing wages on seeking healthcare services (40.9%). The majority of the participants (94.8% among those without LBP and 72.3% among those with LBP) did nothing to prevent or manage LBP. Conclusion The prevalence of LBP in the past one year was high among construction workers where majority of workers never did anything to prevent or manage LBP. Therefore, the public health professionals should set up the health promotion, education, and interventions aimed at increasing awareness on preventive techniques and predisposing factors of LBP.	[Adhikari, Bikram; Ghimire, Anup; Jha, Nilambar; Karkee, Rajendra; Dhakal, Roshan; Niraula, Aarju; Majhi, Sangita; Pandit, Antesh Kumar] BP Koirala Inst Hlth Sci, Sch Publ Hlth & Community Med, Dharan, Nepal; [Shrestha, Archana; Bhandari, Niroj] Kathmandu Univ, Dept Publ Hlth, Sch Med Sci, Dhulikhel, Nepal; [Shrestha, Archana] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Shrestha, Archana; Bhandari, Niroj] Inst Implementat Sci & Hlth, Kathmandu, Nepal	B.P. Koirala Institute of Health Sciences; Yale University	Adhikari, B (corresponding author), BP Koirala Inst Hlth Sci, Sch Publ Hlth & Community Med, Dharan, Nepal.	bikram.adhikariadhitya@gmail.com		Karkee, Rajendra/0000-0003-1510-5457; Adhikari, Bikram/0000-0002-4299-9233				Alghadir Ahmad, 2015, ScientificWorldJournal, V2015, P529873, DOI 10.1155/2015/529873; Araújo Samya Pinheiro, 2016, Fisioter. mov., V29, P751, DOI 10.1590/1980-5918.029.004.ao11; Biswas G., 2016, INT J PHARM RES BIOS, V5, P129; Bjorck-van Dijken C, 2008, J REHABIL MED, V40, P864, DOI 10.2340/16501977-0273; Bodhare Trupti, 2011, Indian J Community Med, V36, P304, DOI 10.4103/0970-0218.91420; Chung JWY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16081404; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; Deacon C, 2005, INT CONGR SER, V1280, P172, DOI 10.1016/j.ics.2005.01.018; Dempsey PG, 1997, J OCCUP ENVIRON MED, V39, P748, DOI 10.1097/00043764-199708000-00010; DEYO RA, 1989, SPINE, V14, P501, DOI 10.1097/00007632-198905000-00005; Duthey B., 2013, BACKGROUND PAPER 6 2, DOI [10.1016/j.jpainsymman.2013.03.015 23870413, DOI 10.1016/J.JPAINSYMMAN.2013.03.01523870413]; Ekpenyong CE, 2014, INT J OCCUP SAF ERGO, V20, P447, DOI 10.1080/10803548.2014.11077057; Estruch R, 1998, ALCOHOL CLIN EXP RES, V22, P2023, DOI 10.1111/j.1530-0277.1998.tb05911.x; Feyer AM, 2000, OCCUP ENVIRON MED, V57, P116, DOI 10.1136/oem.57.2.116; FRYMOYER JW, 1983, J BONE JOINT SURG AM, V65, P213, DOI 10.2106/00004623-198365020-00010; Gallagher S., 2008, PHENOMENOLOGICAL MIN; Goda S, 1971, JPN J IND HEALTH, V13, P37; Gourab Biswas, 2017, International Journal of Medical Science and Public Health, V6, P669; Hammer LB, 2013, J OCCUP ENVIRON MED, V55, pS25, DOI 10.1097/JOM.0000000000000043; Himalowa S., 2010, THESIS U W CAPE; HOLMSTROM EB, 1992, SPINE, V17, P663, DOI 10.1097/00007632-199206000-00005; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Jacobsen HB, 2013, J OCCUP ENVIRON MED, V55, P1197, DOI 10.1097/JOM.0b013e31829c76b3; Kaneda Kazuhiro, 2001, Journal of Nippon Medical School, V68, P310, DOI 10.1272/jnms.68.310; Karki K, 2008, WHO STEPS SURVEILLAN; Kent Peter M, 2005, Chiropr Osteopat, V13, P13, DOI 10.1186/1746-1340-13-13; Lambeek LC, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6414; Latza U, 2002, SCAND J WORK ENV HEA, V28, P314, DOI 10.5271/sjweh.680; LEINO P, 1993, PAIN, V53, P89, DOI 10.1016/0304-3959(93)90060-3; Linton SJ, 2000, SPINE, V25, P1148, DOI 10.1097/00007632-200005010-00017; Louw QA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-105; Lovibond S.H., 1996, MANUAL DEPRESSION AN, DOI DOI 10.1037/T01004-000; Mahto PK, 2018, INT J OCCUP SAF HLTH, V8, P3, DOI [10.3126/ijosh.v8i1.22922, DOI 10.3126/IJOSH.V8I1.22922]; Moore SA, 2017, J PSYCHOEDUC ASSESS, V35, P581, DOI 10.1177/0734282916651537; Ohara H., 1993, JJT O M, V42, P413; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P370; Rahimi A, 2015, TRAUMA MON, V20, DOI 10.5812/traumamon.18686; Reddy Gopireddy M M, 2016, Indian J Occup Environ Med, V20, P144, DOI 10.4103/0019-5278.203134; Reese CD., 2006, HDB OSHA CONSTRUCTIO; Sauter SL, 1996, BEYOND BIOMECHANICS, P3; Schuh-Hofer S, 2013, PAIN, V154, P1613, DOI 10.1016/j.pain.2013.04.046; Schumann B, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3164; SHAH RK, 1994, INT ORTHOP, V18, P288; Sharma S, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010304; Shiri R, 2007, EUR SPINE J, V16, P2043, DOI 10.1007/s00586-007-0362-6; Shrestha B. P., 2011, Health Renaissance, V9, P152, DOI 10.3126/hren.v9i3.5582; Shrestha S., 2019, J ADV CIV ENG MANAG, V2; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stats N. Z, 2019, PAK RAIL; SVENSSON HO, 1983, SPINE, V8, P272, DOI 10.1097/00007632-198304000-00007; Telaprolu N., 2013, NATL J COMMUNITY MED, V22, P36; The World Bank, HOSP BED PER 1000 PE; Thelin A, 2008, J REHABIL MED, V40, P555, DOI 10.2340/16501977-0205; Tonsing KN, 2014, ASIAN J PSYCHIATR, V8, P63, DOI 10.1016/j.ajp.2013.11.001; Ueno S, 1999, IND HEALTH, V37, P449, DOI 10.2486/indhealth.37.449; Volinn E, 1997, SPINE, V22, P1747, DOI 10.1097/00007632-199708010-00013; Vrbanic TS-L., 2011, REUMATIZAM, V58, P105; Yang HO, 2018, SPINE, V43, P28, DOI 10.1097/BRS.0000000000001665; Yang HO, 2016, J MANIP PHYSIOL THER, V39, P459, DOI 10.1016/j.jmpt.2016.07.004	59	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252564	10.1371/journal.pone.0252564	http://dx.doi.org/10.1371/journal.pone.0252564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061897	gold, Green Published			2022-12-26	WOS:000656813600033
J	Amiar, S; Husby, ML; Wijesinghe, KJ; Angel, S; Bhattarai, N; Gerstman, BS; Chapagain, PP; Li, S; Stahelin, RV				Amiar, Souad; Husby, Monica L.; Wijesinghe, Kaveesha J.; Angel, Stephanie; Bhattarai, Nisha; Gerstman, Bernard S.; Chapagain, Prem P.; Li, Sheng; Stahelin, Robert, V			Lipid-specific oligomerization of the Marburg virus matrix protein VP40 is regulated by two distinct interfaces for virion assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EBOLA-VIRUS; PLASMA-MEMBRANE; BINDING PROPERTIES; CELLS; DYNAMICS; BRIGHTNESS; MICROSCOPY; VESICLES; NUMBER; DOMAIN	Marburg virus (MARV) is a lipid-enveloped virus harboring a negative-sense RNA genome, which has caused sporadic outbreaks of viral hemorrhagic fever in sub-Saharan Africa. MARV assembles and buds from the host cell plasma membrane where MARV matrix protein (mVP40) dimers associate with anionic lipids at the plasma membrane inner leaflet and undergo a dynamic and extensive self-oligomerization into the structural matrix layer. The MARV matrix layer confers the virion filamentous shape and stability but how host lipids modulate mVP40 oligomerization is mostly unknown. Using in vitro and cellular techniques, we present a mVP40 assembly model highlighting two distinct oligomerization interfaces: the (N-terminal domain [NTD] and C-terminal domain [CTD]) in mVP40. Cellular studies of NTD and CTD oligomerization interface mutants demonstrate the importance of each interface in matrix assembly. The assembly steps include protein trafficking to the plasma membrane, homo-multimerization that induced protein enrichment, plasma membrane fluidity changes, and elongations at the plasma membrane. An ascorbate peroxidase derivative (APEX)-transmission electron microscopy method was employed to closely assess the ultrastructural localization and formation of viral particles for wildtype mVP40 and NTD and CTD oligomerization interface mutants. Taken together, these studies present a mechanistic model of mVP40 oligomerization and assembly at the plasma membrane during virion assembly that requires interactions with phosphatidylserine for NTD-NTD interactions and phosphatidylinositol-4,5-bisphosphate for proper CTD-CTD interactions. These findings have broader implications in understanding budding of lipid-enveloped viruses from the host cell plasma membrane and potential strategies to target protein-protein or lipid-protein interactions to inhibit virus budding.	[Amiar, Souad; Husby, Monica L.; Wijesinghe, Kaveesha J.; Angel, Stephanie; Stahelin, Robert, V] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Wijesinghe, Kaveesha J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Bhattarai, Nisha; Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Dept Phys, Miami, FL 33199 USA; [Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Notre Dame; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of California System; University of California San Diego	Stahelin, RV (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	rstaheli@purdue.edu		Stahelin, Robert/0000-0001-5443-7863; Chapagain, Prem/0000-0002-0999-4975	NIH [AI081077, GM020501, GM121964, AI117905, NS070899, T32 GM075762]; Purdue Pharmacy Live Cell Imaging Facility [NIH OD027034]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue Pharmacy Live Cell Imaging Facility	These studies were supported by the NIH AI081077 to R. V. S., NIH GM020501, GM121964, AI117905, NS070899 to S. L., NIH T32 GM075762 to M. L. H. and K. J. W., and the Purdue Pharmacy Live Cell Imaging Facility (NIH OD027034 R. V. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V103, pL41, DOI 10.1016/j.bpj.2012.09.026; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; [Anonymous], 2019, EB VIR DIS DEM REP C; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Bagatolli LA, 2003, METHOD ENZYMOL, V360, P481; Beer B, 1999, NATURWISSENSCHAFTEN, V86, P8, DOI 10.1007/s001140050562; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Bobone S, 2017, J VIROL, V91, DOI 10.1128/JVI.00267-17; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Breman JG, 2016, J INFECT DIS, V214, pS93, DOI 10.1093/infdis/jiw207; DARSZON A, 1980, P NATL ACAD SCI-BIOL, V77, P239, DOI 10.1073/pnas.77.1.239; de Armas-Rillo L, 2016, REV MED VIROL, V26, P146, DOI 10.1002/rmv.1872; Del Vecchio K, 2018, J BIOL CHEM, V293, P3335, DOI 10.1074/jbc.M117.816280; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Feldmann H, 1993, Arch Virol Suppl, V7, P81; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Gc JB, 2016, PHYS CHEM CHEM PHYS, V18, P28409, DOI 10.1039/c6cp03776c; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 2018, METHODS MOL BIOL, V1604, P209, DOI 10.1007/978-1-4939-6981-4_15; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Hilsch M, 2014, BIOPHYS J, V107, P912, DOI 10.1016/j.bpj.2014.06.042; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hogue IB, 2011, J VIROL, V85, P9749, DOI 10.1128/JVI.00743-11; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Johnson KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19125; Julkowska Magdalena M, 2013, Methods Mol Biol, V1009, P261, DOI 10.1007/978-1-62703-401-2_24; Ketter E, 2019, ANNU REV VIROL, V6, P319, DOI 10.1146/annurev-virology-092818-015748; Koehler A, 2018, J GEN VIROL, V99, P1614, DOI 10.1099/jgv.0.001169; Kolesnikova L, 2004, J VIROL, V78, P12277, DOI 10.1128/JVI.78.22.12277-12287.2004; Kolesnikova L, 2004, J VIROL, V78, P2382, DOI 10.1128/JVI.78.5.2382-2393.2004; Kolesnikova L, 2002, J VIROL, V76, P1825, DOI 10.1128/JVI.76.4.1825-1838.2002; Kolesnikova L, 2007, J INFECT DIS, V196, pS232, DOI 10.1086/520584; Krementsov DN, 2010, TRAFFIC, V11, P1401, DOI 10.1111/j.1600-0854.2010.01111.x; Leroy EM, 2011, CLIN MICROBIOL INFEC, V17, P964, DOI 10.1111/j.1469-0691.2011.03535.x; Liu YL, 2010, J VIROL, V84, P2294, DOI 10.1128/JVI.02034-09; Lu JH, 2013, J VIROL, V87, P7777, DOI 10.1128/JVI.00470-13; Madsen JJ, 2018, P NATL ACAD SCI USA, V115, pE8595, DOI 10.1073/pnas.1805443115; Makino A, 2011, J INFECT DIS, V204, pS871, DOI 10.1093/infdis/jir309; Mucksch F, 2017, ELIFE, V6, DOI 10.7554/eLife.25287; Nakai K, 2006, J VIROL, V80, P11265, DOI 10.1128/JVI.01203-06; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Oda S, 2016, J VIROL, V90, P1839, DOI 10.1128/JVI.01597-15; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasband, 2015, IMAGEJ SOFTWARE; REEVES JP, 1969, J CELL PHYSIOL, V73, P49, DOI 10.1002/jcp.1040730108; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Slenczka W, 2007, J INFECT DIS, V196, pS131, DOI 10.1086/520551; Suzuki Y, 1997, MOL BIOL EVOL, V14, P800, DOI 10.1093/oxfordjournals.molbev.a025820; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Wan W, 2020, ELIFE, V9, DOI 10.7554/eLife.59225; Wijesinghe KJ, 2017, J BIOL CHEM, V292, P6108, DOI 10.1074/jbc.M116.758300; Wijesinghe KJ, 2016, J VIROL, V90, P3074, DOI 10.1128/JVI.02607-15; Yamashita Y, 2002, BBA-BIOMEMBRANES, V1561, P129, DOI 10.1016/S0005-2736(02)00338-3; You CJ, 2014, ANAL BIOANAL CHEM, V406, P3345, DOI 10.1007/s00216-014-7803-y; Youker RT, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.090801	63	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100796	10.1016/j.jbc.2021.100796	http://dx.doi.org/10.1016/j.jbc.2021.100796			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019871	Green Published, gold			2022-12-26	WOS:000674717300016
J	Ingram, SM; Rana, T; Manson, AM; Yayah, FM; Jackson, EGB; Anderson, C; Davids, BO; Goodwin, JS				Ingram, Shalonda M.; Rana, Tanu; Manson, Ashley M.; Yayah, Faisal M.; Jackson, Evan G. B.; Anderson, Christopher; Davids, Benem-Orom; Goodwin, J. Shawn			Optogenetically-induced multimerization of the dopamine transporter increases uptake and trafficking to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS CRYPTOCHROMES; CIRCADIAN CLOCK; CROSS-LINKING; COCAINE; AMPHETAMINE; METHAMPHETAMINE; OLIGOMERIZATION; MECHANISM; LIGHT; NEURONS	The dopamine transporter (DAT) is essential for the reup-take of the released neurotransmitter dopamine (DA) in the brain. Psychostimulants, methamphetamine and cocaine, have been reported to induce the formation of DAT multimeric complexes in vivo and in vitro. The interpretation of DAT multimer function has been primarily in the context of compounds that induce structural and functional modifications of the DAT, complicating the understanding of the significance of DAT multimers. To examine multimerization in the absence of DAT ligands as well as in their presence, we developed a novel, optogenetic fusion chimera of cryptochrome 2 and DAT with an mCherry fluorescent reporter (Cry2-DAT). Using blue light to induce Cry2-DAT multimeric protein complex formation, we were able to simultaneously test the functional contributions of DAT multimerization in the absence or presence of substrates or inhibitors with high spatiotemporal precision. We found that blue light-stimulated Cry2-DAT multimers significantly increased IDT307 uptake and MFZ 9-18 binding in the absence of ligands as well as after methamphetamine and nomifensine treatment. Blue light-induced Cry2-DAT multimerization increased colocalization with recycling endosomal marker Rab11 and had decreased presence in Rab5-positive early endosomes and Rab7-positive late endosomes. Our data suggest that the increased uptake and binding results from induced and rapid trafficking of DAT multimers to the plasma membrane. Our data suggest that DAT multimers may function to help maintain DA homeostasis.	[Ingram, Shalonda M.; Rana, Tanu; Manson, Ashley M.; Yayah, Faisal M.; Jackson, Evan G. B.; Anderson, Christopher; Davids, Benem-Orom; Goodwin, J. Shawn] Meharry Med Coll, Sch Med, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA	Meharry Medical College	Goodwin, JS (corresponding author), Meharry Med Coll, Sch Med, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA.	jgoodwin@mmc.edu			NIH [DA036420, GM059994]; HRSA Grant [D34HP16299-10-00]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HRSA Grant	This work was funded by NIH Grants DA036420 (to J. S. G. and T. R.) and GM059994 (to S. M. I. and B.-O. D.), and HRSA Grant D34HP16299-10-00 (to A. M. M., F. M. Y., C. A., and E. G. B. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baucum AJ, 2004, J NEUROSCI, V24, P3436, DOI 10.1523/JNEUROSCI.0387-04.2004; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Burney S, 2009, FEBS LETT, V583, P1427, DOI 10.1016/j.febslet.2009.03.040; Butler B, 2015, J BIOL CHEM, V290, P29542, DOI 10.1074/jbc.M115.691592; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chang JC, 2012, J NEUROSCI, V32, P8919, DOI 10.1523/JNEUROSCI.0048-12.2012; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Chen R, 2009, J PHARMACOL EXP THER, V328, P912, DOI 10.1124/jpet.108.147959; Cheng MH, 2017, J BIOL CHEM, V292, P12471, DOI 10.1074/jbc.M116.763565; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; Das AK, 2019, J BIOL CHEM, V294, P5632, DOI 10.1074/jbc.RA118.006178; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Duan HC, 2015, DRUG METAB DISPOS, V43, P1773, DOI 10.1124/dmd.115.064824; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Furman CA, 2009, NEUROSCI LETT, V463, P78, DOI 10.1016/j.neulet.2009.07.049; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Gabriel LR, 2013, J NEUROSCI, V33, P17836, DOI 10.1523/JNEUROSCI.3284-13.2013; German CL, 2012, J NEUROCHEM, V123, P288, DOI 10.1111/j.1471-4159.2012.07875.x; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Goodwin JS, 2005, BIOPHYS J, V89, P1398, DOI 10.1529/biophysj.104.055640; Gulley JM, 2003, EUR J PHARMACOL, V479, P139, DOI 10.1016/j.ejphar.2003.08.064; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hong WMC, 2013, FASEB J, V27, P2995, DOI 10.1096/fj.12-218727; Johnson LA, 2005, NEUROPHARMACOLOGY, V49, P750, DOI 10.1016/j.neuropharm.2005.08.018; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Karpowicz RJ, 2013, ACS CHEM NEUROSCI, V4, P858, DOI 10.1021/cn400038u; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lebowitz JJ, 2019, J BIOL CHEM, V294, P6957, DOI 10.1074/jbc.RA119.007441; Li Y, 2010, J NEUROCHEM, V114, P873, DOI 10.1111/j.1471-4159.2010.06818.x; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Muhlhauser WWD, 2017, BBA-MOL CELL RES, V1864, P280, DOI 10.1016/j.bbamcr.2016.11.009; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Shipley MM, 2016, JOVE-J VIS EXP, DOI 10.3791/53193; Siciliano CA, 2018, J NEUROSCI, V38, P484, DOI 10.1523/JNEUROSCI.2604-17.2017; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2018, ELIFE, V7, DOI 10.7554/eLife.32293; Swant J, 2011, J BIOL CHEM, V286, P43933, DOI 10.1074/jbc.M111.241232; Taslimi A, 2016, NAT CHEM BIOL, V12, P425, DOI [10.1038/nchembio.2063, 10.1038/NCHEMBIO.2063]; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Volz TJ, 2007, ADDICTION, V102, P44, DOI 10.1111/j.1360-0443.2007.01771.x; Wu SJ, 2017, J NEUROSCI, V37, P9438, DOI 10.1523/JNEUROSCI.3885-16.2017; Wu S, 2015, P NATL ACAD SCI USA, V112, P15480, DOI 10.1073/pnas.1512957112; Xie ZH, 2009, J PHARMACOL EXP THER, V330, P316, DOI 10.1124/jpet.109.153775; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang YJ, 2008, MOL PLANT, V1, P167, DOI 10.1093/mp/ssm018; Yanovsky MJ, 2001, J BIOL RHYTHM, V16, P523, DOI 10.1177/074873001129002213; Yorgason JT, 2011, NEUROSCIENCE, V182, P125, DOI 10.1016/j.neuroscience.2011.03.017; Zhen J, 2018, J NEUROCHEM, V144, P162, DOI 10.1111/jnc.14259; Zhen J, 2015, J NEUROCHEM, V133, P167, DOI 10.1111/jnc.13025; Zhu J, 2008, CNS NEUROL DISORD-DR, V7, P393, DOI 10.2174/187152708786927877	71	0	0	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100787	10.1016/j.jbc.2021.100787	http://dx.doi.org/10.1016/j.jbc.2021.100787			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34015332	gold, Green Published			2022-12-26	WOS:000674717300008
J	Maras, B; Maggiore, A; Mignogna, G; D'Erme, M; Angiolella, L				Maras, Bruno; Maggiore, Anna; Mignogna, Giuseppina; D'Erme, Maria; Angiolella, Letizia			Hyperexpression of CDRs and HWP1 genes negatively impacts on Candida albicans virulence	PLOS ONE			English	Article							EXPRESSION; TRANSCRIPTION; RESISTANCE; STRAINS; FAMILY; TAC1P; SAP4	C. albicans is a commensal organism present in the human microbiome of more than 60% of the healthy population. Transition from commensalism to invasive candidiasis may occur after a local or a general failure of host's immune system. This transition to a more virulent phenotype may reside either on the capacity to form hyphae or on an acquired resistance to antifungal drugs. Indeed, overexpression of genes coding drug efflux pumps or adhesins, cell wall proteins facilitating the contact between the fungus and the host, usually marks the virulence profile of invasive Candida spp. In this paper, we compare virulence of two clinical isolates of C. albicans with that of laboratory-induced resistant strains by challenging G. mellonella larvae with these pathogens along with monitoring transcriptional profiles of drug efflux pumps genes CDR1, CDR2, MDR1 and the adhesin genes ALS1 and HWP1. Although both clinical isolates were found resistant to both fluconazole and micafungin they were found less virulent than laboratory- induced resistant strains. An unexpected behavior emerged for the former clinical isolate in which three genes, CDR1, CDR2 and HWP1, usually correlated with virulence, although hyperexpressed, conferred a less aggressive phenotype. On the contrary, in the other isolate, we observed a decreased expression of CDR1, CDR2 and HWP1as well as of MDR1 and ALS1 that may be consistent with the less aggressive performance observed in this strain. These altered gene expressions might directly influence Candida virulence or they might be an epiphenomenon of a vaster rearrangement occurred in these strains during the challenge with the host's environment. An in-deepth comprehension of this scenario could be crucial for developing interventions able to counteract C. albicans invasiveness and lethality.	[Maras, Bruno; Maggiore, Anna; Mignogna, Giuseppina; D'Erme, Maria] Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Rome, Italy; [Angiolella, Letizia] Sapienza Univ Roma, Dipartimento Sanita Pubbl & Malattie Infett, Rome, Italy	Sapienza University Rome; Sapienza University Rome	Angiolella, L (corresponding author), Sapienza Univ Roma, Dipartimento Sanita Pubbl & Malattie Infett, Rome, Italy.	letizia.angiolella@uniroma1.it	Angiolella, Letizia/P-3878-2015	Angiolella, Letizia/0000-0002-0473-5587	 [RM 1181641E9150B3]		LA, GM, BM. Grant number: RM 1181641E9150B3 Sapienza University of Rome https://wwwuniroma1.it The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolella L, 2002, ANTIMICROB AGENTS CH, V46, P1688, DOI 10.1128/AAC.46.6.1688-1694.2002; Angiolella L, 2008, ANTIMICROB AGENTS CH, V52, P927, DOI 10.1128/AAC.01223-07; Bhattacharya S, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9060312; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Coste A, 2006, GENETICS, V172, P2139, DOI 10.1534/genetics.105.054767; D'Enfert C., 2021, FEMS Microbiology Reviews, V45, DOI 10.1093/femsre/fuaa060; de Groot PWJ, 2013, EUKARYOT CELL, V12, P470, DOI 10.1128/EC.00364-12; Felk A, 2002, INFECT IMMUN, V70, P3689, DOI 10.1128/IAI.70.7.3689-3700.2002; Garcia-Rubio R, 2020, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02993; Harding CR, 2013, JOVE-J VIS EXP, DOI 10.3791/50964; Hosseini SS, 2019, MYCOPATHOLOGIA, V184, P261, DOI 10.1007/s11046-019-00327-w; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Huang GH, 2019, MOL MICROBIOL, V111, P6, DOI 10.1111/mmi.14148; Kim S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192260; Kumar CPG, 2006, MYCOPATHOLOGIA, V161, P213, DOI 10.1007/s11046-005-0157-4; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Liu ZL, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01342-17; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohberger A, 2014, EUKARYOT CELL, V13, P127, DOI 10.1128/EC.00245-13; Maras B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098387; Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Naglik JR, 1999, INFECT IMMUN, V67, P2482, DOI 10.1128/IAI.67.5.2482-2490.1999; Nas T, 2008, FOLIA MICROBIOL, V53, P179; National Committee for Clinical Laboratory Standards (NCCLS), 12ILA6T1992 NCCLS, V30th; Pappas PC, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.26; Romera D, 2020, PATHOG DIS, V78, DOI 10.1093/femspd/ftaa067; Romo JA, 2020, J FUNGI, V6, DOI 10.3390/jof6010016; Shah AH, 2014, BIOCHEM J, V460, P223, DOI 10.1042/BJ20140010; Shariq M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46084; Sundstrom P, 2002, J INFECT DIS, V185, P521, DOI 10.1086/338836	31	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252555	10.1371/journal.pone.0252555	http://dx.doi.org/10.1371/journal.pone.0252555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061886	Green Published, gold			2022-12-26	WOS:000656813600049
J	Ueda, K; Sekoguchi, T; Yanagisawa, H				Ueda, Kazutaka; Sekoguchi, Takahiro; Yanagisawa, Hideyoshi			How predictability affects habituation to novelty	PLOS ONE			English	Article							P300 HABITUATION; COMPLEXITY; STIMULUS; MODEL; ACETYLCHOLINE; RESPONSES; COGNITION; RELEASE; AROUSAL; GABA	One becomes accustomed to repeated exposures, even for a novel event. In the present study, we investigated how predictability affects habituation to novelty by applying a mathematical model of arousal that we previously developed, and through the use of psychophysiological experiments to test the model's prediction. We formalized habituation to novelty as a decrement in Kullback-Leibler divergence from Bayesian prior to posterior (i.e., information gain) representing arousal evoked from a novel event through Bayesian update. The model predicted an interaction effect between initial uncertainty and initial prediction error (i.e., predictability) on habituation to novelty: the greater the initial uncertainty, the faster the decrease in information gain (i.e., the sooner habituation occurs). This prediction was supported by experimental results using subjective reports of surprise and event-related potential (P300) evoked by visual-auditory incongruity. Our findings suggest that in highly uncertain situations, repeated exposure to stimuli can enhance habituation to novel stimuli.	[Ueda, Kazutaka] Univ Tokyo, Dept Mech Engn, Creat Design Lab, Tokyo, Japan; [Sekoguchi, Takahiro; Yanagisawa, Hideyoshi] Univ Tokyo, Dept Mech Engn, Design Engn Lab, Tokyo, Japan	University of Tokyo; University of Tokyo	Yanagisawa, H (corresponding author), Univ Tokyo, Dept Mech Engn, Design Engn Lab, Tokyo, Japan.	hide@mech.t.u-tokyo.ac.jp	Yanagisawa, Hideyoshi/AAY-3731-2020	Yanagisawa, Hideyoshi/0000-0002-0175-7537	KAKEN from the Japan Society for the Promotion of Science [18H03318, 21H03528]	KAKEN from the Japan Society for the Promotion of Science	This study was supported by KAKEN grant number 18H03318 and 21H03528 from the Japan Society for the Promotion of Science.	Acquas E, 1996, J NEUROSCI, V16, P3089; Bennett D, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13431; Bennett D, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0076-15.2015; BERLYNE DE, 1970, PERCEPT PSYCHOPHYS, V8, P279, DOI 10.3758/BF03212593; BRADLEY MM, 1993, BEHAV NEUROSCI, V107, P970, DOI 10.1037/0735-7044.107.6.970; Colibazzi T, 2010, EMOTION, V10, P377, DOI 10.1037/a0018484; Croy I, 2013, INT J PSYCHOPHYSIOL, V88, P104, DOI 10.1016/j.ijpsycho.2013.02.005; Fonken YM, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13400; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Itti L, 2009, VISION RES, V49, P1295, DOI 10.1016/j.visres.2008.09.007; Kececi H, 2006, COGN BEHAV NEUROL, V19, P130, DOI 10.1097/01.wnn.0000213911.80019.c1; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KOECHLING UM, 1991, ALCOHOL ALCOHOLISM, V26, P315, DOI 10.1093/oxfordjournals.alcalc.a045117; Kolossa A, 2015, NEUROIMAGE, V106, P222, DOI 10.1016/j.neuroimage.2014.11.007; Kolossa A, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00359; Kopp B., 2007, COGNITIVE SCI, V2, P113; Kopp B, 2016, COGN AFFECT BEHAV NE, V16, P911, DOI 10.3758/s13415-016-0442-3; LECUYER R, 1989, HUM DEV, V32, P148, DOI 10.1159/000276462; Levy CM, 2006, ACTA PSYCHOL, V123, P394, DOI 10.1016/j.actpsy.2006.06.006; LEW GS, 1993, PHYSIOL BEHAV, V53, P111, DOI 10.1016/0031-9384(93)90018-B; Littman M.L, 1994, P 11 INT C INT C MAC, P157; Mars RB, 2008, J NEUROSCI, V28, P12539, DOI 10.1523/JNEUROSCI.2925-08.2008; Mullen TR, 2015, IEEE T BIO-MED ENG, V62, P2553, DOI 10.1109/TBME.2015.2481482; Okubo Matia, 2014, Shinrigaku Kenkyu, V85, P474; Pan JB, 2000, INT J PSYCHOPHYSIOL, V37, P149, DOI 10.1016/S0167-8760(00)00086-6; POLICH J, 1989, PSYCHOBIOLOGY, V17, P19; POLICH J, 1994, INT J PSYCHOPHYSIOL, V17, P25, DOI 10.1016/0167-8760(94)90052-3; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ravden D, 1998, INT J PSYCHOPHYSIOL, V30, P359, DOI 10.1016/S0167-8760(98)00039-7; Ravden D, 1999, BIOL PSYCHOL, V51, P59, DOI 10.1016/S0301-0511(99)00015-0; Romero R, 1996, PHYSIOL BEHAV, V59, P517, DOI 10.1016/0031-9384(95)02099-3; Sekoguchi T., 2019, INT S AFF SCI ENG, V2019, P1, DOI [10.5057/isase.2019-C000036, DOI 10.5057/ISASE.2019-C000036]; Sekoguchi T, 2019, IEEE SYS MAN CYBERN, P1115, DOI 10.1109/SMC.2019.8914626; Silvia PJ, 2005, REV GEN PSYCHOL, V9, P342, DOI 10.1037/1089-2680.9.4.342; STEIN L, 1966, PSYCHOL REV, V73, P352, DOI 10.1037/h0023449; Stone EA, 2006, SYNAPSE, V59, P299, DOI 10.1002/syn.20243; Wintink AJ, 2001, BRAIN COGNITION, V46, P307, DOI 10.1016/S0278-2626(01)80090-7; Yanagisawa H, 2019, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00002; Yanagisawa H, 2016, J SENS STUD, V31, P430, DOI 10.1111/joss.12233	39	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0237278	10.1371/journal.pone.0237278	http://dx.doi.org/10.1371/journal.pone.0237278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SL3JC	34061853	Green Submitted, Green Published, gold			2022-12-26	WOS:000656813600025
J	Gaborit, B; Govers, R; Altie, A; Brunel, JM; Morange, P; Peiretti, F				Gaborit, Benedicte; Govers, Roland; Altie, Alexandre; Brunel, Jean Michel; Morange, Pierre; Peiretti, Franck			The aminosterol Claramine inhibits beta-secretase 1-mediated insulin receptor cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; GOLGI NETWORK; UBIQUITIN; DEGRADATION; AUTOPHAGY; PROTEASOME; BACE1; SENSITIVITY	The cleavage of the insulin receptor by beta-secretase 1 (BACE1) in the liver increases during diabetes, which contributes to reduce insulin receptor levels and impair insulin signaling. However, the precise signaling events that lead to this increased cleavage are unclear. We showed that BACE1 cleaves the insulin receptor in the early secretory pathway. Indeed, coimmunoprecipitation experiments reveal the interaction of the proforms of the two proteins. Moreover, fragments of insulin receptor are detected in the early secretory pathway and a mutated form of BACE1 that retains its prodomain cleaves an early secretory pathway-resident form of the insulin receptor. We showed that BACE1 proform levels are regulated by proteasome and/or lysosome-dependent degradation systems whose efficiencies are dependent on the O-GlcNacylation process. Our results showed that enhanced O-GlcNacylation reduces the efficiency of intracellular protein degradation systems, leading to the accumulation of the proform of BACE1 in the early secretory pathway where it cleaves the precursor of the insulin receptor. All these dysregulations are found in the livers of diabetic mice. In addition, we performed a screen of molecules according to their ability to increase levels of the insulin receptor at the surface of BACE1-overexpressing cells. This approach identified the aminosterol Claramine, which accelerated intracellular trafficking of the proform of BACE1 and increased autophagy. Both of these effects likely contribute to the reduced amount of the proform of BACE1 in the early secretory pathway, thereby reducing insulin receptor cleavage. These newly described properties of Claramine are consistent with its insulin sensitizing effect.	[Gaborit, Benedicte; Govers, Roland; Altie, Alexandre; Morange, Pierre; Peiretti, Franck] Aix Marseille Univ, C2VN, INRAE, INSERM, Marseille, France; [Gaborit, Benedicte] AP HM, Endocrinol Metab Dis & Nutr Dept, Marseille, France; [Brunel, Jean Michel] Aix Marseille Univ, MCT, SSA, INSERM, Marseille, France; [Morange, Pierre] La Timone Hosp, AP HM, Hematol Lab, Marseille, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Peiretti, F (corresponding author), Aix Marseille Univ, C2VN, INRAE, INSERM, Marseille, France.	franck.peiretti@univ-amu.fr	GABORIT, Bénédicte/AAK-3842-2020; Peiretti, Franck/GLV-3378-2022; peiretti, franck/L-2718-2017; Morange, Pierre/T-9070-2019; Govers, Roland/O-5782-2016	GABORIT, Bénédicte/0000-0002-4180-158X; Peiretti, Franck/0000-0001-7198-0534; peiretti, franck/0000-0001-7198-0534; Morange, Pierre/0000-0002-9065-722X; Govers, Roland/0000-0003-1359-5333	Institut National de la Sante et la Recherche Medicale (Inserm)	Institut National de la Sante et la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank J.F. Landrier, J. Astier, and C. Couturier for providing mouse liver samples. Funding was obtained from Institut National de la Sante et la Recherche Medicale (Inserm).	Bao J, 2018, P NATL ACAD SCI USA, V115, P3954, DOI 10.1073/pnas.1800498115; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Beckman M, 2006, BIOCHEMISTRY-US, V45, P6703, DOI 10.1021/bi052498t; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Blanchet M, 2018, CHEMMEDCHEM, V13, P1018, DOI 10.1002/cmdc.201800073; Blanquart C, 2005, MOL PHARMACOL, V68, P885, DOI 10.1124/mol.105.013151; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Cao JQ, 2019, NEUROSCI LETT, V703, P68, DOI 10.1016/j.neulet.2019.03.016; Choi E, 2016, CELL, V166, P567, DOI 10.1016/j.cell.2016.05.074; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Dev R, 2018, ANN ONCOL, V29, P18, DOI 10.1093/annonc/mdx815; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Dodd GT, 2019, CELL REP, V28, P2905, DOI 10.1016/j.celrep.2019.08.019; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fregno I, 2019, CRIT REV BIOCHEM MOL, V54, P153, DOI 10.1080/10409238.2019.1610351; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Kang EL, 2012, J BIOL CHEM, V287, P42867, DOI 10.1074/jbc.M112.407072; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kara I, 2015, J BIOL CHEM, V290, P2812, DOI 10.1074/jbc.M114.592543; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; Kocaturk NM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00128; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kou XJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090927; Krishnan N, 2018, J BIOL CHEM, V293, P1517, DOI 10.1074/jbc.C117.819110; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Meakin PJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03755-2; Nagarajan A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12639; Neth BJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00345; Opoku-Nsiah KA, 2018, TRANSL RES, V198, P48, DOI 10.1016/j.trsl.2018.05.002; Ortiz-Meoz RF, 2015, ACS CHEM BIOL, V10, P1392, DOI 10.1021/acschembio.5b00004; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pomytkin I, 2018, CNS NEUROSCI THER, V24, P763, DOI 10.1111/cns.12866; Qin ZH, 2015, BIOCHEM BIOPH RES CO, V458, P21, DOI 10.1016/j.bbrc.2015.01.040; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Rahman MA, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6279313; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schmidt V, 2016, J CLIN INVEST, V126, P2706, DOI 10.1172/JCI84708; Singh AK, 2015, AGING CELL, V14, P595, DOI 10.1111/acel.12335; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Vella V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113615; Vieira MNN, 2017, FRONT AGING NEUROSCI, V9, DOI [10.3389/fnagi.2077.00007, 10.3389/fnagi.2017.00007]; Wang YC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124945; Wani WY, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0311-1; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Yamagishi N, 2012, BIOCHEM BIOPH RES CO, V417, P364, DOI 10.1016/j.bbrc.2011.11.118; Yamamoto S, 2018, CELL REP, V23, P3286, DOI 10.1016/j.celrep.2018.05.032; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhang KZ, 2018, DIABETES, V67, P180, DOI 10.2337/dbi17-0048; Zhang L, 2013, J LIPID RES, V54, P1410, DOI 10.1194/jlr.M035774; Zhang MM, 2012, J NEUROCHEM, V120, P1129, DOI 10.1111/j.1471-4159.2011.07644.x	58	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100818	10.1016/j.jbc.2021.100818	http://dx.doi.org/10.1016/j.jbc.2021.100818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029592	gold, Green Published, Green Submitted			2022-12-26	WOS:000678068400020
J	Nie, YY; Li, YX; Liu, L; Ren, SY; Tian, YH; Yang, F				Nie, Yingying; Li, Yanxin; Liu, Lei; Ren, Shouyan; Tian, Yuhua; Yang, Fan			Molecular mechanism underlying modulation of TRPV1 heat activation by polyols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN-RECEPTOR; ION-CHANNEL; THERMAL-STABILITY; PORE TURRET; TEMPERATURE; THERMOSENSATION; FRAMEWORK; RESPONSES; SOLUTES; DOMAIN	Sensing noxiously high temperatures is crucial for living organisms to avoid heat-induced injury. The TRPV1 channel has long been known as a sensor for noxious heat. However, the mechanism of how this channel is activated by heat remains elusive. Here we found that a series of polyols including sucrose, sorbitol, and hyaluronan significantly elevate the heat activation threshold temperature of TRPV1. The modulatory effects of these polyols were only observed when they were perfused extracellularly. Interestingly, mutation of residues E601 and E649 in the outer pore region of TRPV1 largely abolished the effects of these polyols. We further observed that intraplantar injection of polyols into the hind paws of rats reduced their heat-induced pain response. Our observations not only suggest that the extracellular regions of TRPV1 are critical for the modulation of heat activation by polyols, but also indicate a potential role of polyols in reducing heat-induced pain sensation.	[Nie, Yingying; Li, Yanxin; Liu, Lei; Tian, Yuhua] Qingdao Univ, Sch Pharm, Dept Pharmacol, Med Coll, Qingdao, Peoples R China; [Ren, Shouyan] Qingdao Univ, Dept Otorhinolaryngol, Affiliated Hosp, Qingdao, Shandong, Peoples R China; [Yang, Fan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Biophys, Hangzhou, Zhejiang, Peoples R China; [Yang, Fan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Kidney Dis Ctr, Hangzhou, Zhejiang, Peoples R China	Qingdao University; Qingdao University; Zhejiang University; Zhejiang University	Tian, YH (corresponding author), Qingdao Univ, Sch Pharm, Dept Pharmacol, Med Coll, Qingdao, Peoples R China.; Yang, F (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Biophys, Hangzhou, Zhejiang, Peoples R China.; Yang, F (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Kidney Dis Ctr, Hangzhou, Zhejiang, Peoples R China.	yhtian05250@qdu.edu.cn; fanyanga@zju.edu.cn	Yang, Fan/AAA-6904-2022	Yang, Fan/0000-0002-0520-5254; Tian, Yuhua/0000-0001-8239-6560	National Natural Science Foundation of China [31971040, 31800990]; Zhejiang Provincial Natural Science Foundation of China [LR20C050002]; Natural Science Foundation of Shandong Province [ZR2020MH161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by National Natural Science Foundation of China (31971040 and 31800990 to F. Y.), Zhejiang Provincial Natural Science Foundation of China (LR20C050002 to F. Y.), and Natural Science Foundation of Shandong Province (ZR2020MH161 to Y. T.).	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bae C, 2016, ELIFE, V5, DOI 10.7554/eLife.11273; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Caires R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9095; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao X, 2014, J GEN PHYSIOL, V143, P75, DOI 10.1085/jgp.201311025; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chowdhury S, 2014, CELL, V158, P1148, DOI 10.1016/j.cell.2014.07.026; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; Davis-Searles PR, 2001, ANNU REV BIOPH BIOM, V30, P271, DOI 10.1146/annurev.biophys.30.1.271; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Du GX, 2020, J BIOL CHEM, V295, P9641, DOI 10.1074/jbc.RA120.013037; Feng Q, 2014, CURR TOP MEMBR, V74, P19, DOI 10.1016/B978-0-12-800181-3.00002-6; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Jara-Oseguera A, 2016, ELIFE, V5, DOI 10.7554/eLife.13356; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Lee SL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1917745; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liao YH, 2002, PHARM RES-DORDR, V19, P1847, DOI 10.1023/A:1021445608807; Liu FF, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3453713; Nolden AA, 2019, PHYSIOL BEHAV, V208, DOI 10.1016/j.physbeh.2019.05.018; O'Connor TF, 2004, J AM CHEM SOC, V126, P11794, DOI 10.1021/ja0481777; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pozo MA, 1997, EXP BRAIN RES, V116, P3, DOI 10.1007/PL00005742; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Xu LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17582-x; Yang F, 2020, ADV SCI, V7, DOI 10.1002/advs.202000575; Yang F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05339-6; Yang F, 2015, NAT CHEM BIOL, V11, P518, DOI [10.1038/NCHEMBIO.1835, 10.1038/nchembio.1835]; Yang F, 2014, J GEN PHYSIOL, V143, P91, DOI 10.1085/jgp.201311024; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yang S., 2020, P NATL ACAD SCI USA, V117, P22714; Yang SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700810; Yang SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9297; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Zhu AQ, 2020, TOXICON, V178, P41, DOI 10.1016/j.toxicon.2020.02.016	51	3	3	6	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100806	10.1016/j.jbc.2021.100806	http://dx.doi.org/10.1016/j.jbc.2021.100806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34022223	gold, Green Published			2022-12-26	WOS:000678068400011
J	Gerschermann, S; Ballhaus, C; Gab, F				Gerschermann, Sydney; Ballhaus, Chris; Gaeb, Fabian			Rheological properties of calcite oozes: Implications for the fossilisation in the plattenkalks of the Solnhofen-Eichstatt lagoons in the Franconian Alb, Germany	PLOS ONE			English	Article							HUNSRUCK SLATE; TRILOBITE BED; STROMATOLITES; DIAGENESIS; DECAY; AREA	We report on an experimental study to investigate the sedimentation behaviour and rheological properties of extremely fine-grained calcite oozes. The experiments are aimed at clarifying if thixotropic behaviour may have played a role in the preservation of marine biota in plattenkalks of the Solnhofen lagoons of the Franconian Alb. Calcite particles with grain sizes from 2.2 to 4.4 mu m were sedimented from water, seawater proxies, and hypersaline brines with up to 14 wt.% NaCl, for 170 days. High salinities as envisioned for the bottom waters of some Solnhofen lagoons slow down settling rates of calcite and may produce plattenkalks more porous and more friable than plattenkalks elsewhere in the Solnhofen archipelago. Rheological properties of calcite suspensions were measured with an oscillation rheometer. Calcite oozes with 40 vol.% calcite in suspension behave thixotropically regardless of the salinity of the pore solutions. Thixotropic behaviour may have the potential to promote the fossilisation of marine biota. Even if the sediment cover is thin, i.e. a few millimeters, a carcass covered by a thixotropic sediment would be largely isolated from the overlying water column because pore solutions in thixotropic media hardly communicate with the overlying water column. A fish carcass covered by a thixotropic sediment could impose local-scale physicochemical conditions on its direct sedimentary envelope favourable for preservation and the replacement of organic material by inorganic materials.	[Gerschermann, Sydney; Ballhaus, Chris; Gaeb, Fabian] Univ Bonn, Inst Geowissensch, Bonn, Germany; [Gerschermann, Sydney] Univ Cologne, Geograph Inst, Cologne, Germany	University of Bonn; University of Cologne	Ballhaus, C (corresponding author), Univ Bonn, Inst Geowissensch, Bonn, Germany.	ballhaus@uni-bonn.de			German Research Council (DFG) [Ba 964/36]	German Research Council (DFG)(German Research Foundation (DFG))	C.B. Ba 964/36 Chris Ballhaus Financial support by the German Research Council (DFG). https://www.dfg.de/.This is contribution no. 39 of the DFG Research Unit 2685 "The Limits of the Fossil Record: Analytical and Experimental Approaches to Fossilization". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON PA, 1988, PALEOBIOLOGY, V14, P139, DOI 10.1017/S009483730001188X; [Anonymous], 2010, ANN BOOK ASTM STANDA; [Anonymous], 2008, 5301912008 DIN; Barnes HA, 1997, J NON-NEWTON FLUID, V70, P1, DOI 10.1016/S0377-0257(97)00004-9; Barthel K. W., 1964, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V4, P37; Barthel K.W., 1990, SOLNHOFEN STUDY MESO; Boswell P., 1948, Q J GEOLOGICAL SOC, V104, P499, DOI [10.1144/GSL.JGS.1948.104.01-04.23, DOI 10.1144/GSL.JGS.1948.104.01-04.23]; BRETT C E, 1986, Palaios, V1, P207, DOI 10.2307/3514686; BRIGGS DEG, 1991, GEOLOGY, V19, P1221, DOI 10.1130/0091-7613(1991)019<1221:POSBFB>2.3.CO;2; Burns BP, 2004, ENVIRON MICROBIOL, V6, P1096, DOI 10.1111/j.1462-2920.2004.00651.x; De Baets K, 2013, PALAEONTOGR ABT A, V299, P1; de H.D, 1818, NOUVEAU DICT DHISTOI, V27, P310; Dupraz C, 2005, TRENDS MICROBIOL, V13, P429, DOI 10.1016/j.tim.2005.07.008; Ebert M., 2011, AM J PATHOL, V179, P2720; Ebert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116140; Ebert Martin, 2013, Archaeopteryx, V31, P22; Freundlich H, 1928, KOLLOID Z, V46, P289, DOI 10.1007/BF01422714; Fuersich FT, 2007, PALAEOGEOGR PALAEOCL, V243, P92, DOI 10.1016/j.palaeo.2006.07.007; Gub F., 2020, SCI REP-UK, V10, P1, DOI DOI 10.1038/S41598-019-56847-4; HALLAM A, 1975, JURASSIC ENV; Iniesto M, 2013, PALAIOS, V28, P56, DOI 10.2110/palo.2011.p11-099r; Jeong SW., 2006, INFLUENCE PHYS CHEM; KEUPP H, 1977, Palaeontologische Zeitschrift, V51, P102; Keupp H., 1994, GEOBIOS-LYON, V27, P71; Keupp H, 2007, NEUES JAHRB GEOL P-A, V245, P3, DOI 10.1127/0077-7749/2007/0245-0003; KNIGHT JB, 1993, PHYS REV LETT, V70, P3728, DOI 10.1103/PhysRevLett.70.3728; Meyer H.von., 1861, NEUES JB MINERALOGIE, V1861, P678; Mezger T.G, 2016, RHEOLOGIE HDB, V5; MILLIMAN JD, 1993, J SEDIMENT PETROL, V63, P589; Munnecke A, 2008, SEDIMENTOLOGY, V55, P1931, DOI 10.1111/j.1365-3091.2008.00975.x; Pan YH, 2019, NEUES JAHRB GEOL P-A, V292, P73, DOI 10.1127/njgpa/2019/0809; Park MH, 2003, NEWSL STRATIGR, V39, P125, DOI 10.1127/nos/39/2003/125; Park MH, 2001, INT J EARTH SCI, V90, P847; Petrovich R, 2001, AM J SCI, V301, P683, DOI 10.2475/ajs.301.8.683; Raiswell R, 2008, AM J SCI, V308, P105, DOI 10.2475/02.2008.01; ROSATO A, 1987, PHYS REV LETT, V58, P1038, DOI 10.1103/PhysRevLett.58.1038; Schuster R, 2013, ROCKY AUSTRIA GEOLOG; SEILACHER A, 1985, PHILOS T ROY SOC B, V311, P5, DOI 10.1098/rstb.1985.0134; Stipp SLS, 1999, GEOCHIM COSMOCHIM AC, V63, P3121, DOI 10.1016/S0016-7037(99)00239-2; Sutcliffe OE, 1999, GEOLOGY, V27, P275, DOI 10.1130/0091-7613(1999)027<0275:IEFTES>2.3.CO;2; Tischlinger Helmut, 1998, Archaeopteryx, V16, P1; Viohl G, 2015, SOLNHOFEN FENSTER JU, P78; Viohl G., 2015, SOLNHOFEN FENSTER JU, P56; Viohl G, 2007, NEUES JAHRB GEOL P-A, V245, P127, DOI 10.1127/0077-7749/2007/0245-0127; Zhang XW, 2017, SOILS FOUND, V57, P23, DOI 10.1016/j.sandf.2017.01.002	45	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252469	10.1371/journal.pone.0252469	http://dx.doi.org/10.1371/journal.pone.0252469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077479	Green Published, gold			2022-12-26	WOS:000664638500045
J	Malhotra, A; Rachet, B; Bonaventure, A; Pereira, SP; Woods, LM				Malhotra, Ananya; Rachet, Bernard; Bonaventure, Audrey; Pereira, Stephen P.; Woods, Laura M.			Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data	PLOS ONE			English	Article							BIOMARKERS; URINE; BLOOD	Background Pancreatic cancer (PC) represents a substantial public health burden. Pancreatic cancer patients have very low survival due to the difficulty of identifying cancers early when the tumour is localised to the site of origin and treatable. Recent progress has been made in identifying biomarkers for PC in the blood and urine, but these cannot be used for population-based screening as this would be prohibitively expensive and potentially harmful. Methods We conducted a case-control study using prospectively-collected electronic health records from primary care individually-linked to cancer registrations. Our cases were comprised of 1,139 patients, aged 15-99 years, diagnosed with pancreatic cancer between January 1, 2005 and June 30, 2009. Each case was age-, sex- and diagnosis time-matched to four non-pancreatic (cancer patient) controls. Disease and prescription codes for the 24 months prior to diagnosis were used to identify 57 individual symptoms. Using a machine learning approach, we trained a logistic regression model on 75% of the data to predict patients who later developed PC and tested the model's performance on the remaining 25%. Results We were able to identify 41.3% of patients < = 60 years at 'high risk' of developing pancreatic cancer up to 20 months prior to diagnosis with 72.5% sensitivity, 59% specificity and, 66% AUC. 43.2% of patients >60 years were similarly identified at 17 months, with 65% sensitivity, 57% specificity and, 61% AUC. We estimate that combining our algorithm with currently available biomarker tests could result in 30 older and 400 younger patients per cancer being identified as 'potential patients', and the earlier diagnosis of around 60% of tumours. Conclusion After further work this approach could be applied in the primary care setting and has the potential to be used alongside a non-invasive biomarker test to increase earlier diagnosis. This would result in a greater number of patients surviving this devastating disease.	[Malhotra, Ananya; Rachet, Bernard; Woods, Laura M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, Inequal Canc Outcomes Network, London, England; [Bonaventure, Audrey] Univ Paris, Epidemiol Childhood & Adolescent Canc Team, CRESS, INSERM, Villejuif, France; [Pereira, Stephen P.] UCL, UCL Inst Liver & Digest Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	Malhotra, A (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, Inequal Canc Outcomes Network, London, England.	Ananya.Malhotra@lshtm.ac.uk	Malhotra, Ananya/AAZ-6801-2020; Woods, Laura M/Q-1714-2017; Pereira, Stephen/C-5639-2009	Malhotra, Ananya/0000-0002-0691-0705; Woods, Laura M/0000-0002-2178-1577; Pereira, Stephen/0000-0003-0821-1809; Bonaventure, Audrey/0000-0001-6665-8145; Rachet, Bernard/0000-0001-5837-7773	Pancreatic Cancer Research Fund; UCLH/UCL Comprehensive Biomedical Centre; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Cancer Research UK [C7923/A18525, C23409/A11415]; Fondation ARC pour la Recherche sur le Cancer [PDF20190508759]	Pancreatic Cancer Research Fund; UCLH/UCL Comprehensive Biomedical Centre; Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by Pancreatic Cancer Research Fund (https://www.pcrf.org.uk/, AM and BR, no grant number); UCLH/UCL Comprehensive Biomedical Centre (https://www.uclh.nhs.uk/Research/BRC/Pages/Home.aspx, SPP, no grant number); Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme (https://www.nihr.ac.uk/, SPP, no grant number); Cancer Research UK [https://www.cancerresearchuk.org/, LMW, grant numbers - C7923/A18525, C23409/A11415] and Fondation ARC pour la Recherche sur le Cancer [https://www.fondation-arc.org/, AB, grant number - PDF20190508759]. The funding sources were not involved in the design, data collection, analysis, interpretation or any other aspect pertinent to this study. They had no role in the decision for submission of this research article for publication. AM, LMW, and BR had full access to the underlying data, all authors had full access to the data on request.	[Anonymous], CANC REGISTRATION ST; [Anonymous], POPULATION ESTIMATES; [Anonymous], LSHTM DATA COMPASS; Bhaskaran K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003389; Blyuss O, 2020, BRIT J CANCER, V122, P692, DOI 10.1038/s41416-019-0694-0; Bradley MC, 2010, BRIT J CANCER, V102, P1415, DOI 10.1038/sj.bjc.6605636; CALIBER, DEN LAB; Capello M, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw266; Carrato A, 2015, J Gastrointest Cancer, V46, P201, DOI 10.1007/s12029-015-9724-1; Chari ST, 2005, GASTROENTEROLOGY, V129, P504, DOI 10.1053/j.gastro.2005.05.007; Cohen JD, 2018, SCIENCE, V359, P926, DOI 10.1126/science.aar3247; Daoud AZ, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6284-y; Exarchakou A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k764; Hess AS, 2017, TRANSFUSION, V57, P877, DOI 10.1111/trf.14057; Holly EA, 2004, CLIN GASTROENTEROL H, V2, P510, DOI 10.1016/S1542-3565(04)00171-5; Lennon AM, 2014, CANCER RES, V74, P3381, DOI 10.1158/0008-5472.CAN-14-0734; Lux A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133305; Mansfield K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031537; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Mitry E, 2008, BRIT J CANCER, V99, pS21, DOI 10.1038/sj.bjc.6604576; O'Brien DP, 2015, CLIN CANCER RES, V21, P622, DOI 10.1158/1078-0432.CCR-14-0365; Oldfield LE, 2017, TRENDS CANCER, V3, P336, DOI 10.1016/j.trecan.2017.04.005; Pereira SP, 2020, LANCET GASTROENTEROL, V5, P698, DOI 10.1016/S2468-1253(19)30416-9; Radon TP, 2015, CLIN CANCER RES, V21, P3512, DOI 10.1158/1078-0432.CCR-14-2467; Schultz NA, 2014, JAMA-J AM MED ASSOC, V311, P392, DOI 10.1001/jama.2013.284664; Singhi AD, 2019, GASTROENTEROLOGY, V156, P2024, DOI 10.1053/j.gastro.2019.01.259; Stapley S, 2012, BRIT J CANCER, V106, P1940, DOI 10.1038/bjc.2012.190; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Szatkowski L, 2010, FAM PRACT, V27, P673, DOI 10.1093/fampra/cmq046; Team R, 2020, RSTUDIO INT DEV R ST	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251876	10.1371/journal.pone.0251876	http://dx.doi.org/10.1371/journal.pone.0251876			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077433	gold, Green Published, Green Accepted			2022-12-26	WOS:000664638500019
J	Kurano, M; Kobayashi, T; Sakai, E; Tsukamoto, K; Yatomi, Y				Kurano, Makoto; Kobayashi, Tamaki; Sakai, Eri; Tsukamoto, Kazuhisa; Yatomi, Yutaka			Lysophosphatidylinositol, especially albumin-bound form, induces inflammatory cytokines in macrophages	FASEB JOURNAL			English	Article						inflammation; lipoproteins; lysophosphatidylinositol; macrophage	SPHINGOSINE 1-PHOSPHATE; INSULIN-SECRETION; APOLIPOPROTEIN M; RECEPTOR GPR55; LYSOPHOSPHOLIPIDS; AGONIST; PROTEIN; IDENTIFICATION; INVOLVEMENT; ACTIVATION	Lysophosphatidylinositol (LPI) is a glycero-lysophospholipid and a natural agonist against GPR55. The roles of the LPI/GPR55 axis in the pathogenesis of inflammation have been controversial. In the present study, we attempted to elucidate the roles of the LPI/GPR55 axis in inflammation, especially the secretion of inflammatory cytokines, IL-6 and TNF-alpha from macrophages. We treated RAW264.7 cells and mouse peritoneal macrophages (MPMs) with LPI and observed that LPI induced the secretion of IL-6 and TNF-alpha from these cells, as well as the phosphorylation of p38. These responses were inhibited by treatment with CID16020046 (CID), an antagonist against GPR55, or SB202190, an inhibitor of p38 cascade or knockdown of GPR55 with siRNA. Treatment with CID or ML-193, another antagonist against GPR55, attenuated the elevation of inflammatory cytokines in the plasma or tissue of db/db mice and in a septic mouse model induced using lipopolysaccharide, suggesting contributions to the improvement of insulin resistance and protection against organ injuries by treatment with CID or ML-193, respectively. In human subjects, although the serum LPI levels were not different, the levels of LPI in the lipoprotein fractions were lower and the levels in the lipoprotein-depleted fractions were higher in subjects with diabetes. LPI bound to albumin induced the secretion of IL-6 and TNF-alpha from RAW264.7 cells to a greater degree than LPI bound to LDL or HDL. These results suggest that LPI, especially the albumin-bound form, induced inflammatory cytokines depending on the GPR55/p38 pathway, which might contribute to the pathogenesis of obesity-induced inflammation and acute inflammation.	[Kurano, Makoto; Yatomi, Yutaka] Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Tokyo, Japan; [Kurano, Makoto; Kobayashi, Tamaki; Sakai, Eri; Yatomi, Yutaka] Univ Tokyo Hosp, Dept Clin Lab, Tokyo, Japan; [Tsukamoto, Kazuhisa] Teikyo Univ, Dept Internal Med, Sch Med, Tokyo, Japan	University of Tokyo; University of Tokyo; Teikyo University	Kurano, M; Yatomi, Y (corresponding author), Univ Tokyo, Grad Sch Med, Dept Clin Lab Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurano-tky@umin.ac.jp; kurano-tky@umin.ac.jp		Yatomi, Yutaka/0000-0003-1719-4297	JSPS KAKENHI [16H06236, 20H03573]; Japan Heart Foundation; MSD Life Science Foundation; Public Interest Incorporated Foundation; Takeda Science Foundation; AMED;  [15H05906]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Heart Foundation; MSD Life Science Foundation; Public Interest Incorporated Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); AMED; 	JSPS KAKENHI, Grant/Award Number: 16H06236 and 20H03573; Japan Heart Foundation; MSD Life Science Foundation, Public Interest Incorporated Foundation; Takeda Science Foundation; AMED; Grant-in--Aid for Scientific Research on Innovative Areas, Grant/Award Number: 15H05906	Alhouayek M, 2018, TRENDS PHARMACOL SCI, V39, P586, DOI 10.1016/j.tips.2018.02.011; AlSuleimani YM, 2015, BRIT J PHARMACOL, V172, P3043, DOI 10.1111/bph.13107; Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Bjursell M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167965; Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551; Deliu E, 2015, MOL PHARMACOL, V88, P265, DOI 10.1124/mol.115.099333; Emoto S, 2017, J LIPID RES, V58, P763, DOI 10.1194/jlr.P072090; FALASCA M, 1995, ONCOGENE, V10, P2113; Fondevila MF, 2021, HEPATOLOGY, V73, P606, DOI 10.1002/hep.31290; Galvani S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2581; Harada K, 2017, J BIOL CHEM, V292, P10855, DOI 10.1074/jbc.M117.788653; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kobayashi T, 2021, J ATHEROSCLER THROMB, V28, P730, DOI 10.5551/jat.55699; Kotsikorou E, 2011, BIOCHEMISTRY-US, V50, P5633, DOI 10.1021/bi200010k; Kurano M, 2019, BIOCHEM J, V476, P3565, DOI 10.1042/BCJ20190498; Kurano M, 2019, FREE RADICAL RES, V53, P892, DOI 10.1080/10715762.2019.1641603; Kurano M, 2019, FASEB J, V33, P5181, DOI 10.1096/fj.201801748R; Kurano M, 2018, THROMB HAEMOSTASIS, V118, P1021, DOI 10.1055/s-0038-1641750; Kurano M, 2018, J ATHEROSCLER THROMB, V25, P16, DOI 10.5551/jat.RV17010; Kurano M, 2017, ARTERIOSCL THROM VAS, V37, P506, DOI 10.1161/ATVBAHA.116.308692; Kurano M, 2017, J LIPID RES, V58, P433, DOI 10.1194/jlr.P071803; Kurano M, 2015, ARTERIOSCL THROM VAS, V35, P463, DOI 10.1161/ATVBAHA.114.304748; Kurano M, 2014, BBA-MOL CELL BIOL L, V1841, P1217, DOI 10.1016/j.bbalip.2014.05.002; Kurano M, 2011, J ATHEROSCLER THROMB, V18, P373, DOI 10.5551/jat.6999; Lin XH, 2011, NEUROGASTROENT MOTIL, V23, P862, DOI 10.1111/j.1365-2982.2011.01742.x; Liu B, 2016, DIABETES OBES METAB, V18, P1263, DOI 10.1111/dom.12780; Lu YH, 2016, DIABETOLOGIA, V59, P2349, DOI 10.1007/s00125-016-4069-2; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; Masquelier J, 2018, BBA-MOL CELL BIOL L, V1863, P1458, DOI 10.1016/j.bbalip.2018.09.003; Meadows A, 2016, INT J OBESITY, V40, P417, DOI 10.1038/ijo.2015.209; METZ SA, 1988, BIOCHIM BIOPHYS ACTA, V968, P239, DOI 10.1016/0167-4889(88)90013-4; Minamihata T, 2020, INFLAMMATION, V43, P1971, DOI 10.1007/s10753-020-01271-4; Morita Y, 2019, LIPIDS, V54, P487, DOI 10.1002/lipd.12175; Munawar N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00136; Nishikawa M, 2015, J ATHEROSCLER THROMB, V22, P518, DOI 10.5551/jat.25650; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; Reustle A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123761; Schicho R, 2011, INFLAMM BOWEL DIS, V17, P1651, DOI 10.1002/ibd.21538; Sisay S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076907; Stancic A, 2015, NEUROGASTROENT MOTIL, V27, P1432, DOI 10.1111/nmo.12639; SUZUKI E, 1992, DIABETES RES CLIN PR, V18, P153, DOI 10.1016/0168-8227(92)90140-M; Thomas G, 2013, CELL REP, V5, P508, DOI 10.1016/j.celrep.2013.08.047; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; Wu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060314; Yamashita A, 2013, PROSTAG OTH LIPID M, V107, P103, DOI 10.1016/j.prostaglandins.2013.05.004; Yatomi Y, 2018, P JPN ACAD B-PHYS, V94, P373, DOI 10.2183/pjab.94.025	49	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21673	10.1096/fj.202100245R	http://dx.doi.org/10.1096/fj.202100245R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042213				2022-12-26	WOS:000655695900034
J	Larson-Casey, JL; Gu, LL; Davis, D; Cai, GQ; Ding, Q; He, C; Carter, AB				Larson-Casey, Jennifer L.; Gu, Linlin; Davis, Dana; Cai, Guo-Qiang; Ding, Qiang; He, Chao; Carter, A. Brent			Post-translational regulation of PGC-1 alpha modulates fibrotic repair	FASEB JOURNAL			English	Article						mitochondrial biogenesis; monocyte&#8208; derived macrophages; PGC&#8208; 1&#945; pulmonary fibrosis	ACTIVATED-RECEPTOR-GAMMA; IDIOPATHIC PULMONARY-FIBROSIS; P38 MAP KINASE; MITOCHONDRIAL BIOGENESIS; ALTERNATIVE ACTIVATION; APOPTOSIS RESISTANCE; TRANSCRIPTION FACTOR; KIDNEY FIBROSIS; GENE-EXPRESSION; MACROPHAGES	Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease associated with mitochondrial oxidative stress. Mitochondrial reactive oxygen species (mtROS) are important for cell homeostasis by regulating mitochondrial dynamics. Here, we show that IPF BAL cells exhibited increased mitochondrial biogenesis that is, in part, due to increased nuclear expression of peroxisome proliferator-activated receptor-gamma (PPAR gamma) coactivator (PGC)-1 alpha. Increased PPARGC1A mRNA expression directly correlated with reduced pulmonary function in IPF subjects. Oxidant-mediated activation of the p38 MAPK via Akt1 regulated PGC-1 alpha activation to increase mitochondrial biogenesis in monocyte-derived macrophages. Demonstrating the importance of PGC-1 alpha in fibrotic repair, mice harboring a conditional deletion of Ppargc1a in monocyte-derived macrophages or mice administered a chemical inhibitor of mitochondrial division had reduced biogenesis and increased apoptosis, and the mice were protected from pulmonary fibrosis. These observations suggest that Akt1-mediated regulation of PGC-1 alpha maintains mitochondrial homeostasis in monocyte-derived macrophages to induce apoptosis resistance, which contributes to the pathogenesis of pulmonary fibrosis.	[Larson-Casey, Jennifer L.; Gu, Linlin; Davis, Dana; He, Chao; Carter, A. Brent] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, 1918 Univ Blvd,404 MCLM, Birmingham, AL 35294 USA; [Cai, Guo-Qiang; Ding, Qiang] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Mol & Translat Biomed, Birmingham, AL USA; [Carter, A. Brent] Birmingham Vet Adm Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, 1918 Univ Blvd,404 MCLM, Birmingham, AL 35294 USA.	bcarter1@uab.edu		Larson-Casey, Jennifer L./0000-0001-7238-7986	HHS \ NIH \ National Institute of Environmental Health Sciences (NIEHS) [2R01ES015981-14, P42 ES027723]; HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [P01 HL114470-7]; U.S. Department of Veterans Affairs (VA) [1 I01 CX001715-01]; Parker Foundation; American Lung Association (Lung Association) [RG-507440]	HHS \ NIH \ National Institute of Environmental Health Sciences (NIEHS); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); Parker Foundation; American Lung Association (Lung Association)	HHS vertical bar NIH vertical bar National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: 2R01ES015981-14 and P42 ES027723; HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: P01 HL114470-7; U.S. Department of Veterans Affairs (VA), Grant/Award Number: 1 I01 CX001715-01; Parker Foundation; American Lung Association (Lung Association), Grant/ Award Number: RG-507440	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Alzaid F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88689; [Anonymous], 2015, AM CANC SOC CANC FAC; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bauer Yasmina, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00074-2016; Besse-Patin A, 2019, P NATL ACAD SCI USA, V116, P4285, DOI 10.1073/pnas.1815150116; Breunig C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.364; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Carter KB, 2000, J BIOL CHEM, V275, P27858; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Eschbach J, 2013, HUM MOL GENET, V22, P3477, DOI 10.1093/hmg/ddt202; Geng TY, 2011, AM J PATHOL, V178, P1738, DOI 10.1016/j.ajpath.2011.01.005; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Gu LL, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101307; Gu LL, 2017, FASEB J, V31, P3072, DOI 10.1096/fj.201601371R; Han L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.30; Han SH, 2017, J AM SOC NEPHROL, V28, P3312, DOI 10.1681/ASN.2017020130; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; He C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126551; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Hughes R, 2015, CANCER RES, V75, P3479, DOI 10.1158/0008-5472.CAN-14-3587; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Hutchinson J, 2015, EUR RESPIR J, V46, P795, DOI 10.1183/09031936.00185114; Hutchinson John P, 2014, Ann Am Thorac Soc, V11, P1176, DOI 10.1513/AnnalsATS.201404-145OC; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Ikeda Y, 2015, CIRC RES, V116, P264, DOI 10.1161/CIRCRESAHA.116.303356; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Larson-Casey JL, 2019, J CLIN INVEST, V129, P4962, DOI [10.1172/JCl127959, 10.1172/JCI127959]; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Larson-Casey JL, 2014, J BIOL CHEM, V289, P36204, DOI 10.1074/jbc.M114.593285; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Mannam P, 2014, AM J PHYSIOL-LUNG C, V306, pL604, DOI 10.1152/ajplung.00272.2013; McCubbrey AL, 2018, AM J RESP CELL MOL, V58, P66, DOI 10.1165/rcmb.2017-0154OC; Meinecke I, 2007, P NATL ACAD SCI USA, V104, P5073, DOI 10.1073/pnas.0608773104; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Richards TJ, 2012, AM J RESP CRIT CARE, V185, P67, DOI 10.1164/rccm.201101-0058OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Shearn AIU, 2012, ARTERIOSCL THROM VAS, V32, P1142, DOI 10.1161/ATVBAHA.111.239111; Sheikh AQ, 2018, CELL REP, V23, P1152, DOI 10.1016/j.celrep.2018.03.043; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suliman HB, 2007, J CLIN INVEST, V117, P3730, DOI 10.1172/JCI32967; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yu GY, 2018, NAT MED, V24, P39, DOI 10.1038/nm.4447; Zhang LW, 2018, MOL MED REP, V17, P4490, DOI 10.3892/mmr.2018.8433; Zhao C, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.69	77	2	2	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21675	10.1096/fj.202100339R	http://dx.doi.org/10.1096/fj.202100339R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34038004	hybrid, Green Published			2022-12-26	WOS:000655695900064
J	Rugard, M; Jaylet, T; Taboureau, O; Tromelin, A; Audouze, K				Rugard, Marylene; Jaylet, Thomas; Taboureau, Olivier; Tromelin, Anne; Audouze, Karine			Smell compounds classification using UMAP to increase knowledge of odors and molecular structures linkages	PLOS ONE			English	Article							OF-THE-ART; OLFACTORY RECEPTORS; PERCEPTION; PLEASANTNESS; DESCRIPTORS; FINGERPRINT; GENERATION; PREDICTION; RESPONSES	This study aims to highlight the relationships between the structure of smell compounds and their odors. For this purpose, heterogeneous data sources were screened, and 6038 odorant compounds and their known associated odors (162 odor notes) were compiled, each individual molecule being represented with a set of 1024 structural fingerprint. Several dimensional reduction techniques (PCA, MDS, t-SNE and UMAP) with two clustering methods (k-means and agglomerative hierarchical clustering AHC) were assessed based on the calculated fingerprints. The combination of UMAP with k-means and AHC methods allowed to obtain a good representativeness of odors by clusters, as well as the best visualization of the proximity of odorants on the basis of their molecular structures. The presence or absence of molecular substructures has been calculated on odorant in order to link chemical groups to odors. The results of this analysis bring out some associations for both the odor notes and the chemical structures of the molecules such as "woody" and "spicy" notes with allylic and bicyclic structures, "balsamic" notes with unsaturated rings, both "sulfurous" and "citrus" with aldehydes, alcohols, carboxylic acids, amines and sulfur compounds, and "oily", "fatty" and "fruity" characterized by esters and with long carbon chains. Overall, the use of UMAP associated to clustering is a promising method to suggest hypotheses on the odorant structure-odor relationships.	[Rugard, Marylene; Jaylet, Thomas; Audouze, Karine] Univ Paris, T3S, INSERM, UMR S 1124, Paris, France; [Taboureau, Olivier] Univ Paris, INSERM, U1133, CNRS,UMR 8251, Paris, France; [Tromelin, Anne] Univ Bourgogne Franche Comte, AgroSup Dijon, CNRS, Ctr Sci Gout & Alimentat,INRAE, Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Audouze, K (corresponding author), Univ Paris, T3S, INSERM, UMR S 1124, Paris, France.	karine.audouze@u-paris.fr	Tromelin, Anne/A-2722-2009	Tromelin, Anne/0000-0002-3322-951X; Audouze, Karine/0000-0001-7525-4089	Agence Nationale de la Recherche [ANR-18-CE21-0006]	Agence Nationale de la Recherche(French National Research Agency (ANR))	The authors (AT, OT, KA) received funding for this work by Agence Nationale de la Recherche, ANR-18-CE21-0006, project MULTIMIX (https://anr.fr/en).	Abbas OA, 2008, INT ARAB J INF TECHN, V5; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Abraham R., 1988, APPL MATH SCI, V75; [Anonymous], GOOD SCENTS CO; Armanino N, 2020, ANGEW CHEM INT EDIT, V59, P16310, DOI 10.1002/anie.202005719; Arora Sanjeev, 2018, P MACHINE LEARNING R, P1455; Audouze K, 2000, ANALUSIS, V28, P625, DOI 10.1051/analusis:2000139; Audouze K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093037; Bajusz D, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0069-3; Becht E., 2018, EVALUATION UMAP ALTE, DOI [10.1101/298430, DOI 10.1101/298430]; Behrens M, 2018, CHEM SENSES, V43, P81, DOI 10.1093/chemse/bjx083; Borg I., 2018, APPL MULTIDIMENSIONA; Braga A, 2018, FOOD BIOPROCESS TECH, V11, P2217, DOI 10.1007/s11947-018-2180-8; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; Capecchi A, 2020, J CHEMINFORMATICS, V12, DOI 10.1186/s13321-020-00445-4; Charlier L, 2012, CELL MOL LIFE SCI, V69, P4205, DOI 10.1007/s00018-012-1116-0; Chastrette M, 1996, J CHEM INF COMP SCI, V36, P108, DOI 10.1021/ci950154b; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; Dinu V, 2020, EUR BIOPHYS J BIOPHY, V49, P799, DOI 10.1007/s00249-020-01475-4; Ennis M., 2003, NEUROSCIENCE MED, P579; Ferdenzi C, 2013, CHEM SENSES, V38, P175, DOI 10.1093/chemse/bjs083; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Gabler S, 2013, MOL INFORM, V32, P855, DOI 10.1002/minf.201300037; Genva M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123018; Glen RC, 2006, IDRUGS, V9, P199; Hamakawa M, 2018, FLAVOUR FRAG J, V33, P420, DOI 10.1002/ffj.3469; Kaushik, 2014, INT J SOFTWARE HARDW, V2, P93, DOI DOI 10.30534/IJETER/2020/20852020; Kermen F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00206; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Kini AD, 2001, CHIMIA, V55, P453; Launay G, 2012, PROTEIN ENG DES SEL, V25, P377, DOI 10.1093/protein/gzs037; Lee SJ, 2019, NAT REV DRUG DISCOV, V18, P116, DOI 10.1038/s41573-018-0002-3; Leffingwell & Associates, FLAV BAS, V9th; Li X, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11083320; Licon CC, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006945; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Lotsch J, 2019, CHEM SENSES, V44, P11, DOI 10.1093/chemse/bjy067; Mainland JD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.2; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McInnes L., 2020, ARXIV180203426CSSTAT; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]; Meierhenrich UJ, 2004, ANGEW CHEM INT EDIT, V43, P6410, DOI 10.1002/anie.200462322; MORGAN HL, 1965, J CHEM DOC, V5, P107, DOI 10.1021/c160017a018; O'Boyle NM, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0148-0; Ordonez C., 2003, P 8 ACM SIGMOD WORKS, P12; Peterlin Z, 2014, J GEN PHYSIOL, V143, P527, DOI 10.1085/jgp.201311151; Pintore M., 2002, DATA SCI J, V1, P99; Poivet E, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao6086; Poivet E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11157; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Ros F, 2000, SAR QSAR ENVIRON RES, V11, P281, DOI 10.1080/10629360008033236; Saeed N, 2019, IEEE COMMUN SURV TUT, V21, P3565, DOI 10.1109/COMST.2019.2921972; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Schmuker M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-11; Sell CS, 2014, CHEMISTRY AND THE SENSE OF SMELL, P388; Stahl M, 2005, J CHEM INF MODEL, V45, P542, DOI 10.1021/ci050011h; Touhara K, 2002, MICROSC RES TECHNIQ, V58, P135, DOI 10.1002/jemt.10131; Tromelin A, 2018, FLAVOUR FRAG J, V33, P106, DOI 10.1002/ffj.3430; Tromelin A, 2016, FLAVOUR FRAG J, V31, P107, DOI 10.1002/ffj.3295; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Zarzo M, 2009, ATTEN PERCEPT PSYCHO, V71, P225, DOI 10.3758/APP.71.2.225	63	5	5	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252486	10.1371/journal.pone.0252486	http://dx.doi.org/10.1371/journal.pone.0252486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048487	Green Published, gold			2022-12-26	WOS:000664636100058
J	Tsai, ST; Lin, FY; Chen, PS; Chiang, HY; Kuo, CC				Tsai, Sheng-Ta; Lin, Fu-Yu; Chen, Pei-Shan; Chiang, Hsiu-Yin; Kuo, Chin-Chi			Three-year mortality in cryptococcal meningitis: Hyperglycemia predict unfavorable outcome	PLOS ONE			English	Article							HIV-UNINFECTED PATIENTS; DIABETES-MELLITUS; NEOFORMANS; DISEASE; EPIDEMIOLOGY; PREVALENCE; GLUCOSE	Existing evidence revealed grave prognosis for cryptococcal meningitis (CM), particularly its short-term mortality. However, its long-term survival and prognostic factors remained unknown. This study investigated 3-year mortality and analyzed its predictive factors in patients with CM. This retrospective cohort study with 83 cerebrospinal fluid culture-confirmed CM patients was conducted at China Medical University Hospital from 2003 to 2016. The 3-year mortality rate in patients with CM was 54% (45 deaths among 83 patients). Advanced age, human immunodeficiency virus (HIV) seronegative state, low Glasgow Coma Scale score on admission, decreased hemoglobin and hyperglycemia on diagnosis were associated with 3-year mortality. After multivariate adjustment in the Cox proportional hazard model, only severe hyperglycemia (serum glucose >= 200 mg/dL) on diagnosis could predict 3-year mortality.	[Tsai, Sheng-Ta; Lin, Fu-Yu] China Med Univ, China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Tsai, Sheng-Ta; Lin, Fu-Yu; Chen, Pei-Shan; Chiang, Hsiu-Yin; Kuo, Chin-Chi] China Med Univ, Coll Med, Taichung, Taiwan; [Chen, Pei-Shan; Chiang, Hsiu-Yin; Kuo, Chin-Chi] China Med Univ, China Med Univ Hosp, Big Data Ctr, Taichung, Taiwan; [Kuo, Chin-Chi] China Med Univ, China Med Univ Hosp, Div Nephrol, Dept Internal Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lin, FY (corresponding author), China Med Univ, China Med Univ Hosp, Dept Neurol, Taichung, Taiwan.; Lin, FY (corresponding author), China Med Univ, Coll Med, Taichung, Taiwan.	linfuyu95@gmail.com	Tsai, Sheng Ta/AAV-6747-2021	Tsai, Sheng Ta/0000-0001-9932-7801	Ministry of Science and Technology, Taiwan [MOST 108-2314-B-039-038-MY3, MOST 109-2321-B-468-001]; CMUH [DMR-109-130]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); CMUH	This study was supported by grants from the Ministry of Science and Technology, Taiwan Grant number: MOST 108-2314-B-039-038-MY3 and MOST 109-2321-B-468-001) and from CMUH (DMR-109-130). This study was not sponsored by industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemi B, 2014, J INT AIDS SOC, V17, P88, DOI 10.7448/IAS.17.4.19623; Butler EK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051291; Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chiang HY, 2021, DIABETES CARE, V44, P107, DOI 10.2337/dc19-0963; Ecevit IZ, 2006, CLIN INFECT DIS, V42, P1443, DOI 10.1086/503570; Gandhi V, 2015, GASTROENTEROLOGY, V148, pS651; Hakyemez IN, 2018, EUR J CLIN MICROBIOL, V37, P1231, DOI 10.1007/s10096-017-3142-1; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Kawakami K, 1996, CLIN EXP IMMUNOL, V106, P468, DOI 10.1046/j.1365-2249.1996.d01-870.x; Lakoh S, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4862-x; Lee SJ, 2011, YONSEI MED J, V52, P482, DOI 10.3349/ymj.2011.52.3.482; Lee YC, 2011, J MICROBIOL IMMUNOL, V44, P338, DOI 10.1016/j.jmii.2010.08.011; Li WA, 2013, NEUROL RES, V35, P479, DOI 10.1179/1743132813Y.0000000209; Li YF, 2017, MYCOSES, V60, P706, DOI 10.1111/myc.12645; Liang HY, 2020, J AM SOC ECHOCARDIOG, V33, P469, DOI 10.1016/j.echo.2019.11.013; Ligtenberg JJM, 2005, CHEST, V127, P2283, DOI 10.1378/chest.127.6.2283; Lin KH, 2016, J INFECTION, V72, P608, DOI 10.1016/j.jinf.2016.01.016; Liu BF, 1999, DIABETES, V48, P2074, DOI 10.2337/diabetes.48.10.2074; Nyazika TK, 2016, J MED MICROBIOL, V65, P1281, DOI 10.1099/jmm.0.000354; Pappas Peter G, 2013, Trans Am Clin Climatol Assoc, V124, P61; Pasquier E, 2018, CLIN INFECT DIS, V66, P1122, DOI 10.1093/cid/cix870; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; SATOMI N, 1985, J NATL CANCER I, V74, P1255; Schut ES, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-57; Shi J, 2016, ONCOTARGET, V7, P71052, DOI 10.18632/oncotarget.11958; Sloan DJ, 2014, CLIN EPIDEMIOL, V6, P169, DOI 10.2147/CLEP.S38850; Spec A, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv197; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tugume L, 2017, HIV MED, V18, P13, DOI 10.1111/hiv.12387	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0251749	10.1371/journal.pone.0251749	http://dx.doi.org/10.1371/journal.pone.0251749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048463	gold, Green Published			2022-12-26	WOS:000664636100016
J	Zafri, NM; Afroj, S; Ali, MA; Hasan, MMU; Rahman, MH				Zafri, Niaz Mahmud; Afroj, Sadia; Ali, Mohammad Ashraf; Hasan, Md. Musleh Uddin; Rahman, Md. Hamidur			Effectiveness of containment strategies and local cognition to control vehicular traffic volume in Dhaka, Bangladesh during COVID-19 pandemic: Use of Google Map based real-time traffic data	PLOS ONE			English	Article							IMPACT; CONGESTION; KNOWLEDGE; TRAVEL; NEWS	Background To prevent the viral transmission from higher infected to lower infected area, controlling the vehicular traffic, consequently public movement on roads is crucial. Containment strategies and local cognition regarding pandemic might be helpful to control vehicular movement. This study aimed to ascertain the effectiveness of containment strategies and local cognition for controlling traffic volume during COVID-19 pandemic in Dhaka, Bangladesh. Method Six containment strategies were considered to explore their influence on traffic condition, including declaration of general holiday, closure of educational institution, deployment of force, restriction on religious gathering, closure of commercial activities, and closure of garments factories. Newspaper coverage and public concern about COVID-19 were considered as local cognition in this research. The month of Ramadan as a potential event was also taken into account considering it might have an impact on the overall situation. Average daily journey speed (ADJS) was calculated from real-time traffic data of Google Map to understand the vehicular traffic scenario of Dhaka. A multiple linear regression method was developed to comprehend the findings. Results The results showed that among the containment strategies, declaration of general holiday and closure of educational institutions could increase the ADJS significantly, thereby referring to less traffic movement. Besides, local cognition could not significantly affect the traffic condition, although the month of Ramadan could increase the ADJS significantly. Conclusion It is expected that these findings would provide new insights into decision-making and help to take appropriate strategies to tackle the future pandemic situation.	[Zafri, Niaz Mahmud; Afroj, Sadia; Ali, Mohammad Ashraf; Hasan, Md. Musleh Uddin] Bangladesh Univ Engn & Technol BUET, Dept Urban & Reg Planning, Dhaka, Bangladesh; [Rahman, Md. Hamidur] Asian Disaster Preparedness Ctr ADPC, Dhaka, Bangladesh	Bangladesh University of Engineering & Technology (BUET)	Zafri, NM (corresponding author), Bangladesh Univ Engn & Technol BUET, Dept Urban & Reg Planning, Dhaka, Bangladesh.	zafri@urp.buet.ac.bd	Rahman, Md. Hamidur/ABA-7465-2021; Zafri, Niaz Mahmud/AAG-2299-2020; Ali, Mohammad Ashraf/GPX-2766-2022	Rahman, Md. Hamidur/0000-0003-1315-0625; Zafri, Niaz Mahmud/0000-0002-0120-1862; Afroj, Sadia/0000-0002-1961-2360				Aalberg T, 2013, JOURNALISM STUD, V14, P387, DOI 10.1080/1461670X.2013.765636; Adnan T, 2018, J MASS COMMUNICATION, V8, P357; Akhter S, 2020, NEW AGE BANGLADESH; Alamgir M., 2020, DAILY STAR; Alvarez P, 2018, INT J LOGIST-RES APP, V21, P529, DOI 10.1080/13675567.2018.1457634; [Anonymous], 2012, J TRANSP TECHNOL; [Anonymous], 2020, CORONAVIRUS COVID 19; Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154; Anzai A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020601; Atik F., 2020, BDNEWS24COM; Azman AS, 2020, LANCET INFECT DIS, V20, P756, DOI 10.1016/S1473-3099(20)30264-4; Bauchner H, 2020, JAMA-J AM MED ASSOC, V324, P151, DOI 10.1001/jama.2020.10242; Bhuiyan JH, 2017, J LEG PLUR UNOFF LAW, V49, P204, DOI 10.1080/07329113.2017.1341479; BIF, PERM CAL PRAYER FAST; Boldog P, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020571; Colak S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10793; Di Gennaro F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082690; Elefteriadou L, 2014, INTRO TRAFFIC FLOW T, P61; Fischhoff B, 2020, JAMA-J AM MED ASSOC, V324, P139, DOI 10.1001/jama.2020.10178; Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P2137, DOI 10.1001/jama.2020.5460; Haque A., 2020, BANGLADESH POST; Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169; IECDR, 2020, BANGL COVID 19 UPD; JICA, 2010, PREP SURV REP DHAK U; Kamruzzaman M., 2020, BANGLADESH IMPOSES T; Khan ME., 2016, LIVING WAGE REPORT D; Kim H., 2013, ASSESSMENT TRAVEL TI; Knipe Duleeka, 2020, Wellcome Open Res, V5, P82, DOI [10.12688/wellcomeopenres.15870.2, 10.12688/wellcomeopenres.15870.1]; Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7; Mamun S, 2020, DHAKA TRIBUNE; McDowell E, 2020, BUSINESS INSIDER; Mithu AI., 2020, BUSINESS STANDARD; Moazzem KG., 2018, DATA U BANGLADESHS R, DOI [10.1007/s11356-017-1121-9, DOI 10.1007/S11356-017-1121-9]; Mondschein A, 2017, J TRANSP GEOGR, V64, P65, DOI 10.1016/j.jtrangeo.2017.08.007; Paskevicius, 2020, ASIAN J DISTANCE ED, V15, P1, DOI [10.5281/zenodo.3878572, DOI 10.5281/ZENODO.3878572]; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; RAJUK, 2015, DHAK STRUCT PLAN 201; Rezzouqi H., 2019, INTELLIGENT SYSTEMS, P2019; Sajid E., 2020, BUSINESS STANDARD; Sakib SN, 2020, COVID 19 BANGLADESH; Sharma R, 2017, GOOGLE MAPS GETS ITS; Shawon A.A., 2020, DHAKA TRIBUNE; Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005; Shi X, 2017, TRANSP RES PROC, V25, P1300, DOI 10.1016/j.trpro.2017.05.153; Shilpa K, 2014, MED J DR DY PATIL U, V7, P732; TBS, 2020, BUSINESS STANDARD; Valenzuela S, 2009, J MASS COMMUN Q, V86, P756, DOI 10.1177/107769900908600403; Vigo D, 2020, JAMA PSYCHIAT, V77, P1207, DOI 10.1001/jamapsychiatry.2020.2174; Wilson JM, 2009, DISASTER MED PUBLIC, V3, pS148, DOI 10.1097/DMP.0b013e3181abd603; Wisniewski S, 2018, BULL GEOGR SOCIO-ECO, V41, P45, DOI 10.2478/bog-2018-0025; Worldometer, 2020, COUNTR COV 19 HAS SP; Yang WT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072563; Yulianto B, 2017, AIP CONF PROC, V1855, DOI 10.1063/1.4985525; Zhang WT, 2020, LANCET INFECT DIS, V20, P1121, DOI 10.1016/S1473-3099(20)30280-2	54	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252228	10.1371/journal.pone.0252228	http://dx.doi.org/10.1371/journal.pone.0252228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043702	Green Published, gold			2022-12-26	WOS:000664635700075
J	Golden, GJ; Grady, MJ; McLean, HE; Shriner, SA; Hartwig, A; Bowen, RA; Kimball, BA				Golden, Glen J.; Grady, Meredith J.; McLean, Hailey E.; Shriner, Susan A.; Hartwig, Airn; Bowen, Richard A.; Kimball, Bruce A.			Biodetection of a specific odor signature in mallard feces associated with infection by low pathogenic avian influenza A virus	PLOS ONE			English	Article							HEMAGGLUTININ; RESTRICTION; FERRETS; GENES	Outbreaks of avian influenza virus (AIV) infection included the spread of highly pathogenic AIV in commercial poultry and backyard flocks in the spring of 2015. This resulted in estimated losses of more than $8.5 million from federal government expenditures, $1.6 billion from direct losses to produces arising from destroyed turkey and chicken egg production, and economy-wide indirect costs of $3.3 billion from impacts on retailers and the food service industries. Additionally, these outbreaks resulted in the death or depopulation of nearly 50 million domestic birds. Domesticated male ferrets (Mustela putorius furo) were trained to display a specific conditioned behavior (i.e. active scratch alert) in response to feces from AIV-infected mallards in comparison to feces from healthy ducks. In order to establish that ferrets were identifying samples based on odors associated with infection, additional experiments controlled for potentially confounding effects, such as: individual duck identity, housing and feed, inoculation concentration, and day of sample collection (post-infection). A final experiment revealed that trained ferrets could detect AIV infection status even in the presence of samples from mallards inoculated with Newcastle disease virus or infectious laryngotracheitis virus. These results indicate that mammalian biodetectors are capable of discriminating the specific odors emitted from the feces of non-infected versus AIV infected mallards, suggesting that the health status of waterfowl can be evaluated non-invasively for AIV infection via monitoring of volatile fecal metabolites. Furthermore, in situ monitoring using trained biodetectors may be an effective tool for assessing population health.	[Golden, Glen J.; Hartwig, Airn; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Grady, Meredith J.; McLean, Hailey E.; Shriner, Susan A.] USDA, APHIS, WS, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Kimball, Bruce A.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA	Colorado State University; United States Department of Agriculture (USDA); Monell Chemical Senses Center	Golden, GJ (corresponding author), Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.	glen.golden@colostate.edu		Shriner, Susan/0000-0003-0349-7182; Golden, Glen/0000-0003-4080-2414	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center;  [16-7422-1255-CA]	U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center(United States Department of Agriculture (USDA)); 	This research was supported by the intramural research program of the U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services, National Wildlife Research Center and cooperative agreement #16-7422-1255-CA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angle C, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00047; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Carriere KC, 2001, COMMUN STAT-SIMUL C, V30, P327, DOI 10.1081/SAC-100002370; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; DeMatteo KE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32244-1; DOTY BA, 1967, SCIENCE, V155, P1579, DOI 10.1126/science.155.3769.1579; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Grimm-Seyfarth A, 2019, NAT CONSERV-BULGARIA, P81, DOI 10.3897/natureconservation.37.48208; Hernadi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043267; HUGHES JE, 1994, LAB ANIM SCI, V44, P135; Kasstan B, 2019, J BIOSOC SCI, V51, P436, DOI 10.1017/S0021932018000408; Kelliher KR, 2001, J NEUROSCI, V21, P5832, DOI 10.1523/JNEUROSCI.21-15-05832.2001; Kimball BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075411; LANDIS JR, 1978, INT STAT REV, V46, P237, DOI 10.2307/1402373; Leigh KA, 2015, METHODS ECOL EVOL, V6, P745, DOI 10.1111/2041-210X.12374; LI SQ, 1990, J VIROL, V64, P3297, DOI 10.1128/JVI.64.7.3297-3303.1990; Oh Y, 2015, IEEE SENS J, V15, P637, DOI 10.1109/JSEN.2014.2358261; Paula J, 2011, J NAT CONSERV, V19, P202, DOI 10.1016/j.jnc.2011.01.002; Poling A, 2011, BEHAV ANALYST, V34, P47, DOI 10.1007/BF03392234; ROHM C, 1995, VIROLOGY, V209, P664, DOI 10.1006/viro.1995.1301; Rowland NE, 2007, COMPARATIVE MED, V57, P149; Vaidyanathan R, 2013, AM J TROP MED HYG, V88, P619, DOI 10.4269/ajtmh.12-0493; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	25	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251841	10.1371/journal.pone.0251841	http://dx.doi.org/10.1371/journal.pone.0251841			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038460	Green Published, gold			2022-12-26	WOS:000664633500031
J	Marcelino, AA; Fregonezi, G; Marques, L; Lista-Paz, A; Torres-Castro, R; Resqueti, V				Marcelino, Ana Aline; Fregonezi, Guilherme; Marques, Layana; Lista-Paz, Ana; Torres-Castro, Rodrigo; Resqueti, Vanessa			Reliability of SNIP test and optimal number of maneuvers in 6-11 years healthy children	PLOS ONE			English	Article							NASAL INSPIRATORY PRESSURE; REFERENCE VALUES; MOUTH PRESSURE; REPRODUCIBILITY	Background and purpose Sniff nasal inspiratory pressure (SNIP) is a voluntary inspiratory maneuver measured through a plug occluding one nostril. The investigation of the number of maneuvers necessary to reach the highest peak of SNIP in pediatric populations has been inconsistent. Thus, this study aimed to assess the reliability of SNIP in healthy children aged 6 to 11 years according to sex and age group, and to determine the optimal number of SNIP maneuvers for this age group. Methods This cross-sectional study included healthy children with normal pulmonary function. We performed 12 to 20 SNIP maneuvers, with a 30 s rest between each maneuver. The reliability was tested using the intraclass correlation coefficient (ICC), standard error of measurement (SEM), minimal detectable change (MDC), and Bland-Altman analysis for agreement. Results A total of 121 healthy children (62 girls [51%]) were included in this study. The ICC and corresponding confidence interval (CI) between the highest measure and the first reproducible maneuver were 0.752 (0.656-0.824), SEM = 10.37 cmH(2)O, and MDC = 28.74 cmH(2)O. For children aged 6 to 7 years, the ICC was 0.669 (0.427-0.822), SEM = 10.76 cmH(2)O and MDC = 29.82 cmH(2)O; for children aged 8 to 11 years, the ICC was 0.774 (0.662-0.852), SEM = 9.74 cmH(2)O, and MDC = 26.05 cmH(2)O. For girls, the ICC was 0.817 (0.706-0.889), SEM = 9.40 cmH(2)O and MDC = 26.05 cmH(2)O; for boys, the ICC was 0.671 (0.487-0.798), SEM = 11.51 cmH(2)O, and MDC = 31.90 cmH(2)O. Approximately 80% of the total sample reached the highest SNIP before the 10(th) maneuver. Conclusions SNIP demonstrated moderate reliability between the maneuvers in children aged 6 to 11 years; older children and girls reached the SNIP peak faster. Finally, results indicated that 12 maneuvers were sufficient for healthy children aged 6 to 11 years to achieve the highest SNIP peak.	[Marcelino, Ana Aline; Fregonezi, Guilherme; Marques, Layana; Resqueti, Vanessa] Univ Fed Rio Grande do Norte, PneumoCardioVasc Lab HUOL, Hosp Univ Onofre Lopes, Empresa Brasileira Serv Hosp EBSERH, Natal, RN, Brazil; [Marcelino, Ana Aline; Fregonezi, Guilherme; Marques, Layana; Resqueti, Vanessa] Univ Fed Rio Grande do Norte, Dept Fisioterapia, Lab Inovac Tecnol Reabilitacao, Natal, RN, Brazil; [Fregonezi, Guilherme; Torres-Castro, Rodrigo; Resqueti, Vanessa] Univ A Coruna, Int Physiotherapy Res Network PhysioEvidence, La Coruna, Spain; [Lista-Paz, Ana] Univ A Coruna, Fac Fisioterapia, La Coruna, Spain; [Torres-Castro, Rodrigo] Univ Chile, Dept Kinesiol, Fac Med, Santiago, Chile	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade da Coruna; Universidade da Coruna; Universidad de Chile	Resqueti, V (corresponding author), Univ Fed Rio Grande do Norte, PneumoCardioVasc Lab HUOL, Hosp Univ Onofre Lopes, Empresa Brasileira Serv Hosp EBSERH, Natal, RN, Brazil.; Resqueti, V (corresponding author), Univ Fed Rio Grande do Norte, Dept Fisioterapia, Lab Inovac Tecnol Reabilitacao, Natal, RN, Brazil.; Resqueti, V (corresponding author), Univ A Coruna, Int Physiotherapy Res Network PhysioEvidence, La Coruna, Spain.	vanessaresqueti@hotmail.com	Fregonezi, Guilherme AF/B-2186-2019; Torres-Castro, Rodrigo/E-3630-2014; Lista-Paz, Ana/I-1170-2016	Fregonezi, Guilherme AF/0000-0003-4938-7018; Torres-Castro, Rodrigo/0000-0001-7974-4333; Lista-Paz, Ana/0000-0002-8458-6285	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) [001]; CNPq [312876/2018-1, 315580/2018-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by: 1) Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) - Financing Code 001; 2) GAFF, grant from CNPq number 312876/2018-1, Guilherme Augusto de Freitas Fregonezi; 3) VR, grant from CNPq number 315580/2018-6, Vanessa Resqueti. GAFF and VR had hole in study design, data analysis and revising the manuscript.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Anderson VB, 2012, NEUROMUSCULAR DISORD, V22, P528, DOI 10.1016/j.nmd.2012.02.002; Barnes N, 2014, AGING CLIN EXP RES, V26, P171, DOI 10.1007/s40520-013-0146-2; Culver BH, 2017, AM J RESP CRIT CARE, V196, P1463, DOI 10.1164/rccm.201710-1981ST; Fauroux B, 2009, EUR RESPIR J, V33, P113, DOI 10.1183/09031936.00050708; Fauroux B, 2018, NEUROMUSCULAR DISORD, V28, P731, DOI 10.1016/j.nmd.2018.06.013; FIZ JA, 1989, THORAX, V44, P419, DOI 10.1136/thx.44.5.419; Furlan L, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00095; Graham BL, 2019, AM J RESP CRIT CARE, V200, pE70, DOI 10.1164/rccm.201908-1590ST; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lanza FC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135662; Laveneziana P, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01214-2018; LEVY RD, 1984, AM REV RESPIR DIS, V130, P38; Lofaso F, 2006, EUR RESPIR J, V27, P980, DOI 10.1183/09031936.06.00121305; Maillard JO, 1998, EUR RESPIR J, V11, P901, DOI 10.1183/09031936.98.11040901; Marcelino AA, 2020, PEDIATR PULM, V55, P496, DOI 10.1002/ppul.24591; Morgan RK, 2005, AM J RESP CRIT CARE, V171, P269, DOI 10.1164/rccm.200403-314OC; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; Neve V, 2013, EUR RESPIR J, V42, P671, DOI 10.1183/09031936.00127712; Nikoletou D, 2014, RESPIRATION, V88, P365, DOI 10.1159/000365998; Pereira CA, 2002, J BRAS PNEUMOL, V28, pS1, DOI DOI 10.1590/S1806-37132007000400008; Pessoa IMBS, 2014, CAN RESPIR J, V21, P43, DOI 10.1155/2014/982374; Souza RB., 2002, J PNEUMOL, V28, pS155; Stefanutti D, 1999, AM J RESP CRIT CARE, V159, P107; Terzi N, 2010, RESPIRATION, V80, P379, DOI 10.1159/000254378; ULDRY C, 1995, THORAX, V50, P371, DOI 10.1136/thx.50.4.371; Verma R, 2019, ANN AM THORAC SOC, V16, P478, DOI 10.1513/AnnalsATS.201808-506OC; Zhang S, 2018, BRAIN DEV-JPN, V40, P391, DOI 10.1016/j.braindev.2018.01.008	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252150	10.1371/journal.pone.0252150	http://dx.doi.org/10.1371/journal.pone.0252150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038470	Green Published, gold			2022-12-26	WOS:000664633500055
J	Murali, KM; Mullan, J; Roodenrys, S; Hassan, HIC; Lonergan, M				Murali, Karumathil M.; Mullan, Judy; Roodenrys, Steven; Cheikh Hassan, Hicham I.; Lonergan, Maureen			Changes in measures of cognitive function in patients with end-stage kidney disease on dialysis and the effect of dialysis vintage: A longitudinal cohort study	PLOS ONE			English	Article							HEMODIALYSIS; IMPAIRMENT; HEALTH; PERFORMANCE; MEMORY	Introduction Prevalence of cognitive impairment increases with worsening severity of chronic kidney disease (CKD) and majority of end-stage kidney disease (ESKD) patients on dialysis have cognitive impairment. Trends of cognitive function (CF) in this population are less well known with published studies reporting conflicting results. Methods We assessed CF in a cohort of non-dialysis CKD and ESKD patients undergoing dialysis using modified mini-mental state examination (3MS), trail-making test (TMT-A & B) scores and Stroop task, and evaluated demographics, comorbidities and depression using Beck depression inventory at baseline. We repeated tests of CF and depression >= 1-year after baseline in both groups and compared change scores in CF and depression between ESKD/ CKD sub-groups. Among ESKD patients we compared change scores between patients with dialysis vintage of <1-year and >1-year. Analysis of covariance was used to adjust for the effect of age on these change scores. Results At baseline (N = 211), compared to CKD (N = 108), ESKD (N = 103) patients had significantly worse CF based on 3MS and TMT-A & B scores, and depression scores. On follow-up (N = 160) 3MS scores, especially the memory subscale significantly improved in ESKD, but worsened in CKD, with no significant changes in TMT A /TMT-B, or depression scores after adjusting for age. Among ESKD patients, 3MS, especially memory subscale improved in patients with dialysis vintage <1-year compared to >1-year. The 51 patients who discontinued after baseline assessment had worse baseline CF scores suggesting differential attrition. Conclusion Though baseline cognitive scores were worse in ESKD patients on dialysis, compared to CKD, their 3MS, especially memory subscale improved on follow-up. Among ESKD patients, the improvement was significant only in patients who have been on dialysis for less than one-year which may indicate a beneficial effect of clearance of uraemic toxins. Differential attrition of study subjects may have impacted the observed results.	[Murali, Karumathil M.; Cheikh Hassan, Hicham I.; Lonergan, Maureen] Wollongong Hosp, Dept Nephrol, Wollongong, NSW, Australia; [Murali, Karumathil M.; Mullan, Judy; Cheikh Hassan, Hicham I.; Lonergan, Maureen] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Mullan, Judy] Univ Wollongong, Ctr Hlth Res Illawarra Shoalhaven Populat CHRISP, Wollongong, NSW, Australia; [Roodenrys, Steven] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia	Wollongong Hospital; University of Wollongong; University of Wollongong; University of Wollongong	Murali, KM (corresponding author), Wollongong Hosp, Dept Nephrol, Wollongong, NSW, Australia.; Murali, KM (corresponding author), Univ Wollongong, Sch Med, Wollongong, NSW, Australia.	karumathil.murali@health.nsw.gov.au						Agganis BT, 2010, AM J KIDNEY DIS, V56, P704, DOI 10.1053/j.ajkd.2010.04.018; Altmann P, 2007, KIDNEY INT, V71, P252, DOI 10.1038/sj.ki.5001932; Bossola M, 2011, J PSYCHOSOM RES, V71, P50, DOI 10.1016/j.jpsychores.2011.01.001; Cabrera VJ, 2017, CLIN J AM SOC NEPHRO, V12, P687, DOI 10.2215/CJN.01650216; D'Elia L.F., 2005, HDB NORMATIVE DATA N, P648; Dixon BS, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0223-9; Drew DA, 2019, AM J KIDNEY DIS, V74, P782, DOI 10.1053/j.ajkd.2019.05.017; Drew DA, 2017, AM J KIDNEY DIS, V69, P780, DOI 10.1053/j.ajkd.2016.11.015; Drew DA, 2013, NEPHRON CLIN PRACT, V124, P151, DOI 10.1159/000356393; Findlay MD, 2019, J AM SOC NEPHROL, V30, P147, DOI 10.1681/ASN.2018050462; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; Griva K, 2010, AM J KIDNEY DIS, V56, P693, DOI 10.1053/j.ajkd.2010.07.003; Gronewold J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166530; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hickey GL, 2018, EUR J CARDIO-THORAC, V54, P4, DOI 10.1093/ejcts/ezy169; Iyasere O, 2017, CLIN KIDNEY J, V10, P89, DOI 10.1093/ckj/sfw128; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Matthews FE, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-12; McAdams-DeMarco MA, 2015, CLIN J AM SOC NEPHRO, V10, P2181, DOI 10.2215/CJN.01960215; MCCAFFREY RJ, 1993, ARCH CLIN NEUROPSYCH, V8, P519; Murray AM, 2006, NEUROLOGY, V67, P216, DOI 10.1212/01.wnl.0000225182.15532.40; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Rapp SR, 2003, AGING MENT HEALTH, V7, P217, DOI 10.1080/1360786031000101201; Seidel UK, 2014, KIDNEY INT, V85, P693, DOI 10.1038/ki.2013.366; Sharma A, 2016, AM J NEPHROL, V44, P462, DOI 10.1159/000451059; Smith T, 2007, CAN J PSYCHIAT, V52, P329, DOI 10.1177/070674370705200508; Steer RA, 1999, J CLIN PSYCHOL, V55, P117, DOI 10.1002/(SICI)1097-4679(199901)55:1<117::AID-JCLP12>3.0.CO;2-A; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tripepi G, 2010, NEPHRON CLIN PRACT, V115, pC94, DOI 10.1159/000312871; Viggiano D, 2020, NAT REV NEPHROL, V16, P452, DOI 10.1038/s41581-020-0266-9	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252237	10.1371/journal.pone.0252237	http://dx.doi.org/10.1371/journal.pone.0252237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OL	34033657	Green Published, gold, Green Submitted			2022-12-26	WOS:000664633100040
J	Schneider, AJ; Grimes, M; Lyon, W; Kemper, A; Wang, SJ; Bushman, W				Schneider, Andrew J.; Grimes, Matthew; Lyon, Will; Kemper, Amanda; Wang, Sijian; Bushman, Wade			Cluster analysis of men undergoing surgery for BPH/LUTS reveals prominent roles of both bladder outlet obstruction and diminished bladder contractility	PLOS ONE			English	Article							URINARY-TRACT DYSFUNCTION; URODYNAMIC FOLLOW-UP; NATURAL-HISTORY; TRANSURETHRAL RESECTION; DETRUSOR UNDERACTIVITY; AFTERLOAD REDUCTION; PROSTATE; VASODILATORS	Lower urinary tract symptoms (LUTS) in aging men are commonly attributed to bladder outlet obstruction from benign prostatic hyperplasia (BPH) but BPH/LUTS often reflects a confluence of many factors. We performed a hierarchical cluster analysis using four objective patient characteristics (age, HTN, DM, and BMI), and five pre-operative urodynamic variables (volume at first uninhibited detrusor contraction, number of uninhibited contractions, Bladder Outlet Obstruction Index (BOOI), Bladder Contractility Index (BCI) and Bladder Power at Qmax) to identify meaningful subgroups within a cohort of 94 men undergoing surgery for BPH/LUTS. Two meaningful subgroups (clusters) were identified. Significant differences between the two clusters included Prostate Volume (95 vs 53 cc; p-value = 0.001), BOOI (mean 70 vs 49; p-value = 0.001), BCI (mean 129 vs 83; p-value <0.001), Power (689 vs 236; p-value <0.001), Qmax (8.3 vs 4.9 cc/sec; p-value <0.001) and post-void residual (106 vs 250 cc; p-value = 0.001). One cluster is distinguished by larger prostate volume, greater outlet resistance and better bladder contractility. The other is distinguished by smaller prostate volume, lower outlet resistance and worse bladder contractility. Remarkably, the second cluster exhibited greater impairment of urine flow and bladder emptying. Surgery improved flow and emptying for patients in both clusters. These findings reveal important roles for both outlet obstruction and diminished detrusor function in development of diminished urine flow and impaired bladder emptying in patients with BPH/LUTS.	[Schneider, Andrew J.; Grimes, Matthew; Bushman, Wade] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA; [Schneider, Andrew J.; Bushman, Wade] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA; [Lyon, Will] Med Coll Wisconsin, Dept Med, Div Geriatrics Gerontol, Milwaukee, WI USA; [Kemper, Amanda] Univ Wisconsin Madison, Coll Engn, Dept Mech Engn, Madison, WI USA; [Wang, Sijian] Rutgers State Univ, Dept Stat, Piscataway, NJ USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; Rutgers State University New Brunswick	Bushman, W (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA.; Bushman, W (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.	bushman@urology.wisc.edu	Lyon, Will/GLR-3887-2022	Schneider, Andrew/0000-0002-3111-0216	Department of Veteran's Affairs Merit Award [I01 BX003454-01]	Department of Veteran's Affairs Merit Award(US Department of Veterans Affairs)	This work was supported by a Department of Veteran's Affairs Merit Award I01 BX003454-01 awarded to WB (www.research.va.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaivas JG, 2017, INT BRAZ J UROL, V43, P540, DOI [10.1590/S1677-5538.IBJU.2016.0405, 10.1590/s1677-5538.ibju.2016.0405]; Chacko S, 2004, SCAND J UROL NEPHROL, V38, P26, DOI 10.1080/03008880410015147; Cho MC, 2019, BJU INT, V123, pE34, DOI 10.1111/bju.14661; Engel JD, 2002, NEUROUROL URODYNAM, V21, P524, DOI 10.1002/nau.10084; Jock M, 2014, BJU INT, V114, P946, DOI 10.1111/bju.12687; MASON DT, 1978, AM J MED, V65, P106, DOI 10.1016/0002-9343(78)90700-3; Min DS, 2013, KOREAN J UROL, V54, P840, DOI 10.4111/kju.2013.54.12.840; Oelke M, 2014, WORLD J UROL, V32, P1177, DOI 10.1007/s00345-014-1358-6; Schmidt F, 2002, J UROLOGY, V168, P1458, DOI 10.1016/S0022-5347(05)64473-4; STEVENSON LW, 1987, AM J CARDIOL, V60, P654, DOI 10.1016/0002-9149(87)90376-6; Tanaka Y, 2006, INT J UROL, V13, P1398, DOI 10.1111/j.1442-2042.2006.01589.x; Thomas AW, 2005, BJU INT, V96, P1295, DOI 10.1111/j.1464-410X.2005.05891.x; Thomas AW, 2005, BJU INT, V96, P1301, DOI 10.1111/j.1464-410X.2005.05815.x; Thomas AW, 2005, J UROLOGY, V174, P1887, DOI 10.1097/01.ju.0000176740.76061.24; Thomas AW, 2004, BJU INT, V93, P745, DOI 10.1111/j.1464-410X.2003.04719.x; Van Mastrigt R., 1992, NEUROUROL URODYNAM, V11, P315	16	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0251721	10.1371/journal.pone.0251721	http://dx.doi.org/10.1371/journal.pone.0251721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029333	Green Published, gold			2022-12-26	WOS:000664632800011
J	Prajapati, M; Conboy, HL; Hojyo, S; Fukada, T; Budnik, B; Bartnikas, TB				Prajapati, Milankumar; Conboy, Heather L.; Hojyo, Shintaro; Fukada, Toshiyuki; Budnik, Bogdan; Bartnikas, Thomas B.			Biliary excretion of excess iron in mice requires hepatocyte iron import by Slc39a14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFLUX TRANSPORTER SLC30A10; TRANSFERRIN-BOUND IRON; RADIOACTIVE IRON; BILE; OVERLOAD; FERRITIN; LIVER; PLASMA; HYPOTHYROIDISM; DEFICIENCY	Iron is essential for erythropoiesis and other biological processes, but is toxic in excess. Dietary absorption of iron is a highly regulated process and is a major determinant of body iron levels. Iron excretion, however, is considered a passive, unregulated process, and the underlying pathways are unknown. Here we investigated the role of metal transporters SLC39A14 and SLC30A10 in biliary iron excretion. While SLC39A14 imports manganese into the liver and other organs under physiological conditions, it imports iron under conditions of iron excess. SLC30A10 exports manganese from hepatocytes into the bile. We hypothesized that biliary excretion of excess iron would be impaired by SLC39A14 and SLC30A10 deficiency. We therefore analyzed biliary iron excretion in Slc39a14-and Slc30a10-deficient mice raised on iron-sufficient and -rich diets. Bile was collected surgically from the mice, then analyzed with nonheme iron assays, mass spectrometry, ELISAs, and an electrophoretic assay for iron-loaded ferritin. Our results support a model in which biliary excretion of excess iron requires iron import into hepatocytes by SLC39A14, followed by iron export into the bile predominantly as ferritin, with iron export occurring independently of SLC30A10. To our knowledge, this is the first report of a molecular determinant of mammalian iron excretion and can serve as basis for future investigations into mechanisms of iron excretion and relevance to iron homeostasis.	[Prajapati, Milankumar; Conboy, Heather L.; Bartnikas, Thomas B.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Hojyo, Shintaro] Hokkaido Univ, Grad Sch Med, Inst Genet Med, Div Mol Psychoimmunol, Sapporo, Hokkaido, Japan; [Fukada, Toshiyuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Mol & Cellular Physiol, Tokushima, Japan; [Budnik, Bogdan] Harvard Univ, Fac Arts & Sci, Div Sci, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA; [Conboy, Heather L.] Akebia Therapeut, Cambridge, MA USA	Brown University; Hokkaido University; Tokushima Bunri University; Harvard University	Bartnikas, TB (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	thomas_bartnikas@brown.edu	Budnik, Bogdan/AGG-8824-2022	Budnik, Bogdan/0000-0003-3622-2003; Prajapati, Milankumar/0000-0003-3399-3697	NIH [DK11049]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant DK11049 (T. B. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anagianni S, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0942-y; Arosio P, 2017, IUBMB LIFE, V69, P414, DOI 10.1002/iub.1621; Aydemir TB, 2020, AM J PHYSIOL-GASTR L, V318, pG673, DOI 10.1152/ajpgi.00301.2019; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; BRADFORD WD, 1969, AM J PATHOL, V56, P201; BRISSOT P, 1994, AM J PHYSIOL, V267, pG135, DOI 10.1152/ajpgi.1994.267.1.G135; BRISSOT P, 1994, ADV EXP MED BIOL, V356, P277; Brissot P, 1997, HEPATOLOGY, V25, P1457, DOI 10.1002/hep.510250625; CHAM BE, 1985, ANAL BIOCHEM, V151, P561, DOI 10.1016/0003-2697(85)90220-9; CLETON MI, 1986, HEPATOLOGY, V6, P30, DOI 10.1002/hep.1840060107; Corradini E, 2020, MOL ASPECTS MED, V75, DOI 10.1016/j.mam.2020.100896; Fini A, 1997, J INORG BIOCHEM, V68, P251, DOI 10.1016/S0162-0134(97)00093-7; Hahn PF, 1939, J EXP MED, V70, P443, DOI 10.1084/jem.70.5.443; Hawkins WB, 1944, J EXP MED, V80, P31, DOI 10.1084/jem.80.1.31; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; HULTCRANTZ R, 1989, GASTROENTEROLOGY, V96, P1539, DOI 10.1016/0016-5085(89)90524-6; HULTCRANTZ R, 1982, LAB INVEST, V46, P383; Hutchens S, 2017, J BIOL CHEM, V292, P9760, DOI 10.1074/jbc.M117.783605; IANCU TC, 1985, J HEPATOL, V1, P261, DOI 10.1016/S0168-8278(85)80054-4; JACOBS A, 1970, GUT, V11, P732, DOI 10.1136/gut.11.9.732; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kall L, 2008, BIOINFORMATICS, V24, pI42, DOI 10.1093/bioinformatics/btn294; Katsarou A, 2020, MOL ASPECTS MED, V75, DOI 10.1016/j.mam.2020.100866; Knutson MD, 2017, J BIOL CHEM, V292, P12735, DOI 10.1074/jbc.R117.786632; LESAGE GD, 1986, J CLIN INVEST, V77, P90, DOI 10.1172/JCI112307; LEVY P, 1991, GASTROENTEROLOGY, V101, P1673, DOI 10.1016/0016-5085(91)90407-C; Liu CY, 2017, J BIOL CHEM, V292, P16605, DOI 10.1074/jbc.M117.804989; Mercadante CJ, 2019, J CLIN INVEST, V129, P5442, DOI 10.1172/JCI129710; Mercadante CJ, 2019, HAEMATOLOGICA, V104, P678, DOI 10.3324/haematol.2018.198382; REGOECZI E, 1994, HEPATOLOGY, V19, P1476, DOI 10.1002/hep.1840190624; REGOECZI E, 1995, HEPATOLOGY, V21, P1063, DOI 10.1016/0270-9139(95)90256-2; Santana-Codina N, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040114; Scheiber IF, 2019, J BIOL CHEM, V294, P9147, DOI 10.1074/jbc.RA119.008762; SCHUMANN K, 1986, RES EXP MED, V186, P215, DOI 10.1007/BF01852047; Taylor CA, 2019, J BIOL CHEM, V294, P1860, DOI 10.1074/jbc.RA118.005628; Vinchi F, 2014, GASTROENTEROLOGY, V146, P1325, DOI 10.1053/j.gastro.2014.01.053; Wang PC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw6127; Winslow JWW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093304; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xia ZD, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006892; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; YU SG, 1992, BIOL TRACE ELEM RES, V35, P73, DOI 10.1007/BF02786239; Yu YY, 2020, BLOOD, V136, P726, DOI 10.1182/blood.2019002907; ZUYDERHOUDT FMJ, 1985, BIOCHIM BIOPHYS ACTA, V838, P381, DOI 10.1016/0304-4165(85)90238-7	47	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100835	10.1016/j.jbc.2021.100835	http://dx.doi.org/10.1016/j.jbc.2021.100835			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051234	gold, Green Published			2022-12-26	WOS:000678068400035
J	Lin, SL; Lin, RF; Yan, N; Huang, JP				Lin, Shanlang; Lin, Ruofei; Yan, Na; Huang, Junpei			Traffic control and social distancing evidence from COVID-19 in China	PLOS ONE			English	Article							INTERVENTIONS; SPREAD	We collected COVID-19 epidemiological and epidemic control measures-related data in mainland China during the period January 1 to February 19, 2020, and empirically tested the practical effects of the epidemic control measures implemented in China by applying the econometrics approach. The results show that nationally, both traffic control and social distancing have played an important role in controlling the outbreak of the epidemic, however, neither of the two measures have had a significant effect in low-risk areas. Moreover, the effect of traffic control is more successful than that of social distancing. Both measures complement each other, and their combined effect achieves even better results. These findings confirm the effectiveness of the measures currently in place in China, however, we would like to emphasize that control measures should be more tailored, which implemented according to each specific city's situation, in order to achieve a better epidemic prevention and control.	[Lin, Shanlang; Lin, Ruofei; Yan, Na; Huang, Junpei] Tongji Univ, Sch Econ & Management, Shanghai, Peoples R China	Tongji University	Huang, JP (corresponding author), Tongji Univ, Sch Econ & Management, Shanghai, Peoples R China.	1830263@tongji.edu.cn	yan, na/HDM-3747-2022; lin, ruofei/GSN-4705-2022	Huang, junpei/0000-0002-8357-0273				Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; Chong KC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-309; Dave D, 2021, ECON INQ, V59, P29, DOI 10.1111/ecin.12944; Ding Y, 2020, SCI CHINA LIFE SCI, V63, P936, DOI 10.1007/s11427-020-1695-5; Fang HM, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104272; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; Koenig KL, 2015, ANN EMERG MED, V65, P330, DOI 10.1016/j.annemergmed.2014.12.003; Li Q., 2020, NEW ENGL J MED, V382, P1199; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Mizumoto K, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01691-x; Rashid H, 2015, PAEDIATR RESPIR REV, V16, P119, DOI 10.1016/j.prrv.2014.01.003; Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa038; Sakaguchi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031289; Wang L, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.032901; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216	23	3	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252300	10.1371/journal.pone.0252300	http://dx.doi.org/10.1371/journal.pone.0252300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QL	34077487	gold, Green Published			2022-12-26	WOS:000664638500036
J	Su, MI; Liu, CW				Su, Min-I.; Liu, Cheng-Wei			Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; PERIPHERAL ARTERIAL-DISEASE; INFLAMMATION; SEVERITY	Purpose Association of the neutrophil-to-lymphocyte ratio (NLR) with mortality has not been comprehensively explored in critical limb ischemia (CLI) patients. We investigated the association between the NLR and clinical outcomes in CLI. Materials and methods We retrospectively enrolled consecutive CLI patients between 1/1/2013 and 12/31/2018. Receiver operating characteristic curve analysis determined NLR cutoffs for 1-year in-hospital, all-cause and cardiac-related mortality; major adverse cardiovascular events (MACEs); and major adverse limb events (MALEs). Results Among 195 patients (age, 74.0 years, SD: 11.5; 51.8% male; body mass index, 23.4 kg/m(2), SD: 4.2), 14.4% exhibited acute limb ischemia. After 1 year, patients with NLR>8 had higher in-hospital mortality (21.1% vs. 3.6%, P<0.001), all-cause mortality (54.4% vs. 13.8%, P<0.001), cardiac-related mortality (28.1% vs. 6.5%, P<0.001), MACE (29.8% vs. 13.0%, P = 0.008), and MALE (28.1% vs. 13.0%, P = 0.021) rates than those with NLR<8. In multivariate logistic regression, NLR >= 8 was significantly associated with all-cause (P<0.001) and cardiac-related (adjusted HR: 5.286, 95% CI: 2.075-13.47, P<0.001) mortality, and NLR >= 6 was significantly associated with MALEs (adjusted HR: 2.804, 95% CI: 1.292-6.088, P = 0.009). Each increase in the NLR was associated with increases in all-cause (adjusted HR: 1.028, 95% CI: 1.008-1.049, P = 0.007) and cardiac-related (adjusted HR:1.027, 95% CI: 0.998-1.057, P = 0.073) mortality but not in-hospital mortality or MACEs. Conclusion CLI patients with high NLRs had significantly higher risks of 1-year all-cause and cardiac-related mortality and MALEs. The NLR can be used for prognostic prediction in these patients.	[Su, Min-I.] Taitung MacKay Mem Hosp, Div Cardiol, Dept Internal Med, Taitung, Taiwan; [Su, Min-I.] MacKay Med Coll, Dept Med, New Taipei, Taiwan; [Liu, Cheng-Wei] Triserv Gen Hosp, Songshan Branch, Natl Def Med Ctr, Dept Internal Med, Taipei, Taiwan; [Liu, Cheng-Wei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Medical College; National Defense Medical Center; Tri-Service General Hospital; National Taiwan University	Liu, CW (corresponding author), Triserv Gen Hosp, Songshan Branch, Natl Def Med Ctr, Dept Internal Med, Taipei, Taiwan.; Liu, CW (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	issac700319@gmai.com	Liu, Cheng-Wei/AAV-2919-2020	Liu, Cheng-Wei/0000-0001-5095-8039				Abu Dabrh AM, 2015, J VASC SURG, V62, P1642, DOI 10.1016/j.jvs.2015.07.065; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; Angkananard T, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2703518; Aykan AC, 2016, ANATOL J CARDIOL, V16, P497, DOI 10.5152/AnatolJCardiol.2015.6240; Bath J, 2020, J VASC SURG, V72, P622, DOI 10.1016/j.jvs.2019.10.094; Bhat TM, 2016, EXPERT REV CARDIOVAS, V14, P871, DOI 10.1586/14779072.2016.1165091; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V304, P1350, DOI 10.1001/jama.2010.1322; Chan C, 2014, J VASC SURG, V60, P661, DOI 10.1016/j.jvs.2014.03.277; de Pablo R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/671087; Erturk M, 2014, J CARDIOL, V64, P371, DOI 10.1016/j.jjcc.2014.02.019; Faria SS, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.702; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; Izaks GJ, 2003, J AM GERIATR SOC, V51, P1461, DOI 10.1046/j.1532-5415.2003.51467.x; Kinlay S, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.001946; Kithcart Aaron P, 2018, J Am Coll Cardiol, V72, P2789, DOI 10.1016/j.jacc.2018.09.041; Li X, 2018, J CANCER, V9, P861, DOI 10.7150/jca.23367; Liu CW, 2019, NUTR METAB CARDIOVAS, V29, P30, DOI 10.1016/j.numecd.2018.10.001; Liu CW, 2020, ACTA CARDIOL SIN, V36, P483, DOI 10.6515/ACS.202009_36(5).20200406A; Liu CW, 2018, MIL MED, V183, pE391, DOI 10.1093/milmed/usy097; Liu CW, 2017, J CARDIOVASC THORAC, V9, P62, DOI 10.15171/jcvtr.2017.10; Reinecke H, 2015, EUR HEART J, V36, P932, DOI 10.1093/eurheartj/ehv006; Shishehbor MH, 2016, J AM COLL CARDIOL, V68, P2002, DOI 10.1016/j.jacc.2016.04.071; Signorelli SS, 2014, INT J MOL MED, V33, P777, DOI 10.3892/ijmm.2014.1657; Silvestre-Roig C, 2020, NAT REV CARDIOL, V17, P327, DOI 10.1038/s41569-019-0326-7; Song SY, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01032; Spark JI, 2010, J VASC SURG, V52, P632, DOI 10.1016/j.jvs.2010.03.067; Tasoglu I, 2014, CLIN APPL THROMB-HEM, V20, P645, DOI 10.1177/1076029613475474; Teperman J, 2017, INT J CARDIOL, V228, P201, DOI 10.1016/j.ijcard.2016.11.097; Wisman PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131356; Ye M, 2020, ANN VASC SURG, V64, P221, DOI 10.1016/j.avsg.2019.09.005; Zhang S, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0812-6	32	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252030	10.1371/journal.pone.0252030	http://dx.doi.org/10.1371/journal.pone.0252030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043672	gold, Green Published, Green Submitted			2022-12-26	WOS:000664635700045
J	Xing, LF; Yao, M; Goyal, H; Hong, YC; Zhang, ZH				Xing, Lifeng; Yao, Min; Goyal, Hemant; Hong, Yucai; Zhang, Zhongheng			Latent transition analysis of cardiac arrest patients treated in the intensive care unit	PLOS ONE			English	Article							TARGETED TEMPERATURE MANAGEMENT; COMATOSE SURVIVORS; PROFILE ANALYSIS; SUBPHENOTYPES; RESUSCITATION; 33-DEGREES-C	Background and objective Post-cardiac arrest (CA) syndrome is heterogenous in their clinical presentations and outcomes. This study aimed to explore the transition and stability of subphenotypes (profiles) of CA treated in the intensive care unit (ICU). Patients and methods Clinical features of CA patients on day 1 and 3 after ICU admission were modeled by latent transition analysis (LTA) to explore the transition between subphenotypes over time. The association between different transition patterns and mortality outcome was explored using multivariable logistic regression. Results We identified 848 eligible patients from the database. The LPA identified three distinct subphenotypes: Profile 1 accounted for the largest proportion (73%) and was considered as the baseline subphenotype. Profile 2 (13%) was characterized by brain injury and profile 3 (14%) was characterized by multiple organ dysfunctions. The same three subphenotypes were identified on day 3. The LTA showed consistent subphenotypes. A majority of patients in profile 2 (72%) and 3 (82%) on day 1 switched to profile 1 on day 3. In the logistic regression model, patients in profile 1 on day 1 transitioned to profile 3 had worse survival outcome than those continue to remain in profile 1 (OR: 20.64; 95% CI: 6.01 to 70.94; p < 0.001) and transitioned to profile 2 (OR: 8.42; 95% CI: 2.22 to 31.97; p = 0.002) on day 3. Conclusion The study identified three subphenotypes of CA, which was consistent on day 1 and 3 after ICU admission. Patients who transitioned to profile 3 on day 3 had significantly worse survival outcome than those remained in profile 1 or 2.	[Xing, Lifeng; Hong, Yucai; Zhang, Zhongheng] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Emergency Med, Hangzhou, Peoples R China; [Yao, Min] Boston Univ, Sch Med, Dept Surg, Wound Care Clin Res Program, Boston, MA 02118 USA; [Yao, Min] Boston Med Ctr, Boston, MA USA; [Goyal, Hemant] Mercer Univ, Sch Med, Dept Internal Med, Macon, GA 31207 USA; [Zhang, Zhongheng] Hainan Med Univ, Coll Emergency & Trauma, Minist Educ, Key Lab Emergency & Trauma, Haikou, Hainan, Peoples R China	Zhejiang University; Boston University; Boston Medical Center; Mercer University; Hainan Medical University	Hong, YC; Zhang, ZH (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Emergency Med, Hangzhou, Peoples R China.; Zhang, ZH (corresponding author), Hainan Med Univ, Coll Emergency & Trauma, Minist Educ, Key Lab Emergency & Trauma, Haikou, Hainan, Peoples R China.	zrhyc@hotmail.com; zh_zhang1984@zju.edu.cn	Goyal, Hemant/E-3153-2012; zhang, zh/GWV-4677-2022; Zhang, Zhongheng/E-1282-2011	Goyal, Hemant/0000-0002-9433-9042; Zhang, Zhongheng/0000-0002-2336-5323	Yilu "Gexin" - Fluid Therapy Research Fund Project [YLGX-ZZ-2020005]; Health Science and Technology Plan of Zhejiang Province [2021KY745]; Key Laboratory of Tropical Cardiovascular Diseases Research of Hainan Province [KLTCDR-202001]; Key Laboratory of Emergency and Trauma (Hainan Medical University), Ministry of Education [KLET-202017]; Key Research & Development project of Zhejiang Province [2021C03071]; clinical research foundation of Zhejiang Medical Association [2019ZYC-A87]	Yilu "Gexin" - Fluid Therapy Research Fund Project; Health Science and Technology Plan of Zhejiang Province; Key Laboratory of Tropical Cardiovascular Diseases Research of Hainan Province; Key Laboratory of Emergency and Trauma (Hainan Medical University), Ministry of Education; Key Research & Development project of Zhejiang Province; clinical research foundation of Zhejiang Medical Association	Z.Z. received funding from Yilu "Gexin" - Fluid Therapy Research Fund Project (YLGX-ZZ-2020005), Health Science and Technology Plan of Zhejiang Province (2021KY745), the Key Laboratory of Tropical Cardiovascular Diseases Research of Hainan Province (Grant.KLTCDR-202001) and Key Laboratory of Emergency and Trauma (Hainan Medical University), Ministry of Education (Grant.KLET-202017). Y.H. received funding from Key Research & Development project of Zhejiang Province (2021C03071). The study was funded by clinical research foundation of Zhejiang Medical Association (2019ZYC-A87).	Arola O, 2017, J AM COLL CARDIOL, V70, P2652, DOI 10.1016/j.jacc.2017.09.1088; Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Beijers L, 2018, PSYCHOL MED, V4, P1, DOI [DOI 10.1017/S0033291718001307, 10.1017/S0033291718001307]; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Collins LM., 2013, LATENT CLASS LATENT, DOI [https://doi.org/10.1002/9780470567333, DOI 10.1002/9780470567333]; Courcoul A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090334; Delucchi K, 2018, THORAX, V73, P439, DOI 10.1136/thoraxjnl-2017-211090; Donnino MW, 2015, CIRCULATION, V132, P2448, DOI 10.1161/CIR.0000000000000313; Famous KR, 2017, AM J RESP CRIT CARE, V195, P331, DOI 10.1164/rccm.201603-0645OC; Gardlund B, 2018, J CRIT CARE, V47, P70, DOI 10.1016/j.jcrc.2018.06.012; Hassager C, 2018, LANCET, V391, P989, DOI 10.1016/S0140-6736(18)30315-5; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Lilja G, 2015, CIRCULATION, V131, P1340, DOI 10.1161/CIRCULATIONAHA.114.014414; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nasserinejad K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168838; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nishikimi M, 2018, RESUSCITATION, V128, P11, DOI 10.1016/j.resuscitation.2018.04.029; Pastor DA, 2007, CONTEMP EDUC PSYCHOL, V32, P8, DOI 10.1016/j.cedpsych.2006.10.003; RIBEIRO A, 2021, PLOONE PUBLIC LIB, V16, DOI DOI 10.1371/JOURNAL.PONE.0247101; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Stockl M, 2017, RESUSCITATION, V120, P14, DOI 10.1016/j.resuscitation.2017.08.238; Vallabhajosyula S, 2020, MAYO CLIN PROC, V95, P611, DOI 10.1016/j.mayocp.2019.12.007; Varvarousis D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16857-6; Varvarousis D, 2015, AM J EMERG MED, V33, P1297, DOI 10.1016/j.ajem.2015.06.066; Yuan Y, 2020, APPL MATH MECH-ENGL, V41, P587, DOI 10.1007/s10483-020-2600-6; Zhang ZH, 2020, J EVID-BASED MED, V13, P301, DOI 10.1111/jebm.12418; Zhang ZH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50178-0; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.12.63	33	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252318	10.1371/journal.pone.0252318	http://dx.doi.org/10.1371/journal.pone.0252318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043699	Green Published, gold			2022-12-26	WOS:000664635700085
J	Hanif, AM; Hasan, M; Khan, MSA; Hossain, MM; Shamim, A; Hossaine, M; Ullah, MA; Sarker, SK; Rahman, SMM; Bulbul, MMI; Mitra, DK; Mridha, MK				Hanif, Abu Abdullah Mohammad; Hasan, Mehedi; Khan, Md Showkat Ali; Hossain, Md. Mokbul; Shamim, Abu Ahmed; Hossaine, Moyazzam; Ullah, Mohammad Aman; Sarker, Samir Kanti; Rahman, S. M. Mustafizur; Bulbul, Md Mofijul Islam; Mitra, Dipak Kumar; Mridha, Malay Kanti			Ten-years cardiovascular risk among Bangladeshi population using non-laboratory-based risk chart of the World Health Organization: Findings from a nationally representative survey	PLOS ONE			English	Article							DISEASE PREVENTION; RURAL-POPULATION; CORONARY; HYPERTENSION; KNOWLEDGE; EDUCATION; WOMEN	The World Health Organization (WHO) has recently developed a non-laboratory based cardiovascular disease (CVD) risk chart considering the parameters age, sex, current smoking status, systolic blood pressure, and body mass index. Using the chart, we estimated the 10-years CVD risk among the Bangladeshi population aged 40-74 years. We analyzed data from a nationally representative survey conducted in 2018-19. The survey enrolled participants from 82 clusters (57 rural, 15 non-slum urban, and 10 slums) selected by multistage cluster sampling. Using the non-laboratory-based CVD risk chart of the World Health Organization (WHO), we categorized the participants into 5 risk groups: very low (<5%), low (5% to <10%), moderate (10% to <20%), high (20% to <30%) and very high (> = 30%) risk. We performed descriptive analyses to report the distribution of CVD risk and carried out univariable and multivariable logistic regression to identify factors associated with elevated CVD risk (> = 10% CVD risk). Of the 7,381 participants, 46.0% were female. The median age (IQR) was 59.0 (48.0-64.7) years. Overall, the prevalence of very low, low, moderate, high, and very high CVD risk was 34.7%, 37.8%, 25.9%, 1.6%, and 0.1%, respectively. Elevated CVD risk (> = 10%) was associated with poor education, currently unmarried, insufficient physical inactivity, smokeless tobacco use, and self-reported diabetes in both sexes, higher household income, and higher sedentary time among males, and slum-dwelling and non-Muslim religions among females. One in every four Bangladeshi adults had elevated levels of CVD risk, and males are at higher risk of occurring CVD events. Non-laboratory-based risk prediction charts can be effectively used in low resource settings. The government of Bangladesh and other developing countries should train the primary health care workers on the use of WHO non-laboratory-based CVD risk charts, especially in settings where laboratory tests are not available.	[Hanif, Abu Abdullah Mohammad; Hasan, Mehedi; Khan, Md Showkat Ali; Hossain, Md. Mokbul; Shamim, Abu Ahmed; Hossaine, Moyazzam; Mridha, Malay Kanti] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Noncommunicable Dis & Nutr, Dhaka, Bangladesh; [Ullah, Mohammad Aman; Sarker, Samir Kanti; Rahman, S. M. Mustafizur; Bulbul, Md Mofijul Islam] Natl Nutr Serv NNS, Inst Publ Hlth Nutr IPHN, Dhaka, Bangladesh; [Mitra, Dipak Kumar] North South Univ, Dhaka, Bangladesh	Bangladesh Rural Advancement Committee BRAC; BRAC University; North South University (NSU)	Mridha, MK (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Ctr Noncommunicable Dis & Nutr, Dhaka, Bangladesh.	malay.mridha@bracu.ac.bd	Mridha, Malay Kanti/AAJ-5539-2020; Hasan, Mehedi/HHC-4236-2022; Hanif, Abu Abdullah Mohammad/AAG-4636-2020; Mitra, Dipak/W-9569-2018	Mridha, Malay Kanti/0000-0001-9226-457X; Hanif, Abu Abdullah Mohammad/0000-0001-6274-5612; Mitra, Dipak/0000-0001-8680-4146	National Nutrition Services (NNS), Institute of Public Health Nutrition, Ministry of Health and Family Welfare, Government of Bangladesh; National Institute for Health Research (NIHR) from the UK Government [16/136/68]; Wellcome Trust [212945/Z/18/Z]	National Nutrition Services (NNS), Institute of Public Health Nutrition, Ministry of Health and Family Welfare, Government of Bangladesh; National Institute for Health Research (NIHR) from the UK Government; Wellcome Trust(Wellcome Trust)	The study was funded by the National Nutrition Services (NNS), Institute of Public Health Nutrition, Ministry of Health and Family Welfare, Government of Bangladesh. Besides, salaries and administrative support for some of authors came from the National Institute for Health Research (NIHR) (16/136/68) using UK aid from the UK Government to support global health research, and by Wellcome Trust (212945/Z/18/Z). The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care.	[Anonymous], 2019, NATL PROTOCOLS MANAG, VSecond Edition.; Bangladesh Bureau of Statistics, 2014, BANGL POP HOUS CENS; Bangladesh Bureau of Statistics (BBS), CENS SLUM AR FLOAT P; Buttar Harpal S, 2005, Exp Clin Cardiol, V10, P229; Cogill B, 2003, ANTHROPOMETRIC INDIC; Di Angelantonio E, 2019, LANCET GLOB HEALTH, V7, pE1332, DOI 10.1016/S2214-109X(19)30318-3; Fatema K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008140; Ghorpade AG, 2015, INT J HEALTH POLICY, V4, P531, DOI 10.15171/ijhpm.2015.88; Guidelines Review Committee, 2010, GLOB REC PHYS ACT HL; Institute for Health M Evaluation, 2018, FINDINGS GLOBAL BURD; Islam JY, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035842; Khanal Mahesh Kumar, 2017, BMC Res Notes, V10, P120, DOI 10.1186/s13104-017-2436-9; Lavrakas P. J., 2008, ENCY SURVEY RES METH, DOI [DOI 10.4135/9781412963947, 10.4135/9781412963947]; Liew SM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-017711; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; McDermott MM, 2003, ARCH INTERN MED, V163, P2157, DOI 10.1001/archinte.163.18.2157; Merz CNB, 2003, J AM COLL CARDIOL, V41, P413, DOI 10.1016/S0735-1097(02)02763-8; Misra A, 2006, INT J OBESITY, V30, P106, DOI 10.1038/sj.ijo.0803111; Moran A, 2013, GLOB HEART, V8, P139, DOI 10.1016/j.gheart.2013.04.001; National Health Services (NHS), CARD DIS 2018; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Rehman H, 2018, INDIAN HEART J, V70, P721, DOI 10.1016/j.ihj.2018.01.029; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Samal D, 2007, STROKE, V38, P1304, DOI 10.1161/01.STR.0000259733.43470.27; Schultz WM, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005890; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; TENCONI MT, 1992, EUR J EPIDEMIOL, V8, P763, DOI 10.1007/BF00145317; Tuffrey V., 2016, NUTR SURVEILLANCE SY; World Health Organization, NONC DIS NCD; World Health Organization (WHO), CARD DIS CVDS KEY FA	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251967	10.1371/journal.pone.0251967	http://dx.doi.org/10.1371/journal.pone.0251967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038457	Green Published, gold			2022-12-26	WOS:000664633500034
J	Kawata, H; Kohno, M; Nukina, K; Horiuchi, I; Goda, H; Kuwahara, T; Yoshimori, K; Miyaji, A; Kamachi, T; Yoshikawa, T				Kawata, Hiroyuki; Kohno, Masahiro; Nukina, Kohei; Horiuchi, Isanori; Goda, Hisataka; Kuwahara, Tomomi; Yoshimori, Kosei; Miyaji, Akimitsu; Kamachi, Toshiaki; Yoshikawa, Toshikazu			Identifying the chloroperoxyl radical in acidified sodium chlorite solution	PLOS ONE			English	Article							ELECTRON-SPIN-RESONANCE; CHLOROUS ACID; ESCHERICHIA-COLI; ANTIMICROBIAL TREATMENT; SINGLET OXYGEN; DIOXIDE CLO2; DISPROPORTIONATION; GENERATION; OXIDATION; KINETICS	The present study identified the active radical species in acidic sodium chlorite and investigated the feasibility of quantifying these species with the diethylphenylenediamine (DPD) method. Electron spin resonance (ESR) spectroscopy was used to identify the active species generated in solutions containing sodium chlorite (NaClO2). The ESR signal was directly observed in an acidified sodium chlorite (ASC) aqueous solution at room temperature. This ESR signal was very long-lived, indicating that the radical was thermodynamically stable. The ESR parameters of this signal did not coincide with previously reported values of the chlorine radical (Cl-.) or chlorine dioxide radical (O = Cl-.-O and O = Cl-O-.). We refer to this signal as being from the chloroperoxyl radical (Cl-O-O-.). Quantum chemical calculations revealed that the optimal structure of the chloroperoxyl radical is much more thermodynamically stable than that of the chlorine dioxide radical. The UV-visible spectrum of the chloroperoxyl radical showed maximum absorbance at 354 nm. This absorbance had a linear relationship with the chloroperoxyl radical ESR signal intensity. Quantifying the free chlorine concentration by the DPD method also revealed a linear relationship with the maximum absorbance at 354 nm, which in turn showed a linear relationship with the chloroperoxyl radical ESR signal intensity. These linear relationships suggest that the DPD method can quantify chloroperoxyl radicals, which this study considers to be the active species in ASC aqueous solution.	[Kawata, Hiroyuki; Nukina, Kohei; Horiuchi, Isanori; Goda, Hisataka] Sankei Co Ltd, Chuou Ku, Osaka, Japan; [Kohno, Masahiro; Yoshimori, Kosei; Kamachi, Toshiaki] Tokyo Inst Technol, Dept Life Sci & Technol, Meguro Ku, Tokyo, Japan; [Kuwahara, Tomomi] Kagawa Univ, Dept Microbiol, Fac Med, Miki, Kagawa, Japan; [Miyaji, Akimitsu] Tokyo Inst Technol, Sch Mat & Chem Technol, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa, Japan; [Yoshikawa, Toshikazu] Louis Pasteur Ctr Med Res, Sakyo Ku, Tanaka Monzen Cho, Kyoto, Japan	Tokyo Institute of Technology; Kagawa University; Tokyo Institute of Technology	Kohno, M (corresponding author), Tokyo Inst Technol, Dept Life Sci & Technol, Meguro Ku, Tokyo, Japan.	kohno.m.aa@m.titech.ac.jp	Kamachi, Toshiaki/C-4230-2015	Kamachi, Toshiaki/0000-0002-9720-0265	Sankei Co. Ltd.	Sankei Co. Ltd.	Sankei Co. Ltd. provided support for this study in the form of salaries for HK, KN, IH, and HG. The specific roles of these authors are articulated in the `author contributions' section. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ADRIAN FJ, 1972, J CHEM PHYS, V56, P6251, DOI 10.1063/1.1677181; AIETA EM, 1984, J AM WATER WORKS ASS, V76, P64; Castillo A, 1999, J FOOD PROTECT, V62, P580, DOI 10.4315/0362-028X-62.6.580; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; EACHUS RS, 1967, CHEM COMMUN, P1036, DOI 10.1039/c19670001036; Frisch G. W., 2013, GAUSSIAN 09; Goda H, 2018, JPN J INFECT DIS, V71, P333, DOI 10.7883/yoken.JJID.2018.089; Goda H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176718; Hashimoto M, 1997, CHEM LETT, P71, DOI 10.1246/cl.1997.71; Hatanaka N, 2020, FOOD CONTROL, V111, DOI 10.1016/j.foodcont.2019.107046; HONG CC, 1968, CAN J CHEMISTRY, V46, P2053, DOI 10.1139/v68-335; HOQ MF, 1992, IND ENG CHEM RES, V31, P137, DOI 10.1021/ie00001a020; Horvath AK, 2003, J PHYS CHEM A, V107, P6966, DOI 10.1021/jp027411h; Inatsu Y, 2005, J FOOD PROTECT, V68, P999, DOI 10.4315/0362-028X-68.5.999; Inatsu Y, 2005, J FOOD PROTECT, V68, P251, DOI 10.4315/0362-028X-68.2.251; Kamireddy N, 2008, J FOOD PROTECT, V71, P973, DOI 10.4315/0362-028X-71.5.973; Kemp GK, 2000, J FOOD PROTECT, V63, P1087, DOI 10.4315/0362-028X-63.8.1087; KIEFFER RG, 1968, INORG CHEM, V7, P239, DOI 10.1021/ic50060a014; KIEFFER RG, 1968, INORG CHEM, V7, P235, DOI 10.1021/ic50060a013; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Mazej Z, 2020, INORG CHEM, V59, P2092, DOI 10.1021/acs.inorgchem.9b03518; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Miyaji A, 2017, J CLIN BIOCHEM NUTR, V60, P86, DOI 10.3164/jcbn.16-38; Miyaji A, 2017, BIOCHEM BIOPH RES CO, V483, P178, DOI 10.1016/j.bbrc.2016.12.171; Miyaji A, 2016, BIOCHEM BIOPH RES CO, V471, P450, DOI 10.1016/j.bbrc.2016.02.056; Ni Y, 1998, IND ENG CHEM RES, V37, P2367, DOI 10.1021/ie970608p; Oyarzabal OA, 2004, J FOOD PROTECT, V67, P2288, DOI 10.4315/0362-028X-67.10.2288; Ozawa T, 1996, FREE RADICAL BIO MED, V20, P837, DOI 10.1016/0891-5849(95)02092-6; OZAWA T, 1983, CHEM PHARM BULL, V31, P2864; Pryke DC, 1997, ENVIRON SCI TECHNOL, V31, pA394, DOI 10.1021/es9724250; Su YC, 2003, J FOOD PROTECT, V66, P812, DOI 10.4315/0362-028X-66.5.812; TAUBE H, 1949, J AM CHEM SOC, V71, P3330, DOI 10.1021/ja01178a016; Warriner K, 2005, J SCI FOOD AGR, V85, P2307, DOI 10.1002/jsfa.2256	33	2	2	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252079	10.1371/journal.pone.0252079	http://dx.doi.org/10.1371/journal.pone.0252079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038445	gold, Green Published			2022-12-26	WOS:000664633500046
J	Eriksson, H; Toren, K; Rosengren, A; Andersson, E; Soderberg, M				Eriksson, Helena; Toren, Kjell; Rosengren, Annika; Andersson, Eva; Soderberg, Mia			Psychosocial job exposure and risk of coronary artery calcification	PLOS ONE			English	Article							DEMAND-CONTROL-SUPPORT; HEART-DISEASE; METABOLIC SYNDROME; CALCIUM; STRAIN; BLOOD; ATHEROSCLEROSIS; QUANTIFICATION; PREDICT	Purpose The aim was to examine potential associations between psychosocial job exposures, evaluated with the Job Demand-Control-model, and presence of coronary artery calcium. Methods We performed a cross-sectional study using the Swedish CArdioPulmonary bioImage Study,(SCAPIS)pilot study. Coronary artery calcium was assessed through computed tomography of the coronary arteries and with coronary artery scoring, CACS. Main outcome was CACS >= 100 compared to CACS 0. Job demand and control was analysed according to the standard categorization of the two variables into: high strain, active, passive and low strain (reference). Associations between these variables and CACS were calculated with prevalence ratios (PR) using Cox regression with robust variance, 95% confidence intervals (CI) and adjusted for age, smoking, education, socioeconomic area and metabolic syndrome. Results In total 777 participants were used in our analyses, for which 20% of the men and 5% of the women had CACS >= 100, respectively. The PR of having CACS >= 100 was non-significantly elevated for men in high strain jobs 1.54 (95% CI 0.88-2.69) and in active jobs 1.67 (95% CI 0.92-3.06), adjusted for covariates. For women there was no association between exposure to high strain and having CACS >= 100 PR 1.02 (95% CI 0.24-4.31). Among women reporting passive job, the PR was non-significantly elevated, 2.40 (95% CI 0.83-6.92), adjusted for covariates. Conclusion The statistical power of the study was limited, but our results suggests the possibility that exposure to a high strain or an active job situation may increase the risk of CACS in men, while in women, it may rather be exposure to passive job.	[Eriksson, Helena; Toren, Kjell; Andersson, Eva] Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden; [Eriksson, Helena; Toren, Kjell; Andersson, Eva; Soderberg, Mia] Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Occupat & Environm Med,Inst Med, Gothenburg, Sweden; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; University of Gothenburg	Eriksson, H (corresponding author), Sahlgrens Univ Hosp, Dept Occupat & Environm Med, Gothenburg, Sweden.; Eriksson, H (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Occupat & Environm Med,Inst Med, Gothenburg, Sweden.	helena.eriksson@amm.gu.se		Eriksson, Helena/0000-0002-0184-5078; Soderberg, Mia/0000-0003-0662-6541; Toren, Kjell/0000-0001-8509-7603	Swedish Heart and Lung Foundation; AFA insurance [16-0334, 140624]	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); AFA insurance	SCAPIS is financially supported by the Swedish Heart and Lung Foundation. There is no grant number for this support. https://www.hjartlungfonden.se/forskning.AR received funding from AFA insurance grant number 16-0334. KT received funding from AFA insurance grant number 140624. https://fou.afaforsakring.se/sv.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Alamir M, 2018, J LIPIDS, V2018, DOI 10.1155/2018/5607349; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Anand SS, 2008, EUR HEART J, V29, P932, DOI 10.1093/eurheartj/ehn018; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Belkic KL, 2004, SCAND J WORK ENV HEA, V30, P85, DOI 10.5271/sjweh.769; Bergstrom G, 2015, J INTERN MED, V278, P645, DOI 10.1111/joim.12384; Deprez FC, 2013, J CARDIOVASC COMPUT, V7, P58, DOI 10.1016/j.jcct.2012.11.006; Edwards EM, 2012, J OCCUP ENVIRON MED, V54, P1447, DOI 10.1097/JOM.0b013e3182783f27; Ekblom-Bak E, 2018, EUR J PREV CARDIOL, V25, P309, DOI 10.1177/2047487317745177; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; Gilbert-Ouimet M, 2014, SCAND J WORK ENV HEA, V40, P109, DOI 10.5271/sjweh.3390; Greenlund KJ, 2010, ANN EPIDEMIOL, V20, P323, DOI 10.1016/j.annepidem.2010.02.007; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hansen AM, 2009, BASIC CLIN PHARMACOL, V105, P73, DOI 10.1111/j.1742-7843.2009.00444.x; Karasek R., 1992, HLTH WORK STRESS PRO; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kivimaki M, 2018, NAT REV CARDIOL, V15, P215, DOI 10.1038/nrcardio.2017.189; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; Liew G, 2017, HEART LUNG CIRC, V26, P1239, DOI 10.1016/j.hlc.2017.05.130; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; McCollough CH, 2007, RADIOLOGY, V243, P527, DOI 10.1148/radiol.2432050808; Nyberg ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067323; Osawa K, 2016, GLOB HEART, V11, P287, DOI 10.1016/j.gheart.2016.08.001; Panh L, 2017, ARCH CARDIOVASC DIS, V110, P550, DOI 10.1016/j.acvd.2017.04.003; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Truong QA, 2018, J CARDIOVASC COMPUT, V12, P451, DOI 10.1016/j.jcct.2018.10.019; Rozanski A, 2011, PSYCHOSOM MED, V73, P7, DOI 10.1097/PSY.0b013e3181fd94f5; Sandfort V, 2017, DIAGN INTERV IMAG, V98, P3, DOI 10.1016/j.diii.2016.06.007; Sanne B, 2005, SCAND J PUBLIC HEALT, V33, P166, DOI 10.1080/14034940410019217; SBU, 2015, 240 SBU; Swedish Work Environment Authority, 2018, 20181 SWED WORK ENV; Swedish Work Environment Authority, 2018, WORK ENV 2017 ARB RE	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252192	10.1371/journal.pone.0252192	http://dx.doi.org/10.1371/journal.pone.0252192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033665	Green Published, gold			2022-12-26	WOS:000664633100035
J	Banerjee, H; Singh, R				Banerjee, Hiren; Singh, Ravinder			Genomic and cDNA selection-amplification identifies transcriptome-wide binding sites for the Drosophila protein sex-lethal	PLOS ONE			English	Article							AUXILIARY FACTOR U2AF(65); DOSAGE COMPENSATION; RNA-BINDING; IN-VITRO; EXPONENTIAL ENRICHMENT; SYSTEMATIC EVOLUTION; GERM-CELLS; TRANSFORMER; EXPRESSION; LIGANDS	Background Downstream targets for a large number of RNA-binding proteins remain to be identified. The Drosophila master sex-switch protein Sex-lethal (SXL) is an RNA-binding protein that controls splicing, polyadenylation, or translation of certain mRNAs to mediate female-specific sexual differentiation. Whereas some targets of SXL are known, previous studies indicate that additional targets of SXL have escaped genetic screens. Methodology/Principal findings Here, we have used an alternative molecular approach of GEnomic Selective Enrichment of Ligands by Exponential enrichment (GESELEX) using both the genomic DNA and cDNA pools from several Drosophila developmental stages to identify new potential targets of SXL. Our systematic analysis provides a comprehensive view of the Drosophila transcriptome for potential SXL-binding sites. Conclusion/Significance We have successfully identified new SXL-binding sites in the Drosophila transcriptome. We discuss the significance of our analysis and that the newly identified binding sites and sequences could serve as a useful resource for the research community. This approach should also be applicable to other RNA-binding proteins for which downstream targets are unknown.	[Banerjee, Hiren; Singh, Ravinder] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Singh, R (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	rsingh@colorado.edu			National Institutes of Health; University of Colorado - University of Colorado Boulder Libraries Open Access Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado - University of Colorado Boulder Libraries Open Access Fund	This work was supported in part by funding in the past from the National Institutes of Health and support from the University of Colorado to RS. Publication of this article was funded by the University of Colorado Boulder Libraries Open Access Fund.	Antson AA, 2000, CURR OPIN STRUC BIOL, V10, P87, DOI 10.1016/S0959-440X(99)00054-8; Banerjee H, 2003, RNA, V9, P88, DOI 10.1261/rna.2131603; Banerjee H, 2004, RNA, V10, P240, DOI 10.1261/rna.5153204; BARBAS JA, 1991, GENE DEV, V5, P132, DOI 10.1101/gad.5.1.132; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; Breaker R R, 1994, Chem Biol, V1, P223, DOI 10.1016/1074-5521(94)90014-0; Burtis KC, 1993, CURR OPIN CELL BIOL, V5, P1006, DOI 10.1016/0955-0674(93)90085-5; Chau J, 2009, GENETICS, V182, P121, DOI 10.1534/genetics.109.100693; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Evans DS, 2013, P NATL ACAD SCI USA, V110, pE4474, DOI 10.1073/pnas.1319063110; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Forch P, 2003, Prog Mol Subcell Biol, V31, P127; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Gawande B, 2006, EMBO J, V25, P1263, DOI 10.1038/sj.emboj.7601022; Gebauer F, 1998, RNA, V4, P142; Hager JH, 1997, DEVELOPMENT, V124, P5033; KANAAR R, 1995, EMBO J, V14, P4530, DOI 10.1002/j.1460-2075.1995.tb00132.x; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KELLEY RL, 1995, SCIENCE, V270, P1607, DOI 10.1126/science.270.5242.1607; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Lorenz C, 2006, NAT PROTOC, V1, P2204, DOI 10.1038/nprot.2006.372; Lucchesi JC, 1996, BIOESSAYS, V18, P541, DOI 10.1002/bies.950180705; Ota R, 2017, DEV GROWTH DIFFER, V59, P713, DOI 10.1111/dgd.12408; Penn JKM, 2007, DEV CELL, V12, P275, DOI 10.1016/j.devcel.2007.01.009; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Robida MD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000520; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; SAKASHITA E, 1994, NUCLEIC ACIDS RES, V22, P4082, DOI 10.1093/nar/22.20.4082; Salz HK, 2010, FLY, V4, P60, DOI 10.4161/fly.4.1.11277; Sambrook J, 1989, MOL CLONING; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; Schutt C, 2000, DEVELOPMENT, V127, P667; Singer BS, 1997, NUCLEIC ACIDS RES, V25, P781, DOI 10.1093/nar/25.4.781; Singh R, 2002, GENE EXPRESSION, V10, P79; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; Vied C, 2003, DEV BIOL, V253, P214, DOI 10.1016/S0012-1606(02)00012-X; Yanowitz JL, 1999, MOL CELL BIOL, V19, P3018	42	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0250592	10.1371/journal.pone.0250592	http://dx.doi.org/10.1371/journal.pone.0250592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029324	Green Published, gold			2022-12-26	WOS:000664632800002
J	Orsatti, L; Orsale, MV; di Pasquale, P; Vecchi, A; Colaceci, F; Ciammaichella, A; Rossetti, I; Bonelli, F; Baumgaertel, K; Liu, K; Elbaum, D; Monteagudo, E				Orsatti, Laura; Orsale, Maria Vittoria; di Pasquale, Pamela; Vecchi, Andrea; Colaceci, Fabrizio; Ciammaichella, Alina; Rossetti, Ilaria; Bonelli, Fabio; Baumgaertel, Karsten; Liu, Kai; Elbaum, Daniel; Monteagudo, Edith			Turnover rate of coenzyme A in mouse brain and liver	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; NUDIX HYDROLASE; COA; PANTOTHENATE; NEURODEGENERATION; DEGRADATION; PEROXISOMES; DEFICIENCY; METABOLISM; EXPRESSION	Coenzyme A (CoA) is a fundamental cofactor involved in a number of important biochemical reactions in the cell. Altered CoA metabolism results in severe conditions such as pantothenate kinase-associated neurodegeneration (PKAN) in which a reduction of the activity of pantothenate kinase isoform 2 (PANK2) present in CoA biosynthesis in the brain consequently lowers the level of CoA in this organ. In order to develop a new drug aimed at restoring the sufficient amount of CoA in the brain of PKAN patients, we looked at its turnover. We report here the results of two experiments that enabled us to measure the half-life of pantothenic acid, free CoA (CoASH) and acetylCoA in the brains and livers of male and female C57BL/6N mice, and total CoA in the brains of male mice. We administered (intrastriatally or orally) a single dose of a [C-13(3)-N-15-O-18]-labelled coenzyme A precursor (fosmetpantotenate or [C-13(3)-N-15]-pantothenic acid) to the mice and measured, by liquid chromatography-mass spectrometry, unlabelled- and labelled-coenzyme A species appearance and disappearance over time. We found that the turnover of all metabolites was faster in the liver than in the brain in both genders with no evident gender difference observed. In the oral study, the CoASH half-life was: 69 +/- 5 h (male) and 82 +/- 6 h (female) in the liver; 136 +/- 14 h (male) and 144 +/- 12 h (female) in the brain. AcetylCoA half-life was 74 +/- 9 h (male) and 71 +/- 7 h (female) in the liver; 117 +/- 13 h (male) and 158 +/- 23 (female) in the brain. These results were in accordance with the corresponding values obtained after intrastriatal infusion of labelled-fosmetpantotenate (CoASH 124 +/- 13 h, acetylCoA 117 +/- 11 and total CoA 144 +/- 17 in male brain).	[Orsatti, Laura; Orsale, Maria Vittoria; di Pasquale, Pamela; Vecchi, Andrea; Colaceci, Fabrizio; Bonelli, Fabio; Monteagudo, Edith] IRBM SpA, ADME DMPK Dept, Rome, Italy; [Ciammaichella, Alina; Rossetti, Ilaria] IRBM SpA, Med Chem Dept, Rome, Italy; [Baumgaertel, Karsten; Liu, Kai; Elbaum, Daniel] Retrophin, San Diego, CA USA; [Vecchi, Andrea] Birra Peroni, Rome, Italy; [Elbaum, Daniel] QurAlis, Cambridge, MA USA		Orsatti, L; Monteagudo, E (corresponding author), IRBM SpA, ADME DMPK Dept, Rome, Italy.	l.orsatti@irbm.com; e.monteagudo@irbm.com		Orsatti, Laura/0000-0002-5430-9965	Retrophin, Inc.; IRBM	Retrophin, Inc.; IRBM	This study was funded by Retrophin, Inc. IRBM was working under contract to Retrophin, Inc. Birra Peroni and QurAlis were not involved in this study. The funder provided support in the term of salaries for authors KL, KB and DE, but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the authors are articulated in the `authors contribution' section.	AbdelRaheim SR, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-5; Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; BRASS EP, 1990, J NUTR, V120, P290, DOI 10.1093/jn/120.3.290; BREMER J, 1972, EUR J BIOCHEM, V25, P90, DOI 10.1111/j.1432-1033.1972.tb01684.x; Czumaj A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239057; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; Di Meo I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11564-8; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Elbaum D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192028; Ellis BA, 2000, AM J PHYSIOL-ENDOC M, V279, pE554, DOI 10.1152/ajpendo.2000.279.3.E554; Gasmi L, 2001, BIOCHEM J, V357, P33, DOI 10.1042/0264-6021:3570033; Gregersen N, 2004, EUR J BIOCHEM, V271, P470, DOI 10.1046/j.1432-1033.2003.03949.x; Hogarth P, 2017, MOL GENET METAB, V120, P278, DOI 10.1016/j.ymgme.2016.11.004; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Klopstock T, 2019, CLIN TRIALS, V16, P410, DOI 10.1177/1740774519845673; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; MCALLISTER RA, 1988, BRIT J CANCER, V57, P83, DOI 10.1038/bjc.1988.14; Naquet P, 2020, PROG LIPID RES, V78, DOI 10.1016/j.plipres.2020.101028; Ofman R, 2006, BIOCHEM J, V393, P537, DOI 10.1042/BJ20050893; Orellana DI, 2016, EMBO MOL MED, V8, P1197, DOI 10.15252/emmm.201606391; Paul DS, 2014, BBA-MOL CELL BIOL L, V1841, P880, DOI 10.1016/j.bbalip.2014.03.001; Peng YJ, 2016, AUTOPHAGY, V12, P1051, DOI 10.1080/15548627.2016.1164369; REIBEL DK, 1981, AM J PHYSIOL, V240, pH606, DOI 10.1152/ajpheart.1981.240.4.H606; Sabari BR, 2017, NAT REV MOL CELL BIO, V18, P90, DOI 10.1038/nrm.2016.140; Sharma LK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06703-2; Shibata K, 2012, ANAL BIOCHEM, V430, P151, DOI 10.1016/j.ab.2012.08.010; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Shumar SA, 2018, J BIOL CHEM, V293, P4134, DOI 10.1074/jbc.RA117.001358; SKREDE S, 1973, EUR J BIOCHEM, V38, P401, DOI 10.1111/j.1432-1033.1973.tb03073.x; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Virga KG, 2006, BIOORGAN MED CHEM, V14, P1007, DOI 10.1016/j.bmc.2005.09.021; WITTWER CT, 1983, J BIOL CHEM, V258, P9733; Zano SP, 2015, MOL GENET METAB, V116, P281, DOI 10.1016/j.ymgme.2015.10.011; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251981	10.1371/journal.pone.0251981	http://dx.doi.org/10.1371/journal.pone.0251981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019583	Green Published, gold			2022-12-26	WOS:000664632300044
J	Hove, PR; Magunda, F; Marques, MAD; Islam, MN; Harton, MR; Jackson, M; Belisle, JT				Hove, Petronella R.; Magunda, Forgivemore; Marques, Maria Angela de Mello; Islam, M. Nurul; Harton, Marisa R.; Jackson, Mary; Belisle, John T.			Identification and functional analysis of a galactosyltransferase capable of cholesterol glycolipid formation in the Lyme disease spirochete Borrelia burgdorferi	PLOS ONE			English	Article							HELICOBACTER-PYLORI; LIPID RAFTS; STEROL; METABOLISM; SEQUENCE; GLUCOSYLTRANSFERASE; CLASSIFICATION; GALACTOSIDES; EXPRESSION; GLUCOSIDE	Borrelia burgdorferi (Bb), the etiological agent of Lyme disease, produces a series of simple glycolipids where diacylglycerol and cholesterol serve as the precursor. The cholesterol-based glycolipids, cholesteryl 6-O-acyl-beta-D-galactopyranoside (ACGal) and cholesteryl-beta-D-galactopyranoside (CGal) are immunogenic and proposed to contribute to the pathogenesis of Lyme disease. Detailed studies of CGal and ACGal in Bb have been hampered by a lack of knowledge of their underlying biosynthetic processes. The genome of Bb encodes four putative glycosyltransferases, and only one of these, BB0572, was predicted to be an inverting family 2 glycosyltransferase (GT2 enzyme) capable of using UDP-galactose as a substrate and forming a beta-glycosidic bond. Comparison of the 42 kDa BB0572 amino acid sequence from Bb with other Borrelia spp demonstrates that this protein is highly conserved. To establish BB0572 as the galactosyltransferase capable of cholesterol glycolipid formation in Bb, the protein was produced as a recombinant product in Escherichia coli and tested in a cell-free assay with C-14-cholesterol and UDP-galactose as the substrates. This experiment resulted in a radiolabeled lipid that migrated with the cholesterol glycolipid standard of CGal when evaluated by thin layer chromatography. Additionally, mutation in the predicted active site of BB0572 resulted in a recombinant protein that was unable to catalyze the formation of the cholesterol glycolipid. These data characterize BB0572 as a putative cholesterol galactosyltransferase. This provides the first step in understanding how Bb cholesterol glycolipids are formed and will allow investigations into their involvement in pathogen transmission and disease development.	[Hove, Petronella R.; Magunda, Forgivemore; Marques, Maria Angela de Mello; Islam, M. Nurul; Harton, Marisa R.; Jackson, Mary; Belisle, John T.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Hove, PR (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	petronella.hove@colostate.edu	Jackson, Mary/D-5345-2017	Jackson, Mary/0000-0002-9212-0258; Islam, M. Nurul/0000-0002-2396-6444	NIH, NIAID [R01 AI141656]	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the NIH, NIAID grant R01 AI141656 awarded to JTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Bioanalysis and Omics (ARC-BIO) Facility team (Colorado State university) for the mass spectrometry analysis of BB0572 with special mention to Kitty Brown. Dr Hataichanok (Mam) Scherman the director of The Protein Expression and Purification (PEP) Facility (Colorado State University) for her assistance in expression of BB0572.	ABRAHAM W, 1987, J LIPID RES, V28, P446; Ben-Menachem G, 2003, P NATL ACAD SCI USA, V100, P7913, DOI 10.1073/pnas.1232451100; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chang JM, 2015, NUCLEIC ACIDS RES, V43, pW3, DOI 10.1093/nar/gkv310; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Crowley JT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003109; Cutler SJ, 2017, MOL CELL PROBE, V31, P22, DOI 10.1016/j.mcp.2016.08.003; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; HAQUE M, 1995, J BACTERIOL, V177, P5334, DOI 10.1128/jb.177.18.5334-5337.1995; HIRAI Y, 1995, J BACTERIOL, V177, P5327, DOI 10.1128/jb.177.18.5327-5333.1995; Hove PR, 2014, INFECT IMMUN, V82, P43, DOI 10.1128/IAI.01061-13; Huang Z, 2016, CHEM PHYS LIPIDS, V199, P11, DOI 10.1016/j.chemphyslip.2016.03.002; HUNGUND BL, 1994, CHEM PHYS LIPIDS, V69, P167, DOI 10.1016/0009-3084(94)90038-8; KASTELICSUHADOLC T, 1980, BIOCHIM BIOPHYS ACTA, V620, P322, DOI 10.1016/0005-2760(80)90213-1; Kerstholt M, 2020, TICKS TICK-BORNE DIS, V11, DOI 10.1016/j.ttbdis.2020.101386; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LaRocca TJ, 2010, CELL HOST MICROBE, V8, P331, DOI 10.1016/j.chom.2010.09.001; Lebrun AH, 2006, J BIOL CHEM, V281, P27765, DOI 10.1074/jbc.M603345200; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVERMORE BP, 1978, INFECT IMMUN, V20, P215, DOI 10.1128/IAI.20.1.215-220.1978; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Magunda PRH, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0806-4; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marques AR, 2015, INFECT DIS CLIN N AM, V29, P295, DOI 10.1016/j.idc.2015.02.005; Marques MAM, 2015, J BACTERIOL, V197, P3698, DOI 10.1128/JB.00625-15; MAYBERRY WR, 1983, BIOCHIM BIOPHYS ACTA, V752, P434, DOI 10.1016/0005-2760(83)90273-4; McGee DJ, 2011, ANTIMICROB AGENTS CH, V55, P2897, DOI 10.1128/AAC.00016-11; MCGEOCH DJ, 1985, VIRUS RES, V3, P271, DOI 10.1016/0168-1702(85)90051-6; MCMORRIS TC, 1977, BIOCHIM BIOPHYS ACTA, V486, P308, DOI 10.1016/0005-2760(77)90026-1; MUHIUDEEN IA, 1984, J LIPID RES, V25, P1117; MurakamiMurofushi K, 1997, J BIOL CHEM, V272, P486; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nielsen H, 2019, PROTEIN J, V38, P200, DOI 10.1007/s10930-019-09838-3; Ostberg Y, 2007, FEMS MICROBIOL LETT, V272, P22, DOI 10.1111/j.1574-6968.2007.00728.x; Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8; RAZIN S, 1975, J BACTERIOL, V124, P570, DOI 10.1128/JB.124.1.570-572.1975; Rini JM., 2015, ESSENTIALS GLYCOBIOL; Rottem S, 2002, BIOCHEM BIOPH RES CO, V292, P1289, DOI 10.1006/bbrc.2001.2023; Samanta D, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00165; Schroder NWJ, 2003, J BIOL CHEM, V278, P33645, DOI 10.1074/jbc.M305799200; Schroder NWJ, 2008, IMMUNOBIOLOGY, V213, P329, DOI 10.1016/j.imbio.2007.11.003; SMITH PF, 1971, J BACTERIOL, V108, P986, DOI 10.1128/JB.108.3.986-991.1971; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Stubs G, 2011, FEMS IMMUNOL MED MIC, V63, P140, DOI 10.1111/j.1574-695X.2011.00827.x; Stubs G, 2010, CHEM-EUR J, V16, P3536, DOI 10.1002/chem.200902205; Stubs G, 2009, J BIOL CHEM, V284, P13326, DOI 10.1074/jbc.M809575200; Toledo A, 2018, MOL MICROBIOL, V108, P63, DOI 10.1111/mmi.13914; Toledo A, 2018, METHODS MOL BIOL, V1690, P69, DOI 10.1007/978-1-4939-7383-5_6; Toledo A, 2015, PROTEOMICS, V15, P3662, DOI 10.1002/pmic.201500093; Toledo A, 2014, MBIO, V5, DOI 10.1128/mBio.00899-14; TYORINOJA K, 1974, BIOCHEM J, V141, P133; ULLMANN P, 1993, BIOCHIMIE, V75, P713, DOI 10.1016/0300-9084(93)90102-X; Veron B, 1996, LIPIDS, V31, P989, DOI 10.1007/BF02522694; WERTZ PW, 1986, J LIPID RES, V27, P427; WOJCIECHOWSKI ZA, 1979, BIOCHIM BIOPHYS ACTA, V570, P363, DOI 10.1016/0005-2744(79)90156-6; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; ZUCKERKANDL EMILE, 1965, P97	66	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252214	10.1371/journal.pone.0252214	http://dx.doi.org/10.1371/journal.pone.0252214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061884	gold, Green Published			2022-12-26	WOS:000656813600023
J	Ou, ZZ; Gao, F; Zhu, LJ; Zhao, HJ; Xun, ZH				Ou, Zhenzhen; Gao, Feng; Zhu, Lingjian; Zhao, Huaijun; Xun, Zihan			Study on aluminum nitride/addition-cure liquid silicone rubber composite for high-voltage power encapsulation	PLOS ONE			English	Article							THERMAL-CONDUCTIVITY; BORON-NITRIDE; DESIGN	In view of the development direction of high power and miniaturization of high-voltage power supply, higher requirements are put forward for the breakdown strength, thermal conductivity of packaging materials for its high voltage output module. An electric-insulated heat-conducted material with aluminium nitride as heat conducting filler and addition-cure liquid silicone rubber (ALSR) as matrix for high voltage power encapsulation has been studied. Initially, the thermal conductivity and breakdown strength of composites were explored at different filler fractions. With increase of filler fraction, the thermal conductivity increased and the breakdown strength decreased. Then, with the packaging module volume as the optimization objective and the working temperature as the optimization condition, the temperature distribution of high voltage power supply was studied by using the finite element method, and 40wt% filling fraction was selected as the optimal ratio. Finally, the actual packaging experiment of the high voltage module is carried out. and the variation of the output voltage and temperature with the working time is obtained. According to the experimental results, the output voltage of the high voltage module is basically stable, and the maximum surface temperature is 40.4 degrees C. The practicability of the electric-insulated heat-conducted material has been proved.	[Ou, Zhenzhen; Gao, Feng; Zhu, Lingjian; Zhao, Huaijun; Xun, Zihan] Xian Univ Technol, Coll Mech & Precis Instrument Engn, Xian, Peoples R China	Xi'an University of Technology	Zhu, LJ (corresponding author), Xian Univ Technol, Coll Mech & Precis Instrument Engn, Xian, Peoples R China.	zlj_zhy@xaut.edu.cn			National Science and Technology Major Project of the Ministry of Science and Technology of China [2017YFF0104403]	National Science and Technology Major Project of the Ministry of Science and Technology of China	This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2017YFF0104403).	BARCOHEN A, 1983, MECH ENG, V105, P53; Dissado L.A., 2008, ELECT DEGRADATION BR, DOI [10.1049/PBED009E, DOI 10.1049/PBED009E]; Guo FM, 2020, ADV FUNCT MATER, V30, DOI 10.1002/adfm.201910826; Han JK, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201900412; He SJ, 2018, POLYM TEST, V67, P295, DOI 10.1016/j.polymertesting.2018.03.023; Hong H, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9090413; Hongqiang, 2018, EFFECT MECH UREIDO M, V70; Lazzarin, 2018, HIGH VOLTAGE POWER S, P1; Lei YX, 2018, MACROMOL RES, V26, P602, DOI 10.1007/s13233-018-6090-4; Li HD, 2017, IEEE T IND APPL, V53, P1063, DOI 10.1109/TIA.2016.2641396; Li Q, 2016, P NATL ACAD SCI USA, V113, P9995, DOI 10.1073/pnas.1603792113; Liu PY, 2019, J ALLOY COMPD, V774, P396, DOI 10.1016/j.jallcom.2018.10.002; Lu Y., 2017, DESIGN CONSIDERATION, P1; Mo HL, 2015, IEEE T DIELECT EL IN, V22, P906, DOI 10.1109/TDEI.2015.7076791; Plesa I, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8050173; Ryu S, 2018, POLYM COMPOSITE, V39, pE1692, DOI 10.1002/pc.24680; Sogunuru A, 2018, DEFENCE SCI J, V68, P235, DOI 10.14429/dsj.68.12252; Song QS, 2020, COMPOS PART A-APPL S, V135, DOI 10.1016/j.compositesa.2020.105933; Song QS, 2019, COMPOS PART A-APPL S, V127, DOI 10.1016/j.compositesa.2019.105654; Trubitsyn AA, 2019, INSTRUM EXP TECH+, V62, P640, DOI 10.1134/S0020441219040237; Umar, 2017, ELECT PROPERTIES DIF, DOI [10.1038/s41598-017-16969-z, DOI 10.1038/S41598-017-16969-Z]; Verma AR, 2018, IEEE T DIELECT EL IN, V25, P46, DOI 10.1109/TDEI.2018.006672; Wang, 1981, TELECOMMUN ENG, V4, P98; Xiao C, 2019, COMPOS PART A-APPL S, V116, P98, DOI 10.1016/j.compositesa.2018.10.023; XJPD, 2019, STABILITY EFFECTIVE, V167; Yan NP, 2018, IEEE T DIELECT EL IN, V25, P162, DOI 10.1109/TDEI.2018.007130; Yang CR, 2020, INT J THERM SCI, V155, DOI 10.1016/j.ijthermalsci.2020.106431; Yu ZH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200842; Yuan Y, 2019, CERAM INT, V45, P16569, DOI 10.1016/j.ceramint.2019.05.194; Zha JW, 2014, IEEE T DIELECT EL IN, V21, P1989, DOI 10.1109/TDEI.2014.004330; Zhang, 2019, DESIGN VOLTAGE MEASU, P1; Zhang HY, 2020, IEEE T IND ELECTRON, V67, P4496, DOI 10.1109/TIE.2019.2931265; Zhao XD, 2019, 2019 OPTICAL FIBER COMMUNICATIONS CONFERENCE AND EXHIBITION (OFC); Zheng JJ, 2020, MATERIALS, V13, DOI 10.3390/ma13112489	34	0	0	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252619	10.1371/journal.pone.0252619	http://dx.doi.org/10.1371/journal.pone.0252619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061909	gold, Green Published			2022-12-26	WOS:000656813600001
J	Wolfschlag, M; Hakansson, A				Wolfschlag, Mirjam; Hakansson, Anders			Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: A nationwide register study in Sweden	PLOS ONE			English	Article							IMPULSE-CONTROL DISORDER; DOPAMINE AGONIST THERAPY; PARKINSONS-DISEASE; TASK-PERFORMANCE; RELEASE; NEUROBIOLOGY; ASSOCIATION; PREVALENCE; OLANZAPINE; SAFETY	Gambling Disorder (GD) has recently been reclassified from an impulse-control disorder to a behavioural addiction and, as in other addictive disorders, the dopaminergic reward system is involved. According to neuroimaging studies, alterations within the striatal dopaminergic signalling can occur in GD. However, the findings to date are controversial and there has been no agreement yet on how the reward system is affected on a molecular basis. Within the last 20 years, there has been growing evidence for a higher risk to develop GD in response to certain dopaminergic medication. Especially the dopamine agonists pramipexole and ropinirole, and the dopamine modulator aripiprazole seem to increase the likelihood for GD. The goal of this study was to examine the association between a prescription for either of the three pharmaceuticals and a GD diagnosis in a large cross-sectional study of the Swedish population. Compared to patients with any other dopaminergic drug prescription (38.7% with GD), the diagnosis was more common in patients with a dopamine agonist prescription (69.8% with GD), resulting in an odds ratio of 3.2. A similar association was found between aripiprazole prescriptions and GD diagnoses, which were analysed within the subgroup of all patients with schizophrenia or a schizotypal, delusional, or another non-mood psychotic disorder. An aripiprazole prescription increased the likelihood of GD (88.8%) in comparison to patients without an aripiprazole prescription (71.2%) with an odds ratio of 3.4. This study contributes to the increasingly reliable evidence for an association between several dopaminergic drugs and a higher risk for developing GD. Therefore, one future research goal should be a better understanding of the neurobiology in GD to be able to design more selective dopaminergic medication with less severe side effects. Additionally, this knowledge could enable the development of pharmacotherapy in GD and other addictive disorders.	[Wolfschlag, Mirjam; Hakansson, Anders] Lund Univ, Fac Med, Dept Clin Sci Lund, Psychiat, Lund, Sweden; [Wolfschlag, Mirjam; Hakansson, Anders] Malmo Addict Ctr, Clin Res Unit, Malmo, Sweden	Lund University	Wolfschlag, M (corresponding author), Lund Univ, Fac Med, Dept Clin Sci Lund, Psychiat, Lund, Sweden.; Wolfschlag, M (corresponding author), Malmo Addict Ctr, Clin Res Unit, Malmo, Sweden.	mirjam.wolfschlag@kabelmail.de		Wolfschlag, Mirjam/0000-0002-5215-0276				Canovas AA, 2014, NEUROLOGIA, V29, P230, DOI 10.1016/j.nrl.2011.04.012; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Balodis IM, 2020, PROG NEURO-PSYCHOPH, V99, DOI 10.1016/j.pnpbp.2019.109847; Boileau I, 2014, MOL PSYCHIATR, V19, P1305, DOI 10.1038/mp.2013.163; Boileau I, 2013, ADDICTION, V108, P953, DOI 10.1111/add.12066; Calado F, 2016, J BEHAV ADDICT, V5, P592, DOI 10.1556/2006.5.2016.073; Clark L, 2019, MOL PSYCHIATR, V24, P674, DOI 10.1038/s41380-018-0230-2; Clark L, 2012, NEUROIMAGE, V63, P40, DOI 10.1016/j.neuroimage.2012.06.067; Dowling NA, 2016, J GAMBL STUD, V32, P935, DOI 10.1007/s10899-015-9582-6; Driver-Dunckley E, 2003, NEUROLOGY, V61, P422, DOI 10.1212/01.WNL.0000076478.45005.EC; Etminan M, 2017, J CLIN PSYCHOPHARM, V37, P102, DOI 10.1097/JCP.0000000000000634; Lanteri PF, 2018, PSYCHIAT RES, V269, P593, DOI 10.1016/j.psychres.2018.09.008; Fong T, 2008, PHARMACOL BIOCHEM BE, V89, P298, DOI 10.1016/j.pbb.2007.12.025; Garcia-Ruiz PJ, 2014, J NEUROL NEUROSUR PS, V85, P841, DOI 10.1136/jnnp-2013-306787; Grall-Bronnec M, 2016, J CLIN PSYCHOPHARM, V36, P63, DOI 10.1097/JCP.0000000000000444; Gschwandtner U, 2001, CLIN NEUROPHARMACOL, V24, P170, DOI 10.1097/00002826-200105000-00009; Hakansson A, 2020, J ADDICT MED, V14, pE10, DOI 10.1097/ADM.0000000000000690; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jolly T, 2021, ADDICT BEHAV, V118, DOI 10.1016/j.addbeh.2021.106872; Jost WH, 2005, CNS DRUG REV, V11, P253; Joutsa J, 2012, NEUROIMAGE, V60, P1992, DOI 10.1016/j.neuroimage.2012.02.006; Karlsson A, 2018, J BEHAV ADDICT, V7, P1091, DOI 10.1556/2006.7.2018.112; Kessler RC, 2008, PSYCHOL MED, V38, P1351, DOI 10.1017/S0033291708002900; Lee JY, 2010, PARKINSONISM RELAT D, V16, P202, DOI 10.1016/j.parkreldis.2009.12.002; Leeman RF, 2013, CAN J PSYCHIAT, V58, P260, DOI 10.1177/070674371305800503; Leeman RF, 2012, PSYCHOPHARMACOLOGY, V219, P469, DOI 10.1007/s00213-011-2550-7; Linnet J, 2012, PSYCHIAT RES-NEUROIM, V204, P55, DOI 10.1016/j.pscychresns.2012.04.012; Linnet J, 2011, SCAND J PSYCHOL, V52, P28, DOI 10.1111/j.1467-9450.2010.00837.x; Linnet J, 2011, ADDICTION, V106, P383, DOI 10.1111/j.1360-0443.2010.03126.x; Marder SR, 2003, SCHIZOPHR RES, V61, P123, DOI 10.1016/S0920-9964(03)00050-1; McElroy SL, 2008, J CLIN PSYCHIAT, V69, P433, DOI 10.4088/JCP.v69n0314; Moghaddam JF, 2015, AM J ADDICTION, V24, P292, DOI 10.1111/ajad.12197; Molina JA, 2000, MOVEMENT DISORD, V15, P869, DOI 10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I; Ondo WG, 2008, PARKINSONISM RELAT D, V14, P28, DOI 10.1016/j.parkreldis.2007.05.006; Pan B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132722; Perez-Lloret S, 2012, CLIN NEUROPHARMACOL, V35, P261, DOI 10.1097/WNF.0b013e31826e6e6d; Petruccelli F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/167438; Piercey MF, 1998, CLIN NEUROPHARMACOL, V21, P141; Poletti M, 2013, J CLIN PSYCHOPHARM, V33, P691, DOI 10.1097/JCP.0b013e3182979830; Potenza MN, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0099-7; Potenza MN, 2013, CURR OPIN NEUROBIOL, V23, P660, DOI 10.1016/j.conb.2013.03.004; Rizos A, 2016, EUR J NEUROL, V23, P1255, DOI 10.1111/ene.13034; Scavone C, 2020, J GAMBL STUD, V36, P85, DOI 10.1007/s10899-019-09828-1; Seeman P, 2015, SYNAPSE, V69, P183, DOI 10.1002/syn.21805; Smart K, 2013, NEUROPHARMACOLOGY, V73, P66, DOI 10.1016/j.neuropharm.2013.05.015; Stocchi F, 2014, EXPERT OPIN DRUG SAF, V13, P383, DOI 10.1517/14740338.2014.870152; Torti M, 2019, DRUGS, V79, P693, DOI 10.1007/s40265-019-01103-2; Trenkwalder C, 2018, LANCET NEUROL, V17, P994, DOI 10.1016/S1474-4422(18)30311-9; Tuplin EW, 2017, CURR NEUROPHARMACOL, V15, P1192, DOI 10.2174/1570159X15666170413115754; U.S. Food and Drug Administration, 2021, FDA DRUG SAFETY COMM; van Holst RJ, 2018, BIOL PSYCHIAT, V83, P1036, DOI 10.1016/j.biopsych.2017.06.010; Weintraub D, 2010, ARCH NEUROL-CHICAGO, V67, P589, DOI 10.1001/archneurol.2010.65; World Health Organization, 2020, ICD 11 MORB MORT STA; Zack M, 2004, NEUROPSYCHOPHARMACOL, V29, P195, DOI 10.1038/sj.npp.1300333; Zack M, 2007, NEUROPSYCHOPHARMACOL, V32, P1678, DOI 10.1038/sj.npp.1301295; Zack M, 2020, PROG NEURO-PSYCHOPH, V99, DOI 10.1016/j.pnpbp.2019.109853	56	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252516	10.1371/journal.pone.0252516	http://dx.doi.org/10.1371/journal.pone.0252516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SL3JC	34061895	Green Published, gold			2022-12-26	WOS:000656813600028
J	Tortolero, GA; Brown, MR; Sharma, SV; Otto, MCD; Yamal, JM; Aguilar, D; Gunther, MD; Mofleh, DI; Harris, RD; John, JC; de Vries, PS; Ramphul, R; Serbo, DM; Kiger, J; Banerjee, D; Bonvino, N; Merchant, A; Clifford, W; Mikhail, J; Xu, H; Murphy, RE; Wei, Q; Vahidy, FS; Morrison, AC; Boerwinkle, E				Tortolero, Guillermo A.; Brown, Michael R.; Sharma, Shreela V.; Otto, Marcia C. de Oliveira; Yamal, Jose-Miguel; Aguilar, David; Gunther, Matt D.; Mofleh, Dania I.; Harris, Rachel D.; John, Jemima C.; de Vries, Paul S.; Ramphul, Ryan; Serbo, Dritana Marko; Kiger, Jennifer; Banerjee, Deborah; Bonvino, Nick; Merchant, Angela; Clifford, Warren; Mikhail, Jenny; Xu, Hua; Murphy, Robert E.; Wei, Qiang; Vahidy, Farhaan S.; Morrison, Alanna C.; Boerwinkle, Eric			Leveraging a health information exchange for analyses of COVID-19 outcomes including an example application using smoking history and mortality	PLOS ONE			English	Article								Understanding sociodemographic, behavioral, clinical, and laboratory risk factors in patients diagnosed with COVID-19 is critically important, and requires building large and diverse COVID-19 cohorts with both retrospective information and prospective follow-up. A large Health Information Exchange (HIE) in Southeast Texas, which assembles and shares electronic health information among providers to facilitate patient care, was leveraged to identify COVID-19 patients, create a cohort, and identify risk factors for both favorable and unfavorable outcomes. The initial sample consists of 8,874 COVID-19 patients ascertained from the pandemic's onset to June 12(th), 2020 and was created for the analyses shown here. We gathered demographic, lifestyle, laboratory, and clinical data from patient's encounters across the healthcare system. Tobacco use history was examined as a potential risk factor for COVID-19 fatality along with age, gender, race/ethnicity, body mass index (BMI), and number of comorbidities. Of the 8,874 patients included in the cohort, 475 died from COVID-19. Of the 5,356 patients who had information on history of tobacco use, over 26% were current or former tobacco users. Multivariable logistic regression showed that the odds of COVID-19 fatality increased among those who were older (odds ratio = 1.07, 95% CI 1.06, 1.08), male (1.91, 95% CI 1.58, 2.31), and had a history of tobacco use (2.45, 95% CI 1.93, 3.11). History of tobacco use remained significantly associated (1.65, 95% CI 1.27, 2.13) with COVID-19 fatality after adjusting for age, gender, and race/ethnicity. This effort demonstrates the impact of having an HIE to rapidly identify a cohort, aggregate sociodemographic, behavioral, clinical and laboratory data across disparate healthcare providers electronic health record (HER) systems, and follow the cohort over time. These HIE capabilities enable clinical specialists and epidemiologists to conduct outcomes analyses during the current COVID-19 pandemic and beyond. Tobacco use appears to be an important risk factor for COVID-19 related death.	[Tortolero, Guillermo A.; Brown, Michael R.; Sharma, Shreela V.; Otto, Marcia C. de Oliveira; Yamal, Jose-Miguel; Aguilar, David; Gunther, Matt D.; Mofleh, Dania I.; Harris, Rachel D.; John, Jemima C.; de Vries, Paul S.; Ramphul, Ryan; Serbo, Dritana Marko; Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Kiger, Jennifer] Harris Cty Publ Hlth, Houston, TX USA; [Banerjee, Deborah] City Houston Hlth Dept, Houston, TX USA; [Bonvino, Nick; Merchant, Angela; Clifford, Warren; Mikhail, Jenny] Greater Houston Healthconnect, Houston, TX USA; [Xu, Hua; Murphy, Robert E.; Wei, Qiang] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Vahidy, Farhaan S.] Ctr Outcomes Res, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston	Boerwinkle, E (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA.	eric.boerwinkle@uth.tmc.edu	Aguilar, David/GZM-1928-2022; Mofleh, Dania/AAL-9535-2021; Mofleh, Dania/GQR-1061-2022	Aguilar, David/0000-0002-0916-2722; Mofleh, Dania/0000-0001-5269-978X; John, Jemima/0000-0002-3710-4984; Tortolero, Guillermo/0000-0001-7063-156X				Abdolvahab MH, 2021, INT IMMUNOPHARMACOL, V90, DOI 10.1016/j.intimp.2020.107171; Adrish M, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000716; Berlin I, 2020, NICOTINE TOB RES, V22, P1650, DOI 10.1093/ntr/ntaa059; CDC (Centers for Disease Control and Prevention), 2012, BEHAV RISK FACT SURV; Fadini GP, 2020, J ENDOCRINOL INVEST, V43, P867, DOI 10.1007/s40618-020-01236-2; Fung M, 2021, TRANSPL INFECT DIS, V23, DOI 10.1111/tid.13477; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Harrison SL, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003321; Hosseini M, 2017, J BIOMED INFORM, V74, P123, DOI 10.1016/j.jbi.2017.09.001; Hussain A, 2020, OBES RES CLIN PRACT, V14, P295, DOI 10.1016/j.orcp.2020.07.002; Jiang C, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/123845; Kaur G, 2020, J INFLAMM-LOND, V17, DOI 10.1186/s12950-020-00250-8; Kendale SM., 2020, COVID 19 PANDEMIC HI, VXXX, P1; Lenert L, 2020, J AM MED INFORM ASSN, V27, P963, DOI 10.1093/jamia/ocaa039; Mantovani A, 2020, LIVER INT, V40, P1316, DOI 10.1111/liv.14465; Mehta Jatan, 2020, PLANETARY SOC 1123; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Pranata R, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104949; Simons D, 2021, ADDICTION, V116, P1319, DOI 10.1111/add.15276; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zheng ZH, 2020, J INFECTION, V81, pE16, DOI 10.1016/j.jinf.2020.04.021	21	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0247235	10.1371/journal.pone.0247235	http://dx.doi.org/10.1371/journal.pone.0247235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081724	Green Published, gold			2022-12-26	WOS:000664639200001
J	Krishnan, N; Hall, MJ; Hellmich, RL; Coats, JR; Bradbury, SP				Krishnan, Niranjana; Hall, Maura J.; Hellmich, Richard L.; Coats, Joel R.; Bradbury, Steven P.			Evaluating toxicity of Varroa mite (Varroa destructor)-active dsRNA to monarch butterfly (Danaus plexippus) larvae	PLOS ONE			English	Article							OXALIC-ACID; RNA INTERFERENCE; RISK-ASSESSMENT; JACOBSONI OUD.; HONEY-BEES; V-ATPASE; LEPIDOPTERA; RESISTANCE; NYMPHALIDAE; HYMENOPTERA	Varroa mites (Varroa destructor) are parasitic mites that, combined with other factors, are contributing to high levels of honey bee (Apis mellifera) colony losses. A Varroa-active dsRNA was recently developed to control Varroa mites within honey bee brood cells. This dsRNA has 372 base pairs that are homologous to a sequence region within the Varroa mite calmodulin gene (cam). The Varroa-active dsRNA also shares a 21-base pair match with monarch butterfly (Danaus plexippus) calmodulin mRNA, raising the possibility of non-target effects if there is environmental exposure. We chronically exposed the entire monarch larval stage to common (Asclepias syriaca) and tropical (Asclepias curassavica) milkweed leaves treated with concentrations of Varroa-active dsRNA that are one- and ten-fold higher than those used to treat honey bee hives. This corresponded to concentrations of 0.025-0.041 and 0.211-0.282 mg/g leaf, respectively. Potassium arsenate and a previously designed monarch-active dsRNA with a 100% base pair match to the monarch v-ATPase A mRNA (leaf concentration was 0.020-0.034 mg/g) were used as positive controls. The Varroa mite and monarch-active dsRNA's did not cause significant differences in larval mortality, larval or pupal development, pupal weights, or adult eclosion rates when compared to negative controls. Irrespective of control or dsRNA treatment, larvae that consumed approximately 7500 to 10,500-mg milkweed leaf within 10 to 12 days had the highest pupal weights. The lack of mortality and sublethal effects following dietary exposure to dsRNA with 21-base pair and 100% base pair match to mRNAs that correspond to regulatory genes suggest monarch mRNA may be refractory to silencing by dsRNA or monarch dsRNase may degrade dsRNA to a concentration that is insufficient to silence mRNA signaling.	[Krishnan, Niranjana; Hall, Maura J.; Coats, Joel R.; Bradbury, Steven P.] Iowa State Univ, Toxicol Program, Ames, IA 50011 USA; [Krishnan, Niranjana; Hall, Maura J.; Coats, Joel R.; Bradbury, Steven P.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA; [Hellmich, Richard L.] USDA, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Bradbury, Steven P.] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA USA	Iowa State University; Iowa State University; United States Department of Agriculture (USDA); Iowa State University	Krishnan, N (corresponding author), Iowa State Univ, Toxicol Program, Ames, IA 50011 USA.; Krishnan, N (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	nkrish@iastate.edu	Krishnan, Niranjana/AAT-5853-2021	Krishnan, Niranjana/0000-0003-1945-0581	Iowa State University (ISU) [141323]; Bayer Crop Science	Iowa State University (ISU); Bayer Crop Science(Bayer AG)	Authors who received grant: SPB, JRC, RLH. Grant number: Iowa State University (ISU) ID#141323. Full name of funder: Bayer Crop Science. URL of funder website: https://www.cropscience.bayer.com/. The funders provided design suggestions, but the final design formulation and decision was made by the authors. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Aliano NP, 2006, J ECON ENTOMOL, V99, P1579, DOI 10.1603/0022-0493-99.5.1579; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; Bolognesi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047534; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Brower LP, 2012, INSECT CONSERV DIVER, V5, P95, DOI 10.1111/j.1752-4598.2011.00142.x; Choi MY, 2019, J ECON ENTOMOL, V112, P434, DOI 10.1093/jee/toy356; Christiaens O., 2018, EFSA Supporting Publications, V15, p1424E, DOI 10.2903/sp.efsa.2018.en-1424; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Elzen PJ, 2000, APIDOLOGIE, V31, P437, DOI 10.1051/apido:2000134; Garbian Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003035; Giovenazzo P, 2011, EXP APPL ACAROL, V55, P65, DOI 10.1007/s10493-011-9447-3; Gunes N, 2017, J APICULT RES, V56, DOI 10.1080/00218839.2017.1291229; Habel JC, 2016, CONSERV BIOL, V30, P754, DOI 10.1111/cobi.12656; Higes M, 1999, APIDOLOGIE, V30, P289, DOI 10.1051/apido:19990404; Kanga LHB, 2016, FLA ENTOMOL, V99, P324, DOI 10.1653/024.099.0231; Krishnan N, 2020, ENVIRON TOXICOL CHEM, V39, P923, DOI 10.1002/etc.4672; Kumar M, 2009, J INSECT PHYSIOL, V55, P273, DOI 10.1016/j.jinsphys.2008.12.005; Mahak, 2016, U.S. Patent, Patent No. 62156751; Mamta B, 2017, PHYSIOL MOL BIOL PLA, V23, P487, DOI 10.1007/s12298-017-0443-x; Mao JJ, 2015, PESTIC BIOCHEM PHYS, V118, P71, DOI 10.1016/j.pestbp.2014.11.013; Marshansky V, 2019, CURR TOP MEMBR, V83, P77, DOI 10.1016/bs.ctm.2019.01.008; Martin-Hernandez R, 2007, SPAN J AGRIC RES, V5, P474, DOI 10.5424/sjar/2007054-270; Mattila HR, 2000, AM BEE J, V140, P68; Milani N, 1999, APIDOLOGIE, V30, P229, DOI 10.1051/apido:19990211; MILANI N, 1995, APIDOLOGIE, V26, P415, DOI 10.1051/apido:19950507; Mohamed AAM, 2011, ARCH INSECT BIOCHEM, V78, P216, DOI 10.1002/arch.20455; Ostermann DJ, 2004, J ECON ENTOMOL, V97, P1500, DOI 10.1603/0022-0493-97.5.1500; Pan HP, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00242; Pasquinelli AE, 2002, TRENDS GENET, V18, P171, DOI 10.1016/S0168-9525(01)02624-5; Peng YC, 2020, PESTIC BIOCHEM PHYS, V162, P86, DOI 10.1016/j.pestbp.2019.09.011; Petschenka G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1865; Pocius VM, 2017, ENVIRON ENTOMOL, V46, P1098, DOI 10.1093/ee/nvx137; Pocius VM, 2017, J LEPID SOC, V71, P153, DOI 10.18473/lepi.71i3.a5; Ramsey SD, 2019, P NATL ACAD SCI USA, V116, P1792, DOI 10.1073/pnas.1818371116; Rana S, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00427; RAWLINS JE, 1981, J KANSAS ENTOMOL SOC, V54, P387; Rinkevich FD, 2017, INSECTS, V8, DOI 10.3390/insects8010009; Romeis J, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00679; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; San Miguel K, 2016, PEST MANAG SCI, V72, P801, DOI 10.1002/ps.4056; Sanchez-Bayo F, 2019, BIOL CONSERV, V232, P8, DOI 10.1016/j.biocon.2019.01.020; Semmens BX, 2016, SCI REP-UK, V6, DOI 10.1038/srep23265; Shukla JN, 2016, RNA BIOL, V13, P656, DOI 10.1080/15476286.2016.1191728; Spreafico M, 2001, APIDOLOGIE, V32, P49, DOI 10.1051/apido:2001110; Tan JG, 2016, ENVIRON TOXICOL CHEM, V35, P287, DOI 10.1002/etc.3075; Taning CNT, 2020, PEST MANAG SCI, V76, P841, DOI 10.1002/ps.5686; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; US Environmental Protection Agency, 2009, MICR PEST TEST GUID; US Environmental Protection Agency, 2012, OCSPP 850 3000 BACKG; US Environmental Protection Agency, 2018, EPA REG PEST PROD AP; US Fish and Wildlife Service, 2020, ASS STAT MON BUTT; Velez AM, 2016, CHEMOSPHERE, V144, P1083, DOI 10.1016/j.chemosphere.2015.09.068; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; ZALUCKI MP, 1982, J AUST ENTOMOL SOC, V21, P241	58	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251884	10.1371/journal.pone.0251884	http://dx.doi.org/10.1371/journal.pone.0251884			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077444	Green Published, gold			2022-12-26	WOS:000664638500020
J	Negash, Z; Berha, AB; Shibeshi, W; Ahmed, A; Woldu, MA; Engidawork, E				Negash, Zenebe; Berha, Alemseged Beyene; Shibeshi, Workineh; Ahmed, Abdurezak; Woldu, Minyahil Alebachew; Engidawork, Ephrem			Impact of medication therapy management service on selected clinical and humanistic outcomes in the ambulatory diabetes patients of Tikur Anbessa Specialist Hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article							TREATMENT SATISFACTION; HEALTH; CARE; INTERVENTIONS; MELLITUS; DISEASES	Background Diabetes mellitus (DM) patients are at increased risk of developing drug therapy problems (DTPs). The patients had a variety of comorbidities and complications, and they were given multiple medications. Medication therapy management (MTM) is a distinct service or group of services that optimize therapeutic outcomes for individual patients. The study assessed the impact of provision of MTM service on selected clinical and humanistic outcomes of diabetes patients at the diabetes mellitus clinic of Tikur Anbessa Specialized Hospital (TASH). Methods A pre-post interventional study design was carried out at DM clinic from July 2018 to April 2019. The intervention package included identifying and resolving drug therapy problems, counseling patients in person at the clinic or through telephone calls, and providing educational materials for six months. This was followed by four months of post-intervention assessment of clinical outcomes, DTPs, and treatment satisfaction. The interventions were provided by pharmacist in collaboration with physician and nurse. The study included all adult patients who had been diagnosed for diabetes (both type I & II) and had been taking anti-diabetes medications for at least three months. Patients with gestational diabetes, those who decided to change their follow-up clinic, and those who refused to participate in the study were excluded. Data were analyzed using Statistical Package for the Social Sciences (SPSS). Descriptive statistics, t-test, and logistic regressions were performed for data analyses. Results Of the 423 enrolled patients, 409 fulfilled the criteria and included in the final data analysis. The intervention showed a decrease in average hemoglobin A1c (HbA1c), fasting blood sugar (FBS), and systolic blood pressure (SBP) by 0.92%, 25.04 mg/dl, and 6.62 mmHg, respectively (p<0.05). The prevalence of DTPs in the pre- and post-intervention of MTM services was found to be 72.9% and 26.2%, respectively (p<0.001). The overall mean score of treatment satisfaction was 90.1(SD, 11.04). Diabetes patients of age below 40 years (92.84 (SD, 9.54)), type-I DM (93.04 (SD, 9.75)) & being on one medication regimen (93.13(SD, 9.17)) had higher satisfaction score (p<0.05). Conclusion Provision of MTM service had a potential to reduce DTPs, improve the clinical parameters, and treatment satisfaction in the post-intervention compared to the pre-intervention phase.	[Negash, Zenebe; Berha, Alemseged Beyene; Shibeshi, Workineh; Woldu, Minyahil Alebachew; Engidawork, Ephrem] Addis Ababa Univ, Sch Pharm, Dept Pharmacol & Clin Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia; [Ahmed, Abdurezak] Sci Addis Ababa Univ, Sch Med, Dept Internal Med, Coll Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Negash, Z (corresponding author), Addis Ababa Univ, Sch Pharm, Dept Pharmacol & Clin Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia.	zenebe.negash@aau.edu.et	Woldu, Minyahil/ABD-9452-2020; Engidawork, Ephrem/K-7551-2019	Woldu, Minyahil/0000-0002-3163-0326; Engidawork, Ephrem/0000-0002-9931-6421; Negash, Zenebe/0000-0001-9676-8943; Berha, Alemseged/0000-0003-3825-2863; Abdela, Abdurezak Ahmed/0000-0001-7795-752X	Addis Ababa University (AAU) Medication Therapy Management (MTM) thematic research project; Office of the Graduate Programs, AAU	Addis Ababa University (AAU) Medication Therapy Management (MTM) thematic research project; Office of the Graduate Programs, AAU	This study received funding support from Addis Ababa University (AAU) Medication Therapy Management (MTM) thematic research project grant and Office of the Graduate Programs, AAU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegaz Tadesse M., 2018, Journal of Pharmacy Practice and Research, V48, P320, DOI 10.1002/jppr.1400; Adnyana IK, 2017, J BASIC CLIN PHARM, V8; Al Hamid A, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050479; Al-Azzam SI, 2016, THER CLIN RISK MANAG, V12, P233, DOI 10.2147/TCRM.S98165; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; Barnes J, 2015, CLIMATE CULTURES ANT, P1; Barnett MJ, 2009, J MANAGE CARE PHARM, V15, P18, DOI 10.18553/jmcp.2009.15.1.18; Bener A, 2014, NIGER J CLIN PRACT, V17, P218, DOI 10.4103/1119-3077.127562; Boban B, 2017, CLIN EPIDEMIOL GLOB, V5, P70, DOI 10.1016/j.cegh.2016.11.002; Brummel AR, 2013, POPUL HEALTH MANAG, V16, P28, DOI 10.1089/pop.2012.0023; Bukhsh A, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009847; Campbell ANC, 2015, J SUBST ABUSE TREAT, V53, P9, DOI 10.1016/j.jsat.2014.12.006; Christensen DB, 2007, J AM PHARM ASSOC, V47, P471, DOI 10.1331/JAPhA.2007.06111; Chung AYS, 2017, HONG KONG MED J, V23, P158, DOI 10.12809/hkmj165014; Cipolle R.J., 2012, PHARM CAR PRACT PAT, V3rd ed.; Cranor Carole W, 2003, J Am Pharm Assoc (Wash), V43, P173, DOI 10.1331/108658003321480713; Davis Courtney S, 2017, J Pharm Pract, V30, P286, DOI 10.1177/0897190016631894; de Oliveira DR, 2010, J MANAGE CARE PHARM, V16, P185, DOI 10.18553/jmcp.2010.16.3.185; Demoz GT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222985; Huri HZ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1192; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Jalil A, 2017, BMC HEALTH SERV RES, V17, P1, DOI 10.1186/s12913-017-2094-6; Law RM., 2017, PHARMACOTHERAPY PATH; Lochner Kimberly A, 2013, Medicare Medicaid Res Rev, V3, DOI 10.5600/mmrr.003.03.b02; McAdam-Marx Carrie, 2015, J Manag Care Spec Pharm, V21, P452; Meyer L, 2003, DIABETES CARE, V26, P1655, DOI 10.2337/diacare.26.5.1655-a; Ndefo Uche Anadu, 2017, P T, V42, P632; Nivya K, 2015, SAUDI PHARM J, V23, P1, DOI 10.1016/j.jsps.2013.05.006; Ogallo W, 2017, AMIA ANN S P, P984; Ogbonna B, 2014, INT J ADV INNOV RES, V3, P494; Ombengi D., 2016, J PHARM CARE HLTH SY, V3, P1; Pathania M, 2016, J CLIN DIAGN RES, V10, pOC22, DOI 10.7860/JCDR/2016/16053.7271; Pharmaceutical Services Division Ministry of Health Malaysia., 2013, KUALA LUMPUR, P1; Pinto SL, 2014, POPUL HEALTH MANAG, V17, P21, DOI 10.1089/pop.2012.0124; Ploenzke C, 2016, J AM PHARM ASSOC, V56, P303, DOI 10.1016/j.japh.2016.01.009; Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458; Rejas J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-142; Rodis JL, 2017, J PRIM CARE COMMUNIT, V8, P324, DOI 10.1177/2150131917701797; Ruiz MA, 2008, VALUE HEALTH, V11, P913, DOI 10.1111/j.1524-4733.2008.00323.x; Schofield T, 2000, J AM COLL HEALTH, V48, P247, DOI 10.1080/07448480009596266; SEMDSA 2017, 2017, J ENDOCRINOL METAB D, V22, pS1, DOI DOI 10.1080/16089677.2015.1056468; Shareef J, 2015, INT J PHARM SCI RES, V6, P4424, DOI 10.13040/IJPSR.0975-8232.6(10).4424-32; Srivastava S., 2015, J INT MEDI SCI ACAD, V28, P47; Strand LM, 2004, CURR PHARM DESIGN, V10, P3987, DOI 10.2174/1381612043382576; Tilton JJ, 2019, ANN PHARMACOTHER, V53, P13, DOI 10.1177/1060028018794860; Tunpichart S., 2012, INT J MED MED SCI, V4, P90; U.S. Department of Health and Human Services' Office of Disease Prevention and Health Promotion, 2014, NAT ACT PLAN ADV DRU; van Mourik MSM, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-25; Viswanathan M, 2015, JAMA INTERN MED, V175, P76, DOI 10.1001/jamainternmed.2014.5841; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538; WHO, 2016, GLOB REP PSOR; Yimama Mohammed, 2018, BMC Res Notes, V11, P679, DOI 10.1186/s13104-018-3785-8; Zeind CS., 2018, APPL THERAPEUTICS CL; Zillich AJ, 2014, HEALTH SERV RES, V49, P1537, DOI 10.1111/1475-6773.12176; Zoungas S, 2014, DIABETOLOGIA, V57, P2465, DOI 10.1007/s00125-014-3369-7; Zyoud SH, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-191	57	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0251709	10.1371/journal.pone.0251709	http://dx.doi.org/10.1371/journal.pone.0251709			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QL	34077431	Green Published, gold			2022-12-26	WOS:000664638500015
J	Markworth, JF; Sugg, KB; Sarver, DC; Maddipati, KR; Brooks, SV				Markworth, James F.; Sugg, Kristoffer B.; Sarver, Dylan C.; Maddipati, Krishna Rao; Brooks, Susan V.			Local shifts in inflammatory and resolving lipid mediators in response to tendon overuse	FASEB JOURNAL			English	Article						eicosanoid; inflammation; lipid mediator; mass spectrometry; resolution; tendon	ANTIINFLAMMATORY MEDICATION; MACROPHAGES ACCUMULATE; DOCOSAHEXAENOIC ACID; COLLAGEN-SYNTHESIS; REPETITIVE MOTION; PATELLAR TENDON; SKELETAL-MUSCLE; THROMBOXANE A2; SUBSTANCE-P; HUMAN-BLOOD	Tendon inflammation has been implicated in both adaptive connective tissue remodeling and overuse-induced tendinopathy. Lipid mediators control both the initiation and resolution of inflammation, but their roles within tendon are largely unknown. Here, we profiled local shifts in intratendinous lipid mediators via liquid chromatography-tandem mass spectrometry in response to synergist ablation-induced plantaris tendon overuse. Sixty-four individual lipid mediators were detected in homogenates of plantaris tendons from ambulatory control rats. This included many bioactive metabolites of the cyclooxygenase (COX), lipoxygenase (LOX), and epoxygenase (CYP) pathways. Synergist ablation induced a robust inflammatory response at day 3 post-surgery characterized by epitenon infiltration of polymorphonuclear leukocytes and monocytes/macrophages (M phi), heightened expression of inflammation-related genes, and increased intratendinous concentrations of the pro-inflammatory eicosanoids thromboxane B-2 and prostaglandin E-2. By day 7, M phi became the predominant myeloid cell type in tendon and there were further delayed increases in other COX metabolites including prostaglandins D-2, F-2 alpha, and I-2. Specialized pro-resolving mediators including protectin D1, resolvin D2 and D6, as well as related pathway markers of D-resolvins (17-hydroxy-docosahexaenoic acid), E-resolvins (18-hydroxy-eicosapentaenoic acid), and lipoxins (15-hydroxy-eicosatetraenoic acid) were also increased locally in response to tendon overuse, as were anti-inflammatory fatty acid epoxides of the CYP pathway (eg, epoxy-eicosatrienoic acids). Nevertheless, intratendinous prostaglandins remained markedly increased even following 28 days of tendon overuse together with a lingering M phi presence. These data reveal a delayed and prolonged local inflammatory response to tendon overuse characterized by an overwhelming predominance of pro-inflammatory eicosanoids and a relative lack of specialized pro-resolving lipid mediators.	[Markworth, James F.; Brooks, Susan V.] Univ Michigan, Dept Mol & Integrat Physiol, 2029 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA; [Markworth, James F.; Sugg, Kristoffer B.; Sarver, Dylan C.] Univ Michigan, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Sugg, Kristoffer B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Sarver, Dylan C.] Johns Hopkins Univ, Dept Cellular & Mol Physiol, Baltimore, MD USA; [Maddipati, Krishna Rao] Wayne State Univ, Dept Pathol, Lipid Core Facil, Detroit, MI 48202 USA; [Brooks, Susan V.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Johns Hopkins University; Wayne State University; University of Michigan System; University of Michigan	Brooks, SV (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, 2029 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	svbrooks@umich.edu	Maddipati, Krishna Rao/G-1859-2011	Maddipati, Krishna Rao/0000-0003-1445-791X; Markworth, James/0000-0002-5348-1464	Glenn Foundation for Medical Research Post-Doctoral Fellowship in Aging Research; University of Michigan Department of Orthopedic Surgery; National Institutes of Health (NIH) [R01 (AG050676), PO1 (AG051442), P30 (AR069620), S10 (RR027926)]	Glenn Foundation for Medical Research Post-Doctoral Fellowship in Aging Research; University of Michigan Department of Orthopedic Surgery(University of Michigan System); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Glenn Foundation for Medical Research Post-Doctoral Fellowship in Aging Research (JFM), the University of Michigan Department of Orthopedic Surgery, and the National Institutes of Health (NIH) under the awards R01 (AG050676) (SVB), PO1 (AG051442) (SVB), P30 (AR069620) (SVB), and S10 (RR027926) (KRM).	Abat F, 2017, J Exp Orthop, V4, P18, DOI 10.1186/s40634-017-0092-6; Abate M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2723; Ali A E, 1980, Adv Prostaglandin Thromboxane Res, V6, P533; ALMEKINDERS LC, 1993, MED SCI SPORT EXER, V25, P603; ALMEKINDERS LC, 1995, AM J SPORT MED, V23, P119, DOI 10.1177/036354659502300120; Andersson G, 2011, BRIT J SPORT MED, V45, P1017, DOI 10.1136/bjsm.2010.082750; Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; BACKMAN C, 1990, J ORTHOPAED RES, V8, P541, DOI 10.1002/jor.1100080410; Barbe MF, 2008, J ORTHOP RES, V26, P1320, DOI 10.1002/jor.20674; Barbe MF, 2003, J ORTHOPAED RES, V21, P167, DOI 10.1016/S0736-0266(02)00086-4; Bergqvist F, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1855-5; BRYANT RW, 1978, J BIOL CHEM, V253, P8134; Chbinou N, 2004, AM J PHYSIOL-REG I, V286, pR952, DOI 10.1152/ajpregu.00536.2003; Chiang N, 2017, MOL ASPECTS MED, V58, P114, DOI 10.1016/j.mam.2017.03.005; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Christensen B, 2011, J APPL PHYSIOL, V110, P137, DOI 10.1152/japplphysiol.00942.2010; Christie WW, 2020, ESSAYS BIOCHEM, V64, P401, DOI 10.1042/EBC20190082; Dakin SG, 2019, AM J PATHOL, V189, P2258, DOI 10.1016/j.ajpath.2019.07.011; Dakin SG, 2019, FASEB J, V33, P8043, DOI 10.1096/fj.201900196R; Dakin SG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11188-y; Dakin SG, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4269; Dakin SG, 2014, VET IMMUNOL IMMUNOP, V158, P121, DOI 10.1016/j.vetimm.2014.01.007; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048978; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032333; Dalli J, 2019, BRIT J PHARMACOL, V176, P1024, DOI 10.1111/bph.14336; Dalli J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01400; ENWEMEKA CS, 1989, PHYS THER, V69, P816, DOI 10.1093/ptj/69.10.816; Fedorczyk JM, 2010, J ORTHOP RES, V28, P298, DOI 10.1002/jor.20984; Fenwick SA, 2002, ARTHRITIS RES, V4, P252, DOI 10.1186/ar416; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Giannakis N, 2019, NAT IMMUNOL, V20, P626, DOI 10.1038/s41590-019-0356-7; Gilroy DW, 2019, BRIT J PHARMACOL, V176, P1009, DOI 10.1111/bph.14587; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; GOLDBERG AL, 1967, AM J PHYSIOL, V213, P1193, DOI 10.1152/ajplegacy.1967.213.5.1193; Gottfried E, 2008, SCAND J IMMUNOL, V67, P453, DOI 10.1111/j.1365-3083.2008.02091.x; HONDA H, 1990, IMMUNOLOGY, V70, P272; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; HUMES JL, 1977, NATURE, V269, P149, DOI 10.1038/269149a0; Jomaa G, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-3094-y; KANG H J, 1990, Yonsei Medical Journal, V31, P264; Kawamura S, 2005, J ORTHOP RES, V23, P1425, DOI 10.1016/j.orthres.2005.01.014; Khan KM, 2002, BRIT MED J, V324, P626, DOI 10.1136/bmj.324.7338.626; Kietrys DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046954; Kongsgaard M, 2007, ACTA PHYSIOL, V191, P111, DOI 10.1111/j.1748-1716.2007.01714.x; KURLAND JI, 1978, J EXP MED, V147, P952, DOI 10.1084/jem.147.3.952; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; Langberg H, 1999, J PHYSIOL-LONDON, V521, P299, DOI 10.1111/j.1469-7793.1999.00299.x; Langberg H, 2003, J PHYSIOL-LONDON, V551, P683, DOI 10.1113/jphysiol.2003.046094; Lehner C, 2019, DIS MODEL MECH, V12, DOI 10.1242/dmm.041384; Leuti A, 2020, ADV DRUG DELIVER REV, V159, P133, DOI 10.1016/j.addr.2020.06.028; LEWIS RA, 1982, J IMMUNOL, V129, P1627; Li ZZ, 2004, AM J SPORT MED, V32, P435, DOI 10.1177/0095399703258680; Maddipati KR, 2014, FASEB J, V28, P4835, DOI 10.1096/fj.14-254383; Markworth JF, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137713; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Markworth JF., 2020, LIPIDOMIC PROFILING, DOI [10.1101/2020.11.05.370056, DOI 10.1101/2020.11.05.370056]; Marsolais D, 2003, LAB INVEST, V83, P991, DOI 10.1097/01.LAB.0000078688.07696.AC; Marsolais D, 2001, J ORTHOPAED RES, V19, P1203, DOI 10.1016/S0736-0266(01)00031-6; McArthur S, 2020, J CLIN INVEST, V130, P1156, DOI 10.1172/JCI124635; MCLENNAN IS, 1991, J ANAT, V178, P243; Messner K, 1999, CELLS TISSUES ORGANS, V165, P30, DOI 10.1159/000016671; Mosca MJ, 2018, BMJ OPEN SPORT EXERC, V4, DOI 10.1136/bmjsem-2017-000332; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Nieman DC, 2020, FRONT NUTR, V7, DOI 10.3389/fnut.2020.00121; Nieman DC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213676; Norris PC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36679-4; Pingel J, 2013, SCAND J MED SCI SPOR, V23, pE353, DOI 10.1111/sms.12089; Plein LM, 2018, BRIT J PHARMACOL, V175, P2717, DOI 10.1111/bph.13750; Pouliot M, 1998, FASEB J, V12, P1109, DOI 10.1096/fasebj.12.12.1109; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Sansbury BE, 2020, P NATL ACAD SCI USA, V117, P14354, DOI 10.1073/pnas.1918163117; Serhan CN, 2017, MOL ASPECTS MED, V58, P1, DOI 10.1016/j.mam.2017.03.001; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Serhan CN, 2011, FASEB J, V25, P1441, DOI 10.1096/fj.11-0502ufm; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; SERHAN CN, 1986, P NATL ACAD SCI USA, V83, P1983, DOI 10.1073/pnas.83.7.1983; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; SERHAN CN, 1986, J BIOL CHEM, V261, P6340; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Signini EF, 2020, METABOLITES, V10, DOI 10.3390/metabo10060264; Stanford KI, 2018, CELL METAB, V27, P1111, DOI 10.1016/j.cmet.2018.03.020; Su B, 2013, J APPL PHYSIOL, V115, P892, DOI 10.1152/japplphysiol.00053.2013; SVENSSON J, 1976, ACTA PHYSIOL SCAND, V98, P285, DOI 10.1111/j.1748-1716.1976.tb10313.x; Thorpe CT, 2016, ADV EXP MED BIOL, V920, P3, DOI 10.1007/978-3-319-33943-6_1; Trappe TA, 2008, AM J PHYSIOL-REG I, V294, pR192, DOI 10.1152/ajpregu.00669.2007; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Vella L, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14108; Wang JHC, 2003, CONNECT TISSUE RES, V44, P128, DOI 10.1080/03008200390223909; Wang YJ, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12650; WEKSLER BB, 1977, P NATL ACAD SCI USA, V74, P3922, DOI 10.1073/pnas.74.9.3922; Werner M, 2019, FASEB J, V33, P6140, DOI 10.1096/fj.201802509R; WILLIAMS TJ, 1979, BRIT J PHARMACOL, V65, P517, DOI 10.1111/j.1476-5381.1979.tb07860.x; WOJCIAK B, 1993, CLIN EXP IMMUNOL, V93, P108; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380; Zhang JY, 2014, J ORTHOP TRANSL, V2, P75, DOI 10.1016/j.jot.2014.01.001; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067303; Zhang JY, 2010, J ORTHOP RES, V28, P1178, DOI 10.1002/jor.21123; Zhang MJ, 2016, CIRCULATION, V134, P666, DOI 10.1161/CIRCULATIONAHA.116.021894; Zhao GY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222369; ZUCALI JR, 1986, J CLIN INVEST, V77, P1857, DOI 10.1172/JCI112512; Zurier R B, 1975, Inflammation, V1, P93, DOI 10.1007/BF00918062	103	3	3	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21655	10.1096/fj.202100078R	http://dx.doi.org/10.1096/fj.202100078R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042218	Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000655695900026
J	Zhu, ZS; Wu, XL; Li, Q; Zhang, JQ; Yu, S; Shen, QY; Zhou, Z; Pan, Q; Yue, W; Qin, DZ; Zhang, Y; Zhao, WX; Zhang, R; Peng, S; Li, N; Zhang, SQ; Lei, AM; Miao, YL; Liu, ZH; Chen, XQ; Wang, HY; Liao, MZ; Hua, JL				Zhu, Zhenshuo; Wu, Xiaolong; Li, Qun; Zhang, Juqing; Yu, Shuai; Shen, Qiaoyan; Zhou, Zhe; Pan, Qin; Yue, Wei; Qin, Dezhe; Zhang, Ying; Zhao, Wenxu; Zhang, Rui; Peng, Sha; Li, Na; Zhang, Shiqiang; Lei, Anmin; Miao, Yi-Liang; Liu, Zhonghua; Chen, Xingqi; Wang, Huayan; Liao, Mingzhi; Hua, Jinlian			Histone demethylase complexes KDM3A and KDM3B cooperate with OCT4/SOX2 to define a pluripotency gene regulatory network	FASEB JOURNAL			English	Article						histone demethylase complexes; KDM3A; 3B; pluripotency	STEM-LIKE CELLS; TRANSCRIPTION FACTORS; SELF-RENEWAL; GENERATION; OCT4; ACTIVATION; CHROMATIN; SOX2; ESTABLISHMENT; ANNOTATION	The pluripotency gene regulatory network of porcine induced pluripotent stem cells(piPSCs), especially in epigenetics, remains elusive. To determine the biological function of epigenetics, we cultured piPSCs in different culture conditions. We found that activation of pluripotent gene- and pluripotency-related pathways requires the erasure of H3K9 methylation modification which was further influenced by mouse embryonic fibroblast (MEF) served feeder. By dissecting the dynamic change of H3K9 methylation during loss of pluripotency, we demonstrated that the H3K9 demethylases KDM3A and KDM3B regulated global H3K9me2/me3 level and that their co-depletion led to the collapse of the pluripotency gene regulatory network. Immunoprecipitation-mass spectrometry (IP-MS) provided evidence that KDM3A and KDM3B formed a complex to perform H3K9 demethylation. The genome-wide regulation analysis revealed that OCT4 (O) and SOX2 (S), the core pluripotency transcriptional activators, maintained the pluripotent state of piPSCs depending on the H3K9 hypomethylation. Further investigation revealed that O/S cooperating with histone demethylase complex containing KDM3A and KDM3B promoted pluripotency genes expression to maintain the pluripotent state of piPSCs. Together, these data offer a unique insight into the epigenetic pluripotency network of piPSCs.	[Zhu, Zhenshuo; Wu, Xiaolong; Zhang, Juqing; Yu, Shuai; Shen, Qiaoyan; Zhou, Zhe; Pan, Qin; Yue, Wei; Qin, Dezhe; Zhang, Ying; Zhao, Wenxu; Zhang, Rui; Peng, Sha; Li, Na; Zhang, Shiqiang; Lei, Anmin; Wang, Huayan; Hua, Jinlian] Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, 3rd Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China; [Li, Qun; Liao, Mingzhi] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Miao, Yi-Liang] Huazhong Agr Univ, Inst Stem Cell & Regenerat Biol, Coll Anim Sci & Vet Med, Wuhan, Peoples R China; [Liu, Zhonghua] North East Agr Univ, Coll Life Sci, Key Lab Anim Cellular & Genet Engn Heilongjiang P, Harbin, Peoples R China; [Chen, Xingqi] Karolinska Inst, Dept Cell & Mol Biol, Solna, Sweden	Northwest A&F University - China; Northwest A&F University - China; Huazhong Agricultural University; Karolinska Institutet	Hua, JL (corresponding author), Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, 3rd Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.; Liao, MZ (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	liaomz@nwsuaf.edu.cn; jinlianhua@nwsuaf.edu.cn		LEI, An-min/0000-0002-5066-8709; chen, xingqi/0000-0002-5657-2839; Li, Qun/0000-0002-7194-7504	Program of National Natural Science Foundation of China [32072806, 62072377]; National Key Research and Development Program of China Stem Cell and Translational Research [2016YFA0100203]; Program of Shaanxi Province Science and Technology Innovation Team [2019TD-036]; China Postdoctoral Science Foundation National Natural Science Foundation of China [32002246]; Fundamental research funds for the central Universities, NWSUAF [Z1090219146, Z102022004]	Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China Stem Cell and Translational Research; Program of Shaanxi Province Science and Technology Innovation Team; China Postdoctoral Science Foundation National Natural Science Foundation of China; Fundamental research funds for the central Universities, NWSUAF(Fundamental Research Funds for the Central Universities)	This work was supported by grants from Program of National Natural Science Foundation of China (32072806, 62072377); The National Key Research and Development Program of China Stem Cell and Translational Research (Grant No.2016YFA0100203), Program of Shaanxi Province Science and Technology Innovation Team (2019TD--036), the China Postdoctoral Science Foundation National Natural Science Foundation of China (32002246), Fundamental research funds for the central Universities, NWSUAF (Z1090219146, Z102022004).	Abdelalim EM, 2014, STEM CELLS DEV, V23, P2687, DOI 10.1089/scd.2014.0297; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cha HJ, 2018, REPROD DOMEST ANIM, V53, P176, DOI 10.1111/rda.13088; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Choi HW, 2016, STEM CELL REP, V7, P911, DOI 10.1016/j.stemcr.2016.09.012; Choi KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158046; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chronis C, 2017, CELL, V168, P442, DOI 10.1016/j.cell.2016.12.016; Criqui M, 2020, ELIFE, V9, DOI 10.7554/eLife.47333; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Ezashi T, 2016, ANNU REV ANIM BIOSCI, V4, P223, DOI 10.1146/annurev-animal-021815-111202; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Fang L, 2016, STEM CELLS, V34, P565, DOI 10.1002/stem.2250; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Haraguchi S, 2012, J REPROD DEVELOP, V58, P707, DOI 10.1262/jrd.2012-008; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Hou DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep25838; Huang B, 2019, ISCIENCE, V21, P375, DOI 10.1016/j.isci.2019.10.041; Kim JY, 2012, MOL CELL BIOL, V32, P2917, DOI 10.1128/MCB.00133-12; Kim S, 2010, ZYGOTE, V18, P93, DOI 10.1017/S0967199409990372; Kuroki S, 2018, STEM CELL REP, V10, P1340, DOI 10.1016/j.stemcr.2018.02.002; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; Li DW, 2017, CELL STEM CELL, V21, P819, DOI 10.1016/j.stem.2017.10.012; Li J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15146; Li N, 2019, CELL DEATH DIFFER, V26, P2115, DOI 10.1038/s41418-019-0280-2; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173047; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Liu ZL, 2015, INT J BIOL SCI, V11, P494, DOI 10.7150/ijbs.11849; Liu ZL, 2010, J BIOL CHEM, V285, P2758, DOI 10.1074/jbc.M109.066845; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Ma KY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00033; Ma YY, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0015-4; Malik V, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11054-7; Mao J, 2017, STEM CELL REP, V8, P11, DOI 10.1016/j.stemcr.2016.11.013; Narayan S, 2017, CELL REP, V20, P1585, DOI 10.1016/j.celrep.2017.07.071; Okada Y, 2007, NATURE, V450, P119, DOI 10.1038/nature06236; Prather RS, 2013, NAT BIOTECHNOL, V31, P122, DOI 10.1038/nbt.2490; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramos-Ibeas P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08387-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarac H, 2020, ONCOGENE, V39, P2187, DOI 10.1038/s41388-019-1116-8; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tran KA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7188; Veerapandian V, 2018, STEM CELL REP, V11, P593, DOI 10.1016/j.stemcr.2018.07.002; Walters Eric M, 2013, Mo Med, V110, P212; Wang HY, 2019, NUCLEIC ACIDS RES, V47, P2349, DOI 10.1093/nar/gky1317; Wang JY, 2013, STEM CELL REV REP, V9, P700, DOI 10.1007/s12015-013-9439-2; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wei YD, 2021, ZOOL RES, V42, P14, DOI 10.24272/j.issn.2095-8137.2020.186; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Wu Z, 2009, J MOL CELL BIOL, V1, P46, DOI 10.1093/jmcb/mjp003; Xiao F, 2017, STEM CELL REP, V9, P927, DOI 10.1016/j.stemcr.2017.07.013; Xue BH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151737; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu N, 2007, MOL CELL BIOL, V27, P8859, DOI 10.1128/MCB.01724-07; Zhu ZS, 2021, CELL PROLIFERAT, V54, DOI 10.1111/cpr.12932	69	8	9	4	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21664	10.1096/fj.202100230R	http://dx.doi.org/10.1096/fj.202100230R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34042215				2022-12-26	WOS:000655695900051
J	Aasbrenn, M; Svendstrup, M; Schnurr, TM; Hansen, DL; Worm, D; Balslev-Harder, M; Grarup, N; Burgdorf, KS; Vestergaard, H; Pedersen, O; Angquist, L; Fenger, M; Sorensen, TIA; Madsbad, S; Hansen, T				Aasbrenn, Martin; Svendstrup, Mathilde; Schnurr, Theresia M.; Hansen, Dorte Lindqvist; Worm, Dorte; Balslev-Harder, Marie; Grarup, Niels; Burgdorf, Kristoffer Solvsten; Vestergaard, Henrik; Pedersen, Oluf; Angquist, Larsa; Fenger, Mogens; Sorensen, Thorkild I. A.; Madsbad, Sten; Hansen, Torben			Genetic markers of abdominal obesity and weight loss after gastric bypass surgery	PLOS ONE			English	Article							ADIPOSE-TISSUE; BARIATRIC SURGERY; LOSS RESPONSE; RISK SCORE; LINK; FIBROSIS; INFLAMMATION; METABOLISM; HYPOXIA; VARIANT	Background Weight loss after bariatric surgery varies widely between individuals, partly due to genetic differences. In addition, genetic determinants of abdominal obesity have been shown to attenuate weight loss after dietary intervention with special attention paid to the rs1358980-T risk allele in the VEGFA locus. Here we aimed to test if updated genetic risk scores (GRSs) for adiposity measures and the rs1358980-T risk allele are linked with weight loss following gastric bypass surgery. Methods Five hundred seventy six patients with morbid obesity underwent Roux-en-Y gastric bypass. A GRS for BMI and a GRS for waist-hip-ratio adjusted for BMI (proxy for abdominal obesity), respectively, were constructed. All patients were genotyped for the rs1358980-T risk allele. Associations between the genetic determinants and weight loss after bariatric surgery were evaluated. Results The GRS for BMI was not associated with weight loss (beta = -2.0 kg/100 risk alleles, 95% CI -7.5 to 3.3, p = 0.45). Even though the GRS for abdominal obesity was associated with an attenuated weight loss response adjusted for age, sex and center (beta = -14.6 kg/100 risk alleles, 95% CI -25.4 to -3.8, p = 0.008), it was not significantly associated with weight loss after adjustment for baseline BMI (beta = -7.9 kg/100 risk alleles, 95% CI -17.5 to 1.6, p = 0.11). Similarly, the rs1358980-T risk allele was not significantly associated with weight loss (beta = -0.8 kg/risk allele, 95% CI -2.2 to 0.6, p = 0.25). Discussion GRSs for adiposity derived from large meta-analyses and the rs1358980-T risk allele in the VEGFA locus did not predict weight loss after gastric bypass surgery. The association between a GRS for abdominal obesity and the response to bariatric surgery may be dependent on the association between the GRS and baseline BMI.	[Aasbrenn, Martin; Svendstrup, Mathilde; Schnurr, Theresia M.; Balslev-Harder, Marie; Grarup, Niels; Vestergaard, Henrik; Pedersen, Oluf; Angquist, Larsa; Sorensen, Thorkild I. A.; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Aasbrenn, Martin] Bispebjerg Frederiksberg Univ Hosp, Geriatr Res Unit, Dept Geriatr, Copenhagen, Denmark; [Svendstrup, Mathilde] Bispebjerg Frederiksberg Univ Hosp, Dept Endocrinol, Copenhagen, Denmark; [Svendstrup, Mathilde; Hansen, Dorte Lindqvist] Steno Diabet Ctr Copenhagen, Gentofte, Denmark; [Worm, Dorte] Amager Hosp, Dept Med, Copenhagen, Denmark; [Burgdorf, Kristoffer Solvsten] Copenhagen Univ Hosp, Dept Clin Immunol, Copenhagen, Denmark; [Vestergaard, Henrik] Bornholms Hosp, Ronne, Denmark; [Fenger, Mogens] Hvidovre Univ Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Madsbad, Sten] Hvidovre Univ Hosp, Dept Endocrinol, Copenhagen, Denmark; [Svendstrup, Mathilde] Copenhagen Univ Hosp, Dept Endocrinol, Copenhagen, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; Steno Diabetes Center; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Aasbrenn, M (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.; Aasbrenn, M (corresponding author), Bispebjerg Frederiksberg Univ Hosp, Geriatr Res Unit, Dept Geriatr, Copenhagen, Denmark.	Martin.Aasbrenn@gmail.com	Pedersen, Oluf/Z-1731-2019; Grarup, Niels/K-2807-2015	Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Vestergaard, Henrik/0000-0003-3090-269X; Hansen, Torben/0000-0001-8748-3831; Angquist, Lars/0000-0002-9516-4424; Schnurr, Theresia/0000-0002-6573-4959	Ministry of Higher Education and Science The UNIK Initiative: Food, Fitness AMP; Pharma for Health and Disease; Challenge Programme MicrobLiver [NNF15OC0016692]; Novo Nordisk Foundation	Ministry of Higher Education and Science The UNIK Initiative: Food, Fitness AMP; Pharma for Health and Disease; Challenge Programme MicrobLiver; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was funded by a grant from The Ministry of Higher Education and Science The UNIK Initiative: Food, Fitness & Pharma for Health and Disease (TH, http://ufm.dk).The project was also supported with funds from the Challenge Programme MicrobLiver (Grant No. NNF15OC0016692) (TH, http://challenge.novonordiskfoundation.com).The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research centre at the University of Copenhagen and is partly funded by an unrestricted donation from the Novo Nordisk Foundation.	Aasbrenn M, 2019, OBES SURG, V29, P2554, DOI 10.1007/s11695-019-03878-5; Alligier M, 2012, J CLIN ENDOCR METAB, V97, pE183, DOI 10.1210/jc.2011-2314; Bandstein M, 2016, OBES SURG, V26, P2183, DOI 10.1007/s11695-016-2072-9; Bandstein M, 2016, SCAND J GASTROENTERO, V51, P1050, DOI 10.3109/00365521.2016.1166519; Borisenko O, 2015, OBES SURG, V25, P1408, DOI 10.1007/s11695-014-1537-y; Colquitt JL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub4; Cooiman MI, 2020, OBES SURG, V30, P470, DOI 10.1007/s11695-019-04184-w; de Toro-Martin J, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122011; Dirksen C, 2013, INT J OBESITY, V37, P1452, DOI 10.1038/ijo.2013.15; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Fenger M, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0140-8; Hainer V, 2008, PHYSIOL RES, V57, pS1, DOI 10.33549/physiolres.931485; Hainer V, 2000, INT J OBESITY, V24, P1051, DOI 10.1038/sj.ijo.0801358; Hatoum IJ, 2013, AM J HUM GENET, V92, P827, DOI 10.1016/j.ajhg.2013.04.009; Hatoum IJ, 2011, J CLIN ENDOCR METAB, V96, pE1630, DOI 10.1210/jc.2011-1130; Kakela P, 2014, OBES SURG, V24, P128, DOI 10.1007/s11695-013-1080-2; Katsareli EA, 2020, OBES SURG, V30, P1482, DOI 10.1007/s11695-019-04320-6; Krogager ML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208645; Lassen PB, 2017, J CLIN ENDOCR METAB, V102, P2443, DOI 10.1210/jc.2017-00138; Lemoine AY, 2012, J CLIN ENDOCR METAB, V97, pE775, DOI 10.1210/jc.2011-2649; Livingstone KM, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4707; Lu YC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10495; Madsbad S, 2014, LANCET DIABETES ENDO, V2, P152, DOI 10.1016/S2213-8587(13)70218-3; Ngo DTM, 2014, CIRCULATION, V130, P1072, DOI 10.1161/CIRCULATIONAHA.113.008171; Nielsen MS, 2020, INT J OBESITY, V44, P2291, DOI 10.1038/s41366-020-0576-9; Palleja A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0312-1; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pulit SL, 2019, HUM MOL GENET, V28, P166, DOI 10.1093/hmg/ddy327; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Rinella ES, 2013, J CLIN ENDOCR METAB, V98, pE1131, DOI 10.1210/jc.2012-3421; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Svendstrup M, 2018, INT J OBESITY, V42, P370, DOI 10.1038/ijo.2017.279; van de Laar AW, 2016, OBES SURG, V26, P612, DOI 10.1007/s11695-015-1967-1; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yengo L, 2018, HUM MOL GENET, V27, P3641, DOI 10.1093/hmg/ddy271	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252525	10.1371/journal.pone.0252525	http://dx.doi.org/10.1371/journal.pone.0252525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048505	Green Published, gold			2022-12-26	WOS:000664636100063
J	Burnham, KK; Burnham, JL; Johnson, JA; Huffman, A				Burnham, Kurt K.; Burnham, Jennifer L.; Johnson, Jeff A.; Huffman, Abby			Migratory movements of Atlantic puffins Fratercula arctica naumanni from high Arctic Greenland	PLOS ONE			English	Article							SEA-ICE; WINTER DISTRIBUTION; OCEANIC SEABIRD; BODY-SIZE; MARINE; STRATEGIES; ABUNDANCE; PATTERNS; AREAS; BIRDS	Although the Atlantic puffin Fratercula arctica is well studied throughout its temperate and low Arctic breeding range, few have studied the species in its far northern distribution. This study is the first to present data on the migratory movements of the "large-billed" subspecies, F. a. naumanni, that breeds in the high Arctic and which has significantly larger body size than those farther south. During 2013-2015, migration tracks were collected from nine adult puffins (6 males and 3 females) tagged with geolocators in northwest Greenland. Overall, female puffins traveled farther than males on their annual migration, with one female puffin traveling over 13,600 km, which was nearly a third farther than any tagged male in our study. Differential migration was observed in migratory phenology and route, with males using a form of chain migration with acute synchrony between individuals while females appeared to largely use leap-frog migration and showed little synchrony between individuals. Extreme sexual segregation in wintering areas was evidenced by two females that migrated to the southern limit of the species' range while the six males remained at the northern limit, and wintered along the sea ice edge during portions of the non-breeding season. Male puffins thus wintered in regions with sea surface temperatures up to 10 degrees C cooler than female puffins, and in areas with generally colder sea surface temperatures when compared to previously known wintering areas of temperate and low Arctic puffin breeding populations. The degree to which body size enables male F. a. naumanni to remain in colder waters likely reflects differing life history constraints between sexes and populations (i.e., subspecies). Further study is warranted to investigate how recent changes in climate have further exacerbated the observed differences between sexes in high Arctic puffins and possibly other marine avian species.	[Burnham, Kurt K.] High Arctic Inst, Orion, IL 61273 USA; [Burnham, Jennifer L.; Huffman, Abby] Augustana Coll, Dept Geog, Rock Isl, IL 61201 USA; [Johnson, Jeff A.] Univ North Texas, Dept Biol Sci, Denton, TX 76203 USA; [Johnson, Jeff A.] Wolf Creek Operating Fdn, Wolf, WY USA	University of North Texas System; University of North Texas Denton	Burnham, KK (corresponding author), High Arctic Inst, Orion, IL 61273 USA.	kburnham@higharctic.org		Burnham, Kurt/0000-0002-1169-6512	Offield Family Foundation; Wolf Creek Charitable Trust; Augustana College; Patagonia; University of North Texas; Trout/Jarvis Family; Cafferty Family	Offield Family Foundation; Wolf Creek Charitable Trust; Augustana College; Patagonia; University of North Texas; Trout/Jarvis Family; Cafferty Family	Funding to conduct this research was provided to the High Arctic Institute by The Offield Family Foundation, Wolf Creek Charitable Trust, Augustana College, Patagonia, University of North Texas, Trout/Jarvis Family, Cafferty Family, Kim Pelle, and numerous other individual donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2020, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00826; Anker-Nilssen T, 2009, POLAR BIOL, V32, P1657, DOI 10.1007/s00300-009-0665-7; Ashton KG, 2002, GLOBAL ECOL BIOGEOGR, V11, P505, DOI 10.1046/j.1466-822X.2002.00313.x; Bailleul F, 2012, CLIM RES, V53, P169, DOI 10.3354/cr01104; Baran MA, 2019, THESIS U NEW BRUNSWI; BARRETT R T, 1985, Ringing and Migration, V6, P102; Bennison A, 2015, BIRD STUDY, V62, P262, DOI 10.1080/00063657.2015.1011601; Berger J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19416-9; BirdLife International, SPEC FACTSH FRAT ARC; BirdLife International, 2015, EUR RED LIST BIRDS, DOI [10.2779/975810, DOI 10.2779/975810]; Boertmann D, 2004, BIRD CONSERV INT, V14, P87, DOI 10.1017/S0959270904000127; Boertmann D, 2007, GREENLANDS RED LIST; Boertmann DA., 1996, 170 NERI NAT ENV RES; Boertmann D, 2020, ARCTIC, V73, P20, DOI 10.14430/arctic69885; Boertmann David, 2011, Marine Ornithology, V39, P183; Boertmann David, 1994, Meddelelser om Gronland Bioscience, V38, P1; Bond AL, 2016, J ORNITHOL, V157, P875, DOI 10.1007/s10336-016-1332-8; Burnham KK., 2012, BIOSCIENCE, V352, P1; Burnham KK, 2020, POLAR RES, V39, DOI 10.33265/polar.v39.5242; Burnham KK, 2011, IBIS, V153, P468, DOI 10.1111/j.1474-919X.2011.01141.x; Cappelen J., 2008 DMI; Catry Paulo, 2005, P351; Chambault P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75658-6; Cherry SG, 2013, J ANIM ECOL, V82, P912, DOI 10.1111/1365-2656.12050; Convention on Biological Diversity [Internet, EC BIOL SIGN MAR AR; Cristol Daniel A., 1999, Current Ornithology, V15, P33; Deakin Z, 2019, MAR ECOL PROG SER, V622, P191, DOI 10.3354/meps12986; Dias MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049376; Dunn DC, 2014, MAR POLICY, V49, P137, DOI 10.1016/j.marpol.2013.12.002; Durinck J, 1996, POLAR RES, V15, P23, DOI 10.1111/j.1751-8369.1996.tb00456.x; Environment and Climate Change Canada, CAN CONS AR; ESRI ArcGIS [Internet, WORLD COUNTR BOUND A; Fair J., 2010, ORNITHOLOGICAL COUNC; Fayet AL, 2017, CURR BIOL, V27, P3871, DOI 10.1016/j.cub.2017.11.009; Fayet AL, 2016, BEHAV ECOL, V27, P1061, DOI 10.1093/beheco/arw013; Fetterer F., 2017, UPDATED DAILY SEA IC, DOI [10.7265/N5K072F8, DOI 10.7265/N5K072F8]; Fort J, 2013, DIVERS DISTRIB, V19, P1322, DOI 10.1111/ddi.12105; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Frederiksen M, 2016, BIOL CONSERV, V200, P26, DOI 10.1016/j.biocon.2016.05.011; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gaston A.J., 1998, THE AUKS; Gilg O, 2010, J AVIAN BIOL, V41, P532, DOI 10.1111/j.1600-048X.2010.05125.x; Glew KS, 2019, MOV ECOL, V7, DOI 10.1186/s40462-019-0174-4; Gonzalez-Solis J, 2007, AQUAT CONSERV, V17, pS22, DOI 10.1002/aqc.911; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Hallgrimsson GT, 2012, J ORNITHOL, V153, P603, DOI 10.1007/s10336-012-0816-4; Harris M.P., 2011, THE PUFFIN; Harris MP, 2010, MAR BIOL, V157, P827, DOI 10.1007/s00227-009-1365-0; Hovinen JEH, 2014, ECOL EVOL, V4, P3127, DOI 10.1002/ece3.1160; Hunt GL, 1996, ARCTIC, V49, P53; Jessopp MJ, 2013, MAR BIOL, V160, P2755, DOI 10.1007/s00227-013-2268-7; KETTERSON ED, 1976, ECOLOGY, V57, P679, DOI 10.2307/1936182; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Lam CH, 2010, MAR ECOL PROG SER, V419, P71, DOI 10.3354/meps08862; Le Corre M, 2017, J MAMMAL, V98, P260, DOI 10.1093/jmammal/gyw177; Limited Biotrack., 2013, M SER GEOL US MAN V, V11; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; Loe LE, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1374; Lowther PE., 2020, BIRDS OF THE WORLD, DOI [10.2173/bow.atlpuf.01, DOI 10.2173/BOW.ATLPUF.01]; Lyngs Peter, 2003, Dansk Ornitologisk Forenings Tidsskrift, V97, P1; Mallory ML, 2009, POLAR BIOL, V32, P529, DOI 10.1007/s00300-008-0547-4; Marine Conservation Institute, MPATLAS; Mehlum F, 1997, POLAR BIOL, V18, P116, DOI 10.1007/s003000050166; Merkel B, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0091-8; Milner-Gulland EJ., 2011, ANIM MIGR; Montevecchi WA, 2012, BIOL CONSERV, V156, P62, DOI 10.1016/j.biocon.2011.12.001; Mosbech A, 1999, POLAR RES, V18, P1, DOI 10.1111/j.1751-8369.1999.tb00273.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nilsson C, 2013, AM NAT, V181, P837, DOI 10.1086/670335; NOAA, NOAA NCEP EMC CMB GL; Paiva VH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151340; Pelletier D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230262; Pennycuick CJ, 1997, J EXP BIOL, V200, P2355; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips RA, 2017, MAR ECOL PROG SER, V578, P117, DOI 10.3354/meps12217; Ramos R, 2015, J BIOGEOGR, V42, P1651, DOI 10.1111/jbi.12541; Ratcliffe N, 2014, J BIOGEOGR, V41, P1183, DOI 10.1111/jbi.12279; Richman SE, 2011, PHYSIOL BIOCHEM ZOOL, V84, P316, DOI 10.1086/660008; Salomonsen F, 1944, MEDDELANDEN FRAN GOT, V108; Salomonsen F, 1950, GRONLANDS FUGLE; Schulenberg T.S., 2020, BIRDS OF THE WORLD; Stirling I, 1997, J MARINE SYST, V10, P9, DOI 10.1016/S0924-7963(96)00054-1; Stirling I, 2012, GLOBAL CHANGE BIOL, V18, P2694, DOI 10.1111/j.1365-2486.2012.02753.x; Strom H., 2019, ARCTIC REPORT CARD 2, P66; Surman CA, 2018, J ORNITHOL, V159, P867, DOI 10.1007/s10336-018-1556-x; Thoman RL., 2020, ARCTIC REPORT CARD 2, DOI [10.25923/mn5p-t549, DOI 10.25923/MN5P-T549]; Timmermans M.-L., 2020, NOAA ARCTIC REPORT C, DOI [10.25923/v0fs-m920, DOI 10.25923/V0FS-M920]; Tranquilla LAM, 2013, MAR ECOL PROG SER, V472, P287, DOI 10.3354/meps10053; UNEP-WCMC and IUCN, PROT PLAN WORLD DAT; Vaurie C, 1965, BIRDS PALEARCTIC FAU; Weimerskirch H, 2000, NATURE, V406, P955, DOI 10.1038/35023068; Weimerskirch H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08853; Yurkowski DJ, 2019, DIVERS DISTRIB, V25, P328, DOI 10.1111/ddi.12860	94	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252055	10.1371/journal.pone.0252055	http://dx.doi.org/10.1371/journal.pone.0252055			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048451	gold, Green Published			2022-12-26	WOS:000664636100019
J	Ghimire, S; Kim, J				Ghimire, Subash; Kim, Joomyeong			PEG3 controls lipogenesis through ACLY	PLOS ONE			English	Article							ATP-CITRATE LYASE; EXPRESSED IMPRINTED GENE; COA REDUCTASE INHIBITORS; TARGETS; CANCER; DEHYDROGENASE; METABOLISM; BINDING; REGION; ALPHA	Peg3 (Paternally expressed gene 3) is an imprinted gene encoding a DNA-binding protein that is a well-known transcriptional repressor. Previous studies have shown that the mutant phenotypes of Peg3 are associated with the over-expression of genes involved in lipid metabolism. In the current study, we investigated four potential downstream genes of Peg3, which were identified through ChIP-seq data: Acly, Fasn, Idh1, and Hmgcr. In vivo binding of PEG3 to the promoter region of these key genes involved in lipogenesis was subsequently confirmed through individual ChIP experiments. We observed the opposite response of Acly expression levels against the variable gene dosages of Peg3, involving 0x, 1x, and 2x Peg3. This suggests the transcriptional repressor role of Peg3 in the expression levels of Acly. Another set of analyses showed a sex-biased response in the expression levels of Acly, Fasn, and Idh1 against 0x Peg3 with higher levels in female and lower levels in male mammary glands. These results overall highlight that Peg3 may be involved in regulating the expression levels of several key genes in adipogenesis.	[Ghimire, Subash; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu		Kim, Joomyeong/0000-0001-6577-5526; Ghimire, Subash/0000-0001-9544-4410				Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; Behl C, 1999, TRENDS PHARMACOL SCI, V20, P441, DOI 10.1016/S0165-6147(99)01392-9; Bretz CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197069; Bretz CL, 2017, EPIGENETICS-US, V12, P945, DOI 10.1080/15592294.2017.1377869; Chu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08801; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; DADAMO AF, 1965, J BIOL CHEM, V240, P613; Davidson MH, 2001, DRUGS, V61, P197, DOI 10.2165/00003495-200161020-00005; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Favara DM, 2019, METABOLITES, V9, DOI 10.3390/metabo9120287; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Fernandez S, 2019, CELL REP, V27, P2772, DOI 10.1016/j.celrep.2019.04.112; Frey WD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202476; Frey WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144459; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Han Q., 2020, HEPATOBILIARY PANCRE, DOI [10.1016/j.hbpd.2020.05.010, DOI 10.1016/J.HBPD.2020.05.010]; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; He H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167541; He HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38136; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Ivanova E, 2011, J MOL ENDOCRINOL, V47, pR67, DOI 10.1530/JME-11-0065; Jensen RG, 1999, LIPIDS, V34, P1243, DOI 10.1007/s11745-999-0477-2; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Keverne EB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0327; Kim J, 2003, HUM MOL GENET, V12, P233, DOI 10.1093/hmg/ddg028; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224287; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kim J, 2012, HUM MOL GENET, V21, P2677, DOI 10.1093/hmg/dds092; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsson O, 1996, CRIT REV ONCOL HEMAT, V22, P197, DOI 10.1016/1040-8428(96)00193-X; Lee S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145531; Li MY, 2017, ONCOTARGET, V8, P34534, DOI 10.18632/oncotarget.15837; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; Makowska Z, 2012, CYTOKINE, V59, P563, DOI 10.1016/j.cyto.2012.06.231; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Nye MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056325; Perera BPU, 2016, SCI REP-UK, V6, DOI 10.1038/srep24438; Sivanand S, 2017, MOL CELL, V67, P252, DOI 10.1016/j.molcel.2017.06.008; SZUTOWICZ A, 1979, BRIT J CANCER, V39, P681, DOI 10.1038/bjc.1979.120; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Turyn J, 2003, HORM METAB RES, V35, P565, DOI 10.1055/s-2003-43500; Varis A, 2002, CANCER RES, V62, P2625; Varlamov O, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00241; Wan LB, 2008, ADV GENET, V61, P207, DOI 10.1016/S0065-2660(07)00007-7; WATSON JA, 1969, ARCH BIOCHEM BIOPHYS, V135, P209, DOI 10.1016/0003-9861(69)90532-3; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yancy Haile F, 2007, J Carcinog, V6, P8; Ye A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178363; Ye A, 2016, EPIGENETICS-US, V11, P889, DOI 10.1080/15592294.2016.1255385; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112; Zhang C, 2016, GENE DEV, V30, P1956, DOI 10.1101/gad.283283.116; Zhang M, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201648; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	64	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252354	10.1371/journal.pone.0252354	http://dx.doi.org/10.1371/journal.pone.0252354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048454	Green Published, gold			2022-12-26	WOS:000664636100038
J	Ballard, KR; Klein, AH; Hayes, RA; Wang, TF; Cummins, SF				Ballard, Kaylene R.; Klein, Anne H.; Hayes, Richard A.; Wang, Tianfang; Cummins, Scott F.			The protein and volatile components of trail mucus in the Common Garden Snail, Cornu aspersum	PLOS ONE			English	Article							D-LIMONENE; HEART-RATE; COLEOPTERA-CURCULIONIDAE; ANTIMICROBIAL ACTIVITY; PEPTIDE PHEROMONES; CHEMICAL-ANALYSIS; HELIX; ATTRACTIN; TEMPTIN; IMPACT	The Common or Brown Garden Snail, Cornu aspersum, is an invasive land snail that has successfully colonized a diverse range of global environments. Like other invasive land snails, it is a significant pest of a variety of agricultural crops, including citrus, grapes and canola. Cornu aspersum secretes a mucus trail when mobile that facilitates locomotion. The involvement of the trail in conspecific chemical communication has also been postulated. Our study found that anterior tentacle contact with conspecific mucus elicited a significant increase in heart rate from 46.9 to 51 beats per minute. In order to gain a better understanding of the constituents of the trail mucus and the role it may play in snail communication, the protein and volatile components of mucus trails were investigated. Using two different protein extraction methods, mass spectrometry analysis yielded 175 different proteins, 29 of which had no significant similarity to any entries in the non-redundant protein sequence database. Of the mucus proteins, 22 contain features consistent with secreted proteins, including a perlucin-like protein. The eight most abundant volatiles detected using gas chromatography were recorded (including propanoic acid and limonene) and their potential role as putative pheromones are discussed. In summary, this study has provided an avenue for further research pertaining to the role of trail mucus in snail communication and provides a useful repository for land snail trail mucus components. This may be utilized for further research regarding snail attraction and dispersal, which may be applied in the fields of agriculture, ecology and human health.	[Ballard, Kaylene R.; Klein, Anne H.; Wang, Tianfang; Cummins, Scott F.] Univ Sunshine Coast, Genecol Res Ctr, Sunshine Coast, Qld, Australia; [Ballard, Kaylene R.; Klein, Anne H.; Wang, Tianfang; Cummins, Scott F.] Univ Sunshine Coast, Sch Sci Technol & Engn, Sunshine Coast, Qld, Australia; [Hayes, Richard A.] Univ Sunshine Coast, Forest Res Inst, Forest Ind Res Ctr, Sunshine Coast, Qld, Australia	University of the Sunshine Coast; University of the Sunshine Coast; University of the Sunshine Coast	Cummins, SF (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Sunshine Coast, Qld, Australia.; Cummins, SF (corresponding author), Univ Sunshine Coast, Sch Sci Technol & Engn, Sunshine Coast, Qld, Australia.	scummins@usc.edu.au	Hayes, R. Andrew/AAW-5185-2020; Wang, Tianfang/L-5192-2016	Hayes, R. Andrew/0000-0002-4860-0107; Wang, Tianfang/0000-0002-4876-7767; Klein, Anne/0000-0002-7165-0049	Grains Research Development Corporation [USU1903-001RSX]	Grains Research Development Corporation(Grains R&D Corp)	Grains Research Development Corporation, Contract code is USU1903-001RSX The GRDC has provided funding for this project; however, they had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez LA, 2009, PLANT PATHOL, V58, P956, DOI 10.1111/j.1365-3059.2009.02088.x; Angioy AM, 2003, CHEM SENSES, V28, P279, DOI 10.1093/chemse/28.4.279; Baker Geoff H., 2002, P193, DOI 10.1079/9780851993201.0193; Baker GH., 2003, BASHEM BURNEM BAITEM; Barker G. M., 2001, The biology of terrestrial molluscs, DOI 10.1079/9780851993188.0000; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Berillis P, 2013, MOLLUSCAN RES, V33, P6, DOI 10.1080/13235818.2012.754143; Billeter JC, 2018, J CHEM ECOL, V44, P750, DOI 10.1007/s10886-018-0947-z; Bose U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177064; Bouchard P, 1997, J CHEM ECOL, V23, P2049, DOI 10.1023/B:JOEC.0000006488.58081.66; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; CAMPION M, 1961, Q J MICROSC SCI, V102, P195; Chabot D, 1996, J CHEM ECOL, V22, P839, DOI 10.1007/BF02033590; Charwat SM, 1999, J INVERTEBR PATHOL, V74, P55, DOI 10.1006/jipa.1999.4855; Charwat SM, 2000, BIOCONTROL SCI TECHN, V10, P147, DOI 10.1080/09583150029288; Chase R., 2002, BEHAV ITS NEURAL CON; Cilia Giovanni, 2018, J Complement Integr Med, V15, DOI 10.1515/jcim-2017-0168; McCormick ALC, 2012, J CHEM ECOL, V38, P63, DOI 10.1007/s10886-011-0051-0; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Cowie R., 2015, CORNU ASPERSUM COMMO; Cummins SF, 2008, PEPTIDES, V29, P152, DOI 10.1016/j.peptides.2007.07.031; Cummins SF, 2007, FEBS J, V274, P5425, DOI 10.1111/j.1742-4658.2007.06070.x; Cummins SE, 2005, PEPTIDES, V26, P121, DOI 10.1016/j.peptides.2004.07.017; Cummins SF, 2006, PEPTIDES, V27, P597, DOI 10.1016/j.peptides.2005.08.026; Cummins SF, 2005, PEPTIDES, V26, P351, DOI 10.1016/j.peptides.2004.10.024; Cummins SF, 2004, J BIOL CHEM, V279, P25614, DOI 10.1074/jbc.M313585200; Davies MS, 1999, MAR ECOL PROG SER, V179, P247, DOI 10.3354/meps179247; Davis EC, 2007, AM MALACOL BULL, V22, P157, DOI 10.4003/0740-2783-22.1.157; Dodenhof T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097126; Dolashka Pavlina, 2015, Journal of Bioscience and Biotechnology, P147; Dolashka P, 2016, CURR PHARM BIOTECHNO, V17, P263, DOI 10.2174/1389201016666150907113435; Duduman ML, 2014, AGR FOREST ENTOMOL, V16, P102, DOI 10.1111/afe.12039; Dzieciol M, 2012, RES VET SCI, V93, P1241, DOI 10.1016/j.rvsc.2012.02.009; E-Kobon T, 2016, COMPUT STRUCT BIOTEC, V14, P49, DOI 10.1016/j.csbj.2015.11.005; El Mubarak MAS, 2013, J CHROMATOGR A, V1322, P49, DOI 10.1016/j.chroma.2013.10.086; Ellijimi C, 2018, BIOMED PHARMACOTHER, V101, P871, DOI 10.1016/j.biopha.2018.03.020; Foulon V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010197; Guo W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001291; Hall MR, 2017, NATURE, V544, P231, DOI 10.1038/nature22033; Hanley ME, 2011, PLANT ECOL, V212, P727, DOI 10.1007/s11258-010-9845-3; Hardege JD, 2004, PEPTIDES, V25, P1517, DOI 10.1016/j.peptides.2003.11.029; Hee Young Y., 2016, NAT COMMUN, P7; Hoddle MS, 2013, CROP PROT, V53, P152, DOI 10.1016/j.cropro.2013.07.010; Holland BS., 2018, INVERTEBR BIOL, DOI [10.1111/ivb.12223, DOI 10.1111/IVB.12223]; Johannesson K, 2008, EVOLUTION, V62, P3178, DOI 10.1111/j.1558-5646.2008.00510.x; Johnson CT, 2013, AM MALACOL BULL, V31, P51, DOI 10.4003/006.031.0116; Kishi R, 2018, BUILD ENVIRON, V136, P293, DOI 10.1016/j.buildenv.2018.03.056; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li DM, 2007, COMP BIOCHEM PHYS B, V148, P192, DOI 10.1016/j.cbpb.2007.05.009; Liddon J, 2015, J MOLLUS STUD, V81, P299, DOI 10.1093/mollus/eyu082; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; Mc Donnell R, 2016, BIOCONTROL SCI TECHN, V26, P331, DOI 10.1080/09583157.2015.1111298; MCFARLANE JE, 1983, J CHEM ECOL, V9, P1307, DOI 10.1007/BF00994799; MCNAMEE D, 1993, LANCET, V342, P801, DOI 10.1016/0140-6736(93)91561-Y; Miller JA, 2011, ONCOL REV, V5, P31, DOI 10.1007/s12156-010-0066-8; National Center for Biotechnology Information, 2 ETH; Ng TPT, 2013, BIOL REV, V88, P683, DOI 10.1111/brv.12023; Ng TPT, 2011, ANIM BEHAV, V82, P459, DOI 10.1016/j.anbehav.2011.05.017; Nordeus K, 2012, VET REC, V170, p496B, DOI 10.1136/vr.100583; Nuttley WM, 2001, LEARN MEMORY, V8, P170, DOI 10.1101/lm.36501; OTSUKAFUCHINO H, 1992, COMP BIOCHEM PHYS C, V101, P607, DOI 10.1016/0742-8413(92)90094-N; Patel K, 2014, BRAIN BEHAV, V4, P83, DOI 10.1002/brb3.198; Petrova TA, 2016, J EVOL BIOCHEM PHYS+, V52, P37, DOI 10.1134/S002209301601004X; Pila EA, 2017, J COMP PHYSIOL A, V203, P855, DOI 10.1007/s00359-017-1198-0; Pitt SJ, 2019, BRIT J BIOMED SCI, V76, P129, DOI 10.1080/09674845.2019.1603794; Pitt SJ, 2015, BRIT J BIOMED SCI, V72, P174, DOI 10.1080/09674845.2015.11665749; QIN XX, 1995, J EXP BIOL, V198, P633; Rodriguez A, 2011, PLANT SIGNAL BEHAV, V6, P1820, DOI 10.4161/psb.6.11.16980; Sallam A. A. A., 2009, Archives of Phytopathology and Plant Protection, V42, P874, DOI 10.1080/03235400701494448; Sanderson Graeme, 2002, P255, DOI 10.1079/9780851993201.0255; Santana WA, 2012, INT J MORPHOL, V30, P365, DOI 10.4067/S0717-95022012000200001; Saranya R, 2015, APPL MICROBIOL BIOT, V99, P4423, DOI 10.1007/s00253-015-6573-6; Shaheen N, 2005, ANIM BEHAV, V70, P1067, DOI 10.1016/j.anbehav.2005.02.017; Shannon RWR, 2016, ANN BOT-LONDON, V117, P1073, DOI 10.1093/aob/mcw032; Smith AM, 2017, BIOFOULING, V33, P741, DOI 10.1080/08927014.2017.1361413; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Suckling DM, 2012, CROP PROT, V42, P327, DOI 10.1016/j.cropro.2012.07.009; Sun J, 2007, ALTERN MED REV, V12, P259; Tara DS., 2013, SCI REP-UK, V3; Taylor A., 2018, MAR BIOTECHNOL, P1; Toyoda F, 2004, PEPTIDES, V25, P1531, DOI 10.1016/j.peptides.2003.10.025; Wang TF, 2016, J PROTEOMICS, V146, P195, DOI 10.1016/j.jprot.2016.07.002; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Yu X, 2018, ONCOTARGETS THER, V11, P1833, DOI 10.2147/OTT.S155716; Zeeck E, 1998, CHEMOECOLOGY, V8, P33, DOI 10.1007/PL00001801; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhuang J, 2015, DEV COMP IMMUNOL, V49, P96, DOI 10.1016/j.dci.2014.11.008	87	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251565	10.1371/journal.pone.0251565	http://dx.doi.org/10.1371/journal.pone.0251565			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043643	gold, Green Published			2022-12-26	WOS:000664635700026
J	Baysal, O; Ghafoor, NA; Silme, RS; Ignatov, AN; Kniazeva, V				Baysal, Omur; Ghafoor, Naeem Abdul; Silme, Ragip Soner; Ignatov, Alexander N.; Kniazeva, Volha			Molecular dynamics analysis of N-acetyl-D-glucosamine against specific SARS-CoV-2's pathogenicity factors	PLOS ONE			English	Article							SOFTWARE NEWS; CORONAVIRUS; DISCOVERY; DOCKING	The causative agent of the pandemic identified as SARS-CoV-2 leads to a severe respiratory illness similar to SARS and MERS with fever, cough, and shortness of breath symptoms and severe cases that can often be fatal. In our study, we report our findings based on molecular docking analysis which could be the new effective way for controlling the SARS-CoV-2 virus and additionally, another manipulative possibilities involving the mimicking of immune system as occurred during the bacterial cell recognition system. For this purpose, we performed molecular docking using computational biology techniques on several SARS-CoV-2 proteins that are responsible for its pathogenicity against N-acetyl-D-glucosamine. A similar molecular dynamics analysis has been carried out on both SARS-CoV-2 and anti-Staphylococcus aureus neutralizing antibodies to establish the potential of N-acetyl-D-glucosamine which likely induces the immune response against the virus. The results of molecular dynamic analysis have confirmed that SARS-CoV-2 spike receptor-binding domain (PDB: 6M0J), RNA-binding domain of nucleocapsid phosphoprotein (PDB: 6WKP), refusion SARS-CoV-2 S ectodomain trimer (PDB: 6X79), and main protease 3clpro at room temperature (PDB: 7JVZ) could bind with N-acetyl-D-glucosamine that these proteins play an important role in SARS-CoV-2's infection and evade the immune system. Moreover, our molecular docking analysis has supported a strong protein-ligand interaction of N-acetyl-D-glucosamine with these selected proteins. Furthermore, computational analysis against the D614G mutant of the virus has shown that N-acetyl-D-glucosamine affinity and its binding potential were not affected by the mutations occurring in the virus' receptor binding domain. The analysis on the affinity of N-acetyl-D-glucosamine towards human antibodies has shown that it could potentially bind to both SARS-CoV-2 proteins and antibodies based on our predictive modelling work. Our results confirmed that N-acetyl-D-glucosamine holds the potential to inhibit several SARS-CoV-2 proteins as well as induce an immune response against the virus in the host.	[Baysal, Omur; Ghafoor, Naeem Abdul] Mugla Sitki Kocman Univ, Fac Sci, Dept Mol Biol & Genet, Mol Microbiol Unit, Mentese Mugla, Turkey; [Silme, Ragip Soner] Istanbul Univ, Ctr Res & Practice Biotechnol & Genet Engn, Istanbul, Turkey; [Ignatov, Alexander N.] Peoples Friendship Univ Russia, Fed State Autonomous Educ Inst, Moscow, Russia; [Kniazeva, Volha] Natl Acad Sci Belarus, Inst Biophys & Cell Engn, Minsk, BELARUS	Mugla Sitki Kocman University; Istanbul University; Peoples Friendship University of Russia; National Academy of Sciences of Belarus (NASB); Institute of Biophysics & Cell Engineering of the National Academy of Sciences of Belarus	Baysal, O (corresponding author), Mugla Sitki Kocman Univ, Fac Sci, Dept Mol Biol & Genet, Mol Microbiol Unit, Mentese Mugla, Turkey.	omurbaysal@mu.edu.tr	Baysal, Ömür/AAC-8891-2022; Biology and Genetics / Molecular Microbiology and Genetics, Ömür Baysal Ph.D. Professor on Molecular/C-8869-2013; Ignatov, Alexander N./L-3438-2013	Baysal, Ömür/0000-0001-5104-0983; Ignatov, Alexander N./0000-0003-2948-753X; ABDUL GHAFOOR, Naeem/0000-0002-4200-7679; SILME, RAGIP SONER/0000-0001-6547-3747				Karim SAS, 2021, NEW ENGL J MED, V384, P1866, DOI 10.1056/NEJMc2100362; Adem S., 2020, IDENTIFICATION POTEN, DOI [DOI 10.20944/PREPRINT202003.0333.V1, 10.20944/PREPRINTS202003.0333.V1, DOI 10.20944/PREPRINTS202003.0333.V1]; Ton AT, 2020, MOL INFORM, V39, DOI 10.1002/minf.202000028; [Anonymous], PYMOL MOL GRAPHICS S; Baysal O, 2021, FRESEN ENVIRON BULL, V30, P2848; CHECHIK BE, 1988, BIOCHEM CELL BIOL, V66, P1333, DOI 10.1139/o88-154; Chen CA, 2013, ORG BIOMOL CHEM, V11, P7687, DOI 10.1039/c3ob41622d; Chen Yu Wai, 2020, F1000Res, V9, P129, DOI 10.12688/f1000research.22457.2; Cheng MH., 2021, BIORXIV PREPRINT, DOI [10.1101/2021.01.10.426143v1, DOI 10.1101/2021.01.10.426143V1]; Chiba S, 2021, WIEN KLIN WOCHENSCHR, V133, P292, DOI 10.1007/s00508-020-01780-0; Conti P, 2021, J BIOL REG HOMEOS AG, V35, P1; De Vivo M, 2016, J MED CHEM, V59, P4035, DOI 10.1021/acs.jmedchem.5b01684; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; DiNicolantonio JJ, 2020, IMMUNOL LETT, V228, P83, DOI 10.1016/j.imlet.2020.09.008; Dodda LS, 2017, NUCLEIC ACIDS RES, V45, pW331, DOI 10.1093/nar/gkx312; Dodda LS, 2017, J PHYS CHEM B, V121, P3864, DOI 10.1021/acs.jpcb.7b00272; dos Santos CA, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab066; Fischer A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103626; Gentile D, 2020, MAR DRUGS, V18, DOI 10.3390/md18040225; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Halgren TA, 1996, J COMPUT CHEM, V17, P616, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009; Hulikova K, 2009, INT IMMUNOPHARMACOL, V9, P792, DOI 10.1016/j.intimp.2009.03.007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jorgensen WL, 2005, P NATL ACAD SCI USA, V102, P6665, DOI 10.1073/pnas.0408037102; Jourdan JP, 2020, J PHARM PHARMACOL, V72, P1145, DOI 10.1111/jphp.13273; Kang SS, 2020, ACTA PHARM SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li Y., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.01.28.922922v2, DOI 10.1101/2020.01.28.922922V2]; Liu X, 2020, J GENET GENOMICS, V47, P119, DOI 10.1016/j.jgg.2020.02.001; McCallum M, 2020, NAT STRUCT MOL BIOL, V27, P942, DOI 10.1038/s41594-020-0483-8; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; National Center for Biotechnology Information, 2021, PUBCHEM COMP SUMM CI; Nguyen DD., 2020, 20200205936013 BIORX, DOI 10.1101/2020.02.05.936013v1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0014475; Rudrapal M., 2020, DRUG REPURPOSING, DOI [10.5772/intechopen.93193, DOI 10.5772/INTECHOPEN.93193, 10.5772/INTECHOPEN.93193]; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Schmidt M, 2020, SARS COV 2 MAIN PROT, DOI [10.2210/pdb7jvz/pdb, DOI 10.2210/PDB7JVZ/PDB]; Soliman C, 2018, J BIOL CHEM, V293, P5079, DOI 10.1074/jbc.RA117.001170; Song N, 2019, CELL REP, V28, P2386, DOI 10.1016/j.celrep.2019.07.085; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Talluri S, 2021, COMB CHEM HIGH T SCR, V24, P716, DOI 10.2174/1386207323666200814132149; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Phan T, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104211; UNICEF, 2022, WHO COR COVID 19 DAS; Wang GM, 2016, FUTURE MED CHEM, V8, DOI 10.4155/fmc-2016-0143; Xu Z., 2020, MOL DOCKING BINDING, DOI [10.1101/2020.01.27.921627v1, 10.1101/2020.01.27.921627]; Yuki K, 2020, CLIN IMMUNOL, V215, DOI 10.1016/j.clim.2020.108427	52	2	2	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252571	10.1371/journal.pone.0252571	http://dx.doi.org/10.1371/journal.pone.0252571			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043733	Green Published, gold, Green Submitted			2022-12-26	WOS:000664635700109
J	Solomon, N; Molla, M; Ketema, B				Solomon, Nahom; Molla, Mitike; Ketema, Bezawit			"I want to perform and succeed more than those who are HIV-seronegative" Lived experiences of youth who acquired HIV perinetally and attend Zewditu Memorial Hospital ART clinic, Addis Ababa, Ethiopia	PLOS ONE			English	Article							ADOLESCENTS; CURRICULUM	Background In Ethiopian Human Immunodeficiency Virus (HIV) prevention program one of the focusing areas is prevention of mother-to-child transmission and decreasing morbidity and mortality among those who already acquired it. However, the needs and the sexual behavior of children who acquired HIV perinatally was not given due attention. Therefore, we conducted this study with the aim of exploring the lived experiences of youth who acquired HIV perinatally to contribute to HIV prevention and control program. Methods We conducted a qualitative study using a phenomenological approach from March to May 2018 among 16 purposively selected youth who were infected with HIV vertically and receive ART services at Zewditu Memorial Hospital, Addis Ababa, Ethiopia. They were recruited based on their willingness after obtaining written informed consent and assent. Data were audio taped, transcribed verbatim in Amharic and later translated to English, and coded using Open Code version 4.02 software. Findings were summarized under four themes by applying interpretative phenomenological analysis. Findings Seven males and nine females, aged 16 to 22 years have participated in the study. These youth reported as they had support from families and ART clinics, while pill-load, and fear of stigma are some of challenges they have faced, especially majorities don't want to disclose their status because of fear of stigma and discrimination. Half of them have ever had sexual relations usually with a seronegative partner and most of these had their first sex in their17-18 years of age. Unsafe sex was common among them where four girls reported to have had unprotected sex with their seropositive or seronegative sexual partners. Most wish to have purposeful life and love mate of the same serostatus but also fear they may remain alone. Conclusion Youth who had acquired HIV from parents are challenged due to their serostatus and were not sure what type of life they may have in the future. They were also not comfortable in disclosing their serostatus and also engaged in unsafe sexual relation. This calls for an urgent intervention among HIV infected youth and their families; health care providers, and young people in general to halt HIV transmission. Special attention should be given on sexual behavior of all young people (10-24) and in disclosure of HIV status to children and life skills education to cop-up with stigma and discrimination.	[Solomon, Nahom] Mizan Tepi Univ, Dept Publ Hlth, Mizan Aman, Ethiopia; [Molla, Mitike; Ketema, Bezawit] Addis Ababa Univ, Dept Prevent Med, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Solomon, N (corresponding author), Mizan Tepi Univ, Dept Publ Hlth, Mizan Aman, Ethiopia.	nahomsolomon83@gmail.com	Habtamu, Nahom Solomon/AGV-6067-2022	Habtamu, Nahom Solomon/0000-0002-8610-450X				Abubakar A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2854-y; Alase A., 2017, INTERPRETATIVE PHENO, V5; Alexis Z., 2014, GROWING HIV KISUMU K, P101; Arabia S., 2014, LIVED EXPERIENCE LIV, P215; Biru M., 2017, COMPR CHILD ADOLESC, V00, P1; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV, P221; Cloete A, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/420270; Dorrell Judith., 2008, GROWING HIV EXPERIEN, P3; Ethiopian Public Health Institute, 2017, HIV RELATED ESTIMATE, P2; Jena PP., 2014, EXPLORING LIVED EXPE, P3; Kafle NP., 2013, BODHI INTERDISCIPL J, V5, P181, DOI [10.3126/bodhi.v5i1.8053, DOI 10.3126/BODHI.V5I1.8053, DOI 10.3126/BODHI.V5I1.805]; Madiba S, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/2607249; Mayer KH, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P1; Mbalinda C., 2015, REPROD HEALTH; Midtbo V., 2012, ADOLESCENTS LIVING H, P1; Nottingham T, 2014, STORY PERSPECTIVES Y; Rydstrom LL, 2013, J ADV NURS, V69, P1357, DOI 10.1111/j.1365-2648.2012.06127.x; Setlhare V., 2015, S AFRICAN FAM PRACT, P1; Silva-suarez G., 2014, LIFE EXPERIENCES YOU, P41, DOI [10.1177/1524839913510919, DOI 10.1177/1524839913510919]; Sloan A, 2014, QUAL QUANT, V48, P1291, DOI 10.1007/s11135-013-9835-3; Sutton Jane, 2015, Can J Hosp Pharm, V68, P226; Tshuma S., 2015, CHALLENGES FACED ADO, P4; Umea: and Department of Public Health and Clinical Medicine Umea University Sweden, 2011, UM DEP PUBL HLTH CLI, P1; UNICEF, 2016, ANN RES REP WAT SAN, P1; Unicef, 2015, HIV AIDS ANN RES REP, P2; United Nations Human Settlements Programme, 2008, REG TECHN COOP; Vd S., 2010, ADOLESCENT HIV AIDS, V31, P1; WHO, 10 FACTS HIV AIDS; Williams EF., 2014, GROWING HIV LIVED EX, P3; Winskell K, 2016, CHILD YOUTH SERV REV, V61, P253, DOI 10.1016/j.childyouth.2015.12.017; Wolf HT., 2014, IT IS ALL FEAR BEING, P1; Woollett N, 2016, CHILD YOUTH SERV REV, V70, P269, DOI 10.1016/j.childyouth.2016.09.039; Zewditu Memorial Hospital ART clinic, 2018, FACT SHEET MONTHL RE	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251848	10.1371/journal.pone.0251848	http://dx.doi.org/10.1371/journal.pone.0251848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043659	Green Published, gold			2022-12-26	WOS:000664635700037
J	Caplan, HW; Prabhakara, KS; Furman, NET; Zorofchian, S; Martin, C; Xue, HS; Olson, SD; Cox, CS				Caplan, Henry W.; Prabhakara, Karthik S.; Furman, Naama E. Toledano; Zorofchian, Soheil; Martin, Cecilia; Xue, Hasen; Olson, Scott D.; Cox, Charles S., Jr.			Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an experimental rat traumatic brain injury model	PLOS ONE			English	Article							REGULATORY T-CELLS; MESENCHYMAL STEM-CELLS; STROMAL CELLS; AMPHIREGULIN; DELIVERY	Traumatic brain injury (TBI) causes both physical disruption of the blood brain barrier (BBB) and altered immune responses that can lead to significant secondary brain injury and chronic inflammation within the central nervous system (CNS). Cell therapies, including mesenchymal stromal cells (MSC), have been shown to restore BBB integrity and augment endogenous splenic regulatory T cells (Treg), a subset of CD4+ T cells that function to regulate immune responses and prevent autoimmunity. We have recently shown that infusion of human cord blood-derived Treg decreased neuroinflammation after TBI in vivo and in vitro. However, while both cells have demonstrated anti-inflammatory and regenerative potential, they likely utilize differing, although potentially overlapping, mechanisms. Furthermore, studies investigating these two cell types together, as a combination therapy, are lacking. In this study, we compared the ability of Treg+MSC combination therapy, as well as MSC and Treg monotherapies, to improve BBB permeability in vivo and suppress inflammation in vitro. While Treg+MSC combination did not significantly augment potency in vivo, our in vitro data demonstrates that combination therapy may augment therapeutic potency and immunosuppressive potential compared to Treg or MSC monotherapy.	[Caplan, Henry W.; Prabhakara, Karthik S.; Furman, Naama E. Toledano; Zorofchian, Soheil; Martin, Cecilia; Xue, Hasen; Olson, Scott D.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Olson, SD; Cox, CS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, McGovern Med Sch, Houston, TX 77030 USA.	scott.d.olson@uth.tmc.edu; charles.s.cox@uth.tmc.edu		Martin, Cecilia/0000-0001-7096-986X	NIH NIGMS 2T32 grant [GM0879201-11A1]	NIH NIGMS 2T32 grant	This study was supported by the NIH NIGMS 2T32 grant GM0879201-11A1 (CSC and supporting HWC), www.nigms.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Caplan H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01645; Caplan HW, 2020, STEM CELL TRANSL MED, V9, P903, DOI 10.1002/sctm.19-0444; Cox CS, 2019, TRANSFUSION, V59, P858, DOI 10.1111/trf.14834; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Engela AU, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00126; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; George MJ, 2018, STEM CELL TRANSL MED, V7, P731, DOI 10.1002/sctm.18-0015; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Jackson ML, 2017, J SURG RES, V214, P38, DOI 10.1016/j.jss.2017.02.078; Ko JH, 2020, CELL REP, V30, P3806, DOI 10.1016/j.celrep.2020.02.062; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kota DJ, 2017, STEM CELLS, V35, P1416, DOI 10.1002/stem.2603; Le Blanc K, 2015, IMMUNOL LETT, V168, P140, DOI 10.1016/j.imlet.2015.05.004; Lee ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138846; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ma OKF, 2016, WORLD J STEM CELLS, V8, P268, DOI 10.4252/wjsc.v8.i9.268; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meng HL, 2019, P NATL ACAD SCI USA, V116, P5558, DOI 10.1073/pnas.1814394116; Negi N, 2020, STEM CELLS, V38, P596, DOI 10.1002/stem.3151; Pati S, 2011, STEM CELLS DEV, V20, P89, DOI 10.1089/scd.2010.0013; Prabhakara KS, 2018, MOL THER, V26, P2152, DOI 10.1016/j.ymthe.2018.06.022; Prevention CfDCa, 2015, REPORT C TRAUMATIC B; Ritzel RM, 2018, J NEUROTRAUM, V35, P1419, DOI 10.1089/neu.2017.5399; Rodriguez-Perea AL, 2016, CLIN EXP IMMUNOL, V185, P281, DOI 10.1111/cei.12804; Sanchez-Fueyo A, 2020, AM J TRANSPLANT, V20, P1125, DOI 10.1111/ajt.15700; Schiavon V, 2019, P NATL ACAD SCI USA, V116, P6298, DOI 10.1073/pnas.1812471116; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Takahashi T, 2014, STEM CELL TRANSL MED, V3, P1484, DOI 10.5966/sctm.2014-0012; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Zaiss DM, 2019, IMMUNOLOGY, V157, P190, DOI 10.1111/imm.13057; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zhou YF, 2014, J THORAC CARDIOV SUR, V148, P1131, DOI 10.1016/j.jtcvs.2014.06.029	38	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251601	10.1371/journal.pone.0251601	http://dx.doi.org/10.1371/journal.pone.0251601			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038436	Green Published, gold			2022-12-26	WOS:000664633500026
J	Ely, B				Ely, Bert			Genomic GC content drifts downward in most bacterial genomes	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; PLUS CYTOSINE CONTENT; BASE COMPOSITION; CODON USAGE; EVOLUTION; SEQUENCE	In every kingdom of life, GC->AT transitions occur more frequently than any other type of mutation due to the spontaneous deamination of cytidine. In eukaryotic genomes, this slow loss of GC base pairs is counteracted by biased gene conversion which increases genomic GC content as part of the recombination process. However, this type of biased gene conversion has not been observed in bacterial genomes, so we hypothesized that GC->AT transitions cause a reduction of genomic GC content in prokaryotic genomes on an evolutionary time scale. To test this hypothesis, we used a phylogenetic approach to analyze triplets of closely related genomes representing a wide range of the bacterial kingdom. The resulting data indicate that genomic GC content is drifting downward in bacterial genomes where GC base pairs comprise 40% or more of the total genome. In contrast, genomes containing less than 40% GC base pairs have fewer opportunities for GC->AT transitions to occur so genomic GC content is relatively stable or actually increasing. It should be noted that this observed change in genomic GC content is the net change in shared parts of the genome and does not apply to parts of the genome that have been lost or acquired since the genomes being compared shared common ancestor. However, a more detailed analysis of two Caulobacter genomes revealed that the acquisition of mobile elements by the two genomes actually reduced the total genomic GC content as well.	[Ely, Bert] Univ South Carolina, Dept Biol Sci, Columbia, SC USA	University of South Carolina System; University of South Carolina Columbia	Ely, B (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC USA.	ely@sc.edu						Bohlin J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4984-3; Bolotin E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01536; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dixit PD, 2015, P NATL ACAD SCI USA, V112, P9070, DOI 10.1073/pnas.1510839112; Ely B, 2018, CURR MICROBIOL, V76, P159, DOI DOI 10.1007/s00284-018-1606-x; Ely B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227987; Eyre-Walker A, 1999, GENETICS, V152, P675; Fischer S, 2016, ENV MICROBIOL REP, V8, P227, DOI 10.1111/1758-2229.12372; Friedman R, 2012, CURR MICROBIOL, V65, P639, DOI 10.1007/s00284-012-0205-5; Galtier N, 2001, GENETICS, V159, P907; Halldorsson BV, 2019, SCIENCE, V363, P364, DOI 10.1126/science.aau1043; Halldorsson BV, 2016, NAT GENET, V48, P1377, DOI 10.1038/ng.3669; Haywood-Farmer E, 2003, EVOLUTION, V57, P1783; Hershberg R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018077; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Hildebrand F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001107; KAGAWA Y, 1984, J BIOL CHEM, V259, P2956; Lassalle F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004941; Lightfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017677; Long HA, 2018, NAT ECOL EVOL, V2, P237, DOI 10.1038/s41559-017-0425-y; Martins-Pinheiro M, 2017, GENE, V626, P251, DOI 10.1016/j.gene.2017.05.038; McEwan CEA, 1998, HEREDITAS, V128, P173, DOI 10.1111/j.1601-5223.1998.00173.x; Mitchell D, 2007, BIOCHEM BIOPH RES CO, V353, P207, DOI 10.1016/j.bbrc.2006.12.008; Naya H, 2002, J MOL EVOL, V55, P260, DOI 10.1007/s00239-002-2323-3; Patel S, 2015, CURR MICROBIOL, V70, P355, DOI 10.1007/s00284-014-0726-1; Slomka S, 2020, GENETICS, V216, P543, DOI 10.1534/genetics.120.303401; Valencia AO, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-gmb-2018-0283, 10.1590/1678-4685-GMB-2018-0283]; Wu H, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-2	29	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0244163	10.1371/journal.pone.0244163	http://dx.doi.org/10.1371/journal.pone.0244163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038432	Green Submitted, gold, Green Published			2022-12-26	WOS:000664633500003
J	Gibbons, J				Gibbons, Joseph			Distancing the socially distanced: Racial/ethnic composition's association with physical distancing in response to COVID-19 in the US	PLOS ONE			English	Article							GEOGRAPHICALLY WEIGHTED REGRESSION; HEALTH-CARE-SYSTEM; SELF-RATED HEALTH; RESIDENTIAL SEGREGATION; RACIAL DISPARITIES; INTERVENTION; ATTITUDES; DISTRUST; DENSITY; ACCESS	Social distancing prescribed by policy makers in response to COVID-19 raises important questions as to how effectively people of color can distance. Due to inequalities from residential segregation, Hispanic and Black populations have challenges in meeting health expectations. However, segregated neighborhoods also support the formation of social bonds that relate to healthy behaviors. We evaluate the question of non-White distancing using social mobility data from Google on three sites: workplaces, grocery stores, and recreational locations. Employing hierarchical linear modeling and geographically weighted regression, we find the relation of race/ethnicity to COVID-19 distancing is varied across the United States. The HLM models show that compared to Black populations, Hispanic populations overall more effectively distance from recreation sites and grocery stores: each point increase in percent Hispanic was related to residents being 0.092 percent less likely (p< 0.05) to visit recreational sites and 0.127 percent less likely (p< 0.01) to visit grocery stores since the onset of COVID-19. However, the GWR models show there are places where the percent Black is locally related to recreation distancing while percent Hispanic is not. Further, these models show the association of percent Black to recreation and grocery distancing can be locally as strong as 1.057 percent (p< 0.05) and 0.989 percent (p< 0.05), respectively. Next, the HLM models identified that Black/White residential isolation was related to less distancing, with each point of isolation residents were 11.476 percent more likely (p< 0.01) to go to recreational sites and 7.493 percent more likely (p< 0.05) to visit grocery stores compared to before COVID-19. These models did not find a measurable advantage/disadvantage for Black populations in these places compared to White populations. COVID-19 policy should not assume disadvantage in achieving social distancing accrue equally to different racial/ethnic minorities.	[Gibbons, Joseph] San Diego State Univ, Sociol, San Diego, CA 92182 USA	California State University System; San Diego State University	Gibbons, J (corresponding author), San Diego State Univ, Sociol, San Diego, CA 92182 USA.	jgibbons@sdsu.edu						ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Babitsch Birgit, 2012, Psychosoc Med, V9, pDoc11, DOI 10.3205/psm000089; Baldwin J., 1960, ESQUIRE; Barrios JM, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104310; Becares L, 2013, ETHNIC HEALTH, V18, P544, DOI 10.1080/13557858.2013.828831; Bragg CA., 2011, AABSS J, V15, P1; Bray H., 2014, YOU ARE HERE COMPASS; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Callahan Y., 2020, ESSENCE; Carman T., 2018, WASH POST; Carpenter Z., 2020, WHAT WE KNOW COVID 1; Chen DH, 2014, SOC SCI MED, V104, P64, DOI 10.1016/j.socscimed.2013.12.021; Chiu J, 2008, AIDS EDUC PREV, V20, P519, DOI 10.1521/aeap.2008.20.6.519; Conley D., 2009, ELSEWHERE US WE GOT; Cooper LA, 2012, AM J PUBLIC HEALTH, V102, P979, DOI 10.2105/AJPH.2011.300558; da Silva AR, 2016, GEOGR ANAL, V48, P233, DOI 10.1111/gean.12084; Dean L, 2014, SOC SCI MED, V104, P148, DOI 10.1016/j.socscimed.2013.11.057; Dean LT, 2015, AM J MENS HEALTH, V9, P385, DOI 10.1177/1557988314546491; Enos RD., 2017, SPACE US SOCIAL GEOG, DOI [10.1017/9781108354943, DOI 10.1017/9781108354943]; Fotheringham AS, 2016, J GEOGR SYST, V18, P303, DOI 10.1007/s10109-016-0239-5; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; Gibbons J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113910; Gibbons J, 2019, CITY COMMUNITY, V18, P321, DOI 10.1111/cico.12370; Gibbons J, 2018, APPL SPAT ANAL POLIC, V11, P37, DOI 10.1007/s12061-016-9211-5; Gibbons J, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0067-3; Goldberg N., 2020, NYDAILYNEWS 0507; Wahl AMG, 2007, SOC SCI RES, V36, P995, DOI 10.1016/j.ssresearch.2006.07.004; Google LLC., 2020, GOOGL COVID 19 COMM; Google LLC., GOOGL MAPS IPHONE; Grady SC, 2006, SOC SCI MED, V63, P3013, DOI 10.1016/j.socscimed.2006.08.017; Harris P, 2010, ANN ASSOC AM GEOGR, V100, P286, DOI 10.1080/00045600903550378; HUTCHINSON J, 1992, J NATL MED ASSOC, V84, P119; Klinenberg E, 2003, NEW ENGL J MED, V348, P666, DOI 10.1056/NEJM200302133480721; Kutner NG., 2007, SOCIOLOGY KATRINA PE, P203; Kwate NOA, 2008, HEALTH PLACE, V14, P32, DOI 10.1016/j.healthplace.2007.04.001; Lee J, 2020, LANCET CHILD ADOLESC, V4, P421, DOI 10.1016/S2352-4642(20)30109-7; Lewis ML., 2019, STAY GO CHALLENGES H, V19; Lin J, 1998, RECONSTRUCTING CHINA; Lindsay BR, 2011, FEDERAL EVACUATION P, V16; Lipscomb J., 2017, MIAMI NEW TIMES; Logan JR, 2021, METROPOLITAN SEGREGA; Maslow A., 1954, MOTIVATION PERSONALI; Massey D., 1993, AM APARTHEID SEGREGA; McMillan DW, 1996, J COMMUNITY PSYCHOL, V24, P315, DOI 10.1002/(SICI)1520-6629(199610)24:4<315::AID-JCOP2>3.0.CO;2-T; MCMILLAN DW, 1986, J COMMUNITY PSYCHOL, V14, P6, DOI 10.1002/1520-6629(198601)14:1<6::AID-JCOP2290140103>3.0.CO;2-I; McRoberts Omar., 2003, STREETS GLORY CHURCH; Mitchell MN., 2020, INTERPRETING VISUALI, VSecond ed; O'Sullivan D, 2003, GEOGR ANAL, V35, P272, DOI 10.1353/geo.2003.0008; Oishi S, 2010, PERSPECT PSYCHOL SCI, V5, P5, DOI 10.1177/1745691609356781; Oppel RA., 2020, NEW YORK TIMES; Oshan TM, 2018, GEOGR ANAL, V50, P53, DOI 10.1111/gean.12133; Pew Research Center. Public Trust in Government: 1958-2019, 2019, PEW RES CTR US POL P; Ploeg MV., 2010, 8 USDA; Portes A, 2014, P NATL ACAD SCI USA, V111, P18407, DOI 10.1073/pnas.1421888112; Prassl J, 2018, HUMANS SERVICE PROMI; PUTNAM RD, 1995, J DEMOCRACY, V0006; Ray EL, 2020, MEDRXIV; Reardon SF, 2004, SOCIOL METHODOL, V34, P121, DOI 10.1111/j.0081-1750.2004.00150.x; Reardon SF, 2002, SOCIOL METHODOL, V32, P85, DOI 10.1111/1467-9531.00112; Reeves TF, 2020, BROOKINGS 0616; Reich JA, 2020, SOC SCI MED, V257, DOI 10.1016/j.socscimed.2018.10.027; Research Edison., 2018, GIG EC; Reverby SM, 2011, J POLICY HIST, V23, P6, DOI 10.1017/S0898030610000291; Romer AMP C., 2020, BROOKINGS 0226; Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199; Rothstein R, 2018, COLOR LAW FORGOTTEN, VReprint Edition; RUPASINGHA A, 2006, J SOCIOECONOMICS, V0035; Sampson R.J., 2012, GREAT AMERICAN CITY; Saunders MR, 2014, J RACIAL ETHN HEALTH, V1, P291, DOI 10.1007/s40615-014-0036-0; Stuesse A, 2016, SCRATCHING OUT LIVIN; Teruya SA, 2013, HISPANIC J BEHAV SCI, V35, P486, DOI 10.1177/0739986313499004; Thakur N, 2020, AM J RESP CRIT CARE, V202, P943, DOI 10.1164/rccm.202005-1523PP; The National Association of Counties, 2020, NAT ASS COUNT COUNT; Thompson WM, 2013, PUBLIC HEALTH NURS, V30, P221, DOI 10.1111/phn.12009; Villalonga-Olives E, 2017, SOC SCI MED, V194, P105, DOI 10.1016/j.socscimed.2017.10.020; Wingood GM, 2013, AM J PUBLIC HEALTH, V103, P2226, DOI 10.2105/AJPH.2013.301386; Woldoff RA, 2011, WHITE FLIGHTBLACK FL; Wu Jialin, 2020, Oncol Res, DOI 10.3727/096504020X16061317886881; Yang TC, 2012, HEALTH PLACE, V18, P576, DOI 10.1016/j.healthplace.2012.01.007; Yong S by E., 2020, ATLANTIC	82	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251960	10.1371/journal.pone.0251960	http://dx.doi.org/10.1371/journal.pone.0251960			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038459	Green Published, gold			2022-12-26	WOS:000664633500033
J	Papamihali, K; Collins, D; Karamouzian, M; Purssell, R; Graham, B; Buxton, J				Papamihali, Kristi; Collins, Dylan; Karamouzian, Mohammad; Purssell, Roy; Graham, Brittany; Buxton, Jane			Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services	PLOS ONE			English	Article							STREET-INVOLVED YOUTH; INJECTION-DRUG USE; NON-MSM; HEROIN; INITIATION; FENTANYL; OVERDOSE; CLIENTS; COHORT; SITES	Introduction Increased use of crystal methamphetamine ("crystal meth") has been observed across North America and international jurisdictions, including a notable increase in the presence of methamphetamines in illicit drug toxicity deaths in British Columbia (BC), Canada. We used data from a cross-sectional survey and urine toxicology screening to report the prevalence, correlates, and validity of self-reported crystal meth use among clients of harm reduction sites in BC. Materials and methods Survey data were collected from 1,107 participants across 25 communities in BC, through the 2018 and 2019 Harm Reduction Client Survey. We described reported substance use and used a multivariate logistic regression model to characterize crystal meth use. Urine samples provided by a subset of participants were used to derive validity of self-reported three-day crystal meth use compared to urine toxicology screening. Results Excluding tobacco, crystal meth was the most frequently reported substance used in the past three days in 2018 and 2019 (59.7% and 71.7%, respectively). Smoking was the dominant route of administration for crystal meth, crack, heroin, and fentanyl. Multivariate analysis determined significantly higher odds of crystal meth use among those who used opioids (Adjusted Odds Ratio [AOR] = 3.13), cannabis (AOR = 2.10), and alcohol (1.41), and among those who were not regularly housed (AOR = 2.08) and unemployed (AOR = 1.75). Age >= 50 was inversely associated with crystal meth use (AOR = 0.63). Sensitivity of self-reported crystal meth use was 86%, specificity was 86%, positive predictive value was 96%, and negative predictive value was 65%. Conclusions Crystal meth was the most commonly used substance among clients of harm reduction sites in BC in 2018 and 2019, and was frequently used concurrently with opioids. Comparison to urine samples demonstrated high validity of self-reported crystal meth use. Understanding evolving patterns of substance use will be imperative in tailoring harm reduction and substance use services for individuals that use crystal meth.	[Papamihali, Kristi; Purssell, Roy; Graham, Brittany; Buxton, Jane] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Collins, Dylan] Univ British Columbia, Fac Med, Vancouver, BC, Canada; [Karamouzian, Mohammad; Buxton, Jane] Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada; [Karamouzian, Mohammad] Kerman Univ Med Sci, HIV STI Surveillance Res Ctr, Kerman, Iran; [Karamouzian, Mohammad] Kerman Univ Med Sci, Inst Futures Studies Hlth, WHO Collaborating Ctr HIV Surveillance, Kerman, Iran; [Purssell, Roy] Univ British Columbia, Dept Emergency Med, Fac Med, Vancouver, BC, Canada; [Purssell, Roy] British Columbia Drug & Poison Informat Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; Kerman University of Medical Sciences; Kerman University of Medical Sciences; World Health Organization; University of British Columbia	Papamihali, K (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC, Canada.	Kristi.Papamihali@bccdc.ca		Papamihali, Kristi/0000-0002-6875-6811	Health Canada's Substance Use and Addictions Program (SUAP) [1819-HQ000054]; Canadian Institutes of Health Research (CIHR) [170288]; British Columbia Ministry of Health; Pierre Elliott Trudeau Foundation Doctoral Scholarship	Health Canada's Substance Use and Addictions Program (SUAP); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); British Columbia Ministry of Health; Pierre Elliott Trudeau Foundation Doctoral Scholarship	Author JAB is the principal investigator for the Harm Reduction Client Survey project funded by Health Canada's Substance Use and Addictions Program (SUAP) (Grant 1819-HQ000054), and had full access to all study data and final responsibility for the decision to submit for publication. Components of this study were funded by the Canadian Institutes of Health Research (CIHR) (Funding Reference Number 170288) and by the British Columbia Ministry of Health. Author MK is supported by the Pierre Elliott Trudeau Foundation Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 2011, INT ENCY STAT SCI, P25, DOI DOI 10.1007/978-3-642-04898-2_110; Al-Tayyib A, 2017, SUBST USE MISUSE, V52, P1051, DOI 10.1080/10826084.2016.1271432; Bach P, 2020, DRUG ALCOHOL REV, V39, P932, DOI 10.1111/dar.13126; Baldwin N, 2018, DRUG ALCOHOL DEPEN, V185, P322, DOI 10.1016/j.drugalcdep.2017.12.032; British Columbia Coroners Service, ILL DRUG TOX DEATHS; British Columbia Ministry of Health, 2019, COMM HLTH SERV AR CH; Buxton JA, 2008, CAN MED ASSOC J, V178, P1537, DOI 10.1503/cmaj.071234; Canadian Centre on Substance Use and Addiction Canadian Community Epidemiology Network on Drug Use, 2019, CHANG STIM US REL HA; Canadian Institute for Substance Use Research, 2020, VICT STREET INV AD W; Chen TZ, 2019, ADDICTION, V114, P259, DOI 10.1111/add.14451; Chen WJ, 2006, ADDICT BEHAV, V31, P2304, DOI 10.1016/j.addbeh.2006.02.015; Curran C, 2004, BRIT J PSYCHIAT, V185, P196, DOI 10.1192/bjp.185.3.196; Damon W, 2019, J PUBLIC HEALTH-UK, V41, P36, DOI 10.1093/pubmed/fdx187; Davis A, 2016, SUBSTANCE USE TRENDS; Ellis MS, 2018, DRUG ALCOHOL DEPEN, V193, P14, DOI 10.1016/j.drugalcdep.2018.08.029; Fairbairn N, 2008, PUBLIC HEALTH, V122, P70, DOI 10.1016/j.puhe.2007.02.016; Fast D, 2014, SOC SCI MED, V110, P41, DOI 10.1016/j.socscimed.2014.03.029; Glick SN, 2018, DRUG ALCOHOL DEPEN, V182, P86, DOI 10.1016/j.drugalcdep.2017.10.011; Harris JL, 2013, J URBAN HEALTH, V90, P299, DOI 10.1007/s11524-012-9720-8; Health Canada Drug Analysis Service, 2020, AN DRUG REP 2020 3 Q; Horyniak D, 2015, INT J DRUG POLICY, V26, P43, DOI 10.1016/j.drugpo.2014.09.002; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Jones CM, 2020, ADDICTION, V115, P347, DOI 10.1111/add.14812; Karamouzian M, 2020, INT J DRUG POLICY, V77, DOI 10.1016/j.drugpo.2020.102665; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Kuo M, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-13; LaRue L, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2851; Lopez A. M., 2019, COUSE METHAMPHETAMIN; Mcneil R, 2020, DRUG ALCOHOL REV, V39, P209, DOI 10.1111/dar.13049; Meacham MC, 2015, SUBST USE MISUSE, V50, P1351, DOI 10.3109/10826084.2015.1013132; Moeller KE, 2008, MAYO CLIN PROC, V83, P66, DOI 10.4065/83.1.66; Moustaqim-Barrette A, 2019, DRUG ALCOHOL DEPEN, V205, DOI 10.1016/j.drugalcdep.2019.107609; Napper LE, 2010, ADDICT BEHAV, V35, P350, DOI 10.1016/j.addbeh.2009.12.006; Nordahl TE, 2003, J NEUROPSYCH CLIN N, V15, P317, DOI 10.1176/appi.neuropsych.15.3.317; Papamihali K., 2020, HARM REDUCTION STRAT; Pauly B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229208; Rhodes T, 2006, ADDICTION, V101, P1384, DOI 10.1111/j.1360-0443.2006.01556.x; Rowe C, 2018, SUBST USE MISUSE, V53, P1742, DOI 10.1080/10826084.2018.1432649; Shreffler J, 2020, STATPEARLS; Stahlman S, 2013, SEX TRANSM DIS, V40, P632, DOI 10.1097/01.OLQ.0000430801.14841.75; Statistics Canada, 2017, POP CTR RUR AR CLASS; The R Foundation, 2021, R R PROJ STAT COMP; Uhlmann S, 2014, AM J ADDICTION, V23, P393, DOI 10.1111/j.1521-0391.2014.12123.x; United Nations Office on Drugs and Crime, 2019, WORLD DRUG REPORT 20; Werb D, 2013, CAN MED ASSOC J, V185, P1569, DOI 10.1503/cmaj.130295; Wohl AR, 2008, AIDS BEHAV, V12, P705, DOI 10.1007/s10461-007-9315-7; Wood E, 2008, DRUG ALCOHOL REV, V27, P270, DOI 10.1080/09595230801914750; Wood E, 2009, AM J ADDICTION, V18, P248, DOI 10.1080/10550490902787023; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.02.15	49	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252090	10.1371/journal.pone.0252090	http://dx.doi.org/10.1371/journal.pone.0252090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038452	gold, Green Published			2022-12-26	WOS:000664633500048
J	Rosa, LG; Zia, JS; Inan, OT; Sawicki, GS				Rosa, Luis G.; Zia, Jonathan S.; Inan, Omer T.; Sawicki, Gregory S.			Machine learning to extract muscle fascicle length changes from dynamic ultrasound images in real-time	PLOS ONE			English	Article							SOLEUS MUSCLE; FORCE; TRACKING	Background and objective Dynamic muscle fascicle length measurements through B-mode ultrasound have become popular for the non-invasive physiological insights they provide regarding musculoskeletal structure-function. However, current practices typically require time consuming post-processing to track muscle length changes from B-mode images. A real-time measurement tool would not only save processing time but would also help pave the way toward closed-loop applications based on feedback signals driven by in vivo muscle length change patterns. In this paper, we benchmark an approach that combines traditional machine learning (ML) models with B-mode ultrasound recordings to obtain muscle fascicle length changes in real-time. To gauge the utility of this framework for 'in-the-loop' applications, we evaluate accuracy of the extracted muscle length change signals against time-series' derived from a standard, post-hoc automated tracking algorithm. Methods We collected B-mode ultrasound data from the soleus muscle of six participants performing five defined ankle motion tasks: (a) seated, constrained ankle plantarflexion, (b) seated, free ankle dorsi/plantarflexion, (c) weight-bearing, calf raises (d) walking, and then a (e) mix. We trained machine learning (ML) models by pairing muscle fascicle lengths obtained from standardized automated tracking software (UltraTrack) with the respective B-mode ultrasound image input to the tracker, frame-by-frame. Then we conducted hyperparameter optimizations for five different ML models using a grid search to find the best performing parameters for a combination of high correlation and low RMSE between ML and UltraTrack processed muscle fascicle length trajectories. Finally, using the global best model/hyperparameter settings, we comprehensively evaluated training-testing outcomes within subject (i.e., train and test on same subject), cross subject (i.e., train on one subject, test on another) and within/direct cross task (i.e., train and test on same subject, but different task). Results Support vector machine (SVM) was the best performing model with an average r = 0.70 0.34 and average RMSE = 2.86 +/- 2.55 mm across all direct training conditions and average r = 0.65 +/- 0.35 and average RMSE = 3.28 +/- 2.64 mm when optimized for all cross-participant conditions. Comparisons between ML vs. UltraTrack (i.e., ground truth) tracked muscle fascicle length versus time data indicated that ML tracked images reliably capture the salient qualitative features in ground truth length change data, even when correlation values are on the lower end. Furthermore, in the direct training, calf raises condition, which is most comparable to previous studies validating automated tracking performance during isolated contractions on a dynamometer, our ML approach yielded 0.90 average correlation, in line with other accepted tracking methods in the field. Conclusions By combining B-mode ultrasound and classical ML models, we demonstrate it is possible to achieve real-time tracking of human soleus muscle fascicles across a number of functionally relevant contractile conditions. This novel sensing modality paves the way for muscle physiology in-the-loop applications that could be used to modify gait via biofeedback or unlock novel wearable device control techniques that could enable restored or augmented locomotion performance.	[Rosa, Luis G.; Sawicki, Gregory S.] Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA; [Rosa, Luis G.; Zia, Jonathan S.; Inan, Omer T.] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; [Zia, Jonathan S.] Emory Univ, Sch Med, Atlanta, GA USA; [Sawicki, Gregory S.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Emory University; University System of Georgia; Georgia Institute of Technology	Rosa, LG (corresponding author), Georgia Inst Technol, Sch Mech Engn, Atlanta, GA 30332 USA.; Rosa, LG (corresponding author), Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA.	lrosa3@gatech.edu		Rosa, Luis/0000-0002-9879-2223	National Science Foundation [1545287]; National Institute of Health, Institute of Biomedical Imaging and Bioengineering [1R01EB023808]; G.S.S.'s U.S. Army Natick Soldier Research, Development and Engineering Center Award [W911QY18C0140]; G.S.S.'s National Institute of Health's, Institute of Aging Award [R0106052017]	National Science Foundation(National Science Foundation (NSF)); National Institute of Health, Institute of Biomedical Imaging and Bioengineering; G.S.S.'s U.S. Army Natick Soldier Research, Development and Engineering Center Award; G.S.S.'s National Institute of Health's, Institute of Aging Award	This work was supported in part by L.G. R.'s National Science Foundation NRT: Accessibility, Rehabilitation, and Movement Science (ARMS): An Interdisciplinary Traineeship Program in Human-Centered Robotics Award: 1545287 (https://www.nsf.gov/awardsearch/showAward?AWD_ID= 1545287&HistoricalAwards=false), O.T.I.'s National Institute of Health, Institute of Biomedical Imaging and Bioengineering Award: 1R01EB023808 (https://grantome.com/grant/NIH/R01-EB023808-01), G.S.S.'s U.S. Army Natick Soldier Research, Development and Engineering Center Award: W911QY18C0140 (https://www.hsdl.org/?abstract&did=453253), and G.S.S.'s National Institute of Health's, Institute of Aging Award: R0106052017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkus Z, 2019, J AM COLL RADIOL, V16, P1318, DOI 10.1016/j.jacr.2019.06.004; [Anonymous], PHYS THERAPY RES PRI, V2; Beck ON, 2019, EXERC SPORT SCI REV, V47, P237, DOI 10.1249/JES.0000000000000204; Bohm S, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.2560; Brattain LJ, 2018, ABDOM RADIOL, V43, P786, DOI 10.1007/s00261-018-1517-0; Cronin N. J, 2020, FULLY AUTOMATED ANAL; Cronin NJ, 2011, J APPL PHYSIOL, V111, P1491, DOI 10.1152/japplphysiol.00530.2011; Cunningham RJ, 2017, APPL DEEP CONVOLUTIO; Cunningham R, 2018, J IMAGING, V4, DOI 10.3390/jimaging4020029; Drazan JF, 2019, PEERJ, V7, DOI 10.7717/peerj.7120; Ebrahimi A, 2020, FRONT SPORTS ACT LIV, V2, DOI 10.3389/fspor.2020.00069; Farris DJ, 2016, COMPUT METH PROG BIO, V128, P111, DOI 10.1016/j.cmpb.2016.02.016; Farris DJ, 2013, J APPL PHYSIOL, V115, P579, DOI 10.1152/japplphysiol.00253.2013; Farris DJ, 2012, J APPL PHYSIOL, V113, P1862, DOI 10.1152/japplphysiol.00802.2012; Farris DJ, 2012, P NATL ACAD SCI USA, V109, P977, DOI 10.1073/pnas.1107972109; FRIDEN J, 1992, MED SCI SPORT EXER, V24, P521; Gillett JG, 2013, COMPUT METHOD BIOMEC, V16, P678, DOI 10.1080/10255842.2011.633516; Huang QH, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5137904; Khera Preeti, 2020, Journal of Medical Engineering & Technology, V44, DOI 10.1080/03091902.2020.1822940; Kwah LK, 2013, J APPL PHYSIOL, V114, P761, DOI 10.1152/japplphysiol.01430.2011; LIEBER RL, 1993, J APPL PHYSIOL, V74, P520, DOI 10.1152/jappl.1993.74.2.520; Liu SF, 2019, ENGINEERING-PRC, V5, P261, DOI 10.1016/j.eng.2018.11.020; Matijevich ES, 2018, J BIOMECH, V72, P200, DOI 10.1016/j.jbiomech.2018.03.013; Miyoshi T, 2009, MED ENG PHYS, V31, P558, DOI 10.1016/j.medengphy.2008.11.004; Muller KR, 2008, J NEUROSCI METH, V167, P82, DOI 10.1016/j.jneumeth.2007.09.022; Nuckols RW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60360-4; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rosten E, 2006, LECT NOTES COMPUT SC, V3951, P430, DOI 10.1007/11744023_34; Sawicki GS., EXOSKELETON EXPANSIO, DOI [10.1186/s12984-020-00663-9, DOI 10.1186/S12984-020-00663-9]; Son J, 2020, CLIN BIOMECH, V75, DOI 10.1016/j.clinbiomech.2020.105007; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Thorp JE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241339; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; Van Hooren B, 2020, J APPL PHYSIOL, V128, P978, DOI 10.1152/japplphysiol.00835.2019; Wang SJ, 2012, MED IMAGE ANAL, V16, P933, DOI 10.1016/j.media.2012.02.005; Wang WJ, 2018, IOP CONF SER-MAT SCI, V324, DOI 10.1088/1757-899X/324/1/012049	37	3	3	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0246611	10.1371/journal.pone.0246611	http://dx.doi.org/10.1371/journal.pone.0246611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038426	Green Published, Green Submitted, gold			2022-12-26	WOS:000664633500004
J	Freidle, M; Johansson, H; Lebedev, AV; Ekman, U; Lovden, M; Franzen, E				Freidle, Malin; Johansson, Hanna; Lebedev, Alexander V.; Ekman, Urban; Lovden, Martin; Franzen, Erika			Measuring implicit sequence learning and dual task ability in mild to moderate Parkinson ' s disease: A feasibility study	PLOS ONE			English	Article							MONTREAL COGNITIVE ASSESSMENT; PERFORMANCE; BALANCE; GAIT	We investigated the feasibility aspects of two choice reaction time tasks designed to assess implicit sequence learning and dual task ability in individuals with mild to moderate Parkinson's disease in comparison to healthy individuals. Twelve individuals with mild to moderate Parkinson's disease and 12 healthy individuals, all >= 60 years of age, were included. A serial reaction time task was used as a measure of implicit sequence learning and a similar task but with the addition of a simple counting task, was used as a measure of dual task ability. We have present thorough descriptive statistics of the data but we have refrained from any inferential statistics due to the small sample size. All participants understood the task instructions and the difficulty level of both tasks was deemed acceptable. There were indications of task fatigue that demand careful choices for how best to analyse the data from such tasks in future trials. Ceiling effects were present in several accuracy outcomes, but not in the reaction time outcomes. Overall, we found both tasks to be feasible to use in samples of individuals with mild to moderate Parkinson's disease and healthy older individuals.	[Freidle, Malin; Johansson, Hanna; Franzen, Erika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Stockholm, Sweden; [Johansson, Hanna; Franzen, Erika] Karolinska Univ Hosp, Funct Area Occupat Therapy & Physiotherapy, Allied Hlth Profess Funct, Stockholm, Sweden; [Lebedev, Alexander V.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Ekman, Urban] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Stockholm, Sweden; [Ekman, Urban] Karolinska Univ Hosp, Med Unit Med Psychol, Allied Hlth Profess Funct, Stockholm, Sweden; [Lovden, Martin] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden; [Lovden, Martin] Gothenburg Univ, Dept Psychol, Gothenburg, Sweden; [Franzen, Erika] Stockholms Sjukhem, R&D Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Gothenburg	Freidle, M (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Stockholm, Sweden.	malin.freidle@ki.se		Ekman, Urban/0000-0003-3926-8656	Swedish Research Council [2016-01965]; Parkinson research foundation; Centre for Innovative Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinson research foundation; Centre for Innovative Medicine	E.F. Swedish Research Council, https://www.vr.se, 2016-01965 E.F. Parkinson research foundation, https://parkinsonfoundation.se, grant number not applicable/used E.F. Centre for Innovative Medicine for financial support, https://cimed.ki.se, grant number not applicable/used The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong RA, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/908306; Clark GM, 2014, NEUROPSYCHOLOGY, V28, P945, DOI 10.1037/neu0000121; Conradsson D, 2015, NEUROREHAB NEURAL RE, V29, P827, DOI 10.1177/1545968314567150; Franzen E, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1520-2; Hackney ME, 2010, NEUROREHAB NEURAL RE, V24, P97, DOI 10.1177/1545968309341061; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Pereira VAI, 2019, GAIT POSTURE, V73, P291, DOI 10.1016/j.gaitpost.2019.07.375; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Lofgren N, 2019, NEUROPSYCHOLOGY, V33, P147, DOI 10.1037/neu0000496; Luce RD, 1986, RESPONSE TIMES THEIR; Luis CA, 2009, INT J GERIATR PSYCH, V24, P197, DOI 10.1002/gps.2101; Masters RSW, 2004, REHABIL PSYCHOL, V49, P79, DOI 10.1037/0090-5550.49.1.79; Maxwell JP, 2003, CONSCIOUS COGN, V12, P376, DOI 10.1016/S1053-8100(03)00005-9; Mullen R, 2007, BRIT J PSYCHOL, V98, P141, DOI 10.1348/000712606X114336; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Olson M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00062; Raffegeau TE, 2019, PARKINSONISM RELAT D, V62, P28, DOI 10.1016/j.parkreldis.2018.12.012; Rieckmann A, 2010, NEUROIMAGE, V50, P1303, DOI 10.1016/j.neuroimage.2010.01.015; Rochester L, 2014, NEUROSCIENCE, V265, P83, DOI 10.1016/j.neuroscience.2014.01.041; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443; Vogt WP, 1993, DICT STAT METHODOLOG; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Wise S. P., 2009, ENCY NEUROSCIENCE, P1057, DOI DOI 10.1016/B978-008045046-9.00774-9	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251849	10.1371/journal.pone.0251849	http://dx.doi.org/10.1371/journal.pone.0251849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019565	Green Published, gold			2022-12-26	WOS:000664632300036
J	Guo, M; Goudarzi, KM; Abedi, S; Pieber, M; Sjoberg, E; Behnan, J; Zhang, XM; Harris, RA; Bartek, J; Lindstrom, MS; Nister, M; Hagerstrand, D				Guo, Min; Goudarzi, Kaveh M.; Abedi, Shiva; Pieber, Melanie; Sjoberg, Elin; Behnan, Jinan; Zhang, Xing-Mei; Harris, Robert A.; Bartek, Jiri; Lindstrom, Mikael S.; Nister, Monica; Hagerstrand, Daniel			SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma	ONCOGENE			English	Article							STEM-LIKE CELLS; GROWTH-FACTOR; INTRATUMORAL HETEROGENEITY; KINASE INHIBITOR; CONNECTIVITY MAP; TUMOR; EXPRESSION; EGFR; PROLIFERATION; AMPLIFICATION	Intratumoral heterogeneity is a characteristic of glioblastomas that contain an intermixture of cell populations displaying different glioblastoma subtype gene expression signatures. Proportions of these populations change during tumor evolution, but the occurrence and regulation of glioblastoma subtype transition is not well described. To identify regulators of glioblastoma subtypes we utilized a combination of in vitro experiments and in silico analyses, using experimentally generated as well as publicly available data. Through this combined approach SOX2 was identified to confer a proneural glioblastoma subtype gene expression signature. SFRP2 was subsequently identified as a SOX2-antagonist, able to induce a mesenchymal glioblastoma subtype signature. A subset of patient glioblastoma samples with high SFRP2 and low SOX2 expression was particularly enriched with mesenchymal subtype samples. Phenotypically, SFRP2 decreased tumor sphere formation, stemness as assessed by limiting dilution assay, and overall cell proliferation but increased cell motility, whereas SOX2 induced the opposite effects. Furthermore, an SFRP2/non-canonical-WNT/KLF4/PDGFR/phospho-AKT/SOX2 signaling axis was found to be involved in the mesenchymal transition. Analysis of human tumor tissue spatial gene expression patterns showed distinct expression of SFRP2- and SOX2-correlated genes in vascular and cellular areas, respectively. Finally, conditioned media from SFRP2 overexpressing cells increased CD206 on macrophages. Together, these findings present SFRP2 as a SOX2-antagonist with the capacity to induce a mesenchymal subtype transition in glioma cells located in vascular tumor areas, highlighting its role in glioblastoma tumor evolution and intratumoral heterogeneity.	[Guo, Min; Abedi, Shiva; Nister, Monica; Hagerstrand, Daniel] Karolinska Inst, Dept Oncol Pathol, BioClinicum, Solna, Sweden; [Guo, Min] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing, Peoples R China; [Goudarzi, Kaveh M.] Karolinska Inst, Dept Oncol Pathol, Sci Life Lab, Solna, Sweden; [Pieber, Melanie; Zhang, Xing-Mei; Harris, Robert A.] Karolinska Inst, Ctr Mol Med, Dept Clin Neurosci, Solna, Sweden; [Sjoberg, Elin] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Behnan, Jinan] Karolinska Inst, Dept Med Biochem & Biophys, Div Mol Neurobiol, Solna, Sweden; [Behnan, Jinan] Albert Einstein Coll Med, Dept Neurosurg, Bronx, NY 10467 USA; [Bartek, Jiri; Lindstrom, Mikael S.] Karolinska Inst, Dept Med Biochem & Biophys, Solna, Sweden; [Bartek, Jiri] Danish Canc Soc Res Ctr, Copenhagen, Denmark; [Hagerstrand, Daniel] Karolinska Inst, Dept Mol Med & Surg, BioClinicum, Solna, Sweden	Karolinska Institutet; Capital Medical University; Karolinska Institutet; Karolinska Institutet; Uppsala University; Karolinska Institutet; Yeshiva University; Albert Einstein College of Medicine; Karolinska Institutet; Danish Cancer Society; Karolinska Institutet	Guo, M (corresponding author), Karolinska Inst, Dept Oncol Pathol, BioClinicum, Solna, Sweden.; Guo, M (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing, Peoples R China.	min.guo@ki.se	Sjöberg, Elin/AFQ-2245-2022; Hägerstrand, Daniel/AAH-3009-2019; Lindström, Mikael S/AAA-1451-2019; Hägerstrand, Daniel C/D-1584-2014	Hägerstrand, Daniel/0000-0001-7270-0776; Lindström, Mikael S/0000-0003-1148-8497; Hägerstrand, Daniel C/0000-0001-7270-0776; Behnan, Jinan/0000-0001-5780-0971; Harris, Robert/0000-0003-4990-509X	Chinese Scholarship Council; Karolinska Institutet KID funding; European Commission, Research Executive Agency Marie S.Curie Individual Fellowships, H2020MSCA-IF-2018 [844948]; Swedish Cancer Society [150733, CAN 2014/836, 160334, CAN 2017/737, 180538, 2019 190316Pj]; Swedish Research Council [VR-MH 2014-46602-117891-30, K201467X-15399-10-4, VR-MH 2018-02452]; King Gustaf V's Jubilee Foundation [164102]; The Cancer Society in Stockholm [2015151213, 2018-181223]; Swedish Childhood Cancer Foundation [PR2014-0021, PR 2017-0062]; Stockholm County Council (SLL); Magnus Bergvall's stiftelse	Chinese Scholarship Council(China Scholarship Council); Karolinska Institutet KID funding(Karolinska Institutet); European Commission, Research Executive Agency Marie S.Curie Individual Fellowships, H2020MSCA-IF-2018; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V's Jubilee Foundation; The Cancer Society in Stockholm; Swedish Childhood Cancer Foundation(European Commission); Stockholm County Council (SLL)(Stockholm County Council); Magnus Bergvall's stiftelse	MG: The Chinese Scholarship Council. KMG: Karolinska Institutet KID funding. JB: European Commission, Research Executive Agency Marie S.Curie Individual Fellowships, H2020MSCA-IF-2018 (Project: 844948). JB: The Swedish Cancer Society (JB, contract 150733); The Swedish Research Council (VR-MH 2014-46602-117891-30). MSL: Karolinska Institutet Funds; King Gustaf V's Jubilee Foundation (contract 164102). MN: Karolinska Institutet Funds; LA-private donations; The Swedish Cancer Society (CAN 2014/836, contract 160334, CAN 2017/737, contract 180538, and 2019 190316Pj); The Cancer Society in Stockholm (2015151213 and 2018-181223); The Swedish Research Council (K201467X-15399-10-4, VR-MH 2018-02452); The Swedish Childhood Cancer Foundation (PR2014-0021 and PR 2017-0062); Stockholm County Council (SLL). DH: Karolinska Institutet Funds; Magnus Bergvall's stiftelse; LA-private donations.	An ZJ, 2019, CELL REP, V29, P1986, DOI 10.1016/j.celrep.2019.10.026; Baer K, 2007, EXP NEUROL, V204, P828, DOI 10.1016/j.expneurol.2006.12.008; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brinkmann EM, 2016, J BIOL CHEM, V291, P13730, DOI 10.1074/jbc.M116.733766; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; Garros-Regulez L, 2016, EXPERT OPIN THER TAR, V20, P393, DOI 10.1517/14728222.2016.1151002; Goudarzi KM, 2018, CANCER RES, V78, P5901, DOI 10.1158/0008-5472.CAN-18-0320; Guo Min, 2020, Neurooncol Adv, V2, pvdaa061, DOI 10.1093/noajnl/vdaa061; Hagerstrand D, 2006, ONCOGENE, V25, P4913, DOI 10.1038/sj.onc.1209497; Hagerstrand D, 2011, NEURO-ONCOLOGY, V13, P1178, DOI 10.1093/neuonc/nor113; Han MZ, 2020, BRAIN, V143, P512, DOI 10.1093/brain/awz406; HERMANSON M, 1992, CANCER RES, V52, P3213; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jeong CH, 2010, STEM CELLS, V28, P2141, DOI 10.1002/stem.540; Kaffes I, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655360; Kong WH, 2012, EVOL DEV, V14, P168, DOI 10.1111/j.1525-142X.2012.00533.x; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu LJ, 2017, NAT CELL BIOL, V19, P177, DOI 10.1038/ncb3474; Marques S, 2016, SCIENCE, V352, P1326, DOI 10.1126/science.aaf6463; Meyer M, 2015, P NATL ACAD SCI USA, V112, P851, DOI 10.1073/pnas.1320611111; Minata M, 2019, CELL REP, V26, P1893, DOI 10.1016/j.celrep.2019.01.076; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Puchalski RB, 2018, SCIENCE, V360, P660, DOI 10.1126/science.aaf2666; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Savary K, 2013, ONCOGENE, V32, P5409, DOI 10.1038/onc.2013.67; Segerman A, 2016, CELL REP, V17, P2994, DOI 10.1016/j.celrep.2016.11.056; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang JM, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0074-2; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wald JH, 2017, ONCOGENE, V36, P5158, DOI 10.1038/onc.2017.126; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003; Wang Z, 2019, ONCOGENE, V38, P5250, DOI 10.1038/s41388-019-0790-x; Wurth R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00144; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Zhao Z, 2021, GENOM PROTEOM BIOINF, V19, P1, DOI 10.1016/j.gpb.2020.10.005; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989	52	5	5	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 12	2021	40	32					5066	5080		10.1038/s41388-021-01825-2	http://dx.doi.org/10.1038/s41388-021-01825-2		MAY 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UA7OD	34021259	hybrid, Green Published			2022-12-26	WOS:000652945900002
J	Inoue, K; Morimoto, H; Ohgidani, M; Ueki, T				Inoue, Koichi; Morimoto, Hiroyuki; Ohgidani, Masahiro; Ueki, Takatoshi			Modulation of inflammatory responses by fractalkine signaling in microglia	PLOS ONE			English	Article							NITRIC-OXIDE; MEDIATED PHOSPHORYLATION; TRAUMATIC BRAIN; SPINAL-CORD; ACTIVATION; CX3CR1; INJURY; NEUROTOXICITY; EXPRESSION; ALPHA	Reactive microglia are suggested to be involved in neurological disorders, and the mechanisms underlying microglial activity may provide insights into therapeutic strategies for neurological diseases. Microglia produce immunological responses to various stimuli, which include fractalkine (FKN or CX3CL1). CX3CR1, a FKN receptor, is present in microglial cells, and when FKN is applied before lipopolysaccharide (LPS) administration, LPS-induced inflammatory responses are inhibited, suggesting that the activation of the FKN signal is beneficial. Considering the practical administration for treatment, we investigated the influence of FKN on immunoreactive microglia using murine primary microglia and BV-2, a microglial cell line. The administration of LPS leads to nitric oxide (NO) production. NO was reduced when FKN was administered 4 h after LPS administration without a change in inducible nitric oxide synthase expression. In contrast, morphological changes, migratory activity, and proliferation were not altered by delayed FKN treatment. LPS decreases the CX3CR1 mRNA concentration, and the overexpression of CX3CR1 restores the FKN-mediated decrease in NO. CX3CR1 overexpression decreased the NO production that is mediated by LPS even without the application of FKN. ATP and ethanol also reduced CX3CR1 mRNA concentrations. In conclusion, the delayed FKN administration modified the LPS-induced microglial activation. The FKN signals were attenuated by a reduction in CX3CR1 by some inflammatory stimuli, and this modulated the inflammatory response of microglial cells, at least partially.	[Inoue, Koichi; Morimoto, Hiroyuki; Ohgidani, Masahiro; Ueki, Takatoshi] Nagoya City Univ, Grad Sch Med Sci, Dept Integrat Anat, Nagoya, Aichi, Japan	Nagoya City University	Inoue, K; Ueki, T (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Integrat Anat, Nagoya, Aichi, Japan.	ino-k@umin.ac.jp; ueki@med.nagoya-cu.ac.jp			Salt Science Research Foundation [1721]; Nagoya City University [2013004]; KAKENHI [16H06404]	Salt Science Research Foundation; Nagoya City University; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Salt Science Research Foundation Grant 1721 (K.I.), Grant-in-Aid for Research in Nagoya City University Grant (2013004) (K.I.) and a KAKENHI Grant-in-Aid for Scientific Research on Innovative Areas "Willdynamics" (16H06404) (K.I. and T.U.)."The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Hayato, 2018, Int J Physiol Pathophysiol Pharmacol, V10, P115; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cederblad L, 2016, BIOCHEM J, V473, P641, DOI 10.1042/BJ20150520; Chen X, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01882-6; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; Dheen ST, 2005, GLIA, V50, P21, DOI 10.1002/glia.20153; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Fan Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00309; Fumagalli S, 2013, GLIA, V61, P827, DOI 10.1002/glia.22474; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Gresa-Arribas N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045227; Gunner G, 2019, NAT NEUROSCI, V22, P1075, DOI 10.1038/s41593-019-0419-y; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hao F, 2013, NEUROCHEM RES, V38, P1002, DOI 10.1007/s11064-013-1010-7; Hausel P, 2006, ONCOGENE, V25, P198, DOI 10.1038/sj.onc.1209030; Hellwig S, 2016, BRAIN BEHAV IMMUN, V55, P126, DOI 10.1016/j.bbi.2015.11.008; Ho CY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01857-7; Inoue K, 2020, NEUROREPORT, V31, P571, DOI 10.1097/WNR.0000000000001449; Inoue K, 2012, J BIOL CHEM, V287, P20839, DOI 10.1074/jbc.M111.319418; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Jones BA, 2010, MOL INTERV, V10, P263, DOI 10.1124/mi.10.5.3; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Lauro C, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00414; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee M, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e5; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Liang Y, 2018, J CANCER, V9, P3603, DOI 10.7150/jca.26497; Liu WM, 2019, ONCOL REP, V41, P1911, DOI 10.3892/or.2019.6957; Lyons A, 2009, J NEUROCHEM, V110, P1547, DOI 10.1111/j.1471-4159.2009.06253.x; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Pandur E, 2019, CELL MOL NEUROBIOL, V39, P985, DOI 10.1007/s10571-019-00694-4; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Sheridan GK, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130181; Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272; Tanaka A, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0223-y; TODA KI, 1990, CANCER RES, V50, P5526; Winkler Z, 2017, BEHAV BRAIN RES, V334, P119, DOI 10.1016/j.bbr.2017.07.023; Wynne AM, 2010, BRAIN BEHAV IMMUN, V24, P1190, DOI 10.1016/j.bbi.2010.05.011; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; Zhang SZ, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1439-x; Zhang YK, 2007, J BIOL CHEM, V282, P32453, DOI 10.1074/jbc.M706242200	46	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252118	10.1371/journal.pone.0252118	http://dx.doi.org/10.1371/journal.pone.0252118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019594	Green Published, gold			2022-12-26	WOS:000664632300054
J	Cai, CE; Gu, K; Zhao, H; Steinhagen, S; He, PM; Wichard, T				Cai, Chuner; Gu, Kai; Zhao, Hui; Steinhagen, Sophie; He, Peimin; Wichard, Thomas			Screening and verification of extranuclear genetic markers in green tide algae from the Yellow Sea	PLOS ONE			English	Article							CHLOROPLAST GENOME SEQUENCE; MITOCHONDRIAL GENOME; ULVA-PROLIFERA; MOLECULAR CHARACTERIZATION; AQUACULTURE RAFTS; CHLOROPHYTA; DIVERSITY; NUCLEAR; ORIGIN; BLOOMS	Over the past decade, Ulva compressa, a cosmopolitan green algal species, has been identified as a component of green tides in the Yellow Sea, China. In the present study, we sequenced and annotated the complete chloroplast genome of U. compressa (alpha-numeric code: RD9023) and focused on the assessment of genome length, homology, gene order and direction, intron size, selection strength, and substitution rate. We compared the chloroplast genome with the mitogenome. The generated phylogenetic tree was analyzed based on single and aligned genes in the chloroplast genome of Ulva compared to mitogenome genes to detect evolutionary trends. U. compressa and U. mutabilis chloroplast genomes had similar gene queues, with individual genes exhibiting high homology levels. Chloroplast genomes were clustered together in the entire phylogenetic tree and shared several forward/palindromic/tandem repetitions, similar to those in U. prolifera and U. linza. However, U. fasciata and U. ohnoi were more divergent, especially in sharing complementary/palindromic repetitions. In addition, phylogenetic analyses of the aligned genes from their chloroplast genomes and mitogenomes confirmed the evolutionary trends of the extranuclear genomes. From phylogenetic analysis, we identified the petA chloroplast genes as potential genetic markers that are similar to the tufA marker. Complementary/forward/palindromic interval repetitions were more abundant in chloroplast genomes than in mitogenomes. Interestingly, a few tandem repetitions were significant for some Ulva subspecies and relatively more evident in mitochondria than in chloroplasts. Finally, the tandem repetition [GAAATATATAATAATA x 3, abbreviated as TRg)] was identified in the mitogenome of U. compressa and the conspecific strain U. mutabilis but not in other algal species of the Yellow Sea. Owing to the high morphological plasticity of U. compressa, the findings of this study have implications for the rapid non-sequencing detection of this species during the occurrence of green tides in the region.	[Cai, Chuner; Gu, Kai; Zhao, Hui; He, Peimin] Shanghai Ocean Univ, Coll Marine Ecol & Environm, Shanghai, Peoples R China; [Cai, Chuner; Wichard, Thomas] Friedrich Schiller Univ Jena, Jena Sch Microbial Commun, Inst Inorgan & Analyt Chem, Jena, Germany; [Steinhagen, Sophie] Univ Gothenburg, Dept Marine Sci, Tjarno Marine Lab, Stromstad, Sweden	Shanghai Ocean University; Friedrich Schiller University of Jena; University of Gothenburg	Cai, CE (corresponding author), Shanghai Ocean Univ, Coll Marine Ecol & Environm, Shanghai, Peoples R China.; Cai, CE; Wichard, T (corresponding author), Friedrich Schiller Univ Jena, Jena Sch Microbial Commun, Inst Inorgan & Analyt Chem, Jena, Germany.	cecai@shou.edu.cn; thomas.wichard@uni-jena.de	he, peimin/ABG-4220-2021; Wichard, Thomas/C-2794-2009	Wichard, Thomas/0000-0003-0061-4160; He, Peimin/0000-0003-3704-7905	Natural Science Foundation of Shanghai [18ZR1417400]; Shanghai Port and Offshore Ecological Environment Technology Service Platform Project [19DZ2292500]; Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, S.O.A. [MATHAB201817]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) of the Friedrich Schiller University Jena [SFB 1127/2 ChemBioSys 239748522]	Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Port and Offshore Ecological Environment Technology Service Platform Project; Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, S.O.A.; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) of the Friedrich Schiller University Jena(German Research Foundation (DFG))	The project was funded by the Natural Science Foundation of Shanghai (18ZR1417400) (CC), the Shanghai Port and Offshore Ecological Environment Technology Service Platform Project (19DZ2292500) (CC), the Key Laboratory of Integrated Marine Monitoring and Applied Technologies for Harmful Algal Blooms, S.O.A. (MATHAB201817) (RJ) and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - SFB 1127/2 ChemBioSys 239748522 of the Friedrich Schiller University Jena (TW). The funders had no involvement in the study design, data collection/analysis, or manuscript preparation or publication.	Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bock R, 2008, BIOESSAYS, V30, P556, DOI 10.1002/bies.20761; Cai CE, 2018, GENETICA, V146, P529, DOI 10.1007/s10709-018-0046-7; Cai CN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184196; Chiappetta A, 2017, SCI HORTIC-AMSTERDAM, V226, P42, DOI 10.1016/j.scienta.2017.08.022; Choi KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138727; Chung DY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123800; Coat G, 1998, EUR J PHYCOL, V33, P81, DOI 10.1017/S0967026297001455; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; Cui JJ, 2018, PHYCOLOGIA, V57, P692, DOI 10.2216/17-139.1; Cui JJ, 2015, MAR POLLUT BULL, V101, P660, DOI 10.1016/j.marpolbul.2015.10.033; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; De Clerck O, 2018, CURR BIOL, V28, P2921, DOI 10.1016/j.cub.2018.08.015; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Duminil J, 2014, METHODS MOL BIOL, V1115, P121, DOI 10.1007/978-1-62703-767-9_6; EATON J. W., 1966, BRIT PHYCOL BULL, V3, P53; El Zerey-Belaskri A, 2018, SCI HORTIC-AMSTERDAM, V227, P278, DOI 10.1016/j.scienta.2017.09.016; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fucikova K, 2014, GENOME BIOL EVOL, V6, P2170, DOI 10.1093/gbe/evu172; Gray MW, 2001, GENOME BIOL, V2; Han W, 2013, HARMFUL ALGAE, V28, P46, DOI 10.1016/j.hal.2013.05.018; Hauska G, 2004, PHOTOSYNTH RES, V80, P277, DOI 10.1023/B:PRES.0000030425.69092.4f; Hayden HS, 2002, J PHYCOL, V38, P1200, DOI 10.1046/j.1529-8817.2002.01167.x; He Peimin., 2019, GREEN TIDE CHINA; Hughey JR, 2019, J PHYCOL, V55, P503, DOI 10.1111/jpy.12860; Huo YZ, 2015, MAR POLLUT BULL, V93, P210, DOI 10.1016/j.marpolbul.2015.01.014; Huo YZ, 2014, HARMFUL ALGAE, V39, P357, DOI 10.1016/j.hal.2014.09.008; Huo YZ, 2013, LIMNOL OCEANOGR, V58, P2206, DOI 10.4319/lo.2013.58.6.2206; Jiang GF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31473; Kazi MA, 2016, PHYCOLOGIA, V55, P45, DOI 10.2216/15-11.1; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kuang DY, 2011, GENOME, V54, P663, DOI [10.1139/G11-026, 10.1139/g11-026]; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee HW, 2019, ALGAE-SEOUL, V34, P253, DOI 10.4490/algae.2019.34.12.9; Lei WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21669; Leliaert F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25367; Leliaert F, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1418-3; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Lemieux C, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0544-5; Lemieux C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0211-2; Li Y, 2014, HARMFUL ALGAE, V39, P40, DOI 10.1016/j.hal.2014.05.013; Liu C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-715; Liu DY, 2010, MAR POLLUT BULL, V60, P1423, DOI 10.1016/j.marpolbul.2010.05.015; Liu F, 2017, J APPL PHYCOL, V29, P3261, DOI 10.1007/s10811-017-1143-1; Liu F, 2015, CURR GENET, V61, P621, DOI 10.1007/s00294-015-0488-8; Liu F, 2013, MAR ENVIRON RES, V83, P38, DOI 10.1016/j.marenvres.2012.10.007; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lu F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014663; Malta EJ, 1999, EUR J PHYCOL, V34, P443, DOI 10.1080/09541449910001718801; Marin B, 2012, PROTIST, V163, P778, DOI 10.1016/j.protis.2011.11.004; McFadden GI, 2001, PLANT PHYSIOL, V125, P50, DOI 10.1104/pp.125.1.50; Melton JT, 2017, MITOCHONDRIAL DNA A, V28, P93, DOI 10.3109/19401736.2015.1110814; Melton JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121020; Mitsuhashi C, 2020, GENES GENET SYST, V95, P55, DOI 10.1266/ggs.19-00054; Mualler-Stoll, 1952, REGENERATION POLRITA, V139, P148; Nazareno AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129930; NEI M, 1986, MOL BIOL EVOL, V3, P418; OTT FRANKLYN D., 1965, VIRGINIA J SCI, V16, P205; Pan LM, 2017, SCI HORTIC-AMSTERDAM, V225, P171, DOI 10.1016/j.scienta.2017.06.053; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Raman G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141329; Ramanathan KR, 1939, ANN BOT-LONDON, V3, P375; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Salinas E, 2012, MOL PHYLOGENET EVOL, V64, P166, DOI 10.1016/j.ympev.2012.03.014; Rybak A, 2014, EUR J PHYCOL, V49, P471, DOI 10.1080/09670262.2014.976662; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Shi C, 2016, SCI REP-UK, V6, DOI 10.1038/srep30135; Shih PM, 2013, P NATL ACAD SCI USA, V110, P12355, DOI 10.1073/pnas.1305813110; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Song W, 2019, AQUAT BOT, V156, P38, DOI 10.1016/j.aquabot.2019.04.004; Steinhagen S, 2019, J PHYCOL, V55, P25, DOI 10.1111/jpy.12804; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612; Sun LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20528; Sun S., 2008, NATURE PRECEDINGS, DOI 10101/npre.2008.2266.1; Tang Q, 2020, NAT ECOL EVOL, V4, P543, DOI 10.1038/s41559-020-1122-9; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Turmel M, 2008, J PHYCOL, V44, P739, DOI 10.1111/j.1529-8817.2008.00510.x; Turmel M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148934; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang JF, 2010, AQUAT BOT, V93, P25, DOI 10.1016/j.aquabot.2010.03.001; Wang LK, 2017, CONSERV GENET RESOUR, V9, P463, DOI 10.1007/s12686-016-0682-0; Wheeler GL, 2008, GENETICS, V179, P193, DOI 10.1534/genetics.107.085936; Wichard T, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00072; WILLEY DL, 1988, PHOTOSYNTH RES, V17, P125, DOI 10.1007/BF00047685; Williams AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125768; Wu ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143792; Xiao J, 2013, HARMFUL ALGAE, V27, P130, DOI 10.1016/j.hal.2013.05.003; Xue JH, 2012, AM J BOT, V99, pE240, DOI 10.3732/ajb.1100547; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Yao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep28559; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8; Zhang JH, 2016, MAR POLLUT BULL, V104, P101, DOI 10.1016/j.marpolbul.2016.01.056; Zhang JH, 2015, ESTUAR COAST SHELF S, V164, P418, DOI 10.1016/j.ecss.2015.08.007; Zhang QC, 2015, ESTUAR COAST SHELF S, V163, P103, DOI 10.1016/j.ecss.2014.09.004; Zhang YY, 2019, NATL SCI REV, V6, P825, DOI 10.1093/nsr/nwz026; Zhao J, 2013, CHINESE SCI BULL, V58, P2298, DOI 10.1007/s11434-012-5441-3; Zheng WW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071084; Zheng XM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01518-5; Zimorski V, 2014, CURR OPIN MICROBIOL, V22, P38, DOI 10.1016/j.mib.2014.09.008	102	4	4	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0250968	10.1371/journal.pone.0250968	http://dx.doi.org/10.1371/journal.pone.0250968			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061855	gold, Green Published			2022-12-26	WOS:000656813600038
J	Inomata, Y; Abe, T; Tsuda, M; Takeda, S; Hirota, K				Inomata, Yuriko; Abe, Takuya; Tsuda, Masataka; Takeda, Shunichi; Hirota, Kouji			Division of labor of Y-family polymerases in translesion-DNA synthesis for distinct types of DNA damage	PLOS ONE			English	Article							ESCHERICHIA-COLI; MULTIPLE ROLES; IOTA; REPLICATION; KAPPA; REPAIR; ETA; FIDELITY; CELLS; DELTA	Living organisms are continuously under threat from a vast array of DNA-damaging agents, which impact genome DNA. DNA replication machinery stalls at damaged template DNA. The stalled replication fork is restarted via bypass replication by translesion DNA-synthesis polymerases, including the Y-family polymerases Pol eta, Pol iota, and Pol kappa, which possess the ability to incorporate nucleotides opposite the damaged template. To investigate the division of labor among these polymerases in vivo, we generated POL eta(-/-), POL iota(-/-), POL kappa(-/-), double knockout (KO), and triple knockout (TKO) mutants in all combinations from human TK6 cells. TKO cells exhibited a hypersensitivity to ultraviolet (UV), cisplatin (CDDP), and methyl methanesulfonate (MMS), confirming the pivotal role played by these polymerases in bypass replication of damaged template DNA. POL eta(-/-) cells, but not POL iota(-/-) or POL kappa(-/-) cells, showed a strong sensitivity to UV and CDDP, while TKO cells showed a slightly higher sensitivity to UV and CDDP than did POL eta(-/-) cells. On the other hand, TKO cells, but not all single KO cells, exhibited a significantly higher sensitivity to MMS than did wild-type cells. Consistently, DNA-fiber assay revealed that Pol eta plays a crucial role in bypassing lesions caused by UV-mimetic agent 4-nitroquinoline-1-oxide and CDDP, while all three polymerases play complementary roles in bypassing MMS-induced damage. Our findings indicate that the three Y-family polymerases play distinctly different roles in bypass replication, according to the type of DNA damage generated on the template strand.	[Inomata, Yuriko; Abe, Takuya; Hirota, Kouji] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Hachioji, Tokyo, Japan; [Tsuda, Masataka; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Kyoto, Japan; [Tsuda, Masataka] Hiroshima Univ, Grad Sch Integrated Sci Life, Program Math & Life Sci, Higashihiroshima, Japan	Tokyo Metropolitan University; Kyoto University; Hiroshima University	Hirota, K (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Hachioji, Tokyo, Japan.	khirota@tmu.ac.jp		Tsuda, Masataka/0000-0002-1267-3777; Hirota, Kouji/0000-0003-1676-979X	JSPS KAKENHI [JP20H04337, JP19KK0210, JP16H06306]; Networktype Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Nagasaki University; Fukushima Medical University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Networktype Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Nagasaki University; Fukushima Medical University	This work was supported by JSPS KAKENHI (JP20H04337, JP19KK0210, and JP16H06306 to KH, and JP16H06306 to ST). This work was also partly supported by the Networktype Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University, Nagasaki University, and Fukushima Medical University (to KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120614; Akagi J, 2018, DNA REPAIR, V61, P76, DOI 10.1016/j.dnarep.2017.11.006; Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Branzei D, 2017, CRIT REV BIOCHEM MOL, V52, P381, DOI 10.1080/10409238.2017.1304355; Branzei D, 2016, DNA REPAIR, V44, P68, DOI 10.1016/j.dnarep.2016.05.008; Branzei D, 2016, CURR OPIN CELL BIOL, V40, P137, DOI 10.1016/j.ceb.2016.03.015; Capoulade C, 1998, ONCOGENE, V16, P1603, DOI 10.1038/sj.onc.1201702; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Duxin JP, 2015, CURR OPIN CELL BIOL, V37, P49, DOI 10.1016/j.ceb.2015.09.002; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Federico MB, 2020, ONCOGENE, V39, P3952, DOI 10.1038/s41388-020-1265-9; Fijalkowska IJ, 2012, FEMS MICROBIOL REV, V36, P1105, DOI 10.1111/j.1574-6976.2012.00338.x; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Fuchs RP, 2007, DNA REPAIR, V6, P1032, DOI 10.1016/j.dnarep.2007.02.021; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Gueranger Q, 2008, DNA REPAIR, V7, P1551, DOI 10.1016/j.dnarep.2008.05.012; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hamppa S, 2016, P NATL ACAD SCI USA, V113, pE4311, DOI 10.1073/pnas.1605828113; Hirota K, 2016, NUCLEIC ACIDS RES, V44, P7242, DOI 10.1093/nar/gkw439; Hirota K, 2015, NUCLEIC ACIDS RES, V43, P1671, DOI 10.1093/nar/gkv023; Hirota K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001151; Honma M, 2005, ENVIRON MOL MUTAGEN, V45, P162, DOI 10.1002/em.20113; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jansen JG, 2014, NUCLEIC ACIDS RES, V42, P11071, DOI 10.1093/nar/gku779; Ji K, 2009, ENVIRON HEALTH PERSP, V117, P1737, DOI 10.1289/ehp.0900842; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kanao R, 2015, DNA REPAIR, V29, P139, DOI 10.1016/j.dnarep.2015.02.006; Kannouche P, 2003, EMBO J, V22, P1223, DOI 10.1093/emboj/7595006; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2003, DNA REPAIR, V2, P135, DOI 10.1016/S1568-7864(02)00224-0; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; LEVY JA, 1968, CANCER-AM CANCER SOC, V22, P517, DOI 10.1002/1097-0142(196809)22:3<517::AID-CNCR2820220305>3.0.CO;2-A; Maede Y, 2014, MOL CANCER THER, V13, P214, DOI 10.1158/1535-7163.MCT-13-0551; Makarova AV, 2015, DNA REPAIR, V29, P47, DOI 10.1016/j.dnarep.2015.02.012; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Masumura K, 2017, ENVIRON MOL MUTAGEN, V58, P644, DOI 10.1002/em.22146; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McDonald JP, 2003, J EXP MED, V198, P635, DOI 10.1084/jem.20030767; Mohiuddin M, 2018, P NATL ACAD SCI USA, V115, P12793, DOI 10.1073/pnas.1716349115; Nakazato A, 2018, DNA REPAIR, V68, P50, DOI 10.1016/j.dnarep.2018.06.003; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Okada T, 2005, MOL CELL BIOL, V25, P6103, DOI 10.1128/MCB.25.14.6103-6111.2005; Prado F, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120603; Prindle MJ, 2012, ENVIRON MOL MUTAGEN, V53, P666, DOI 10.1002/em.21745; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Tissier A, 2000, GENE DEV, V14, P1642; Tonzi P, 2019, DNA REPAIR, V78, P20, DOI 10.1016/j.dnarep.2019.03.016; Tsuda M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188320; Tsuda M, 2017, ONCOTARGET, V8, P33457, DOI 10.18632/oncotarget.16508; Vaisman A, 2017, CRIT REV BIOCHEM MOL, V52, P274, DOI 10.1080/10409238.2017.1291576; Wang HB, 2010, NEURO-ONCOLOGY, V12, P679, DOI 10.1093/neuonc/nop074; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yang W, 2018, ANNU REV BIOCHEM, V87, P239, DOI 10.1146/annurev-biochem-062917-012405; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000; Ziv O, 2009, P NATL ACAD SCI USA, V106, P11552, DOI 10.1073/pnas.0812548106	63	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252587	10.1371/journal.pone.0252587	http://dx.doi.org/10.1371/journal.pone.0252587			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061890	Green Published, gold			2022-12-26	WOS:000656813600015
J	Guo, WT; Wei, JH; Estillore, JP; Zhang, L; Wang, RW; Sun, B; Chen, SRW				Guo, Wenting; Wei, Jinhong; Estillore, John Paul; Zhang, Lin; Wang, Ruiwu; Sun, Bo; Chen, S. R. Wayne			RyR2 disease mutations at the C-terminal domain intersubunit interface alter closed-state stability and channel activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC RYANODINE RECEPTOR; POLYMORPHIC VENTRICULAR-TACHYCARDIA; SUDDEN UNEXPLAINED DEATH; INDUCED CA2+ RELEASE; EXON 3 DELETION; SARCOPLASMIC-RETICULUM; MOLECULAR-BASIS; COMMON DEFECT; MUSCLE; THRESHOLD	Ryanodine receptors (RyRs) are ion channels that mediate the release of Ca2+ from the sarcoplasmic reticulum/endoplasmic reticulum, mutations of which are implicated in a number of human diseases. The adjacent C-terminal domains (CTDs) of cardiac RyR (RyR2) interact with each other to form a ring-like tetrameric structure with the intersubunit interface undergoing dynamic changes during channel gating. This mobile CTD intersubunit interface harbors many disease-associated mutations. However, the mechanisms of action of these mutations and the role of CTD in channel function are not well understood. Here, we assessed the impact of CTD disease-associated mutations P4902S, P4902L, E4950K, and G4955E on Ca2+- and caffeine-mediated activation of RyR2. The G4955E mutation dramatically increased both the Ca2+-independent basal activity and Ca2+-dependent activation of [H-3]ryanodine binding to RyR2. The P4902S and E4950K mutations also increased Ca2+ activation but had no effect on the basal activity of RyR2. All four disease mutations increased caffeine-mediated activation of RyR2 and reduced the threshold for activation and termination of spontaneous Ca2+ release. G4955D dramatically increased the basal activity of RyR2, whereas G4955K mutation markedly suppressed channel activity. Similarly, substitution of P4902 with a negatively charged residue (P4902D), but not a positively charged residue (P4902K), also dramatically increased the basal activity of RyR2. These data suggest that electrostatic interactions are involved in stabilizing the CTD intersubunit interface and that the G4955E disease mutation disrupts this interface, and thus the stability of the closed state. Our studies shed new insights into the mechanisms of action of RyR2 CTD disease mutations.	[Guo, Wenting; Wei, Jinhong; Estillore, John Paul; Zhang, Lin; Wang, Ruiwu; Sun, Bo; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Sun, Bo] Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China	Libin Cardiovascular Institute Of Alberta; University of Calgary; Kunming University of Science & Technology	Sun, B; Chen, SRW (corresponding author), Univ Calgary, Libin Cardiovasc Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Sun, B (corresponding author), Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China.	sunbo1025@hotmail.com; swchen@ucalgary.ca	Wei, Jinhong/GWV-0561-2022	Wei, Jinhong/0000-0002-5251-9192	Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada; Heart and Stroke Foundation Chair in Cardiovascular Research	Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of CanadaCanadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation Chair in Cardiovascular Research	This work was supported by research grants from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, and Heart and Stroke Foundation Chair in Cardiovascular Research (to S. R. W. C.).	Aiba I, 2016, P NATL ACAD SCI USA, V113, pE4895, DOI 10.1073/pnas.1605216113; Alkon DL, 1998, TRENDS NEUROSCI, V21, P529, DOI 10.1016/S0166-2236(98)01277-6; Alvarado FJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126544; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bhuiyan ZA, 2007, CIRCULATION, V116, P1569, DOI 10.1161/CIRCULATIONAHA.107.711606; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Campbell MJ, 2015, AM J MED GENET A, V167, P2197, DOI 10.1002/ajmg.a.37140; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chi XM, 2019, P NATL ACAD SCI USA, V116, P25575, DOI 10.1073/pnas.1914451116; d'Amati G, 2005, HUM PATHOL, V36, P761, DOI 10.1016/j.humpath.2005.04.019; Denniss A, 2018, INT J BIOCHEM CELL B, V101, P49, DOI 10.1016/j.biocel.2018.05.004; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Dharmawan T, 2019, ANN NONINVAS ELECTRO, V24, DOI 10.1111/anec.12623; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fokstuen S, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0080-4; Fujii Y, 2017, HEART RHYTHM, V14, P98, DOI 10.1016/j.hrthm.2016.10.015; Fujino N, 2006, CIRCULATION, V114, P165; FURUICHI T, 1994, J NEUROSCI, V14, P4794; GIANNINI G, 1995, MED RES REV, V15, P313, DOI 10.1002/med.2610150405; Gong DS, 2019, NATURE, V572, P347, DOI 10.1038/s41586-019-1377-y; Guo WT, 2020, J BIOL CHEM, V295, P15622, DOI 10.1074/jbc.RA120.013512; Guo WT, 2016, J BIOL CHEM, V291, P2150, DOI 10.1074/jbc.M115.693325; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hata Y, 2016, HEART RHYTHM, V13, P1544, DOI 10.1016/j.hrthm.2016.03.038; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INUI M, 1987, J BIOL CHEM, V262, P15637; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kawamura M, 2013, CIRC J, V77, P1705, DOI 10.1253/circj.CJ-12-1460; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; Kohli U, 2019, PACE, V42, P1146, DOI 10.1111/pace.13668; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laitinen PJ, 2003, EUR J HUM GENET, V11, P888, DOI 10.1038/sj.ejhg.5201061; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Lieve KV, 2016, CIRC J, V80, P1285, DOI 10.1253/circj.CJ-16-0326; Lieve KVV, 2019, HEART RHYTHM, V16, P220, DOI 10.1016/j.hrthm.2018.08.025; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; Mandikian D, 2014, J COMP NEUROL, V522, P3555, DOI 10.1002/cne.23641; Marjamaa A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-12; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Murayama T, 1996, J BIOL CHEM, V271, P5079; Napolitano C, 2007, HEART RHYTHM, V4, P675, DOI 10.1016/j.hrthm.2006.12.048; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nishio H, 2006, CIRC J, V70, P1402, DOI 10.1253/circj.70.1402; Ohno S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131517; Ohno S, 2014, EUROPACE, V16, P1646, DOI 10.1093/europace/eut382; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Postma AV, 2005, J MED GENET, V42, P863, DOI 10.1136/jmg.2004.028993; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Roston TM, 2017, J ELECTROCARDIOL, V50, P227, DOI 10.1016/j.jelectrocard.2016.09.006; ROUSSEAU E, 1989, AM J PHYSIOL, V256, pH328, DOI 10.1152/ajpheart.1989.256.2.H328; Sun B, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aba7287; Szentpali Z, 2013, CIRCULATION, V127, P1165, DOI 10.1161/CIRCULATIONAHA.112.144949; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Thomas LN, 2004, CARDIOVASC RES, V64, P52, DOI 10.1016/j.cardiores.2004.06.009; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van der Werf C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P748, DOI 10.1161/CIRCEP.112.970517; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Ware JS, 2013, J CARDIOVASC TRANSL, V6, P94, DOI 10.1007/s12265-012-9401-8; Xiao ZC, 2016, J BIOL CHEM, V291, P24528, DOI 10.1074/jbc.M116.756528; Yao JJ, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108169; Yap SM, 2019, SEIZURE-EUR J EPILEP, V67, P11, DOI 10.1016/j.seizure.2019.02.017	79	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100808	10.1016/j.jbc.2021.100808	http://dx.doi.org/10.1016/j.jbc.2021.100808			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34022226	gold, Green Published			2022-12-26	WOS:000678068400012
J	Meng, ZY; Xu, R; Xie, LX; Wu, YT; He, Q; Gao, P; He, XH; Chen, Q; Xie, Q; Zhang, JQ; Yang, QW				Meng, Zhaoyou; Xu, Rui; Xie, Lexing; Wu, Yutong; He, Qian; Gao, Pan; He, Xiaohui; Chen, Qiong; Xie, Qi; Zhang, Jiqiang; Yang, Qingwu			A20/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48-and K63-linked polyubiquitination of effectors MyD88 and TBK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; QUANTITATIVE PROTEOMICS REVEALS; NEGATIVE REGULATION; A20; UBIQUITINATION; DEGRADATION; TNFAIP3; INJURY; GENE; INHIBITION	A20 is a potent anti-inflammatory protein that mediates both inflammation and ubiquitination in mammals, but the related mechanisms are not clear. In this study, we performed mass spectrometry (MS) screening, gene ontology (GO) analysis, and coimmunoprecipitation (co-IP) in a lipopolysaccharide (LPS)-induced inflammatory cell model to identify novel A20-interacting proteins. We confirmed that the E3 ubiquitin ligase Nrdp1, also known as ring finger protein 41 (RNF41), interacted with A20 in LPS-stimulated cells. Further co-IP analysis demonstrated that when A20 was knocked out, degradation-inducing K48-linked ubiquitination of inflammatory effector MyD88 was decreased, but protein interaction-mediating K63-linked ubiquitination of another inflammatory effector TBK1 was increased. Moreover, western blot experiments showed that A20 inhibition induced an increase in levels of MyD88 and phosphorylation of downstream effector proteins as well as of TBK1 and a downstream effector, while Nrdp1 inhibition induced an increase in MyD88 but a decrease in TBK1 levels. When A20 and Nrdp1 were coinhibited, no further change in MyD88 was observed, but TBK1 levels were significantly decreased compared with those upon A20 inhibition alone. Gain- and loss-of-function analyses revealed that the ZnF4 domain of A20 is required for Nrdp1 polyubiquitination. Upon LPS stimulation, the inhibition of Nrdp1 alone increased the secretion of IL-6 and TNF-alpha but decreased IFN-beta secretion, as observed in other studies, suggesting that Nrdp1 preferentially promotes the production of IFN-beta. Taken together, these results demonstrated that A20/Nrdp1 interaction is important for A20 anti-inflammation, thus revealing a novel mechanism for the anti-inflammatory effects of A20.	[Meng, Zhaoyou; Xu, Rui; Xie, Lexing; Wu, Yutong; He, Qian; Gao, Pan; He, Xiaohui; Chen, Qiong; Xie, Qi; Yang, Qingwu] Army Med Univ, Xinqiao Hosp, Dept Neurol, Mil Med Univ 3, Chongqing, Peoples R China; [Meng, Zhaoyou; Zhang, Jiqiang] Army Med Univ, Dept Neurobiol, Mil Med Univ 3, Chongqing, Peoples R China	Army Medical University; Army Medical University	Xie, Q; Yang, QW (corresponding author), Army Med Univ, Xinqiao Hosp, Dept Neurol, Mil Med Univ 3, Chongqing, Peoples R China.; Zhang, JQ (corresponding author), Army Med Univ, Dept Neurobiol, Mil Med Univ 3, Chongqing, Peoples R China.	xieqi.tmmu@gmail.com; zhangjiqiang@tmmu.edu.cn; yangqwmlys@163.com			National Natural Science Foundation of China [81701548]; China Postdoctoral Science Foundation [2019M653976]; Chongqing Natural Science Foundation [cstc2019jcyj-msxmX0255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This study was supported by the National Natural Science Foundation of China (81701548), China Postdoctoral Science Foundation Grant (2019M653976), and Chongqing Natural Science Foundation (cstc2019jcyj-msxmX0255).	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chi H, 2018, NAT BIOTECHNOL, V36, P1059, DOI 10.1038/nbt.4236; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Hamerman JA, 2016, IMMUNOL REV, V269, P212, DOI 10.1111/imr.12381; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Kanayama M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6779; Kinsella S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1143-3; Lassot I, 2018, CELL REP, V25, P2484, DOI 10.1016/j.celrep.2018.11.002; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li ZP, 2019, BRAIN BEHAV IMMUN, V79, P228, DOI 10.1016/j.bbi.2019.02.005; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Martens A, 2020, NAT IMMUNOL, V21, P381, DOI 10.1038/s41590-020-0621-9; Martens A, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036418; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Meng ZY, 2017, J IMMUNOL, V198, P820, DOI 10.4049/jimmunol.1600334; Moll HP, 2014, J BIOL CHEM, V289, P30912, DOI 10.1074/jbc.M114.591966; Nakamura BN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195893; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Ping LY, 2013, J PROTEOME RES, V12, P5978, DOI 10.1021/pr400775w; Priem D, 2020, TRENDS IMMUNOL, V41, P421, DOI 10.1016/j.it.2020.03.001; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Song GH, 2016, NAT IMMUNOL, V17, P1342, DOI 10.1038/ni.3588; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vetters J, 2019, J EXP MED, V216, P2010, DOI 10.1084/jem.20182164; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Xie Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep41089; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Xu P, 2012, J PROTEOME RES, V11, P4403, DOI 10.1021/pr300613c; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052; Zhong L, 2005, J BIOL CHEM, V280, P9425, DOI 10.1074/jbc.M408955200; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	52	1	1	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100811	10.1016/j.jbc.2021.100811	http://dx.doi.org/10.1016/j.jbc.2021.100811			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023381	gold, Green Published			2022-12-26	WOS:000678068400014
J	Rao, Y; Gammon, ST; Sutton, MN; Zacharias, NM; Bhattacharya, P; Piwnica-Worms, D				Rao, Yi; Gammon, Seth T.; Sutton, Margie N.; Zacharias, Niki M.; Bhattacharya, Pratip; Piwnica-Worms, David			Excess exogenous pyruvate inhibits lactate dehydrogenase activity in live cells in an MCT1-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCARBOXYLATE TRANSPORTERS; BRAIN METABOLISM; METABOLOMICS; SUBSTRATE	Cellular pyruvate is an essential metabolite at the crossroads of glycolysis and oxidative phosphorylation, capable of supporting fermentative glycolysis by reduction to lactate mediated by lactate dehydrogenase (LDH) among other functions. Several inherited diseases of mitochondrial metabolism impact extracellular (plasma) pyruvate concentrations, and [1-C-13]pyruvate infusion is used in isotope-labeled metabolic tracing studies, including hyperpolarized magnetic resonance spectroscopic imaging. However, how these extracellular pyruvate sources impact intracellular metabolism is not clear. Herein, we examined the effects of excess exogenous pyruvate on intracellular LDH activity, extracellular acidification rates (ECARs) as a measure of lactate production, and hyperpolarized [1-C-13]pyruvate-to-[1-C-13]lactate conversion rates across a panel of tumor and normal cells. Combined LDH activity and LDHB/LDHA expression analysis intimated various heterotetrameric isoforms comprising LDHA and LDHB in tumor cells, not only canonical LDHA. Millimolar concentrations of exogenous pyruvate induced substrate inhibition of LDH activity in both enzymatic assays ex vivo and in live cells, abrogated glycolytic ECAR, and inhibited hyperpolarized [1-C-13]pyruvate-to-[1-C-13]lactate conversion rates in cellulo. Of importance, the extent of exogenous pyruvate-induced inhibition of LDH and glycolytic ECAR in live cells was highly dependent on pyruvate influx, functionally mediated by monocarboxylate transporter-1 localized to the plasma membrane. These data provided evidence that highly concentrated bolus injections of pyruvate in vivo may transiently inhibit LDH activity in a tissue type- and monocarboxylate transporter-1-dependent manner. Maintaining plasma pyruvate at submillimolar concentrations could potentially minimize transient metabolic perturbations, improve pyruvate therapy, and enhance quantification of metabolic studies, including hyperpolarized [1-C-13]pyruvate magnetic resonance spectroscopic imaging and stable isotope tracer experiments.	[Rao, Yi; Gammon, Seth T.; Sutton, Margie N.; Bhattacharya, Pratip; Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Zacharias, Niki M.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Piwnica-Worms, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA.	dpiwnica-worms@mdanderson.org		Piwnica-Worms, David/0000-0002-2120-7217	National Institutes of Health [P50 CA94056]; Gerald Dewey Dodd, Jr, Endowed Distinguished Chair of the University of Texas MD Anderson Cancer Center, a faculty UT STARs Award; University of Texas MD Anderson Cancer Center Independent Research Grant (MDACC IRG); Erickson Kidney Cancer Research Foundation; NCI Cancer Center Support Grant [P30 CA016672, P50 CA221707, U01 CA214263]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerald Dewey Dodd, Jr, Endowed Distinguished Chair of the University of Texas MD Anderson Cancer Center, a faculty UT STARs Award; University of Texas MD Anderson Cancer Center Independent Research Grant (MDACC IRG); Erickson Kidney Cancer Research Foundation; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Institutes of Health grant P50 CA94056 to the MD Anderson Cancer Center-Washington University Inter-Institutional Molecular Imaging Center, the Gerald Dewey Dodd, Jr, Endowed Distinguished Chair of the University of Texas MD Anderson Cancer Center, a faculty UT STARs Award, a University of Texas MD Anderson Cancer Center Independent Research Grant (MDACC IRG), and the Erickson Kidney Cancer Research Foundation. We would like to thank the Biostatistics Resource and the Small Animal Imaging Facility (SAIF) of MDACC for animal imaging assistance, especially Charles Kingsley, which obtain support from an NCI Cancer Center Support Grant (P30 CA016672). Financial support was also obtained from P50 CA221707 and U01 CA214263. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bhattacharya P, 2009, EXP BIOL MED, V234, P1395, DOI 10.3181/0904-MR-135; Brindle KM, 2011, MAGN RESON MED, V66, P505, DOI 10.1002/mrm.22999; Chokkathukalam A, 2014, BIOANALYSIS, V6, P511, DOI 10.4155/bio.13.348; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dutta P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040340; Feng YB, 2018, CANCER MED-US, V7, P6124, DOI 10.1002/cam4.1820; Fernandez-Garcia J, 2020, TRENDS BIOCHEM SCI, V45, P185, DOI 10.1016/j.tibs.2019.12.002; Fujii T, 2014, MOL GENET METAB, V112, P133, DOI 10.1016/j.ymgme.2014.04.008; Gammon ST, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121487; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Guglielmetti C, 2017, P NATL ACAD SCI USA, V114, pE6982, DOI 10.1073/pnas.1613345114; GUTFREUND H, 1968, BIOCHEM J, V106, P683, DOI 10.1042/bj1060683; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jin L, 2017, ONCOGENE, V36, P3797, DOI 10.1038/onc.2017.6; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kurhanewicz J, 2019, NEOPLASIA, V21, P1, DOI 10.1016/j.neo.2018.09.006; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Marsac C, 1997, HUM GENET, V99, P785, DOI 10.1007/s004390050449; Miloushev VZ, 2018, CANCER RES, V78, P3755, DOI 10.1158/0008-5472.CAN-18-0221; Miloushev VZ, 2017, J MAGN RESON, V275, P120, DOI 10.1016/j.jmr.2016.12.009; Moreno KX, 2010, AM J PHYSIOL-HEART C, V298, pH1556, DOI 10.1152/ajpheart.00656.2009; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Park I, 2018, MAGN RESON MED, V80, P864, DOI 10.1002/mrm.27077; Perez-Escuredo J, 2016, BBA-MOL CELL RES, V1863, P2481, DOI 10.1016/j.bbamcr.2016.03.013; Rao Y, 2020, P NATL ACAD SCI USA, V117, P22378, DOI 10.1073/pnas.2003537117; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; Saito K, 2012, MAGN RESON MED, V67, P801, DOI 10.1002/mrm.23065; Sattlar UGA, 2007, LAB INVEST, V87, P84, DOI 10.1038/labinvest.3700493; Serrao EM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00059; STAMBAUGH R, 1966, J BIOL CHEM, V241, P1462; Valvona CJ, 2016, BRAIN PATHOL, V26, P3, DOI 10.1111/bpa.12299; WANG CS, 1977, EUR J BIOCHEM, V78, P569, DOI 10.1111/j.1432-1033.1977.tb11770.x; Wang Dong, 2009, GENEREVIEWS R, P1993; Wojtkowiak JW, 2015, CANCER METAB, V3, DOI 10.1186/s40170-014-0026-z; Zacharias NM, 2019, MOL CANCER THER, V18, P1937, DOI 10.1158/1535-7163.MCT-18-0985	38	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100775	10.1016/j.jbc.2021.100775	http://dx.doi.org/10.1016/j.jbc.2021.100775			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34022218	Green Published, gold			2022-12-26	WOS:000678068400005
J	Akima, H; Maeda, H; Koike, T; Ishida, K				Akima, Hiroshi; Maeda, Hisashi; Koike, Teruhiko; Ishida, Koji			Effect of elbow joint angles on electromyographic activity versus force relationships of synergistic muscles of the triceps brachii	PLOS ONE			English	Article							VASTUS INTERMEDIUS MUSCLE; FIBER-TYPE COMPOSITION; MOTOR UNITS; SURFACE ELECTROMYOGRAPHY; FIRING RATE; 3 HEADS; EMG; QUADRICEPS; ACTIVATION; TORQUE	The electromyographic (EMG) activity and force relationship, i.e. EMG-force relationship, is a valuable indicator of the degree of the neuromuscular activation during isometric force production. However, there is minimal information available regarding the EMG-force relationship of individual triceps brachii (TB) muscles at different elbow joint angles. This study aimed to compare the EMG-force relationships of the medial (TB-Med), lateral (TB-Lat), and long heads (TB-Long) of the TB. 7 men and 10 women performed force matching isometric tasks at 20%, 40%, 60%, and 80%maximum voluntary contraction (MVC) at 60 degrees, 90 degrees, and 120 degrees of extension. During the submaximal force matching tasks, the surface EMG signals of the TB-Med, TB-Lat, and TB-Long were recorded and calculated the root mean square (RMS). RMS of each force level were then normalized by RMS at 100%MVC. For the TB-Med, ultrasonography was used to determine the superficial region of the muscle that faced the skin surface to minimize cross-talk. The joint angle was monitored using an electrogoniometer. The elbow extension force, elbow joint angle, and surface EMG signals were simultaneously sampled at 2 kHz and stored on a personal computer. The RMS did not significantly differ between the three muscles, except between the TB-Med and TB-Lat during 20%MVC at 60 degrees. The RMS during force levels of >= 60%MVC at 120 degrees was significantly lower than that at 60 degrees or 90 degrees for each muscle. The sum of difference, which represents the difference in RMS from the identical line, did not significantly differ in any of the assessed muscles in the present study. This suggests that a relatively smaller neuromuscular activation could be required when the elbow joint angle was extended. However, neuromuscular activation levels and relative force levels were matched in all three TB synergists when the elbow joint angle was at 90 degrees or a more flexed position.	[Akima, Hiroshi; Koike, Teruhiko; Ishida, Koji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi, Japan; [Akima, Hiroshi] Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi, Japan; [Maeda, Hisashi; Koike, Teruhiko; Ishida, Koji] Nagoya Univ, Grad Sch Med, Nagoya, Aichi, Japan; [Maeda, Hisashi] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan	Nagoya University; Nagoya University; Nagoya University; National Cerebral & Cardiovascular Center - Japan	Akima, H (corresponding author), Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi, Japan.; Akima, H (corresponding author), Nagoya Univ, Grad Sch Educ & Human Dev, Nagoya, Aichi, Japan.	akima@nagoya-u.jp			Ministry of Education, Culture, Sports, Science and Technology Grants [17H02142]	Ministry of Education, Culture, Sports, Science and Technology Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	HA 17H02142 Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology Grants https://www.jsps.go.jp/english/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2017, CLIN PHYSIOL FUNCT I, V37, P750, DOI 10.1111/cpf.12370; Akima H, 2013, MUSCLE NERVE, V47, P682, DOI 10.1002/mus.23647; Ali MA, 2015, J HUM KINET, V46, P69, DOI 10.1515/hukin-2015-0035; Ali MA, 2014, TECHNOL HEALTH CARE, V22, P617, DOI 10.3233/THC-140833; Alkner BA, 2000, MED SCI SPORT EXER, V32, P459, DOI 10.1097/00005768-200002000-00030; Conwit RA, 1999, CLIN NEUROPHYSIOL, V110, P1270, DOI 10.1016/S1388-2457(99)00054-1; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P113, DOI 10.1113/jphysiol.1982.sp014293; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Del Valle A, 2004, CAN J PHYSIOL PHARM, V82, P769, DOI 10.1139/Y04-084; Doheny EP, 2008, J ELECTROMYOGR KINES, V18, P760, DOI 10.1016/j.jelekin.2007.03.006; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211, DOI 10.1152/jappl.1992.73.4.1211; HARRIDGE SDR, 1993, EUR J APPL PHYSIOL O, V67, P218, DOI 10.1007/BF00864218; Harwood B, 2013, EXP BRAIN RES, V231, P501, DOI 10.1007/s00221-013-3714-y; Hermens HJ, 1999, SURFACE ELECTROMYOGR; Hussain J, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00112; Hussain J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228089; Kawakami Y, 1995, EUR J APPL PHYSIOL O, V72, P37, DOI 10.1007/BF00964112; KAWAKAMI Y, 1993, J APPL PHYSIOL, V74, P2740, DOI 10.1152/jappl.1993.74.6.2740; KOMI PV, 1976, ACTA PHYSIOL SCAND, V96, P267, DOI 10.1111/j.1748-1716.1976.tb10195.x; KUKULKA CG, 1981, BRAIN RES, V219, P45, DOI 10.1016/0006-8993(81)90266-3; LAWRENCE JH, 1983, J APPL PHYSIOL, V54, P1653, DOI 10.1152/jappl.1983.54.6.1653; LEBOZEC S, 1987, EUR J APPL PHYSIOL, V56, P350, DOI 10.1007/BF00690904; MILES TS, 1986, J PHYSIOL-LONDON, V370, P457, DOI 10.1113/jphysiol.1986.sp015944; MORITANI T, 1986, J APPL PHYSIOL, V60, P1179, DOI 10.1152/jappl.1986.60.4.1179; Murray WM, 2000, J BIOMECH, V33, P943, DOI 10.1016/S0021-9290(00)00051-8; Pincivero DM, 2003, J ELECTROMYOGR KINES, V13, P159, DOI 10.1016/S1050-6411(02)00096-2; Pincivero DM, 2000, MUSCLE NERVE, V23, P393, DOI 10.1002/(SICI)1097-4598(200003)23:3<393::AID-MUS11>3.0.CO;2-P; Praagman M, 2003, J BIOMECH, V36, P905, DOI 10.1016/S0021-9290(03)00081-2; Saito A, 2013, J ELECTROMYOGR KINES, V23, P1406, DOI 10.1016/j.jelekin.2013.08.009; Saito A, 2013, J ELECTROMYOGR KINES, V23, P831, DOI 10.1016/j.jelekin.2013.02.005; Srinivasan RC, 2007, CLIN ANAT, V20, P144, DOI 10.1002/ca.20349; Stevens JP., 2007, INTERMEDIATE STAT MO, V3rd ed; Terzis G, 2003, EUR J APPL PHYSIOL, V90, P10, DOI 10.1007/s00421-003-0847-x; VANDERLINDEN DW, 1991, EXP BRAIN RES, V84, P210, DOI 10.1007/BF00231776; Wade MD, 2018, ANAT REC, V301, P473, DOI 10.1002/ar.23741; Watanabe K, 2011, SCAND J MED SCI SPOR, V21, pE412, DOI 10.1111/j.1600-0838.2011.01347.x; Watanabe K, 2011, J NEUROSCI METH, V198, P332, DOI 10.1016/j.jneumeth.2011.03.014; Watanabe Kohei, 2009, J Electromyogr Kinesiol, V19, pe280, DOI 10.1016/j.jelekin.2008.06.002; Watanabe K, 2009, EUR J APPL PHYSIOL, V106, P665, DOI 10.1007/s00421-009-1064-z; WOODS JJ, 1983, AM J PHYS MED REHAB, V62, P287	42	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252644	10.1371/journal.pone.0252644	http://dx.doi.org/10.1371/journal.pone.0252644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081721	gold, Green Published			2022-12-26	WOS:000664639200038
J	Carvalho, T; Faria, P; Antunes, L; Moniz, N				Carvalho, Tania; Faria, Pedro; Antunes, Luis; Moniz, Nuno			Fundamental privacy rights in a pandemic state	PLOS ONE			English	Article								Faced with the emergence of the Covid-19 pandemic, and to better understand and contain the disease's spread, health organisations increased the collaboration with other organisations sharing health data with data scientists and researchers. Data analysis assists such organisations in providing information that could help in decision-making processes. For this purpose, both national and regional health authorities provided health data for further processing and analysis. Shared data must comply with existing data protection and privacy regulations. Therefore, a robust de-identification procedure must be used, and a re-identification risk analysis should also be performed. De-identified data embodies state-of-the-art approaches in Data Protection by Design and Default because it requires the protection of direct and indirect identifiers (not just direct). This article highlights the importance of assessing re-identification risk before data disclosure by analysing a data set of individuals infected by Covid-19 that was made available for research purposes. We stress that it is highly important to make this data available for research purposes and that this process should be based on the state of the art methods in Data Protection by Design and by Default. Our main goal is to consider different re-identification risk analysis scenarios since the information on the intruder side is unknown. Our conclusions show that there is a risk of identity disclosure for all of the studied scenarios. For one, in particular, we proceed to an example of a re-identification attack. The outcome of such an attack reveals that it is possible to identify individuals with no much effort.	[Carvalho, Tania; Antunes, Luis; Moniz, Nuno] Univ Porto, Dept Comp Sci, Fac Sci, Porto, Portugal; [Faria, Pedro] TekPrivacy, Porto, Portugal; [Moniz, Nuno] INESC TEC, Porto, Portugal	Universidade do Porto; INESC TEC	Carvalho, T (corresponding author), Univ Porto, Dept Comp Sci, Fac Sci, Porto, Portugal.	tania.carvalho@fc.up.pt	Antunes, Luis Filipe/D-2395-2011	Antunes, Luis Filipe/0000-0002-9988-594X; Moniz, Nuno/0000-0003-4322-1076; Carvalho, Tania/0000-0002-7700-1955	COMPETE 2020, under the PORTUGAL 2020 Partnership Agreement; EU [830929]; Portuguese funding agency, FCT -Fundacao para a Ciencia e a Tecnologia [UID/EEA/50014/2019]; COMPETE 2020 through the European Development Fund (EDF);  [POCI-01-0247-FEDER-041435]	COMPETE 2020, under the PORTUGAL 2020 Partnership Agreement; EU(European Commission); Portuguese funding agency, FCT -Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); COMPETE 2020 through the European Development Fund (EDF); 	The work of TC and LA is supported by Project POCI-01-0247-FEDER-041435 (Safe Cities) and financed by the COMPETE 2020, under the PORTUGAL 2020 Partnership Agreement, and through the European Development Fund (EDF). The work of LA is also supported by EU H2020SU-ICT-03-2018 Project No. 830929 CyberSec4Europe (cybersec4europe.eu). The work of NM is financed by National Funds through the Portuguese funding agency, FCT -Fundacao para a Ciencia e a Tecnologia within project UID/EEA/50014/2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amram D, 2020, COMPUT LAW SECUR REV, V37, DOI 10.1016/j.clsr.2020.105413; [Anonymous], 2002, Bull World Health Organ, V80, P983; Carpov S, 2016, IEEE INT CONF CLOUD, P593, DOI [10.1109/CLOUD.2016.82, 10.1109/CLOUD.2016.0084]; Council of Europe, 1953, EUR CONV HUM RIGHTS; De Bruin J., 2019, ZENODO; Dusetzina SB, 2014, LINKING DATA HLTH SE; Dwork C, 2006, LECT NOTES COMPUT SC, V4052, P1; European Convention, 2000, CHART FUND RIGHTS EU; European Council, 2020, EUROPEAN SOLIDARITY; European Data Protection Supervisor, 2016, DAT PROT EUR DAT PRO; European Union, 2014, OFF J EUR UNION, VL257, P135; Eurosurveillance editorial team, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.6.2002131; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Hejblum BP, 2019, SCI DATA, V6, DOI 10.1038/sdata.2018.298; Karapiperis D., 2019, DISTRIB PARALLEL DAT, P1; Machanavajjhala A., 2006, ACM T KNOWL DISCOV D, V1, P3, DOI DOI 10.1145/1217299.1217302; Malgieri G, 2020, COMPUT LAW SECUR REV, V37, DOI 10.1016/j.clsr.2020.105431; Narayanan A, 2008, P IEEE S SECUR PRIV, P111, DOI 10.1109/SP.2008.33; Ochoa S, 2001, REIDENTIFICATION IND; Official Journal of the European Union, 2016, GEN DAT PROT REG; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; Ramachandran A., 2012, 2012 Tenth Annual International Conference on Privacy, Security and Trust (PST), P35, DOI 10.1109/PST.2012.6297917; Samarati P., 1998, PROTECTING PRIVACY D; Taneja H, 2015, PROCEDIA COMPUT SCI, V70, P448, DOI 10.1016/j.procs.2015.10.073; Truta TM, 2003, SSDBM 2002: 15TH INTERNATIONAL CONFERENCE ON SCIENTIFIC AND STATISTICAL DATABASE MANAGEMENT, P15, DOI 10.1109/SSDM.2003.1214948; United Nations General Assembly, 1948, UN DECL HUM RIGHTS; Weiskopf NG, 2013, J BIOMED INFORM, V46, P830, DOI 10.1016/j.jbi.2013.06.010; Wood A, 2020, ACM COMPUT SURV, V53, DOI 10.1145/3394658	28	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252169	10.1371/journal.pone.0252169	http://dx.doi.org/10.1371/journal.pone.0252169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077454	Green Published, gold			2022-12-26	WOS:000664638500031
J	Marcinek, P; Haag, F; Geithe, C; Krautwurst, D				Marcinek, Patrick; Haag, Franziska; Geithe, Christiane; Krautwurst, Dietmar			An evolutionary conserved olfactory receptor for foodborne and semiochemical alkylpyrazines	FASEB JOURNAL			English	Article						chemical ecology; chemosensory evolution; odorant receptor; olfaction	KEY AROMA COMPOUNDS; HUMAN ODORANT RECEPTOR; BEHAVIORAL-RESPONSES; FUNCTIONAL EXPRESSION; ALARM PHEROMONE; INNATE THREAT; FOOD ODORANT; CD-1 MICE; MOUSE; FEAR	Molecular recognition is a fundamental principle in biological systems. The olfactory detection of both food and predators via ecological relevant odorant cues are abilities of eminent evolutionary significance for many species. Pyrazines are such volatile cues, some of which act as both human-centered key food odorants (KFOs) and semiochemicals. A pyrazine-selective odorant receptor has been elusive. Here we screened 2,3,5-trimethylpyrazine, a KFO and semiochemical, and 2,5-dihydro-2,4,5-trimethylthiazoline, an innate fear-associated non-KFO, against 616 human odorant receptor variants, in a cell-based luminescence assay. OR5K1 emerged as sole responding receptor. Tested against a comprehensive collection of 178 KFOs, we newly identified 18 pyrazines and (2R/2S)-4-methoxy-2,5-dimethylfuran-3(2H)-one as agonists. Notably, OR5K1 orthologs in mouse and domesticated species displayed a human-like, potency-ranked activation pattern of pyrazines, suggesting a domestication-led co-evolution of OR5K1 and its orthologs. In summary, OR5K1 is a specialized olfactory receptor across mammals for the detection of pyrazine-based key food odors and semiochemicals.	[Marcinek, Patrick; Haag, Franziska; Geithe, Christiane; Krautwurst, Dietmar] Tech Univ Munich, Leibniz Inst Food Syst Biol, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany; [Marcinek, Patrick] Hamilton Germany GmbH, Grafelfing, Germany; [Geithe, Christiane] Brandenburg Univ Technol Cottbus Senftenberg, Senftenberg, Germany	Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Technical University of Munich; Brandenburg University of Technology Cottbus	Krautwurst, D (corresponding author), Tech Univ Munich, Leibniz Inst Food Syst Biol, Lise Meitner Str 34, D-85354 Freising Weihenstephan, Germany.	d.krautwurst.leibniz-lsb@tum.de		Haag, Franziska/0000-0003-4210-0475; Marcinek, Patrick/0000-0003-4003-9308; Geithe, Christiane/0000-0002-7302-8851	Altria Client Services Inc, Richmond, VA, USA; MARS Inc, McLean, VA, USA	Altria Client Services Inc, Richmond, VA, USA; MARS Inc, McLean, VA, USA	We thank Tim Frey, Sandra Hoffmann, and Julia Bauer for expert technical assistance. FH has been supported partially by a collaboration project with Altria Client Services Inc, Richmond, VA, USA. CG has been supported partially by a collaboration project with MARS Inc, McLean, VA, USA.	Adipietro KA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002821; Alberto FJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03206-y; Anson JR, 2013, OECOLOGIA, V171, P367, DOI 10.1007/s00442-012-2424-7; Apfelbach R, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00263; Ayers LW, 2013, BEHAV BRAIN RES, V253, P54, DOI 10.1016/j.bbr.2013.06.034; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Bautze V, 2012, CHEM SENSES, V37, P479, DOI 10.1093/chemse/bjr130; Binkowski B, 2009, CURR OPIN BIOTECH, V20, P14, DOI 10.1016/j.copbio.2009.02.013; Bohman B, 2014, NEW PHYTOL, V203, P939, DOI 10.1111/nph.12800; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buttery RG, 1999, J AGR FOOD CHEM, V47, P4353, DOI 10.1021/jf990140w; Chamaille-Jammes S, 2014, OECOLOGIA, V174, P1151, DOI 10.1007/s00442-013-2843-0; Charpentier MJE, 2008, MOL ECOL, V17, P3225, DOI 10.1111/j.1365-294X.2008.03831.x; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Dewan A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05129-0; Dunkel A, 2014, ANGEW CHEM INT EDIT, V53, P7124, DOI 10.1002/anie.201309508; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gardiner A, 2008, MOL ECOL, V17, P1648, DOI 10.1111/j.1365-294X.2008.03713.x; Geithe C, 2017, CELL MOL LIFE SCI, V74, P4209, DOI 10.1007/s00018-017-2576-z; Geithe C, 2017, CHEM SENSES, V42, P181, DOI 10.1093/chemse/bjw117; Geithe C, 2015, J AGR FOOD CHEM, V63, P9410, DOI 10.1021/acs.jafc.5b01884; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; Guan D, 2014, J AGR FOOD CHEM, V62, P11924, DOI 10.1021/jf505191s; Hellwig M, 2014, ANGEW CHEM INT EDIT, V53, P10316, DOI 10.1002/anie.201308808; Henning C, 2016, GLYCOCONJUGATE J, V33, P499, DOI 10.1007/s10719-016-9694-y; Horio N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07940-1; Hunter P, 2018, EMBO REP, V19, P201, DOI 10.15252/embr.201745664; Inlamea OF, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008081; Jiang Y, 2015, CURR OPIN NEUROBIOL, V34, P54, DOI 10.1016/j.conb.2015.01.014; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; KOSUGE T, 1962, NATURE, V193, P776, DOI 10.1038/193776a0; Krautwurst Dietmar, 2013, Methods Mol Biol, V1003, P85, DOI 10.1007/978-1-62703-377-0_6; Kreissl J., 2019, LEIBNIZ LSB TUM ODOR; Kriventseva EV, 2019, NUCLEIC ACIDS RES, V47, pD807, DOI 10.1093/nar/gky1053; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Larson G, 2014, ANNU REV ECOL EVOL S, V45, P115, DOI 10.1146/annurev-ecolsys-110512-135813; Laska M, 2009, J EXP ZOOL PART A, V311A, P278, DOI 10.1002/jez.527; LAW JH, 1971, ANNU REV BIOCHEM, V40, P533, DOI 10.1146/annurev.bi.40.070171.002533; Li F, 2013, J NEUROSCI, V33, P7975, DOI 10.1523/JNEUROSCI.5563-12.2013; Li JY, 2015, J NEUROCHEM, V134, P47, DOI 10.1111/jnc.13095; Li YY, 2018, MOLECULES, V23, DOI 10.3390/molecules23071661; Lindstrom L, 2001, P ROY SOC B-BIOL SCI, V268, P159, DOI 10.1098/rspb.2000.1344; Llaneza L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093015; Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404; Man O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000682; Masanetz C, 1998, FLAVOUR FRAG J, V13, P115, DOI [10.1002/(SICI)1099-1026(199803/04)13:2&lt;115::AID-FFJ706&gt;3.0.CO;2-6, 10.1002/(SICI)1099-1026(199803/04)13:2<115::AID-FFJ706>3.3.CO;2-Y]; Matsui A, 2010, MOL BIOL EVOL, V27, P1192, DOI 10.1093/molbev/msq003; Moine F, 2018, BMC BIOL, V16, DOI 10.1186/s12915-017-0479-y; Muller R, 2010, APPL MICROBIOL BIOT, V85, P1315, DOI 10.1007/s00253-009-2362-4; Neta ERD, 2008, J FOOD SCI, V73, pC632, DOI 10.1111/j.1750-3841.2008.00948.x; Nielsen BL, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00226; Niimura Yoshihito, 2009, Human Genomics, V4, P107; Noe Franziska, 2017, Journal of Biological Methods, V4, pe82, DOI 10.14440/jbm.2017.207; Noe Franziska, 2017, Journal of Biological Methods, V4, pe81, DOI 10.14440/jbm.2017.206; Noe F, 2017, CHEM SENSES, V42, P195, DOI 10.1093/chemse/bjw118; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Osada K, 2017, J CHEM ECOL, V43, P263, DOI 10.1007/s10886-017-0822-3; Osada K, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00363; Osada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061753; Paudel Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1449-9; Pickett JA, 2014, BIOCHEM SOC T, V42, P846, DOI 10.1042/BST20140134; Rampin O, 2018, CHEM SENSES, V43, P105, DOI 10.1093/chemse/bjx075; REGNIER FE, 1971, BIOL REPROD, V4, P309, DOI 10.1093/biolreprod/4.3.309; Rosen JB, 2008, NEUROSCI BIOBEHAV R, V32, P1267, DOI 10.1016/j.neubiorev.2008.05.006; Rosen JB, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00292; Rouquier S, 2000, P NATL ACAD SCI USA, V97, P2870, DOI 10.1073/pnas.040580197; Sahlen E, 2016, ECOL EVOL, V6, P791, DOI 10.1002/ece3.1866; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Saito H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16011; Saraiva LR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0396; Saraiva LR, 2016, P NATL ACAD SCI USA, V113, pE3300, DOI 10.1073/pnas.1605973113; Sbarbati A, 2006, CELLS TISSUES ORGANS, V183, P206, DOI 10.1159/000096511; Schieberle P., 2011, CHEM FUNCTIONAL PROP, P413; Schleidt Wolfgang, 2003, Evolution and Cognition, V9, P57; Schweizer RM, 2016, MOL ECOL, V25, P357, DOI 10.1111/mec.13467; Seyfried C, 2019, J AGR FOOD CHEM, V67, P5827, DOI 10.1021/acs.jafc.8b06183; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Sievert T, 2016, CHEM SENSES, V41, P399, DOI 10.1093/chemse/bjw015; Silva EA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20953-6; Son S, 2020, GENES GENOM, V42, P1107, DOI 10.1007/s13258-020-00978-w; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Sullivan AP, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0065; Verbeurgt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096333; Verhulst NO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-28; Wagner J, 2017, J AGR FOOD CHEM, V65, P132, DOI 10.1021/acs.jafc.6b04499; Wagner J, 2016, J AGR FOOD CHEM, V64, P8388, DOI 10.1021/acs.jafc.6b03676; Wagner R, 1999, Z LEBENSM UNTERS F A, V208, P308, DOI 10.1007/s002170050422; Wang YB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04324-3; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wyatt TD, 2017, CURR BIOL, V27, pR739, DOI 10.1016/j.cub.2017.06.039; Zhang K, 2020, ANIM GENET, V51, P637, DOI 10.1111/age.12974	95	5	5	8	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2021	35	6							e21638	10.1096/fj.202100224R	http://dx.doi.org/10.1096/fj.202100224R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	SJ7FH	34047404	hybrid			2022-12-26	WOS:000655695900061
J	Bhavsar, NA; Doerfler, SM; Giczewska, A; Alhanti, B; Lutz, A; Thigpen, CA; George, SZ				Bhavsar, Nrupen A.; Doerfler, Shannon M.; Giczewska, Anna; Alhanti, Brooke; Lutz, Adam; Thigpen, Charles A.; George, Steven Z.			Prevalence and predictors of no-shows to physical therapy for musculoskeletal conditions	PLOS ONE			English	Article							LOW-BACK-PAIN; OUTPATIENT APPOINTMENTS; UNITED-STATES; NONATTENDANCE; MANAGEMENT; OUTCOMES; COSTS; RATES; CARE; INITIATION	Objectives Chronic pain affects 50 million Americans and is often treated with non-pharmacologic approaches like physical therapy. Developing a no-show prediction model for individuals seeking physical therapy care for musculoskeletal conditions has several benefits including enhancement of workforce efficiency without growing the existing provider pool, delivering guideline adherent care, and identifying those that may benefit from telehealth. The objective of this paper was to quantify the national prevalence of no-shows for patients seeking physical therapy care and to identify individual and organizational factors predicting whether a patient will be a no-show when seeking physical therapy care. Design Retrospective cohort study. Setting Commercial provider of physical therapy within the United States with 828 clinics across 26 states. Participants Adolescent and adult patients (age cutoffs: 14-117 years) seeking non-pharmacological treatment for musculoskeletal conditions from January 1, 2016, to December 31, 2017 (n = 542,685). Exclusion criteria were a primary complaint not considered an MSK condition or improbable values for height, weight, or body mass index values. The study included 444,995 individuals. Primary and secondary outcome measures Prevalence of no-shows for musculoskeletal conditions and predictors of patient no-show. Results In our population, 73% missed at least 1 appointment for a given physical therapy care episode. Our model had moderate discrimination for no-shows (c-statistic:0.72, all appointments; 0.73, first 7 appointments) and was well calibrated, with predicted and observed no-shows in good agreement. Variables predicting higher no-show rates included insurance type; smoking-status; higher BMI; and more prior cancellations, time between visit and scheduling date, and between current and previous visit. Conclusions The high prevalence of no-shows when seeking care for musculoskeletal conditions from physical therapists highlights an inefficiency that, unaddressed, could limit delivery of guideline-adherent care that advocates for earlier use of non-pharmacological treatments for musculoskeletal conditions and result in missed opportunities for using telehealth to deliver physical therapy.	[Bhavsar, Nrupen A.] Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, Durham, NC 27706 USA; [Doerfler, Shannon M.; Giczewska, Anna; Alhanti, Brooke; George, Steven Z.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Lutz, Adam; Thigpen, Charles A.] ATI Phys Therapy, Greenville, SC USA; [Lutz, Adam; Thigpen, Charles A.] Univ South Carolina, Arnold Sch Publ Hlth, Exercise Sci, Columbia, SC 29208 USA; [Thigpen, Charles A.] Univ South Carolina, Arnold Sch Publ Hlth, Ctr Effectiveness Res Orthopaed, Columbia, SC 29208 USA; [George, Steven Z.] Duke Univ, Sch Med, Dept Orthopaed Surg, Durham, NC USA	Duke University; Duke University; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; Duke University	Bhavsar, NA (corresponding author), Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, Durham, NC 27706 USA.	nrupen.bhavsar@duke.edu		Giczewska, Anna/0000-0003-0533-2453; THIGPEN, CHARLES/0000-0003-2487-1399	Duke Clinical Research Institute; National Heart, Lung, and Blood Institute [K01HL140146]; National Center for Complementary and Integrative Health [UG3AT009790]	Duke Clinical Research Institute; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Complementary and Integrative Health	The Duke Clinical Research Institute provided funding through its Investment in Innovation program (N.A.B. and S.M.D.). N.A.B. is a recipient of a career development award through the National Heart, Lung, and Blood Institute (K01HL140146). The National Center for Complementary and Integrative Health provided funding through an UG3AT009790 award (S.M.G.).	Agency for Healthcare Research and Quality, 2014, MED EXP PAN SURV HOU; [Anonymous], 2020, RMS REGRESSION MODEL; Awh K, 2019, CONGENIT HEART DIS, V14, P726, DOI 10.1111/chd.12784; Bates M MM, MATRIX SPARSE DENSE; Bettger JP, 2020, PHYS THER, V100, P1913, DOI 10.1093/ptj/pzaa151; Chapman Cole G, 2018, JB JS Open Access, V3, pe0005, DOI 10.2106/JBJS.OA.18.00005; Childs JD, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0830-3; Chou R, 2017, ANN INTERN MED, V166, P493, DOI 10.7326/M16-2459; Cohen AD, 2008, J EUR ACAD DERMATOL, V22, P1178, DOI 10.1111/j.1468-3083.2008.02740.x; Cronin PR, 2013, JAMA DERMATOL, V149, P1435, DOI 10.1001/jamadermatol.2013.5771; Crown WH, 2015, VALUE HEALTH, V18, P137, DOI 10.1016/j.jval.2014.12.005; Denninger TR, 2018, J ORTHOP SPORT PHYS, V48, P63, DOI 10.2519/jospt.2018.7423; Ding XR, 2018, J AM MED INFORM ASSN, V25, P924, DOI 10.1093/jamia/ocy002; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Eccleston C, 2020, PAIN, V161, P889, DOI 10.1097/j.pain.0000000000001885; Eid WE, 2016, ENDOCR PRACT, V22, P983, DOI 10.4158/EP161198.OR; Fonseca H, 2009, ARCH DIS CHILD, V94, P104, DOI 10.1136/adc.2008.139915; Fonti V., 2017, FEATURE SELECTION US; French LRM, 2017, BRIT J GEN PRACT, V67, pE483, DOI 10.3399/bjgp17X691373; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fritz JM, 2013, ARCH PHYS MED REHAB, V94, P808, DOI 10.1016/j.apmr.2013.01.008; Giunta D, 2013, PATIENT PREFER ADHER, V7, P1163, DOI 10.2147/PPA.S51841; Gleeson R., 1991, AUST OCCUP THER J, V38, P55; Guzek LM, 2015, PEDIATR NEUROL, V52, P198, DOI 10.1016/j.pediatrneurol.2014.10.020; Hack LM., 2017, MODEL PROJECT SUPPLY; Han T GJ., 2019, UROL PRACT; Harvey HB, 2017, J AM COLL RADIOL, V14, P1303, DOI 10.1016/j.jacr.2017.05.007; Horn Maggie E, 2017, Mayo Clin Proc Innov Qual Outcomes, V1, P226, DOI 10.1016/j.mayocpiqo.2017.09.001; Hunter BN, 2019, AM J RHINOL ALLERGY, V33, P317, DOI 10.1177/1945892419826247; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Johson BJ, 2007, ANN FAM MED, V5, P534, DOI 10.1370/afm.752; Jr HF, 2020, HMISC HARRELL MISCEL; Katzan IL, 2019, SPINE J, V19, P645, DOI 10.1016/j.spinee.2018.10.002; Kazis LE, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028633; Kheirkhah P, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-015-1243-z; Lee YS, 2018, INT J HEALTH PLAN M, V33, pE873, DOI 10.1002/hpm.2551; Liu XL, 2018, PHYS THER, V98, P336, DOI 10.1093/ptj/pzy023; Lotfi V, 2014, SOCIO-ECON PLAN SCI, V48, P115, DOI 10.1016/j.seps.2014.01.002; Luckett R, 2015, J WOMENS HEALTH, V24, P608, DOI 10.1089/jwh.2014.5111; Lynn JV, 2018, CLEFT PALATE-CRAN J, V55, P1440, DOI 10.1177/1055665618764739; MARGOLIS KL, 1993, J GEN INTERN MED, V8, P602, DOI 10.1007/BF02599713; Mbada C.E.NJ., 2013, HONG KONG PHYSIOTHER, V31; Mbada CE AO., 2013, J PHY THER, V7, P12; McMullen MJ, 2015, CLIN OPHTHALMOL, V9, DOI 10.2147/OPTH.S82151; Middleton A, 2020, PHYS THER, V100, P1278, DOI 10.1093/ptj/pzaa089; Mikolajczyk RT, 2008, INT J PUBLIC HEALTH, V53, P214, DOI 10.1007/s00038-008-7123-0; Moore CG, 2001, FAM MED, V33, P522; NIDA, OP SUMM STAT 2018; Norris JB, 2014, DECIS SUPPORT SYST, V57, P428, DOI 10.1016/j.dss.2012.10.048; Ojha HA, 2016, J ORTHOP SPORT PHYS, V46, P56, DOI 10.2519/jospt.2016.6138; PANG AHT, 1995, INT J SOC PSYCHIATR, V41, P103, DOI 10.1177/002076409504100203; Partin MR, 2016, CLIN GASTROENTEROL H, V14, P259, DOI 10.1016/j.cgh.2015.07.051; Priebe JA, 2020, J PAIN RES, V13, P1823, DOI 10.2147/JPR.S260761; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Reid MW, 2016, AM J GASTROENTEROL, V111, P1267, DOI 10.1038/ajg.2016.269; Rosenbaum JI, 2018, J AM COLL RADIOL, V15, P944, DOI 10.1016/j.jacr.2018.03.053; RUST CT, 1995, ARCH PEDIAT ADOL MED, V149, P693, DOI 10.1001/archpedi.1995.02170190103018; Sarkar D, 2008, USE R, P1; Shmagel A, 2018, J PAIN, V19, P1104, DOI 10.1016/j.jpain.2018.04.004; Shuja A, 2019, J CLIN GASTROENTEROL, V53, P29, DOI 10.1097/MCG.0000000000000928; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stevans JM, 2017, PHYS THER, V97, P615, DOI 10.1093/ptj/pzx049; Strothman K, 2015, ANN ALLERG ASTHMA IM, V114, P529, DOI 10.1016/j.anai.2015.03.011; Sun E, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.5909; Taylor NF, 2012, ARCH PHYS MED REHAB, V93, P21, DOI 10.1016/j.apmr.2011.08.007; Team RRC, 2019, R LANG ENV STAT COMP; WHe, 2019, J OPEN SOURCE SOFTW; Wolthers OD, 2018, DAN MED J, V65; Xakellis GC, 2001, FAM MED, V33, P533; Zheng P, 2017, SPINE, V42, P670, DOI 10.1097/BRS.0000000000001875; Zirkle Molly S, 2011, Ear Nose Throat J, V90, pE32	71	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0251336	10.1371/journal.pone.0251336	http://dx.doi.org/10.1371/journal.pone.0251336			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048440	Green Published, gold			2022-12-26	WOS:000664636100012
J	van den Broek-Altenburg, E; Atherly, A				van den Broek-Altenburg, Eline; Atherly, Adam			Adherence to COVID-19 policy measures: Behavioral insights from The Netherlands and Belgium	PLOS ONE			English	Article								Background Since the start of the global COVID-19 pandemic, countries have been mirroring each other's policies to mitigate the spread of the virus. Whether current measures alone will lead to behavioral change such as social distancing, washing hands, and wearing a facemask is not well understood. The objective of this study is to better understand individual variation in behavioral responses to COVID-19 by exploring the influence of beliefs, motivations and policy measures on public health behaviors. We do so by comparing The Netherlands and Flanders, the Dutch speaking part of Belgium. Methods and findings Our final sample included 2,637 respondents from The Netherlands and 1,678 from Flanders. The data was nationally representative along three dimensions: age, gender, and household income in both countries. Our key outcome variables of interest were beliefs about policy effectiveness; stated reasons for complying with public rules; and changes in behavior. For control variables, we included a number of measures of how severe the respondent believed Covid-19 to be and a number of negative side effects that the person may have experienced: loneliness, boredom, anxiety, and conflicts with friends and neighbors. Finally, we controlled for socio-demographic factors: age, gender, income (categorical), education (categorical) and the presence of Covid-19 risk factors (diabetes, high blood pressure, heart disease, asthma, allergies). The dependent variable for each of the estimation models is dichotomous, so we used Probit models to predict the probability of engaging in a given behavior. We found that motivations, beliefs about the effectiveness of measures, and pre-pandemic behavior play an important role. The Dutch were more likely to wash their hands than the Flemish (15.4%, p<0.01), visit family (15.5%, p < .01), run errands (12.0%, p<0.05) or go to large closed spaces such as a shopping mall (21.2%, p<0.01). The Dutch were significantly less likely to wear a mask (87.6%, p<0.01). We also found that beliefs about the virus, psychological effects of the virus, as well as pre-pandemic behavior play a role in adherence to recommendations. Conclusions Our results suggest that policymakers should consider behavioral motivations specific to their country in their COVID-19 strategies. In addition, the belief that a policy is effective significantly increased the probability of the behavior, so policy measures should be accompanied by public health campaigns to increase adherence.	[van den Broek-Altenburg, Eline] Univ Vermont, Dept Radiol, Larner Coll Med, Burlington, VT 05405 USA; [Atherly, Adam] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA	University of Vermont; University of Vermont	van den Broek-Altenburg, E (corresponding author), Univ Vermont, Dept Radiol, Larner Coll Med, Burlington, VT 05405 USA.	Eline.Altenburg@med.uvm.edu		van den Broek-Altenburg, Eline/0000-0002-4831-9083				Belot M., 2020, 6 COUNTRY SURVEY COV; Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447; Briscese G, 2020, NBER WORKING PAPER S; Brzozowski A, 2020, BELGIUM EXIT LOCKDOW; Chang KC, 2020, J FORMOS MED ASSOC, V119, P1772, DOI 10.1016/j.jfma.2020.07.032; Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464; Everett J.A., 2020, EFFECTIVENESS MORAL, DOI [10.31234/osf.io/9yqs8, DOI 10.31234/OSF.IO/9YQS8]; Fernandes N., 2020, EC EFFECTS CORONAVIR, DOI [10.2139/ssrn.3557504, DOI 10.2139/SSRN.3557504]; Hale T., 2020, BLAVATNIK SCH GOV; Harper C.A., 2020, INT J MENT HEALTH AD, P1, DOI DOI 10.1007/s11469-020-00281-5; Ioannidis J., 2020, B WORLD HEALTH ORGAN, P2020, DOI [10.1101/2020.05.13.20101253, DOI 10.2471/BLT.20.265892]; Ioannidis J. P. A., 2020, STAT-US; Lin M.-W., 2020, SOC HLTH BEHAV, V3, P72, DOI [10.4103/SHB.SHB_18_20, DOI 10.4103/SHB.SHB_18_20, https://doi.org/10.4103/SHB.SHB_18_20]; McKibbin W., 2020, GLOBAL MACROECONOMIC, DOI [DOI 10.2139/SSRN.3547729, 10.2139/ssrn.3547729]; McLachlan Scott, 2020, CONVERSATION; Morgenstern J., 2020, FIRST10EM BLOG, V6; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Ogiermann E, 2009, J POLITENESS RES-LAN, V5, P189, DOI 10.1515/JPLR.2009.011; Olatunji O. S., 2020, SOCIAL HLTH BEHAV, V3, P152, DOI 10.4103/SHB.SHB_43_20; Ornell F, 2020, BRAZ J PSYCHIAT, V42, P232, DOI 10.1590/1516-4446-2020-0008; Pakpour A.H., 2020, J CONCURR DISORD, V2, P58, DOI [10.54127/WCIC8036, DOI 10.54127/WCIC8036]; Papageorge NW, 2020, SOCIODEMOGRAPHIC FAC, DOI [10.3386/w27378, DOI 10.3386/W27378]; Pramukti I, 2020, J MED INTERNET RES, V22, DOI 10.2196/24487; Rieger M., 2020, SOC HLTH BEHAV, V3, P50, DOI [10.4103/SHB.SHB_23_20, DOI 10.4103/SHB.SHB_23_20]; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van der Wijst P., 1995, TEXT, V15, P477; Wang J, 2020, IRISH J MED SCI, V189, P1143, DOI 10.1007/s11845-020-02218-2; Wright T, 2020, IZA DISCUSSION PAPER	28	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0250302	10.1371/journal.pone.0250302	http://dx.doi.org/10.1371/journal.pone.0250302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048441	gold, Green Published			2022-12-26	WOS:000664636100007
J	Gulut, KY; Duymus, E; Solmaz, I; Torun, AA				Gulut, Kemal Yalcin; Duymus, Ebru; Solmaz, Ilknur; Torun, Ayfer Alkan			Nitrogen and boron nutrition in grafted watermelon II: Impact on nutrient accumulation in fruit rind and flesh	PLOS ONE			English	Article							PUMPKIN ROOTSTOCK IMPROVES; USE EFFICIENCY; ROOT TRAITS; PLANTS; EXPRESSION; CHALLENGES; GROWTH; ANTIOXIDANT	Turkey ranks second in watermelon (Citrullus lunatus L.) production globally and the highest production is witnessed for Cukurova plains the country. Although watermelon is extensively cultivated in the Cukurova region, studies on optimum nitrogen (N) and boron (B) doses for watermelon cultivation are quite limited. This study, evaluated the impact of increasing N (0, 90, 180 and 270 kg ha(-1)) and B (0 and 2 kg ha(-1) B) doses on nutrient uptake in rind (exocarp) and flesh (endocarp) of watermelon fruit. Grafted watermelon variety 'Starburst', widely cultivated in the region was used as experimental material. The concentrations of different macro and micronutrients were analyzed from fruit rind and flesh. Individual and interactive effect of N and B doses significantly altered macro and micronutrients' uptake in rind and flesh. Higher amounts of macro and micronutrients were accumulated in rind than flesh. Nutrients' uptake was increased with increasing N doses, whereas B had limited impact. The accumulated nutrients were within the safe limits for human consumption. The N concentrations of rind and flesh increased with increasing N dose. Similarly, B concentration in rind and flesh and N concentration in rind significantly increased, while N concentration in flesh decreased with B application. It was concluded that 270 kg ha(-1) N and 2 kg ha(-1) B are optimum for better nutrient uptake in watermelon fruit. Thus, these doses must be used for watermelon cultivation in Cukurova plains of the country.	[Gulut, Kemal Yalcin; Duymus, Ebru; Torun, Ayfer Alkan] Cukurova Univ, Dept Soil Sci & Plant Nutr, Fac Agr, Adana, Turkey; [Solmaz, Ilknur] Cukurova Univ, Dept Hort, Fac Agr, Adana, Turkey	Cukurova University; Cukurova University	Gulut, KY (corresponding author), Cukurova Univ, Dept Soil Sci & Plant Nutr, Fac Agr, Adana, Turkey.	kygulut@cu.edu.tr		GULUT, KEMAL YALCIN/0000-0003-0534-2969; DUYMUS, Ebru/0000-0002-6463-6812	Cukurova University Scientific Research Projects Coordination Unit [FBA-2018-10970]	Cukurova University Scientific Research Projects Coordination Unit(Cukurova University)	This study was partially supported by Cukurova University Scientific Research Projects Coordination Unit (Project No: FBA-2018-10970). There were no additional external funding involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albacete A, 2015, J EXP BOT, V66, P2211, DOI 10.1093/jxb/erv027; Bahari M, 2012, SCI WORLD J, P1, DOI 10.1100/2012/543158; Bie ZL, 2017, VEGETABLE GRAFTING: PRINCIPLES AND PRACTICES, P1, DOI 10.1079/9781780648972.0001; Bingham FT, 1983, METHODS SOIL ANAL 2, V9, P431; Bolat I., 2017, Bartin Orman Fakultesi Dergisi, V19, P218; Boualem A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155444; BREMNER J. M., 1960, JOUR AGRIC SCI, V55, P11, DOI 10.1017/S0021859600021572; Brown PH, 2002, PLANT BIOLOGY, V4, P205, DOI 10.1055/s-2002-25740; Brown PH., 1996, ANN BOT-LONDON, V77, P497; Colla G, 2011, J PLANT NUTR SOIL SC, V174, P933, DOI 10.1002/jpln.201000325; Colla G, 2010, HORTSCIENCE, V45, P559, DOI 10.21273/HORTSCI.45.4.559; Curci PL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01377-0; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; Demirbas A, 2017, SCI PAP-SER B-HORTIC, V61, P327; Fageria NK., 2016, USE NUTR CROP PLANTS; Goldbach HE, 2001, J PLANT NUTR SOIL SC, V164, P173, DOI 10.1002/1522-2624(200104)164:2<173::AID-JPLN173>3.0.CO;2-F; Goldbach HE, 2007, J PLANT NUTR SOIL SC, V170, P39, DOI 10.1002/jpln.200625161; Gormus O, 2016, COMMUN SOIL SCI PLAN, V47, P915, DOI 10.1080/00103624.2016.1147046; Gregory PJ, 2013, J EXP BOT, V64, P1209, DOI 10.1093/jxb/ers385; Gunes N. T., 2017, BALKAN NEAR E J SOC, V3, P37; Gupta U., 2013, INT J BIOASSAYS, V2, P1048; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kacar B., 2008, PLANT ANAL, P145; KELLEY OJ, 1946, IND ENG CHEM, V18, P319, DOI 10.1021/i560153a018; Krug BA, 2013, HORTSCIENCE, V48, P311, DOI 10.21273/HORTSCI.48.3.311; Landi M., 2012, American Journal of Agricultural and Biological Sciences, V7, P255; Landi M, 2019, PLANTA, V250, P1011, DOI 10.1007/s00425-019-03220-4; Lordkaew S, 2011, PLANT SOIL, V342, P207, DOI 10.1007/s11104-010-0685-7; Luo J, 2013, J EXP BOT, V64, P4207, DOI 10.1093/jxb/ert234; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Meister R, 2014, TRENDS PLANT SCI, V19, P779, DOI 10.1016/j.tplants.2014.08.005; Moustafa-Farag M, 2016, J PLANT NUTR, V39, P1989, DOI 10.1080/01904167.2015.1105263; Munisse P., 2013, AFRICAN J BIOTECHNOL, V12; Nawaz MA., 2016, FRONT PLANT SCI, V7, P1457, DOI [10.3389/fpls.2016.01457, DOI 10.3389/fpls.2016.01457]; Nawaz MA, 2017, INT J AGRIC BIOL, V19, P1165, DOI 10.17957/IJAB/15.0404; Nawaz MA, 2018, PLANT GROWTH REGUL, V85, P41, DOI 10.1007/s10725-018-0372-x; Nawaz MA, 2017, PLANT GROWTH REGUL, V82, P233, DOI 10.1007/s10725-017-0254-7; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; Ozmen S., 2014, DUZCE U BILIM VE TEK, V2, P141; Ozturk M, 2010, PLANT ADAPTATION AND PHYTOREMEDIATION, P275, DOI 10.1007/978-90-481-9370-7_13; Prinsi B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-113; Pulgar G, 2000, BIOL PLANTARUM, V43, P607, DOI 10.1023/A:1002856117053; Rogers ED, 2015, CURR OPIN BIOTECH, V32, P93, DOI 10.1016/j.copbio.2014.11.015; Sakcali MS, 2015, TOXICOL IND HEALTH, V31, P712, DOI 10.1177/0748233713483202; Sarwar N., 2021, J KING SAUD U SCI; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sheng O, 2009, SCI HORTIC-AMSTERDAM, V121, P278, DOI 10.1016/j.scienta.2009.02.009; Shireen F, 2020, PLANT PHYSIOL BIOCH, V154, P204, DOI 10.1016/j.plaphy.2020.06.003; Shireen F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071856; Steel R., 1997, BIOMETRICAL APPROACH; Takei K, 2001, PLANT CELL PHYSIOL, V42, P85, DOI 10.1093/pcp/pce009; Tischner R, 2000, PLANT CELL ENVIRON, V23, P1005, DOI 10.1046/j.1365-3040.2000.00595.x; Tombuloglu H, 2017, J PLANT PHYSIOL, V216, P212, DOI 10.1016/j.jplph.2017.06.013; Tombuloglu H, 2013, MOL GENET GENOMICS, V288, P141, DOI 10.1007/s00438-013-0740-1; Torun AA., 2018, INT J AGR NAT SCI, V1, P228; Wehner Todd C., 2008, V1, P381; Wissuwa M, 2016, J EXP BOT, V67, P3605, DOI 10.1093/jxb/erw061; Xue YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093895	58	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252437	10.1371/journal.pone.0252437	http://dx.doi.org/10.1371/journal.pone.0252437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043729	gold, Green Published			2022-12-26	WOS:000664635700102
J	Kim, HJ; Lee, JH; Kim, SW; Lee, SH; Jung, DW; Williams, DR				Kim, Hyun-Jun; Lee, Ji-Hyung; Kim, Seon-Wook; Lee, Sang-Hoon; Jung, Da-Woon; Williams, Darren R.			Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy	PLOS ONE			English	Article							UBIQUITIN LIGASES; PROTEIN; MECHANISMS; EXERCISE; PATHWAY; MITOCHONDRIA; DEGRADATION; RESISTANCE; SARCOPENIA; SYMPTOMS	Skeletal muscle atrophy is a feature of aging (termed sarcopenia) and various diseases, such as cancer and kidney failure. Effective drug treatment options for muscle atrophy are lacking. The tapeworm medication, niclosamide is being assessed for repurposing to treat numerous diseases, including end-stage cancer metastasis and hepatic steatosis. In this study, we investigated the potential of niclosamide as a repurposing drug for muscle atrophy. In a myotube atrophy model using the glucocorticoid, dexamethasone, niclosamide did not prevent the reduction in myotube diameter or the decreased expression of phosphorylated FOXO3a, which upregulates the ubiquitin-proteasome pathway of muscle catabolism. Treatment of normal myotubes with niclosamide did not activate mTOR, a major regulator of muscle protein synthesis, and increased the expression of atrogin-1, which is induced in catabolic states. Niclosamide treatment also inhibited myogenesis in muscle precursor cells, enhanced the expression of myoblast markers Pax7 and Myf5, and downregulated the expression of differentiation markers MyoD, MyoG and Myh2. In an animal model of muscle atrophy, niclosamide did not improve muscle mass, grip strength or muscle fiber cross-sectional area. Muscle atrophy is also feature of cancer cachexia. IC50 analyses indicated that niclosamide was more cytotoxic for myoblasts than cancer cells. In addition, niclosamide did not suppress the induction of iNOS, a key mediator of atrophy, in an in vitro model of cancer cachexia and did not rescue myotube diameter. Overall, these results suggest that niclosamide may not be a suitable repurposing drug for glucocorticoid-induced skeletal muscle atrophy or cancer cachexia. Nevertheless, niclosamide may be employed as a compound to study mechanisms regulating myogenesis and catabolic pathways in skeletal muscle.	[Kim, Hyun-Jun; Lee, Ji-Hyung; Kim, Seon-Wook; Lee, Sang-Hoon; Jung, Da-Woon; Williams, Darren R.] Gwangju Inst Sci & Technol, Sch Life Sci, New Drug Targets Lab, Gwangju, Jeollanam Do, South Korea	Gwangju Institute of Science & Technology (GIST)	Jung, DW; Williams, DR (corresponding author), Gwangju Inst Sci & Technol, Sch Life Sci, New Drug Targets Lab, Gwangju, Jeollanam Do, South Korea.	jung@gist.ac.kr; darren@gist.ac.kr		Lee, Ji-Hyung/0000-0001-6201-0739; Williams, Darren/0000-0003-2555-3069	National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF-2020R1A2C2014194, NRF-2019R1A2C1006331]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT) [NRF-2020M3A9G3080282]; Institute for Information and Communications Technology Promotion (IITP) grant - Korea government (MSIP) [2019-0-00567]	National Research Foundation of Korea (NRF) - Korean government (MSIT); Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Korean government (MSIT); Institute for Information and Communications Technology Promotion (IITP) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) funded by the Korean government (MSIT) (NRF-2020R1A2C2014194 and NRF-2019R1A2C1006331) and the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. NRF-2020M3A9G3080282). This work was partly supported by the Institute for Information and Communications Technology Promotion (IITP) grant funded by the Korea government (MSIP; No. 2019-0-00567, Development of Intelligent SW systems for uncovering genetic variation and developing personalized medicine for cancer patients with unknown molecular genetic mechanisms). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X; Arend RC, 2016, ONCOTARGET, V7, P86803, DOI 10.18632/oncotarget.13466; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bonetto A, 2012, AM J PHYSIOL-ENDOC M, V303, pE410, DOI 10.1152/ajpendo.00039.2012; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Burton LA, 2010, CLIN INTERV AGING, V5, P217; Carter HN, 2015, PHYSIOLOGY, V30, P208, DOI 10.1152/physiol.00039.2014; Chai WH, 2020, ANTICANCER RES, V40, P1405, DOI 10.21873/anticanres.14082; Chen HJ, 2013, ACS MED CHEM LETT, V4, P180, DOI 10.1021/ml3003082; Chen W, 2017, CELL SIGNAL, V41, P89, DOI 10.1016/j.cellsig.2017.04.001; Chen XZ, 2016, J CACHEXIA SARCOPENI, V7, P224, DOI 10.1002/jcsm.12054; Cheng BX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184324; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Di Marco S, 2005, MOL CELL BIOL, V25, P6533, DOI 10.1128/MCB.25.15.6533-6545.2005; Domingues-Faria C, 2016, AGEING RES REV, V26, P22, DOI 10.1016/j.arr.2015.12.004; Drew L, 2018, NATURE, V555, pS15, DOI 10.1038/d41586-018-02479-z; Duzgunes N, 1999, ADV DRUG DELIVER REV, V40, P3, DOI 10.1016/S0169-409X(99)00037-X; Eley HL, 2008, AM J PHYSIOL-ENDOC M, V295, pE1417, DOI 10.1152/ajpendo.90567.2008; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Fearon KCH, 2002, INT J CARDIOL, V85, P73, DOI 10.1016/S0167-5273(02)00235-8; Feoktistova Maria, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot087379; Fong WN, 2019, CELL MOL LIFE SCI, V76, P3383, DOI 10.1007/s00018-019-03134-0; Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638; Goates S, 2019, J FRALITY AGING, V8, P93, DOI 10.14283/jfa.2019.10; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guadagnin E, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082265; GULVE EA, 1989, BIOCHEM J, V260, P377, DOI 10.1042/bj2600377; Hatamipour M, 2019, ANTI-CANCER AGENT ME, V19, P1618, DOI 10.2174/1871520619666190705120011; Hulseberg CE, 2019, J VIROL, V93, DOI [10.1128/JVI.02185-18, 10.1128/jvi.02185-18]; Jung DW, 2012, ACS CHEM BIOL, V7, P1773, DOI 10.1021/cb3003368; Kwak JY, 2019, ANN GERIATR MED RES, V23, P98, DOI 10.4235/agmr.19.0028; Li J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15201; Li R, 2013, MOL CANCER THER, V12, P2200, DOI 10.1158/1535-7163.MCT-13-0095; Luo F, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0733-7; Miyake T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028628; Molinari F, 2017, J CACHEXIA SARCOPENI, V8, P954, DOI 10.1002/jcsm.12226; Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978; Park JH, 2018, INT J PHARMACEUT, V553, P467, DOI 10.1016/j.ijpharm.2018.10.053; Park SJ, 2011, BMB REP, V44, P517, DOI 10.5483/BMBRep.2011.44.8.517; Phillips SM, 2015, ADV NUTR, V6, P452, DOI 10.3945/an.115.008367; Rajamuthiah R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124595; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ruan Y, 2015, CELL PHYSIOL BIOCHEM, V35, P1116, DOI 10.1159/000373937; Sakuma K, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00230; Sala D, 2016, CURR OPIN CLIN NUTR, V19, P171, DOI 10.1097/MCO.0000000000000273; Shen SN, 2019, J CACHEXIA SARCOPENI, V10, P429, DOI 10.1002/jcsm.12393; Singleton JR, 2000, ENDOCRINOLOGY, V141, P2945, DOI 10.1210/en.141.8.2945; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Suzuki A, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.168351; Suzuki A, 2015, MOL CELL BIOL, V35, P1763, DOI 10.1128/MCB.01180-14; Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699; Tomasin R, 2019, J CACHEXIA SARCOPENI, V10, P1183, DOI 10.1002/jcsm.12475; Uzu M, 2019, J PHARMACOL SCI, V140, P109, DOI 10.1016/j.jphs.2019.04.005; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; Yoon MS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00788; Zhan H, INT J CLIN EXP MED, V13, P440; Zhang LP, 2013, CELL METAB, V18, P368, DOI 10.1016/j.cmet.2013.07.012; Zhang XW, 2015, J MICROENCAPSUL, V32, P496, DOI 10.3109/02652048.2015.1057251; Zhao WD, 2009, BIOCHEM BIOPH RES CO, V378, P668, DOI 10.1016/j.bbrc.2008.11.123; Zhu YX, 2019, BIOCHEM PHARMACOL, V169, DOI 10.1016/j.bcp.2019.08.012; Zimmers TA, 2016, SEMIN CELL DEV BIOL, V54, P28, DOI 10.1016/j.semcdb.2016.02.009	62	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0252135	10.1371/journal.pone.0252135	http://dx.doi.org/10.1371/journal.pone.0252135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OP	34038481	gold, Green Published			2022-12-26	WOS:000664633500054
J	Chang, CH; Lin, YL; Tyan, YS; Chiu, YH; Liang, YH; Chen, CP; Wu, JC; Wang, HS				Chang, Chun-Hao; Lin, Yun-Li; Tyan, Yeu-Sheng; Chiu, Yun-Hsuan; Liang, Ya-Han; Chen, Chie-Pein; Wu, Jiahn-Chun; Wang, Hwai-Shi			Interleukin-1 beta-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration	PLOS ONE			English	Article							NF-KAPPA-B; EXPRESSION; TRANSPLANTATION; ALPHA; MMP3	Human umbilical cord Wharton's jelly derived mesenchymal stem cells (hUCMSCs), a source of cell therapy, have received a great deal of attention due to their homing or migrating ability in response to signals emanating from damaged sites. It has been found that IL-1 beta possesses the ability to induce the expression of matrix metalloproteinase-3 (MMP-3) in bone marrow MSCs. MMP-3 is involved in cell migration in various types of cells, including glioblastoma, vascular smooth muscle, and adult neural progenitor cells. In this study, we proposed that IL-1 beta influences hUCMSCs migration involving MMP-3. The expression level of MMP-3 in IL-1 beta -induced hUCMSCs was verified using cDNA microarray analysis, quantitative real-time PCR, ELISA and Western blot. Wound-healing and trans-well assay were used to investigate the cell migration and invasion ability of IL-1 beta -treated hUCMSCs. In addition, we pre-treated hUCMSCs with interleukin-1 receptor antagonist, MMP-3 inhibitors (ALX-260-165, UK 356618), or transfected with MMP-3 siRNA to confirm the role of MMP3 in IL-1 beta -induced cell migration. Our results showed that IL-1 beta induced MMP-3 expression is related to the migration of hUCMSCs. Moreover, extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) inhibitor U0126, p38 inhibitor SB205380, JNK inhibitor SP600125 and Akt inhibitor GSK 690693 decreased IL-1 beta -induced MMP-3 mRNA and protein expression. The migration and invasion ability analyses showed that these inhibitors attenuated the IL-1 beta -induced migration and invasion ability of hUCMSCs. In conclusion, we have found that IL-1 beta induces the expression of MMP-3 through ERK1/2, JNK, p38 MAPK and Akt signaling pathways to enhance the migration of hUCMSCs. These results provide further understanding of the mechanisms in IL-1 beta -induced hUCMSCs migration to injury sites.	[Chang, Chun-Hao; Lin, Yun-Li; Chiu, Yun-Hsuan; Liang, Ya-Han; Wu, Jiahn-Chun; Wang, Hwai-Shi] Natl Yang Ming Chiao Tung Univ, Sch Med, Inst Anat & Cell Biol, Taipei, Taiwan; [Tyan, Yeu-Sheng] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung, Taiwan; [Chen, Chie-Pein] Mackay Mem Hosp, Div High Risk Pregnancy, Taipei, Taiwan	National Yang Ming Chiao Tung University; Chung Shan Medical University; Chung Shan Medical University Hospital; Mackay Memorial Hospital	Wang, HS (corresponding author), Natl Yang Ming Chiao Tung Univ, Sch Med, Inst Anat & Cell Biol, Taipei, Taiwan.	hswang@ym.edu.tw	CHEN, CHEN/HDM-6657-2022		Ministry of Science and Technology of the Republic of China, Taiwan [MOST-104-2320-B-010-0090MY3, MOST-107-2320-B-010-029-MY3]; Ministry of Education, Taiwan, Aim for the Top University Plan	Ministry of Science and Technology of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Aim for the Top University Plan	This work is financially supported by the Ministry of Science and Technology of the Republic of China, Taiwan, under project number MOST-104-2320-B-010-0090MY3 and MOST-107-2320B-010-029-MY3 (H.-S. Wang), and from the Ministry of Education, Taiwan, Aim for the Top University Plan to H.-S. Wang.	Aftab Q, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00143; Allers C, 2004, TRANSPLANTATION, V78, P503, DOI 10.1097/01.TP.0000128334.93343.B3; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; BACON KB, 1989, BIOCHEM BIOPH RES CO, V165, P349, DOI 10.1016/0006-291X(89)91076-0; Bayo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095171; Carrero R, 2012, STEM CELL REV REP, V8, P905, DOI 10.1007/s12015-012-9364-9; Chen MS, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/3524759; Cheng CY, 2009, J CELL PHYSIOL, V219, P183, DOI 10.1002/jcp.21669; EBISAWA M, 1992, J IMMUNOL, V149, P4021; Fu XB, 2009, WOUND REPAIR REGEN, V17, P185, DOI 10.1111/j.1524-475X.2009.00454.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kang SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/342968; Kelley MJ, 2007, INVEST OPHTH VIS SCI, V48, P2634, DOI 10.1167/iovs.06-1445; Kollar Katarina, 2009, Int J Cell Biol, V2009, P904682, DOI 10.1155/2009/904682; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Lin CC, 2009, CELL SIGNAL, V21, P1652, DOI 10.1016/j.cellsig.2009.07.002; Lin TH, 2016, ARTERIOSCL THROM VAS, V36; Liu G Y, 2017, Zhonghua Yi Xue Za Zhi, V97, P698, DOI 10.3760/cma.j.issn.0376-2491.2017.09.014; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Mountain DJH, 2007, AM J PHYSIOL-CELL PH, V292, pC867, DOI 10.1152/ajpcell.00161.2006; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Tseng HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057955; Wang FM, 2005, BREAST CANCER RES TR, V89, P5, DOI 10.1007/s10549-004-1002-z; Wang X, 2011, INT J MOL MED, V27, P583, DOI 10.3892/ijmm.2011.611; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Zhao M, 2012, CANCER BIOL THER, V13, P782, DOI 10.4161/cbt.20561	27	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252163	10.1371/journal.pone.0252163	http://dx.doi.org/10.1371/journal.pone.0252163			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019587	Green Published, gold			2022-12-26	WOS:000664632300057
J	Cho, T; Pendar, H; Chung, J				Cho, Taewon; Pendar, Hodjat; Chung, Julianne			Computational tools for inversion and uncertainty estimation in respirometry	PLOS ONE			English	Article							PHYSIOLOGICAL SYSTEMS; DECONVOLUTION; ALGORITHMS	In many physiological systems, real-time endogeneous and exogenous signals in living organisms provide critical information and interpretations of physiological functions; however, these signals or variables of interest are not directly accessible and must be estimated from noisy, measured signals. In this paper, we study an inverse problem of recovering gas exchange signals of animals placed in a flow-through respirometry chamber from measured gas concentrations. For large-scale experiments (e.g., long scans with high sampling rate) that have many uncertainties (e.g., noise in the observations or an unknown impulse response function), this is a computationally challenging inverse problem. We first describe various computational tools that can be used for respirometry reconstruction and uncertainty quantification when the impulse response function is known. Then, we address the more challenging problem where the impulse response function is not known or only partially known. We describe nonlinear optimization methods for reconstruction, where both the unknown model parameters and the unknown signal are reconstructed simultaneously. Numerical experiments show the benefits and potential impacts of these methods in respirometry.	[Cho, Taewon; Chung, Julianne] Virginia Tech, Dept Math, Blacksburg, VA 24061 USA; [Pendar, Hodjat] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Chung, Julianne] Virginia Tech, Acad Integrated Sci, Computat Modeling & Data Analyt Div, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Chung, J (corresponding author), Virginia Tech, Dept Math, Blacksburg, VA 24061 USA.; Chung, J (corresponding author), Virginia Tech, Acad Integrated Sci, Computat Modeling & Data Analyt Div, Blacksburg, VA 24061 USA.	jmchung@vt.edu		Pendar, Hodjat/0000-0001-8853-0062	National Science Foundation [DMS-1654175, DMS-1638521, IOS-1558052]	National Science Foundation(National Science Foundation (NSF))	This work was partially supported by the National Science Foundation under Grants DMS-1654175 (to JC), DMS-1638521 to the Statistical and Applied Mathematical Sciences Institute, and IOS-1558052 (to HP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardsley JM., 2018, COMPUTATIONAL UNCERT; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; Beck A, 2009, IEEE T IMAGE PROCESS, V18, P2419, DOI 10.1109/TIP.2009.2028250; Benzi M, 2002, J COMPUT PHYS, V182, P418, DOI 10.1006/jcph.2002.7176; Bjorck A., 1996, NUMERICAL METHODS LE; Bubba TA, 2019, INVERSE PROBL, V35, DOI 10.1088/1361-6420/ab10ca; Bui-Thanh T, 2012, INT CONF HIGH PERFOR; Calvetti D., 2007, INTRO BAYESIAN SCI C, V2; Campos-Delgado DU, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.7.075010; CHAN RH, 1989, SIAM J SCI STAT COMP, V10, P104, DOI 10.1137/0910009; CHAN RH, 1994, SIAM J MATRIX ANAL A, V15, P80, DOI 10.1137/S0895479891223021; Chan T. F., 1994, NUMER ALGORITHMS, V1, P89, DOI [10.1007/BF02149764, DOI 10.1007/BF02149764]; Cho T, 2021, INVERSE PROBL, V37, DOI 10.1088/1361-6420/abd29d; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; Chung J, 2007, ELECTRON T NUMER ANA, V28, P149; Chung J, 2006, INVERSE PROBL, V22, P1261, DOI 10.1088/0266-5611/22/4/009; Chung J, 2019, SIAM J SCI COMPUT, V41, pS149, DOI 10.1137/18M1194456; Chung J, 2017, SIAM J SCI COMPUT, V39, pS24, DOI 10.1137/16M1081968; DeNicolao G, 1997, AUTOMATICA, V33, P851, DOI 10.1016/S0005-1098(96)00254-3; Gazzola S, 2019, NUMER ALGORITHMS, V81, P773, DOI 10.1007/s11075-018-0570-7; Golub GH., 2013, MATRIX COMPUTATIONS; Groenewald B, 2012, J EXP BIOL, V215, P2301, DOI 10.1242/jeb.070995; HANKE M, 1993, NUMERICAL LINEAR ALGEBRA, P141; Hansen P.C., 2013, LEAST SQUARES DATA F; Hansen PC, 2010, FUND ALGORITHMS, pIX; Harrison JF, 1997, AM ZOOL, V37, P73; Harrison JF, 2013, PHYSIOLOGY, V28, P18, DOI 10.1152/physiol.00043.2012; Hochstenbach ME, 2010, J INTEGRAL EQU APPL, V22, P465, DOI 10.1216/JIE-2010-22-3-465; Kaipio J., 2006, STAT COMPUTATIONAL I, V160; Kazemi N, 2018, GEOPHYSICS, V83, pV345, DOI 10.1190/GEO2018-0136.1; Kilmer ME, 2001, SIAM J MATRIX ANAL A, V22, P1204, DOI 10.1137/S0895479899345960; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; OLEARY DP, 1981, SIAM J SCI STAT COMP, V2, P474, DOI 10.1137/0902037; Pendar H, 2016, BIOL OPEN, V5, P1163, DOI 10.1242/bio.019133; Pendar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139508; Pendar H, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0259; Reichel L, 2012, APPL NUMER MATH, V62, P1215, DOI 10.1016/j.apnum.2010.10.002; Saad Y., 2003, ITERATIVE METHODS SP; Saibaba AK, 2020, NUMER LINEAR ALGEBR, V27, DOI 10.1002/nla.2325; Tan BT, 2013, SIAM J SCI COMPUT, V35, pA2494, DOI 10.1137/12089586X; Tartes U, 2002, COMP BIOCHEM PHYS A, V133, P611, DOI 10.1016/S1095-6433(02)00173-3; VELDHUIS JD, 1987, P NATL ACAD SCI USA, V84, P7686, DOI 10.1073/pnas.84.21.7686; Wang Z, 2017, SIAM J SCI COMPUT, V39, pS140, DOI 10.1137/16M1080938; Westneat MW, 2003, SCIENCE, V299, P558, DOI 10.1126/science.1078008; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892	45	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0251926	10.1371/journal.pone.0251926	http://dx.doi.org/10.1371/journal.pone.0251926			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019586	gold, Green Published			2022-12-26	WOS:000664632300040
J	Jez, JM				Jez, Joseph M.			The tail of chlorophyll: Fates for phytol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DEGRADATION; MUTANT	Understanding the pathways involved in chlorophyll breakdown provides a molecular map to the color changes observed in plant life on a global scale each fall. Surprisingly, little is known about the fate of phytol, chlorophyll's 20-carbon branched-chain tail, during this process. A recent study from Gutbrod et al. provides evidence using physiological, genetic, and exquisitely sensitive analytical approaches that phytenal is an intermediate in plant phytol catabolism. These insights and techniques open the door to further investigation of this complicated metabolic system, with implications for plant health and agriculture.						Welti, Ruth/0000-0003-4373-2538	USDA National Institute of Food and Agriculture [1013013]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Research on plant lipid metabolism in the Durrett and Welti groups is supported by the USDA National Institute of Food and Agriculture, Hatch/Multi-State project 1013013. This is contribution 21-255-J from the Kansas Agricultural Experiment Station.	Gutbrod K, 2019, PROG LIPID RES, V74, P1, DOI 10.1016/j.plipres.2019.01.002; Gutbrod P., 2021, J BIOL CHEM, V296; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Lippold F, 2012, PLANT CELL, V24, P2001, DOI 10.1105/tpc.112.095588; Rontani JF, 1996, PHYTOCHEMISTRY, V42, P347, DOI 10.1016/0031-9422(95)00872-1; Shimada H, 2005, PLANT J, V41, P627, DOI 10.1111/j.1365-313X.2004.02326.x; Valentin HE, 2006, PLANT CELL, V18, P212, DOI 10.1105/tpc.105.037077; van den Brink DM, 2005, J BIOL CHEM, V280, P26838, DOI 10.1074/jbc.M501861200; vom Dorp K, 2015, PLANT CELL, V27, P2846, DOI 10.1105/tpc.15.00395	10	1	1	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100802	10.1016/j.jbc.2021.100802	http://dx.doi.org/10.1016/j.jbc.2021.100802			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022219	gold, Green Published			2022-12-26	WOS:000674717300022
J	Matsubara, T; Addison, WN; Kokabu, S; Neff, L; Horne, W; Gori, F; Baron, R				Matsubara, Takuma; Addison, William N.; Kokabu, Shoichiro; Neff, Lynn; Horne, William; Gori, Francesca; Baron, Roland			Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-ACTIVITY; FAMILY KINASES; TYROSINE KINASES; LIPID RAFTS; SH3 DOMAINS; CBL; DIFFERENTIATION; BINDING; BONE; GENE	Deletion of c-Src, a ubiquitously expressed tyrosine kinase, results in osteoclast dysfunction and osteopetrosis, in which bones harden into "stone." In contrast, deletion of the genes encoding other members of the Src family kinase (SFK) fails to produce an osteopetrotic phenotype. This suggests that c-Src performs a unique function in the osteoclast that cannot be compensated for by other SFKs. We aimed to identify the molecular basis of this unique role in osteoclasts and bone resorption. We found that c-Src, Lyn, and Fyn were the most highly expressed SFKs in WT osteoclasts, whereas Hck, Lck, Blk, and Fgr displayed low levels of expression. Formation of the podosome belt, clusters of unique actin assemblies, was disrupted in src(-/-) osteoclasts; introduction of constitutively activated SFKs revealed that only c-Src and Fyn could restore this process. To identify the key structural domains responsible, we constructed chimeric Src-Hck and Src-Lyn constructs in which the unique, SH3, SH2, or catalytic domains had been swapped. We found that the Src unique, SH3, and kinase domains were each crucial to establish Src functionality. The SH2 domain could however be substituted with Lyn or Hck SH2 domains. Furthermore, we demonstrate that c-Src's functionality is, in part, derived from an SH3-proximal proline-rich domain interaction with c-Cbl, leading to phosphorylation of c-Cbl Tyr700. These data help clarify Src's unique functionality in the organization of the cytoskeleton in osteoclasts, required for efficient bone resorption and explain why c-Src cannot be replaced, in osteoclasts, by other SFKs.	[Matsubara, Takuma; Addison, William N.; Neff, Lynn; Horne, William; Gori, Francesca; Baron, Roland] Harvard Sch Dent Med, Div Bone & Mineral Res, Oral Med Infect & Immun, Boston, MA 02115 USA; [Matsubara, Takuma; Addison, William N.; Kokabu, Shoichiro] Kyushu Dent Univ, Dept Hlth Improvement, Div Mol Signaling & Biochem, Fukuoka, Japan; [Baron, Roland] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Baron, Roland] MGH, Endocrine Unit, Boston, MA 02114 USA	Harvard University; Harvard School of Dental Medicine; Kyushu Dental University; Harvard University; Harvard Medical School	Matsubara, T; Baron, R (corresponding author), Harvard Sch Dent Med, Div Bone & Mineral Res, Oral Med Infect & Immun, Boston, MA 02115 USA.; Matsubara, T (corresponding author), Kyushu Dent Univ, Dept Hlth Improvement, Div Mol Signaling & Biochem, Fukuoka, Japan.; Baron, R (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Baron, R (corresponding author), MGH, Endocrine Unit, Boston, MA 02114 USA.	r15matsubara@fa.kyu-dent.ac.jp; Roland_Baron@hsdm.harvard.edu		Kokabu, Shoichiro/0000-0002-6663-4327	Japan Society for the Promotion of Science [18K09509, 18K09524, 22-43]; NIH [R01AR042927, R01-AR062054]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Japan Society for the Promotion of Science (Postdoctoral fellowship for research abroad 22-43 and 18K09509 for T. M. and 18K09524 for S. K.) and Grants from the NIH to R. B. (R01AR042927 and R01-AR062054). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Brdickova N, 2003, J EXP MED, V198, P1453, DOI 10.1084/jem.20031484; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Cai HJ, 2011, P NATL ACAD SCI USA, V108, P6579, DOI 10.1073/pnas.1103904108; Chiusaroli R, 2003, DEV BIOL, V261, P537, DOI 10.1016/S0012-1606(03)00299-9; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kelley LC, 2010, J CELL SCI, V123, P3923, DOI 10.1242/jcs.075200; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kojima H, 2005, J BIOL CHEM, V280, P2944, DOI 10.1074/jbc.M311598200; LEVINSON AD, 1980, J BIOL CHEM, V255, P1973; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Lowell CA, 1996, BLOOD, V87, P1780; Matsubara T, 2010, J BONE MINER RES, V25, P1068, DOI 10.1359/jbmr.091039; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Miyazaki Tsuyoshi, 2006, Mod Rheumatol, V16, P68; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sanjay A, 2006, FEBS J, V273, P5442, DOI 10.1111/j.1742-4658.2006.05535.x; Scaife RM, 2000, J CELL SCI, V113, P215; Sirvent A, 2008, ONCOGENE, V27, P3494, DOI 10.1038/sj.onc.1211011; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Szymkiewicz I, 2004, FEBS LETT, V565, P33, DOI 10.1016/j.febslet.2004.03.100; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Yoon SH, 2009, FEBS LETT, V583, P1164, DOI 10.1016/j.febslet.2009.03.005; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	46	4	4	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100790	10.1016/j.jbc.2021.100790	http://dx.doi.org/10.1016/j.jbc.2021.100790			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019873	Green Published, gold			2022-12-26	WOS:000674717300011
J	Yuan, BCA; Wu, ZW; Ji, W; Liu, D; Guo, X; Yang, DH; Fan, AL; Jia, HL; Ma, M; Lin, WH				Yuan, Bochuan; Wu, Ziwei; Ji, Wei; Liu, Dong; Guo, Xiang; Yang, Donghui; Fan, Aili; Jia, Hongli; Ma, Ming; Lin, Wenhan			Discovery of cyclohexadepsipeptides with anti-Zika virus activities and biosynthesis of the nonproteinogenic building block (3S)-methyl-L-proline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEAUVERIA-FELINA; INSECTICIDAL ACTIVITY; CYCLODEPSIPEPTIDES; FUNGUS; METABOLITES; DESTRUXINS; ACID; IDENTIFICATION; EXPRESSION; LEADS	The fungal cyclohexadepsipeptides destruxins (DTXs), isaridins (ISDs), and isariins (ISRs) are nonribosomal peptides whose structures include a 19-membered ring composed of five amino acid residues and one alpha- or beta-hydroxy acid residue. These cyclohexadepsipeptides contain unusual nonproteinogenic amino acid-building blocks and possess a range of antiviral, antibacterial, and other activities. The biosynthetic gene clusters for ISDs and ISRs have not been identified, and the biosynthesis of the nonproteinogenic (3S)-methyl-L-proline residue, which is found in DTXs, ISDs, and many other natural products, lacks full characterization. In an ongoing effort to identify compounds that can inhibit the Zika virus (ZIKV), we examined the extract of marine-derived fungus Beauveria felina SX-6-22 and discovered 30 DTXs, ISDs, and ISRs (1-30) including seven new compounds (1-7). The anti-ZIKV assays showed that 9-12 and 16-18 possess inhibitory activities against ZIKV RNA replication and NS5 (nonstructural protein 5) production in ZIKV-infected A549 cells. We sequenced the genome of B. felina SX-6-22 and identified three biosynthetic gene clusters detx, isd and isr, which are responsible for the biosynthesis of DTXs, ISDs, and ISRs, respectively. Comparative analyses of the three gene clusters clarified the biosynthetic relationships among these cyclohexadepsipeptides. Finally, we characterized the entire biosynthesis of nonproteinogenic building block (3S)-methyl-L-proline. The.1-pyrroline-5-carboxylate reductases (P5CRs), also used in the biosynthesis of L-proline, were demonstrated to catalyze the final reduction step in (3S)-methyl-L-proline formation, suggesting potential cross talk between primary and secondary metabolisms. These results provide opportunities for biosynthetic pathway engineering to generate new anti-ZIKV cyclohexadepsipeptides.	[Yuan, Bochuan; Wu, Ziwei; Liu, Dong; Guo, Xiang; Yang, Donghui; Fan, Aili; Jia, Hongli; Ma, Ming; Lin, Wenhan] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Ji, Wei] Peking Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Lin, Wenhan] Peking Univ, Inst Ocean Res, Beijing, Peoples R China	Peking University; Peking University; Peking University	Ma, M; Lin, WH (corresponding author), Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China.; Lin, WH (corresponding author), Peking Univ, Inst Ocean Res, Beijing, Peoples R China.	mma@bjmu.edu.cn; whlin@bjmu.edu.cn			National Natural Science Foundation of China [81991525-5, 81630089, 21861142006, 81872793]; MOST of China [2018ZX09711001-001-008, 2019YFC0312502]; COMRA [DY135-B-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST of China(Ministry of Science and Technology, China); COMRA	This work was supported by grants from National Natural Science Foundation of China (81991525-5, 81630089, 21861142006, 81872793), COMRA (DY135-B-05), and MOST of China (2018ZX09711001-001-008, 2019YFC0312502).	Bezsudnova EY, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1572, DOI 10.1134/S0006297917130028; Cavelier F, 1998, PESTIC SCI, V52, P81, DOI 10.1002/(SICI)1096-9063(199801)52:1&lt;81::AID-PS666&gt;3.0.CO;2-H; Chambellon E, 2009, J BACTERIOL, V191, P873, DOI 10.1128/JB.01114-08; Che Y, 2001, J NAT PROD, V64, P555, DOI 10.1021/np000547r; Chiang YM, 2008, CHEM BIOL, V15, P527, DOI 10.1016/j.chembiol.2008.05.010; Chooi YH, 2010, CHEM BIOL, V17, P791, DOI 10.1016/j.chembiol.2010.08.001; Chung YM, 2013, J NAT PROD, V76, P1260, DOI 10.1021/np400143j; Crone WJK, 2016, ANGEW CHEM INT EDIT, V55, P9639, DOI 10.1002/anie.201604304; de Vita-Marques AM, 2008, QUIM NOVA, V31, P1099, DOI 10.1590/S0100-40422008000500030; Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Du FY, 2014, J NAT PROD, V77, P1164, DOI 10.1021/np4011037; Du FY, 2014, MAR DRUGS, V12, P2816, DOI 10.3390/md12052816; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; El-Elimat T, 2013, J NAT PROD, V76, P1709, DOI 10.1021/np4004307; Fichman Y, 2015, BIOL REV, V90, P1065, DOI 10.1111/brv.12146; Fredenhagen A, 2006, J ANTIBIOT, V59, P267, DOI 10.1038/ja.2006.38; Han PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060771; Hou XM, 2019, J ORG CHEM, V84, P1228, DOI 10.1021/acs.joc.8b02614; Jiang W, 2013, J AM CHEM SOC, V135, P4457, DOI 10.1021/ja312572v; Kim HM, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1530-8; Langenfeld A, 2011, J NAT PROD, V74, P825, DOI 10.1021/np100890n; Li L, 2018, J AM CHEM SOC, V140, P2067, DOI 10.1021/jacs.8b00056; Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737; Liu BL, 2012, BIOTECHNOL ADV, V30, P1242, DOI 10.1016/j.biotechadv.2011.10.006; Lozano-Tovar MD, 2015, J ECON ENTOMOL, V108, P462, DOI 10.1093/jee/tov041; Lukassen MB, 2015, MAR DRUGS, V13, P4331, DOI 10.3390/md13074331; Lukat P, 2017, CHEM SCI, V8, P7521, DOI 10.1039/c7sc02622f; Miller KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035953; Morais-Urano RP, 2012, EXP PARASITOL, V132, P362, DOI 10.1016/j.exppara.2012.08.011; ODIER F, 1992, BIOL CELL, V74, P267, DOI 10.1016/0248-4900(92)90037-2; Olivon F, 2019, J NAT PROD, V82, P330, DOI 10.1021/acs.jnatprod.8b00800; Owczarek K, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0349-z; Prieto C, 2012, BIOINFORMATICS, V28, P426, DOI 10.1093/bioinformatics/btr659; Sabareesh V, 2007, J NAT PROD, V70, P715, DOI 10.1021/np060532e; Shimamura H, 2009, ANGEW CHEM INT EDIT, V48, P914, DOI 10.1002/anie.200804138; Stocking EM, 1996, J AM CHEM SOC, V118, P7008, DOI 10.1021/ja961322z; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tan LT, 2003, J ORG CHEM, V68, P8767, DOI 10.1021/jo030191z; Tanner JJ, 2018, BIOCHEMISTRY-US, V57, P3433, DOI 10.1021/acs.biochem.8b00215; VINING LC, 1962, CAN J CHEM, V40, P1579, DOI 10.1139/v62-239; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Yeh SF, 1996, BIOCHEM BIOPH RES CO, V229, P65, DOI 10.1006/bbrc.1996.1758; Yoshida M, 2015, CHEM-EUR J, V21, P18417, DOI 10.1002/chem.201502970; Yoshida M, 2010, ORG LETT, V12, P3792, DOI 10.1021/ol101449x; Yuan BC, 2020, APPL MICROBIOL BIOT, V104, P6149, DOI 10.1007/s00253-020-10678-w; Zhou YM, 2018, MAR DRUGS, V16, DOI 10.3390/md16120519	47	3	3	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100822	10.1016/j.jbc.2021.100822	http://dx.doi.org/10.1016/j.jbc.2021.100822			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029593	gold, Green Published			2022-12-26	WOS:000678068400024
J	Fleisher, I; Geboy, AG; Nichols, W; Desale, S; Fernandez, S; Basch, P; Fishbein, DA				Fleisher, Ilan; Geboy, Alexander G.; Nichols, Whitney; Desale, Sameer; Fernandez, Stephen; Basch, Peter; Fishbein, Dawn A.			HIV testing in patients who are HCV positive: Compliance with CDC guidelines in a large healthcare system	PLOS ONE			English	Article							RECOMMENDATIONS	Background There are approximately 300,000 people in the United States who are co-infected with HIV and HCV. Several organizations recommend that individuals who are HCV infected, as well as persons over the age of 13, should be HIV tested. Comorbidities associated with HCV can be reduced with early identification of HIV. Our objective was to determine whether providers routinely followed HIV testing guidelines for patients who tested HCV positive (HCV+). Methods A retrospective chart review was conducted of all patients in primary care at an academic health system from 7/2015-3/2017 who tested HCV+. As part of a primary database, HCV testing data was collected; HIV testing data was abstracted manually. We collected and described the intervals between HCV and HIV tests. To determine associations with HIV testing univariable and multivariable analyses were performed. Results We identified 445 patients who tested HCV+: 56.6% were tested for HIV, the mean age was 57 10.9 years, 77% were from the Birth Cohort born 1945-1965 (BC); 61% were male; and 51% were Black/AA. Patients in the BC were more likely to be HIV tested if they were: male (p = 0.019), Black/AA (p<0.001), and had Medicaid (p = 0.005). These differences were not found in the non-BC. Six patients who were tested for both HIV and HCV were found to be newly HIV positive at the time of testing. Conclusion As demonstrated, providers did not routinely follow CDC recommendations as almost half of the HCV+ patients were not correctly tested for HIV. It is important to emphasize that six persons were tested HIV positive simultaneously with their HCV+ diagnosis. If providers did not follow the CDC guidelines, then these patients may not have been identified. Improvements in EHR clinical decision support tools and provider education can help improve the HIV testing rate among individuals who are HCV+.	[Fleisher, Ilan; Geboy, Alexander G.; Nichols, Whitney; Desale, Sameer; Fernandez, Stephen; Fishbein, Dawn A.] MedStar Hlth Res Inst, MedStar Hlth, Hyattsville, MD 20782 USA; [Fleisher, Ilan] New York Med Coll, Valhalla, NY 10595 USA; [Geboy, Alexander G.] Assoc Amer Med Coll, Washington, DC USA; [Nichols, Whitney] Frank H Netter Sch Med Quinnipiac, North Haven, CT USA; [Basch, Peter] MedStar Hlth, Columbia, MD USA; [Fishbein, Dawn A.] MedStar Washington Hosp Ctr, Washington, DC USA	MedStar Health Research Institute; New York Medical College; Association of American Medical Colleges; MedStar Washington Hospital Center	Fleisher, I (corresponding author), MedStar Hlth Res Inst, MedStar Hlth, Hyattsville, MD 20782 USA.; Fleisher, I (corresponding author), New York Med Coll, Valhalla, NY 10595 USA.	ifleish@gmail.com		Fleisher, Ilan/0000-0001-7418-9908	Gilead Sciences FOCUS Partnership	Gilead Sciences FOCUS Partnership	Dr. Fishbein has been funded by Gilead Sciences FOCUS Partnership for her research and as an Advisor to Gilead on HCV Elimination. No other authors had any relevant conflict of interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bini EJ, 2006, J CLIN GASTROENTEROL, V40, P732, DOI 10.1097/00004836-200609000-00014; Bosh KA, 2018, EPIDEMIOL INFECT, V146, P920, DOI [10.1017/S0950268818000766, 10.1017/s0950268818000766]; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CDCP, 1998, MMWR, V47; Centers for Disease Control and Prevention, 2018, HIV SURV REP, V31; Hoover KW, 2020, MMWR-MORBID MORTAL W, V69, P776, DOI 10.15585/mmwr.mm6925a2; Ireland G, 2018, HIV MED, V19, pE54, DOI 10.1111/hiv.12525; Krain A, 2004, MAYO CLIN PROC, V79, P51, DOI 10.4065/79.1.51; Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926; Ngo-Metzger Q, 2013, ANN INTERN MED, V159, P364, DOI 10.7326/0003-4819-159-5-201309030-00675; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	11	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252412	10.1371/journal.pone.0252412	http://dx.doi.org/10.1371/journal.pone.0252412			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077476	Green Published, gold			2022-12-26	WOS:000664638500043
J	Ouboter, DA; Kadosoe, VS; Ouboter, PE				Ouboter, Dimitri A.; Kadosoe, Vanessa S.; Ouboter, Paul E.			Impact of ecotourism on abundance, diversity and activity patterns of medium-large terrestrial mammals at Brownsberg Nature Park, Suriname	PLOS ONE			English	Article							OCELOT LEOPARDUS-PARDALIS; JAGUAR PANTHERA-ONCA; PUMA PUMA-CONCOLOR; CAMERA-TRAPS; RAIN-FOREST; SEEDLING RECRUITMENT; HUMAN DISTURBANCE; FEEDING ECOLOGY; NATIONAL-PARK; HABITAT USE	The impacts of ecotourism on biodiversity are poorly understood and the outcome of this type of research is often contradictory. On the one hand ecotourism could impact the occurrence, survival or behavior of species, on the other hand ecotourism is often mentioned as providing a "human shield" by deterring negative practices like gold mining, logging and hunting. Brownsberg Nature Park is easily the most visited protected area of Suriname, with a high number of ecotourists visiting from abroad. A four-year study on the impact of ecotourism on medium-large terrestrial mammals was carried out between 2013 and 2016 using 16 camera trap stations. The area has a clear gradient of tourism pressure, with the pressure decreasing further away from the lodging facilities. Evidently, the impacts of human presence on the mammal communities were more significant in the busiest areas. Most species avoided areas with many hikers or switched to a more nocturnal activity pattern. In these areas the impact was not reflected in species numbers, however it was causing a significant decrease in the diversity of mammals. On the other hand, vehicles had little impact on species avoidance or diversity, but did increase nocturnality, even more than hikers. A few species seemed to be "attracted" by hikers and/or traffic. Giant armadillos (Priodontes maximus) and spotted pacas (Cuniculus paca) used the pools in the road created by traffic. Ocelots (Leopardus pardalis), margays (Leopardus wiedii) and red-rumped agoutis (Dasyprocta leporina) seemed to favor human disturbance probably because of predator release. Some of the most impacted species were the jaguar (Panthera onca), puma (Puma concolor) and lowland tapir (Tapirus terrestris), all three species with significant contribution to ecosystem balance. Management measures should focus on lowering the number of hikers in popular places and limiting the number of vehicles in recreational areas.	[Ouboter, Dimitri A.; Kadosoe, Vanessa S.; Ouboter, Paul E.] Inst Neotrop Wildlife & Environm Studies, Paramaribo, Suriname		Ouboter, PE (corresponding author), Inst Neotrop Wildlife & Environm Studies, Paramaribo, Suriname.	paul.ouboter@neowild.org		Ouboter, Paul/0000-0003-3114-8676	Belgian Directorate-General for Development Cooperation (DGDC); Flemish Interuniversity Council (VLIR-UOS)	Belgian Directorate-General for Development Cooperation (DGDC); Flemish Interuniversity Council (VLIR-UOS)	This work was partly supported by funding from the Belgian Directorate-General for Development Cooperation (DGDC) and the Flemish Interuniversity Council (VLIR-UOS). The funders had no role in study design, data and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C., 2017, R PACKAGECIRCULARCIR; Ahumada JA, 2011, PHILOS T R SOC B, V366, P2703, DOI 10.1098/rstb.2011.0115; Aliaga-Rossel E, 2006, BIOTROPICA, V38, P691, DOI 10.1111/j.1744-7429.2006.00192.x; Arets EJMM, 2006, 1359 ALT, P1; Astete S, 2017, J ARID ENVIRON, V146, P27, DOI 10.1016/j.jaridenv.2017.07.005; Aylward B, 1996, BIODIVERS CONSERV, V5, P315, DOI 10.1007/BF00051777; Beck H, 2006, J MAMMAL, V87, P519, DOI 10.1644/05-MAMM-A-174R1.1; Blake John G., 2017, Neotropical Biodiversity, V3, P57, DOI 10.1080/23766808.2017.1292756; Blake JG, 2014, REV BIOL TROP, V62, P689, DOI 10.15517/rbt.v62i2.11115; Blake JG, 2012, ECOTROPICA, V18, P137; Bogoni JA, 2016, J MAMMAL, V97, P713, DOI 10.1093/jmammal/gyv215; Bookbinder MP, 1998, CONSERV BIOL, V12, P1399, DOI 10.1046/j.1523-1739.1998.97229.x; BRANAN WV, 1985, J WILDLIFE MANAGE, V49, P972, DOI 10.2307/3801381; Brocardo CR, 2013, BIOL CONSERV, V163, P107, DOI 10.1016/j.biocon.2013.04.024; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; Cunha AA, 2010, J NAT CONSERV, V18, P291, DOI 10.1016/j.jnc.2010.01.001; De Dijn Bart P.E., 2007, RAP Bulletin of Biological Assessment, V43, P135; de Oliveira TG, 2014, J MAMM EVOL, V21, P427, DOI 10.1007/s10914-013-9251-4; Martins SD, 2007, BIODIVERS CONSERV, V16, P857, DOI 10.1007/s10531-006-9094-x; EMMONS LH, 1987, BEHAV ECOL SOCIOBIOL, V20, P271, DOI 10.1007/BF00292180; Emsens WJ, 2014, ACTA THERIOL, V59, P257, DOI 10.1007/s13364-013-0159-4; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Feer F, 1997, NEOTROPICAL RAINFORE; FITZGERALD KA, 2002, BROWNSBERG NATURE PA; Foster VC, 2013, BIOTROPICA, V45, P373, DOI 10.1111/btp.12021; Fragoso JMV, 2000, J TROP ECOL, V16, P369, DOI 10.1017/S0266467400001462; Galetti M, 2015, GLOB ECOL CONSERV, V3, P824, DOI 10.1016/j.gecco.2015.04.008; Gaynor KM, 2018, SCIENCE, V360, P1232, DOI 10.1126/science.aar7121; Geffroy B, 2015, TRENDS ECOL EVOL, V30, P755, DOI 10.1016/j.tree.2015.09.010; Gonzalez-Maya JF., 2007, THESIS CTR AGRONOMIC; Gonzalez-Maya JF., CAT NEWS, V53, P11; GRIFFITHS M, 1993, CONSERV BIOL, V7, P623, DOI 10.1046/j.1523-1739.1993.07030623.x; Grossberg R, 2003, ENVIRON CONSERV, V30, P40, DOI 10.1017/S0376892903000031; Gutierrez Beatriz Lopez, 2020, Journal of Ecotourism, V19, P197; Harmsen BJ, 2010, BIOTROPICA, V42, P126, DOI 10.1111/j.1744-7429.2009.00544.x; Hidinger LA., 1996, YALE FOR ENV B, V99, P49; Hoop CU, 1991, VERDRONKEN LAND VERD; Isasi-Catala E, 2012, THESIS U S BOLIVAR S; Jax Elinor, 2015, Journal of Threatened Taxa, V7, P6739, DOI 10.11609/JoTT.o3915.6739-49; Kadosoe VS., 2020, THESIS A DEKOM U SUR; Kelly MJ, 2008, J MAMMAL, V89, P408, DOI 10.1644/06-MAMM-A-424R.1; Kerley LL, 2002, CONSERV BIOL, V16, P97, DOI 10.1046/j.1523-1739.2002.99290.x; Kruger O, 2005, BIODIVERS CONSERV, V14, P579, DOI 10.1007/s10531-004-3917-4; Kurten EL, 2013, BIOL CONSERV, V163, P22, DOI 10.1016/j.biocon.2013.04.025; Lim BK, 2005, ANN CARNEGIE MUS, V74, P225, DOI 10.2992/0097-4463(2005)74[225:ROTAFE]2.0.CO;2; Maffei L, 2002, REV BOLIVIANA ECOLOG, V11, P55; Maffei L, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P119, DOI 10.1007/978-4-431-99495-4_8; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mayor P, 2011, ANIM REPROD SCI, V128, P123, DOI 10.1016/j.anireprosci.2011.09.009; Meredith M, 2018, OVERVIEW OVERLAP PAC, P1; Moreno RS, 2006, J MAMMAL, V87, P808, DOI 10.1644/05-MAMM-A-360R2.1; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Nagy-Reis MB, 2019, MAMM BIOL, V95, P1, DOI 10.1016/j.mambio.2018.12.005; Ngoprasert D, 2017, MAMM BIOL, V82, P65, DOI 10.1016/j.mambio.2016.11.004; Norconk Marilyn A., 2003, Neotropical Primates, V11, P94; Nunez Rodrigo, 2002, P107; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; O'Farrill G, 2013, INTEGR ZOOL, V8, P4, DOI 10.1111/j.1749-4877.2012.00316.x; Ouboter P.E., 2016, ACAD J SURINAME, V7, P643; Ouboter P.E., 2011, ACAD J SURINAME, V2, P176; Ouboter PE, 2012, AMBIO, V41, P873, DOI 10.1007/s13280-012-0299-9; Paviolo A, 2009, J MAMMAL, V90, P926, DOI 10.1644/08-MAMM-A-128.1; Place S., 1995, Geojournal, V35, P161, DOI 10.1007/BF00814062; R Core Team, 2020, R LANG ENV STAT COMP; Reichart HA., 1997, BROWNSBERG NATURE PA, V2nd; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Rocha-Mendes F, 2010, BIOTA NEOTROP, V10, P21, DOI 10.1590/S1676-06032010000400001; Roe D., 1997, TAKE ONLY PHOTOGRAPH; Rowcliffe JM, 2008, ANIM CONSERV, V11, P185, DOI 10.1111/j.1469-1795.2008.00180.x; SBB, 2017, FOR COV MON SUR US R; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; SEYMOUR K L, 1989, Mammalian Species, P1, DOI 10.2307/3504096; Sijlbing HA, 2010, WORLDW HOSP TOUR THE, V2, P192, DOI 10.1108/17554211011037886; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Soria-Diaz L, 2010, ANIM BIOL, V60, P361, DOI 10.1163/157075610X523251; Srbek-Araujo AC, 2005, J TROP ECOL, V21, P121, DOI 10.1017/S0266467404001956; Stem C. J., 2003, Journal of Sustainable Tourism, V11, P322, DOI 10.1080/09669580308667210; Tablado Z., 2017, ECOTOURISMS PROMISE, P97; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thieurmel B, 2019, **DATA OBJECT**; UNEP-WCMC, 2021, PROT AR PROF SUR WOR; Versteeg AH, 2003, SURINAME COLUMBUS; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Zambrano A. M. A., 2010, Journal of Ecotourism, V9, P62, DOI 10.1080/14724040902953076	87	2	3	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0250390	10.1371/journal.pone.0250390	http://dx.doi.org/10.1371/journal.pone.0250390			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077471	gold, Green Published			2022-12-26	WOS:000664638500004
J	Braha, M; Porciatti, V; Chou, TH				Braha, Michelle; Porciatti, Vittorio; Chou, Tsung-Han			Retinal and cortical visual acuity in a common inbred albino mouse	PLOS ONE			English	Article							TRANSGENIC MICE; OPTOMOTOR RESPONSE; THRESHOLDS; STRAINS; ADULT; MODEL; ROD	While albino mice are widely used in research which includes the use of visually guided behavioral tests, information on their visual capability is scarce. We compared the spatial resolution (acuity) of albino mice (BALB/c) with that of pigmented mice (C57BL/6J). We used a high-throughput pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) method for objective assessment of retinal and cortical acuity, as well as optomotor head-tracking response/ reflex (OMR). We found that PERG, PVEP, and OMR acuities of C57BL/6J mice were all in the range of 0.5-0.6 cycles/degree (cyc/deg). BALB/c mice had PERG and PVEP acuities in the range of 0.1-0.2 cyc/deg but were unresponsive to OMR stimulus. Results indicate that retinal and cortical acuity can be reliably determined with electrophysiological methods in BALB/c mice, although PERG/PVEP acuities are lower than those of C57BL/6J mice. The reduced acuity of BALB/c mice appears to be primarily determined at retinal level.	[Braha, Michelle; Porciatti, Vittorio; Chou, Tsung-Han] Univ Miami, Bascom Palmer Eye Inst, Miller Sch Med, Miami, FL 33146 USA	Bascom Palmer Eye Institute; University of Miami	Chou, TH (corresponding author), Univ Miami, Bascom Palmer Eye Inst, Miller Sch Med, Miami, FL 33146 USA.	tchou@med.miami.edu		Braha, Michelle/0000-0003-3061-169X; Chou, Tsung-Han/0000-0002-1986-6088	NIH-NEI [RO1 EY019077]; NIH center grant [P30-EY014801]; Research to Prevent Blindness, Inc.; National Eye Institute (NEI); Research to Prevent Blindness (RPB)	NIH-NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	NIH-NEI RO1 EY019077, NIH center grant P30-EY014801, unrestricted grant to Bascom Palmer Eye Institute from Research to Prevent Blindness, Inc. National Eye Institute (NEI) URL, https://www.nei.nih.gov/grants-and-training Research to Prevent Blindness (RPB) URL, https://www.rpbusa.org/rpb/grants-and-research/grants/overview/Vittorio Porciatti (VP) received all three awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Barabas P, 2011, INVEST OPHTH VIS SCI, V52, P6766, DOI 10.1167/iovs.10-7147; CAVONIUS CR, 1973, J PHYSIOL-LONDON, V232, P239, DOI 10.1113/jphysiol.1973.sp010267; Chou TH, 2018, METHODS MOL BIOL, V1695, P63, DOI 10.1007/978-1-4939-7407-8_6; Chou TH, 2014, INVEST OPHTH VIS SCI, V55, P5602, DOI 10.1167/iovs.14-14793; Creel D.J., 1995, VISUAL AUDITORY ANOM; Donatien P, 2002, INVEST OPHTH VIS SCI, V43, P1198; Gianfranceschi L, 2003, P NATL ACAD SCI USA, V100, P12486, DOI 10.1073/pnas.1934836100; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; HAYES JM, 1993, VISUAL NEUROSCI, V10, P931, DOI 10.1017/S0952523800006143; HAYES JM, 1993, BEHAV GENET, V23, P395, DOI 10.1007/BF01067442; JACOBSON SG, 1984, DOC OPHTHALMOL, V56, P337, DOI 10.1007/BF00155678; Jeffery G, 1997, TRENDS NEUROSCI, V20, P165, DOI 10.1016/S0166-2236(96)10080-1; Jeffery G, 1997, DEV BRAIN RES, V99, P95, DOI 10.1016/S0165-3806(96)00211-8; Kretschmer F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078058; Leinonen H, 2018, BEHAV BRAIN RES, V352, P172, DOI 10.1016/j.bbr.2017.07.040; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Porciatti V, 1996, P NATL ACAD SCI USA, V93, P14955, DOI 10.1073/pnas.93.25.14955; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Puk O, 2008, FRONT BIOSCI-LANDMRK, V13, P6269, DOI 10.2741/3153; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Saleh M, 2007, INVEST OPHTH VIS SCI, V48, P4564, DOI 10.1167/iovs.07-0483; Schmucker C, 2005, INVEST OPHTH VIS SCI, V46, P398, DOI 10.1167/iovs.04-0959; Shi C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27329-w; SIEVING PA, 1987, J NEUROPHYSIOL, V57, P104, DOI 10.1152/jn.1987.57.1.104; Summers C G, 1996, Trans Am Ophthalmol Soc, V94, P1095; Traber GL, 2012, INVEST OPHTH VIS SCI, V53, P5737, DOI 10.1167/iovs.12-10137; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x; Xia X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108524; Yeritsyan N, 2012, EUR J NEUROSCI, V36, P2801, DOI 10.1111/j.1460-9568.2012.08195.x; Zhang PF, 2016, INVEST OPHTH VIS SCI, V57, P3650, DOI 10.1167/iovs.16-19393	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0242394	10.1371/journal.pone.0242394	http://dx.doi.org/10.1371/journal.pone.0242394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048428	Green Submitted, Green Published, gold			2022-12-26	WOS:000664636100002
J	Shimatani, H; Inoue, Y; Maekawa, Y; Miyake, T; Yamaguchi, Y; Doi, M				Shimatani, Hiroyuki; Inoue, Yuichi; Maekawa, Yota; Miyake, Takahito; Yamaguchi, Yoshiaki; Doi, Masao			Thermographic imaging of mouse across circadian time reveals body surface temperature elevation associated with non-locomotor body movements	PLOS ONE			English	Article							SLEEP-WAKE; THERMOGENESIS; RHYTHMS; BEHAVIOR; MICE	Circadian clocks orchestrate multiple different physiological rhythms in a well-synchronized manner. However, how these separate rhythms are interconnected is not exactly understood. Here, we developed a method that allows for the real-time simultaneous measurement of locomotor activity and body temperature of mice using infrared video camera imaging. As expected from the literature, temporal profiles of body temperature and locomotor activity were positively correlated with each other. Basically, body temperatures were high when animals were in locomotion. However, interestingly, increases in body temperature were not always associated with the appearance of locomotor activity. Video imaging revealed that mice exhibit non-locomotor activities such as grooming and postural adjustments, which alone induce considerable elevation of body temperature. Noticeably, non-locomotor movements always preceded the initiation of locomotor activity. Nevertheless, non-locomotor movements were not always accompanied by locomotor movements, suggesting that non-locomotor movements provide a mechanism of thermoregulation independent of locomotor activity. In addition, in the current study, we also report the development of a machine learning-based recording method for the detection of circadian feeding and drinking behaviors of mice. Our data illustrate the potential utility of thermal video imaging in the investigation of different physiological rhythms.	[Shimatani, Hiroyuki; Inoue, Yuichi; Maekawa, Yota; Miyake, Takahito; Yamaguchi, Yoshiaki; Doi, Masao] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Kyoto, Japan	Kyoto University	Doi, M (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Syst Biol, Kyoto, Japan.	doimasao@pharm.kyoto-u.ac.jp	; Yamaguchi, Yoshiaki/K-9418-2013	Doi, Masao/0000-0001-6264-9217; Yamaguchi, Yoshiaki/0000-0003-4126-542X	Project for Elucidating and Controlling Mechanisms of Ageing and Longevity of the Japan Agency for Medical Research and Development [JP21gm5010002]; Ministry of Education, Culture, Sports, Science and Technology of Japan [17H01524, 18H04015, 20B307]; Kobayashi Foundation; Kusunoki 125 of Kyoto University 125th Anniversary Fund	Project for Elucidating and Controlling Mechanisms of Ageing and Longevity of the Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobayashi Foundation; Kusunoki 125 of Kyoto University 125th Anniversary Fund	This work was supported in part by research grants from the Project for Elucidating and Controlling Mechanisms of Ageing and Longevity of the Japan Agency for Medical Research and Development (JP21gm5010002), the Ministry of Education, Culture, Sports, Science and Technology of Japan (17H01524, 18H04015, 20B307), the Kobayashi Foundation, and the Kusunoki 125 of Kyoto University 125th Anniversary Fund.	Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Challet E, 2019, NAT REV ENDOCRINOL, V15, P393, DOI 10.1038/s41574-019-0210-x; Conti B, 2006, SCIENCE, V314, P825, DOI 10.1126/science.1132191; Doi M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10532-2; EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301; EDGAR DM, 1991, PHYSIOL BEHAV, V50, P373, DOI 10.1016/0031-9384(91)90080-8; GANDER P H, 1986, Journal of Biological Rhythms, V1, P119, DOI 10.1177/074873048600100203; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Gizowski C, 2016, NATURE, V537, P685, DOI 10.1038/nature19756; Goda T, 2018, GENE DEV, V32, P140, DOI 10.1101/gad.307884.117; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Gordon CJ, 2017, PHYSIOL BEHAV, V179, P55, DOI 10.1016/j.physbeh.2017.05.026; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Jhuang H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1064; Lavie P, 2001, ANNU REV PSYCHOL, V52, P277, DOI 10.1146/annurev.psych.52.1.277; Levine JA, 2000, AM J CLIN NUTR, V72, P1451; Levine James A., 1999, Science (Washington D C), V283, P212, DOI 10.1126/science.283.5399.212; Liu DQ, 2020, SCIENCE, V367, P440, DOI 10.1126/science.aaz0956; Louhichi S, 2014, 2014 WORLD CONGRESS ON COMPUTER APPLICATIONS AND INFORMATION SYSTEMS (WCCAIS); Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Patke A, 2020, NAT REV MOL CELL BIO, V21, P67, DOI 10.1038/s41580-019-0179-2; Periasamy M, 2017, DIABETES METAB J, V41, P327, DOI 10.4093/dmj.2017.41.5.327; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Refinetti R, 1999, AM J PHYSIOL-REG I, V277, pR1493, DOI 10.1152/ajpregu.1999.277.5.R1493; Saper CB, 2005, TRENDS NEUROSCI, V28, P152, DOI 10.1016/j.tins.2004.12.009; SMITH RE, 1969, J APPL PHYSIOL, V26, P554, DOI 10.1152/jappl.1969.26.5.554; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Takahashi TM, 2020, NATURE, V583, P109, DOI 10.1038/s41586-020-2163-6; van der Vinne V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77786-5; Weinert D, 1998, PHYSIOL BEHAV, V63, P837, DOI 10.1016/S0031-9384(97)00546-5; Yasumoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116476	32	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252447	10.1371/journal.pone.0252447	http://dx.doi.org/10.1371/journal.pone.0252447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PN	34048467	Green Published, gold			2022-12-26	WOS:000664636100052
J	Dejenie, M; Kerie, S; Reba, K				Dejenie, Mekdes; Kerie, Sitotaw; Reba, Kidist			Undiagnosed hypertension and associated factors among bank workers in Bahir Dar City, Northwest, Ethiopia, 2020. A cross-sectional study	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; RISK-FACTORS; UNITED-STATES; PREVALENCE; ADULTS; HEALTH; COMMUNITY; PREVENTION; KNOWLEDGE; AWARENESS	Background Undiagnosed hypertension is defined as individuals who were hypertensive but did not report having been told by a health professional that they have hypertension. It is an important risk factor for development of chronic kidney disease, cardiovascular disease and all-cause mortality. Despite those problems and benefits of finding individuals with undiagnosed hypertension to prevent its outcomes, no enough investigations have been done regarding the prevalence and associated factors of undiagnosed hypertension. Therefore, the objective of this study was to assess the prevalence of undiagnosed hypertension and its associated factors among bank workers in Ethiopia. Methods An institutional based cross-sectional study was held at Bahir Dar city bank workers. The simple random sampling technique was used to select the study participants. Self-administered structured questionnaire and physical measurement were used to collect data. The data were entered into EPI data 3.1 versions and exported to SPSS version 23.0 statistical software for further analysis. In order to decide the association between independent and dependent variables; multivariate logistic regression analysis was implemented. A P-value of < 0.05 was used as the criterion for statistical significance and OR with 95% confidence interval was used to indicate the strength of association. Result In this study from a total of 524 participants 513 were completed the questionnaire correctly, which gives a response rate of 97.9%. The overall prevalence of undiagnosed hypertension among bank workers was 24.8% with (95% CI 21.1-28.5). Multivariate logistic regression revealed that age 35-44 [AOR = 2.56, 95% CI: (1.60-4.09)], being male [AOR = 3.61, 95% CI: (1.84-7.05)], having moderate knowledge [AOR = 3.81, 95% CI: (2.29-6.34)], having poor knowledge [AOR = 6.19, 95% CI: (3.07-)12.48], and being physically inactivity [AOR = 2.91, 95% CI: (1.26-6.76)] were variables significantly associated with undiagnosed hypertension. Conclusion The prevalence of undiagnosed hypertension among bank workers in Bahir Dar city was found to be high. An age group of 35-44 years, being male, having moderate and poor knowledge and being physically inactivity was the variables that were significantly associated with undiagnosed hypertension. Therefore, creating awareness, frequent screening and implementation of an appropriate intervention for this vulnerable group is important.	[Dejenie, Mekdes] Debre Tabor Hlth Sci Coll, Dept Nursing, Debre Tabor, Ethiopia; [Kerie, Sitotaw; Reba, Kidist] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Nursing, Bahir Dar, Ethiopia	Bahir Dar University	Kerie, S (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Nursing, Bahir Dar, Ethiopia.	sitkere5@gmail.com			Amhara regional health bureau	Amhara regional health bureau	This study was funded by Amhara regional health bureau.	Ahmed S, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0930-5; Alfred R., 2018, KNOWLEDGE ATTITUDE P; [Anonymous], 2015, NONC DIS RISK FACT O, VI, P2; [Anonymous], 2016, AK AF KNOWL PERC HYP; Ataklte F, 2015, HYPERTENSION, V65, P291, DOI 10.1161/HYPERTENSIONAHA.114.04394; Ayanian JZ, 2003, AM J PUBLIC HEALTH, V93, P2051, DOI 10.2105/AJPH.93.12.2051; Bekele A, 2017, ETHIOP J HEALTH DEV, V31, P362; Bushara SO, 2015, RENAL FAILURE, V37, P1022, DOI 10.3109/0886022X.2015.1052951; Carey RM, 2018, ANN INTERN MED, V168, P351, DOI 10.7326/M17-3203; Chakraborty N, 2017, INT J COMMUNITY MED, V8, P60; Chau K, 2019, FAM PRACT, V36, P276, DOI 10.1093/fampra/cmy075; Chikhladze N, 2012, SYSTEMIC HYPERTENSIO, P29; Chockalingam A, 2007, CAN J CARDIOL, V23, P517, DOI 10.1016/S0828-282X(07)70795-X; Choo EH, 2014, INT J CARDIOL, V172, pE465, DOI 10.1016/j.ijcard.2014.01.040; Dereje N., 2019, UNDIAGNOSED DIAGNOSE; Desta DM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228953; Dolatabadi AA, 2014, TRAUMA MON, V19, DOI 10.5812/traumamon.7328; Egan BM, 2003, ARCH INTERN MED, V163, P681, DOI 10.1001/archinte.163.6.681; Getachew F., 2018, J COMMUNITY MED HLTH, V8; Ghannadiasl F., 2019, Journal of Community Health Research, V8, P203; Gulec S, 2013, KIDNEY INT SUPPL, V3, P332, DOI 10.1038/kisup.2013.69; Ismail IM., 2013, SAHEL MED J, V16, P139; Jayawardana NWIA, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0600-8; Kanj H, 2018, HEALTH SERV INSIGHTS, V11, DOI 10.1177/1178632918791576; Kanungo S, 2017, J HUM HYPERTENS, V31, P56, DOI 10.1038/jhh.2016.30; Korhonen PE, 2014, BRIT J GEN PRACT, V64, pE611, DOI 10.3399/bjgp14X681769; Kumar SG., 2014, INT J OCCUP ENV MED, V5; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lim JU, 2017, INT J CHRONIC OBSTR, V12, P2465, DOI 10.2147/COPD.S141295; Lim OW, 2019, MALAYS J MED SCI, V26, P98, DOI 10.21315/mjms2019.26.5.9; Mazimpaka C, ASSESSING MAGNITUDE; Mosca I, 2014, INT J PUBLIC HEALTH, V59, P759, DOI 10.1007/s00038-014-0573-7; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Musa D, 2018, HIGHLAND MED RES J, V18, P22; Noor SK, 2016, RENAL FAILURE, V38, P352, DOI 10.3109/0886022X.2015.1128839; Organization WH, 2013, GLOB BRIEF HYP WORLD; Organization WH, 2005, WHO STEPS SURV MAN W; Osman H., 2018, DIAGN PATHOL OPEN, V3; Parmar P., 2014, INT J CURR MICROBIOL, V3, P680; Rahman M., 2018, MOJ PUBLIC HLTH, V7, P211, DOI DOI 10.15406/MOJPH.2018.07.00231; Ramirez LA, 2018, AM J HYPERTENS, V31, P1247, DOI 10.1093/ajh/hpy148; Salaudeen AG, 2014, AFR HEALTH SCI, V14, P593, DOI 10.4314/ahs.v14i3.14; Semachew A., 2017, J HYPERTENS LOS ANGE, V6; Shukla AN, 2015, ADV EPIDEMIOLOGY, V2015; Solomon I., 2017, J MED RES, V3, P136, DOI DOI 10.31254/JMR.2017.3310; Undavalli VK., 2018, INT J COMMUNITY MED, V5, P1366; Vincent-Onabajo G., 2016, INT J COMMUNITY MED, V3, P1963; Vincent-Onabajo GO, 2017, ANN MED HEALTH SCI R, V7, P97; Wachamo D., 2019, UNDIAGNOSED HYPERTEN; Wizner B, 2000, Przegl Lek, V57, P402; Yoon SS, 2015, HYPERTENSION, V65, P54, DOI 10.1161/HYPERTENSIONAHA.114.04012; Young DR, 2016, CIRCULATION, V134, pE262, DOI 10.1161/CIR.0000000000000440	52	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252298	10.1371/journal.pone.0252298	http://dx.doi.org/10.1371/journal.pone.0252298			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PJ	34043717	Green Published, gold			2022-12-26	WOS:000664635700083
J	McNally, KL; Innis, CJ; Kennedy, A; Bowen, JL				McNally, Kerry L.; Innis, Charles J.; Kennedy, Adam; Bowen, Jennifer L.			Characterization of oral and cloacal microbial communities in cold-stunned Kemp's ridley sea turtles (Lepidochelys kempii) during the time course of rehabilitation	PLOS ONE			English	Article							GUT MICROBIOME; ANTIBIOTIC-RESISTANCE; CHELONIA-MYDAS; CAPE-COD; WILD; INSIGHTS; DISEASE; RNA; VS.	Microbial communities of animals play a role in health and disease, including immunocompromised conditions. In the northeastern United States, cold-stunning events often cause endangered Kemp's ridley turtles (Lepidochelys kempii) to become stranded on beaches in autumn. These sea turtles are admitted to rehabilitation facilities when rescued alive and are presumed immunocompromised secondary to hypothermia. To better understand the role that microbes play in the health of cold-stunned sea turtles, we characterized the oral and cloacal microbiome from Kemp's ridley turtles at multiple timepoints during rehabilitation, from admission to pre-release, by using Illumina sequencing to analyze the 16S rRNA gene. Microbial communities were distinct between body sites and among turtles that survived and those that died. We found that clinical parameters such as presence of pneumonia or values for various blood analytes did not correlate with oral or cloacal microbial community composition. We also investigated the effect of antibiotics on the microbiome during rehabilitation and prior to release and found that the type of antibiotic altered the microbial community composition, yet overall taxonomic diversity remained the same. The microbiome of cold-stunned Kemp's ridley turtles gradually changed through the course of rehabilitation with environment, antibiotics, and disease status all playing a role in those changes and ultimately the release status of the turtles.	[McNally, Kerry L.; Innis, Charles J.] New England Aquarium, Dept Anim Hlth, Boston, MA 02110 USA; [McNally, Kerry L.] Univ Massachusetts, Boston, MA 02125 USA; [Kennedy, Adam] New England Aquarium, Rescue & Rehabil Dept, Boston, MA USA; [Bowen, Jennifer L.] Northeastern Univ, Ctr Marine Sci, Dept Marine & Environm Sci, Nahant, MA 01908 USA	University of Massachusetts System; University of Massachusetts Boston; Northeastern University	McNally, KL (corresponding author), New England Aquarium, Dept Anim Hlth, Boston, MA 02110 USA.; McNally, KL (corresponding author), Univ Massachusetts, Boston, MA 02125 USA.	kmcnally@neaq.org	Bowen, Jennifer L./ABG-5329-2021	Bowen, Jennifer L./0000-0003-0339-1564	University of Massachusetts Boston; Northeastern University	University of Massachusetts Boston; Northeastern University	Sequencing costs were supported with Dr. Robert W. Spayne Research Grant 2015 and the Nancy Goranson Endowment Fund 2015 from University of Massachusetts Boston to KLM and start-up funds to JLB from Northeastern University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrhman KFA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01060; Ahasan MS, 2018, MICROBIOL RES, V207, P91, DOI 10.1016/j.micres.2017.11.010; Ahasan MS, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix139; Ahasan MS, 2017, MAR POLLUT BULL, V120, P18, DOI 10.1016/j.marpolbul.2017.04.046; Althani AA, 2016, J CELL PHYSIOL, V231, P1688, DOI 10.1002/jcp.25284; Apprill A, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00222; Arizza V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220329; Biagi E, 2019, ENV MICROBIOL REP, V11, P361, DOI 10.1111/1758-2229.12683; Bik EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10516; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Bloodgood JCG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227060; Bourne DG, 2016, ANNU REV MICROBIOL, V70, P317, DOI 10.1146/annurev-micro-102215-095440; Boylan S.M., 2017, SEA TURTLE HLTH REHA, P325; Breider S, 2017, INT J SYST EVOL MICR, V67, P2153, DOI 10.1099/ijsem.0.001879; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Chittick EJ, 2002, J AM VET MED ASSOC, V221, P1019, DOI 10.2460/javma.2002.221.1019; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Dickson RP, 2014, LANCET RESP MED, V2, P238, DOI 10.1016/S2213-2600(14)70028-1; Dittmann KK, 2019, ENV MICROBIOL REP, V11, P401, DOI 10.1111/1758-2229.12698; Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8; Egan S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00991; Eren AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066643; Erlacher-Reid CD, 2013, J ZOO WILDLIFE MED, V44, P408, DOI 10.1638/2012-0071R.1; Ferrer M, 2017, BIOCHEM PHARMACOL, V134, P114, DOI 10.1016/j.bcp.2016.09.007; FOGHANDERSEN N, 1981, CLIN CHEM, V27, P1264; Gibson KM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43875-3; Griffin LP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211503; Harms CA, 2003, J WILDLIFE DIS, V39, P366, DOI 10.7589/0090-3558-39.2.366; Heppell SS, 2003, CRC MAR BIOL SER, P275; Hyde ER, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00046-16; Innis CJ, 2012, J VET PHARMACOL THER, V35, P82, DOI 10.1111/j.1365-2885.2011.01290.x; Innis C.J., 2017, SEA TURTLE HLTH REHA, P675; Innis Charles, 2020, Journal of Herpetological Medicine and Surgery, V30, P142, DOI 10.5818/19-10-216.1; Innis C, 2009, J WILDLIFE DIS, V45, P594, DOI 10.7589/0090-3558-45.3.594; Innis CJ, 2007, J COMP PHYSIOL B, V177, P623, DOI 10.1007/s00360-007-0160-9; Innis Charles J., 2016, Journal of Herpetological Medicine and Surgery, V26, P100, DOI 10.5818/1529-9651-26.3-4.100; Innis CJ, 2014, JAVMA-J AM VET MED A, V245, P315, DOI 10.2460/javma.245.3.315; Innis CJ, 2009, JAVMA-J AM VET MED A, V235, P426, DOI 10.2460/javma.235.4.426; Innis CJ., 2017, SEA TURTLE HLTH REHA, P497; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jani AJ, 2014, P NATL ACAD SCI USA, V111, pE5049, DOI 10.1073/pnas.1412752111; Keenan SW, 2013, SCI REP-UK, V3, DOI 10.1038/srep02877; Keller KA, 2012, JAVMA-J AM VET MED A, V240, P317, DOI 10.2460/javma.240.3.317; Kennedy Adam, 2012, Journal of Herpetological Medicine and Surgery, V22, P25, DOI 10.5818/1529-9651-22.1-2.25; Kueneman JG, 2014, MOL ECOL, V23, P1238, DOI 10.1111/mec.12510; Lee K, 2018, MAR GENOM, V37, P26, DOI 10.1016/j.margen.2017.09.004; Lewbart GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096487; Looft T, 2014, ISME J, V8, P1566, DOI 10.1038/ismej.2014.12; McFall-Ngai M, 2013, P NATL ACAD SCI USA, V110, P3229, DOI 10.1073/pnas.1218525110; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McNally KL, 2021, ENDANGER SPECIES RES, V45, P21, DOI 10.3354/esr01116; Mettel C, 2010, APPL ENVIRON MICROB, V76, P5995, DOI 10.1128/AEM.03047-09; Moffatt MF, 2017, CLIN MED, V17, P525, DOI 10.7861/clinmedicine.17-6-525; Morreale SJ, 2005, CHELONIAN CONSERV BI, V4, P872; Murali A, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0521-5; Oksanen J., 2019, R PACKAGE VERSION; Pace A, 2019, MAR POLLUT BULL, V149, DOI 10.1016/j.marpolbul.2019.110575; Price JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177642; R Core Team, 2020, R LANG ENV STAT COMP; Samuelson MM, 2020, ENDANGER SPECIES RES, V43, P121, DOI 10.3354/esr01043; Scheelings TF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65321-5; Scheelings TF, 2020, ANIM MICROBIOME, V2, DOI 10.1186/s42523-020-00034-8; Solano M, 2008, VET RADIOL ULTRASOUN, V49, P388, DOI 10.1111/j.1740-8261.2008.00387.x; STABENAU EK, 1991, COMP BIOCHEM PHYS A, V99, P107, DOI 10.1016/0300-9629(91)90243-6; Stacy NI, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot003; Stacy NI., 2017, SEA TURTLE HLTH REHA, P147; Still BM, 2005, CHELONIAN CONSERV BI, V4, P883; Stockman J, 2013, JAVMA-J AM VET MED A, V242, P675, DOI 10.2460/javma.242.5.675; Sun CH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02331; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wibbels T., 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2019-2.RLTS.T11533A142050590.en, DOI 10.2305/IUCN.UK.2019-2.RLTS.T11533A142050590.EN]; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; WITHERINGTON BE, 1989, COPEIA, P696; Wyneken JE., 2006, REPTILE MED SURG, P972; Yuan ML, 2015, MOL ECOL, V24, P2521, DOI 10.1111/mec.13169; Zaneveld JR, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.121; Zaura E, 2015, MBIO, V6, DOI 10.1128/mBio.01693-15; Zhang L, 2013, ANTIMICROB AGENTS CH, V57, P3659, DOI 10.1128/AAC.00670-13	82	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252086	10.1371/journal.pone.0252086	http://dx.doi.org/10.1371/journal.pone.0252086			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043685	Green Published, gold			2022-12-26	WOS:000664635700051
J	Park, J; Yea, JW; Park, JW; Oh, SA				Park, Jaehyeon; Yea, Ji Woon; Park, Jae Won; Oh, Se An			Evaluation of the setup discrepancy between 6D ExacTrac and cone beam computed tomography in spine stereotactic body radiation therapy	PLOS ONE			English	Article							METASTASES	The objective of this study was to analyze the difference in residual setup errors between 6D ExacTrac and 3D cone-beam computed tomography (CBCT) image-guided systems in spinal stereotactic body radiation therapy (SBRT). We investigated 76 patients with spinal tumors who received SBRT using Novalis Tx at our institution between January 2013 and September 2020. A Vac-lok (EZ-FIX (R), Arlico Medical Company, South Korea) fixture and an assistive device, based on the region involved, were used to immobilize patients and to increase the inter-fractional setup reproducibility. The difference in the root mean square (RMS) between the 6D ExacTrac and 3D CBCT was -0.75 mm, 0.45 mm, 0.16 mm, and -0.03 degrees; the RMS value was 1.31 mm, 1.06 mm, 0.87 mm, and 0.64 degrees; and the standard deviation was 0.80 mm, 0.72 mm, 0.62 mm, and 0.44 degrees for lateral, longitudinal, vertical, and yaw directions, respectively. The difference in the average RMS between ExacTrac and CBCT was <1.03 mm in the translation direction and <0.47 degrees in the rotational direction; the results were statistically significant in the lateral, longitudinal, and vertical directions, but not in the yaw direction. Thus, it is necessary to verify the ExacTrac image according to the CBCT image.	[Park, Jaehyeon; Yea, Ji Woon; Park, Jae Won; Oh, Se An] Yeungnam Univ, Med Ctr, Dept Radiat Oncol, Daegu, South Korea; [Park, Jaehyeon; Yea, Ji Woon; Park, Jae Won; Oh, Se An] Yeungnam Univ, Coll Med, Dept Radiat Oncol, Daegu, South Korea	Yeungnam University; Yeungnam University	Oh, SA (corresponding author), Yeungnam Univ, Med Ctr, Dept Radiat Oncol, Daegu, South Korea.; Oh, SA (corresponding author), Yeungnam Univ, Coll Med, Dept Radiat Oncol, Daegu, South Korea.	sean.oh5235@gmail.com		Oh, SeAn/0000-0002-8835-2814	Yeungnam University	Yeungnam University	This work was supported by the 2020 Yeungnam University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Chang Z, 2010, RADIOTHER ONCOL, V95, P116, DOI 10.1016/j.radonc.2009.12.036; Gong YN, 2019, CANCER MED-US, V8, P6176, DOI 10.1002/cam4.2546; Greco C, 2015, REP PRACT ONCOL RADI, V20, P454, DOI 10.1016/j.rpor.2015.03.004; Guckenberger M., 2014, RADIAT ONCOL, V9, P1, DOI [10.1186/1748-717X-9-1, DOI 10.1186/1748-717X-9-1]; Kim J, 2012, J APPL CLIN MED PHYS, V13, P124, DOI 10.1120/jacmp.v13i3.3729; Kim SH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216655; Mantel F, 2014, STRAHLENTHER ONKOL, V190, P1141, DOI 10.1007/s00066-014-0706-1; Oh SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177798; Oh SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151709; OHSEAN, 2013, [PROGRESS in MEDICAL PHYSICS, 의학물리], V24, P145, DOI 10.14316/pmp.2013.24.3.145; Redmond KJ, 2016, INT J RADIAT ONCOL, V95, P1414, DOI 10.1016/j.ijrobp.2016.03.027; Zhuang HQ, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00826	13	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252234	10.1371/journal.pone.0252234	http://dx.doi.org/10.1371/journal.pone.0252234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043724	gold, Green Published			2022-12-26	WOS:000664635700076
J	Balla, K; Karsai, I; Kiss, T; Horvath, A; Berki, Z; Cseh, A; Bonis, P; Arendas, T; Veisz, O				Balla, Krisztina; Karsai, Ildiko; Kiss, Tibor; Horvath, Adam; Berki, Zita; Cseh, Andras; Bonis, Peter; Arendas, Tamas; Veisz, Otto			Single versus repeated heat stress in wheat: What are the consequences in different developmental phases?	PLOS ONE			English	Article							ENHANCES THERMO-TOLERANCE; HIGH-TEMPERATURE STRESS; TRITICUM-AESTIVUM L.; WINTER-WHEAT; GRAIN-YIELD; DROUGHT STRESS; MULTIPLE HEAT; GROWTH-STAGES; PHOTOSYNTHESIS; ANTHESIS	With a possible reference to heat priming and to characterize the extent and variation in the heat stress responses in wheat, the effects of single vs. repeated heat stresses were examined by measuring the changes in morphological and grain yield-related traits and photosynthetic parameters. To achieve these objectives, 51 winter wheat cultivars of various geographic origins were included in two independent experiments covering different phenological stages. In Experiment I, a single heat stress event was applied at stem elongation (SE) and booting (B), and the repeated heat stress was applied at both of these stages (SE+B). In Experiment II, the single heat stress was applied at stem elongation (SE) and full heading (CH), while the repeated heat stress was applied at both stages (SE+CH). While genotype was a more important factor for determining the morphological and yield-related traits, it was the treatment effect that mostly influenced the photosynthetic parameters, with the exception of the chlorophyll content. The heading stage was more sensitive to heat stress than the booting stage, which was primarily due to the larger decrease in the average seed number. The importance of biomass in contributing to grain yield intensified with the heat stress treatments. There was a large variation between the wheat cultivars not only in yielding abilities under control conditions but also in sensitivities to the various heat stresses, based on which 7 distinct groups with specific response profiles could be identified at a highly significant level. The 7 wheat groups were also characterized by their reaction patterns of different magnitudes and directions in their responses to single vs. repeated heat stresses, which depended on the phenological phases during the second cycle of heat stress. The possible association between these findings and heat priming is discussed.	[Balla, Krisztina; Karsai, Ildiko; Horvath, Adam; Berki, Zita; Cseh, Andras; Bonis, Peter; Arendas, Tamas; Veisz, Otto] ELKH, Ctr Agr Res, Agr Inst, Martonvasar, Hungary; [Kiss, Tibor] Eszterhazy Karoly Univ, Food & Wine Res Inst, Eger, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Balla, K (corresponding author), ELKH, Ctr Agr Res, Agr Inst, Martonvasar, Hungary.	balla.krisztina@atk.hu		Horvath, Adam/0000-0002-9256-3040; Cseh, Andras/0000-0002-8681-6654	National Scientific Research Fund (NKFIH) [K-119801, GINOP-2.3.2-152016-00029]	National Scientific Research Fund (NKFIH)(National Research, Development & Innovation Office (NRDIO) - Hungary)	This research program was funded by a grant from the National Scientific Research Fund (NKFIH) K-119801 and by the GINOP-2.3.2-152016-00029 project. The funders had no role in study design, data collection and analysis, decision to publish, or prepartion of the manuscript.	Balla K, 2006, CEREAL RES COMMUN, V34, P381; Balla K, 2008, CEREAL RES COMMUN, V36, P1103; Balla K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222639; Balla K, 2014, CENT EUR J BIOL, V9, P519, DOI 10.2478/s11535-014-0288-z; Banyai J, 2020, CEREAL RES COMMUN, V48, P355, DOI 10.1007/s42976-020-00034-z; Barber HM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00051; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; BHULLAR SS, 1985, AUST J PLANT PHYSIOL, V12, P363, DOI 10.1071/PP9850363; Burke JJ, 2001, PHYSIOL PLANTARUM, V112, P167, DOI 10.1034/j.1399-3054.2001.1120203.x; Fan YH, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00805; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Hlavacova M, 2018, FIELD CROP RES, V221, P182, DOI 10.1016/j.fcr.2018.02.022; Hlavacova M, 2017, PLANT SOIL ENVIRON, V63, P139, DOI 10.17221/73/2017-PSE; Hutsch BW, 2019, J AGRON CROP SCI, V205, P22, DOI 10.1111/jac.12298; Islam M.R., 2014, J SCIENTIA AGR, V8, P13, DOI [10.15192/PSCP.SA.2014.4.1.1318, DOI 10.15192/PSCP.SA.2014.4.1.1318]; Kiss T, 2017, PLANT CELL ENVIRON, V40, P1629, DOI 10.1111/pce.12971; Larkindale J, 2004, ENVIRON EXP BOT, V51, P57, DOI 10.1016/S0098-8472(03)00060-1; Lee DG, 2007, PROTEOMICS, V7, P3369, DOI 10.1002/pmic.200700266; Liu B, 2017, AGR FOREST METEOROL, V247, P476, DOI 10.1016/j.agrformet.2017.08.018; Liu B, 2016, GLOBAL CHANGE BIOL, V22, P1890, DOI 10.1111/gcb.13212; Mendanha T, 2018, PLANT PHYSIOL BIOCH, V132, P213, DOI 10.1016/j.plaphy.2018.09.002; PAULSEN GM, 1994, PHYSIOLOGY AND DETERMINATION OF CROP YIELD, P365; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Poudel P.B, 2020, J BIOL TODAYS WORLD, V9, P1; Prasad PVV, 2014, FUNCT PLANT BIOL, V41, P1261, DOI 10.1071/FP14061; Qaseem MF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43477-z; Rahman M. A., 2009, BANGLADESH J, V34, P360; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Sharkey TD, 2001, PLANT PHYSIOL, V125, P2001, DOI 10.1104/pp.125.4.2001; SLAFER GA, 1995, PLANT CELL ENVIRON, V18, P671, DOI 10.1111/j.1365-3040.1995.tb00568.x; Slafer GA, 2015, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, 2ND EDITION, P285, DOI 10.1016/B978-0-12-417104-6.00012-1; Talukder ASMHM, 2014, FIELD CROP RES, V160, P54, DOI 10.1016/j.fcr.2014.01.013; TOTTMAN DR, 1979, ANN APPL BIOL, V93, P221, DOI 10.1111/j.1744-7348.1979.tb06534.x; Ugarte C, 2007, FIELD CROP RES, V100, P240, DOI 10.1016/j.fcr.2006.07.010; Vassileva V, 2011, J PLANT RES, V124, P147, DOI 10.1007/s10265-010-0340-7; Wang X, 2017, J INTEGR AGR, V16, P2709, DOI 10.1016/S2095-3119(17)61786-6; Wang X, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00501; Wang X, 2014, PLANT PHYSIOL BIOCH, V74, P185, DOI 10.1016/j.plaphy.2013.11.014; Wang X, 2012, J CEREAL SCI, V55, P331, DOI 10.1016/j.jcs.2012.01.004; Wang X, 2011, J PLANT PHYSIOL, V168, P585, DOI 10.1016/j.jplph.2010.09.016; Wollenweber B, 2003, J AGRON CROP SCI, V189, P142, DOI 10.1046/j.1439-037X.2003.00025.x; YORDANOV I, 1986, PHOTOBIOCH PHOTOBIOP, V12, P147; Zhang XX, 2016, ENVIRON EXP BOT, V127, P26, DOI 10.1016/j.envexpbot.2016.03.004; Zhang XX, 2013, J CEREAL SCI, V57, P134, DOI 10.1016/j.jcs.2012.10.010; Zou J, 2011, PLANT CELL REP, V30, P2155, DOI 10.1007/s00299-011-1122-y	46	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0252070	10.1371/journal.pone.0252070	http://dx.doi.org/10.1371/journal.pone.0252070			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34033647	Green Accepted, gold, Green Published			2022-12-26	WOS:000664633100028
J	Manomohan, V; Saravanan, R; Pichler, R; Murali, N; Sivakumar, K; Sudhakar, K; Nachiappan, RK; Periasamy, K				Manomohan, Vandana; Saravanan, Ramasamy; Pichler, Rudolf; Murali, Nagarajan; Sivakumar, Karuppusamy; Sudhakar, Krovvidi; Nachiappan, Raja K.; Periasamy, Kathiravan			Legacy of draught cattle breeds of South India: Insights into population structure, genetic admixture and maternal origin	PLOS ONE			English	Article							BOS-TAURUS; MICROSATELLITE; DIVERSITY; SOFTWARE; PERFORMANCE; NETWORKS	The present study is the first comprehensive report on diversity, population structure, genetic admixture and mitochondrial DNA variation in South Indian draught type zebu cattle. The diversity of South Indian cattle was moderately high. A significantly strong negative correlation coefficient of -0.674 (P<0.05) was observed between the effective population size of different breeds and their estimated F-IS. The genetic structure analysis revealed the distinctness of Kangayam, Vechur and Punganur cattle from the rest of the zebu breeds. The results showed the influence of Hallikar breed in the development of most Mysore type cattle breeds of South India with the exception of Kangayam. Bayesian clustering analysis was performed to assess the taurine admixture in South Indian zebu cattle using purebred Jersey and Holstein-Friesian as reference genotypes. Relatively high levels of taurine admixture (>6.25%) was observed in Punganur, Vechur, Umblachery and Pulikulam cattle breeds. Two major maternal haplogroups, I1 and I2, typical of zebu cattle were observed, with the former being predominant than the later. The pairwise differences among the I2 haplotypes of South Indian cattle were relatively higher than West Indian (Indus valley site) zebu cattle. The results indicated the need for additional sampling and comprehensive analysis of mtDNA control region variations to unravel the probable location of origin and domestication of I2 zebu lineage. The present study also revealed major concerns on South Indian zebu cattle (i) risk of endangerment due to small effective population size and high rate of inbreeding (ii) lack of sufficient purebred zebu bulls for breeding and (iii) increasing level of taurine admixture in zebu cattle. Availability of purebred semen for artificial insemination, incorporation of genomic/molecular information to identify purebred animals and increased awareness among farmers will help to maintain breed purity, conserve and improve these important draught cattle germplasms of South India.	[Manomohan, Vandana; Pichler, Rudolf; Periasamy, Kathiravan] IAEA, Anim Prod & Hlth Sect, Joint FAO IAEA Div Nucl Techn Food & Agr, Vienna, Austria; [Manomohan, Vandana; Saravanan, Ramasamy; Murali, Nagarajan; Sivakumar, Karuppusamy] Vet Coll & Res Inst, Namakkal, Tamil Nadu, India; [Manomohan, Vandana; Saravanan, Ramasamy; Murali, Nagarajan; Sivakumar, Karuppusamy] Vet & Anim Sci Univ, Chennai, Tamil Nadu, India; [Sudhakar, Krovvidi] Sri Venkateswara Vet Univ, NTR Coll Vet Sci, Tirupati, Andhra Pradesh, India; [Nachiappan, Raja K.] Natl Bur Anim Genet Resources, Karnal, Haryana, India; [Periasamy, Kathiravan] Food & Agr Org United Nations, Anim Genet Resources Branch, Anim Prod & Hlth Div, Rome, Italy	International Atomic Energy Agency; Tamil Nadu Veterinary & Animal Sciences University; Tamil Nadu Veterinary & Animal Sciences University; Sri Venkateswara Veterinary University; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources; Food & Agriculture Organization of the United Nations (FAO)	Periasamy, K (corresponding author), IAEA, Anim Prod & Hlth Sect, Joint FAO IAEA Div Nucl Techn Food & Agr, Vienna, Austria.; Periasamy, K (corresponding author), Food & Agr Org United Nations, Anim Genet Resources Branch, Anim Prod & Hlth Div, Rome, Italy.	kathirvet@yahoo.co.in		KROVVIDI, SUDHAKAR/0000-0003-2054-8607	Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency (IAEA), Vienna, Austria [D3.10.28]; IAEA	Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency (IAEA), Vienna, Austria; IAEA(International Atomic Energy Agency)	The present study is part of the Coordinated Research Project D3.10.28 of Joint FAO/IAEA Division of Nuclear Techniques in Food and Agriculture, International Atomic Energy Agency (IAEA), Vienna, Austria. The funding provided by IAEA for internship training of the firstauthor at Animal Production and Health Laboratory, Seibersdorf, Austria is gratefully acknowledged.	Akila Natarajan, 2016, Agricultural Reviews, V37, P49; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Basu P, 2009, ANN ASSOC AM GEOGR, V99, P746, DOI 10.1080/00045600903102808; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Bonfiglio S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015760; Chen SY, 2010, MOL BIOL EVOL, V27, P1, DOI 10.1093/molbev/msp213; DADF, 2015, EST LIV POP BREED WI; de Oliveira JFC, 2005, GENET MOL BIOL, V28, P54, DOI 10.1590/S1415-47572005000100010; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dongre VB, 2017, INDIAN J ANIM SCI, V87, P800; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAO, 2011, MOL GEN CHAR AN GEN; FAO, 2013, FAO ANIM PROD HLTH G; Ganapathi P., 2009, Indian Veterinary Journal, V86, P971; Grant WS, 2015, J HERED, V106, P333, DOI 10.1093/jhered/esv020; Gunn WD, 1909, B DEP AGR; Hiendleder S, 2008, CYTOGENET GENOME RES, V120, P150, DOI 10.1159/000118756; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; ICAR-NBAGR, 2016, GUIDELINES MANAGEMEN; Joshi NR, 1953, ZEBU CATTLE INDIA PA, P14; Kanakraj P, 2006, STUDY PHYS PRO UNPUB; Kannadhasan MS., 2018, INT J CURRENT MICROB, V7, P1100, DOI [10.20546/ijcmas.2018.711.128, DOI 10.20546/IJCMAS.2018.711.128]; Kantanen J, 2009, HEREDITY, V103, P404, DOI 10.1038/hdy.2009.68; Kienzle AshburnerJE., 2013, INTEGRATED CROP MANA; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Li MH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-32; Littlewood RW, 1936, LIVESTOCK SO INDIA, P51; Livestock Census, 2019, 20 LIV CENS IND KEY; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; Moroke ND, 2014, J EC BEHAV STUDIES, V6, P858; Natarajan A, 2012, INDIAN J ANIM SCI, V82, P1440; Panneerselvam S., 2008, KANGAYAM CATTLE A RE; Phillips RW, 1944, J HERED, V35, P273; Pritchard JK, 2000, GENETICS, V155, P945; Pundir RK, 2009, INDIAN J ANIM SCI, V79, P681; Radhika G, 2018, ANIM BIOTECHNOL, V29, P50, DOI 10.1080/10495398.2017.1297719; Reddi OS, 1957, THESIS U MADRAS MADR; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Sambrook J., 2001, MOL CLONING LAB MANU; Schenekar T, 2011, HEREDITY, V107, P511, DOI 10.1038/hdy.2011.48; Scherf BD, 2015, 2 REPORT STATE WORLD; Shah TM, 2013, ANIM GENET, V44, P442, DOI 10.1111/age.12013; Sharma R, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0221-0; Sharma R, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-359; Singh C.V., 2016, ADV DAIRY RES, V4, P158; Singh PK, 2008, INDIAN J ANIM SCI, V78, P211; Singh PK, 2017, INDIAN J ANIM SCI, V87, P316; Singh PK, 2012, INDIAN J ANIM SCI, V82, P1587; Singh S., 2014, AGR ENG TODAY, V39, P48; Surendrakumar A, 1988, THESIS TAMIL NADU AG; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Troy CS, 2001, NATURE, V410, P1088, DOI 10.1038/35074088; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanessa R, 2018, AIP CONF PROC, V2014, DOI 10.1063/1.5054459; Ware, 1942, MISCELLANEOUS B IMPE; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zhou XS, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10093015	62	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2021	16	5							e0246497	10.1371/journal.pone.0246497	http://dx.doi.org/10.1371/journal.pone.0246497			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OI	34029341	gold, Green Published, Green Submitted			2022-12-26	WOS:000664632800001
J	Bernardo, EL; Nhampossa, T; Clouse, K; Carlucci, JG; Fernandez-Luis, S; Fuente-Soro, L; Nhacolo, A; Sidat, M; Naniche, D; Moon, TD				Bernardo, Edson L.; Nhampossa, Tacilta; Clouse, Kate; Carlucci, James G.; Fernandez-Luis, Sheila; Fuente-Soro, Laura; Nhacolo, Ariel; Sidat, Mohsin; Naniche, Denise; Moon, Troy D.			Patterns of mobility and its impact on retention in care among people living with HIV in the Manhica District, Mozambique	PLOS ONE			English	Article								Introduction Retention in HIV care is a challenge in Mozambique. Mozambiques southern provinces have the highest mobility levels of the country. Mobility may result in poorer response to HIV care and treatment initiatives. Methods We conducted a cross-sectional survey to explore the impact of mobility on retention for HIV-positive adults on ART presenting to the clinic in December 2017 and January 2018. Survey data were linked to participant clinical records from the HIV care and treatment program. This study took place in Manhica District, southern Mozambique. We enrolled self-identified migrants (moved outside of Manhica District <= 12 months prior to survey) and non-migrants, matched by age and sex. Results 390 HIV-positive adults were included. We found frequent movement: 45% of migrants reported leaving the district 3-5 times over the past 12 months, usually for extended stays. South Africa was the most common destination (71%). Overall, 30% of participants had at least one delay (15-60 days) in ART pick-up and 11% were delayed >60 days, though no significant difference was seen between mobile and non-mobile cohorts. Few migrants accessed care while traveling. Conclusion Our population of mobile and non-mobile participants showed frequent lapses in ART pick-up. Mobility could be for extended time periods and HIV care frequently did not continue at the destination. Studies are needed to evaluate the impact of Mozambique ' s approach of providing 3-months ART among mobile populations and barriers to care while traveling, as is better education on how and where to access care when traveling.	[Bernardo, Edson L.; Clouse, Kate; Carlucci, James G.; Moon, Troy D.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Bernardo, Edson L.; Nhampossa, Tacilta; Fernandez-Luis, Sheila; Fuente-Soro, Laura; Nhacolo, Ariel; Naniche, Denise] Manhica Hlth Res Ctr, Manhica, Mozambique; [Nhampossa, Tacilta] Natl Inst Hlth Mozambique, Maputo, Mozambique; [Clouse, Kate] Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA; [Carlucci, James G.; Moon, Troy D.] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Nashville, TN 37232 USA; [Fernandez-Luis, Sheila; Fuente-Soro, Laura; Naniche, Denise] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Inst Global Hlth, Barcelona, Spain; [Sidat, Mohsin] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique	Vanderbilt University; Centro de Investigacao em Saude de Manhica; Vanderbilt University; Vanderbilt University; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Eduardo Mondlane University	Moon, TD (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA.; Moon, TD (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Nashville, TN 37232 USA.	troy.moon@vumc.org	Naniche, Denise/S-1814-2018	Naniche, Denise/0000-0002-4495-6325; Fuente-Soro, Laura/0000-0002-8580-5857; Moon, Troy/0000-0002-1637-829X; Sidat, Mohsin/0000-0002-8378-2014; Carlucci, James/0000-0002-3969-8544; Fernandez-Luis, Sheila/0000-0003-3684-6713	Fogarty International Center of the National Institutes of Health [D43 TW009745]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by the Fogarty International Center of the National Institutes of Health under Award Number D43 TW009745, awarded to TM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; [Anonymous], 2010, D4318 ASTM; [Anonymous], 2018, ASTM C33C33M 18, DOI DOI 10.1520/C0033_C0033M-18; Bygrave H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013198; Camlin CS, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25136; Ciampa PJ, 2012, JAIDS-J ACQ IMM DEF, V60, pE46, DOI 10.1097/QAI.0b013e31824c0267; CISM, HLTH RES CTR MANH; Clouse K, 2020, TRIALS, V21, DOI 10.1186/s13063-020-4190-x; da Silva M, 2015, AIDS BEHAV, V19, P666, DOI 10.1007/s10461-014-0874-0; de Bruijn M, MOBILE AFRICA CHANGI; Faturiyele I, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5594-3; Filimao DBC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213804; Fuente-Soro L, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020236; Fuente-Soro L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222028; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; Groh K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-650; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Jobarteh K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166444; Kwena ZA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054523; Marson KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078900; Moon Troy D, 2010, Retrovirology (Auckl), V3, P1; Mozambican Ministry of Health, HIV CAR TREATM GUID; Mugabe D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224102; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Nhassengo P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205919; Nosyk B, 2015, AIDS, V29, P1681, DOI 10.1097/QAD.0000000000000746; Research, WHOL SYST IMP AUSTR; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Shepherd BE, 2013, AM J EPIDEMIOL, V178, P819, DOI 10.1093/aje/kwt030; Taylor BS, 2014, AIDS PATIENT CARE ST, V28, P284, DOI 10.1089/apc.2014.0028	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0250844	10.1371/journal.pone.0250844	http://dx.doi.org/10.1371/journal.pone.0250844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019556	Green Published, gold			2022-12-26	WOS:000664632300014
J	Urraza-Robledo, AI; Giralt, M; Gonzalez-Galarza, FF; Villarroya, F; Perez, AAM; Flores, PR; Perez, MEG; Domingo, P; Lopez-Marquez, FC				Ivonne Urraza-Robledo, Arguine; Giralt, Marta; Francisco Gonzalez-Galarza, Faviel; Villarroya, Francesc; Miranda Perez, Alberto Alejandro; Ruiz Flores, Pablo; Gutierrez Perez, Maria Elena; Domingo, Pere; Carlos Lopez-Marquez, Francisco			FGF21 serum levels are related to insulin resistance, metabolic changes and obesity in Mexican people living with HIV (PLWH)	PLOS ONE			English	Article							GROWTH-FACTOR 21; ANTIRETROVIRAL THERAPY; LIPODYSTROPHY; EXPRESSION; FGF-21	Background Antiretroviral therapy has significantly improved prognosis in treatment against HIV infection, however, prolonged exposure is associated to cardiovascular diseases, lipodystrophy, type 2 diabetes, insulin resistance, metabolic alteration, as obesity which includes the accumulation of oxidative stress in adipose tissue. FGF21 is a peptide hormone that is known to regulate glucose and lipid metabolism. FGF21 is expressed and secreted primarily in the liver and adipose tissue, promoting oxidation of glucose/fatty acids and insulin sensitivity. Alterations in FGF21 may be associated with the development of insulin resistance, metabolic syndrome and cardiovascular disease. We hypothesized that FGF21 protein levels are associated with metabolic abnormalities, placing special attention to the alterations in relation to the concurrence of overweight/obesity in people living with HIV (PLWH). Design Serum FGF21 was analyzed in 241 subjects, 160 PLWH and 81 unrelated HIV-uninfected subjects as a control group. Clinical records were consulted to obtain CD4+ cell counting and number of viral RNA copies. Serum FGF21 levels were tested for correlation with anthropometric and metabolic parameters; glucose, cholesterol, HDL, LDL, VLDL, triglycerides, insulin and indexes of atherogenesis and insulin resistance (HOMA). Results The participants were classified into four groups: (i) PLWH with normal weight, (ii) PLWH with overweight/obesity, (iii) HIV-uninfected with normal weight, and (iv) HIV-uninfected with overweight/obesity. Insulin levels were higher in normal-weight PLWH than in the HIV-uninfected group but not statistically significant, however, for the overweight/obesity PLWH group, insulin levels were significantly higher in comparison with the other three groups (p<0.0001). For FGF21, serum levels were slightly higher in the overweight/obesity groups in both patients and controls. In HIV-infected subjects, FGF21 levels showed a strong positive correlation with triglycerides, insulin levels and insulin resistance with a p-value <0.0001. In the seronegative group, FGF21 was only correlated with weight and waist circumference, showing an important association of FGF21 levels with the degree of obesity of the individuals. Conclusion Insulin resistance and FGF21 elevations were observed in overweight-obese PLWH. FGF21 elevation could be viewed as a compensation mechanism as, in the control group, FGF21 correlations appeared to be confined to weight and waist circumference. This can be explained based on the action of FGF21 promoting the uptake of glucose in adipose tissue. In PLWH, FGF21 was low, possibly as a result of a change in adiposity leading to a metabolic disruption.	[Ivonne Urraza-Robledo, Arguine] Autonomous Univ Coahuila IMSS, Med Sch, Ctr Biomed Res, Torreon, Mexico; [Ivonne Urraza-Robledo, Arguine] Mexican Social Secur Inst, High Specialty Med Unit UMAE 71, Mexico City, DF, Mexico; [Giralt, Marta; Villarroya, Francesc] Univ Barcelona, CIBER Fisiopatol Obesidad & Nutr, Dept Bioquim & Biomed Mol, Barcelona, Spain; [Giralt, Marta; Villarroya, Francesc] Univ Barcelona, CIBER Fisiopatol Obesidad & Nutr, Inst Biomed IBUB, Barcelona, Spain; [Francisco Gonzalez-Galarza, Faviel; Ruiz Flores, Pablo; Carlos Lopez-Marquez, Francisco] Autonomous Univ Coahuila, Fac Med, Ctr Biomed Res, Torreon, Mexico; [Miranda Perez, Alberto Alejandro; Gutierrez Perez, Maria Elena] Autonomous Univ Coahuila, Med Sch, Biomed Res Ctr, Torreon, Mexico; [Domingo, Pere] Hosp Santa Creu & Sant Pau, Inst Recerca, Dept Infect Dis, Barcelona, Spain	Instituto Mexicano del Seguro Social; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Barcelona; Universidad Autonoma de Coahuila; Universidad Autonoma de Coahuila; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital of Santa Creu i Sant Pau	Lopez-Marquez, FC (corresponding author), Autonomous Univ Coahuila, Fac Med, Ctr Biomed Res, Torreon, Mexico.	francisco.lopez@uadec.edu.mx	Giralt, Marta/A-4756-2013	Giralt, Marta/0000-0001-7968-4190; LOPEZ MARQUEZ, FRANCISCO CARLOS/0000-0003-2939-7411	State Council of Science and Technology (FONCYT) [COAH-2019-C13-C054]; Instituto de Salud Carlos III, Spain [PI17/00498, PI17/00420]; European Regional Development Fund	State Council of Science and Technology (FONCYT)(FONCyT); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); European Regional Development Fund(European Commission)	We received funding from The State Council of Science and Technology (FONCYT) COAH-2019-C13-C054, for the purchase of reagents used in this project, in addition to having a grant from supported by PI17/00498 & PI17/00420 from the Instituto de Salud Carlos III, Spain, co-financed by the European Regional Development Fund.	Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff; Berti L, 2015, MOL METAB, V4, P519, DOI 10.1016/j.molmet.2015.04.002; Calza L, 2016, J ANTIMICROB CHEMOTH, V71, P1451, DOI 10.1093/jac/dkv494; Calza L, 2009, DRUG HEALTHC PATIENT, V1, P25; Cheng P, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1540267; Domingo P, 2010, AIDS, V24, P2629, DOI 10.1097/QAD.0b013e3283400088; Domouzoglou EM, 2015, AM J PHYSIOL-HEART C, V309, pH1029, DOI 10.1152/ajpheart.00527.2015; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Girer NG, 2016, J BIOL CHEM, V291, P15378, DOI 10.1074/jbc.M116.715151; Gomez-Ambrosi J, 2017, CLIN NUTR, V36, P861, DOI 10.1016/j.clnu.2016.04.027; Hernández Yero José Arturo, 2011, Rev Cubana Endocrinol, V22, P69; Huang YY, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1658062; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Kotler DP., 2005, LIPODYSTROPHY WHATS, V10; Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915; Li L, 2008, DIABETES RES CLIN PR, V82, P209, DOI 10.1016/j.diabres.2008.07.012; Li X., 2014, INSUL INSISTENCE SYN, V2, P91; Limsreng S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160306; Lindegaard B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127249; Liu HX, 2015, ONCOTARGET, V6, P9686, DOI 10.18632/oncotarget.3531; Miehle K, 2016, CYTOKINE, V83, P239, DOI 10.1016/j.cyto.2016.04.015; Nansseu JRN, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0240-3; Ong KL, 2012, J CLIN ENDOCR METAB, V97, P4701, DOI 10.1210/jc.2012-2267; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Paula AA, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-32; Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019; Ribera E, 2011, ENFERM INFEC MICR CL, V29, P362, DOI 10.1016/j.eimc.2011.02.004; Ros Perez Manuel, 2011, Endocrinol Nutr, V58, P360, DOI 10.1016/j.endonu.2011.05.008; Santiprabhob J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7481597; Spolcova A, 2014, PHYSIOL RES, V63, P483, DOI 10.33549/physiolres.932714; Tabari FS, 2019, REV ENDOCR METAB DIS, V20, P103, DOI 10.1007/s11154-019-09488-x; Vandanmagsar B, 2016, CELL REP, V15, P1686, DOI 10.1016/j.celrep.2016.04.057; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Xu PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155598	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0252144	10.1371/journal.pone.0252144	http://dx.doi.org/10.1371/journal.pone.0252144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019585	gold, Green Published			2022-12-26	WOS:000664632300055
J	Baunez, C; Degoulet, M; Luchini, S; Pintus, PA; Teschl, M				Baunez, Christelle; Degoulet, Mickael; Luchini, Stephane; Pintus, Patrick A.; Teschl, Miriam			Tracking the dynamics and allocating tests for COVID-19 in real-time: An acceleration index with an application to French age groups and departements	PLOS ONE			English	Article								An acceleration index is proposed as a novel indicator to track the dynamics of COVID-19 in real-time. Using data on cases and tests in France for the period between the first and second lock-downs-May 13 to October 25, 2020-our acceleration index shows that the pandemic resurgence can be dated to begin around July 7. It uncovers that the pandemic acceleration was stronger than national average for the [59-68] and especially the 69 and older age groups since early September, the latter being associated with the strongest acceleration index, as of October 25. In contrast, acceleration among the [19-28] age group was the lowest and is about half that of the [69-78]. In addition, we propose an algorithm to allocate tests among French "departements" (roughly counties), based on both the acceleration index and the feedback effect of testing. Our acceleration-based allocation differs from the actual distribution over French territories, which is population-based. We argue that both our acceleration index and our allocation algorithm are useful tools to guide public health policies as France might possibly enter a third lock-down period with indeterminate duration.	[Baunez, Christelle; Degoulet, Mickael] Aix Marseille Univ, Inst Neurosci Timone, CNRS, Marseille, France; [Luchini, Stephane; Pintus, Patrick A.] Aix Marseille Univ, Aix Marseille Sch Econ, CNRS, Marseille, France; [Teschl, Miriam] Aix Marseille Univ, Aix Marseille Sch Econ, EHESS, CNRS, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Pintus, PA (corresponding author), Aix Marseille Univ, Aix Marseille Sch Econ, CNRS, Marseille, France.	patrick.pitus@univ-amu.fr		Pintus, Patrick/0000-0003-2263-0655				ARROW KJ, 1961, REV ECON STAT, V43, P225, DOI 10.2307/1927286; Baunez C., 2020, COVID EC, V12, P192; Baunez C., 2020, MEDR, DOI [10.1101/2020.11.11.20230243, DOI 10.1101/2020.11.11.20230243]; Baunez C., 2020, MEDR, DOI [10.1101/2020.12.01.20241570v2, DOI 10.1101/2020.12.01.20241570V2]; Britton T, 2020, SCIENCE, V369, P846, DOI 10.1126/science.abc6810; Degoulet M., 2021, SENSITIVITY RARE EXT; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Gurdasani D, 2020, LANCET GLOB HEALTH, V8, pE776, DOI 10.1016/S2214-109X(20)30219-9; Haleem A, 2020, AM J EMERG MED, V38, P1524, DOI 10.1016/j.ajem.2020.04.022; Haleem Abid, 2020, Curr Med Res Pract, V10, P78, DOI 10.1016/j.cmrp.2020.03.011; Han J, 2012, MOR KAUF D, P1; HYERS DH, 1952, P AM MATH SOC, V3, P821, DOI 10.2307/2032186; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lee EC, 2020, SCIENCE, V370, P406, DOI 10.1126/science.abd8755; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Taleb N. N., 2012, ANTIFRAGILE THINGS G	16	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252443	10.1371/journal.pone.0252443	http://dx.doi.org/10.1371/journal.pone.0252443			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SL3JC	34061892	Green Submitted, Green Published, gold			2022-12-26	WOS:000656813600035
J	Brixius-Anderko, S; Scott, EE				Brixius-Anderko, Simone; Scott, Emily E.			Structural and functional insights into aldosterone synthase interaction with its redox partner protein adrenodoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; ELECTRON-TRANSFER; MOLECULAR RECOGNITION; REDUCTASE; CYP11B1; GENE; MUTATIONS; COMPLEX; HYPERTENSION; P450SCC	Aldosterone is the major mineralocorticoid in the human body controlling blood pressure and salt homeostasis. Over-production of aldosterone leads to primary aldosteronism, which is the most common form of secondary hypertension with limited treatment options. Production of aldosterone by cytochrome P450 11B2 (CYP11B2, aldosterone synthase) requires two reduction events with the electrons delivered by the iron/sulfur protein adrenodoxin. Very limited information is available about the structural and functional basis of adrenodoxin/CYP11B2 interaction, which impedes the development of new treatment options for primary aldosteronism. A systematic study was carried out to determine if adrenodoxin interaction with CYP11B2 might also have an allosteric component in addition to electron transfer. Indeed, local increases in adrenodoxin concentration promote binding of the substrate 11-deoxycorticosterone and the inhibitor osilodrostat (LCI699) in the active site-over 17 angstrom away-as well as enhance the inhibitory effect of this latter drug. The CYP11B2 structure in complex with adrenodoxin identified specific residues at the protein-protein interface interacting via five salt bridges and four hydrogen bonds. Comparisons with cholesterol-metabolizing CYP11A1 and cortisol-producing CYP11B1, which also bind adrenodoxin, revealed substantial structural differences in these regions. The structural and functional differences between different P450 interactions with adrenodoxin may provide valuable clues for an orthogonal treatment approach for primary aldosteronism by specifically targeting the interaction between CYP11B2 and adrenodoxin.	[Brixius-Anderko, Simone; Scott, Emily E.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA.; Scott, EE (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	scottee@umich.edu		Brixius-Anderko, Simone/0000-0002-3036-9285	DOE Office of Science [DE-AC02-06CH11357]; American Heart Association (AHA) [19POST34430199]; University of Michigan	DOE Office of Science(United States Department of Energy (DOE)); American Heart Association (AHA)(American Heart Association); University of Michigan(University of Michigan System)	This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Constructs for expression of adrenodoxin and adrenodoxin reductase were gifts from Dr Richard Auchus at the University of Michigan. Generation of the CYP11B2 and Adx-CYP11B2 fusion constructs, expression, purification, and characterization was supported by startup funds from the University of Michigan. Adx-CYP11B2 coexpression with fadrozole, conducted binding and inhibition studies, protein crystallography and structure determination were supported by a Postdoctoral Fellowship Award of the American Heart Association (AHA, Award No. 19POST34430199). The content of this publication is solely the responsibility of the authors and do not necessarily represent the official views of AHA.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amar L, 2010, HYPERTENSION, V56, P831, DOI 10.1161/HYPERTENSIONAHA.110.157271; Beckert V, 1997, J BIOL CHEM, V272, P4883, DOI 10.1074/jbc.272.8.4883; Birtcher KK, 2004, CIRCULATION, V110, pE296, DOI 10.1161/01.CIR.0000141564.89465.4E; Brixius-Anderko S., HYPERTENSION, V78, P751; Brixius-Anderko S, 2019, J BIOL CHEM, V294, P453, DOI 10.1074/jbc.RA118.006214; BROWNE LJ, 1991, J MED CHEM, V34, P725, DOI 10.1021/jm00106a038; Bureik M, 2002, BIOL CHEM, V383, P1537, DOI 10.1515/BC.2002.174; Chien Y, 2017, MOL CELL ENDOCRINOL, V441, P55, DOI 10.1016/j.mce.2016.10.030; Connell JMC, 2005, J ENDOCRINOL, V186, P1, DOI 10.1677/joe.1.06017; CURNOW KM, 1993, P NATL ACAD SCI USA, V90, P4552, DOI 10.1073/pnas.90.10.4552; Duggan S, 2020, DRUGS, V80, P495, DOI 10.1007/s40265-020-01277-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ewen KM, 2012, IUBMB LIFE, V64, P506, DOI 10.1002/iub.1029; Funder JW, 2006, J HYPERTENS, V24, P16; Godamudunage MP, 2018, DRUG METAB DISPOS, V46, P1329, DOI 10.1124/dmd.118.082032; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hartfield KA, 2013, J STEROID BIOCHEM, V136, P47, DOI 10.1016/j.jsbmb.2012.11.001; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; Holloway CD, 2009, CLIN ENDOCRINOL, V70, P363, DOI 10.1111/j.1365-2265.2008.03383.x; Hu QZ, 2014, J MED CHEM, V57, P5011, DOI 10.1021/jm401430e; KATAGIRI M, 1977, BIOCHEM BIOPH RES CO, V77, P804, DOI 10.1016/S0006-291X(77)80049-1; Khattab A, 2017, P NATL ACAD SCI USA, V114, pE1933, DOI 10.1073/pnas.1621082114; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar A, 2020, BIOCHEMISTRY-US, V59, P1537, DOI 10.1021/acs.biochem.0c00107; LAMBETH JD, 1976, J BIOL CHEM, V251, P7545; LIN D, 1990, P NATL ACAD SCI USA, V87, P8516, DOI 10.1073/pnas.87.21.8516; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monticone S, 2018, LANCET DIABETES ENDO, V6, P41, DOI 10.1016/S2213-8587(17)30319-4; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parajes S, 2010, J CLIN ENDOCR METAB, V95, P779, DOI 10.1210/jc.2009-0651; Peng HM, 2018, J STEROID BIOCHEM, V181, P63, DOI 10.1016/j.jsbmb.2018.03.003; Peng HM, 2017, BIOCHEMISTRY-US, V56, P2282, DOI 10.1021/acs.biochem.7b00034; Reddish MJ, 2019, J BIOL CHEM, V294, P12975, DOI 10.1074/jbc.RA119.009830; Roumen L, 2007, J COMPUT AID MOL DES, V21, P455, DOI 10.1007/s10822-007-9128-9; Schiffer L, 2019, J STEROID BIOCHEM, V194, DOI 10.1016/j.jsbmb.2019.105439; Schiffer L, 2015, J STEROID BIOCHEM, V151, P38, DOI 10.1016/j.jsbmb.2014.10.011; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Usanov SA, 2002, BIOCHEMISTRY-US, V41, P8310, DOI 10.1021/bi0255928; Vickery LE, 1997, STEROIDS, V62, P124, DOI 10.1016/S0039-128X(96)00170-5; Ye ZQ, 2010, CHINESE MED J-PEKING, V123, P1264, DOI 10.3760/cma.j.issn.0366-6999.2010.10.007; Zollner A, 2002, J INORG BIOCHEM, V91, P644, DOI 10.1016/S0162-0134(02)00463-4	46	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100794	10.1016/j.jbc.2021.100794	http://dx.doi.org/10.1016/j.jbc.2021.100794			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34015331	Green Published, gold			2022-12-26	WOS:000674717300014
J	Fleming, K				Fleming, Karen			Na(v)igating the intricacies of cellular machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Voltage-gated sodium channels (Na(V)s) underlie the initiation of action potentials in various excitable cell types and are regulated by channel-interacting proteins, including the cellular calcium sensor calmodulin and fibroblast growth factor homologous factors. Both of these are known to bind the Na-V cytosolic C-terminal domain and modulate the channel's electrophysiology, but it was unknown whether they had any allosteric interactions with each other. A recent rigorous study provides insights into the molecular interactions of these ion channels and their partners that crucially take the cellular landscape into consideration.					Gabelli, Sandra/A-3705-2008	Gabelli, Sandra/0000-0003-1205-5204	National Institutes of Health NHLBI [HL128743]	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health NHLBI (HL128743).	Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Dover K, 2010, J PHYSIOL-LONDON, V588, P3695, DOI 10.1113/jphysiol.2010.192559; Evans TIA, 2009, PROTEINS, V76, P47, DOI 10.1002/prot.22317; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Mahling R., 2021, J BIOL CHEM, V296; Nathan S, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012722; Niu J, 2018, ELIFE, V7, DOI 10.7554/eLife.35222; Pitt GS, 2016, PROTEIN SCI, V25, P1573, DOI 10.1002/pro.2960; Yoder JB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09570-7	10	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100832	10.1016/j.jbc.2021.100832	http://dx.doi.org/10.1016/j.jbc.2021.100832			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34048713	gold, Green Published			2022-12-26	WOS:000674717300027
J	Ashami, K; Falk, AS; Hurd, C; Garg, S; Cervantes, SA; Rawat, A; Siemer, AB				Ashami, Kidist; Falk, Alexander S.; Hurd, Connor; Garg, Samridhi; Cervantes, Silvia A.; Rawat, Anoop; Siemer, Ansgar B.			Droplet and fibril formation of the functional amyloid Orb2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; LIQUID PHASE-SEPARATION; DOMAINS; ORGANIZATION; TRANSITION; RESONANCE; PROTEINS; CORE	The functional amyloid Orb2 belongs to the cytoplasmic polyadenylation element binding (CPEB) protein family and plays an important role in long-term memory formation in Drosophila. The Orb2 domain structure combines RNA recognition motifs with low-complexity sequences similar to many RNA-binding proteins shown to form protein droplets via liquid-liquid phase separation (LLPS) in vivo and in vitro. This similarity suggests that Orb2 might also undergo LLPS. However, cellular Orb2 puncta have very little internal protein mobility, and Orb2 forms fibrils in Drosophila brains that are functionally active indicating that LLPS might not play a role for Orb2. In the present work, we reconcile these two views on Orb2 droplet formation. Using fluorescence microscopy, we show that soluble Orb2 can indeed phase separate into protein droplets. However, fluorescence recovery after photobleaching (FRAP) data shows that these droplets have either no or only an extremely short-lived liquid phase and appear maturated right after formation. Orb2 fragments that lack the C-terminal RNA-binding domain (RBD) form fibrils out of these droplets. Solid-state NMR shows that these fibrils have well-ordered static domains in addition to the Gln/His-rich fibril core. Further, we find that full-length Orb2B, which is by far the major component of Orb2 fibrils in vivo, does not transition into fibrils but remains in the droplet phase. Together, our data suggest that phase separation might play a role in initiating the formation of functional Orb2 fibrils.	[Ashami, Kidist; Falk, Alexander S.; Hurd, Connor; Garg, Samridhi; Cervantes, Silvia A.; Rawat, Anoop; Siemer, Ansgar B.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA; [Falk, Alexander S.] Kite Pharma, Emeryville, CA USA; [Garg, Samridhi] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	University of Southern California; University of Wisconsin System; University of Wisconsin Madison	Siemer, AB (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA.	asiemer@usc.edu	Rawat, Anoop/GPS-5531-2022; Rawat, Anoop/AAO-6795-2021	Rawat, Anoop/0000-0002-5838-0275; Siemer, Ansgar B./0000-0003-0901-011X	National Institutes of Health [F31GM120858]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.B.S. would like to acknowledge funding from the National Institutes of Health (R01NS084345, R01GM110521). A.S.F. would like to acknowledge funding from the National Institutes of Health (F31GM120858). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Audas TE, 2016, DEV CELL, V39, P155, DOI 10.1016/j.devcel.2016.09.002; Babinchak WM, 2020, J MOL BIOL, V432, P1910, DOI 10.1016/j.jmb.2020.03.004; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Cervantes SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38265; Chen XD, 2020, NAT NEUROSCI, V23, P301, DOI 10.1038/s41593-019-0579-9; Darling AL, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.118984; Detken A, 2002, CHEM PHYS LETT, V356, P298, DOI 10.1016/S0009-2614(02)00335-4; Freeman R., 2007, ENCY MAGNETIC RESONA; Halfmann R, 2016, CURR OPIN STRUC BIOL, V38, P18, DOI 10.1016/j.sbi.2016.05.002; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hardenberg M, 2020, P NATL ACAD SCI USA, V117, P33254, DOI 10.1073/pnas.2007670117; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Hervas R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186910; Hervas R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002361; Hoop CL, 2016, P NATL ACAD SCI USA, V113, P1546, DOI 10.1073/pnas.1521933113; Hoop CL, 2014, BIOCHEMISTRY-US, V53, P6653, DOI 10.1021/bi501010q; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Isas JM, 2017, BIOCHEMISTRY-US, V56, P3579, DOI 10.1021/acs.biochem.7b00138; Isas JM, 2015, BIOCHEMISTRY-US, V54, P3942, DOI 10.1021/acs.biochem.5b00281; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li LY, 2016, CURR BIOL, V26, P3143, DOI 10.1016/j.cub.2016.09.054; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; Pandey NK, 2018, J BIOL CHEM, V293, P2597, DOI 10.1074/jbc.M117.813667; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peskett TR, 2018, MOL CELL, V70, P588, DOI 10.1016/j.molcel.2018.04.007; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Schutz AK, 2014, BIOMOL NMR ASSIGN, V8, P349, DOI 10.1007/s12104-013-9515-1; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Si K, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021774; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Siemer AB, 2020, SOLID STATE NUCL MAG, V106, DOI 10.1016/j.ssnmr.2020.101643; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Sokolov PA, 2017, COMPUT PHYS COMMUN, V214, P199, DOI 10.1016/j.cpc.2017.01.011; Takashimizu Y, 2016, PROG EARTH PLANET SC, V3, DOI 10.1186/s40645-015-0078-x; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Taylor NO, 2019, BIOPHYS J, V117, P1285, DOI 10.1016/j.bpj.2019.08.030; Verel R, 2001, J MAGN RESON, V150, P81, DOI 10.1006/jmre.2001.2310; White-Grindley E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001786; Woodruff JB, 2018, TRENDS BIOCHEM SCI, V43, P81, DOI 10.1016/j.tibs.2017.11.005; Wu XD, 2020, DEV CELL, V55, P18, DOI 10.1016/j.devcel.2020.06.012; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	51	2	2	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100804	10.1016/j.jbc.2021.100804	http://dx.doi.org/10.1016/j.jbc.2021.100804			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34044018	gold, Green Submitted, Green Published			2022-12-26	WOS:000678068400010
J	Cai, T; Yu, ZB; Wang, Z; Liang, C; Richard, S				Cai, Ting; Yu, Zhenbao; Wang, Zhen; Liang, Chen; Richard, Stephane			Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-SEPARATION; PHOSPHORYLATION; METHYLTRANSFERASE; IDENTIFICATION; VIRUS; SITES; LOCALIZATION; RECRUITMENT; INHIBITOR; CHROMATIN	Viral proteins are known to be methylated by host protein arginine methyltransferases (PRMTs) necessary for the viral life cycle, but it remains unknown whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins are methylated. Herein, we show that PRMT1 methylates SARS-CoV-2 nucleocapsid (N) protein at residues R95 and R177 within RGG/RG motifs, preferred PRMT target sequences. We confirmed arginine methylation of N protein by immunoblotting viral proteins extracted from SARS-CoV-2 virions isolated from cell culture. Type I PRMT inhibitor (MS023) or substitution of R95 or R177 with lysine inhibited interaction of N protein with the 5'-UTR of SARS-CoV-2 genomic RNA, a property required for viral packaging. We also defined the N protein interactome in HEK293 cells, which identified PRMT1 and many of its RGG/RG substrates, including the known interacting protein G3BP1 as well as other components of stress granules (SGs), which are part of the host antiviral response. Methylation of R95 regulated the ability of N protein to suppress the formation of SGs, as R95K substitution or MS023 treatment blocked N-mediated suppression of SGs. Also, the coexpression of methylarginine reader Tudor domain-containing protein 3 quenched N protein-mediated suppression of SGs in a dose-dependent manner. Finally, pretreatment of VeroE6 cells with MS023 significantly reduced SARS-CoV-2 replication. Because type I PRMT inhibitors are already undergoing clinical trials for cancer treatment, inhibiting arginine methylation to target the later stages of the viral life cycle such as viral genome packaging and assembly of virions may represent an additional therapeutic application of these drugs.	[Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ, Canada; [Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada; [Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Med, Montreal, PQ, Canada; [Wang, Zhen; Liang, Chen] McGill Univ, McGill Ctr Viral Dis, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Wang, Zhen; Liang, Chen] McGill Univ, Dept Med, Dept Microbiol & Immunol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; McGill University	Richard, S (corresponding author), McGill Univ, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ, Canada.; Richard, S (corresponding author), McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada.; Richard, S (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.; Richard, S (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Richard, S (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	stephane.richard@mcgill.ca			Canadian Institutes of Health Research [FDN-154303]; Fonds de recherche du Quebec en Sante studentship award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec en Sante studentship award	This work was funded by a Canadian Institutes of Health Research FDN-154303 award (to S. R.). T. C. holds a Fonds de recherche du Quebec en Sante studentship award.	Akter KA, 2016, TUMOR BIOL, V37, P4531, DOI 10.1007/s13277-015-4310-5; Barrera A, 2020, NUCLEIC ACIDS RES, V48, P10479, DOI 10.1093/nar/gkaa765; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Burbelo PD, 2020, J INFECT DIS, DOI DOI 10.1093/INFDIS/JIAA273; Carlson CR, 2020, MOL CELL, V80, P1092, DOI 10.1016/j.molcel.2020.11.025; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen H, 2020, CELL RES, V30, P1143, DOI 10.1038/s41422-020-00408-2; Chen SC, 2010, VIROLOGY, V401, P29, DOI 10.1016/j.virol.2010.02.007; Chong PA, 2018, J MOL BIOL, V430, P4650, DOI 10.1016/j.jmb.2018.06.014; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Corbet Giulia Ada, 2019, Cold Spring Harb Symp Quant Biol, V84, P203, DOI 10.1101/sqb.2019.84.040329; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Cubuk J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21953-3; Denison MR, 1999, J VIROL, V73, P6862, DOI 10.1128/JVI.73.8.6862-6871.1999; Dinesh DC, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009100; Eram MS, 2016, ACS CHEM BIOL, V11, P772, DOI 10.1021/acschembio.5b00839; Fedoriw A, 2019, CANCER CELL, V36, P100, DOI 10.1016/j.ccell.2019.05.014; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Gao B, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1008690; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Guccione E, 2019, NAT REV MOL CELL BIO, V20, P642, DOI 10.1038/s41580-019-0155-x; Guillen-Boixet J, 2020, CELL, V181, P346, DOI 10.1016/j.cell.2020.03.049; Gurunathan G, 2015, SCI REP-UK, V5, DOI 10.1038/srep10475; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Heaton B.E., 2020, SRSF PROTEIN KINASES, DOI [10.1101/2020.08.14.251207, DOI 10.1101/2020.08.14.251207]; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Huang CY, 2020, CELL DEATH DIFFER, V27, P227, DOI 10.1038/s41418-019-0350-5; Iserman C, 2020, MOL CELL, V80, P1078, DOI 10.1016/j.molcel.2020.11.041; Jack A, 2021, PLOS BIOL, V19, DOI [10.1371/journal.pbio.3001425, 10.1101/2020.09.14.295824]; Jarrold J, 2019, TRENDS MOL MED, V25, P993, DOI 10.1016/j.molmed.2019.05.007; Kang SS, 2020, ACTA PHARM SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009; Khan S, 2022, J BIOMOL STRUCT DYN, V40, P6286, DOI 10.1080/07391102.2021.1882337; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Lee YJ, 2012, J CELL BIOCHEM, V113, P2721, DOI 10.1002/jcb.24151; Li JJ, 2021, MED-CAMBRIDGE, V2, P99, DOI 10.1016/j.medj.2020.07.002; Lin SM, 2020, J MED CHEM, V63, P3131, DOI 10.1021/acs.jmedchem.9b01913; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Lu S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20768-y; Lubyova B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186982; Luo LL, 2021, SCI BULL, V66, P1194, DOI 10.1016/j.scib.2021.01.013; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; McCormick C, 2017, NAT REV IMMUNOL, V17, P647, DOI 10.1038/nri.2017.63; Nabeel-Shah S, 2020, SARS COV 2 NUCLEOCAP, DOI [10.1101/2020.10.23.342113, DOI 10.1101/2020.10.23.342113]; Nakagawa K, 2018, J VIROL, V92, DOI 10.1128/JVI.00902-18; Nakayama Kazuhide, 2018, Oncotarget, V9, P18480, DOI 10.18632/oncotarget.24883; Nikolakaki E, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00219; Noorimotlagh Z, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106738; Omer A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18734-9; Paris J, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0428-z; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Perdikari TM, 2020, EMBO J, V39, DOI 10.15252/embj.2020106478; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Rabouw HH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005982; Hernandez ER, 2021, VIRAL IMMUNOL, V34, P165, DOI 10.1089/vim.2020.0174; Ray Manisha, 2020, Genomics & Informatics, V18, pe43, DOI 10.5808/GI.2020.18.4.e43; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sarkar B., 2020, ESSENTIAL FACTS WUHA, DOI [DOI 10.1101/2020.02.05.935072, 10.1101/2020.02.05.935072]; Savastano A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19843-1; Schneider WM, 2021, CELL, V184, P120, DOI 10.1016/j.cell.2020.12.006; Shen YD, 2020, J MED CHEM, V63, P9977, DOI 10.1021/acs.jmedchem.0c01111; Song JW, 2015, MOL CELL BIOL, V35, P1926, DOI 10.1128/MCB.01488-14; Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; STOHLMAN SA, 1988, J VIROL, V62, P4288, DOI 10.1128/JVI.62.11.4288-4295.1988; Sun L, 2021, CELL, V184, P1865, DOI 10.1016/j.cell.2021.02.008; Szewczyk MM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16271-z; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsai WC, 2016, J BIOL CHEM, V291, P22671, DOI 10.1074/jbc.M116.739573; Tugaeva KV, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166875; Wall ML, 2017, J MOL BIOL, V429, P295, DOI 10.1016/j.jmb.2016.12.011; Wang J, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-020-00240-3; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028; Wei Jin, 2020, bioRxiv, DOI 10.1101/2020.06.16.155101; White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001; Woodsmith J, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800178; Wu CH, 2014, CELL HOST MICROBE, V16, P462, DOI 10.1016/j.chom.2014.09.009; Wu CH, 2009, J BIOL CHEM, V284, P5229, DOI 10.1074/jbc.M805747200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang PG, 2020, CELL, V181, P325, DOI 10.1016/j.cell.2020.03.046; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Ye QZ, 2020, PROTEIN SCI, V29, P1890, DOI [10.1002/pro.3909, 10.1101/2020.05.17.100685]; Zhu YK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21213-4	93	19	20	4	17	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100821	10.1016/j.jbc.2021.100821	http://dx.doi.org/10.1016/j.jbc.2021.100821			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029587	Green Published, gold			2022-12-26	WOS:000678068400023
J	Ide, K; Takahashi, S; Sakai, K; Taga, Y; Ueno, T; Dickens, D; Jenkins, R; Falciani, F; Sasaki, T; Ooi, K; Kawashiri, S; Mizuno, K; Hattori, S; Sakai, T				Ide, Kentaro; Takahashi, Sanai; Sakai, Keiko; Taga, Yuki; Ueno, Tomonori; Dickens, David; Jenkins, Rosalind; Falciani, Francesco; Sasaki, Takako; Ooi, Kazuhiro; Kawashiri, Shuichi; Mizuno, Kazunori; Hattori, Shunji; Sakai, Takao			The dipeptide prolyl-hydroxyproline promotes cellular homeostasis and lamellipodia-driven motility via active beta 1-integrin in adult tendon cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-DERIVED DIPEPTIDE; HUMAN-BLOOD; TGF-BETA; EXTRACELLULAR-MATRIX; ADHESION DYNAMICS; HOMEOBOX GENE; INTEGRIN; DIFFERENTIATION; SCLERAXIS; MIGRATION	Collagen-derived hydroxyproline (Hyp)-containing peptides have a variety of biological effects on cells. These bioactive collagen peptides are locally generated by the degradation of endogenous collagen in response to injury. However, no comprehensive study has yet explored the functional links between Hyp-containing peptides and cellular behavior. Here, we show that the dipeptide prolyl-4-hydroxyproline (Pro-Hyp) exhibits pronounced effects on mouse tendon cells. Pro-Hyp promotes differentiation/maturation of tendon cells with modulation of lineage-specific factors and induces significant chemotactic activity in vitro. In addition, Pro-Hyp has pro-found effects on cell proliferation, with significantly upregulated extracellular signal-regulated kinase phosphorylation and extracellular matrix production and increased type I collagen network organization. Using proteomics, we have predicted molecular transport, cellular assembly and organization, and cellular movement as potential linked-network pathways that could be altered in response to Pro-Hyp. Mechanistically, cells treated with Pro-Hyp demonstrate increased directional persistence and significantly increased directed motility and migration velocity. They are accompanied by elongated lamellipodial protrusions with increased levels of active beta 1-integrin-containing focal contacts, as well as reorganization of thicker peripheral F-actin fibrils. Pro-Hyp-mediated chemotactic activity is significantly reduced (p < 0.001) in cells treated with the mitogen-activated protein kinase kinase 1/2 inhibitor PD98059 or the alpha 5 beta 1-integrin antagonist ATN-161. Furthermore, ATN-161 significantly inhibits uptake of Pro-Hyp into adult tenocytes. Thus, our findings document the molecular basis of the functional benefits of the Pro-Hyp dipeptide in cellular behavior. These dynamic properties of collagen-derived Pro-Hyp dipeptide could lead the way to its application in translational medicine.	[Ide, Kentaro; Takahashi, Sanai; Sakai, Keiko; Dickens, David; Jenkins, Rosalind; Sakai, Takao] Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Syst Mol & Integrat Biol, Dept Pharmacol & Therapeut, Liverpool, Merseyside, England; [Taga, Yuki; Ueno, Tomonori; Mizuno, Kazunori; Hattori, Shunji] Nippi Res Inst Biomatrix, Toride, Ibaraki, Japan; [Falciani, Francesco] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Biochem & Syst Biol, Liverpool, Merseyside, England; [Sasaki, Takako] Oita Univ, Fac Med, Dept Biochem, Oita, Japan; [Ide, Kentaro; Ooi, Kazuhiro; Kawashiri, Shuichi] Kanazawa Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	University of Liverpool; University of Liverpool; Oita University; Kanazawa University	Sakai, T (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Syst Mol & Integrat Biol, Dept Pharmacol & Therapeut, Liverpool, Merseyside, England.	sakait@liverpool.ac.uk	Taga, Yuki/I-2781-2019; Mizuno, Kazunori/AAY-7613-2021; Dickens, David/H-3105-2016	Taga, Yuki/0000-0001-9100-758X; Mizuno, Kazunori/0000-0003-3354-6264; Ide, Kentaro/0000-0003-0701-1207; Dickens, David/0000-0001-8295-0752	Knowledge Exchange Funding Scheme, University of Liverpool, United Kingdom; Nippi, Inc, Japan	Knowledge Exchange Funding Scheme, University of Liverpool, United Kingdom; Nippi, Inc, Japan	This work was supported in part by the Knowledge Exchange Funding Scheme, University of Liverpool, United Kingdom, and Nippi, Inc, Japan (to T. S.).	Anderson DM, 2006, DEV DYNAM, V235, P792, DOI 10.1002/dvdy.20671; Aslan H, 2008, J CLIN INVEST, V118, P439, DOI 10.1172/JCI33944; Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Bagchi RA, 2012, BBA-MOL CELL RES, V1823, P1936, DOI 10.1016/j.bbamcr.2012.07.002; Barkan D, 2011, CLIN CANCER RES, V17, P7219, DOI 10.1158/1078-0432.CCR-11-0642; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Durzynska J, 2015, J PHARMACOL EXP THER, V354, P32, DOI 10.1124/jpet.115.223305; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Gallo M, 2019, ARCH BIOCHEM BIOPHYS, V661, P74, DOI 10.1016/j.abb.2018.11.010; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Havis E, 2016, DEVELOPMENT, V143, P3839, DOI 10.1242/dev.136242; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Honda K, 2007, CARCINOGENESIS, V28, P2074, DOI 10.1093/carcin/bgm112; Huang AH, 2015, J ORTHOP RES, V33, P800, DOI 10.1002/jor.22834; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Innocenti M, 2018, CELL ADHES MIGR, V12, P401, DOI 10.1080/19336918.2018.1448352; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Iwai K, 2005, J AGR FOOD CHEM, V53, P6531, DOI 10.1021/jf050206p; Iwasaki A, 2016, J BIOL CHEM, V291, P72, DOI 10.1074/jbc.M115.691519; Jain P, 2012, JOVE-J VIS EXP, DOI 10.3791/3585; Jimi S., 2017, CLIN RES DERMATOL OP, V4, P1, DOI [10.15226/2378-1726/4/2/00155, DOI 10.15226/2378-1726/4/2/00155]; Kimira Y, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0060-2; Kimira Y, 2014, BIOCHEM BIOPH RES CO, V453, P498, DOI 10.1016/j.bbrc.2014.09.121; Kitakaze T, 2016, BIOCHEM BIOPH RES CO, V478, P1292, DOI 10.1016/j.bbrc.2016.08.114; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Kumagai K, 2012, OSTEOARTHR CARTILAGE, V20, P1258, DOI 10.1016/j.joca.2012.07.013; Kusubata M, 2015, BIOSCI BIOTECH BIOCH, V79, P1356, DOI 10.1080/09168451.2015.1027653; LASKIN DL, 1986, J LEUKOCYTE BIOL, V39, P255, DOI 10.1002/jlb.39.3.255; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Liu HH, 2015, STEM CELLS, V33, P443, DOI 10.1002/stem.1866; Liu ZH, 2011, PEPTIDES, V32, P747, DOI 10.1016/j.peptides.2011.01.019; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Mana G, 2020, BIOCHEM SOC T, V48, P83, DOI 10.1042/BST20190309; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; Minaguchi J, 2005, J NUTR SCI VITAMINOL, V51, P169, DOI 10.3177/jnsv.51.169; Moreno-Layseca P, 2019, NAT CELL BIOL, V21, P122, DOI 10.1038/s41556-018-0223-z; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nakatani S, 2009, OSTEOARTHR CARTILAGE, V17, P1620, DOI 10.1016/j.joca.2009.07.001; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; OBrien M, 1997, SCAND J MED SCI SPOR, V7, P55; Ogese MO, 2019, HEPATOLOGY, V70, P1732, DOI 10.1002/hep.30701; Ohara H, 2010, J DERMATOL, V37, P330, DOI 10.1111/j.1346-8138.2010.00827.x; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; POSTLETHWAITE AE, 1976, J EXP MED, V143, P1299, DOI 10.1084/jem.143.6.1299; POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871; Pozzi M, 1998, J CELL BIOL, V142, P587; Praet SFE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010076; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sakabe T, 2018, J BIOL CHEM, V293, P5766, DOI 10.1074/jbc.RA118.001987; Sakabe T, 2011, BRIT MED BULL, V99, P211, DOI 10.1093/bmb/ldr025; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 1998, J BIOL CHEM, V273, P19378, DOI 10.1074/jbc.273.31.19378; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Saneyasu T., 2016, COMPOSITION FUNCTION, P235; Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295; Sato K, 2019, INT J FOOD SCI TECH, V54, P1976, DOI 10.1111/ijfs.14145; Schunck M., 2013, J INT SOC SPORTS NUT, V10, pP23, DOI [10.1186/1550-2783-10-S1-P23, DOI 10.1186/1550-2783-10-S1-P23]; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Shigemura Y, 2009, J AGR FOOD CHEM, V57, P444, DOI 10.1021/jf802785h; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Tabujew I., 2015, BIONANOMATERIALS, V16, P59, DOI [10.1515/bnm-2015-0001, DOI 10.1515/BNM-2015-0001]; Taga Y, 2019, J AGR FOOD CHEM, V67, P4671, DOI 10.1021/acs.jafc.9b00571; Taga Y, 2018, J AGR FOOD CHEM, V66, P8737, DOI 10.1021/acs.jafc.8b03648; Taga Y, 2018, J FUNCT FOODS, V46, P456, DOI 10.1016/j.jff.2018.05.017; Taga Y, 2014, J AGR FOOD CHEM, V62, P12096, DOI 10.1021/jf5039597; Tanimura S, 2017, J BIOCHEM, V162, P145, DOI 10.1093/jb/mvx048; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Truong H, 2009, CELL ADHES MIGR, V3, P179, DOI 10.4161/cam.3.2.8036; Tsuruoka N, 2007, BIOSCI BIOTECH BIOCH, V71, P2680, DOI 10.1271/bbb.70287; Ueda H, 2008, J VET MED SCI, V70, P1295, DOI 10.1292/jvms.70.1295; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wang WQ, 2011, INVEST OPHTH VIS SCI, V52, P7213, DOI 10.1167/iovs.10-7097; Wu J, 2004, J BONE MINER METAB, V22, P547, DOI 10.1007/s00774-004-0522-2; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	95	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100819	10.1016/j.jbc.2021.100819	http://dx.doi.org/10.1016/j.jbc.2021.100819			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029590	Green Published, gold			2022-12-26	WOS:000678068400021
J	Snitz, K; Andelman-Gur, M; Pinchover, L; Weissgross, R; Weissbrod, A; Mishor, E; Zoller, R; Linetsky, V; Medhanie, A; Shushan, S; Jaffe, E; Sobel, N				Snitz, Kobi; Andelman-Gur, Michal; Pinchover, Liron; Weissgross, Reut; Weissbrod, Aharon; Mishor, Eva; Zoller, Roni; Linetsky, Vera; Medhanie, Abebe; Shushan, Sagit; Jaffe, Eli; Sobel, Noam			Proof of concept for real-time detection of SARS CoV-2 infection with an electronic nose	PLOS ONE			English	Article							EXHALED BREATH ANALYSIS; LUNG-CANCER	Rapid diagnosis is key to curtailing the Covid-19 pandemic. One path to such rapid diagnosis may rely on identifying volatile organic compounds (VOCs) emitted by the infected body, or in other words, identifying the smell of the infection. Consistent with this rationale, dogs can use their nose to identify Covid-19 patients. Given the scale of the pandemic, however, animal deployment is a challenging solution. In contrast, electronic noses (eNoses) are machines aimed at mimicking animal olfaction, and these can be deployed at scale. To test the hypothesis that SARS CoV-2 infection is associated with a body-odor detectable by an eNose, we placed a generic eNose in-line at a drive-through testing station. We applied a deep learning classifier to the eNose measurements, and achieved real-time detection of SARS CoV-2 infection at a level significantly better than chance, for both symptomatic and non-symptomatic participants. This proof of concept with a generic eNose implies that an optimized eNose may allow effective real-time diagnosis, which would provide for extensive relief in the Covid-19 pandemic.	[Snitz, Kobi; Andelman-Gur, Michal; Pinchover, Liron; Weissgross, Reut; Weissbrod, Aharon; Mishor, Eva; Zoller, Roni; Linetsky, Vera; Medhanie, Abebe; Shushan, Sagit; Sobel, Noam] Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel; [Snitz, Kobi; Andelman-Gur, Michal; Pinchover, Liron; Weissgross, Reut; Weissbrod, Aharon; Mishor, Eva; Zoller, Roni; Linetsky, Vera; Medhanie, Abebe; Shushan, Sagit; Sobel, Noam] Weizmann Inst Sci, Azrieli Ctr Human Brain Imaging & Res, Rehovot, Israel; [Shushan, Sagit] Edith Wolfson Med Ctr, Dept Otolaryngol & Head & Neck Surg, Holon, Israel; [Jaffe, Eli] Ben Gurion Univ Negev, Magen David Adom Israel, Beer Sheva, Israel; [Jaffe, Eli] Ben Gurion Univ Negev, Dept Emergency Med, Beer Sheva, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Ben Gurion University; Ben Gurion University	Snitz, K; Sobel, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, Rehovot, Israel.; Snitz, K; Sobel, N (corresponding author), Weizmann Inst Sci, Azrieli Ctr Human Brain Imaging & Res, Rehovot, Israel.	kobi.snitz@weizmann.ac.il; noam.sobel@weizmann.ac.il		Jaffe, Eli/0000-0002-8380-0219; Andelman-Gur, Michal M./0000-0003-4401-5952	MAFAT: The Israeli Ministry of Defense Directorate of Defense Research and Development; European Research Council [670798, 662629]	MAFAT: The Israeli Ministry of Defense Directorate of Defense Research and Development; European Research Council(European Research Council (ERC)European Commission)	This study was supported by pilot grants from MAFAT: The Israeli Ministry of Defense Directorate of Defense Research and Development, and from Sonia T. Marschak. This effort also relied on ongoing Sobel lab resources, provided by a European Research Council AdG. grant #670798 (SocioSmell) and Horizon 2020 FET Open project #662629 (NanoSmell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov AA, 2014, CHEMBIOCHEM, V15, P1040, DOI 10.1002/cbic.201300695; Bach JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132227; Baietto M, 2010, SENSORS-BASEL, V10, P1062, DOI 10.3390/s100201062; Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801; Brekelmans MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151715; Broza YY, 2015, ANGEW CHEM INT EDIT, V54, P11036, DOI 10.1002/anie.201500153; Bruins M, 2013, TUBERCULOSIS, V93, P232, DOI 10.1016/j.tube.2012.10.002; Doleman BJ, 2001, SENSOR ACTUAT B-CHEM, V72, P41, DOI 10.1016/S0925-4005(00)00635-3; Dragonieri S, 2012, LUNG CANCER, V75, P326, DOI 10.1016/j.lungcan.2011.08.009; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Fens N, 2013, CLIN EXP ALLERGY, V43, P705, DOI 10.1111/cea.12052; FREUND MS, 1995, P NATL ACAD SCI USA, V92, P2652, DOI 10.1073/pnas.92.7.2652; Gardner J.W., 2006, HDB MACHINE OLFACTIO; Gardner JW, 2000, SENSOR ACTUAT B-CHEM, V70, P19, DOI 10.1016/S0925-4005(00)00548-7; Jendrny P, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05281-3; Jeon HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200605; Joensen O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115584; Lamote K, 2020, J BREATH RES, V14, DOI 10.1088/1752-7163/aba105; Lewis JE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172724; Machado RF, 2005, AM J RESP CRIT CARE, V171, P1286, DOI 10.1164/rccm.200409-1184OC; Meinhardt J, 2021, NAT NEUROSCI, V24, P168, DOI 10.1038/s41593-020-00758-5; Pickel D, 2004, APPL ANIM BEHAV SCI, V89, P107, DOI 10.1016/j.applanim.2004.04.008; Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q; Saktiawati AMI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217963; Scarlata S, 2015, EXPERT REV MOL DIAGN, V15, P933, DOI 10.1586/14737159.2015.1043895; Schnabel RM, 2015, RESP MED, V109, P1454, DOI 10.1016/j.rmed.2015.09.014; Seo IS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192629; Shafiek H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135199; Shah A, 2020, MAYO CLIN PROC, V95, P1420, DOI 10.1016/j.mayocp.2020.04.030; Shan BJ, 2020, ACS NANO, V14, P12125, DOI 10.1021/acsnano.0c05657; Swanson B, 2020, J ASSOC NURSE AIDS C, V31, P71, DOI 10.1097/JNC.0000000000000146; Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20; van der Schee MP, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/1/016002; van Geffen WH, 2016, J BREATH RES, V10, DOI 10.1088/1752-7155/10/3/036001; Wintjens AGWE, 2021, SURG ENDOSC, V35, P6671, DOI 10.1007/s00464-020-08169-0	36	9	9	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2021	16	6							e0252121	10.1371/journal.pone.0252121	http://dx.doi.org/10.1371/journal.pone.0252121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QL	34077435	gold, Green Published			2022-12-26	WOS:000664638500029
J	Silva, JP; Singh, A; Oldenburg, B; Gunathunga, W; Alagiyawanna, AMAAP; Mavoa, S				Silva, J. Padmaka; Singh, Ankur; Oldenburg, Brian; Gunathunga, Wasantha; Alagiyawanna, A. M. A. A. P.; Mavoa, Suzanne			Associations between residential greenness and self-reported heart disease in Sri Lankan men: A cross-sectional study	PLOS ONE			English	Article							NON COMMUNICABLE DISEASES; AIR-POLLUTION; RISK-FACTORS; CARDIOVASCULAR-DISEASES; NEIGHBORHOOD GREENNESS; BUILT ENVIRONMENT; PHYSICAL-ACTIVITY; HEALTH; EXPOSURE; MORTALITY	Cardiovascular diseases (CVDs) are major contributors to morbidity and mortality in lower-middle-income countries (LMICs). Features of the natural environment, such as greenness, are a potential, modifiable determinant of CVD, yet there is a lack of evidence, particularly in LMICs. Our study investigated associations between residential greenness, measured using the Normalized Difference Vegetation Index (NDVI), and self-reported heart disease in 5268 Sri Lankan men aged 34 to 55 years. Multivariable logistic regression models were fitted to examine associations between mean NDVI within 100 m, 400 m, 800 m, 1600 m, and 2000 m of the residential address, adjusting for age, marital status, income, education, alcohol consumption, smoking and road length. Fully adjusted models showed that a 0.1 increase in mean NDVI was associated with lower odds of heart disease when using the 400 m (OR: 0.80; 95% CI: 0.64, 1.00), 800 m (OR: 0.85; 95% CI: 0.63, 1.14), and 2000 m (OR: 0.74; 95% CI: 0.48, 1.13) buffers. Further research in different contexts, and with improved outcome measures, is needed to confirm relationships between residential greenness and heart disease in rural areas and in LMICs.	[Silva, J. Padmaka] Off Reg Director Hlth Serv, Monaragala, Sri Lanka; [Silva, J. Padmaka; Singh, Ankur; Oldenburg, Brian; Mavoa, Suzanne] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Australia; [Gunathunga, Wasantha] Univ Colombo, Fac Med, Dept Community Med, Colombo, Sri Lanka; [Alagiyawanna, A. M. A. A. P.] Minist Hlth, Hlth Promot Bur, Colombo, Sri Lanka	University of Melbourne; University of Colombo	Mavoa, S (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Australia.	suzanne.mavoa@unimelb.edu.au	; Singh, Ankur/J-2413-2014	Mavoa, Suzanne/0000-0002-6071-2988; Singh, Ankur/0000-0003-1336-6493	Postgraduate Institute of Medicine, University of Colombo, Sri Lanka; Australian National Health and Medical Research Council Early Career Fellowship [1121035]; University of Melbourne Faculty of Medicine, Dentistry and Health Sciences Research Fellowship	Postgraduate Institute of Medicine, University of Colombo, Sri Lanka; Australian National Health and Medical Research Council Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne Faculty of Medicine, Dentistry and Health Sciences Research Fellowship	JP Silva was supported by the Postgraduate Institute of Medicine, University of Colombo, Sri Lanka. S Mavoa was supported by an Australian National Health and Medical Research Council Early Career Fellowship (#1121035). Dr Mavoa: University of Melbourne Faculty of Medicine, Dentistry and Health Sciences Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asri AK, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abbbaf; Browning M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070675; Chaix B, 2009, SOC SCI MED, V69, P1306, DOI 10.1016/j.socscimed.2009.07.018; Chandrabose M, 2019, OBES REV, V20, P41, DOI 10.1111/obr.12759; da Silveira IH, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000290, 10.11606/s1518-8787.2018052000290]; DCS, 2020, PADD STAT SRI LANK; Dendup T, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010078; Engelgau M, 2010, PREVENTION CONTROL S; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Flies EJ, 2019, ENVIRON INT, V133, DOI 10.1016/j.envint.2019.105187; Fong KC, 2018, CURR ENV HLTH REP, V5, P77, DOI 10.1007/s40572-018-0179-y; Gascon M, 2016, ENVIRON INT, V86, P60, DOI 10.1016/j.envint.2015.10.013; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Hedblom M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46099-7; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-912; Ingiriya City, NTR; Iyer HS, 2021, ENVIRON RES, V196, DOI 10.1016/j.envres.2020.110397; Jacquez GM, 2012, SPAT SPATIO-TEMPORAL, V3, P7, DOI 10.1016/j.sste.2012.02.002; James Peter, 2015, Curr Epidemiol Rep, V2, P131; Jennings V, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030452; Kasturiratne A., 2009, CEYLON MED J, V50; Katulanda P, 2013, PUBLIC HEALTH NUTR, V16, P1684, DOI 10.1017/S1368980012003990; Khan J, 2018, SCI TOTAL ENVIRON, V634, P661, DOI 10.1016/j.scitotenv.2018.03.374; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Lane KJ, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/ehp541, 10.1289/EHP541]; Lanki T, 2017, ENVIRON RES, V159, P176, DOI 10.1016/j.envres.2017.07.039; Liu T, 2021, INT J HYG ENVIR HEAL, V234, DOI 10.1016/j.ijheh.2021.113738; Malekzadeh A, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1846904; Markevych I, 2017, ENVIRON RES, V158, P301, DOI 10.1016/j.envres.2017.06.028; Markevych I, 2014, HEALTH PLACE, V26, P39, DOI 10.1016/j.healthplace.2013.12.001; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Ministry of Health, 2016, HLTH STRAT MAST PLAN; Ministry of Healthcare and Nutrition Sri Lanka, 2009, NATL HLTH POLICY STR; Mygind L, 2021, ENVIRON BEHAV, V53, P184, DOI 10.1177/0013916519873376; Neergheen VL, 2019, BRAIN BEHAV IMMUN, V76, P28, DOI 10.1016/j.bbi.2018.10.008; Nowak David J., 2006, Urban Forestry & Urban Greening, V5, P93, DOI [10.1016/j.ufug.2006.04.002, 10.1016/j.ufug.2006.01.007]; Pereira G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-466; QGIS.org, 2020, QGIS GEOGR INF SYST; Rajagopalan S, 2018, J AM COLL CARDIOL, V72, P2054, DOI 10.1016/j.jacc.2018.07.099; Ramsey S., 2020, GEE IMAGE EXPORT GIT; Redlands CA, 2018, ARCGIS, V10.6; Richardson E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-240; Riggs DW, 2021, AM J PHYSIOL-HEART C, V320, pH1102, DOI 10.1152/ajpheart.00689.2020; Rose N, 2009, ATMOS ENVIRON, V43, P5009, DOI 10.1016/j.atmosenv.2009.06.049; Roy DP, 2014, REMOTE SENS ENVIRON, V145, P154, DOI 10.1016/j.rse.2014.02.001; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Shah ASV, 2013, LANCET, V382, P1039, DOI 10.1016/S0140-6736(13)60898-3; Shuvo FK, 2020, URBAN FOR URBAN GREE, V52, DOI 10.1016/j.ufug.2020.126662; Silva JP, 2016, ASIA-PAC J PUBLIC HE, V28, p10S, DOI 10.1177/1010539515611723; StataCorp, 2019, STAT; Sugathan TN, 2008, INDIAN J MED RES, V127, P555; Tomita A, 2017, LANCET PLANET HEALTH, V1, pE152, DOI 10.1016/S2542-5196(17)30063-3; Twohig-Bennett C, 2018, ENVIRON RES, V166, P628, DOI 10.1016/j.envres.2018.06.030; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; United States Geological Survey, 2018, NDVI FDN REM SENS PH, DOI [10.3390/s18113676, DOI 10.3390/S18113676]; van den Bosch M, 2017, ENVIRON RES, V158, P373, DOI 10.1016/j.envres.2017.05.040; van Kempen E, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020379; WHO, 2013, PMNCH KNOWL SUMM 15; Yeager R, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009117; Yuan Y, 2021, AGING CLIN EXP RES, V33, P1783, DOI 10.1007/s40520-020-01710-0	61	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2021	16	5							e0252382	10.1371/journal.pone.0252382	http://dx.doi.org/10.1371/journal.pone.0252382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6PN	34048455	Green Published, gold			2022-12-26	WOS:000664636100042
J	You, J; Li, JY; Ke, CL; Xiao, YR; Lu, CH; Huang, FK; Mi, YJ; Xia, RM; Li, QY				You, Jun; Li, Jiayi; Ke, Chunlin; Xiao, Yanru; Lu, Chuanhui; Huang, Fakun; Mi, Yanjun; Xia, Rongmu; Li, Qiyuan			Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer	ONCOGENE			English	Article							THERAPEUTIC TARGET; HGF/C-MET; REGULATORY NETWORK; SIGNALING PATHWAY; MICRORNA; CONSTRUCTION; BIOMARKERS; MIRNA	Emerging evidences suggest that long noncoding RNA (lncRNA) plays a vital role in tumorigenesis and cancer progression. Here, the aim of this study is to investigate the biological function of long intervening noncoding RNA Linc00284 in colorectal cancer (CRC). The expression levels of Linc00284, miR-27a and c-Met were evaluated by qPCR and/or Western blotting. Immunohistochemistry was used to detect the expression of Ki67 and Phh3 in tumor tissues. The interaction between Linc00284, miR-27a and c-Met was validated by luciferase reporter assay and RNA immunoprecipitation (RIP) assay. Cell function experiments, including CCK-8, wound-healing and transwell invasion assays, were conducted. The in vivo studies were performed with the subcutaneous tumor xenograft mouse models. Our findings reveal that Linc00284 is upregulated in CRC tissues and colorectal cancer cell lines HCT116 and SW480 in comparison with corresponding para-carcinoma tissues and human fetal colonic mucosa cells FHC. High expression of Linc00284 in tumor tissues is associated with tumor metastasis and predicts a poor clinical outcome in CRC patients. Serum Linc00284 is increased, while miR-27a is decreased in CRC patients compared to healthy controls. ROC curve analysis indicates that serum Linc00284 and miR-27a produce the area under the curve (AUC) value of at 0.8151 and 0.7316 in patients with colorectal cancer compared to healthy individuals, respectively. Additionally, results in vitro and in vivo experiments suggest that Linc00284 silencing significantly suppresses CRC cell proliferation and/or invasion. Mechanistically, Linc00284 promotes c-Met expression by acting as miR-27a sponge, leading to the activation of downstream signaling pathways, thereby causing malignant phenotypes of CRC cells. Taken together, Linc00284 exhibits oncogenic function and the disturbance of Linc00284/miR-27a/c-Met regulatory axis contributes to CRC progression, providing new insight into the pathogenesis of colorectal cancer. Importantly, the expression levels of serum Linc00284 and miR-27a may serve as clinical biomarkers for CRC diagnosis.	[You, Jun] Xiamen Univ, Canc Ctr, Affiliated Hosp 1, Dept Gastrointestinal Oncol Surg, Xiamen, Fujian, Peoples R China; [You, Jun] Fujian Med Univ, Sch Clin Med, Fuzhou, Fujian, Peoples R China; [Li, Jiayi] Fujian Med Univ, Sch Clin Med, Dept Med Oncol,Xiamen Univ, Xiamen Key Lab Antitumor Drug Transformat Res,Aff, Xiamen, Fujian, Peoples R China; [Ke, Chunlin] Fujian Med Univ, Dept Radiotherapy, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Xiao, Yanru] Fujian Med Univ, Dept Med Oncol, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China; [Lu, Chuanhui] Fujian Med Univ, Teaching Hosp, Xiamen Canc Ctr, Dept Colorectal Canc Surg,Xiamen Univ,Affiliated, Xiamen, Fujian, Peoples R China; [Huang, Fakun] Fujian Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Mi, Yanjun] Fujian Med Univ, Xiamen Key Lab Thorac Tumor Diag & Treatment, Inst Lung Canc, Dept Med Oncol,Sch Clin Med,Xiamen Univ,Affiliate, Xiamen, Fujian, Peoples R China; [Xia, Rongmu] Xiamen Univ, Sch Med, Xiamen, Fujian, Peoples R China; [Li, Qiyuan] Xiamen Univ, Natl Inst Data Sci Hlth & Med, Sch Med, Xiamen, Fujian, Peoples R China	Xiamen University; Fujian Medical University; Fujian Medical University; Xiamen University; Fujian Medical University; Fujian Medical University; Fujian Medical University; Xiamen University; Fujian Medical University; Fujian Medical University; Xiamen University; Xiamen University; Xiamen University	Ke, CL (corresponding author), Fujian Med Univ, Dept Radiotherapy, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China.; Mi, YJ (corresponding author), Fujian Med Univ, Xiamen Key Lab Thorac Tumor Diag & Treatment, Inst Lung Canc, Dept Med Oncol,Sch Clin Med,Xiamen Univ,Affiliate, Xiamen, Fujian, Peoples R China.; Xia, RM (corresponding author), Xiamen Univ, Sch Med, Xiamen, Fujian, Peoples R China.; Li, QY (corresponding author), Xiamen Univ, Natl Inst Data Sci Hlth & Med, Sch Med, Xiamen, Fujian, Peoples R China.	ke_chunlin@yeah.net; Miyj77@xmu.edu.cn; xiarongmu@126.com; liqiyuanxm@126.com	rongmu, xia/CAG-5933-2022	rongmu, xia/0000-0002-8678-1367; Li, Qiyuan/0000-0002-8934-8948	National Natural Science Foundation of China [81871877]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81871877).	Acunzo Mario, 2015, Adv Biol Regul, V57, P1, DOI 10.1016/j.jbior.2014.09.013; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chae DK, 2017, MOL CARCINOGEN, V56, P1992, DOI 10.1002/mc.22655; Chen SY, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0959-5; Chi Victor, 2007, J Vis Exp, P308, DOI 10.3791/308; Czyz M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123844; Drobatz Kenneth J, 2009, J Vet Cardiol, V11 Suppl 1, pS33, DOI 10.1016/j.jvc.2009.03.004; Gupta SC, 2017, INT J CANCER, V140, P1955, DOI 10.1002/ijc.30546; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jae N, 2019, VASC PHARMACOL, V114, P13, DOI 10.1016/j.vph.2018.03.003; Li XW, 2019, J CANCER, V10, P2836, DOI 10.7150/jca.31361; Liang JT, 2017, ONCOTARGET, V8, P82991, DOI 10.18632/oncotarget.19635; Liu JW, 2019, DIGEST DIS SCI, V64, P1868, DOI 10.1007/s10620-019-05506-9; Lu SR, 2018, EXP THER MED, V16, P4879, DOI 10.3892/etm.2018.6775; Matsumoto K, 2017, CANCER SCI, V108, P296, DOI 10.1111/cas.13156; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Mo Hong-Nan, 2017, Chronic Dis Transl Med, V3, P148, DOI 10.1016/j.cdtm.2017.06.002; Parizadeh SM, 2019, IUBMB LIFE, V71, P802, DOI 10.1002/iub.2063; Pothula SP, 2017, ONCOTARGET, V8, P76722, DOI 10.18632/oncotarget.20822; Puccini A, 2019, DRUG SAFETY, V42, P211, DOI 10.1007/s40264-018-0780-x; Ruan ZY, 2019, FASEB J, V33, P12047, DOI 10.1096/fj.201900101RR; Shen P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18092003; Shin VY, 2014, WORLD J GASTROENTERO, V20, P10432, DOI 10.3748/wjg.v20.i30.10432; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vidovic D, 2020, CELL DEATH DIFFER, V27, P363, DOI 10.1038/s41418-019-0362-1; Vishnoi A, 2017, METHODS MOL BIOL, V1509, P1, DOI 10.1007/978-1-4939-6524-3_1; Wan WB, 2019, EUR REV MED PHARMACO, V23, P6453, DOI 10.26355/eurrev_201908_18528; Wang SS, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/9696285; Wang Z, 2014, DIAGN PATHOL, V9; Xing C, 2018, CLIN LAB, V64, P1661, DOI 10.7754/Clin.Lab.2018.180419; Xu J, 2019, MOL MED REP, V20, P5021, DOI 10.3892/mmr.2019.10736; You WK, 2008, BMB REP, V41, P833, DOI 10.5483/BMBRep.2008.41.12.833; Zhang HL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113295; Zhang JC, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00893; Zhao YJ, 2018, ONCOL REP, V39, P1197, DOI 10.3892/or.2018.6207; Zhen Q, 2015, CYTOGENET GENOME RES, V146, P1, DOI 10.1159/000434741; Zhou L, 2016, ONCOTARGET, V7, P51943, DOI 10.18632/oncotarget.10460	42	9	9	2	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 17	2021	40	24					4151	4166		10.1038/s41388-021-01839-w	http://dx.doi.org/10.1038/s41388-021-01839-w		MAY 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SU3OE	34050266	Green Published, hybrid			2022-12-26	WOS:000655826000001
J	Lehikoinen, A; Pohjola, P; Valkama, J; Mutanen, M; Pohjoismaki, JLO				Lehikoinen, Aleksi; Pohjola, Pekka; Valkama, Jari; Mutanen, Marko; Pohjoismaki, Jaakko L. O.			Promiscuous specialists: Host specificity patterns among generalist louse flies	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; CRATAERINA-PALLIDA; DIPTERA; ECOLOGY; BIRDS; GENUS; FLY	Ectoparasites such as louse flies (Diptera: Hippoboscidae) have tendency for host specialization, which is driven by adaptation to host biology as well as competition avoidance between parasites of the same host. However, some louse fly species, especially in genera attacking birds, show wide range of suitable hosts. In the presented study, we have surveyed the current status of bird specific louse flies in Finland to provide comprehensive host association data to analyse the ecological requirements of the generalist species. A thorough sampling of 9342 birds, representing 134 species, recovered 576 specimens of louse flies, belonging to six species: Crataerina hirundinis, C. pallida, Ornithomya avicularia, O. chloropus, O. fringillina and Ornithophila metallica. Despite some overlapping hosts, the three Ornithomya species showed a notable pattern in their host preference, which was influenced not only by the host size but also by the habitat and host breeding strategy. We also provide DNA barcodes for ten Finnish species of Hippoboscidae, which can be used as a resource for species identification as well as metabarcoding studies in the future.	[Lehikoinen, Aleksi; Valkama, Jari] Univ Helsinki, Helsinki Lab Ornithol, Finnish Museum Nat Hist, Helsinki, Finland; [Pohjola, Pekka; Pohjoismaki, Jaakko L. O.] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Mutanen, Marko] Univ Oulu, Ecol & Genet Res Unit, Oulu, Finland	University of Helsinki; University of Eastern Finland; University of Oulu	Pohjoismaki, JLO (corresponding author), Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland.	Jaakko.Pohjoismaki@uef.fi		Pohjoismaki, Jaakko/0000-0002-1185-3610; Lehikoinen, Aleksi/0000-0002-1989-277X	Kone Foundation; Finnish Cultural Foundation; Academy of Finland; Academy of Finland [323527, 329251]	Kone Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Academy of Finland(Academy of Finland)	The Finnish Barcode of Life campaign has been funded by the Kone Foundation, the Finnish Cultural Foundation, and the Academy of Finland (through FinBIF research infrastructure project). Aleksi Lehikoinen received funding from Academy of Finland (grants 323527 and 329251).	ANDERSSON H, 1985, Entomologisk Tidskrift, V106, P15; Andersson N, 2018, ORNIS FENNICA, V95, P70; Bashey F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0301; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P352, DOI 10.1016/j.ympev.2013.05.002; Boutellis A, 2014, INFECT GENET EVOL, V23, P209, DOI 10.1016/j.meegid.2014.01.017; Brinck-Lindroth G, 2007, FLEAS SIPHONAPTERA F; Cramp S., 1994, BIRDS W PALEARCTIC; deWaard JR., 2008, METHODS MOL BIOL, V410, P275, DOI 10.1007/978-1-59745-548-0%5F15; Grunin KY., 1988, Family Hippoboscidae; Haarto A., 2019, TRUE FLIES DIPTERA B; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hamback PA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-92; Hargrove JW., 2004, TRYPANOSOMIASES, P113; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Heikkila M, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0520-0; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kochin BF, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000524; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; Laaksonen T, 2013, BIOL CONSERV, V168, P99, DOI 10.1016/j.biocon.2013.09.007; Mutanen M, 2020, ECOL LETT, V23, P851, DOI 10.1111/ele.13486; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Obona J, 2019, ZOOKEYS, P129, DOI 10.3897/zookeys.862.25992; Orr MR, 1997, ECOL ENTOMOL, V22, P305, DOI 10.1046/j.1365-2311.1997.00072.x; Pentinsaari M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35275; Pohjoismaki J, 2014, ZOOKEYS, P383, DOI 10.3897/zookeys.441.7252; Poulin R, 2011, PHILOS T R SOC B, V366, P2379, DOI 10.1098/rstb.2011.0048; R Core Team, 2020, R LANG ENV STAT COMP; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Saurola P., 2013, FINNISH BIRD RINGING, DOI [10.1007/s00442-012-2411-z, DOI 10.1007/S00442-012-2411-Z]; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; Small RW, 2005, VET PARASITOL, V130, P141, DOI 10.1016/j.vetpar.2005.03.005; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Vaisanen R., 1998, MUUTTUVA PESIMALINNU; Valkama J., 2014, FINNISH BIRD RINGING; Vesterinen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082168; Walker MD, 2011, EXP PARASITOL, V129, P48, DOI 10.1016/j.exppara.2011.05.016; Walker MD, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.19301; Zhang YZ, 2011, BIOL CONTROL, V58, P182, DOI 10.1016/j.biocontrol.2011.05.006	39	2	2	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0247698	10.1371/journal.pone.0247698	http://dx.doi.org/10.1371/journal.pone.0247698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043636	Green Published, gold, Green Submitted			2022-12-26	WOS:000664635700007
J	Liang, Q; Lin, T; Wu, F; Zhang, F; Xiong, W				Liang, Qing; Lin, Tian; Wu, Feng; Zhang, Fan; Xiong, Wei			A dynamic source routing protocol based on path reliability and link monitoring repair	PLOS ONE			English	Article							AD HOC NETWORKS; DSR; PERFORMANCE; SCHEME; ENERGY; POWER	The two most essential factors for mobile self-organizing networks applicable to drones are reliability and stability. In harsh communication environments, such as mountainous regions and natural disasters, the use of satellites and terrestrial communication stations has severe time delays due to the high speed of UAVs, resulting in frequent communication interruptions with UAVs. Therefore, UAVs need to establish self-organizing networks for communication and information sharing. High-speed movement will lead to rapid changes in the network topology, resulting in established links being in an unstable connection state and even frequent routing errors, thus preventing the establishment of stable communication links. In order to improve the communication quality of UAVs under high-speed movement, we propose a dynamic source routing protocol based on path reliability and monitoring repair mechanism (DSR-PM). The model performs data transmission by filtering the best reliability path. The link state information is monitored during transmission and broken links are repaired in time to ensure the communication stability and reliability of the links and improve the data transmission efficiency. We simulated the approach in NS2 software and the simulation results show that the DSR-PM protocol effectively reduces parameters such as overhead, packet loss and delay, improves network throughput, and provides better communication performance.	[Liang, Qing; Lin, Tian; Wu, Feng; Zhang, Fan] Xian Univ Posts & Telecommun, Sch Elect Engn, Xian, Shaanxi, Peoples R China; [Xiong, Wei] Xian Univ Posts & Telecommun, Sch Automat, Xian, Shaanxi, Peoples R China	Xi'an University of Posts & Telecommunications; Xi'an University of Posts & Telecommunications	Lin, T (corresponding author), Xian Univ Posts & Telecommun, Sch Elect Engn, Xian, Shaanxi, Peoples R China.	lt1477600473@163.com		lin, tian/0000-0002-1352-2225	Natural Science Foundation of Shaanxi Province [2018GY-150]	Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	The work in this paper was supported by the Natural Science Foundation of Shaanxi Province under project number 2018GY-150, awarded to QL.	Aguilar Igartua, 2007, IEEE LATIN AM T, V5, P448, DOI [10.1109/TLA.2007.4395234, DOI 10.1109/TLA.2007.4395234]; Ali HA, 2018, SIMUL MODEL PRACT TH, V80, P50, DOI 10.1016/j.simpat.2017.09.005; Annan Y, 2019, SENSORS-BASEL, V19, P2120, DOI [10.3390/s19092120, DOI 10.3390/S19092120]; Arafat MY, 2019, IEEE ACCESS, V7, P498, DOI 10.1109/ACCESS.2018.2885539; Arora B, 2015, PROCEDIA COMPUT SCI, V57, P1242, DOI 10.1016/j.procs.2015.07.424; Barakabitze AA, 2020, COMPUT NETW, V167, DOI 10.1016/j.comnet.2019.106984; Bujari A, 2018, IEEE T MOBILE COMPUT, V17, P2468, DOI 10.1109/TMC.2018.2811490; Choi YH, 2019, IEEE ACCESS, V7, P85937, DOI 10.1109/ACCESS.2019.2923837; Dang SP, 2020, NAT ELECTRON, V3, P20, DOI 10.1038/s41928-019-0355-6; Del-Valle-Soto C, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19112489; Han S, 2021, EURASIP J WIREL COMM, V2021, DOI 10.1186/s13638-021-01931-5; Hong J, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8030274; Kojima H, 2019, IEEE ACCESS, V7, P74849, DOI 10.1109/ACCESS.2019.2916318; Lenin GD, 2019, EURASIP J WIREL COMM, V1, P1, DOI [10.1186/s13638-019-1375-7, DOI 10.1186/S13638-019-1375-7]; Leung R, 2001, CONF LOCAL COMPUT NE, P132, DOI 10.1109/LCN.2001.990778; Mandhare VV, 2018, WIRELESS PERS COMMUN, V98, P505, DOI 10.1007/s11277-017-4881-0; Mohammadi P, 2019, WIRELESS PERS COMMUN, V106, P365, DOI 10.1007/s11277-019-06166-8; Mythili V, 2019, COGN SYST RES, V58, P143, DOI 10.1016/j.cogsys.2019.02.005; Preetha KG, 2017, COMPUT ELECTR ENG, V64, P595, DOI 10.1016/j.compeleceng.2017.04.028; Preetha KG, 2015, PROCEDIA COMPUT SCI, V46, P1209, DOI 10.1016/j.procs.2015.01.035; Salari-Moghaddam S, 2019, WIRELESS PERS COMMUN, V109, P1, DOI 10.1007/s11277-019-06546-0; Sharma V, 2019, APPL ARTIFICIAL INTE; Sivaram M, 2019, IEEE ACCESS, V7, P85098, DOI 10.1109/ACCESS.2019.2918723; Thillaikarasi R, 2017, WIRELESS PERS COMMUN, V95, P3477, DOI 10.1007/s11277-017-4008-7; Tilwari V, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9081582; Upadhyay R, 2016, PROCEDIA COMPUT SCI, V78, P68, DOI 10.1016/j.procs.2016.02.012; Yang H, 2019, EURASIP J WIREL COMM, DOI 10.1186/s13638-019-1442-0; Yimin Z, 2019, CONSTRAINED CODING A, V19, P2252, DOI [10.3390/s19102252, DOI 10.3390/S19102252]; Yu LS, 2020, IEEE VEH TECHNOL MAG, V15, P43, DOI 10.1109/MVT.2020.3018100	29	3	3	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251548	10.1371/journal.pone.0251548	http://dx.doi.org/10.1371/journal.pone.0251548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043662	gold, Green Published			2022-12-26	WOS:000664635700025
J	Rao, A; Nagourney, EM; Chen, VH; Hill, S; Klein, EY; Whalen, M; Quinn, TC; Hansoti, B				Rao, Aditi; Nagourney, Emily M.; Chen, Victoria H.; Hill, Sarah; Klein, Eili Y.; Whalen, Madeleine; Quinn, Thomas C.; Hansoti, Bhakti			Assessing attitudes to ED-based HIV testing: Development of a short-structured survey instrument	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; HEALTH-CARE; PATIENT; IMPLEMENTATION; INNOVATIONS; PERCEPTIONS; ACCEPTANCE; SETTINGS; BARRIERS; NUMBER	Introduction Emergency Department (ED)-based HIV counseling and testing (HCT) has had a significant impact on improving rates of HIV diagnosis and linkage to care. Unfortunately, expansion of this strategy to low- and middle-income countries has been limited. Successful implementation of ED-based HCT is dependent on patient and provider acceptance of the intervention, and their attitudes and pre-existing biases towards the disease. This study sought to develop validated survey instruments to assess attitudes towards ED-based HCT. Methods This cross-sectional study surveyed patients and providers in three EDs in the Eastern Cape province, South Africa. A convenience sample of patients and providers in the ED were surveyed. Exploratory factor analysis was conducted using questions on attitudes to HIV testing to develop validated survey instruments. An ANOVA test assessed variance in attitudes towards HCT based on demographic variables collected. Results A total of 104 patient and 132 provider surveys were completed. Exploratory factor analysis resulted in a 17- and 7-question attitudes survey for patients and providers, respectively. Overall, 92.3% of patients and 70.7% of providers supported ED-based HCT, however, both groups displayed only mildly positive attitudes. Questions representing 'confidentiality' and 'stigma around HIV testing' had the least positive influence on patients' overall attitudes. Questions representing 'comfort with HIV testing' had the least positive influence on providers' overall attitudes. Conclusion Our study demonstrated ED patients and providers are generally supportive of ED-based HCT. A validated survey instrument was able to provide a standardized approach to identify barriers to HCT implementation in an ED setting, across contexts. For successful implementation, behavioral interventions must focus on strengthening patient beliefs around confidentiality and the consent process, and providers' comfort levels with providing HIV testing services in the ED.	[Rao, Aditi; Nagourney, Emily M.; Hansoti, Bhakti] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Chen, Victoria H.; Hill, Sarah] Johns Hopkins Univ, Krieger Sch Arts & Sci, Baltimore, MD USA; [Klein, Eili Y.; Whalen, Madeleine; Hansoti, Bhakti] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Quinn, Thomas C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Quinn, Thomas C.] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rao, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	aditi.rao@jhu.edu		Rao, Aditi/0000-0003-4966-5778; Hill, Sarah/0000-0002-5184-2190	South African Medical Research Council; National Institutes of Health, National Institute of Allergy and Infectious Diseases	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B.H. received intramural support to carry out this study from the South African Medical Research Council (https://www.samrc.ac.za/) and in part from the National Institutes of Health, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/).Due to the intramural nature of funds, there is no associated grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann TK, 2008, NURS FORUM, V43, P144, DOI 10.1111/j.1744-6198.2008.00106.x; Aluisio AR, 2018, AIDS, V32, P1377, DOI [10.1097/QAD.0000000000001876, 10.1097/qad.0000000000001876]; Arbelaez C, 2012, J EMERG MED, V42, P7, DOI 10.1016/j.jemermed.2009.07.038; Atkins L, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0605-9; Batey DS, 2012, AIDS RES HUM RETROV, V28, P352, DOI 10.1089/aid.2011.0074; Boshamer CB, 1999, AIDS EDUC PREV, V11, P400; Brooks L, 2009, SEX TRANSM DIS, V36, P127, DOI 10.1097/OLQ.0b013e318191701c; Brown J, 2008, PUBLIC HEALTH REP, V123, P21, DOI 10.1177/00333549081230S304; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chimoyi L, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.26950; Christensen A, 2012, INT HEALTH, V4, P185, DOI 10.1016/j.inhe.2012.03.001; Curry Chris, 2005, Emerg Med Australas, V17, P359, DOI 10.1111/j.1742-6723.2005.00757.x; DoHRoS A., 2015, MIDYEAR POPULATION E; DoHRoS A., 2015, NATL HIV COUNSELLING; Fassin D, 2003, EMBO REP, V4, pS4, DOI 10.1038/sj.embor.embor856; Favre-Bulle T, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14206; Fee E, 2008, J PUBLIC HEALTH POL, V29, P54, DOI 10.1057/palgrave.jphp.3200160; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Hansoti B, 2019, ECLINICALMEDICINE, V15, P14, DOI 10.1016/j.eclinm.2019.08.007; Hansoti B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193858; Hansoti B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187443; Hansoti B, 2017, S AFR J HIV MED, V18, DOI 10.4102/sajhivmed.v18i1.707; Hardcastle TC, 2016, S AFR J BIOETH LAW, V9, P57, DOI 10.7196/SAJBL.2016.v9i2.486; Hecht CR, 2011, ANN EMERG MED, V58, pS28, DOI 10.1016/j.annemergmed.2011.03.020; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hsieh YH, 2009, ACAD EMERG MED, V16, P1165, DOI 10.1111/j.1553-2712.2009.00507.x; Hsu H, 2011, ANN EMERG MED, V58, pS145, DOI 10.1016/j.annemergmed.2011.03.039; Jacobs SR, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0657-3; Jeffrey TK, 2007, AM FAM PHYSICIAN, V76, P1459; Johnson LF, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30314; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Khumalo GE, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037876; Leclerc-Madlala S, 2009, HIV/AIDS IN SOUTH AFRICA 25 YEARS ON: PSYCHOSOCIAL PERSPECTIVES, P13, DOI 10.1007/978-1-4419-0306-8_2; Leidel S, 2015, AIDS CARE, V27, P1455, DOI 10.1080/09540121.2015.1058895; Leon N, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-8; Moullin JC, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0005-z; Mwisongo A, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0940-y; Nachega JBL D.A., 2005, J ACQUIRED IMMUNE DE, V38, P5; Naidoo P, 2006, S AFR FAM PRACT, V48, P55, DOI 10.1080/20786204.2006.10873343; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; Nyblade L, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-15; Phili RK Q.A., 2015, SOUTH AFR J INFECT D, V30, P5; Posel D, 2007, SCAND J PUBLIC HEALT, V35, P138, DOI 10.1080/14034950701356443; Randolph KC, 2012, HUMAN RIGHTS BRIEF; Rao A, 2020, S AFR J HIV MED, V21, DOI 10.4102/sajhivmed.v21i1.1105; Reis C, 2005, PLOS MED, V2, P743, DOI 10.1371/journal.pmed.0020246; Rothman RE, 2003, ACAD EMERG MED, V10, P278, DOI 10.1111/j.1553-2712.2003.tb02004.x; Simbayi LC ZK., 2019, S AFRICAN NATL HIV P; Simbayi LS O., 2012, AFRICAN NATL HIV P; Twomey M, 2012, INT EMERG NURS, V20, P142, DOI 10.1016/j.ienj.2011.08.002; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2019, UNAIDS DAT 2019; Wagner ACH T.A., 2014, AIDS BEHAV, V18, P11; Wallis P, 2011, B HIST MED, V85, P620, DOI 10.1353/bhm.2011.0092; Waxman MJ, 2008, INT J EMERG MED, V1, P317, DOI 10.1007/s12245-008-0065-8	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0252372	10.1371/journal.pone.0252372	http://dx.doi.org/10.1371/journal.pone.0252372			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043713	gold, Green Published			2022-12-26	WOS:000664635700094
J	Sarfaraz, S; Shaikh, Q; Saleem, SG; Rahim, A; Herekar, FF; Junejo, S; Hussain, A				Sarfaraz, Samreen; Shaikh, Quratulain; Saleem, Syed Ghazanfar; Rahim, Anum; Herekar, Fivzia Farooq; Junejo, Samina; Hussain, Aneela			Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan	PLOS ONE			English	Article							SOFA; CARE; NLR	A prospective cohort study was conducted at the Indus Hospital Karachi, Pakistan between March and June 2020 to estimate the in-hospital mortality among hospitalized COVID-19 patients and its determinants. A total of 170 adult patients were enrolled and all-cause mortality was found to be 39% (67/170). Most non-survivors were above 60 years of age (64%) while gender distribution was quite similar in both groups (males: 77% vs 78%). Most (80.6%) non-survivors came with peripheral oxygen saturation less than 93% while 95% of them had critical disease on arrival. Use of non-invasive ventilation in emergency room was higher among non-survivors (56.7%) versus survivors (26.2%). Median Interleukin-6 levels were higher among non-survivors (78.6: IQR = 33.8-49.0) compared to survivors (21.8: IQR = 12.6-36.3). Most patients in the non-survivor group (86.6%) required invasive ventilator support during hospital stay compared to 7.8% in the survivors. The median duration of ICU stay was longer for non-survivors (9: IQR = 6-12) compared to survivors (5: IQR = 3-7) days. Univariable binary logistic regression showed that age above 60 years, oxygen saturation below 93%, Neutrophil to lymphocyte ratio above 5, procalcitonin above 2ng/ml, unit increase in SOFA score and arterial lactate levels were associated with mortality. We also found that a unit decrease in Pao2/FiO2 ratio and serum albumin were associated with mortality in our patients. Multivariable regression showed that age above 60 years (aOR = 3.4: 95% CI = 1.6-6.9), peripheral oxygen saturation below 93% (aOR = 3.5:95% CI = 1.6-7.7) and serum pro-calcitonin above 2ng/ml (aOR = 4.8; 95% CI = 1.9-12.2) were associated with higher odds of mortality when adjusted by month of admission. Most common cause of death was multisystem organ failure in 35 (56.6%) non-survivors while 22 (35.5%) died due to respiratory failure. Larger prospective studies are needed to further strengthen these findings.	[Sarfaraz, Samreen] Ind Hosp, Dept Infect Dis, Karachi, Pakistan; [Shaikh, Quratulain] Ind Hosp, Ind Hosp Res Ctr, Karachi, Pakistan; [Saleem, Syed Ghazanfar] Ind Hosp, Emergency Dept, Karachi, Pakistan; [Rahim, Anum] Ind Hosp, Ind Hosp Res Ctr, Karachi, Pakistan; [Herekar, Fivzia Farooq] Ind Hosp, Dept Internal Med, Karachi, Pakistan; [Junejo, Samina] Ind Hosp, Paediat Infect Dis, Karachi, Pakistan; [Hussain, Aneela] Ind Hosp, Dept Infect Dis, Karachi, Pakistan		Sarfaraz, S (corresponding author), Ind Hosp, Dept Infect Dis, Karachi, Pakistan.; Shaikh, Q (corresponding author), Ind Hosp, Ind Hosp Res Ctr, Karachi, Pakistan.	samreen2002@gmail.com; docquratshaikh@gmail.com		Saleem, Syed Ghazanfar/0000-0002-1218-3962; Shaikh, Quratulain/0000-0001-6106-2713				[Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; Audit IJA., 2020, ICNARC REPORT COVID, V10, P2020; Banik A, 2020, GLOB BUS REV, V21, P607, DOI 10.1177/0972150920929897; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cates J, 2020, MMWR-MORBID MORTAL W, V69, P1528, DOI 10.15585/mmwr.mm6942e3; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; College Station TSL, 2015, STAT STAT SOFTW REL; de la Rica R, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8081106; Dondorp AM, 2020, AM J TROP MED HYG, V102, P1191, DOI 10.4269/ajtmh.20-0283; FDA, 2020, EUA 046 REMD FS PAR; Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6; Grasselli G, 2020, JAMA INTERN MED, V180, P1345, DOI 10.1001/jamainternmed.2020.3539; Gupta Snehil, 2020, Gen Psychiatr, V33, pe100284, DOI 10.1136/gpsych-2020-100284; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Jeronimo CMP., 2020, CLIN INFECT DIS; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Lee DW, 2019, BIOL BLOOD MARROW TR, V25, P625, DOI 10.1016/j.bbmt.2018.12.758; Liu SJ, 2020, AM J EMERG MED, V38, P2074, DOI 10.1016/j.ajem.2020.07.019; Malgie J, 2021, CLIN INFECT DIS, V72, pE742, DOI 10.1093/cid/ciaa1445; Nalbant A, 2020, REV ASSOC MED BRAS, V66, P746, DOI 10.1590/1806-9282.66.6.746; Nasir N., 2020, PREDICTORS SEVERITY; Pakistan Go, 2020, HLTH ADVISORY; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Qureshi S, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008682; Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Santus P, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-043651; Sarfaraz S., 2020, IS TOCILIZUMAB EFFEC; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836; Twigg IIIHL., 2020, MORTALITY RATES DIVE, V2; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang Y, 2020, AM J RESP CRIT CARE, V201, P1430, DOI 10.1164/rccm.202003-0736LE; WHO, 2020, CLIN MAN COVID 19; WHO/-nCoV/Corticosteroids/.1 WHOJWrn, 2020, CORT COVID 19 LIV GU; Worldometer, 2020, CORONAVIRUS COVID 19; WSJ, 2020, WHY YOUTHF CONS PAK; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang AP, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106504; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237	46	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2021	16	5							e0251754	10.1371/journal.pone.0251754	http://dx.doi.org/10.1371/journal.pone.0251754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6PJ	34043674	Green Published, Green Submitted, gold			2022-12-26	WOS:000664635700032
J	Thodberg, K; Videbech, PB; Hansen, TGB; Pedersen, AB; Christensen, JW				Thodberg, Karen; Videbech, Poul B.; Hansen, Tia G. B.; Pedersen, Anne Bak; Christensen, Janne W.			Dog visits in nursing homes - increase complexity or keep it simple? A randomised controlled study	PLOS ONE			English	Article							ANIMAL-ASSISTED INTERVENTIONS; TERM-CARE RESIDENTS; ENGAGEMENT; DEMENTIA; THERAPY; PARTICIPATION; PEOPLE; IMPACT; STATE; PET	Objective To compare the immediate response of nursing home residents to dog visits with or without an activity, and the impact of cognitive ability. Methods In a randomly controlled trial, 174 nursing home residents were allocated to 12 bi-weekly 10-minute visits: either ordinary dog visits (D, n = 57, 49 analysed), dog visits with an activity (DA, n = 56, 48 analysed), or visits with activity but no dog (A, n = 61, 54 analysed). We recorded frequency and duration of residents' verbal and physical interactions with the dog and persons. Data were analysed in three periods of four visits (period 1-3) as binomial variables (generalised linear models) or durations (non-parametric statistics). Results Both visit type and impairment level affected the likelihood of interacting with the dog (D and DA). In some periods increased cognitive impairment lowered odds of touching the dog in DA visits (period 1: F-1,F-85 = 5.17, P < 0.05) and talking to it directly (period 1: F-1,F-90 = 4.60, P < 0.05; period 3: F-1,F-87 = 5.34, P < 0.05). Throughout, residents talked less to persons during DA visits compared to D and A (P = 0.01-0.05), and level of cognitive impairment correlated negatively with talk duration (P < 0.001). Generally, high cognitive impairment level lowered odds of interacting with (period 1: F-1,F-89 = 7.89, P < 0.01; period 2: F-1,F-97 = 6.76, P = 0.01; period 3: F-1,F-92 = 13.57, P < 0.001) and talking about the activities (period 1: F-1,F-89 = 13.78, P <0.001; period 2: F-1,F-88 = 3.27, P = 0.07; period 3: F-1,F-86 = 3.88, P = 0.05). Conclusion Visits without specific activities stimulated residents to interact with the dog, whereas increasing the complexity of dog visits by adding activities resulted in less interaction with the dog for severely impaired residents. The optimal dog visit for the less cognitively impaired residents could include activities and thereby a possibility to interact with the dog in different ways, whereas for severely impaired residents, just being with the dog seems more appropriate.	[Thodberg, Karen; Pedersen, Anne Bak; Christensen, Janne W.] Aarhus Univ, Dept Anim Sci, Aarhus, Denmark; [Videbech, Poul B.] Psychiat Ctr Glostrup, Glostrup, Denmark; [Hansen, Tia G. B.] Aalborg Univ, Ctr Dev & Appl Psychol Sci, Aalborg, Denmark	Aarhus University; Aalborg University	Thodberg, K (corresponding author), Aarhus Univ, Dept Anim Sci, Aarhus, Denmark.	karen.thodberg@anis.au.dk		Christensen, Janne Winther/0000-0003-0227-0648; Hansen, Tia Gitte Bondesen/0000-0002-8823-5183; Thodberg, Karen/0000-0001-8369-9491	TrygFonden [106330]	TrygFonden	The study was supported by a grant from TrygFonden to KT (106330; TrygFonden.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarskog NK, 2019, PHYS OCCUP THER GERI, V37, P77, DOI 10.1080/02703181.2019.1613466; Ambrosi C, 2019, PSYCHOGERIATRICS, V19, P55, DOI 10.1111/psyg.12367; Bernstein PL, 2000, ANTHROZOOS, V13, P213, DOI 10.2752/089279300786999743; Bjork S, 2017, J ADV NURS, V73, P1884, DOI 10.1111/jan.13275; Brane G, 2001, DEMENT GERIATR COGN, V12, P1, DOI 10.1159/000051230; Chung JCC, 2004, OTJR-OCCUP PART HEAL, V24, P22, DOI 10.1177/153944920402400104; Cohen-Mansfield J, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0357-z; Cohen-Mansfield J, 2017, PSYCHIAT RES, V257, P375, DOI 10.1016/j.psychres.2017.07.045; Cohen-Mansfield J, 2010, PSYCHIAT RES, V177, P216, DOI 10.1016/j.psychres.2009.02.010; Cohen-Mansfield J, 2009, INT J GERIATR PSYCH, V24, P755, DOI 10.1002/gps.2192; De Santis M, 2018, VET ITAL, V54, P323, DOI 10.12834/VetIt.1226.6831.1; Dobbs D, 2005, GERONTOLOGIST, V45, P81, DOI 10.1093/geront/45.suppl_1.81; FICK KM, 1993, AM J OCCUP THER, V47, P529, DOI 10.5014/ajot.47.6.529; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Friedmann E, 2019, ANTHROZOOS, V32, P221, DOI 10.1080/08927936.2019.1569905; Gee NR, 2019, ANTHROZOOS, V32, P183, DOI 10.1080/08927936.2019.1569903; Zafra-Tanaka JH, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-018-2009-z; Handlin L, 2018, ANTHROZOOS, V31, P567, DOI 10.1080/08927936.2018.1505268; Hediger K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42280-0; HENDY HM, 1987, INT J AGING HUM DEV, V25, P279, DOI 10.2190/D3DD-VB2N-UQJ8-8AGN; Hughes MJ, 2020, CLIN GERONTOLOGIST, V43, P365, DOI 10.1080/07317115.2019.1650863; IAHAIO, IAHAIO WHIT PAP DEF; Jadhav A, 2019, APPL ARTIF INTELL, V33, P913, DOI 10.1080/08839514.2019.1637138; Jain B, 2020, INT J OLDER PEOPLE N, V15, DOI 10.1111/opn.12320; Kaps M., 2017, BIOSTATISTICS ANIMAL, V3rd; Klimova B, 2016, J APPL BIOMED, V14, P97, DOI 10.1016/j.jab.2016.02.002; Kramer SC, 2009, ANTHROZOOS, V22, P43, DOI 10.2752/175303708X390464; Lai NM, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013243.pub2; Lundqvist M, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1844-7; Martin P., 2007, MEASURING BEHAV; Ministry of Health, NAT UND FORTH PA PLE; Olsen C, 2019, DEMENTIA-LONDON, V18, P245, DOI 10.1177/1471301216667320; Peluso S, 2018, J GERIATR PSYCH NEUR, V31, P149, DOI 10.1177/0891988718774634; Petersson M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01796; Schuurmans L, 2016, J AM MED DIR ASSOC, V17, P647, DOI 10.1016/j.jamda.2016.03.015; Sengupta M, 2019, J HOUS ELDER, V33, P120, DOI 10.1080/02763893.2018.1534178; Smit D, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0564-7; Tak SH, 2015, EDUC GERONTOL, V41, P182, DOI 10.1080/03601277.2014.937217; Thodberg K., 2014, Animal Frontiers, V4, P43, DOI 10.2527/af.2014-0021; Thodberg K, 2016, ANTHROZOOS, V29, P107, DOI 10.1080/08927936.2015.1089011; Tierney L, 2020, INT J OLDER PEOPLE N, V15, DOI 10.1111/opn.12306; Wells DL, 2019, ANTHROZOOS, V32, P169, DOI 10.1080/08927936.2019.1569902; Wesenberg S, 2019, PSYCHOGERIATRICS, V19, P219, DOI 10.1111/psyg.12385; Yakimicki ML, 2019, CLIN NURS RES, V28, P9, DOI 10.1177/1054773818756987	44	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2021	16	5							e0251571	10.1371/journal.pone.0251571	http://dx.doi.org/10.1371/journal.pone.0251571			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6OP	34038451	Green Published, gold			2022-12-26	WOS:000664633500024
J	Amri, M; Abbes, Z; Trabelsi, I; Ghanem, ME; Mentag, R; Kharrat, M				Amri, Moez; Abbes, Zouhaier; Trabelsi, Imen; Ghanem, Michel Edmond; Mentag, Rachid; Kharrat, Mohamed			Chlorophyll content and fluorescence as physiological parameters for monitoring Orobanche foetida Poir. infection in faba bean	PLOS ONE			English	Article							L. GENOTYPES; CRENATA FORSK.; RESISTANCE; PHOTOSYNTHESIS; FIELD; INFESTATION; RESPONSES; NITROGEN	Orobanche spp. are root parasitic plants that cause yield losses in faba bean (Vicia faba L.). In Tunisia, O. crenata and O. foetida are among the major problems limiting faba bean production and productivity. Breeding for resistance and development of resistant varieties remain the most efficient control strategy to combat these parasites. In our study, field trials were conducted over two consecutive cropping seasons. A set of 42 genotypes were used in this study; 39 advanced lines and three checks; Najeh and Baraca (resistant) and Badi (susceptible). The trials were conducted in highly infested O. foetida plot at Oued-Beja Research Station in Tunisia. Results showed that advanced lines XAR-VF00.13-1-2-1-2-1 and XBJ90.04-2-3-1-1-1-2A expressed high resistance level exceeding those recorded for resistance checks Najeh and Baraca. O. foetida significantly affected the biomass, grain yield, chlorophyll content index (CCI) and the maximum quantum efficiency (F-v/F-m ratio). No significant effect was observed on host plant water content (WC). CCI decreases varied from 46.4% for the susceptible check Badi and 4.2% and 9.3%, respectively, for Baraca and XBJ90.04-2-3-1-1-1-2A. Orobanche parasitism resulted in a slight decreases of F-v/F-m ratio for the advanced lines XBJ90.04-2-3-1-1-1-2A and XAR-VF00.13-1-2-1-2-1 against important decreases observed for Badi and Baraca. Correlation between resistance to O. foetida and CCI and F-v/F-m makes this, easy-to-measure, parameter very useful as a practical screening tool for early parasitism detection, diagnosis and identification and selection of high resistant plants against this parasite.	[Amri, Moez; Ghanem, Michel Edmond] Univ Mohammed VI Polytech UM6P, AgroBioSci AgBS, African Integrated Plant & Soil Res Grp AiPlaS, Ben Guerir, Morocco; [Amri, Moez; Abbes, Zouhaier; Kharrat, Mohamed] Carthage Univ, Field Crop Lab, Natl Inst Agr Res Tunisia INRAT, Tunis, Tunisia; [Trabelsi, Imen] Carthage Univ, Lab Agron Sci & Techn, Natl Inst Agr Res Tunisia INRAT, Tunis, Tunisia; [Mentag, Rachid] CRRA Rabat, Biotechnol Unit, Reg Ctr Agr Res INRA, Rabat, Morocco	Mohammed VI Polytechnic University; Universite de Carthage; Universite de Carthage	Amri, M (corresponding author), Univ Mohammed VI Polytech UM6P, AgroBioSci AgBS, African Integrated Plant & Soil Res Grp AiPlaS, Ben Guerir, Morocco.; Amri, M (corresponding author), Carthage Univ, Field Crop Lab, Natl Inst Agr Res Tunisia INRAT, Tunis, Tunisia.	amrmoez@gmail.com	Kharrat, Mohamed/AAU-9032-2021; Amri, Moez/N-7493-2017; ABBES, Zouhaier/AAQ-2409-2021	Amri, Moez/0000-0002-4707-0618; ABBES, Zouhaier/0000-0003-4419-4639; Ghanem, Michel Edmond/0000-0003-0626-7622	Tunisian Ministry of Agriculture, Hydraulic Resources and Fishery and Ministry of Higher Education and Scientific Research	Tunisian Ministry of Agriculture, Hydraulic Resources and Fishery and Ministry of Higher Education and Scientific Research	This work was supported by the Tunisian Ministry of Agriculture, Hydraulic Resources and Fishery and Ministry of Higher Education and Scientific Research.	Abbes Z, 2007, CROP PROT, V26, P1777, DOI 10.1016/j.cropro.2007.03.012; Abbes Z., 2010, Acta Phytopathologica et Entomologica Hungarica, V45, P267, DOI 10.1556/APhyt.45.2010.2.3; Abbes Z, 2007, PHYTOPROTECTION, V88, P83, DOI 10.7202/018953ar; Abbes Z, 2011, PAK J BOT, V43, P2017; Abu-Irmaileh BE, 2017, PROBLEM OROBANCHE SP; Amri M., 2014, Bulgarian Journal of Agricultural Science, V20, P647; Amri M., 2013, Tunisian Journal of Plant Protection, V8, P127; Amri M, 2019, INT J AGRIC BIOL, V21, P499, DOI 10.17957/IJAB/15.0921; Briache FZ, 2019, J PLANT DIS PROTECT, V126, P211, DOI 10.1007/s41348-019-00207-x; BUTLER WL, 1975, BIOCHIM BIOPHYS ACTA, V376, P116, DOI 10.1016/0005-2728(75)90210-8; Cameron DD, 2005, FOLIA GEOBOT, V40, P217, DOI 10.1007/BF02803236; Cameron DD, 2008, ANN BOT-LONDON, V101, P573, DOI 10.1093/aob/mcm324; Dale H, 1998, NEW PHYTOL, V140, P65, DOI 10.1046/j.1469-8137.1998.00247.x; Ennami M., 2017, Journal of Agricultural Science (Toronto), V9, P164, DOI 10.5539/jas.v9n4p164; Ennami M., 2020, J CROP PROTECTION, V127; Habimana S, 2014, J SOIL SCI PLANT NUT, V14, P43, DOI 10.4067/S0718-95162014005000004; Hibberd JM, 1998, PLANT CELL ENVIRON, V21, P333, DOI 10.1046/j.1365-3040.1998.00272.x; Jeschke WD, 1997, PLANT CELL ENVIRON, V20, P47, DOI 10.1046/j.1365-3040.1997.d01-2.x; Kharrat M, 2010, TUNIS J PLANT PROT, V5, P125; Kharrat M., 2004, INTEGRATED MANAGEMEN, P106; Kharrat M., 2002, P 2 SEM REMAFEVE REM, P89; Korres NE, 2003, ANN APPL BIOL, V143, P53, DOI 10.1111/j.1744-7348.2003.tb00268.x; Mauromicale G, 2008, WEED SCI, V56, P574, DOI 10.1614/WS-07-147.1; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Millan T., 2015, SERIES HDB PLANT BRE, V10, P499; Nadal S., 2004, CROP SCI, V44; Nefzi F, 2016, CHIL J AGR RES, V76, P170, DOI 10.4067/S0718-58392016000200006; Pavlovic D, 2008, PEST MANAG SCI, V64, P101, DOI 10.1002/ps.1473; Perez-De-Luque A, 2005, ANN BOT-LONDON, V95, P935, DOI 10.1093/aob/mci105; Rousseau C, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0068-4; Shamsullah SKL., 2019, INT J BIOSCI, V15, P126, DOI DOI 10.12692/ijb/15.6.126-136; Shen H, 2011, BOT STUD, V52, P89; Trabelsi I, 2017, S AFR J BOT, V108, P15, DOI 10.1016/j.sajb.2016.09.009; Trabelsi I, 2016, PLANT PROD SCI, V19, P562, DOI 10.1080/1343943X.2016.1221734; Trabelsi I, 2015, CHIL J AGR RES, V75, P27, DOI 10.4067/S0718-58392015000100004; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Walters DR., 2015, PHYSIOL RESPONSES PL, P248; Yordanov I, 2000, PHOTOSYNTHETICA, V38, P171, DOI 10.1023/A:1007201411474; Briache FZ, 2020, PLANT PATHOLOGY J, V36, P476, DOI 10.5423/PPJ.OA.03.2020.0056	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2021	16	5							e0241527	10.1371/journal.pone.0241527	http://dx.doi.org/10.1371/journal.pone.0241527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OL	34032807	Green Published, gold			2022-12-26	WOS:000664633100002
J	Davik, J; Wilson, RC; Njah, RG; Grini, PE; Randall, SK; Alsheik, MK; Sargent, DJ				Davik, Jahn; Wilson, Robert C.; Njah, Relindis G.; Grini, Paul E.; Randall, Stephen K.; Alsheik, Muath K.; Sargent, Daniel James			Genetic mapping and identification of a QTL determining tolerance to freezing stress in Fragaria vesca L.	PLOS ONE			English	Article							ASCORBATE OXIDASE; OVER-EXPRESSION; COLD-STRESS; ALCOHOL-DEHYDROGENASE; DIPLOID STRAWBERRY; RESPONSE PATHWAY; OXIDATIVE STRESS; ABIOTIC STRESSES; ARABIDOPSIS; DEHYDRIN	Extreme cold and frost cause significant stress to plants which can potentially be lethal. Low temperature freezing stress can cause significant and irreversible damage to plant cells and can induce physiological and metabolic changes that impact on growth and development. Low temperatures cause physiological responses including winter dormancy and autumn cold hardening in strawberry (Fragaria) species, and some diploid F. vesca accessions have been shown to have adapted to low-temperature stresses. To study the genetics of freezing tolerance, a F. vesca mapping population of 143 seedlings segregating for differential responses to freezing stress was raised. The progeny was mapped using 'Genotyping-by-Sequencing' and a linkage map of 2,918 markers at 851 loci was resolved. The mapping population was phenotyped for freezing tolerance response under controlled and replicated laboratory conditions and subsequent quantitative trait loci analysis using interval mapping revealed a single significant quantitative trait locus on Fvb2 in the physical interval 10.6 Mb and 15.73 Mb on the F. vesca v4.0 genome sequence. This physical interval contained 896 predicted genes, several of which had putative roles associated with tolerance to abiotic stresses including freezing. Differential expression analysis of the 896 QTL-associated gene predictions in the leaves and crowns from 'Alta' and 'NCGR1363' parental genotypes revealed genotype-specific changes in transcript accumulation in response to low temperature treatment as well as expression differences between genotypes prior to treatment for many of the genes. The putative roles, and significant interparental differential expression levels of several of the genes reported here identified them as good candidates for the control of the effects of freezing tolerance at the QTL identified in this investigation and the possible role of these candidate genes in response to freezing stress is discussed.	[Davik, Jahn] Norwegian Inst Bioecon Res, Div Biotechnol & Plant Hlth, As, Norway; [Wilson, Robert C.; Njah, Relindis G.] Norway Univ Appl Sci, Fac Appl Ecol Agr Sci & Biotechnol, Dept Biotechnol, Hamar, Norway; [Njah, Relindis G.; Grini, Paul E.] Univ Oslo, Dept Biosci, Sect Genet & Evolutionary Biol, Oslo, Norway; [Randall, Stephen K.] Indiana Univ Purdue Univ Indianapolis, Dept Biol, Indiana, PA USA; [Alsheik, Muath K.] Graminor Breeding Ltd, Ridabu, Norway; [Alsheik, Muath K.] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Sargent, Daniel James] NIAB EMR, Dept Genet Genom & Breeding, East Malling, Kent, England; [Sargent, Daniel James] Univ Greenwich, Nat Resources Inst, Medway Campus, Chatham, Kent, England	Norwegian Institute of Bioeconomy Research; University of Oslo; Indiana University System; Indiana University-Purdue University Indianapolis; Norwegian University of Life Sciences; University of Greenwich	Davik, J (corresponding author), Norwegian Inst Bioecon Res, Div Biotechnol & Plant Hlth, As, Norway.	jahn.davik@nibio.no	Grini, Paul/H-9471-2016	Grini, Paul/0000-0003-3898-6277; Davik, Jahn/0000-0002-3621-6888	Research Council of Norway [199554/I10, 244658/E50]	Research Council of Norway(Research Council of Norway)	The research was supported by grants from The Research Council of Norway to MKA (#199554/I10 and #244658/E50). Graminor AS provided support for this study in the form of salaries for MKA. The specific roles of the authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuqamar S, 2013, MOL PLANT PATHOL, V14, P813, DOI 10.1111/mpp.12049; Alsheikh MK, 2005, PLANT CELL ENVIRON, V28, P1114, DOI 10.1111/j.1365-3040.2005.01348.x; An JP, 2018, J PLANT PHYSIOL, V221, P74, DOI 10.1016/j.jplph.2017.12.009; [Anonymous], 2013, PREPRINTS; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bajwa VS, 2014, J PINEAL RES, V56, P238, DOI 10.1111/jpi.12115; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen T, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00807; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Daugaard H, 1998, FRUIT VARIETIES J, V52, P154; Davik J, 2000, ADV STRAWBERRY RES, V19, P13; Davik J, 2013, PLANTA, V237, P265, DOI 10.1007/s00425-012-1771-2; Davis TM, 1997, J HERED, V88, P215, DOI 10.1093/oxfordjournals.jhered.a023091; Deng ZX, 2005, DNA SEQUENCE, V16, P28, DOI 10.1080/10425170500040180; DiMeglio LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102237; Edger PP, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix124; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Essers L, 2000, PLANT CELL, V12, P211, DOI 10.1105/tpc.12.2.211; Fotopoulos V, 2006, J EXP BOT, V57, P3933, DOI 10.1093/jxb/erl147; Gao H, 2018, FOOD CHEM, V245, P659, DOI 10.1016/j.foodchem.2017.10.008; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Garcia ME, 2008, PLANT MOL BIOL, V67, P643, DOI 10.1007/s11103-008-9344-2; Garrison E., 2012, ARXIV12073907; Govan CL, 2008, MOL BREEDING, V22, P649, DOI 10.1007/s11032-008-9206-2; Guo XY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225090; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; Hawkins C, 2017, HORTIC RES-ENGLAND, V4, DOI 10.1038/hortres.2017.29; He WD, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00282; Houde M, 2004, PLANT BIOTECHNOL J, V2, P381, DOI 10.1111/j.1467-7652.2004.00082.x; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Joly-Lopez Z, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02027; Jung S, 2019, NUCLEIC ACIDS RES, V47, pD1137, DOI 10.1093/nar/gky1000; Kang CY, 2013, PLANT CELL, V25, P1960, DOI 10.1105/tpc.113.111732; Kazemi-Shahandashti SS, 2018, J PLANT PHYSIOL, V226, P123, DOI 10.1016/j.jplph.2018.03.022; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Kim SJ, 2012, BIOCHEM BIOPH RES CO, V420, P141, DOI 10.1016/j.bbrc.2012.02.131; Kim SY, 2010, PLANT CELL REP, V29, P203, DOI 10.1007/s00299-009-0813-0; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Koehler G, 2012, PLANT PHYSIOL, V159, P1787, DOI 10.1104/pp.112.198267; Kumar M, 2014, J PLANT BIOL, V57, P383, DOI 10.1007/s12374-014-0487-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Hir R, 2015, MOL PLANT, V8, P1687, DOI 10.1016/j.molp.2015.08.007; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lindlof A, 2007, LECT NOTES COMPUT SC, V4414, P48; Merlaen B, 2018, HORTIC RES-ENGLAND, V5, DOI 10.1038/s41438-018-0019-0; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nestby, 2011, EUROPEAN J PLANT SCI, P42; Nestby R, 2000, J HORTIC SCI BIOTECH, V75, P119, DOI 10.1080/14620316.2000.11511210; Ohbayashi I, 2017, PLANT CELL, V29, P2644, DOI 10.1105/tpc.17.00255; Puhakainen T, 2004, PLANT MOL BIOL, V54, P743, DOI 10.1023/B:PLAN.0000040903.66496.a4; R Core Team, 2016, R LANG PROGR ENV STA; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakuraba Y, 2015, PLANT CELL, V27, P1771, DOI 10.1105/tpc.15.00222; Sanmartin M, 2003, PLANTA, V216, P918, DOI 10.1007/s00425-002-0944-9; Shi YT, 2012, PLANT CELL, V24, P2578, DOI 10.1105/tpc.112.098640; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Song Y, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02072; Staudt, 1999, TAX STUD GEN FRAG; Surbanovski N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074945; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; WOLYN DJ, 1990, PLANT MOL BIOL, V14, P855, DOI 10.1007/BF00016518; Xie C, 2012, NEW PHYTOL, V195, P124, DOI 10.1111/j.1469-8137.2012.04136.x; Yamamoto A, 2005, J EXP BOT, V56, P1785, DOI 10.1093/jxb/eri167; Yu Y, 2018, MOLECULES, V23, DOI 10.3390/molecules23081887; Zhou B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152927; Zhuo XK, 2018, GENES-BASEL, V9, DOI 10.3390/genes9100494	70	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 21	2021	16	5							e0248089	10.1371/journal.pone.0248089	http://dx.doi.org/10.1371/journal.pone.0248089			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6OD	34019543	Green Published, gold, Green Submitted			2022-12-26	WOS:000664632300004
J	Badre-Esfahani, S; Petersen, LK; Tatari, CR; Blaakaer, J; Andersen, B; Seibaek, L				Badre-Esfahani, Sara; Petersen, Lone Kjeld; Tatari, Camilla Rahr; Blaakaer, Jan; Andersen, Berit; Seibaek, Lene			Perceptions of cervical cancer prevention among a group of ethnic minority women in Denmark-A qualitative study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; HPV-VACCINATION; HEALTH-CARE; ATTITUDES; BARRIERS	Background Cervical cancer screening (CCS) and human papillomavirus vaccination (HPVV) are effective measures against cervical cancer (CC). Attendance in HPVV and CCS provides the greatest protection, while combined non-attendance in HPVV and CCS provides little to no protection. It is hence concerning that some large ethnic minority groups show considerably lower HPVV and CCS attendance than other women-especially women from Middle-Eastern and North African (MENA) countries and Pakistan. Little is, however, known about the reasons for this low combined attendance pattern n. Aim To explore perceptions of and barriers to HPVV and CCS, among MENA and Pakistani women in Denmark. Method Focus group interviews were conducted. Data was transcribed verbatim, and analysed using systematic text condensation. Findings Seventeen long-term resident women originating from six major MENA countries and Pakistan were included. Mean age was 36 years. We found that these women, across different age groups and descent, had sparse knowledge and understanding about CC, and their perceived relevance of disease prevention was low. Compared to HPVV, their barriers to CCS were more fixed and often linked to socio-cultural factors such as taboos related to female genitals and sexuality. Moreover, they presented unmet expectations and signs of mistrust in the healthcare system. However, at the end of the interviews, participants became more attentive toward CC prevention, particularly toward HPVV. Conclusion Elements of insufficient knowledge and understanding of CC and its prevention were found among a group of MENA and Pakistani women. Their socio-cultural background further represents a barrier particularly towards CCS. Additionally, negative experiences and unmet expectations lessen their trust in the healthcare system. All of which underlines the need for new tailored CC preventive strategies for this group. Based on our findings we suggest that future studies develop and evaluate interventions aiming to improve HPVV and CCS, including user-involvement.	[Badre-Esfahani, Sara; Seibaek, Lene] Aarhus Univ Hosp, Dept Gynaecol & Obstet, Aarhus N, Denmark; [Badre-Esfahani, Sara; Tatari, Camilla Rahr; Andersen, Berit] Randers Reg Hosp, Dept Publ Hlth Programmes, Randers NO, Denmark; [Badre-Esfahani, Sara; Tatari, Camilla Rahr; Andersen, Berit; Seibaek, Lene] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Petersen, Lone Kjeld; Blaakaer, Jan] Odense Univ Hosp, Dept Gynaecol & Obstet, Odense C, Denmark; [Petersen, Lone Kjeld] Univ Southern Denmark, Open Patient Data Explorat Network, Odense, Denmark; [Petersen, Lone Kjeld; Blaakaer, Jan] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark	Badre-Esfahani, S (corresponding author), Aarhus Univ Hosp, Dept Gynaecol & Obstet, Aarhus N, Denmark.; Badre-Esfahani, S (corresponding author), Randers Reg Hosp, Dept Publ Hlth Programmes, Randers NO, Denmark.; Badre-Esfahani, S (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	sarbad@rm.dk	; Andersen, Berit/J-3402-2017	Badre-Esfahani, Sara/0000-0002-1500-9273; Andersen, Berit/0000-0003-4074-6504; Tatari, Camilla Rahr/0000-0002-5129-3582; Koed Badre-Esfahani, Sara/0000-0003-1940-9482; Seibaek, Lene/0000-0002-2396-8669	The Family Hede Nielsen's Foundation	The Family Hede Nielsen's Foundation	This study was funded by following sponsors; The Family Hede Nielsen's Foundation rewarded 15,000 DKKR to the first author (https://www.hedenielsensfond.dk/) Helsefonden, rewarded 300,000 DKKR to the first author (https://helsefonden.dk/) The sponsors had no influence on the scientific process.	Aasbo G, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029505; Abakporo U, 2018, J IMMIGR MINOR HEALT, V20, P1230, DOI 10.1007/s10903-017-0642-0; Ahmadi A, 2016, MED ANTHROPOL Q, V30, P222, DOI 10.1111/maq.12202; Allen EM, 2019, J TRANSCULT NURS, V30, P55, DOI 10.1177/1043659618796909; Azar M, 2016, SEX REPROD HEALTHC, V8, P13, DOI 10.1016/j.srhc.2016.01.001; Azerkan F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107624; Badre-Esfahani S., PMEDR19303R1; Baumann A, 2019, VACCINE-X, V2, DOI 10.1016/j.jvacx.2019.100020; Brinkmann S, 2020, INTERVIEWS LEARNING; Chan DNS, 2017, CANCER NURS, V40, pE1, DOI 10.1097/NCC.0000000000000436; Connor JJ, 2016, J SEX RES, V53, P346, DOI 10.1080/00224499.2015.1008966; Danish Helath Authority, 2018, CERVICAL CANC SCREEN; de Casadevante VF, 2016, PAPILLOMAVIRUS RES, V2, P78, DOI 10.1016/j.pvr.2016.03.003; Dillner J, 2018, VACCINE, V36, P3820, DOI 10.1016/j.vaccine.2018.05.019; Ferdous M, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0654-5; Gele AA, 2017, INT J WOMENS HEALTH, V9, P487, DOI 10.2147/IJWH.S139160; Grandahl M, 2015, HEALTH EXPECT, V18, P344, DOI 10.1111/hex.12034; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Hanley SJB, 2015, LANCET, V385, P2571, DOI 10.1016/S0140-6736(15)61152-7; Harder E, 2018, PREV MED, V111, P94, DOI 10.1016/j.ypmed.2018.02.035; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; Hertzum-Larsen R, 2019, EUROPEAN J CANC PREV; Hertzum-Larsen R, 2019, PREV MED, V123, P55, DOI 10.1016/j.ypmed.2019.02.023; Johnson CE, 2008, J LOW GENIT TRACT DI, V12, P232, DOI 10.1097/LGT.0b013e31815d8d88; Kulczycki A, 2011, VIOLENCE AGAINST WOM, V17, P1442, DOI 10.1177/1077801211434127; LIPSON JG, 1983, WESTERN J MED, V139, P854; Lokdam N, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1346-1; Malterud K, 2020, KVALITATIVE FORSKNIN; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; Malterud K, 2012, SCAND J PUBLIC HEALT, V40, P795, DOI 10.1177/1403494812465030; Marlow LAV, 2015, J FAM PLAN REPROD H, V41, P248, DOI 10.1136/jfprhc-2014-101082; Marlow LAV, 2009, HUM VACCINES, V5, P105, DOI 10.4161/hv.5.2.7368; Matin M, 2004, WOMEN HEALTH, V39, P63, DOI [10.1300/J013v39n03_05, 10.1300/j013v39n03_05]; Mortensen GL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-68; Netfa F, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5020058; Salad J, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0198-3; Singh R., 2020, ARXIV PREPRINT ARXIV; Statens Serum Institut, 2020, DAN CHILDH VACC PROG; Statistic Denmark, 2021, POPULATION; Suppli CH, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6268-x; Suppli Camilla Hiul, 2018, Prev Med Rep, V10, P93, DOI 10.1016/j.pmedr.2018.02.005; Thamsborg LH, 2018, INT J CANCER, V143, P1662, DOI 10.1002/ijc.31568; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; Walling EB, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3863; Wang JR, 2019, PREV MED, V120, P26, DOI 10.1016/j.ypmed.2018.12.014; Wilson L, 2018, VACCINE, V36, P1055, DOI 10.1016/j.vaccine.2018.01.025; Zeraiq L, 2015, SCAND J PUBLIC HEALT, V43, P408, DOI 10.1177/1403494815569105	48	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0250816	10.1371/journal.pone.0250816	http://dx.doi.org/10.1371/journal.pone.0250816			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SL3JC	34061863	gold, Green Published			2022-12-26	WOS:000656813600027
J	Brewster, JL; Pachl, P; McKellar, JLO; Selmer, M; Squire, CJ; Patrick, WM				Brewster, Jodi L.; Pachl, Petr; McKellar, James L. O.; Selmer, Maria; Squire, Christopher J.; Patrick, Wayne M.			Structures and kinetics of Thermotoga maritima MetY reveal new insights into the predominant sulfurylation enzyme of bacterial methionine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE GAMMA-SYNTHASE; O-ACETYLHOMOSERINE SULFHYDRYLASE; L-HOMOSERINE SULFHYDRYLASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PARTIAL-PURIFICATION; BETA-LYASE; HOMOCYSTEINE; METABOLISM; SOFTWARE	Bacterial methionine biosynthesis can take place by either the trans-sulfurylation route or direct sulfurylation. The enzymes responsible for trans-sulfurylation have been characterized extensively because they occur in model organisms such as Escherichia coli. However, direct sulfurylation is actually the predominant route for methionine biosynthesis across the phylogenetic tree. In this pathway, most bacteria use an Oacetylhomo-serine aminocarboxypropyltransferase (MetY) to catalyze the formation of homocysteine from O-acetylhomoserine and bisulfide. Despite the widespread distribution of MetY, this pyridoxal 50-phosphate-dependent enzyme remains comparatively understudied. To address this knowledge gap, we have characterized the MetY from Thermotoga maritima (TmMetY). At its optimal temperature of 70 degrees C, TmMetY has a turnover number (apparent k(cat) = 900 s(-1)) that is 10- to 700-fold higher than the three other MetY enzymes for which data are available. We also present crystal structures of TmMetY in the internal aldimine form and, fortuitously, with a beta,gamma-unsaturated ketimine reaction intermediate. This intermediate is identical to that found in the catalytic cycle of cystathionine.-synthase (MetB), which is a homologous enzyme from the trans-sulfurylation pathway. By comparing the TmMetY and MetB structures, we have identified Arg270 as a critical determinant of specificity. It helps to wall off the active site of TmMetY, disfavoring the binding of the first MetB substrate, O-succinylhomoserine. It also ensures a strict specificity for bisulfide as the second substrate of MetY by occluding the larger MetB substrate, cysteine. Overall, this work illuminates the subtle structural mechanisms by which homologous pyridoxal 50-phosphate-dependent enzymes can effect different catalytic, and therefore metabolic, outcomes.	[Brewster, Jodi L.; McKellar, James L. O.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Pachl, Petr] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Squire, Christopher J.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Patrick, Wayne M.] Victoria Univ Wellington, Ctr Biodiscovery, Sch Biol Sci, Wellington, New Zealand; [Brewster, Jodi L.] Univ Wollongong, Sch Chem & Mol Biosci, Wollongong, NSW 2522, Australia	University of Otago; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Uppsala University; University of Auckland; Victoria University Wellington; University of Wollongong	Patrick, WM (corresponding author), Victoria Univ Wellington, Ctr Biodiscovery, Sch Biol Sci, Wellington, New Zealand.	wayne.patrick@vuw.ac.nz	Pachl, Petr/H-1344-2014; Brewster, Jodi/AAP-6952-2021	Pachl, Petr/0000-0001-9215-9817; Brewster, Jodi/0000-0001-8569-1813; Selmer, Maria/0000-0001-9079-2774	Marsden Fund [18-VUW-050]; Rutherford Discovery Fellowship	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Rutherford Discovery Fellowship	This work was supported by a grant from the Marsden Fund (18-VUW-050) and the award of a Rutherford Discovery Fellowship, both to W. M. P.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aitken SM, 2005, ARCH BIOCHEM BIOPHYS, V433, P166, DOI 10.1016/j.abb.2004.08.024; Aitken SM, 2003, BIOCHEMISTRY-US, V42, P11297, DOI 10.1021/bi035107o; Aitken SM, 2011, BBA-PROTEINS PROTEOM, V1814, P1511, DOI 10.1016/j.bbapap.2011.03.006; Aledo JC, 2019, PROTEIN SCI, V28, P1785, DOI 10.1002/pro.3698; Bastard K, 2017, NAT CHEM BIOL, V13, P858, DOI 10.1038/nchembio.2397; Berney M, 2015, P NATL ACAD SCI USA, V112, P10008, DOI 10.1073/pnas.1513033112; BRZOVIC P, 1990, BIOCHEMISTRY-US, V29, P442, DOI 10.1021/bi00454a020; Chaton CT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56722-2; Choi CK, 2005, SEP SCI TECHNOL-SER, V6, P123; Clausen T, 1998, EMBO J, V17, P6827, DOI 10.1093/emboj/17.23.6827; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; Davidi D, 2020, EMBO J, V39, DOI 10.15252/embj.2019104081; Dou C, 2005, CLIN CHEM, V51, P1987, DOI 10.1373/clinchem.2005.053421; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferla MP, 2017, MOL MICROBIOL, V105, P508, DOI 10.1111/mmi.13737; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; Frick B, 2003, CLIN CHIM ACTA, V331, P19, DOI 10.1016/S0009-8981(03)00076-7; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giardina G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11948-w; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Goudarzi M, 2006, EXTREMOPHILES, V10, P469, DOI 10.1007/s00792-006-0522-3; Hacham Y, 2003, MOL BIOL EVOL, V20, P1513, DOI 10.1093/molbev/msg169; Hesse H, 2004, J EXP BOT, V55, P1799, DOI 10.1093/jxb/erh139; Ngo HPT, 2012, ACTA CRYSTALLOGR F, V68, P1515, DOI 10.1107/S1744309112042819; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Hwang BJ, 2007, J MICROBIOL BIOTECHN, V17, P1010; Imagawa T., 2005, PDB ID 2CTZ CRYSTAL; Imagawa T., 2007, PDB ID 2CB1 CRYSTAL; Iwama T, 2004, BIOSCI BIOTECH BIOCH, V68, P1357, DOI 10.1271/bbb.68.1357; Jeske L, 2019, NUCLEIC ACIDS RES, V47, pD542, DOI 10.1093/nar/gky1048; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAPLAN MM, 1966, J BIOL CHEM, V241, P5781; KERR DS, 1971, J BIOL CHEM, V246, P95; Kulikova V. V., 2021, PROTEIN EXPRES PURIF, V180; Kulikova VV, 2019, IUBMB LIFE, V71, P1815, DOI 10.1002/iub.2139; Kusmierek K, 2009, J CHROMATOGR B, V877, P3300, DOI 10.1016/j.jchromb.2009.03.038; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Liang J, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00004; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Messerschmidt A, 2003, BIOL CHEM, V384, P373, DOI 10.1515/BC.2003.043; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Ngo H. P. T., 2020, PDB ID 6LD8 CRYSTAL, DOI [10.2210/pdb2216LD2218/pdb, DOI 10.2210/PDB2216LD2218/PDB]; Omura H, 2003, J BIOSCI BIOENG, V96, P53, DOI 10.1016/S1389-1723(03)90096-X; OZAKI H, 1982, J BIOCHEM-TOKYO, V91, P1163, DOI 10.1093/oxfordjournals.jbchem.a133799; Raboni S, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P273; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Richard JP, 2009, CURR OPIN CHEM BIOL, V13, P475, DOI 10.1016/j.cbpa.2009.06.023; ROWBURY RJ, 1964, J GEN MICROBIOL, V36, P341, DOI 10.1099/00221287-36-3-341; ROWBURY RJ, 1964, NATURE, V203, P977, DOI 10.1038/203977a0; Savchenko A., 2014, PDB ID 4OC9 235 RESO; Shimizu H, 2001, BBA-PROTEIN STRUCT M, V1549, P61, DOI 10.1016/S0167-4838(01)00245-X; SMITH DA, 1966, HEREDITY, V21, P265, DOI 10.1038/hdy.1966.22; Soo VWC, 2016, J BIOL CHEM, V291, P19873, DOI 10.1074/jbc.M116.739557; Tawfik DS, 2016, CURR OPIN CHEM BIOL, V31, pV, DOI 10.1016/j.cbpa.2016.03.002; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; Tran TH, 2011, ACTA CRYSTALLOGR D, V67, P831, DOI 10.1107/S0907444911028010; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu YP, 2018, BIOCHEMISTRY-US, V57, P3134, DOI 10.1021/acs.biochem.8b00092; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Vickers CJ, 2021, PROTEIN SCI, V30, P914, DOI 10.1002/pro.4041; Wang ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046463; YAMAGATA S, 1984, J BIOCHEM, V96, P1511, DOI 10.1093/oxfordjournals.jbchem.a134980; YAMAGATA S, 1971, J BIOCHEM-TOKYO, V70, P1035, DOI 10.1093/oxfordjournals.jbchem.a129712; Zierenberg RA, 2000, P NATL ACAD SCI USA, V97, P12961, DOI 10.1073/pnas.210395997	71	1	1	5	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100797	10.1016/j.jbc.2021.100797	http://dx.doi.org/10.1016/j.jbc.2021.100797			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019879	gold, Green Published			2022-12-26	WOS:000674717300017
J	Ji, JJ; Chao, NP; Wei, ST; Barnett, GA				Ji, Jiaojiao; Chao, Naipeng; Wei, Shitong; Barnett, George A.			Microblog credibility indicators regarding misinformation of genetically modified food on Weibo	PLOS ONE			English	Article							SOCIAL NETWORK; RUMOR; INFORMATION; MEDIA; SCIENCE; NEWS	The considerable amount of misinformation on social media regarding genetically modified (GM) food will not only hinder public understanding but also mislead the public to make unreasoned decisions. This study discovered a new mechanism of misinformation diffusion in the case of GM food and applied a framework of supervised machine learning to identify effective credibility indicators for the misinformation prediction of GM food. Main indicators are proposed, including user identities involved in spreading information, linguistic styles, and propagation dynamics. Results show that linguistic styles, including sentiment and topics, have the dominant predictive power. In addition, among the user identities, engagement, and extroversion are effective predictors, while reputation has almost no predictive power in this study. Finally, we provide strategies that readers should be aware of when assessing the credibility of online posts and suggest improvements that Weibo can use to avoid rumormongering and enhance the science communication of GM food.	[Ji, Jiaojiao] Univ Sci & Technol China, Dept Sci & Technol Commun, Hefei, Anhui, Peoples R China; [Chao, Naipeng] Shenzhen Univ, Sch Commun, Shenzhen, Guangdong, Peoples R China; [Wei, Shitong] Univ Calif Davis, Dept Stat, Davis, CA USA; [Barnett, George A.] Univ Calif Davis, Dept Commun, Davis, CA USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Shenzhen University; University of California System; University of California Davis; University of California System; University of California Davis	Ji, JJ (corresponding author), Univ Sci & Technol China, Dept Sci & Technol Commun, Hefei, Anhui, Peoples R China.	jjj@ustc.edu.cn		JI, JIAOJIAO/0000-0003-1571-6135	National Social Science Foundation of China [18CXW027]; Major Program of National Fund of Philosophy and Social Science of China [19ZDA324]	National Social Science Foundation of China; Major Program of National Fund of Philosophy and Social Science of China	JJ received a National Social Science Foundation of China(18CXW027), and CN received a Major Program of National Fund of Philosophy and Social Science of China(19ZDA324). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abma BJM., 2009, THESIS U TWENTE; ALLPORT GW, 1947, PSYCHOL REV, V54, P182, DOI 10.1037/h0059200; Armstrong CL, 2009, J COMPUT-MEDIAT COMM, V14, P435, DOI 10.1111/j.1083-6101.2009.01448.x; Blei DM, 2012, COMMUN ACM, V55, P77, DOI 10.1145/2133806.2133826; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bordia P, 1998, HUM COMMUN RES, V25, P163, DOI 10.1111/j.1468-2958.1998.tb00441.x; Bordia P., 2005, RUMOR MILLSOCIAL I, P87; Bordia P., 2007, RUMOR PSYCHOL SOCIAL; Brossard D, 2013, P NATL ACAD SCI USA, V110, P14096, DOI 10.1073/pnas.1212744110; Castillo C., 2011, P 20 INT C WORLD WID, P675, DOI [DOI 10.1145/1963405.1963500, 10.1145/1963405.1963500]; Chen X., 2013, P ASS INF SCI TECHNO, V50, P1, DOI [10.1002/meet.14505001102, DOI 10.1002/MEET.14505001102]; Cui K, 2018, NPJ SCI FOOD, V2, DOI 10.1038/s41538-018-0018-4; Dang A, 2019, PROCEEDINGS OF THE 52ND ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, P2355; Fernbach PM, 2019, NAT HUM BEHAV, V3, P251, DOI 10.1038/s41562-018-0520-3; Gaskell G, 2013, SUCCESSFUL AGR INNOV, P331; Greenhill KM, 2017, INT STUD QUART, V61, P660, DOI 10.1093/isq/sqx015; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Ji JJ, 2019, TELEMAT INFORM, V37, P1, DOI 10.1016/j.tele.2019.01.005; Juvonen J, 2013, J YOUTH ADOLESCENCE, V42, P1801, DOI 10.1007/s10964-012-9894-0; KARLOVA Natascha A., 2013, INFORM RES, V18; Kwon S, 2013, IEEE DATA MINING, P1103, DOI 10.1109/ICDM.2013.61; Lang JT, 2005, RISK ANAL, V25, P1241, DOI 10.1111/j.1539-6924.2005.00668.x; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Liang G, 2015, IEEE TRANS COMPUT SO, V2, P99, DOI 10.1109/TCSS.2016.2517458; Liang Wu, 2019, ACM SIGKDD Explorations Newsletter, V21, P80, DOI 10.1145/3373464.3373475; Ma J., 2015, P 24 ACM INT C INF K, P1751; McGlynn J., 2020, HARVARD KENNEDY SCH, P1; Metzger MJ, 2007, J AM SOC INF SCI TEC, V58, P2078, DOI 10.1002/asi.20672; Metzger MJ, 2010, J COMMUN, V60, P413, DOI 10.1111/j.1460-2466.2010.01488.x; Microsoft, 2015, MICR AZ MACH LEARN S; Morris M.R., 2012, P ACM 2012 C COMP SU, P441, DOI [10.1145/, DOI 10.1145/2145204.2145274]; Newman David, 2010, HUMAN LANGUAGE TECHN, P100, DOI DOI 10.5555/1857999.1858011; ROSNOW RL, 1991, AM PSYCHOL, V46, P484, DOI 10.1037/0003-066X.46.5.484; Ruths D, 2014, SCIENCE, V346, P1063, DOI 10.1126/science.346.6213.1063; Scheufele DA, 2019, P NATL ACAD SCI USA, V116, P7662, DOI 10.1073/pnas.1805871115; Shao CC, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16 COMPANION), P745, DOI 10.1145/2872518.2890098; Shin J, 2017, NEW MEDIA SOC, V19, P1214, DOI 10.1177/1461444816634054; Stevens LE, 1995, SOC COGNITION, V13, P189, DOI 10.1521/soco.1995.13.3.189; Viviani M, 2017, WIRES DATA MIN KNOWL, V7, DOI 10.1002/widm.1209; Vosoughi S., 2015, AUTOMATIC DETECTION; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Westerman D, 2012, COMPUT HUM BEHAV, V28, P199, DOI 10.1016/j.chb.2011.09.001; Wu L., 2016, BIG DATA COMPLEX SOC, P125; Yang YK, 2015, INT JOINT CONF COMP, P41, DOI 10.1109/JCSSE.2015.7219767; Zhang CW, 2019, EUR J OPER RES, V279, P1036, DOI 10.1016/j.ejor.2019.06.022; Zhang XC, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2019.03.004; Zollo F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138740; Zubiaga A, 2018, ACM COMPUT SURV, V51, DOI 10.1145/3161603; Zubiaga A, 2018, INFORM PROCESS MANAG, V54, P273, DOI 10.1016/j.ipm.2017.11.009	52	1	1	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	6							e0252392	10.1371/journal.pone.0252392	http://dx.doi.org/10.1371/journal.pone.0252392			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SL3JC	34061876	Green Published, gold			2022-12-26	WOS:000656813600046
